{"TNFSF13": {"27336026": {"pubYear": "2015", "dateOfCreation": "2016-06-23", "pubModel": "Electronic-eCollection", "authorString": "Joshi D, Catts VS, Olaya JC, Shannon Weickert C.", "affiliation": "Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27336026", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Joshi D", "initials": "D", "firstName": "Dipesh", "lastName": "Joshi"}, {"affiliation": "Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Catts VS", "initials": "VS", "firstName": "Vibeke S", "lastName": "Catts"}, {"affiliation": "Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Olaya JC", "initials": "JC", "firstName": "Juan C", "lastName": "Olaya"}, {"affiliation": "Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Shannon Weickert C", "initials": "C", "firstName": "Cynthia", "lastName": "Shannon Weickert"}]}, "title": "Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27336026", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-03-04", "language": "eng", "doi": "10.1038/npjschz.2014.4", "isOpenAccess": "Y", "pageInfo": "14004", "pmcid": "PMC4849439", "hasDbCrossReferences": "N", "abstractText": "Recently, we provided evidence showing reductions in GAD67 and Dlx mRNAs in the orbital frontal cortex (OFC) in schizophrenia. It is unknown whether these reductions relate mainly to somatostatin (SST) or parvalbumin (PV) mRNA expression changes, and/or whether these reductions are related to decreased SST mRNA+ interneuron density.To determine whether inhibitory interneuron deficits in the OFC from people with schizophrenia are greatest for SST or PV mRNAs, and whether any such deficits relate to mRNAs encoding cell death signalling molecules.Inhibitory interneuron mRNAs (SST; PV: in situ hybridization, quantitative PCR (qPCR)) and death signaling mRNAs [FAS receptor (FASR); TNFSF13: qPCR] were measured in control and schizophrenia subjects (38/38). SST mRNA+ interneuron-like cells were quantified in layer II in the gyrus rectus. Gray matter SST and PV mRNAs were correlated with interstitial white matter neuron (IWMN) density (GAD65/67; NeuN) and death signaling mRNAs.SST mRNA was reduced in OFC layers I-VI in schizophrenia (both in situ and qPCR), with greatest deficit in layer II (67%). Layer II SST mRNA+ neuron density was reduced in schizophrenia (~29%). PV mRNA was reduced in layers III (18%) and IV (31%) with no significant diagnostic difference in PV mRNA measured by qPCR. FASR mRNA was increased in schizophrenia (34%). SST, but not PV, expression correlated negatively with FASR and TNFSF13 expressions and with IWMN density.Our study demonstrates that SST interneurons are predominantly linked to the inhibitory interneuron pathology in the OFC in schizophrenia and that increased death receptor signaling mRNAs relate to prominent laminar deficits in SST mRNA in the OFC in schizophrenia. We suggest that SST interneurons may be more vulnerable to increased death receptor signaling than PV interneurons.", "electronicPublicationDate": "2015-03-04", "license": "cc by-nc-sa", "dateOfCompletion": "2016-06-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4849439?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4849439", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/npjschz.2014.4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-06-29", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "NPJ schizophrenia", "medlineAbbreviation": "NPJ Schizophr", "isoabbreviation": "NPJ Schizophr", "nlmid": "101657919", "essn": "2334-265X"}, "monthOfPublication": 0, "volume": "1", "yearOfPublication": 2015, "journalIssueId": 2300275, "dateOfPublication": "2015"}}, "22545112": {"pubYear": "2012", "dateOfCreation": "2012-04-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "TNFSF13 protein, human"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Antigens, CD95"}, {"registryNumber": "0", "name": "Tumor Necrosis Factor Ligand Superfamily Member 13"}]}, "authorString": "Catts VS, Weickert CS.", "affiliation": "Schizophrenia Research Laboratory, Schizophrenia Research Institute, Sydney, New South Wales, Australia. v.catts@NeuRA.edu.au", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R24AA012725"}]}, "hasPDF": "Y", "id": "22545112", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Catts", "fullName": "Catts VS", "firstName": "Vibeke S\u00f8rensen", "initials": "VS"}, {"lastName": "Weickert", "fullName": "Weickert CS", "firstName": "Cynthia Shannon", "initials": "CS"}]}, "title": "Gene expression analysis implicates a death receptor pathway in schizophrenia pathology.", "hasSuppl": "Y", "citedByCount": 11, "source": "MED", "pmid": "22545112", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, CD95", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Necrosis Factor Ligand Superfamily Member 13", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Real-Time Polymerase Chain Reaction", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-04-24", "doi": "10.1371/journal.pone.0035511", "isOpenAccess": "Y", "pageInfo": "e35511", "pmcid": "PMC3335850", "hasDbCrossReferences": "N", "abstractText": "An increase in apoptotic events may underlie neuropathology in schizophrenia. By data-mining approaches, we identified significant expression changes in death receptor signaling pathways in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, particularly implicating the Tumor Necrosis Factor Superfamily member 6 (FAS) receptor and the Tumor Necrosis Factor [ligand] Superfamily member 13 (TNFSF13) in schizophrenia. We sought to confirm and replicate in an independent tissue collection the noted mRNA changes with quantitative real-time RT-PCR. To test for regional and diagnostic specificity, tissue from orbital frontal cortex (OFC) was examined and a bipolar disorder group included. In schizophrenia, we confirmed and replicated significantly increased expression of TNFSF13 mRNA in the DLPFC. Also, a significantly larger proportion of subjects in the schizophrenia group had elevated FAS receptor expression in the DLPFC relative to unaffected controls. These changes were not observed in the bipolar disorder group. In the OFC, there were no significant differences in TNFSF13 or FAS receptor mRNA expression. Decreases in BH3 interacting domain death agonist (BID) mRNA transcript levels were found in the schizophrenia and bipolar disorder groups affecting both the DLPFC and the OFC. We tested if TNFSF13 mRNA expression correlated with neuronal mRNAs in the DLPFC, and found significant negative correlations with interneuron markers, parvalbumin and somatostatin, and a positive correlation with PPP1R9B (spinophilin), but not DLG4 (PSD-95). The expression of TNFSF13 mRNA in DLPFC correlated negatively with tissue pH, but decreasing pH in cultured cells did not cause increased TNFSF13 mRNA nor did exogenous TNFSF13 decrease pH. We concluded that increased TNFSF13 expression may be one of several cell-death cytokine abnormalities that contribute to the observed brain pathology in schizophrenia, and while increased TNFSF13 may be associated with lower brain pH, the change is not necessarily causally related to brain pH.", "electronicPublicationDate": "2012-04-24", "language": "eng", "dateOfCompletion": "2012-08-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3335850?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3335850", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22545112", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22545112&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0035511", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-25", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1920705, "issue": "4", "dateOfPublication": "2012 "}}, "17212772": {"pubYear": "2007", "dateOfCreation": "2007-01-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "PDS5B protein, human"}]}, "authorString": "Thangarajh M, Masterman T, Hillert J, Moerk S, Jonsson R.", "affiliation": "Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway. mathula.thangarajh@ki.se", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17212772", "inEPMC": "N", "authorList": {"author": [{"lastName": "Thangarajh", "fullName": "Thangarajh M", "initials": "M"}, {"lastName": "Masterman", "fullName": "Masterman T", "initials": "T"}, {"lastName": "Hillert", "fullName": "Hillert J", "initials": "J"}, {"lastName": "Moerk", "fullName": "Moerk S", "initials": "S"}, {"lastName": "Jonsson", "fullName": "Jonsson R", "initials": "R"}]}, "title": "A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis.", "citedByCount": 23, "source": "MED", "pmid": "17212772", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Astrocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "B-Lymphocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glioblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Brain Chemistry", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-01-01", "doi": "10.1111/j.1365-3083.2006.01867.x", "isOpenAccess": "N", "pageInfo": "92-98", "hasDbCrossReferences": "N", "abstractText": "A proliferation-inducing ligand (APRIL) is a newly described member of the tumour necrosis factor (TNF) superfamily that was first identified as a factor favouring tumorigenesis. APRIL is also important for several immune functions, including B-cell survival. Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) that is commonly diagnosed in early adulthood. Several TNF superfamily members have been identified in brains of patients with MS, although their exact function within the CNS is presently unknown. To investigate whether APRIL is expressed in the CNS, we studied APRIL protein expression by immunohistochemistry in MS patients and controls. Morphologically, APRIL-positive cells appeared to be astrocytes. A two-colour immunohistochemistry revealed that APRIL expression was cytoplasmic, granular and restricted to GFAP-positive cells. Conversely, HLA class II-positive microglial cells were negative for APRIL expression. APRIL-positive cells were fewer in brains of controls compared with those with MS. We further corroborated our findings by studying APRIL protein expression in several glioblastoma cell lines, and found APRIL to be expressed by most cell lines analysed. APRIL's binding partner syndecan-1 (CD138) was detected in brains of neither MS nor control patients. Furthermore, B cells were detectable in the brain of one of five patients with MS. We conclude that APRIL is expressed by reactive astrocytes in MS and may be of relevance in gliotic scar formation.", "language": "eng", "dateOfCompletion": "2007-02-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1365-3083.2006.01867.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2008-05-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-01-01", "journal": {"medlineAbbreviation": "Scand J Immunol", "isoabbreviation": "Scand. J. Immunol.", "title": "Scandinavian journal of immunology", "issn": "0300-9475", "nlmid": "0323767", "essn": "1365-3083"}, "monthOfPublication": 1, "volume": "65", "yearOfPublication": 2007, "journalIssueId": 1371525, "issue": "1", "dateOfPublication": "2007 Jan"}}}, "EPHX1": {"23426996": {"pubYear": "2013", "dateOfCreation": "2013-02-21", "pubModel": "Print-Electronic", "authorString": "Li H, Fu WP, Hong ZH.", "affiliation": "Department of Genetics and Developmental Biology, Southeast University School of Medicine; Nanjing 210009; ; The Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University, Nanjing 210009;", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23426996", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Genetics and Developmental Biology, Southeast University School of Medicine; Nanjing 210009; ; The Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University, Nanjing 210009;", "fullName": "Li H", "initials": "H", "firstName": "Hui", "lastName": "Li"}, {"lastName": "Fu", "fullName": "Fu WP", "firstName": "Wei-Ping", "initials": "WP"}, {"lastName": "Hong", "fullName": "Hong ZH", "firstName": "Ze-Hui", "initials": "ZH"}]}, "title": "Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "23426996", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-12-28", "language": "eng", "doi": "10.3892/ol.2012.1099", "isOpenAccess": "Y", "pageInfo": "1022-1030", "pmcid": "PMC3576314", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Polymorphism", "Meta-analysis", "chronic obstructive pulmonary disease", "Microsomal Epoxide Hydrolase Gene"]}, "abstractText": "Microsomal epoxide hydrolase (EPHX1) is an enzyme involved in the detoxification the products of smoking and is proposed to be a genetic factor for the development of chronic obstructive pulmonary disease (COPD). Two functional polymorphisms of EPHX1, T113C and A139G, have been analyzed in numerous studies to assess the COPD risk attributed to these variants. However, the conclusions were controversial. We performed a comprehensive meta-analysis to clarify these findings. A total of 24 studies comprising 8,259 COPD patients and 42,883 controls were included. The overall results showed that the EPHX1 113 mutant homozygote was significantly associated with an increased risk of COPD (OR, 1.33; 95% CI, 1.06-1.69). The subgroup analyses demonstrated this association in Caucasian individuals (OR, 1.61; 95% CI, 1.12-2.31) but not in Asian individuals. The 139 mutant heterozygote was significantly associated with a decreased risk of COPD in Asian populations (OR, 0.82; 95% CI, 0.68-0.99) but not in Caucasian populations. Pooled analyses revealed that the extremely slow (OR, 1.77; 95% CI, 1.23-2.55) and slow EPHX1 enzyme activity (OR, 1.44; 95% CI, 1.13-1.85) were associated with an increased risk of COPD, while the fast enzyme activity was not associated with a decreased risk of COPD. The stratified analysis demonstrated this association in Caucasian but not in Asian individuals. Furthermore, a modest difference in the risk of COPD was observed between the subgroups by using the cigarette smokers or the non-smokers as controls. A significant correlation between the two functional polymorphisms, T113C and A139G, of the EPHX1 gene and the enzyme activity and the individual's susceptibility to COPD was noted. In addition, the results supported a contribution of EPHX1 to the aetiology of COPD.", "electronicPublicationDate": "2012-12-28", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3576314?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3576314", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3892/ol.2012.1099", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-03-01", "journal": {"medlineAbbreviation": "Oncol Lett", "isoabbreviation": "Oncol Lett", "title": "Oncology letters", "issn": "1792-1074", "nlmid": "101531236", "essn": "1792-1082"}, "monthOfPublication": 3, "volume": "5", "yearOfPublication": 2013, "journalIssueId": 2012934, "issue": "3", "dateOfPublication": "2013 Mar"}}, "20886582": "", "16926176": "", "19841609": "", "11124296": "", "22738861": {"pubYear": "2012", "dateOfCreation": "2012-11-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.8.1", "name": "PON1 protein, human"}, {"registryNumber": "61-90-5", "name": "Leucine"}, {"registryNumber": "74-79-3", "name": "Arginine"}, {"registryNumber": "63-68-3", "name": "Methionine"}, {"registryNumber": "7004-03-7", "name": "Valine"}, {"registryNumber": "71-00-1", "name": "Histidine"}, {"registryNumber": "147-85-3", "name": "Proline"}, {"registryNumber": "56-45-1", "name": "Serine"}, {"registryNumber": "EC 2.1.1.6", "name": "Catechol O-Methyltransferase"}, {"registryNumber": "EC 3.1.8.1", "name": "Aryldialkylphosphatase"}, {"registryNumber": "EC 1.6.5.2", "name": "NAD(P)H Dehydrogenase (Quinone)"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}, {"registryNumber": "EC 1.6.5.2", "name": "NQO1 protein, human"}]}, "authorString": "Bauer M, Gr\u00e4bsch C, Schlink U, Klopp N, Illig T, Kr\u00e4mer U, von Berg A, Schaaf B, Borte M, Heinrich J, Herbarth O, Lehmann I, R\u00f6der S, LISAplus Study Group.", "affiliation": "UFZ-Helmholtz Centre for Environmental Research, Department of Environmental Immunology, Leipzig, Germany. mario.bauer@ufz.de", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "22738861", "inEPMC": "N", "authorList": {"author": [{"lastName": "Bauer", "fullName": "Bauer M", "firstName": "Mario", "initials": "M"}, {"lastName": "Gr\u00e4bsch", "fullName": "Gr\u00e4bsch C", "firstName": "Carolin", "initials": "C"}, {"lastName": "Schlink", "fullName": "Schlink U", "authorId": {"type": "ORCID", "value": "0000-0002-3109-9459"}, "firstName": "Uwe", "initials": "U"}, {"lastName": "Klopp", "fullName": "Klopp N", "firstName": "Norman", "initials": "N"}, {"lastName": "Illig", "fullName": "Illig T", "firstName": "Thomas", "initials": "T"}, {"lastName": "Kr\u00e4mer", "fullName": "Kr\u00e4mer U", "firstName": "Ursula", "initials": "U"}, {"lastName": "von Berg", "fullName": "von Berg A", "firstName": "Andrea", "initials": "A"}, {"lastName": "Schaaf", "fullName": "Schaaf B", "firstName": "Beate", "initials": "B"}, {"lastName": "Borte", "fullName": "Borte M", "firstName": "Michael", "initials": "M"}, {"lastName": "Heinrich", "fullName": "Heinrich J", "firstName": "Joachim", "initials": "J"}, {"lastName": "Herbarth", "fullName": "Herbarth O", "firstName": "Olf", "initials": "O"}, {"lastName": "Lehmann", "fullName": "Lehmann I", "firstName": "Irina", "initials": "I"}, {"lastName": "R\u00f6der", "fullName": "R\u00f6der S", "firstName": "Stefan", "initials": "S"}, {"collectiveName": "LISAplus Study Group"}]}, "title": "Genetic association between obstructive bronchitis and enzymes of oxidative stress.", "citedByCount": 1, "source": "MED", "pmid": "22738861", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3109-9459"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Bronchitis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lung Diseases, Obstructive", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pregnancy Complications", "majorTopic_YN": "N"}, {"descriptorName": "Prenatal Exposure Delayed Effects", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aryldialkylphosphatase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "NAD(P)H Dehydrogenase (Quinone)", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Catechol O-Methyltransferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Arginine", "majorTopic_YN": "N"}, {"descriptorName": "Leucine", "majorTopic_YN": "N"}, {"descriptorName": "Valine", "majorTopic_YN": "N"}, {"descriptorName": "Histidine", "majorTopic_YN": "N"}, {"descriptorName": "Proline", "majorTopic_YN": "N"}, {"descriptorName": "Methionine", "majorTopic_YN": "N"}, {"descriptorName": "Serine", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Chi-Square Distribution", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "Y"}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Germany", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Gene-Environment Interaction", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-26", "doi": "10.1016/j.metabol.2012.05.013", "isOpenAccess": "N", "pageInfo": "1771-1779", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVE: Obstructive respiratory diseases, mainly the chronic obstructive pulmonary disease (COPD) and asthma, are associated with functional polymorphisms of xenobiotic-metabolizing enzymes (XMEs). To date, association for obstructive bronchitis has not been described. MATERIAL/METHODS: In this study, we investigated the genotypes from 26 functional polymorphisms of 20 XMEs in children (n, 1028) at the age of 6 years from the German prospective birth cohort study (LISAplus) and analyzed the associations between genotypes and obstructive bronchitis. RESULTS: For the first time, we found noteworthy gene-disease associations for the functional PON1 M55L and EPHX1 H139R polymorphisms and gene-environment associations for the functional COMT V158M and NQO1 P187S polymorphisms after stratification for maternal active smoking behaviour during pregnancy. The noteworthy associations were substantiated by the biological findings that all the risk genotypes belong to genes involved in oxidative stress and code for proteins with a fast enzymatic activity or concomitantly appear in common estrogene-metabolizing pathway (COMT, NQO1). CONCLUSION: The oxidative stress has to be taken into account in mechanism of the obstructive bronchitis in early childhood. The risk genotypes may serve as risk factors for respiratory obstruction rather than for signs of COPD or asthma.", "electronicPublicationDate": "2012-06-26", "language": "eng", "dateOfCompletion": "2013-01-23", "investigatorList": {"investigator": [{"lastName": "Beckmann", "fullName": "Beckmann C", "firstName": "C", "initials": "C"}, {"lastName": "Klyucheva", "fullName": "Klyucheva M", "firstName": "M", "initials": "M"}, {"lastName": "Gro\u00df", "fullName": "Gro\u00df I", "firstName": "I", "initials": "I"}, {"lastName": "Sugiri", "fullName": "Sugiri D", "firstName": "D", "initials": "D"}, {"lastName": "Link", "fullName": "Link E", "firstName": "E", "initials": "E"}, {"lastName": "Cramer", "fullName": "Cramer C", "firstName": "C", "initials": "C"}, {"lastName": "Schins", "fullName": "Schins R", "firstName": "R", "initials": "R"}, {"lastName": "Wichmann", "fullName": "Wichmann E", "firstName": "E", "initials": "E"}, {"lastName": "Gillig", "fullName": "Gillig G", "firstName": "G", "initials": "G"}, {"lastName": "Br\u00fcske", "fullName": "Br\u00fcske I", "firstName": "I", "initials": "I"}, {"lastName": "Sausenthaler", "fullName": "Sausenthaler S", "firstName": "S", "initials": "S"}, {"lastName": "Rzehak", "fullName": "Rzehak P", "firstName": "P", "initials": "P"}, {"lastName": "Schnappinger", "fullName": "Schnappinger M", "firstName": "M", "initials": "M"}, {"lastName": "Schneller", "fullName": "Schneller H", "firstName": "H", "initials": "H"}, {"lastName": "Schnabel", "fullName": "Schnabel E", "firstName": "E", "initials": "E"}, {"lastName": "Lohr", "fullName": "Lohr W", "firstName": "W", "initials": "W"}, {"lastName": "Standl", "fullName": "Standl M", "firstName": "M", "initials": "M"}, {"lastName": "Kohlbock", "fullName": "Kohlbock G", "firstName": "G", "initials": "G"}, {"lastName": "Bauer", "fullName": "Bauer CP", "firstName": "C P", "initials": "CP"}, {"lastName": "Gr\u00fcbl", "fullName": "Gr\u00fcbl A", "firstName": "A", "initials": "A"}, {"lastName": "Hoffmann", "fullName": "Hoffmann U", "firstName": "U", "initials": "U"}, {"lastName": "Ring", "fullName": "Ring J", "firstName": "J", "initials": "J"}, {"lastName": "Weidinger", "fullName": "Weidinger S", "firstName": "S", "initials": "S"}, {"lastName": "Grosch", "fullName": "Grosch J", "firstName": "J", "initials": "J"}, {"lastName": "Martin", "fullName": "Martin F", "firstName": "F", "initials": "F"}, {"lastName": "Behrendt", "fullName": "Behrendt H", "firstName": "H", "initials": "H"}, {"lastName": "Herberth", "fullName": "Herberth G", "firstName": "G", "initials": "G"}, {"lastName": "Franck", "fullName": "Franck U", "firstName": "U", "initials": "U"}, {"lastName": "Nowak", "fullName": "Nowak M", "firstName": "M", "initials": "M"}, {"lastName": "Schilde", "fullName": "Schilde M", "firstName": "M", "initials": "M"}, {"lastName": "Rolle-Kampczyk", "fullName": "Rolle-Kampczyk U", "firstName": "U", "initials": "U"}, {"lastName": "Diez", "fullName": "Diez U", "firstName": "U", "initials": "U"}]}, "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.metabol.2012.05.013", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-12-01", "journal": {"medlineAbbreviation": "Metabolism", "isoabbreviation": "Metab. Clin. Exp.", "title": "Metabolism: clinical and experimental", "issn": "0026-0495", "nlmid": "0375267", "essn": "1532-8600"}, "monthOfPublication": 12, "volume": "61", "yearOfPublication": 2012, "journalIssueId": 1985642, "issue": "12", "dateOfPublication": "2012 Dec"}}, "22214149": "", "17885617": "", "15618730": "", "17380322": "", "26555147": {"pubYear": "2015", "dateOfCreation": "2015-11-11", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anticonvulsants"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}, {"registryNumber": "0", "name": "NAV1.1 Voltage-Gated Sodium Channel"}, {"registryNumber": "0", "name": "SCN1A protein, human"}, {"registryNumber": "33CM23913M", "name": "Carbamazepine"}]}, "authorString": "Daci A, Beretta G, Vllasaliu D, Shala A, Govori V, Norata GD, Krasniqi S.", "affiliation": "Department of Pharmacological and Biomolecular Sciences, Universit\u00e0 degli Studi di Milano, Milan, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26555147", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmacological and Biomolecular Sciences, Universit\u00e0 degli Studi di Milano, Milan, Italy.", "fullName": "Daci A", "initials": "A", "firstName": "Armond", "lastName": "Daci"}, {"affiliation": "Department of Pharmaceutical Sciences, Universit\u00e0 degli Studi di Milano, Milan, Italy.", "fullName": "Beretta G", "initials": "G", "firstName": "Giangiacomo", "lastName": "Beretta"}, {"firstName": "Driton", "lastName": "Vllasaliu", "affiliation": "University of Lincoln, School of Pharmacy, Joseph Banks Laboratories, Green Lane, Lincoln, LN6 7DL, United Kingdom.", "authorId": {"type": "ORCID", "value": "0000-0002-4379-6171"}, "fullName": "Vllasaliu D", "initials": "D"}, {"affiliation": "Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.", "fullName": "Shala A", "initials": "A", "firstName": "Aida", "lastName": "Shala"}, {"affiliation": "Neurology Clinic, University Clinical Center of Kosova, Prishtina, Kosovo.", "fullName": "Govori V", "initials": "V", "firstName": "Valbona", "lastName": "Govori"}, {"affiliation": "Center for the Study of Atherosclerosis, Ospedale Bassini, Cinisello Balsamo, Italy.", "fullName": "Norata GD", "initials": "GD", "firstName": "Giuseppe Danilo", "lastName": "Norata"}, {"affiliation": "Institute of Pharmacology and Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.", "fullName": "Krasniqi S", "initials": "S", "firstName": "Shaip", "lastName": "Krasniqi"}]}, "title": "Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26555147", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4379-6171"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carbamazepine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anticonvulsants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N"}, {"descriptorName": "Spectrophotometry, Ultraviolet", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Ethnic Groups", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Albania", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "NAV1.1 Voltage-Gated Sodium Channel", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-11-10", "language": "eng", "doi": "10.1371/journal.pone.0142408", "isOpenAccess": "Y", "pageInfo": "e0142408", "pmcid": "PMC4640545", "hasDbCrossReferences": "N", "abstractText": "The present study aimed to evaluate the effects of gene variants in key genes influencing pharmacokinetic and pharmacodynamic of carbamazepine (CBZ) on the response in patients with epilepsy.Five SNPs in two candidate genes influencing CBZ transport and metabolism, namely ABCB1 or EPHX1, and CBZ response SCN1A (sodium channel) were genotyped in 145 epileptic patients treated with CBZ as monotherapy and 100 age and sex matched healthy controls. Plasma concentrations of CBZ, carbamazepine-10,11-epoxide (CBZE) and carbamazepine-10,11-trans dihydrodiol (CBZD) were determined by HPLC-UV-DAD and adjusted for CBZ dosage/kg of body weight.The presence of the SCN1A IVS5-91G>A variant allele is associated with increased epilepsy susceptibility. Furthermore, carriers of the SCN1A IVS5-91G>A variant or of EPHX1 c.337T>C variant presented significantly lower levels of plasma CBZ compared to carriers of the common alleles (0.71 \u00b1 0.28 vs 1.11\u00b10.69 \u03bcg/mL per mg/Kg for SCN1A IVS5-91 AA vs GG and 0.76 \u00b1 0.16 vs 0.94 \u00b1 0.49 \u03bcg/mL per mg/Kg for EPHX1 c.337 CC vs TT; P<0.05 for both). Carriers of the EPHX1 c.416A>G showed a reduced microsomal epoxide hydrolase activity as reflected by a significantly decreased ratio of CBZD to CBZ (0.13 \u00b1 0.08 to 0.26 \u00b1 0.17, p<0.05) also of CBZD to CBZE (1.74 \u00b1 1.06 to 3.08 \u00b1 2.90; P<0.05) and CDRCBZD (0.13 \u00b1 0.08 vs 0.24 \u00b1 0.19 \u03bcg/mL per mg/Kg; P<0.05). ABCB1 3455C>T SNP and SCN1A 3148A>G variants were not associated with significant changes in CBZ pharmacokinetic. Patients resistant to CBZ treatment showed increased dosage of CBZ (657 \u00b1 285 vs 489 \u00b1 231 mg/day; P<0.001) but also increased plasma levels of CBZ (9.84 \u00b1 4.37 vs 7.41 \u00b1 3.43 \u03bcg/mL; P<0.001) compared to patients responsive to CBZ treatment. CBZ resistance was not related to any of the SNPs investigated.The SCN1A IVS5-91G>A SNP is associated with susceptibility to epilepsy. SNPs in EPHX1 gene are influencing CBZ metabolism and disposition. CBZ plasma levels are not an indicator of resistance to the therapy.", "electronicPublicationDate": "2015-11-10", "license": "cc by", "dateOfCompletion": "2016-06-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4640545?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4640545", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0142408", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-11-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2015, "journalIssueId": 2338480, "issue": "11", "dateOfPublication": "2015"}}, "17082176": "", "16614120": "", "27276192": {"pubYear": "2016", "dateOfCreation": "2016-06-09", "pubModel": "Print", "authorString": "Chbili C, Fathallah N, Laouani A, Nouira M, Hassine A, Ben Amor S, Ben Ammou S, Ben Salem C, Saguem S.", "affiliation": "a Metabolic Biophysics, Professional Toxicology and Applied Environmental Laboratory, Department of Biophysics, Medicine Faculty of Sousse , Sousse University , Sousse , Tunisia ;", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27276192", "inEPMC": "N", "authorList": {"author": [{"affiliation": "a Metabolic Biophysics, Professional Toxicology and Applied Environmental Laboratory, Department of Biophysics, Medicine Faculty of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Chbili C", "initials": "C", "firstName": "Chahra", "lastName": "Chbili"}, {"affiliation": "b Department of Pharmacovigilance, Faculty of Medicine of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Fathallah N", "initials": "N", "firstName": "Neila", "lastName": "Fathallah"}, {"affiliation": "a Metabolic Biophysics, Professional Toxicology and Applied Environmental Laboratory, Department of Biophysics, Medicine Faculty of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Laouani A", "initials": "A", "firstName": "Aicha", "lastName": "Laouani"}, {"affiliation": "a Metabolic Biophysics, Professional Toxicology and Applied Environmental Laboratory, Department of Biophysics, Medicine Faculty of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Nouira M", "initials": "M", "firstName": "Manel", "lastName": "Nouira"}, {"affiliation": "c Neurology Department , Central Hospital University (CHU), Sousse University , Sousse , Tunisia.", "fullName": "Hassine A", "initials": "A", "firstName": "Anis", "lastName": "Hassine"}, {"affiliation": "c Neurology Department , Central Hospital University (CHU), Sousse University , Sousse , Tunisia.", "fullName": "Ben Amor S", "initials": "S", "firstName": "Sana", "lastName": "Ben Amor"}, {"affiliation": "c Neurology Department , Central Hospital University (CHU), Sousse University , Sousse , Tunisia.", "fullName": "Ben Ammou S", "initials": "S", "firstName": "Sofiene", "lastName": "Ben Ammou"}, {"affiliation": "b Department of Pharmacovigilance, Faculty of Medicine of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Ben Salem C", "initials": "C", "firstName": "Chaker", "lastName": "Ben Salem"}, {"affiliation": "a Metabolic Biophysics, Professional Toxicology and Applied Environmental Laboratory, Department of Biophysics, Medicine Faculty of Sousse , Sousse University , Sousse , Tunisia ;", "fullName": "Saguem S", "initials": "S", "firstName": "Saad", "lastName": "Saguem"}]}, "title": "Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.", "citedByCount": 0, "source": "MED", "pmid": "27276192", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-03-01", "doi": "10.3109/01677063.2016.1155571", "isOpenAccess": "N", "pageInfo": "16-21", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Drug metabolism", "Ephx1 Gene", "Cyp3a4*22"]}, "abstractText": "The aim of this study was to evaluate the impact of polymorphisms in the EPHX1 (c.416A\u2009>\u2009G, c.337T\u2009>\u2009C) and CYP3A4*22 genes involved in carbamazepine (CBZ) metabolism and pharmacoresistance among 118 Tunisian patients with epilepsy under maintenance dose of CBZ. These genetic polymorphisms were analyzed by PCR-RFLP. Associations between plasma CBZ concentration, CBZ-E concentration, maintenance doses and metabolic ratio (CBZ-E:CBZ, CBZ-D:CBZ-E) were analyzed with each polymorphism. Both variants of EPHX1 c.416A\u2009>\u2009G and c.337T\u2009>\u2009C are significantly associated with higher metabolic ratio CBZ-E:CBZ and seem to decrease the activity of the epoxide hydrolase. The CYP3A4*22 variant allele is significantly associated with lower CBZ-D:CBZ-E ratio and seems also to be associated with less activity of the cytochrome. Our data suggest that certain polymorphisms of metabolizing enzyme genes could influence inter-individual variability of CBZ metabolism.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/01677063.2016.1155571", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-03-01", "journal": {"medlineAbbreviation": "J Neurogenet", "isoabbreviation": "J. Neurogenet.", "title": "Journal of neurogenetics", "issn": "0167-7063", "nlmid": "8406473", "essn": "1563-5260"}, "monthOfPublication": 3, "volume": "30", "yearOfPublication": 2016, "journalIssueId": 2417539, "issue": "1", "dateOfPublication": "2016 Mar"}}, "PMC4033946": "", "16630050": "", "25495409": {"pubYear": "2014", "dateOfCreation": "2014-12-16", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ARFIP2 protein, human"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "P-Glycoproteins"}, {"registryNumber": "EC 1.14.14.1", "name": "cytochrome P-450 CYP3A"}, {"registryNumber": "EC 1.14.13.67", "name": "CYP3A4 protein, human"}, {"registryNumber": "EC 1.14.14.1", "name": "CYP3A5 protein, human"}, {"registryNumber": "0", "name": "ABCB1 protein, human"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}, {"registryNumber": "33CM23913M", "name": "Carbamazepine"}]}, "authorString": "Zhu X, Yun W, Sun X, Qiu F, Zhao L, Guo Y.", "affiliation": "Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, 110004, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25495409", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, 110004, China.", "fullName": "Zhu X", "initials": "X", "firstName": "Xu", "lastName": "Zhu"}, {"lastName": "Yun", "fullName": "Yun W", "firstName": "Wenting", "initials": "W"}, {"lastName": "Sun", "fullName": "Sun X", "firstName": "Xiaofu", "initials": "X"}, {"lastName": "Qiu", "fullName": "Qiu F", "firstName": "Feng", "initials": "F"}, {"lastName": "Zhao", "fullName": "Zhao L", "firstName": "Limei", "initials": "L"}, {"lastName": "Guo", "fullName": "Guo Y", "firstName": "Yingjie", "initials": "Y"}]}, "title": "Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.", "citedByCount": 3, "source": "MED", "pmid": "25495409", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carbamazepine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}, {"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "P-Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP3A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-01", "doi": "10.2217/pgs.14.142", "isOpenAccess": "N", "pageInfo": "1867-1879", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Polymorphism", "Metabolism", "CYP3A4", "CYP3A5", "carbamazepine", "Abcb1", "Por", "Ephx1"]}, "abstractText": "AIM: The present study aimed to evaluate the effects of SNPs of major transporter and metabolizing enzyme genes on carbamazepine (CBZ) metabolism in Chinese patients with epilepsy. MATERIALS & METHODS: For 210 epileptic patients treated with CBZ as monotherapy, nine SNPs in candidate genes ABCB1, CYP3A4, CYP3A5, POR and EPHX1 were analyzed by PCR-RFLP or direct sequencing. Serum concentrations of CBZ, carbamazepine-10,11-epoxide (CBZE) and carbamazepine-10,11-trans dihydrodiol (CBZD) were determined by HPLC. Dose-adjusted concentrations of CBZ (CDRCBZ), CBZE (CDRCBZE), CBZD (CDRCBZ D) and CBZD:CBZE ratio were used as evaluation parameters for CBZ metabolism. RESULTS: The ABCB1 c.3435C>T was significantly associated with the CDR of CBZ and its major metabolites. CYP3A4*1G and CYP3A5*3 could influence CBZ metabolism, while POR*28 had no effect on it. The EPHX1 c.416A>G and c.128G>C variants were significantly associated with CBZD:CBZE ratio. CONCLUSION: Our data suggest that certain polymorphisms of major transporter and metabolizing enzyme genes could in part influence interindividual variability of CBZ metabolism in Chinese patients with epilepsy.", "language": "eng", "dateOfCompletion": "2015-08-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.2217/pgs.14.142", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "Pharmacogenomics", "isoabbreviation": "Pharmacogenomics", "title": "Pharmacogenomics", "issn": "1462-2416", "nlmid": "100897350", "essn": "1744-8042"}, "monthOfPublication": 0, "volume": "15", "yearOfPublication": 2014, "journalIssueId": 2249836, "issue": "15", "dateOfPublication": "2014 "}}, "20091863": "", "18298806": "", "19952982": "", "15774926": "", "11255266": "", "15654505": "", "16029924": "", "20602612": "", "22610071": {"pubYear": "2012", "dateOfCreation": "2012-07-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Carcinogens"}]}, "authorString": "Catsburg C, Joshi AD, Corral R, Lewinger JP, Koo J, John EM, Ingles SA, Stern MC.", "affiliation": "Department of Preventive Medicine, University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "DP", "orderIn": 0, "agency": "NCCDPHP CDC HHS", "grantId": "1U58DP000807-3"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "5P30 ES07048"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA84979"}, {"acronym": "PC", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "N01-PC-35139"}, {"acronym": "PC", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "N01-PC-35136"}]}, "hasPDF": "Y", "id": "22610071", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Catsburg", "fullName": "Catsburg C", "firstName": "Chelsea", "initials": "C"}, {"lastName": "Joshi", "fullName": "Joshi AD", "firstName": "Amit D", "initials": "AD"}, {"lastName": "Corral", "fullName": "Corral R", "firstName": "Rom\u00e1n", "initials": "R"}, {"lastName": "Lewinger", "fullName": "Lewinger JP", "firstName": "Juan Pablo", "initials": "JP"}, {"lastName": "Koo", "fullName": "Koo J", "firstName": "Jocelyn", "initials": "J"}, {"lastName": "John", "fullName": "John EM", "firstName": "Esther M", "initials": "EM"}, {"lastName": "Ingles", "fullName": "Ingles SA", "firstName": "Sue A", "initials": "SA"}, {"lastName": "Stern", "fullName": "Stern MC", "firstName": "Mariana C", "initials": "MC"}]}, "title": "Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer.", "hasSuppl": "Y", "citedByCount": 19, "source": "MED", "pmid": "22610071", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Fishes", "majorTopic_YN": "Y"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Prostatic Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Carcinogens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Seafood", "majorTopic_YN": "Y"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-05-18", "doi": "10.1093/carcin/bgs175", "isOpenAccess": "N", "pageInfo": "1352-1359", "pmcid": "PMC3499053", "hasDbCrossReferences": "N", "abstractText": "Cooking fish at high temperature can produce potent carcinogens such as heterocyclic amines and polycyclic aromatic hydrocarbons. The effects of these carcinogens may undergo modification by the enzymes responsible for their detoxification and/or activation. In this study, we investigated genetic polymorphisms in nine carcinogen metabolism enzymes and their modifying effects on the association between white or dark fish consumption and prostate cancer (PCA) risk. We genotyped 497 localized and 936 advanced PCA cases and 760 controls from the California Collaborative Case-Control Study of Prostate Cancer. Three polymorphisms, EPHX1 Tyr113His, CYP1B1 Leu432Val and GSTT1 null/present, were associated with localized PCA risk. The PTGS2 765 G/C polymorphism modified the association between white fish consumption and advanced PCA risk (interaction P 5 0.002), with high white fish consumption being positively associated with risk only among carriers of the C allele. This effect modification by PTGS2 genotype was stronger when restricted to consumption of well-done white fish (interaction P 5 0.021). These findings support the hypotheses that changes in white fish brought upon by high-temperature cooking methods, such as carcinogen accumulation and/or fatty acid composition changes, may contribute to prostate carcinogenesis. However, the gene-diet interactions should be interpreted with caution given the limited sample size. Thus, our findings require further validation with additional studies.", "electronicPublicationDate": "2012-05-18", "language": "eng", "dateOfCompletion": "2012-10-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3499053?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3499053", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22610071&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22610071", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/carcin/bgs175", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-07-01", "journal": {"medlineAbbreviation": "Carcinogenesis", "isoabbreviation": "Carcinogenesis", "title": "Carcinogenesis", "issn": "0143-3334", "nlmid": "8008055", "essn": "1460-2180"}, "monthOfPublication": 7, "volume": "33", "yearOfPublication": 2012, "journalIssueId": 1952320, "issue": "7", "dateOfPublication": "2012 Jul"}}, "24260161": {"pubYear": "2013", "dateOfCreation": "2013-11-22", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Polycyclic Hydrocarbons, Aromatic"}]}, "authorString": "Barrington-Trimis JL, Searles Nielsen S, Preston-Martin S, Gauderman WJ, Holly EA, Farin FM, Mueller BA, McKean-Cowdin R.", "affiliation": "Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California, United States of America.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "2T32ES013678-06"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "5P30ES07048"}, {"acronym": "CN", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "N01-CN-05230"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "P30 ES007048"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "T32ES07262"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA116724"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R03CA106011"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "T32 ES013678"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "P30ES007033"}]}, "hasPDF": "Y", "id": "24260161", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California, United States of America.", "fullName": "Barrington-Trimis JL", "initials": "JL", "firstName": "Jessica L", "lastName": "Barrington-Trimis"}, {"lastName": "Searles Nielsen", "fullName": "Searles Nielsen S", "firstName": "Susan", "initials": "S"}, {"lastName": "Preston-Martin", "fullName": "Preston-Martin S", "firstName": "Susan", "initials": "S"}, {"lastName": "Gauderman", "fullName": "Gauderman WJ", "firstName": "W James", "initials": "WJ"}, {"lastName": "Holly", "fullName": "Holly EA", "firstName": "Elizabeth A", "initials": "EA"}, {"lastName": "Farin", "fullName": "Farin FM", "firstName": "Federico M", "initials": "FM"}, {"lastName": "Mueller", "fullName": "Mueller BA", "firstName": "Beth A", "initials": "BA"}, {"lastName": "McKean-Cowdin", "fullName": "McKean-Cowdin R", "firstName": "Roberta", "initials": "R"}]}, "title": "Parental smoking and risk of childhood brain tumors by functional polymorphisms in polycyclic aromatic hydrocarbon metabolism genes.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "24260161", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polycyclic Hydrocarbons, Aromatic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Maternal Exposure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-11-18", "doi": "10.1371/journal.pone.0079110", "isOpenAccess": "Y", "pageInfo": "e79110", "pmcid": "PMC3832498", "hasDbCrossReferences": "N", "abstractText": "BACKGROUND: A recent meta-analysis suggested an association between exposure to paternal smoking during pregnancy and childhood brain tumor risk, but no studies have evaluated whether this association differs by polymorphisms in genes that metabolize tobacco-smoke chemicals. METHODS: We assessed 9 functional polymorphisms in 6 genes that affect the metabolism of polycyclic aromatic hydrocarbons (PAH) to evaluate potential interactions with parental smoking during pregnancy in a population-based case-control study of childhood brain tumors. Cases (N\u200a=\u200a202) were \u226410 years old, diagnosed from 1984-1991 and identified in three Surveillance, Epidemiology, and End Results (SEER) registries in the western U.S. Controls in the same regions (N\u200a=\u200a286) were frequency matched by age, sex, and study center. DNA for genotyping was obtained from archived newborn dried blood spots. RESULTS: We found positive interaction odds ratios (ORs) for both maternal and paternal smoking during pregnancy, EPHX1 H139R, and childhood brain tumors (P(interaction)\u200a=\u200a0.02; 0.10), such that children with the high-risk (greater PAH activation) genotype were at a higher risk of brain tumors relative to children with the low-risk genotype when exposed to tobacco smoke during pregnancy. A dose-response pattern for paternal smoking was observed among children with the EPHX1 H139R high-risk genotype only (OR(no exposure)\u200a=\u200a1.0; OR(\u22643 hours/day)\u200a=\u200a1.32, 95% CI: 0.52-3.34; OR(>3 hours/day\u200a)=\u200a3.18, 95% CI: 0.92-11.0; P(trend\u200a)=\u200a0.07). CONCLUSION: Parental smoking during pregnancy may be a risk factor for childhood brain tumors among genetically susceptible children who more rapidly activate PAH in tobacco smoke.", "electronicPublicationDate": "2013-11-18", "language": "eng", "dateOfCompletion": "2014-07-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3832498?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3832498", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24260161", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24260161&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0079110", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-03-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2093574, "issue": "11", "dateOfPublication": "2013 "}}, "11471167": "", "15055294": "", "21228703": "", "11289100": "", "17564249": "", "22500060": {"pubYear": "2012", "dateOfCreation": "2012-04-13", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "64-17-5", "name": "Ethanol"}]}, "authorString": "Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, De Feo E, Pandolfini M, Gall\u00ec P, Paludetti G, Ricciardi G.", "affiliation": "Institute of Otorhinolaryngology, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy. gabriella.cadoni@rm.unicatt.it", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "Y", "id": "22500060", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Cadoni", "fullName": "Cadoni G", "firstName": "G", "initials": "G"}, {"lastName": "Boccia", "fullName": "Boccia S", "firstName": "S", "initials": "S"}, {"lastName": "Petrelli", "fullName": "Petrelli L", "firstName": "L", "initials": "L"}, {"lastName": "Di Giannantonio", "fullName": "Di Giannantonio P", "firstName": "P", "initials": "P"}, {"lastName": "Arzani", "fullName": "Arzani D", "firstName": "D", "initials": "D"}, {"lastName": "Giorgio", "fullName": "Giorgio A", "firstName": "A", "initials": "A"}, {"lastName": "De Feo", "fullName": "De Feo E", "firstName": "E", "initials": "E"}, {"lastName": "Pandolfini", "fullName": "Pandolfini M", "firstName": "M", "initials": "M"}, {"lastName": "Gall\u00ec", "fullName": "Gall\u00ec P", "firstName": "P", "initials": "P"}, {"lastName": "Paludetti", "fullName": "Paludetti G", "firstName": "G", "initials": "G"}, {"lastName": "Ricciardi", "fullName": "Ricciardi G", "firstName": "G", "initials": "G"}]}, "title": "A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism.", "hasSuppl": "N", "citedByCount": 11, "source": "MED", "pmid": "22500060", "abstractText": "The purpose of this report is to review the relationship between genetic polymorphisms involved in carcinogen metabolism, alcohol metabolism and cell-cycle control with the risk of head and neck cancer. The review was performed on available studies on genetic polymorphisms and head and neck cancer (HNC) published in PubMed up to September 2011. 246 primary articles and 7 meta-analyses were published. Among these, a statistically significant association was reported for glutathione S-transferases (GSTM1), glutathione S-transferases (GSTT1) and human microsomal epoxide hydrolase (EPHX1) genes. An increased risk for HNC was also associated reported for P53 codon 72 Pro/Pro, ALDH2 and three variants of the ADH gene: ADH1B (rs1229984), ADH7 (rs1573496) and ADH1C (rs698).", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Head and Neck Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ethanol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Epidemiology", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-02-01", "isOpenAccess": "Y", "pageInfo": "1-11", "pmcid": "PMC3324962", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Genetic susceptibility", "Genetic polymorphisms", "Head And Neck Cancer"]}, "hasLabsLinks": "N", "language": "eng", "license": "cc by-nc-nd", "dateOfCompletion": "2012-08-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3324962?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3324962", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22500060&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22500060", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-02-01", "journal": {"medlineAbbreviation": "Acta Otorhinolaryngol Ital", "isoabbreviation": "Acta Otorhinolaryngol Ital", "title": "Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale", "issn": "0392-100X", "nlmid": "8213019", "essn": "1827-675X"}, "monthOfPublication": 2, "volume": "32", "yearOfPublication": 2012, "journalIssueId": 1922996, "issue": "1", "dateOfPublication": "2012 Feb"}}, "21445251": "", "22415791": {"pubYear": "2013", "dateOfCreation": "2013-07-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}]}, "authorString": "Nisa H, Budhathoki S, Morita M, Toyomura K, Nagano J, Ohnaka K, Kono S, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R.", "affiliation": "Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22415791", "inEPMC": "N", "authorList": {"author": [{"lastName": "Nisa", "fullName": "Nisa H", "firstName": "Hoirun", "initials": "H"}, {"lastName": "Budhathoki", "fullName": "Budhathoki S", "authorId": {"type": "ORCID", "value": "0000-0003-1662-3109"}, "firstName": "Sanjeev", "initials": "S"}, {"lastName": "Morita", "fullName": "Morita M", "firstName": "Makiko", "initials": "M"}, {"lastName": "Toyomura", "fullName": "Toyomura K", "firstName": "Kengo", "initials": "K"}, {"lastName": "Nagano", "fullName": "Nagano J", "firstName": "Jun", "initials": "J"}, {"lastName": "Ohnaka", "fullName": "Ohnaka K", "firstName": "Keizo", "initials": "K"}, {"lastName": "Kono", "fullName": "Kono S", "firstName": "Suminori", "initials": "S"}, {"lastName": "Ueki", "fullName": "Ueki T", "firstName": "Takashi", "initials": "T"}, {"lastName": "Tanaka", "fullName": "Tanaka M", "firstName": "Masao", "initials": "M"}, {"lastName": "Kakeji", "fullName": "Kakeji Y", "firstName": "Yoshihiro", "initials": "Y"}, {"lastName": "Maehara", "fullName": "Maehara Y", "firstName": "Yoshihiko", "initials": "Y"}, {"lastName": "Okamura", "fullName": "Okamura T", "firstName": "Takeshi", "initials": "T"}, {"lastName": "Ikejiri", "fullName": "Ikejiri K", "firstName": "Koji", "initials": "K"}, {"lastName": "Futami", "fullName": "Futami K", "firstName": "Kitaroh", "initials": "K"}, {"lastName": "Maekawa", "fullName": "Maekawa T", "firstName": "Takafumi", "initials": "T"}, {"lastName": "Yasunami", "fullName": "Yasunami Y", "firstName": "Yohichi", "initials": "Y"}, {"lastName": "Takenaka", "fullName": "Takenaka K", "firstName": "Kenji", "initials": "K"}, {"lastName": "Ichimiya", "fullName": "Ichimiya H", "firstName": "Hitoshi", "initials": "H"}, {"lastName": "Terasaka", "fullName": "Terasaka R", "firstName": "Reiji", "initials": "R"}]}, "title": "Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.", "citedByCount": 3, "source": "MED", "pmid": "22415791", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1662-3109"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Colorectal Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Body Mass Index", "majorTopic_YN": "N"}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Risk", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "Y"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-13", "doi": "10.1002/mc.21897", "isOpenAccess": "N", "pageInfo": "619-626", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Polymorphism", "Cigarette smoking", "Microsomal epoxide hydrolase", "Colorectal Cancer"]}, "abstractText": "Microsomal epoxide hydrolase (EPHX1) plays an important role in the activation and detoxification of polycyclic aromatic hydrocarbons, carcinogens found in cigarette smoke. Polymorphisms in exon 3 (Y113H) and exon 4 (H139R) of the EPHX1 have been associated with enzyme activity. We investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates. The interaction between the EPHX1 polymorphisms and selected genetic polymorphisms was also examined. We used data from Fukuoka Colorectal Cancer Study, a community-based case-control study, including 685 cases and 778 controls. In-person interviews were conducted to assess lifestyle factors. The EPHX1 Y113H and H139R polymorphisms were determined by the TaqMan assay and the polymerase chain reaction-restriction fragment length polymorphism, respectively. Neither of the two polymorphisms nor the imputed EPHX1 phenotype was associated with colorectal cancer risk. Cigarette smoking and alcohol intake showed no effect modification on the association with the EPHX1 polymorphisms or the imputed EPHX1 phenotype. Increased risks of colorectal cancer associated with the 113Y allele and imputed EPHX1 phenotype were observed among individuals with high body mass index (BMI; \u226525.0\u2009kg/m(2)), but not among those with low BMI (<25.0\u2009kg/m(2)). The risk decreased with an increasing number of the 139R allele in the null genotypes of GSTM1/GSTT1. It is unlikely that the EPHX1 polymorphisms play an important role in colorectal carcinogenesis. The observed interactions of the EPHX1 polymorphisms with BMI and the GSTM1/GSTT1 genotypes warrant further investigation.", "electronicPublicationDate": "2012-03-13", "language": "eng", "dateOfCompletion": "2013-09-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/mc.21897", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-08-01", "journal": {"medlineAbbreviation": "Mol Carcinog", "isoabbreviation": "Mol. Carcinog.", "title": "Molecular carcinogenesis", "issn": "0899-1987", "nlmid": "8811105", "essn": "1098-2744"}, "monthOfPublication": 8, "volume": "52", "yearOfPublication": 2013, "journalIssueId": 2056941, "issue": "8", "dateOfPublication": "2013 Aug"}}, "17418242": "", "21715529": "", "22301281": {"pubYear": "2012", "dateOfCreation": "2012-04-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Carcinogens"}, {"registryNumber": "0", "name": "Enzymes"}]}, "authorString": "Jang JH, Cotterchio M, Borgida A, Gallinger S, Cleary SP.", "affiliation": "Population Studies and Surveillance, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA97075"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "U24 CA074783"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "U01 CA074783"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "RFA # CA-95-011"}]}, "hasPDF": "Y", "id": "22301281", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Population Studies and Surveillance, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7.", "fullName": "Jang JH", "initials": "JH", "firstName": "Ji-Hyun", "lastName": "Jang"}, {"lastName": "Cotterchio", "fullName": "Cotterchio M", "firstName": "Michelle", "initials": "M"}, {"lastName": "Borgida", "fullName": "Borgida A", "firstName": "Ayelet", "initials": "A"}, {"lastName": "Gallinger", "fullName": "Gallinger S", "firstName": "Steven", "initials": "S"}, {"lastName": "Cleary", "fullName": "Cleary SP", "firstName": "Sean P", "initials": "SP"}]}, "title": "Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.", "hasSuppl": "N", "citedByCount": 18, "pageInfo": "818-827", "source": "MED", "pmid": "22301281", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pancreatic Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Enzymes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carcinogens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "Y"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-02-02", "doi": "10.1093/carcin/bgs028", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 54, "type": "Erratum in", "reference": "Carcinogenesis. 2012 Jul;33(7):1430"}]}, "pmcid": "PMC3324443", "hasDbCrossReferences": "N", "abstractText": "Individual susceptibility to the toxic effects of cigarette smoke may be modified by inherited variability in carcinogen metabolism. The purpose of the present study was to investigate pancreatic cancer risk associated with cigarette smoking and 33 variants within carcinogen metabolism genes and examine whether these variants modify the association between smoking and pancreatic cancer. A population-based study was conducted with 455 pancreatic cancer cases and 893 controls. Epidemiological and smoking data were collected from questionnaires and variants were genotyped by mass spectrometry. Age- and sex-adjusted odds ratio (ASOR) and multivariate-adjusted odds ratio (MVOR) estimates were obtained using multivariate logistic regression, and interactions between each variant and smoking were investigated. Current smoker status [MVOR = 2.29, 95% confidence interval (95% CI): 1.62, 3.22], 10-27 pack-years (MVOR = 1.57, 95% CI: 1.13, 2.18), >27 pack-years (MVOR = 1.77, 95% CI: 1.27, 2.46) and longer durations of smoking (19-32 years: MVOR = 1.46, 95% CI: 1.05, 2.05; >32 years: MVOR = 1.78, 95% CI: 1.30, 2.45) were associated with increased pancreatic cancer risk. CYP1B1-4390-GG (ASOR = 0.36, 95% CI: 0.15, 0.86) and Uridine 5'-diphospho glucuronosyltransferase 1 family, polypeptide A7-622-CT (ASOR = 0.77, 95% CI: 0.60, 0.99) were associated with reduced risk. N-acetyltransferase 1-640-GT/GG (ASOR = 1.75, 95% CI: 1.00, 3.05), GSTM1 (rs737497)-GG (ASOR = 1.41, 95% CI: 1.02, 1.95), GSTM1 gene deletion (ASOR = 4.89, 95% CI: 3.52, 6.79) and glutathione S-transferase theta-1 gene deletion (ASOR = 4.41, 95% CI: 2.67, 7.29) were associated with increased risk. Significant interactions were observed between pack-years and EPHX1-415 (P = 0.04) and smoking status and N-acetyltransferase 2-857 (P = 0.03). Variants of carcinogen metabolism genes are independently associated with pancreatic cancer risk and may modify the risk posed by smoking.", "electronicPublicationDate": "2012-02-02", "language": "eng", "dateOfCompletion": "2012-05-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3324443?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3324443", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22301281&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22301281", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/carcin/bgs028", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-04-01", "journal": {"medlineAbbreviation": "Carcinogenesis", "isoabbreviation": "Carcinogenesis", "title": "Carcinogenesis", "issn": "0143-3334", "nlmid": "8008055", "essn": "1460-2180"}, "monthOfPublication": 4, "volume": "33", "yearOfPublication": 2012, "journalIssueId": 1922520, "issue": "4", "dateOfPublication": "2012 Apr"}}, "11281420": "", "27421065": {"pubYear": "2016", "dateOfCreation": "2016-07-15", "pubModel": "Print-Electronic", "authorString": "Zivka M, Aleksandra T, Djordje F, Marija S, Ljudmila NO, Bojan M, Dragica R.", "affiliation": "a Faculty of Pharmacy, University of Bijeljina , Bijeljina , Bosnia and Herzegovina.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27421065", "inEPMC": "N", "authorList": {"author": [{"affiliation": "a Faculty of Pharmacy, University of Bijeljina , Bijeljina , Bosnia and Herzegovina.", "fullName": "Zivka M", "initials": "M", "firstName": "Malic", "lastName": "Zivka"}, {"affiliation": "b Department of Medical Biochemistry , Faculty of Pharmacy, University of Belgrade , Belgrade , Serbia.", "fullName": "Aleksandra T", "initials": "T", "firstName": "Topic", "lastName": "Aleksandra"}, {"affiliation": "c Institute of Molecular Genetics and Genetic Engineering, University of Belgrade , Belgrade , Serbia.", "fullName": "Djordje F", "initials": "F", "firstName": "Francuski", "lastName": "Djordje"}, {"affiliation": "c Institute of Molecular Genetics and Genetic Engineering, University of Belgrade , Belgrade , Serbia.", "fullName": "Marija S", "initials": "S", "firstName": "Stankovic", "lastName": "Marija"}, {"affiliation": "d Clinic for Pulmonary Diseases Clinical Centre of Serbia, University of Belgrade, School of Medicine , Belgrade , Serbia.", "fullName": "Ljudmila NO", "initials": "NO", "firstName": "Nagorni-Obradovic", "lastName": "Ljudmila"}, {"affiliation": "e Department of Pharmaceutical Chemistry , Faculty of Pharmacy, University of Belgrade , Belgrade , Serbia.", "fullName": "Bojan M", "initials": "M", "firstName": "Markovic", "lastName": "Bojan"}, {"affiliation": "c Institute of Molecular Genetics and Genetic Engineering, University of Belgrade , Belgrade , Serbia.", "fullName": "Dragica R", "initials": "R", "firstName": "Radojkovic", "lastName": "Dragica"}]}, "title": "Oxidative Stress and Genetic Variants of Xenobiotic-Metabolising Enzymes Associated with COPD Development and Severity in Serbian Adults.", "citedByCount": 0, "source": "MED", "pmid": "27421065", "abstractText": "The genetic and non-genetic factors that contribute to the development of chronic obstructive pulmonary disease (COPD) are still poorly understood. We investigated the potential role of genetic variants of xenobiotic-metabolising enzymes (glutathione-S-transferase M1, GSTM1; glutathione-S-transferase T1, GSTT1; microsomal epoxide hydrolase, mEH), oxidative stress (assessed by urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxodG/creatinine), sex, ageing and smoking habits on susceptibility to development of COPD and its severity in Serbian population. The investigated population consisted of 153 healthy subjects (85 males and 68 females) and 71 patients with COPD (33 males and 38 females). Detection of GSTM1*null, GSTT1*null, mEH Tyr113His and mEH His139Arg gene variants was performed by PCR/RFLP method. Urinary 8-oxodG was determined using HPLC-MS/MS, and expressed as 8-oxodG/creatinine. We revealed that increased urinary 8-oxodG/creatinine and leucocytosis are the strongest independent predictors for COPD development. Increased level of oxidative stress increased the risk for COPD in males [odds ratio (OR), 95% confidence interval (CI): 8.42, 2.26-31.28], more than in females (OR, 95% CI: 3.60, 1.37-9.45). Additionally, independent predictors for COPD were ageing in males (OR, 95% CI: 1.29, 1.12-1.48), while in females they were at least one GSTM1 or GSTT1 gene deletion in combination (OR, 95% CI: 23.67, 2.62-213.46), and increased cumulative cigarette consumption (OR, 95% CI: 1.09, 1.01-1.16). Severity of COPD was associated with the combined effect of low mEH activity phenotype, high level of oxidative stress and heavy smoking. In conclusion, early identification of GSTM1*null or GSTT1*null genotypes in females, low mEH activity phenotype in heavy smokers and monitoring of oxidative stress level can be useful diagnostic and prognostic biomarkers.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-07-15", "isOpenAccess": "N", "pageInfo": "1-10", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["COPD", "Microsomal epoxide hydrolase", "Glutathione-s-transferase M1", "Glutathione-s-transferase T1", "8-Oxodg/creatinine"]}, "hasLabsLinks": "N", "electronicPublicationDate": "2016-07-15", "language": "eng", "dateOfRevision": "2016-07-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-07-01", "journal": {"medlineAbbreviation": "COPD", "isoabbreviation": "COPD", "title": "COPD", "issn": "1541-2555", "nlmid": "101211769", "essn": "1541-2563"}, "monthOfPublication": 7, "yearOfPublication": 2016, "journalIssueId": 2426613, "dateOfPublication": "2016 Jul"}}, "17526865": "", "24817818": {"pubYear": "2014", "dateOfCreation": "2014-05-12", "pubModel": "Electronic-eCollection", "authorString": "Caruso A, Bellia C, Pivetti A, Agnello L, Bazza F, Scazzone C, Bivona G, Lo Sasso B, Ciaccio M.", "affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24817818", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Caruso A", "initials": "A", "firstName": "Antonietta", "lastName": "Caruso"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Bellia C", "initials": "C", "firstName": "Chiara", "lastName": "Bellia"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Pivetti A", "initials": "A", "firstName": "Alessia", "lastName": "Pivetti"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Agnello L", "initials": "L", "firstName": "Luisa", "lastName": "Agnello"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Bazza F", "initials": "F", "firstName": "Federica", "lastName": "Bazza"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Scazzone C", "initials": "C", "firstName": "Concetta", "lastName": "Scazzone"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Bivona G", "initials": "G", "firstName": "Giulia", "lastName": "Bivona"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Lo Sasso B", "initials": "B", "firstName": "Bruna", "lastName": "Lo Sasso"}, {"affiliation": "Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.", "fullName": "Ciaccio M", "initials": "M", "firstName": "Marcello", "lastName": "Ciaccio"}]}, "title": "Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24817818", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-04-02", "language": "eng", "doi": "10.2147/pgpm.s55548", "isOpenAccess": "Y", "pageInfo": "117-120", "pmcid": "PMC4012346", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Drug metabolism", "Ephx1 Gene", "Cbz 10", "11-Epoxide", "Cyp3a4*22"]}, "abstractText": "BACKGROUND: The aim of this study was to investigate the effect of two genetic polymorphisms in the coding regions (exon 3 and exon 4) of the EPHX1 gene, ie, 337T>C and 416A>G, respectively, on the metabolism of carbamazepine (CBZ) 10,11-epoxide (the active metabolite of CBZ) by evaluating the variation in serum CBZ 10,11-epoxide levels 4 hours after administration of the drug. Moreover, we reported the genotype frequencies of the CYP3A4*22 (rs 35599367, C>T) variant and its influence on the metabolism of CBZ. METHODS: The analysis was performed in 50 patients receiving CBZ as monotherapy. DNA was extracted from leukocytes using a commercially available kit. Serum CBZ 10,11-epoxide levels were measured by high-performance liquid chromatography. Allelic discrimination was performed using polymerase chain reaction-restriction fragment length polymorphism. Statistical analysis of the difference in mean values for CBZ 10,11-epoxide levels according to genotype was performed using the Student's t-test with Statistical Package for the Social Sciences version 13 software. RESULTS: Fourteen percent of the study group were CC, 42% were CT, and 44% were TT for the EPHX1 337T>C variant. No GG homozygote was identified for the EPHX1 416A>G variant; 64% were AA and 36% were AG. When we compared serum CBZ 10,11-epoxide levels 4 hours after drug administration, we found no statistically significant difference between the 337 CC, CT, and TT genotypes. Similarly, no difference in serum CBZ 10,11-epoxide levels was found between 416A>G AA and AG. Genotype frequencies for the CYP3A4*22 (rs 35599367 C>T) allelic variant were 94% for CC and 6% for CT, with no statistically significant difference in serum CBZ 10,11-epoxide levels between these genotypes 4 hours after administration of the drug (2.6\u00b11.3 \u03bcg/\u03bcL and 2.5\u00b11.2 \u03bcg/\u03bcL, respectively). CONCLUSION: Although there is some evidence of involvement of these polymorphisms in enzyme activity in vitro, we found no interference with CBZ metabolism in vivo.", "electronicPublicationDate": "2014-04-02", "license": "cc by-nc", "dateOfCompletion": "2014-05-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4012346?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4012346", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24817818", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24817818&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.2147/PGPM.S55548", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2014-05-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "Pharmacogenomics and personalized medicine", "medlineAbbreviation": "Pharmgenomics Pers Med", "isoabbreviation": "Pharmgenomics Pers Med", "nlmid": "101514107", "essn": "1178-7066"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2014, "journalIssueId": 2125868, "dateOfPublication": "2014 "}}, "24845160": {"pubYear": "2014", "dateOfCreation": "2014-07-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.5.1.-", "name": "glutathione S-transferase T1"}, {"registryNumber": "EC 3.1.8.1", "name": "PON2 protein, human"}, {"registryNumber": "0", "name": "Solvents"}, {"registryNumber": "EC 2.5.1.18", "name": "Glutathione Transferase"}, {"registryNumber": "EC 3.1.8.1", "name": "Aryldialkylphosphatase"}]}, "authorString": "Li S, Fang K, Wang W, Hu Y, Chen D.", "affiliation": "Department of Biostatistics and Epidemiology, School of Public Health, Peking University, No.38, Xueyuan Road, Beijing, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "1R01 ES08337-01"}, {"acronym": "HD", "orderIn": 0, "agency": "NICHD NIH HHS", "grantId": "1R01HD32505-01"}, {"acronym": "OH", "orderIn": 0, "agency": "NIOSH CDC HHS", "grantId": "1R01 OH03027"}]}, "hasPDF": "Y", "id": "24845160", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Shuai", "lastName": "Li", "affiliation": "Department of Biostatistics and Epidemiology, School of Public Health, Peking University, No.38, Xueyuan Road, Beijing, China.", "authorId": {"type": "ORCID", "value": "0000-0002-8696-8594"}, "fullName": "Li S", "initials": "S"}, {"lastName": "Fang", "fullName": "Fang K", "firstName": "Kai", "initials": "K"}, {"lastName": "Wang", "fullName": "Wang W", "firstName": "Wenjian", "initials": "W"}, {"lastName": "Hu", "fullName": "Hu Y", "firstName": "Yonghua", "initials": "Y"}, {"lastName": "Chen", "fullName": "Chen D", "firstName": "Dafang", "initials": "D"}]}, "title": "Gene-environment interaction among GSTT1, PON2 polymorphisms and organic solvents on gestational age in a Chinese women cohort.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24845160", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-8696-8594"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Aryldialkylphosphatase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glutathione Transferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Solvents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Gestational Age", "majorTopic_YN": "Y"}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "Y"}, {"descriptorName": "Gene-Environment Interaction", "majorTopic_YN": "Y"}]}, "inPMC": "N", "embargoDate": "2015-07-01", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-05-21", "doi": "10.1007/s10815-014-0256-6", "isOpenAccess": "N", "pageInfo": "881-888", "pmcid": "PMC4096872", "hasDbCrossReferences": "Y", "abstractText": "PURPOSE: To investigate interactions on gestational age among two environmental risk factors and four maternal genetic polymorphisms: organic solvents, passive smoking, CYP1A1 rs4646903 (MspI), EPHX1 rs2234922 (His139Arg), GSTT1 and PON2 rs12026 (Ala148Gly). METHODS: A pregnant women cohort was conducted at Beijing Yanshan Petrochemical Corporation, and 1,097 mothers with live singleton births were included in analysis. Generalized Multifactor Dimensionality Reduction (GMDR) method was used to explore interactions among these factors with adjustment for important potential confounders. Multiple linear regression models were used to estimate the association of interaction with gestational age. RESULTS: A three-factor model of organic solvents, GSTT1 and PON2 rs12026 had the highest testing balanced accuracy (57.05 %) and best cross-validation consistency (10/10). Compared with organic solvents unexposed mothers with GSTT1 non-null genotype and PON2 rs12026 CC genotype, organic solvents exposed mothers with GSTT1 null genotype and PON2 rs12026 CG + GG genotype had the largest reduction in gestational age (-0.36 weeks, 95%CI: -0.70 to -0.02). The significant reductions in different groups were from 0.24 weeks to 0.36 weeks. CONCLUSIONS: Maternal genetic susceptibility GSTT1 and PON2 rs12026 could significantly modify the association of organic solvents with gestational age.", "electronicPublicationDate": "2014-05-21", "language": "eng", "dateOfCompletion": "2015-03-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4096872?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4096872", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s10815-014-0256-6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-07-01", "journal": {"medlineAbbreviation": "J Assist Reprod Genet", "isoabbreviation": "J. Assist. Reprod. Genet.", "title": "Journal of assisted reproduction and genetics", "issn": "1058-0468", "nlmid": "9206495", "essn": "1573-7330"}, "monthOfPublication": 7, "volume": "31", "yearOfPublication": 2014, "journalIssueId": 2180902, "issue": "7", "dateOfPublication": "2014 Jul"}}, "17548691": "", "11480169": "", "17608547": "", "19598248": "", "15692831": "", "24125961": {"pubYear": "2013", "dateOfCreation": "2013-12-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.14.14.1", "name": "cytochrome P-450 CYP3A"}, {"registryNumber": "EC 1.14.13.67", "name": "CYP3A4 protein, human"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}, {"registryNumber": "0", "name": "NAV1.1 Voltage-Gated Sodium Channel"}, {"registryNumber": "0", "name": "SCN1A protein, human"}, {"registryNumber": "33CM23913M", "name": "Carbamazepine"}]}, "authorString": "Yun W, Zhang F, Hu C, Luo X, Xue P, Wang J, Ge Y, Meng H, Guo Y.", "affiliation": "The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun 130021, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24125961", "inEPMC": "N", "authorList": {"author": [{"affiliation": "The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun 130021, China.", "fullName": "Yun W", "initials": "W", "firstName": "Wenting", "lastName": "Yun"}, {"lastName": "Zhang", "fullName": "Zhang F", "firstName": "Feng", "initials": "F"}, {"lastName": "Hu", "fullName": "Hu C", "firstName": "Cheng", "initials": "C"}, {"lastName": "Luo", "fullName": "Luo X", "firstName": "Xiaopei", "initials": "X"}, {"lastName": "Xue", "fullName": "Xue P", "firstName": "Peng", "initials": "P"}, {"lastName": "Wang", "fullName": "Wang J", "firstName": "Jing", "initials": "J"}, {"lastName": "Ge", "fullName": "Ge Y", "firstName": "Yubin", "initials": "Y"}, {"lastName": "Meng", "fullName": "Meng H", "firstName": "Hongmei", "initials": "H"}, {"lastName": "Guo", "fullName": "Guo Y", "firstName": "Yingjie", "initials": "Y"}]}, "title": "Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.", "citedByCount": 3, "source": "MED", "pmid": "24125961", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carbamazepine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Drug Resistance", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP3A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "NAV1.1 Voltage-Gated Sodium Channel", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-09-30", "doi": "10.1016/j.eplepsyres.2013.09.011", "isOpenAccess": "N", "pageInfo": "231-237", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Polymorphism", "Epilepsy", "plasma concentration", "carbamazepine", "Pharmacoresistance"]}, "abstractText": "The pharmacokinetics and pharmacodynamics of carbamazepine (CBZ) vary widely among patients with epilepsy. In this study, we sought to investigate the effects of genetic polymorphisms of the microsomal epoxide hydrolase (EPHX1), the sodium channel \u03b1 subunit type I (SCN1A) and the cytochrome P450 3A4 (CYP3A4) genes on plasma CBZ concentrations and pharmacoresistance in Chinese patients with epilepsy. The EPHX1 c.337T>C, c.416A>G, SCN1A IVS5-91G>A or CYP3A4*1G polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism approach or direct DNA sequencing in 83 Chinese patients treated with CBZ monotherapy. Patients with the variant EPHX1 c.416A>G genotypes had higher adjusted plasma CBZ concentrations compared to those with the wild type genotype (P<0.05). In contrast, the SCN1A IVS5-91G>A and CYP3A4*1G variant alleles had no significant effects on CBZ maintenance doses or adjusted CBZ concentrations. There were no associations between all the studied genotypes involving EPHX1 c.337T>C, c.416A>G, SCN1A IVS5-91G>A or CYP3A4*1G polymorphisms and pharmacoresistance in this patient cohort. These results suggest that the EPHX1 c.416A>G polymorphism affects CBZ metabolism in Chinese patients with epilepsy. However, whether it contributes to CBZ resistance needs to be further investigated in a larger cohort of patients.", "electronicPublicationDate": "2013-09-30", "language": "eng", "dateOfCompletion": "2014-08-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.eplepsyres.2013.09.011", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-12-01", "journal": {"medlineAbbreviation": "Epilepsy Res", "isoabbreviation": "Epilepsy Res.", "title": "Epilepsy research", "issn": "0920-1211", "nlmid": "8703089", "essn": "1872-6844"}, "monthOfPublication": 12, "volume": "107", "yearOfPublication": 2013, "journalIssueId": 2099309, "issue": "3", "dateOfPublication": "2013 Dec"}}, "23252947": {"pubYear": "2013", "dateOfCreation": "2012-12-20", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "pregnane X receptor"}, {"registryNumber": "0", "name": "multidrug resistance-associated protein 2"}, {"registryNumber": "0", "name": "Anticonvulsants"}, {"registryNumber": "298-46-4", "name": "Carbamazepine"}, {"registryNumber": "0", "name": "Receptors, Steroid"}, {"registryNumber": "0", "name": "P-Glycoprotein"}, {"registryNumber": "0", "name": "Multidrug Resistance-Associated Proteins"}, {"registryNumber": "EC 1.14.14.1", "name": "cytochrome P-450 CYP3A"}, {"registryNumber": "EC 1.14.13.67", "name": "CYP3A4 protein, human"}, {"registryNumber": "0", "name": "ABCB1 protein, human"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Puranik YG, Birnbaum AK, Marino SE, Ahmed G, Cloyd JC, Remmel RP, Leppik IE, Lamba JK.", "affiliation": "Department of Experimental & Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "K01NS050309"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG026390"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "P50 NS16308"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "P50 NS016308"}]}, "hasPDF": "Y", "id": "23252947", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Puranik", "fullName": "Puranik YG", "firstName": "Yogita Ghodke", "initials": "YG"}, {"lastName": "Birnbaum", "fullName": "Birnbaum AK", "firstName": "Angela K", "initials": "AK"}, {"lastName": "Marino", "fullName": "Marino SE", "firstName": "Susan E", "initials": "SE"}, {"lastName": "Ahmed", "fullName": "Ahmed G", "firstName": "Ghada", "initials": "G"}, {"lastName": "Cloyd", "fullName": "Cloyd JC", "firstName": "James C", "initials": "JC"}, {"lastName": "Remmel", "fullName": "Remmel RP", "firstName": "Rory P", "initials": "RP"}, {"lastName": "Leppik", "fullName": "Leppik IE", "firstName": "Ilo E", "initials": "IE"}, {"lastName": "Lamba", "fullName": "Lamba JK", "firstName": "Jatinder K", "initials": "JK"}]}, "title": "Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.", "hasSuppl": "Y", "citedByCount": 12, "source": "MED", "pmid": "23252947", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carbamazepine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Multidrug Resistance-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "P-Glycoprotein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Steroid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anticonvulsants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biological Transport", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP3A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-01-01", "doi": "10.2217/pgs.12.180", "isOpenAccess": "N", "pageInfo": "35-45", "pmcid": "PMC3570048", "hasDbCrossReferences": "N", "abstractText": " AIM: The aim of this study was to evaluate the association of genetic variants in the major genes involved in carbamazepine (CBZ) metabolism and transport with its pharmacokinetics in epilepsy patients. MATERIALS & METHODS: Twenty-five SNPs within seven CBZ pathway genes, namely CYP3A4, CYP3A5, EPHX1, NR1I2, UGT2B7, ABCB1 and ABCC2, were analyzed for association with CBZ pharmacokinetics in 90 epilepsy patients. RESULTS: The CYP3A4*1B SNP was significantly associated with CBZ clearance. Significant association of EPHX1 SNPs was observed with greater carbamazepine-10,11-trans dihydrodiol:carbamazepine 10-11 epoxide ratios. Among drug transporters, ABCB1 and ABCC2 SNPs were significantly associated with altered CBZ clearance. CONCLUSION: SNPs within CBZ pathway genes contribute to interpatient variation in CBZ pharmacokinetics and might contribute to pharmacoresistant epilepsy. Although our results need further clinical validation in a larger patient cohort, they indicate that genetic variation in CBZ pathway genes could influence its pharmacokinetics, and hence would have clinical significance.", "language": "eng", "dateOfCompletion": "2013-09-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3570048?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3570048", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23252947", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23252947&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.futuremedicine.com/doi/abs/10.2217/pgs.12.180", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "www.futuremedicine.com"}, {"url": "http://dx.doi.org/10.2217/pgs.12.180", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://www.futuremedicine.com/doi/pdf/10.2217/pgs.12.180", "documentStyle": "pdf", "availability": "Subscription required", "availabilityCode": "S", "site": "www.futuremedicine.com"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-11-06", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Pharmacogenomics", "isoabbreviation": "Pharmacogenomics", "title": "Pharmacogenomics", "issn": "1462-2416", "nlmid": "100897350", "essn": "1744-8042"}, "monthOfPublication": 1, "volume": "14", "yearOfPublication": 2013, "journalIssueId": 1994279, "issue": "1", "dateOfPublication": "2013 Jan"}}, "22257321": {"pubYear": "2013", "dateOfCreation": "2013-01-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HEPN1 protein, human"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Bhaskar LV, Thangaraj K, Patel M, Shah AM, Gopal K, Saikrishna L, Tamang R, Singh L, Rao VR.", "affiliation": "Centre for Cellular and Molecular Biology, Hyderabad, India.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22257321", "inEPMC": "N", "authorList": {"author": [{"lastName": "Bhaskar", "fullName": "Bhaskar LV", "firstName": "L V K S", "initials": "LV"}, {"lastName": "Thangaraj", "fullName": "Thangaraj K", "firstName": "K", "initials": "K"}, {"lastName": "Patel", "fullName": "Patel M", "firstName": "Minarbha", "initials": "M"}, {"lastName": "Shah", "fullName": "Shah AM", "firstName": "Anish M", "initials": "AM"}, {"lastName": "Gopal", "fullName": "Gopal K", "firstName": "K", "initials": "K"}, {"lastName": "Saikrishna", "fullName": "Saikrishna L", "firstName": "L", "initials": "L"}, {"lastName": "Tamang", "fullName": "Tamang R", "firstName": "Rakesh", "initials": "R"}, {"lastName": "Singh", "fullName": "Singh L", "firstName": "Lalji", "initials": "L"}, {"lastName": "Rao", "fullName": "Rao VR", "firstName": "V R", "initials": "VR"}]}, "title": "EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations.", "citedByCount": 1, "source": "MED", "pmid": "22257321", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2977-6454"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alcoholism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "India", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-01-19", "doi": "10.3109/00952990.2011.643991", "isOpenAccess": "N", "pageInfo": "16-22", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: The microsomal epoxide hydrolase is a phase II enzyme of the biotransformation. The human epoxide hydrolase 1 (EPHX1) gene lies in the chromosomal region 1q42.1 and exhibits polymorphism. Two single nucleotide polymorphisms (SNPs) have been described in the coding region of the EPHX1 gene that produces two protein variants. SUBJECTS AND METHODS: A total of 604 samples belonging to 13 Indian populations were included in this study. Based on the DSM-IV criteria, 184 individuals from Kota population were classified into alcoholism cases (100) and controls (84). Genotypes of Tyr113His and His139Arg polymorphisms in the EPHX1 gene were determined using PCR and sequencing. Associations were tested using Pearson's \u03c7(2) test and haplotype analyses. RESULTS: We found significant association between EPHX1 gene Tyr113His polymorphism and alcoholism in the Kota population (T vs. C: OR = .615, 95% CI = .399-.949, p = .027; TT vs. CC + CT: OR = .536, 95% CI = .297-.969, p = .038). The very slow activity haplotype CA (113His-139His) was also found to be associated with alcohol dependence (p = .048). Analysis of additional populations demonstrated that the Tyr113His polymorphism significantly deviated from Hardy-Weinberg equilibrium in four populations but only one population deviated for the His139Arg locus. All populations shared the four possible two-site haplotypes. Linkage disequilibrium between these two loci was not significant in any of the population studied. CONCLUSION: EPHX1 gene polymorphisms and haplotypes are associated with an increased risk for alcoholism in the Kota population. This is the first report from India that will serve as a template for future investigations of the prevalence of EPHX1 alleles in association with various clinical entities.", "electronicPublicationDate": "2012-01-19", "language": "eng", "dateOfCompletion": "2013-06-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/00952990.2011.643991", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Am J Drug Alcohol Abuse", "isoabbreviation": "Am J Drug Alcohol Abuse", "title": "The American journal of drug and alcohol abuse", "issn": "0095-2990", "nlmid": "7502510", "essn": "1097-9891"}, "monthOfPublication": 1, "volume": "39", "yearOfPublication": 2013, "journalIssueId": 1997939, "issue": "1", "dateOfPublication": "2013 Jan"}}, "8222491": "", "22103900": {"pubYear": "2012", "dateOfCreation": "2011-11-22", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Neoplasm Proteins"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Sivonova MK, Dobrota D, Matakova T, Dusenka R, Grobarcikova S, Habala V, Salagovic J, Tajtakova M, Pidanicova A, Valansky L, Lachvacs L, Kliment J, Nagy V, Kliment J.", "affiliation": "Department of Medical Biochemistry, Comenius University, Bratislava, Slovakia. sivonova@jfmed.uniba.sk", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22103900", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sivonova", "fullName": "Sivonova MK", "firstName": "M Kmetov", "initials": "MK"}, {"lastName": "Dobrota", "fullName": "Dobrota D", "firstName": "D", "initials": "D"}, {"lastName": "Matakova", "fullName": "Matakova T", "firstName": "T", "initials": "T"}, {"lastName": "Dusenka", "fullName": "Dusenka R", "firstName": "R", "initials": "R"}, {"lastName": "Grobarcikova", "fullName": "Grobarcikova S", "firstName": "S", "initials": "S"}, {"lastName": "Habala", "fullName": "Habala V", "firstName": "V", "initials": "V"}, {"lastName": "Salagovic", "fullName": "Salagovic J", "firstName": "J", "initials": "J"}, {"lastName": "Tajtakova", "fullName": "Tajtakova M", "firstName": "M", "initials": "M"}, {"lastName": "Pidanicova", "fullName": "Pidanicova A", "firstName": "A", "initials": "A"}, {"lastName": "Valansky", "fullName": "Valansky L", "firstName": "L", "initials": "L"}, {"lastName": "Lachvacs", "fullName": "Lachvacs L", "firstName": "L", "initials": "L"}, {"lastName": "Kliment", "fullName": "Kliment J Jr", "firstName": "J", "initials": "J"}, {"lastName": "Nagy", "fullName": "Nagy V", "firstName": "V", "initials": "V"}, {"lastName": "Kliment", "fullName": "Kliment J", "firstName": "J", "initials": "J"}]}, "title": "Microsomal epoxide hydrolase polymorphisms, cigarette smoking  and prostate cancer risk in the Slovak population.", "citedByCount": 4, "source": "MED", "pmid": "22103900", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Microsomes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Adenocarcinoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prostatic Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neoplasm Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Risk", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Substitution", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biotransformation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Exons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Slovakia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2012-01-01", "doi": "10.4149/neo_2012_010", "isOpenAccess": "N", "pageInfo": "79-84", "hasDbCrossReferences": "Y", "abstractText": "Polymorphisms in tobacco carcinogen metabolizing enzymes may generate interindividual variations towards the risk of developing prostate cancer. One of these enzymes is microsomal epoxide hydrolase (EPHX1) which metabolizes polycyclic aromatic hydrocarbons, or PAH, carcinogens found in cigarette smoke. The activity of this enzyme is affected by two polymorphisms, a substitution of Tyr113 by His in exon 3 and a substitution of His139 by Arg in exon 4. The aim of this study was to use a population-based case-control study to investigate whether or not such genetic polymorphisms in EPHX1 gene can modify the relationship between smoking status and the risk of developing prostate cancer. We used restriction fragment length polymorphism, or PCR-RFLP to determine EPHX1 genotypes in subjects comprising 194 patients with histologically verified prostate cancer and 305 healthy individuals as control. We found no overall association between prostate cancer risk and functional polymorphisms of EPHX1 gene in exon 3 and exon 4. We further analysed the association between the EPHX1 genotypes and smoking. Smokers carrying the exon 3 Tyr/Tyr and Tyr/His genotypes were at no significant risk compared to non-smokers with the \"rapid\" Tyr/Tyr genotype. By contrast, a significant interaction of smoking and the exon 4 polymorphism was present.", "language": "eng", "dateOfCompletion": "2012-07-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.4149/neo_2012_010", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "www.elis.sk"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Neoplasma", "isoabbreviation": "Neoplasma", "title": "Neoplasma", "issn": "0028-2685", "nlmid": "0377266", "essn": "1338-4317"}, "monthOfPublication": 0, "volume": "59", "yearOfPublication": 2012, "journalIssueId": 1882646, "issue": "1", "dateOfPublication": "2012 "}}, "10676631": "", "22118311": {"pubYear": "2011", "dateOfCreation": "2011-11-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Bronchodilator Agents"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Chen CZ, Wang RH, Lee CH, Lin CC, Chang HY, Hsiue TR.", "affiliation": "Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Medical College and Hospital, No. 138 Sheng-Li Road, Tainan 704, Taiwan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22118311", "inEPMC": "N", "authorList": {"author": [{"lastName": "Chen", "fullName": "Chen CZ", "firstName": "Chiung-Zuei", "initials": "CZ"}, {"lastName": "Wang", "fullName": "Wang RH", "firstName": "Ru-Hsueh", "initials": "RH"}, {"lastName": "Lee", "fullName": "Lee CH", "firstName": "Cheng-Hung", "initials": "CH"}, {"lastName": "Lin", "fullName": "Lin CC", "firstName": "Chien-Chung", "initials": "CC"}, {"lastName": "Chang", "fullName": "Chang HY", "firstName": "Han-Yu", "initials": "HY"}, {"lastName": "Hsiue", "fullName": "Hsiue TR", "firstName": "Tzuen-Ren", "initials": "TR"}]}, "title": "Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response.", "citedByCount": 3, "source": "MED", "pmid": "22118311", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pulmonary Disease, Chronic Obstructive", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Bronchodilator Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Polymorphism, Restriction Fragment Length", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2011-10-20", "doi": "10.1016/j.jfma.2011.09.003", "isOpenAccess": "N", "pageInfo": "685-689", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND/PURPOSE: Microsomal epoxide hydrolase (EPHX) is an important enzyme that metabolizes harmful reactive epoxides from smoking. Genetic variations of this enzyme are thought to increase the risk of developing chronic obstructive pulmonary disease (COPD). The aim of this study was to confirm and advance our knowledge of the role of this genetic variation in COPD. In addition, the association between this gene and important COPD-related phenotype bronchodilator responses (BDRs) was studied. METHODS: This was a hospital-based case-control study. The EPHX1 genetic mutations of 105 smokers with COPD and 103 control smokers without COPD were evaluated by polymerase chain reaction, followed by restriction fragment length polymorphism analysis. The association of genetic mutations and COPD phenotypes was also studied. RESULTS: Subjects with EPHX1 113 (His(113)/His(113)) homozygote mutation had a strong correlation with COPD (odds ratio: 2.7, 95% confidence interval: 1.5-5.2). In addition, compared with other genotypes, the His(113) homozygote mutation patients had significantly lower BDRs, as shown by the absolute and percentage changes from baseline, in COPD patients (91.7\u00a0\u00b1\u00a012.5\u00a0mL vs. 141.6\u00a0\u00b1\u00a015.1\u00a0mL, p\u00a0=\u00a00.01 and 8.3\u00a0\u00b1\u00a01.2% vs. 13.4\u00a0\u00b1\u00a01.4%, p\u00a0=\u00a00.006). CONCLUSION: A strong correlation between the EPHX1 113 mutant homozygote and smoking-related COPD was noted. This genetic polymorphism was also associated with lower BDRs in COPD patients.", "electronicPublicationDate": "2011-10-20", "language": "eng", "dateOfCompletion": "2012-03-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jfma.2011.09.003", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-11-01", "journal": {"title": "Journal of the Formosan Medical Association = Taiwan yi zhi", "issn": "0929-6646", "isoabbreviation": "J. Formos. Med. Assoc.", "medlineAbbreviation": "J Formos Med Assoc", "nlmid": "9214933"}, "monthOfPublication": 11, "volume": "110", "yearOfPublication": 2011, "journalIssueId": 1883674, "issue": "11", "dateOfPublication": "2011 Nov"}}, "21097530": "", "12141066": "", "22928041": {"pubYear": "2012", "dateOfCreation": "2012-08-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Liu F, Yuan D, Wei Y, Wang W, Yan L, Wen T, Xu M, Yang J, Li B.", "affiliation": "Division of Liver Transplantation, Department of Liver and Vascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.", "pubTypeList": {"pubType": ["Journal Article", "Meta-Analysis", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22928041", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Liu", "fullName": "Liu F", "firstName": "Fei", "initials": "F"}, {"lastName": "Yuan", "fullName": "Yuan D", "firstName": "Ding", "initials": "D"}, {"lastName": "Wei", "fullName": "Wei Y", "firstName": "Yonggang", "initials": "Y"}, {"lastName": "Wang", "fullName": "Wang W", "firstName": "Wentao", "initials": "W"}, {"lastName": "Yan", "fullName": "Yan L", "firstName": "Lvnan", "initials": "L"}, {"lastName": "Wen", "fullName": "Wen T", "firstName": "Tianfu", "initials": "T"}, {"lastName": "Xu", "fullName": "Xu M", "firstName": "Mingqing", "initials": "M"}, {"lastName": "Yang", "fullName": "Yang J", "firstName": "Jiayin", "initials": "J"}, {"lastName": "Li", "fullName": "Li B", "firstName": "Bo", "initials": "B"}]}, "title": "Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.", "hasSuppl": "Y", "citedByCount": 13, "source": "MED", "pmid": "22928041", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Colorectal Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Publication Bias", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-08-23", "doi": "10.1371/journal.pone.0043821", "isOpenAccess": "Y", "pageInfo": "e43821", "pmcid": "PMC3426545", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Microsomal epoxide hydrolase (EPHX1) plays an important role in both the activation and detoxification of PAHs, which are carcinogens found in cooked meat and tobacco smoking. Polymorphisms at exons 3 and 4 of the EPHX1 gene have been reported to be associated with variations in EPHX1 activity. The aim of this study is to quantitatively summarize the relationship between EPHX1 polymorphisms and colorectal cancer (CRC) risk. METHODS: Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Databases for studies published before June 2012. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for EPHX1 Tyr113His (rs1051740) and His139Arg (rs2234922) polymorphisms and CRC were calculated in a fixed-effects model and a random-effects model when appropriate. RESULTS: This meta-analysis yielded 14 case-control studies, which included 13 studies for Tyr113His (6395 cases and 7893 controls) and 13 studies for His139Arg polymorphisms (5375 cases and 6962 controls). Overall, the pooled results indicated that EPHX1 Tyr113His polymorphism was not associated with CRC risk; while the His139Arg polymorphism was significantly associated with decreased CRC risk (Arg/His vs. His/His, OR\u200a=\u200a0.90, 95%CI\u200a=\u200a0.83-0.98; dominant model, OR\u200a=\u200a0.92, 95%CI\u200a=\u200a0.85-0.99). The statistically significant association between EPHX1 His139Arg polymorphism and CRC was observed among Caucasians and population-based case-control studies. This association showed little heterogeneity and remained consistently strong when analyses were limited to studies in which genotype frequencies were in Hardy-Weinberg equilibrium, or limited to studies with matched controls. When cumulative meta-analyses of the two associations were conducted by studies' publication time, the results were persistent and robust. CONCLUSION: This meta-analysis suggests that EPHX1 Tyr113His polymorphism may be not associated with CRC development; while the EPHX1 His139Arg polymorphism may have a potential protective effect on CRC.", "electronicPublicationDate": "2012-08-23", "language": "eng", "dateOfCompletion": "2013-01-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3426545?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3426545", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22928041", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22928041&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0043821", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1942688, "issue": "8", "dateOfPublication": "2012 "}}, "27220440": {"pubYear": "2016", "dateOfCreation": "2016-05-25", "pubModel": "Print", "authorString": "Wang HY, Ma YM, Cui JZ, Zhao D, Liu AJ, Hong J, Lu YG, Wang KJ.", "affiliation": "Department of Neurosurgery, Worker's Hospital of Tangshan, Tangshan 063000, China.", "pubTypeList": {"pubType": ["Journal Article", "English Abstract"]}, "id": "27220440", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Neurosurgery, Worker's Hospital of Tangshan, Tangshan 063000, China.", "fullName": "Wang HY", "initials": "HY", "firstName": "H Y", "lastName": "Wang"}, {"lastName": "Ma", "fullName": "Ma YM", "firstName": "Y M", "initials": "YM"}, {"lastName": "Cui", "fullName": "Cui JZ", "firstName": "J Z", "initials": "JZ"}, {"lastName": "Zhao", "fullName": "Zhao D", "firstName": "D", "initials": "D"}, {"lastName": "Liu", "fullName": "Liu AJ", "firstName": "A J", "initials": "AJ"}, {"lastName": "Hong", "fullName": "Hong J", "firstName": "J", "initials": "J"}, {"lastName": "Lu", "fullName": "Lu YG", "firstName": "Y G", "initials": "YG"}, {"lastName": "Wang", "fullName": "Wang KJ", "firstName": "K J", "initials": "KJ"}]}, "title": "[The role of smoking and metabolic enzyme polymorphisms in the organic solvent induced chronic encephalopathy].", "citedByCount": 0, "source": "MED", "pmid": "27220440", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-03-01", "doi": "10.3760/cma.j.issn.1001-9391.2016.03.009", "isOpenAccess": "N", "pageInfo": "199-202", "hasDbCrossReferences": "N", "abstractText": "The organic solvents and other exogenous compounds of metabolic enzymes genetic variation may affect the risk of the toxic effect of organic solvents exposure. Therefore, this research we observed the glutathione transferase M1 and T1 (GSTM1, GSTT1) deletion mutation genotype, two kinds of microsomal epoxide hydrolase (mEPHX) genetic polymorphism, organic solvents exposure and smoking effection in chronic cases of toxic encephalopathy (CTE) correlation.The object was 115 patients who had a long history of organic solvents exposure, were divieded into two groups: CTE (n=83) , no CET (n=32) according to clinical diagnosis. DNA was isolated from patients in white blood cells through the multiple-polymerase chain reaction to determine the loss of GSTM1 and GSTT1 genotype. two kinds of mEPHX polymorphism were analysised through the PCR-RFLP (restriction fragment length polymorphism).The relative risk has obviously improved when lack of GSTM1 genotypes to CTE (RR=2.35, 95% CI 2.35 0.96). in according to the patient's Smoking condition and classify genotype, patients lack of GSTM1 genotypes had a significantly higher risk CTE than GSTM1+genotype patients (RR=3.13, 95% CI 3.13 1.2) , both mEPHX polymorphisms had nothing to do with an increased risk of CTE.The GSTM1 genotypes played an important role in the organic solvent induced the CTE of susceptibility.it was Influenced by the interaction between smoking at the same time.", "language": "chi", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3760/cma.j.issn.1001-9391.2016.03.009", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-03-01", "journal": {"title": "Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases", "issn": "1001-9391", "isoabbreviation": "Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi", "medlineAbbreviation": "Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi", "nlmid": "8410840"}, "monthOfPublication": 3, "volume": "34", "yearOfPublication": 2016, "journalIssueId": 2411967, "issue": "3", "dateOfPublication": "2016 Mar"}}, "11815396": "", "22206016": {"pubYear": "2011", "dateOfCreation": "2011-12-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.14.14.1", "name": "Cytochrome P-450 CYP1A1"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Ihsan R, Chauhan PS, Mishra AK, Yadav DS, Kaushal M, Sharma JD, Zomawia E, Verma Y, Kapur S, Saxena S.", "affiliation": "National Institute of Pathology (Indian Council of Medical Research) Safdarjung Hospital Campus, New Delhi, India.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "Y", "id": "22206016", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Ihsan", "fullName": "Ihsan R", "firstName": "Rakhshan", "initials": "R"}, {"lastName": "Chauhan", "fullName": "Chauhan PS", "firstName": "Pradeep Singh", "initials": "PS"}, {"lastName": "Mishra", "fullName": "Mishra AK", "firstName": "Ashwani Kumar", "initials": "AK"}, {"lastName": "Yadav", "fullName": "Yadav DS", "firstName": "Dhirendra Singh", "initials": "DS"}, {"lastName": "Kaushal", "fullName": "Kaushal M", "firstName": "Mishi", "initials": "M"}, {"lastName": "Sharma", "fullName": "Sharma JD", "firstName": "Jagannath Dev", "initials": "JD"}, {"lastName": "Zomawia", "fullName": "Zomawia E", "firstName": "Eric", "initials": "E"}, {"lastName": "Verma", "fullName": "Verma Y", "firstName": "Yogesh", "initials": "Y"}, {"lastName": "Kapur", "fullName": "Kapur S", "firstName": "Sujala", "initials": "S"}, {"lastName": "Saxena", "fullName": "Saxena S", "firstName": "Sunita", "initials": "S"}]}, "title": "Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.", "hasSuppl": "Y", "citedByCount": 28, "source": "MED", "pmid": "22206016", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP1A1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "False Positive Reactions", "majorTopic_YN": "N"}, {"descriptorName": "Logistic Models", "majorTopic_YN": "N"}, {"descriptorName": "Probability", "majorTopic_YN": "N"}, {"descriptorName": "Statistics, Nonparametric", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Sample Size", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Data Mining", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Multifactor Dimensionality Reduction", "majorTopic_YN": "N"}, {"descriptorName": "Gene-Environment Interaction", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-12-19", "doi": "10.1371/journal.pone.0029431", "isOpenAccess": "Y", "pageInfo": "e29431", "pmcid": "PMC3242784", "hasDbCrossReferences": "N", "abstractText": "Complex disease such as cancer results from interactions of multiple genetic and environmental factors. Studying these factors singularly cannot explain the underlying pathogenetic mechanism of the disease. Multi-analytical approach, including logistic regression (LR), classification and regression tree (CART) and multifactor dimensionality reduction (MDR), was applied in 188 lung cancer cases and 290 controls to explore high order interactions among xenobiotic metabolizing genes and environmental risk factors. Smoking was identified as the predominant risk factor by all three analytical approaches. Individually, CYP1A1*2A polymorphism was significantly associated with increased lung cancer risk (OR\u200a=\u200a1.69;95%CI\u200a=\u200a1.11-2.59,p\u200a=\u200a0.01), whereas EPHX1 Tyr113His and SULT1A1 Arg213His conferred reduced risk (OR\u200a=\u200a0.40;95%CI\u200a=\u200a0.25-0.65,p<0.001 and OR\u200a=\u200a0.51;95%CI\u200a=\u200a0.33-0.78,p\u200a=\u200a0.002 respectively). In smokers, EPHX1 Tyr113His and SULT1A1 Arg213His polymorphisms reduced the risk of lung cancer, whereas CYP1A1*2A, CYP1A1*2C and GSTP1 Ile105Val imparted increased risk in non-smokers only. While exploring non-linear interactions through CART analysis, smokers carrying the combination of EPHX1 113TC (Tyr/His), SULT1A1 213GG (Arg/Arg) or AA (His/His) and GSTM1 null genotypes showed the highest risk for lung cancer (OR\u200a=\u200a3.73;95%CI\u200a=\u200a1.33-10.55,p\u200a=\u200a0.006), whereas combined effect of CYP1A1*2A 6235CC or TC, SULT1A1 213GG (Arg/Arg) and betel quid chewing showed maximum risk in non-smokers (OR\u200a=\u200a2.93;95%CI\u200a=\u200a1.15-7.51,p\u200a=\u200a0.01). MDR analysis identified two distinct predictor models for the risk of lung cancer in smokers (tobacco chewing, EPHX1 Tyr113His, and SULT1A1 Arg213His) and non-smokers (CYP1A1*2A, GSTP1 Ile105Val and SULT1A1 Arg213His) with testing balance accuracy (TBA) of 0.6436 and 0.6677 respectively. Interaction entropy interpretations of MDR results showed non-additive interactions of tobacco chewing with SULT1A1 Arg213His and EPHX1 Tyr113His in smokers and SULT1A1 Arg213His with GSTP1 Ile105Val and CYP1A1*2C in nonsmokers. These results identified distinct gene-gene and gene environment interactions in smokers and non-smokers, which confirms the importance of multifactorial interaction in risk assessment of lung cancer.", "electronicPublicationDate": "2011-12-19", "language": "eng", "dateOfCompletion": "2012-04-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3242784?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3242784", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22206016", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22206016&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0029431", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2011, "journalIssueId": 1885771, "issue": "12", "dateOfPublication": "2011 "}}, "14992466": "", "18614560": "", "10643291": "", "11849215": "", "10913664": "", "15349030": "", "11692079": "", "20516053": "", "11352855": "", "15746160": "", "12484240": "", "22994552": {"pubYear": "2012", "dateOfCreation": "2012-10-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Neoplasm Proteins"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Lupo PJ, Nousome D, Okcu MF, Chintagumpala M, Scheurer ME.", "affiliation": "Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K07 CA131505"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P50 CA127001"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30CA125123"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K07CA131505"}]}, "hasPDF": "Y", "id": "22994552", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Philip J", "lastName": "Lupo", "affiliation": "Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-0978-5863"}, "fullName": "Lupo PJ", "initials": "PJ"}, {"lastName": "Nousome", "fullName": "Nousome D", "firstName": "Darryl", "initials": "D"}, {"lastName": "Okcu", "fullName": "Okcu MF", "firstName": "M Fatih", "initials": "MF"}, {"lastName": "Chintagumpala", "fullName": "Chintagumpala M", "firstName": "Murali", "initials": "M"}, {"lastName": "Scheurer", "fullName": "Scheurer ME", "authorId": {"type": "ORCID", "value": "0000-0002-8379-6088"}, "firstName": "Michael E", "initials": "ME"}]}, "title": "Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "22994552", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0978-5863"}, {"type": "ORCID", "value": "0000-0002-8379-6088"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neoplasm Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-09-20", "doi": "10.3109/08880018.2012.722747", "isOpenAccess": "N", "pageInfo": "679-685", "pmcid": "PMC3855527", "hasDbCrossReferences": "Y", "abstractText": "Common epidemiologic study designs used for evaluating germline genetic determinants of childhood medulloblastoma are often subject to population stratification bias and do not account for maternal genetic effects, a proxy for the intrauterine environment, which may be important in determining etiologic factors for this outcome. The case-parent triad design overcomes these limitations. Therefore, we conducted an exploratory study among 27 childhood medulloblastoma case-parent triads recruited from the Childhood Cancer Epidemiology and Prevention Center at Texas Children's Hospital (Houston, USA) between 2003 and 2010. We assessed 13 single nucleotide polymorphisms (SNPs) in nine xenobiotic detoxification genes, as deficiencies in this pathway may induce brain tumorigenesis. Log-linear modeling was used to assess the association between medulloblastoma and both the offspring (i.e., case) and maternal genotypes of each SNP. In our population, there were no offspring genotypes that were significantly associated with disease risk. However, the maternal EPHX1 rs1051740 genotype (RR = 3.26, P = .01) was associated with medulloblastoma risk. This exploratory study highlights the utility of the case-parent triad design, but these results should be interpreted cautiously due to the limited sample size.", "electronicPublicationDate": "2012-09-20", "language": "eng", "dateOfCompletion": "2013-04-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3855527?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3855527", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22994552", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22994552&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.3109/08880018.2012.722747", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-12-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-11-01", "journal": {"medlineAbbreviation": "Pediatr Hematol Oncol", "isoabbreviation": "Pediatr Hematol Oncol", "title": "Pediatric hematology and oncology", "issn": "0888-0018", "nlmid": "8700164", "essn": "1521-0669"}, "monthOfPublication": 11, "volume": "29", "yearOfPublication": 2012, "journalIssueId": 1977889, "issue": "8", "dateOfPublication": "2012 Nov"}}, "25261893": {"pubYear": "2014", "dateOfCreation": "2015-03-02", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Yang X, Wang Y, Wang G.", "pubTypeList": {"pubType": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25261893", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Yang", "fullName": "Yang X", "firstName": "Xiaoqin", "initials": "X"}, {"lastName": "Wang", "fullName": "Wang Y", "firstName": "Yubing", "initials": "Y"}, {"lastName": "Wang", "fullName": "Wang G", "firstName": "Guiping", "initials": "G"}]}, "title": "Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25261893", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Risk", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Publication Bias", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-09-28", "language": "eng", "doi": "10.1186/s13046-014-0082-9", "isOpenAccess": "Y", "pageInfo": "82", "pmcid": "PMC4189664", "hasDbCrossReferences": "Y", "abstractText": "PURPOSE: Previous studies investigating the association between EPHX1 polymorphisms (Tyr113His and His139Arg) and cancer risk have yielded inconsistent results. This meta-analysis was performed to derive a more precise estimation of relationship between two EPHX1 polymorphisms and risk of different types of cancer. METHODS: Data were extracted from relevant studies detected by a systematic literature search. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of the association between EPHX1 polymorphisms and cancer risk. RESULTS: This meta-analysis carefully collected 99 studies on these two polymorphisms and cancer risk published up to March 2014, consisting of 45 studies (20,091 cases and 27,396 controls) for Tyr113His and 54 studies (19,437 cases and 27,289 controls) for His139Arg. The results in overall population did not show any significant association between these two polymorphisms and cancer risk for all genetic models. However, EPHX1 Tyr113His homozygote individuals have a significantly increased risk of cancer among Asians (homozygote model: OR =1.46, 95% CI=1.05-2.03; recessive model: OR =1.39, 95% CI =1.10-1.76) and mixed population (homozygote model: OR =1.17, 95% CI =1.02-1.34; recessive model: OR =1.17, 95% CI =1.02-1.33), but not Caucasians. CONCLUSION: His/His genotype of EPHX1 Tyr113His polymorphism is a risk factor for developing caner for Asian and mixed population, while no evidence was found for the association between the EPHX1 His139Arg polymorphism and increased cancer risk.", "electronicPublicationDate": "2014-09-28", "license": "cc by", "dateOfCompletion": "2015-09-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4189664?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4189664", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s13046-014-0082-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://dx.doi.org/10.1186/PREACCEPT-1877117814129047", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-03-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "J Exp Clin Cancer Res", "isoabbreviation": "J. Exp. Clin. Cancer Res.", "title": "Journal of experimental & clinical cancer research : CR", "issn": "0392-9078", "nlmid": "8308647", "essn": "1756-9966"}, "monthOfPublication": 0, "volume": "33", "yearOfPublication": 2014, "journalIssueId": 2130623, "dateOfPublication": "2014 "}}, "24861996": {"pubYear": "2014", "dateOfCreation": "2014-08-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anticonvulsants"}, {"registryNumber": "0", "name": "Histocompatibility Antigens Class I"}, {"registryNumber": "0", "name": "Molecular Chaperones"}, {"registryNumber": "0", "name": "P-Glycoprotein"}, {"registryNumber": "0", "name": "Antigens, CD95"}, {"registryNumber": "EC 1.14.14.1", "name": "cytochrome P-450 CYP3A"}, {"registryNumber": "0", "name": "MHC class I-related chain A"}, {"registryNumber": "EC 1.14.13.67", "name": "CYP3A4 protein, human"}, {"registryNumber": "0", "name": "FAS protein, human"}, {"registryNumber": "0", "name": "ABCB1 protein, human"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}, {"registryNumber": "0", "name": "BAG6 protein, human"}, {"registryNumber": "0", "name": "NAV1.1 Voltage-Gated Sodium Channel"}, {"registryNumber": "0", "name": "SCN1A protein, human"}, {"registryNumber": "33CM23913M", "name": "Carbamazepine"}]}, "authorString": "He XJ, Jian LY, He XL, Tang M, Wu Y, Xu YY, Sun XJ, Zhao LM.", "affiliation": "Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China; School of Pharmacy, China Medical University, Shenyang, China.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24861996", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China; School of Pharmacy, China Medical University, Shenyang, China.", "fullName": "He XJ", "initials": "XJ", "firstName": "Xiao-Jing", "lastName": "He"}, {"lastName": "Jian", "fullName": "Jian LY", "firstName": "Ling-Yan", "initials": "LY"}, {"lastName": "He", "fullName": "He XL", "firstName": "Xiao-Lin", "initials": "XL"}, {"lastName": "Tang", "fullName": "Tang M", "firstName": "Man", "initials": "M"}, {"lastName": "Wu", "fullName": "Wu Y", "firstName": "Yan", "initials": "Y"}, {"lastName": "Xu", "fullName": "Xu YY", "firstName": "Yuan-Yuan", "initials": "YY"}, {"lastName": "Sun", "fullName": "Sun XJ", "firstName": "Xiao-Jie", "initials": "XJ"}, {"lastName": "Zhao", "fullName": "Zhao LM", "firstName": "Li-Mei", "initials": "LM"}]}, "title": "Association of ABCB1,\u00a0CYP3A4,\u00a0EPHX1,\u00a0FAS,\u00a0SCN1A,\u00a0MICA, and\u00a0BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.", "citedByCount": 0, "source": "MED", "pmid": "24861996", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Stevens-Johnson Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carbamazepine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "P-Glycoprotein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD95", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Chaperones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anticonvulsants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Histocompatibility Antigens Class I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP3A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "NAV1.1 Voltage-Gated Sodium Channel", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-05-23", "doi": "10.1111/epi.12655", "isOpenAccess": "N", "pageInfo": "1301-1306", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["carbamazepine", "Ephx1", "Sjs/ten"]}, "abstractText": "OBJECTIVE: This study explored the association between the risk of carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and CBZ dose, dose-adjusted concentration, and ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms in patients of Han ethnicity with epilepsy who were living in northeastern China. MATERIALS AND METHODS: We determined the genotypes of patients with CBZ-SJS/TEN and CBZ-tolerant patients, who were used as controls, for ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms by polymerase chain reaction (PCR) amplification and direct sequencing. We measured the steady-state serum CBZ concentrations using fluorescence polarization immunoassay for the control patients. RESULTS: We observed statistically significant differences in EPHX1 c.337T>C polymorphisms between patients with CBZ-SJS/TEN and CBZ-tolerant controls in terms of allelic and genotypic frequencies (p = 0.011 and p = 0.007, respectively). The C allele and the C-G diplotype of EPHX1 may play important roles in increasing the risk of CBZ-SJS/TEN development (odds ratio [OR] 0.478, 95% confidence interval [CI] = 0.267-0.855, p = 0.011; OR = 0.213, 95% CI = 0.049-0.930, p = 0.025, respectively). We did not observe any significant associations between ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA or BAG6 genes and CBZ dose or dose-adjusted concentration in CBZ-tolerant patients. SIGNIFICANCE: We found a significant association between EPHX1 c.337T>C polymorphisms and the development of CBZ-SJS/TEN in patients of Han ethnicity living in northeastern China. EPHX1 c.337T>C polymorphisms may contribute to the risk of severe CBZ-SJS/TEN by increasing the concentration of a CBZ metabolite, CBZ-10,11-epoxide, in patients with epilepsy.", "electronicPublicationDate": "2014-05-23", "language": "eng", "dateOfCompletion": "2014-09-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/epi.12655", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-08-01", "journal": {"medlineAbbreviation": "Epilepsia", "isoabbreviation": "Epilepsia", "title": "Epilepsia", "issn": "0013-9580", "nlmid": "2983306R", "essn": "1528-1167"}, "monthOfPublication": 8, "volume": "55", "yearOfPublication": 2014, "journalIssueId": 2188870, "issue": "8", "dateOfPublication": "2014 Aug"}}, "24013430": {"pubYear": "2014", "dateOfCreation": "2014-02-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "11002-13-4", "name": "Angiotensinogen"}, {"registryNumber": "0", "name": "Estrogen Receptor alpha"}, {"registryNumber": "EC 1.14.13.39", "name": "NOS3 protein, human"}, {"registryNumber": "EC 1.14.13.39", "name": "Nitric Oxide Synthase Type III"}, {"registryNumber": "EC 3.3.2.-", "name": "Epoxide Hydrolases"}, {"registryNumber": "EC 3.3.2.9", "name": "EPHX1 protein, human"}]}, "authorString": "Groten T, Schleussner E, Lehmann T, Reister F, Holzer B, Danso KA, Zeillinger R.", "affiliation": "Department of Obstetrics, University Hospital Jena, Bachstrasse 18, 07743, Jena, Germany, tanja.groten@med.uni-jena.de.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "24013430", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Obstetrics, University Hospital Jena, Bachstrasse 18, 07743, Jena, Germany, tanja.groten@med.uni-jena.de.", "fullName": "Groten T", "initials": "T", "firstName": "T", "lastName": "Groten"}, {"lastName": "Schleussner", "fullName": "Schleussner E", "firstName": "E", "initials": "E"}, {"lastName": "Lehmann", "fullName": "Lehmann T", "firstName": "T", "initials": "T"}, {"lastName": "Reister", "fullName": "Reister F", "firstName": "F", "initials": "F"}, {"lastName": "Holzer", "fullName": "Holzer B", "firstName": "B", "initials": "B"}, {"lastName": "Danso", "fullName": "Danso KA", "firstName": "K A", "initials": "KA"}, {"lastName": "Zeillinger", "fullName": "Zeillinger R", "authorId": {"type": "ORCID", "value": "0000-0001-6771-4591"}, "firstName": "R", "initials": "R"}]}, "title": "eNOSI4 and EPHX1 polymorphisms affect maternal susceptibility to preeclampsia: analysis of five polymorphisms predisposing to cardiovascular disease in 279 Caucasian and 241 African women.", "citedByCount": 2, "source": "MED", "pmid": "24013430", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6771-4591"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pre-Eclampsia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epoxide Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Angiotensinogen", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Estrogen Receptor alpha", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Introns", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "African Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "European Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ghana", "majorTopic_YN": "N"}, {"descriptorName": "Germany", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Nitric Oxide Synthase Type III", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-09-08", "doi": "10.1007/s00404-013-2991-9", "isOpenAccess": "N", "pageInfo": "581-593", "hasDbCrossReferences": "Y", "abstractText": "PURPOSE: The aim of this study was to evaluate possible associations of genetic polymorphisms predisposing to cardiovascular disease with the development and/or the severity of preeclampsia. METHODS: A two hospital-based prospective case-control study was performed in Germany and Ghana. 470 blood samples of 250 Caucasian and 220 black African have been genotyped by pyrosequencing and fragment length analysis. We evaluated the distribution of the epoxide hydrolase 1 (EPHX1) polymorphism on exon 3, the endothelial nitric oxide synthase (eNOS) polymorphisms on exon 7 and on intron 4, the angiotensinogen polymorphism on exon 2 and the estrogen receptor 1 polymorphism in intron 1. RESULTS: 74 Caucasian and 84 African were classified as preeclampsia with 27 Caucasian developing a hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome and 17 African women experiencing eclampsia. Multivariate logistic regression analysis adjusting for ethnicity, age and parity revealed for carriers of eNOSI4 VNTR4a a 1.7-fold increased (95% CI 1.10-2.711, p = 0.016) risk to develop preeclampsia and a 3.6-fold increase for carriers of the EPHX1 113Tyr (95% CI 1.366-8.750, p = 0.009) to develop severest preeclampsia. CONCLUSION: Our finding of eNOSI4 polymorphism predisposing to preeclampsia independently of ethnicity, age and parity supports the concept of NO being involved in the endothelial disorder preeclampsia. Since EPHX1 is highly expressed in the liver, can interact with various signaling pathways and is involved in central nervous system disorders, the association of EPHX1 polymorphism with the HELLP syndrome and eclampsia may hint to EPHX being a further key player in the pathogenesis of preeclampsia.", "electronicPublicationDate": "2013-09-08", "language": "eng", "dateOfCompletion": "2014-10-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00404-013-2991-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-03-01", "journal": {"medlineAbbreviation": "Arch Gynecol Obstet", "isoabbreviation": "Arch. Gynecol. Obstet.", "title": "Archives of gynecology and obstetrics", "issn": "0932-0067", "nlmid": "8710213", "essn": "1432-0711"}, "monthOfPublication": 3, "volume": "289", "yearOfPublication": 2014, "journalIssueId": 2125998, "issue": "3", "dateOfPublication": "2014 Mar"}}, "17465707": "", "21598178": "", "12160895": "", "17611777": ""}, "DIP2A": {"26452339": {"pubYear": "2016", "dateOfCreation": "2016-02-16", "pubModel": "Print-Electronic", "authorString": "Kong R, Shao S, Wang J, Zhang X, Guo S, Zou L, Zhong R, Lou J, Zhou J, Zhang J, Song R.", "affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26452339", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Kong R", "initials": "R", "firstName": "Rui", "lastName": "Kong"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Shao S", "initials": "S", "firstName": "Shanshan", "lastName": "Shao"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Wang J", "initials": "J", "firstName": "Jia", "lastName": "Wang"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Zhang X", "initials": "X", "firstName": "Xiaohui", "lastName": "Zhang"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Guo S", "initials": "S", "firstName": "Shengnan", "lastName": "Guo"}, {"affiliation": "Department of Health Care, Baoan Maternal and Child Health Hospital, Shenzhen, China.", "fullName": "Zou L", "initials": "L", "firstName": "Li", "lastName": "Zou"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Zhong R", "initials": "R", "firstName": "Rong", "lastName": "Zhong"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Lou J", "initials": "J", "firstName": "Jiao", "lastName": "Lou"}, {"affiliation": "Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, District of Columbia.", "fullName": "Zhou J", "initials": "J", "firstName": "Jie", "lastName": "Zhou"}, {"affiliation": "Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, District of Columbia.", "fullName": "Zhang J", "initials": "J", "firstName": "Jiajia", "lastName": "Zhang"}, {"affiliation": "Department of Maternal and Child Health and MOE (Ministry of Education) Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.", "fullName": "Song R", "initials": "R", "firstName": "Ranran", "lastName": "Song"}]}, "title": "Genetic variant in DIP2A gene is associated with developmental dyslexia in Chinese population.", "citedByCount": 0, "source": "MED", "pmid": "26452339", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-10-09", "doi": "10.1002/ajmg.b.32392", "isOpenAccess": "N", "pageInfo": "203-208", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Chinese", "Single nucleotide polymorphism", "Association study", "Developmental Dyslexia", "Dip2a"]}, "abstractText": "Increasing evidence suggests that there is a substantial heritable component including several risk loci and candidate genes for developmental dyslexia (DD). DIP2A has been identified to be partially deleted on chromosome region 21q22.3, which cosegregates with DD. And it fits into a theoretical molecular network of DD implicated in the development of DD. Compared with some DD candidate genes that have been extensively studied (e.g., DYX1C1, DCDC2, KIAA0319, and ROBO1), very little is known about the association between candidate gene DIP2A and DD susceptibility. And given the linguistic and genetic differences between Chinese and other Western populations, it is worthwhile validating the association of DIP2A in Chinese dyslexic children. Here, we investigated two genetic variants, selected by bioinformatics analysis, in DIP2A in a Chinese population with 409 dyslexic cases and 410 healthy controls. We observed a significantly increased DD risk associated with rs2255526 G allele (OR\u2009=\u20091.297, 95% CI\u2009=\u20091.036-1.623, Padjusted \u2009=\u20090.023) and GG genotypes (OR\u2009=\u20091.833, 95% CI\u2009=\u20091.043-3.223, Padjusted \u2009=\u20090.035), compared with their wild-type counterparts. In addition, it was marginally significantly associated with DD under the recessive model (OR\u2009=\u20091.677, 95% CI\u2009=\u20090.967-2.908, Padjusted \u2009=\u20090.066) and the dominant model (OR\u2009=\u20091.314, 95% CI\u2009=\u20090.992-1.741, Padjusted \u2009=\u20090.057). However, we found no evidence of an association of SNP rs16979358 with DD. In conclusion, this study showed that a genetic variant in the DIP2A gene was associated with increased DD risk in China.", "electronicPublicationDate": "2015-10-09", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.b.32392", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-03-01", "journal": {"medlineAbbreviation": "Am J Med Genet B Neuropsychiatr Genet", "isoabbreviation": "Am. J. Med. Genet. B Neuropsychiatr. Genet.", "title": "American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics", "issn": "1552-4841", "nlmid": "101235742", "essn": "1552-485X"}, "monthOfPublication": 3, "volume": "171B", "yearOfPublication": 2016, "journalIssueId": 2420218, "issue": "2", "dateOfPublication": "2016 Mar"}}, "25877001": {"pubYear": "2015", "dateOfCreation": "2015-07-27", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Microtubule-Associated Proteins"}, {"registryNumber": "0", "name": "DCDC2 protein, human"}, {"registryNumber": "0", "name": "S100 Calcium Binding Protein beta Subunit"}, {"registryNumber": "0", "name": "S100B protein, human"}]}, "authorString": "Matsson H, Huss M, Persson H, Einarsdottir E, Tiraboschi E, Nopola-Hemmi J, Schumacher J, Neuhoff N, Warnke A, Lyytinen H, Schulte-K\u00f6rne G, N\u00f6then MM, Lepp\u00e4nen PH, Peyrard-Janvid M, Kere J.", "affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25877001", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "fullName": "Matsson H", "initials": "H", "firstName": "Hans", "lastName": "Matsson"}, {"firstName": "Mikael", "lastName": "Huss", "affiliation": "1] Science for Life Laboratory, Stockholm, Sweden [2] Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.", "authorId": {"type": "ORCID", "value": "0000-0003-0839-2451"}, "fullName": "Huss M", "initials": "M"}, {"firstName": "Helena", "lastName": "Persson", "affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "authorId": {"type": "ORCID", "value": "0000-0002-5187-6446"}, "fullName": "Persson H", "initials": "H"}, {"firstName": "Elisabet", "lastName": "Einarsdottir", "affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "authorId": {"type": "ORCID", "value": "0000-0003-3101-2285"}, "fullName": "Einarsdottir E", "initials": "E"}, {"affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "fullName": "Tiraboschi E", "initials": "E", "firstName": "Ettore", "lastName": "Tiraboschi"}, {"affiliation": "Division of Child Neurology, Department of Gynecology and Pediatrics, Jorvi Hospital, University Central Hospital, Espoo, Finland.", "fullName": "Nopola-Hemmi J", "initials": "J", "firstName": "Jaana", "lastName": "Nopola-Hemmi"}, {"affiliation": "Institute of Human Genetics and Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.", "fullName": "Schumacher J", "initials": "J", "firstName": "Johannes", "lastName": "Schumacher"}, {"affiliation": "Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Munich, Munich, Germany.", "fullName": "Neuhoff N", "initials": "N", "firstName": "Nina", "lastName": "Neuhoff"}, {"affiliation": "Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany.", "fullName": "Warnke A", "initials": "A", "firstName": "Andreas", "lastName": "Warnke"}, {"affiliation": "Department of Psychology and Child Research Center, University of Jyv\u00e4skyl\u00e4, Jyv\u00e4skyl\u00e4, Finland.", "fullName": "Lyytinen H", "initials": "H", "firstName": "Heikki", "lastName": "Lyytinen"}, {"affiliation": "Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Munich, Munich, Germany.", "fullName": "Schulte-K\u00f6rne G", "initials": "G", "firstName": "Gert", "lastName": "Schulte-K\u00f6rne"}, {"affiliation": "Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.", "fullName": "N\u00f6then MM", "initials": "MM", "firstName": "Markus M", "lastName": "N\u00f6then"}, {"affiliation": "Department of Psychology, University of Jyv\u00e4skyl\u00e4, Jyv\u00e4skyl\u00e4, Finland.", "fullName": "Lepp\u00e4nen PH", "initials": "PH", "firstName": "Paavo H T", "lastName": "Lepp\u00e4nen"}, {"affiliation": "Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.", "fullName": "Peyrard-Janvid M", "initials": "M", "firstName": "Myriam", "lastName": "Peyrard-Janvid"}, {"firstName": "Juha", "lastName": "Kere", "affiliation": "1] Department of Biosciences and Nutrition, and Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden [2] Science for Life Laboratory, Stockholm, Sweden [3] Molecular Neurology Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland [4] Folkh\u00e4lsan Institute of Genetics, Helsinki, Finland.", "authorId": {"type": "ORCID", "value": "0000-0003-1974-0271"}, "fullName": "Kere J", "initials": "J"}]}, "title": "Polymorphisms in DCDC2 and S100B associate with developmental dyslexia.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25877001", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0839-2451"}, {"type": "ORCID", "value": "0000-0002-5187-6446"}, {"type": "ORCID", "value": "0000-0003-3101-2285"}, {"type": "ORCID", "value": "0000-0003-1974-0271"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dyslexia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Microtubule-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Analysis, DNA", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}, {"descriptorName": "S100 Calcium Binding Protein beta Subunit", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-04-16", "language": "eng", "doi": "10.1038/jhg.2015.37", "isOpenAccess": "Y", "pageInfo": "399-401", "pmcid": "PMC4521290", "hasDbCrossReferences": "Y", "abstractText": "Genetic studies of complex traits have become increasingly successful as progress is made in next-generation sequencing. We aimed at discovering single nucleotide variation present in known and new candidate genes for developmental dyslexia: CYP19A1, DCDC2, DIP2A, DYX1C1, GCFC2 (also known as C2orf3), KIAA0319, MRPL19, PCNT, PRMT2, ROBO1 and S100B. We used next-generation sequencing to identify single-nucleotide polymorphisms in the exons of these 11 genes in pools of 100 DNA samples of Finnish individuals with developmental dyslexia. Subsequent individual genotyping of those 100 individuals, and additional cases and controls from the Finnish and German populations, validated 92 out of 111 different single-nucleotide variants. A nonsynonymous polymorphism in DCDC2 (corrected P = 0.002) and a noncoding variant in S100B (corrected P = 0.016) showed a significant association with spelling performance in families of German origin. No significant association was found for the variants neither in the Finnish case-control sample set nor in the Finnish family sample set. Our findings further strengthen the role of DCDC2 and implicate S100B, in the biology of reading and spelling.", "electronicPublicationDate": "2015-04-16", "license": "cc by-nc-nd", "dateOfCompletion": "2016-01-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4521290?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4521290", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/jhg.2015.37", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-07-01", "journal": {"medlineAbbreviation": "J Hum Genet", "isoabbreviation": "J. Hum. Genet.", "title": "Journal of human genetics", "issn": "1434-5161", "nlmid": "9808008", "essn": "1435-232X"}, "monthOfPublication": 7, "volume": "60", "yearOfPublication": 2015, "journalIssueId": 2308631, "issue": "7", "dateOfPublication": "2015 Jul"}}, "25139876": {"pubYear": "2014", "dateOfCreation": "2014-09-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Follistatin-Related Proteins"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "158709-62-7", "name": "Fstl1 protein, rat"}, {"registryNumber": "EC 2.7.11.1", "name": "Proto-Oncogene Proteins c-akt"}]}, "authorString": "Liang X, Hu Q, Li B, McBride D, Bian H, Spagnoli P, Chen D, Tang J, Zhang JH.", "affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS043338"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS043338"}]}, "hasPDF": "Y", "id": "25139876", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Liang X", "initials": "X", "firstName": "Xiping", "lastName": "Liang"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Hu Q", "initials": "Q", "firstName": "Qin", "lastName": "Hu"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Li B", "initials": "B", "firstName": "Bo", "lastName": "Li"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "McBride D", "initials": "D", "firstName": "Devin", "lastName": "McBride"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Bian H", "initials": "H", "firstName": "Hetao", "lastName": "Bian"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Spagnoli P", "initials": "P", "firstName": "Pierre", "lastName": "Spagnoli"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Chen D", "initials": "D", "firstName": "Di", "lastName": "Chen"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.).", "fullName": "Tang J", "initials": "J", "firstName": "Jiping", "lastName": "Tang"}, {"affiliation": "From the Departments of Physiology and Pharmacology (X.L., Q.H., B.L., D.M., H.B., P.S., D.C., J.T., J.H.Z.) and Neurosurgery (J.H.Z.), Loma Linda University School of Medicine, CA; and Department of Neurology, Chongqing Medical University, Chongqing, China (X.L.). johnzhang3910@yahoo.com.", "fullName": "Zhang JH", "initials": "JH", "firstName": "John H", "lastName": "Zhang"}]}, "title": "Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25139876", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Infarction, Middle Cerebral Artery", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reperfusion Injury", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Follistatin-Related Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N"}, {"descriptorName": "Fluorescent Antibody Technique", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Nick-End Labeling", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-akt", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Knockdown Techniques", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2015-10-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-08-19", "doi": "10.1161/strokeaha.114.006092", "isOpenAccess": "N", "pageInfo": "3048-3054", "pmcid": "PMC4174959", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Apoptosis", "Infarction, Middle Cerebral Artery", "Follistatin-related Proteins"]}, "abstractText": "BACKGROUND AND PURPOSE: Follistatin-like 1 (FSTL1), an extracellular glycoprotein, has been reported to decrease apoptosis in ischemic cardiac diseases, but its effect in ischemic stroke has not been examined. We hypothesized that recombinant FSTL1 attenuates neuronal apoptosis through its receptor disco-interacting protein 2 homolog A (DIP2A) and the Akt pathway after middle cerebral artery occlusion (MCAO) in rats. METHODS: One hundred forty male Sprague-Dawley rats were subjected to 2 hours of MCAO followed by reperfusion. In a subset of animals, the time course and location of FSTL1 and DIP2A were detected by Western blot and immunofluorescence double staining. Another set of animals were intracerebroventricularly given either recombinant FSTL1 1 hour after reperfusion or FSTL1-small interfering RNA (siRNA) 48 hours before reperfusion. Additionally, DIP2A was knockdown by siRNA in some animals. Infarction volume and neurological deficits were measured, and the expression of FSTL1, DIP2A, phosphorylated Akt, cleaved caspase-3, and terminal deoxynucleotidyl transferase dUTP nick end labeling were quantified using Western blot. RESULTS: The expression of FSTL1 and DIP2A was increased in neurons and peaked 24 hours after MCAO. Recombinant FSTL1 reduced brain infarction and improved neurological deficits 24 and 72 hours after MCAO via activation of its receptor DIP2A and downstream phosphorylation of Akt. These effects were reversed by DIP2A-siRNA and FSTL1-siRNA. CONCLUSIONS: Recombinant FSTL1 decreases neuronal apoptosis and improves neurological deficits through phosphorylation of Akt by activation of its receptor DIP2A after MCAO in rats. Thus, FSTL1 may have potentials as a treatment for patients with ischemic stroke.", "electronicPublicationDate": "2014-08-19", "language": "eng", "dateOfCompletion": "2015-01-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4174959?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4174959", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1161/STROKEAHA.114.006092", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-10-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "Stroke", "isoabbreviation": "Stroke", "title": "Stroke; a journal of cerebral circulation", "issn": "0039-2499", "nlmid": "0235266", "essn": "1524-4628"}, "monthOfPublication": 10, "volume": "45", "yearOfPublication": 2014, "journalIssueId": 2204027, "issue": "10", "dateOfPublication": "2014 Oct"}}, "18521840": {"pubYear": "2009", "dateOfCreation": "2009-01-27", "pubModel": "Print", "authorString": "Poelmans G, Engelen JJ, Van Lent-Albrechts J, Smeets HJ, Schoenmakers E, Franke B, Buitelaar JK, Wuisman-Frerker M, Erens W, Steyaert J, Schrander-Stumpel C.", "affiliation": "Department of Clinical Genetics, Academic Hospital Maastricht, The Netherlands. geert_poelmans@yahoo.com", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "18521840", "inEPMC": "N", "authorList": {"author": [{"lastName": "Poelmans", "fullName": "Poelmans G", "firstName": "G", "initials": "G"}, {"lastName": "Engelen", "fullName": "Engelen JJ", "firstName": "J J M", "initials": "JJ"}, {"lastName": "Van Lent-Albrechts", "fullName": "Van Lent-Albrechts J", "firstName": "J", "initials": "J"}, {"lastName": "Smeets", "fullName": "Smeets HJ", "firstName": "H J", "initials": "HJ"}, {"lastName": "Schoenmakers", "fullName": "Schoenmakers E", "firstName": "E", "initials": "E"}, {"lastName": "Franke", "fullName": "Franke B", "authorId": {"type": "ORCID", "value": "0000-0003-4375-6572"}, "firstName": "B", "initials": "B"}, {"lastName": "Buitelaar", "fullName": "Buitelaar JK", "firstName": "J K", "initials": "JK"}, {"lastName": "Wuisman-Frerker", "fullName": "Wuisman-Frerker M", "firstName": "M", "initials": "M"}, {"lastName": "Erens", "fullName": "Erens W", "firstName": "W", "initials": "W"}, {"lastName": "Steyaert", "fullName": "Steyaert J", "authorId": {"type": "ORCID", "value": "0000-0003-2512-4694"}, "firstName": "J", "initials": "J"}, {"lastName": "Schrander-Stumpel", "fullName": "Schrander-Stumpel C", "firstName": "C", "initials": "C"}]}, "title": "Identification of novel dyslexia candidate genes through the analysis of a chromosomal deletion.", "citedByCount": 17, "source": "MED", "pmid": "18521840", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4375-6572"}, {"type": "ORCID", "value": "0000-0003-2512-4694"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 21", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dyslexia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromosome Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Hybridization, Fluorescence", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Neuropsychological Tests", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Linkage", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-01-01", "doi": "10.1002/ajmg.b.30787", "isOpenAccess": "N", "pageInfo": "140-147", "hasDbCrossReferences": "N", "abstractText": "Dyslexia is the most common childhood learning disorder and it is a significantly heritable trait. At least nine chromosomal loci have been linked to dyslexia, and additional susceptibility loci on other chromosomes have been suggested. Within two of these loci, DYX1C1 (15q21) and ROBO1 (3p12) have recently been proposed as dyslexia candidate genes through the molecular analysis of translocation breakpoints in dyslexic individuals carrying balanced chromosomal translocations. Moreover, genetic association studies have indicated a cluster of five dyslexia candidate genes in another linkage region on chromosome 6p22, although there is currently no consensus about which of these five genes contributes to the genetic susceptibility for dyslexia. In this article, we report the identification of four new dyslexia candidate genes (PCNT, DIP2A, S100B, and PRMT2) on chromosome region 21q22.3 by FISH and SNP microarray analyses of a very small deletion in this region, which cosegregates with dyslexia in a father and his three sons.", "language": "eng", "dateOfCompletion": "2009-03-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.b.30787", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2010-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"medlineAbbreviation": "Am J Med Genet B Neuropsychiatr Genet", "isoabbreviation": "Am. J. Med. Genet. B Neuropsychiatr. Genet.", "title": "American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics", "issn": "1552-4841", "nlmid": "101235742", "essn": "1552-485X"}, "monthOfPublication": 1, "volume": "150B", "yearOfPublication": 2009, "journalIssueId": 1594007, "issue": "1", "dateOfPublication": "2009 Jan"}}, "20956978": {"pubYear": "2011", "dateOfCreation": "2011-03-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}]}, "authorString": "Poelmans G, Buitelaar JK, Pauls DL, Franke B.", "affiliation": "Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20956978", "inEPMC": "N", "authorList": {"author": [{"lastName": "Poelmans", "fullName": "Poelmans G", "firstName": "G", "initials": "G"}, {"lastName": "Buitelaar", "fullName": "Buitelaar JK", "firstName": "J K", "initials": "JK"}, {"lastName": "Pauls", "fullName": "Pauls DL", "firstName": "D L", "initials": "DL"}, {"lastName": "Franke", "fullName": "Franke B", "authorId": {"type": "ORCID", "value": "0000-0003-4375-6572"}, "firstName": "B", "initials": "B"}]}, "title": "A theoretical molecular network for dyslexia: integrating available genetic findings.", "citedByCount": 35, "source": "MED", "pmid": "20956978", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4375-6572"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dyslexia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychometrics", "majorTopic_YN": "N"}, {"descriptorName": "Meta-Analysis as Topic", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Linkage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["INTERPRO"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-10-19", "doi": "10.1038/mp.2010.105", "isOpenAccess": "N", "pageInfo": "365-382", "hasDbCrossReferences": "Y", "abstractText": "Developmental dyslexia is a common specific childhood learning disorder with a strong heritable component. Previous studies using different genetic approaches have identified several genetic loci and candidate genes for dyslexia. In this article, we have integrated the current knowledge on 14 dyslexia candidate genes suggested by cytogenetic findings, linkage and association studies. We found that 10 of the 14 dyslexia candidate genes (ROBO1, KIAA0319, KIAA0319L, S100B, DOCK4, FMR1, DIP2A, GTF2I, DYX1C1 and DCDC2) fit into a theoretical molecular network involved in neuronal migration and neurite outgrowth. Based on this, we also propose three novel dyslexia candidate genes (SLIT2, HMGB1 and VAPA) from known linkage regions, and we discuss the possible involvement of genes emerging from the two reported genome-wide association studies for reading impairment-related phenotypes in the identified network.", "electronicPublicationDate": "2010-10-19", "language": "eng", "dateOfCompletion": "2011-07-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/mp.2010.105", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-04-01", "journal": {"medlineAbbreviation": "Mol Psychiatry", "isoabbreviation": "Mol. Psychiatry", "title": "Molecular psychiatry", "issn": "1359-4184", "nlmid": "9607835", "essn": "1476-5578"}, "monthOfPublication": 4, "volume": "16", "yearOfPublication": 2011, "journalIssueId": 1818446, "issue": "4", "dateOfPublication": "2011 Apr"}}}, "NUAK2": {"22689267": {"pubYear": "2012", "dateOfCreation": "2012-07-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.1.-", "name": "ARK5 protein, mouse"}]}, "authorString": "Ohmura T, Shioi G, Hirano M, Aizawa S.", "affiliation": "Laboratory for Vertebrate Body Plan, Center for Developmental Biology, RIKEN Kobe, Kobe, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22689267", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ohmura", "fullName": "Ohmura T", "firstName": "Tomomi", "initials": "T"}, {"lastName": "Shioi", "fullName": "Shioi G", "firstName": "Go", "initials": "G"}, {"lastName": "Hirano", "fullName": "Hirano M", "firstName": "Mariko", "initials": "M"}, {"lastName": "Aizawa", "fullName": "Aizawa S", "firstName": "Shinichi", "initials": "S"}]}, "title": "Neural tube defects by NUAK1 and NUAK2 double mutation.", "citedByCount": 2, "source": "MED", "pmid": "22689267", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Mutant Strains", "majorTopic_YN": "N"}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Hybridization", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Neural Tube", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-22", "doi": "10.1002/dvdy.23816", "isOpenAccess": "N", "pageInfo": "1350-1364", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: NUAK1 and NUAK2, members of the AMP-activated protein kinase family of serine/threonine kinases, are prominently expressed in neuroectoderm, but their functions in neurulation have not been elucidated. RESULTS: NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida. Median hinge point was formed, but dorsolateral hinge point formation was not apparent in cranial neural plate; neither apical constriction nor apico-basal elongation took place efficiently in the double mutants during the 5-10-somite stages. Concomitantly, the apical concentration of phosphorylated myosin light chain 2, F-actin, and cortactin was insignificant, and development of acetylated \u03b1-tubulin-positive microtubules was poor. However, the distribution of F-actin, cortactin, Shroom3, Rho, myosin heavy chain IIB, phosphorylated myosin light chain 2, \u03b1-tubulin, \u03b3-tubulin, or acetylated \u03b1-tubulin was apparently normal in the double mutant neuroepithelia at the 5-somite stage. CONCLUSIONS: NUAK1 and NUAK2 complementarily function in the apical constriction and apico-basal elongation that associate with the dorsolateral hinge point formation in cephalic neural plate during the 5- to 10-somite stages. In the double mutant neural plate, phosphorylated myosin light chain 2, F-actin, and cortactin did not concentrate efficiently in apical surfaces, and acetylated \u03b1-tubulin-positive microtubules did not develop significantly.", "electronicPublicationDate": "2012-06-22", "language": "eng", "dateOfCompletion": "2012-11-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/dvdy.23816", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-08-01", "journal": {"medlineAbbreviation": "Dev Dyn", "isoabbreviation": "Dev. Dyn.", "title": "Developmental dynamics : an official publication of the American Association of Anatomists", "issn": "1058-8388", "nlmid": "9201927", "essn": "1097-0177"}, "monthOfPublication": 8, "volume": "241", "yearOfPublication": 2012, "journalIssueId": 1950003, "issue": "8", "dateOfPublication": "2012 Aug"}}}, "CELF2": {"21379329": {"pubYear": "2011", "dateOfCreation": "2011-03-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "clusterin"}, {"registryNumber": "0", "name": "BIN1 protein, human"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Apolipoproteins E"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "CLU protein, human"}, {"registryNumber": "0", "name": "CELF2 protein, human"}, {"registryNumber": "0", "name": "CELF Proteins"}]}, "authorString": "Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD, Bennett DA, Diaz-Arrastia R, Goate AM, Farlow M, Ghetti B, Sweet RA, Foroud TM, Mayeux R, NIA-LOAD/NCRAD Family Study Group.", "affiliation": "Division of Medical Genetics, University of Washington, Seattle, Washington, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268200782096C"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "U24AG026395"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG03991"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG05138"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG07232"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30 AG010133"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG008017"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG010133"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG013846"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG028377"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG028383"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG10124"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG10161"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG12300"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30AG13854"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50 AG005136"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG005133"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG016579"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG016582"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG05128"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG05134"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG05136"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG05142"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG05681"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG08702"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50AG165574"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG015819"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG027224"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG027224-04"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG041797"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01AG027224"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R37AG015473"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "U24 AG021886"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "U24AG021886"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG02219"}]}, "hasPDF": "Y", "id": "21379329", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Ellen M", "lastName": "Wijsman", "affiliation": "Division of Medical Genetics, University of Washington, Seattle, Washington, United States of America.", "authorId": {"type": "ORCID", "value": "0000-0002-2725-6669"}, "fullName": "Wijsman EM", "initials": "EM"}, {"lastName": "Pankratz", "fullName": "Pankratz ND", "firstName": "Nathan D", "initials": "ND"}, {"lastName": "Choi", "fullName": "Choi Y", "firstName": "Yoonha", "initials": "Y"}, {"lastName": "Rothstein", "fullName": "Rothstein JH", "firstName": "Joseph H", "initials": "JH"}, {"lastName": "Faber", "fullName": "Faber KM", "firstName": "Kelley M", "initials": "KM"}, {"lastName": "Cheng", "fullName": "Cheng R", "firstName": "Rong", "initials": "R"}, {"lastName": "Lee", "fullName": "Lee JH", "authorId": {"type": "ORCID", "value": "0000-0002-2000-4821"}, "firstName": "Joseph H", "initials": "JH"}, {"lastName": "Bird", "fullName": "Bird TD", "firstName": "Thomas D", "initials": "TD"}, {"lastName": "Bennett", "fullName": "Bennett DA", "firstName": "David A", "initials": "DA"}, {"lastName": "Diaz-Arrastia", "fullName": "Diaz-Arrastia R", "firstName": "Ramon", "initials": "R"}, {"lastName": "Goate", "fullName": "Goate AM", "firstName": "Alison M", "initials": "AM"}, {"lastName": "Farlow", "fullName": "Farlow M", "firstName": "Martin", "initials": "M"}, {"lastName": "Ghetti", "fullName": "Ghetti B", "firstName": "Bernardino", "initials": "B"}, {"lastName": "Sweet", "fullName": "Sweet RA", "firstName": "Robert A", "initials": "RA"}, {"lastName": "Foroud", "fullName": "Foroud TM", "firstName": "Tatiana M", "initials": "TM"}, {"lastName": "Mayeux", "fullName": "Mayeux R", "firstName": "Richard", "initials": "R"}, {"collectiveName": "NIA-LOAD/NCRAD Family Study Group"}]}, "title": "Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.", "hasSuppl": "Y", "citedByCount": 78, "source": "MED", "pmid": "21379329", "abstractText": "Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p\u200a=\u200a3.2\u00d710(-81)), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE \u03b54 homozygotes (e.g., rs201119, p\u200a=\u200a1.5\u00d710(-8)). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p\u200a=\u200a0.009 with, and p\u200a=\u200a0.03 without, APOE adjustment) and CLU (rs11136000, p\u200a=\u200a0.023 with, and p\u200a=\u200a0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p\u200a=\u200a0.69 with, and p\u200a=\u200a0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies.", "tmAccessionTypeList": {"accessionType": ["refsnp", " omim", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2725-6669"}, {"type": "ORCID", "value": "0000-0002-2000-4821"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Apolipoproteins E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Family", "majorTopic_YN": "N"}, {"descriptorName": "Population Dynamics", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Heterozygote", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome, Human", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Principal Component Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "European Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Clusterin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "Y"}, {"descriptorName": "CELF Proteins", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2011-02-17", "doi": "10.1371/journal.pgen.1001308", "isOpenAccess": "Y", "pageInfo": "e1001308", "pmcid": "PMC3040659", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "electronicPublicationDate": "2011-02-17", "language": "eng", "dateOfCompletion": "2011-08-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3040659?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3040659", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21379329&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21379329", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pgen.1001308", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-02-01", "journal": {"medlineAbbreviation": "PLoS Genet", "isoabbreviation": "PLoS Genet.", "title": "PLoS genetics", "issn": "1553-7390", "nlmid": "101239074", "essn": "1553-7404"}, "monthOfPublication": 2, "volume": "7", "yearOfPublication": 2011, "journalIssueId": 1808591, "issue": "2", "dateOfPublication": "2011 Feb"}}, "12110949": {"pubYear": "2002", "dateOfCreation": "2002-07-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "adhesion receptor"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Protein Isoforms"}, {"registryNumber": "0", "name": "Membrane Glycoproteins"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "CELF2 protein, human"}]}, "authorString": "Lichtner P, Atti\u00e9-Bitach T, Schuffenhauer S, Henwood J, Bouvagnet P, Scambler PJ, Meitinger T, Vekemans M.", "affiliation": "Institute of Human Genetics, Klinikum Rechts der Isar, Technical University, Munich, Germany. lichtner@gsf.de", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "12110949", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lichtner", "fullName": "Lichtner P", "initials": "P"}, {"lastName": "Atti\u00e9-Bitach", "fullName": "Atti\u00e9-Bitach T", "initials": "T"}, {"lastName": "Schuffenhauer", "fullName": "Schuffenhauer S", "initials": "S"}, {"lastName": "Henwood", "fullName": "Henwood J", "initials": "J"}, {"lastName": "Bouvagnet", "fullName": "Bouvagnet P", "initials": "P"}, {"lastName": "Scambler", "fullName": "Scambler PJ", "initials": "PJ"}, {"lastName": "Meitinger", "fullName": "Meitinger T", "initials": "T"}, {"lastName": "Vekemans", "fullName": "Vekemans M", "initials": "M"}]}, "title": "Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p.", "citedByCount": 21, "source": "MED", "pmid": "12110949", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Fetal Heart", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thymus Gland", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 10", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Heart Defects, Congenital", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DiGeorge Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromosome Deletion", "majorTopic_YN": "N"}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Glycoproteins", "majorTopic_YN": "N"}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Protein Isoforms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "In Situ Hybridization, Fluorescence", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Developmental", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Gestational Age", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2002-04-04", "doi": "10.1007/s00109-002-0331-9", "isOpenAccess": "N", "pageInfo": "431-442", "hasDbCrossReferences": "Y", "abstractText": "Partial monosomy 10p is a rare chromosomal aberration. Patients often show symptoms of the DiGeorge/velocardiofacial syndrome spectrum. The phenotype is the result of haploinsufficiency of at least two regions on 10p, the HDR1 region associated with hypoparathyroidism, sensorineural deafness, and renal defects (HDR syndrome) and the more proximal region DGCR2 responsible for heart defects and thymus hypoplasia/aplasia. While GATA3 was identified as the disease causing gene for HDR syndrome, no genes have been identified thus far for the symptoms associated with DGCR2 haploinsufficiency. We constructed a deletion map of partial monosomy 10p patients and narrowed the critical region DGCR2 to about 300 kb. The genomic draft sequence of this region contains only one known gene, BRUNOL3 ( NAPOR, CUGBP2, ETR3). In situ hybridization of human embryos and fetuses revealed as well as in other tissues a strong expression of BRUNOL3 in thymus during different developmental stages. BRUNOL3 appears to be an important factor for thymus development and is therefore a candidate gene for the thymus hypoplasia/aplasia seen in partial monosomy 10p patients. We did not find BRUNOL3 mutations in 92 DiGeorge syndrome-like patients without chromosomal deletions and in 8 parents with congenital heart defect children.", "electronicPublicationDate": "2002-04-04", "language": "eng", "dateOfCompletion": "2003-03-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00109-002-0331-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "SpringerLink"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-07-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2002-07-01", "journal": {"medlineAbbreviation": "J Mol Med (Berl)", "isoabbreviation": "J. Mol. Med.", "title": "Journal of molecular medicine (Berlin, Germany)", "issn": "0946-2716", "nlmid": "9504370", "essn": "1432-1440"}, "monthOfPublication": 7, "volume": "80", "yearOfPublication": 2002, "journalIssueId": 1099809, "issue": "7", "dateOfPublication": "2002 Jul"}}, "22660636": {"pubYear": "2012", "dateOfCreation": "2012-09-07", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Receptors, Androgen"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "MicroRNAs"}, {"registryNumber": "0", "name": "Mutant Proteins"}, {"registryNumber": "0", "name": "MIRN196 microRNA, human"}, {"registryNumber": "0", "name": "CELF2 protein, human"}]}, "authorString": "Miyazaki Y, Adachi H, Katsuno M, Minamiyama M, Jiang YM, Huang Z, Doi H, Matsumoto S, Kondo N, Iida M, Tohnai G, Tanaka F, Muramatsu S, Sobue G.", "affiliation": "Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22660636", "inEPMC": "N", "authorList": {"author": [{"lastName": "Miyazaki", "fullName": "Miyazaki Y", "firstName": "Yu", "initials": "Y"}, {"lastName": "Adachi", "fullName": "Adachi H", "authorId": {"type": "ORCID", "value": "0000-0002-9302-4663"}, "firstName": "Hiroaki", "initials": "H"}, {"lastName": "Katsuno", "fullName": "Katsuno M", "firstName": "Masahisa", "initials": "M"}, {"lastName": "Minamiyama", "fullName": "Minamiyama M", "firstName": "Makoto", "initials": "M"}, {"lastName": "Jiang", "fullName": "Jiang YM", "firstName": "Yue-Mei", "initials": "YM"}, {"lastName": "Huang", "fullName": "Huang Z", "firstName": "Zhe", "initials": "Z"}, {"lastName": "Doi", "fullName": "Doi H", "firstName": "Hideki", "initials": "H"}, {"lastName": "Matsumoto", "fullName": "Matsumoto S", "firstName": "Shinjiro", "initials": "S"}, {"lastName": "Kondo", "fullName": "Kondo N", "firstName": "Naohide", "initials": "N"}, {"lastName": "Iida", "fullName": "Iida M", "firstName": "Madoka", "initials": "M"}, {"lastName": "Tohnai", "fullName": "Tohnai G", "firstName": "Genki", "initials": "G"}, {"lastName": "Tanaka", "fullName": "Tanaka F", "firstName": "Fumiaki", "initials": "F"}, {"lastName": "Muramatsu", "fullName": "Muramatsu S", "authorId": {"type": "ORCID", "value": "0000-0002-3185-7790"}, "firstName": "Shin-ichi", "initials": "S"}, {"lastName": "Sobue", "fullName": "Sobue G", "firstName": "Gen", "initials": "G"}]}, "title": "Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.", "citedByCount": 44, "pageInfo": "1136-1141", "source": "MED", "pmid": "22660636", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9302-4663"}, {"type": "ORCID", "value": "0000-0002-3185-7790"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Dependovirus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Muscular Atrophy, Spinal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Androgen", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "MicroRNAs", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Rotarod Performance Test", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Gene Silencing", "majorTopic_YN": "Y"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Nucleic Acid Conformation", "majorTopic_YN": "N"}, {"descriptorName": "RNA Stability", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Mutant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Knockdown Techniques", "majorTopic_YN": "N"}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Therapy", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-07-01", "doi": "10.1038/nm.2791", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "22772549", "reference": "Nat Med. 2012 Jul;18(7):1011-2"}]}, "hasDbCrossReferences": "Y", "abstractText": "Spinal and bulbar muscular atrophy (SBMA) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine (polyQ) tract of the androgen receptor (AR-polyQ). Characteristics of SBMA include proximal muscular atrophy, weakness, contraction fasciculation and bulbar involvement. MicroRNAs (miRNAs) are a diverse class of highly conserved small RNA molecules that function as crucial regulators of gene expression in animals and plants. Recent functional studies have shown the potent activity of specific miRNAs as disease modifiers both in vitro and in vivo. Thus, potential therapeutic approaches that target the miRNA processing pathway have recently attracted attention. Here we describe a novel therapeutic approach using the adeno-associated virus (AAV) vector\u2013mediated delivery of a specific miRNA for SBMA. We found that miR-196a enhanced the decay of the AR mRNA by silencing CUGBP, Elav-like family member 2 (CELF2). CELF2 directly acted on AR mRNA and enhanced the stability of AR mRNA. Furthermore, we found that the early intervention of miR-196a delivered by an AAV vector ameliorated the SBMA phenotypes in a mouse model. Our results establish the proof of principle that disease-specific miRNA delivery could be useful in neurodegenerative diseases.", "language": "eng", "dateOfCompletion": "2012-09-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/nm.2791", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-07-01", "journal": {"medlineAbbreviation": "Nat Med", "isoabbreviation": "Nat. Med.", "title": "Nature medicine", "issn": "1078-8956", "nlmid": "9502015", "essn": "1546-170X"}, "monthOfPublication": 7, "volume": "18", "yearOfPublication": 2012, "journalIssueId": 1964560, "issue": "7", "dateOfPublication": "2012 Jul"}}, "25801238": {"pubYear": "2015", "dateOfCreation": "2015-03-24", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Cytoskeletal Proteins"}, {"registryNumber": "0", "name": "DNMBP protein, human"}, {"registryNumber": "0", "name": "CELF2 protein, human"}, {"registryNumber": "0", "name": "CELF Proteins"}]}, "authorString": "Yang P, Xu M, Liu Z, Tao Q, Lu S, Li H, Guo Q, Sun Y, Wu Z.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EH", "qualifierName": "ethnology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cytoskeletal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EH", "qualifierName": "ethnology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}, {"descriptorName": "CELF Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "id": "25801238", "inEPMC": "N", "authorList": {"author": [{"lastName": "Yang", "fullName": "Yang P", "firstName": "Ping", "initials": "P"}, {"lastName": "Xu", "fullName": "Xu M", "firstName": "Miao", "initials": "M"}, {"lastName": "Liu", "fullName": "Liu Z", "firstName": "Zhi- Jun", "initials": "Z"}, {"lastName": "Tao", "fullName": "Tao Q", "firstName": "Qing- Qing", "initials": "Q"}, {"lastName": "Lu", "fullName": "Lu S", "firstName": "Shen- Ji", "initials": "S"}, {"lastName": "Li", "fullName": "Li H", "firstName": "Hong- Lei", "initials": "H"}, {"lastName": "Guo", "fullName": "Guo Q", "firstName": "Qi- Hao", "initials": "Q"}, {"lastName": "Sun", "fullName": "Sun Y", "firstName": "Yi- Min", "initials": "Y"}, {"affiliation": "Department of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. zhiyingwu@zju.edu.cn.", "fullName": "Wu Z", "initials": "Z", "firstName": "Zhi- Ying", "lastName": "Wu"}]}, "title": "Genetic association of CUGBP2 and DNMBP with Alzheimer' s disease in the Chinese Han population.", "citedByCount": 0, "source": "MED", "pmid": "25801238", "abstractText": "Recently, candidate genetic studies revealed the single nucleotide polymorphisms (SNPs) of CUGBP2 (rs2242451) and DNMBP (rs11190305 and rs3740058) associated with Alzheimer's disease (AD). Due to genetic heterogeneity and different ethnic background, the purpose of our study was to confirm the association between these 3 SNPs with AD risk in the Chinese Han population.We investigated 482 sporadic AD (SAD) patients and 813 unrelated cognitive normal controls of the Chinese Han population. The genotypes of the 3 SNPs (rs2242451, rs11190305, rs3740058) were carried out by MassARRAY iPLEX system.The genotype and the allele frequency of rs2242451 were significantly different between AD and control group in total subject (genotype: p=0.019, allele frequency: p=0.022, OR=0.760, 95%CI=0.601- 0.962) with A allele decreasing AD risk. After stratification by age at onset, gender, APOE \u03b54 carrying status and homozygous APOE \u03b54, the protective effect of A allele remained in female and APOE \u03b54\u03b54 non-carrying subgroups. The rs3740058 in DNMBP was significantly differently in genotype between AD and control in APOE \u03b54\u03b54 subgroup, but showed no effect on AD risk, either did rs11190305 polymorphisms in DNMBP. Meta-analysis was performed in rs11190305 and rs3740058 of DNMBP respectively. Positive relationship with AD was found in rs11190305 (OR=1.11, 95%CI=1.01-1.21), but not in rs3740058 (OR=1.05, 95%CI=0.98-1.13). Moreover, the genotypes of these 3 SNPs had no effect on age at onset of AD.The A allele of rs2242451 in CUGBP2 might decrease SAD risk in the Chinese Han population.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-01-01", "isOpenAccess": "N", "pageInfo": "228-232", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "language": "eng", "dateOfCompletion": "2015-12-15", "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Curr Alzheimer Res", "isoabbreviation": "Curr Alzheimer Res", "title": "Current Alzheimer research", "issn": "1567-2050", "nlmid": "101208441", "essn": "1875-5828"}, "monthOfPublication": 0, "volume": "12", "yearOfPublication": 2015, "journalIssueId": 2266132, "issue": "3", "dateOfPublication": "2015 "}}}, "CALR": {"24203089": {"pubYear": "2014", "dateOfCreation": "2014-03-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "37221-79-7", "name": "Vasoactive Intestinal Peptide"}, {"registryNumber": "0", "name": "Calbindin 2"}]}, "authorString": "Beuscher N, Jabari S, Strehl J, Neuhuber W, Brehmer A.", "affiliation": "Institute of Anatomy I, University of Erlangen-Nuremberg, Krankenhausstra\u00dfe 9, 91054, Erlangen, Germany.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "24203089", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Institute of Anatomy I, University of Erlangen-Nuremberg, Krankenhausstra\u00dfe 9, 91054, Erlangen, Germany.", "fullName": "Beuscher N", "initials": "N", "firstName": "Nicholas", "lastName": "Beuscher"}, {"lastName": "Jabari", "fullName": "Jabari S", "firstName": "Samir", "initials": "S"}, {"lastName": "Strehl", "fullName": "Strehl J", "firstName": "Johanna", "initials": "J"}, {"lastName": "Neuhuber", "fullName": "Neuhuber W", "firstName": "Winfried", "initials": "W"}, {"lastName": "Brehmer", "fullName": "Brehmer A", "firstName": "Axel", "initials": "A"}]}, "title": "What neurons hide behind calretinin immunoreactivity in the human gut?", "citedByCount": 5, "source": "MED", "pmid": "24203089", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Intestinal Mucosa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Colon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "N"}, {"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Vasoactive Intestinal Peptide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Calbindin 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-11-08", "doi": "10.1007/s00418-013-1163-0", "isOpenAccess": "N", "pageInfo": "393-405", "hasDbCrossReferences": "N", "abstractText": "Calretinin (CALR) is often used as an immunohistochemical marker for the histopathological diagnosis of human intestinal neuropathies. However, little is known about its distribution pattern with respect to specific human enteric neuron types. Prior studies revealed CALR in both myenteric and submucosal neurons, most of which colabel with choline acetyl transferase (ChAT). Here, we specified the chemical code of CALR-positive neurons in small and large intestinal wholemounts in a series of 28 patients. Besides other markers, we evaluated the labeling pattern of CALR in combination with vasoactive intestinal peptide (VIP). In colonic submucosa, CALR and VIP were almost completely colocalized in about three-quarters of all submucosal neurons. In the small intestinal submucosa, both the colocalization rate of CALR and VIP as well as the proportion of these neurons were lower (about one-third). In the myenteric plexus of both small intestine and colon, CALR amounted to 11 and 10\u00a0%, respectively, whereas VIP to 5 and 4\u00a0% of the whole neuron population, respectively. Colocalization of both markers was found in only 2 and 3\u00a0% of myenteric neurons, respectively. In section specimens, nerve fibers coreactive for CALR and VIP were found in the mucosa but not in the muscle coat. Summarizing the present and earlier results, CALR was found in at least one submucosal and two myenteric neuron populations. Submucosal CALR+/VIP+/ChAT\u00b1 neurons innervate mucosal structures. Furthermore, CALR immunoreactivity in the myenteric plexus was observed in morphological type II (supposed primary afferent) and spiny type I (supposed inter- or motor-) neurons.", "electronicPublicationDate": "2013-11-08", "language": "eng", "dateOfCompletion": "2015-02-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00418-013-1163-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-04-01", "journal": {"medlineAbbreviation": "Histochem Cell Biol", "isoabbreviation": "Histochem. Cell Biol.", "title": "Histochemistry and cell biology", "issn": "0948-6143", "nlmid": "9506663", "essn": "1432-119X"}, "monthOfPublication": 4, "volume": "141", "yearOfPublication": 2014, "journalIssueId": 2140771, "issue": "4", "dateOfPublication": "2014 Apr"}}, "14528906": "", "12576225": "", "26300886": {"pubYear": "2015", "dateOfCreation": "2015-08-24", "pubModel": "Electronic-eCollection", "authorString": "Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R.", "affiliation": "Sotio , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "id": "26300886", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Sotio , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "fullName": "Fucikova J", "initials": "J", "firstName": "Jitka", "lastName": "Fucikova"}, {"affiliation": "Sotio , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "fullName": "Moserova I", "initials": "I", "firstName": "Irena", "lastName": "Moserova"}, {"affiliation": "Sotio , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "fullName": "Urbanova L", "initials": "L", "firstName": "Linda", "lastName": "Urbanova"}, {"affiliation": "Equipe 11 labellis\u00e9e par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Sorbonne Paris Cit\u00e9, Universit\u00e9 Paris Descartes , Paris , France ; Universit\u00e9 Pierre et Marie Curie , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif , France.", "fullName": "Bezu L", "initials": "L", "firstName": "Lucillia", "lastName": "Bezu"}, {"affiliation": "Equipe 11 labellis\u00e9e par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Sorbonne Paris Cit\u00e9, Universit\u00e9 Paris Descartes , Paris , France ; Universit\u00e9 Pierre et Marie Curie , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif , France.", "fullName": "Kepp O", "initials": "O", "firstName": "Oliver", "lastName": "Kepp"}, {"affiliation": "Sorbonne Paris Cit\u00e9, Universit\u00e9 Paris Descartes , Paris , France ; Universit\u00e9 Pierre et Marie Curie , Paris , France ; Equipe 13, Centre de Recherche des Cordeliers , Paris , France.", "fullName": "Cremer I", "initials": "I", "firstName": "Isabelle", "lastName": "Cremer"}, {"affiliation": "Institute of Hematology and Blood Transfusion , Prague , Czech Republic.", "fullName": "Salek C", "initials": "C", "firstName": "Cyril", "lastName": "Salek"}, {"affiliation": "Department of Gynecology and Obsterics, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "fullName": "Strnad P", "initials": "P", "firstName": "Pavel", "lastName": "Strnad"}, {"affiliation": "Equipe 11 labellis\u00e9e par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Sorbonne Paris Cit\u00e9, Universit\u00e9 Paris Descartes , Paris , France ; Universit\u00e9 Pierre et Marie Curie , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif , France ; P\u00f4le de Biologie, Hopit\u00e2l Europ\u00e9en George Pompidou, AP-HP , Paris , France.", "fullName": "Kroemer G", "initials": "G", "firstName": "Guido", "lastName": "Kroemer"}, {"affiliation": "Equipe 11 labellis\u00e9e par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Sorbonne Paris Cit\u00e9, Universit\u00e9 Paris Descartes , Paris , France ; Universit\u00e9 Pierre et Marie Curie , Paris , France ; Gustave Roussy Comprehensive Cancer Institute , Villejuif , France.", "fullName": "Galluzzi L", "initials": "L", "firstName": "Lorenzo", "lastName": "Galluzzi"}, {"affiliation": "Sotio , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.", "fullName": "Spisek R", "initials": "R", "firstName": "Radek", "lastName": "Spisek"}]}, "title": "Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "26300886", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-07", "language": "eng", "doi": "10.3389/fimmu.2015.00402", "isOpenAccess": "Y", "pageInfo": "402", "pmcid": "PMC4528281", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["ATP", "Type I interferon", "calreticulin", "Autophagy", "ER stress response", "Hsps"]}, "abstractText": "It is now clear that human neoplasms form, progress, and respond to therapy in the context of an intimate crosstalk with the host immune system. In particular, accumulating evidence demonstrates that the efficacy of most, if not all, chemo- and radiotherapeutic agents commonly employed in the clinic critically depends on the (re)activation of tumor-targeting immune responses. One of the mechanisms whereby conventional chemotherapeutics, targeted anticancer agents, and radiotherapy can provoke a therapeutically relevant, adaptive immune response against malignant cells is commonly known as \"immunogenic cell death.\" Importantly, dying cancer cells are perceived as immunogenic only when they emit a set of immunostimulatory signals upon the activation of intracellular stress response pathways. The emission of these signals, which are generally referred to as \"damage-associated molecular patterns\" (DAMPs), may therefore predict whether patients will respond to chemotherapy or not, at least in some settings. Here, we review clinical data indicating that DAMPs and DAMP-associated stress responses might have prognostic or predictive value for cancer patients.", "electronicPublicationDate": "2015-08-07", "license": "cc by", "dateOfCompletion": "2015-08-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4528281?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4528281", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3389/fimmu.2015.00402", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-08-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Frontiers in immunology", "medlineAbbreviation": "Front Immunol", "isoabbreviation": "Front Immunol", "nlmid": "101560960", "essn": "1664-3224"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2015, "journalIssueId": 2260597, "dateOfPublication": "2015"}}, "25429433": {"pubYear": "2014", "dateOfCreation": "2014-11-28", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Biological Markers"}, {"registryNumber": "0", "name": "Calreticulin"}]}, "authorString": "Lin Q, Cao Y, Gao J.", "affiliation": "Department of Internal Medicine, the Fourth Affiliated Hospital of China Medical University, Shenyang 110005, China. qiaolinsy@163.com.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "25429433", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Internal Medicine, the Fourth Affiliated Hospital of China Medical University, Shenyang 110005, China. qiaolinsy@163.com.", "fullName": "Lin Q", "initials": "Q", "firstName": "Qiao", "lastName": "Lin"}, {"affiliation": "Neural Department of Internal Medicine, the First Affiliated Hospital of China Medical University, Shenyang 110001, China. caoyun2@163.com.", "fullName": "Cao Y", "initials": "Y", "firstName": "Yunpeng", "lastName": "Cao"}, {"affiliation": "Department of Anatomy, the First Affiliated Hospital of China Medical University, Shenyang 110001, China. gaojie3@163.com.", "fullName": "Gao J", "initials": "J", "firstName": "Jie", "lastName": "Gao"}]}, "title": "Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25429433", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Enzyme-Linked Immunosorbent Assay", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Demography", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Real-Time Polymerase Chain Reaction", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-11-25", "language": "eng", "doi": "10.3390/ijms151221740", "isOpenAccess": "Y", "pageInfo": "21740-21753", "pmcid": "PMC4284675", "hasDbCrossReferences": "Y", "abstractText": "Calreticulin is down-regulated in the cortical neurons of patients with Alzheimer's disease (AD) and may be a potential biomarker for the diagnosis of AD. A total of 128 AD patients were randomly recruited from May 2012 to July 2013. The mRNA levels of calreticulin were measured from the serum of tested subjects using real-time quantitative reverse transcriptase-PCR (real-time qRT-PCR). Serum levels of calreticulin were determined by ELISA and Western Blot. Serum levels of calreticulin in AD patients were significantly lower than those from a healthy group (p < 0.01). The baseline characters indicated that sample size, gender, mean age, diabetes and BMI (body mass index) were not major sources of heterogeneity. The serum levels of mRNA and protein of calreticulin were lower in AD patients than those from a healthy group, and negatively associated with the progression of AD according to CDR scores (p < 0.01). Thus, there is a trend toward decreased serum levels of calreticulin in the patients with progression of AD. Serum levels of calreticulin can be a negative biomarker for the diagnosis of AD patients.", "electronicPublicationDate": "2014-11-25", "license": "cc by", "dateOfCompletion": "2015-07-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4284675?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4284675", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3390/ijms151221740", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "International journal of molecular sciences", "medlineAbbreviation": "Int J Mol Sci", "isoabbreviation": "Int J Mol Sci", "nlmid": "101092791", "essn": "1422-0067"}, "monthOfPublication": 0, "volume": "15", "yearOfPublication": 2014, "journalIssueId": 2223091, "issue": "12", "dateOfPublication": "2014 "}}, "22507216": {"pubYear": "2012", "dateOfCreation": "2012-04-17", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "99-66-1", "name": "Valproic Acid"}, {"registryNumber": "0", "name": "Antimanic Agents"}, {"registryNumber": "0", "name": "Calreticulin"}]}, "authorString": "Ohadi M, Mirabzadeh A, Esmaeilzadeh-Gharehdaghi E, Rezazadeh M, Hosseinkhanni S, Oladnabi M, Firouzabadi SG, Darvish H.", "affiliation": "Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. rahaannn@yahoo.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22507216", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ohadi", "fullName": "Ohadi M", "firstName": "M", "initials": "M"}, {"lastName": "Mirabzadeh", "fullName": "Mirabzadeh A", "firstName": "A", "initials": "A"}, {"lastName": "Esmaeilzadeh-Gharehdaghi", "fullName": "Esmaeilzadeh-Gharehdaghi E", "firstName": "E", "initials": "E"}, {"lastName": "Rezazadeh", "fullName": "Rezazadeh M", "firstName": "M", "initials": "M"}, {"lastName": "Hosseinkhanni", "fullName": "Hosseinkhanni S", "firstName": "S", "initials": "S"}, {"lastName": "Oladnabi", "fullName": "Oladnabi M", "authorId": {"type": "ORCID", "value": "0000-0001-7037-5084"}, "firstName": "M", "initials": "M"}, {"lastName": "Firouzabadi", "fullName": "Firouzabadi SG", "firstName": "S Ghasemi", "initials": "SG"}, {"lastName": "Darvish", "fullName": "Darvish H", "firstName": "H", "initials": "H"}]}, "title": "Novel evidence of the involvement of calreticulin in major psychiatric disorders.", "citedByCount": 1, "source": "MED", "pmid": "22507216", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7037-5084"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Valproic Acid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antimanic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Mental Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2012-02-21", "doi": "10.1016/j.pnpbp.2012.02.007", "isOpenAccess": "N", "pageInfo": "276-281", "hasDbCrossReferences": "Y", "abstractText": "Calreticulin (CALR) is a multi-functional protein that is strictly conserved across species. Two mRNA transcripts have been recognized for the CALR gene in humans, which use a common promoter sequence. We have recently reported mutations in the CALR promoter that co-occur with psychosis. One of those mutations at -220A increases gene expression in human BE(2)-C and HEK-293 cell lines. This mutation is the first instance of a functional cognition-deficit mutation reversing a human gene promoter to the primitive type. In the current study, we analyzed the effect of the most widely-used mood-stabilizing drug, valproic acid (VPA), on nucleotide -220 in two neuronal cell lines, LAN-5 and N2A. Remarkably, VPA increased gene expression in the cells with the wild-type -220C construct, whereas a dramatic decrease in gene expression was observed in the cell lines with the mutant construct (p<0.000004 and p<0.016, respectively). We also sequenced the 600-bp CALR promoter, and the highly conserved intron 1 sequence in an independent sample of patients afflicted with major psychiatric disorders and controls. A new case of major depressive disorder with psychotic features with the -220A mutation was identified. A novel 1-bp insertion was also detected in intron 1 at IVSI-310, in a case of amphetamine-induced psychosis. As for the psychosis-linked CALR promoter mutations identified to-date, the IVSI mutation was not detected in the control pool. This mutation creates a RREB-1 transcription factor binding site within the first intron. Our present findings identify the site of action of VPA in the CALR promoter, and introduce a novel mutation in a case of substance-induced psychosis in the first intron of CALR.", "electronicPublicationDate": "2012-02-21", "language": "eng", "dateOfCompletion": "2012-08-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pnpbp.2012.02.007", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-06-01", "journal": {"medlineAbbreviation": "Prog Neuropsychopharmacol Biol Psychiatry", "isoabbreviation": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "title": "Progress in neuro-psychopharmacology & biological psychiatry", "issn": "0278-5846", "nlmid": "8211617", "essn": "1878-4216"}, "monthOfPublication": 6, "volume": "37", "yearOfPublication": 2012, "journalIssueId": 1923966, "issue": "2", "dateOfPublication": "2012 Jun"}}, "21831887": {"pubYear": "2011", "dateOfCreation": "2011-11-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Pmp22 protein, mouse"}, {"registryNumber": "0", "name": "Myelin Proteins"}, {"registryNumber": "0", "name": "Molecular Chaperones"}, {"registryNumber": "0", "name": "Myelin P0 Protein"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "139873-08-8", "name": "Calnexin"}, {"registryNumber": "EC 5.3.4.1", "name": "Pdia3 protein, mouse"}, {"registryNumber": "EC 5.3.4.1", "name": "Protein Disulfide-Isomerases"}, {"registryNumber": "0", "name": "MPZ protein, human"}]}, "authorString": "Jung J, Coe H, Michalak M.", "affiliation": "Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "MOP-15291"}]}, "hasPDF": "N", "id": "21831887", "inEPMC": "N", "authorList": {"author": [{"lastName": "Jung", "fullName": "Jung J", "firstName": "Joanna", "initials": "J"}, {"lastName": "Coe", "fullName": "Coe H", "firstName": "Helen", "initials": "H"}, {"lastName": "Michalak", "fullName": "Michalak M", "firstName": "Marek", "initials": "M"}]}, "title": "Specialization of endoplasmic reticulum chaperones for the folding and function of myelin glycoproteins P0 and PMP22.", "citedByCount": 6, "source": "MED", "pmid": "21831887", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Calnexin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}]}}, {"descriptorName": "Myelin P0 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Myelin Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Molecular Chaperones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Folding", "majorTopic_YN": "N"}, {"descriptorName": "Protein Disulfide-Isomerases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2011-08-10", "doi": "10.1096/fj.11-184911", "isOpenAccess": "N", "pageInfo": "3929-3937", "hasDbCrossReferences": "Y", "abstractText": "Peripheral myelin protein 22 (PMP22) and protein 0 (P0) are major peripheral myelin glycoproteins, and mutations in these two proteins are associated with hereditary demyelinating peripheral neuropathies. Calnexin, calreticulin, and ERp57 are critical components of protein quality control responsible for proper folding of newly synthesized glycoproteins. Here, using confocal microscopy, we show that cell surface targeting of P0 and PMP22 is not affected in the absence of the endoplasmic reticulum chaperones. However, the folding and function (adhesiveness) of PMP22 and P0, measured using the adhesion assay, are affected significantly in the absence of calnexin but not in the absence of calreticulin. Deficiency in oxidoreductase ERp57 results in impaired folding and function of P0, a disulfide bond-containing protein, but does not have any effect on folding or function of PMP22 (a protein that does not contain a disulfide bond). We concluded that calnexin and ERp57, but not calreticulin, play an important role in the biology of peripheral myelin proteins PMP22 and P0, and, consequently, these chaperones may contribute to the pathogenesis of peripheral neuropathies and the diversity of these neurological disorders.", "electronicPublicationDate": "2011-08-10", "language": "eng", "dateOfCompletion": "2011-12-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1096/fj.11-184911", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-02-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-11-01", "journal": {"medlineAbbreviation": "FASEB J", "isoabbreviation": "FASEB J.", "title": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology", "issn": "0892-6638", "nlmid": "8804484", "essn": "1530-6860"}, "monthOfPublication": 11, "volume": "25", "yearOfPublication": 2011, "journalIssueId": 1876715, "issue": "11", "dateOfPublication": "2011 Nov"}}, "27359173": {"pubYear": "2016", "dateOfCreation": "2016-06-30", "pubModel": "Print-Electronic", "authorString": "Liu M, Xu F, Tao T, Song D, Li D, Li Y, Guo Y, Liu X.", "affiliation": "From the Department of Pathophysiology (Liu, Xu, Tao, Song, Li D, Li Y, Guo, Liu), Chinese PLA General Hospital, Beijing, China; and State Key Laboratory of Kidney Disease (Xiuhua), Chinese PLA General Hospital, Beijing, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27359173", "inEPMC": "N", "authorList": {"author": [{"affiliation": "From the Department of Pathophysiology (Liu, Xu, Tao, Song, Li D, Li Y, Guo, Liu), Chinese PLA General Hospital, Beijing, China; and State Key Laboratory of Kidney Disease (Xiuhua), Chinese PLA General Hospital, Beijing, China.", "fullName": "Liu M", "initials": "M", "firstName": "Mi", "lastName": "Liu"}, {"lastName": "Xu", "fullName": "Xu F", "firstName": "Feifei", "initials": "F"}, {"lastName": "Tao", "fullName": "Tao T", "firstName": "Tianqi", "initials": "T"}, {"lastName": "Song", "fullName": "Song D", "firstName": "Dandan", "initials": "D"}, {"lastName": "Li", "fullName": "Li D", "firstName": "Dong", "initials": "D"}, {"lastName": "Li", "fullName": "Li Y", "firstName": "Yuzhen", "initials": "Y"}, {"lastName": "Guo", "fullName": "Guo Y", "firstName": "Yucheng", "initials": "Y"}, {"lastName": "Liu", "fullName": "Liu X", "firstName": "Xiuhua", "initials": "X"}]}, "title": "Molecular Mechanisms of Stress-Induced Myocardial Injury in a Rat Model Simulating Posttraumatic Stress Disorder.", "citedByCount": 0, "source": "MED", "pmid": "27359173", "abstractText": "Posttraumatic stress disorder (PTSD) is an independent risk factor for cardiovascular diseases. This study investigated the molecular mechanisms underlying myocardial injury induced by simulated PTSD.Sprague-Dawley rats were randomly divided into two groups: control group (n = 18) and PTSD group (n = 30). The PTSD model was replicated using the single prolonged stress (SPS) method. On the 14th day poststress, the apoptotic cells in myocardium were assessed using both TUNEL method and transmission electron microscopy; the protein levels of the endoplasmic reticulum stress (ERS) molecules were measured by using Western blotting analysis.Exposure to SPS resulted in characteristic morphologic changes of apoptosis in cardiomyocytes assessed by transmission electron microscopy. Moreover, TUNEL staining was also indicative of the elevated apoptosis rate of cardiomyocytes from the SPS rats (30.69% versus 7.26%, p < .001). Simulated PTSD also induced ERS in myocardium, demonstrated by up-regulation of protein levels of glucose-regulated protein 78 (0.64 versus 0.26, p = .017), calreticulin (p = .040), and CCAAT/enhancer-binding protein-homologous protein (0.95 versus 0.43, p = .047), phosphorylation of protein kinase RNA-like ER kinase (p = .003), and caspase 12 activation (0.30 versus 0.06, p < .001) in myocardium from the SPS rats. The ratio of Bcl-2 to Bax decreased significantly in myocardium from the SPS rats (p = .005).The ERS-related apoptosis mediated by the protein kinase RNA-like ER kinase/CCAAT/enhancer-binding protein-homologous protein and caspase 12 pathways may be associated with myocardial injury in a rat model simulating PTSD. This study may advance our understanding of how PTSD contributes to myocardial injury on a molecular level.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-06-29", "isOpenAccess": "N", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "electronicPublicationDate": "2016-06-29", "language": "eng", "dateOfRevision": "2016-06-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"medlineAbbreviation": "Psychosom Med", "isoabbreviation": "Psychosom Med", "title": "Psychosomatic medicine", "issn": "0033-3174", "nlmid": "0376505", "essn": "1534-7796"}, "monthOfPublication": 6, "yearOfPublication": 2016, "journalIssueId": 2418259, "dateOfPublication": "2016 Jun"}}, "23575574": {"pubYear": "2013", "dateOfCreation": "2013-06-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.22.-", "name": "caspase 12"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "EC 2.7.11.17", "name": "Calcium-Calmodulin-Dependent Protein Kinase Type 2"}]}, "authorString": "Liu H, Han F, Shi Y.", "affiliation": "Department of Histology and Embryology, Institute of Pathology and Pathophysiology, Basic Medical Sciences College, China Medical University, 92 North 2nd Road, Shenyang, 110001, Liaoning Province, People's Republic of China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23575574", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Histology and Embryology, Institute of Pathology and Pathophysiology, Basic Medical Sciences College, China Medical University, 92 North 2nd Road, Shenyang, 110001, Liaoning Province, People's Republic of China.", "fullName": "Liu H", "initials": "H", "firstName": "Hong", "lastName": "Liu"}, {"lastName": "Han", "fullName": "Han F", "firstName": "Fang", "initials": "F"}, {"lastName": "Shi", "fullName": "Shi Y", "firstName": "Yuxiu", "initials": "Y"}]}, "title": "Effect of calreticulin on Ca2+/CaM kinaseII\u03b1 and endoplasmic reticulum stress in hippocampal in a rat model of post-traumatic stress disorder.", "citedByCount": 3, "source": "MED", "pmid": "23575574", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "Y"}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N"}, {"descriptorName": "Microscopy, Electron, Transmission", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Stress Disorders, Post-Traumatic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Caspase 12", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calcium-Calmodulin-Dependent Protein Kinase Type 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-11", "doi": "10.1007/s11064-013-1038-8", "isOpenAccess": "N", "pageInfo": "1407-1414", "hasDbCrossReferences": "Y", "abstractText": "The purpose of the present study was to examine the changes in the molecular chaperone calreticulin (CRT), calcium signaling pathway Ca(2+)-calmodulin (CaM)-CaM kinaseII\u03b1 (CaMKII\u03b1), and the endoplasmic reticulum (ER) apoptotic modulator caspase-12 in hippocampal neurons of rats exposed to single-prolonged stress (SPS), a model of post-traumatic stress disorder (PTSD). Molecular markers and proteins were assessed using immunohistochemistry, western blot and reverse transcript-polymerase chain reaction in rats exposed to SPS at 1 day (1d), 4 and 7 days post-stress and time matched controls. We found that at 7 days, SPS rats had the highest CRT expression. The intracellular free Ca(2+) and the CaM expression reached peak at 1 day post-SPS whereas the CaMKII\u03b1 had the opposite trend. Caspase-12 was most active at 4 days and was found to decrease thereafter. Signs of apoptosis were identified using transmission electron microscopy in the rats exposed to SPS. The results indicate that signs of ER stress in the hippocampus of rats exposed to SPS trigger the molecular changes in the intracellular cytoplasm which in turn activate the apoptotic pathway through caspase-12. Therefore, we propose that the hippocampal apoptosis could be one of the pathological mechanisms related to the memory disorders in PTSD.", "electronicPublicationDate": "2013-04-11", "language": "eng", "dateOfCompletion": "2014-01-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s11064-013-1038-8", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "Neurochem Res", "isoabbreviation": "Neurochem. Res.", "title": "Neurochemical research", "issn": "0364-3190", "nlmid": "7613461", "essn": "1573-6903"}, "monthOfPublication": 7, "volume": "38", "yearOfPublication": 2013, "journalIssueId": 2044680, "issue": "7", "dateOfPublication": "2013 Jul"}}, "23771339": {"pubYear": "2013", "dateOfCreation": "2013-06-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "AIF1 protein, human"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Calcium-Binding Proteins"}, {"registryNumber": "0", "name": "Calcium Channels, L-Type"}]}, "authorString": "Hurley MJ, Brandon B, Gentleman SM, Dexter DT.", "affiliation": "Centre for Neuroinflammation and Neurodegeneration, Division of Brain Sciences, Imperial College, London, W12 0NN, UK. m.hurley@imperial.ac.uk", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Parkinson's UK", "grantId": "G-0909"}]}, "hasPDF": "N", "id": "23771339", "inEPMC": "N", "authorList": {"author": [{"firstName": "Michael J", "lastName": "Hurley", "affiliation": "Centre for Neuroinflammation and Neurodegeneration, Division of Brain Sciences, Imperial College, London, W12 0NN, UK. m.hurley@imperial.ac.uk", "authorId": {"type": "ORCID", "value": "0000-0001-8022-9283"}, "fullName": "Hurley MJ", "initials": "MJ"}, {"lastName": "Brandon", "fullName": "Brandon B", "firstName": "Bianca", "initials": "B"}, {"lastName": "Gentleman", "fullName": "Gentleman SM", "firstName": "Steve M", "initials": "SM"}, {"lastName": "Dexter", "fullName": "Dexter DT", "firstName": "David T", "initials": "DT"}]}, "title": "Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.", "citedByCount": 22, "pageInfo": "2077-2097", "source": "MED", "pmid": "23771339", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-8022-9283"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calcium-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calcium Channels, L-Type", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Stereotaxic Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Densitometry", "majorTopic_YN": "N"}, {"descriptorName": "Cell Count", "majorTopic_YN": "N"}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-06-14", "doi": "10.1093/brain/awt134", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "23788521", "reference": "Brain. 2013 Jul;136(Pt 7):2015-6"}]}, "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Calcium channel", "Calcium-binding proteins", "Dyskinesia", "Parkinson\u2019s Disease", "dihydropyridines"]}, "abstractText": "In Parkinson's disease oxidative stress and calcium-induced excitotoxicity have been considered important mechanisms leading to cell death for decades, but the factors that make some neurons vulnerable to neurodegeneration while others remain resistant are not fully understood. Studies of the disorder in animal models suggest that the voltage-gated calcium channel subtype Ca(V)1.3 has a role in making neurons susceptible to neurodegeneration and support earlier work in post-mortem human brain that suggested loss of calcium buffering capacity in neurons correlated with areas of neuronal loss in the substantia nigra of parkinsonian brain. This study examined expression of Ca(V)1 subtypes and the calcium-binding proteins calbindin, calmodulin and calreticulin in areas vulnerable and resistant to neurodegeneration in Parkinson's disease, in brain from neurologically normal individuals and patients with Parkinson's disease. In control brain the expression of a specific Ca(V)1 subtype or distribution of each calcium-binding protein did not associate with those regions prone to neurodegeneration in Parkinson's disease. Whereas, alterations in the amount of both Ca(V)1 subtypes and the calcium-binding proteins were found throughout the brain in Parkinson's disease. Some changes reflected the cell loss seen in Parkinson's disease, whereas others represented altered levels of cellular expression, which as they occurred in the absence of cell loss could not be explained as solely compensatory to the neurodegeneration. The finding of increased Ca(V)1.3 subtype expression in the cerebral cortex of early stage Parkinson's disease, before the appearance of pathological changes, supports the view that disturbed calcium homeostasis is an early feature of Parkinson's disease and not just a compensatory consequence to the neurodegenerative process. This interpretation is supported further by the finding that the ratio of Ca(V)1 subtypes differed throughout the brain in patients with Parkinson's disease compared with control subjects, in favour of an increased use of Ca(V)1.3, which would add to the metabolic burden for cells that rely on this Ca(V)1 subtype for electrical activity and could therefore render specific neuronal populations more vulnerable to neurodegeneration.", "electronicPublicationDate": "2013-06-14", "language": "eng", "dateOfCompletion": "2013-08-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1093/brain/awt134", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2014-03-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 7, "volume": "136", "yearOfPublication": 2013, "journalIssueId": 2051586, "issue": "Pt 7", "dateOfPublication": "2013 Jul"}}, "26395641": {"pubYear": "2015", "dateOfCreation": "2015-10-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Molecular Chaperones"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "calreticulin, human"}]}, "authorString": "Gold L, Williams D, Groenendyk J, Michalak M, Eggleton P.", "affiliation": "Department of Medicine, New York University, 462 First Ave, New York, NY, 10016, USA. Leslie.Gold@nyumc.org.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26395641", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Medicine, New York University, 462 First Ave, New York, NY, 10016, USA. Leslie.Gold@nyumc.org.", "fullName": "Gold L", "initials": "L", "firstName": "Leslie", "lastName": "Gold"}, {"affiliation": "Department of Biochemistry, University of Toronto, Toronto, ON, M5S 1A8, Canada.", "fullName": "Williams D", "initials": "D", "firstName": "David", "lastName": "Williams"}, {"affiliation": "Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.", "fullName": "Groenendyk J", "initials": "J", "firstName": "Jody", "lastName": "Groenendyk"}, {"affiliation": "Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.", "fullName": "Michalak M", "initials": "M", "firstName": "Marek", "lastName": "Michalak"}, {"affiliation": "Institute of Biomedical and Clinical Science, University of Exeter School of Medicine, Devon, EX1 2LU, UK.", "fullName": "Eggleton P", "initials": "P", "firstName": "Paul", "lastName": "Eggleton"}]}, "title": "Unfolding the complexities of ER chaperones in health and disease: report on the 11th international calreticulin workshop.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "26395641", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Molecular Chaperones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Transport", "majorTopic_YN": "N"}, {"descriptorName": "Unfolded Protein Response", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "embargoDate": "2016-05-01", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-09-22", "doi": "10.1007/s12192-015-0638-4", "isOpenAccess": "N", "pageInfo": "875-883", "pmcid": "PMC4595441", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Wound healing", "Immune regulation", "Unfolded protein response", "glycoprotein folding", "ER stress", "calreticulin", "Cancer Modulation", "Er Associated Protein Degradation"]}, "abstractText": "The 11th International Calreticulin workshop was held May 15-18, 2015 at New York University School of Medicine-Langone Medical Center, New York. The meeting highlighted many of the new discoveries in the past 2 years involving the important role of molecular chaperones in physiological and pathological processes. Crucial to the understanding of these disease processes was the role of chaperones in maintaining quality control of protein processing in the endoplasmic reticulum, the importance of Ca(2) regulation acting through its action in stress-related diseases, and the trafficking of glycoproteins to the cell surface. Central to maintaining healthy cell physiology is the correct ER-associated protein degradation of specific misfolded proteins. Information on different mechanisms involved in the degradation of misfolded proteins was revealed. This was a landmark meeting for the chaperone field in terms of new insights into their roles in physiology. These insights included the unfolded protein response, innate/adaptive immunity, tissue repair, the functions of calreticulin/chaperones from the cell surface, and extracellular environment. Diseases included neurodegenerative disorders, prion disease, autoimmunity, fibrosis-related disease, the host immune response to cancer, and hematologic diseases associated with calreticulin mutations. The 12th calreticulin workshop is planned for the spring of 2017 in Delphi, Greece.", "electronicPublicationDate": "2015-09-22", "language": "eng", "dateOfCompletion": "2016-06-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4595441?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4595441", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s12192-015-0638-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 11, "volume": "20", "yearOfPublication": 2015, "journalIssueId": 2331195, "issue": "6", "dateOfPublication": "2015 Nov"}}, "19760677": "", "18801343": "", "26241350": {"pubYear": "2015", "dateOfCreation": "2015-08-05", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Receptors, GABA-A"}, {"registryNumber": "0", "name": "Receptors, GABA-B"}, {"registryNumber": "0", "name": "GABRB2 protein, human"}, {"registryNumber": "0", "name": "GABBR2 protein, human"}, {"registryNumber": "0", "name": "GABRA1 protein, human"}, {"registryNumber": "0", "name": "GABRB1 protein, human"}]}, "authorString": "Mueller TM, Remedies CE, Haroutunian V, Meador-Woodruff JH.", "affiliation": "Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH064673"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH53327"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH066392"}]}, "hasPDF": "Y", "id": "26241350", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.", "fullName": "Mueller TM", "initials": "TM", "firstName": "T M", "lastName": "Mueller"}, {"affiliation": "1] Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA [2] Science and Technology Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA.", "fullName": "Remedies CE", "initials": "CE", "firstName": "C E", "lastName": "Remedies"}, {"affiliation": "Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA.", "fullName": "Haroutunian V", "initials": "V", "firstName": "V", "lastName": "Haroutunian"}, {"affiliation": "Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.", "fullName": "Meador-Woodruff JH", "initials": "JH", "firstName": "J H", "lastName": "Meador-Woodruff"}]}, "title": "Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "26241350", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Temporal Lobe", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Subcellular Fractions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Receptors, GABA-B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, GABA-A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glycosylation", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-04", "language": "eng", "doi": "10.1038/tp.2015.102", "isOpenAccess": "Y", "pageInfo": "e612", "pmcid": "PMC4564557", "hasDbCrossReferences": "N", "abstractText": "Inhibitory neurotransmission is primarily mediated by \u03b3-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA(A)R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the \u03b11-6, \u03b21-3 or \u03b32 GABA(A)R subunits in the superior temporal gyrus (STG) in schizophrenia, the \u03b11, \u03b21 and \u03b22 GABA(A)R subunits are abnormally N-glycosylated. N-glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N-glycosylation has on the assembly and trafficking of GABA(A)Rs in schizophrenia, this study used western blot analysis to measure the expression of \u03b11, \u03b12, \u03b21, \u03b22 and \u03b32 GABA(A)R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia (N = 16) and comparison (N = 14) subjects and found evidence of abnormal localization of the \u03b21 and \u03b22 GABA(A)R subunits and subunit isoforms in schizophrenia. The \u03b22 subunit is expressed as three isoforms at 52 kDa (\u03b22(52 kDa)), 50 kDa (\u03b22(50 kDa)) and 48 kDa (\u03b22(48 kDa)). In the ER, we found increased total \u03b22 GABA(A)R subunit (\u03b22(ALL)) expression driven by increased \u03b22(50 kDa), a decreased ratio of \u03b2(248 kDa):\u03b22(ALL) and an increased ratio of \u03b22(50 kDa):\u03b22(48 kDa). Decreased ratios of \u03b21:\u03b22(ALL) and \u03b21:\u03b22(50 kDa) in both the ER and SYN fractions and an increased ratio of \u03b22(52 kDa):\u03b2(248 kDa) at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N-glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA(A)Rs.", "electronicPublicationDate": "2015-08-04", "license": "cc by", "dateOfCompletion": "2016-04-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4564557?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4564557", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/tp.2015.102", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-09-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Translational psychiatry", "medlineAbbreviation": "Transl Psychiatry", "isoabbreviation": "Transl Psychiatry", "nlmid": "101562664", "essn": "2158-3188"}, "monthOfPublication": 0, "volume": "5", "yearOfPublication": 2015, "journalIssueId": 2242669, "dateOfPublication": "2015"}}, "23523122": {"pubYear": "2013", "dateOfCreation": "2013-05-06", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Recombinant Proteins"}, {"registryNumber": "0", "name": "Antigens, CD5"}, {"registryNumber": "130068-27-8", "name": "Interleukin-10"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "Toll-Like Receptor 4"}, {"registryNumber": "0", "name": "Tlr4 protein, mouse"}, {"registryNumber": "0", "name": "Cd5 protein, mouse"}, {"registryNumber": "0", "name": "Antigens, CD1d"}, {"registryNumber": "0", "name": "Cd1d1 protein, mouse"}, {"registryNumber": "0", "name": "IL10 protein, mouse"}]}, "authorString": "Hong C, Zhang T, Gao XM.", "affiliation": "Institute of Biology and Medical Sciences, Soochow University, Suzhou, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23523122", "inEPMC": "N", "authorList": {"author": [{"lastName": "Hong", "fullName": "Hong C", "firstName": "Chao", "initials": "C"}, {"lastName": "Zhang", "fullName": "Zhang T", "firstName": "Tengteng", "initials": "T"}, {"lastName": "Gao", "fullName": "Gao XM", "firstName": "Xiao-Ming", "initials": "XM"}]}, "title": "Recombinant murine calreticulin fragment 39-272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice.", "citedByCount": 1, "source": "MED", "pmid": "23523122", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "B-Lymphocyte Subsets", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "N"}]}}, {"descriptorName": "T-Lymphocyte Subsets", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Encephalomyelitis, Autoimmune, Experimental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Recombinant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD5", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Interleukin-10", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lymphocyte Activation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Toll-Like Receptor 4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD1d", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-03-21", "doi": "10.1016/j.molimm.2013.02.003", "isOpenAccess": "N", "pageInfo": "237-246", "hasDbCrossReferences": "Y", "abstractText": "Calreticulin (CRT) is a Ca\u00b2\u207a binding molecular chaperone in the endoplasmic reticulum, but can also accumulate in soluble form in serum and/or synovial fluid of patients with rheumatic disorders. We have recently shown that a prokaryotically expressed recombinant CRT fragment 39-272 (rCRT/39-272) exhibited potent stimulatory activities against macrophages and B cells. However, intraperitoneal (i.p.) administration of rCRT/39-272 effectively suppressed delayed-type hypersensitivity in mice, attributable to production of anti-CRT Abs favoring Th2 cell differentiation. In this study, we further demonstrate that i.p. injection of rCRT/39-272 reduced disease severity in mouse model of experimental autoimmune encephalomyelitis (EAE), by inhibiting autoantigen-specific Th1 differentiation in vivo. Interestingly, the EAE-modulating effect of rCRT/39-272 was attributed to activation/expansion of CD1d(hi)CD5\u207a IL-10-secreting B (B10) cells rather than induction of CRT-specific antibodies in mice. In vitro, rCRT/39-272 could activate and expand murine splenic B10 cells through a Toll like receptor 4 (TLR4)-dependent pathway. The rCRT-activated B10 cells were able to not only enhance Th2 cell differentiation in vitro but also reduce EAE scores of recipient animals in passive transfer experiments. These results revealed soluble CRT, likely released by tissue cells under stress conditions, as a potentially important multi-faced player in immunoregulation and immunopathological responses.", "electronicPublicationDate": "2013-03-21", "language": "eng", "dateOfCompletion": "2013-07-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.molimm.2013.02.003", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-10-01", "journal": {"medlineAbbreviation": "Mol Immunol", "isoabbreviation": "Mol. Immunol.", "title": "Molecular immunology", "issn": "0161-5890", "nlmid": "7905289", "essn": "1872-9142"}, "monthOfPublication": 10, "volume": "55", "yearOfPublication": 2013, "journalIssueId": 2035965, "issue": "3-4", "dateOfPublication": "2013 Oct"}}, "9513044": "", "25407822": {"pubYear": "2015", "dateOfCreation": "2015-04-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Receptors, Glucocorticoid"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "EC 2.7.11.13", "name": "Protein Kinase C"}, {"registryNumber": "SY7Q814VUP", "name": "Calcium"}]}, "authorString": "Wen L, Han F, Shi Y.", "affiliation": "PTSD Lab, Department of Histology and Embryology, Institute of Pathology and Pathophysiology, Basic Medical Sciences College, China Medical University, Shenyang, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25407822", "inEPMC": "N", "authorList": {"author": [{"affiliation": "PTSD Lab, Department of Histology and Embryology, Institute of Pathology and Pathophysiology, Basic Medical Sciences College, China Medical University, Shenyang, China.", "fullName": "Wen L", "initials": "L", "firstName": "Lili", "lastName": "Wen"}, {"lastName": "Han", "fullName": "Han F", "firstName": "Fan", "initials": "F"}, {"lastName": "Shi", "fullName": "Shi Y", "firstName": "Yuxiu", "initials": "Y"}]}, "title": "Changes in the glucocorticoid receptor and Ca\u00b2\u207a/calreticulin-dependent signalling pathway in the medial prefrontal cortex of rats with post-traumatic stress disorder.", "citedByCount": 0, "source": "MED", "pmid": "25407822", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Calcium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinase C", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Glucocorticoid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Maze Learning", "majorTopic_YN": "N"}, {"descriptorName": "Stress Disorders, Post-Traumatic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "Y"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-11-19", "doi": "10.1007/s12031-014-0464-7", "isOpenAccess": "N", "pageInfo": "24-34", "hasDbCrossReferences": "N", "abstractText": "The glucocorticoid receptor (GR), calreticulin (CRT) and protein kinase C (PKC) have all been implicated in the Ca(2+)-dependent signalling pathway, which plays an important role in the plasticity of the central nervous system, learning and memory. The medial prefrontal cortex (mPFC) is known to be involved in mechanisms of learning and memory. In the present study, single prolonged stress (SPS) was used as an animal model of post-traumatic stress disorder (PTSD). The Morris water maze test was used to detect rats' ability for spatial memory and learning. A fluorescence spectrophotometer was used to measure the concentration of intracellular Ca(2+) in mPFC. Immunohistochemistry, immunofluorescence, western blot and reverse transcription polymerase chain reaction were used to explore changes in GR, CRT and PKC in mPFC of SPS rats. The concentration of Ca(2+) in mPFC was increased in the SPS rats. We found increased intensity of GR and CRT immunoreactivity and increased messenger RNA (mRNA) levels of GR, CRT and PKC in mPFC of the SPS groups, although the degree and time of increase was different among them. The protein levels of cytoplasmic GR, cytoplasmic CRT and cytoplasmic pPKC increased in mPFC of the SPS groups, whereas the protein level of nuclear GR decreased in comparison with the control group. As a conclusion, changed CRT and GR/PKC were involved in the mechanism of SPS-induced dysfunctional mPFC.", "electronicPublicationDate": "2014-11-19", "language": "eng", "dateOfCompletion": "2015-12-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s12031-014-0464-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "J Mol Neurosci", "isoabbreviation": "J. Mol. Neurosci.", "title": "Journal of molecular neuroscience : MN", "issn": "0895-8696", "nlmid": "9002991", "essn": "1559-1166"}, "monthOfPublication": 5, "volume": "56", "yearOfPublication": 2015, "journalIssueId": 2269644, "issue": "1", "dateOfPublication": "2015 May"}}, "23162777": {"pubYear": "2012", "dateOfCreation": "2012-11-19", "pubModel": "Print", "authorString": "Yi Y, Zhou Z, Shu S, Fang Y, Twitty C, Hilton TL, Aung S, Urba WJ, Fox BA, Hu HM, Li Y.", "affiliation": "Cancer Research and Biotherapy Center; Second Affiliated Hospital of Southeast University; Nanjing, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23162777", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Cancer Research and Biotherapy Center; Second Affiliated Hospital of Southeast University; Nanjing, China.", "fullName": "Yi Y", "initials": "Y", "firstName": "Yongxiang", "lastName": "Yi"}, {"lastName": "Zhou", "fullName": "Zhou Z", "firstName": "Zhenxian", "initials": "Z"}, {"lastName": "Shu", "fullName": "Shu S", "firstName": "Su", "initials": "S"}, {"lastName": "Fang", "fullName": "Fang Y", "firstName": "Yuan", "initials": "Y"}, {"lastName": "Twitty", "fullName": "Twitty C", "firstName": "Chris", "initials": "C"}, {"lastName": "Hilton", "fullName": "Hilton TL", "firstName": "Traci L", "initials": "TL"}, {"lastName": "Aung", "fullName": "Aung S", "firstName": "Sandra", "initials": "S"}, {"lastName": "Urba", "fullName": "Urba WJ", "firstName": "Walter J", "initials": "WJ"}, {"lastName": "Fox", "fullName": "Fox BA", "firstName": "Bernard A", "initials": "BA"}, {"lastName": "Hu", "fullName": "Hu HM", "firstName": "Hong-Ming", "initials": "HM"}, {"lastName": "Li", "fullName": "Li Y", "firstName": "Yuhuan", "initials": "Y"}]}, "title": "Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs.", "hasSuppl": "N", "citedByCount": 11, "source": "MED", "pmid": "23162777", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-09-01", "doi": "10.4161/onci.20059", "isOpenAccess": "Y", "pageInfo": "976-978", "pmcid": "PMC3489765", "hasDbCrossReferences": "N", "abstractText": "It is generally believed that most tumor antigens are passively released from either health or dying tumor cells as intact soluble antigens, peptide fragments complexed with heat shock proteins (HSPs), or packaged in secretary vesicles in the form of microparticles or exosomes. The passive release of tumor antigens is generally non-inflammatory and non-immunogenic; however, results from others and our laboratories suggest that autophagy is critically involved in immunogenic cell death.", "language": "eng", "license": "cc by-nc", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3489765?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3489765", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.4161/onci.20059", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-09-01", "journal": {"medlineAbbreviation": "Oncoimmunology", "isoabbreviation": "Oncoimmunology", "title": "Oncoimmunology", "issn": "2162-4011", "nlmid": "101570526", "essn": "2162-402X"}, "monthOfPublication": 9, "volume": "1", "yearOfPublication": 2012, "journalIssueId": 1984993, "issue": "6", "dateOfPublication": "2012 Sep"}}, "10693161": "", "12401949": "", "21182888": {"pubYear": "2011", "dateOfCreation": "2011-03-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Calreticulin"}]}, "authorString": "Farokhashtiani T, Mirabzadeh A, Olad Nabi M, Magham ZG, Khorshid HR, Najmabadi H, Ohadi M.", "affiliation": "Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21182888", "inEPMC": "N", "authorList": {"author": [{"lastName": "Farokhashtiani", "fullName": "Farokhashtiani T", "firstName": "T", "initials": "T"}, {"lastName": "Mirabzadeh", "fullName": "Mirabzadeh A", "firstName": "A", "initials": "A"}, {"lastName": "Olad Nabi", "fullName": "Olad Nabi M", "authorId": {"type": "ORCID", "value": "0000-0001-7037-5084"}, "firstName": "M", "initials": "M"}, {"lastName": "Magham", "fullName": "Magham ZG", "firstName": "Z Ghaem", "initials": "ZG"}, {"lastName": "Khorshid", "fullName": "Khorshid HR", "firstName": "H R Khorram", "initials": "HR"}, {"lastName": "Najmabadi", "fullName": "Najmabadi H", "authorId": {"type": "ORCID", "value": "0000-0002-6084-7778"}, "firstName": "H", "initials": "H"}, {"lastName": "Ohadi", "fullName": "Ohadi M", "firstName": "M", "initials": "M"}]}, "title": "Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation.", "citedByCount": 6, "source": "MED", "pmid": "21182888", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7037-5084"}, {"type": "ORCID", "value": "0000-0002-6084-7778"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychotic Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Species Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-12-21", "doi": "10.1016/j.pnpbp.2010.12.012", "isOpenAccess": "N", "pageInfo": "541-544", "hasDbCrossReferences": "Y", "abstractText": "Development-dependent, tissue-specific expression of the calreticulin (CALR) gene in the gray matter coincides with the expression of psychoses phenotypes. We have recently reported instances of mutations within the core promoter sequence of the gene in schizoaffective disorder. In view of the mounting evidence on the genetic overlap in the psychiatric spectrum, we investigated this gene in a spectrum of patients afflicted with schizophrenia, schizoaffective disorder and major affective disorder. We found that a unique mutation at nucleotide -220 from the transcription start site, located at a conserved genomic block in the promoter region of the gene, co-occurs with the spectrum of psychoses (p<0.005). This mutation reverts the human promoter sequence to the ancestral type observed in chimpanzee, mouse, and several other species, implying that the genomic block harboring nucleotide -220 may be involved in the evolution of human-specific higher-order functions of the brain (e.g. language, conceptual thinking, and judgment), that are ubiquitously impaired in psychoses. We propose that CALR is not only a promising candidate in the spectrum of psychoses, but also, a gene that may be important in the human-unique brain processes.", "electronicPublicationDate": "2010-12-21", "language": "eng", "dateOfCompletion": "2011-11-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pnpbp.2010.12.012", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-03-01", "journal": {"medlineAbbreviation": "Prog Neuropsychopharmacol Biol Psychiatry", "isoabbreviation": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "title": "Progress in neuro-psychopharmacology & biological psychiatry", "issn": "0278-5846", "nlmid": "8211617", "essn": "1878-4216"}, "monthOfPublication": 3, "volume": "35", "yearOfPublication": 2011, "journalIssueId": 1819038, "issue": "2", "dateOfPublication": "2011 Mar"}}, "24860980": {"pubYear": "2014", "dateOfCreation": "2014-08-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Adrenergic Agents"}, {"registryNumber": "20350-15-6", "name": "Brefeldin A"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "139873-08-8", "name": "Calnexin"}, {"registryNumber": "EC 5.3.4.1", "name": "Grp58 protein, rat"}, {"registryNumber": "EC 5.3.4.1", "name": "Protein Disulfide-Isomerases"}, {"registryNumber": "0", "name": "Proteasome Inhibitors"}, {"registryNumber": "8HW4YBZ748", "name": "Oxidopamine"}]}, "authorString": "Kuang XL, Liu F, Chen H, Li Y, Liu Y, Xiao J, Shan G, Li M, Snider BJ, Qu J, Barger SW, Wu S.", "affiliation": "School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China; State Key Laboratory Cultivation Base and Key Laboratory of Vision Science, Ministry of Health, Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang, People's Republic of China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG012411"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01 AG012411"}]}, "hasPDF": "Y", "id": "24860980", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China; State Key Laboratory Cultivation Base and Key Laboratory of Vision Science, Ministry of Health, Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang, People's Republic of China.", "fullName": "Kuang XL", "initials": "XL", "firstName": "Xiu-Li", "lastName": "Kuang"}, {"lastName": "Liu", "fullName": "Liu F", "firstName": "Fang", "initials": "F"}, {"lastName": "Chen", "fullName": "Chen H", "firstName": "Huifang", "initials": "H"}, {"lastName": "Li", "fullName": "Li Y", "firstName": "Yiping", "initials": "Y"}, {"lastName": "Liu", "fullName": "Liu Y", "firstName": "Yimei", "initials": "Y"}, {"lastName": "Xiao", "fullName": "Xiao J", "firstName": "Jian", "initials": "J"}, {"lastName": "Shan", "fullName": "Shan G", "authorId": {"type": "ORCID", "value": "0000-0002-3561-2088"}, "firstName": "Ge", "initials": "G"}, {"lastName": "Li", "fullName": "Li M", "firstName": "Mingjie", "initials": "M"}, {"lastName": "Snider", "fullName": "Snider BJ", "firstName": "B Joy", "initials": "BJ"}, {"lastName": "Qu", "fullName": "Qu J", "firstName": "Jia", "initials": "J"}, {"lastName": "Barger", "fullName": "Barger SW", "firstName": "Steven W", "initials": "SW"}, {"lastName": "Wu", "fullName": "Wu S", "authorId": {"type": "ORCID", "value": "0000-0003-1154-2369"}, "firstName": "Shengzhou", "initials": "S"}]}, "title": "Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24860980", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3561-2088"}, {"type": "ORCID", "value": "0000-0003-1154-2369"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neocortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Animals, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Oxidopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brefeldin A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calnexin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adrenergic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Disulfide-Isomerases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endoplasmic Reticulum Stress", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteasome Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-05-23", "doi": "10.1002/jnr.23413", "isOpenAccess": "N", "pageInfo": "1319-1329", "pmcid": "PMC4412743", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Chaperone", "Unfolded protein response (UPR)", "Parkinson's Disease", "endoplasmic reticulum stress", "Er Quality Control", "Endoplasmic Reticulum-associated Degradation (Erad)", "Ubiquitin-proteasome System (Ups)", "Calreticulin/calnexin Cycle"]}, "abstractText": "Evidence indicates that the ubiquitin-proteasome system and the endoplasmic retculum (ER) quality-control system work in concert to ensure that proteins are correctly folded in the ER and that misfolded proteins are retrotransported to the cytosol for degradation by proteasomes. Dysfunction of either system results in developmental abnormalities and even death in animals. This study investigates whether and how proteasome inhibition impacts the components of the calreticulin (CRT)/calnexin (CNX) glycoprotein folding machinery, a typical ER protein quality-control system, in the context of early neuronal injury. Here we report that proteasome inhibitor treatments, at nonlethal levels, reduced protein levels of CRT and ERp57 but not of CNX. These treatments increased protein levels of CRT in culture media, an effect blocked by brefeldin A, an inhibitor of protein trafficking; by contrast, ERp57 was not detected in culture media. Knockdown of CRT levels alone increased the vulnerability of SH-SY5Y, a neuronal cell line, to 6-hydroxydopamine (6-OHDA) toxicity. In a rat model of Parkinson's disease, intrastriatal 6-OHDA lesions resulted in decreased levels of CRT and ERp57 in the midbrain. These findings suggest that reduction of the components of CRT/CNX glycoprotein quality-control system may play a role in neuronal injury in Parkinson's disease and other neurodegenerative disorders associated with dysfunction of the ubiquitin-proteasome system.", "electronicPublicationDate": "2014-05-23", "language": "eng", "dateOfCompletion": "2015-05-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4412743?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4412743", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1002/jnr.23413", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-05-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "J Neurosci Res", "isoabbreviation": "J. Neurosci. Res.", "title": "Journal of neuroscience research", "issn": "0360-4012", "nlmid": "7600111", "essn": "1097-4547"}, "monthOfPublication": 10, "volume": "92", "yearOfPublication": 2014, "journalIssueId": 2191687, "issue": "10", "dateOfPublication": "2014 Oct"}}, "24167764": {"pubYear": "2013", "dateOfCreation": "2013-10-29", "pubModel": "Print-Electronic", "authorString": "Koido S, Homma S, Okamoto M, Namiki Y, Kan S, Takakura K, Kajihara M, Uchiyama K, Hara E, Ohkusa T, Gong J, Tajiri H.", "affiliation": "Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan ; Institute of Clinical Medicine and Research; The Jikei University School of Medicine; Tokyo, Japan ; Department of Oncology; Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24167764", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan ; Institute of Clinical Medicine and Research; The Jikei University School of Medicine; Tokyo, Japan ; Department of Oncology; Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan.", "fullName": "Koido S", "initials": "S", "firstName": "Shigeo", "lastName": "Koido"}, {"lastName": "Homma", "fullName": "Homma S", "firstName": "Sadamu", "initials": "S"}, {"lastName": "Okamoto", "fullName": "Okamoto M", "firstName": "Masato", "initials": "M"}, {"lastName": "Namiki", "fullName": "Namiki Y", "firstName": "Yoshihisa", "initials": "Y"}, {"lastName": "Kan", "fullName": "Kan S", "firstName": "Shin", "initials": "S"}, {"lastName": "Takakura", "fullName": "Takakura K", "firstName": "Kazuki", "initials": "K"}, {"lastName": "Kajihara", "fullName": "Kajihara M", "firstName": "Mikio", "initials": "M"}, {"lastName": "Uchiyama", "fullName": "Uchiyama K", "firstName": "Kan", "initials": "K"}, {"lastName": "Hara", "fullName": "Hara E", "firstName": "Eiich", "initials": "E"}, {"lastName": "Ohkusa", "fullName": "Ohkusa T", "firstName": "Toshifumi", "initials": "T"}, {"lastName": "Gong", "fullName": "Gong J", "firstName": "Jianlin", "initials": "J"}, {"lastName": "Tajiri", "fullName": "Tajiri H", "firstName": "Hisao", "initials": "H"}]}, "title": "Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "24167764", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-07-01", "language": "eng", "doi": "10.4161/onci.25375", "isOpenAccess": "Y", "pageInfo": "e25375", "pmcid": "PMC3805650", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Toll-like receptor", "Cytotoxic T lymphocyte", "Dendritic Cell", "Dc/tumor Cell Fusion Vaccine", "Immunologic Tumor Cell Death"]}, "abstractText": "Tumor-derived transforming growth factor \u03b21 (TGF\u03b21) generally abrogates the immunogenicity of dendritic cells (DCs) fused to whole cancer cells. We have recently revealed that ethanol-treated neoplastic cells fused to DCs exposed to 2 Toll-like receptor agonists efficiently induce cytotoxic T lymphocytes via TGF\u03b21 blockade and the production of interleukin-12.", "electronicPublicationDate": "2013-07-01", "license": "cc by-nc", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3805650?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3805650", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.4161/onci.25375", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-08-01", "journal": {"medlineAbbreviation": "Oncoimmunology", "isoabbreviation": "Oncoimmunology", "title": "Oncoimmunology", "issn": "2162-4011", "nlmid": "101570526", "essn": "2162-402X"}, "monthOfPublication": 8, "volume": "2", "yearOfPublication": 2013, "journalIssueId": 2079810, "issue": "8", "dateOfPublication": "2013 Aug"}}, "24336086": {"pubYear": "2013", "dateOfCreation": "2013-12-16", "pubModel": "Electronic", "authorString": "Hou W, Zhang Q, Yan Z, Chen R, Zeh Iii HJ, Kang R, Lotze MT, Tang D.", "affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA160417"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR000005"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA160417"}]}, "hasPDF": "Y", "id": "24336086", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Hou W", "initials": "W", "firstName": "W", "lastName": "Hou"}, {"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Zhang Q", "initials": "Q", "firstName": "Q", "lastName": "Zhang"}, {"affiliation": "1] Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA [2] Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.", "fullName": "Yan Z", "initials": "Z", "firstName": "Z", "lastName": "Yan"}, {"affiliation": "1] Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA [2] Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha 410008, China.", "fullName": "Chen R", "initials": "R", "firstName": "R", "lastName": "Chen"}, {"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Zeh Iii HJ", "initials": "HJ", "firstName": "H J", "lastName": "Zeh Iii"}, {"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Kang R", "initials": "R", "firstName": "R", "lastName": "Kang"}, {"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Lotze MT", "initials": "MT", "firstName": "M T", "lastName": "Lotze"}, {"affiliation": "Department of Surgery-DAMP Laboratory, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh 15213, PA, USA.", "fullName": "Tang D", "initials": "D", "firstName": "D", "lastName": "Tang"}]}, "title": "Strange attractors: DAMPs and autophagy link tumor cell death and immunity.", "hasSuppl": "N", "citedByCount": 29, "source": "MED", "pmid": "24336086", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Transformation, Neoplastic", "majorTopic_YN": "N"}, {"descriptorName": "Cell Death", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autophagy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-12", "language": "eng", "doi": "10.1038/cddis.2013.493", "isOpenAccess": "Y", "pageInfo": "e966", "pmcid": "PMC3877563", "hasDbCrossReferences": "N", "abstractText": "Resistance to 'apoptotic' cell death is one of the major hallmarks of cancer, contributing to tumor development and therapeutic resistance. Damage-associated molecular patterns (DAMPs) are molecules released or exposed by dead, dying, injured, or stressed non-apoptotic cells, with multiple roles in inflammation and immunity. Release of DAMPs not only contributes to tumor growth and progression but also mediates skewing of antitumor immunity during so-called immunogenic tumor cell death (ICD). Autophagy is a lysosome-mediated homeostatic degradation process in which cells digest their own effete organelles and macromolecules to meet bioenergetic needs and enable protein synthesis. For tumor cells, autophagy is a double-edged sword. Autophagy, in balance with apoptosis, can function as a tumor suppressor; autophagy deficiency, associated with alterations in apoptosis, initiates tumorigenesis in many settings. In contrast, autophagy-related stress tolerance generally promotes cell survival, which enables tumor growth and promotes therapeutic resistance. Most anticancer therapies promote DAMP release and enhance autophagy. Autophagy not only regulates DAMP release and degradation, but also is triggered and regulated by DAMPs. This interplay between autophagy and DAMPs, serving as 'strange attractors' in the dynamic system that emerges in cancer, regulates the effectiveness of antitumor treatment. This interplay also shapes the immune response to dying cells upon ICD, culling the least fit tumor cells and promoting survival of others. Thus, DAMPs and autophagy are suitable emergent targets for cancer therapy, considering their more nuanced role in tumor progression.", "electronicPublicationDate": "2013-12-12", "license": "cc by-nc-nd", "dateOfCompletion": "2014-06-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3877563?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3877563", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24336086", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24336086&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/cddis.2013.493", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Cell death & disease", "medlineAbbreviation": "Cell Death Dis", "isoabbreviation": "Cell Death Dis", "nlmid": "101524092", "essn": "2041-4889"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2013, "journalIssueId": 1999726, "dateOfPublication": "2013 "}}, "21602432": {"pubYear": "2011", "dateOfCreation": "2011-07-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anthracyclines"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "HMGB1 Protein"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSP90 Heat-Shock Proteins"}]}, "authorString": "Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Sp\u00edsek R.", "affiliation": "Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21602432", "inEPMC": "N", "authorList": {"author": [{"lastName": "Fucikova", "fullName": "Fucikova J", "firstName": "Jitka", "initials": "J"}, {"lastName": "Kralikova", "fullName": "Kralikova P", "firstName": "Petra", "initials": "P"}, {"lastName": "Fialova", "fullName": "Fialova A", "firstName": "Anna", "initials": "A"}, {"lastName": "Brtnicky", "fullName": "Brtnicky T", "firstName": "Tomas", "initials": "T"}, {"lastName": "Rob", "fullName": "Rob L", "firstName": "Lukas", "initials": "L"}, {"lastName": "Bartunkova", "fullName": "Bartunkova J", "firstName": "Jirina", "initials": "J"}, {"lastName": "Sp\u00edsek", "fullName": "Sp\u00edsek R", "firstName": "Radek", "initials": "R"}]}, "title": "Human tumor cells killed by anthracyclines induce a tumor-specific immune response.", "citedByCount": 63, "source": "MED", "pmid": "21602432", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Dendritic Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "T-Lymphocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ovarian Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prostatic Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anthracyclines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "HMGB1 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Death", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phagocytosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP90 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2011-05-20", "doi": "10.1158/0008-5472.can-11-0950", "isOpenAccess": "N", "pageInfo": "4821-4833", "hasDbCrossReferences": "N", "abstractText": "Immunogenic cell death is characterized by the early surface exposure of chaperones including calreticulin and HSPs, which affect dendritic cell (DC) maturation and the uptake and presentation of tumor antigens. It has also been shown that it is characterized by the late release of high mobility group box 1 (HMGB1), which acts through Toll-like receptor 4 (TLR4) and augments the presentation of antigens from dying tumor cells to DCs. Most of the data on immunogenic tumor cell death were obtained using mouse models. In this study, we investigated the capacity of clinically used chemotherapeutics to induce immunogenic cell death in human tumor cell lines and primary tumor cells. We found that only anthracyclines induced a rapid translocation of calreticulin, HSP70, and HSP90 to the cell surface and the release of HMGB1 12 hours after the treatment. The interaction of immature DCs with immunogenic tumor cells led to an increased tumor cell uptake and induces moderate phenotypic maturation of DCs. Killed tumor cell-loaded DCs efficiently stimulated tumor-specific IFN-\u03b3-producing T cells. DCs pulsed with killed immunogenic tumor cells also induced significantly lower numbers of regulatory T cells than those pulsed with nonimmunogenic tumor cells. These data indicate that human prostate cancer, ovarian cancer, and acute lymphoblastic leukemia cells share the key features of immunogenic cell death with mice tumor cells. These data also identify anthracyclines as anticancer drugs capable of inducing immunogenic cell death in sensitive human tumor cells.", "electronicPublicationDate": "2011-05-20", "language": "eng", "dateOfCompletion": "2011-10-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1158/0008-5472.CAN-11-0950", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-07-01", "journal": {"medlineAbbreviation": "Cancer Res", "isoabbreviation": "Cancer Res.", "title": "Cancer research", "issn": "0008-5472", "nlmid": "2984705R", "essn": "1538-7445"}, "monthOfPublication": 7, "volume": "71", "yearOfPublication": 2011, "journalIssueId": 1849055, "issue": "14", "dateOfPublication": "2011 Jul"}}, "21723904": {"pubYear": "2011", "dateOfCreation": "2011-08-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Calreticulin"}]}, "authorString": "Esmaeilzadeh-Gharehdaghi E, Banan M, Farashi S, Mirabzadeh A, Farokhashtiani T, Hosseinkhani S, Heidari A, Najmabadi H, Ohadi M.", "affiliation": "Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21723904", "inEPMC": "N", "authorList": {"author": [{"lastName": "Esmaeilzadeh-Gharehdaghi", "fullName": "Esmaeilzadeh-Gharehdaghi E", "firstName": "E", "initials": "E"}, {"lastName": "Banan", "fullName": "Banan M", "firstName": "M", "initials": "M"}, {"lastName": "Farashi", "fullName": "Farashi S", "firstName": "S", "initials": "S"}, {"lastName": "Mirabzadeh", "fullName": "Mirabzadeh A", "firstName": "A", "initials": "A"}, {"lastName": "Farokhashtiani", "fullName": "Farokhashtiani T", "firstName": "T", "initials": "T"}, {"lastName": "Hosseinkhani", "fullName": "Hosseinkhani S", "firstName": "S", "initials": "S"}, {"lastName": "Heidari", "fullName": "Heidari A", "firstName": "A", "initials": "A"}, {"lastName": "Najmabadi", "fullName": "Najmabadi H", "authorId": {"type": "ORCID", "value": "0000-0002-6084-7778"}, "firstName": "H", "initials": "H"}, {"lastName": "Ohadi", "fullName": "Ohadi M", "firstName": "M", "initials": "M"}]}, "title": "Support for down-tuning of the calreticulin gene in the process of human evolution.", "citedByCount": 4, "source": "MED", "pmid": "21723904", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6084-7778"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neuroblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Cognition Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schizophrenia, Paranoid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sequence Homology", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biological Evolution", "majorTopic_YN": "Y"}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-06-24", "doi": "10.1016/j.pnpbp.2011.06.009", "isOpenAccess": "N", "pageInfo": "1770-1773", "hasDbCrossReferences": "Y", "abstractText": "Tissue-specific expression of the CALR gene in the brain gray matter in late-adolescence and early adulthood coincides with the expression of the psychoses phenotypes. Indeed, increased expression of the chaperone genes in the prefrontal cortex has been reported in patients affected by schizophrenia. We have previously reported cases of psychosis-associated mutations in the CALR gene promoter. One of those mutations at -48 was found to increase the expression of the gene in comparison with the wild type sequence. A recently identified mutation at -220 reverts the conserved block harboring nucleotide -220 to the ancestral type, and has an approximate prevalence of 0.7% in psychoses. In this study, we analyzed the functional implication of this mutation in the human neuroblastoma cell line BE(2)-C, and non-neural Human Embryonic Kidney 293 (HEK-293), and show that the -220A mutation results in a constitutive increase in the expression of the CALR gene (p<0.0003). We checked homology of the first 1000-bp CALR promoter sequence across species, and found that nucleotide -220C is the only human-unique nucleotide in that stretch. The -220A mutation, on the other hand, co-occurs with severe cognition deficit in humans, and is the rule across the species except humans. To our knowledge, the -220A mutation is the first reported instance of a cognition-deficit-associated mutation which reverses a human gene promoter to the primitive type. It may be speculated that, at least the basal transcription of the CALR gene, relating to the proximal promoter region, has been decreased during the process of evolution to humans.", "electronicPublicationDate": "2011-06-24", "language": "eng", "dateOfCompletion": "2012-02-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pnpbp.2011.06.009", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-08-01", "journal": {"medlineAbbreviation": "Prog Neuropsychopharmacol Biol Psychiatry", "isoabbreviation": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "title": "Progress in neuro-psychopharmacology & biological psychiatry", "issn": "0278-5846", "nlmid": "8211617", "essn": "1878-4216"}, "monthOfPublication": 8, "volume": "35", "yearOfPublication": 2011, "journalIssueId": 1855807, "issue": "7", "dateOfPublication": "2011 Aug"}}, "16511840": "", "22492046": {"pubYear": "2012", "dateOfCreation": "2012-04-11", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.-", "name": "SOD1 G93A protein"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "Antigens, CD95"}, {"registryNumber": "0", "name": "FAS protein, human"}]}, "authorString": "Bernard-Marissal N, Moumen A, Sunyach C, Pellegrino C, Dudley K, Henderson CE, Raoul C, Pettmann B.", "affiliation": "INSERM-Avenir Team, The Mediterranean Institute of Neurobiology, 13273 Marseille, France.", "pubTypeList": {"pubType": ["Journal Article", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "MITOTARGET", "orderIn": 0, "agency": "European Commission FP7", "grantId": "FP7_223388"}]}, "hasPDF": "N", "id": "22492046", "inEPMC": "N", "authorList": {"author": [{"lastName": "Bernard-Marissal", "fullName": "Bernard-Marissal N", "firstName": "Nathalie", "initials": "N"}, {"lastName": "Moumen", "fullName": "Moumen A", "firstName": "Anice", "initials": "A"}, {"lastName": "Sunyach", "fullName": "Sunyach C", "firstName": "Claire", "initials": "C"}, {"lastName": "Pellegrino", "fullName": "Pellegrino C", "firstName": "Christophe", "initials": "C"}, {"lastName": "Dudley", "fullName": "Dudley K", "firstName": "Keith", "initials": "K"}, {"lastName": "Henderson", "fullName": "Henderson CE", "authorId": {"type": "ORCID", "value": "0000-0002-9936-3279"}, "firstName": "Christopher E", "initials": "CE"}, {"lastName": "Raoul", "fullName": "Raoul C", "firstName": "C\u00e9dric", "initials": "C"}, {"lastName": "Pettmann", "fullName": "Pettmann B", "firstName": "Brigitte", "initials": "B"}]}, "title": "Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS.", "citedByCount": 23, "source": "MED", "pmid": "22492046", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9936-3279"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Motor Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antigens, CD95", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Death", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Endoplasmic Reticulum Stress", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2012-04-01", "doi": "10.1523/jneurosci.5431-11.2012", "isOpenAccess": "N", "pageInfo": "4901-4912", "hasDbCrossReferences": "Y", "abstractText": "Cellular responses to protein misfolding are thought to play key roles in triggering neurodegeneration. In the mutant superoxide dismutase (mSOD1) model of amyotrophic lateral sclerosis (ALS), subsets of motoneurons are selectively vulnerable to degeneration. Fast fatigable motoneurons selectively activate an endoplasmic reticulum (ER) stress response that drives their early degeneration while a subset of mSOD1 motoneurons show exacerbated sensitivity to activation of the motoneuron-specific Fas/NO pathway. However, the links between the two mechanisms and the molecular basis of their cellular specificity remained unclear. We show that Fas activation leads, specifically in mSOD1 motoneurons, to reductions in levels of calreticulin (CRT), a calcium-binding ER chaperone. Decreased expression of CRT is both necessary and sufficient to trigger SOD1(G93A) motoneuron death through the Fas/NO pathway. In SOD1(G93A) mice in vivo, reductions in CRT precede muscle denervation and are restricted to vulnerable motor pools. In vitro, both reduced CRT and Fas activation trigger an ER stress response that is restricted to, and required for death of, vulnerable SOD1(G93A) motoneurons. Our data reveal CRT as a critical link between a motoneuron-specific death pathway and the ER stress response and point to a role of CRT levels in modulating motoneuron vulnerability to ALS.", "language": "eng", "dateOfCompletion": "2012-05-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1523/JNEUROSCI.5431-11.2012", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-04-01", "journal": {"medlineAbbreviation": "J Neurosci", "isoabbreviation": "J. Neurosci.", "title": "The Journal of neuroscience : the official journal of the Society for Neuroscience", "issn": "0270-6474", "nlmid": "8102140", "essn": "1529-2401"}, "monthOfPublication": 4, "volume": "32", "yearOfPublication": 2012, "journalIssueId": 1922609, "issue": "14", "dateOfPublication": "2012 Apr"}}, "10725457": "", "23585889": {"pubYear": "2013", "dateOfCreation": "2013-04-15", "pubModel": "Electronic-Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "amyloid beta-protein (1-42)"}, {"registryNumber": "0", "name": "amyloid beta-protein (1-40)"}, {"registryNumber": "0", "name": "presenilin-1"}, {"registryNumber": "0", "name": "nicastrin protein"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Membrane Glycoproteins"}, {"registryNumber": "0", "name": "Recombinant Proteins"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "EC 3.4.-", "name": "Amyloid Precursor Protein Secretases"}, {"registryNumber": "0", "name": "PSEN1 protein, human"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}]}, "authorString": "Stemmer N, Strekalova E, Djogo N, Pl\u00f6ger F, Loers G, Lutz D, Buck F, Michalak M, Schachner M, Kleene R.", "affiliation": "Zentrum f\u00fcr Molekulare Neurobiologie, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "MOP-15291"}]}, "hasPDF": "Y", "id": "23585889", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Stemmer", "fullName": "Stemmer N", "firstName": "Nina", "initials": "N"}, {"lastName": "Strekalova", "fullName": "Strekalova E", "firstName": "Elena", "initials": "E"}, {"lastName": "Djogo", "fullName": "Djogo N", "firstName": "Nevena", "initials": "N"}, {"lastName": "Pl\u00f6ger", "fullName": "Pl\u00f6ger F", "firstName": "Frank", "initials": "F"}, {"lastName": "Loers", "fullName": "Loers G", "firstName": "Gabriele", "initials": "G"}, {"lastName": "Lutz", "fullName": "Lutz D", "firstName": "David", "initials": "D"}, {"lastName": "Buck", "fullName": "Buck F", "firstName": "Friedrich", "initials": "F"}, {"lastName": "Michalak", "fullName": "Michalak M", "firstName": "Marek", "initials": "M"}, {"lastName": "Schachner", "fullName": "Schachner M", "firstName": "Melitta", "initials": "M"}, {"lastName": "Kleene", "fullName": "Kleene R", "firstName": "Ralf", "initials": "R"}]}, "title": "Generation of amyloid-\u03b2 is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "23585889", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "CHO Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Recombinant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Binding Sites", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Protein Structure, Tertiary", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Cricetinae", "majorTopic_YN": "N"}, {"descriptorName": "Amyloid Precursor Protein Secretases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Presenilin-1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteolysis", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["INTACT", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-09", "doi": "10.1371/journal.pone.0061299", "isOpenAccess": "Y", "pageInfo": "e61299", "pmcid": "PMC3621835", "hasDbCrossReferences": "Y", "abstractText": "Dysregulation of the proteolytic processing of amyloid precursor protein by \u03b3-secretase and the ensuing generation of amyloid-\u03b2 is associated with the pathogenesis of Alzheimer's disease. Thus, the identification of amyloid precursor protein binding proteins involved in regulating processing of amyloid precursor protein by the \u03b3-secretase complex is essential for understanding the mechanisms underlying the molecular pathology of the disease. We identified calreticulin as novel amyloid precursor protein interaction partner that binds to the \u03b3-secretase cleavage site within amyloid precursor protein and showed that this Ca(2+)- and N-glycan-independent interaction is mediated by amino acids 330-344 in the C-terminal C-domain of calreticulin. Co-immunoprecipitation confirmed that calreticulin is not only associated with amyloid precursor protein but also with the \u03b3-secretase complex members presenilin and nicastrin. Calreticulin was detected at the cell surface by surface biotinylation of cells overexpressing amyloid precursor protein and was co-localized by immunostaining with amyloid precursor protein and presenilin at the cell surface of hippocampal neurons. The P-domain of calreticulin located between the N-terminal N-domain and the C-domain interacts with presenilin, the catalytic subunit of the \u03b3-secretase complex. The P- and C-domains also interact with nicastrin, another functionally important subunit of this complex. Transfection of amyloid precursor protein overexpressing cells with full-length calreticulin leads to a decrease in amyloid-\u03b242 levels in culture supernatants, while transfection with the P-domain increases amyloid-\u03b240 levels. Similarly, application of the recombinant P- or C-domains and of a synthetic calreticulin peptide comprising amino acid 330-344 to amyloid precursor protein overexpressing cells result in elevated amyloid-\u03b240 and amyloid-\u03b242 levels, respectively. These findings indicate that the interaction of calreticulin with amyloid precursor protein and the \u03b3-secretase complex regulates the proteolytic processing of amyloid precursor protein by the \u03b3-secretase complex, pointing to calreticulin as a potential target for therapy in Alzheimer's disease.", "electronicPublicationDate": "2013-04-09", "language": "eng", "dateOfCompletion": "2013-10-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3621835?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3621835", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23585889&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23585889", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0061299", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2026959, "issue": "4", "dateOfPublication": "2013 "}}, "24321043": {"pubYear": "2014", "dateOfCreation": "2014-04-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Gene Products, tax"}, {"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "tax protein, Human T-lymphotrophic virus 1"}, {"registryNumber": "0", "name": "calreticulin, human"}]}, "authorString": "Medina F, Quintremil S, Alberti C, Barriga A, Cartier L, Puente J, Ram\u00edrez E, Ferreira A, Tanaka Y, Valenzuela MA.", "affiliation": "1 Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular, Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile , Santiago, Chile .", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24321043", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "1 Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular, Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile , Santiago, Chile .", "fullName": "Medina F", "initials": "F", "firstName": "Fernando", "lastName": "Medina"}, {"lastName": "Quintremil", "fullName": "Quintremil S", "firstName": "Sebastian", "initials": "S"}, {"lastName": "Alberti", "fullName": "Alberti C", "firstName": "Carolina", "initials": "C"}, {"lastName": "Barriga", "fullName": "Barriga A", "firstName": "Andres", "initials": "A"}, {"lastName": "Cartier", "fullName": "Cartier L", "firstName": "Luis", "initials": "L"}, {"lastName": "Puente", "fullName": "Puente J", "firstName": "Javier", "initials": "J"}, {"lastName": "Ram\u00edrez", "fullName": "Ram\u00edrez E", "firstName": "Eugenio", "initials": "E"}, {"lastName": "Ferreira", "fullName": "Ferreira A", "firstName": "Arturo", "initials": "A"}, {"lastName": "Tanaka", "fullName": "Tanaka Y", "firstName": "Yuetsu", "initials": "Y"}, {"lastName": "Valenzuela", "fullName": "Valenzuela MA", "firstName": "Maria Antonieta", "initials": "MA"}]}, "title": "Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24321043", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}, {"code": "X", "name": "AIDS/HIV research"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Leukocytes, Mononuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "VI", "qualifierName": "virology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Human T-lymphotropic virus 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HTLV-I Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "VI", "qualifierName": "virology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Products, tax", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microscopy, Confocal", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Flow Cytometry", "majorTopic_YN": "N"}, {"descriptorName": "Immunoprecipitation", "majorTopic_YN": "N"}, {"descriptorName": "Protein Interaction Mapping", "majorTopic_YN": "Y"}, {"descriptorName": "Protein Processing, Post-Translational", "majorTopic_YN": "N"}, {"descriptorName": "Host-Pathogen Interactions", "majorTopic_YN": "Y"}]}, "inPMC": "N", "embargoDate": "2015-04-01", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-24", "doi": "10.1089/aid.2013.0036", "isOpenAccess": "N", "pageInfo": "370-379", "pmcid": "PMC3976577", "hasDbCrossReferences": "Y", "abstractText": "The human retrovirus human T cell lymphotropic virus type-I (HTLV-1) is the etiologic agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Axonal degeneration in HAM/TSP patients occurs without neuron infection, with the secreted viral Tax protein proposed to be involved. We previously found that Tax secreted into the culture medium of MT-2 cells (HTLV-1-infected cell line) produced neurite retraction in neuroblastoma cells differentiated to neuronal type. To assess the relevance of Tax posttranslational modifications on this effect, we addressed the question of whether Tax secreted by MT-2 cells and peripheral blood mononuclear cells (PBMCs) of HTLV-1-infected subjects is modified. The interaction of Tax with calreticulin (CRT) that modulates intracellular Tax localization and secretion has been described. We studied Tax localization and modifications in MT-2 cells and its interaction with CRT. Intracellular Tax in MT-2 cells was assessed by flow cytometry, corresponding mainly to a 71-kDa protein followed by western blot. This protein reported as a chimera with gp21 viral protein-confirmed by mass spectrometry-showed no ubiquitination or SUMOylation. The Tax-CRT interaction was determined by confocal microscopy and coimmunoprecipitation. Extracellular Tax from HAM/TSP PBMCs is ubiquitinated according to western blot, and its interaction with CRT was shown by coimmunoprecipitation. A positive correlation between Tax and CRT secretion was observed in HAM/TSP PBMCs and asymptomatic carriers. For both proteins inhibitors and activators of secretion showed secretion through the endoplasmic reticulum-Golgi complex. Tax, present in PBMC culture medium, produced neurite retraction in differentiated neuroblastoma cells. These results suggest that Tax, whether ubiquitinated or not, is active for neurite retraction.", "electronicPublicationDate": "2014-01-24", "language": "eng", "dateOfCompletion": "2014-11-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3976577?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3976577", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1089/AID.2013.0036", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-04-01", "journal": {"medlineAbbreviation": "AIDS Res Hum Retroviruses", "isoabbreviation": "AIDS Res. Hum. Retroviruses", "title": "AIDS research and human retroviruses", "issn": "0889-2229", "nlmid": "8709376", "essn": "1931-8405"}, "monthOfPublication": 4, "volume": "30", "yearOfPublication": 2014, "journalIssueId": 2146499, "issue": "4", "dateOfPublication": "2014 Apr"}}, "15673657": "", "10963362": "", "27275382": {"pubYear": "2016", "dateOfCreation": "2016-06-09", "pubModel": "Print-Electronic", "authorString": "Farashi S, Ohadi M, Hosseinkhani S, Darvish H, Mirabzadeh A.", "affiliation": "Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands ; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27275382", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands ; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "fullName": "Farashi S", "initials": "S", "firstName": "S", "lastName": "Farashi"}, {"affiliation": "Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran ; Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "fullName": "Ohadi M", "initials": "M", "firstName": "M", "lastName": "Ohadi"}, {"affiliation": "Department of Biophysics & Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.", "fullName": "Hosseinkhani S", "initials": "S", "firstName": "S", "lastName": "Hosseinkhani"}, {"affiliation": "Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran.", "fullName": "Darvish H", "initials": "H", "firstName": "H", "lastName": "Darvish"}, {"affiliation": "Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.", "fullName": "Mirabzadeh A", "initials": "A", "firstName": "A", "lastName": "Mirabzadeh"}]}, "title": "Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.", "citedByCount": 0, "source": "MED", "pmid": "27275382", "hasLabsLinks": "Y", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-11-27", "doi": "10.1007/s11571-015-9366-9", "isOpenAccess": "N", "pageInfo": "269-274", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Mutation", "Promoter", "Expression", "Valproic acid", "calreticulin", "Psychiatric Disorder"]}, "abstractText": "Accumulating evidence of population association studies support the hypothesis that the high heritability of major psychiatric disorders is a combination of relatively common alleles of modest effect, and rare alleles some with relatively larger effects. We have previously reported low frequency mutations in the proximal promoter of the human calreticulin (CALR) gene that co-occur with the spectrum of major psychiatric disorders. One of those mutations at -205C>T (rs556992558) was detected in an isolate case of schizoaffective disorder. In the current study, the functional implication of mutation -205T is studied in the human neuronal cell lines LAN-5, BE(2)-C and HEK-293. In contrast with other mutations in the promoter region which increase gene expression activity, the -205T mutation significantly decreased gene expression in those cell lines in comparison with the wild-type -205C nucleotide (p\u00a0<\u00a00.000001, p\u00a0<\u00a00.0005, and p\u00a0<\u00a00.017, respectively). Treatment of the cell lines with the mood-stabilizing drug, valproic acid (VPA) resulted in differential gene expression activity in the mutant -205T versus the wild-type -205C construct. VPA increased gene expression activity in both constructs, while a significantly higher expression activity was observed in the mutant construct (p\u00a0<\u00a00.01), indicative of the creation of a positive effector binding site for VPA as a result of the -205T mutation. We conclude that deviation from normalcy in the level of CALR in either direction is associated with major psychiatric disorders.", "electronicPublicationDate": "2015-11-27", "language": "eng", "dateOfCompletion": "2016-06-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s11571-015-9366-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-06-10", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"medlineAbbreviation": "Cogn Neurodyn", "isoabbreviation": "Cogn Neurodyn", "title": "Cognitive neurodynamics", "issn": "1871-4080", "nlmid": "101306907", "essn": "1871-4099"}, "monthOfPublication": 6, "volume": "10", "yearOfPublication": 2016, "journalIssueId": 2417325, "issue": "3", "dateOfPublication": "2016 Jun"}}, "15298707": "", "19720113": "", "21998667": {"pubYear": "2011", "dateOfCreation": "2011-10-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Biological Markers"}, {"registryNumber": "0", "name": "Proteome"}]}, "authorString": "Nardo G, Pozzi S, Pignataro M, Lauranzano E, Spano G, Garbelli S, Mantovani S, Marinou K, Papetti L, Monteforte M, Torri V, Paris L, Bazzoni G, Lunetta C, Corbo M, Mora G, Bendotti C, Bonetto V.", "affiliation": "Dulbecco Telethon Institute, Milano, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Telethon", "grantId": "TCR08002"}, {"acronym": "EURO-MOTOR", "orderIn": 0, "agency": "European Commission FP7", "grantId": "FP7_259867"}]}, "hasPDF": "Y", "id": "21998667", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Dulbecco Telethon Institute, Milano, Italy.", "fullName": "Nardo G", "initials": "G", "firstName": "Giovanni", "lastName": "Nardo"}, {"lastName": "Pozzi", "fullName": "Pozzi S", "firstName": "Silvia", "initials": "S"}, {"lastName": "Pignataro", "fullName": "Pignataro M", "firstName": "Mauro", "initials": "M"}, {"lastName": "Lauranzano", "fullName": "Lauranzano E", "authorId": {"type": "ORCID", "value": "0000-0002-9297-3242"}, "firstName": "Eliana", "initials": "E"}, {"lastName": "Spano", "fullName": "Spano G", "firstName": "Giorgia", "initials": "G"}, {"lastName": "Garbelli", "fullName": "Garbelli S", "firstName": "Silvia", "initials": "S"}, {"lastName": "Mantovani", "fullName": "Mantovani S", "authorId": {"type": "ORCID", "value": "0000-0002-5885-2842"}, "firstName": "Stefania", "initials": "S"}, {"lastName": "Marinou", "fullName": "Marinou K", "firstName": "Kalliopi", "initials": "K"}, {"lastName": "Papetti", "fullName": "Papetti L", "firstName": "Laura", "initials": "L"}, {"lastName": "Monteforte", "fullName": "Monteforte M", "firstName": "Marta", "initials": "M"}, {"lastName": "Torri", "fullName": "Torri V", "firstName": "Valter", "initials": "V"}, {"lastName": "Paris", "fullName": "Paris L", "firstName": "Luca", "initials": "L"}, {"lastName": "Bazzoni", "fullName": "Bazzoni G", "firstName": "Gianfranco", "initials": "G"}, {"lastName": "Lunetta", "fullName": "Lunetta C", "authorId": {"type": "ORCID", "value": "0000-0002-4788-1875"}, "firstName": "Christian", "initials": "C"}, {"lastName": "Corbo", "fullName": "Corbo M", "firstName": "Massimo", "initials": "M"}, {"lastName": "Mora", "fullName": "Mora G", "firstName": "Gabriele", "initials": "G"}, {"lastName": "Bendotti", "fullName": "Bendotti C", "firstName": "Caterina", "initials": "C"}, {"lastName": "Bonetto", "fullName": "Bonetto V", "firstName": "Valentina", "initials": "V"}]}, "title": "Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells.", "hasSuppl": "Y", "citedByCount": 21, "source": "MED", "pmid": "21998667", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9297-3242"}, {"type": "ORCID", "value": "0000-0002-5885-2842"}, {"type": "ORCID", "value": "0000-0002-4788-1875"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Leukocytes, Mononuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Progression", "majorTopic_YN": "N"}, {"descriptorName": "Proteome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Proteomics", "majorTopic_YN": "N"}, {"descriptorName": "Translational Medical Research", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-10-05", "doi": "10.1371/journal.pone.0025545", "isOpenAccess": "Y", "pageInfo": "e25545", "pmcid": "PMC3187793", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease, for which there are still no diagnostic/prognostic test and therapy. Specific molecular biomarkers are urgently needed to facilitate clinical studies and speed up the development of effective treatments. METHODOLOGY/PRINCIPAL FINDINGS: We used a two-dimensional difference in gel electrophoresis approach to identify in easily accessible clinical samples, peripheral blood mononuclear cells (PBMC), a panel of protein biomarkers that are closely associated with ALS. Validations and a longitudinal study were performed by immunoassays on a selected number of proteins. The same proteins were also measured in PBMC and spinal cord of a G93A SOD1 transgenic rat model. We identified combinations of protein biomarkers that can distinguish, with high discriminatory power, ALS patients from healthy controls (98%), and from patients with neurological disorders that may resemble ALS (91%), between two levels of disease severity (90%), and a number of translational biomarkers, that link responses between human and animal model. We demonstrated that TDP-43, cyclophilin A and ERp57 associate with disease progression in a longitudinal study. Moreover, the protein profile changes detected in peripheral blood mononuclear cells of ALS patients are suggestive of possible intracellular pathogenic mechanisms such as endoplasmic reticulum stress, nitrative stress, disturbances in redox regulation and RNA processing. CONCLUSIONS/SIGNIFICANCE: Our results indicate that PBMC multiprotein biomarkers could contribute to determine amyotrophic lateral sclerosis diagnosis, differential diagnosis, disease severity and progression, and may help to elucidate pathogenic mechanisms.", "electronicPublicationDate": "2011-10-05", "language": "eng", "dateOfCompletion": "2012-02-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3187793?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3187793", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21998667&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21998667", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0025545", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-03-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2011, "journalIssueId": 1871072, "issue": "10", "dateOfPublication": "2011 "}}, "24782985": {"pubYear": "2014", "dateOfCreation": "2014-04-30", "pubModel": "Electronic-eCollection", "authorString": "Guo ZS, Liu Z, Bartlett DL.", "affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine , Pittsburgh, PA , USA.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA155925"}]}, "id": "24782985", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine , Pittsburgh, PA , USA.", "fullName": "Guo ZS", "initials": "ZS", "firstName": "Zong Sheng", "lastName": "Guo"}, {"affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine , Pittsburgh, PA , USA.", "fullName": "Liu Z", "initials": "Z", "firstName": "Zuqiang", "lastName": "Liu"}, {"affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine , Pittsburgh, PA , USA.", "fullName": "Bartlett DL", "initials": "DL", "firstName": "David L", "lastName": "Bartlett"}]}, "title": "Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.", "hasSuppl": "N", "citedByCount": 24, "source": "MED", "pmid": "24782985", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-04-10", "language": "eng", "doi": "10.3389/fonc.2014.00074", "isOpenAccess": "Y", "pageInfo": "74", "pmcid": "PMC3989763", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Immune tolerance", "Tumor-associated antigen", "PAMP", "Antitumor immunity", "Cross-presentation", "Autophagy", "Damps", "Immunogenic Cancer Cell Death"]}, "abstractText": "Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both oncolysis and elicited antitumor immunity. OVs induce mostly immunogenic cancer cell death (ICD), including immunogenic apoptosis, necrosis/necroptosis, pyroptosis, and autophagic cell death, leading to exposure of calreticulin and heat-shock proteins to the cell surface, and/or released ATP, high-mobility group box 1, uric acid, and other damage-associated molecular patterns as well as pathogen-associated molecular patterns as danger signals, along with tumor-associated antigens, to activate dendritic cells and elicit adaptive antitumor immunity. Dying the right way may greatly potentiate adaptive antitumor immunity. The mode of cancer cell death may be modulated by individual OVs and cancer cells as they often encode and express genes that inhibit/promote apoptosis, necroptosis, or autophagic cell death. We can genetically engineer OVs with death-pathway-modulating genes and thus skew the infected cancer cells toward certain death pathways for the enhanced immunogenicity. Strategies combining with some standard therapeutic regimens may also change the immunological consequence of cancer cell death. In this review, we discuss recent advances in our understanding of danger signals, modes of cancer cell death induced by OVs, the induced danger signals and functions in eliciting subsequent antitumor immunity. We also discuss potential combination strategies to target cells into specific modes of ICD and enhance cancer immunogenicity, including blockade of immune checkpoints, in order to break immune tolerance, improve antitumor immunity, and thus the overall therapeutic efficacy.", "electronicPublicationDate": "2014-04-10", "license": "cc by", "dateOfCompletion": "2014-06-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3989763?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3989763", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24782985&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24782985", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.3389/fonc.2014.00074", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-04-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "Frontiers in oncology", "medlineAbbreviation": "Front Oncol", "isoabbreviation": "Front Oncol", "nlmid": "101568867", "essn": "2234-943X"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2014, "journalIssueId": 2120431, "dateOfPublication": "2014 "}}}, "PCSK5": {"22515798": {"pubYear": "2012", "dateOfCreation": "2012-04-20", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "7782-44-7", "name": "Oxygen"}]}, "authorString": "Zhang G, Yin H, Zhou YL, Han HY, Wu YH, Xing W, Xu HZ, Zuo XN.", "affiliation": "Department of Acupuncture, No. 1 Affiliated Hospital, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22515798", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zhang", "fullName": "Zhang G", "firstName": "Gang", "initials": "G"}, {"lastName": "Yin", "fullName": "Yin H", "firstName": "Hao", "initials": "H"}, {"lastName": "Zhou", "fullName": "Zhou YL", "firstName": "You-Long", "initials": "YL"}, {"lastName": "Han", "fullName": "Han HY", "firstName": "Hong-Yan", "initials": "HY"}, {"lastName": "Wu", "fullName": "Wu YH", "firstName": "Yun-Hu", "initials": "YH"}, {"lastName": "Xing", "fullName": "Xing W", "firstName": "Wei", "initials": "W"}, {"lastName": "Xu", "fullName": "Xu HZ", "firstName": "Hong-Zhou", "initials": "HZ"}, {"lastName": "Zuo", "fullName": "Zuo XN", "authorId": {"type": "ORCID", "value": "0000-0001-9110-585X"}, "firstName": "Xi-Nian", "initials": "XN"}]}, "title": "Capturing amplitude changes of low-frequency fluctuations in functional magnetic resonance imaging signal: a pilot acupuncture study on NeiGuan (PC6).", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "22515798", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9110-585X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blood", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Oxygen", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acupuncture Therapy", "majorTopic_YN": "Y"}, {"descriptorName": "Acupuncture Points", "majorTopic_YN": "Y"}, {"descriptorName": "Brain Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Pilot Projects", "majorTopic_YN": "N"}, {"descriptorName": "Cognition Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Rest", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-04-01", "doi": "10.1089/acm.2010.0205", "isOpenAccess": "N", "pageInfo": "387-393", "pmcid": "PMC3326268", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVES: This study aims to examine amplitude changes of low-frequency oscillations (fALFF) in the blood-oxygen level-dependent (BOLD) signal associated with acupuncture on NeiGuan (PC6). EXPERIMENTAL DESIGN: Ten (10) healthy adults participated in a functional magnetic resonance imaging (i.e., nuclear medicine; fMRI) study. During the brain-imaging procedure, the participants were instructed to lie quietly; they did not perform any cognitive task. MAIN OUTCOME MEASURES: Three (3) fMRI scans were conducted for each participant: a first resting-state scan (R1), a stimulating-acupoint scan (AP), and a second resting-state scan (R2) after AP. Individual fALFF maps were calculated for each scan. RESULTS: During R1, consistent with previous studies, the default network regions showed significantly detectable fALFF amplitudes. Acupuncture on PC6 increased fALFF amplitudes within the anterior cingulate cortex (ACC), occipital fusiform gyrus, posterior cingulate cortex, and precuneus (PCC/PCU). In contrast, during R2, fALFF within PCC is still significantly higher than R1 while ACC and cerebellum showed decreased fALFF. CONCLUSIONS: These findings imply that stimulating PC6 can change the amplitude of the intrinsic cortical activity of the brain. In particular, a continuous and temporally consistent effect of acupuncture within PCC not the common brain circuit of pain including ACC and cerebellum was observed. Considering the cognitive functions and deficits of the relevant areas in mild cognitive impairment and Alzheimer disease, acupuncture on PC6 could potentially affect both psychiatric and neurological disorders. Thus, stimulating PC6 may be a candidate method for improving cognitive impairment.", "language": "eng", "dateOfCompletion": "2012-08-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3326268?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3326268", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22515798", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22515798&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1089/acm.2010.0205", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-04-01", "journal": {"medlineAbbreviation": "J Altern Complement Med", "isoabbreviation": "J Altern Complement Med", "title": "Journal of alternative and complementary medicine (New York, N.Y.)", "issn": "1075-5535", "nlmid": "9508124", "essn": "1557-7708"}, "monthOfPublication": 4, "volume": "18", "yearOfPublication": 2012, "journalIssueId": 1924990, "issue": "4", "dateOfPublication": "2012 Apr"}}, "19429024": {"pubYear": "2009", "dateOfCreation": "2009-05-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "50-22-6", "name": "Corticosterone"}, {"registryNumber": "0", "name": "Neuropeptide Y"}]}, "authorString": "Lee B, Shim I, Lee HJ, Yang Y, Hahm DH.", "affiliation": "Acupuncture and Meridian Science Research Center, Kyung Hee University, Seoul, Republic of Korea.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19429024", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lee", "fullName": "Lee B", "firstName": "Bombi", "initials": "B"}, {"lastName": "Shim", "fullName": "Shim I", "firstName": "Insop", "initials": "I"}, {"lastName": "Lee", "fullName": "Lee HJ", "firstName": "Hye-Jung", "initials": "HJ"}, {"lastName": "Yang", "fullName": "Yang Y", "firstName": "Young", "initials": "Y"}, {"lastName": "Hahm", "fullName": "Hahm DH", "firstName": "Dae-Hyun", "initials": "DH"}]}, "title": "Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats.", "citedByCount": 24, "source": "MED", "pmid": "19429024", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Pituitary-Adrenal System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hypothalamo-Hypophyseal System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Paraventricular Hypothalamic Nucleus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Chronic Disease", "majorTopic_YN": "N"}, {"descriptorName": "Corticosterone", "majorTopic_YN": "Y"}, {"descriptorName": "Neuropeptide Y", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acupuncture Therapy", "majorTopic_YN": "Y"}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Depression", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CI", "qualifierName": "chemically induced", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anxiety", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Maze Learning", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-02-04", "doi": "10.1016/j.neulet.2009.01.076", "isOpenAccess": "N", "pageInfo": "151-156", "hasDbCrossReferences": "N", "abstractText": "Repeated injection of corticosterone (CORT) induces dysregulation in the HPA axis, resulting in depression and anxiety. Many studies have shown that acupuncture, which is widely used for the treatment of stress and mental illness, in East Asian countries, is an effective therapeutic intervention for psychosomatic disorders. We investigated the influence of acupuncture therapy on chronic CORT-induced behavioral responses to the forced swimming test (FST) and elevated plus maze (EPM) and expression of neuropeptide Y (NPY) in the rat brain using immunohistochemistry. Male Sprague-Dawley rats were injected with CORT (40 mg/kg, i.p.) once daily for 19 consecutive days. The dysregulation of HPA axis by external injection of CORT was confirmed by measuring the CORT concentration in plasma and the expression level of CRF in hypothalamus. Acupuncture was performed at the PC6 acupoint for 5 min before CORT injection. Acupuncture significantly reduced depression- and anxiety-like behavior and increased NPY expression in the hypothalamus. These results demonstrated that stimulation of the PC6 acupoint suppresses the symptopathology of the hypoactivated HPA axis in chronic CORT-induced rat model of depression.", "electronicPublicationDate": "2009-02-04", "language": "eng", "dateOfCompletion": "2009-06-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neulet.2009.01.076", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-04-01", "journal": {"medlineAbbreviation": "Neurosci Lett", "isoabbreviation": "Neurosci. Lett.", "title": "Neuroscience letters", "issn": "0304-3940", "nlmid": "7600130", "essn": "1872-7972"}, "monthOfPublication": 4, "volume": "453", "yearOfPublication": 2009, "journalIssueId": 1621760, "issue": "3", "dateOfPublication": "2009 Apr"}}, "19073777": {"pubYear": "2011", "dateOfCreation": "2012-05-30", "pubModel": "Print-Electronic", "authorString": "Lambert C, Berlin I, Lee TL, Hee SW, Tan AS, Picard D, Han JS.", "affiliation": "Moleac Pte Ltd, Helios Building #09-08, 11, Biopolis way, Singapore 138667, Singapore.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "19073777", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Lambert", "fullName": "Lambert C", "firstName": "Caroline", "initials": "C"}, {"lastName": "Berlin", "fullName": "Berlin I", "firstName": "Ivan", "initials": "I"}, {"lastName": "Lee", "fullName": "Lee TL", "firstName": "Tat-Leang", "initials": "TL"}, {"lastName": "Hee", "fullName": "Hee SW", "authorId": {"type": "ORCID", "value": "0000-0002-0415-263X"}, "firstName": "Siew Wan", "initials": "SW"}, {"lastName": "Tan", "fullName": "Tan AS", "firstName": "Audrey S L", "initials": "AS"}, {"lastName": "Picard", "fullName": "Picard D", "firstName": "David", "initials": "D"}, {"lastName": "Han", "fullName": "Han JS", "firstName": "Ji Sheng", "initials": "JS"}]}, "title": "A standardized transcutaneous electric acupoint stimulation for relieving tobacco urges in dependent smokers.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "19073777", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0415-263X"}]}, "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-06-05", "doi": "10.1093/ecam/nen074", "isOpenAccess": "Y", "pageInfo": "195714", "pmcid": "PMC3135870", "hasDbCrossReferences": "N", "abstractText": "The efficacy of acupuncture in smoking cessation, and its effect on the urge to smoke are unclear. We evaluated the effect of a standardized protocol of transcutaneous electric acupoint stimulations (TEAS) on alleviating the urge to smoke. Ninety-eight smokers were recruited in two double-blind studies. Participants abstained from smoking for 26\u2009h, and were randomized to receive TEAS alternating between 2 and 100\u2009Hz at four acupoints (LI4 and PC8, PC6 and TE5) at four different intensities (10, 5, Intermittent 5 or 0\u2009mA). The urge to smoke was assessed by the Questionnaire of Smoking Urges (QSU-Brief). In Experiment 1, the 10\u2009mA group (n = 20) was compared with the 5\u2009mA group (n = 20); the increase in smoking urges did not differ significantly. Considering the possibility that 5\u2009mA may be an active intervention, in Experiment 2, a true placebo (0\u2009mA), and a proxy of placebo [Intermittent 5\u2009mA (i5\u2009mA)] were compared with 10 mA TEAS. In this experiment, 10\u2009mA (n = 20) TEAS showed a tendency to alleviate smoking urges compared with 0\u2009mA (n = 16), and i5 mA (n = 19) TEAS. Only when the data of smokers with Fagerst\u00f6m Test for Nicotine Dependence score \u22655 were analyzed that the difference between the 10\u2009mA group and the control group (0 and i5\u2009mA) became significant. Based on these preliminary findings, we conclude that TEAS applied on the skin may antagonize the increase in urge to smoke in abstinent-dependent smokers. It seems warranted to assess the efficacy of TEAS in smoking cessation clinical trials involving a larger population of dependent smokers.", "electronicPublicationDate": "2011-06-05", "language": "eng", "dateOfCompletion": "2012-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3135870?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3135870", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19073777", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19073777&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/ecam/nen074", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-03-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2011", "yearOfPublication": 2011, "journalIssueId": 1766212, "dateOfPublication": "2011 "}}, "22474521": {"pubYear": "2012", "dateOfCreation": "2012-04-04", "pubModel": "Print-Electronic", "authorString": "Lin JG, Chan YY, Chen YH.", "affiliation": "School of Chinese Medicine, China Medical University, No. 91 Hsueh-Shih Road, Taichung 40402, Taiwan.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "22474521", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Lin", "fullName": "Lin JG", "firstName": "Jaung-Geng", "initials": "JG"}, {"lastName": "Chan", "fullName": "Chan YY", "firstName": "Yuan-Yu", "initials": "YY"}, {"lastName": "Chen", "fullName": "Chen YH", "firstName": "Yi-Hung", "initials": "YH"}]}, "title": "Acupuncture for the treatment of opiate addiction.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "22474521", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-02-22", "doi": "10.1155/2012/739045", "isOpenAccess": "Y", "pageInfo": "739045", "pmcid": "PMC3296192", "hasDbCrossReferences": "N", "abstractText": "Acupuncture is an accepted treatment worldwide for various clinical conditions, and the effects of acupuncture on opiate addiction have been investigated in many clinical trials. The present review systematically analyzed data from randomized clinical trials published in Chinese and English since 1970. We found that the majority agreed on the efficacy of acupuncture as a strategy for the treatment of opiate addiction. However, some of the methods in several included trials have been criticized for their poor quality. This review summarizes the quality of the study design, the types of acupuncture applied, the commonly selected acupoints or sites of the body, the effectiveness of the treatment, and the possible mechanism underlying the effectiveness of acupuncture in these trials.", "electronicPublicationDate": "2012-02-22", "language": "eng", "dateOfCompletion": "2012-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3296192?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3296192", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22474521", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22474521&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1155/2012/739045", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2012", "yearOfPublication": 2012, "journalIssueId": 1844213, "dateOfPublication": "2012 "}}, "20633457": {"pubYear": "2008", "dateOfCreation": "2010-07-16", "pubModel": "Print-Electronic", "authorString": "Rivas-Vilchis JF, Escorcia-Gaona R, Cervantes-Reyes JA, Rom\u00e1n-Ramos R.", "affiliation": "Divisi\u00f3n de Ciencias Biol\u00f3gicas y de la Salud, Especializaci\u00f3n en Acupuntura y Fitoterapia, Universidad Aut\u00f3noma Metropolitana-Iztapalapa, Distrito Federal, M\u00e9xico. jfrv@xanum.uam.mx", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "20633457", "inEPMC": "N", "authorList": {"author": [{"lastName": "Rivas-Vilchis", "fullName": "Rivas-Vilchis JF", "firstName": "Jos\u00e9 F", "initials": "JF"}, {"lastName": "Escorcia-Gaona", "fullName": "Escorcia-Gaona R", "firstName": "Ricardo", "initials": "R"}, {"lastName": "Cervantes-Reyes", "fullName": "Cervantes-Reyes JA", "firstName": "Jorge A", "initials": "JA"}, {"lastName": "Rom\u00e1n-Ramos", "fullName": "Rom\u00e1n-Ramos R", "firstName": "Rub\u00e9n", "initials": "R"}]}, "title": "Vascular responses to manual PC6 acupuncture in nonsmokers and smokers assessed by the second derivative of the finger photoplethysmogram waveform.", "citedByCount": 1, "source": "MED", "pmid": "20633457", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Fingers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BS", "qualifierName": "blood supply", "majorTopic_YN": "Y"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Photoplethysmography", "majorTopic_YN": "N"}, {"descriptorName": "Acupuncture Therapy", "majorTopic_YN": "Y"}, {"descriptorName": "Acupuncture Points", "majorTopic_YN": "Y"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blood Pressure", "majorTopic_YN": "N"}, {"descriptorName": "Heart Rate", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-09-01", "doi": "10.1016/s2005-2901(09)60009-1", "isOpenAccess": "N", "pageInfo": "58-62", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Smoking is reported to increase arterial stiffness. Indices obtained from the second derivative of digital volume pulse (SDDVP) waveform have been proposed to characterize vascular aging and arterial rigidity. PC6 (Neiguan) is a traditional acupoint in each forearm that has been shown to modify cardiovascular functioning. OBJECTIVE: To investigate the acute effects of manual needling with PC6 on SDDVP indices in healthy chronic smoker and nonsmoker subjects. SUBJECTS AND METHODS: Aging index (AI) was defined as (b - c - d - e)/a, B:A was calculated as the ratio of the absolute value for the height of the b wave (B) to that of the a wave (A), and D:A was calculated as the ratio of the absolute value for the height of the d wave (D) to that of the a wave (A). These indices derived of the wave components of SDDVP of healthy nonsmokers (n=40; 28.3+/-3.0 years old) vs. chronic smokers (n=30; 29.9+/-2.9 years old) were compared. The digital volume pulse (DVP) was obtained by measuring infrared light transmission through the finger. Of each subject, a DVP registration 20 minutes long was obtained. PC6 was stimulated unilaterally by manual needling for 5 minutes (1-6 minutes). SDDVP indices were compared in each subject in pre- vs. post-acupuncture periods (30 seconds vs. 18 minutes, respectively). RESULTS: At baseline, we found significant difference in B:A between nonsmokers and smokers. Comparing pre- vs. post-acupuncture periods, B:A and D:A did not show significant differences among nonsmokers, but B:A improved significantly in smokers and AI improved significantly in both nonsmokers and smokers. CONCLUSION: These findings suggest that manual needling with PC6 could revert some of the deleterious effects on vascular functioning produced by chronic cigarette smoking.", "electronicPublicationDate": "2009-03-24", "language": "eng", "dateOfCompletion": "2010-10-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/S2005-2901(09)60009-1", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-08-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-09-01", "journal": {"medlineAbbreviation": "J Acupunct Meridian Stud", "isoabbreviation": "J Acupunct Meridian Stud", "title": "Journal of acupuncture and meridian studies", "issn": "2005-2901", "nlmid": "101490763", "essn": "2093-8152"}, "monthOfPublication": 9, "volume": "1", "yearOfPublication": 2008, "journalIssueId": 1747187, "issue": "1", "dateOfPublication": "2008 Sep"}}, "22644205": {"pubYear": "2012", "dateOfCreation": "2012-05-30", "pubModel": "Print", "authorString": "Allais G, Rolando S, Castagnoli Gabellari I, Burzio C, Airola G, Borgogno P, Schiapparelli P, Allais R, Benedetto C.", "affiliation": "Department of Gynecology and Obstetrics, Women's Headache Center, University of Turin, Via Ventimiglia 3, 10126 Turin, Italy. gb.allais@tiscali.it", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "22644205", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Allais", "fullName": "Allais G", "firstName": "Gianni", "initials": "G"}, {"lastName": "Rolando", "fullName": "Rolando S", "firstName": "Sara", "initials": "S"}, {"lastName": "Castagnoli Gabellari", "fullName": "Castagnoli Gabellari I", "firstName": "Ilaria", "initials": "I"}, {"lastName": "Burzio", "fullName": "Burzio C", "firstName": "Chiara", "initials": "C"}, {"lastName": "Airola", "fullName": "Airola G", "firstName": "Gisella", "initials": "G"}, {"lastName": "Borgogno", "fullName": "Borgogno P", "firstName": "Paola", "initials": "P"}, {"lastName": "Schiapparelli", "fullName": "Schiapparelli P", "firstName": "Paola", "initials": "P"}, {"lastName": "Allais", "fullName": "Allais R", "firstName": "Rita", "initials": "R"}, {"lastName": "Benedetto", "fullName": "Benedetto C", "authorId": {"type": "ORCID", "value": "0000-0003-1514-4771"}, "firstName": "Chiara", "initials": "C"}]}, "title": "Acupressure in the control of migraine-associated nausea.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "22644205", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1514-4771"}, {"type": "ORCID", "value": "0000-0002-1946-0109"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Wrist", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Nausea", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acupressure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IS", "qualifierName": "instrumentation", "majorTopic_YN": "Y"}, {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acupuncture Points", "majorTopic_YN": "Y"}, {"descriptorName": "Medical Records", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Migraine Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-05-01", "doi": "10.1007/s10072-012-1069-y", "isOpenAccess": "Y", "pageInfo": "S207-10", "pmcid": "PMC3362706", "hasDbCrossReferences": "N", "abstractText": "Migraine is a disabling neurological disorder, aggravated by accompanying symptomatology, such as nausea. One of the most interesting approaches to nausea adopted by traditional Chinese medicine is the stimulation of the acupoint PC6 Neiguan. Actually there are no studies in medical literature as to the efficacy of treating PC6 acupoint for gastrointestinal symptoms in migraine attacks. Our study aimed at verifying if pressure applied to the acupoint PC6 was effective on nausea during migraine. Forty female patients suffering from migraine without aura were enrolled, if nausea was always present as accompanying symptomatology of their migraine. The patients were treated randomly for a total of six migraine attacks: three with the application of a device, the Sea-Band(\u00ae) wristband, which applies continual pressure to the PC6 acupoint (phase SB), and three without it (phase C). The intensities of nausea at the onset, at 30, 60, 120 and 240 min were evaluated on a scale from 0 to 10. The values were always significantly lower in phase SB than in phase C. Also the number of patients who reported at least a 50 % reduction in the nausea score was significantly higher in phase SB than in phase C at 30, 60 and 120 min. Moreover, the consistency of the treatment (response in at least two out of three treated attacks) was reached in 28 % patients at 60 min; in 40 % at 120 min and 59 % at 240 min. Our results encourage the application of PC6 acupressure for the treatment of migraine-associated nausea.", "language": "eng", "dateOfCompletion": "2013-04-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3362706?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3362706", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22644205&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22644205", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s10072-012-1069-y", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-05-01", "journal": {"medlineAbbreviation": "Neurol Sci", "isoabbreviation": "Neurol. Sci.", "title": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology", "issn": "1590-1874", "nlmid": "100959175", "essn": "1590-3478"}, "monthOfPublication": 5, "volume": "33 Suppl 1", "yearOfPublication": 2012, "journalIssueId": 1935832, "dateOfPublication": "2012 May"}}, "23049896": {"pubYear": "2012", "dateOfCreation": "2012-10-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Apolipoproteins E"}]}, "authorString": "Kim DS, Stanaway IB, Rajagopalan R, Bernbaum JC, Solot CB, Burnham N, Zackai EH, Clancy RR, Nicolson SC, Gerdes M, Nickerson DA, Hakonarson H, Gaynor JW, Jarvik GP.", "affiliation": "Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Seattle, Washington, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL071834"}]}, "hasPDF": "Y", "id": "23049896", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Kim", "fullName": "Kim DS", "firstName": "Daniel S", "initials": "DS"}, {"lastName": "Stanaway", "fullName": "Stanaway IB", "firstName": "Ian B", "initials": "IB"}, {"lastName": "Rajagopalan", "fullName": "Rajagopalan R", "firstName": "Ramakrishnan", "initials": "R"}, {"lastName": "Bernbaum", "fullName": "Bernbaum JC", "firstName": "Judy C", "initials": "JC"}, {"lastName": "Solot", "fullName": "Solot CB", "firstName": "Cynthia B", "initials": "CB"}, {"lastName": "Burnham", "fullName": "Burnham N", "firstName": "Nancy", "initials": "N"}, {"lastName": "Zackai", "fullName": "Zackai EH", "firstName": "Elaine H", "initials": "EH"}, {"lastName": "Clancy", "fullName": "Clancy RR", "firstName": "Robert R", "initials": "RR"}, {"lastName": "Nicolson", "fullName": "Nicolson SC", "firstName": "Susan C", "initials": "SC"}, {"lastName": "Gerdes", "fullName": "Gerdes M", "firstName": "Marsha", "initials": "M"}, {"lastName": "Nickerson", "fullName": "Nickerson DA", "firstName": "Deborah A", "initials": "DA"}, {"lastName": "Hakonarson", "fullName": "Hakonarson H", "firstName": "Hakon", "initials": "H"}, {"lastName": "Gaynor", "fullName": "Gaynor JW", "authorId": {"type": "ORCID", "value": "0000-0001-7955-5604"}, "firstName": "J William", "initials": "JW"}, {"lastName": "Jarvik", "fullName": "Jarvik GP", "firstName": "Gail P", "initials": "GP"}]}, "title": "Results of genome-wide analyses on neurodevelopmental phenotypes at four-year follow-up following cardiac surgery in infancy.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "23049896", "abstractText": " BACKGROUND: Adverse neurodevelopmental sequelae are reported among children who undergo early cardiac surgery to repair congenital heart defects (CHD). APOE genotype has previously been determined to contribute to the prediction of these outcomes. Understanding further genetic causes for the development of poor neurobehavioral outcomes should enhance patient risk stratification and improve both prevention and treatment strategies. METHODS: We performed a prospective observational study of children who underwent cardiac surgery before six months of age; this included a neurodevelopmental evaluation between their fourth and fifth birthdays. Attention and behavioral skills were assessed through parental report utilizing the Attention Deficit-Hyperactivity Disorder-IV scale preschool edition (ADHD-IV), and Child Behavior Checklist (CBCL/1.5-5), respectively. Of the seven investigated, three neurodevelopmental phenotypes met genomic quality control criteria. Linear regression was performed to determine the effect of genome-wide genetic variation on these three neurodevelopmental measures in 316 subjects. RESULTS: This genome-wide association study identified single nucleotide polymorphisms (SNPs) associated with three neurobehavioral phenotypes in the postoperative children ADHD-IV Impulsivity/Hyperactivity, CBCL/1.5-5 PDPs, and CBCL/1.5-5 Total Problems. The most predictive SNPs for each phenotype were: a LGALS8 intronic SNP, rs4659682, associated with ADHD-IV Impulsivity (P=1.03 \u00d7 10(-6)); a PCSK5 intronic SNP, rs2261722, associated with CBCL/1.5-5 PDPs (P=1.11 \u00d7 10(-6)); and an intergenic SNP, rs11617488, 50 kb from FGF9, associated with CBCL/1.5-5 Total Problems (P=3.47 \u00d7 10(-7)). 10 SNPs (3 for ADHD-IV Impulsivity, 5 for CBCL/1.5-5 PDPs, and 2 for CBCL/1.5-5 Total Problems) had p<10(-5). CONCLUSIONS: No SNPs met genome-wide significance for our three neurobehavioral phenotypes; however, 10 SNPs reached a threshold for suggestive significance (p<10(-5)). Given the unique nature of this cohort, larger studies and/or replication are not possible. Studies to further investigate the mechanisms through which these newly identified genes may influence neurodevelopment dysfunction are warranted.", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7955-5604"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Heart Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SU", "qualifierName": "surgery", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apolipoproteins E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Cardiac Surgical Procedures", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Attention Deficit Disorder with Hyperactivity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Child Behavior Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Developmental Disabilities", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-09-25", "doi": "10.1371/journal.pone.0045936", "isOpenAccess": "Y", "pageInfo": "e45936", "pmcid": "PMC3457986", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "electronicPublicationDate": "2012-09-25", "language": "eng", "dateOfCompletion": "2013-05-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3457986?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3457986", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23049896&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23049896", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0045936", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1963765, "issue": "9", "dateOfPublication": "2012 "}}, "24396277": {"pubYear": "2013", "dateOfCreation": "2014-01-07", "pubModel": "Print", "authorString": "Turpeinen H, Ortutay Z, Pesu M.", "affiliation": "Immunoregulation, Institute of Biomedical Technology, University of Tampere, and BioMediTech, Tampere, Finland;", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24396277", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Immunoregulation, Institute of Biomedical Technology, University of Tampere, and BioMediTech, Tampere, Finland;", "fullName": "Turpeinen H", "initials": "H", "firstName": "Hannu", "lastName": "Turpeinen"}, {"affiliation": "Immunoregulation, Institute of Biomedical Technology, University of Tampere, and BioMediTech, Tampere, Finland;", "fullName": "Ortutay Z", "initials": "Z", "firstName": "Zsuzsanna", "lastName": "Ortutay"}, {"affiliation": "Immunoregulation, Institute of Biomedical Technology, University of Tampere, and BioMediTech, Tampere, Finland; ; Fimlab laboratories, Pirkanmaa Hospital District, Finland.", "fullName": "Pesu M", "initials": "M", "firstName": "Marko", "lastName": "Pesu"}]}, "title": "Genetics of the first seven proprotein convertase enzymes in health and disease.", "hasSuppl": "N", "citedByCount": 8, "source": "MED", "pmid": "24396277", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-11-01", "doi": "10.2174/1389202911314050010", "isOpenAccess": "Y", "pageInfo": "453-467", "pmcid": "PMC3867721", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Genetics", "Proprotein convertase", "Furin", "Association."]}, "abstractText": "Members of the substilisin/kexin like proprotein convertase (PCSK) protease family cleave and convert immature pro-proteins into their biologically active forms. By cleaving for example prohormones, cytokines and cell membrane proteins, PCSKs participate in maintaining the homeostasis in a healthy human body. Conversely, erratic enzymatic function is thought to contribute to the pathogenesis of a wide variety of diseases, including obesity and hypercholestrolemia. The first characterized seven PCSK enzymes (PCSK1-2, FURIN, PCSK4-7) process their substrates at a motif made up of paired basic amino acid residues. This feature results in a variable degree of biochemical redundancy in vitro, and consequently, shared substrate molecules between the different PCSK enzymes. This redundancy has confounded our understanding of the specific biological functions of PCSKs. The physiological roles of these enzymes have been best illustrated by the phenotypes of genetically engineered mice and patients that carry mutations in the PCSK genes. Recent developments in genome-wide methodology have generated a large amount of novel information on the genetics of the first seven proprotein convertases. In this review we summarize the reported genetic alterations and their associated phenotypes.", "language": "eng", "license": "cc by-nc", "dateOfCompletion": "2014-01-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3867721?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3867721", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24396277&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24396277", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.2174/1389202911314050010", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2014-05-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-11-01", "journal": {"medlineAbbreviation": "Curr Genomics", "isoabbreviation": "Curr. Genomics", "title": "Current genomics", "issn": "1389-2029", "nlmid": "100960527", "essn": "1875-5488"}, "monthOfPublication": 11, "volume": "14", "yearOfPublication": 2013, "journalIssueId": 2111315, "issue": "7", "dateOfPublication": "2013 Nov"}}, "23589718": {"pubYear": "2013", "dateOfCreation": "2013-04-16", "pubModel": "Print-Electronic", "authorString": "Kang X, Shen X, Xia Y.", "affiliation": "Shanghai Research Center for Acupuncture and Meridians, Shanghai 201203, China ; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23589718", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Kang", "fullName": "Kang X", "firstName": "Xuezhi", "initials": "X"}, {"lastName": "Shen", "fullName": "Shen X", "firstName": "Xueyong", "initials": "X"}, {"lastName": "Xia", "fullName": "Xia Y", "firstName": "Ying", "initials": "Y"}]}, "title": "Electroacupuncture-induced attenuation of experimental epilepsy: a comparative evaluation of acupoints and stimulation parameters.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "23589718", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-03-26", "doi": "10.1155/2013/149612", "isOpenAccess": "Y", "pageInfo": "149612", "pmcid": "PMC3622388", "hasDbCrossReferences": "N", "abstractText": "The efficacy of electroacupuncture (EA) on epilepsy remains to be verified because of previous controversies that might be due to the complexity of the effects induced by different acupoints and stimulation approaches adopted. Therefore, we investigated the effects of EA on epilepsy to determine the specific acupoints and optimal stimulation parameters in this work. Experimental epilepsy was induced by injecting kainic acid to the lateral cerebral ventricle of adult male SD rats. EA with a low-frequency (10\u2009Hz/1\u2009mA) or high-frequency (100\u2009Hz/1\u2009mA) current was applied to the epileptic model for 30 minutes starting at 0.5 hour after the injection. Four pairs of acupoints were tested, that is, Shuigou (DU26) + Dazhui (DU14), Jinsuo (DU8) + Yaoqi (EXB9), Neiguan (PC6) + Quchi (LI11), and Fenglong (ST40) + Yongquan (KI1). We found that (1) low- or high-frequency EA at different acupoints reduced epileptic seizures (P < 0.05 versus the control) with an exception of low-frequency EA at Neiguan (PC6) and Quchi (LI11); (2) low-frequency EA induced a better effect at Fenglong (ST40) plus Yongquan (KI1) than that of the other acupoints (P < 0.05); (3) there is no significant difference in the effects of high-frequency EA at these acupoints; and (4) the high-frequency EA elicited a greater effect than that of low-frequency EA in all groups (P < 0.05), with an exception at Jinsuo (DU8) + Yaoqi (EXB9). The EA-induced attenuation appeared 1-1.5 hours after EA with no appreciable effect in the first hour after EA in either the EEG or the behavioral tests. We conclude that EA attenuation of epileptic seizures is dependent on the stimulation parameters and acupoints and that the delay in appearance of the EA effect could be a reflection of the time required by the EA signal to regulate neural function in the central nervous system.", "electronicPublicationDate": "2013-03-26", "language": "eng", "dateOfCompletion": "2013-04-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3622388?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3622388", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23589718", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23589718&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1155/2013/149612", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-04-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2013", "yearOfPublication": 2013, "journalIssueId": 2004961, "dateOfPublication": "2013 "}}, "22570670": {"pubYear": "2012", "dateOfCreation": "2012-05-09", "pubModel": "Print-Electronic", "authorString": "Litscher G, Cheng G, Wang L, Cheng W, Su H, Niu Q, Zou T, Wang Y, Feng X, Gaischek I, Sheng Z, Kuang H.", "affiliation": "Stronach Research Unit for Complementary and Integrative Laser Medicine, Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, and TCM Research Center Graz, Medical University Graz, Auenbruggerplatz 29, 8036 Graz, Austria.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "22570670", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Litscher", "fullName": "Litscher G", "firstName": "Gerhard", "initials": "G"}, {"lastName": "Cheng", "fullName": "Cheng G", "firstName": "Guangyu", "initials": "G"}, {"lastName": "Wang", "fullName": "Wang L", "firstName": "Lu", "initials": "L"}, {"lastName": "Cheng", "fullName": "Cheng W", "firstName": "Weiping", "initials": "W"}, {"lastName": "Su", "fullName": "Su H", "firstName": "Hang", "initials": "H"}, {"lastName": "Niu", "fullName": "Niu Q", "firstName": "Qianqian", "initials": "Q"}, {"lastName": "Zou", "fullName": "Zou T", "firstName": "Tianyu", "initials": "T"}, {"lastName": "Wang", "fullName": "Wang Y", "firstName": "Yongyue", "initials": "Y"}, {"lastName": "Feng", "fullName": "Feng X", "firstName": "Xiao", "initials": "X"}, {"lastName": "Gaischek", "fullName": "Gaischek I", "firstName": "Ingrid", "initials": "I"}, {"lastName": "Sheng", "fullName": "Sheng Z", "firstName": "Zemin", "initials": "Z"}, {"lastName": "Kuang", "fullName": "Kuang H", "firstName": "Haixue", "initials": "H"}]}, "title": "Biomedical Teleacupuncture between China and Austria Using Heart Rate Variability-Part 2: Patients with Depression.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "22570670", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-04-17", "doi": "10.1155/2012/145904", "isOpenAccess": "Y", "pageInfo": "145904", "pmcid": "PMC3337670", "hasDbCrossReferences": "N", "abstractText": "It has been shown in previous studies that the autonomic nervous system can be affected by acupuncture. Within this study, teleacupuncture between China and Austria is used for quantifying the effects of heart rate (HR) and heart rate variability (HRV) in 33 Chinese patients (27 females, 6 males; mean age \u00b1 SD 49.5 \u00b1 13.1 years; range 22-72 years) suffering from depression. Electrocardiographic signals before, during, and after acupuncture at the acupoint Baihui (GV20) were recorded in Harbin and analyzed in Graz using teleacupuncture. HRV data were analyzed in the time and frequency domain. Mean HR decreased significantly (P < 0.05) during and after acupuncture, whereas total HRV increased significantly after the third acupuncture stimulation period (P < 0.05) and also 5-10 minutes after (P < 0.05) acupuncture. The study shows that HRV could be a useful parameter for quantifying clinical effects of acupuncture on the autonomic nervous system.", "electronicPublicationDate": "2012-04-17", "language": "eng", "dateOfCompletion": "2012-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3337670?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3337670", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22570670&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22570670", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1155/2012/145904", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-04-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2012", "yearOfPublication": 2012, "journalIssueId": 1844213, "dateOfPublication": "2012 "}}, "23259001": {"pubYear": "2012", "dateOfCreation": "2012-12-21", "pubModel": "Print-Electronic", "authorString": "Yeung WF, Chung KF, Poon MM, Ho FY, Zhang SP, Zhang ZJ, Ziea ET, Wong Taam V.", "affiliation": "Department of Psychiatry, University of Hong Kong, Pokfulam Road, Hong Kong.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23259001", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Yeung", "fullName": "Yeung WF", "authorId": {"type": "ORCID", "value": "0000-0002-7980-3126"}, "firstName": "Wing-Fai", "initials": "WF"}, {"lastName": "Chung", "fullName": "Chung KF", "authorId": {"type": "ORCID", "value": "0000-0002-2045-9260"}, "firstName": "Ka-Fai", "initials": "KF"}, {"lastName": "Poon", "fullName": "Poon MM", "authorId": {"type": "ORCID", "value": "0000-0002-2157-7445"}, "firstName": "Maggie Man-Ki", "initials": "MM"}, {"lastName": "Ho", "fullName": "Ho FY", "firstName": "Fiona Yan-Yee", "initials": "FY"}, {"lastName": "Zhang", "fullName": "Zhang SP", "firstName": "Shi-Ping", "initials": "SP"}, {"lastName": "Zhang", "fullName": "Zhang ZJ", "firstName": "Zhang-Jin", "initials": "ZJ"}, {"lastName": "Ziea", "fullName": "Ziea ET", "firstName": "Eric Tat-Chi", "initials": "ET"}, {"lastName": "Wong Taam", "fullName": "Wong Taam V", "firstName": "Vivian", "initials": "V"}]}, "title": "Prescription of chinese herbal medicine and selection of acupoints in pattern-based traditional chinese medicine treatment for insomnia: a systematic review.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "23259001", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7980-3126"}, {"type": "ORCID", "value": "0000-0002-2045-9260"}, {"type": "ORCID", "value": "0000-0002-2157-7445"}, {"type": "ORCID", "value": "0000-0002-6413-5778"}]}, "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-11-28", "doi": "10.1155/2012/902578", "isOpenAccess": "Y", "pageInfo": "902578", "pmcid": "PMC3521464", "hasDbCrossReferences": "N", "abstractText": "Traditional Chinese medicine (TCM) treatments are often prescribed based on individuals' pattern diagnoses. A systematic review of Chinese and English literatures on TCM pattern differentiation, treatment principle, and pattern-based treatment for insomnia has therefore been conducted. A total of 227 studies, 17916 subjects, and 87 TCM patterns were analyzed. There was a limited consistency in pattern-based TCM treatment of insomnia across practitioners. Except for Gui Pi Tang, An Shen Ding Zhi Wan, and Wen Dan Tang which were used more commonly for deficiency of both the heart and spleen, internal disturbance of phlegm-heat, and qi deficiency of the heart and gallbladder, respectively, the selection of herbal formula for other patterns and pattern-based prescription of individual herbs and acupoints were not consistent. Suanzaoren (Semen Z. spinosae), Fuling (Poria), Yejiaoteng (Caulis P. multiflori), Gancao (Radix Glycyrrhizae), Baishao (Radix P. alba), Shenmen (HT7), Yintang (EX-HN3), Sanyinjiao (SP6), Baihui (GV20), Anmian (EX-HN22), and Sishencong (EX-HN1) were commonly used, but nonspecifically for many patterns. Treatment principles underlying herb and acupoint selection were seldom reported. Although many studies were reviewed, the study quality and diagnostic process were inadequate. More high quality studies are needed to examine the additional benefits of pattern differentiation and pattern-based TCM treatment.", "electronicPublicationDate": "2012-11-28", "language": "eng", "dateOfCompletion": "2012-12-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3521464?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3521464", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23259001", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23259001&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1155/2012/902578", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-04-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2012", "yearOfPublication": 2012, "journalIssueId": 1844213, "dateOfPublication": "2012 "}}, "21869897": {"pubYear": "2011", "dateOfCreation": "2011-08-26", "pubModel": "Print-Electronic", "authorString": "Zhao ZL, Zhao GW, Li HZ, Yang XD, Wu YY, Lin F, Guan LX, Zhai FG, Liu JQ, Yang CH, Kim SC, Kim KW, Zhao RJ.", "affiliation": "Department of Pharmacology, Mudanjiang Medical University, Mudanjiang 157011, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "21869897", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zhao", "fullName": "Zhao ZL", "firstName": "Zheng Lin", "initials": "ZL"}, {"lastName": "Zhao", "fullName": "Zhao GW", "firstName": "Guang Wen", "initials": "GW"}, {"lastName": "Li", "fullName": "Li HZ", "firstName": "Hou Zhong", "initials": "HZ"}, {"lastName": "Yang", "fullName": "Yang XD", "firstName": "Xu Dong", "initials": "XD"}, {"lastName": "Wu", "fullName": "Wu YY", "firstName": "Yi Yan", "initials": "YY"}, {"lastName": "Lin", "fullName": "Lin F", "firstName": "Feng", "initials": "F"}, {"lastName": "Guan", "fullName": "Guan LX", "firstName": "Li Xin", "initials": "LX"}, {"lastName": "Zhai", "fullName": "Zhai FG", "firstName": "Feng Guo", "initials": "FG"}, {"lastName": "Liu", "fullName": "Liu JQ", "firstName": "Jia Qi", "initials": "JQ"}, {"lastName": "Yang", "fullName": "Yang CH", "firstName": "Chae Ha", "initials": "CH"}, {"lastName": "Kim", "fullName": "Kim SC", "firstName": "Sang Chan", "initials": "SC"}, {"lastName": "Kim", "fullName": "Kim KW", "firstName": "Kee Won", "initials": "KW"}, {"lastName": "Zhao", "fullName": "Zhao RJ", "firstName": "Rong Jie", "initials": "RJ"}]}, "title": "Acupuncture Attenuates Anxiety-Like Behavior by Normalizing Amygdaloid Catecholamines during Ethanol Withdrawal in Rats.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "21869897", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0515-0764"}]}, "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-02-14", "doi": "10.1093/ecam/neq045", "isOpenAccess": "Y", "pageInfo": "429843", "pmcid": "PMC3159395", "hasDbCrossReferences": "N", "abstractText": "Previously, we demonstrated acupuncture at acupoint HT7 (Shen-Men) attenuated ethanol withdrawal syndrome by normalizing the dopamine release in nucleus accumbens shell. In the present study, we investigated the effect of acupuncture on anxiety-like behavior in rats and its relevant mechanism by studying neuro-endocrine parameters during ethanol withdrawal. Rats were treated with 3\u2009g\u2009kg(-1)day(-1) of ethanol (20%, w/v) or saline by intraperitoneal injections for 28 days. The rats undergoing ethanol withdrawal exhibited anxiety-like behavior 72\u2009h after the last dose of ethanol characterized by the decrease of time spent in the open arms of the elevated plus maze compared with the saline-treated rats (P < .05). Radioimmunoassay exhibited there were notably increased concentrations of plasma corticosterone in ethanol-withdrawn rats compared with saline-treated rats (P < .05). Additionally, high performance liquid chromatography analysis also showed the levels of norepinephrine and 3-methoxy-4-hydroxy-phenylglycol were markedly increased while the levels of dopamine and 3,4-dihydroxyphenylacetic acid were significantly decreased in the central nucleus of the amygdala of ethanol-withdrawn rats compared with saline-treated rats (P < .01). Acupuncture groups were treated with acupuncture at acupoint HT7 or PC6 (Nei-Guan). Acupuncture at HT7 but not PC6 greatly attenuated the anxiety-like behavior during ethanol withdrawal as evidenced by significant increases in the percentage of time spent in open arms (P < .05). In the meantime, acupuncture at HT7 also markedly inhibited the alterations of neuro-endocrine parameters induced by ethanol withdrawal (P < .05). These results suggest that acupuncture may attenuate anxiety-like behavior during ethanol withdrawal through regulation of neuro-endocrine system.", "electronicPublicationDate": "2011-02-14", "language": "eng", "dateOfCompletion": "2011-11-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3159395?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3159395", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21869897&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21869897", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/ecam/neq045", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Evid Based Complement Alternat Med", "isoabbreviation": "Evid Based Complement Alternat Med", "title": "Evidence-based complementary and alternative medicine : eCAM", "issn": "1741-427X", "nlmid": "101215021", "essn": "1741-4288"}, "monthOfPublication": 0, "volume": "2011", "yearOfPublication": 2011, "journalIssueId": 1766212, "dateOfPublication": "2011 "}}}, "AKR1A1": {"23295227": {"pubYear": "2013", "dateOfCreation": "2013-03-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "82964-04-3", "name": "tolrestat"}, {"registryNumber": "53-59-8", "name": "NADP"}, {"registryNumber": "0", "name": "Naphthalenes"}, {"registryNumber": "0", "name": "Enzyme Inhibitors"}, {"registryNumber": "EC 1.1.1.21", "name": "Aldehyde Reductase"}, {"registryNumber": "0", "name": "Imidazolidines"}, {"registryNumber": "EC 1.1.-", "name": "Alcohol Oxidoreductases"}, {"registryNumber": "8SH8T1164U", "name": "fidarestat"}, {"registryNumber": "EC 1.1.1.21", "name": "carbonyl reductase (NADPH)"}]}, "authorString": "Ruiz FX, Cousido-Siah A, Mitschler A, Farr\u00e9s J, Par\u00e9s X, Podjarny A.", "affiliation": "Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire, Illkirch, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23295227", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire, Illkirch, France.", "fullName": "Ruiz FX", "initials": "FX", "firstName": "Francesc Xavier", "lastName": "Ruiz"}, {"lastName": "Cousido-Siah", "fullName": "Cousido-Siah A", "firstName": "Alexandra", "initials": "A"}, {"lastName": "Mitschler", "fullName": "Mitschler A", "firstName": "Andr\u00e9", "initials": "A"}, {"lastName": "Farr\u00e9s", "fullName": "Farr\u00e9s J", "authorId": {"type": "ORCID", "value": "0000-0001-9069-3987"}, "firstName": "Jaume", "initials": "J"}, {"lastName": "Par\u00e9s", "fullName": "Par\u00e9s X", "firstName": "Xavier", "initials": "X"}, {"lastName": "Podjarny", "fullName": "Podjarny A", "authorId": {"type": "ORCID", "value": "0000-0002-7685-1077"}, "firstName": "Alberto", "initials": "A"}]}, "title": "X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.", "citedByCount": 3, "source": "MED", "pmid": "23295227", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9069-3987"}, {"type": "ORCID", "value": "0000-0002-7685-1077"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Imidazolidines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Naphthalenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "NADP", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Alcohol Oxidoreductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aldehyde Reductase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Enzyme Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Crystallography, X-Ray", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Inhibitory Concentration 50", "majorTopic_YN": "N"}, {"descriptorName": "Binding Sites", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["PDB", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-04", "doi": "10.1016/j.cbi.2012.12.013", "isOpenAccess": "N", "pageInfo": "178-185", "hasDbCrossReferences": "Y", "abstractText": "Only one crystal structure is currently available for tumor marker AKR1B10, complexed with NADP(+) and tolrestat, which is an aldose reductase inhibitor (ARI) of the carboxylic acid type. Here, the X-ray structure of the complex of the V301L substituted AKR1B10 holoenzyme with fidarestat, an ARI of the cyclic imide type, was obtained at 1.60\u00c5 resolution by replacement soaking of crystals containing tolrestat. Previously, fidarestat was found to be safe in phase III trials for diabetic neuropathy and, consistent with its low in vivo side effects, was highly selective for aldose reductase (AR or AKR1B1) versus aldehyde reductase (AKR1A1). Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat. Structural analysis of the V301L AKR1B10-fidarestat complex displayed enzyme-inhibitor interactions similar to those of the AR-fidarestat complex. However, a close inspection of both the new crystal structure and a computer model of the wild-type AKR1B10 complex with fidarestat revealed subtle changes that could affect fidarestat binding. In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement. This was due to the presence of the more voluminous Gln-303 side chain (Ser-302 in AR) and of a water molecule buried in a subpocket located at the base of flexible loop A. In the wild-type AKR1B10 model, a short contact was predicted between the Val-301 side chain and fidarestat, but would not be present in AR or in V301L AKR1B10. Overall, these changes could contribute to the difference in inhibitory potency of fidarestat between AR and AKR1B10.", "electronicPublicationDate": "2013-01-04", "language": "eng", "dateOfCompletion": "2013-08-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.cbi.2012.12.013", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2014-03-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-02-01", "journal": {"medlineAbbreviation": "Chem Biol Interact", "isoabbreviation": "Chem. Biol. Interact.", "title": "Chemico-biological interactions", "issn": "0009-2797", "nlmid": "0227276", "essn": "1872-7786"}, "monthOfPublication": 2, "volume": "202", "yearOfPublication": 2013, "journalIssueId": 2020816, "issue": "1-3", "dateOfPublication": "2013 Feb"}}}, "RARS2": {"22283595": {"pubYear": "2012", "dateOfCreation": "2012-04-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Rahman S.", "affiliation": "Mitochondrial Research Group, Clinical and Molecular Genetics Unit, UCL Institute of Child Health, University College London, 30 Guilford Street, London, UK. s.rahman@ich.ucl.ac.uk", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Medical Research Council"}, {"orderIn": 0, "agency": "Great Ormond Street Hospital Childrens Charity", "grantId": "V1220"}]}, "hasPDF": "N", "id": "22283595", "inEPMC": "N", "authorList": {"author": [{"lastName": "Rahman", "fullName": "Rahman S", "firstName": "Shamima", "initials": "S"}]}, "title": "Mitochondrial disease and epilepsy.", "citedByCount": 26, "source": "MED", "pmid": "22283595", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Encephalomyopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "MELAS Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Diseases, Metabolic, Inborn", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Diagnosis, Differential", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Ketogenic Diet", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Testing", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-01-28", "doi": "10.1111/j.1469-8749.2011.04214.x", "isOpenAccess": "N", "pageInfo": "397-406", "hasDbCrossReferences": "N", "abstractText": "Mitochondrial respiratory chain disorders are relatively common inborn errors of energy metabolism, with a combined prevalence of one in 5000. These disorders typically affect tissues with high energy requirements, and cerebral involvement occurs frequently in childhood, often manifesting in seizures. Mitochondrial diseases are genetically heterogeneous; to date, mutations have been reported in all 37 mitochondrially encoded genes and more than 80 nuclear genes. The major genetic causes of mitochondrial epilepsy are mitochondrial DNA mutations (including those typically associated with the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS] and myoclonic epilepsy with ragged red fibres [MERRF] syndromes); mutations in POLG (classically associated with Alpers syndrome but also presenting as the mitochondrial recessive ataxia syndrome [MIRAS], spinocerebellar ataxia with epilepsy [SCAE], and myoclonus, epilepsy, myopathy, sensory ataxia [MEMSA] syndromes in older individuals) and other disorders of mitochondrial DNA maintenance; complex I deficiency; disorders of coenzyme Q(10)  biosynthesis; and disorders of mitochondrial translation such as RARS2 mutations. It is not clear why some genetic defects, but not others, are particularly associated with seizures. Epilepsy may be the presenting feature of mitochondrial disease but is often part of a multisystem clinical presentation. Mitochondrial epilepsy may be very difficult to manage, and is often a poor prognostic feature. At present there are no curative treatments for mitochondrial disease. Individuals with mitochondrial epilepsy are frequently prescribed multiple anticonvulsants, and the role of vitamins and other nutritional supplements and the ketogenic diet remain unproven.", "electronicPublicationDate": "2012-01-28", "language": "eng", "dateOfCompletion": "2012-05-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1469-8749.2011.04214.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-05-01", "journal": {"medlineAbbreviation": "Dev Med Child Neurol", "isoabbreviation": "Dev Med Child Neurol", "title": "Developmental medicine and child neurology", "issn": "0012-1622", "nlmid": "0006761", "essn": "1469-8749"}, "monthOfPublication": 5, "volume": "54", "yearOfPublication": 2012, "journalIssueId": 1922031, "issue": "5", "dateOfPublication": "2012 May"}}, "24047924": {"pubYear": "2013", "dateOfCreation": "2013-11-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 6.1.1.19", "name": "Arginine-tRNA Ligase"}]}, "authorString": "Kastrissianakis K, Anand G, Quaghebeur G, Price S, Prabhakar P, Marinova J, Brown G, McShane T.", "affiliation": "Department of Paediatric Neurology, Oxford University Hospitals, , Oxford, UK.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "24047924", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Paediatric Neurology, Oxford University Hospitals, , Oxford, UK.", "fullName": "Kastrissianakis K", "initials": "K", "firstName": "Katherina", "lastName": "Kastrissianakis"}, {"lastName": "Anand", "fullName": "Anand G", "firstName": "Geetha", "initials": "G"}, {"lastName": "Quaghebeur", "fullName": "Quaghebeur G", "firstName": "Gerardine", "initials": "G"}, {"lastName": "Price", "fullName": "Price S", "firstName": "Sue", "initials": "S"}, {"lastName": "Prabhakar", "fullName": "Prabhakar P", "firstName": "Prab", "initials": "P"}, {"lastName": "Marinova", "fullName": "Marinova J", "firstName": "Jasmina", "initials": "J"}, {"lastName": "Brown", "fullName": "Brown G", "firstName": "Garry", "initials": "G"}, {"lastName": "McShane", "fullName": "McShane T", "firstName": "Tony", "initials": "T"}]}, "title": "Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations.", "citedByCount": 3, "source": "MED", "pmid": "24047924", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Olivopontocerebellar Atrophies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Subdural Effusion", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Arginine-tRNA Ligase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Diagnosis, Differential", "majorTopic_YN": "N"}, {"descriptorName": "Siblings", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2013-09-18", "doi": "10.1136/archdischild-2013-304308", "isOpenAccess": "N", "pageInfo": "1004-1007", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Epilepsy", "Subdural effusion", "Microcephaly", "Pontocerebellar Hypoplasia Type 6", "Rars2"]}, "abstractText": "Mutations in the recently described RARS2 gene encoding for mitochondrial arginyl-transfer RNA synthetase give rise to a disorder characterised by early onset seizures, progressive microcephaly and developmental delay. The disorder was named pontocerebellar hypoplasia type 6 (PCH6) based on the corresponding radiological findings observed in the original cases. We report two siblings with the RARS2 mutation who displayed typical clinical features of PCH6, but who had distinct neuroimaging features. Early scans showed marked supratentorial, rather than infratentorial, atrophy, and the pons remained preserved throughout. One sibling also had bilateral subdural effusions at presentation. The deceleration in head growth pointed to an evolving genetic/metabolic process giving rise to cerebral atrophy and secondary subdural effusions. RARS2 mutations should be considered in infants presenting with seizures, subdural effusions, decelerating head growth and evidence of cerebral atrophy even in the absence of pontocerebellar hypoplasia on imaging. ", "electronicPublicationDate": "2013-09-18", "language": "eng", "dateOfCompletion": "2014-01-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1136/archdischild-2013-304308", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-12-01", "journal": {"medlineAbbreviation": "Arch Dis Child", "isoabbreviation": "Arch. Dis. Child.", "title": "Archives of disease in childhood", "issn": "0003-9888", "nlmid": "0372434", "essn": "1468-2044"}, "monthOfPublication": 12, "volume": "98", "yearOfPublication": 2013, "journalIssueId": 2093877, "issue": "12", "dateOfPublication": "2013 Dec"}}, "26970947": {"pubYear": "2016", "dateOfCreation": "2016-04-08", "pubModel": "Print-Electronic", "authorString": "Nishri D, Goldberg-Stern H, Noyman I, Blumkin L, Kivity S, Saitsu H, Nakashima M, Matsumoto N, Leshinsky-Silver E, Lerman-Sagie T, Lev D.", "affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Child Development Center, Central District, Maccabi Health Services, Tel Aviv, Israel.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26970947", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Child Development Center, Central District, Maccabi Health Services, Tel Aviv, Israel.", "fullName": "Nishri D", "initials": "D", "firstName": "Daniella", "lastName": "Nishri"}, {"affiliation": "Epilepsy Center, Schneider's Children Medical Center, Petah Tiqwa, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.", "fullName": "Goldberg-Stern H", "initials": "H", "firstName": "Hadassa", "lastName": "Goldberg-Stern"}, {"affiliation": "Pediatric Neurology Unit, Soroka Medical Center, Beer-Sheba, Israel.", "fullName": "Noyman I", "initials": "I", "firstName": "Iris", "lastName": "Noyman"}, {"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.", "fullName": "Blumkin L", "initials": "L", "firstName": "Lubov", "lastName": "Blumkin"}, {"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Epilepsy Center, Schneider's Children Medical Center, Petah Tiqwa, Israel.", "fullName": "Kivity S", "initials": "S", "firstName": "Sara", "lastName": "Kivity"}, {"affiliation": "Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.", "fullName": "Saitsu H", "initials": "H", "firstName": "Hirotomo", "lastName": "Saitsu"}, {"affiliation": "Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.", "fullName": "Nakashima M", "initials": "M", "firstName": "Mitsuko", "lastName": "Nakashima"}, {"affiliation": "Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.", "fullName": "Matsumoto N", "initials": "N", "firstName": "Naomichi", "lastName": "Matsumoto"}, {"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Molecular Genetics Laboratory, Wolfson Medical Center, Holon, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.", "fullName": "Leshinsky-Silver E", "initials": "E", "firstName": "Esther", "lastName": "Leshinsky-Silver"}, {"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.", "fullName": "Lerman-Sagie T", "initials": "T", "firstName": "Tally", "lastName": "Lerman-Sagie"}, {"affiliation": "Metabolic-Neurogenetic Clinic, Wolfson Medical Center, Holon, Israel; Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: dorlev@post.tau.ac.il.", "fullName": "Lev D", "initials": "D", "firstName": "Dorit", "lastName": "Lev"}]}, "title": "RARS2 mutations cause early onset epileptic encephalopathy without ponto-cerebellar hypoplasia.", "citedByCount": 0, "source": "MED", "pmid": "26970947", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-03-02", "doi": "10.1016/j.ejpn.2016.02.012", "isOpenAccess": "N", "pageInfo": "412-417", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Mitochondrial", "Epileptic Encephalopathy", "Rars2", "Pontocerebellar Hypoplasia"]}, "abstractText": "Early onset epileptic encephalopathies (EOEEs) are a group of devastating diseases, manifesting in the first year of life with frequent seizures and/or prominent interictal epileptiform discharges on the electroencephalogram, developmental delay or regression and usually a poor prognosis. There are numerous causes for EOEEs making the diagnostic workup time consuming and costly.We describe two siblings with fatal EOEE, profound global developmental delay and post-natal microcephaly that underwent extensive biochemical and metabolic workup in vain. Neuro-imaging disclosed non-specific progressive cerebral atrophy.Whole-exome sequencing (WES) disclosed compound heterozygous mutations in the gene encoding for mitochondrial arginyl-transfer RNA synthetase, RARS2. This gene has been previously described as the cause of pontocerebellar hypoplasia type 6.We suggest that RARS2 gene mutations can cause a metabolic neurodegenerative disease manifesting primarily as EOEE with post-natal microcephaly, without the distinctive radiological features of pontocerebellar hypoplasia.", "electronicPublicationDate": "2016-03-02", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.ejpn.2016.02.012", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-05-01", "journal": {"medlineAbbreviation": "Eur J Paediatr Neurol", "isoabbreviation": "Eur. J. Paediatr. Neurol.", "title": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society", "issn": "1090-3798", "nlmid": "9715169", "essn": "1532-2130"}, "monthOfPublication": 5, "volume": "20", "yearOfPublication": 2016, "journalIssueId": 2396121, "issue": "3", "dateOfPublication": "2016 May"}}, "22427329": {"pubYear": "2012", "dateOfCreation": "2012-04-30", "pubModel": "Print-Electronic", "authorString": "Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB.", "affiliation": "Neuroradiology, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, CA 94913-0628, USA. james.barkovich@ucsf.edu", "pubTypeList": {"pubType": ["Historical Article", "Journal Article", "Review", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS058721"}]}, "hasPDF": "Y", "id": "22427329", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Barkovich", "fullName": "Barkovich AJ", "firstName": "A James", "initials": "AJ"}, {"lastName": "Guerrini", "fullName": "Guerrini R", "firstName": "Renzo", "initials": "R"}, {"lastName": "Kuzniecky", "fullName": "Kuzniecky RI", "firstName": "Ruben I", "initials": "RI"}, {"lastName": "Jackson", "fullName": "Jackson GD", "firstName": "Graeme D", "initials": "GD"}, {"lastName": "Dobyns", "fullName": "Dobyns WB", "firstName": "William B", "initials": "WB"}]}, "title": "A developmental and genetic classification for malformations of cortical development: update 2012.", "hasSuppl": "Y", "citedByCount": 136, "source": "MED", "pmid": "22427329", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebral Cortex", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Diagnostic Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Developmental Disabilities", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Biology", "majorTopic_YN": "N"}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "History, 21st Century", "majorTopic_YN": "N"}, {"descriptorName": "Malformations of Cortical Development", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "N"}, {"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-16", "language": "eng", "doi": "10.1093/brain/aws019", "isOpenAccess": "Y", "pageInfo": "1348-1369", "pmcid": "PMC3338922", "hasDbCrossReferences": "N", "abstractText": "Malformations of cerebral cortical development include a wide range of developmental disorders that are common causes of neurodevelopmental delay and epilepsy. In addition, study of these disorders contributes greatly to the understanding of normal brain development and its perturbations. The rapid recent evolution of molecular biology, genetics and imaging has resulted in an explosive increase in our knowledge of cerebral cortex development and in the number and types of malformations of cortical development that have been reported. These advances continue to modify our perception of these malformations. This review addresses recent changes in our perception of these disorders and proposes a modified classification based upon updates in our knowledge of cerebral cortical development.", "electronicPublicationDate": "2012-03-16", "license": "cc by-nc", "dateOfCompletion": "2012-06-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3338922?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3338922", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22427329&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22427329", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/brain/aws019", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-05-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 5, "volume": "135", "yearOfPublication": 2012, "journalIssueId": 1926850, "issue": "Pt 5", "dateOfPublication": "2012 May"}}}, "ATP5B": {"25560755": {"pubYear": "2015", "dateOfCreation": "2015-10-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Antipsychotic Agents"}, {"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "0", "name": "Ubiquitin"}]}, "authorString": "Arion D, Corradi JP, Tang S, Datta D, Boothe F, He A, Cacace AM, Zaczek R, Albright CF, Tseng G, Lewis DA.", "affiliation": "Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH043784"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH084053"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH103204"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R37 MH043784"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "P50 MH103204"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH043784"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "P50 MH084053"}]}, "hasPDF": "Y", "id": "25560755", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Arion D", "initials": "D", "firstName": "D", "lastName": "Arion"}, {"firstName": "J P", "lastName": "Corradi", "affiliation": "Bristol-Myers Squibb, Research Parkway, Wallingford, CT, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-3456-4974"}, "fullName": "Corradi JP", "initials": "JP"}, {"affiliation": "Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Tang S", "initials": "S", "firstName": "S", "lastName": "Tang"}, {"affiliation": "Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Datta D", "initials": "D", "firstName": "D", "lastName": "Datta"}, {"affiliation": "Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Boothe F", "initials": "F", "firstName": "F", "lastName": "Boothe"}, {"affiliation": "Bristol-Myers Squibb, Research Parkway, Wallingford, CT, USA.", "fullName": "He A", "initials": "A", "firstName": "A", "lastName": "He"}, {"affiliation": "Bristol-Myers Squibb, Research Parkway, Wallingford, CT, USA.", "fullName": "Cacace AM", "initials": "AM", "firstName": "A M", "lastName": "Cacace"}, {"affiliation": "Bristol-Myers Squibb, Research Parkway, Wallingford, CT, USA.", "fullName": "Zaczek R", "initials": "R", "firstName": "R", "lastName": "Zaczek"}, {"affiliation": "Bristol-Myers Squibb, Research Parkway, Wallingford, CT, USA.", "fullName": "Albright CF", "initials": "CF", "firstName": "C F", "lastName": "Albright"}, {"affiliation": "Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Tseng G", "initials": "G", "firstName": "G", "lastName": "Tseng"}, {"affiliation": "Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Lewis DA", "initials": "DA", "firstName": "D A", "lastName": "Lewis"}]}, "title": "Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "25560755", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3456-4974"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Pyramidal Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Macaca fascicularis", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ubiquitin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antipsychotic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Psychotic Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Transcriptome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Laser Capture Microdissection", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2016-05-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-06", "doi": "10.1038/mp.2014.171", "isOpenAccess": "Y", "pageInfo": "1397-1405", "pmcid": "PMC4492919", "hasDbCrossReferences": "N", "abstractText": "Schizophrenia is associated with alterations in working memory that reflect dysfunction of dorsolateral prefrontal cortex (DLPFC) circuitry. Working memory depends on the activity of excitatory pyramidal cells in DLPFC layer 3 and, to a lesser extent, in layer 5. Although many studies have profiled gene expression in DLPFC gray matter in schizophrenia, little is known about cell-type-specific transcript expression in these two populations of pyramidal cells. We hypothesized that interrogating gene expression, specifically in DLPFC layer 3 or 5 pyramidal cells, would reveal new and/or more robust schizophrenia-associated differences that would provide new insights into the nature of pyramidal cell dysfunction in the illness. We also sought to determine the impact of other variables, such as a diagnosis of schizoaffective disorder or medication use at the time of death, on the patterns of gene expression in pyramidal neurons. Individual pyramidal cells in DLPFC layers 3 or 5 were captured by laser microdissection from 36 subjects with schizophrenia or schizoaffective disorder and matched normal comparison subjects. The mRNA from cell collections was subjected to transcriptome profiling by microarray followed by quantitative PCR validation. Expression of genes involved in mitochondrial (MT) or ubiquitin-proteasome system (UPS) functions were markedly downregulated in the patient group (P-values for MT-related and UPS-related pathways were <10(-7) and <10(-5), respectively). MT-related gene alterations were more prominent in layer 3 pyramidal cells, whereas UPS-related gene alterations were more prominent in layer 5 pyramidal cells. Many of these alterations were not present, or found to a lesser degree, in samples of DLPFC gray matter from the same subjects, suggesting that they are pyramidal cell specific. Furthermore, these findings principally reflected alterations in the schizophrenia subjects were not present or present to a lesser degree in the schizoaffective disorder subjects (diagnosis of schizoaffective disorder was the most significant covariate, P<10(-6)) and were not attributable to factors frequently comorbid with schizophrenia. In summary, our findings reveal expression deficits in MT- and UPS-related genes specific to layer 3 and/or layer 5 pyramidal cells in the DLPFC of schizophrenia subjects. These cell type-specific transcriptome signatures are not characteristic of schizoaffective disorder, providing a potential molecular-cellular basis of differences in clinical phenotypes.", "electronicPublicationDate": "2015-01-06", "language": "eng", "dateOfCompletion": "2016-08-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4492919?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4492919", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/mp.2014.171", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"medlineAbbreviation": "Mol Psychiatry", "isoabbreviation": "Mol. Psychiatry", "title": "Molecular psychiatry", "issn": "1359-4184", "nlmid": "9607835", "essn": "1476-5578"}, "monthOfPublication": 11, "volume": "20", "yearOfPublication": 2015, "journalIssueId": 2335362, "issue": "11", "dateOfPublication": "2015 Nov"}}, "26300727": {"pubYear": "2015", "dateOfCreation": "2015-08-24", "pubModel": "Electronic-eCollection", "authorString": "Alves CJ, Dariolli R, Jorge FM, Monteiro MR, Maximino JR, Martins RS, Strauss BE, Krieger JE, Callegaro D, Chadi G.", "affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26300727", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Alves CJ", "initials": "CJ", "firstName": "Chrystian J", "lastName": "Alves"}, {"firstName": "Rafael", "lastName": "Dariolli", "affiliation": "Laboratory of Genetics and Molecular Cardiology/LIM13, Heart Institute, University of S\u00e3o Paulo School of Medicine S\u00e3o Paulo, Brazil.", "authorId": {"type": "ORCID", "value": "0000-0003-0957-1259"}, "fullName": "Dariolli R", "initials": "R"}, {"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Jorge FM", "initials": "FM", "firstName": "Frederico M", "lastName": "Jorge"}, {"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Monteiro MR", "initials": "MR", "firstName": "Matheus R", "lastName": "Monteiro"}, {"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Maximino JR", "initials": "JR", "firstName": "Jessica R", "lastName": "Maximino"}, {"affiliation": "Department of Neurosurgery, Surgical Center of Functional Neurosurgery, Clinics Hospital of University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Martins RS", "initials": "RS", "firstName": "Roberto S", "lastName": "Martins"}, {"affiliation": "Viral Vector Laboratory, Center for Translational Investigation in Oncology/LIM24, Cancer Institute of S\u00e3o Paulo, University of S\u00e3o Paulo School of Medicine S\u00e3o Paulo, Brazil.", "fullName": "Strauss BE", "initials": "BE", "firstName": "Bryan E", "lastName": "Strauss"}, {"affiliation": "Laboratory of Genetics and Molecular Cardiology/LIM13, Heart Institute, University of S\u00e3o Paulo School of Medicine S\u00e3o Paulo, Brazil.", "fullName": "Krieger JE", "initials": "JE", "firstName": "Jos\u00e9 E", "lastName": "Krieger"}, {"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Callegaro D", "initials": "D", "firstName": "Dagoberto", "lastName": "Callegaro"}, {"affiliation": "Department of Neurology, Neuroregeneration Center, University of S\u00e3o Paulo School of Medicine, University of S\u00e3o Paulo S\u00e3o Paulo, Brazil.", "fullName": "Chadi G", "initials": "G", "firstName": "Gerson", "lastName": "Chadi"}]}, "title": "Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "26300727", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0957-1259"}, {"type": "ORCID", "value": "0000-0002-4113-9450"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-04", "language": "eng", "doi": "10.3389/fncel.2015.00289", "isOpenAccess": "Y", "pageInfo": "289", "pmcid": "PMC4523944", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Microarray", "Amyotrophic Lateral Sclerosis", "Induced Pluripotent Stem Cells", "Sporadic Als", "Motor Neuron Differentiation"]}, "abstractText": "Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that leads to widespread motor neuron death, general palsy and respiratory failure. The most prevalent sporadic ALS form is not genetically inherited. Attempts to translate therapeutic strategies have failed because the described mechanisms of disease are based on animal models carrying specific gene mutations and thus do not address sporadic ALS. In order to achieve a better approach to study the human disease, human induced pluripotent stem cell (hiPSC)-differentiated motor neurons were obtained from motor nerve fibroblasts of sporadic ALS and non-ALS subjects using the STEMCCA Cre-Excisable Constitutive Polycistronic Lentivirus system and submitted to microarray analyses using a whole human genome platform. DAVID analyses of differentially expressed genes identified molecular function and biological process-related genes through Gene Ontology. REVIGO highlighted the related functions mRNA and DNA binding, GTP binding, transcription (co)-repressor activity, lipoprotein receptor binding, synapse organization, intracellular transport, mitotic cell cycle and cell death. KEGG showed pathways associated with Parkinson's disease and oxidative phosphorylation, highlighting iron homeostasis, neurotrophic functions, endosomal trafficking and ERK signaling. The analysis of most dysregulated genes and those representative of the majority of categorized genes indicates a strong association between mitochondrial function and cellular processes possibly related to motor neuron degeneration. In conclusion, iPSC-derived motor neurons from motor nerve fibroblasts of sporadic ALS patients may recapitulate key mechanisms of neurodegeneration and may offer an opportunity for translational investigation of sporadic ALS. Large gene profiling of differentiated motor neurons from sporadic ALS patients highlights mitochondrial participation in the establishment of autonomous mechanisms associated with sporadic ALS.", "electronicPublicationDate": "2015-08-04", "license": "cc by", "dateOfCompletion": "2015-08-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4523944?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4523944", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3389/fncel.2015.00289", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-08-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Frontiers in cellular neuroscience", "medlineAbbreviation": "Front Cell Neurosci", "isoabbreviation": "Front Cell Neurosci", "nlmid": "101477935", "essn": "1662-5102"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2015, "journalIssueId": 2260587, "dateOfPublication": "2015"}}}, "SEPT7": {"20385374": {"pubYear": "2010", "dateOfCreation": "2010-07-08", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "SYNPR protein, human"}, {"registryNumber": "0", "name": "anillin"}, {"registryNumber": "0", "name": "Neurabin"}, {"registryNumber": "0", "name": "CDC42EP3 protein, human"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Antipsychotic Agents"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Cytoskeletal Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Synaptophysin"}, {"registryNumber": "0", "name": "GTP-Binding Protein Regulators"}, {"registryNumber": "EC 3.6.5.2", "name": "cdc42 GTP-Binding Protein"}, {"registryNumber": "0", "name": "DLG4 protein, human"}]}, "authorString": "Ide M, Lewis DA.", "affiliation": "Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH043784"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH084053"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R37 MH043784-12"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "P50 MH084053-019001"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R37 MH043784"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "P50 MH084053"}]}, "hasPDF": "Y", "id": "20385374", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA.", "fullName": "Ide M", "initials": "M", "firstName": "Masayuki", "lastName": "Ide"}, {"lastName": "Lewis", "fullName": "Lewis DA", "firstName": "David A", "initials": "DA"}]}, "title": "Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits.", "hasSuppl": "Y", "citedByCount": 28, "source": "MED", "pmid": "20385374", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Pyramidal Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dendritic Spines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Macaca fascicularis", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "cdc42 GTP-Binding Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "GTP-Binding Protein Regulators", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytoskeletal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Synaptophysin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antipsychotic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-04-10", "doi": "10.1016/j.biopsych.2010.02.016", "isOpenAccess": "N", "pageInfo": "25-32", "pmcid": "PMC2900524", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Spine density on the basilar dendrites of pyramidal neurons is lower in layer 3, but not in layers 5 and 6, in the dorsolateral prefrontal cortex (DLPFC) of subjects with schizophrenia. The expression of CDC42 (cell division cycle 42), a RhoGTPase that regulates the outgrowth of the actin cytoskeleton and promotes spine formation, is also lower in schizophrenia; however, CDC42 mRNA is lower across layers 3-6, suggesting that other lamina-specific molecular alterations are critical for the spine deficits in the illness. The CDC42 effector proteins 3 and 4 (CDC42EP3, CDC42EP4) are preferentially expressed in DLPFC layers 2 and 3, and CDC42EP3 appears to assemble septin filaments in spine necks. Therefore, alterations in CDC42EP3 could contribute to the lamina-specific spine deficits in schizophrenia. METHODS: We measured transcript levels of CDC42, CDC42EP3, CDC42EP4; their interacting proteins (septins [SEPT2, 3, 5, 6, 7, 8, and 11], anillin), and other spine-specific proteins (spinophilin, PSD-95, and synaptopodin) in the DLPFC from 31 subjects with schizophrenia and matched normal comparison subjects. RESULTS: The expression of CDC42EP3 mRNA was significantly increased by 19.7%, and SEPT7 mRNA was significantly decreased by 6.9% in subjects with schizophrenia. Cortical levels of CDC42EP3 and SEPT7 mRNAs were not altered in monkeys chronically exposed to antipsychotic medications. CONCLUSIONS: Activated CDC42 is thought to disrupt septin filaments transiently in spine necks, allowing the molecular translocations required for synaptic potentiation. Thus, altered CDC42 signaling via CDC42EP3 may perturb synaptic plasticity and contribute to the spine deficits observed in layer 3 pyramidal neurons in schizophrenia.", "electronicPublicationDate": "2010-04-10", "language": "eng", "dateOfCompletion": "2010-10-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2900524?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2900524", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20385374", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20385374&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.biopsych.2010.02.016", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-09-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-07-01", "journal": {"medlineAbbreviation": "Biol Psychiatry", "isoabbreviation": "Biol. Psychiatry", "title": "Biological psychiatry", "issn": "0006-3223", "nlmid": "0213264", "essn": "1873-2402"}, "monthOfPublication": 7, "volume": "68", "yearOfPublication": 2010, "journalIssueId": 1744711, "issue": "1", "dateOfPublication": "2010 Jul"}}, "21772061": {"pubYear": "2011", "dateOfCreation": "2011-08-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "neuronal Cdk5 activator (p25-p35)"}, {"registryNumber": "EC 3.6.1.-", "name": "OPA1 protein, human"}, {"registryNumber": "0", "name": "Mucoproteins"}, {"registryNumber": "0", "name": "Pyridines"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Benzamides"}, {"registryNumber": "EC 3.6.1.-", "name": "GTP Phosphohydrolases"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 2.7.-", "name": "Phosphotransferases"}, {"registryNumber": "EC 3.6.1.-", "name": "SEPT7 protein, human"}, {"registryNumber": "0", "name": "Histone Deacetylase Inhibitors"}, {"registryNumber": "EC 3.6.1.-", "name": "Septins"}, {"registryNumber": "1ZNY4FKK9H", "name": "entinostat"}, {"registryNumber": "0", "name": "Cdk5r1 protein, mouse"}, {"registryNumber": "0", "name": "lysin, gastropoda"}]}, "authorString": "Engmann O, Hortob\u00e1gyi T, Pidsley R, Troakes C, Bernstein HG, Kreutz MR, Mill J, Nikolic M, Giese KP.", "affiliation": "Department for Neuroscience, King\u2019s College, London SE5 9NU, UK.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0600676"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0800393"}, {"orderIn": 0, "agency": "Medical Research Council"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH087463"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01-MH-087463-01A1"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G9817803B"}]}, "hasPDF": "Y", "id": "21772061", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department for Neuroscience, King\u2019s College, London SE5 9NU, UK.", "fullName": "Engmann O", "initials": "O", "firstName": "Olivia", "lastName": "Engmann"}, {"lastName": "Hortob\u00e1gyi", "fullName": "Hortob\u00e1gyi T", "firstName": "Tibor", "initials": "T"}, {"lastName": "Pidsley", "fullName": "Pidsley R", "firstName": "Ruth", "initials": "R"}, {"lastName": "Troakes", "fullName": "Troakes C", "firstName": "Claire", "initials": "C"}, {"lastName": "Bernstein", "fullName": "Bernstein HG", "firstName": "Hans-Gert", "initials": "HG"}, {"lastName": "Kreutz", "fullName": "Kreutz MR", "firstName": "Michael R", "initials": "MR"}, {"lastName": "Mill", "fullName": "Mill J", "authorId": {"type": "ORCID", "value": "0000-0003-1115-3224"}, "firstName": "Jonathan", "initials": "J"}, {"lastName": "Nikolic", "fullName": "Nikolic M", "firstName": "Margareta", "initials": "M"}, {"lastName": "Giese", "fullName": "Giese KP", "firstName": "Karl Peter", "initials": "KP"}]}, "title": "Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.", "hasSuppl": "Y", "citedByCount": 22, "source": "MED", "pmid": "21772061", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1115-3224"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Postmortem Changes", "majorTopic_YN": "N"}, {"descriptorName": "Benzamides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pyridines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "GTP Phosphohydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phosphotransferases", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mucoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acoustic Stimulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Exploratory Behavior", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Inhibition (Psychology)", "majorTopic_YN": "N"}, {"descriptorName": "Motor Activity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interpersonal Relations", "majorTopic_YN": "N"}, {"descriptorName": "Maze Learning", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Reward", "majorTopic_YN": "N"}, {"descriptorName": "Cognition Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sex Factors", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Histone Deacetylase Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endophenotypes", "majorTopic_YN": "N"}, {"descriptorName": "Septins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-07-19", "doi": "10.1093/brain/awr155", "isOpenAccess": "N", "pageInfo": "2408-2421", "pmcid": "PMC3155706", "hasDbCrossReferences": "Y", "abstractText": "Cyclin-dependent kinase 5 is activated by small subunits, of which p35 is the most abundant. The functions of cyclin-dependent kinase 5 signalling in cognition and cognitive disorders remains unclear. Here, we show that in schizophrenia, a disorder associated with impaired cognition, p35 expression is reduced in relevant brain regions. Additionally, the expression of septin 7 and OPA1, proteins downstream of truncated p35, is decreased in schizophrenia. Mimicking a reduction of p35 in heterozygous knockout mice is associated with cognitive endophenotypes. Furthermore, a reduction of p35 in mice results in protein changes similar to schizophrenia post-mortem brain. Hence, heterozygous p35 knockout mice model both cognitive endophenotypes and molecular changes reminiscent of schizophrenia. These changes correlate with reduced acetylation of the histone deacetylase 1 target site H3K18 in mice. This site has previously been shown to be affected by truncated p35. By restoring H3K18 acetylation with the clinically used specific histone deacetylase 1 inhibitor MS-275 both cognitive and molecular endophenotypes of schizophrenia can be rescued in p35 heterozygous knockout mice. In summary, we suggest that reduced p35 expression in schizophrenia has an impact on synaptic protein expression and cognition and that these deficits can be rescued, at least in part, by the inhibition of histone deacetylase 1.", "electronicPublicationDate": "2011-07-19", "language": "eng", "dateOfCompletion": "2011-10-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3155706?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3155706", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21772061&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21772061", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/brain/awr155", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-08-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 8, "volume": "134", "yearOfPublication": 2011, "journalIssueId": 1856590, "issue": "Pt 8", "dateOfPublication": "2011 Aug"}}}, "ABCG1": {"11093066": {"pubYear": "2000", "dateOfCreation": "2001-02-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ABCG1 protein, human"}, {"registryNumber": "9007-49-2", "name": "DNA"}, {"registryNumber": "0", "name": "Genetic Markers"}, {"registryNumber": "0", "name": "ATP-Binding Cassette Transporters"}]}, "authorString": "Rujescu D, Giegling I, Dahmen N, Szegedi A, Anghelescu I, Gietl A, Sch\u00e4fer M, M\u00fcller-Siecheneder F, Bondy B, M\u00f6ller HJ.", "affiliation": "Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany. Dan.Rujescu@psy.med.uni-muenchen.de", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "hasPDF": "N", "id": "11093066", "inEPMC": "N", "authorList": {"author": [{"lastName": "Rujescu", "fullName": "Rujescu D", "initials": "D"}, {"lastName": "Giegling", "fullName": "Giegling I", "initials": "I"}, {"lastName": "Dahmen", "fullName": "Dahmen N", "initials": "N"}, {"lastName": "Szegedi", "fullName": "Szegedi A", "initials": "A"}, {"lastName": "Anghelescu", "fullName": "Anghelescu I", "initials": "I"}, {"lastName": "Gietl", "fullName": "Gietl A", "initials": "A"}, {"lastName": "Sch\u00e4fer", "fullName": "Sch\u00e4fer M", "initials": "M"}, {"lastName": "M\u00fcller-Siecheneder", "fullName": "M\u00fcller-Siecheneder F", "initials": "F"}, {"lastName": "Bondy", "fullName": "Bondy B", "initials": "B"}, {"lastName": "M\u00f6ller", "fullName": "M\u00f6ller HJ", "initials": "HJ"}]}, "title": "Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3.", "citedByCount": 6, "source": "MED", "pmid": "11093066", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 21", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N"}, {"descriptorName": "Suicide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mood Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2000-01-01", "doi": "10.1159/000054847", "isOpenAccess": "N", "pageInfo": "22-25", "hasDbCrossReferences": "N", "abstractText": "The gene that codes for the ABC transporter ABCG1 is located in a chromosomal susceptibility region (21q22.3) for affective disorders. Genetic variations in ABCG1 have been associated with affective disorders in Japanese males. In this study, we investigated the distribution of a G2457A polymorphism in patients with affective disorders, suicide attempters with various psychiatric diagnoses and healthy subjects. We initially found a trend towards a modest association with affective disorders in males (p = 0.046 for allele frequencies and p = 0.046 for AA versus GG). We conducted a replication study with independent patients and controls. There was no association with affective disorders, either in the replication or in the combined group. Furthermore, we found no association with suicidal behavior. These findings do not support the hypothesis that ABCG1 is a susceptibility gene for affective disorders or suicidal behavior.", "language": "eng", "dateOfCompletion": "2001-02-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1159/000054847", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "www.karger.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2004-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2000-01-01", "journal": {"medlineAbbreviation": "Neuropsychobiology", "isoabbreviation": "Neuropsychobiology", "title": "Neuropsychobiology", "issn": "0302-282X", "nlmid": "7512895", "essn": "1423-0224"}, "monthOfPublication": 0, "volume": "42 Suppl 1", "yearOfPublication": 2000, "journalIssueId": 1078637, "dateOfPublication": "2000 "}}, "19239689": {"pubYear": "2009", "dateOfCreation": "2009-03-16", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ABCG1 protein, mouse"}, {"registryNumber": "0", "name": "Lipoproteins"}, {"registryNumber": "57-88-5", "name": "Cholesterol"}]}, "authorString": "Parkinson PF, Kannangara TS, Eadie BD, Burgess BL, Wellington CL, Christie BR.", "affiliation": "The Department of Pathology and Laboratory Medicine, Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada. parkinsonpam@gmail.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "19239689", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Parkinson", "fullName": "Parkinson PF", "firstName": "Pamela F", "initials": "PF"}, {"lastName": "Kannangara", "fullName": "Kannangara TS", "firstName": "Timal S", "initials": "TS"}, {"lastName": "Eadie", "fullName": "Eadie BD", "firstName": "Brennan D", "initials": "BD"}, {"lastName": "Burgess", "fullName": "Burgess BL", "firstName": "Braydon L", "initials": "BL"}, {"lastName": "Wellington", "fullName": "Wellington CL", "firstName": "Cheryl L", "initials": "CL"}, {"lastName": "Christie", "fullName": "Christie BR", "authorId": {"type": "ORCID", "value": "0000-0002-6830-0160"}, "firstName": "Brian R", "initials": "BR"}]}, "title": "Cognition, learning behaviour and hippocampal synaptic plasticity are not disrupted in mice over-expressing the cholesterol transporter ABCG1.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "19239689", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6830-0160"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Cholesterol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lipoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Motor Activity", "majorTopic_YN": "N"}, {"descriptorName": "Anxiety", "majorTopic_YN": "N"}, {"descriptorName": "Cognition", "majorTopic_YN": "Y"}, {"descriptorName": "Learning", "majorTopic_YN": "Y"}, {"descriptorName": "Memory", "majorTopic_YN": "N"}, {"descriptorName": "Organ Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Biological Transport", "majorTopic_YN": "N"}, {"descriptorName": "Neuronal Plasticity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-02-24", "language": "eng", "doi": "10.1186/1476-511x-8-5", "isOpenAccess": "Y", "pageInfo": "5", "pmcid": "PMC2654451", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Cognitive deficits are a hallmark feature of both Down Syndrome (DS) and Alzheimer's Disease (AD). Extra copies of the genes on chromosome 21 may also play an important role in the accelerated onset of AD in DS individuals. Growing evidence suggests an important function for cholesterol in the pathogenesis of AD, particularly in APP metabolism and production of A beta peptides. The ATP-Binding Cassette-G1 (ABCG1) transporter is located on chromosome 21, and participates in the maintenance of tissue cholesterol homeostasis. RESULTS: To assess the role of ABCG1 in DS-related cognition, we evaluated the cognitive performance of mice selectively over-expressing the ABCG1 gene from its endogenous regulatory signals. Both wild-type and ABCG1 transgenic mice performed equivalently on several behavioral tests, including measures of anxiety, as well as on reference and working memory tasks. No deficits in hippocampal CA1 synaptic plasticity as determined with electrophysiological studies were apparent in mice over-expressing ABCG1. CONCLUSION: These findings indicate that although ABCG1 may play a role in maintaining cellular or tissue cholesterol homeostasis, it is unlikely that excess ABCG1 expression contributes to the cognitive deficits in DS individuals.", "electronicPublicationDate": "2009-02-24", "license": "cc by", "dateOfCompletion": "2009-07-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2654451?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2654451", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.biomedcentral.com/content/pdf/1476-511X-8-5.pdf", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/1476-511X/8/5/abstract", "documentStyle": "abs", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/1476-511X/8/5", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19239689&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19239689", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1476-511X-8-5", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2009-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"title": "Lipids in health and disease", "medlineAbbreviation": "Lipids Health Dis", "isoabbreviation": "Lipids Health Dis", "nlmid": "101147696", "essn": "1476-511X"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2009, "journalIssueId": 1594244, "dateOfPublication": "2009 "}}, "25084356": {"pubYear": "2014", "dateOfCreation": "2014-08-02", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "EC 2.4.1.41", "name": "polypeptide N-acetylgalactosaminyltransferase"}, {"registryNumber": "0", "name": "ABCG1 protein, human"}, {"registryNumber": "EC 1.1.1.-", "name": "Hydroxymethylglutaryl CoA Reductases"}, {"registryNumber": "0", "name": "Biological Markers"}, {"registryNumber": "EC 2.4.1.-", "name": "N-Acetylgalactosaminyltransferases"}, {"registryNumber": "EC 1.1.1.-", "name": "HMGCR protein, human"}]}, "authorString": "Peng P, Wang L, Yang X, Huang X, Ba Y, Chen X, Guo J, Lian J, Zhou J.", "affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China; The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25084356", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China; The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Peng P", "initials": "P", "firstName": "Ping", "lastName": "Peng"}, {"affiliation": "School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.", "fullName": "Wang L", "initials": "L", "firstName": "Lu", "lastName": "Wang"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Yang X", "initials": "X", "firstName": "Xi", "lastName": "Yang"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Huang X", "initials": "X", "firstName": "Xiaoyan", "lastName": "Huang"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China; The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Ba Y", "initials": "Y", "firstName": "Yanna", "lastName": "Ba"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China; The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Chen X", "initials": "X", "firstName": "Xiaoliang", "lastName": "Chen"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China; The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Guo J", "initials": "J", "firstName": "Jian", "lastName": "Guo"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Lian J", "initials": "J", "firstName": "Jiangfang", "lastName": "Lian"}, {"affiliation": "Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.", "fullName": "Zhou J", "initials": "J", "firstName": "Jianqing", "lastName": "Zhou"}]}, "title": "A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "25084356", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Coronary Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hydroxymethylglutaryl CoA Reductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "N-Acetylgalactosaminyltransferases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk", "majorTopic_YN": "N"}, {"descriptorName": "DNA Methylation", "majorTopic_YN": "Y"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-08-01", "language": "eng", "doi": "10.1371/journal.pone.0102265", "isOpenAccess": "Y", "pageInfo": "e102265", "pmcid": "PMC4118847", "hasDbCrossReferences": "Y", "abstractText": "AIMS: To investigate the association of ABCG1, GALNT2 and HMGCR genes promoter DNA methylation with coronary heart disease (CHD) and explore the interaction between their methylation status and the CHD patients' clinical characteristics in Han Chinese population. METHODS AND RESULTS: Methylation-specific polymerase chain reaction (MSP) technology was used to examine the role of the aberrant gene promoter methylation in CHD in Han Chinese population. A total of 85 CHD patients and 54 participants without CHD confirmed by angiography were recruited. 82.8% of the participants with ABCG1 gene promoter hypermethylation have CHD, while only 17.4% of the participants without hypermethylation have it. The average age of the participants with GALNT2 gene promoter hypermethylation is 62.10 \u00b1 8.21, while that of the participants without hypermethylation is 57.28 \u00b1 9.87; in the former group, 75.4% of the participants have CHD, compared to only 50% in the latter group. As for the HMGCR gene, the average age of the participants with promoter hypermethylation is 63.24 \u00b1 8.10 and that of the participants without hypermethylation is 57.79 \u00b1 9.55; its promoter hypermethylation is likely to be related to smoking. Our results indicated a significant statistical association of promoter methylation of the ABCG1 gene with increased risk of CHD (OR = 19.966; 95% CI, 7.319-54.468; P*<0.001; P*: adjusted for age, gender, smoking, lipid level, hypertension, and diabetes). Similar results were obtained for that of the GALNT2 gene (OR = 2.978; 95% CI, 1.335-6.646; P*\u200a= 0.008), but not of HMGCR gene (OR = 1.388; 95% CI, 0.572-3.371; P*\u200a = 0.469). CONCLUSIONS: The present work provides evidence to support the association of promoter DNA methylation status with the risk profile of CHD. Our data indicates that promoter DNA hypermethylation of the ABCG1 and GALNT2 genes, but not the HMGCR gene, is associated with an increased risk of CHD. CHD, smoking and aging are likely to be the important factors influencing DNA hypermethylation.", "electronicPublicationDate": "2014-08-01", "license": "cc by", "dateOfCompletion": "2015-04-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4118847?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4118847", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=25084356&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=25084356", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0102265", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2014, "journalIssueId": 2185563, "issue": "8", "dateOfPublication": "2014 "}}, "15349865": {"pubYear": "2004", "dateOfCreation": "2004-09-06", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Genetic Markers"}]}, "authorString": "Dauvilliers Y, Blouin JL, Neidhart E, Carlander B, Eliaou JF, Antonarakis SE, Billiard M, Tafti M.", "affiliation": "Service de Neurologie B, H\u00f4pital Gui-de-Chauliac, Montpellier, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "15349865", "inEPMC": "N", "authorList": {"author": [{"lastName": "Dauvilliers", "fullName": "Dauvilliers Y", "firstName": "Yves", "initials": "Y"}, {"lastName": "Blouin", "fullName": "Blouin JL", "firstName": "Jean-Louis", "initials": "JL"}, {"lastName": "Neidhart", "fullName": "Neidhart E", "firstName": "Elisabeth", "initials": "E"}, {"lastName": "Carlander", "fullName": "Carlander B", "firstName": "Bertrand", "initials": "B"}, {"lastName": "Eliaou", "fullName": "Eliaou JF", "firstName": "Jean-Fran\u00e7ois", "initials": "JF"}, {"lastName": "Antonarakis", "fullName": "Antonarakis SE", "authorId": {"type": "ORCID", "value": "0000-0001-8907-5823"}, "firstName": "Stylianos E", "initials": "SE"}, {"lastName": "Billiard", "fullName": "Billiard M", "firstName": "Michel", "initials": "M"}, {"lastName": "Tafti", "fullName": "Tafti M", "firstName": "Mehdi", "initials": "M"}]}, "title": "A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q.", "citedByCount": 18, "source": "MED", "pmid": "15349865", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-8907-5823"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 21", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Narcolepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "Y"}, {"descriptorName": "Physical Chromosome Mapping", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Lod Score", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Linkage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2004-09-01", "doi": "10.1002/ana.20208", "isOpenAccess": "N", "pageInfo": "382-388", "hasDbCrossReferences": "Y", "abstractText": "The genetic basis of human narcolepsy remains poorly understood. Multiplex families with full-blown narcolepsy-cataplexy are rare, whereas families with both narcolepsy-cataplexy and excessive daytime sleepiness without cataplexy are more common. We performed a genomewide linkage analysis in a large French family with four members affected with narcolepsy-cataplexy and 10 others with isolated recurrent naps or lapses into sleep. Only three regions showed logarithm of odds (LOD) scores greater than 1 in two-point linkage analysis (D6S1960, D11S2359, and D21S228). Genotyping additional markers provided support for linkage to 9 markers on chromosome 21 (maximum two-point LOD score, 3.36 at D21S1245). The multipoint linkage analysis using SimWalk2 provided further evidence for linkage to the same region (maximum parametric LOD score, 4.00 at 21GT26K). A single haplotype was shared by all affected individuals and informative crossovers indicated that the elusive gene that confers susceptibility to narcolepsy is likely to be located between markers D21S267 and ABCG1, in a 5.15 Mb region of 21q.", "language": "eng", "dateOfCompletion": "2004-10-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ana.20208", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2010-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-09-01", "journal": {"medlineAbbreviation": "Ann Neurol", "isoabbreviation": "Ann. Neurol.", "title": "Annals of neurology", "issn": "0364-5134", "nlmid": "7707449", "essn": "1531-8249"}, "monthOfPublication": 9, "volume": "56", "yearOfPublication": 2004, "journalIssueId": 1175405, "issue": "3", "dateOfPublication": "2004 Sep"}}, "25601961": {"pubYear": "2015", "dateOfCreation": "2015-02-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ATP binding cassette transporter 1"}, {"registryNumber": "97C5T2UQ7J", "name": "Cholesterol"}, {"registryNumber": "0", "name": "ABCA1 protein, human"}]}, "authorString": "Song W, Wang W, Dou LY, Wang Y, Xu Y, Chen LF, Yan XW.", "affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "pubTypeList": {"pubType": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25601961", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Song W", "initials": "W", "firstName": "Wei", "lastName": "Song"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Wang W", "initials": "W", "firstName": "Wei", "lastName": "Wang"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Dou LY", "initials": "LY", "firstName": "Li-Yang", "lastName": "Dou"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Wang Y", "initials": "Y", "firstName": "Yu", "lastName": "Wang"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Xu Y", "initials": "Y", "firstName": "Yan", "lastName": "Xu"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Chen LF", "initials": "LF", "firstName": "Lian-Feng", "lastName": "Chen"}, {"affiliation": "Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China.", "fullName": "Yan XW", "initials": "XW", "firstName": "Xiao-Wei", "lastName": "Yan"}]}, "title": "The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25601961", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Macrophages", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cholesterol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Smoking Cessation", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Coronary Artery Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP Binding Cassette Transporter 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-19", "language": "eng", "doi": "10.1194/jlr.p055491", "isOpenAccess": "Y", "pageInfo": "682-691", "pmcid": "PMC4340315", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Macrophages", "Tobacco", "ABCA1"]}, "abstractText": "We investigated ATP-binding cassette transporters A1/G1 expression and function in mediating cholesterol efflux by examining the macrophages of cigarette-smoking patients with coronary artery disease (CAD) before and after smoking abstinence. Peripheral blood monocyte cells were collected from nonsmokers (n = 17), non-CAD (NCAD) smokers (n = 35), and CAD smokers (n = 32) before and after 3 months of smoking cessation. We found that the ABCA1 expression level was lower in macrophages from NCAD and CAD smokers than from nonsmokers at baseline. The ABCA1 function of mediating cholesterol efflux was reduced in NCAD and CAD smokers as compared with nonsmokers. After 3 months of smoking cessation, ABCA1 expression and function were improved in CAD smokers. However, ABCG1 expression and function did not change after smoking cessation. Furthermore, ABCA1 expression was inhibited by tar in human acute monocytic leukemia cell line THP-1-derived macrophages through the inhibition of liver X receptors. Nicotine and carbon monoxide did not inhibit ABCA1 expression. Our results indicate that chronic cigarette smoking impaired ABCA1-mediated cholesterol efflux in macrophages and that tobacco abstinence reversed the function and expression of ABCA1, especially in CAD patients. It was tobacco tar, rather than nicotine or carbon monoxide, that played a major role in the tobacco-induced disturbance of cellular cholesterol homeostasis.", "electronicPublicationDate": "2015-01-19", "license": "cc by", "dateOfCompletion": "2015-11-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4340315", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1194/jlr.P055491", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "J Lipid Res", "isoabbreviation": "J. Lipid Res.", "title": "Journal of lipid research", "issn": "0022-2275", "nlmid": "0376606", "essn": "1539-7262"}, "monthOfPublication": 3, "volume": "56", "yearOfPublication": 2015, "journalIssueId": 2258255, "issue": "3", "dateOfPublication": "2015 Mar"}}, "27196068": {"pubYear": "2016", "dateOfCreation": "2016-05-20", "pubModel": "Electronic-eCollection", "authorString": "Sano O, Tsujita M, Shimizu Y, Kato R, Kobayashi A, Kioka N, Remaley AT, Michikawa M, Ueda K, Matsuo M.", "affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27196068", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "fullName": "Sano O", "initials": "O", "firstName": "Osamu", "lastName": "Sano"}, {"affiliation": "Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan.", "fullName": "Tsujita M", "initials": "M", "firstName": "Maki", "lastName": "Tsujita"}, {"affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "fullName": "Shimizu Y", "initials": "Y", "firstName": "Yuji", "lastName": "Shimizu"}, {"affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "fullName": "Kato R", "initials": "R", "firstName": "Reiko", "lastName": "Kato"}, {"affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "fullName": "Kobayashi A", "initials": "A", "firstName": "Aya", "lastName": "Kobayashi"}, {"affiliation": "Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, 606-8502, Japan.", "fullName": "Kioka N", "initials": "N", "firstName": "Noriyuki", "lastName": "Kioka"}, {"affiliation": "Lipoprotein Metabolism Section, NHLBI, National Institutes of Health, Bethesda, MD, 20892-1508, United States of America.", "fullName": "Remaley AT", "initials": "AT", "firstName": "Alan T", "lastName": "Remaley"}, {"affiliation": "Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan.", "fullName": "Michikawa M", "initials": "M", "firstName": "Makoto", "lastName": "Michikawa"}, {"affiliation": "iCeMS, Kyoto University, Kyoto, 606-8502, Japan.", "fullName": "Ueda K", "initials": "K", "firstName": "Kazumitsu", "lastName": "Ueda"}, {"affiliation": "Department of Food and Nutrition, Faculty of Home Economics, Kyoto Women's University, Kyoto, 605-8501, Japan.", "fullName": "Matsuo M", "initials": "M", "firstName": "Michinori", "lastName": "Matsuo"}]}, "title": "ABCG1 and ABCG4 Suppress \u03b3-Secretase Activity and Amyloid \u03b2 Production.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27196068", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refseq"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2016-05-19", "doi": "10.1371/journal.pone.0155400", "isOpenAccess": "Y", "pageInfo": "e0155400", "pmcid": "PMC4872999", "hasDbCrossReferences": "N", "abstractText": "ATP-binding cassette G1 (ABCG1) and ABCG4, expressed in neurons and glia in the central nervous system, mediate cholesterol efflux to lipid acceptors. The relationship between cholesterol level in the central nervous system and Alzheimer's disease has been reported. In this study, we examined the effects of ABCG1 and ABCG4 on amyloid precursor protein (APP) processing, the product of which, amyloid \u03b2 (A\u03b2), is involved in the pathogenesis of Alzheimer's disease. Expression of ABCG1 or ABCG4 in human embryonic kidney 293 cells that stably expressed Swedish-type mutant APP increased cellular and cell surface APP levels. Products of cleavage from APP by \u03b1-secretase and by \u03b2-secretase also increased. The levels of secreted A\u03b2, however, decreased in the presence of ABCG1 and ABCG4, but not ABCG4-KM, a nonfunctional Walker-A lysine mutant. In contrast, secreted A\u03b2 levels increased in differentiated SH-SY5Y neuron-like cells in which ABCG1 and ABCG4 were suppressed. Furthermore, A\u03b242 peptide in the cerebrospinal fluid from Abcg1 null mice significantly increased compared to the wild type mice. To examine the underlying mechanism, we analyzed the activity and distribution of \u03b3-secretase. ABCG1 and ABCG4 suppressed \u03b3-secretase activity and disturbed \u03b3-secretase localization in the raft domains where \u03b3-secretase functions. These results suggest that ABCG1 and ABCG4 alter the distribution of \u03b3-secretase on the plasma membrane, leading to the decreased \u03b3-secretase activity and suppressed A\u03b2 secretion. ABCG1 and ABCG4 may inhibit the development of Alzheimer's disease and can be targets for the treatment of Alzheimer's disease.", "electronicPublicationDate": "2016-05-19", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4872999?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4872999", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0155400", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-06-10", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "11", "yearOfPublication": 2016, "journalIssueId": 2403348, "issue": "5", "dateOfPublication": "2016"}}, "17293612": {"pubYear": "2007", "dateOfCreation": "2007-05-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ABCG1 protein, human"}, {"registryNumber": "0", "name": "ABCG1 protein, mouse"}, {"registryNumber": "0", "name": "Lipoproteins"}, {"registryNumber": "57-88-5", "name": "Cholesterol"}, {"registryNumber": "0", "name": "Protein Subunits"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "EC 3.4.-", "name": "Amyloid Precursor Protein Secretases"}]}, "authorString": "Tansley GH, Burgess BL, Bryan MT, Su Y, Hirsch-Reinshagen V, Pearce J, Chan JY, Wilkinson A, Evans J, Naus KE, McIsaac S, Bromley K, Song W, Yang HC, Wang N, DeMattos RB, Wellington CL.", "affiliation": "Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17293612", "inEPMC": "N", "authorList": {"author": [{"lastName": "Tansley", "fullName": "Tansley GH", "firstName": "Gavin H", "initials": "GH"}, {"lastName": "Burgess", "fullName": "Burgess BL", "firstName": "Braydon L", "initials": "BL"}, {"lastName": "Bryan", "fullName": "Bryan MT", "firstName": "Matt T", "initials": "MT"}, {"lastName": "Su", "fullName": "Su Y", "firstName": "Yuan", "initials": "Y"}, {"lastName": "Hirsch-Reinshagen", "fullName": "Hirsch-Reinshagen V", "firstName": "Veronica", "initials": "V"}, {"lastName": "Pearce", "fullName": "Pearce J", "firstName": "Jonathan", "initials": "J"}, {"lastName": "Chan", "fullName": "Chan JY", "firstName": "Jeniffer Y", "initials": "JY"}, {"lastName": "Wilkinson", "fullName": "Wilkinson A", "firstName": "Anna", "initials": "A"}, {"lastName": "Evans", "fullName": "Evans J", "firstName": "Jeanette", "initials": "J"}, {"lastName": "Naus", "fullName": "Naus KE", "firstName": "Kathryn E", "initials": "KE"}, {"lastName": "McIsaac", "fullName": "McIsaac S", "firstName": "Sean", "initials": "S"}, {"lastName": "Bromley", "fullName": "Bromley K", "firstName": "Kelley", "initials": "K"}, {"lastName": "Song", "fullName": "Song W", "firstName": "Weihong", "initials": "W"}, {"lastName": "Yang", "fullName": "Yang HC", "firstName": "Hsui-Chiung", "initials": "HC"}, {"lastName": "Wang", "fullName": "Wang N", "firstName": "Nan", "initials": "N"}, {"lastName": "DeMattos", "fullName": "DeMattos RB", "firstName": "Ronald B", "initials": "RB"}, {"lastName": "Wellington", "fullName": "Wellington CL", "firstName": "Cheryl L", "initials": "CL"}]}, "title": "The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein.", "citedByCount": 18, "source": "MED", "pmid": "17293612", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Down Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cholesterol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lipoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Subunits", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Amyloid Precursor Protein Secretases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2007-02-10", "doi": "10.1194/jlr.m600542-jlr200", "isOpenAccess": "N", "pageInfo": "1022-1034", "hasDbCrossReferences": "Y", "abstractText": "Although intracellular cholesterol levels are known to influence the proteolysis of beta-amyloid precursor protein (APP), the effect of specific genes that regulate cholesterol metabolism on APP processing remains poorly understood. The cholesterol transporter ABCG1 facilitates cholesterol efflux to HDL and is expressed in brain. Notably, the human ABCG1 gene maps to chromosome 21q22.3, and individuals with Down syndrome (DS) typically manifest with Alzheimer's disease (AD) neuropathology in their 30s. Here, we demonstrate that expression of ABCG1 enhances amyloid-beta protein (Abeta) production in transfected HEK cells in a manner that requires functional cholesterol transporter activity. ABCG1-expressing cells also exhibit increased secreted APP (sAPP)alpha and sAPPbeta secretion and display increased cell surface-associated APP. These results suggest that ABCG1 increases the availability of APP as a secretase substrate for both the amyloidogenic and nonamyloidogenic pathways. In vivo, ABCG1 mRNA levels are 2-fold more abundant in DS brain compared with age- and sex-matched normal controls. Finally, both Abeta and sAPPalpha levels are increased in DS cortex relative to normal controls. These findings suggest that altered cholesterol metabolism and APP trafficking mediated by ABCG1 may contribute to the accelerated onset of AD neuropathology in DS.", "electronicPublicationDate": "2007-02-10", "language": "eng", "dateOfCompletion": "2007-06-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1194/jlr.M600542-JLR200", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-05-01", "journal": {"medlineAbbreviation": "J Lipid Res", "isoabbreviation": "J. Lipid Res.", "title": "Journal of lipid research", "issn": "0022-2275", "nlmid": "0376606", "essn": "1539-7262"}, "monthOfPublication": 5, "volume": "48", "yearOfPublication": 2007, "journalIssueId": 1392493, "issue": "5", "dateOfPublication": "2007 May"}}, "25644384": {"pubYear": "2015", "dateOfCreation": "2015-03-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HMGN1 Protein"}]}, "authorString": "Davies G, Armstrong N, Bis JC, Bressler J, Chouraki V, Giddaluru S, Hofer E, Ibrahim-Verbaas CA, Kirin M, Lahti J, van der Lee SJ, Le Hellard S, Liu T, Marioni RE, Oldmeadow C, Postmus I, Smith AV, Smith JA, Thalamuthu A, Thomson R, Vitart V, Wang J, Yu L, Zgaga L, Zhao W, Boxall R, Harris SE, Hill WD, Liewald DC, Luciano M, Adams H, Ames D, Amin N, Amouyel P, Assareh AA, Au R, Becker JT, Beiser A, Berr C, Bertram L, Boerwinkle E, Buckley BM, Campbell H, Corley J, De Jager PL, Dufouil C, Eriksson JG, Espeseth T, Faul JD, Ford I, Generation Scotland, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Heiss G, Hofman A, Holliday EG, Huffman J, Kardia SL, Kochan N, Knopman DS, Kwok JB, Lambert JC, Lee T, Li G, Li SC, Loitfelder M, Lopez OL, Lundervold AJ, Lundqvist A, Mather KA, Mirza SS, Nyberg L, Oostra BA, Palotie A, Papenberg G, Pattie A, Petrovic K, Polasek O, Psaty BM, Redmond P, Reppermund S, Rotter JI, Schmidt H, Schuur M, Schofield PW, Scott RJ, Steen VM, Stott DJ, van Swieten JC, Taylor KD, Trollor J, Trompet S, Uitterlinden AG, Weinstein G, Widen E, Windham BG, Jukema JW, Wright AF, Wright MJ, Yang Q, Amieva H, Attia JR, Bennett DA, Brodaty H, de Craen AJ, Hayward C, Ikram MA, Lindenberger U, Nilsson LG, Porteous DJ, R\u00e4ikk\u00f6nen K, Reinvang I, Rudan I, Sachdev PS, Schmidt R, Schofield PR, Srikanth V, Starr JM, Turner ST, Weir DR, Wilson JF, van Duijn C, Launer L, Fitzpatrick AL, Seshadri S, Mosley TH, Deary IJ.", "affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Department of Psychology, University of Edinburgh, Edinburgh, UK.", "pubTypeList": {"pubType": ["Journal Article", "Meta-Analysis"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council", "grantId": "BB/F019394/1"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR000135"}, {"orderIn": 0, "agency": "Chief Scientist Office", "grantId": "CZB/4/710"}, {"orderIn": 0, "agency": "Chief Scientist Office", "grantId": "CZD/16/6/4"}, {"orderIn": 0, "agency": "Chief Scientist Office", "grantId": "ETM/55"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0700704"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0700704B"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MC_PC_U127561128"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/K026992/1"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P30 AG010161"}, {"acronym": "DK", "orderIn": 0, "agency": "NIDDK NIH HHS", "grantId": "P30 DK063491"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50 AG005133"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG017917"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "RF1 AG015819"}, {"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council", "grantId": "S18386"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "U01 AG049505"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR000124"}, {"orderIn": 0, "agency": "Chief Scientist Office", "grantId": "CZB/4/505"}]}, "hasPDF": "Y", "id": "25644384", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Davies G", "initials": "G", "firstName": "G", "lastName": "Davies"}, {"firstName": "N", "lastName": "Armstrong", "affiliation": "School of Mathematics and Statistics, University of Sydney, Sydney, NSW, Australia.", "authorId": {"type": "ORCID", "value": "0000-0002-4477-293X"}, "fullName": "Armstrong N", "initials": "N"}, {"affiliation": "Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.", "fullName": "Bis JC", "initials": "JC", "firstName": "J C", "lastName": "Bis"}, {"affiliation": "Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.", "fullName": "Bressler J", "initials": "J", "firstName": "J", "lastName": "Bressler"}, {"firstName": "V", "lastName": "Chouraki", "affiliation": "1] Inserm-UMR744, Institut Pasteur de Lille, Unit\u00e9 d'Epid\u00e9miologie et de Sant\u00e9 Publique, Lille, France [2] Department of Neurology, Boston University School of Medicine, Boston, MA, USA.", "authorId": {"type": "ORCID", "value": "0000-0002-4698-1794"}, "fullName": "Chouraki V", "initials": "V"}, {"affiliation": "1] K.G. Jebsen Centre for Psychosis Research and the Norwegian Centre for Mental Disorders Research (NORMENT), Department of Clinical Science, University of Bergen, Bergen, Norway [2] Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.", "fullName": "Giddaluru S", "initials": "S", "firstName": "S", "lastName": "Giddaluru"}, {"affiliation": "1] Department of Neurology, Medical University of Graz, Graz, Austria [2] Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.", "fullName": "Hofer E", "initials": "E", "firstName": "E", "lastName": "Hofer"}, {"affiliation": "1] Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "Ibrahim-Verbaas CA", "initials": "CA", "firstName": "C A", "lastName": "Ibrahim-Verbaas"}, {"affiliation": "Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.", "fullName": "Kirin M", "initials": "M", "firstName": "M", "lastName": "Kirin"}, {"affiliation": "1] Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland [2] Folkh\u00e4lsan Research Centre, Helsinki, Finland.", "fullName": "Lahti J", "initials": "J", "firstName": "J", "lastName": "Lahti"}, {"affiliation": "Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "van der Lee SJ", "initials": "SJ", "firstName": "S J", "lastName": "van der Lee"}, {"affiliation": "1] K.G. Jebsen Centre for Psychosis Research and the Norwegian Centre for Mental Disorders Research (NORMENT), Department of Clinical Science, University of Bergen, Bergen, Norway [2] Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.", "fullName": "Le Hellard S", "initials": "S", "firstName": "S", "lastName": "Le Hellard"}, {"affiliation": "1] Max Planck Institute for Human Development, Berlin, Germany [2] Max Planck Institute for Molecular Genetics, Berlin, Germany.", "fullName": "Liu T", "initials": "T", "firstName": "T", "lastName": "Liu"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK [3] Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.", "fullName": "Marioni RE", "initials": "RE", "firstName": "R E", "lastName": "Marioni"}, {"affiliation": "Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW, Australia.", "fullName": "Oldmeadow C", "initials": "C", "firstName": "C", "lastName": "Oldmeadow"}, {"affiliation": "1] Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "Postmus I", "initials": "I", "firstName": "I", "lastName": "Postmus"}, {"affiliation": "1] Icelandic Heart Association, Kopavogur, Iceland [2] University of Iceland, Reykjavik, Iceland.", "fullName": "Smith AV", "initials": "AV", "firstName": "A V", "lastName": "Smith"}, {"affiliation": "Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.", "fullName": "Smith JA", "initials": "JA", "firstName": "J A", "lastName": "Smith"}, {"affiliation": "Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Thalamuthu A", "initials": "A", "firstName": "A", "lastName": "Thalamuthu"}, {"affiliation": "Menzies Research Institute, Hobart, Tasmania.", "fullName": "Thomson R", "initials": "R", "firstName": "R", "lastName": "Thomson"}, {"affiliation": "MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.", "fullName": "Vitart V", "initials": "V", "firstName": "V", "lastName": "Vitart"}, {"affiliation": "1] Framingham Heart Study, Framingham, MA, USA [2] Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.", "fullName": "Wang J", "initials": "J", "firstName": "J", "lastName": "Wang"}, {"affiliation": "Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.", "fullName": "Yu L", "initials": "L", "firstName": "L", "lastName": "Yu"}, {"firstName": "L", "lastName": "Zgaga", "affiliation": "1] Department of Public Health and Primary Care, Trinity College Dublin, Dublin, Ireland [2] Andrija Stampar School of Public Health, Medical School, University of Zagreb, Zagreb, Croatia.", "authorId": {"type": "ORCID", "value": "0000-0003-4089-9703"}, "fullName": "Zgaga L", "initials": "L"}, {"affiliation": "Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.", "fullName": "Zhao W", "initials": "W", "firstName": "W", "lastName": "Zhao"}, {"affiliation": "Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK.", "fullName": "Boxall R", "initials": "R", "firstName": "R", "lastName": "Boxall"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK.", "fullName": "Harris SE", "initials": "SE", "firstName": "S E", "lastName": "Harris"}, {"affiliation": "Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Hill WD", "initials": "WD", "firstName": "W D", "lastName": "Hill"}, {"affiliation": "Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.", "fullName": "Liewald DC", "initials": "DC", "firstName": "D C", "lastName": "Liewald"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Luciano M", "initials": "M", "firstName": "M", "lastName": "Luciano"}, {"firstName": "H", "lastName": "Adams", "affiliation": "1] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0003-3687-2508"}, "fullName": "Adams H", "initials": "H"}, {"affiliation": "1] National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, VIC, Australia [2] Academic Unit for Psychiatry of Old Age, St George's Hospital, University of Melbourne, Kew, Australia.", "fullName": "Ames D", "initials": "D", "firstName": "D", "lastName": "Ames"}, {"affiliation": "1] Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "Amin N", "initials": "N", "firstName": "N", "lastName": "Amin"}, {"firstName": "P", "lastName": "Amouyel", "affiliation": "Inserm-UMR744, Institut Pasteur de Lille, Unit\u00e9 d'Epid\u00e9miologie et de Sant\u00e9 Publique, Lille, France.", "authorId": {"type": "ORCID", "value": "0000-0001-9088-234X"}, "fullName": "Amouyel P", "initials": "P"}, {"affiliation": "Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Assareh AA", "initials": "AA", "firstName": "A A", "lastName": "Assareh"}, {"affiliation": "1] Department of Neurology, Boston University School of Medicine, Boston, MA, USA [2] Framingham Heart Study, Framingham, MA, USA.", "fullName": "Au R", "initials": "R", "firstName": "R", "lastName": "Au"}, {"affiliation": "1] Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA [2] Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA [3] Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Becker JT", "initials": "JT", "firstName": "J T", "lastName": "Becker"}, {"affiliation": "1] Department of Neurology, Boston University School of Medicine, Boston, MA, USA [2] Framingham Heart Study, Framingham, MA, USA.", "fullName": "Beiser A", "initials": "A", "firstName": "A", "lastName": "Beiser"}, {"affiliation": "1] Inserm, U106, Montpellier, France [2] Universit\u00e9 Montpellier I, Montpellier, France.", "fullName": "Berr C", "initials": "C", "firstName": "C", "lastName": "Berr"}, {"affiliation": "1] Max Planck Institute for Molecular Genetics, Berlin, Germany [2] Faculty of Medicine, School of Public Health, Imperial College, London, UK.", "fullName": "Bertram L", "initials": "L", "firstName": "L", "lastName": "Bertram"}, {"affiliation": "1] Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA [2] Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA [3] Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.", "fullName": "Boerwinkle E", "initials": "E", "firstName": "E", "lastName": "Boerwinkle"}, {"affiliation": "Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland.", "fullName": "Buckley BM", "initials": "BM", "firstName": "B M", "lastName": "Buckley"}, {"firstName": "H", "lastName": "Campbell", "affiliation": "Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.", "authorId": {"type": "ORCID", "value": "0000-0002-6169-6262"}, "fullName": "Campbell H", "initials": "H"}, {"affiliation": "Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Corley J", "initials": "J", "firstName": "J", "lastName": "Corley"}, {"affiliation": "1] Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.", "fullName": "De Jager PL", "initials": "PL", "firstName": "P L", "lastName": "De Jager"}, {"affiliation": "1] Inserm U708, Neuroepidemiology, Paris, France [2] Inserm U897, Universit\u00e9 Bordeaux Segalen, Bordeaux, France.", "fullName": "Dufouil C", "initials": "C", "firstName": "C", "lastName": "Dufouil"}, {"affiliation": "1] Folkh\u00e4lsan Research Centre, Helsinki, Finland [2] National Institute for Health and Welfare, Helsinki, Finland [3] Department of General Practice and Primary health Care, University of Helsinki, Helsinki, Finland [4] Unit of General Practice, Helsinki University Central Hospital, Helsinki, Finland.", "fullName": "Eriksson JG", "initials": "JG", "firstName": "J G", "lastName": "Eriksson"}, {"affiliation": "1] K.G. Jebsen Centre for Psychosis Research, Norwegian Centre For Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway [2] Department of Psychology, University of Oslo, Oslo, Norway.", "fullName": "Espeseth T", "initials": "T", "firstName": "T", "lastName": "Espeseth"}, {"affiliation": "Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.", "fullName": "Faul JD", "initials": "JD", "firstName": "J D", "lastName": "Faul"}, {"affiliation": "Robertson Center for Biostatistics, Glasgow, UK.", "fullName": "Ford I", "initials": "I", "firstName": "I", "lastName": "Ford"}, {"affiliation": "Generation Scotland, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK.", "collectiveName": "Generation Scotland"}, {"affiliation": "Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.", "fullName": "Gottesman RF", "initials": "RF", "firstName": "R F", "lastName": "Gottesman"}, {"affiliation": "Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS, USA.", "fullName": "Griswold ME", "initials": "ME", "firstName": "M E", "lastName": "Griswold"}, {"firstName": "V", "lastName": "Gudnason", "affiliation": "1] Icelandic Heart Association, Kopavogur, Iceland [2] University of Iceland, Reykjavik, Iceland.", "authorId": {"type": "ORCID", "value": "0000-0001-5696-0084"}, "fullName": "Gudnason V", "initials": "V"}, {"affiliation": "Intramural Research Program National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA.", "fullName": "Harris TB", "initials": "TB", "firstName": "T B", "lastName": "Harris"}, {"affiliation": "Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.", "fullName": "Heiss G", "initials": "G", "firstName": "G", "lastName": "Heiss"}, {"affiliation": "1] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "Hofman A", "initials": "A", "firstName": "A", "lastName": "Hofman"}, {"affiliation": "Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW, Australia.", "fullName": "Holliday EG", "initials": "EG", "firstName": "E G", "lastName": "Holliday"}, {"firstName": "J", "lastName": "Huffman", "affiliation": "MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.", "authorId": {"type": "ORCID", "value": "0000-0002-9672-2491"}, "fullName": "Huffman J", "initials": "J"}, {"affiliation": "Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.", "fullName": "Kardia SL", "initials": "SL", "firstName": "S L R", "lastName": "Kardia"}, {"affiliation": "1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia [2] Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, NSW, Australia.", "fullName": "Kochan N", "initials": "N", "firstName": "N", "lastName": "Kochan"}, {"affiliation": "Department of Neurology, Mayo Clinic, Rochester, MN, USA.", "fullName": "Knopman DS", "initials": "DS", "firstName": "D S", "lastName": "Knopman"}, {"affiliation": "1] Neuroscience Research Australia, Randwick, NSW, Australia [2] School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Kwok JB", "initials": "JB", "firstName": "J B", "lastName": "Kwok"}, {"affiliation": "Inserm-UMR744, Institut Pasteur de Lille, Unit\u00e9 d'Epid\u00e9miologie et de Sant\u00e9 Publique, Lille, France.", "fullName": "Lambert JC", "initials": "JC", "firstName": "J-C", "lastName": "Lambert"}, {"affiliation": "1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia [2] Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, NSW, Australia.", "fullName": "Lee T", "initials": "T", "firstName": "T", "lastName": "Lee"}, {"affiliation": "Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.", "fullName": "Li G", "initials": "G", "firstName": "G", "lastName": "Li"}, {"affiliation": "1] Max Planck Institute for Human Development, Berlin, Germany [2] Technische Universit\u00e4t Dresden, Dresden, Germany.", "fullName": "Li SC", "initials": "SC", "firstName": "S-C", "lastName": "Li"}, {"affiliation": "Department of Neurology, Medical University of Graz, Graz, Austria.", "fullName": "Loitfelder M", "initials": "M", "firstName": "M", "lastName": "Loitfelder"}, {"affiliation": "Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Lopez OL", "initials": "OL", "firstName": "O L", "lastName": "Lopez"}, {"affiliation": "1] Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway [2] Kavli Research Centre for Aging and Dementia, Haraldsplass Deaconess Hospital, Bergen, Norway [3] K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway.", "fullName": "Lundervold AJ", "initials": "AJ", "firstName": "A J", "lastName": "Lundervold"}, {"affiliation": "Ume\u00e5 Center for Functional Brain Imaging (UFBI), Ume\u00e5 University, Ume\u00e5, Sweden.", "fullName": "Lundqvist A", "initials": "A", "firstName": "A", "lastName": "Lundqvist"}, {"affiliation": "Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Mather KA", "initials": "KA", "firstName": "K A", "lastName": "Mather"}, {"affiliation": "1] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "Mirza SS", "initials": "SS", "firstName": "S S", "lastName": "Mirza"}, {"affiliation": "1] Ume\u00e5 Center for Functional Brain Imaging (UFBI), Ume\u00e5 University, Ume\u00e5, Sweden [2] Department of Radiation Sciences, Ume\u00e5 University, Ume\u00e5, Sweden [3] Department of Integrative Medical Biology, Ume\u00e5 University, Ume\u00e5, Sweden.", "fullName": "Nyberg L", "initials": "L", "firstName": "L", "lastName": "Nyberg"}, {"affiliation": "Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "Oostra BA", "initials": "BA", "firstName": "B A", "lastName": "Oostra"}, {"affiliation": "1] Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK [2] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [3] Department of Medical Genetics, University of Helsinki and University Central Hospital, Helsinki, Finland.", "fullName": "Palotie A", "initials": "A", "firstName": "A", "lastName": "Palotie"}, {"affiliation": "1] Max Planck Institute for Human Development, Berlin, Germany [2] Karolinska Institutet, Aging Research Center, Stockholm University, Stockholm, Sweden.", "fullName": "Papenberg G", "initials": "G", "firstName": "G", "lastName": "Papenberg"}, {"affiliation": "Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Pattie A", "initials": "A", "firstName": "A", "lastName": "Pattie"}, {"affiliation": "Department of Neurology, Medical University of Graz, Graz, Austria.", "fullName": "Petrovic K", "initials": "K", "firstName": "K", "lastName": "Petrovic"}, {"firstName": "O", "lastName": "Polasek", "affiliation": "Faculty of Medicine, Department of Public Health, University of Split, Split, Croatia.", "authorId": {"type": "ORCID", "value": "0000-0002-5765-1862"}, "fullName": "Polasek O", "initials": "O"}, {"affiliation": "1] Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA [2] Deparment of Epidemiology, University of Washington, Seattle, WA, USA [3] Deparment of Health Services, University of Washington, Seattle, WA, USA [4] Group Health Research Unit, Group Health Cooperative, Seattle, WA, USA.", "fullName": "Psaty BM", "initials": "BM", "firstName": "B M", "lastName": "Psaty"}, {"affiliation": "Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Redmond P", "initials": "P", "firstName": "P", "lastName": "Redmond"}, {"affiliation": "Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Reppermund S", "initials": "S", "firstName": "S", "lastName": "Reppermund"}, {"affiliation": "1] Institute for Translational Genomics and Population Sciences Los Angeles BioMedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, CA, USA [2] Division of Genetic Outcomes, Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, CA, USA.", "fullName": "Rotter JI", "initials": "JI", "firstName": "J I", "lastName": "Rotter"}, {"affiliation": "1] Department of Neurology, Medical University of Graz, Graz, Austria [2] Centre for Molecular Medicine, Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.", "fullName": "Schmidt H", "initials": "H", "firstName": "H", "lastName": "Schmidt"}, {"affiliation": "1] Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "Schuur M", "initials": "M", "firstName": "M", "lastName": "Schuur"}, {"affiliation": "School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.", "fullName": "Schofield PW", "initials": "PW", "firstName": "P W", "lastName": "Schofield"}, {"affiliation": "Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW, Australia.", "fullName": "Scott RJ", "initials": "RJ", "firstName": "R J", "lastName": "Scott"}, {"affiliation": "1] K.G. Jebsen Centre for Psychosis Research and the Norwegian Centre for Mental Disorders Research (NORMENT), Department of Clinical Science, University of Bergen, Bergen, Norway [2] Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.", "fullName": "Steen VM", "initials": "VM", "firstName": "V M", "lastName": "Steen"}, {"affiliation": "Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.", "fullName": "Stott DJ", "initials": "DJ", "firstName": "D J", "lastName": "Stott"}, {"affiliation": "Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "van Swieten JC", "initials": "JC", "firstName": "J C", "lastName": "van Swieten"}, {"affiliation": "1] Institute for Translational Genomics and Population Sciences Los Angeles BioMedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, CA, USA [2] Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, CA, USA.", "fullName": "Taylor KD", "initials": "KD", "firstName": "K D", "lastName": "Taylor"}, {"affiliation": "1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia [2] Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Trollor J", "initials": "J", "firstName": "J", "lastName": "Trollor"}, {"affiliation": "1] Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands [2] Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.", "fullName": "Trompet S", "initials": "S", "firstName": "S", "lastName": "Trompet"}, {"affiliation": "1] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands [3] Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.", "fullName": "Uitterlinden AG", "initials": "AG", "firstName": "A G", "lastName": "Uitterlinden"}, {"affiliation": "1] Department of Neurology, Boston University School of Medicine, Boston, MA, USA [2] Framingham Heart Study, Framingham, MA, USA.", "fullName": "Weinstein G", "initials": "G", "firstName": "G", "lastName": "Weinstein"}, {"affiliation": "Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.", "fullName": "Widen E", "initials": "E", "firstName": "E", "lastName": "Widen"}, {"affiliation": "Division of Geriatrics, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.", "fullName": "Windham BG", "initials": "BG", "firstName": "B G", "lastName": "Windham"}, {"affiliation": "1] Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands [2] Durrer Center for Cardiogenetic Research, Amsterdam, The Netherlands [3] Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands.", "fullName": "Jukema JW", "initials": "JW", "firstName": "J W", "lastName": "Jukema"}, {"affiliation": "MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.", "fullName": "Wright AF", "initials": "AF", "firstName": "A F", "lastName": "Wright"}, {"affiliation": "Neuroimaging Genetics Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.", "fullName": "Wright MJ", "initials": "MJ", "firstName": "M J", "lastName": "Wright"}, {"affiliation": "1] Framingham Heart Study, Framingham, MA, USA [2] Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.", "fullName": "Yang Q", "initials": "Q", "firstName": "Q", "lastName": "Yang"}, {"affiliation": "Inserm U897, Universit\u00e9 Bordeaux Segalen, Bordeaux, France.", "fullName": "Amieva H", "initials": "H", "firstName": "H", "lastName": "Amieva"}, {"affiliation": "Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW, Australia.", "fullName": "Attia JR", "initials": "JR", "firstName": "J R", "lastName": "Attia"}, {"affiliation": "Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.", "fullName": "Bennett DA", "initials": "DA", "firstName": "D A", "lastName": "Bennett"}, {"affiliation": "1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia [2] Dementia Collaborative Research Centre, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Brodaty H", "initials": "H", "firstName": "H", "lastName": "Brodaty"}, {"affiliation": "1] Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "de Craen AJ", "initials": "AJ", "firstName": "A J M", "lastName": "de Craen"}, {"affiliation": "MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.", "fullName": "Hayward C", "initials": "C", "firstName": "C", "lastName": "Hayward"}, {"firstName": "M A", "lastName": "Ikram", "affiliation": "1] Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [3] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands [4] Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0003-0372-8585"}, "fullName": "Ikram MA", "initials": "MA"}, {"affiliation": "Max Planck Institute for Human Development, Berlin, Germany.", "fullName": "Lindenberger U", "initials": "U", "firstName": "U", "lastName": "Lindenberger"}, {"affiliation": "ARC, Karolinska Institutet, Stockholm and UFBI, Ume\u00e5 University, Ume\u00e5, Sweden.", "fullName": "Nilsson LG", "initials": "LG", "firstName": "L-G", "lastName": "Nilsson"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK [3] Generation Scotland, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK.", "fullName": "Porteous DJ", "initials": "DJ", "firstName": "D J", "lastName": "Porteous"}, {"affiliation": "Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland.", "fullName": "R\u00e4ikk\u00f6nen K", "initials": "K", "firstName": "K", "lastName": "R\u00e4ikk\u00f6nen"}, {"affiliation": "Department of Psychology, University of Oslo, Oslo, Norway.", "fullName": "Reinvang I", "initials": "I", "firstName": "I", "lastName": "Reinvang"}, {"firstName": "I", "lastName": "Rudan", "affiliation": "Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.", "authorId": {"type": "ORCID", "value": "0000-0001-6993-6884"}, "fullName": "Rudan I", "initials": "I"}, {"firstName": "P S", "lastName": "Sachdev", "affiliation": "1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia [2] Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, NSW, Australia.", "authorId": {"type": "ORCID", "value": "0000-0002-9595-3220"}, "fullName": "Sachdev PS", "initials": "PS"}, {"affiliation": "Department of Neurology, Medical University of Graz, Graz, Austria.", "fullName": "Schmidt R", "initials": "R", "firstName": "R", "lastName": "Schmidt"}, {"affiliation": "1] Neuroscience Research Australia, Sydney, NSW, Australia [2] Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.", "fullName": "Schofield PR", "initials": "PR", "firstName": "P R", "lastName": "Schofield"}, {"affiliation": "1] Menzies Research Institute, Hobart, Tasmania [2] Stroke and Ageing Research, Medicine, Southern Clinical School, Monash University, Melbourne, VIC, Australia.", "fullName": "Srikanth V", "initials": "V", "firstName": "V", "lastName": "Srikanth"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.", "fullName": "Starr JM", "initials": "JM", "firstName": "J M", "lastName": "Starr"}, {"affiliation": "Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.", "fullName": "Turner ST", "initials": "ST", "firstName": "S T", "lastName": "Turner"}, {"affiliation": "Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.", "fullName": "Weir DR", "initials": "DR", "firstName": "D R", "lastName": "Weir"}, {"firstName": "J F", "lastName": "Wilson", "affiliation": "Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.", "authorId": {"type": "ORCID", "value": "0000-0001-5751-9178"}, "fullName": "Wilson JF", "initials": "JF"}, {"affiliation": "1] Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands [2] Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands.", "fullName": "van Duijn C", "initials": "C", "firstName": "C", "lastName": "van Duijn"}, {"affiliation": "Intramural Research Program National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA.", "fullName": "Launer L", "initials": "L", "firstName": "L", "lastName": "Launer"}, {"affiliation": "1] Deparment of Epidemiology, University of Washington, Seattle, WA, USA [2] Department of Global Health, University of Washington, Seattle, WA, USA.", "fullName": "Fitzpatrick AL", "initials": "AL", "firstName": "A L", "lastName": "Fitzpatrick"}, {"firstName": "S", "lastName": "Seshadri", "affiliation": "1] Department of Neurology, Boston University School of Medicine, Boston, MA, USA [2] Framingham Heart Study, Framingham, MA, USA.", "authorId": {"type": "ORCID", "value": "0000-0001-6135-2622"}, "fullName": "Seshadri S", "initials": "S"}, {"affiliation": "Division of Geriatrics, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.", "fullName": "Mosley TH Jr", "initials": "TH", "firstName": "T H", "lastName": "Mosley"}, {"affiliation": "1] Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK [2] Department of Psychology, University of Edinburgh, Edinburgh, UK.", "fullName": "Deary IJ", "initials": "IJ", "firstName": "I J", "lastName": "Deary"}]}, "title": "Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).", "hasSuppl": "N", "citedByCount": 12, "source": "MED", "pmid": "25644384", "abstractText": "General cognitive function is substantially heritable across the human life course from adolescence to old age. We investigated the genetic contribution to variation in this important, health- and well-being-related trait in middle-aged and older adults. We conducted a meta-analysis of genome-wide association studies of 31 cohorts (N=53,949) in which the participants had undertaken multiple, diverse cognitive tests. A general cognitive function phenotype was tested for, and created in each cohort by principal component analysis. We report 13 genome-wide significant single-nucleotide polymorphism (SNP) associations in three genomic regions, 6q16.1, 14q12 and 19q13.32 (best SNP and closest gene, respectively: rs10457441, P=3.93 \u00d7 10(-9), MIR2113; rs17522122, P=2.55 \u00d7 10(-8), AKAP6; rs10119, P=5.67 \u00d7 10(-9), APOE/TOMM40). We report one gene-based significant association with the HMGN1 gene located on chromosome 21 (P=1 \u00d7 10(-6)). These genes have previously been associated with neuropsychiatric phenotypes. Meta-analysis results are consistent with a polygenic model of inheritance. To estimate SNP-based heritability, the genome-wide complex trait analysis procedure was applied to two large cohorts, the Atherosclerosis Risk in Communities Study (N=6617) and the Health and Retirement Study (N=5976). The proportion of phenotypic variation accounted for by all genotyped common SNPs was 29% (s.e.=5%) and 28% (s.e.=7%), respectively. Using polygenic prediction analysis, ~1.2% of the variance in general cognitive function was predicted in the Generation Scotland cohort (N=5487; P=1.5 \u00d7 10(-17)). In hypothesis-driven tests, there was significant association between general cognitive function and four genes previously associated with Alzheimer's disease: TOMM40, APOE, ABCG1 and MEF2C.", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4477-293X"}, {"type": "ORCID", "value": "0000-0002-4698-1794"}, {"type": "ORCID", "value": "0000-0003-4089-9703"}, {"type": "ORCID", "value": "0000-0003-3687-2508"}, {"type": "ORCID", "value": "0000-0001-9088-234X"}, {"type": "ORCID", "value": "0000-0002-6169-6262"}, {"type": "ORCID", "value": "0000-0001-5696-0084"}, {"type": "ORCID", "value": "0000-0002-9672-2491"}, {"type": "ORCID", "value": "0000-0002-5765-1862"}, {"type": "ORCID", "value": "0000-0003-0372-8585"}, {"type": "ORCID", "value": "0000-0001-6993-6884"}, {"type": "ORCID", "value": "0000-0002-9595-3220"}, {"type": "ORCID", "value": "0000-0001-5751-9178"}, {"type": "ORCID", "value": "0000-0001-6135-2622"}, {"type": "ORCID", "value": "0000-0001-7133-4970"}, {"type": "ORCID", "value": "0000-0002-3575-5468"}, {"type": "ORCID", "value": "0000-0003-1942-5845"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HMGN1 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Cognition", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cognition Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neuropsychological Tests", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Scotland", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Atherosclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-02-03", "language": "eng", "doi": "10.1038/mp.2014.188", "isOpenAccess": "Y", "pageInfo": "183-192", "pmcid": "PMC4356746", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "electronicPublicationDate": "2015-02-03", "license": "cc by", "dateOfCompletion": "2016-03-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4356746?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4356746", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/mp.2014.188", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-02-01", "journal": {"medlineAbbreviation": "Mol Psychiatry", "isoabbreviation": "Mol. Psychiatry", "title": "Molecular psychiatry", "issn": "1359-4184", "nlmid": "9607835", "essn": "1476-5578"}, "monthOfPublication": 2, "volume": "20", "yearOfPublication": 2015, "journalIssueId": 2258369, "issue": "2", "dateOfPublication": "2015 Feb"}}, "11673795": {"pubYear": "2001", "dateOfCreation": "2001-10-23", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "white protein, Drosophila"}, {"registryNumber": "0", "name": "ABCG1 protein, human"}, {"registryNumber": "73-22-3", "name": "Tryptophan"}, {"registryNumber": "0", "name": "Eye Proteins"}, {"registryNumber": "0", "name": "Insect Proteins"}, {"registryNumber": "0", "name": "Drosophila Proteins"}, {"registryNumber": "0", "name": "3' Untranslated Regions"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "0", "name": "DNA, Complementary"}, {"registryNumber": "0", "name": "ATP-Binding Cassette Transporters"}]}, "authorString": "Kirov G, Lowry CA, Stephens M, Oldfield S, O'Donovan MC, Lightman SL, Owen MJ.", "affiliation": "Neuropsychiatric Genetics Unit, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK. kirov@cardiff.ac.uk", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "11673795", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kirov", "fullName": "Kirov G", "initials": "G"}, {"lastName": "Lowry", "fullName": "Lowry CA", "initials": "CA"}, {"lastName": "Stephens", "fullName": "Stephens M", "initials": "M"}, {"lastName": "Oldfield", "fullName": "Oldfield S", "initials": "S"}, {"lastName": "O'Donovan", "fullName": "O'Donovan MC", "authorId": {"type": "ORCID", "value": "0000-0001-7073-2379"}, "initials": "MC"}, {"lastName": "Lightman", "fullName": "Lightman SL", "initials": "SL"}, {"lastName": "Owen", "fullName": "Owen MJ", "initials": "MJ"}]}, "title": "Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder.", "citedByCount": 11, "source": "MED", "pmid": "11673795", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7073-2379"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Drosophila", "majorTopic_YN": "N"}, {"descriptorName": "Tryptophan", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Eye Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Insect Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Drosophila Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "DNA, Complementary", "majorTopic_YN": "N"}, {"descriptorName": "3' Untranslated Regions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Screening", "majorTopic_YN": "Y"}, {"descriptorName": "Bipolar Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microsatellite Repeats", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "Y"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "5' Flanking Region", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Introns", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2001-11-01", "doi": "10.1038/sj.mp.4000899", "isOpenAccess": "N", "pageInfo": "671-677", "hasDbCrossReferences": "Y", "abstractText": "ABCG1 encodes a transporter protein that may be involved in the cellular uptake of tryptophan. Tryptophan is the precursor for serotonin, which is implicated in the regulation of mood. The gene maps to chromosome 21q22.3, a region implicated in bipolar disorder I (BPI) in genetic linkage studies. ABCG1 is thus a suitable candidate gene for study in BP1. We screened all 15 exons and 700 bases of the 5' flanking region of ABCG1 for mutations, using Denaturing High Performance Liquid Chromatography (DHPLC). A total of 13 single nucleotide polymorphisms (SNPs) were identified. Ten of the SNPs were intronic, two lie within the 5' flanking region and one within the 3' UTR. We identified a GCC repeat within Exon 1 and two novel intronic VNTRs. Eight of the SNPs, the two VNTRs, the GCC repeat and two known microsatellite markers within the gene were tested for association with BP1 in a sample of 110 parent-offspring trios using the Extended Transmission Disequilibrium Test (ETDT). No alleles or haplotypes were significantly preferentially transmitted from parents to affected offspring. However, the trend for preferential transmission of markers in the 3'UTR is in the same direction as in a previous report for association with mood and panic disorders and therefore warrants attempts at replication. Marker-to-marker linkage disequilibrium (LD) showed that strong LD was present over relatively short distances of up to 20 kb and was present for SNPs as well as for polymorphic repeats. The polymorphisms identified in this study will be useful in examining the role of this gene in other neuropsychiatric disorders and behavioural traits.", "language": "eng", "dateOfCompletion": "2002-01-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/sj.mp.4000899", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2001-11-01", "journal": {"medlineAbbreviation": "Mol Psychiatry", "isoabbreviation": "Mol. Psychiatry", "title": "Molecular psychiatry", "issn": "1359-4184", "nlmid": "9607835", "essn": "1476-5578"}, "monthOfPublication": 11, "volume": "6", "yearOfPublication": 2001, "journalIssueId": 1022432, "issue": "6", "dateOfPublication": "2001 Nov"}}, "26981778": {"pubYear": "2016", "dateOfCreation": "2016-08-01", "pubModel": "Print", "authorString": "Chen YH, Cimino PJ, Luo J, Dahiya S, Gutmann DH.", "affiliation": "Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26981778", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.", "fullName": "Chen YH", "initials": "YH", "firstName": "Yi-Hsien", "lastName": "Chen"}, {"firstName": "Patrick J", "lastName": "Cimino", "affiliation": "Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-0441-4502"}, "fullName": "Cimino PJ", "initials": "PJ"}, {"affiliation": "Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.", "fullName": "Luo J", "initials": "J", "firstName": "Jingqin", "lastName": "Luo"}, {"affiliation": "Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA.", "fullName": "Dahiya S", "initials": "S", "firstName": "Sonika", "lastName": "Dahiya"}, {"affiliation": "Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.", "fullName": "Gutmann DH", "initials": "DH", "firstName": "David H", "lastName": "Gutmann"}]}, "title": "ABCG1 maintains high-grade glioma survival in vitro and in vivo.", "citedByCount": 0, "source": "MED", "pmid": "26981778", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0441-4502"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-03-10", "doi": "10.18632/oncotarget.8030", "isOpenAccess": "N", "pageInfo": "23416-23424", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Apoptosis", "Glioblastoma", "ER stress", "Brain tumor", "Glioma Stem Cell"]}, "abstractText": "The overall survival for adults with malignant glioma (glioblastoma) remains poor despite advances in radiation and chemotherapy. One of the mechanisms by which cancer cells develop relative resistance to treatment is through de-regulation of endoplasmic reticulum (ER) homeostasis. We have recently shown that ABCG1, an ATP-binding cassette transporter, maintains ER homeostasis and suppresses ER stress-induced apoptosis in low-grade glioma. Herein, we demonstrate that ABCG1 expression is increased in human adult glioblastoma, where it correlates with poor survival in individuals with the mesenchymal subtype. Leveraging a mouse model of mesenchymal glioblastoma (NPcis), shRNA-mediated Abcg1 knockdown (KD) increased CHOP ER stress protein expression and resulted in greater NPcis glioma cell death in vitro. Moreover, Abcg1 KD reduced NPcis glioma growth and increased mouse survival in vivo. Collectively, these results demonstrate that ABCG1 is critical for malignant glioma cell survival, and might serve as a future therapeutic target for these deadly brain cancers.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.18632/oncotarget.8030", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-04-01", "journal": {"title": "Oncotarget", "medlineAbbreviation": "Oncotarget", "isoabbreviation": "Oncotarget", "nlmid": "101532965", "essn": "1949-2553"}, "monthOfPublication": 4, "volume": "7", "yearOfPublication": 2016, "journalIssueId": 2435228, "issue": "17", "dateOfPublication": "2016 Apr"}}, "25217640": {"pubYear": "2014", "dateOfCreation": "2014-11-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.4.8", "name": "guanylate kinase"}, {"registryNumber": "0", "name": "amyloid beta-protein (1-42)"}, {"registryNumber": "0", "name": "LG 100268"}, {"registryNumber": "0", "name": "ATP binding cassette transporter 1"}, {"registryNumber": "0", "name": "ABCG1 protein, mouse"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Lipoproteins"}, {"registryNumber": "0", "name": "Nicotinic Acids"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Tetrahydronaphthalenes"}, {"registryNumber": "0", "name": "Apolipoproteins E"}, {"registryNumber": "0", "name": "Retinoid X Receptors"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}, {"registryNumber": "EC 2.7.4.8", "name": "Dlgh4 protein, mouse"}, {"registryNumber": "0", "name": "ABCA1 protein, mouse"}, {"registryNumber": "A61RXM4375", "name": "bexarotene"}]}, "authorString": "Tai LM, Koster KP, Luo J, Lee SH, Wang YT, Collins NC, Ben Aissa M, Thatcher GR, LaDu MJ.", "affiliation": "From the Department of Anatomy and Cell Biology.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01 AG030128"}, {"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "UL1RR029879"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P01AG030128"}]}, "hasPDF": "N", "id": "25217640", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "From the Department of Anatomy and Cell Biology.", "fullName": "Tai LM", "initials": "LM", "firstName": "Leon M", "lastName": "Tai"}, {"affiliation": "From the Department of Anatomy and Cell Biology.", "fullName": "Koster KP", "initials": "KP", "firstName": "Kevin P", "lastName": "Koster"}, {"affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and.", "fullName": "Luo J", "initials": "J", "firstName": "Jia", "lastName": "Luo"}, {"affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and.", "fullName": "Lee SH", "initials": "SH", "firstName": "Sue H", "lastName": "Lee"}, {"affiliation": "the UICentre (Drug Discovery at UIC), University of Illinois at Chicago, Chicago, Illinois 60612.", "fullName": "Wang YT", "initials": "YT", "firstName": "Yue-ting", "lastName": "Wang"}, {"affiliation": "From the Department of Anatomy and Cell Biology.", "fullName": "Collins NC", "initials": "NC", "firstName": "Nicole C", "lastName": "Collins"}, {"affiliation": "From the Department of Anatomy and Cell Biology.", "fullName": "Ben Aissa M", "initials": "M", "firstName": "Manel", "lastName": "Ben Aissa"}, {"affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and.", "fullName": "Thatcher GR", "initials": "GR", "firstName": "Gregory R J", "lastName": "Thatcher"}, {"affiliation": "From the Department of Anatomy and Cell Biology, mladu@uic.edu.", "fullName": "LaDu MJ", "initials": "MJ", "firstName": "Mary Jo", "lastName": "LaDu"}]}, "title": "Amyloid-\u03b2 pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.", "hasSuppl": "N", "citedByCount": 11, "source": "MED", "pmid": "25217640", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Liver", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nicotinic Acids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}, {"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tetrahydronaphthalenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}, {"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lipoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Apolipoproteins E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinoid X Receptors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Organ Size", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Administration, Oral", "majorTopic_YN": "N"}, {"descriptorName": "Drug Evaluation, Preclinical", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Solubility", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Guanylate Kinase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "ATP Binding Cassette Transporter 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "embargoDate": "2015-10-31", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-09-12", "doi": "10.1074/jbc.m114.600833", "isOpenAccess": "N", "pageInfo": "30538-30555", "pmcid": "PMC4215234", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Alzheimer disease", "Drug action", "Hepatomegaly", "Drug Delivery", "Apolipoprotein E (Apoe)", "Rxr Agonists", "Amyloid-\u03b2 (Ab)", "Apoe/a\u03b2 Complex", "Abca1/abcg1 Lipid Transporters", "Oligomeric A\u03b2"]}, "abstractText": "Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-\u03b2 (A\u03b2) in Alzheimer disease (AD)-transgenic mice either by increasing the levels of mouse apolipoprotein E (apoE) or increasing ABCA1/ABCG1-induced apoE lipoprotein association/lipidation. However, although the mechanism of action of RXR agonists remains unclear, a major concern for their use is human (h)-APOE4, the greatest AD genetic risk factor. If APOE4 imparts a toxic gain-of-function, then increasing apoE4 may increase soluble A\u03b2, likely the proximal AD neurotoxin. If the APOE4 loss-of-function is lipidation of apoE4, then induction of ABCA1/ABCG1 may be beneficial. In novel EFAD-Tg mice (overexpressing h-A\u03b242 with h-APOE), levels of soluble A\u03b2 (A\u03b242 and oligomeric A\u03b2) are highest in E4FAD hippocampus (HP) > E3FAD-HP > E4FAD cortex (CX) > E3FAD-CX, whereas levels of lipoprotein-associated/lipidated apoE have the opposite pattern (6 months). In E4FAD-HP, short-term RXR agonist treatment (Bex or LG100268; 5.75-6 months) increased ABCA1, apoE4 lipoprotein-association/lipidation, and apoE4/A\u03b2 complex, decreased soluble A\u03b2, and increased PSD95. In addition, hydrogel delivery, which mimics low sustained release, was equally effective as gavage for Bex and LG100268. RXR agonists induced no beneficial effects in the E4FAD-HP in a prevention protocol (5-6 months) and actually increased soluble A\u03b2 levels in E3FAD-CX and E4FAD-CX with the short-term protocol, possibly the result of systemic hepatomegaly. Thus, RXR agonists address the loss-of-function associated with APOE4 and exacerbated by A\u03b2 pathology, i.e. low levels of apoE4 lipoprotein association/lipidation. Further studies are vital to address whether RXR agonists are an APOE4-specific AD therapeutic and the systemic side effects that limit translational application.", "electronicPublicationDate": "2014-09-12", "language": "eng", "dateOfCompletion": "2014-12-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4215234", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1074/jbc.M114.600833", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-10-31", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 10, "volume": "289", "yearOfPublication": 2014, "journalIssueId": 2215693, "issue": "44", "dateOfPublication": "2014 Oct"}}}, "EIF5B": {"24252779": {"pubYear": "2013", "dateOfCreation": "2013-11-22", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Calreticulin"}, {"registryNumber": "0", "name": "calreticulin, human"}]}, "authorString": "N\u00ed Fhlathartaigh M, McMahon J, Reynolds R, Connolly D, Higgins E, Counihan T, Fitzgerald U.", "affiliation": "National Centre for Biomedical Engineering Science, Galway Neuroscience Centre, National University of Ireland, Galway, Ireland. una.fitzgerald@nuigalway.ie.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24252779", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "National Centre for Biomedical Engineering Science, Galway Neuroscience Centre, National University of Ireland, Galway, Ireland. una.fitzgerald@nuigalway.ie.", "fullName": "N\u00ed Fhlathartaigh M", "initials": "M", "firstName": "Mary", "lastName": "N\u00ed Fhlathartaigh"}, {"lastName": "McMahon", "fullName": "McMahon J", "firstName": "Jill", "initials": "J"}, {"lastName": "Reynolds", "fullName": "Reynolds R", "firstName": "Richard", "initials": "R"}, {"lastName": "Connolly", "fullName": "Connolly D", "firstName": "David", "initials": "D"}, {"lastName": "Higgins", "fullName": "Higgins E", "firstName": "Eibhl\u00edn", "initials": "E"}, {"lastName": "Counihan", "fullName": "Counihan T", "firstName": "Timothy", "initials": "T"}, {"lastName": "Fitzgerald", "fullName": "Fitzgerald U", "firstName": "Una", "initials": "U"}]}, "title": "Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "24252779", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Astrocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Demyelinating Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Calreticulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fluorescent Antibody Technique", "majorTopic_YN": "N"}, {"descriptorName": "Enzyme-Linked Immunosorbent Assay", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Endoplasmic Reticulum Stress", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-07-15", "language": "eng", "doi": "10.1186/2051-5960-1-37", "isOpenAccess": "Y", "pageInfo": "37", "pmcid": "PMC3893522", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Calreticulin (CRT) is a chaperone protein, which aids correct folding of glycosylated proteins in the endoplasmic reticulum (ER). Under conditions of ER stress, CRT is upregulated and may be displayed on the surface of cells or be secreted. This 'ecto-CRT' may activate the innate immune response or it may aid clearance of apoptotic cells. Our and other studies have demonstrated upregulation of ER stress markers CHOP, BiP, ATF4, XBP1 and phosphorylated e-IF2 alpha (p-eIF2 alpha) in biopsy and post-mortem human multiple sclerosis (MS) samples. We extend this work by analysing changes in expression of CRT, BiP, CHOP, XBP1 and p-eIF2 alpha in a rat model of inflammatory demyelination. Demyelination was induced in the spinal cord by intradermal injection of recombinant mouse MOG mixed with incomplete Freund's adjuvant (IFA) at the base of the tail. Tissue samples were analysed by semi-quantitative scoring of immunohistochemically stained frozen tissue sections. Data generated following sampling of tissue from animals with spinal cord lesions, was compared to that obtained using tissue derived from IFA- or saline-injected controls. CRT present in rat serum and in a cohort of human serum derived from 14 multiple sclerosis patients and 11 healthy controls was measured by ELISA. RESULTS: Stained tissue scores revealed significantly (p<0.05) increased amounts of CRT, CHOP and p-eIF2 alpha in the lesion, lesion edge and normal-appearing white matter when compared to controls. CHOP and p-eIF2 alpha were also significantly raised in regions of grey matter and the central canal (p<0.05). Immunofluorescent dual-label staining confirmed expression of these markers in astrocytes, microglia or neurons. Dual staining of rat and human spinal cord lesions with Oil Red O and CRT antibody showed co-localisation of CRT with the rim of myelin fragments. ELISA testing of sera from control and EAE rats demonstrated significant down-regulation (p<0.05) of CRT in the serum of EAE animals, compared to saline and IFA controls. This contrasted with significantly increased amounts of CRT detected in the sera of MS patients (p<0.05), compared to controls. CONCLUSION: This data highlights the potential importance of CRT and other ER stress proteins in inflammatory demyelination.", "electronicPublicationDate": "2013-07-15", "license": "cc by", "dateOfCompletion": "2015-03-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3893522?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3893522", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24252779&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24252779", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/2051-5960-1-37", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-06-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Acta neuropathologica communications", "medlineAbbreviation": "Acta Neuropathol Commun", "isoabbreviation": "Acta Neuropathol Commun", "nlmid": "101610673", "essn": "2051-5960"}, "monthOfPublication": 0, "volume": "1", "yearOfPublication": 2013, "journalIssueId": 2296560, "dateOfPublication": "2013 "}}, "11916503": {"pubYear": "2002", "dateOfCreation": "2002-03-27", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "EC 6.3.2.19", "name": "MDM2 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Proto-Oncogene Proteins c-mdm2"}]}, "authorString": "Giordana MT, Du\u00f3 D, Gasverde S, Trevisan E, Boghi A, Morra I, Pradotto L, Mauro A, Chi\u00f3 A.", "affiliation": "Department of Neuroscience, University of Turin, 10126, Italy. giordana@unito.it", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "11916503", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Giordana", "fullName": "Giordana MT", "firstName": "Maria Teresa", "initials": "MT"}, {"lastName": "Du\u00f3", "fullName": "Du\u00f3 D", "firstName": "Debora", "initials": "D"}, {"lastName": "Gasverde", "fullName": "Gasverde S", "firstName": "Sabrina", "initials": "S"}, {"lastName": "Trevisan", "fullName": "Trevisan E", "firstName": "Elisa", "initials": "E"}, {"lastName": "Boghi", "fullName": "Boghi A", "firstName": "Andrea", "initials": "A"}, {"lastName": "Morra", "fullName": "Morra I", "firstName": "Isabella", "initials": "I"}, {"lastName": "Pradotto", "fullName": "Pradotto L", "firstName": "Luca", "initials": "L"}, {"lastName": "Mauro", "fullName": "Mauro A", "authorId": {"type": "ORCID", "value": "0000-0001-9072-7454"}, "firstName": "Alessandro", "initials": "A"}, {"lastName": "Chi\u00f3", "fullName": "Chi\u00f3 A", "authorId": {"type": "ORCID", "value": "0000-0001-9579-5341"}, "firstName": "Adriano", "initials": "A"}]}, "title": "MDM2 overexpression is associated with short survival in adults with medulloblastoma.", "hasSuppl": "N", "citedByCount": 15, "source": "MED", "pmid": "11916503", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9072-7454"}, {"type": "ORCID", "value": "0000-0001-9579-5341"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}, {"abbreviation": "RT", "qualifierName": "radiotherapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}, {"abbreviation": "RT", "qualifierName": "radiotherapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "Immunoenzyme Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Survival Rate", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "Gene Amplification", "majorTopic_YN": "N"}, {"descriptorName": "Genes, p53", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Proto-Oncogene Proteins c-mdm2", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2002-04-01", "doi": "10.1215/s152285170100062x", "isOpenAccess": "N", "pageInfo": "115-122", "pmcid": "PMC1920659", "hasDbCrossReferences": "N", "abstractText": "In adult medulloblastoma, postoperative radiotherapy is significantly effective in prolonging time to recurrence and survival time; however, the response of individual cases to radiotherapy, that is the total survival, is different. Apoptosis is an important cellular response to radiation. It can be hypothesized that the individual radiosensitivity of medulloblastomas depends on the individual capability to undergo apoptosis. p53 protein is involved in the apoptotic response to ionizing radiation; loss of function of p53 can be the consequence not only of TP53 mutations, but also of amplification and/or overexpression of the MDM2 gene. We have analyzed cerebellar medulloblastomas from 51 adults (>16 years of age) for MDM2 gene amplification (by differential polymerase chain reaction assay), TP53 gene mutation (by polymerase chain reaction single-strand conformation polymorphism analysis of exons 5-8), and immunohistochemical expression of p53 (clone DO1) and MDM2 (clone IF2). The results have been evaluated in relation to age, tumor location, classic or desmoplastic type, MIB-1 labeling index, and total survival. No tumor had MDM2 amplification. Ten tumors had MDM2 positive tumor cells. One case had a mutated TP53 gene; 16/51 cases had intense p53 immunostaining. Only 2 MDM2 protein-positive tumors were also p53-positive. Both subgroups of MDM2 - and p53-positive tumors had a significantly shorter postoperative survival. In conclusion, the overexpression of MDM2 protein and the accumulation of wild-type p53 are unrelated in adult medulloblastoma; they may result in a reduced apoptotic response after radiotherapy and contribute to a shortened survival. Also, MDM2 amplification and TP53 gene mutation are rare events in medulloblastomas of adults.", "language": "eng", "dateOfCompletion": "2002-05-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC1920659?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC1920659", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/neuonc/4.2.115", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://dx.doi.org/10.1215/S152285170100062X", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ingentaconnect"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2008-11-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2002-04-01", "journal": {"medlineAbbreviation": "Neuro Oncol", "isoabbreviation": "Neuro-oncology", "title": "Neuro-oncology", "issn": "1522-8517", "nlmid": "100887420", "essn": "1523-5866"}, "monthOfPublication": 4, "volume": "4", "yearOfPublication": 2002, "journalIssueId": 1065297, "issue": "2", "dateOfPublication": "2002 Apr"}}}, "KCNA3": {"25129674": {"pubYear": "2014", "dateOfCreation": "2014-09-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "3K9958V90M", "name": "Ethanol"}]}, "authorString": "McClintick JN, Brooks AI, Deng L, Liang L, Wang JC, Kapoor M, Xuei X, Foroud T, Tischfield JA, Edenberg HJ.", "affiliation": "Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA12725"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10AA008401"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10 AA008401"}]}, "hasPDF": "Y", "id": "25129674", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.", "fullName": "McClintick JN", "initials": "JN", "firstName": "Jeanette N", "lastName": "McClintick"}, {"affiliation": "Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.", "fullName": "Brooks AI", "initials": "AI", "firstName": "Andrew I", "lastName": "Brooks"}, {"affiliation": "Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.", "fullName": "Deng L", "initials": "L", "firstName": "Li", "lastName": "Deng"}, {"affiliation": "Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.", "fullName": "Liang L", "initials": "L", "firstName": "Li", "lastName": "Liang"}, {"affiliation": "Department of Psychiatry, B8134, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.", "fullName": "Wang JC", "initials": "JC", "firstName": "Jen C", "lastName": "Wang"}, {"affiliation": "Department of Psychiatry, B8134, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.", "fullName": "Kapoor M", "initials": "M", "firstName": "Manav", "lastName": "Kapoor"}, {"affiliation": "Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.", "fullName": "Xuei X", "initials": "X", "firstName": "Xiaoling", "lastName": "Xuei"}, {"affiliation": "Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.", "fullName": "Foroud T", "initials": "T", "firstName": "Tatiana", "lastName": "Foroud"}, {"firstName": "Jay A", "lastName": "Tischfield", "affiliation": "Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-3217-8287"}, "fullName": "Tischfield JA", "initials": "JA"}, {"affiliation": "Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: edenberg@iu.edu.", "fullName": "Edenberg HJ", "initials": "HJ", "firstName": "Howard J", "lastName": "Edenberg"}]}, "title": "Ethanol treatment of lymphoblastoid cell lines from alcoholics and non-alcoholics causes many subtle changes in gene expression.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "25129674", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3217-8287"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lymphocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alcoholism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ethanol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["ARXPR"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-07-22", "doi": "10.1016/j.alcohol.2014.07.004", "isOpenAccess": "N", "pageInfo": "603-610", "pmcid": "PMC4730944", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Cytokines", "TNF", "NFkappaB", "Lymphoblastoid cell lines", "Gene Expression", "alcoholism"]}, "abstractText": "To elucidate the effects of a controlled exposure to ethanol on gene expression, we studied lymphoblastoid cell lines (LCLs) from 21 alcoholics and 21 controls. We cultured each cell line for 24\u00a0h with and without 75\u00a0mM ethanol and measured gene expression using microarrays. Differences in expression between LCLs from alcoholics and controls included 13 genes previously identified as associated with alcoholism or related traits, including KCNA3, DICER1, ZNF415, CAT, SLC9A9, and PPARGC1B. The paired design allowed us to detect very small changes due to ethanol treatment: ethanol altered the expression of 37% of the probe sets (51% of the unique named genes) expressed in these LCLs, most by modest amounts. Ninety-nine percent of the named genes expressed in the LCLs were also expressed in brain. Key pathways affected by ethanol include cytokine, TNF, and NF\u03baB signaling. Among the genes affected by ethanol were ANK3, EPHB1, SLC1A1, SLC9A9, NRD1, and SH3BP5, which were reported to be associated with alcoholism or related phenotypes in 2 genome-wide association studies. Genes that either differed in expression between alcoholics and controls or were affected by ethanol exposure are candidates for further study.", "electronicPublicationDate": "2014-07-22", "language": "eng", "dateOfCompletion": "2015-06-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4730944?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4730944", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.alcohol.2014.07.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-09-01", "journal": {"medlineAbbreviation": "Alcohol", "isoabbreviation": "Alcohol", "title": "Alcohol (Fayetteville, N.Y.)", "issn": "0741-8329", "nlmid": "8502311", "essn": "1873-6823"}, "monthOfPublication": 9, "volume": "48", "yearOfPublication": 2014, "journalIssueId": 2201117, "issue": "6", "dateOfPublication": "2014 Sep"}}}, "ADAM9": {"19237226": {"pubYear": "2011", "dateOfCreation": "2010-11-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.24.-", "name": "ADAM9 protein, human"}, {"registryNumber": "0", "name": "Estrogens"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "50-28-2", "name": "Estradiol"}, {"registryNumber": "521-18-6", "name": "Dihydrotestosterone"}, {"registryNumber": "EC 3.4.24.-", "name": "ADAM Proteins"}]}, "authorString": "Cong L, Jia J.", "affiliation": "Department of Neurology, Xuan Wu Hospital of Capital Medical University, Beijing 100053, PR China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19237226", "inEPMC": "N", "authorList": {"author": [{"lastName": "Cong", "fullName": "Cong L", "firstName": "Lin", "initials": "L"}, {"lastName": "Jia", "fullName": "Jia J", "authorId": {"type": "ORCID", "value": "0000-0003-4624-0336"}, "firstName": "Jianping", "initials": "J"}]}, "title": "Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease.", "citedByCount": 2, "source": "MED", "pmid": "19237226", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4624-0336"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neuroblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dihydrotestosterone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Estradiol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Estrogens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Electrophoretic Mobility Shift Assay", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chi-Square Distribution", "majorTopic_YN": "N"}, {"descriptorName": "Transfection", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "ADAM Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-02-23", "doi": "10.1016/j.neurobiolaging.2009.01.001", "isOpenAccess": "N", "pageInfo": "54-62", "hasDbCrossReferences": "N", "abstractText": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the formation of amyloid beta-peptides (A\u03b2 peptides) and their deposition in the brain. A disintegrin and metalloproteinase (ADAM) 9 can cleave the amyloid precursor protein (APP) within the A\u03b2 domain and preclude generation of A\u03b2 peptides. We systematically screened ADAM9 gene promoter region and found four polymorphisms: -542C/T (rs10105311), -600A/C (rs7840270), -963A/G (rs6991968) and -1314T/C (rs7006414). The -1314C allele was over-represented in 345 healthy individuals when compared to that in 473 sporadic AD (SAD) patients (P=0.005) and constructed a relatively protective haplotype -542C/-600A/-963G/-1314C (OR=0.422, 95% CI 0.229-0.779). Luciferase reporter assay indicated that both -963G/-1314C and -963A/-1314C had higher transcriptional activity (1.5- to 1.8-fold and 1.4- to 1.7-fold respectively) than -963A/-1314T. Electrophoretic mobility shift assay (EMSA) revealed that the -1314C allele bound nuclear factors more strongly than the -1314T allele. Additionally, increased ADAM9 transcriptional activity was seen under estrogen treatment. Our data suggest that promoter polymorphisms which regulate ADAM9 transcription are protective against SAD.", "electronicPublicationDate": "2009-02-23", "language": "eng", "dateOfCompletion": "2011-03-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neurobiolaging.2009.01.001", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Neurobiol Aging", "isoabbreviation": "Neurobiol. Aging", "title": "Neurobiology of aging", "issn": "0197-4580", "nlmid": "8100437", "essn": "1558-1497"}, "monthOfPublication": 1, "volume": "32", "yearOfPublication": 2011, "journalIssueId": 1785649, "issue": "1", "dateOfPublication": "2011 Jan"}}, "21197111": {"pubYear": "2010", "dateOfCreation": "2011-01-03", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.24.-", "name": "ADAM Proteins"}]}, "authorString": "Hodgkinson LM, Wang L, Duncan G, Edwards DR, Wormstone IM.", "affiliation": "School of Biological Sciences, University of East Anglia, Norwich, UK. lisa.hodg@hotmail.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council"}]}, "hasPDF": "Y", "id": "21197111", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Hodgkinson", "fullName": "Hodgkinson LM", "firstName": "Lisa M", "initials": "LM"}, {"lastName": "Wang", "fullName": "Wang L", "firstName": "Lixin", "initials": "L"}, {"lastName": "Duncan", "fullName": "Duncan G", "firstName": "George", "initials": "G"}, {"lastName": "Edwards", "fullName": "Edwards DR", "firstName": "Dylan R", "initials": "DR"}, {"lastName": "Wormstone", "fullName": "Wormstone IM", "firstName": "I Michael", "initials": "IM"}]}, "title": "ADAM and ADAMTS gene expression in native and wound healing human lens epithelial cells.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "21197111", "abstractText": " PURPOSE: The ADAMs (a disintegrin and metalloproteinase) and the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin-like motifs) are extracellular proteases that mediate cellular interactions and cell signaling via the modulation of adhesion and the cleavage of cell surface protein ectodomains and extracellular matrix molecules. Gene expression profiling was undertaken to better understand the role of the ADAM and ADAMTS families in the clear native human lenses and following surgical injury with particular relevance to posterior capsule opacification. METHODS: To carry out profile analysis, the lens (t=0d) was dissected into three regions; anterior epithelia, equatorial region, and fiber cells. Capsular bag culture was undertaken as a means of assessing short-term changes (t=6d) and post-cataractous lens capsular bags (ex vivo) were used to predict long-term changes in ADAM/ADAMTS gene expression. RNA was isolated and quantitative real-time (TaqMan) reverse transcription-PCR (RT-PCR) performed. Data were analyzed in terms of cycle threshold number (C(T)) and also normalized relative to endogenous 18S rRNA. RESULTS: High expression of ADAM-9, -10, -15, and -17 was detected in all native lens regions. ADAM-15 expression was a characteristic of the native lens epithelia more than the fibers. Post-surgical injury, lens capsular bags showed a positive shift in ADAM/ADAMTS expression that was significant for ADAM-9, -15, and ADAMTS-3. Ex vivo capsular bags, with a long-term post surgical injury period, maintained high expression of ADAM-9 and -10 genes. CONCLUSIONS: The native human lens expresses ADAM and ADAMTS genes that are differentially regulated following surgical injury. Roles in maintaining cellular adhesion may be of particular importance to native lens tissue integrity and may be lost in the lens wound healing response following cataract surgery.", "tmAccessionTypeList": {"accessionType": ["refseq"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lens, Crystalline", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epithelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Wound Healing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Enzymologic", "majorTopic_YN": "Y"}, {"descriptorName": "Stress, Mechanical", "majorTopic_YN": "N"}, {"descriptorName": "Reference Standards", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "ADAM Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2010-12-15", "language": "eng", "isOpenAccess": "Y", "pageInfo": "2765-2776", "pmcid": "PMC3008711", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "electronicPublicationDate": "2010-12-15", "license": "cc by", "dateOfCompletion": "2011-02-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3008711?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3008711", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21197111", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21197111&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"title": "Molecular vision", "medlineAbbreviation": "Mol Vis", "isoabbreviation": "Mol. Vis.", "nlmid": "9605351", "essn": "1090-0535"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2010, "journalIssueId": 1687844, "dateOfPublication": "2010 "}}, "26592768": {"pubYear": "2016", "dateOfCreation": "2015-12-16", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.24.-", "name": "ADAM9 protein, human"}, {"registryNumber": "0", "name": "Estrogens"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Protein Isoforms"}, {"registryNumber": "0", "name": "Estrogen Receptor alpha"}, {"registryNumber": "0", "name": "Estrogen Receptor beta"}, {"registryNumber": "EC 3.4.24.-", "name": "ADAM Proteins"}]}, "authorString": "Shen B, Wang Y, Wang X, Du Y, Guo S, Cong L.", "affiliation": "Department of Urology, Shandong Provincial Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "26592768", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Urology, Shandong Provincial Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, China.", "fullName": "Shen B", "initials": "B", "firstName": "Bin", "lastName": "Shen"}, {"affiliation": "Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China.", "fullName": "Wang Y", "initials": "Y", "firstName": "Yongxiang", "lastName": "Wang"}, {"affiliation": "Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China.", "fullName": "Wang X", "initials": "X", "firstName": "Xiang", "lastName": "Wang"}, {"affiliation": "Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China.", "fullName": "Du Y", "initials": "Y", "firstName": "Yifeng", "lastName": "Du"}, {"affiliation": "Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China.", "fullName": "Guo S", "initials": "S", "firstName": "Shougang", "lastName": "Guo"}, {"affiliation": "Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China. Electronic address: conglin667@163.com.", "fullName": "Cong L", "initials": "L", "firstName": "Lin", "lastName": "Cong"}]}, "title": "Estrogen induced the expression of ADAM9 through estrogen receptor \u03b1 but not estrogen receptor \u03b2 in cultured human neuronal cells.", "citedByCount": 0, "source": "MED", "pmid": "26592768", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Isoforms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Estrogen Receptor alpha", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Estrogen Receptor beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Estrogens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "ADAM Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-11-16", "doi": "10.1016/j.gene.2015.11.014", "isOpenAccess": "N", "pageInfo": "823-827", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Alzheimer's disease", "ER\u03b2", "SH-SY5Y cells", "Er\u03b1", "Adam9"]}, "abstractText": "To investigate the induction of 'a disintegrin and metalloprotease' 9 (ADAM9) by which estrogen receptor (ER) subtypes and estrogen regulation of expression in cultured human neuronal cells.SH-SY5Y cells were treated with E2 and the expression of ADAM9 were detected by RT-PCR and Western blot analysis. The peGFP-C3-ER\u03b1 and peGFP-C3-ER\u03b2 vectors were constructed and transfected into SH-SY5Y cells. Then, the mRNA and protein expression level of ADAM9 were detected by RT-PCR and Western blot analyses with the treatment of E2. E2, the ER\u03b1 agonist PPT, the ER\u03b2 agonist DPN and the non-specific ER antagonist ICI 182,780 were added, and the expression of ADAM9 protein and transcriptional activities of ADAM9 promoter were detected by Western blot and luciferase assays, respectively.E2 induced ADAM9 expression with a time-dependent manner in SHSY5Y cells, reaching the peak at 24h. peGFP-C3-ER\u03b1 transfection significantly increased ADAM9 expression in the presence of E2, whereas peGFP-C3-ER\u03b2 had no effect. The E2-induced overexpression of ADAM9 protein was downregulated by ICI 182,780. PPT significantly increased ADAM9 protein expression, whereas DPN had no effect. The E2-induced increase in the transcriptional activities of the ADAM9 promoter was downregulated by ICI 182,780. PPT significantly increased the transcriptional activities of the ADAM9 promoter, whereas DPN had no effect.Activation of ER\u03b1 but not ER\u03b2 increases ADAM9 expression in cultured human neuronal cells, implicating that ER\u03b1-activation functions in the direct mechanism underlying the estrogen-mediated preventative effects against A\u03b2 production and further reduction in the risk of Alzheimer's disease.", "electronicPublicationDate": "2015-11-24", "language": "eng", "dateOfCompletion": "2016-05-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.gene.2015.11.014", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-02-01", "journal": {"medlineAbbreviation": "Gene", "isoabbreviation": "Gene", "title": "Gene", "issn": "0378-1119", "nlmid": "7706761", "essn": "1879-0038"}, "monthOfPublication": 2, "volume": "576", "yearOfPublication": 2016, "journalIssueId": 2354770, "issue": "2 Pt 2", "dateOfPublication": "2016 Feb"}}, "25091951": {"pubYear": "2014", "dateOfCreation": "2014-11-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.24.-", "name": "ADAM9 protein, human"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "RNA Splice Sites"}, {"registryNumber": "EC 3.4.24.-", "name": "ADAM Proteins"}]}, "authorString": "El-Haig WM, Jakobsson C, Favez T, Schorderet DF, Abouzeid H.", "affiliation": "Department of Ophthalmology, Zagazig University, Zagazig, Egypt.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "25091951", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Ophthalmology, Zagazig University, Zagazig, Egypt.", "fullName": "El-Haig WM", "initials": "WM", "firstName": "Wael M", "lastName": "El-Haig"}, {"affiliation": "IRO-Institute for Research in Ophthalmology, Sion, Switzerland Department of Ophthalmology, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.", "fullName": "Jakobsson C", "initials": "C", "firstName": "Cecilia", "lastName": "Jakobsson"}, {"affiliation": "IRO-Institute for Research in Ophthalmology, Sion, Switzerland.", "fullName": "Favez T", "initials": "T", "firstName": "Tatiana", "lastName": "Favez"}, {"affiliation": "IRO-Institute for Research in Ophthalmology, Sion, Switzerland Department of Ophthalmology, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland EPFL-Facult\u00e9 des Sciences du Vivant, Ecole polytechnique f\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland.", "fullName": "Schorderet DF", "initials": "DF", "firstName": "Daniel F", "lastName": "Schorderet"}, {"affiliation": "IRO-Institute for Research in Ophthalmology, Sion, Switzerland Department of Ophthalmology, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.", "fullName": "Abouzeid H", "initials": "H", "firstName": "Hana", "lastName": "Abouzeid"}]}, "title": "Novel ADAM9 homozygous mutation in a consanguineous Egyptian family with severe cone-rod dystrophy and cataract.", "citedByCount": 0, "source": "MED", "pmid": "25091951", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Retinitis Pigmentosa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA Splice Sites", "majorTopic_YN": "N"}, {"descriptorName": "Fluorescein Angiography", "majorTopic_YN": "N"}, {"descriptorName": "Electroretinography", "majorTopic_YN": "N"}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Consanguinity", "majorTopic_YN": "Y"}, {"descriptorName": "Homozygote", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Recessive", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Exons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Egypt", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "ADAM Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-08-04", "doi": "10.1136/bjophthalmol-2014-305231", "isOpenAccess": "N", "pageInfo": "1718-1723", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Retina", "Genetics", "Vision", "Dystrophy"]}, "abstractText": "OBJECTIVE: To genetically and phenotypically describe a new ADAM9 homozygous mutation in a consanguineous family from Egypt with autosomal recessive cone-rod dystrophy (arCRD), anterior polar and posterior subcapsular cataract. DESIGN, SETTING AND PARTICIPANTS: The parents and their six children were included. They underwent a complete ophthalmic examination with fundus photography and optical coherence tomography (OCT). INTERVENTION: DNA was extracted from peripheral blood from all family members. Screening for mutations in genes known to be implicated in retinal disorders was done with the IROme, an in-solution enrichment array, followed by high-throughput sequencing. Validation of the results was done by bidirectional Sanger sequencing of ADAM9 exon 14, including exon-intron junctions. Screening of normal controls was done by denaturing high-performance liquid chromatography. RESULTS: arCRD was diagnosed in the mother and two of her children. Bilateral anterior polar and posterior subcapsular cataract was observed in the mother and bilateral dot cataract was diagnosed in three of the four children not affected with arCRD, one of whom also had glaucoma. The characteristics of the arCRD were childhood-onset visual impairment, reorganisation of the retinal pigment epithelium with mid-periphery greyish-white discolouration, attenuated retinal vasculatur and optic disc pallor. A coloboma-like macular lesion was observed in one of the arCRD-affected children. IROme analysis identified a c.1396-2A>G homozygous mutation in the splice acceptor site of intron 13 of ADAM9. This mutation was homozygous in the two children affected by arCRD and in their affected mother. This mutation was heterozygous in the unaffected father and the four unaffected children. CONCLUSIONS AND RELEVANCE: We identified a novel autosomal recessive ADAM9 mutation causing arCRD in a consanguineous Egyptian family. The percentage of arCRD cases caused by mutation in ADAM9 remains to be determined. Few families are reported in the literature to date; hence extensive clinical descriptions of families with ADAM9 mutations are of significant importance.", "electronicPublicationDate": "2014-08-04", "language": "eng", "dateOfCompletion": "2015-02-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1136/bjophthalmol-2014-305231", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-12-01", "journal": {"medlineAbbreviation": "Br J Ophthalmol", "isoabbreviation": "Br J Ophthalmol", "title": "The British journal of ophthalmology", "issn": "0007-1161", "nlmid": "0421041", "essn": "1468-2079"}, "monthOfPublication": 12, "volume": "98", "yearOfPublication": 2014, "journalIssueId": 2220310, "issue": "12", "dateOfPublication": "2014 Dec"}}, "21956108": {"pubYear": "2011", "dateOfCreation": "2011-11-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.24.-", "name": "ADAM9 protein, human"}, {"registryNumber": "EC 3.4.24.81", "name": "ADAM10 protein, human"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Protease Inhibitors"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "EC 3.4.-", "name": "Amyloid Precursor Protein Secretases"}, {"registryNumber": "EC 3.4.24.-", "name": "ADAM Proteins"}]}, "authorString": "Moss ML, Powell G, Miller MA, Edwards L, Qi B, Sang QX, De Strooper B, Tesseur I, Lichtenthaler SF, Taverna M, Zhong JL, Dingwall C, Ferdous T, Schlomann U, Zhou P, Griffith LG, Lauffenburger DA, Petrovich R, Bartsch JW.", "affiliation": "BioZyme Inc., Apex, North Carolina 27523, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "EB", "orderIn": 0, "agency": "NIBIB NIH HHS", "grantId": "R01 EB010246"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01GM081336"}, {"acronym": "EB", "orderIn": 0, "agency": "NIBIB NIH HHS", "grantId": "R01EB010246"}]}, "hasPDF": "N", "id": "21956108", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Moss", "fullName": "Moss ML", "firstName": "Marcia L", "initials": "ML"}, {"lastName": "Powell", "fullName": "Powell G", "firstName": "Gary", "initials": "G"}, {"lastName": "Miller", "fullName": "Miller MA", "firstName": "Miles A", "initials": "MA"}, {"lastName": "Edwards", "fullName": "Edwards L", "firstName": "Lori", "initials": "L"}, {"lastName": "Qi", "fullName": "Qi B", "firstName": "Bin", "initials": "B"}, {"lastName": "Sang", "fullName": "Sang QX", "firstName": "Qing-Xiang Amy", "initials": "QX"}, {"lastName": "De Strooper", "fullName": "De Strooper B", "firstName": "Bart", "initials": "B"}, {"lastName": "Tesseur", "fullName": "Tesseur I", "firstName": "Ina", "initials": "I"}, {"lastName": "Lichtenthaler", "fullName": "Lichtenthaler SF", "firstName": "Stefan F", "initials": "SF"}, {"lastName": "Taverna", "fullName": "Taverna M", "firstName": "Mara", "initials": "M"}, {"lastName": "Zhong", "fullName": "Zhong JL", "firstName": "Julia Li", "initials": "JL"}, {"lastName": "Dingwall", "fullName": "Dingwall C", "firstName": "Colin", "initials": "C"}, {"lastName": "Ferdous", "fullName": "Ferdous T", "firstName": "Taheera", "initials": "T"}, {"lastName": "Schlomann", "fullName": "Schlomann U", "firstName": "Uwe", "initials": "U"}, {"lastName": "Zhou", "fullName": "Zhou P", "firstName": "Pei", "initials": "P"}, {"lastName": "Griffith", "fullName": "Griffith LG", "firstName": "Linda G", "initials": "LG"}, {"lastName": "Lauffenburger", "fullName": "Lauffenburger DA", "firstName": "Douglas A", "initials": "DA"}, {"lastName": "Petrovich", "fullName": "Petrovich R", "firstName": "Robert", "initials": "R"}, {"lastName": "Bartsch", "fullName": "Bartsch JW", "firstName": "J\u00f6rg W", "initials": "JW"}]}, "title": "ADAM9 inhibition increases membrane activity of ADAM10 and controls \u03b1-secretase processing of amyloid precursor protein.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "21956108", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Cell Membrane", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protease Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Array Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Protein Structure, Tertiary", "majorTopic_YN": "N"}, {"descriptorName": "ADAM Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid Precursor Protein Secretases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biocatalysis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-09-28", "doi": "10.1074/jbc.m111.280495", "isOpenAccess": "N", "pageInfo": "40443-40451", "pmcid": "PMC3220463", "hasDbCrossReferences": "Y", "abstractText": "Prodomains of A disintegrin and metalloproteinase (ADAM) metallopeptidases can act as highly specific intra- and intermolecular inhibitors of ADAM catalytic activity. The mouse ADAM9 prodomain (proA9; amino acids 24-204), expressed and characterized from Escherichia coli, is a competitive inhibitor of human ADAM9 catalytic/disintegrin domain with an overall inhibition constant of 280 \u00b1 34 nM and high specificity toward ADAM9. In SY5Y neuroblastoma cells overexpressing amyloid precursor protein, proA9 treatment reduces the amount of endogenous ADAM10 enzyme in the medium while increasing membrane-bound ADAM10, as shown both by Western and activity assays with selective fluorescent peptide substrates using proteolytic activity matrix analysis. An increase in membrane-bound ADAM10 generates higher levels of soluble amyloid precursor protein \u03b1 in the medium, whereas soluble amyloid precursor protein \u03b2 levels are decreased, demonstrating that inhibition of ADAM9 increases \u03b1-secretase activity on the cell membrane. Quantification of physiological ADAM10 substrates by a proteomic approach revealed that substrates, such as epidermal growth factor (EGF), HER2, osteoactivin, and CD40-ligand, are increased in the medium of BT474 breast tumor cells that were incubated with proA9, demonstrating that the regulation of ADAM10 by ADAM9 applies for many ADAM10 substrates. Taken together, our results demonstrate that ADAM10 activity is regulated by inhibition of ADAM9, and this regulation may be used to control shedding of amyloid precursor protein by enhancing \u03b1-secretase activity, a key regulatory step in the etiology of Alzheimer disease.", "electronicPublicationDate": "2011-09-28", "language": "eng", "dateOfCompletion": "2012-01-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3220463", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21956108", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1074/jbc.M111.280495", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-11-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 11, "volume": "286", "yearOfPublication": 2011, "journalIssueId": 1882316, "issue": "47", "dateOfPublication": "2011 Nov"}}, "14551530": {"pubYear": "2003", "dateOfCreation": "2003-10-10", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA Primers"}]}, "authorString": "Hawse JR, Hejtmancik JF, Huang Q, Sheets NL, Hosack DA, Lempicki RA, Horwitz J, Kantorow M.", "affiliation": "Biomedical Sciences, Florida Atlantic University, Boca Raton, FL 33431-0991, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, P.H.S.", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY03897"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY013022-04"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY013022"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY13022"}]}, "hasPDF": "Y", "id": "14551530", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Biomedical Sciences, Florida Atlantic University, Boca Raton, FL 33431-0991, USA.", "fullName": "Hawse JR", "initials": "JR", "firstName": "John R", "lastName": "Hawse"}, {"lastName": "Hejtmancik", "fullName": "Hejtmancik JF", "firstName": "James F", "initials": "JF"}, {"lastName": "Huang", "fullName": "Huang Q", "firstName": "Quingling", "initials": "Q"}, {"lastName": "Sheets", "fullName": "Sheets NL", "firstName": "Nancy L", "initials": "NL"}, {"lastName": "Hosack", "fullName": "Hosack DA", "firstName": "Douglas A", "initials": "DA"}, {"lastName": "Lempicki", "fullName": "Lempicki RA", "authorId": {"type": "ORCID", "value": "0000-0002-7059-409X"}, "firstName": "Richard A", "initials": "RA"}, {"lastName": "Horwitz", "fullName": "Horwitz J", "firstName": "Joseph", "initials": "J"}, {"lastName": "Kantorow", "fullName": "Kantorow M", "firstName": "Marc", "initials": "M"}]}, "title": "Identification and functional clustering of global gene expression differences between human age-related cataract and clear lenses.", "hasSuppl": "N", "citedByCount": 30, "source": "MED", "pmid": "14551530", "abstractText": "PURPOSE: Age-related cataract is a multi-factorial disease with a poorly understood etiology. Numerous studies provide evidence that the human eye lens has evolved specific regulatory and protective systems to ameliorate lens damage associated with cataract. Other studies suggest that the presence of cataract is associated with the altered expression of specific genes including metallothionein IIa, osteonectin, transglutaminase 2, betaig-h3, multiple ribosomal proteins, ADAM9, and protein phosphatase 2A. Here, we sought to identify further gene expression changes that are associated with cataract and to cluster the identified genes into specific biological pathways. METHODS: Oligonucleotide microarray hybridization was used to analyze the full complement of gene expression differences between lens epithelia isolated from human age-related cataract relative to clear lenses. The expression levels of a subset of the identified genes were further evaluated by semi-quantitative RT-PCR. The identified genes were functionally clustered into specific categories and the probability of over-representation of each category was determined using the computer program EASE. RESULTS: 412 transcripts were observed to be increased and 919 transcripts were observed to be decreased by 2 fold or more in lens epithelia isolated from age-related cataract relative to clear lenses. Of these, 74 were increased and 241 were decreased at the 5 fold level or greater. Seventeen genes selected for further confirmation exhibited similar trends in expression when examined by RT-PCR using both the original and separately prepared clear and cataract RNA populations. Functional clustering of the identified genes using the EASE bioinformatics software package revealed that, among others, transcripts increased in cataract are associated with transcriptional control, chromosomal organization, ionic and cytoplasmic transport, and extracellular matrix components while transcripts decreased in cataract are associated with protein synthesis, defense against oxidative stress, heat-shock/chaperone activity, structural components of the lens, and cell cycle control. CONCLUSIONS: These data suggest that cataract is associated with multiple previously identified and novel changes in lens epithelial gene expression and they point to numerous pathways likely to play important roles in lens protection, maintenance, and age-related cataract.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7059-409X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lens, Crystalline", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epithelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "Y"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2003-10-07", "isOpenAccess": "N", "pageInfo": "515-537", "pmcid": "PMC2831407", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "electronicPublicationDate": "2003-10-07", "language": "eng", "dateOfCompletion": "2003-12-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2831407?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2831407", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=14551530&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=14551530", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-09-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2003-10-01", "journal": {"title": "Molecular vision", "medlineAbbreviation": "Mol Vis", "isoabbreviation": "Mol. Vis.", "nlmid": "9605351", "essn": "1090-0535"}, "monthOfPublication": 10, "volume": "9", "yearOfPublication": 2003, "journalIssueId": 1163054, "dateOfPublication": "2003 Oct"}}, "23761811": {"pubYear": "2013", "dateOfCreation": "2013-06-13", "pubModel": "Print-Electronic", "authorString": "Zhang J, Qi J, Chen N, Fu W, Zhou B, He A.", "affiliation": "Department of Molecular Targeted Therapeutics, China Medical University Lung Cancer Center, The First Hospital of China Medical University, Shenyang, P.R. China ; Department of Thoracic Surgery 1, China Medical University Lung Cancer Center, The First Hospital of China Medical University, Shenyang, P.R. China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23761811", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Molecular Targeted Therapeutics, China Medical University Lung Cancer Center, The First Hospital of China Medical University, Shenyang, P.R. China ; Department of Thoracic Surgery 1, China Medical University Lung Cancer Center, The First Hospital of China Medical University, Shenyang, P.R. China.", "fullName": "Zhang J", "initials": "J", "firstName": "Jun", "lastName": "Zhang"}, {"lastName": "Qi", "fullName": "Qi J", "firstName": "Juan", "initials": "J"}, {"lastName": "Chen", "fullName": "Chen N", "firstName": "Ning", "initials": "N"}, {"lastName": "Fu", "fullName": "Fu W", "firstName": "Weineng", "initials": "W"}, {"lastName": "Zhou", "fullName": "Zhou B", "firstName": "Baosen", "initials": "B"}, {"lastName": "He", "fullName": "He A", "firstName": "Anguang", "initials": "A"}]}, "title": "High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "23761811", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-02-22", "language": "eng", "doi": "10.3892/ol.2013.1209", "isOpenAccess": "Y", "pageInfo": "1461-1466", "pmcid": "PMC3678878", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Immunohistochemistry", "Prognosis", "Lung neoplasm", "Lobectomy", "Adam9"]}, "abstractText": "The aim of this study was to investigate the abnormal expression of a disintegrin and metalloproteinase-9 (ADAM9) in human resected non-small cell lung cancer (NSCLC) tissue, in order to evaluate the significance of ADAM9 expression in surgically resected NSCLC. Sixty-four cases of completely resected stage I NSCLC with mediastinal N2 lymph node dissection were immunohistochemically analyzed for ADAM9 protein expression. Survival, univariate and multivariate analyses were conducted to assess the significance of ADAM9 expression and its correlation with other clinicopathological characteristics. ADAM9 was observed to be significantly more highly expressed in NSCLC tissue compared with normal control lung tissue (P=0.001). The 5-year survival rate for patients with NSCLC tissues highly expressing ADAM9 was significantly lower when compared with NSCLC tissues of patients exhibiting low expression of ADAM9 (56.9 vs. 88.9%, P= 0.012). Multivariate analysis identified that high expression of ADAM9 is an independent factor of shortened survival time in resected stage I NSCLC (HR, 3.385; 95% CI, 1.224-9.360; P=0.019). These results clearly demonstrate that ADAM9 is highly expressed in NSCLC and highly expressed ADAM9 correlates with shortened survival time, suggesting that ADAM9 is a novel biomarker for predicting prognosis in resected stage I NSCLC. ADAM9 may also become a useful predictive biomarker for the selection of adjuvant chemotherapy treatment of NSCLC.", "electronicPublicationDate": "2013-02-22", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3678878?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3678878", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3892/ol.2013.1209", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-05-01", "journal": {"medlineAbbreviation": "Oncol Lett", "isoabbreviation": "Oncol Lett", "title": "Oncology letters", "issn": "1792-1074", "nlmid": "101531236", "essn": "1792-1082"}, "monthOfPublication": 5, "volume": "5", "yearOfPublication": 2013, "journalIssueId": 2048388, "issue": "5", "dateOfPublication": "2013 May"}}}, "HSPA1L": {"18813331": {"pubYear": "2009", "dateOfCreation": "2009-02-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSP72 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSPA1B protein, human"}]}, "authorString": "Konings A, Van Laer L, Michel S, Pawelczyk M, Carlsson PI, Bondeson ML, Rajkowska E, Dudarewicz A, Vandevelde A, Fransen E, Huyghe J, Borg E, Sliwinska-Kowalska M, Van Camp G.", "affiliation": "Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Action on Hearing Loss", "grantId": "G26"}]}, "hasPDF": "Y", "id": "18813331", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Konings", "fullName": "Konings A", "firstName": "Annelies", "initials": "A"}, {"lastName": "Van Laer", "fullName": "Van Laer L", "firstName": "Lut", "initials": "L"}, {"lastName": "Michel", "fullName": "Michel S", "firstName": "Sophie", "initials": "S"}, {"lastName": "Pawelczyk", "fullName": "Pawelczyk M", "firstName": "Malgorzata", "initials": "M"}, {"lastName": "Carlsson", "fullName": "Carlsson PI", "authorId": {"type": "ORCID", "value": "0000-0001-6667-9923"}, "firstName": "Per-Inge", "initials": "PI"}, {"lastName": "Bondeson", "fullName": "Bondeson ML", "firstName": "Marie-Louise", "initials": "ML"}, {"lastName": "Rajkowska", "fullName": "Rajkowska E", "firstName": "Elzbieta", "initials": "E"}, {"lastName": "Dudarewicz", "fullName": "Dudarewicz A", "firstName": "Adam", "initials": "A"}, {"lastName": "Vandevelde", "fullName": "Vandevelde A", "firstName": "Ann", "initials": "A"}, {"lastName": "Fransen", "fullName": "Fransen E", "firstName": "Erik", "initials": "E"}, {"lastName": "Huyghe", "fullName": "Huyghe J", "firstName": "Jeroen", "initials": "J"}, {"lastName": "Borg", "fullName": "Borg E", "firstName": "Erik", "initials": "E"}, {"lastName": "Sliwinska-Kowalska", "fullName": "Sliwinska-Kowalska M", "firstName": "Mariola", "initials": "M"}, {"lastName": "Van Camp", "fullName": "Van Camp G", "authorId": {"type": "ORCID", "value": "0000-0001-5105-9000"}, "firstName": "Guy", "initials": "G"}]}, "title": "Variations in HSP70 genes associated with noise-induced hearing loss in two independent populations.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "18813331", "abstractText": "Noise-induced hearing loss (NIHL) is one of the most important occupational health hazards. Millions of people worldwide are exposed daily to harmful levels of noise. NIHL is a complex disease resulting from an interaction between genetic and environmental factors. Although the environmental risk factors have been studied extensively, little is known about the genetic factors. Heat-shock proteins (HSPs) are induced after exposure to severe noise. When first induced by exposure to moderate sound levels, they can protect the ear from damage from excessive noise exposure. This protection is highly variable between individuals. An association of HSP70 genes with NIHL has been described by Yang et al (2006) in a Chinese sample set of noise-exposed workers. In this study, three polymorphisms (rs1043618, rs1061581 and rs2227956) in HSP70-1, HSP70-2 and HSP70-hom, respectively, were genotyped in 206 Swedish and 238 Polish DNA samples of noise-exposed subjects and analyzed. One SNP, rs2227956 in HSP70-hom, resulted in a significant association with NIHL in both sample sets. In addition, rs1043618 and rs1061581 were significant in the Swedish sample set. Analysis of the haplotypes composed of the three SNPs revealed significant associations between NIHL and haplotype GAC in both sample sets and with haplotype CGT in the Swedish sample set. In conclusion, this study replicated the association of HSP70 genes with NIHL in a second and third independent noise-exposed sample set, hereby adding to the evidence that HSP70 genes may be NIHL susceptibility genes.", "tmAccessionTypeList": {"accessionType": ["refsnp", " omim", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6667-9923"}, {"type": "ORCID", "value": "0000-0001-5105-9000"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hearing Loss, Noise-Induced", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Genetics, Population", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP72 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2008-09-24", "doi": "10.1038/ejhg.2008.172", "isOpenAccess": "N", "pageInfo": "329-335", "pmcid": "PMC2986160", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "electronicPublicationDate": "2008-09-24", "language": "eng", "dateOfCompletion": "2009-04-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2986160?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2986160", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=18813331&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=18813331", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/ejhg.2008.172", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-05", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-03-01", "journal": {"medlineAbbreviation": "Eur J Hum Genet", "isoabbreviation": "Eur. J. Hum. Genet.", "title": "European journal of human genetics : EJHG", "issn": "1018-4813", "nlmid": "9302235", "essn": "1476-5438"}, "monthOfPublication": 3, "volume": "17", "yearOfPublication": 2009, "journalIssueId": 1599117, "issue": "3", "dateOfPublication": "2009 Mar"}}, "17428599": {"pubYear": "2007", "dateOfCreation": "2007-05-31", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPA1A protein, human"}, {"registryNumber": "9007-49-2", "name": "DNA"}, {"registryNumber": "0", "name": "Antidepressive Agents"}, {"registryNumber": "0", "name": "Genetic Markers"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}]}, "authorString": "Pae CU, Mandelli L, Serretti A, Patkar AA, Kim JJ, Lee CU, Lee SJ, Lee C, De Ronchi D, Paik IH.", "affiliation": "Department of Psychiatry, Kangnam St Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "17428599", "inEPMC": "N", "authorList": {"author": [{"lastName": "Pae", "fullName": "Pae CU", "firstName": "Chi-Un", "initials": "CU"}, {"lastName": "Mandelli", "fullName": "Mandelli L", "firstName": "Laura", "initials": "L"}, {"lastName": "Serretti", "fullName": "Serretti A", "firstName": "Alessandro", "initials": "A"}, {"lastName": "Patkar", "fullName": "Patkar AA", "firstName": "Ashwin A", "initials": "AA"}, {"lastName": "Kim", "fullName": "Kim JJ", "firstName": "Jung-Jin", "initials": "JJ"}, {"lastName": "Lee", "fullName": "Lee CU", "firstName": "Chang-Uk", "initials": "CU"}, {"lastName": "Lee", "fullName": "Lee SJ", "firstName": "Soo-Jung", "initials": "SJ"}, {"lastName": "Lee", "fullName": "Lee C", "firstName": "Chul", "initials": "C"}, {"lastName": "De Ronchi", "fullName": "De Ronchi D", "firstName": "Diana", "initials": "D"}, {"lastName": "Paik", "fullName": "Paik IH", "firstName": "In-Ho", "initials": "IH"}]}, "title": "Heat-shock protein-70 genes and response to antidepressants in major depression.", "citedByCount": 10, "source": "MED", "pmid": "17428599", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antidepressive Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N"}, {"descriptorName": "Hospitalization", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Depressive Disorder, Major", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychiatric Status Rating Scales", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-02-27", "doi": "10.1016/j.pnpbp.2007.02.011", "isOpenAccess": "N", "pageInfo": "1006-1011", "hasDbCrossReferences": "Y", "abstractText": "In the search of predictors of antidepressant efficacy, much interest has recently focused on pro-inflammatory proteins, as they were found to be elevated during major depressives states and decreased by antidepressant drugs. In the present paper we investigated the role of the genes coding for heat-shock-70 family proteins, recently hypothesized to be activated by antidepressants and thus mediate the reduction of pro-inflammatory cytosines. One hundred and forty two hospitalised patients, affected by major depression and treated with antidepressants drugs for a major depressive episode were evaluated for depressive severity at the baseline and at the discharge and genotyped for five SNPs within the genes HSPA1L, HSPA1A and HSPA1B. Markers were not individually associated with symptom severity after treatment. Instead, we found a three markers haplotype, including SNPs within HSPA1L and HSPA1A, associated with a poorer response to antidepressant treatment (p=0.005). Single markers as well as haplotypes were not associated with other clinical features. In conclusion, genetic variants within the genes coding for HSP-70 family proteins may affect the action of antidepressants and thus their therapeutic efficacy.", "electronicPublicationDate": "2007-02-27", "language": "eng", "dateOfCompletion": "2007-08-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pnpbp.2007.02.011", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-06-01", "journal": {"medlineAbbreviation": "Prog Neuropsychopharmacol Biol Psychiatry", "isoabbreviation": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "title": "Progress in neuro-psychopharmacology & biological psychiatry", "issn": "0278-5846", "nlmid": "8211617", "essn": "1878-4216"}, "monthOfPublication": 6, "volume": "31", "yearOfPublication": 2007, "journalIssueId": 1398486, "issue": "5", "dateOfPublication": "2007 Jun"}}, "15963589": {"pubYear": "2005", "dateOfCreation": "2005-08-01", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}]}, "authorString": "Pae CU, Kim TS, Kwon OJ, Artioli P, Serretti A, Lee CU, Lee SJ, Lee C, Paik IH, Kim JJ.", "affiliation": "Department of Psychiatry, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Republic of Korea.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "N", "id": "15963589", "inEPMC": "N", "authorList": {"author": [{"lastName": "Pae", "fullName": "Pae CU", "firstName": "Chi-Un", "initials": "CU"}, {"lastName": "Kim", "fullName": "Kim TS", "firstName": "Tae-Suk", "initials": "TS"}, {"lastName": "Kwon", "fullName": "Kwon OJ", "firstName": "Oh-Joo", "initials": "OJ"}, {"lastName": "Artioli", "fullName": "Artioli P", "firstName": "Paola", "initials": "P"}, {"lastName": "Serretti", "fullName": "Serretti A", "firstName": "Alessandro", "initials": "A"}, {"lastName": "Lee", "fullName": "Lee CU", "firstName": "Chang-Uk", "initials": "CU"}, {"lastName": "Lee", "fullName": "Lee SJ", "firstName": "Soo-Jung", "initials": "SJ"}, {"lastName": "Lee", "fullName": "Lee C", "firstName": "Chul", "initials": "C"}, {"lastName": "Paik", "fullName": "Paik IH", "firstName": "In-Ho", "initials": "IH"}, {"lastName": "Kim", "fullName": "Kim JJ", "firstName": "Jung-Jin", "initials": "JJ"}]}, "title": "Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia.", "citedByCount": 16, "source": "MED", "pmid": "15963589", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Confidence Intervals", "majorTopic_YN": "N"}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Chi-Square Distribution", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2005-09-01", "doi": "10.1016/j.neures.2005.05.004", "isOpenAccess": "N", "pageInfo": "8-13", "hasDbCrossReferences": "Y", "abstractText": "The heat shock protein 70 (HSP70) is believed to be involved in the pathogenesis of schizophrenia with regards to neurodevelopment. An aberration in the HSP70 has been proposed in schizophrenia patients, suggesting that it is a candidate gene for schizophrenia. This study aimed to investigate the association between the three polymorphisms of HSP70-1 (HSPA1A), HSP70-hom (HSPA1L) and HSP70-2 (HSPA1B) and schizophrenia. One hundred and sixty-one patients with schizophrenia and 165 controls were enrolled in the study. A polymerase chain reaction (PCR) with a restriction fragment length enzyme (RFLP) was used to genotype the HSPA1A, HSPA1L and HSPA1B polymorphisms. There were no significant differences in the allelic or genotype frequencies of the HSPA1A and HSPA1L polymorphisms between the schizophrenia patients and the controls, while there was a marginal difference in the genotype frequency of the HSPA1B polymorphisms, and a significant difference in the allelic frequency of the HSPA1B polymorphisms between the schizophrenia patients and the controls. There was no evidence of an association between the clinical variables and schizophrenia across the genotypes among the three HSP70 gene polymorphisms. These results suggest that a HSPA1B polymorphism might be related to the pathogenesis of schizophrenia at least in the Korean population. Therefore, larger studies from different ethnic groups should be performed to confirm these results.", "language": "eng", "dateOfCompletion": "2005-10-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neures.2005.05.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-09-01", "journal": {"medlineAbbreviation": "Neurosci Res", "isoabbreviation": "Neurosci. Res.", "title": "Neuroscience research", "issn": "0168-0102", "nlmid": "8500749", "essn": "1872-8111"}, "monthOfPublication": 9, "volume": "53", "yearOfPublication": 2005, "journalIssueId": 1252365, "issue": "1", "dateOfPublication": "2005 Sep"}}, "19439993": {"pubYear": "2009", "dateOfCreation": "2009-06-09", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPA1A protein, human"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSPA1B protein, human"}, {"registryNumber": "0", "name": "HSPA1L protein, human"}]}, "authorString": "Pae CU, Drago A, Kim JJ, Mandelli L, De Ronchi D, Serretti A.", "affiliation": "Department of Psychiatry, Holy Family Hospital, Catholic University of Korea College of Medicine, Wonmi-Gu, Bucheon, Republic of Korea. pae@catholic.ac.kr", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19439993", "inEPMC": "N", "authorList": {"author": [{"lastName": "Pae", "fullName": "Pae CU", "firstName": "Chi-Un", "initials": "CU"}, {"lastName": "Drago", "fullName": "Drago A", "authorId": {"type": "ORCID", "value": "0000-0002-2529-7256"}, "firstName": "Antonio", "initials": "A"}, {"lastName": "Kim", "fullName": "Kim JJ", "firstName": "Jung-Jin", "initials": "JJ"}, {"lastName": "Mandelli", "fullName": "Mandelli L", "firstName": "Laura", "initials": "L"}, {"lastName": "De Ronchi", "fullName": "De Ronchi D", "firstName": "Diana", "initials": "D"}, {"lastName": "Serretti", "fullName": "Serretti A", "firstName": "Alessandro", "initials": "A"}]}, "title": "The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients.", "citedByCount": 9, "source": "MED", "pmid": "19439993", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2529-7256"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Hospitalization", "majorTopic_YN": "N"}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Multivariate Analysis", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychiatric Status Rating Scales", "majorTopic_YN": "N"}, {"descriptorName": "Age of Onset", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2009-05-12", "doi": "10.1159/000218075", "isOpenAccess": "N", "pageInfo": "135-141", "hasDbCrossReferences": "Y", "abstractText": "We previously investigated a group of single-nucleotide polymorphisms of a set of genes coding for heat shock proteins (HSPA1A, HSPA1B and HSPA1L) and found a significant association between one HSPA1B variation and schizophrenia (SZ). We now report an association between a set of variations (rs2227956, rs2075799, rs1043618, rs562047 and rs539689) within the same genes and a larger sample of schizophrenic inpatients. A single variation, rs539689 (HSPA1B), was found to be marginally associated with Positive and Negative Syndrome Scale (PANSS) positive scores at discharge, and haplotype analysis revealed a significant association between improvement in PANSS scores with both A-C-G-G and A-C-G-G haplotypes. These findings further support a role of heat shock proteins in the pathophysiology of SZ.", "electronicPublicationDate": "2009-05-12", "language": "eng", "dateOfCompletion": "2009-09-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1159/000218075", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"medlineAbbreviation": "Neuropsychobiology", "isoabbreviation": "Neuropsychobiology", "title": "Neuropsychobiology", "issn": "0302-282X", "nlmid": "7512895", "essn": "1423-0224"}, "monthOfPublication": 0, "volume": "59", "yearOfPublication": 2009, "journalIssueId": 1628584, "issue": "3", "dateOfPublication": "2009 "}}, "15592518": {"pubYear": "2005", "dateOfCreation": "2005-01-28", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "135844-47-2", "name": "Sp100 protein, human"}, {"registryNumber": "0", "name": "Autoantigens"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "0", "name": "Antigens, Nuclear"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "proto-oncogene proteins c-ets"}, {"registryNumber": "0", "name": "ETS1 protein, human"}, {"registryNumber": "0", "name": "Proto-Oncogene Protein c-ets-1"}]}, "authorString": "Yordy JS, Moussa O, Pei H, Chaussabel D, Li R, Watson DK.", "affiliation": "Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P01CA78582"}]}, "hasPDF": "N", "id": "15592518", "inEPMC": "N", "authorList": {"author": [{"lastName": "Yordy", "fullName": "Yordy JS", "firstName": "John S", "initials": "JS"}, {"lastName": "Moussa", "fullName": "Moussa O", "firstName": "Omar", "initials": "O"}, {"lastName": "Pei", "fullName": "Pei H", "firstName": "Huiping", "initials": "H"}, {"lastName": "Chaussabel", "fullName": "Chaussabel D", "authorId": {"type": "ORCID", "value": "0000-0002-6131-7242"}, "firstName": "Damien", "initials": "D"}, {"lastName": "Li", "fullName": "Li R", "firstName": "Runzhao", "initials": "R"}, {"lastName": "Watson", "fullName": "Watson DK", "firstName": "Dennis K", "initials": "DK"}]}, "title": "SP100 inhibits ETS1 activity in primary endothelial cells.", "citedByCount": 14, "source": "MED", "pmid": "15592518", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6131-7242"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Endothelium, Vascular", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Umbilical Veins", "majorTopic_YN": "N"}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antigens, Nuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N"}, {"descriptorName": "Autoantigens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Cell Division", "majorTopic_YN": "N"}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-ets", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Protein c-ets-1", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2005-01-01", "doi": "10.1038/sj.onc.1208245", "isOpenAccess": "N", "pageInfo": "916-931", "hasDbCrossReferences": "Y", "abstractText": "SP100 was first identified as a nuclear autoimmune antigen and is a constituent of the nuclear body. SP100 interacts with the ETS1 transcription factor, and we have previously shown that SP100 reduces ETS1-DNA binding and inhibits ETS1 transcriptional activity on the MMP1 and uPA promoters. We now demonstrate that SP100 expression is upregulated by interferons, which have been shown to be antiangiogenic, in primary endothelial cells. As ETS1 is functionally important in promoting angiogenesis, we tested the hypothesis that ETS1 activity is negatively modulated by SP100 in endothelial cells. SP100 directly antagonizes ETS1-mediated morphological changes in human umbilical vein endothelial cell (HUVEC) network formation and reduces HUVEC migration and invasion. To further understand the functional relationship between ETS1 and SP100, cDNA microarray analysis was utilized to assess reprogramming of gene expression by ETS1 and SP100. A subset of the differentially regulated genes, including heat-shock proteins (HSPs) H11, HSPA1L, HSPA6, HSPA8, HSPE1 and AXIN1, BRCA1, CD14, CTGF (connective tissue growth factor), GABRE (gamma-aminobutyric acid A receptor epsilon), ICAM1, SNAI1, SRD5A1 (steroid-5-alpha-reductase 1) and THY1, were validated by real-time PCR and a majority showed reciprocal expression in response to ETS1 and SP100. Interestingly, genes that are negatively regulated by ETS1 and upregulated by SP100 have antimigratory or antiangiogenic properties. Collectively, these data indicate that SP100 negatively modulates ETS1-dependent downstream biological processes.", "language": "eng", "dateOfCompletion": "2005-03-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/sj.onc.1208245", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-01-01", "journal": {"medlineAbbreviation": "Oncogene", "isoabbreviation": "Oncogene", "title": "Oncogene", "issn": "0950-9232", "nlmid": "8711562", "essn": "1476-5594"}, "monthOfPublication": 1, "volume": "24", "yearOfPublication": 2005, "journalIssueId": 1217273, "issue": "5", "dateOfPublication": "2005 Jan"}}, "23893339": {"pubYear": "2014", "dateOfCreation": "2014-02-25", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPA1A protein, human"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSPA1B protein, human"}, {"registryNumber": "0", "name": "HSPA1L protein, human"}]}, "authorString": "Kowalczyk M, Owczarek A, Suchanek R, Paul-Samojedny M, Fila-Danilow A, Borkowska P, Kucia K, Kowalski J.", "affiliation": "Department of Medical Genetics, Medical University of Silesia, Ostrogorska 30, 41-200, Sosnowiec, Poland, mary.kow@interia.pl.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "23893339", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Medical Genetics, Medical University of Silesia, Ostrogorska 30, 41-200, Sosnowiec, Poland, mary.kow@interia.pl.", "fullName": "Kowalczyk M", "initials": "M", "firstName": "Malgorzata", "lastName": "Kowalczyk"}, {"lastName": "Owczarek", "fullName": "Owczarek A", "firstName": "Aleksander", "initials": "A"}, {"lastName": "Suchanek", "fullName": "Suchanek R", "firstName": "Renata", "initials": "R"}, {"lastName": "Paul-Samojedny", "fullName": "Paul-Samojedny M", "firstName": "Monika", "initials": "M"}, {"lastName": "Fila-Danilow", "fullName": "Fila-Danilow A", "firstName": "Anna", "initials": "A"}, {"lastName": "Borkowska", "fullName": "Borkowska P", "firstName": "Paulina", "initials": "P"}, {"lastName": "Kucia", "fullName": "Kucia K", "firstName": "Krzysztof", "initials": "K"}, {"lastName": "Kowalski", "fullName": "Kowalski J", "firstName": "Jan", "initials": "J"}]}, "title": "Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "23893339", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia, Paranoid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Poland", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-07-28", "doi": "10.1007/s12192-013-0446-7", "isOpenAccess": "N", "pageInfo": "205-215", "pmcid": "PMC3933617", "hasDbCrossReferences": "Y", "abstractText": "HSP70 genes have been considered as promising schizophrenia candidate genes based on their protective role in the central nervous system under stress conditions. In this study, we analyzed the potential implication of HSPA1A +190G/C, HSPA1B +1267A/G, and HSPA1L +2437T/C polymorphisms in the susceptibility to paranoid schizophrenia in a homogenous Caucasian Polish population. In addition, we investigated the association of the polymorphisms with the clinical variables of the disease. Two hundred and three patients with paranoid schizophrenia and 243 healthy controls were enrolled in the study. Polymorphisms of HSPA1A, -1B, and -1L genes were genotyped using the PCR-RFLP technique. Analyses were conducted in entire groups and in subgroups that were stratified according to gender. There were significant differences in the genotype and allele frequencies of HSPA1A polymorphism between the patients and controls. The +190CC genotype and +190C allele were over-represented in the patients and significantly increased the risk for developing schizophrenia (OR\u2009=\u20093.45 and OR\u2009=\u20091.61, respectively). Interestingly, such a risk was higher for females with the +190CC genotype than for males with the +190CC genotype (OR\u2009=\u20095.78 vs. OR\u2009=\u20092.76). We also identified the CGT haplotype as a risk haplotype for schizophrenia and demonstrated the effects of HSPA1A and HSPA1B genotypes on the psychopathology and age of onset. Our study provided the first evidence that the HSPA1A polymorphism may potentially increase the risk of developing paranoid schizophrenia. Further independent analyses in different populations to evaluate the role of gender are needed to replicate these results.", "electronicPublicationDate": "2013-07-28", "language": "eng", "dateOfCompletion": "2014-10-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3933617?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3933617", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23893339", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23893339&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s12192-013-0446-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-03-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 3, "volume": "19", "yearOfPublication": 2014, "journalIssueId": 2132167, "issue": "2", "dateOfPublication": "2014 Mar"}}, "23666708": {"pubYear": "2013", "dateOfCreation": "2013-10-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPA1A protein, human"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSPA1B protein, human"}, {"registryNumber": "0", "name": "HSPA1L protein, human"}]}, "authorString": "Zhang Y, Gong J, Zhang L, Xue D, Liu H, Liu P.", "affiliation": "Eye Hospital, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23666708", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Eye Hospital, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, China.", "fullName": "Zhang Y", "initials": "Y", "firstName": "Yi", "lastName": "Zhang"}, {"lastName": "Gong", "fullName": "Gong J", "firstName": "JianYing", "initials": "J"}, {"lastName": "Zhang", "fullName": "Zhang L", "firstName": "Lan", "initials": "L"}, {"lastName": "Xue", "fullName": "Xue D", "firstName": "DaXi", "initials": "D"}, {"lastName": "Liu", "fullName": "Liu H", "firstName": "HanRuo", "initials": "H"}, {"lastName": "Liu", "fullName": "Liu P", "firstName": "Ping", "initials": "P"}]}, "title": "Genetic polymorphisms of HSP70 in age-related cataract.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "23666708", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-05-11", "doi": "10.1007/s12192-013-0420-4", "isOpenAccess": "N", "pageInfo": "703-709", "pmcid": "PMC3789879", "hasDbCrossReferences": "Y", "abstractText": "Polymorphisms have been identified in several HSP70 genes, which may affect HSP70 repair efficiency. We investigated the association of the polymorphisms in HSPA1A, HSPA1B, and HSPA1L genes in the HSPs repair pathway with the risk of cataract in a Chinese population. The study included 415 cataract patients and 386 controls. Genotyping was done by the polymerase chain reaction-restriction fragment length polymorphism method. HSPA1B 1267 A/A genotype seems to have a protective role against cataract (p\u2009=\u20090.014, odds ratio (OR)\u2009=\u20090.664, 95\u00a0% confidence intervals (CI)\u2009=\u20090.480-0.919), and the G allele (p\u2009=\u20090.057, OR\u2009=\u20091.216, 95\u00a0% CI\u2009=\u20090.999-1.479) does not seem to have a deleterious role in the development of cataract. Haplotypes with frequencies of GAT were significantly different than those of controls (p\u2009=\u20090.005). In HSPA1A G190C and HSPA1L T2437C polymorphisms, there were no significant differences in frequencies of the variant homozygous in patients compared to controls. We conclude that the A/A genotype of HSPA1B A1267G polymorphism seem to have a protective role against age-related cataract.", "electronicPublicationDate": "2013-05-11", "language": "eng", "dateOfCompletion": "2014-04-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3789879?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3789879", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23666708&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23666708", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s12192-013-0420-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-05-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-11-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 11, "volume": "18", "yearOfPublication": 2013, "journalIssueId": 2083453, "issue": "6", "dateOfPublication": "2013 Nov"}}, "19496026": {"pubYear": "2010", "dateOfCreation": "2009-12-09", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Heat-Shock Proteins"}, {"registryNumber": "0", "name": "Inflammation Mediators"}]}, "authorString": "Sonna LA, Hawkins L, Lissauer ME, Maldeis P, Towns M, Johnson SB, Moore R, Singh IS, Cowan MJ, Hasday JD.", "affiliation": "University of Maryland School of Medicine, Baltimore, MD 21201, USA. larry_sonna@hotmail.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL69057"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL085256"}]}, "hasPDF": "Y", "id": "19496026", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Sonna", "fullName": "Sonna LA", "firstName": "Larry A", "initials": "LA"}, {"lastName": "Hawkins", "fullName": "Hawkins L", "firstName": "Lauren", "initials": "L"}, {"lastName": "Lissauer", "fullName": "Lissauer ME", "authorId": {"type": "ORCID", "value": "0000-0002-6008-9778"}, "firstName": "Matthew E", "initials": "ME"}, {"lastName": "Maldeis", "fullName": "Maldeis P", "firstName": "Pam", "initials": "P"}, {"lastName": "Towns", "fullName": "Towns M", "firstName": "Michael", "initials": "M"}, {"lastName": "Johnson", "fullName": "Johnson SB", "firstName": "Steven B", "initials": "SB"}, {"lastName": "Moore", "fullName": "Moore R", "firstName": "Richard", "initials": "R"}, {"lastName": "Singh", "fullName": "Singh IS", "firstName": "Ishwar S", "initials": "IS"}, {"lastName": "Cowan", "fullName": "Cowan MJ", "firstName": "Mark J", "initials": "MJ"}, {"lastName": "Hasday", "fullName": "Hasday JD", "firstName": "Jeffrey D", "initials": "JD"}]}, "title": "Core temperature correlates with expression of selected stress and immunomodulatory genes in febrile patients with sepsis and noninfectious SIRS.", "hasSuppl": "N", "citedByCount": 10, "source": "MED", "pmid": "19496026", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6008-9778"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Sepsis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fever", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Inflammation Mediators", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Body Temperature", "majorTopic_YN": "Y"}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Severity of Illness Index", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Systemic Inflammatory Response Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-06-04", "doi": "10.1007/s12192-009-0121-1", "isOpenAccess": "N", "pageInfo": "55-66", "pmcid": "PMC2866972", "hasDbCrossReferences": "N", "abstractText": "Environmental hyperthermia and exercise produce extensive changes in gene expression in human blood cells, but it is unknown whether this also happens during febrile-range hyperthermia. We tested the hypothesis that heat shock protein (HSP) and immunomodulatory stress gene expression correlate with fever in intensive care unit patients. Whole blood messenger RNA was obtained over consecutive days from 100 hospitalized patients suffering from sepsis or noninfectious systemic inflammatory response syndrome (SIRS) as defined by conventional criteria. The most abnormal body temperature in the preceding 24 h was recorded for each sample. Expression analysis was performed using the Affymetrix U133 chip. ANCOVA followed by correlation analysis was performed on a subset of 278 prospectively identified sequences of interest. Temperature affected expression of 60 sequences, either independently or as a function of clinical diagnosis. Forty-eight of these (representing 38 genes) were affected by temperature only, including several HSPs, transcription factors heat shock factor (HSF)-1 and HSF-4, cellular adhesion molecules such as ICAM1/CD54 and JAM3, toll receptors TLR-6 and TLR-7, ribosomal proteins, and a number of molecules involved in inflammatory pathways. Twelve sequences demonstrated temperature-dependent responses that differed significantly between patients with sepsis and noninfectious SIRS: CXCL-13; heat shock proteins DNAJB12 and DNAJC4; the F11 receptor; folate hydrolase 1; HSF-2; HSP 70 proteins HSPA1A, HSPA1B, and HSPA1L; interleukin 8; lipopolysaccharide binding protein; and prostaglandin E synthase. Febrile-range temperatures achieved during sepsis and noninfectious SIRS correlate with detectable changes in stress gene expression in vivo, suggesting that fever can activate HSP gene expression and modify innate immune responses. For some genes, it appears that clinical condition can alter temperature-sensitive gene expression. Collectively, these data underscore the potential importance of body temperature in shaping the immune response to infection and injury.", "electronicPublicationDate": "2009-06-04", "language": "eng", "dateOfCompletion": "2010-02-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2866972?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2866972", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.bioone.org/bioone/?request=get-abstract&issn=1355-8145&volume=015&issue=01&page=0055", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "BioOne"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19496026&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19496026", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s12192-009-0121-1", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://www.bioone.org/pdfserv/i1355-8145-015-01-0055.pdf", "documentStyle": "pdf", "availability": "Subscription required", "availabilityCode": "S", "site": "BioOne"}, {"url": "http://www.bioone.org/bioone/?request=get-document&issn=1355-8145&volume=015&issue=01&page=0055", "documentStyle": "html", "availability": "Subscription required", "availabilityCode": "S", "site": "BioOne"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2010-09-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 1, "volume": "15", "yearOfPublication": 2010, "journalIssueId": 1682862, "issue": "1", "dateOfPublication": "2010 Jan"}}, "20704535": {"pubYear": "2010", "dateOfCreation": "2010-11-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}]}, "authorString": "Wang Y, Zhou F, Wu Y, Xu D, Li W, Liang S.", "affiliation": "Department of Occupational Health, College of Public Health, Zhengzhou University, Zhengzhou, P.R. China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20704535", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Occupational Health, College of Public Health, Zhengzhou University, Zhengzhou, P.R. China.", "fullName": "Wang Y", "initials": "Y", "firstName": "Yuzhen", "lastName": "Wang"}, {"lastName": "Zhou", "fullName": "Zhou F", "firstName": "Fang", "initials": "F"}, {"lastName": "Wu", "fullName": "Wu Y", "firstName": "Yiming", "initials": "Y"}, {"lastName": "Xu", "fullName": "Xu D", "firstName": "Dong", "initials": "D"}, {"lastName": "Li", "fullName": "Li W", "firstName": "Weihui", "initials": "W"}, {"lastName": "Liang", "fullName": "Liang S", "firstName": "Shoupei", "initials": "S"}]}, "title": "The relationship between three heat shock protein 70 gene polymorphisms and susceptibility to lung cancer.", "citedByCount": 7, "source": "MED", "pmid": "20704535", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-08-13", "doi": "10.1515/cclm.2010.304", "isOpenAccess": "N", "pageInfo": "1657-1663", "hasDbCrossReferences": "Y", "abstractText": "Heat shock protein 70 (Hsp70) has been shown to act as a chaperone and be associated with a variety of tumors. We investigated HSP70-1 G+190C, HSP70-2 A+1267G, and HSP70-hom T+2437C polymorphisms to assess whether genetic variation in HSP70 plays a role in the occurrence and development of lung cancer.A case-control study was conducted using 159 patients with lung cancer and 202 control subjects. Genomic DNA was typed for HSP70 polymorphisms using polymerase chain reactions with restriction fragment length polymorphism (PCR-RFLP). Unconditional logistic regression was used to estimate the relative risks of lung cancer.There were significant differences in genotype and allele distributions between patients and controls for the HSP70-1 G+190C polymorphisms with and without adjustment for age, gender, smoking history, drinking history and family history of cancer (p<0.05). No significant differences were found in the polymorphisms of HSP70-2 A+1267G and HSP70-hom T+2437C. The haplotype analysis showed that the G/A/C and C/G/T haplotypes were associated with a significantly increased risk of lung cancer compared to the G/G/T haplotype. After adjustments for other risk factors, such as age, gender, drinking history and family history of cancer, the interactions between the HSP70-1 and HSP70-hom genotypes and smoking were confirmed [I(AB), 2.56 and 5.12, respectively].HSP70-1 G+190C may be a functional polymorphism and affect susceptibility to lung cancer, and homozygous C/C genotype may enhance the risk of lung cancer. In addition, smoking along with HSP70-1 G+190C and HSP70-hom T+2437C, may increase the risk of lung cancer.", "electronicPublicationDate": "2010-08-13", "language": "eng", "dateOfCompletion": "2011-02-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1515/CCLM.2010.304", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2015-12-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-11-01", "journal": {"medlineAbbreviation": "Clin Chem Lab Med", "isoabbreviation": "Clin. Chem. Lab. Med.", "title": "Clinical chemistry and laboratory medicine", "issn": "1434-6621", "nlmid": "9806306", "essn": "1437-4331"}, "monthOfPublication": 11, "volume": "48", "yearOfPublication": 2010, "journalIssueId": 1783097, "issue": "11", "dateOfPublication": "2010 Nov"}}, "18299791": {"pubYear": "2008", "dateOfCreation": "2008-09-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}]}, "authorString": "Kim JJ, Mandelli L, Lim S, Lim HK, Kwon OJ, Pae CU, Serretti A, Nimgaonkar VL, Paik IH, Jun TY.", "affiliation": "Department of Psychiatry, The Catholic University of Korea College of Medicine, Kangnam St Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Republic of Korea.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "18299791", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kim", "fullName": "Kim JJ", "firstName": "Jung Jin", "initials": "JJ"}, {"lastName": "Mandelli", "fullName": "Mandelli L", "firstName": "Laura", "initials": "L"}, {"lastName": "Lim", "fullName": "Lim S", "firstName": "Suzy", "initials": "S"}, {"lastName": "Lim", "fullName": "Lim HK", "firstName": "Hyun Kook", "initials": "HK"}, {"lastName": "Kwon", "fullName": "Kwon OJ", "firstName": "Oh Joo", "initials": "OJ"}, {"lastName": "Pae", "fullName": "Pae CU", "firstName": "Chi Un", "initials": "CU"}, {"lastName": "Serretti", "fullName": "Serretti A", "firstName": "Alessandro", "initials": "A"}, {"lastName": "Nimgaonkar", "fullName": "Nimgaonkar VL", "firstName": "Vishwajit L", "initials": "VL"}, {"lastName": "Paik", "fullName": "Paik IH", "firstName": "In-Ho", "initials": "IH"}, {"lastName": "Jun", "fullName": "Jun TY", "firstName": "Tae-Youn", "initials": "TY"}]}, "title": "Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia.", "citedByCount": 13, "source": "MED", "pmid": "18299791", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Association", "majorTopic_YN": "Y"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-06-01", "doi": "10.1007/s00406-007-0791-6", "isOpenAccess": "N", "pageInfo": "239-244", "hasDbCrossReferences": "Y", "abstractText": " OBJECTIVES: Heat shock proteins (HSPs) are a promising candidate gene in schizophrenia as they are believed to play a protective role in the central nervous system. An alteration in the titers of antibodies to the HSPs in schizophrenia patients has been suggested. Association between the three polymorphisms of HSP70-1 (HSPA1A), HSP70-hom (HSPA1L) and HSP70-2 (HSPA1B) and schizophrenia has been reported. Therefore, this study investigated the association between an enlarged set of SNPs at HSP70 gene and schizophrenia. METHODS: Two hundred and ninety-four patients with schizophrenia and 287 controls were enrolled in the study. Genotypings of 5 SNPs of HSP70 were performed using pyrosequencing method. Haploview 3.2 was used to generate a linkage disequilibrium map and to test for Hardy-Weinberg equilibrium. Single locus and haplotype-based associations were tested. Tests for associations using and multi-marker haplotypes were performed by using a COCAPHASE v2.403. Association of SNP markers and clinical variables were analyzed by analysis of variance. RESULTS: Significant association was detected at rs2075799 (allele A, X2 = 8.03, df = 1, P = 0.0046), but not at rs2227956 (P = 0.28), rs1043618 (P = 0.88), rs562047 (P = 0.47) or rs539689 (P = 0.32). In fact, the rs2075799*G/A genotype was more represented in patients with schizophrenia than in controls (X2 = 8.23, df= 1, P = 0.0041). Haplotype based associations were also detected (global P value 0.000003); the T-A-C-C-G haplotype was more prevalent among the patients (odds ratio, OR 5.95). Sliding windows analysis revealed a major contribution from rs2227956 and rs2075799 (global-P value 0.0075), with T-A haplotype significantly associated with schizophrenia. There was no evidence of an association between the clinical variables and schizophrenia across the genotypes. CONCLUSION: Our results raise the possibility that HSP70 gene (i.e., haplotypes of rs2075799) might be implicated in the development of schizophrenia, although limited by rare haplotypic association with the disease. Hence further studies from different ethnics should be performed to confirm these results.", "language": "eng", "dateOfCompletion": "2008-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00406-007-0791-6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-05-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-06-01", "journal": {"medlineAbbreviation": "Eur Arch Psychiatry Clin Neurosci", "isoabbreviation": "Eur Arch Psychiatry Clin Neurosci", "title": "European archives of psychiatry and clinical neuroscience", "issn": "0940-1334", "nlmid": "9103030", "essn": "1433-8491"}, "monthOfPublication": 6, "volume": "258", "yearOfPublication": 2008, "journalIssueId": 1554090, "issue": "4", "dateOfPublication": "2008 Jun"}}}, "BLOC1S6": {"26294018": {"pubYear": "2015", "dateOfCreation": "2016-01-15", "pubModel": "Print-Electronic", "authorString": "Spiegel S, Chiu A, James AS, Jentsch JD, Karlsgodt KH.", "affiliation": "Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "UL1-DE019580"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "RL1 MH083269"}]}, "id": "26294018", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.", "fullName": "Spiegel S", "initials": "S", "firstName": "S", "lastName": "Spiegel"}, {"affiliation": "Department of Pharmacology, University of California Irvine, Irvine.", "fullName": "Chiu A", "initials": "A", "firstName": "A", "lastName": "Chiu"}, {"affiliation": "Department of Psychology, UCLA, Los Angeles, CA.", "fullName": "James AS", "initials": "AS", "firstName": "A S", "lastName": "James"}, {"affiliation": "Department of Psychiatry, UCLA, Los Angeles, CA.", "fullName": "Jentsch JD", "initials": "JD", "firstName": "J D", "lastName": "Jentsch"}, {"firstName": "K H", "lastName": "Karlsgodt", "affiliation": "Department of Psychiatry, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-3332-4231"}, "fullName": "Karlsgodt KH", "initials": "KH"}]}, "title": "Recognition deficits in mice carrying mutations of genes encoding BLOC-1 subunits pallidin or dysbindin.", "citedByCount": 0, "source": "MED", "pmid": "26294018", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3332-4231"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-08-21", "doi": "10.1111/gbb.12240", "isOpenAccess": "N", "pageInfo": "618-624", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Genetics", "Memory", "Schizophrenia", "Object Recognition", "Recognition Memory", "Social Recognition", "Dysbindin", "Chromosome 6", "Pallidin"]}, "abstractText": "Numerous studies have implicated DTNBP1, the gene encoding dystrobrevin-binding protein or dysbindin, as a candidate risk gene for schizophrenia, though this relationship remains somewhat controversial. Variation in dysbindin, and its location on chromosome 6p, has been associated with cognitive processes, including those relying on a complex system of glutamatergic and dopaminergic interactions. Dysbindin is one of the seven protein subunits that comprise the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Dysbindin protein levels are lower in mice with null mutations in pallidin, another gene in the BLOC-1, and pallidin levels are lower in mice with null mutations in the dysbindin gene, suggesting that multiple subunit proteins must be present to form a functional oligomeric complex. Furthermore, pallidin and dysbindin have similar distribution patterns in a mouse and human brain. Here, we investigated whether the apparent correspondence of pallid and dysbindin at the level of gene expression is also found at the level of behavior. Hypothesizing a mutation leading to underexpression of either of these proteins should show similar phenotypic effects, we studied recognition memory in both strains using the novel object recognition task (NORT) and social novelty recognition task (SNRT). We found that mice with a null mutation in either gene are impaired on SNRT and NORT when compared with wild-type controls. These results support the conclusion that deficits consistent with recognition memory impairment, a cognitive function that is impaired in schizophrenia, result from either pallidin or dysbindin mutations, possibly through degradation of BLOC-1 expression and/or function.", "electronicPublicationDate": "2015-09-10", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/gbb.12240", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"medlineAbbreviation": "Genes Brain Behav", "isoabbreviation": "Genes Brain Behav.", "title": "Genes, brain, and behavior", "issn": "1601-1848", "nlmid": "101129617", "essn": "1601-183X"}, "monthOfPublication": 11, "volume": "14", "yearOfPublication": 2015, "journalIssueId": 2363873, "issue": "8", "dateOfPublication": "2015 Nov"}}, "23750231": {"pubYear": "2013", "dateOfCreation": "2013-06-10", "pubModel": "Electronic-Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "PLDN protein, human"}, {"registryNumber": "0", "name": "DTNBP1 protein, human"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Lectins"}, {"registryNumber": "0", "name": "Carrier Proteins"}, {"registryNumber": "0", "name": "Methyl-CpG-binding protein 2"}]}, "authorString": "Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V.", "affiliation": "Department of Biology, Agnes Scott College, Decatur, Georgia, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM0099130-01"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM077569"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "K12 GM000680"}, {"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "UL1 RR025750"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS-40593"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "P30NS055077"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01 GM077569"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS-065027"}]}, "hasPDF": "Y", "id": "23750231", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biology, Agnes Scott College, Decatur, Georgia, USA.", "fullName": "Larimore J", "initials": "J", "firstName": "Jennifer", "lastName": "Larimore"}, {"lastName": "Ryder", "fullName": "Ryder PV", "firstName": "Pearl V", "initials": "PV"}, {"lastName": "Kim", "fullName": "Kim KY", "firstName": "Kun-Yong", "initials": "KY"}, {"lastName": "Ambrose", "fullName": "Ambrose LA", "firstName": "L Alex", "initials": "LA"}, {"lastName": "Chapleau", "fullName": "Chapleau C", "firstName": "Christopher", "initials": "C"}, {"lastName": "Calfa", "fullName": "Calfa G", "firstName": "Gaston", "initials": "G"}, {"lastName": "Gross", "fullName": "Gross C", "firstName": "Christina", "initials": "C"}, {"lastName": "Bassell", "fullName": "Bassell GJ", "firstName": "Gary J", "initials": "GJ"}, {"lastName": "Pozzo-Miller", "fullName": "Pozzo-Miller L", "firstName": "Lucas", "initials": "L"}, {"lastName": "Smith", "fullName": "Smith Y", "firstName": "Yoland", "initials": "Y"}, {"lastName": "Talbot", "fullName": "Talbot K", "firstName": "Konrad", "initials": "K"}, {"lastName": "Park", "fullName": "Park IH", "firstName": "In-Hyun", "initials": "IH"}, {"lastName": "Faundez", "fullName": "Faundez V", "authorId": {"type": "ORCID", "value": "0000-0002-2114-5271"}, "firstName": "Victor", "initials": "V"}]}, "title": "MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.", "hasSuppl": "N", "citedByCount": 10, "source": "MED", "pmid": "23750231", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2114-5271"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Carrier Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lectins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Computational Biology", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Methyl-CpG-Binding Protein 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Induced Pluripotent Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Interaction Maps", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-06-04", "doi": "10.1371/journal.pone.0065069", "isOpenAccess": "Y", "pageInfo": "e65069", "pmcid": "PMC3672180", "hasDbCrossReferences": "Y", "abstractText": "Clinical, epidemiological, and genetic evidence suggest overlapping pathogenic mechanisms between autism spectrum disorder (ASD) and schizophrenia. We tested this hypothesis by asking if mutations in the ASD gene MECP2 which cause Rett syndrome affect the expression of genes encoding the schizophrenia risk factor dysbindin, a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), and associated interacting proteins. We measured mRNA and protein levels of key components of a dysbindin interaction network by, quantitative real time PCR and quantitative immunohistochemistry in hippocampal samples of wild-type and Mecp2 mutant mice. In addition, we confirmed results by performing immunohistochemistry of normal human hippocampus and quantitative qRT-PCR of human inducible pluripotent stem cells (iPSCs)-derived human neurons from Rett syndrome patients. We defined the distribution of the BLOC-1 subunit pallidin in human and mouse hippocampus and contrasted this distribution with that of symptomatic Mecp2 mutant mice. Neurons from mutant mice and Rett syndrome patients displayed selectively reduced levels of pallidin transcript. Pallidin immunoreactivity decreased in the hippocampus of symptomatic Mecp2 mutant mice, a feature most prominent at asymmetric synapses as determined by immunoelectron microcopy. Pallidin immunoreactivity decreased concomitantly with reduced BDNF content in the hippocampus of Mecp2 mice. Similarly, BDNF content was reduced in the hippocampus of BLOC-1 deficient mice suggesting that genetic defects in BLOC-1 are upstream of the BDNF phenotype in Mecp2 deficient mice. Our results demonstrate that the ASD-related gene Mecp2 regulates the expression of components belonging to the dysbindin interactome and these molecular differences may contribute to synaptic phenotypes that characterize Mecp2 deficiencies and ASD.", "electronicPublicationDate": "2013-06-04", "language": "eng", "dateOfCompletion": "2014-09-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3672180?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3672180", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23750231&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23750231", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0065069", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-11-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2046964, "issue": "6", "dateOfPublication": "2013 "}}, "23563589": {"pubYear": "2013", "dateOfCreation": "2013-06-28", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HPS4 protein, human"}, {"registryNumber": "0", "name": "Proteins"}]}, "authorString": "Saito A, Kuratomi G, Ito C, Matsuoka H, Suzuki T, Ozeki Y, Watanabe T, Fujii K, Shimoda K, Fukushima Y, Inukai T, Ohmori K, Akiyama K.", "affiliation": "Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23563589", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.", "fullName": "Saito A", "initials": "A", "firstName": "Atsushi", "lastName": "Saito"}, {"lastName": "Kuratomi", "fullName": "Kuratomi G", "firstName": "Go", "initials": "G"}, {"lastName": "Ito", "fullName": "Ito C", "firstName": "Chihiro", "initials": "C"}, {"lastName": "Matsuoka", "fullName": "Matsuoka H", "firstName": "Hiroo", "initials": "H"}, {"lastName": "Suzuki", "fullName": "Suzuki T", "firstName": "Tamio", "initials": "T"}, {"lastName": "Ozeki", "fullName": "Ozeki Y", "firstName": "Yuji", "initials": "Y"}, {"lastName": "Watanabe", "fullName": "Watanabe T", "firstName": "Takashi", "initials": "T"}, {"lastName": "Fujii", "fullName": "Fujii K", "firstName": "Kumiko", "initials": "K"}, {"lastName": "Shimoda", "fullName": "Shimoda K", "firstName": "Kazutaka", "initials": "K"}, {"lastName": "Fukushima", "fullName": "Fukushima Y", "firstName": "Yasutsugu", "initials": "Y"}, {"lastName": "Inukai", "fullName": "Inukai T", "firstName": "Toshihiko", "initials": "T"}, {"lastName": "Ohmori", "fullName": "Ohmori K", "firstName": "Kenichi", "initials": "K"}, {"lastName": "Akiyama", "fullName": "Akiyama K", "firstName": "Kazufumi", "initials": "K"}]}, "title": "An association study of the Hermansky-Pudlak syndrome type 4 gene in schizophrenic patients.", "citedByCount": 2, "source": "MED", "pmid": "23563589", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hermanski-Pudlak Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Family", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-08-01", "doi": "10.1097/ypg.0b013e32836130a9", "isOpenAccess": "N", "pageInfo": "163-173", "hasDbCrossReferences": "N", "abstractText": "OBJECTIVE: We encountered two Japanese siblings who had Hermansky-Pudlak syndrome (HPS) and major mental disorders (schizophrenia and major depression) as well. As it is known that HPS is caused by a local mutation in one of the human genes, named HPS1 to HPS8 and PLDN (HPS9), encoding subunit proteins involved in endosomal trafficking pathways, here, we report the mutation causing the siblings disease and a case-control association study of schizophrenia using polymorphisms of a gene to be screened in the mutation analysis. METHODS: We analyzed three HPS-causing genes, HPS1, HPS4, and HPS7, to identify a genetic mutation involved in the siblings. A case-control association study of nine tagging single-nucleotide polymorphisms of the entire genetic region of the HPS4 gene resulting from the screening in the siblings was carried out for schizophrenic patients (n=422) and controls (n=578). RESULTS: The two patients with HPS were homozygous for nonsense mutation (T/T) for the c.541C>T (rs119471022) in the HPS4 gene, which is mapped to human chromosome 22q12.1. The same nonsense mutation existed in the heterozygous state (C/T) in their mother and in two other siblings. The genotypic distribution of rs9608491 (C/T) in intron 4 showed a trend toward an association with schizophrenia as indicated by a corrected P-value of 0.053 controlling for multiple testing. Haplotype analyses showed that two of two-locus haplotypes, and all of three-locus, four-locus, and five-locus haplotypes, as they share rs9608491, yielded significant evidence for association with schizophrenia as shown by the following omnibus P-values. When rs4822724, rs61276843, rs9608491, rs713998, and rs2014410, five haplotype tagging single-nucleotide polymorphisms, are assigned serial numerals (1, 2, 3, 4, and 5), the omnibus P-values for the resulting haplotypes were P=0.0039 for 2-3, P=0.0142 for 3-4, P=0.0083 for 1-2-3, P=0.0187 for 2-3-4, P=0.0191 for 3-4-5, P=0.0270 for 1-2-3-4, P=0.0246 for 2-3-4-5, and 0.0261 for 1-2-3-4-5. CONCLUSION: These results suggest that the HPS4 gene confers a susceptibility to schizophrenia.", "language": "eng", "dateOfCompletion": "2014-04-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/YPG.0b013e32836130a9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-08-01", "journal": {"medlineAbbreviation": "Psychiatr Genet", "isoabbreviation": "Psychiatr. Genet.", "title": "Psychiatric genetics", "issn": "0955-8829", "nlmid": "9106748", "essn": "1473-5873"}, "monthOfPublication": 8, "volume": "23", "yearOfPublication": 2013, "journalIssueId": 2051906, "issue": "4", "dateOfPublication": "2013 Aug"}}}, "SKP2": {"17760257": {"pubYear": "2007", "dateOfCreation": "2007-08-31", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "S-Phase Kinase-Associated Proteins"}]}, "authorString": "Zhao J, Yang CL, Zhao SY.", "affiliation": "Department of Thoracic Surgery, The First Affiliated Hospital of China Medical Univercity, Shenyang 110001, China.", "pubTypeList": {"pubType": ["Journal Article", "English Abstract"]}, "hasPDF": "N", "id": "17760257", "inEPMC": "N", "authorList": {"author": [{"lastName": "Zhao", "fullName": "Zhao J", "firstName": "Jun", "initials": "J"}, {"lastName": "Yang", "fullName": "Yang CL", "firstName": "Chun-lu", "initials": "CL"}, {"lastName": "Zhao", "fullName": "Zhao SY", "firstName": "Su-ying", "initials": "SY"}]}, "title": "[Expression of SKP2 protein in lung carcinoma and its implication for prognosis].", "citedByCount": 2, "source": "MED", "pmid": "17760257", "abstractText": " OBJECTIVE: To investigate the characteristics of SKP2 protein expression in lung carcinoma tissues and its implication for prognosis. METHODS: The expression of SKP2 protein was detected in 89 NSCLC, 13 SCLC, 5 benign lung neoplasms, 5 normal bronchus and lung tissues by tissue chip and immunohistochemical techniques. RESULTS: The positive rate of SKP2 staining was (23.52 +/-13.57)% in NSCLC tissues and (53.85 +/- 12.26)% in SCLC tissues, significantly higher than (2.91 +/- 1.27)% in benign lung neoplasms and normal bronchus and lung tissues. Its expression was highest in SCLC tissues and lowest in benign lung tissues, with a significant difference between them (P <0.01). The expressive level of SKP2 protein in lung carcinoma tissues was closely related to cell differentiation and lymph node metastasis, but not to age, sex, smoking history, tumor site and size, and TNM staging, etc. The survival analysis revealed that the 5-year survival rate of lung carcinoma patients was much lower in SKP2 protein positive expression group than that in negative expression group (P < 0.01). CONCLUSION: The positive expression of SKP2 protein is higher in lung carcinoma than in benign or normal lung tissues, in particular, much higher in SCLC tissue. Moreover, it may be an independent factor to exert negative influence on prognosis of patients with lung carcinoma.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Bronchi", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carcinoma, Small Cell", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carcinoma, Non-Small-Cell Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lymphatic Metastasis", "majorTopic_YN": "N"}, {"descriptorName": "S-Phase Kinase-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neoplasm Staging", "majorTopic_YN": "N"}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Survival Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2007-04-01", "isOpenAccess": "N", "pageInfo": "289-292", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "chi", "dateOfCompletion": "2008-05-05", "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-04-01", "journal": {"title": "Zhonghua zhong liu za zhi [Chinese journal of oncology]", "issn": "0253-3766", "isoabbreviation": "Zhonghua Zhong Liu Za Zhi", "medlineAbbreviation": "Zhonghua Zhong Liu Za Zhi", "nlmid": "7910681"}, "monthOfPublication": 4, "volume": "29", "yearOfPublication": 2007, "journalIssueId": 1459575, "issue": "4", "dateOfPublication": "2007 Apr"}}}, "ECT2": {"27034531": {"pubYear": "2016", "dateOfCreation": "2016-04-01", "pubModel": "Print-Electronic", "authorString": "Li CW, Chen BS.", "affiliation": "Lab of Control and Systems Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "27034531", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Lab of Control and Systems Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.", "fullName": "Li CW", "initials": "CW", "firstName": "Cheng-Wei", "lastName": "Li"}, {"firstName": "Bor-Sen", "lastName": "Chen", "affiliation": "Lab of Control and Systems Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.", "authorId": {"type": "ORCID", "value": "0000-0003-1644-6106"}, "fullName": "Chen BS", "initials": "BS"}]}, "title": "Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27034531", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1644-6106"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2016-02-29", "doi": "10.1155/2016/4149608", "isOpenAccess": "Y", "pageInfo": "4149608", "pmcid": "PMC4789422", "hasDbCrossReferences": "N", "abstractText": "Epigenetic and microRNA (miRNA) regulation are associated with carcinogenesis and the development of cancer. By using the available omics data, including those from next-generation sequencing (NGS), genome-wide methylation profiling, candidate integrated genetic and epigenetic network (IGEN) analysis, and drug response genome-wide microarray analysis, we constructed an IGEN system based on three coupling regression models that characterize protein-protein interaction networks (PPINs), gene regulatory networks (GRNs), miRNA regulatory networks (MRNs), and epigenetic regulatory networks (ERNs). By applying system identification method and principal genome-wide network projection (PGNP) to IGEN analysis, we identified the core network biomarkers to investigate bladder carcinogenic mechanisms and design multiple drug combinations for treating bladder cancer with minimal side-effects. The progression of DNA repair and cell proliferation in stage 1 bladder cancer ultimately results not only in the derepression of miR-200a and miR-200b but also in the regulation of the TNF pathway to metastasis-related genes or proteins, cell proliferation, and DNA repair in stage 4 bladder cancer. We designed a multiple drug combination comprising gefitinib, estradiol, yohimbine, and fulvestrant for treating stage 1 bladder cancer with minimal side-effects, and another multiple drug combination comprising gefitinib, estradiol, chlorpromazine, and LY294002 for treating stage 4 bladder cancer with minimal side-effects.", "electronicPublicationDate": "2016-02-29", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4789422?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4789422", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1155/2016/4149608", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-04-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Dis Markers", "isoabbreviation": "Dis. Markers", "title": "Disease markers", "issn": "0278-0240", "nlmid": "8604127", "essn": "1875-8630"}, "monthOfPublication": 0, "volume": "2016", "yearOfPublication": 2016, "journalIssueId": 2375703, "dateOfPublication": "2016 "}}}, "HSPB1": {"10774938": "", "19399179": "", "18514628": "", "25965061": {"pubYear": "2015", "dateOfCreation": "2015-05-13", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPB1 protein, human"}, {"registryNumber": "0", "name": "Molecular Chaperones"}, {"registryNumber": "0", "name": "HSP20 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSPB6 protein, human"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}]}, "authorString": "Muranova LK, Weeks SD, Strelkov SV, Gusev NB.", "affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25965061", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "fullName": "Muranova LK", "initials": "LK", "firstName": "Lydia K", "lastName": "Muranova"}, {"firstName": "Stephen D", "lastName": "Weeks", "affiliation": "Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.", "authorId": {"type": "ORCID", "value": "0000-0002-1360-0852"}, "fullName": "Weeks SD", "initials": "SD"}, {"affiliation": "Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.", "fullName": "Strelkov SV", "initials": "SV", "firstName": "Sergei V", "lastName": "Strelkov"}, {"affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "fullName": "Gusev NB", "initials": "NB", "firstName": "Nikolai B", "lastName": "Gusev"}]}, "title": "Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25965061", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-1360-0852"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Motor Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Muscular Atrophy, Spinal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Chaperones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Structure, Quaternary", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "HSP20 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Multimerization", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteolysis", "majorTopic_YN": "N"}, {"descriptorName": "Protein Aggregation, Pathological", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-12", "language": "eng", "doi": "10.1371/journal.pone.0126248", "isOpenAccess": "Y", "pageInfo": "e0126248", "pmcid": "PMC4429025", "hasDbCrossReferences": "Y", "abstractText": "Physico-chemical properties of the mutations G34R, P39L and E41K in the N-terminal domain of human heat shock protein B1 (HspB1), which have been associated with hereditary motor neuron neuropathy, were analyzed. Heat-induced aggregation of all mutants started at lower temperatures than for the wild type protein. All mutations decreased susceptibility of the N- and C-terminal parts of HspB1 to chymotrypsinolysis. All mutants formed stable homooligomers with a slightly larger apparent molecular weight compared to the wild type protein. All mutations analyzed decreased or completely prevented phosphorylation-induced dissociation of HspB1 oligomers. When mixed with HspB6 and heated, all mutants yielded heterooligomers with apparent molecular weights close to ~400 kDa. Finally, the three HspB1 mutants possessed lower chaperone-like activity towards model substrates (lysozyme, malate dehydrogenase and insulin) compared to the wild type protein, conversely the environmental probe bis-ANS yielded higher fluorescence with the mutants than with the wild type protein. Thus, in vitro the analyzed N-terminal mutations increase stability of large HspB1 homooligomers, prevent their phosphorylation-dependent dissociation, modulate their interaction with HspB6 and decrease their chaperoning capacity, preventing normal functioning of HspB1.", "electronicPublicationDate": "2015-05-12", "license": "cc by", "dateOfCompletion": "2016-02-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4429025?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4429025", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0126248", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-05-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2015, "journalIssueId": 2278532, "issue": "5", "dateOfPublication": "2015"}}, "20150973": "", "24898650": {"pubYear": "2014", "dateOfCreation": "2014-10-25", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "amyloid beta-protein (1-42)"}, {"registryNumber": "0", "name": "amyloid beta-protein (1-40)"}, {"registryNumber": "0", "name": "enhanced green fluorescent protein"}, {"registryNumber": "0", "name": "Hspb1 protein, rat"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "147336-22-9", "name": "Green Fluorescent Proteins"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}]}, "authorString": "Conway M, Nafar F, Straka T, Mearow K.", "affiliation": "Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "ROP 108435"}]}, "hasPDF": "N", "id": "24898650", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.", "fullName": "Conway M", "initials": "M", "firstName": "Megan", "lastName": "Conway"}, {"affiliation": "Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.", "fullName": "Nafar F", "initials": "F", "firstName": "Firoozeh", "lastName": "Nafar"}, {"affiliation": "Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.", "fullName": "Straka T", "initials": "T", "firstName": "Tatjana", "lastName": "Straka"}, {"affiliation": "Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.", "fullName": "Mearow K", "initials": "K", "firstName": "Karen", "lastName": "Mearow"}]}, "title": "Modulation of amyloid-\u03b2 protein precursor expression by HspB1.", "citedByCount": 0, "source": "MED", "pmid": "24898650", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Green Fluorescent Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Enzyme-Linked Immunosorbent Assay", "majorTopic_YN": "N"}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Immunoprecipitation", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-01-01", "doi": "10.3233/jad-140348", "isOpenAccess": "N", "pageInfo": "435-450", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Cell line", "Protein expression", "Small heat shock protein", "A\u03b2ppsw", "A\u03b2ppwt"]}, "abstractText": "Upregulation of heat shock proteins, such as Hsp70 and HspB1/Hsp27, have been associated with an amelioration of the deficits in animal models of Alzheimer's disease (AD). HspB1 is reported to be increased in AD brains and to accumulate in plaques, but whether this localization is an attempt by HspB1 to ameliorate the detrimental effects of amyloid-\u03b2 (A\u03b2) on cells or part of the disease process is unknown. Here we explore the potential effects of the HspB1 on amyloid-\u03b2 protein precursor (A\u03b2PP) processing and distribution within HEK293 stable cell lines expressing either A\u03b2PPwt or A\u03b2PPsw. We compare A\u03b2PP production, distribution, and release of proteolytic products (including A\u03b240 and A\u03b242) to determine possible modifications in the presence of HspB1. We also investigate whether HspB1 interacts with A\u03b2 or its precursor, A\u03b2PP, and whether, through this interaction, it is able to alter A\u03b2PP processing or release of A\u03b2 peptide. Coexpression of HspB1 resulted in increased cellular holoA\u03b2PP as well as C-terminal fragments. Further, expression of HspB1 attenuated the release of A\u03b242 from the A\u03b2PPsw cells. In summary, we have shown that expression of HspB1 alters A\u03b2PP expression and processing in cell lines expressing A\u03b2PPwt and A\u03b2PPsw. Furthermore, the presence of HspB1 decreased the amount of A\u03b242 released by the cell lines. Thus in addition to its effects on protecting cells from the potentially toxic effects of A\u03b2, HspB1 also appears to be involved in modulating cellular levels of A\u03b2PP, although an understanding of the underlying mechanisms requires further investigation.", "language": "eng", "dateOfCompletion": "2015-07-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3233/JAD-140348", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "J Alzheimers Dis", "isoabbreviation": "J. Alzheimers Dis.", "title": "Journal of Alzheimer's disease : JAD", "issn": "1387-2877", "nlmid": "9814863", "essn": "1875-8908"}, "monthOfPublication": 0, "volume": "42", "yearOfPublication": 2014, "journalIssueId": 2214820, "issue": "2", "dateOfPublication": "2014 "}}, "16825994": "", "25220807": {"pubYear": "2014", "dateOfCreation": "2016-06-30", "pubModel": "Print-Electronic", "authorString": "Chalova AS, Sudnitsyna MV, Strelkov SV, Gusev NB.", "affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "25220807", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "fullName": "Chalova AS", "initials": "AS", "firstName": "Anna S", "lastName": "Chalova"}, {"affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation.", "fullName": "Sudnitsyna MV", "initials": "MV", "firstName": "Maria V", "lastName": "Sudnitsyna"}, {"affiliation": "Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.", "fullName": "Strelkov SV", "initials": "SV", "firstName": "Sergei V", "lastName": "Strelkov"}, {"affiliation": "Department of Biochemistry, School of Biology, Moscow State University, Moscow 119991, Russian Federation. Electronic address: NBGusev@mail.ru.", "fullName": "Gusev NB", "initials": "NB", "firstName": "Nikolai B", "lastName": "Gusev"}]}, "title": "Characterization of human small heat shock protein HspB1 that carries C-terminal domain mutations associated with hereditary motor neuron diseases.", "citedByCount": 1, "source": "MED", "pmid": "25220807", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-09-16", "doi": "10.1016/j.bbapap.2014.09.005", "isOpenAccess": "N", "pageInfo": "2116-2126", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Thermal stability", "Small heat shock protein", "Hydrophobic properties", "Peripheral Neuropathy", "Oligomeric Structure", "Chaperone-like Activity"]}, "abstractText": "Physico-chemical properties of four mutants (T164A, T180I, P182S and R188W) of human small heat shock protein HspB1 (Hsp27) associated with neurodegenerative diseases were analyzed by means of fluorescence spectroscopy, dynamic light scattering, size-exclusion chromatography and measurement of chaperone-like activity. Mutation T164A was accompanied by destabilization of the quaternary structure and decrease of thermal stability without any significant changes of chaperone-like activity. Mutations T180I and P182S are adjacent or within the conserved C-terminal motif IPI/V. Replacement T180\u21d2I leading to the formation of hydrophobic cluster consisting of three Ile produced small increase of thermal stability without changes of chaperone-like activity. Mutation P182S induced the formation of metastable large oligomers of HspB1 with apparent molecular weight of more than 1000kDa. Oligomers of P182S have very low thermal stability and undergo irreversible aggregation at low temperature. The P182S mutant forms mixed oligomers with the wild type HspB1 and the properties of these mixed oligomers are intermediate between those of the wild type HspB1 and its mutant. Mutation R188W did not significantly affect quaternary structure or thermal stability of HspB1, but was accompanied by a pronounced decrease of its chaperone-like activity. All mutations analyzed are associated with hereditary motor neuropathies or Charcot-Marie-Tooth disease type 2; however, molecular mechanisms underlying pathological effects are specific for each of these mutants.", "electronicPublicationDate": "2014-09-16", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.bbapap.2014.09.005", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-12-01", "journal": {"title": "Biochimica et biophysica acta", "issn": "0006-3002", "isoabbreviation": "Biochim. Biophys. Acta", "medlineAbbreviation": "Biochim Biophys Acta", "nlmid": "0217513"}, "monthOfPublication": 12, "volume": "1844", "yearOfPublication": 2014, "journalIssueId": 2423927, "issue": "12", "dateOfPublication": "2014 Dec"}}, "24621945": {"pubYear": "2015", "dateOfCreation": "2015-01-22", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "alpha-Crystallin B Chain"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}]}, "authorString": "Beltran Valls MR, Wilkinson DJ, Narici MV, Smith K, Phillips BE, Caporossi D, Atherton PJ.", "affiliation": "Department of Movement, Human and Health Sciences, Unit of Biology, Genetics and Biochemistry, University of Rome \"ForoItalico,\" Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council", "grantId": "BB/C516779/1"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/K00414X/1"}, {"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council", "grantId": "BB/X510697/1338"}]}, "hasPDF": "Y", "id": "24621945", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Movement, Human and Health Sciences, Unit of Biology, Genetics and Biochemistry, University of Rome \"ForoItalico,\" Italy.", "fullName": "Beltran Valls MR", "initials": "MR", "firstName": "Maria R", "lastName": "Beltran Valls"}, {"affiliation": "Division of Medical Sciences & Graduate Entry Medicine, MRC-ARUK Centre of Excellence for Musculoskeletal Ageing Research, University of Nottingham, Royal Derby Hospital Centre.", "fullName": "Wilkinson DJ", "initials": "DJ", "firstName": "Daniel J", "lastName": "Wilkinson"}, {"affiliation": "Division of Medical Sciences & Graduate Entry Medicine, MRC-ARUK Centre of Excellence for Musculoskeletal Ageing Research, University of Nottingham, Royal Derby Hospital Centre.", "fullName": "Narici MV", "initials": "MV", "firstName": "Marco V", "lastName": "Narici"}, {"affiliation": "Division of Medical Sciences & Graduate Entry Medicine, MRC-ARUK Centre of Excellence for Musculoskeletal Ageing Research, University of Nottingham, Royal Derby Hospital Centre.", "fullName": "Smith K", "initials": "K", "firstName": "Kenneth", "lastName": "Smith"}, {"affiliation": "Division of Medical Sciences & Graduate Entry Medicine, MRC-ARUK Centre of Excellence for Musculoskeletal Ageing Research, University of Nottingham, Royal Derby Hospital Centre.", "fullName": "Phillips BE", "initials": "BE", "firstName": "Bethan E", "lastName": "Phillips"}, {"firstName": "Daniela", "lastName": "Caporossi", "affiliation": "Department of Movement, Human and Health Sciences, Unit of Biology, Genetics and Biochemistry, University of Rome \"ForoItalico,\" Italy.", "authorId": {"type": "ORCID", "value": "0000-0001-9628-0665"}, "fullName": "Caporossi D", "initials": "D"}, {"affiliation": "Division of Medical Sciences & Graduate Entry Medicine, MRC-ARUK Centre of Excellence for Musculoskeletal Ageing Research, University of Nottingham, Royal Derby Hospital Centre. Philip.atherton@nottingham.ac.uk.", "fullName": "Atherton PJ", "initials": "PJ", "firstName": "Philip J", "lastName": "Atherton"}]}, "title": "Protein carbonylation and heat shock proteins in human skeletal muscle: relationships to age and sarcopenia.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "24621945", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9628-0665"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondria, Muscle", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "alpha-Crystallin B Chain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Carbonylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Muscle Strength", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sarcopenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-03-12", "language": "eng", "doi": "10.1093/gerona/glu007", "isOpenAccess": "Y", "pageInfo": "174-181", "pmcid": "PMC4301601", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Mitochondria", "Sarcopenia", "Carbonylation", "Heat Shock Protein."]}, "abstractText": "Aging is associated with a gradual loss of muscle mass termed sarcopenia, which has significant impact on quality-of-life. Because oxidative stress is proposed to negatively impact upon musculoskeletal aging, we investigated links between human aging and markers of oxidative stress, and relationships to muscle mass and strength in young and old nonsarcopenic and sarcopenic adults. Sixteen young and 16 old males (further subdivided into \"old\" and \"old sarcopenic\") were studied. The abundance of protein carbonyl adducts within skeletal muscle sarcoplasmic, myofibrillar, and mitochondrial protein subfractions from musculus vastus lateralis biopsies were determined using Oxyblot immunoblotting techniques. In addition, concentrations of recognized cytoprotective proteins (eg, heat shock proteins [HSP], \u03b1\u03b2-crystallin) were also assayed. Aging was associated with increased mitochondrial (but not myofibrillar or sarcoplasmic) protein carbonyl adducts, independently of (stage-I) sarcopenia. Correlation analyses of all subjects revealed that mitochondrial protein carbonyl abundance negatively correlated with muscle strength ([1-repetition maximum], p = .02, r (2) = -.16), but not muscle mass (p = .13, r (2) = -.08). Abundance of cytoprotective proteins, including various HSPs (HSP 27 and 70), were unaffected by aging/sarcopenia. To conclude, these data reveal that mitochondrial protein carbonylation increases moderately with age, and that this increase may impact upon skeletal muscle function, but is not a hallmark of (stage-I) sarcopenia, per se.", "electronicPublicationDate": "2014-03-12", "license": "cc by", "dateOfCompletion": "2015-03-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4301601?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4301601", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/gerona/glu007", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-02-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-02-01", "journal": {"medlineAbbreviation": "J Gerontol A Biol Sci Med Sci", "isoabbreviation": "J. Gerontol. A Biol. Sci. Med. Sci.", "title": "The journals of gerontology. Series A, Biological sciences and medical sciences", "issn": "1079-5006", "nlmid": "9502837", "essn": "1758-535X"}, "monthOfPublication": 2, "volume": "70", "yearOfPublication": 2015, "journalIssueId": 2245376, "issue": "2", "dateOfPublication": "2015 Feb"}}, "8814840": "", "16203614": "", "23874478": "", "15921884": "", "23728742": "", "23826100": "", "23379525": "", "21785432": "", "10037719": "", "8979274": "", "22734906": "", "26728796": {"pubYear": "2016", "dateOfCreation": "2016-01-05", "pubModel": "Print-Electronic", "authorString": "Sun GX, Chen Y, Liu CP, Li S, Fu J.", "affiliation": "College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, People's Republic of China. 838032055@qq.com.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26728796", "inEPMC": "N", "authorList": {"author": [{"affiliation": "College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, People's Republic of China. 838032055@qq.com.", "fullName": "Sun GX", "initials": "GX", "firstName": "G X", "lastName": "Sun"}, {"affiliation": "College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, People's Republic of China. 1373768879@qq.com.", "fullName": "Chen Y", "initials": "Y", "firstName": "Y", "lastName": "Chen"}, {"affiliation": "College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, People's Republic of China. liuchunpeng@neau.edu.cn.", "fullName": "Liu CP", "initials": "CP", "firstName": "C P", "lastName": "Liu"}, {"affiliation": "College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, People's Republic of China. lishu@neau.edu.cn.", "fullName": "Li S", "initials": "S", "firstName": "S", "lastName": "Li"}, {"affiliation": "Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. jf699@cornell.edu.", "fullName": "Fu J", "initials": "J", "firstName": "J", "lastName": "Fu"}]}, "title": "Effect of Selenium Against Lead-Induced Damage on the Gene Expression of Heat Shock Proteins and Inflammatory Cytokines in Peripheral Blood Lymphocytes of Chickens.", "citedByCount": 0, "source": "MED", "pmid": "26728796", "abstractText": "The possible beneficial role of selenium (Se) in heat shock proteins (HSPs) and inflammation damage induced by lead (Pb) in chickens is unclear. Therefore, the aim of this study was to investigate the effect of Se against Pb on the messenger RNA (mRNA) expression levels of HSPs (HSP 27, 40, 60, 70, and 90); heme oxygenase-1 (HO-1); and the inflammatory cytokines nuclear factor kappa B (NF-\u03baB), tumor necrosis factor alpha (TNF-\u03b1), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) in the peripheral blood lymphocytes of chickens. A total of 360 1-day-old broiler chickens were randomly allocated into four groups (n\u2009=\u200990/group). The control group was fed a basic diet containing 0.2\u00a0mg/kg Se and 0.5\u00a0mg/kg Pb; the Se supplementation group (+Se group) was fed a Se-adequate (sodium selenite) diet containing 1\u00a0mg/kg Se and 0.5\u00a0mg/kg Pb; the Pb-supplemented group (+Pb group) was fed a Pb acetate diet containing 0.2\u00a0mg/kg Se and 350\u00a0mg/kg Pb; and the Se and Pb compound group (Se\u2009+\u2009Pb group) was fed a diet containing 1\u00a0mg/kg Se and 350\u00a0mg/kg Pb. The blood was collected and examined for the mRNA levels of HSP and inflammatory cytokine genes at 30 and 60\u00a0days old. The results showed that Pb poisoning induced the mRNA expression of HSPs and inflammatory cytokines in the peripheral blood lymphocytes of chickens. In addition, Se alleviated the Pb-induced increase in HSP and inflammatory cytokine mRNA levels in chicken peripheral blood lymphocytes. In conclusion, Se can antagonize the toxic effects of Pb on chickens and protect the chickens' peripheral blood lymphocytes in normal physiological function.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-01-04", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Lead", "Selenium", "Heat Shock protein", "Inflammatory cytokines", "Chicken Peripheral Blood Lymphocytes"]}, "hasLabsLinks": "N", "electronicPublicationDate": "2016-01-04", "language": "eng", "dateOfRevision": "2016-01-06", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Biol Trace Elem Res", "isoabbreviation": "Biol Trace Elem Res", "title": "Biological trace element research", "issn": "0163-4984", "nlmid": "7911509", "essn": "1559-0720"}, "monthOfPublication": 1, "yearOfPublication": 2016, "journalIssueId": 2359269, "dateOfPublication": "2016 Jan"}}, "24719117": {"pubYear": "2014", "dateOfCreation": "2014-04-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Heat-Shock Proteins"}]}, "authorString": "Kakkar V, Meister-Broekema M, Minoia M, Carra S, Kampinga HH.", "affiliation": "University Medical Center Groningen, University of Groningen, Department of Cell Biology, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24719117", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "University Medical Center Groningen, University of Groningen, Department of Cell Biology, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.", "fullName": "Kakkar V", "initials": "V", "firstName": "Vaishali", "lastName": "Kakkar"}, {"lastName": "Meister-Broekema", "fullName": "Meister-Broekema M", "firstName": "Melanie", "initials": "M"}, {"lastName": "Minoia", "fullName": "Minoia M", "firstName": "Melania", "initials": "M"}, {"lastName": "Carra", "fullName": "Carra S", "authorId": {"type": "ORCID", "value": "0000-0003-0939-0140"}, "firstName": "Serena", "initials": "S"}, {"lastName": "Kampinga", "fullName": "Kampinga HH", "firstName": "Harm H", "initials": "HH"}]}, "title": "Barcoding heat shock proteins to human diseases: looking beyond the heat shock response.", "hasSuppl": "N", "citedByCount": 10, "source": "MED", "pmid": "24719117", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0939-0140"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Heat-Shock Response", "majorTopic_YN": "Y"}, {"descriptorName": "Proteostasis Deficiencies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-04-01", "doi": "10.1242/dmm.014563", "isOpenAccess": "Y", "pageInfo": "421-434", "pmcid": "PMC3974453", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Heat Shock protein", "Chaperonopathies", "Protein-aggregation Diseases"]}, "abstractText": "There are numerous human diseases that are associated with protein misfolding and the formation of toxic protein aggregates. Activating the heat shock response (HSR)--and thus generally restoring the disturbed protein homeostasis associated with such diseases--has often been suggested as a therapeutic strategy. However, most data on activating the HSR or its downstream targets in mouse models of diseases associated with aggregate formation have been rather disappointing. The human chaperonome consists of many more heat shock proteins (HSPs) that are not regulated by the HSR, however, and researchers are now focusing on these as potential therapeutic targets. In this Review, we summarize the existing literature on a set of aggregation diseases and propose that each of them can be characterized or 'barcoded' by a different set of HSPs that can rescue specific types of aggregation. Some of these 'non-canonical' HSPs have demonstrated effectiveness in vivo, in mouse models of protein-aggregation disease. Interestingly, several of these HSPs also cause diseases when mutated--so-called chaperonopathies--which are also discussed in this Review.", "language": "eng", "license": "cc by", "dateOfCompletion": "2014-11-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3974453", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24719117", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1242/dmm.014563", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-04-01", "journal": {"medlineAbbreviation": "Dis Model Mech", "isoabbreviation": "Dis Model Mech", "title": "Disease models & mechanisms", "issn": "1754-8403", "nlmid": "101483332", "essn": "1754-8411"}, "monthOfPublication": 4, "volume": "7", "yearOfPublication": 2014, "journalIssueId": 2146743, "issue": "4", "dateOfPublication": "2014 Apr"}}, "11145923": "", "24765217": "", "16696328": "", "21670152": "", "15571513": "", "23950959": "", "24327604": {"pubYear": "2013", "dateOfCreation": "2014-01-06", "pubModel": "Print", "authorString": "Abdi J, Chen G, Chang H.", "affiliation": "Dept. of Laboratory Medicine & Pathobiology, University of Toronto, Ontario, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24327604", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Dept. of Laboratory Medicine & Pathobiology, University of Toronto, Ontario, Canada.", "fullName": "Abdi J", "initials": "J", "firstName": "Jahangir", "lastName": "Abdi"}, {"lastName": "Chen", "fullName": "Chen G", "firstName": "Guoan", "initials": "G"}, {"lastName": "Chang", "fullName": "Chang H", "firstName": "Hong", "initials": "H"}]}, "title": "Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.", "hasSuppl": "N", "citedByCount": 16, "pageInfo": "2186-2207", "source": "MED", "pmid": "24327604", "abstractText": "In the era of new and mostly effective therapeutic protocols, multiple myeloma still tends to be a hard-to-treat hematologic cancer. This hallmark of the disease is in fact a sequel to drug resistant phenotypes persisting initially or emerging in the course of treatment. Furthermore, the heterogeneous nature of multiple myeloma makes treating patients with the same drug challenging because finding a drugable oncogenic process common to all patients is not yet feasible, while our current knowledge of genetic/epigenetic basis of multiple myeloma pathogenesis is outstanding. Nonetheless, bone marrow microenvironment components are well known as playing critical roles in myeloma tumor cell survival and environment-mediated drug resistance happening most possibly in all myeloma patients. Generally speaking, however; real mechanisms underlying drug resistance in multiple myeloma are not completely understood. The present review will discuss the latest findings and concepts in this regard. It reviews the association of important chromosomal translocations, oncogenes (e.g. TP53) mutations and deranged signaling pathways (e.g. NF\u03baB) with drug response in clinical and experimental investigations. It will also highlight how bone marrow microenvironment signals (Wnt, Notch) and myeloma cancer stem cells could contribute to drug resistance in multiple myeloma.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Myeloma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Drug Resistance, Neoplasm", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-01", "isOpenAccess": "Y", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 240, "type": "Erratum in", "reference": "Oncotarget. 2015 Apr 10;6(10):7364"}, {"source": "MED", "orderIn": 241, "type": "Erratum in", "id": "25924233", "reference": "Oncotarget. 2015 Apr 10;6(10):7364"}]}, "pmcid": "PMC3926819", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "license": "cc by", "dateOfCompletion": "2014-11-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3926819?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3926819", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24327604&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24327604", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-09-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-12-01", "journal": {"title": "Oncotarget", "medlineAbbreviation": "Oncotarget", "isoabbreviation": "Oncotarget", "nlmid": "101532965", "essn": "1949-2553"}, "monthOfPublication": 12, "volume": "4", "yearOfPublication": 2013, "journalIssueId": 2109141, "issue": "12", "dateOfPublication": "2013 Dec"}}, "18325928": "", "26887567": {"pubYear": "2016", "dateOfCreation": "2016-02-18", "pubModel": "Print-Electronic", "authorString": "Oberstadt M, Mitter D, Classen J, Baum P.", "affiliation": "Department of Neurology, University of Leipzig, Liebigstra\u00dfe 20, 04103, Leipzig, Germany.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26887567", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Neurology, University of Leipzig, Liebigstra\u00dfe 20, 04103, Leipzig, Germany.", "fullName": "Oberstadt M", "initials": "M", "firstName": "Moritz", "lastName": "Oberstadt"}, {"affiliation": "Institute of Human Genetics, University of Leipzig, Philipp-Rosenthal-Str. 55, 04103, Leipzig.", "fullName": "Mitter D", "initials": "D", "firstName": "Diana", "lastName": "Mitter"}, {"affiliation": "Department of Neurology, University of Leipzig, Liebigstra\u00dfe 20, 04103, Leipzig, Germany.", "fullName": "Classen J", "initials": "J", "firstName": "Joseph", "lastName": "Classen"}, {"affiliation": "Department of Neurology, University of Leipzig, Liebigstra\u00dfe 20, 04103, Leipzig, Germany.", "fullName": "Baum P", "initials": "P", "firstName": "Petra", "lastName": "Baum"}]}, "title": "Late onset dHMN II caused by c.404C>G mutation in HSPB1 gene.", "citedByCount": 0, "source": "MED", "pmid": "26887567", "hasLabsLinks": "Y", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-02-17", "doi": "10.1111/jns.12165", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["HSP27", "Parkinson's Disease", "Hereditary Neuropathy", "Hspb1", "Dhmn Ii"]}, "abstractText": "Distal hereditary motor neuropathy (dHMN) type II is genetically heterogeneous. We report 3 siblings of a German family with late onset distal motor neuropathy due to the c.404C>G mutation in heat-shock 27-kDa protein 1 gene (HSPB1/HSP27). A 36-year old mutation carrier, daughter of 1 sibling, did not present any clinical or electrophysiological abnormalities. The index patient (oldest brother) developed weakness of the distal lower limbs and nocturnal muscle cramps at the age of 54 years old. Five years later this patient developed an L-DOPA-responsive hypokinetic rigid syndrome, establishing a diagnosis of Parkinson's disease. Although none of the 3 other mutation carriers displayed Parkinsonian signs, a pathogenic relationship with Parkinson's disease remains a possibility, based on the known molecular pathology of HSPB1. The rare pathogenic HSPB1 c.404C>G mutation may predispose for late-onset of dHMN type II.", "electronicPublicationDate": "2016-02-17", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/jns.12165", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-02-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-02-01", "journal": {"medlineAbbreviation": "J Peripher Nerv Syst", "isoabbreviation": "J. Peripher. Nerv. Syst.", "title": "Journal of the peripheral nervous system : JPNS", "issn": "1085-9489", "nlmid": "9704532", "essn": "1529-8027"}, "monthOfPublication": 2, "yearOfPublication": 2016, "journalIssueId": 2371023, "dateOfPublication": "2016 Feb"}}, "23948568": "", "17623484": "", "9426298": "", "15122254": "", "22521462": "", "24307543": {"pubYear": "2014", "dateOfCreation": "2014-06-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antibiotics, Antineoplastic"}, {"registryNumber": "0", "name": "Anthracyclines"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}, {"registryNumber": "80168379AG", "name": "Doxorubicin"}, {"registryNumber": "3Z8479ZZ5X", "name": "Epirubicin"}]}, "authorString": "Nadin SB, Sottile ML, Montt-Guevara MM, Gauna GV, Daguerre P, Leuzzi M, Gago FE, Ibarra J, Cuello-Carri\u00f3n FD, Ciocca DR, Vargas-Roig LM.", "affiliation": "Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, National Scientific and Technical Research Council, Mendoza, Argentina, snadin@mendoza-conicet.gob.ar.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24307543", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Silvina B", "lastName": "Nadin", "affiliation": "Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, National Scientific and Technical Research Council, Mendoza, Argentina, snadin@mendoza-conicet.gob.ar.", "authorId": {"type": "ORCID", "value": "0000-0002-1109-3156"}, "fullName": "Nadin SB", "initials": "SB"}, {"lastName": "Sottile", "fullName": "Sottile ML", "firstName": "Mayra L", "initials": "ML"}, {"lastName": "Montt-Guevara", "fullName": "Montt-Guevara MM", "firstName": "Maria M", "initials": "MM"}, {"lastName": "Gauna", "fullName": "Gauna GV", "firstName": "Gisel V", "initials": "GV"}, {"lastName": "Daguerre", "fullName": "Daguerre P", "firstName": "Pedro", "initials": "P"}, {"lastName": "Leuzzi", "fullName": "Leuzzi M", "firstName": "Marcela", "initials": "M"}, {"lastName": "Gago", "fullName": "Gago FE", "firstName": "Francisco E", "initials": "FE"}, {"lastName": "Ibarra", "fullName": "Ibarra J", "firstName": "Jorge", "initials": "J"}, {"lastName": "Cuello-Carri\u00f3n", "fullName": "Cuello-Carri\u00f3n FD", "firstName": "F Dar\u00edo", "initials": "FD"}, {"lastName": "Ciocca", "fullName": "Ciocca DR", "firstName": "Daniel R", "initials": "DR"}, {"lastName": "Vargas-Roig", "fullName": "Vargas-Roig LM", "firstName": "Laura M", "initials": "LM"}]}, "title": "Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24307543", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-1109-3156"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Breast", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Breast Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anthracyclines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Doxorubicin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epirubicin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antibiotics, Antineoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Neoadjuvant Therapy", "majorTopic_YN": "Y"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-05", "doi": "10.1007/s12192-013-0475-2", "isOpenAccess": "N", "pageInfo": "493-505", "pmcid": "PMC4041939", "hasDbCrossReferences": "N", "abstractText": "Neoadjuvant chemotherapy is used in patients with locally advanced breast cancer to reduce tumor size before surgery. Unfortunately, resistance to chemotherapy may arise from a variety of mechanisms. Heat shock proteins (HSPs), which are highly expressed in mammary tumor cells, have been implicated in anticancer drug resistance. In spite of the widely described value of HSPs as molecular markers in cancer, their implications in breast tumors treated with anthracycline-based neoadjuvant chemotherapy has been poorly explored. In this study, we have evaluated, by immunohistochemistry, the expression of HSP27 (HSPB1) and HSP70 (HSPA) in serial biopsies from locally advanced breast cancer patients (n\u2009=\u200960) treated with doxorubicin (DOX)- or epirubicin (EPI)-based monochemotherapy. Serial biopsies were taken at days 1, 3, 7, and 21, and compared with prechemotherapy and surgical biopsies. After surgery, the patients received additional chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil. High nuclear HSPB1 and HSPA expressions were found in invasive cells after DOX/EPI administration (P\u2009<\u20090.001), but the drug did not affect the cytoplasmic expression of the HSPs. Infiltrating lymphocytes showed high nuclear HSPA (P\u2009<\u20090.01) levels at postchemotherapy. No correlations were found between HSPs expression and the clinical and pathological response to neoadjuvant therapy. However, in postchemotherapy biopsies, high nuclear (>31\u00a0% of the cells) and cytoplasmic HSPA expressions (>11\u00a0% of the tumor cells) were associated with better DFS (P\u2009=\u20090.0348 and P\u2009=\u20090.0118, respectively). We conclude that HSPA expression may be a useful prognostic marker in breast cancer patients treated with neoadjuvant DOX/EPI chemotherapy indicating the need to change the administered drugs after surgery for overcoming drug resistance.", "electronicPublicationDate": "2013-12-05", "language": "eng", "dateOfCompletion": "2015-01-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4041939?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4041939", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s12192-013-0475-2", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-07-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 7, "volume": "19", "yearOfPublication": 2014, "journalIssueId": 2165744, "issue": "4", "dateOfPublication": "2014 Jul"}}, "26782567": {"pubYear": "2015", "dateOfCreation": "2016-01-19", "pubModel": "Electronic", "authorString": "Chen JT, Younusi A, Cao L, Tian Z, Zhou YJ, Song XH.", "affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26782567", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Chen JT", "initials": "JT", "firstName": "J T", "lastName": "Chen"}, {"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Younusi A", "initials": "A", "firstName": "A", "lastName": "Younusi"}, {"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Cao L", "initials": "L", "firstName": "L", "lastName": "Cao"}, {"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Tian Z", "initials": "Z", "firstName": "Z", "lastName": "Tian"}, {"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Zhou YJ", "initials": "YJ", "firstName": "Y J", "lastName": "Zhou"}, {"affiliation": "Orthopaedic Department, The First Affiliated Hospital of XinJiang Medical University, Urumqi, China.", "fullName": "Song XH", "initials": "XH", "firstName": "X H", "lastName": "Song"}]}, "title": "Potential role of heat-shock proteins in giant cell tumors.", "citedByCount": 0, "source": "MED", "pmid": "26782567", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-12-29", "doi": "10.4238/2015.december.29.24", "isOpenAccess": "N", "pageInfo": "19144-19154", "hasDbCrossReferences": "N", "abstractText": "We investigated the differential expression protein profile of giant cell tumors (GCTs), which can be used to monitor the tumor's recurrence and metastasis, to provide preliminary results for further study. We also explored heat-shock protein (HSP) inhibitor that prevents tumors from recurring and migrating. A stable isotope-labeling strategy using isobaric tags for relative and absolute quantitation coupled with two-dimensional liquid chromatography tandem mass spectrometry was used to separate and identify differentially expressed proteins. A total of 467 differentially expressed proteins were identified in GCT tissues. Up to 311 proteins were upregulated, whereas 156 proteins were downregulated in GCT tissues. Three of the differentially expressed HSPs, namely HP90A, HSPB1, and HSPB2, were upregulated. The differentially expressed proteins of GCT tissues will provide a scientific foundation for tumor prognosis, and for further studies exploring HSP inhibitor to prevent tumor recurrence and migration.", "electronicPublicationDate": "2015-12-29", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.4238/2015.December.29.24", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Genetics and molecular research : GMR", "medlineAbbreviation": "Genet Mol Res", "isoabbreviation": "Genet. Mol. Res.", "nlmid": "101169387", "essn": "1676-5680"}, "monthOfPublication": 0, "volume": "14", "yearOfPublication": 2015, "journalIssueId": 2330393, "issue": "4", "dateOfPublication": "2015"}}, "26878578": {"pubYear": "2015", "dateOfCreation": "2016-02-16", "pubModel": "Print", "authorString": "Nefedova VV, Muranova LK, Sudnitsyna MV, Ryzhavskaya AS, Gusev NB.", "affiliation": "Lomonosov Moscow State University, Faculty of Biology, Moscow, 119991, Russia. NBGusev@mail.ru.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "id": "26878578", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Lomonosov Moscow State University, Faculty of Biology, Moscow, 119991, Russia. NBGusev@mail.ru.", "fullName": "Nefedova VV", "initials": "VV", "firstName": "V V", "lastName": "Nefedova"}, {"lastName": "Muranova", "fullName": "Muranova LK", "firstName": "L K", "initials": "LK"}, {"lastName": "Sudnitsyna", "fullName": "Sudnitsyna MV", "firstName": "M V", "initials": "MV"}, {"lastName": "Ryzhavskaya", "fullName": "Ryzhavskaya AS", "firstName": "A S", "initials": "AS"}, {"lastName": "Gusev", "fullName": "Gusev NB", "firstName": "N B", "initials": "NB"}]}, "title": "Small Heat Shock Proteins and Distal Hereditary Neuropathies.", "citedByCount": 0, "source": "MED", "pmid": "26878578", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-12-01", "doi": "10.1134/s000629791513009x", "isOpenAccess": "N", "pageInfo": "1734-1747", "hasDbCrossReferences": "N", "abstractText": "Classification of small heat shock proteins (sHsp) is presented and processes regulated by sHsp are described. Symptoms of hereditary distal neuropathy are described and the genes whose mutations are associated with development of this congenital disease are listed. The literature data and our own results concerning physicochemical properties of HspB1 mutants associated with Charcot-Marie-Tooth disease are analyzed. Mutations of HspB1, associated with hereditary motor neuron disease, can be accompanied by change of the size of HspB1 oligomers, by decreased stability under unfavorable conditions, by changes in the interaction with protein partners, and as a rule by decrease of chaperone-like activity. The largest part of these mutations is accompanied by change of oligomer stability (that can be either increased or decreased) or by change of intermonomer interaction inside an oligomer. Data on point mutation of HspB3 associated with axonal neuropathy are presented. Data concerning point mutations of Lys141 of HspB8 and those associated with hereditary neuropathy and different forms of Charcot-Marie-Tooth disease are analyzed. It is supposed that point mutations of sHsp associated with distal neuropathies lead either to loss of function (for instance, decrease of chaperone-like activity) or to gain of harmful functions (for instance, increase of interaction with certain protein partners).", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1134/S000629791513009X", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-12-01", "journal": {"medlineAbbreviation": "Biochemistry (Mosc)", "isoabbreviation": "Biochemistry Mosc.", "title": "Biochemistry. Biokhimiia", "issn": "0006-2979", "nlmid": "0376536", "essn": "1608-3040"}, "monthOfPublication": 12, "volume": "80", "yearOfPublication": 2015, "journalIssueId": 2375590, "issue": "13", "dateOfPublication": "2015 Dec"}}, "17888590": "", "25780754": {"pubYear": "2015", "dateOfCreation": "2015-03-17", "pubModel": "Electronic-eCollection", "authorString": "Jiang Y, Qin H, Yang L.", "affiliation": "Department of Computer Science and Engineering, University of Tennessee at Chattanooga , TN , USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "25780754", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Computer Science and Engineering, University of Tennessee at Chattanooga , TN , USA.", "fullName": "Jiang Y", "initials": "Y", "firstName": "Yi", "lastName": "Jiang"}, {"affiliation": "Departement of Biology, Spelman College , Atlanta, GA , United States.", "fullName": "Qin H", "initials": "H", "firstName": "Hong", "lastName": "Qin"}, {"affiliation": "Department of Computer Science and Engineering, University of Tennessee at Chattanooga , TN , USA.", "fullName": "Yang L", "initials": "L", "firstName": "Li", "lastName": "Yang"}]}, "title": "Using network clustering to predict copy number variations associated with health disparities.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25780754", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-03-05", "language": "eng", "doi": "10.7717/peerj.677", "isOpenAccess": "Y", "pageInfo": "e677", "pmcid": "PMC4358638", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Clustering", "Gene networks", "gene ontology", "Health Disparities", "Copy Number Variations (Cnvs)", "Gene-disease Association"]}, "abstractText": "Substantial health disparities exist between African Americans and Caucasians in the United States. Copy number variations (CNVs) are one form of human genetic variations that have been linked with complex diseases and often occur at different frequencies among African Americans and Caucasian populations. Here, we aimed to investigate whether CNVs with differential frequencies can contribute to health disparities from the perspective of gene networks. We inferred network clusters from human gene/protein networks based on two different data sources. We then evaluated each network cluster for the occurrences of known pathogenic genes and genes located in CNVs with different population frequencies, and used false discovery rates to rank network clusters. This approach let us identify five clusters enriched with known pathogenic genes and with genes located in CNVs with different frequencies between African Americans and Caucasians. These clustering patterns predict two candidate causal genes located in four population-specific CNVs that play potential roles in health disparities.", "electronicPublicationDate": "2015-03-05", "license": "cc by", "dateOfCompletion": "2015-03-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4358638?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4358638", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.7717/peerj.677", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-03-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "PeerJ", "medlineAbbreviation": "PeerJ", "isoabbreviation": "PeerJ", "nlmid": "101603425", "essn": "2167-8359"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2015, "journalIssueId": 2249781, "dateOfPublication": "2015 "}}, "25728673": {"pubYear": "2015", "dateOfCreation": "2015-11-05", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPB1 protein, human"}, {"registryNumber": "0", "name": "erastin"}, {"registryNumber": "0", "name": "Piperazines"}, {"registryNumber": "0", "name": "Neoplasm Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Reactive Oxygen Species"}, {"registryNumber": "0", "name": "heat shock transcription factor"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}, {"registryNumber": "E1UOL152H7", "name": "Iron"}]}, "authorString": "Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X, Wang H, Cao L, Tang D.", "affiliation": "Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "R01 AT005076"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01 GM063075"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01GM063075"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA160417"}, {"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "R01AT005076"}]}, "hasPDF": "Y", "id": "25728673", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.", "fullName": "Sun X", "initials": "X", "firstName": "X", "lastName": "Sun"}, {"affiliation": "Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.", "fullName": "Ou Z", "initials": "Z", "firstName": "Z", "lastName": "Ou"}, {"affiliation": "Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.", "fullName": "Xie M", "initials": "M", "firstName": "M", "lastName": "Xie"}, {"affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Kang R", "initials": "R", "firstName": "R", "lastName": "Kang"}, {"affiliation": "Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.", "fullName": "Fan Y", "initials": "Y", "firstName": "Y", "lastName": "Fan"}, {"affiliation": "Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.", "fullName": "Niu X", "initials": "X", "firstName": "X", "lastName": "Niu"}, {"affiliation": "Department of Emergency Medicine, North Shore University Hospital, The Feinstein Institute for Medical Research, Manhasset, NY, USA.", "fullName": "Wang H", "initials": "H", "firstName": "H", "lastName": "Wang"}, {"affiliation": "Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.", "fullName": "Cao L", "initials": "L", "firstName": "L", "lastName": "Cao"}, {"affiliation": "Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.", "fullName": "Tang D", "initials": "D", "firstName": "D", "lastName": "Tang"}]}, "title": "HSPB1 as a novel regulator of ferroptotic cancer cell death.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25728673", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred NOD", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, SCID", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms, Experimental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Iron", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reactive Oxygen Species", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Piperazines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neoplasm Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Xenograft Model Antitumor Assays", "majorTopic_YN": "N"}, {"descriptorName": "Cell Death", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Heat-Shock Response", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "embargoDate": "2016-05-05", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-03-02", "doi": "10.1038/onc.2015.32", "isOpenAccess": "Y", "pageInfo": "5617-5625", "pmcid": "PMC4640181", "hasDbCrossReferences": "Y", "abstractText": "Ferroptosis is an iron-dependent form of non-apoptotic cell death, but its molecular mechanism remains largely unknown. Here, we demonstrate that heat shock protein beta-1 (HSPB1) is a negative regulator of ferroptotic cancer cell death. Erastin, a specific ferroptosis-inducing compound, stimulates heat shock factor 1 (HSF1)-dependent HSPB1 expression in cancer cells. Knockdown of HSF1 and HSPB1 enhances erastin-induced ferroptosis, whereas heat shock pretreatment and overexpression of HSPB1 inhibits erastin-induced ferroptosis. Protein kinase C-mediated HSPB1 phosphorylation confers protection against ferroptosis by reducing iron-mediated production of lipid reactive oxygen species. Moreover, inhibition of the HSF1-HSPB1 pathway and HSPB1 phosphorylation increases the anticancer activity of erastin in human xenograft mouse tumor models. Our findings reveal an essential role for HSPB1 in iron metabolism with important effects on ferroptosis-mediated cancer therapy.", "electronicPublicationDate": "2015-03-02", "language": "eng", "dateOfCompletion": "2016-02-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4640181?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4640181", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/onc.2015.32", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-05", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"medlineAbbreviation": "Oncogene", "isoabbreviation": "Oncogene", "title": "Oncogene", "issn": "0950-9232", "nlmid": "8711562", "essn": "1476-5594"}, "monthOfPublication": 11, "volume": "34", "yearOfPublication": 2015, "journalIssueId": 2340065, "issue": "45", "dateOfPublication": "2015 Nov"}}, "22683760": "", "22206013": "", "22721753": "", "26556829": {"pubYear": "2016", "dateOfCreation": "2016-01-09", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "0", "name": "SPG11 protein, human"}]}, "authorString": "Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, Pedroso JL, Terracciano C, Caltagirone C, Massa R, St George-Hyslop PH, Barsottini OG, Kawarai T, Orlacchio A.", "affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "089703"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "081864"}]}, "hasPDF": "N", "id": "26556829", "inEPMC": "N", "authorList": {"author": [{"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "fullName": "Montecchiani C", "initials": "C", "firstName": "Celeste", "lastName": "Montecchiani"}, {"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "fullName": "Pedace L", "initials": "L", "firstName": "Lucia", "lastName": "Pedace"}, {"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy 2 Dipartimento di Medicina dei Sistemi, Universit\u00e0 di Roma \"Tor Vergata\", Rome, Italy.", "fullName": "Lo Giudice T", "initials": "T", "firstName": "Temistocle", "lastName": "Lo Giudice"}, {"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "fullName": "Casella A", "initials": "A", "firstName": "Antonella", "lastName": "Casella"}, {"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "fullName": "Mearini M", "initials": "M", "firstName": "Marzia", "lastName": "Mearini"}, {"affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy.", "fullName": "Gaudiello F", "initials": "F", "firstName": "Fabrizio", "lastName": "Gaudiello"}, {"affiliation": "3 Department of Neurology, Universidade Federal de S\u00e3o Paulo, Brazil.", "fullName": "Pedroso JL", "initials": "JL", "firstName": "Jos\u00e9 L", "lastName": "Pedroso"}, {"affiliation": "2 Dipartimento di Medicina dei Sistemi, Universit\u00e0 di Roma \"Tor Vergata\", Rome, Italy.", "fullName": "Terracciano C", "initials": "C", "firstName": "Chiara", "lastName": "Terracciano"}, {"affiliation": "2 Dipartimento di Medicina dei Sistemi, Universit\u00e0 di Roma \"Tor Vergata\", Rome, Italy 4 Laboratorio di Neurologia Clinica e Comportamentale, IRCCS Santa Lucia, Rome, Italy.", "fullName": "Caltagirone C", "initials": "C", "firstName": "Carlo", "lastName": "Caltagirone"}, {"affiliation": "2 Dipartimento di Medicina dei Sistemi, Universit\u00e0 di Roma \"Tor Vergata\", Rome, Italy.", "fullName": "Massa R", "initials": "R", "firstName": "Roberto", "lastName": "Massa"}, {"affiliation": "5 Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada 6 Department of Medicine, University of Toronto, Toronto, Ontario, Canada 7 Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.", "fullName": "St George-Hyslop PH", "initials": "PH", "firstName": "Peter H", "lastName": "St George-Hyslop"}, {"affiliation": "3 Department of Neurology, Universidade Federal de S\u00e3o Paulo, Brazil.", "fullName": "Barsottini OG", "initials": "OG", "firstName": "Orlando G P", "lastName": "Barsottini"}, {"affiliation": "8 Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.", "fullName": "Kawarai T", "initials": "T", "firstName": "Toshitaka", "lastName": "Kawarai"}, {"firstName": "Antonio", "lastName": "Orlacchio", "affiliation": "1 Laboratorio di Neurogenetica, CERC - IRCCS Santa Lucia, Rome, Italy 2 Dipartimento di Medicina dei Sistemi, Universit\u00e0 di Roma \"Tor Vergata\", Rome, Italy a.orlacchio@hsantalucia.it.", "authorId": {"type": "ORCID", "value": "0000-0002-2602-3281"}, "fullName": "Orlacchio A", "initials": "A"}]}, "title": "ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.", "citedByCount": 1, "source": "MED", "pmid": "26556829", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2602-3281"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Charcot-Marie-Tooth Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Spastic Paraplegia, Hereditary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peripheral Nervous System Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Recessive", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-11-10", "doi": "10.1093/brain/awv320", "isOpenAccess": "N", "pageInfo": "73-85", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Axonal Degeneration", "Spatacsin", "Charcot\u2013marie\u2013tooth Disease", "Als5/spg11/kiaa1840 Mutations"]}, "abstractText": "Charcot-Marie-Tooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes. Hundreds of causative DNA changes have been found, but much of the genetic basis of the disease is still unexplained. Mutations in the ALS5/SPG11/KIAA1840 gene are a frequent cause of autosomal recessive hereditary spastic paraplegia with thin corpus callosum and peripheral axonal neuropathy, and account for \u223c 40% of autosomal recessive juvenile amyotrophic lateral sclerosis. The overlap of axonal Charcot-Marie-Tooth disease with both diseases, as well as the common autosomal recessive inheritance pattern of thin corpus callosum and axonal Charcot-Marie-Tooth disease in three related patients, prompted us to analyse the ALS5/SPG11/KIAA1840 gene in affected individuals with autosomal recessive axonal Charcot-Marie-Tooth disease. We investigated 28 unrelated families with autosomal recessive axonal Charcot-Marie-Tooth disease defined by clinical, electrophysiological, as well as pathological evaluation. Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6). Mitochondrial disorders related to Charcot-Marie-Tooth disease type 2 were also excluded by sequencing POLG and TYMP genes. An additional locus for autosomal recessive Charcot-Marie-Tooth disease type 2H on chromosome 8q13-21.1 was excluded by linkage analysis. Pedigrees originated in Italy, Brazil, Canada, England, Iran, and Japan. Interestingly, we identified 15 ALS5/SPG11/KIAA1840 mutations in 12 families (two sequence variants were never reported before, p.Gln198* and p.Pro2212fs*5). No large deletions/duplications were detected in these patients. The novel mutations seemed to be pathogenic since they co-segregated with the disease in all pedigrees and were absent in 300 unrelated controls. Furthermore, in silico analysis predicted their pathogenic effect. Our results indicate that ALS5/SPG11/KIAA1840 is the causative gene of a wide spectrum of clinical features, including autosomal recessive axonal Charcot-Marie-Tooth disease.", "electronicPublicationDate": "2015-11-10", "language": "eng", "dateOfCompletion": "2016-05-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1093/brain/awv320", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2016-02-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 1, "volume": "139", "yearOfPublication": 2016, "journalIssueId": 2361200, "issue": "Pt 1", "dateOfPublication": "2016 Jan"}}, "23990930": "", "17366478": "", "23963299": "", "24345775": {"pubYear": "2013", "dateOfCreation": "2013-12-18", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 5.3.99.3", "name": "prostaglandin-E synthase"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Receptors, Glucocorticoid"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "EC 5.2.1.-", "name": "Tacrolimus Binding Proteins"}, {"registryNumber": "0", "name": "BCL2-associated athanogene 1 protein"}, {"registryNumber": "EC 5.2.1.8", "name": "tacrolimus binding protein 5"}, {"registryNumber": "EC 5.3.-", "name": "Intramolecular Oxidoreductases"}]}, "authorString": "Sinclair D, Fillman SG, Webster MJ, Weickert CS.", "affiliation": "1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia [4] Neuropsychiatric Signaling Program, Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24345775", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Duncan", "lastName": "Sinclair", "affiliation": "1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia [4] Neuropsychiatric Signaling Program, Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania.", "authorId": {"type": "ORCID", "value": "0000-0001-5961-1007"}, "fullName": "Sinclair D", "initials": "D"}, {"affiliation": "1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.", "fullName": "Fillman SG", "initials": "SG", "firstName": "Stu G", "lastName": "Fillman"}, {"affiliation": "Stanley Medical Research Institute, Laboratory of Brain Research, 9800 Medical Center Drive, Rockville, Maryland 20850.", "fullName": "Webster MJ", "initials": "MJ", "firstName": "Maree J", "lastName": "Webster"}, {"affiliation": "1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.", "fullName": "Weickert CS", "initials": "CS", "firstName": "Cynthia Shannon", "lastName": "Weickert"}]}, "title": "Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "24345775", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5961-1007"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Tacrolimus Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intramolecular Oxidoreductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Glucocorticoid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sequence Analysis, RNA", "majorTopic_YN": "N"}, {"descriptorName": "Stress, Psychological", "majorTopic_YN": "N"}, {"descriptorName": "Bipolar Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-18", "language": "eng", "doi": "10.1038/srep03539", "isOpenAccess": "Y", "pageInfo": "3539", "pmcid": "PMC3866598", "hasDbCrossReferences": "N", "abstractText": "Molecular abnormalities within the glucocorticoid receptor (GR) stress signaling pathway may confer, or reflect, susceptibility to stress in schizophrenia and bipolar disorder, but the extent of such abnormalities in the brain is not known. Using RNA-Seq and qPCR in two postmortem cohorts totaling 55 schizophrenia, 34 bipolar disorder and 55 control individuals, we identified increased FKBP5 and PTGES3 mRNA expression, and decreased BAG1 mRNA expression, in the prefrontal cortex in schizophrenia cases relative to controls (68.0% [p < 0.001], 26.0% [p < 0.01] and 12.1% [p < 0.05] respectively). We also observed increased FKBP5 and decreased BAG1 mRNA expression in bipolar disorder (47.5% [p < 0.05] and 14.9% [p < 0.005]). There were no diagnostic differences in steady-state FKBP51 protein levels, nor in HSPA1A, HSP90AA1, DNAJB1 or HSPB1 mRNA levels. GR, co-factor and chaperone mRNA levels were strongly correlated. These results reveal coordinated cortical dysregulation of FKBP5, PTGES3, BAG1 and GR genes within the glucocorticoid signaling pathway in psychotic illness.", "electronicPublicationDate": "2013-12-18", "license": "cc by-nc-nd", "dateOfCompletion": "2014-10-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3866598?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3866598", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24345775", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24345775&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/srep03539", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Scientific reports", "medlineAbbreviation": "Sci Rep", "isoabbreviation": "Sci Rep", "nlmid": "101563288", "essn": "2045-2322"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2013, "journalIssueId": 1997451, "dateOfPublication": "2013 "}}, "14688473": "", "25997407": {"pubYear": "2015", "dateOfCreation": "2015-07-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Eye Proteins"}, {"registryNumber": "0", "name": "Ribonucleoproteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Tdrd7 protein, human"}]}, "authorString": "Shao DW, Yang CY, Liu B, Chen W, Wang H, Ru HX, Zhang M, Wang Y.", "affiliation": "Department of Ophthalmology, Air Force General Hospital of PLA, Beijing, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "25997407", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Ophthalmology, Air Force General Hospital of PLA, Beijing, China.", "fullName": "Shao DW", "initials": "DW", "firstName": "De-Wang", "lastName": "Shao"}, {"lastName": "Yang", "fullName": "Yang CY", "firstName": "Chun-Yan", "initials": "CY"}, {"lastName": "Liu", "fullName": "Liu B", "firstName": "Bing", "initials": "B"}, {"lastName": "Chen", "fullName": "Chen W", "firstName": "Wei", "initials": "W"}, {"lastName": "Wang", "fullName": "Wang H", "firstName": "Hua", "initials": "H"}, {"lastName": "Ru", "fullName": "Ru HX", "firstName": "Hai-Xia", "initials": "HX"}, {"lastName": "Zhang", "fullName": "Zhang M", "firstName": "Min", "initials": "M"}, {"lastName": "Wang", "fullName": "Wang Y", "firstName": "Ying", "initials": "Y"}]}, "title": "Bioinformatics Analysis of Potential Candidates for Therapy of TDRD7 Deficiency-Induced Congenital Cataract.", "citedByCount": 0, "source": "MED", "pmid": "25997407", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CN", "qualifierName": "congenital", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribonucleoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Eye Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microarray Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Computational Biology", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Regulatory Networks", "majorTopic_YN": "N"}, {"descriptorName": "Gene Knockdown Techniques", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-05-21", "doi": "10.1159/000381478", "isOpenAccess": "N", "pageInfo": "10-17", "hasDbCrossReferences": "N", "abstractText": "The aim of this study was to identify potential candidates and explore the possible mechanism in congenital cataract induced by tudor domain-containing 7 (TDRD7) deficiency.The gene expression profile GSE25812 generated from 18 samples was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between disease and normal groups were identified. Then, gene ontology and pathway enrichment analysis of DEGs were performed. The protein-protein interaction (PPI) network and transcription factor (TF) regulatory network were constructed. The modules in the PPI network were identified. Significant target genes were selected from the TF regulatory network.A total of 329 DEGs were obtained, and downregulated DEGs were significantly enriched in biological processes including defense response and immune response. In the PPI network, high-degree genes of complement component 1, q subcomponent, A/B/C chain (C1QA/C1QB/C1QC), lymphocyte antigen 86 (LY86) and neuroblastoma RAS viral oncogene homolog (NRAS) were identified. From the TF regulatory network, the heat shock 27 kDa protein 1 (HSPB1) was the target of the estrogen receptor 1, and LY86 was the target of the v-myc avian myelocytomatosis viral oncogene homolog.HSPB1, NRAS, immune response, defense response and the related genes LY86, C1QA/C1QB/C1QC may play an important role in the development of congenital cataract induced by TDRD7 deficiency. However, further experiments are still needed.", "electronicPublicationDate": "2015-05-21", "language": "eng", "dateOfCompletion": "2016-03-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1159/000381478", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Ophthalmic Res", "isoabbreviation": "Ophthalmic Res.", "title": "Ophthalmic research", "issn": "0030-3747", "nlmid": "0267442", "essn": "1423-0259"}, "monthOfPublication": 0, "volume": "54", "yearOfPublication": 2015, "journalIssueId": 2300638, "issue": "1", "dateOfPublication": "2015 "}}, "10766137": "", "27262845": {"pubYear": "2016", "dateOfCreation": "2016-06-05", "pubModel": "Print-Electronic", "authorString": "Wu D, Zhang M, Lu Y, Tang S, Kemper N, Hartung J, Bao E.", "affiliation": "College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27262845", "inEPMC": "N", "authorList": {"author": [{"affiliation": "College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.", "fullName": "Wu D", "initials": "D", "firstName": "Di", "lastName": "Wu"}, {"affiliation": "College of Animal Science and Technology, Jinling Institute of Technology, Nanjing, 210038, China.", "fullName": "Zhang M", "initials": "M", "firstName": "Miao", "lastName": "Zhang"}, {"affiliation": "College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.", "fullName": "Lu Y", "initials": "Y", "firstName": "Yinjun", "lastName": "Lu"}, {"affiliation": "College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.", "fullName": "Tang S", "initials": "S", "firstName": "Shu", "lastName": "Tang"}, {"affiliation": "Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.", "fullName": "Kemper N", "initials": "N", "firstName": "N", "lastName": "Kemper"}, {"affiliation": "Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.", "fullName": "Hartung J", "initials": "J", "firstName": "J", "lastName": "Hartung"}, {"affiliation": "College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China. b_endong@njau.edu.cn.", "fullName": "Bao E", "initials": "E", "firstName": "Endong", "lastName": "Bao"}]}, "title": "Aspirin-induced heat stress resistance in chicken myocardial cells can be suppressed by BAPTA-AM in vitro.", "citedByCount": 0, "source": "MED", "pmid": "27262845", "abstractText": "Our recent studies have displayed the protective functions of aspirin against heat stress (HS) in chicken myocardial cells, and it may be associated with heat shock proteins (HSPs). In this study, we further investigated the potential role of HSPs in the aspirin-induced heat stress resistance. Four of the most important HSPs including HspB1 (Hsp27), Hsp60, Hsp70, and Hsp90 were induced by aspirin pretreatment and were suppressed by BAPTA-AM. When HSPs were induced by aspirin, much slighter HS injury was detected. But more serious damages were observed when HSPs were suppressed by BAPTA-AM than those cells exposed to HS without BAPTA-AM, even the myocardial cells have been treated with aspirin in prior. Comparing to other HSPs, HspB1 presented the largest increase after aspirin treatments, 86-fold higher than the baseline (the level before HS). These findings suggested that multiple HSPs participated in aspirin's anti-heat stress function but HspB1 may contribute the most. Interestingly, during the experiments, we also found that apoptosis rate as well as the oxidative stress indicators (T-SOD and MDA) was not consistently responding to heat stress injury as expected. By selecting from a series of candidates, myocardial cell damage-related enzymes (CK-MB and LDH), cytopathological tests, and necrosis rate (measured by flow cytometry assays) are believed to be reliable indicators to evaluate heat stress injury in chicken's myocardial cells and they will be used in our further investigations.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-06-04", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Inhibitor", "Heat stress", "Myocardial cell", "aspirin", "Hsps", "Bapta-am"]}, "hasLabsLinks": "N", "electronicPublicationDate": "2016-06-04", "language": "eng", "dateOfRevision": "2016-06-05", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 6, "yearOfPublication": 2016, "journalIssueId": 2413575, "dateOfPublication": "2016 Jun"}}, "23643870": "", "26694816": {"pubYear": "2015", "dateOfCreation": "2015-12-23", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "HLA-DR Antigens"}, {"registryNumber": "0", "name": "Glial Fibrillary Acidic Protein"}, {"registryNumber": "0", "name": "Myelin Proteolipid Protein"}, {"registryNumber": "0", "name": "Heat-Shock Proteins, Small"}]}, "authorString": "Peferoen LA, Gerritsen WH, Breur M, Ummenthum KM, Peferoen-Baert RM, van der Valk P, van Noort JM, Amor S.", "affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. l.peferoen@vumc.nl.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26694816", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. l.peferoen@vumc.nl.", "fullName": "Peferoen LA", "initials": "LA", "firstName": "Laura A N", "lastName": "Peferoen"}, {"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. w.gerritsen@vumc.nl.", "fullName": "Gerritsen WH", "initials": "WH", "firstName": "Wouter H", "lastName": "Gerritsen"}, {"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. m.breur@vumc.nl.", "fullName": "Breur M", "initials": "M", "firstName": "Marjolein", "lastName": "Breur"}, {"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. k.ummenthum@vumc.nl.", "fullName": "Ummenthum KM", "initials": "KM", "firstName": "Kimberley M D", "lastName": "Ummenthum"}, {"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. r.peferoen-baert@vumc.nl.", "fullName": "Peferoen-Baert RM", "initials": "RM", "firstName": "Regina M B", "lastName": "Peferoen-Baert"}, {"affiliation": "Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. p.vandervalk@vumc.nl.", "fullName": "van der Valk P", "initials": "P", "firstName": "Paul", "lastName": "van der Valk"}, {"affiliation": "Delta Crystallon BV, Leiden, The Netherlands. hans@deltacrystallon.com.", "fullName": "van Noort JM", "initials": "JM", "firstName": "Johannes M", "lastName": "van Noort"}, {"affiliation": "Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. s.amor@vumc.nl.", "fullName": "Amor S", "initials": "S", "firstName": "Sandra", "lastName": "Amor"}]}, "title": "Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26694816", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Central Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glial Fibrillary Acidic Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Myelin Proteolipid Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "HLA-DR Antigens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Statistics, Nonparametric", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Heat-Shock Proteins, Small", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "White Matter", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gray Matter", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-12-22", "language": "eng", "doi": "10.1186/s40478-015-0267-2", "isOpenAccess": "Y", "pageInfo": "87", "pmcid": "PMC4688967", "hasDbCrossReferences": "Y", "abstractText": "The important protective role of small heat-shock proteins (HSPs) in regulating cellular survival and migration, counteracting protein aggregation, preventing apoptosis, and regulating inflammation in the central nervous system is now well-recognized. Yet, their role in the neuroinflammatory disorder multiple sclerosis (MS) is largely undocumented. With the exception of alpha B-crystallin (HSPB5), little is known about the roles of small HSPs in disease.Here, we examined the expression of four small HSPs during lesion development in MS, focussing on their cellular distribution, and regional differences between white matter (WM) and grey matter (GM). It is well known that MS lesions in these areas differ markedly in their pathology, with substantially more intense blood-brain barrier damage, leukocyte infiltration and microglial activation typifying WM but not GM lesions. We analysed transcript levels and protein distribution profiles for HSPB1, HSPB6, HSPB8 and HSPB11 in MS lesions at different stages, comparing them with normal-appearing brain tissue from MS patients and non-neurological controls. During active stages of demyelination in WM, and especially the centre of chronic active MS lesions, we found significantly increased expression of HSPB1, HSPB6 and HSPB8, but not HSPB11. When induced, small HSPs were exclusively found in astrocytes but not in oligodendrocytes, microglia or neurons. Surprisingly, while the numbers of astrocytes displaying high expression of small HSPs were markedly increased in actively demyelinating lesions in WM, no such induction was observed in GM lesions. This difference was particularly obvious in leukocortical lesions covering both WM and GM areas.Since induction of small HSPs in astrocytes is apparently a secondary response to damage, their differential expression between WM and GM likely reflects differences in mediators that accompany demyelination in either WM or GM during MS. Our findings also suggest that during MS, cortical structures fail to benefit from the protective actions of small HSPs.", "electronicPublicationDate": "2015-12-22", "license": "cc by", "dateOfCompletion": "2016-05-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4688967?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4688967", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s40478-015-0267-2", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-12-25", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Acta neuropathologica communications", "medlineAbbreviation": "Acta Neuropathol Commun", "isoabbreviation": "Acta Neuropathol Commun", "nlmid": "101610673", "essn": "2051-5960"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2015, "journalIssueId": 2267140, "dateOfPublication": "2015 "}}, "17568569": "", "20157854": "", "25155585": {"pubYear": "2015", "dateOfCreation": "2015-02-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "85622-93-1", "name": "temozolomide"}, {"registryNumber": "0", "name": "HSPB1 protein, human"}, {"registryNumber": "0", "name": "HSPA1A protein, human"}, {"registryNumber": "0", "name": "Antineoplastic Agents, Alkylating"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Heat-Shock Proteins"}, {"registryNumber": "EC 2.1.1.63", "name": "O(6)-Methylguanine-DNA Methyltransferase"}, {"registryNumber": "EC 6.5.1.-", "name": "DNA Repair Enzymes"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "HSP70 Heat-Shock Proteins"}, {"registryNumber": "0", "name": "HSC70 Heat-Shock Proteins"}, {"registryNumber": "EC 3.6.1.3", "name": "MutS Homolog 2 Protein"}, {"registryNumber": "EC 3.6.1.3", "name": "MSH2 protein, human"}, {"registryNumber": "0", "name": "MLH1 protein, human"}, {"registryNumber": "0", "name": "HSPA8 protein, human"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}, {"registryNumber": "7GR28W0FJI", "name": "Dacarbazine"}]}, "authorString": "Castro GN, Cayado-Guti\u00e9rrez N, Zoppino FC, Fanelli MA, Cuello-Carri\u00f3n FD, Sottile M, Nadin SB, Ciocca DR.", "affiliation": "Oncology Laboratory, IMBECU-CCT, CONICET, National Research Council, Av. Dr. Ruiz Leal s/n, Parque General San Mart\u00edn, CP 5500, Mendoza, Argentina.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25155585", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Oncology Laboratory, IMBECU-CCT, CONICET, National Research Council, Av. Dr. Ruiz Leal s/n, Parque General San Mart\u00edn, CP 5500, Mendoza, Argentina.", "fullName": "Castro GN", "initials": "GN", "firstName": "Gisela Natalia", "lastName": "Castro"}, {"lastName": "Cayado-Guti\u00e9rrez", "fullName": "Cayado-Guti\u00e9rrez N", "firstName": "Niubys", "initials": "N"}, {"lastName": "Zoppino", "fullName": "Zoppino FC", "firstName": "Felipe Carlos Mart\u00edn", "initials": "FC"}, {"lastName": "Fanelli", "fullName": "Fanelli MA", "firstName": "Mariel Andrea", "initials": "MA"}, {"lastName": "Cuello-Carri\u00f3n", "fullName": "Cuello-Carri\u00f3n FD", "firstName": "Fernando Dar\u00edo", "initials": "FD"}, {"lastName": "Sottile", "fullName": "Sottile M", "firstName": "Mayra", "initials": "M"}, {"lastName": "Nadin", "fullName": "Nadin SB", "authorId": {"type": "ORCID", "value": "0000-0002-1109-3156"}, "firstName": "Silvina Beatriz", "initials": "SB"}, {"lastName": "Ciocca", "fullName": "Ciocca DR", "firstName": "Daniel Ram\u00f3n", "initials": "DR"}]}, "title": "Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25155585", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-1109-3156"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glioma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dacarbazine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AA", "qualifierName": "analogs & derivatives", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Repair Enzymes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "O(6)-Methylguanine-DNA Methyltransferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antineoplastic Agents, Alkylating", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HSP70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSC70 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "MutS Homolog 2 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "embargoDate": "2015-09-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-08-26", "doi": "10.1007/s12192-014-0537-0", "isOpenAccess": "N", "pageInfo": "253-265", "pmcid": "PMC4326375", "hasDbCrossReferences": "N", "abstractText": "We previously reported the association of HSPA1A and HSPB1 with high-grade astrocytomas, suggesting that these proteins might be involved in disease outcome and response to treatment. With the aim to better understand the resistance/susceptibility processes associated to temozolomide (TMZ) treatment, the current study was performed in three human malignant glioma cell lines by focusing on several levels: (a) apoptotic index and senescence, (b) DNA damage, and (c) interaction of HSPB1 with players of the DNA damage response. Three human glioma cell lines, Gli36, U87, and DBTRG, were treated with TMZ evaluating cell viability and survival, apoptosis, senescence, and comets (comet assay). The expression of HSPA (HSPA1A and HSPA8), HSPB1, O6-methylguanine-DNA methyltransferase (MGMT), MLH1, and MSH2 was determined by immunocytochemistry, immunofluorescence, and Western blot. Immunoprecipitation was used to analyze protein interaction. The cell lines exhibited differences in viability, apoptosis, and senescence after TMZ administration. We then focused on Gli36 cells (relatively unstudied) which showed very low recovery capacity following TMZ treatment, and this was related to high DNA damage levels; however, the cells maintained their viability. In these cells, MGMT, MSH2, HSPA, and HSPB1 levels increased significantly after TMZ administration. In addition, MSH2 and HSPB1 proteins appeared co-localized by confocal microscopy. This co-localization increased after TMZ treatment, and in immunoprecipitation analysis, MSH2 and HSPB1 appeared interacting. In contrast, HSPB1 did not interact with MGMT. We show in glioma cells the biological effects of TMZ and how this drug affects the expression levels of heat shock proteins (HSPs), MGMT, MSH2, and MLH1. In Gli36 cells, the results suggest that interactions between HSPB1 and MSH2, including co-nuclear localization, may be important in determining cell sensitivity to TMZ.", "electronicPublicationDate": "2014-08-26", "language": "eng", "dateOfCompletion": "2015-11-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4326375?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4326375", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s12192-014-0537-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-09-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "Cell Stress Chaperones", "isoabbreviation": "Cell Stress Chaperones", "title": "Cell stress & chaperones", "issn": "1355-8145", "nlmid": "9610925", "essn": "1466-1268"}, "monthOfPublication": 3, "volume": "20", "yearOfPublication": 2015, "journalIssueId": 2253776, "issue": "2", "dateOfPublication": "2015 Mar"}}, "21745477": "", "8277336": "", "20858900": "", "24141048": "", "15296780": "", "23546289": "", "20514530": "", "18344398": "", "21757921": "", "22375124": "", "22176143": "", "24278676": "", "26675522": {"pubYear": "2015", "dateOfCreation": "2015-12-17", "pubModel": "Electronic-eCollection", "authorString": "Ylikallio E, Konovalova S, Dhungana Y, Hilander T, Junna N, Partanen JV, Toppila JP, Auranen M, Tyynismaa H.", "affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26675522", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Ylikallio E", "initials": "E", "firstName": "Emil", "lastName": "Ylikallio"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Konovalova S", "initials": "S", "firstName": "Svetlana", "lastName": "Konovalova"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Dhungana Y", "initials": "Y", "firstName": "Yogesh", "lastName": "Dhungana"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Hilander T", "initials": "T", "firstName": "Taru", "lastName": "Hilander"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Junna N", "initials": "N", "firstName": "Nella", "lastName": "Junna"}, {"affiliation": "Department of Clinical Neurophysiology, Medical Imaging Center, Helsinki University Central Hospital, Finland.", "fullName": "Partanen JV", "initials": "JV", "firstName": "Juhani V", "lastName": "Partanen"}, {"affiliation": "Department of Clinical Neurophysiology, Medical Imaging Center, Helsinki University Central Hospital, Finland.", "fullName": "Toppila JP", "initials": "JP", "firstName": "Jussi P", "lastName": "Toppila"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland ; Department of Neurology, Helsinki University Central Hospital, Helsinki 00290, Finland.", "fullName": "Auranen M", "initials": "M", "firstName": "Mari", "lastName": "Auranen"}, {"affiliation": "Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, Helsinki 00290, Finland ; Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki 00290, Finland.", "fullName": "Tyynismaa H", "initials": "H", "firstName": "Henna", "lastName": "Tyynismaa"}]}, "title": "Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26675522", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-03-11", "language": "eng", "doi": "10.1016/j.bbacli.2015.03.002", "isOpenAccess": "Y", "pageInfo": "233-242", "pmcid": "PMC4661565", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Heat Shock protein", "protein misfolding", "Hspb1", "Charcot\u2013marie\u2013tooth Neuropathy", "Emg, Electromyography", "Qst, Quantitative Sensory Testing", "Acd, \u0391-crystalline Domain", "Cadd, Combined Annotation Dependent Depletion", "Cmt, Charcot\u2013marie\u2013tooth Disease", "Dhmn, Distal Hereditary Motor Neuropathy", "Enmg, Electroneuromyography", "Evs, Exome Variant Server", "Mup, Motor Unit Potential", "Shsp, Small Heat Shock Protein", "Sisu, Sequencing Initiative Suomi"]}, "abstractText": "HSPB1 belongs to the family of small heat shock proteins (sHSP) that have importance in protection against unfolded protein stress, in cancer cells for escaping drug toxicity stress and in neurons for suppression of protein aggregates. sHSPs have a conserved \u03b1-crystalline domain (ACD), flanked by variable N- and C-termini, whose functions are not fully understood. Dominant missense variants in HSPB1, locating mostly to the ACD, have been linked to inherited neuropathy.Patients underwent detailed clinical and neurophysiologic characterization. Disease causing variants were identified by exome or gene panel sequencing. Primary patient fibroblasts were used to investigate the effects of the dominant defective HSPB1 proteins.Frameshift variant predicting ablation of the entire C-terminus p.(Met169Cfs2*) of HSPB1 and a missense variant p.(Arg127Leu) were identified in patients with dominantly inherited motor-predominant axonal Charcot-Marie-Tooth neuropathy. We show that the truncated protein is stable and binds wild type HSPB1. Both mutations impaired the heat stress tolerance of the fibroblasts. This effect was particularly pronounced for the cells with the truncating variant, independent of heat-induced nuclear translocation and induction of global transcriptional heat response. Furthermore, the truncated HSPB1 increased cellular sensitivity to protein misfolding.Our results suggest that truncation of the non-conserved C-terminus impairs the function of HSPB1 in cellular stress response.sHSPs have important roles in prevention of protein aggregates that induce toxicity. We showed that C-terminal part of HSPB1 is critical for tolerance of unfolded protein stress, and when lacking causes axonal neuropathy in patients.", "electronicPublicationDate": "2015-03-11", "license": "cc by-nc-nd", "dateOfCompletion": "2015-12-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4661565?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4661565", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.bbacli.2015.03.002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-12-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"title": "BBA clinical", "medlineAbbreviation": "BBA Clin", "isoabbreviation": "BBA Clin", "nlmid": "101633879", "essn": "2214-6474"}, "monthOfPublication": 6, "volume": "3", "yearOfPublication": 2015, "journalIssueId": 2239321, "dateOfPublication": "2015 Jun"}}, "16648970": "", "25471284": {"pubYear": "2014", "dateOfCreation": "2014-12-16", "pubModel": "Electronic", "authorString": "Stallings JD, Ippolito DL, Rakesh V, Baer CE, Dennis WE, Helwig BG, Jackson DA, Leon LR, Lewis JA, Reifman J.", "affiliation": "Environmental Health Program, U,S, Army Center for Environmental Health Research, Bldg, 568 Doughten Drive, MD 21702-5010 Fort Detrick, Maryland. jonathan.d.stallings.mil@mail.mil.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}, "hasPDF": "Y", "id": "25471284", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Jonathan D", "lastName": "Stallings", "affiliation": "Environmental Health Program, U,S, Army Center for Environmental Health Research, Bldg, 568 Doughten Drive, MD 21702-5010 Fort Detrick, Maryland. jonathan.d.stallings.mil@mail.mil.", "authorId": {"type": "ORCID", "value": "0000-0002-6430-5888"}, "fullName": "Stallings JD", "initials": "JD"}, {"lastName": "Ippolito", "fullName": "Ippolito DL", "firstName": "Danielle L", "initials": "DL"}, {"lastName": "Rakesh", "fullName": "Rakesh V", "firstName": "Vineet", "initials": "V"}, {"lastName": "Baer", "fullName": "Baer CE", "firstName": "Christine E", "initials": "CE"}, {"lastName": "Dennis", "fullName": "Dennis WE", "firstName": "William E", "initials": "WE"}, {"lastName": "Helwig", "fullName": "Helwig BG", "firstName": "Bryan G", "initials": "BG"}, {"lastName": "Jackson", "fullName": "Jackson DA", "firstName": "David A", "initials": "DA"}, {"lastName": "Leon", "fullName": "Leon LR", "firstName": "Lisa R", "initials": "LR"}, {"lastName": "Lewis", "fullName": "Lewis JA", "firstName": "John A", "initials": "JA"}, {"lastName": "Reifman", "fullName": "Reifman J", "firstName": "Jaques", "initials": "J"}]}, "title": "Patterns of gene expression associated with recovery and injury in heat-stressed rats.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "25471284", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6430-5888"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Cardiomyopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Heat Stress Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "Y"}, {"descriptorName": "Proteomics", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Protein Folding", "majorTopic_YN": "N"}, {"descriptorName": "Heat-Shock Response", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Models, Biological", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Hot Temperature", "majorTopic_YN": "Y"}, {"descriptorName": "Unfolded Protein Response", "majorTopic_YN": "N"}, {"descriptorName": "Transcriptome", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-12-03", "language": "eng", "doi": "10.1186/1471-2164-15-1058", "isOpenAccess": "Y", "pageInfo": "1058", "pmcid": "PMC4302131", "hasDbCrossReferences": "N", "abstractText": "BACKGROUND: The in vivo gene response associated with hyperthermia is poorly understood. Here, we perform a global, multiorgan characterization of the gene response to heat stress using an in vivo conscious rat model. RESULTS: We heated rats until implanted thermal probes indicated a maximal core temperature of 41.8\u00b0C (Tc,Max). We then compared transcriptomic profiles of liver, lung, kidney, and heart tissues harvested from groups of experimental animals at Tc,Max, 24 hours, and 48 hours after heat stress to time-matched controls kept at an ambient temperature. Cardiac histopathology at 48 hours supported persistent cardiac injury in three out of six animals. Microarray analysis identified 78 differentially expressed genes common to all four organs at Tc,Max. Self-organizing maps identified gene-specific signatures corresponding to protein-folding disorders in heat-stressed rats with histopathological evidence of cardiac injury at 48 hours. Quantitative proteomics analysis by iTRAQ (isobaric tag for relative and absolute quantitation) demonstrated that differential protein expression most closely matched the transcriptomic profile in heat-injured animals at 48 hours. Calculation of protein supersaturation scores supported an increased propensity of proteins to aggregate for proteins that were found to be changing in abundance at 24 hours and in animals with cardiac injury at 48 hours, suggesting a mechanistic association between protein misfolding and the heat-stress response. CONCLUSIONS: Pathway analyses at both the transcript and protein levels supported catastrophic deficits in energetics and cellular metabolism and activation of the unfolded protein response in heat-stressed rats with histopathological evidence of persistent heat injury, providing the basis for a systems-level physiological model of heat illness and recovery.", "electronicPublicationDate": "2014-12-03", "license": "cc by", "dateOfCompletion": "2015-07-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4302131?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4302131", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1471-2164-15-1058", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "BMC genomics", "medlineAbbreviation": "BMC Genomics", "isoabbreviation": "BMC Genomics", "nlmid": "100965258", "essn": "1471-2164"}, "monthOfPublication": 0, "volume": "15", "yearOfPublication": 2014, "journalIssueId": 2131045, "dateOfPublication": "2014 "}}, "17661394": "", "22465036": "", "22545178": "", "16541790": "", "7777477": "", "20142617": "", "18479397": "", "25577368": {"pubYear": "2015", "dateOfCreation": "2015-04-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Hspb1 protein, rat"}, {"registryNumber": "0", "name": "Autoantigens"}, {"registryNumber": "0", "name": "S100 Proteins"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}]}, "authorString": "Casola C, Schiwek JE, Reinehr S, Kuehn S, Grus FH, Kramer M, Dick HB, Joachim SC.", "affiliation": "Experimental Eye Research Institute, Eye Hospital, Ruhr-University Bochum, In der Schornau 23-25, 44892, Bochum, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25577368", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Experimental Eye Research Institute, Eye Hospital, Ruhr-University Bochum, In der Schornau 23-25, 44892, Bochum, Germany.", "fullName": "Casola C", "initials": "C", "firstName": "Christina", "lastName": "Casola"}, {"lastName": "Schiwek", "fullName": "Schiwek JE", "firstName": "Jennifer E", "initials": "JE"}, {"lastName": "Reinehr", "fullName": "Reinehr S", "firstName": "Sabrina", "initials": "S"}, {"lastName": "Kuehn", "fullName": "Kuehn S", "firstName": "Sandra", "initials": "S"}, {"lastName": "Grus", "fullName": "Grus FH", "firstName": "Franz H", "initials": "FH"}, {"lastName": "Kramer", "fullName": "Kramer M", "firstName": "Martin", "initials": "M"}, {"lastName": "Dick", "fullName": "Dick HB", "firstName": "H Burkhard", "initials": "HB"}, {"lastName": "Joachim", "fullName": "Joachim SC", "firstName": "Stephanie C", "initials": "SC"}]}, "title": "S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model.", "citedByCount": 2, "source": "MED", "pmid": "25577368", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neuroglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinal Ganglion Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Inbred Lew", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoimmune Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "S100 Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantigens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-11", "doi": "10.1007/s12031-014-0485-2", "isOpenAccess": "N", "pageInfo": "228-236", "hasDbCrossReferences": "N", "abstractText": "As previously shown, immunization with ocular antigens, like heat shock protein 27 (HSP 27), leads to retinal ganglion cell loss in an autoimmune glaucoma model. Aim of this study was to assess how immunization with S100 alone and in combination with HSP 27 affects retinal ganglion and macroglia cells. Rats were immunized with S100 or S100 plus HSP 27 (COMB). Neuronal cell density was evaluated on Nissl-stained flatmounts. Immunized groups showed a significant neuronal cell loss (S100, p\u2009=\u20090.005; COMB, p\u2009=\u20090.0005). A significant loss of retinal ganglion cells was also observed in both immunized groups on Brn-3a stained retinal cross-sections (S100, p\u2009=\u20090.003; COMB, p\u2009=\u20090.001). An increase in GFAP(+) area was noted in both groups (S100, p\u2009=\u20090.01; COMB, p\u2009=\u20090.001). In contrary, vimentin staining was not altered (S100/COMB, p\u2009>\u20090.05). In summary, immunization with solely S100 leads to retinal ganglion cell damage and reactive gliosis. While the combination of S100 plus HSP 27 also caused retinal ganglion cell loss and a glia response, the combination of the two antigens did not cause additional damage or more severe cell loss. We assume that both antigens might interact, possibly having inhibitory effects on each other and thus preventing additional damage to the retina.", "electronicPublicationDate": "2015-01-11", "language": "eng", "dateOfCompletion": "2015-12-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s12031-014-0485-2", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "J Mol Neurosci", "isoabbreviation": "J. Mol. Neurosci.", "title": "Journal of molecular neuroscience : MN", "issn": "0895-8696", "nlmid": "9002991", "essn": "1559-1166"}, "monthOfPublication": 5, "volume": "56", "yearOfPublication": 2015, "journalIssueId": 2269644, "issue": "1", "dateOfPublication": "2015 May"}}, "20178975": "", "25847151": {"pubYear": "2015", "dateOfCreation": "2015-05-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Mitochondrial Proteins"}]}, "authorString": "Pareyson D, Saveri P, Sagnelli A, Piscosquito G.", "affiliation": "Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences - IRCCS Foundation, \"C. Besta\" Neurological Institute, Milan, Italy. Electronic address: davide.pareyson@istituto-besta.it.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "25847151", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences - IRCCS Foundation, \"C. Besta\" Neurological Institute, Milan, Italy. Electronic address: davide.pareyson@istituto-besta.it.", "fullName": "Pareyson D", "initials": "D", "firstName": "Davide", "lastName": "Pareyson"}, {"affiliation": "Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences - IRCCS Foundation, \"C. Besta\" Neurological Institute, Milan, Italy.", "fullName": "Saveri P", "initials": "P", "firstName": "Paola", "lastName": "Saveri"}, {"affiliation": "Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences - IRCCS Foundation, \"C. Besta\" Neurological Institute, Milan, Italy.", "fullName": "Sagnelli A", "initials": "A", "firstName": "Anna", "lastName": "Sagnelli"}, {"firstName": "Giuseppe", "lastName": "Piscosquito", "affiliation": "Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences - IRCCS Foundation, \"C. Besta\" Neurological Institute, Milan, Italy.", "authorId": {"type": "ORCID", "value": "0000-0001-6768-8936"}, "fullName": "Piscosquito G", "initials": "G"}]}, "title": "Mitochondrial dynamics and inherited peripheral nerve diseases.", "citedByCount": 2, "source": "MED", "pmid": "25847151", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6768-8936"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Charcot-Marie-Tooth Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Axonal Transport", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Hereditary Sensory and Motor Neuropathy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Dynamics", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-04-03", "doi": "10.1016/j.neulet.2015.04.001", "isOpenAccess": "N", "pageInfo": "66-77", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Axonal Transport", "Mfn2", "Charcot\u2013marie\u2013tooth Disease", "Mitochondrial Fusion And Fission", "Gdap1", "Mitochondrial Dynamic"]}, "abstractText": "Peripheral nerves have peculiar energetic requirements because of considerable length of axons and therefore correct mitochondria functioning and distribution along nerves is fundamental. Mitochondrial dynamics refers to the continuous change in size, shape, and position of mitochondria within cells. Abnormalities of mitochondrial dynamics produced by mutations in proteins involved in mitochondrial fusion (mitofusin-2, MFN2), fission (ganglioside-induced differentiation-associated protein-1, GDAP1), and mitochondrial axonal transport usually present with a Charcot-Marie-Tooth disease (CMT) phenotype. MFN2 mutations cause CMT type 2A by altering mitochondrial fusion and trafficking along the axonal microtubule system. CMT2A is an axonal autosomal dominant CMT type which in most cases is characterized by early onset and rather severe course. GDAP1 mutations also alter fission, fusion and transport of mitochondria and are associated either with recessive demyelinating (CMT4A) and axonal CMT (AR-CMT2K) and, less commonly, with dominant, milder, axonal CMT (CMT2K). OPA1 (Optic Atrophy-1) is involved in fusion of mitochondrial inner membrane, and its heterozygous mutations lead to early-onset and progressive dominant optic atrophy which may be complicated by other neurological symptoms including peripheral neuropathy. Mutations in several proteins fundamental for the axonal transport or forming the axonal cytoskeleton result in peripheral neuropathy, i.e., CMT, distal hereditary motor neuropathy (dHMN) or hereditary sensory and autonomic neuropathy (HSAN), as well as in hereditary spastic paraplegia. Indeed, mitochondrial transport involves directly or indirectly components of the kinesin superfamily (KIF5A, KIF1A, KIF1B), responsible of anterograde transport, and of the dynein complex and related proteins (DYNC1H1, dynactin, dynamin-2), implicated in retrograde flow. Microtubules, neurofilaments, and chaperones such as heat shock proteins (HSPs) also have a fundamental role in mitochondrial transport and mutations in some of related encoding genes cause peripheral neuropathy (TUBB3, NEFL, HSPB1, HSPB8, HSPB3, DNAJB2). In this review, we address the abnormalities in mitochondrial dynamics and their role in determining CMT disease and related neuropathies.", "electronicPublicationDate": "2015-04-03", "language": "eng", "dateOfCompletion": "2015-10-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neulet.2015.04.001", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"medlineAbbreviation": "Neurosci Lett", "isoabbreviation": "Neurosci. Lett.", "title": "Neuroscience letters", "issn": "0304-3940", "nlmid": "7600130", "essn": "1872-7972"}, "monthOfPublication": 6, "volume": "596", "yearOfPublication": 2015, "journalIssueId": 2283336, "dateOfPublication": "2015 Jun"}}, "22566955": "", "22031878": "", "25982666": {"pubYear": "2016", "dateOfCreation": "2015-12-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "HSPB1 protein, human"}, {"registryNumber": "0", "name": "HSP27 Heat-Shock Proteins"}]}, "authorString": "Nakayoshi T, Adachi H, Ohbu-Murayama K, Enomono M, Fukami A, Kumagai E, Nakamura S, Nohara Y, Nakao E, Sasaki K, Fukumoto Y.", "affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25982666", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Nakayoshi T", "initials": "T", "firstName": "Takaharu", "lastName": "Nakayoshi"}, {"affiliation": "Department of Community Medicine, Kurume University School of Medicine, Kurume, Japan. Electronic address: hadac@med.kurume-u.ac.jp.", "fullName": "Adachi H", "initials": "H", "firstName": "Hisashi", "lastName": "Adachi"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Ohbu-Murayama K", "initials": "K", "firstName": "Kyoko", "lastName": "Ohbu-Murayama"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Enomono M", "initials": "M", "firstName": "Mika", "lastName": "Enomono"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Fukami A", "initials": "A", "firstName": "Ako", "lastName": "Fukami"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Kumagai E", "initials": "E", "firstName": "Eita", "lastName": "Kumagai"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Nakamura S", "initials": "S", "firstName": "Sachiko", "lastName": "Nakamura"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Nohara Y", "initials": "Y", "firstName": "Yume", "lastName": "Nohara"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Nakao E", "initials": "E", "firstName": "Erika", "lastName": "Nakao"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Sasaki K", "initials": "K", "firstName": "Ken-Ichiro", "lastName": "Sasaki"}, {"affiliation": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, Kurume, Japan.", "fullName": "Fukumoto Y", "initials": "Y", "firstName": "Yoshihiro", "lastName": "Fukumoto"}]}, "title": "Plasma heat shock protein 27 is increased in renal dysfunction and habitual smoking in a Japanese general population.", "citedByCount": 0, "source": "MED", "pmid": "25982666", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Kidney Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glomerular Filtration Rate", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Japan", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "HSP27 Heat-Shock Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-05-14", "doi": "10.1016/j.jjcc.2015.04.005", "isOpenAccess": "N", "pageInfo": "110-114", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Heat Shock protein", "epidemiology", "Smoking Habits", "General Population"]}, "abstractText": "Heat shock proteins (HSPs) work as \"chaperones\" to affect protein folding of newly synthesized or denatured proteins. HSP 27 plays an important role in coronary artery disease or renal disease as the result of oxidative stress. Although habitual smoking is well known to induce oxidative stress, there is no epidemiological evidence between plasma HSP 27 and renal dysfunction or smoking habits.A total of 451 residents (167 men and 284 women, age 65.7 years) underwent a history and physical examination, and determination of blood chemistries, including plasma levels of HSP 27. HSP 27 levels were measured by using enzyme-linked immunosorbent assay kits.Elevated HSP 27 levels were independently associated with estimated glomerular filtration rate (eGFR) (p<0.001) and smoking habits (p<0.05). HSP 27 levels were significantly decreased stratified by groups of eGFR (p<0.001 for trend) by analysis of co-variance (ANCOVA) adjusted for age, sex, and smoking habits. HSP 27 levels were increased with more smoking of cigarettes. In particular, HSP 27 levels were increased in the heavy smokers (\u226520cigarettes/day) by ANCOVA adjusted for age, sex, and eGFR compared with non-smokers and light smokers (p<0.05 for trend).The present study demonstrated that HSP 27 levels were strongly related to renal dysfunction and habitual smoking in a dose-response manner in a Japanese general population.", "electronicPublicationDate": "2015-05-14", "language": "eng", "dateOfCompletion": "2016-08-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jjcc.2015.04.005", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "J Cardiol", "isoabbreviation": "J Cardiol", "title": "Journal of cardiology", "issn": "0914-5087", "nlmid": "8804703", "essn": "1876-4738"}, "monthOfPublication": 1, "volume": "67", "yearOfPublication": 2016, "journalIssueId": 2357343, "issue": "1", "dateOfPublication": "2016 Jan"}}, "25178427": {"pubYear": "2015", "dateOfCreation": "2015-01-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phospholipids"}, {"registryNumber": "33515-09-2", "name": "Gonadotropin-Releasing Hormone"}]}, "authorString": "Wortmann SB, Espeel M, Almeida L, Reimer A, Bosboom D, Roels F, de Brouwer AP, Wevers RA.", "affiliation": "Nijmegen Centre for Mitochondrial Disorders (NCMD) at the Amalia Children's Hospital, Radboudumc, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "25178427", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Nijmegen Centre for Mitochondrial Disorders (NCMD) at the Amalia Children's Hospital, Radboudumc, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "fullName": "Wortmann SB", "initials": "SB", "firstName": "Saskia B", "lastName": "Wortmann"}, {"lastName": "Espeel", "fullName": "Espeel M", "firstName": "Marc", "initials": "M"}, {"lastName": "Almeida", "fullName": "Almeida L", "authorId": {"type": "ORCID", "value": "0000-0003-1370-961X"}, "firstName": "Ligia", "initials": "L"}, {"lastName": "Reimer", "fullName": "Reimer A", "firstName": "Annette", "initials": "A"}, {"lastName": "Bosboom", "fullName": "Bosboom D", "firstName": "Dennis", "initials": "D"}, {"lastName": "Roels", "fullName": "Roels F", "firstName": "Frank", "initials": "F"}, {"lastName": "de Brouwer", "fullName": "de Brouwer AP", "firstName": "Arjan P M", "initials": "AP"}, {"lastName": "Wevers", "fullName": "Wevers RA", "firstName": "Ron A", "initials": "RA"}]}, "title": "Inborn errors of metabolism in the biosynthesis and remodelling of phospholipids.", "citedByCount": 0, "source": "MED", "pmid": "25178427", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1370-961X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Osteochondrodysplasias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Muscular Dystrophies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Spastic Paraplegia, Hereditary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anophthalmos", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microphthalmos", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hemolytic-Uremic Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cardiomyopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hypogonadism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phospholipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Family Health", "majorTopic_YN": "N"}, {"descriptorName": "Gonadotropin-Releasing Hormone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Barth Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-09-02", "doi": "10.1007/s10545-014-9759-7", "isOpenAccess": "N", "pageInfo": "99-110", "hasDbCrossReferences": "N", "abstractText": "Since the proposal to define a separate subgroup of inborn errors of metabolism involved in the biosynthesis and remodelling of phospholipids, sphingolipids and long chain fatty acids in 2013, this group is rapidly expanding. This review focuses on the disorders involved in the biosynthesis of phospholipids. Phospholipids are involved in uncountable cellular processes, e.g. as structural components of membranes, by taking part in vesicle and mitochondrial fusion and fission or signal transduction. Here we provide an overview on both pathophysiology and the extremely heterogeneous clinical presentations of the disorders reported so far (Sengers syndrome (due to mutations in AGK), MEGDEL syndrome (or SERAC defect, SERAC1), Barth syndrome (or TAZ defect, TAZ), congenital muscular dystrophy due to CHKB deficiency (CHKB). Boucher-Neuh\u00e4user/Gordon Holmes syndrome (PNPLA6), PHARC syndrome (ABHD12), hereditary spastic paraplegia type 28, 54 and 56 (HSP28, DDHD1; HSP54, DDHD2; HSP56, CYP2U1), Lenz Majewski syndrome (PTDSS1), spondylometaphyseal dysplasia with cone-rod dystrophy (PCYT1A), atypical haemolytic-uremic syndrome due to DGKE deficiency (DGKE).", "electronicPublicationDate": "2014-09-02", "language": "eng", "dateOfCompletion": "2015-10-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10545-014-9759-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "J Inherit Metab Dis", "isoabbreviation": "J. Inherit. Metab. Dis.", "title": "Journal of inherited metabolic disease", "issn": "0141-8955", "nlmid": "7910918", "essn": "1573-2665"}, "monthOfPublication": 1, "volume": "38", "yearOfPublication": 2015, "journalIssueId": 2237978, "issue": "1", "dateOfPublication": "2015 Jan"}}}, "C10orf2": {"14635118": "", "21951382": {"pubYear": "2011", "dateOfCreation": "2012-04-27", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.17.4.-", "name": "RRM2B protein, human"}, {"registryNumber": "EC 2.7.7.-", "name": "POLG protein, human"}, {"registryNumber": "EC 2.7.7.7", "name": "DNA-Directed DNA Polymerase"}, {"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 1.17.4.-", "name": "Ribonucleotide Reductases"}]}, "authorString": "Takata A, Kato M, Nakamura M, Yoshikawa T, Kanba S, Sano A, Kato T.", "affiliation": "Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "Y", "id": "21951382", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.", "fullName": "Takata A", "initials": "A", "firstName": "Atsushi", "lastName": "Takata"}, {"lastName": "Kato", "fullName": "Kato M", "firstName": "Maiko", "initials": "M"}, {"lastName": "Nakamura", "fullName": "Nakamura M", "firstName": "Masayuki", "initials": "M"}, {"lastName": "Yoshikawa", "fullName": "Yoshikawa T", "firstName": "Takeo", "initials": "T"}, {"lastName": "Kanba", "fullName": "Kanba S", "firstName": "Shigenobu", "initials": "S"}, {"lastName": "Sano", "fullName": "Sano A", "firstName": "Akira", "initials": "A"}, {"lastName": "Kato", "fullName": "Kato T", "firstName": "Tadafumi", "initials": "T"}]}, "title": "Exome sequencing identifies a novel missense variant in RRM2B associated with autosomal recessive progressive external ophthalmoplegia.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "21951382", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["omim"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7856-3952"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribonucleotide Reductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Directed DNA Polymerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Analysis, DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Homozygote", "majorTopic_YN": "N"}, {"descriptorName": "Inheritance Patterns", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Testing", "majorTopic_YN": "N"}, {"descriptorName": "Exome", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2011-09-28", "language": "eng", "doi": "10.1186/gb-2011-12-9-r92", "isOpenAccess": "Y", "pageInfo": "R92", "pmcid": "PMC3308055", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Whole-exome sequencing using next-generation technologies has been previously demonstrated to be able to detect rare disease-causing variants. Progressive external ophthalmoplegia (PEO) is an inherited mitochondrial disease that follows either autosomal dominant or recessive forms of inheritance (adPEO or arPEO). AdPEO is a genetically heterogeneous disease and several genes, including POLG1 and C10orf2/Twinkle, have been identified as responsible genes. On the other hand, POLG1 was the only established gene causing arPEO with mitochondrial DNA deletions. We previously reported a case of PEO with unidentified genetic etiology. The patient was born of a first-cousin marriage. Therefore, the recessive form of inheritance was suspected. RESULTS: To identify the disease-causing variant in this patient, we subjected the patient's DNA to whole-exome sequencing and narrowed down the candidate variants using public data and runs of homozygosity analysis. A total of 35 novel, putatively functional variants were detected in the homozygous segments. When we sorted these variants by the conservation score, a novel missense variant in RRM2B, whose heterozygous rare variant had been known to cause adPEO, was ranked at the top. The list of novel, putatively functional variants did not contain any other variant in genes encoding mitochondrial proteins registered in MitoCarta. CONCLUSIONS: Exome sequencing efficiently and effectively identified a novel, homozygous missense variant in RRM2B, which was strongly suggested to be causative for arPEO. The findings in this study indicate arPEO to be a genetically heterogeneous disorder, as is the case for adPEO.", "electronicPublicationDate": "2011-09-28", "license": "cc by", "dateOfCompletion": "2012-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3308055?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3308055", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21951382&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21951382", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/gb-2011-12-9-r92", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Genome Biol", "isoabbreviation": "Genome Biol.", "title": "Genome biology", "issn": "1474-7596", "nlmid": "100960660", "essn": "1474-760X"}, "monthOfPublication": 0, "volume": "12", "yearOfPublication": 2011, "journalIssueId": 1926586, "issue": "9", "dateOfPublication": "2011 "}}, "16919951": "", "17357142": {"pubYear": "2007", "dateOfCreation": "2007-05-31", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Levodopa"}, {"registryNumber": "0", "name": "Antiparkinson Agents"}, {"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Wilcox RA, Churchyard A, Dahl HH, Hutchison WM, Kirby DM, Thyagarajan D.", "affiliation": "Department of Neurology, Flinders Medical Centre, SA, Australia. robert_wilcox@health.qld.gov.au", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17357142", "inEPMC": "N", "authorList": {"author": [{"lastName": "Wilcox", "fullName": "Wilcox RA", "firstName": "Robert A", "initials": "RA"}, {"lastName": "Churchyard", "fullName": "Churchyard A", "firstName": "Andrew", "initials": "A"}, {"lastName": "Dahl", "fullName": "Dahl HH", "firstName": "Henrik H", "initials": "HH"}, {"lastName": "Hutchison", "fullName": "Hutchison WM", "firstName": "Wendy M", "initials": "WM"}, {"lastName": "Kirby", "fullName": "Kirby DM", "firstName": "Denise M", "initials": "DM"}, {"lastName": "Thyagarajan", "fullName": "Thyagarajan D", "firstName": "Dominic", "initials": "D"}]}, "title": "Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.", "citedByCount": 4, "source": "MED", "pmid": "17357142", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosome Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Levodopa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antiparkinson Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pharmacogenetics", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-05-01", "doi": "10.1002/mds.21416", "isOpenAccess": "N", "pageInfo": "1020-1023", "hasDbCrossReferences": "N", "abstractText": "We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy.", "language": "eng", "dateOfCompletion": "2007-08-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/mds.21416", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-05-01", "journal": {"medlineAbbreviation": "Mov Disord", "isoabbreviation": "Mov. Disord.", "title": "Movement disorders : official journal of the Movement Disorder Society", "issn": "0885-3185", "nlmid": "8610688", "essn": "1531-8257"}, "monthOfPublication": 5, "volume": "22", "yearOfPublication": 2007, "journalIssueId": 1397826, "issue": "7", "dateOfPublication": "2007 May"}}, "19513767": {"pubYear": "2010", "dateOfCreation": "2010-01-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "Echaniz-Laguna A, Chanson JB, Wilhelm JM, Sellal F, Mayen\u00e7on M, Mohr M, Tranchant C, Mousson de Camaret B.", "affiliation": "D\u00e9partement de Neurologie, H\u00f4pital Civil, BP 426, 67091, Strasbourg, France, Echaniz-Laguna@medecine.u-strasbg.fr", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "19513767", "inEPMC": "N", "authorList": {"author": [{"lastName": "Echaniz-Laguna", "fullName": "Echaniz-Laguna A", "firstName": "Andoni", "initials": "A"}, {"lastName": "Chanson", "fullName": "Chanson JB", "authorId": {"type": "ORCID", "value": "0000-0003-4221-3840"}, "firstName": "Jean-Baptiste", "initials": "JB"}, {"lastName": "Wilhelm", "fullName": "Wilhelm JM", "firstName": "Jean-Marie", "initials": "JM"}, {"lastName": "Sellal", "fullName": "Sellal F", "firstName": "Fran\u00e7ois", "initials": "F"}, {"lastName": "Mayen\u00e7on", "fullName": "Mayen\u00e7on M", "firstName": "Martine", "initials": "M"}, {"lastName": "Mohr", "fullName": "Mohr M", "firstName": "Michel", "initials": "M"}, {"lastName": "Tranchant", "fullName": "Tranchant C", "firstName": "Christine", "initials": "C"}, {"lastName": "Mousson de Camaret", "fullName": "Mousson de Camaret B", "firstName": "B\u00e9n\u00e9dicte", "initials": "B"}]}, "title": "A novel variation in the Twinkle linker region causing late-onset dementia.", "citedByCount": 5, "source": "MED", "pmid": "19513767", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4221-3840"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Muscular Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dementia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Neurophysiology", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Age of Onset", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Dominant", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-06-10", "doi": "10.1007/s10048-009-0202-4", "isOpenAccess": "N", "pageInfo": "21-25", "hasDbCrossReferences": "Y", "abstractText": "Variations in the mitochondrial helicase Twinkle (PEO1) gene are usually associated with autosomal dominant chronic progressive external ophthalmoplegia (PEO). We describe five patients from two unrelated Alsatian families with the new R374W variation in the Twinkle linker region who progressively developed an autosomal dominant multisystem disorder with PEO, hearing loss, myopathy, dysphagia, dysphonia, sensory neuropathy, and late-onset dementia resembling Alzheimer's disease. These observations demonstrate that Twinkle variations in the linker domain alter cerebral function and further implicate disrupted mitochondrial DNA integrity in the pathogenesis of dementia.", "electronicPublicationDate": "2009-06-10", "language": "eng", "dateOfCompletion": "2010-03-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10048-009-0202-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-02-01", "journal": {"medlineAbbreviation": "Neurogenetics", "isoabbreviation": "Neurogenetics", "title": "Neurogenetics", "issn": "1364-6745", "nlmid": "9709714", "essn": "1364-6753"}, "monthOfPublication": 2, "volume": "11", "yearOfPublication": 2010, "journalIssueId": 1691025, "issue": "1", "dateOfPublication": "2010 Feb"}}, "17420318": "", "24014582": {"pubYear": "2013", "dateOfCreation": "2013-09-09", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}, {"registryNumber": "EC 3.6.4.-", "name": "DNA Helicases"}]}, "authorString": "Gonzalez-Moron D, Bueri J, Kauffman MA.", "affiliation": "Neurogenetics Unit, Hospital JM Ramos Mejia, Buenos Aires, Argentina.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "Y", "id": "24014582", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Neurogenetics Unit, Hospital JM Ramos Mejia, Buenos Aires, Argentina.", "fullName": "Gonzalez-Moron D", "initials": "D", "firstName": "Dolores", "lastName": "Gonzalez-Moron"}, {"lastName": "Bueri", "fullName": "Bueri J", "firstName": "Jose", "initials": "J"}, {"lastName": "Kauffman", "fullName": "Kauffman MA", "firstName": "Marcelo Andres", "initials": "MA"}]}, "title": "Progressive external ophthalmoplegia (PEO) due to a mutation in the C10orf2 (PEO1) gene mimicking a myasthenic crisis.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24014582", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Myasthenia Gravis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Diagnosis, Differential", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2015-09-07", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-09-07", "doi": "10.1136/bcr-2013-010181", "isOpenAccess": "N", "pmcid": "PMC3794138", "hasDbCrossReferences": "N", "abstractText": "We described a case of a patient with autosomal dominant progressive external ophthalmoplegia (PEO) who presented with the acute onset dysphagia, quadriparesis, ptosis and respiratory insufficiency following a cardiac procedure and mimicking a myasthenic crisis. A pathogenic mutation in the C10orf2 (PEO1) gene was confirmed. The unusual presentation of our patient contributes to expand the clinical phenotype of PEO1 mutations and reinforces the need to consider mitochondrial myopathy as differential diagnosis of myasthenia gravis even in the case of acute onset symptoms.", "electronicPublicationDate": "2013-09-07", "language": "eng", "dateOfCompletion": "2014-04-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3794138?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3794138", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1136/bcr-2013-010181", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "BMJ case reports", "medlineAbbreviation": "BMJ Case Rep", "isoabbreviation": "BMJ Case Rep", "nlmid": "101526291", "essn": "1757-790X"}, "monthOfPublication": 0, "volume": "2013", "yearOfPublication": 2013, "journalIssueId": 1996494, "dateOfPublication": "2013 "}}, "26243799": {"pubYear": "2015", "dateOfCreation": "2015-10-07", "pubModel": "Print-Electronic", "authorString": "Qin Y, Jiao X, Simpson JL, Chen ZJ.", "affiliation": "Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, China.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26243799", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, China.", "fullName": "Qin Y", "initials": "Y", "firstName": "Yingying", "lastName": "Qin"}, {"affiliation": "Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, China.", "fullName": "Jiao X", "initials": "X", "firstName": "Xue", "lastName": "Jiao"}, {"affiliation": "Research and Global Programs March of Dimes Foundation, White Plains, NY, USA Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.", "fullName": "Simpson JL", "initials": "JL", "firstName": "Joe Leigh", "lastName": "Simpson"}, {"affiliation": "Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, China Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China chenzijiang@vip.163.com.", "fullName": "Chen ZJ", "initials": "ZJ", "firstName": "Zi-Jiang", "lastName": "Chen"}]}, "title": "Genetics of primary ovarian insufficiency: new developments and opportunities.", "hasSuppl": "Y", "citedByCount": 1, "source": "MED", "pmid": "26243799", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Chromosome Aberrations", "majorTopic_YN": "Y"}, {"descriptorName": "Karyotyping", "majorTopic_YN": "N"}, {"descriptorName": "Genomics", "majorTopic_YN": "N"}, {"descriptorName": "Mosaicism", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Gene Regulatory Networks", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "Y"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}, {"descriptorName": "Primary Ovarian Insufficiency", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Exome", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-08-04", "language": "eng", "doi": "10.1093/humupd/dmv036", "isOpenAccess": "Y", "pageInfo": "787-808", "pmcid": "PMC4594617", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Gene mutation", "Premature ovarian failure", "Chromosomal abnormality", "Genome-wide Association Studies", "Next Generation Sequencing", "Whole-exome Sequencing", "Primary Ovarian Insufficiency"]}, "abstractText": "Primary ovarian insufficiency (POI) is characterized by marked heterogeneity, but with a significant genetic contribution. Identifying exact causative genes has been challenging, with many discoveries not replicated. It is timely to take stock of the field, outlining the progress made, framing the controversies and anticipating future directions in elucidating the genetics of POI.A search for original articles published up to May 2015 was performed using PubMed and Google Scholar, identifying studies on the genetic etiology of POI. Studies were included if chromosomal analysis, candidate gene screening and a genome-wide study were conducted. Articles identified were restricted to English language full-text papers.Chromosomal abnormalities have long been recognized as a frequent cause of POI, with a currently estimated prevalence of 10-13%. Using the traditional karyotype methodology, monosomy X, mosaicism, X chromosome deletions and rearrangements, X-autosome translocations, and isochromosomes have been detected. Based on candidate gene studies, single gene perturbations unequivocally having a deleterious effect in at least one population include Bone morphogenetic protein 15 (BMP15), Progesterone receptor membrane component 1 (PGRMC1), and Fragile X mental retardation 1 (FMR1) premutation on the X chromosome; Growth differentiation factor 9 (GDF9), Folliculogenesis specific bHLH transcription factor (FIGLA), Newborn ovary homeobox gene (NOBOX), Nuclear receptor subfamily 5, group A, member 1 (NR5A1) and Nanos homolog 3 (NANOS3) seem likely as well, but mostly being found in no more than 1-2% of a single population studied. Whole genome approaches have utilized genome-wide association studies (GWAS) to reveal loci not predicted on the basis of a candidate gene, but it remains difficult to locate causative genes and susceptible loci were not always replicated. Cytogenomic methods (array CGH) have identified other regions of interest but studies have not shown consistent results, the resolution of arrays has varied and replication is uncommon. Whole-exome sequencing in non-syndromic POI kindreds has only recently begun, revealing mutations in the Stromal antigen 3 (STAG3), Synaptonemal complex central element 1 (SYCE1), minichromosome maintenance complex component 8 and 9 (MCM8, MCM9) and ATP-dependent DNA helicase homolog (HFM1) genes. Given the slow progress in candidate-gene analysis and relatively small sample sizes available for GWAS, family-based whole exome and whole genome sequencing appear to be the most promising approaches for detecting potential genes responsible for POI.Taken together, the cytogenetic, cytogenomic (array CGH) and exome sequencing approaches have revealed a genetic causation in \u223c20-25% of POI cases. Uncovering the remainder of the causative genes will be facilitated not only by whole genome approaches involving larger cohorts in multiple populations but also incorporating environmental exposures and exploring signaling pathways in intragenic and intergenic regions that point to perturbations in regulatory genes and networks.", "electronicPublicationDate": "2015-08-04", "license": "cc by-nc", "dateOfCompletion": "2016-05-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4594617?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4594617", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/humupd/dmv036", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-10-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"medlineAbbreviation": "Hum Reprod Update", "isoabbreviation": "Hum. Reprod. Update", "title": "Human reproduction update", "issn": "1355-4786", "nlmid": "9507614", "essn": "1460-2369"}, "monthOfPublication": 0, "volume": "21", "yearOfPublication": 2015, "journalIssueId": 2358645, "issue": "6", "dateOfPublication": "2015 Nov-Dec"}}, "26689116": {"pubYear": "2016", "dateOfCreation": "2016-02-12", "pubModel": "Print-Electronic", "authorString": "Paramasivam A, Meena AK, Pedaparthi L, Jyothi V, Uppin MS, Jabeen SA, Sundaram C, Thangaraj K.", "affiliation": "CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26689116", "inEPMC": "N", "authorList": {"author": [{"affiliation": "CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.", "fullName": "Paramasivam A", "initials": "A", "firstName": "Arumugam", "lastName": "Paramasivam"}, {"affiliation": "Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, India.", "fullName": "Meena AK", "initials": "AK", "firstName": "Angamuthu Kannan", "lastName": "Meena"}, {"affiliation": "Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, India.", "fullName": "Pedaparthi L", "initials": "L", "firstName": "Lalitha", "lastName": "Pedaparthi"}, {"affiliation": "CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.", "fullName": "Jyothi V", "initials": "V", "firstName": "Vuskamalla", "lastName": "Jyothi"}, {"affiliation": "Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, India.", "fullName": "Uppin MS", "initials": "MS", "firstName": "Megha S", "lastName": "Uppin"}, {"affiliation": "Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, India.", "fullName": "Jabeen SA", "initials": "SA", "firstName": "Shaikh Afshan", "lastName": "Jabeen"}, {"affiliation": "Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, India.", "fullName": "Sundaram C", "initials": "C", "firstName": "Challa", "lastName": "Sundaram"}, {"affiliation": "CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India. Electronic address: thangs@ccmb.res.in.", "fullName": "Thangaraj K", "initials": "K", "firstName": "Kumarasamy", "lastName": "Thangaraj"}]}, "title": "Novel mutation in C10orf2 associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging.", "citedByCount": 0, "source": "MED", "pmid": "26689116", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-12-12", "doi": "10.1016/j.mito.2015.12.006", "isOpenAccess": "N", "pageInfo": "81-85", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["mtDNA", "Ptosis", "Cpeo", "Multiple Mtdna Deletions", "C10orf2 Mutation"]}, "abstractText": "Chronic progressive external ophthalmoplegia (CPEO) is caused by defects in both mitochondrial and nuclear genes, however, the causal genetic factors in large number of patients remains undetermined. Therefore, our aim was to screen 12 unrelated patients with CPEO for mutation/multiple deletions in mtDNA and mutations in the coding regions of C10orf2, which is essential for mtDNA replication. Histopathological study of muscle biopsy revealed cytochrome c oxidase-deficient fibers and ragged blue fibers in all the patients. Long-range PCR of DNA from skeletal muscle revealed multiple mtDNA deletions in all the 12 patients. Further, sequencing coding regions of C10orf2 revealed three variants in three different patients, of which two were novel (c.1964G>A/p.G655D; c.204G>A/p.G68G) variants and one was reported (c.1052A>G/p. N351S). Sequencing of other nuclear genes that are associated with CPEO and multiple mtDNA deletions, such as; POLG1, POLG2, TK2, ANT1, DGUOK, MPV17 and RRM2B did not reveal any pathogenic mutation in patients with C10orf2 mutation. Since in silico analyses revealed p.G655D could be a potentially pathogenic and it was absent in 200 healthy controls, p.G655D could be the causative factor for CPEO. Therefore, we suggest that C10orf2 gene should be screened in CPEO individuals with multiple mtDNA deletions, which might help in prognosis of this disease and appropriate genetic counseling.", "electronicPublicationDate": "2015-12-12", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.mito.2015.12.006", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Mitochondrion", "isoabbreviation": "Mitochondrion", "title": "Mitochondrion", "issn": "1567-7249", "nlmid": "100968751", "essn": "1872-8278"}, "monthOfPublication": 1, "volume": "26", "yearOfPublication": 2016, "journalIssueId": 2374910, "dateOfPublication": "2016 Jan"}}, "21301859": {"pubYear": "2011", "dateOfCreation": "2011-07-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.7.-", "name": "POLG protein, human"}, {"registryNumber": "EC 2.7.7.7", "name": "DNA-Directed DNA Polymerase"}, {"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Sato K, Yabe I, Yaguchi H, Nakano F, Kunieda Y, Saitoh S, Sasaki H.", "affiliation": "Department of Neurology, Hokkaido University Graduate School of Medicine, N15W7, Kita-ku, Sapporo 060-8638, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21301859", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sato", "fullName": "Sato K", "firstName": "Kazunori", "initials": "K"}, {"lastName": "Yabe", "fullName": "Yabe I", "firstName": "Ichiro", "initials": "I"}, {"lastName": "Yaguchi", "fullName": "Yaguchi H", "firstName": "Hiroaki", "initials": "H"}, {"lastName": "Nakano", "fullName": "Nakano F", "firstName": "Fumihito", "initials": "F"}, {"lastName": "Kunieda", "fullName": "Kunieda Y", "firstName": "Yasuyuki", "initials": "Y"}, {"lastName": "Saitoh", "fullName": "Saitoh S", "firstName": "Shinji", "initials": "S"}, {"lastName": "Sasaki", "fullName": "Sasaki H", "firstName": "Hidenao", "initials": "H"}]}, "title": "Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism.", "citedByCount": 6, "source": "MED", "pmid": "21301859", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Parkinsonian Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosome Deletion", "majorTopic_YN": "N"}, {"descriptorName": "DNA-Directed DNA Polymerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Family Health", "majorTopic_YN": "Y"}, {"descriptorName": "Japan", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Therapy", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-02-08", "doi": "10.1007/s00415-011-5936-x", "isOpenAccess": "N", "pageInfo": "1327-1332", "hasDbCrossReferences": "N", "abstractText": "Mutations in the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1) and DNA polymerase gamma (POLG) genes were reported in patients with progressive external ophthalmoplegia and parkinsonism. However, the genotype-phenotype correlation and pathophysiology of these syndromes are still unknown. In order to define the molecular basis of progressive external ophthalmoplegia and parkinsonism, we screened for mutations in PEO1, ANT1, POLG genes and the whole mitochondrial genome in two families. In results, we identified a compound heterozygous POLG substitutions, c.830A>T (p.H277L) and c.2827C>T (p.R943C) in one of the families. These two mutations in the coding region of POLG alter conserved amino acids in the exonuclease and polymerase domains, respectively, of the POLG protein. Neither of these substitutions was found in the 100 chromosomes of ethnically matched control subjects. In the other family, no mutations were detected in any of the three genes and the whole mitochondrial genome in the blood sample, although mitochondrial DNA deletions were observed in the muscle biopsy sample. Progressive external ophthalmoplegia and parkinsonism are genetically heterogenous disorders, and part of this syndrome may be caused by mutations in other, unknown genes.", "electronicPublicationDate": "2011-02-08", "language": "eng", "dateOfCompletion": "2011-11-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00415-011-5936-x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-07-01", "journal": {"medlineAbbreviation": "J Neurol", "isoabbreviation": "J. Neurol.", "title": "Journal of neurology", "issn": "0340-5354", "nlmid": "0423161", "essn": "1432-1459"}, "monthOfPublication": 7, "volume": "258", "yearOfPublication": 2011, "journalIssueId": 1847202, "issue": "7", "dateOfPublication": "2011 Jul"}}, "20803511": {"pubYear": "2010", "dateOfCreation": "2010-11-11", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.7.-", "name": "POLG protein, human"}, {"registryNumber": "EC 2.7.7.7", "name": "DNA-Directed DNA Polymerase"}, {"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "Schicks J, Synofzik M, Schulte C, Sch\u00f6ls L.", "affiliation": "Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and German Research Centre of Neurodegenerative Diseases, University of T\u00fcbingen, T\u00fcbingen, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20803511", "inEPMC": "N", "authorList": {"author": [{"lastName": "Schicks", "fullName": "Schicks J", "firstName": "Julia", "initials": "J"}, {"lastName": "Synofzik", "fullName": "Synofzik M", "firstName": "Matthis", "initials": "M"}, {"lastName": "Schulte", "fullName": "Schulte C", "authorId": {"type": "ORCID", "value": "0000-0003-4006-1265"}, "firstName": "Claudia", "initials": "C"}, {"lastName": "Sch\u00f6ls", "fullName": "Sch\u00f6ls L", "firstName": "Ludger", "initials": "L"}]}, "title": "POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe.", "citedByCount": 7, "source": "MED", "pmid": "20803511", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4006-1265"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cerebellar Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Directed DNA Polymerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "European Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Europe", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-11-01", "doi": "10.1002/mds.23286", "isOpenAccess": "N", "pageInfo": "2678-2682", "hasDbCrossReferences": "Y", "abstractText": "Nuclear genes, in particular mitochondrial polymerase gamma (POLG) and PEO1, have been increasingly recognized to cause mitochondrial diseases. Both genes assume a complementary role as part of the mitochondrial DNA (mtDNA) replication fork and, accordingly, seem to present with largely overlapping phenotypical spectra. We assessed the frequency and phenotypic spectrum of PEO1 compared to POLG mutations in a cohort of 80 patients with cerebellar ataxia for which common repeat expansion diseases had been excluded. Patients were selected to present additional features previously described for PEO1 mutations, namely early age of onset, progressive external ophthalmoplegia (PEO), or epilepsy. Whereas PEO1 mutations were not found in our cohort, POLG frequently caused ataxia with PEO (47%), psychiatric comorbidities (20%) and, more rarely, with epilepsy (14%). Thus, PEO1 is rare in Central Europe even in those patients displaying characteristic phenotypic features. In contrast, POLG is rather common in Central European ataxia patients. It should be particularly considered in ataxia patients with PEO, psychiatric comorbidities, and/or sensory neuropathy, even if characteristic mitochondrial extra-CNS features are absent.", "language": "eng", "dateOfCompletion": "2011-02-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/mds.23286", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-11-01", "journal": {"medlineAbbreviation": "Mov Disord", "isoabbreviation": "Mov. Disord.", "title": "Movement disorders : official journal of the Movement Disorder Society", "issn": "0885-3185", "nlmid": "8610688", "essn": "1531-8257"}, "monthOfPublication": 11, "volume": "25", "yearOfPublication": 2010, "journalIssueId": 1783400, "issue": "15", "dateOfPublication": "2010 Nov"}}, "18989381": {"pubYear": "2008", "dateOfCreation": "2008-11-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "Liu Z, Ding Y, Du A, Zhang B, Zhao G, Ding M.", "affiliation": "Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "18989381", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Liu", "fullName": "Liu Z", "firstName": "Zhirong", "initials": "Z"}, {"lastName": "Ding", "fullName": "Ding Y", "firstName": "Yao", "initials": "Y"}, {"lastName": "Du", "fullName": "Du A", "firstName": "Ailian", "initials": "A"}, {"lastName": "Zhang", "fullName": "Zhang B", "firstName": "Baorong", "initials": "B"}, {"lastName": "Zhao", "fullName": "Zhao G", "firstName": "Guohua", "initials": "G"}, {"lastName": "Ding", "fullName": "Ding M", "firstName": "Meiping", "initials": "M"}]}, "title": "A novel Twinkle (PEO1) gene mutation in a Chinese family with adPEO.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "18989381", "abstractText": " PURPOSE: Autosomal dominant progressive external ophthalmoplegia (adPEO) is a genetically heterogeneous, adult-onset disease. Thus far, disease loci have been identified on four different nuclear genes. The purpose of this study is to identify the gene responsible for causing adPEO in a Chinese family. METHODS: Clinical data and genomic DNA of a Chinese adPEO family were collected following informed consent. Gene scan by two-point linkage analysis was performed for four genes, and mutation screening was conducted in the Twinkle (PEO1) gene by direct sequencing. RESULTS: A maximum two-point LOD score of 2.8 at theta=0.00 was obtained with marker D10S192 in close proximity to PEO1. A novel missense mutation (c.1423G>A, p.475A>T) was identified. CONCLUSIONS: This study widens the mutation spectrum of PEO1 and is the first to report the PEO1 mutation in the Chinese population.", "tmAccessionTypeList": {"accessionType": ["omim"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Family", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Dominant", "majorTopic_YN": "Y"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "China", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Linkage", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2008-11-03", "language": "eng", "isOpenAccess": "Y", "pageInfo": "1995-2001", "pmcid": "PMC2579934", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "electronicPublicationDate": "2008-11-03", "license": "cc by", "dateOfCompletion": "2009-03-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2579934?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2579934", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=18989381&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=18989381", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-01-01", "journal": {"title": "Molecular vision", "medlineAbbreviation": "Mol Vis", "isoabbreviation": "Mol. Vis.", "nlmid": "9605351", "essn": "1090-0535"}, "monthOfPublication": 0, "volume": "14", "yearOfPublication": 2008, "journalIssueId": 1504408, "dateOfPublication": "2008 "}}, "22353293": {"pubYear": "2012", "dateOfCreation": "2012-02-22", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "D\u00fcndar H, Ozg\u00fcl RK, Yaln\u0131zo\u011flu D, Erdem S, O\u011fuz KK, Tuncel D, Temu\u00e7in CM, Dursun A.", "affiliation": "Metabolism Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, S\u0131hhiye, Ankara, Turkey.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22353293", "inEPMC": "N", "authorList": {"author": [{"lastName": "D\u00fcndar", "fullName": "D\u00fcndar H", "firstName": "Halil", "initials": "H"}, {"lastName": "Ozg\u00fcl", "fullName": "Ozg\u00fcl RK", "firstName": "R\u0131za K\u00f6ksal", "initials": "RK"}, {"lastName": "Yaln\u0131zo\u011flu", "fullName": "Yaln\u0131zo\u011flu D", "firstName": "Dilek", "initials": "D"}, {"lastName": "Erdem", "fullName": "Erdem S", "firstName": "Sevim", "initials": "S"}, {"lastName": "O\u011fuz", "fullName": "O\u011fuz KK", "firstName": "Kader Karl\u0131", "initials": "KK"}, {"lastName": "Tuncel", "fullName": "Tuncel D", "firstName": "Deniz", "initials": "D"}, {"lastName": "Temu\u00e7in", "fullName": "Temu\u00e7in CM", "firstName": "Ca\u011fr\u0131 Mesut", "initials": "CM"}, {"lastName": "Dursun", "fullName": "Dursun A", "firstName": "Ali", "initials": "A"}]}, "title": "Identification of a novel Twinkle mutation in a family with infantile onset spinocerebellar ataxia by whole exome sequencing.", "citedByCount": 12, "source": "MED", "pmid": "22353293", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Spinocerebellar Ataxias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Age of Onset", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Exome", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2012-03-01", "doi": "10.1016/j.pediatrneurol.2011.12.006", "isOpenAccess": "N", "pageInfo": "172-177", "hasDbCrossReferences": "Y", "abstractText": "Whole exome sequencing combined with homozygosity mapping comprises a genetic diagnostic tool to identify genetic defects in families with multiple affected members, compatible with presumed autosomal recessively inherited neurometabolic/neurogenetic disease. These tools were applied to a family with two individuals manifesting ataxia, associated with peripheral sensory neuropathy, athetosis, seizures, deafness, and ophthalmoplegia. A novel homozygous missense mutation c.1366C>G (L456V) in C10orf2 (the Twinkle gene) was identified, confirming infantile onset spinocerebellar ataxia in the probands. Signs in infantile onset spinocerebellar ataxia follow a fairly distinct pattern, affecting early development, followed by ataxia and loss of skills. However, this very rare disease was previously reported only in Finland. We suggest that infantile onset spinocerebellar ataxia should be more frequently considered in the differential diagnosis of neurometabolic diseases in childhood. Next-generation sequencing and its use along with homozygosity mapping offer highly promising techniques for molecular diagnosis, especially in small families affected with very rare neurometabolic disorders such as infantile onset spinocerebellar ataxia.", "language": "eng", "dateOfCompletion": "2012-07-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pediatrneurol.2011.12.006", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-03-01", "journal": {"medlineAbbreviation": "Pediatr Neurol", "isoabbreviation": "Pediatr. Neurol.", "title": "Pediatric neurology", "issn": "0887-8994", "nlmid": "8508183", "essn": "1873-5150"}, "monthOfPublication": 3, "volume": "46", "yearOfPublication": 2012, "journalIssueId": 1907746, "issue": "3", "dateOfPublication": "2012 Mar"}}, "12975295": "", "16135556": "", "20659899": {"pubYear": "2010", "dateOfCreation": "2010-09-20", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "9007-49-2", "name": "DNA"}, {"registryNumber": "0", "name": "Nucleotides"}, {"registryNumber": "0", "name": "Cations, Divalent"}, {"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "0", "name": "Recombinant Proteins"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}, {"registryNumber": "EC 3.6.4.-", "name": "DNA Helicases"}, {"registryNumber": "I38ZP9992A", "name": "Magnesium"}]}, "authorString": "Longley MJ, Humble MM, Sharief FS, Copeland WC.", "affiliation": "Laboratory of Molecular Genetics, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Intramural NIH HHS"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "ES065078"}]}, "hasPDF": "N", "id": "20659899", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Laboratory of Molecular Genetics, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.", "fullName": "Longley MJ", "initials": "MJ", "firstName": "Matthew J", "lastName": "Longley"}, {"lastName": "Humble", "fullName": "Humble MM", "firstName": "Margaret M", "initials": "MM"}, {"lastName": "Sharief", "fullName": "Sharief FS", "firstName": "Farida S", "initials": "FS"}, {"lastName": "Copeland", "fullName": "Copeland WC", "firstName": "William C", "initials": "WC"}]}, "title": "Disease variants of the human mitochondrial DNA helicase encoded by C10orf2 differentially alter protein stability, nucleotide hydrolysis, and helicase activity.", "hasSuppl": "N", "citedByCount": 22, "source": "MED", "pmid": "20659899", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["gen"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Diseases, Inborn", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cations, Divalent", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Magnesium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nucleotides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Recombinant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hydrolysis", "majorTopic_YN": "N"}, {"descriptorName": "Kinetics", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Protein Stability", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2010-07-20", "doi": "10.1074/jbc.m110.151795", "isOpenAccess": "N", "pageInfo": "29690-29702", "pmcid": "PMC2943296", "hasDbCrossReferences": "Y", "abstractText": "Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. To understand the biochemical consequences of C10orf2 mutations, we overproduced wild type and 20 mutant forms of human mtDNA helicase in Escherichia coli and developed novel schemes to purify the recombinant enzymes to near homogeneity. A combination of molecular crowding, non-ionic detergents, Mg(2+) ions, and elevated ionic strength was required to combat insolubility and intrinsic instability of certain mutant variants. A systematic biochemical assessment of the enzymes included analysis of DNA binding affinity, DNA helicase activity, the kinetics of nucleotide hydrolysis, and estimates of thermal stability. In contrast to other studies, we found that all 20 mutant variants retain helicase function under optimized in vitro conditions despite partial reductions in DNA binding affinity, nucleotide hydrolysis, or thermal stability for some mutants. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of C10orf2.", "electronicPublicationDate": "2010-07-20", "language": "eng", "dateOfCompletion": "2010-10-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2943296", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20659899", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://intl.jbc.org/cgi/content/abstract/285/39/29690", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "intl.jbc.org"}, {"url": "http://intl.jbc.org/cgi/content/full/285/39/29690", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "intl.jbc.org"}, {"url": "http://dx.doi.org/10.1074/jbc.M110.151795", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-09-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 9, "volume": "285", "yearOfPublication": 2010, "journalIssueId": 1763096, "issue": "39", "dateOfPublication": "2010 Sep"}}, "25824949": {"pubYear": "2015", "dateOfCreation": "2015-05-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}, {"registryNumber": "EC 3.6.4.-", "name": "DNA Helicases"}]}, "authorString": "Fern\u00e1ndez-Mill\u00e1n P, L\u00e1zaro M, Cans\u0131z-Arda \u015e, Gerhold JM, Rajala N, Schmitz CA, Silva-Espi\u00f1a C, Gil D, Bernad\u00f3 P, Valle M, Spelbrink JN, Sol\u00e0 M.", "affiliation": "Structural MitoLab; Department of Structural Biology, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, E-08028, Spain.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25824949", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Pablo", "lastName": "Fern\u00e1ndez-Mill\u00e1n", "affiliation": "Structural MitoLab; Department of Structural Biology, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, E-08028, Spain.", "authorId": {"type": "ORCID", "value": "0000-0002-7402-4983"}, "fullName": "Fern\u00e1ndez-Mill\u00e1n P", "initials": "P"}, {"firstName": "Melisa", "lastName": "L\u00e1zaro", "affiliation": "Structural Biology Unit. Centre for Cooperative Research in Biosciences, CICbioGUNE, Derio, E-48160, Spain.", "authorId": {"type": "ORCID", "value": "0000-0002-9603-9115"}, "fullName": "L\u00e1zaro M", "initials": "M"}, {"affiliation": "Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands.", "fullName": "Cans\u0131z-Arda \u015e", "initials": "\u015e", "firstName": "\u015eirin", "lastName": "Cans\u0131z-Arda"}, {"firstName": "Joachim M", "lastName": "Gerhold", "affiliation": "Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0002-4972-1947"}, "fullName": "Gerhold JM", "initials": "JM"}, {"affiliation": "Mitochondrial DNA Maintenance Group, BioMediTech, University of Tampere, Tampere, FI-33014, Finland.", "fullName": "Rajala N", "initials": "N", "firstName": "Nina", "lastName": "Rajala"}, {"affiliation": "Structural MitoLab; Department of Structural Biology, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, E-08028, Spain.", "fullName": "Schmitz CA", "initials": "CA", "firstName": "Claus-A", "lastName": "Schmitz"}, {"affiliation": "Structural MitoLab; Department of Structural Biology, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, E-08028, Spain.", "fullName": "Silva-Espi\u00f1a C", "initials": "C", "firstName": "Cristina", "lastName": "Silva-Espi\u00f1a"}, {"firstName": "David", "lastName": "Gil", "affiliation": "Structural Biology Unit. Centre for Cooperative Research in Biosciences, CICbioGUNE, Derio, E-48160, Spain.", "authorId": {"type": "ORCID", "value": "0000-0003-4241-1302"}, "fullName": "Gil D", "initials": "D"}, {"firstName": "Pau", "lastName": "Bernad\u00f3", "affiliation": "Centre de Biochimie Structurale, INSERM-U1054, CNRS UMR-5048, Universit\u00e9 de Montpellier I&II. Montpellier, F-34090, France.", "authorId": {"type": "ORCID", "value": "0000-0001-7395-5922"}, "fullName": "Bernad\u00f3 P", "initials": "P"}, {"firstName": "Mikel", "lastName": "Valle", "affiliation": "Structural Biology Unit. Centre for Cooperative Research in Biosciences, CICbioGUNE, Derio, E-48160, Spain mvalle@cicbiogune.es.", "authorId": {"type": "ORCID", "value": "0000-0001-8268-6912"}, "fullName": "Valle M", "initials": "M"}, {"affiliation": "Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands Mitochondrial DNA Maintenance Group, BioMediTech, University of Tampere, Tampere, FI-33014, Finland hans.spelbrink@radboudumc.nl.", "fullName": "Spelbrink JN", "initials": "JN", "firstName": "Johannes N", "lastName": "Spelbrink"}, {"affiliation": "Structural MitoLab; Department of Structural Biology, Molecular Biology Institute Barcelona (IBMB-CSIC), Barcelona, E-08028, Spain maria.sola@ibmb.csic.es.", "fullName": "Sol\u00e0 M", "initials": "M", "firstName": "Maria", "lastName": "Sol\u00e0"}]}, "title": "The hexameric structure of the human mitochondrial replicative helicase Twinkle.", "hasSuppl": "Y", "citedByCount": 2, "source": "MED", "pmid": "25824949", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["pdb", " sprot", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7402-4983"}, {"type": "ORCID", "value": "0000-0002-9603-9115"}, {"type": "ORCID", "value": "0000-0002-4972-1947"}, {"type": "ORCID", "value": "0000-0003-4241-1302"}, {"type": "ORCID", "value": "0000-0001-7395-5922"}, {"type": "ORCID", "value": "0000-0001-8268-6912"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "X-Ray Diffraction", "majorTopic_YN": "N"}, {"descriptorName": "Protein Structure, Tertiary", "majorTopic_YN": "N"}, {"descriptorName": "Structural Homology, Protein", "majorTopic_YN": "N"}, {"descriptorName": "Models, Molecular", "majorTopic_YN": "N"}, {"descriptorName": "Scattering, Small Angle", "majorTopic_YN": "N"}, {"descriptorName": "Protein Multimerization", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-03-30", "language": "eng", "doi": "10.1093/nar/gkv189", "isOpenAccess": "Y", "pageInfo": "4284-4295", "pmcid": "PMC4417153", "hasDbCrossReferences": "Y", "abstractText": "The mitochondrial replicative helicase Twinkle is involved in strand separation at the replication fork of mitochondrial DNA (mtDNA). Twinkle malfunction is associated with rare diseases that include late onset mitochondrial myopathies, neuromuscular disorders and fatal infantile mtDNA depletion syndrome. We examined its 3D structure by electron microscopy (EM) and small angle X-ray scattering (SAXS) and built the corresponding atomic models, which gave insight into the first molecular architecture of a full-length SF4 helicase that includes an N-terminal zinc-binding domain (ZBD), an intermediate RNA polymerase domain (RPD) and a RecA-like hexamerization C-terminal domain (CTD). The EM model of Twinkle reveals a hexameric two-layered ring comprising the ZBDs and RPDs in one layer and the CTDs in another. In the hexamer, contacts in trans with adjacent subunits occur between ZBDs and RPDs, and between RPDs and CTDs. The ZBDs show important structural heterogeneity. In solution, the scattering data are compatible with a mixture of extended hexa- and heptameric models in variable conformations. Overall, our structural data show a complex network of dynamic interactions that reconciles with the structural flexibility required for helicase activity.", "electronicPublicationDate": "2015-03-30", "license": "cc by-nc", "dateOfCompletion": "2015-07-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4417153?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4417153", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/nar/gkv189", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-05-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-04-01", "journal": {"medlineAbbreviation": "Nucleic Acids Res", "isoabbreviation": "Nucleic Acids Res.", "title": "Nucleic acids research", "issn": "0305-1048", "nlmid": "0411011", "essn": "1362-4962"}, "monthOfPublication": 4, "volume": "43", "yearOfPublication": 2015, "journalIssueId": 2279951, "issue": "8", "dateOfPublication": "2015 Apr"}}, "18195150": {"pubYear": "2008", "dateOfCreation": "2008-01-15", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.7.-", "name": "POLG protein, human"}, {"registryNumber": "EC 3.6.1.-", "name": "OPA1 protein, human"}, {"registryNumber": "EC 1.3.99.1", "name": "Succinate Dehydrogenase"}, {"registryNumber": "EC 2.7.7.7", "name": "DNA-Directed DNA Polymerase"}, {"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "9007-43-6", "name": "Cytochromes c"}, {"registryNumber": "EC 3.6.1.-", "name": "GTP Phosphohydrolases"}, {"registryNumber": "0", "name": "Oncogene Protein p55(v-myc)"}, {"registryNumber": "EC 3.6.5.5", "name": "Dynamins"}, {"registryNumber": "33X04XA5AT", "name": "Lactic Acid"}]}, "authorString": "Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Guti\u00e9rrez R\u00edos P, Hirano M, Copeland WC, DiMauro S.", "affiliation": "Department of Pediatrics, University of Turin, Turin, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural"]}, "grantsList": {"grant": [{"acronym": "HD", "orderIn": 0, "agency": "NICHD NIH HHS", "grantId": "HD32062"}, {"orderIn": 0, "agency": "Intramural NIH HHS", "grantId": "Z01 ES065078-14"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS11766"}]}, "hasPDF": "Y", "id": "18195150", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pediatrics, University of Turin, Turin, Italy.", "fullName": "Ferraris S", "initials": "S", "firstName": "Silvio", "lastName": "Ferraris"}, {"lastName": "Clark", "fullName": "Clark S", "firstName": "Susanna", "initials": "S"}, {"lastName": "Garelli", "fullName": "Garelli E", "firstName": "Emanuela", "initials": "E"}, {"lastName": "Davidzon", "fullName": "Davidzon G", "firstName": "Guido", "initials": "G"}, {"lastName": "Moore", "fullName": "Moore SA", "firstName": "Steven A", "initials": "SA"}, {"lastName": "Kardon", "fullName": "Kardon RH", "firstName": "Randy H", "initials": "RH"}, {"lastName": "Bienstock", "fullName": "Bienstock RJ", "authorId": {"type": "ORCID", "value": "0000-0001-5228-3610"}, "firstName": "Rachelle J", "initials": "RJ"}, {"lastName": "Longley", "fullName": "Longley MJ", "firstName": "Matthew J", "initials": "MJ"}, {"lastName": "Mancuso", "fullName": "Mancuso M", "firstName": "Michelangelo", "initials": "M"}, {"lastName": "Guti\u00e9rrez R\u00edos", "fullName": "Guti\u00e9rrez R\u00edos P", "firstName": "Purificaci\u00f3n", "initials": "P"}, {"lastName": "Hirano", "fullName": "Hirano M", "firstName": "Michio", "initials": "M"}, {"lastName": "Copeland", "fullName": "Copeland WC", "firstName": "William C", "initials": "WC"}, {"lastName": "DiMauro", "fullName": "DiMauro S", "firstName": "Salvatore", "initials": "S"}]}, "title": "Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.", "hasSuppl": "N", "citedByCount": 23, "source": "MED", "pmid": "18195150", "abstractText": "OBJECTIVE: To describe the clinical features, muscle pathological characteristics, and molecular studies of a patient with a mutation in the gene encoding the accessory subunit (p55) of polymerase gamma (POLG2) and a mutation in the OPA1 gene. DESIGN: Clinical examination and morphological, biochemical, and molecular analyses. SETTING: Tertiary care university hospitals and molecular genetics and scientific computing laboratory. PATIENT: A 42-year-old man experienced hearing loss, progressive external ophthalmoplegia (PEO), loss of central vision, macrocytic anemia, and hypogonadism. His family history was negative for neurological disease, and his serum lactate level was normal. RESULTS: A muscle biopsy specimen showed scattered intensely succinate dehydrogenase-positive and cytochrome-c oxidase-negative fibers. Southern blot of muscle mitochondrial DNA showed multiple deletions. The results of screening for mutations in the nuclear genes associated with PEO and multiple mitochondrial DNA deletions, including those in POLG (polymerase gamma gene), ANT1 (gene encoding adenine nucleotide translocator 1), and PEO1, were negative, but sequencing of POLG2 revealed a G1247C mutation in exon 7, resulting in the substitution of a highly conserved glycine with an alanine at codon 416 (G416A). Because biochemical analysis of the mutant protein showed no alteration in chromatographic properties and normal ability to protect the catalytic subunit from N-ethylmaleimide, we also sequenced the OPA1 gene and identified a novel heterozygous mutation (Y582C). CONCLUSION: Although we initially focused on the mutation in POLG2, the mutation in OPA1 is more likely to explain the late-onset PEO and multisystem disorder in this patient.", "tmAccessionTypeList": {"accessionType": ["pdb"]}, "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5228-3610"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hearing Loss", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ophthalmoplegia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Vision Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anemia, Macrocytic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hypogonadism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lactic Acid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Succinate Dehydrogenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytochromes c", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "GTP Phosphohydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dynamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Directed DNA Polymerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oncogene Protein p55(v-myc)", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biopsy", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Southern", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Models, Molecular", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Muscle Fibers, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2008-01-01", "doi": "10.1001/archneurol.2007.9", "isOpenAccess": "N", "pageInfo": "125-131", "pmcid": "PMC2364721", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2008-02-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2364721?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2364721", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=18195150", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://archneur.ama-assn.org/cgi/content/abstract/65/1/125", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "archneur.ama-assn.org"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=18195150&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1001/archneurol.2007.9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://archneur.ama-assn.org/cgi/reprint/65/1/125.pdf", "documentStyle": "pdf", "availability": "Subscription required", "availabilityCode": "S", "site": "archneur.ama-assn.org"}, {"url": "http://archneur.ama-assn.org/cgi/content/full/65/1/125", "documentStyle": "html", "availability": "Subscription required", "availabilityCode": "S", "site": "archneur.ama-assn.org"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-03-25", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-01-01", "journal": {"medlineAbbreviation": "Arch Neurol", "isoabbreviation": "Arch. Neurol.", "title": "Archives of neurology", "issn": "0003-9942", "nlmid": "0372436", "essn": "1538-3687"}, "monthOfPublication": 1, "volume": "65", "yearOfPublication": 2008, "journalIssueId": 1500652, "issue": "1", "dateOfPublication": "2008 Jan"}}, "21112411": {"pubYear": "2011", "dateOfCreation": "2011-02-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Yu-Wai-Man P, Griffiths PG, Chinnery PF.", "affiliation": "Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, UK. Patrick.Yu-Wai-Man@ncl.ac.uk", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0701386"}, {"orderIn": 0, "agency": "Medical Research Council"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "NF-SI-0509-10011"}]}, "hasPDF": "N", "id": "21112411", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, UK. Patrick.Yu-Wai-Man@ncl.ac.uk", "fullName": "Yu-Wai-Man P", "initials": "P", "firstName": "Patrick", "lastName": "Yu-Wai-Man"}, {"lastName": "Griffiths", "fullName": "Griffiths PG", "firstName": "Philip G", "initials": "PG"}, {"lastName": "Chinnery", "fullName": "Chinnery PF", "firstName": "Patrick F", "initials": "PF"}]}, "title": "Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.", "hasSuppl": "N", "citedByCount": 97, "pageInfo": "81-114", "source": "MED", "pmid": "21112411", "abstractText": "Leber hereditary optic neuropathy (LHON) and autosomal-dominant optic atrophy (DOA) are the two most common inherited optic neuropathies in the general population. Both disorders share striking pathological similarities, marked by the selective loss of retinal ganglion cells (RGCs) and the early involvement of the papillomacular bundle. Three mitochondrial DNA (mtDNA) point mutations; m.3460G>A, m.11778G>A, and m.14484T>C account for over 90% of LHON cases, and in DOA, the majority of affected families harbour mutations in the OPA1 gene, which codes for a mitochondrial inner membrane protein. Optic nerve degeneration in LHON and DOA is therefore due to disturbed mitochondrial function and a predominantly complex I respiratory chain defect has been identified using both in vitro and in vivo biochemical assays. However, the trigger for RGC loss is much more complex than a simple bioenergetic crisis and other important disease mechanisms have emerged relating to mitochondrial network dynamics, mtDNA maintenance, axonal transport, and the involvement of the cytoskeleton in maintaining a differential mitochondrial gradient at sites such as the lamina cribosa. The downstream consequences of these mitochondrial disturbances are likely to be influenced by the local cellular milieu. The vulnerability of RGCs in LHON and DOA could derive not only from tissue-specific, genetically-determined biological factors, but also from an increased susceptibility to exogenous influences such as light exposure, smoking, and pharmacological agents with putative mitochondrial toxic effects. Our concept of inherited mitochondrial optic neuropathies has evolved over the past decade, with the observation that patients with LHON and DOA can manifest a much broader phenotypic spectrum than pure optic nerve involvement. Interestingly, these phenotypes are sometimes clinically indistinguishable from other neurodegenerative disorders such as Charcot-Marie-Tooth disease, hereditary spastic paraplegia, and multiple sclerosis, where mitochondrial dysfunction is also thought to be an important pathophysiological player. A number of vertebrate and invertebrate disease models has recently been established to circumvent the lack of human tissues, and these have already provided considerable insight by allowing direct RGC experimentation. The ultimate goal is to translate these research advances into clinical practice and new treatment strategies are currently being investigated to improve the visual prognosis for patients with mitochondrial optic neuropathies.", "tmAccessionTypeList": {"accessionType": ["omim", " refsnp", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Retinal Ganglion Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Optic Nerve", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Optic Atrophy, Hereditary, Leber", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Optic Atrophy, Autosomal Dominant", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Point Mutation", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2010-11-26", "doi": "10.1016/j.preteyeres.2010.11.002", "isOpenAccess": "Y", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 496, "type": "Comment in", "id": "26657167", "reference": "Brain. 2016 Mar;139(Pt 3):e18"}, {"source": "MED", "orderIn": 497, "type": "Comment in", "id": "26657166", "reference": "Brain. 2016 Mar;139(Pt 3):e17"}]}, "pmcid": "PMC3081075", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "electronicPublicationDate": "2010-11-26", "language": "eng", "dateOfCompletion": "2011-05-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3081075", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21112411", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.preteyeres.2010.11.002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-06-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-03-01", "journal": {"medlineAbbreviation": "Prog Retin Eye Res", "isoabbreviation": "Prog Retin Eye Res", "title": "Progress in retinal and eye research", "issn": "1350-9462", "nlmid": "9431859", "essn": "1873-1635"}, "monthOfPublication": 3, "volume": "30", "yearOfPublication": 2011, "journalIssueId": 1807340, "issue": "2", "dateOfPublication": "2011 Mar"}}, "26381753": {"pubYear": "2015", "dateOfCreation": "2016-01-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Whittaker RG, Devine HE, Gorman GS, Schaefer AM, Horvath R, Ng Y, Nesbitt V, Lax NZ, McFarland R, Cunningham MO, Taylor RW, Turnbull DM.", "affiliation": "Institute of Neuroscience, Henry Wellcome Building for Neuroecology, Newcastle University, Newcastle upon Tyne, United Kingdom.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "096919"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "096919Z/11/Z"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601943"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "NF-SI-0510-10187"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0800674"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1000848"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/K000608/1"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0700718"}]}, "hasPDF": "Y", "id": "26381753", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Institute of Neuroscience, Henry Wellcome Building for Neuroecology, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Whittaker RG", "initials": "RG", "firstName": "Roger G", "lastName": "Whittaker"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Devine HE", "initials": "HE", "firstName": "Helen E", "lastName": "Devine"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Gorman GS", "initials": "GS", "firstName": "Grainne S", "lastName": "Gorman"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Schaefer AM", "initials": "AM", "firstName": "Andrew M", "lastName": "Schaefer"}, {"affiliation": "Institute of Genetic Medicine, International Center for Life, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Horvath R", "initials": "R", "firstName": "Rita", "lastName": "Horvath"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Ng Y", "initials": "Y", "firstName": "Yi", "lastName": "Ng"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Nesbitt V", "initials": "V", "firstName": "Victoria", "lastName": "Nesbitt"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Lax NZ", "initials": "NZ", "firstName": "Nichola Z", "lastName": "Lax"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "McFarland R", "initials": "R", "firstName": "Robert", "lastName": "McFarland"}, {"affiliation": "Institute of Neuroscience, Henry Wellcome Building for Neuroecology, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Cunningham MO", "initials": "MO", "firstName": "Mark O", "lastName": "Cunningham"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Taylor RW", "initials": "RW", "firstName": "Robert W", "lastName": "Taylor"}, {"affiliation": "Wellcome Trust Center for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.", "fullName": "Turnbull DM", "initials": "DM", "firstName": "Douglass M", "lastName": "Turnbull"}]}, "title": "Epilepsy in adults with mitochondrial disease: A cohort study.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26381753", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Progression", "majorTopic_YN": "N"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prevalence", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Age of Onset", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Stroke", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-09-18", "language": "eng", "doi": "10.1002/ana.24525", "isOpenAccess": "Y", "pageInfo": "949-957", "pmcid": "PMC4737309", "hasDbCrossReferences": "N", "abstractText": "The aim of this work was to determine the prevalence and progression of epilepsy in adult patients with mitochondrial disease.We prospectively recruited a cohort of 182 consecutive adult patients attending a specialized mitochondrial disease clinic in Newcastle upon Tyne between January 1, 2005 and January 1, 2008. We then followed this cohort over a 7-year period, recording primary outcome measures of occurrence of first seizure, status epilepticus, stroke-like episode, and death.Overall prevalence of epilepsy in the cohort was 23.1%. Mean age of epilepsy onset was 29.4 years. Prevalence varied widely between genotypes, with several genotypes having no cases of epilepsy, a prevalence of 34.9% in the most common genotype (m.3243A>G mutation), and 92.3% in the m.8344A>G mutation. Among the cohort as a whole, focal seizures, with or without progression to bilateral convulsive seizures, was the most common seizure type. Conversely, all of the patients with the m.8344A>G mutation and epilepsy experienced myoclonic seizures. Patients with the m.3243A>G mutation remain at high risk of developing stroke-like episodes (1.16% per year). However, although the standardized mortality ratio for the entire cohort was high (2.86), this ratio did not differ significantly between patients with epilepsy (2.96) and those without (2.83).Epilepsy is a common manifestation of mitochondrial disease. It develops early in the disease and, in the case of the m.3243A>G mutation, often presents in the context of a stroke-like episode or status epilepticus. However, epilepsy does not itself appear to contribute to the increased mortality in mitochondrial disease.", "electronicPublicationDate": "2015-11-17", "license": "cc by", "dateOfCompletion": "2016-05-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4737309?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4737309", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1002/ana.24525", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-12-01", "journal": {"medlineAbbreviation": "Ann Neurol", "isoabbreviation": "Ann. Neurol.", "title": "Annals of neurology", "issn": "0364-5134", "nlmid": "7707449", "essn": "1531-8249"}, "monthOfPublication": 12, "volume": "78", "yearOfPublication": 2015, "journalIssueId": 2363686, "issue": "6", "dateOfPublication": "2015 Dec"}}, "21689831": {"pubYear": "2011", "dateOfCreation": "2011-08-12", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}, {"registryNumber": "EC 3.6.4.-", "name": "DNA Helicases"}]}, "authorString": "Ronchi D, Fassone E, Bordoni A, Sciacco M, Lucchini V, Di Fonzo A, Rizzuti M, Colombo I, Napoli L, Ciscato P, Moggio M, Cosi A, Collotta M, Corti S, Bresolin N, Comi GP.", "affiliation": "Dino Ferrari Centre, Department of Neurological Sciences, University of Milan, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Telethon", "grantId": "GUP09004"}, {"orderIn": 0, "agency": "Telethon", "grantId": "GTB07001"}]}, "hasPDF": "N", "id": "21689831", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Dario", "lastName": "Ronchi", "affiliation": "Dino Ferrari Centre, Department of Neurological Sciences, University of Milan, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.", "authorId": {"type": "ORCID", "value": "0000-0002-6093-9816"}, "fullName": "Ronchi D", "initials": "D"}, {"lastName": "Fassone", "fullName": "Fassone E", "firstName": "Elisa", "initials": "E"}, {"lastName": "Bordoni", "fullName": "Bordoni A", "firstName": "Andreina", "initials": "A"}, {"lastName": "Sciacco", "fullName": "Sciacco M", "firstName": "Monica", "initials": "M"}, {"lastName": "Lucchini", "fullName": "Lucchini V", "firstName": "Valeria", "initials": "V"}, {"lastName": "Di Fonzo", "fullName": "Di Fonzo A", "authorId": {"type": "ORCID", "value": "0000-0001-6478-026X"}, "firstName": "Alessio", "initials": "A"}, {"lastName": "Rizzuti", "fullName": "Rizzuti M", "firstName": "Mafalda", "initials": "M"}, {"lastName": "Colombo", "fullName": "Colombo I", "firstName": "Irene", "initials": "I"}, {"lastName": "Napoli", "fullName": "Napoli L", "firstName": "Laura", "initials": "L"}, {"lastName": "Ciscato", "fullName": "Ciscato P", "firstName": "Patrizia", "initials": "P"}, {"lastName": "Moggio", "fullName": "Moggio M", "firstName": "Maurizio", "initials": "M"}, {"lastName": "Cosi", "fullName": "Cosi A", "firstName": "Alessandra", "initials": "A"}, {"lastName": "Collotta", "fullName": "Collotta M", "firstName": "Martina", "initials": "M"}, {"lastName": "Corti", "fullName": "Corti S", "authorId": {"type": "ORCID", "value": "0000-0001-5425-969X"}, "firstName": "Stefania", "initials": "S"}, {"lastName": "Bresolin", "fullName": "Bresolin N", "firstName": "Nereo", "initials": "N"}, {"lastName": "Comi", "fullName": "Comi GP", "authorId": {"type": "ORCID", "value": "0000-0002-1383-5248"}, "firstName": "Giacomo P", "initials": "GP"}]}, "title": "Two novel mutations in PEO1 (twinkle) gene associated with chronic external ophthalmoplegia.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "21689831", "abstractText": "Maintenance and replication of mitochondrial DNA require the concerted action of several factors encoded by nuclear genome. The mitochondrial helicase Twinkle is a key player of replisome machinery. Heterozygous mutations in its coding gene, PEO1, are associated with progressive external ophthalmoplegia (PEO) characterised by ptosis and ophthalmoparesis, with cytochrome c oxidase (COX)-deficient fibres, ragged-red fibres (RRF) and multiple mtDNA deletions in muscle. Here we describe clinical, histological and molecular features of two patients presenting with mitochondrial myopathy associated with PEO. PEO1 sequencing disclosed two novel mutations in exons 1 and 4 of the gene, respectively. Although mutations in PEO1 exon 1 have already been described, this is the first report of mutation occurring in exon 4.", "tmAccessionTypeList": {"accessionType": ["refseq"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6093-9816"}, {"type": "ORCID", "value": "0000-0001-6478-026X"}, {"type": "ORCID", "value": "0000-0001-5425-969X"}, {"type": "ORCID", "value": "0000-0002-1383-5248"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Exons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2011-09-01", "doi": "10.1016/j.jns.2011.05.042", "isOpenAccess": "Y", "pageInfo": "173-176", "pmcid": "PMC3158327", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2012-05-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3158327", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21689831", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.jns.2011.05.042", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-03-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-09-01", "journal": {"medlineAbbreviation": "J Neurol Sci", "isoabbreviation": "J. Neurol. Sci.", "title": "Journal of the neurological sciences", "issn": "0022-510X", "nlmid": "0375403", "essn": "1878-5883"}, "monthOfPublication": 9, "volume": "308", "yearOfPublication": 2011, "journalIssueId": 1856296, "issue": "1-2", "dateOfPublication": "2011 Sep"}}, "26838077": {"pubYear": "2016", "dateOfCreation": "2016-02-03", "pubModel": "Print", "authorString": "Tafakhori A, Yu Jin Ng A, Tohari S, Venkatesh B, Lee H, Eskin A, Nelson SF, Bonnard C, Reversade B, Kariminejad A.", "affiliation": "Iranian Center of Neurological Research, Neurology Department, Tehran University of Medical Sciences, Tehran, Iran.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26838077", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Iranian Center of Neurological Research, Neurology Department, Tehran University of Medical Sciences, Tehran, Iran.", "fullName": "Tafakhori A", "initials": "A", "firstName": "Abbas", "lastName": "Tafakhori"}, {"affiliation": "Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.", "fullName": "Yu Jin Ng A", "initials": "A", "firstName": "Alvin", "lastName": "Yu Jin Ng"}, {"affiliation": "Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.", "fullName": "Tohari S", "initials": "S", "firstName": "Sumanty", "lastName": "Tohari"}, {"affiliation": "Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.", "fullName": "Venkatesh B", "initials": "B", "firstName": "Byrappa", "lastName": "Venkatesh"}, {"affiliation": "Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA.", "fullName": "Lee H", "initials": "H", "firstName": "Hane", "lastName": "Lee"}, {"affiliation": "Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA.", "fullName": "Eskin A", "initials": "A", "firstName": "Ascia", "lastName": "Eskin"}, {"affiliation": "Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA.", "fullName": "Nelson SF", "initials": "SF", "firstName": "Stanley F", "lastName": "Nelson"}, {"affiliation": "Institute of Medical Biology, A*STAR, Singapore, Singapore.", "fullName": "Bonnard C", "initials": "C", "firstName": "Carine", "lastName": "Bonnard"}, {"affiliation": "2)Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore. 4)Institute of Medical Biology, A*STAR, Singapore, Singapore.", "fullName": "Reversade B", "initials": "B", "firstName": "Bruno", "lastName": "Reversade"}, {"affiliation": "Kariminejad-Najmabadi Pathology and Genetics Center, Tehran Iran.", "fullName": "Kariminejad A", "initials": "A", "firstName": "Ariana", "lastName": "Kariminejad"}]}, "title": "Mutation in TWINKLE in a Large Iranian Family with Progressive External Ophthalmoplegia, Myopathy, Dysphagia and Dysphonia, and Behavior Change.", "citedByCount": 0, "source": "MED", "pmid": "26838077", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-02-01", "doi": "0161902/aim.004", "isOpenAccess": "N", "pageInfo": "87-91", "hasDbCrossReferences": "N", "abstractText": "TWINKLE (c10orf2) gene is responsible for autosomal dominant progressive external ophthalmoplegia (PEO). In rare cases, additional features such as muscle weakness, peripheral neuropathy, ataxia, cardiomyopathy, dysphagia, dysphonia, cataracts, depression, dementia, parkinsonism, and hearing loss have been reported in association with heterozygous mutations of the TWINKLE gene.We have studied a large Iranian family with myopathy, dysphonia, dysphagia, and behavior change in addition to PEO in affected members.We identified a missense mutation c.1121G > A in the c10orf2 gene in all affected members. Early death is a novel feature seen in affected members of this family that has not been reported to date.The association of PEO, myopathy, dysphonia, dysphagia, behavior change and early death has not been previously reported in the literature or other patients with this mutation.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/0161902/AIM.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-02-01", "journal": {"medlineAbbreviation": "Arch Iran Med", "isoabbreviation": "Arch Iran Med", "title": "Archives of Iranian medicine", "issn": "1029-2977", "nlmid": "100889644", "essn": "1735-3947"}, "monthOfPublication": 2, "volume": "19", "yearOfPublication": 2016, "journalIssueId": 2370226, "issue": "2", "dateOfPublication": "2016 Feb"}}, "25652200": {"pubYear": "2015", "dateOfCreation": "2015-04-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai-Man P, Chinnery PF, Taylor RW, Turnbull DM, McFarland R.", "affiliation": "Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, United Kingdom; Institute of Neuroscience, Henry Wellcome Building for Neuroecology, Newcastle upon Tyne, United Kingdom.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "074454/Z/04/Z"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "NIHR-HCS-D12-03-04"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "096919"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "096919Z/11/Z"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "101876"}, {"orderIn": 0, "agency": "Fight for Sight", "grantId": "1479/80"}, {"orderIn": 0, "agency": "NIHR Newcastle Biomedical Research Centre", "grantId": "BH111030"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0400074"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0502157"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601943"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0800674"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0900652"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1002570"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1100540"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/L016451/1"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "084980/Z/08/Z"}]}, "hasPDF": "Y", "id": "25652200", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, United Kingdom; Institute of Neuroscience, Henry Wellcome Building for Neuroecology, Newcastle upon Tyne, United Kingdom.", "fullName": "Gorman GS", "initials": "GS", "firstName": "Gr\u00e1inne S", "lastName": "Gorman"}, {"lastName": "Schaefer", "fullName": "Schaefer AM", "firstName": "Andrew M", "initials": "AM"}, {"lastName": "Ng", "fullName": "Ng Y", "firstName": "Yi", "initials": "Y"}, {"lastName": "Gomez", "fullName": "Gomez N", "firstName": "Nicholas", "initials": "N"}, {"lastName": "Blakely", "fullName": "Blakely EL", "firstName": "Emma L", "initials": "EL"}, {"lastName": "Alston", "fullName": "Alston CL", "authorId": {"type": "ORCID", "value": "0000-0003-2095-5464"}, "firstName": "Charlotte L", "initials": "CL"}, {"lastName": "Feeney", "fullName": "Feeney C", "firstName": "Catherine", "initials": "C"}, {"lastName": "Horvath", "fullName": "Horvath R", "firstName": "Rita", "initials": "R"}, {"lastName": "Yu-Wai-Man", "fullName": "Yu-Wai-Man P", "firstName": "Patrick", "initials": "P"}, {"lastName": "Chinnery", "fullName": "Chinnery PF", "firstName": "Patrick F", "initials": "PF"}, {"lastName": "Taylor", "fullName": "Taylor RW", "firstName": "Robert W", "initials": "RW"}, {"lastName": "Turnbull", "fullName": "Turnbull DM", "firstName": "Douglass M", "initials": "DM"}, {"lastName": "McFarland", "fullName": "McFarland R", "firstName": "Robert", "initials": "R"}]}, "title": "Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.", "hasSuppl": "N", "citedByCount": 16, "source": "MED", "pmid": "25652200", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2095-5464"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Nucleus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prevalence", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "England", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-03-28", "language": "eng", "doi": "10.1002/ana.24362", "isOpenAccess": "Y", "pageInfo": "753-759", "pmcid": "PMC4737121", "hasDbCrossReferences": "N", "abstractText": "The prevalence of mitochondrial disease has proven difficult to establish, predominantly as a result of clinical and genetic heterogeneity. The phenotypic spectrum of mitochondrial disease has expanded significantly since the original reports that associated classic clinical syndromes with mitochondrial DNA (mtDNA) rearrangements and point mutations. The revolution in genetic technologies has allowed interrogation of the nuclear genome in a manner that has dramatically improved the diagnosis of mitochondrial disorders. We comprehensively assessed the prevalence of all forms of adult mitochondrial disease to include pathogenic mutations in both nuclear and mtDNA.Adults with suspected mitochondrial disease in the North East of England were referred to a single neurology center from 1990 to 2014. For the midyear period of 2011, we evaluated the minimum prevalence of symptomatic nuclear DNA mutations and symptomatic and asymptomatic mtDNA mutations causing mitochondrial diseases.The minimum prevalence rate for mtDNA mutations was 1 in 5,000 (20 per 100,000), comparable with our previously published prevalence rates. In this population, nuclear mutations were responsible for clinically overt adult mitochondrial disease in 2.9 per 100,000 adults.Combined, our data confirm that the total prevalence of adult mitochondrial disease, including pathogenic mutations of both the mitochondrial and nuclear genomes (\u22481 in 4,300), is among the commonest adult forms of inherited neurological disorders. These figures hold important implications for the evaluation of interventions, provision of evidence-based health policies, and planning of future services.", "electronicPublicationDate": "2015-03-28", "license": "cc by", "dateOfCompletion": "2015-06-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4737121?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4737121", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1002/ana.24362", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-07-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "Ann Neurol", "isoabbreviation": "Ann. Neurol.", "title": "Annals of neurology", "issn": "0364-5134", "nlmid": "7707449", "essn": "1531-8249"}, "monthOfPublication": 5, "volume": "77", "yearOfPublication": 2015, "journalIssueId": 2276347, "issue": "5", "dateOfPublication": "2015 May"}}, "26251896": {"pubYear": "2015", "dateOfCreation": "2015-08-08", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Ahmed N, Ronchi D, Comi GP.", "affiliation": "Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Centre, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, via Francesco Sforza 35, Milan 20122, Italy. naghia.ahmed89@gmail.com.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26251896", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Centre, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, via Francesco Sforza 35, Milan 20122, Italy. naghia.ahmed89@gmail.com.", "fullName": "Ahmed N", "initials": "N", "firstName": "Naghia", "lastName": "Ahmed"}, {"firstName": "Dario", "lastName": "Ronchi", "affiliation": "Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Centre, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, via Francesco Sforza 35, Milan 20122, Italy. dario.ronchi@gmail.com.", "authorId": {"type": "ORCID", "value": "0000-0002-6093-9816"}, "fullName": "Ronchi D", "initials": "D"}, {"firstName": "Giacomo Pietro", "lastName": "Comi", "affiliation": "Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Centre, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, via Francesco Sforza 35, Milan 20122, Italy. giacomo.comi@unimi.it.", "authorId": {"type": "ORCID", "value": "0000-0002-1383-5248"}, "fullName": "Comi GP", "initials": "GP"}]}, "title": "Genes and Pathways Involved in Adult Onset Disorders Featuring Muscle Mitochondrial DNA Instability.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "26251896", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6093-9816"}, {"type": "ORCID", "value": "0000-0002-1383-5248"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondria, Muscle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genomic Instability", "majorTopic_YN": "N"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-05", "language": "eng", "doi": "10.3390/ijms160818054", "isOpenAccess": "Y", "pageInfo": "18054-18076", "pmcid": "PMC4581235", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Mitochondrial Myopathy", "Progressive External Ophthalmoplegia", "Mtdna Maintenance", "Adult Mitochondrial Disorders", "Multiple Mtdna Deletions"]}, "abstractText": "Replication and maintenance of mtDNA entirely relies on a set of proteins encoded by the nuclear genome, which include members of the core replicative machinery, proteins involved in the homeostasis of mitochondrial dNTPs pools or deputed to the control of mitochondrial dynamics and morphology. Mutations in their coding genes have been observed in familial and sporadic forms of pediatric and adult-onset clinical phenotypes featuring mtDNA instability. The list of defects involved in these disorders has recently expanded, including mutations in the exo-/endo-nuclease flap-processing proteins MGME1 and DNA2, supporting the notion that an enzymatic DNA repair system actively takes place in mitochondria. The results obtained in the last few years acknowledge the contribution of next-generation sequencing methods in the identification of new disease loci in small groups of patients and even single probands. Although heterogeneous, these genes can be conveniently classified according to the pathway to which they belong. The definition of the molecular and biochemical features of these pathways might be helpful for fundamental knowledge of these disorders, to accelerate genetic diagnosis of patients and the development of rational therapies. In this review, we discuss the molecular findings disclosed in adult patients with muscle pathology hallmarked by mtDNA instability.", "electronicPublicationDate": "2015-08-05", "license": "cc by", "dateOfCompletion": "2016-05-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4581235?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4581235", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3390/ijms160818054", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-09-29", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "International journal of molecular sciences", "medlineAbbreviation": "Int J Mol Sci", "isoabbreviation": "Int J Mol Sci", "nlmid": "101092791", "essn": "1422-0067"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2015, "journalIssueId": 2307534, "issue": "8", "dateOfPublication": "2015"}}, "23107649": {"pubYear": "2012", "dateOfCreation": "2012-11-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.17.4.-", "name": "RRM2B protein, human"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 1.17.4.-", "name": "Ribonucleotide Reductases"}]}, "authorString": "Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z, Deschauer M, Pohl U, Roberts ME, Jackson MC, Halfpenny CA, Turnpenny PD, Lunt PW, Hanna MG, Schaefer AM, McFarland R, Horvath R, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS.", "affiliation": "MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "074454/Z/04/Z"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "096919"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "906919"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0500695"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601943"}, {"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0800674"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1000848"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "NF-SI-0509-10011"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "NF-SI-0510-10187"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0700718"}]}, "hasPDF": "Y", "id": "23107649", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.", "fullName": "Pitceathly RD", "initials": "RD", "firstName": "Robert D S", "lastName": "Pitceathly"}, {"lastName": "Smith", "fullName": "Smith C", "firstName": "Conrad", "initials": "C"}, {"lastName": "Fratter", "fullName": "Fratter C", "firstName": "Carl", "initials": "C"}, {"lastName": "Alston", "fullName": "Alston CL", "authorId": {"type": "ORCID", "value": "0000-0003-2095-5464"}, "firstName": "Charlotte L", "initials": "CL"}, {"lastName": "He", "fullName": "He L", "firstName": "Langping", "initials": "L"}, {"lastName": "Craig", "fullName": "Craig K", "firstName": "Kate", "initials": "K"}, {"lastName": "Blakely", "fullName": "Blakely EL", "firstName": "Emma L", "initials": "EL"}, {"lastName": "Evans", "fullName": "Evans JC", "firstName": "Julie C", "initials": "JC"}, {"lastName": "Taylor", "fullName": "Taylor J", "firstName": "John", "initials": "J"}, {"lastName": "Shabbir", "fullName": "Shabbir Z", "firstName": "Zarfishan", "initials": "Z"}, {"lastName": "Deschauer", "fullName": "Deschauer M", "firstName": "Marcus", "initials": "M"}, {"lastName": "Pohl", "fullName": "Pohl U", "firstName": "Ute", "initials": "U"}, {"lastName": "Roberts", "fullName": "Roberts ME", "firstName": "Mark E", "initials": "ME"}, {"lastName": "Jackson", "fullName": "Jackson MC", "firstName": "Matthew C", "initials": "MC"}, {"lastName": "Halfpenny", "fullName": "Halfpenny CA", "firstName": "Christopher A", "initials": "CA"}, {"lastName": "Turnpenny", "fullName": "Turnpenny PD", "firstName": "Peter D", "initials": "PD"}, {"lastName": "Lunt", "fullName": "Lunt PW", "firstName": "Peter W", "initials": "PW"}, {"lastName": "Hanna", "fullName": "Hanna MG", "firstName": "Michael G", "initials": "MG"}, {"lastName": "Schaefer", "fullName": "Schaefer AM", "firstName": "Andrew M", "initials": "AM"}, {"lastName": "McFarland", "fullName": "McFarland R", "firstName": "Robert", "initials": "R"}, {"lastName": "Horvath", "fullName": "Horvath R", "firstName": "Rita", "initials": "R"}, {"lastName": "Chinnery", "fullName": "Chinnery PF", "firstName": "Patrick F", "initials": "PF"}, {"lastName": "Turnbull", "fullName": "Turnbull DM", "firstName": "Douglass M", "initials": "DM"}, {"lastName": "Poulton", "fullName": "Poulton J", "firstName": "Joanna", "initials": "J"}, {"lastName": "Taylor", "fullName": "Taylor RW", "firstName": "Robert W", "initials": "RW"}, {"lastName": "Gorman", "fullName": "Gorman GS", "firstName": "Gr\u00e1inne S", "initials": "GS"}]}, "title": "Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.", "hasSuppl": "Y", "citedByCount": 14, "source": "MED", "pmid": "23107649", "abstractText": "Mutations in the nuclear-encoded mitochondrial maintenance gene RRM2B are an important cause of familial mitochondrial disease in both adults and children and represent the third most common cause of multiple mitochondrial DNA deletions in adults, following POLG [polymerase (DNA directed), gamma] and PEO1 (now called C10ORF2, encoding the Twinkle helicase) mutations. However, the clinico-pathological and molecular features of adults with RRM2B-related disease have not been clearly defined. In this multicentre study of 26 adult patients from 22 independent families, including five additional cases published in the literature, we show that extra-ocular neurological complications are common in adults with genetically confirmed RRM2B mutations. We also demonstrate a clear correlation between the clinical phenotype and the underlying genetic defect. Myopathy was a prominent manifestation, followed by bulbar dysfunction and fatigue. Sensorineural hearing loss and gastrointestinal disturbance were also important findings. Severe multisystem neurological disease was associated with recessively inherited compound heterozygous mutations with a mean age of disease onset at 7 years. Dominantly inherited heterozygous mutations were associated with a milder predominantly myopathic phenotype with a later mean age of disease onset at 46 years. Skeletal muscle biopsies revealed subsarcolemmal accumulation of mitochondria and/or cytochrome c oxidase-deficient fibres. Multiple mitochondrial DNA deletions were universally present in patients who underwent a muscle biopsy. We identified 18 different heterozygous RRM2B mutations within our cohort of patients, including five novel mutations that have not previously been reported. Despite marked clinical overlap between the mitochondrial maintenance genes, key clinical features such as bulbar dysfunction, hearing loss and gastrointestinal disturbance should help prioritize genetic testing towards RRM2B analysis, and sequencing of the gene may preclude performance of a muscle biopsy.", "tmAccessionTypeList": {"accessionType": ["refseq", " pdb", " "]}, "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2095-5464"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Myopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuromuscular Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ribonucleotide Reductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Heterozygote", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-10-29", "language": "eng", "doi": "10.1093/brain/aws231", "isOpenAccess": "Y", "pageInfo": "3392-3403", "pmcid": "PMC3501970", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "electronicPublicationDate": "2012-10-29", "license": "cc by", "dateOfCompletion": "2013-02-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3501970?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3501970", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23107649", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23107649&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/brain/aws231", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-02-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-11-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 11, "volume": "135", "yearOfPublication": 2012, "journalIssueId": 1985344, "issue": "Pt 11", "dateOfPublication": "2012 Nov"}}, "22928142": {"pubYear": "2012", "dateOfCreation": "2012-08-28", "pubModel": "Print-Electronic", "authorString": "Hartley JN, Booth FA, Del Bigio MR, Mhanni AA.", "affiliation": "Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "22928142", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Hartley", "fullName": "Hartley JN", "firstName": "Jessica N", "initials": "JN"}, {"lastName": "Booth", "fullName": "Booth FA", "firstName": "Frances A", "initials": "FA"}, {"lastName": "Del Bigio", "fullName": "Del Bigio MR", "firstName": "Marc R", "initials": "MR"}, {"lastName": "Mhanni", "fullName": "Mhanni AA", "firstName": "Aizeddin A", "initials": "AA"}]}, "title": "Novel Autosomal Recessive c10orf2 Mutations Causing Infantile-Onset Spinocerebellar Ataxia.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "22928142", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["omim"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-08-11", "doi": "10.1155/2012/303096", "isOpenAccess": "Y", "pageInfo": "303096", "pmcid": "PMC3424653", "hasDbCrossReferences": "N", "abstractText": "Recessive mutations in genes encoding mitochondrial DNA replication machinery lead to mitochondrial DNA depletion syndromes. This genetically and phenotypically heterogeneous group includes infantile onset spinocerebellar ataxia (OMIM# 271245) a neurodegenerative disease caused by mutations in the mtDNA helicase gene, c10orf2, with an increased frequency in the Finnish population due to a founder mutation. We describe a child of English descent who presented with a severe phenotype of IOSCA as a result of two-novel mutations in the c10orf2 gene. This paper expands the phenotypic spectrum of IOSCA and adds further evidence for the presence of a genotype-phenotype correlation among patients with recessive mutations in this gene.", "electronicPublicationDate": "2012-08-11", "language": "eng", "dateOfCompletion": "2012-08-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3424653?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3424653", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22928142&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22928142", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1155/2012/303096", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-04-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Case Rep Pediatr", "isoabbreviation": "Case Rep Pediatr", "title": "Case reports in pediatrics", "issn": "2090-6803", "nlmid": "101581030", "essn": "2090-6811"}, "monthOfPublication": 0, "volume": "2012", "yearOfPublication": 2012, "journalIssueId": 1933346, "dateOfPublication": "2012 "}}, "18575922": {"pubYear": "2008", "dateOfCreation": "2008-10-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.7.-", "name": "POLG protein, human"}, {"registryNumber": "EC 2.7.7.7", "name": "DNA-Directed DNA Polymerase"}, {"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "0", "name": "Adenine Nucleotide Translocator 1"}, {"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "Virgilio R, Ronchi D, Hadjigeorgiou GM, Bordoni A, Saladino F, Moggio M, Adobbati L, Kafetsouli D, Tsironi E, Previtali S, Papadimitriou A, Bresolin N, Comi GP.", "affiliation": "Centro Dino Ferrari, Dipartimento di Scienze Neurologiche, Universit\u00e0 degli Studi di Milano, Fondazione I.R.C.C.S. Ospedale Maggiore, Policlinico, Mangiagolli e Regina Elena, Via Sforza 35, 20122, Milano, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Telethon", "grantId": "GTF02008"}]}, "hasPDF": "N", "id": "18575922", "inEPMC": "N", "authorList": {"author": [{"lastName": "Virgilio", "fullName": "Virgilio R", "firstName": "Roberta", "initials": "R"}, {"lastName": "Ronchi", "fullName": "Ronchi D", "authorId": {"type": "ORCID", "value": "0000-0002-6093-9816"}, "firstName": "Dario", "initials": "D"}, {"lastName": "Hadjigeorgiou", "fullName": "Hadjigeorgiou GM", "firstName": "Georgios M", "initials": "GM"}, {"lastName": "Bordoni", "fullName": "Bordoni A", "firstName": "Andreina", "initials": "A"}, {"lastName": "Saladino", "fullName": "Saladino F", "firstName": "Francesca", "initials": "F"}, {"lastName": "Moggio", "fullName": "Moggio M", "firstName": "Maurizio", "initials": "M"}, {"lastName": "Adobbati", "fullName": "Adobbati L", "firstName": "Laura", "initials": "L"}, {"lastName": "Kafetsouli", "fullName": "Kafetsouli D", "firstName": "Demetra", "initials": "D"}, {"lastName": "Tsironi", "fullName": "Tsironi E", "firstName": "Evangelia", "initials": "E"}, {"lastName": "Previtali", "fullName": "Previtali S", "authorId": {"type": "ORCID", "value": "0000-0003-2546-4357"}, "firstName": "Stefano", "initials": "S"}, {"lastName": "Papadimitriou", "fullName": "Papadimitriou A", "firstName": "Alexandros", "initials": "A"}, {"lastName": "Bresolin", "fullName": "Bresolin N", "firstName": "Nereo", "initials": "N"}, {"lastName": "Comi", "fullName": "Comi GP", "authorId": {"type": "ORCID", "value": "0000-0002-1383-5248"}, "firstName": "Giacomo P", "initials": "GP"}]}, "title": "Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia.", "citedByCount": 21, "source": "MED", "pmid": "18575922", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6093-9816"}, {"type": "ORCID", "value": "0000-0003-2546-4357"}, {"type": "ORCID", "value": "0000-0002-1383-5248"}, {"type": "ORCID", "value": "0000-0003-2546-4357"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Mitochondria, Muscle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Directed DNA Polymerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adenine Nucleotide Translocator 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology, Amino Acid", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Heterogeneity", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-06-30", "doi": "10.1007/s00415-008-0926-3", "isOpenAccess": "N", "pageInfo": "1384-1391", "hasDbCrossReferences": "Y", "abstractText": "Multiple deletions of mitochondrial DNA (mtDNA) are associated with different mitochondrial disorders inherited as autosomal dominant and recessive traits. Causative mutations have been found in five genes, mainly involved in mtDNA replication and stability. They include POLG1, the gene encoding the catalytic subunit of mtDNA polymerase (pol gamma), POLG2 encoding its accessory subunit, ANT1 coding the adenine nucleotide translocator and PEO1 which codes for Twinkle, the mitochondrial helicase. Finally OPA1 missense mutations are involved in phenotypes presenting optic atrophy as a major feature.To define the relative contribution of POLG1, POLG2, ANT1 and PEO1 genes to the mtDNA multiple deletion syndromes, we analysed them in a cohort of 67 probands showing accumulation of multiple mtDNA deletions in muscle. The patients were predominantly affected with a mitochondrial myopathy with or without progressive external ophthalmoplegia (PEO). Genetic analysis revealed that 1) PEO1 has a major role in determining familial PEO, since it accounts for 26.8% of familial cases, followed by ANT1 (14.6%) and POLG1 (9.8%); 2) no mutations in any of the known genes were found in 53.7% of probands of this series. Six novel missense mutations contributing to the mutational load of PEO1 gene (p.R334P, p.W315S, p. S426N, p.W474S, p.F478I, p.E479K) were associated with an adult onset PEO phenotype.", "electronicPublicationDate": "2008-06-30", "language": "eng", "dateOfCompletion": "2009-02-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00415-008-0926-3", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-09-01", "journal": {"medlineAbbreviation": "J Neurol", "isoabbreviation": "J. Neurol.", "title": "Journal of neurology", "issn": "0340-5354", "nlmid": "0423161", "essn": "1432-1459"}, "monthOfPublication": 9, "volume": "255", "yearOfPublication": 2008, "journalIssueId": 1574354, "issue": "9", "dateOfPublication": "2008 Sep"}}, "24816431": {"pubYear": "2014", "dateOfCreation": "2014-07-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "0", "name": "Mitochondrial Proteins"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}, {"registryNumber": "EC 3.6.4.-", "name": "DNA Helicases"}]}, "authorString": "Park MH, Woo HM, Hong YB, Park JH, Yoon BR, Park JM, Yoo JH, Koo H, Chae JH, Chung KW, Choi BO, Koo SK.", "affiliation": "Division of Intractable Diseases, Center for Biomedical Sciences, National Institute of Health, Osong Health Technology Administration Complex 643, Yeonje-ri, Osong-eup, Cheongwon-gun, Chungcheongbuk-do, 363-951, South Korea.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24816431", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Division of Intractable Diseases, Center for Biomedical Sciences, National Institute of Health, Osong Health Technology Administration Complex 643, Yeonje-ri, Osong-eup, Cheongwon-gun, Chungcheongbuk-do, 363-951, South Korea.", "fullName": "Park MH", "initials": "MH", "firstName": "Mi-Hyun", "lastName": "Park"}, {"lastName": "Woo", "fullName": "Woo HM", "firstName": "Hae-Mi", "initials": "HM"}, {"lastName": "Hong", "fullName": "Hong YB", "firstName": "Young Bin", "initials": "YB"}, {"lastName": "Park", "fullName": "Park JH", "firstName": "Ji Hoon", "initials": "JH"}, {"lastName": "Yoon", "fullName": "Yoon BR", "firstName": "Bo Ram", "initials": "BR"}, {"lastName": "Park", "fullName": "Park JM", "firstName": "Jin-Mo", "initials": "JM"}, {"lastName": "Yoo", "fullName": "Yoo JH", "firstName": "Jeong Hyun", "initials": "JH"}, {"lastName": "Koo", "fullName": "Koo H", "firstName": "Heasoo", "initials": "H"}, {"lastName": "Chae", "fullName": "Chae JH", "firstName": "Jong-Hee", "initials": "JH"}, {"lastName": "Chung", "fullName": "Chung KW", "firstName": "Ki Wha", "initials": "KW"}, {"lastName": "Choi", "fullName": "Choi BO", "firstName": "Byung-Ok", "initials": "BO"}, {"lastName": "Koo", "fullName": "Koo SK", "firstName": "Soo Kyung", "initials": "SK"}]}, "title": "Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24816431", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["omim"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Skeletal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sural Nerve", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Muscular Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sequence Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Recessive", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Hereditary Sensory and Motor Neuropathy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-05-10", "doi": "10.1007/s10048-014-0405-1", "isOpenAccess": "Y", "pageInfo": "171-182", "pmcid": "PMC4102772", "hasDbCrossReferences": "Y", "abstractText": "Recessive mutations in chromosome 10 open reading frame 2 (C10orf2) are relevant in infantile-onset spinocerebellar ataxia (IOSCA). In this study, we investigated the causative mutation in a Korean family with combined phenotypes of IOSCA, sensorimotor polyneuropathy, and myopathy. We investigated recessive mutations in a Korean family with two individuals affected by IOSCA. Causative mutations were investigated using whole exome sequencing. Electrophysiological analyses and muscle and nerve biopsies were performed, along with magnetic resonance imaging (MRI) of the brain and lower extremities. Compound heterozygous mutations c.1460C>T and c.1485-1G>A in C10orf2 were identified as causative of IOSCA. Skeletal muscle showed mitochondrial DNA (mtDNA) deletions. Both patients showed a period of normal development until 12-15 months, followed by ataxia, athetosis, hearing loss, and intellectual disability. Electrophysiological findings indicated motor and sensory polyneuropathies. Muscle biopsy revealed variations in the size and shape of myofibers with scattered, small, and angulated degenerating myofibers containing abnormal mitochondria; these observations are consistent with myopathy and may be the result of mtDNA deletions. Sural nerve biopsy revealed an axonal neuropathy. High-signal-intensity lesions in the middle cerebellar peduncles were correlated with clinical severity, and MRI of the lower legs was compatible with the hypothesis of length-dependent axonal degeneration. We identified novel compound heterozygous mutations of the C10orf2 gene as the cause of IOSCA with sensorimotor polyneuropathy and myopathy. Signs of motor neuropathy and myopathy were discovered for the first time in IOSCA patients with C10orf2 mutations. These results suggest that the clinical spectrum of IOSCA caused by C10orf2 mutations may be more variable than previously reported.", "electronicPublicationDate": "2014-05-10", "language": "eng", "dateOfCompletion": "2015-02-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4102772?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4102772", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24816431&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24816431", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s10048-014-0405-1", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-08-01", "journal": {"medlineAbbreviation": "Neurogenetics", "isoabbreviation": "Neurogenetics", "title": "Neurogenetics", "issn": "1364-6745", "nlmid": "9709714", "essn": "1364-6753"}, "monthOfPublication": 8, "volume": "15", "yearOfPublication": 2014, "journalIssueId": 2181796, "issue": "3", "dateOfPublication": "2014 Aug"}}, "25281868": {"pubYear": "2014", "dateOfCreation": "2014-11-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}]}, "authorString": "Horga A, Pitceathly RD, Blake JC, Woodward CE, Zapater P, Fratter C, Mudanohwo EE, Plant GT, Houlden H, Sweeney MG, Hanna MG, Reilly MM.", "affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK a.horga@ucl.ac.uk.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "1U54NS065712-01"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "2233"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601943"}, {"orderIn": 0, "agency": "Department of Health"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1001253"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/J004758/1"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MR/K000608/1"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0802760"}]}, "hasPDF": "Y", "id": "25281868", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Alejandro", "lastName": "Horga", "affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK a.horga@ucl.ac.uk.", "authorId": {"type": "ORCID", "value": "0000-0002-2120-2213"}, "fullName": "Horga A", "initials": "A"}, {"affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Pitceathly RD", "initials": "RD", "firstName": "Robert D S", "lastName": "Pitceathly"}, {"affiliation": "2 Department of Clinical Neurophysiology, Norfolk and Norwich University Hospital, Norwich, NR4 7UY, UK.", "fullName": "Blake JC", "initials": "JC", "firstName": "Julian C", "lastName": "Blake"}, {"affiliation": "3 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Woodward CE", "initials": "CE", "firstName": "Catherine E", "lastName": "Woodward"}, {"affiliation": "4 Clinical Pharmacology Section, Hospital General Universitario, Alicante, 03010, Spain.", "fullName": "Zapater P", "initials": "P", "firstName": "Pedro", "lastName": "Zapater"}, {"affiliation": "5 Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, UK.", "fullName": "Fratter C", "initials": "C", "firstName": "Carl", "lastName": "Fratter"}, {"affiliation": "3 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Mudanohwo EE", "initials": "EE", "firstName": "Ese E", "lastName": "Mudanohwo"}, {"affiliation": "6 National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Plant GT", "initials": "GT", "firstName": "Gordon T", "lastName": "Plant"}, {"affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Houlden H", "initials": "H", "firstName": "Henry", "lastName": "Houlden"}, {"affiliation": "3 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Sweeney MG", "initials": "MG", "firstName": "Mary G", "lastName": "Sweeney"}, {"affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Hanna MG", "initials": "MG", "firstName": "Michael G", "lastName": "Hanna"}, {"affiliation": "1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.", "fullName": "Reilly MM", "initials": "MM", "firstName": "Mary M", "lastName": "Reilly"}]}, "title": "Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "25281868", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2120-2213"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Nucleus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Ophthalmoplegia, Chronic Progressive External", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Peripheral Nervous System Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-10-03", "language": "eng", "doi": "10.1093/brain/awu279", "isOpenAccess": "Y", "pageInfo": "3200-3212", "pmcid": "PMC4240292", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Mitochondrial DNA", "Peripheral Neuropathy", "Progressive External Ophthalmoplegia", "Mitochondrial Dna Deletion", "Polg"]}, "abstractText": "Progressive external ophthalmoplegia is a common clinical feature in mitochondrial disease caused by nuclear DNA defects and single, large-scale mitochondrial DNA deletions and is less frequently associated with point mutations of mitochondrial DNA. Peripheral neuropathy is also a frequent manifestation of mitochondrial disease, although its prevalence and characteristics varies considerably among the different syndromes and genetic aetiologies. Based on clinical observations, we systematically investigated whether the presence of peripheral neuropathy could predict the underlying genetic defect in patients with progressive external ophthalmoplegia. We analysed detailed demographic, clinical and neurophysiological data from 116 patients with genetically-defined mitochondrial disease and progressive external ophthalmoplegia. Seventy-eight patients (67%) had a single mitochondrial DNA deletion, 12 (10%) had a point mutation of mitochondrial DNA and 26 (22%) had mutations in either POLG, C10orf2 or RRM2B, or had multiple mitochondrial DNA deletions in muscle without an identified nuclear gene defect. Seventy-seven patients had neurophysiological studies; of these, 16 patients (21%) had a large-fibre peripheral neuropathy. The prevalence of peripheral neuropathy was significantly lower in patients with a single mitochondrial DNA deletion (2%) as compared to those with a point mutation of mitochondrial DNA or with a nuclear DNA defect (44% and 52%, respectively; P<0.001). Univariate analyses revealed significant differences in the distribution of other clinical features between genotypes, including age at disease onset, gender, family history, progressive external ophthalmoplegia at clinical presentation, hearing loss, pigmentary retinopathy and extrapyramidal features. However, binomial logistic regression analysis identified peripheral neuropathy as the only independent predictor associated with a nuclear DNA defect (P=0.002; odds ratio 8.43, 95% confidence interval 2.24-31.76). Multinomial logistic regression analysis identified peripheral neuropathy, family history and hearing loss as significant predictors of the genotype, and the same three variables showed the highest performance in genotype classification in a decision tree analysis. Of these variables, peripheral neuropathy had the highest specificity (91%), negative predictive value (83%) and positive likelihood ratio (5.87) for the diagnosis of a nuclear DNA defect. These results indicate that peripheral neuropathy is a rare finding in patients with single mitochondrial DNA deletions but that it is highly predictive of an underlying nuclear DNA defect. This observation may facilitate the development of diagnostic algorithms. We suggest that nuclear gene testing may enable a more rapid diagnosis and avoid muscle biopsy in patients with progressive external ophthalmoplegia and peripheral neuropathy.", "electronicPublicationDate": "2014-10-03", "license": "cc by", "dateOfCompletion": "2015-03-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4240292?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4240292", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/brain/awu279", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-12-01", "journal": {"medlineAbbreviation": "Brain", "isoabbreviation": "Brain", "title": "Brain : a journal of neurology", "issn": "0006-8950", "nlmid": "0372537", "essn": "1460-2156"}, "monthOfPublication": 12, "volume": "137", "yearOfPublication": 2014, "journalIssueId": 2221645, "issue": "Pt 12", "dateOfPublication": "2014 Dec"}}, "18775955": {"pubYear": "2008", "dateOfCreation": "2008-11-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Mitochondrial"}, {"registryNumber": "EC 1.6.5.3", "name": "Electron Transport Complex I"}, {"registryNumber": "EC 3.6.1.-", "name": "DNA Helicases"}, {"registryNumber": "EC 3.6.4.12", "name": "C10ORF2 protein, human"}]}, "authorString": "Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, Lampinen M, Sajantila A, L\u00f6nnqvist T, Spelbrink JN, Suomalainen A.", "affiliation": "Research Program of Molecular Neurology, University of Helsinki, Helsinki, Finland.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "18775955", "inEPMC": "N", "authorList": {"author": [{"lastName": "Hakonen", "fullName": "Hakonen AH", "firstName": "Anna H", "initials": "AH"}, {"lastName": "Goffart", "fullName": "Goffart S", "firstName": "Steffi", "initials": "S"}, {"lastName": "Marjavaara", "fullName": "Marjavaara S", "firstName": "Sanna", "initials": "S"}, {"lastName": "Paetau", "fullName": "Paetau A", "firstName": "Anders", "initials": "A"}, {"lastName": "Cooper", "fullName": "Cooper H", "firstName": "Helen", "initials": "H"}, {"lastName": "Mattila", "fullName": "Mattila K", "firstName": "Kimmo", "initials": "K"}, {"lastName": "Lampinen", "fullName": "Lampinen M", "firstName": "Milla", "initials": "M"}, {"lastName": "Sajantila", "fullName": "Sajantila A", "firstName": "Antti", "initials": "A"}, {"lastName": "L\u00f6nnqvist", "fullName": "L\u00f6nnqvist T", "firstName": "Tuula", "initials": "T"}, {"lastName": "Spelbrink", "fullName": "Spelbrink JN", "firstName": "Johannes N", "initials": "JN"}, {"lastName": "Suomalainen", "fullName": "Suomalainen A", "firstName": "Anu", "initials": "A"}]}, "title": "Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion.", "citedByCount": 42, "source": "MED", "pmid": "18775955", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Spinocerebellar Ataxias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Electron Transport Complex I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Mitochondrial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amino Acid Motifs", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Protein Transport", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-09-05", "doi": "10.1093/hmg/ddn280", "isOpenAccess": "N", "pageInfo": "3822-3835", "hasDbCrossReferences": "Y", "abstractText": "Infantile-onset spinocerebellar ataxia (IOSCA) is a severe neurodegenerative disorder caused by the recessive mutation in PEO1, leading to an Y508C change in the mitochondrial helicase Twinkle, in its helicase domain. However, no mitochondrial dysfunction has been found in this disease. We studied here the consequences of IOSCA for the central nervous system, as well as the in vitro performance of the IOSCA mutant protein. The results of the mtDNA analyses were compared to findings in a similar juvenile or adult-onset ataxia syndrome, mitochondrial recessive ataxia syndrome (MIRAS), caused by the W748S mutation in the mitochondrial DNA polymerase (POLG). We show here that IOSCA brain does not harbor mtDNA deletions or increased amount of mtDNA point mutations, whereas MIRAS brain shows multiple deletions of mtDNA. However, IOSCA, and to a lesser extent also MIRAS, show mtDNA depletion in the brain and the liver. In both diseases, especially large neurons show respiratory chain complex I (CI) deficiency, but also CIV is decreased in IOSCA. Helicase activity, hexamerization and nucleoid structure of the IOSCA mutant were, however, unaffected. The lack of in vitro helicase defect or cell culture phenotype suggest that Twinkle-Y508C dysfunction affects mtDNA maintenance in a highly context and cell-type specific manner. Our results indicate that IOSCA is a new member of the mitochondrial DNA depletion syndromes.", "electronicPublicationDate": "2008-09-05", "language": "eng", "dateOfCompletion": "2008-12-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://hmg.oxfordjournals.org/cgi/content/abstract/17/23/3822", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "hmg.oxfordjournals.org"}, {"url": "http://hmg.oxfordjournals.org/cgi/content/full/17/23/3822", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "hmg.oxfordjournals.org"}, {"url": "http://dx.doi.org/10.1093/hmg/ddn280", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-12-01", "journal": {"medlineAbbreviation": "Hum Mol Genet", "isoabbreviation": "Hum. Mol. Genet.", "title": "Human molecular genetics", "issn": "0964-6906", "nlmid": "9208958", "essn": "1460-2083"}, "monthOfPublication": 12, "volume": "17", "yearOfPublication": 2008, "journalIssueId": 1577615, "issue": "23", "dateOfPublication": "2008 Dec"}}}, "DCC": {"25950802": {"pubYear": "2015", "dateOfCreation": "2015-05-08", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "158651-98-0", "name": "netrin-1"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Nerve Growth Factors"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "DCC protein, human"}]}, "authorString": "SanGiovanni JP, Chen J, Gupta AS, Smith LE, Sapieha P, Lee PH.", "affiliation": "National Institute of Alcohol Abuse and Alcoholism, Section on Nutritional Neuroscience, National Institutes of Health, Bethesda, MD, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Intramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "221478"}, {"orderIn": 0, "agency": "Intramural NIH HHS"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY024963"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY017017"}]}, "hasPDF": "Y", "id": "25950802", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "National Institute of Alcohol Abuse and Alcoholism, Section on Nutritional Neuroscience, National Institutes of Health, Bethesda, MD, United States of America.", "fullName": "SanGiovanni JP", "initials": "JP", "firstName": "John Paul", "lastName": "SanGiovanni"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States of America.", "fullName": "Chen J", "initials": "J", "firstName": "Jing", "lastName": "Chen"}, {"affiliation": "University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America.", "fullName": "Gupta AS", "initials": "AS", "firstName": "Ankur S", "lastName": "Gupta"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States of America.", "fullName": "Smith LE", "initials": "LE", "firstName": "Lois E H", "lastName": "Smith"}, {"affiliation": "Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, QC, Canada.", "fullName": "Sapieha P", "initials": "P", "firstName": "Przemyslaw", "lastName": "Sapieha"}, {"affiliation": "Analytic & Translational Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.", "fullName": "Lee PH", "initials": "PH", "firstName": "Phil H", "lastName": "Lee"}]}, "title": "Netrin-1 - DCC Signaling Systems and Age-Related Macular Degeneration.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25950802", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Growth Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-05-07", "doi": "10.1371/journal.pone.0125548", "isOpenAccess": "Y", "pageInfo": "e0125548", "pmcid": "PMC4423995", "hasDbCrossReferences": "Y", "abstractText": "We conducted a nested candidate gene study and pathway-based enrichment analysis on data from a multi-national 77,000-person project on the molecular genetics of age-related macular degeneration (AMD) to identify AMD-associated DNA-sequence variants in genes encoding constituents of a netrin-1 (NTN1)-based signaling pathway that converges on DNA-binding transcription complexes through a 3'-5'-cyclic adenosine monophosphate-calcineurin (cAMP-CN)-dependent axis. AMD-associated single nucleotide polymorphisms (SNPs) existed in 9 linkage disequilibrium-independent genomic regions; these included loci overlapping NTN1 (rs9899630, P \u2264 9.48 x 10(-5)), DCC (Deleted in Colorectal Cancer)--the gene encoding a primary NTN1 receptor (rs8097127, P \u2264 3.03 x 10(-5)), and 6 other netrin-related genes. Analysis of the NTN1-DCC pathway with exact methods demonstrated robust enrichment with AMD-associated SNPs (corrected P-value = 0.038), supporting the idea that processes driven by NTN1-DCC signaling systems operate in advanced AMD. The NTN1-DCC pathway contains targets of FDA-approved drugs and may offer promise for guiding applied clinical research on preventive and therapeutic interventions for AMD.", "electronicPublicationDate": "2015-05-07", "language": "eng", "dateOfCompletion": "2016-04-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4423995?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4423995", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0125548", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2015, "journalIssueId": 2278532, "issue": "5", "dateOfPublication": "2015"}}, "22418395": {"pubYear": "2012", "dateOfCreation": "2012-05-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "DCC protein, human"}]}, "authorString": "Grant A, Fathalli F, Rouleau G, Joober R, Flores C.", "affiliation": "Integrated Program in Neuroscience, McGill University, Douglas Mental Health University Institute, 6875 LaSalle Boulevard, Montreal, Quebec, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research"}]}, "hasPDF": "N", "id": "22418395", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Integrated Program in Neuroscience, McGill University, Douglas Mental Health University Institute, 6875 LaSalle Boulevard, Montreal, Quebec, Canada.", "fullName": "Grant A", "initials": "A", "firstName": "Alanna", "lastName": "Grant"}, {"lastName": "Fathalli", "fullName": "Fathalli F", "firstName": "Ferid", "initials": "F"}, {"lastName": "Rouleau", "fullName": "Rouleau G", "firstName": "Guy", "initials": "G"}, {"lastName": "Joober", "fullName": "Joober R", "firstName": "Ridha", "initials": "R"}, {"lastName": "Flores", "fullName": "Flores C", "firstName": "Cecilia", "initials": "C"}]}, "title": "Association between schizophrenia and genetic variation in DCC: a case-control study.", "citedByCount": 10, "source": "MED", "pmid": "22418395", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychiatric Status Rating Scales", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-13", "doi": "10.1016/j.schres.2012.02.023", "isOpenAccess": "N", "pageInfo": "26-31", "hasDbCrossReferences": "Y", "abstractText": "Schizophrenia is a highly heritable neurodevelopmental disorder associated with alterations in synaptic connectivity. Deleted in colorectal cancer (DCC), a receptor for the guidance cue netrin-1, plays a pivotal role in organizing neuronal circuitry by guiding growing axons and dendrites to their correct targets and by influencing synaptic connectivity. Results from experiments we previously conducted in dcc-heterozygous mice show that DCC plays a critical role in the developmental organization of the mesocorticolimbic dopamine (DA) circuitry. Furthermore we have shown that reduced expression of DCC during development and/or throughout life confers resilience to the development of schizophrenia-like DA and behavioural abnormalities. Importantly, this \"protective\" phenotype only emerges after puberty. Here we assess whether DCC may contribute to the risk of schizophrenia. We examined single nucleotide polymorphisms (SNPs) located in the DCC gene for association with schizophrenia using a case-control sample consisting of 556 unrelated schizophrenic patients and 208 healthy controls. We found one SNP, rs2270954, to be nominally associated with schizophrenia; patients were less likely to be heterozygous at this locus and more likely to be homozygous for the minor allele (\u03c7(2)=9.84, df=2, nominal p=0.0071). Intriguingly, this SNP is located within the 3' untranslated region, an area known to contain a number of regulatory sequences that determine the stability and translation efficacy of mRNA. These results, together with our previous findings from studies in rodents, point at DCC as a promising novel candidate gene that may contribute to the genetic basis behind individual differences in susceptibility to schizophrenia.", "electronicPublicationDate": "2012-03-13", "language": "eng", "dateOfCompletion": "2012-09-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.schres.2012.02.023", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2016-05-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-05-01", "journal": {"medlineAbbreviation": "Schizophr Res", "isoabbreviation": "Schizophr. Res.", "title": "Schizophrenia research", "issn": "0920-9964", "nlmid": "8804207", "essn": "1573-2509"}, "monthOfPublication": 5, "volume": "137", "yearOfPublication": 2012, "journalIssueId": 1931919, "issue": "1-3", "dateOfPublication": "2012 May"}}, "25368556": {"pubYear": "2014", "dateOfCreation": "2014-11-04", "pubModel": "Electronic-eCollection", "authorString": "Levy AD, Omar MH, Koleske AJ.", "affiliation": "Interdepartmental Neuroscience Program, Yale University New Haven, CT, USA ; Department of Molecular Biophysics and Biochemistry, Yale University New Haven, CT, USA.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "F31 MH105043"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32 GM007499"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32 GM007223"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS089662"}]}, "id": "25368556", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Aaron D", "lastName": "Levy", "affiliation": "Interdepartmental Neuroscience Program, Yale University New Haven, CT, USA ; Department of Molecular Biophysics and Biochemistry, Yale University New Haven, CT, USA.", "authorId": {"type": "ORCID", "value": "0000-0002-5856-8294"}, "fullName": "Levy AD", "initials": "AD"}, {"affiliation": "Interdepartmental Neuroscience Program, Yale University New Haven, CT, USA ; Department of Molecular Biophysics and Biochemistry, Yale University New Haven, CT, USA.", "fullName": "Omar MH", "initials": "MH", "firstName": "Mitchell H", "lastName": "Omar"}, {"affiliation": "Interdepartmental Neuroscience Program, Yale University New Haven, CT, USA ; Department of Molecular Biophysics and Biochemistry, Yale University New Haven, CT, USA ; Department of Neurobiology, Yale University New Haven, CT, USA.", "fullName": "Koleske AJ", "initials": "AJ", "firstName": "Anthony J", "lastName": "Koleske"}]}, "title": "Extracellular matrix control of dendritic spine and synapse structure and plasticity in adulthood.", "hasSuppl": "N", "citedByCount": 9, "source": "MED", "pmid": "25368556", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5856-8294"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-10-20", "language": "eng", "doi": "10.3389/fnana.2014.00116", "isOpenAccess": "Y", "pageInfo": "116", "pmcid": "PMC4202714", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Extracellular matrix", "Integrins", "RGD peptide", "Agrin", "extracellular proteases", "Reelin", "chondroitin sulfate proteoglycans", "dendritic spine"]}, "abstractText": "Dendritic spines are the receptive contacts at most excitatory synapses in the central nervous system. Spines are dynamic in the developing brain, changing shape as they mature as well as appearing and disappearing as they make and break connections. Spines become much more stable in adulthood, and spine structure must be actively maintained to support established circuit function. At the same time, adult spines must retain some plasticity so their structure can be modified by activity and experience. As such, the regulation of spine stability and remodeling in the adult animal is critical for normal function, and disruption of these processes is associated with a variety of late onset diseases including schizophrenia and Alzheimer's disease. The extracellular matrix (ECM), composed of a meshwork of proteins and proteoglycans, is a critical regulator of spine and synapse stability and plasticity. While the role of ECM receptors in spine regulation has been extensively studied, considerably less research has focused directly on the role of specific ECM ligands. Here, we review the evidence for a role of several brain ECM ligands and remodeling proteases in the regulation of dendritic spine and synapse formation, plasticity, and stability in adults.", "electronicPublicationDate": "2014-10-20", "license": "cc by", "dateOfCompletion": "2014-11-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4202714?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4202714", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3389/fnana.2014.00116", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-11-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "Frontiers in neuroanatomy", "medlineAbbreviation": "Front Neuroanat", "isoabbreviation": "Front Neuroanat", "nlmid": "101477943", "essn": "1662-5129"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2014, "journalIssueId": 2126371, "dateOfPublication": "2014 "}}, "10998440": {"pubYear": "2000", "dateOfCreation": "2000-10-11", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Neoplasm"}, {"registryNumber": "0", "name": "RNA, Neoplasm"}, {"registryNumber": "0", "name": "Codon"}]}, "authorString": "Choi SH, Kong XT, Taki T, Tsuchida Y, Kawaguchi H, Kato H, Hanada R, Look AT, Hayashi Y.", "affiliation": "Department of Pediatrics, Faculty of Medicine, University of Tokyo, Tokyo, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "10998440", "inEPMC": "N", "authorList": {"author": [{"lastName": "Choi", "fullName": "Choi SH", "initials": "SH"}, {"lastName": "Kong", "fullName": "Kong XT", "initials": "XT"}, {"lastName": "Taki", "fullName": "Taki T", "initials": "T"}, {"lastName": "Tsuchida", "fullName": "Tsuchida Y", "initials": "Y"}, {"lastName": "Kawaguchi", "fullName": "Kawaguchi H", "initials": "H"}, {"lastName": "Kato", "fullName": "Kato H", "initials": "H"}, {"lastName": "Hanada", "fullName": "Hanada R", "initials": "R"}, {"lastName": "Look", "fullName": "Look AT", "initials": "AT"}, {"lastName": "Hayashi", "fullName": "Hayashi Y", "initials": "Y"}]}, "title": "Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.", "citedByCount": 1, "source": "MED", "pmid": "10998440", "abstractText": "Genetic alterations occurring in various chromosomes have been described in many human tumors. The DCC gene was originally identified in colorectal cancer and was reported as a tumor suppressor gene that might be related to tumor metastasis. We investigated 10 cell lines and 15 fresh tumors of childhood rhabdomyosarcoma, 7 cell lines of Ewing's sarcoma, and 4 cell lines of primitive neuroectodermal tumor (PNET) for the expression and mutation of DCC gene by RT-PCR analysis and PCR-single stranded conformation polymorphism (SSCP) analysis. Twenty-five pairs of primers were used for PCR-SSCP. Six of ten (60%) cell lines of rhabdomyosarcoma and 3 of 7 (43%) cell lines of Ewing's sarcoma showed reduced or absent expression of DCC gene. There was no mobility shift within 24 exons by SSCP analysis, although 3 types of polymorphism were found at codon 201 in exon 3. Direct sequencing of different bands showed types I, II, and I/II representative of codon 201Gly, codon 201Arg, and codon 201Gly/Arg, respectively. The proportion of type I between fresh rhabdomyosarcoma and normal controls was not significant. Our results suggested that the inactivation of DCC gene may play a role in the pathogenesis of a subset of rhabdomyosarcoma and Ewing's sarcoma.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Tumor Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sarcoma, Ewing's", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Rhabdomyosarcoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuroectodermal Tumors, Primitive", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Neoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Codon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Neoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Substitution", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Heterozygote", "majorTopic_YN": "N"}, {"descriptorName": "Point Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single-Stranded Conformational", "majorTopic_YN": "N"}, {"descriptorName": "Genes, DCC", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2000-10-01", "isOpenAccess": "N", "pageInfo": "463-467", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2000-10-25", "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2000-10-01", "journal": {"medlineAbbreviation": "Int J Mol Med", "isoabbreviation": "Int. J. Mol. Med.", "title": "International journal of molecular medicine", "issn": "1107-3756", "nlmid": "9810955", "essn": "1791-244X"}, "monthOfPublication": 10, "volume": "6", "yearOfPublication": 2000, "journalIssueId": 1062379, "issue": "4", "dateOfPublication": "2000 Oct"}}, "23291093": {"pubYear": "2013", "dateOfCreation": "2013-02-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "158651-98-0", "name": "netrin-1"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Nerve Growth Factors"}, {"registryNumber": "0", "name": "Receptors, N-Methyl-D-Aspartate"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}, {"registryNumber": "EC 3.1.4.3", "name": "Phospholipase C gamma"}, {"registryNumber": "0", "name": "Dcc protein, rat"}, {"registryNumber": "EC 2.7.10.2", "name": "src-Family Kinases"}]}, "authorString": "Horn KE, Glasgow SD, Gobert D, Bull SJ, Luk T, Girgis J, Tremblay ME, McEachern D, Bouchard JF, Haber M, Hamel E, Krimpenfort P, Murai KK, Berns A, Doucet G, Chapman CA, Ruthazer ES, Kennedy TE.", "affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, H3A 2B4, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "247564"}]}, "hasPDF": "N", "id": "23291093", "inEPMC": "N", "authorList": {"author": [{"lastName": "Horn", "fullName": "Horn KE", "firstName": "Katherine E", "initials": "KE"}, {"lastName": "Glasgow", "fullName": "Glasgow SD", "firstName": "Stephen D", "initials": "SD"}, {"lastName": "Gobert", "fullName": "Gobert D", "firstName": "Delphine", "initials": "D"}, {"lastName": "Bull", "fullName": "Bull SJ", "firstName": "Sarah-Jane", "initials": "SJ"}, {"lastName": "Luk", "fullName": "Luk T", "firstName": "Tamarah", "initials": "T"}, {"lastName": "Girgis", "fullName": "Girgis J", "firstName": "Jacklyn", "initials": "J"}, {"lastName": "Tremblay", "fullName": "Tremblay ME", "authorId": {"type": "ORCID", "value": "0000-0003-2863-9626"}, "firstName": "Marie-Eve", "initials": "ME"}, {"lastName": "McEachern", "fullName": "McEachern D", "firstName": "Danielle", "initials": "D"}, {"lastName": "Bouchard", "fullName": "Bouchard JF", "firstName": "Jean-Fran\u00e7ois", "initials": "JF"}, {"lastName": "Haber", "fullName": "Haber M", "firstName": "Michael", "initials": "M"}, {"lastName": "Hamel", "fullName": "Hamel E", "firstName": "Edith", "initials": "E"}, {"lastName": "Krimpenfort", "fullName": "Krimpenfort P", "firstName": "Paul", "initials": "P"}, {"lastName": "Murai", "fullName": "Murai KK", "firstName": "Keith K", "initials": "KK"}, {"lastName": "Berns", "fullName": "Berns A", "firstName": "Anton", "initials": "A"}, {"lastName": "Doucet", "fullName": "Doucet G", "firstName": "Guy", "initials": "G"}, {"lastName": "Chapman", "fullName": "Chapman CA", "firstName": "C Andrew", "initials": "CA"}, {"lastName": "Ruthazer", "fullName": "Ruthazer ES", "authorId": {"type": "ORCID", "value": "0000-0003-0452-3151"}, "firstName": "Edward S", "initials": "ES"}, {"lastName": "Kennedy", "fullName": "Kennedy TE", "firstName": "Timothy E", "initials": "TE"}]}, "title": "DCC expression by neurons regulates synaptic plasticity in the adult brain.", "citedByCount": 17, "source": "MED", "pmid": "23291093", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2863-9626"}, {"type": "ORCID", "value": "0000-0003-0452-3151"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prosencephalon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dendritic Spines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Subcellular Fractions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "src-Family Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Growth Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, N-Methyl-D-Aspartate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Maze Learning", "majorTopic_YN": "N"}, {"descriptorName": "Memory", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Enzyme Activation", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuronal Plasticity", "majorTopic_YN": "Y"}, {"descriptorName": "Long-Term Potentiation", "majorTopic_YN": "N"}, {"descriptorName": "Phospholipase C gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-03", "doi": "10.1016/j.celrep.2012.12.005", "isOpenAccess": "N", "pageInfo": "173-185", "hasDbCrossReferences": "Y", "abstractText": "The transmembrane protein deleted in colorectal cancer (DCC) and its ligand, netrin-1, regulate synaptogenesis during development, but their function in the mature central nervous system is unknown. Given that DCC promotes cell-cell adhesion, is expressed by neurons, and activates proteins that signal at synapses, we hypothesized that DCC expression by neurons regulates synaptic function and plasticity in the adult brain. We report that DCC is enriched in dendritic spines of pyramidal neurons in wild-type mice, and we demonstrate that selective deletion of DCC from neurons in the adult forebrain results in the loss of long-term potentiation (LTP), intact long-term depression, shorter dendritic spines, and impaired spatial and recognition memory. LTP induction requires Src activation of NMDA receptor (NMDAR) function. DCC deletion severely reduced Src activation. We demonstrate that enhancing NMDAR function or activating Src rescues LTP in the absence of DCC. We conclude that DCC activation of Src is required for NMDAR-dependent LTP and certain forms of learning and memory.", "electronicPublicationDate": "2013-01-03", "language": "eng", "dateOfCompletion": "2013-07-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.celrep.2012.12.005", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Cell reports", "medlineAbbreviation": "Cell Rep", "isoabbreviation": "Cell Rep", "nlmid": "101573691", "essn": "2211-1247"}, "monthOfPublication": 1, "volume": "3", "yearOfPublication": 2013, "journalIssueId": 2006100, "issue": "1", "dateOfPublication": "2013 Jan"}}, "26005129": {"pubYear": "2016", "dateOfCreation": "2015-11-30", "pubModel": "Print-Electronic", "authorString": "Reynolds LM, Gifuni AJ, McCrea ET, Shizgal P, Flores C.", "affiliation": "Integrated Program in Neuroscience, McGill University, Montr\u00e9al, QC, Canada; Department of Psychiatry and Department of Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montr\u00e9al, QC, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "MOP-74709"}]}, "id": "26005129", "inEPMC": "N", "authorList": {"author": [{"firstName": "Lauren M", "lastName": "Reynolds", "affiliation": "Integrated Program in Neuroscience, McGill University, Montr\u00e9al, QC, Canada; Department of Psychiatry and Department of Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montr\u00e9al, QC, Canada.", "authorId": {"type": "ORCID", "value": "0000-0003-3798-2055"}, "fullName": "Reynolds LM", "initials": "LM"}, {"affiliation": "Department of Psychiatry and Department of Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montr\u00e9al, QC, Canada.", "fullName": "Gifuni AJ", "initials": "AJ", "firstName": "Anthony J", "lastName": "Gifuni"}, {"affiliation": "Center for Studies in Behavioural Neurobiology/Groupe de recherche en neurobiologie comportementale, Department of Psychology, Concordia University, Montr\u00e9al, QC, Canada.", "fullName": "McCrea ET", "initials": "ET", "firstName": "E Tess", "lastName": "McCrea"}, {"affiliation": "Center for Studies in Behavioural Neurobiology/Groupe de recherche en neurobiologie comportementale, Department of Psychology, Concordia University, Montr\u00e9al, QC, Canada.", "fullName": "Shizgal P", "initials": "P", "firstName": "Peter", "lastName": "Shizgal"}, {"affiliation": "Department of Psychiatry and Department of Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montr\u00e9al, QC, Canada. Electronic address: cecilia.flores@mcgill.ca.", "fullName": "Flores C", "initials": "C", "firstName": "Cecilia", "lastName": "Flores"}]}, "title": "dcc Haploinsufficiency results in blunted sensitivity to cocaine enhancement of reward seeking.", "citedByCount": 0, "source": "MED", "pmid": "26005129", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3798-2055"}]}, "hasPDF": "N", "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-05-22", "doi": "10.1016/j.bbr.2015.05.020", "isOpenAccess": "N", "pageInfo": "27-31", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Resilience", "Addiction", "Adolescent Development", "Netrin-1", "Guidance Cues", "Stimulant Drugs"]}, "abstractText": "Mesocortical dopamine connectivity continues to mature during adolescence. This protracted development confers increased vulnerability for environmental and genetic factors to disrupt mesocortical wiring and subsequently influence responses to drugs of abuse in adulthood. The netrin-1 receptor, DCC, orchestrates medial prefrontal cortex dopamine input during adolescence and dictates the functional organization of local circuitry. Haploinsufficiency of dcc results in increased dopamine innervation to the medial prefrontal cortex, which in turn leads to resilience against the behavioral activating effects of stimulant drugs. However, whether sensitivity to the rewarding effects of drugs of abuse is also altered in dcc haploinsufficiency remains to be resolved. Here, we used the curve-shift method to measure cocaine-induced facilitation of intracranial self-stimulation (ICSS) in adult dcc haploinsufficient mice and wild-type littermates. We found that dcc haploinsufficient mice acquire ICSS behavior at comparable stimulation parameters to wild-type controls. However, cocaine-induced potentiation of ICSS is significantly blunted in dcc haploinsufficient mice. These results are consistent with decreased sensitivity to the rewarding effects of cocaine and/or decreased proclivity to invest effort in the pursuit of reward in dcc haploinsufficient mice. Moreover, these findings suggest that DCC signaling determines adult susceptibility to drug abuse most likely by controlling prefrontal cortex development in adolescence.", "electronicPublicationDate": "2015-05-22", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.bbr.2015.05.020", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-02-01", "journal": {"medlineAbbreviation": "Behav Brain Res", "isoabbreviation": "Behav. Brain Res.", "title": "Behavioural brain research", "issn": "0166-4328", "nlmid": "8004872", "essn": "1872-7549"}, "monthOfPublication": 2, "volume": "298", "yearOfPublication": 2016, "journalIssueId": 2346836, "issue": "Pt A", "dateOfPublication": "2016 Feb"}}, "19788579": {"pubYear": "2009", "dateOfCreation": "2009-10-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "300-62-9", "name": "Amphetamine"}, {"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Central Nervous System Stimulants"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}]}, "authorString": "Grant A, Speed Z, Labelle-Dumais C, Flores C.", "affiliation": "Departments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montreal, Quebec, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19788579", "inEPMC": "N", "authorList": {"author": [{"lastName": "Grant", "fullName": "Grant A", "firstName": "Alanna", "initials": "A"}, {"lastName": "Speed", "fullName": "Speed Z", "firstName": "Zoe", "initials": "Z"}, {"lastName": "Labelle-Dumais", "fullName": "Labelle-Dumais C", "firstName": "Cassandre", "initials": "C"}, {"lastName": "Flores", "fullName": "Flores C", "firstName": "Cecilia", "initials": "C"}]}, "title": "Post-pubertal emergence of a dopamine phenotype in netrin-1 receptor-deficient mice.", "citedByCount": 14, "source": "MED", "pmid": "19788579", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mesencephalon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nucleus Accumbens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred Strains", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amphetamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Central Nervous System Stimulants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sexual Maturation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Locomotion", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-09-24", "doi": "10.1111/j.1460-9568.2009.06919.x", "isOpenAccess": "N", "pageInfo": "1318-1328", "hasDbCrossReferences": "Y", "abstractText": "During the pubertal period the mesocortical dopamine (DA) system undergoes substantial reorganization of neuronal connectivity and functional refinement. Netrins are guidance cues involved in the organization of neuronal circuitry. We have previously shown that adult mice that develop with reduced levels of the netrin-1 receptor [deleted in colorectal cancer (DCC)] display selective reorganization of mesocortical DA circuitry, show enhanced mesocortical DA function and exhibit a behavioural phenotype opposite to that observed in animal models of schizophrenia. Here we assess whether the dcc behavioural and DA phenotypes are present prior to the maturation of the mesocortical DA system by comparing dcc-heterozygous and wild-type mice at the post-weaning and peri-pubertal periods on various indices of DA function. At both the post-weaning and peri-pubertal ages, but unlike in adulthood, dcc-heterozygous and wild-type mice show no differences in the number of midbrain DA neurones or in tyrosine hydroxylase protein levels in the medial prefrontal cortex. Furthermore, the elevated baseline concentration of mesocortical DA and DA metabolites observed in adult dcc-heterozygous mice is not present in either post-weanling or peri-pubertal mice. Interestingly, post-weanling, but not peri-pubertal, dcc-heterozygous mice show greater baseline concentrations of DA metabolites in the nucleus accumbens, opposite to what was observed in adulthood. Finally, neither post-weanling nor peri-pubertal dcc-heterozygous mice demonstrate the blunted amphetamine-induced locomotor response observed in adulthood. Thus, these findings show that the 'protective' dcc phenotype has a post-pubertal emergence and indicate that DCC may play a role in the normal maturation of the mesocorticolimbic DA system.", "electronicPublicationDate": "2009-09-24", "language": "eng", "dateOfCompletion": "2010-01-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1460-9568.2009.06919.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-10-01", "journal": {"medlineAbbreviation": "Eur J Neurosci", "isoabbreviation": "Eur. J. Neurosci.", "title": "The European journal of neuroscience", "issn": "0953-816X", "nlmid": "8918110", "essn": "1460-9568"}, "monthOfPublication": 10, "volume": "30", "yearOfPublication": 2009, "journalIssueId": 1656137, "issue": "7", "dateOfPublication": "2009 Oct"}}, "22926168": {"pubYear": "2013", "dateOfCreation": "2012-12-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Otx transcription factors"}, {"registryNumber": "0", "name": "homeobox protein PITX3"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Homeodomain Proteins"}, {"registryNumber": "0", "name": "DCC protein, human"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}, {"registryNumber": "0", "name": "Otx2 protein, mouse"}, {"registryNumber": "0", "name": "OTX2 protein, human"}]}, "authorString": "Reyes S, Fu Y, Double KL, Cottam V, Thompson LH, Kirik D, Paxinos G, Watson C, Cooper HM, Halliday GM.", "affiliation": "Neuroscience Research Australia and the School of Medical Sciences, The University of New South Wales, Randwick, Sydney, New South Wales, Australia.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22926168", "inEPMC": "N", "authorList": {"author": [{"lastName": "Reyes", "fullName": "Reyes S", "firstName": "Stefanie", "initials": "S"}, {"lastName": "Fu", "fullName": "Fu Y", "firstName": "Yuhong", "initials": "Y"}, {"lastName": "Double", "fullName": "Double KL", "firstName": "Kay L", "initials": "KL"}, {"lastName": "Cottam", "fullName": "Cottam V", "firstName": "Veronica", "initials": "V"}, {"lastName": "Thompson", "fullName": "Thompson LH", "firstName": "Lachlan H", "initials": "LH"}, {"lastName": "Kirik", "fullName": "Kirik D", "firstName": "Deniz", "initials": "D"}, {"lastName": "Paxinos", "fullName": "Paxinos G", "firstName": "George", "initials": "G"}, {"lastName": "Watson", "fullName": "Watson C", "firstName": "Charles", "initials": "C"}, {"lastName": "Cooper", "fullName": "Cooper HM", "firstName": "Helen M", "initials": "HM"}, {"lastName": "Halliday", "fullName": "Halliday GM", "authorId": {"type": "ORCID", "value": "0000-0003-0422-8398"}, "firstName": "Glenda M", "initials": "GM"}]}, "title": "Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.", "citedByCount": 2, "source": "MED", "pmid": "22926168", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-0422-8398"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Substantia Nigra", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ventral Tegmental Area", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Homeodomain Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Otx Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dopaminergic Neurons", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-08-24", "doi": "10.1016/j.neurobiolaging.2012.07.019", "isOpenAccess": "N", "pageInfo": "873-886", "hasDbCrossReferences": "N", "abstractText": "Recent studies suggest a variety of factors characterize substantia nigra neurons vulnerable to Parkinson's disease, including the transcription factors pituitary homeobox 3 (Pitx3) and orthodenticle homeobox 2 (Otx2) and the trophic factor receptor deleted in colorectal cancer (DCC), but there is limited information on their expression and localization in adult humans. Pitx3, Otx2, and DCC were immunohistochemically localized in the upper brainstem of adult humans and mice and protein expression assessed using relative intensity measures and online microarray data. Pitx3 was present and highly expressed in most dopamine neurons. Surprisingly, in our elderly subjects no Otx2 immunoreactivity was detected in dopamine neurons, although Otx2 gene expression was found in younger cases. Enhanced DCC gene expression occurred in the substantia nigra, and higher amounts of DCC protein characterized vulnerable ventral nigral dopamine neurons. Our data show that, at the age when Parkinson's disease typically occurs, there are no significant differences in the expression of transcription factors in brainstem dopamine neurons, but those most vulnerable to Parkinson's disease rely more on the trophic factor receptor DCC than other brainstem dopamine neurons.", "electronicPublicationDate": "2012-08-24", "language": "eng", "dateOfCompletion": "2013-05-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neurobiolaging.2012.07.019", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-03-01", "journal": {"medlineAbbreviation": "Neurobiol Aging", "isoabbreviation": "Neurobiol. Aging", "title": "Neurobiology of aging", "issn": "0197-4580", "nlmid": "8100437", "essn": "1558-1497"}, "monthOfPublication": 3, "volume": "34", "yearOfPublication": 2013, "journalIssueId": 1992616, "issue": "3", "dateOfPublication": "2013 Mar"}}, "14743045": {"pubYear": "2004", "dateOfCreation": "2004-01-26", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA, Bacterial"}]}, "authorString": "Farjo RS, Foxman B, Patel MJ, Zhang L, Pettigrew MM, McCoy SI, Marrs CF, Gilsdorf JR.", "affiliation": "Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109-0244, USA.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S.", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "AI25630"}]}, "hasPDF": "N", "id": "14743045", "inEPMC": "N", "authorList": {"author": [{"lastName": "Farjo", "fullName": "Farjo RS", "firstName": "Rand S", "initials": "RS"}, {"lastName": "Foxman", "fullName": "Foxman B", "authorId": {"type": "ORCID", "value": "0000-0001-6682-238X"}, "firstName": "Betsy", "initials": "B"}, {"lastName": "Patel", "fullName": "Patel MJ", "firstName": "Mayuri J", "initials": "MJ"}, {"lastName": "Zhang", "fullName": "Zhang L", "firstName": "Lixin", "initials": "L"}, {"lastName": "Pettigrew", "fullName": "Pettigrew MM", "firstName": "Melinda M", "initials": "MM"}, {"lastName": "McCoy", "fullName": "McCoy SI", "firstName": "Sandra I", "initials": "SI"}, {"lastName": "Marrs", "fullName": "Marrs CF", "firstName": "Carl F", "initials": "CF"}, {"lastName": "Gilsdorf", "fullName": "Gilsdorf JR", "firstName": "Janet R", "initials": "JR"}]}, "title": "Diversity and sharing of Haemophilus influenzae strains colonizing healthy children attending day-care centers.", "citedByCount": 48, "source": "MED", "pmid": "14743045", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6682-238X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Haemophilus influenzae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Haemophilus Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Otitis Media", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Bacterial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mass Screening", "majorTopic_YN": "N"}, {"descriptorName": "Electrophoresis, Gel, Pulsed-Field", "majorTopic_YN": "N"}, {"descriptorName": "Serotyping", "majorTopic_YN": "N"}, {"descriptorName": "Colony Count, Microbial", "majorTopic_YN": "N"}, {"descriptorName": "Incidence", "majorTopic_YN": "N"}, {"descriptorName": "Risk Assessment", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carrier State", "majorTopic_YN": "Y"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Reference Values", "majorTopic_YN": "N"}, {"descriptorName": "Child Day Care Centers", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Michigan", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2004-01-01", "doi": "10.1097/01.inf.0000106981.89572.d1", "isOpenAccess": "N", "pageInfo": "41-46", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Children attending day-care centers (DCCs) are at risk for Haemophilus influenzae nasopharyngeal colonization and acute otitis media. The degree to which a given strain circulates within a day-care center and the heterogeneity of strains among DCCs in a geographic area are not well-characterized. This study describes the prevalence rates of H. influenzae colonization in a large number of children attending day-care centers and examines the genetic diversity of colonizing strains and the degree of sharing among children. METHODS: Throat cultures were collected from 198 healthy children <3 years old attending 16 day-care centers in Michigan. All H. influenzae isolates were genetically typed by enterobacterial repetitive intergenic consensus PCR as the initial screening technique to identify unique strains within each child. Pulsed field gel electrophoresis was used subsequently to examine the genetic diversity of strains between children. RESULTS: There were 127 (64%) children colonized with H. influenzae. Wide variation in rates of colonization was identified among day-care centers (0 to 95%). A total of 179 genetically unique H. influenzae strains were isolated, and 47 children (37%) were colonized with 2 or more genetically distinct H. influenzae organisms. Evidence of sharing of the same strain in different children was found in 13 of 15 colonized DCCs and 23% of genotypically unique strains were shared. CONCLUSION: The degree of sharing of H. influenzae among children in this study suggests transmission of these potentially pathogenic microorganisms in day-care centers.", "language": "eng", "dateOfCompletion": "2004-02-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/01.inf.0000106981.89572.d1", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "LWWonline"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-01-01", "journal": {"medlineAbbreviation": "Pediatr Infect Dis J", "isoabbreviation": "Pediatr. Infect. Dis. J.", "title": "The Pediatric infectious disease journal", "issn": "0891-3668", "nlmid": "8701858", "essn": "1532-0987"}, "monthOfPublication": 1, "volume": "23", "yearOfPublication": 2004, "journalIssueId": 1189163, "issue": "1", "dateOfPublication": "2004 Jan"}}, "18345717": {"pubYear": "2008", "dateOfCreation": "2008-03-18", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "heptavalent pneumococcal conjugate vaccine"}, {"registryNumber": "0", "name": "Anti-Bacterial Agents"}, {"registryNumber": "0", "name": "Pneumococcal Vaccines"}, {"registryNumber": "74469-00-4", "name": "Amoxicillin-Potassium Clavulanate Combination"}, {"registryNumber": "0", "name": "Meningococcal Vaccines"}]}, "authorString": "Greenberg D, Hoffman S, Leibovitz E, Dagan R.", "affiliation": "Pediatric Infectious Disease Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. dudi@bgu.ac.il", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "18345717", "inEPMC": "N", "authorList": {"author": [{"lastName": "Greenberg", "fullName": "Greenberg D", "firstName": "David", "initials": "D"}, {"lastName": "Hoffman", "fullName": "Hoffman S", "firstName": "Sigalit", "initials": "S"}, {"lastName": "Leibovitz", "fullName": "Leibovitz E", "firstName": "Eugene", "initials": "E"}, {"lastName": "Dagan", "fullName": "Dagan R", "firstName": "Ron", "initials": "R"}]}, "title": "Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention.", "citedByCount": 7, "source": "MED", "pmid": "18345717", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Pharynx", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Streptococcus pneumoniae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pneumococcal Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "N"}]}}, {"descriptorName": "Otitis Media", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acute Disease", "majorTopic_YN": "N"}, {"descriptorName": "Amoxicillin-Potassium Clavulanate Combination", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Meningococcal Vaccines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pneumococcal Vaccines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anti-Bacterial Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Drug Resistance, Bacterial", "majorTopic_YN": "Y"}, {"descriptorName": "Child Day Care Centers", "majorTopic_YN": "Y"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Practice Guidelines as Topic", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-01-01", "doi": "10.2165/00148581-200810020-00002", "isOpenAccess": "N", "pageInfo": "75-83", "hasDbCrossReferences": "N", "abstractText": "Children attending day care centers (DCCs) frequently carry antibacterial-resistant organisms in their nasopharynx, leading to acute otitis media (AOM) that may be refractory to antibacterial treatment. The development and spread of resistant organisms are facilitated in DCCs as a result of the following: (i) large numbers of children; (ii) frequent close person-to-person contact; and (iii) a wide use of antimicrobial medications. Intensive antimicrobial usage provides the selection pressure that favors the emergence of resistant organisms, while DCCs provide an ideal environment for transmission of these organisms. The American Academy of Pediatrics and American Academy of Family Physicians' guidelines recommend high-dose amoxicillin/clavulanic acid (rather than amoxicillin alone) as the first therapeutic choice in the treatment of AOM in children attending DCCs. The introduction of the 7-valent pneumococcal conjugated vaccine (PCV7) had a major role in decreasing the number of episodes of Streptococccus pneumoniae AOM secondary to the serotypes included in the vaccine. It also had a major role in reducing the nasopharyngeal carriage of vaccine-type S. pneumoniae (and in particular of antibacterial-resistant organisms), preventing, in this way, its spread to contacts in the community. However, the recent observation of increased rates of antibacterial-resistant non-vaccine serotype S. pneumoniae may erode the success of PCV7.", "language": "eng", "dateOfCompletion": "2008-08-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.2165/00148581-200810020-00002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ingentaconnect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-01-01", "journal": {"medlineAbbreviation": "Paediatr Drugs", "isoabbreviation": "Paediatr Drugs", "title": "Paediatric drugs", "issn": "1174-5878", "nlmid": "100883685", "essn": "1179-2019"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2008, "journalIssueId": 1515454, "issue": "2", "dateOfPublication": "2008 "}}, "20465487": {"pubYear": "2010", "dateOfCreation": "2010-08-25", "pubModel": "Print", "authorString": "Hatakka K, Piirainen L, Pohjavuori S, Poussa T, Savilahti E, Korpela R.", "affiliation": "Valio R&D, Helsinki, Finland.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20465487", "inEPMC": "N", "authorList": {"author": [{"lastName": "Hatakka", "fullName": "Hatakka K", "firstName": "Katja", "initials": "K"}, {"lastName": "Piirainen", "fullName": "Piirainen L", "firstName": "Laura", "initials": "L"}, {"lastName": "Pohjavuori", "fullName": "Pohjavuori S", "firstName": "Sara", "initials": "S"}, {"lastName": "Poussa", "fullName": "Poussa T", "firstName": "Tuija", "initials": "T"}, {"lastName": "Savilahti", "fullName": "Savilahti E", "firstName": "Erkki", "initials": "E"}, {"lastName": "Korpela", "fullName": "Korpela R", "firstName": "Riitta", "initials": "R"}]}, "title": "Factors associated with acute respiratory illness in day care children.", "citedByCount": 5, "source": "MED", "pmid": "20465487", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Respiratory Tract Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Otitis Media", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acute Disease", "majorTopic_YN": "N"}, {"descriptorName": "Questionnaires", "majorTopic_YN": "N"}, {"descriptorName": "Analysis of Variance", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Regression Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Parents", "majorTopic_YN": "N"}, {"descriptorName": "Environment", "majorTopic_YN": "N"}, {"descriptorName": "Child Day Care Centers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SN", "qualifierName": "statistics & numerical data", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Educational Status", "majorTopic_YN": "N"}, {"descriptorName": "Finland", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-09-01", "doi": "10.3109/00365548.2010.483476", "isOpenAccess": "N", "pageInfo": "704-711", "hasDbCrossReferences": "N", "abstractText": "The aim of this study was to investigate the relationship between child characteristics, parental and environmental factors and the occurrence of acute respiratory illness (ARI) and acute otitis media (AOM) among Finnish children attending day care centres (DCCs). The study was a cross-sectional questionnaire of 594 children aged 1-6 y from 18 DCCs in Helsinki, Finland. Recurrent (> or =4 diseases/y) ARI was present in 44% of the 1-3-y-olds and 23% of the 4-6-y-olds, and recurrent AOM in 15% and 2.5%, respectively. Parent atopic disease (odds ratio (OR) 1.53, p = 0.033), mother's academic education (OR 1.77, p = 0.008) and a medium length of DCC attendance compared to a short period (OR 1.67, p = 0.049) increased, while furry pets (OR 0.44, p = 0.003) and older child age (OR 0.38, p < 0.001) reduced the risk of recurrent ARI. Recurrent ARI (OR 3.96, p = 0.008), mother's academic education (OR 5.02, p = 0.003), and a medium length of DCC attendance compared to a short period (OR 3.34, p = 0.044) increased, while partial breastfeeding > or =6 months (OR 0.20, p = 0.002) and older child age (OR 0.05, p < 0.001) reduced the risk of recurrent AOM. Parental and environmental factors had a significant impact on recurrent ARI and AOM episodes in children attending DCCs. These risk factors should be considered in future studies intending to reduce DCC infections.", "language": "eng", "dateOfCompletion": "2010-12-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/00365548.2010.483476", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-09-01", "journal": {"medlineAbbreviation": "Scand J Infect Dis", "isoabbreviation": "Scand. J. Infect. Dis.", "title": "Scandinavian journal of infectious diseases", "issn": "0036-5548", "nlmid": "0215333", "essn": "1651-1980"}, "monthOfPublication": 9, "volume": "42", "yearOfPublication": 2010, "journalIssueId": 1756829, "issue": "9", "dateOfPublication": "2010 Sep"}}, "24346136": {"pubYear": "2013", "dateOfCreation": "2013-12-18", "pubModel": "Electronic", "authorString": "Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berr\u00edo A, Lopez JP, Yogendran SV, Daubaras MJ, Grant A, Schmidt ER, Tronche F, Krimpenfort P, Cooper HM, Pasterkamp RJ, Kolb B, Turecki G, Wong TP, Nestler EJ, Giros B, Flores C.", "affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "P50 MH096890"}]}, "hasPDF": "Y", "id": "24346136", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Manitt C", "initials": "C", "firstName": "C", "lastName": "Manitt"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Eng C", "initials": "C", "firstName": "C", "lastName": "Eng"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Pokinko M", "initials": "M", "firstName": "M", "lastName": "Pokinko"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Ryan RT", "initials": "RT", "firstName": "R T", "lastName": "Ryan"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Torres-Berr\u00edo A", "initials": "A", "firstName": "A", "lastName": "Torres-Berr\u00edo"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Lopez JP", "initials": "JP", "firstName": "J P", "lastName": "Lopez"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Yogendran SV", "initials": "SV", "firstName": "S V", "lastName": "Yogendran"}, {"firstName": "M J J", "lastName": "Daubaras", "affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "authorId": {"type": "ORCID", "value": "0000-0003-4181-4804"}, "fullName": "Daubaras MJ", "initials": "MJ"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Grant A", "initials": "A", "firstName": "A", "lastName": "Grant"}, {"firstName": "E R E", "lastName": "Schmidt", "affiliation": "Department of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0003-4654-2377"}, "fullName": "Schmidt ER", "initials": "ER"}, {"affiliation": "UMR 7224 CNRS and Universit\u00e9 Pierre et Marie Curie, Paris, France.", "fullName": "Tronche F", "initials": "F", "firstName": "F", "lastName": "Tronche"}, {"affiliation": "Division of Molecular Genetics, Centre for Biomedical Genetics, Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands.", "fullName": "Krimpenfort P", "initials": "P", "firstName": "P", "lastName": "Krimpenfort"}, {"affiliation": "The University of Queensland, Queensland Brain Institute, Brisbane, QLD, Australia.", "fullName": "Cooper HM", "initials": "HM", "firstName": "H M", "lastName": "Cooper"}, {"firstName": "R J", "lastName": "Pasterkamp", "affiliation": "Department of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0003-1631-6440"}, "fullName": "Pasterkamp RJ", "initials": "RJ"}, {"affiliation": "Canadian Centre for Behavioural Neuroscience, University of Lethbridge, 4401 University Drive, Lethbridge, AB, Canada.", "fullName": "Kolb B", "initials": "B", "firstName": "B", "lastName": "Kolb"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Turecki G", "initials": "G", "firstName": "G", "lastName": "Turecki"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Wong TP", "initials": "TP", "firstName": "T P", "lastName": "Wong"}, {"affiliation": "Fishberg Department of Neuroscience and Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA.", "fullName": "Nestler EJ", "initials": "EJ", "firstName": "E J", "lastName": "Nestler"}, {"affiliation": "1] Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada [2] UMR 7224 CNRS and Universit\u00e9 Pierre et Marie Curie, Paris, France.", "fullName": "Giros B", "initials": "B", "firstName": "B", "lastName": "Giros"}, {"affiliation": "Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.", "fullName": "Flores C", "initials": "C", "firstName": "C", "lastName": "Flores"}]}, "title": "dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "24346136", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4181-4804"}, {"type": "ORCID", "value": "0000-0003-4654-2377"}, {"type": "ORCID", "value": "0000-0003-1631-6440"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neural Pathways", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Self-Injurious Behavior", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Suicide", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent Development", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mental Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genes, DCC", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Haploinsufficiency", "majorTopic_YN": "N"}, {"descriptorName": "Dopaminergic Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-17", "language": "eng", "doi": "10.1038/tp.2013.105", "isOpenAccess": "Y", "pageInfo": "e338", "pmcid": "PMC4030324", "hasDbCrossReferences": "Y", "abstractText": "Adolescence is a period of heightened susceptibility to psychiatric disorders of medial prefrontal cortex (mPFC) dysfunction and cognitive impairment. mPFC dopamine (DA) projections reach maturity only in early adulthood, when their control over cognition becomes fully functional. The mechanisms governing this protracted and unique development are unknown. Here we identify dcc as the first DA neuron gene to regulate mPFC connectivity during adolescence and dissect the mechanisms involved. Reduction or loss of dcc from DA neurons by Cre-lox recombination increased mPFC DA innervation. Underlying this was the presence of ectopic DA fibers that normally innervate non-cortical targets. Altered DA input changed the anatomy and electrophysiology of mPFC circuits, leading to enhanced cognitive flexibility. All phenotypes only emerged in adulthood. Using viral Cre, we demonstrated that dcc organizes mPFC wiring specifically during adolescence. Variations in DCC may determine differential predisposition to mPFC disorders in humans. Indeed, DCC expression is elevated in brains of antidepressant-free subjects who committed suicide.", "electronicPublicationDate": "2013-12-17", "license": "cc by-nc-nd", "dateOfCompletion": "2014-06-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4030324?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4030324", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24346136&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24346136", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/tp.2013.105", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-07-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Translational psychiatry", "medlineAbbreviation": "Transl Psychiatry", "isoabbreviation": "Transl Psychiatry", "nlmid": "101562664", "essn": "2158-3188"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2013, "journalIssueId": 2001218, "dateOfPublication": "2013 "}}, "15730872": {"pubYear": "2005", "dateOfCreation": "2005-02-25", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "calbindin"}, {"registryNumber": "158651-98-0", "name": "netrin-1"}, {"registryNumber": "51-61-6", "name": "Dopamine"}, {"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Nerve Growth Factors"}, {"registryNumber": "0", "name": "Cell Adhesion Molecules"}, {"registryNumber": "0", "name": "Calcium-Binding Protein, Vitamin D-Dependent"}, {"registryNumber": "0", "name": "Receptors, Opioid, mu"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}]}, "authorString": "Osborne PB, Halliday GM, Cooper HM, Keast JR.", "affiliation": "Prince of Wales Medical Research Institute, University of New South Wales, Barker Street Randwick, Sydney NSW 2031, Australia. p.osborne@usyd.edu.au", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "N", "id": "15730872", "inEPMC": "N", "authorList": {"author": [{"lastName": "Osborne", "fullName": "Osborne PB", "authorId": {"type": "ORCID", "value": "0000-0002-8458-4159"}, "initials": "PB"}, {"lastName": "Halliday", "fullName": "Halliday GM", "authorId": {"type": "ORCID", "value": "0000-0003-0422-8398"}, "initials": "GM"}, {"lastName": "Cooper", "fullName": "Cooper HM", "initials": "HM"}, {"lastName": "Keast", "fullName": "Keast JR", "initials": "JR"}]}, "title": "Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents.", "citedByCount": 31, "source": "MED", "pmid": "15730872", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-8458-4159"}, {"type": "ORCID", "value": "0000-0003-0422-8398"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neural Pathways", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Growth Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calcium-Binding Protein, Vitamin D-Dependent", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Adhesion Molecules", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N"}, {"descriptorName": "Receptors, Opioid, mu", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fluorescent Antibody Technique", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2005-01-01", "doi": "10.1016/j.neuroscience.2004.11.043", "isOpenAccess": "N", "pageInfo": "671-681", "hasDbCrossReferences": "Y", "abstractText": "DCC (deleted in colorectal cancer)-the receptor of the netrin-1 neuronal guidance factor-is expressed and is active in the central nervous system (CNS) during development, but is down-regulated during maturation. The substantia nigra contains the highest level of netrin-1 mRNA in the adult rodent brain, and corresponding mRNA for DCC has also been detected in this region but has not been localized to any particular neuron type. In this study, an antibody raised against DCC was used to determine if the protein was expressed by adult dopamine neurons, and identify their distribution and projections. Significant DCC-immunoreactivity was detected in midbrain, where it was localized to ventrally displaced A9 dopamine neurons in the substantia nigra, and ventromedial A10 dopamine neurons predominantly situated in and around the interfascicular nucleus. Strong immunoreactivity was not detected in dopamine neurons found elsewhere, or in non-dopamine-containing neurons in the midbrain. Terminal fields selectively labeled with DCC antibody corresponded to known nigrostriatal projections to the dorsolateral striatal patches and dorsomedial shell of the accumbens, and were also detected in prefrontal cortex, septum, lateral habenular and ventral pallidum. The unique distribution of DCC-immunoreactivity in adult ventral midbrain dopamine neurons suggests that netrin-1/DCC signaling could function in plasticity and remodeling previously identified in dopamine projection pathways. In particular, a recent report that DCC is regulated through the ubiquitin-proteosome system via Siah/Sina proteins, is consistent with a potential involvement in genetic and sporadic forms of Parkinson's disease.", "language": "eng", "dateOfCompletion": "2005-06-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neuroscience.2004.11.043", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-01-01", "journal": {"medlineAbbreviation": "Neuroscience", "isoabbreviation": "Neuroscience", "title": "Neuroscience", "issn": "0306-4522", "nlmid": "7605074", "essn": "1873-7544"}, "monthOfPublication": 0, "volume": "131", "yearOfPublication": 2005, "journalIssueId": 1220671, "issue": "3", "dateOfPublication": "2005 "}}, "27106785": {"pubYear": "2016", "dateOfCreation": "2016-05-31", "pubModel": "Print-Electronic", "authorString": "Ji X, Liu H, An C, Wang Y, Zhao H, Zhang Q, Li M, Qi F, Chen Z, Wang X, Wang L.", "affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27106785", "inEPMC": "N", "authorList": {"author": [{"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Ji X", "initials": "X", "firstName": "Xiaomin", "lastName": "Ji"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Liu H", "initials": "H", "firstName": "Haolong", "lastName": "Liu"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "An C", "initials": "C", "firstName": "Chen", "lastName": "An"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Wang Y", "initials": "Y", "firstName": "Yongqiang", "lastName": "Wang"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Zhao H", "initials": "H", "firstName": "Hui", "lastName": "Zhao"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Zhang Q", "initials": "Q", "firstName": "Qiuxia", "lastName": "Zhang"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Li M", "initials": "M", "firstName": "Ming", "lastName": "Li"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Qi F", "initials": "F", "firstName": "Fang", "lastName": "Qi"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China.", "fullName": "Chen Z", "initials": "Z", "firstName": "Zhenzhen", "lastName": "Chen"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China. Electronic address: wxj0517@sina.com.", "fullName": "Wang X", "initials": "X", "firstName": "Xiujuan", "lastName": "Wang"}, {"affiliation": "School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing 100069, PR China. Electronic address: tmwangl@ccmu.edu.cn.", "fullName": "Wang L", "initials": "L", "firstName": "Lei", "lastName": "Wang"}]}, "title": "You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.", "citedByCount": 0, "source": "MED", "pmid": "27106785", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-04-20", "doi": "10.1016/j.jep.2016.04.025", "isOpenAccess": "N", "pageInfo": "123-133", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Nerve regeneration", "experimental autoimmune encephalomyelitis", "Cinnamaldehyde (Pubchem Cid: 637511)", "Loganin (Pubchem Cid: 87691)", "Quercitrin (Pubchem Cid: 5280459)", "Hyperin (Pubchem Cid: 5281643)", "You-gui Pills", "Sweroside (Pubchem Cid: 161036)", "Betaine (Pubchem Cid: 247)", "Netrin1/dcc", "Rho Family Gtpases Rhoa, Rac1 And Cdc42", "Chlorogenic Acid (Pubchem Cid 1794427)", "Fuziline (Pubchem Cid 14163819)", "Neoline (Pubchem Cid: 120682)", "Songorine (Pubchem Cid 71456946)"]}, "abstractText": "You-Gui pills (YGPs) are an effective traditional Chinese formula being used clinically for the treatment of multiple sclerosis (MS). Previous studies demonstrated that YGPs exerted the potent neuroprotective effects in murine models of experimental autoimmune encephalomyelitis (EAE), which is an equivalent animal model for multiple sclerosis (MS). However, the mechanism of YGPs functions remained unclear.The aim of this study was to evaluate the therapeutic effect of YGPs in MOG35-55-induced EAE mice and to further elucidate the underlying molecular mechanism.Female C57BL/6 mice were divided into six groups, including the non-treated EAE model, prednisone acetate- and 1.2, 2.4 or 4.8g/kg YGPs-treated EAE groups, and a normal control group. The EAE model was established by injecting the mice subcutaneously with MOG35-55 antigen. The body weights were measured and the neurological functions were scored in each group. The pathology and morphology of the brain and spinal cord was examined. The expression of MAP-2 was detected by immunofluorescent staining. The levels of netrin1, DCC, RhoA, Rac1, and Cdc42 were assayed by immunohistochemistry, qRT-PCR and Western blot on day 40 post-immunization (PI).YGPs treatments significantly reduced neurological function scores in EAE mice, where the inflammatory infiltration was reduced and the axon and myelin damage in both brain and spinal cord was alleviated. In the brain and spinal cord tissues, YGPs increased the expression of neuronal factors MAP-2, netrin1 and DCC. The expression of Rac1 and Cdc42 were increased, while RhoA was reduced following YGPs treatments.Our results demonstrated that YGPs exhibited a neuroprotective effect on promoting nerve regeneration at the brain and spinal cord in EAE mice induced by MOG35-55. Netrin1, DCC and the Rho family GTPases of RhoA, Racl, Cdc42 were involved in mediating the effects of YGPs on nerve regeneration.", "electronicPublicationDate": "2016-04-20", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jep.2016.04.025", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-07-01", "journal": {"medlineAbbreviation": "J Ethnopharmacol", "isoabbreviation": "J Ethnopharmacol", "title": "Journal of ethnopharmacology", "issn": "0378-8741", "nlmid": "7903310", "essn": "1872-7573"}, "monthOfPublication": 7, "volume": "187", "yearOfPublication": 2016, "journalIssueId": 2413216, "dateOfPublication": "2016 Jul"}}, "23981041": {"pubYear": "2013", "dateOfCreation": "2013-09-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "NR2B NMDA receptor"}, {"registryNumber": "0", "name": "Unc5h3 protein, rat"}, {"registryNumber": "0", "name": "Antiviral Agents"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "24939-03-5", "name": "Poly I-C"}, {"registryNumber": "343-65-7", "name": "Kynurenine"}, {"registryNumber": "0", "name": "Receptors, N-Methyl-D-Aspartate"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Receptor, Serotonin, 5-HT2C"}, {"registryNumber": "EC 1.14.99.1", "name": "Cyclooxygenase 2"}, {"registryNumber": "EC 1.14.99.1", "name": "PTGS2 protein, human"}, {"registryNumber": "0", "name": "alpha-Synuclein"}, {"registryNumber": "0", "name": "Toll-Like Receptor 3"}, {"registryNumber": "0", "name": "Disc1 protein, rat"}, {"registryNumber": "0", "name": "Dcc protein, rat"}, {"registryNumber": "0", "name": "Hedgehog Proteins"}, {"registryNumber": "0", "name": "TLR3 protein, rat"}, {"registryNumber": "0", "name": "sonic hedgehog protein, rat"}]}, "authorString": "Khalil OS, Forrest CM, Pisar M, Smith RA, Darlington LG, Stone TW.", "affiliation": "Institute for Neuroscience and Psychology, University of Glasgow, West Medical Building , Glasgow , United Kingdom and.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "23981041", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Institute for Neuroscience and Psychology, University of Glasgow, West Medical Building , Glasgow , United Kingdom and.", "fullName": "Khalil OS", "initials": "OS", "firstName": "Omari S", "lastName": "Khalil"}, {"lastName": "Forrest", "fullName": "Forrest CM", "firstName": "Caroline M", "initials": "CM"}, {"lastName": "Pisar", "fullName": "Pisar M", "firstName": "Mazura", "initials": "M"}, {"lastName": "Smith", "fullName": "Smith RA", "firstName": "Robert A", "initials": "RA"}, {"lastName": "Darlington", "fullName": "Darlington LG", "firstName": "L Gail", "initials": "LG"}, {"lastName": "Stone", "fullName": "Stone TW", "authorId": {"type": "ORCID", "value": "0000-0002-5532-0031"}, "firstName": "Trevor W", "initials": "TW"}]}, "title": "Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation.", "citedByCount": 1, "source": "MED", "pmid": "23981041", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5532-0031"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Kynurenine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptor, Serotonin, 5-HT2C", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, N-Methyl-D-Aspartate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Poly I-C", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antiviral Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Maternal Exposure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Developmental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Toll-Like Receptor 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclooxygenase 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "alpha-Synuclein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hedgehog Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-08-28", "doi": "10.3109/08923973.2013.828745", "isOpenAccess": "N", "pageInfo": "581-593", "hasDbCrossReferences": "N", "abstractText": "Activation of the immune system during pregnancy is believed to lead to psychiatric and neurological disorders in the offspring, but the molecular changes responsible are unknown. Polyinosinic:polycytidylic acid (poly(I:C)) is a viral-mimetic double-stranded RNA complex which activates Toll-Like-Receptor-3 and can activate the metabolism of tryptophan through the oxidative kynurenine pathway to compounds that modulate activity of glutamate receptors. The aim was to determine whether prenatal administration of poly(I:C) affects the expression of neurodevelopmental proteins in the offspring and whether such effects were mediated via the kynurenine pathway. Pregnant rats were treated with poly(I:C) during late gestation and the offspring were allowed to develop to postnatal day 21 (P21). Immunoblotting of the brains at P21 showed decreased expression of sonic hedgehog, a key protein in dopaminergic neuronal maturation. Expression of \u03b1-synuclein was decreased, while tyrosine hydroxylase was increased. Disrupted in Schizophrenia-1 (DISC-1) and 5-HT2C receptor levels were unaffected, as were the dependence receptors Unc5H1, Unc5H3 and Deleted in Colorectal Cancer (DCC), the inflammation-related transcription factor NFkB and the inducible oxidative enzyme cyclo-oxygenase-2 (COX-2). An examination of embryo brains 5\u2009h after maternal poly(I:C) showed increased expression of GluN2B, with reduced doublecortin and DCC but no change in NFkB. Despite altered protein expression, there were no changes in the kynurenine pathway. The results show that maternal exposure to poly(I:C) alters the expression of proteins in the embryos and offspring which may affect the development of dopaminergic function. The oxidation of tryptophan along the kynurenine pathway is not involved in these effects.", "electronicPublicationDate": "2013-08-28", "language": "eng", "dateOfCompletion": "2014-04-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/08923973.2013.828745", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-10-01", "journal": {"medlineAbbreviation": "Immunopharmacol Immunotoxicol", "isoabbreviation": "Immunopharmacol Immunotoxicol", "title": "Immunopharmacology and immunotoxicology", "issn": "0892-3973", "nlmid": "8800150", "essn": "1532-2513"}, "monthOfPublication": 10, "volume": "35", "yearOfPublication": 2013, "journalIssueId": 2077546, "issue": "5", "dateOfPublication": "2013 Oct"}}, "21594431": {"pubYear": "1996", "dateOfCreation": "2011-05-19", "pubModel": "Print", "authorString": "Aragona M, Muscatello M, Pastura G, Castagnetta L, Mesiti M.", "affiliation": "UNIV MESSINA,IST CLIN ONCOL & RICERCA TUMORI,I-98100 MESSINA,ITALY. POLICLIN UNIV,CLIN PSICHIATR,GAZZI,MESSINA,ITALY. IST NAZL RICERA CANC,SEZ DECENTRATA MESSINA,I-98100 MESSINA,ITALY. UNIV PALERMO,LAB BIOCHIM ORMONI,PALERMO,ITALY.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "21594431", "inEPMC": "N", "authorList": {"author": [{"lastName": "Aragona", "fullName": "Aragona M", "initials": "M"}, {"lastName": "Muscatello", "fullName": "Muscatello M", "initials": "M"}, {"lastName": "Pastura", "fullName": "Pastura G", "initials": "G"}, {"lastName": "Castagnetta", "fullName": "Castagnetta L", "initials": "L"}, {"lastName": "Mesiti", "fullName": "Mesiti M", "initials": "M"}]}, "title": "Estrogen receptor expression and depressive mood disorders in untreated breast cancer patients.", "citedByCount": 0, "source": "MED", "pmid": "21594431", "abstractText": "Women newly admitted to hospital for suspect breast lump (99) were blind studied 5+/-3 days before diagnosis. Depression was evaluated by using DSM-III-R diagnostic criteria and MMPI psychometric test; estrogen receptor (ER) by DCC. High prevalence of depressive mood disorders and particularly of dysthymia were observed in patients with ER(-) tumors (p=0.03), that scored low in MMPI 9-Ma scale (p<0.001) and high in TA index (p=0.01) as expression of depressed mood. On the contrary ER(+) patients showed higher mean values in almost all the MMPI scales and indexes (AV p<0.01; AS p<0.03). In conclusion depressive mood have different prevalence in untreated breast cancer patients depending on ER status.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1996-07-01", "isOpenAccess": "N", "pageInfo": "661-665", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2012-10-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "1996-07-01", "journal": {"medlineAbbreviation": "Oncol Rep", "isoabbreviation": "Oncol. Rep.", "title": "Oncology reports", "issn": "1021-335X", "nlmid": "9422756", "essn": "1791-2431"}, "monthOfPublication": 7, "volume": "3", "yearOfPublication": 1996, "journalIssueId": 1833458, "issue": "4", "dateOfPublication": "1996 Jul"}}, "22748019": {"pubYear": "2012", "dateOfCreation": "2012-07-30", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "netrin receptors"}, {"registryNumber": "0", "name": "Pbx1 protein, mouse"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Homeodomain Proteins"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}]}, "authorString": "Sgad\u00f2 P, Ferretti E, Grbec D, Bozzi Y, Simon HH.", "affiliation": "Laboratory of Molecular Neuropathology, Centre for Integrative Biology, University of Trento, Trento, Italy. sgado@science.unitn.it", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22748019", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Sgad\u00f2", "fullName": "Sgad\u00f2 P", "authorId": {"type": "ORCID", "value": "0000-0002-4963-8473"}, "firstName": "Paola", "initials": "P"}, {"lastName": "Ferretti", "fullName": "Ferretti E", "firstName": "Elisabetta", "initials": "E"}, {"lastName": "Grbec", "fullName": "Grbec D", "firstName": "Daniel", "initials": "D"}, {"lastName": "Bozzi", "fullName": "Bozzi Y", "firstName": "Yuri", "initials": "Y"}, {"lastName": "Simon", "fullName": "Simon HH", "firstName": "Horst H", "initials": "HH"}]}, "title": "The atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons.", "hasSuppl": "N", "citedByCount": 9, "source": "MED", "pmid": "22748019", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4963-8473"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Mesencephalon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Axons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Animals, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Homeodomain Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Developmental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dopaminergic Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-07-02", "language": "eng", "doi": "10.1186/1749-8104-7-24", "isOpenAccess": "Y", "pageInfo": "24", "pmcid": "PMC3407702", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: The pre B-cell leukemia transcription factor 1 (Pbx1) genes belong to the three amino acid loop extension family of homeodomain proteins that form hetero-oligomeric complexes with other homeodomain transcription factors, thereby modulating target specificity, DNA binding affinity and transcriptional activity of their molecular associates. RESULTS: Here, we provide evidence that Pbx1 is expressed in mesencephalic dopaminergic neurons from embryonic day 11 into adulthood and determines some of the cellular properties of this neuronal population. In Pbx1-deficient mice, the mesencephalic dopaminergic axons stall during mid-gestation at the border between di- and telencephalon before entering the ganglionic eminence, leading to a loose organization of the axonal bundle and partial misrouting. In Pbx1-deficient dopaminergic neurons, the high affinity netrin-1 receptor, deleted in colon cancer (DCC), is down-regulated. Interestingly, we found several conserved Pbx1 binding sites in the first intron of DCC, suggesting a direct regulation of DCC transcription by Pbx1. CONCLUSIONS: The expression of Pbx1 in dopaminergic neurons and its regulation of DCC expression make it an important player in defining the axonal guidance of the midbrain dopaminergic neurons, with possible implications for the normal physiology of the nigro-striatal system as well as processes related to the degeneration of neurons during the course of Parkinson's disease.", "electronicPublicationDate": "2012-07-02", "license": "cc by", "dateOfCompletion": "2012-10-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3407702?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3407702", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22748019&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22748019", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1749-8104-7-24", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "Neural development", "medlineAbbreviation": "Neural Dev", "isoabbreviation": "Neural Dev", "nlmid": "101286574", "essn": "1749-8104"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1908906, "dateOfPublication": "2012 "}}, "22676229": {"pubYear": "2012", "dateOfCreation": "2012-09-20", "pubModel": "Electronic", "authorString": "Staaf J, J\u00f6nsson G, J\u00f6nsson M, Karlsson A, Isaksson S, Salomonsson A, Pettersson HM, Soller M, Ewers SB, Johansson L, J\u00f6nsson P, Planck M.", "affiliation": "Department of Oncology, Lund University, Lund, Sweden.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "22676229", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Staaf", "fullName": "Staaf J", "firstName": "Johan", "initials": "J"}, {"lastName": "J\u00f6nsson", "fullName": "J\u00f6nsson G", "firstName": "G\u00f6ran", "initials": "G"}, {"lastName": "J\u00f6nsson", "fullName": "J\u00f6nsson M", "firstName": "Mats", "initials": "M"}, {"lastName": "Karlsson", "fullName": "Karlsson A", "firstName": "Anna", "initials": "A"}, {"lastName": "Isaksson", "fullName": "Isaksson S", "firstName": "Sofi", "initials": "S"}, {"lastName": "Salomonsson", "fullName": "Salomonsson A", "firstName": "Annette", "initials": "A"}, {"lastName": "Pettersson", "fullName": "Pettersson HM", "firstName": "Helen M", "initials": "HM"}, {"lastName": "Soller", "fullName": "Soller M", "firstName": "Maria", "initials": "M"}, {"lastName": "Ewers", "fullName": "Ewers SB", "firstName": "Sven-B\u00f6rje", "initials": "SB"}, {"lastName": "Johansson", "fullName": "Johansson L", "firstName": "Leif", "initials": "L"}, {"lastName": "J\u00f6nsson", "fullName": "J\u00f6nsson P", "firstName": "Per", "initials": "P"}, {"lastName": "Planck", "fullName": "Planck M", "firstName": "Maria", "initials": "M"}]}, "title": "Relation between smoking history and gene expression profiles in lung adenocarcinomas.", "hasSuppl": "Y", "citedByCount": 4, "source": "MED", "pmid": "22676229", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Respiratory Mucosa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Adenocarcinoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "Y"}, {"descriptorName": "Smoking", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["ARXPR"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-07", "language": "eng", "doi": "10.1186/1755-8794-5-22", "isOpenAccess": "Y", "pageInfo": "22", "pmcid": "PMC3447685", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Lung cancer is the worldwide leading cause of death from cancer. Tobacco usage is the major pathogenic factor, but all lung cancers are not attributable to smoking. Specifically, lung cancer in never-smokers has been suggested to represent a distinct disease entity compared to lung cancer arising in smokers due to differences in etiology, natural history and response to specific treatment regimes. However, the genetic aberrations that differ between smokers and never-smokers' lung carcinomas remain to a large extent unclear. METHODS: Unsupervised gene expression analysis of 39 primary lung adenocarcinomas was performed using Illumina HT-12 microarrays. Results from unsupervised analysis were validated in six external adenocarcinoma data sets (n=687), and six data sets comprising normal airway epithelial or normal lung tissue specimens (n=467). Supervised gene expression analysis between smokers and never-smokers were performed in seven adenocarcinoma data sets, and results validated in the six normal data sets. RESULTS: Initial unsupervised analysis of 39 adenocarcinomas identified two subgroups of which one harbored all never-smokers. A generated gene expression signature could subsequently identify never-smokers with 79-100% sensitivity in external adenocarcinoma data sets and with 76-88% sensitivity in the normal materials. A notable fraction of current/former smokers were grouped with never-smokers. Intriguingly, supervised analysis of never-smokers versus smokers in seven adenocarcinoma data sets generated similar results. Overlap in classification between the two approaches was high, indicating that both approaches identify a common set of samples from current/former smokers as potential never-smokers. The gene signature from unsupervised analysis included several genes implicated in lung tumorigenesis, immune-response associated pathways, genes previously associated with smoking, as well as marker genes for alveolar type II pneumocytes, while the best classifier from supervised analysis comprised genes strongly associated with proliferation, but also genes previously associated with smoking. CONCLUSIONS: Based on gene expression profiling, we demonstrate that never-smokers can be identified with high sensitivity in both tumor material and normal airway epithelial specimens. Our results indicate that tumors arising in never-smokers, together with a subset of tumors from smokers, represent a distinct entity of lung adenocarcinomas. Taken together, these analyses provide further insight into the transcriptional patterns occurring in lung adenocarcinoma stratified by smoking history.", "electronicPublicationDate": "2012-06-07", "license": "cc by", "dateOfCompletion": "2013-01-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3447685?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3447685", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1755-8794-5-22", "documentStyle": "doi", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "BMC medical genomics", "medlineAbbreviation": "BMC Med Genomics", "isoabbreviation": "BMC Med Genomics", "nlmid": "101319628", "essn": "1755-8794"}, "monthOfPublication": 0, "volume": "5", "yearOfPublication": 2012, "journalIssueId": 1902378, "dateOfPublication": "2012 "}}, "1889446": {"pubYear": "1991", "dateOfCreation": "1991-10-17", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "2078-54-8", "name": "Propofol"}]}, "authorString": "Lechleitner P, Genser N, Mitterschiffthaler G, Dienstl F.", "affiliation": "Department of Internal Medicine, University of Innsbruck, Austria.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article"]}, "hasPDF": "N", "id": "1889446", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lechleitner", "fullName": "Lechleitner P", "initials": "P"}, {"lastName": "Genser", "fullName": "Genser N", "initials": "N"}, {"lastName": "Mitterschiffthaler", "fullName": "Mitterschiffthaler G", "initials": "G"}, {"lastName": "Dienstl", "fullName": "Dienstl F", "initials": "F"}]}, "title": "Propofol for direct current cardioversion in cardiac risk patients.", "citedByCount": 6, "source": "MED", "pmid": "1889446", "abstractText": "We investigated 69 patients (most belonging to NYHA classes II and III) undergoing elective direct current cardioversion of atrial fibrillation (46 patients) and atrial flutter (23 patients), respectively. Without premedication anaesthesia was induced with the new soya bean emulsion of propofol ('Diprivan') 1.2 mg.kg-1 over 45 s. Recovery time was measured from the start of the anaesthetic injection to the moment at which the patients regained consciousness. Completeness of recovery was assessed with two methods: opening eyes on command and time orientation. Good amnesia was observed in all patients. Conversion was achieved in all but seven patients (90%). After injection of propofol, the mean arterial pressure decreased slightly (2% below baseline). Induction of anaesthesia and successful DCC effected a statistically significant decrease in both the heart rate and the rate pressure product. Eleven patients required assisted ventilation for 2 min due to respiratory depression. Fifteen patients developed arrhythmias. Side-effects, such as myocloni, recall or vomiting, were not observed. In conclusion, propofol may well prove to be the anaesthetic of choice for DCC in cardiac patients because of good amnesia, low incidence of side-effects and short recovery time (mean 5.3 min).", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Atrial Fibrillation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Atrial Flutter", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Propofol", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Electric Countershock", "majorTopic_YN": "Y"}, {"descriptorName": "Respiration, Artificial", "majorTopic_YN": "N"}, {"descriptorName": "Anesthesia, Intravenous", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anesthesia Recovery Period", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Coronary Care Units", "majorTopic_YN": "N"}, {"descriptorName": "Hemodynamics", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1991-07-01", "isOpenAccess": "N", "pageInfo": "813-817", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "1991-10-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://eurheartj.oxfordjournals.org/cgi/content/abstract/12/7/813", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "eurheartj.oxfordjournals.org"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "1991-07-01", "journal": {"medlineAbbreviation": "Eur Heart J", "isoabbreviation": "Eur. Heart J.", "title": "European heart journal", "issn": "0195-668X", "nlmid": "8006263", "essn": "1522-9645"}, "monthOfPublication": 7, "volume": "12", "yearOfPublication": 1991, "journalIssueId": 865685, "issue": "7", "dateOfPublication": "1991 Jul"}}, "25913325": {"pubYear": "2015", "dateOfCreation": "2015-09-16", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nck protein"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Oncogene Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}]}, "authorString": "Lane C, Qi J, Fawcett JP.", "affiliation": "Department of Pharmacology, Dalhousie University, Halifax, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "MOP 84366"}]}, "hasPDF": "N", "id": "25913325", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmacology, Dalhousie University, Halifax, Canada.", "fullName": "Lane C", "initials": "C", "firstName": "Ciaran", "lastName": "Lane"}, {"affiliation": "Department of Pharmacology, Dalhousie University, Halifax, Canada.", "fullName": "Qi J", "initials": "J", "firstName": "Jiansong", "lastName": "Qi"}, {"affiliation": "Department of Surgery, Dalhousie University, Halifax, Canada.", "fullName": "Fawcett JP", "initials": "JP", "firstName": "James P", "lastName": "Fawcett"}]}, "title": "NCK is critical for the development of deleted in colorectal cancer (DCC) sensitive spinal circuits.", "citedByCount": 0, "source": "MED", "pmid": "25913325", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neural Pathways", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Growth Cones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Immunoprecipitation", "majorTopic_YN": "N"}, {"descriptorName": "Neurogenesis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-04-25", "doi": "10.1111/jnc.13137", "isOpenAccess": "N", "pageInfo": "1008-1014", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Spinal Circuits", "Axon Guidance", "Deleted In Colorectal Cancer", "Hopping Gait", "Non-catalytic Region Of Tyrosine Kinase Adaptor"]}, "abstractText": "As our understanding of motor circuit function increases, our need to understand how circuits form to ensure proper function becomes increasingly important. Recently, deleted in colorectal cancer (DCC) has been shown to be important in the development of spinal circuits necessary for gait. Importantly, humans with mutation in DCC show mirror movement disorders pointing to the significance of DCC in the development of spinal circuits for coordinated movement. Although DCC binds a number of ligands, the intracellular signaling cascade leading to the aberrant spinal circuits remains unknown. Here, we show that the non-catalytic region of tyrosine kinase adaptor (NCK) proteins 1 and 2 are distributed in the developing spinal cord. Using dissociated dorsal spinal neuron cultures we show that NCK proteins are necessary for the outgrowth and growth cone architecture of DCC(+ve) dorsal spinal neurons. Consistent with a role for NCK in DCC signaling, we show that loss of NCK proteins leads to a reduction in the thickness of TAG1(+ve) commissural bundles in the floor plate and loss of DCC mRNA in vivo. We suggest that DCC signaling functions through NCK1 and NCK2 and that both proteins are necessary for the establishment of normal spinal circuits necessary for gait. Reduction in NCK proteins in the developing CNS leads to a reduction in TAG1(+ve) commissural tract thickness, a reduction in growth cone complexity of DCC(+ve) spinal interneurons, and a reduction in DCC mRNA. These are consistent with an in vivo role for NCK in the development of critical DCC spinal circuits, and may be important for the normal development of spinal circuits critical for walking.", "electronicPublicationDate": "2015-05-19", "language": "eng", "dateOfCompletion": "2015-12-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/jnc.13137", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-09-01", "journal": {"medlineAbbreviation": "J Neurochem", "isoabbreviation": "J. Neurochem.", "title": "Journal of neurochemistry", "issn": "0022-3042", "nlmid": "2985190R", "essn": "1471-4159"}, "monthOfPublication": 9, "volume": "134", "yearOfPublication": 2015, "journalIssueId": 2324175, "issue": "6", "dateOfPublication": "2015 Sep"}}, "18005074": {"pubYear": "2007", "dateOfCreation": "2007-11-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "300-62-9", "name": "Amphetamine"}, {"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Dopamine Uptake Inhibitors"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Dcc protein, mouse"}]}, "authorString": "Grant A, Hoops D, Labelle-Dumais C, Pr\u00e9vost M, Rajabi H, Kolb B, Stewart J, Arvanitogiannis A, Flores C.", "affiliation": "Douglas Mental Health University Institute, Department of Psychiatry, McGill University, 6875 LaSalle Boulevard, Verdun, Quebec, Canada, H4H 1R3.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "18005074", "inEPMC": "N", "authorList": {"author": [{"lastName": "Grant", "fullName": "Grant A", "firstName": "Alanna", "initials": "A"}, {"lastName": "Hoops", "fullName": "Hoops D", "firstName": "Daniel", "initials": "D"}, {"lastName": "Labelle-Dumais", "fullName": "Labelle-Dumais C", "firstName": "Cassandre", "initials": "C"}, {"lastName": "Pr\u00e9vost", "fullName": "Pr\u00e9vost M", "firstName": "Michael", "initials": "M"}, {"lastName": "Rajabi", "fullName": "Rajabi H", "firstName": "Heshmat", "initials": "H"}, {"lastName": "Kolb", "fullName": "Kolb B", "firstName": "Bryan", "initials": "B"}, {"lastName": "Stewart", "fullName": "Stewart J", "firstName": "Jane", "initials": "J"}, {"lastName": "Arvanitogiannis", "fullName": "Arvanitogiannis A", "firstName": "Andreas", "initials": "A"}, {"lastName": "Flores", "fullName": "Flores C", "firstName": "Cecilia", "initials": "C"}]}, "title": "Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.", "citedByCount": 26, "source": "MED", "pmid": "18005074", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amphetamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dopamine Uptake Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microdialysis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Silver Staining", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Conditioning, Operant", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sex Factors", "majorTopic_YN": "N"}, {"descriptorName": "Neural Inhibition", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dose-Response Relationship, Drug", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-11-14", "doi": "10.1111/j.1460-9568.2007.05888.x", "isOpenAccess": "N", "pageInfo": "3215-3228", "hasDbCrossReferences": "Y", "abstractText": "The mesocorticolimbic dopamine (DA) system is implicated in neurodevelopmental psychiatric disorders including schizophrenia but it is unknown how disruptions in brain development modify this system and increase predisposition to cognitive and behavioural abnormalities in adulthood. Netrins are guidance cues involved in the proper organization of neuronal connectivity during development. We have hypothesized that variations in the function of DCC (deleted in colorectal cancer), a netrin-1 receptor highly expressed by DA neurones, may result in altered development and organization of mesocorticolimbic DA circuitry, and influence DA function in the adult. To test this hypothesis, we assessed the effects of reduced DCC on several indicators of DA function. Using in-vivo microdialysis, we showed that adult mice that develop with reduced DCC display increased basal DA levels in the medial prefrontal cortex and exaggerated DA release in response to the indirect DA agonist amphetamine. In contrast, these mice exhibit normal levels of DA in the nucleus accumbens but significantly blunted amphetamine-induced DA release. Concomitantly, using conditioned place preference, locomotor activity and prepulse inhibition paradigms, we found that reduced DCC diminishes the rewarding and behavioural-activating effects of amphetamine and protects against amphetamine-induced deficits in sensorimotor gating. Furthermore, we found that adult DCC-deficient mice exhibit altered dendritic spine density in layer V medial prefrontal cortex pyramidal neurones but not in nucleus accumbens medium spiny neurones. These findings demonstrate that reduced DCC during development results in a behavioural phenotype opposite to that observed in developmental models of schizophrenia and identify DCC as a critical factor in the development of DA function.", "electronicPublicationDate": "2007-11-14", "language": "eng", "dateOfCompletion": "2008-02-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1460-9568.2007.05888.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-12-01", "journal": {"medlineAbbreviation": "Eur J Neurosci", "isoabbreviation": "Eur. J. Neurosci.", "title": "The European journal of neuroscience", "issn": "0953-816X", "nlmid": "8918110", "essn": "1460-9568"}, "monthOfPublication": 12, "volume": "26", "yearOfPublication": 2007, "journalIssueId": 1482444, "issue": "11", "dateOfPublication": "2007 Dec"}}, "8242611": {"pubYear": "1993", "dateOfCreation": "1994-01-03", "pubModel": "Print", "authorString": "Scheck AC, Coons SW.", "affiliation": "Department of Neuropathology, Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA 50931"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA 25956"}]}, "hasPDF": "N", "id": "8242611", "inEPMC": "N", "authorList": {"author": [{"lastName": "Scheck", "fullName": "Scheck AC", "initials": "AC"}, {"lastName": "Coons", "fullName": "Coons SW", "initials": "SW"}]}, "title": "Expression of the tumor suppressor gene DCC in human gliomas.", "citedByCount": 20, "source": "MED", "pmid": "8242611", "abstractText": "Reduced expression and/or allelic loss of the putative tumor suppressor gene DCC has been demonstrated in colorectal, gastric, pancreatic, esophageal, breast, and hematological malignancies. We examined the expression of the DCC gene in 22 tissue samples from human gliomas (glioblastoma multiforme, oligodendroglioma, and mixed oligodendroglioma/astrocytoma). Seven of 8 glioblastomas multiforme (88%) had reduced or absent DCC expression, and 8 of the other 14 tumors underexpressed DCC when compared to normal brain tissue. These results demonstrate that reduced expression of DCC occurs in human malignant gliomas and may be part of a common genetic pathway leading to neoplastic transformation and/or tumor progression.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glioma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "Y"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Genes, DCC", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1993-12-01", "isOpenAccess": "N", "pageInfo": "5605-5609", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "1994-01-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://cancerres.aacrjournals.org/cgi/content/abstract/53/23/5605", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "cancerres.aacrjournals.org"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "1993-12-01", "journal": {"medlineAbbreviation": "Cancer Res", "isoabbreviation": "Cancer Res.", "title": "Cancer research", "issn": "0008-5472", "nlmid": "2984705R", "essn": "1538-7445"}, "monthOfPublication": 12, "volume": "53", "yearOfPublication": 1993, "journalIssueId": 721745, "issue": "23", "dateOfPublication": "1993 Dec"}}, "24136235": {"pubYear": "2013", "dateOfCreation": "2013-10-18", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "bcl-x protein"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Ligands"}, {"registryNumber": "9007-43-6", "name": "Cytochromes c"}, {"registryNumber": "EC 3.4.22.-", "name": "Caspases"}, {"registryNumber": "0", "name": "bcl-2-Associated X Protein"}, {"registryNumber": "0", "name": "bcl-2 Homologous Antagonist-Killer Protein"}, {"registryNumber": "EC 2.7.10.1", "name": "Proto-Oncogene Proteins c-met"}]}, "authorString": "Lefebvre J, Muharram G, Leroy C, Kherrouche Z, Montagne R, Ichim G, Tauszig-Delamasure S, Chotteau-Lelievre A, Brenner C, Mehlen P, Tulasne D.", "affiliation": "CNRS UMR 8161, Institut de Biologie de Lille - Institut Pasteur de Lille-IFR 142 - Universit\u00e9 de Lille 1-Universit\u00e9 de Lille 2, Lille, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24136235", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "CNRS UMR 8161, Institut de Biologie de Lille - Institut Pasteur de Lille-IFR 142 - Universit\u00e9 de Lille 1-Universit\u00e9 de Lille 2, Lille, France.", "fullName": "Lefebvre J", "initials": "J", "firstName": "J", "lastName": "Lefebvre"}, {"lastName": "Muharram", "fullName": "Muharram G", "firstName": "G", "initials": "G"}, {"lastName": "Leroy", "fullName": "Leroy C", "firstName": "C", "initials": "C"}, {"lastName": "Kherrouche", "fullName": "Kherrouche Z", "firstName": "Z", "initials": "Z"}, {"lastName": "Montagne", "fullName": "Montagne R", "firstName": "R", "initials": "R"}, {"lastName": "Ichim", "fullName": "Ichim G", "firstName": "G", "initials": "G"}, {"lastName": "Tauszig-Delamasure", "fullName": "Tauszig-Delamasure S", "firstName": "S", "initials": "S"}, {"lastName": "Chotteau-Lelievre", "fullName": "Chotteau-Lelievre A", "firstName": "A", "initials": "A"}, {"lastName": "Brenner", "fullName": "Brenner C", "firstName": "C", "initials": "C"}, {"lastName": "Mehlen", "fullName": "Mehlen P", "firstName": "P", "initials": "P"}, {"lastName": "Tulasne", "fullName": "Tulasne D", "firstName": "D", "initials": "D"}]}, "title": "Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "24136235", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Mitochondria, Liver", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Subcellular Fractions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Epithelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Dogs", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Cytochromes c", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Caspases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ligands", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "Y"}, {"descriptorName": "Apoptosis", "majorTopic_YN": "Y"}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N"}, {"descriptorName": "Gene Silencing", "majorTopic_YN": "N"}, {"descriptorName": "Protein Transport", "majorTopic_YN": "N"}, {"descriptorName": "Permeability", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-met", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "bcl-2 Homologous Antagonist-Killer Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "bcl-X Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "bcl-2-Associated X Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Madin Darby Canine Kidney Cells", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-10-17", "language": "eng", "doi": "10.1038/cddis.2013.377", "isOpenAccess": "Y", "pageInfo": "e871", "pmcid": "PMC3824686", "hasDbCrossReferences": "Y", "abstractText": "The receptor tyrosine kinase Met and its ligand, the hepatocyte growth factor, are essential to embryonic development, whereas the deregulation of Met signaling is associated with tumorigenesis. While ligand-activated Met promotes survival, caspase-dependent generation of the p40 Met fragment leads to apoptosis induction - hallmark of the dependence receptor. Although the survival signaling pathways induced by Met are well described, the pro-apoptotic signaling pathways are unknown. We show that, although p40 Met contains the entire kinase domain, it accelerates apoptosis independently of kinase activity. In cell cultures undergoing apoptosis, the fragment shows a mitochondrial localization, required for p40 Met-induced cell death. Fulminant hepatic failure induced in mice leads to the generation of p40 Met localized also in the mitochondria, demonstrating caspase cleavage of Met in vivo. According to its localization, the fragment induces mitochondrial permeabilization, which is inhibited by Bak silencing and Bcl-xL overexpression. Moreover, Met silencing delays mitochondrial permeabilization induced by an apoptotic treatment. Thus, the Met-dependence receptor in addition to its well-known role in survival signaling mediated by its kinase activity, also participates in the intrinsic apoptosis pathway through the generation of p40 Met - a caspase-dependent fragment of Met implicated in the mitochondrial permeabilization process.", "electronicPublicationDate": "2013-10-17", "license": "cc by-nc-sa", "dateOfCompletion": "2014-03-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3824686?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3824686", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24136235", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24136235&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/cddis.2013.377", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Cell death & disease", "medlineAbbreviation": "Cell Death Dis", "isoabbreviation": "Cell Death Dis", "nlmid": "101524092", "essn": "2041-4889"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2013, "journalIssueId": 1999726, "dateOfPublication": "2013 "}}, "27055860": {"pubYear": "2016", "dateOfCreation": "2016-07-28", "pubModel": "Print-Electronic", "authorString": "Yan P, Qiao X, Wu H, Yin F, Zhang J, Ji Y, Wei S, Lai J.", "affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27055860", "inEPMC": "N", "authorList": {"author": [{"affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Yan P", "initials": "P", "firstName": "Peng", "lastName": "Yan"}, {"affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Qiao X", "initials": "X", "firstName": "Xiaomeng", "lastName": "Qiao"}, {"affiliation": "Department of Neurology, Xi'an Children's Hospital, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Wu H", "initials": "H", "firstName": "Hua", "lastName": "Wu"}, {"affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Yin F", "initials": "F", "firstName": "Fangyuan", "lastName": "Yin"}, {"affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Zhang J", "initials": "J", "firstName": "Jing", "lastName": "Zhang"}, {"affiliation": "College of Forensic, Key Laboratory of Ministry of Public Health for Forensic Science, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Ji Y", "initials": "Y", "firstName": "Yuanyuan", "lastName": "Ji"}, {"affiliation": "Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.", "fullName": "Wei S", "initials": "S", "firstName": "Shuguang", "lastName": "Wei"}, {"affiliation": "Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. laijh10111@gmail.com.", "fullName": "Lai J", "initials": "J", "firstName": "Jianghua", "lastName": "Lai"}]}, "title": "An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia.", "citedByCount": 0, "source": "MED", "pmid": "27055860", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-04-07", "doi": "10.1007/s12031-016-0751-6", "isOpenAccess": "N", "pageInfo": "366-375", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Schizophrenia", "Chinese Han population", "Single-nucleotide Polymorphisms", "Glycogen Synthase Kinase-3\u03b2", "Deleted In Colorectal Carcinoma"]}, "abstractText": "Schizophrenia is a severe mental disorder that is likely to be strongly determined by genetic factors. To identify markers of disks, large homolog 2 (DLG2), FAT atypical cadherin 3 (FAT3), kinectin1 (KTN1), deleted in colorectal carcinoma (DCC), and glycogen synthase kinase-3\u03b2 (GSK3\u03b2) that contribute to the genetic susceptibility to schizophrenia, we systematically screened for polymorphisms in the functional regions of these genes. A total of 22 functional single-nucleotide polymorphisms (SNPs) in 940 Chinese subjects were genotyped using SNaPshot. The results first suggested that the allelic and genotypic frequencies of the DCC polymorphism rs2229080 were nominally associated with schizophrenia. The patients were significantly less likely to be CC homozygous (P\u00a0=\u00a00.005, odds ratio [OR]\u00a0=\u00a00.635, 95\u00a0% confidence interval [95\u00a0% CI]\u00a0=\u00a00.462-0.873), and the schizophrenia subjects exhibited lower frequency of the C allele (P\u00a0=\u00a00.024, OR\u00a0=\u00a00.811, 95\u00a0% CI\u00a0=\u00a00.676-0.972). Regarding GSK3\u03b2, there was a significant difference in genotype distribution of rs3755557 between schizophrenia and healthy control subjects (P\u00a0=\u00a00.009). The patients exhibited a significantly lower frequency of the T allele of rs3755557 (P\u00a0=\u00a00.002, OR\u00a0=\u00a00.654, 95\u00a0% CI\u00a0=\u00a00.498-0.860). Our results point to the polymorphisms of DCC and GSK3\u03b2 as contributors to the genetic basis of individual differences in the susceptibility to schizophrenia.", "electronicPublicationDate": "2016-04-07", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s12031-016-0751-6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-07-01", "journal": {"medlineAbbreviation": "J Mol Neurosci", "isoabbreviation": "J. Mol. Neurosci.", "title": "Journal of molecular neuroscience : MN", "issn": "0895-8696", "nlmid": "9002991", "essn": "1559-1166"}, "monthOfPublication": 7, "volume": "59", "yearOfPublication": 2016, "journalIssueId": 2434368, "issue": "3", "dateOfPublication": "2016 Jul"}}}, "CASK": {"24294842": {"pubYear": "2013", "dateOfCreation": "2013-12-10", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.4.8", "name": "guanylate kinase"}, {"registryNumber": "0", "name": "voltage-dependent calcium channel (P-Q type)"}, {"registryNumber": "0", "name": "Calcium Channels, N-Type"}, {"registryNumber": "EC 2.7.4.-", "name": "CASK kinases"}, {"registryNumber": "0", "name": "Receptors, Purinergic P2X3"}]}, "authorString": "Gnanasekaran A, Bele T, Hullugundi S, Simonetti M, Ferrari MD, van den Maagdenberg AM, Nistri A, Fabbretti E.", "affiliation": "Neuroscience Department, International School for Advanced Studies (SISSA), Via Bonomea 265, Trieste 34136, Italy. Elsa.Fabbretti@ung.si.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Telethon", "grantId": "GGP10082"}]}, "hasPDF": "Y", "id": "24294842", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Aswini", "lastName": "Gnanasekaran", "affiliation": "Neuroscience Department, International School for Advanced Studies (SISSA), Via Bonomea 265, Trieste 34136, Italy. Elsa.Fabbretti@ung.si.", "authorId": {"type": "ORCID", "value": "0000-0002-0035-9553"}, "fullName": "Gnanasekaran A", "initials": "A"}, {"lastName": "Bele", "fullName": "Bele T", "firstName": "Tanja", "initials": "T"}, {"lastName": "Hullugundi", "fullName": "Hullugundi S", "firstName": "Swathi", "initials": "S"}, {"lastName": "Simonetti", "fullName": "Simonetti M", "firstName": "Manuela", "initials": "M"}, {"lastName": "Ferrari", "fullName": "Ferrari MD", "firstName": "Michael D", "initials": "MD"}, {"lastName": "van den Maagdenberg", "fullName": "van den Maagdenberg AM", "firstName": "Arn M J M", "initials": "AM"}, {"lastName": "Nistri", "fullName": "Nistri A", "firstName": "Andrea", "initials": "A"}, {"lastName": "Fabbretti", "fullName": "Fabbretti E", "firstName": "Elsa", "initials": "E"}]}, "title": "Mutated CaV2.1 channels dysregulate CASK/P2X3 signaling in mouse trigeminal sensory neurons of R192Q Cacna1a knock-in mice.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "24294842", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0035-9553"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Trigeminal Ganglion", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Calcium Channels, N-Type", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Guanylate Kinase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sensory Receptor Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Purinergic P2X3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-02", "language": "eng", "doi": "10.1186/1744-8069-9-62", "isOpenAccess": "Y", "pageInfo": "62", "pmcid": "PMC4220808", "hasDbCrossReferences": "N", "abstractText": "BACKGROUND: ATP-gated P2X3 receptors of sensory ganglion neurons are important transducers of pain as they adapt their expression and function in response to acute and chronic nociceptive signals. The present study investigated the role of calcium/calmodulin-dependent serine protein kinase (CASK) in controlling P2X3 receptor expression and function in trigeminal ganglia from Cacna1a R192Q-mutated knock-in (KI) mice, a genetic model for familial hemiplegic migraine type-1. RESULTS: KI ganglion neurons showed more abundant CASK/P2X3 receptor complex at membrane level, a result that likely originated from gain-of-function effects of R192Q-mutated CaV2.1 channels and downstream enhanced CaMKII activity. The selective CaV2.1 channel blocker \u03c9-Agatoxin IVA and the CaMKII inhibitor KN-93 were sufficient to return CASK/P2X3 co-expression to WT levels. After CASK silencing, P2X3 receptor expression was decreased in both WT and KI ganglia, supporting the role of CASK in P2X3 receptor stabilization. This process was functionally observed as reduced P2X3 receptor currents. CONCLUSIONS: We propose that, in trigeminal sensory neurons, the CASK/P2X3 complex has a dynamic nature depending on intracellular calcium and related signaling, that are enhanced in a transgenic mouse model of genetic hemiplegic migraine.", "electronicPublicationDate": "2013-12-02", "license": "cc by", "dateOfCompletion": "2014-07-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4220808?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4220808", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1744-8069-9-62", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-11-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Molecular pain", "medlineAbbreviation": "Mol Pain", "isoabbreviation": "Mol Pain", "nlmid": "101242662", "essn": "1744-8069"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2013, "journalIssueId": 2014265, "dateOfPublication": "2013 "}}}, "TRMT10A": {"26526202": {"pubYear": "2016", "dateOfCreation": "2016-08-18", "pubModel": "Print", "authorString": "Yew TW, McCreight L, Colclough K, Ellard S, Pearson ER.", "affiliation": "Department of Medicine, National University Health System, Singapore.", "pubTypeList": {"pubType": ["Case Reports"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "102820"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "098395"}]}, "id": "26526202", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Medicine, National University Health System, Singapore.", "fullName": "Yew TW", "initials": "TW", "firstName": "T W", "lastName": "Yew"}, {"affiliation": "Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK.", "fullName": "McCreight L", "initials": "L", "firstName": "L", "lastName": "McCreight"}, {"affiliation": "Department of Molecular Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.", "fullName": "Colclough K", "initials": "K", "firstName": "K", "lastName": "Colclough"}, {"affiliation": "Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.", "fullName": "Ellard S", "initials": "S", "firstName": "S", "lastName": "Ellard"}, {"affiliation": "Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK.", "fullName": "Pearson ER", "initials": "ER", "firstName": "E R", "lastName": "Pearson"}]}, "title": "tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy.", "citedByCount": 0, "source": "MED", "pmid": "26526202", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-11-03", "doi": "10.1111/dme.13024", "isOpenAccess": "N", "pageInfo": "e21-5", "hasDbCrossReferences": "N", "abstractText": "A syndrome of young-onset diabetes mellitus associated with microcephaly, epilepsy and intellectual disability caused by mutations in the tRNA methyltransferase 10 homologue A (TRMT10A) gene has recently been described.We report two siblings from the fourth family reported to have diabetes mellitus as a result of a TRMT10A mutation. A homozygous nonsense mutation p.Glu27Ter in TRMT10A was identified using targeted next-generation sequencing and confirmed by PCR/Sanger sequencing. Diabetes was diagnosed while the subjects were in their 20s and was characterized by insulin resistance. Epilepsy and intellectual disability were features in common. Mild microcephaly was present at birth but their final head circumferences were normal.Our report provides independent confirmation of the role of TRMT10A mutations in this syndrome and expands its phenotypic description. TRMT10A sequencing should be considered in children or adults with young-onset diabetes who have a history of intellectual disability, microcephaly and epilepsy. This report also shows the advantages of using a targeted panel to identify previously unsuspected monogenic diabetes among young-onset non-insulin-dependent diabetes in the absence of obesity and autoimmunity.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/dme.13024", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2016-08-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-09-01", "journal": {"medlineAbbreviation": "Diabet Med", "isoabbreviation": "Diabet. Med.", "title": "Diabetic medicine : a journal of the British Diabetic Association", "issn": "0742-3071", "nlmid": "8500858", "essn": "1464-5491"}, "monthOfPublication": 9, "volume": "33", "yearOfPublication": 2016, "journalIssueId": 2442202, "issue": "9", "dateOfPublication": "2016 Sep"}}}, "NUAK1": {"26174813": {"pubYear": "2015", "dateOfCreation": "2015-07-27", "pubModel": "Print-Electronic", "authorString": "Alemany S, Ribas\u00e9s M, Vilor-Tejedor N, Bustamante M, S\u00e1nchez-Mora C, Bosch R, Richarte V, Cormand B, Casas M, Ramos-Quiroga JA, Sunyer J.", "affiliation": "CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26174813", "inEPMC": "N", "authorList": {"author": [{"affiliation": "CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.", "fullName": "Alemany S", "initials": "S", "firstName": "Silvia", "lastName": "Alemany"}, {"affiliation": "Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain.", "fullName": "Ribas\u00e9s M", "initials": "M", "firstName": "Marta", "lastName": "Ribas\u00e9s"}, {"firstName": "Nat\u00e0lia", "lastName": "Vilor-Tejedor", "affiliation": "CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.", "authorId": {"type": "ORCID", "value": "0000-0003-4935-6721"}, "fullName": "Vilor-Tejedor N", "initials": "N"}, {"affiliation": "Center for Genomic Regulation (CRG), Barcelona, Spain.", "fullName": "Bustamante M", "initials": "M", "firstName": "Mariona", "lastName": "Bustamante"}, {"affiliation": "Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain.", "fullName": "S\u00e1nchez-Mora C", "initials": "C", "firstName": "Cristina", "lastName": "S\u00e1nchez-Mora"}, {"affiliation": "Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.", "fullName": "Bosch R", "initials": "R", "firstName": "Rosa", "lastName": "Bosch"}, {"affiliation": "Department of Psychiatry and Legal Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain.", "fullName": "Richarte V", "initials": "V", "firstName": "Vanesa", "lastName": "Richarte"}, {"firstName": "Bru", "lastName": "Cormand", "affiliation": "Institut de Biomedicina de la Universitat de Barcelona (IBUB), Catalonia, Spain.", "authorId": {"type": "ORCID", "value": "0000-0001-5318-4382"}, "fullName": "Cormand B", "initials": "B"}, {"affiliation": "Department of Psychiatry and Legal Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain.", "fullName": "Casas M", "initials": "M", "firstName": "Miguel", "lastName": "Casas"}, {"affiliation": "Department of Psychiatry and Legal Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain.", "fullName": "Ramos-Quiroga JA", "initials": "JA", "firstName": "Josep A", "lastName": "Ramos-Quiroga"}, {"affiliation": "IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.", "fullName": "Sunyer J", "initials": "J", "firstName": "Jordi", "lastName": "Sunyer"}]}, "title": "New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder.", "citedByCount": 0, "source": "MED", "pmid": "26174813", "abstractText": "Attention deficit is one of the core symptoms of the attention-deficit/hyperactivity disorder (ADHD). However, the specific genetic variants that may be associated with attention function in adult ADHD remain largely unknown. The present study aimed to identifying SNPs associated with attention function in adult ADHD and tested whether these associations were enriched for specific biological pathways. Commissions, hit-reaction time (HRT), the standard error of HRT (HRTSE), and intraindividual coefficient variability (ICV) of the Conners Continuous Performance Test (CPT-II) were assessed in 479 unmedicated adult ADHD individuals. A Genome-Wide Association Study (GWAS) was conducted for each outcome and, subsequently, gene set enrichment analyses were performed. Although no SNPs reached genome-wide significance (P\u2009<\u20095E-08), 27 loci showed suggestive evidence of association with the CPT outcomes (P\u2009<\u2009E-05). The most relevant associated SNP was located in the SORCS2 gene (P\u2009=\u20093.65E-07), previously associated with bipolar disorder (BP), Alzheimer disease (AD), and brain structure in elderly individuals. We detected other genes suggested to be involved in synaptic plasticity, cognitive function, neurological and neuropsychiatric disorders, and smoking behavior such as NUAK1, FGF20, NETO1, BTBD9, DLG2, TOP3B, and CHRNB4. Also, several of the pathways nominally associated with the CPT outcomes are relevant for ADHD such as the ubiquitin proteasome, neurodegenerative disorders, axon guidance, and AD amyloid secretase pathways. To our knowledge, this is the first GWAS and pathway analysis of attention function in patients with persistent ADHD. Overall, our findings reinforce the conceptualization of attention function as a potential endophenotype for studying the molecular basis of adult ADHD. \u00a9 2015 Wiley Periodicals, Inc.", "hasTextMinedTerms": "N", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4935-6721"}, {"type": "ORCID", "value": "0000-0001-5318-4382"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-07-14", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Adults", "Attention-deficit/hyperactivity Disorder", "Gwas", "Sorcs2", "Conners Continuous Performance Test"]}, "hasLabsLinks": "Y", "electronicPublicationDate": "2015-07-14", "language": "eng", "dateOfRevision": "2015-07-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-07-01", "journal": {"medlineAbbreviation": "Am J Med Genet B Neuropsychiatr Genet", "isoabbreviation": "Am. J. Med. Genet. B Neuropsychiatr. Genet.", "title": "American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics", "issn": "1552-4841", "nlmid": "101235742", "essn": "1552-485X"}, "monthOfPublication": 7, "yearOfPublication": 2015, "journalIssueId": 2304258, "dateOfPublication": "2015 Jul"}}, "22689267": {"pubYear": "2012", "dateOfCreation": "2012-07-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.1.-", "name": "ARK5 protein, mouse"}]}, "authorString": "Ohmura T, Shioi G, Hirano M, Aizawa S.", "affiliation": "Laboratory for Vertebrate Body Plan, Center for Developmental Biology, RIKEN Kobe, Kobe, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22689267", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ohmura", "fullName": "Ohmura T", "firstName": "Tomomi", "initials": "T"}, {"lastName": "Shioi", "fullName": "Shioi G", "firstName": "Go", "initials": "G"}, {"lastName": "Hirano", "fullName": "Hirano M", "firstName": "Mariko", "initials": "M"}, {"lastName": "Aizawa", "fullName": "Aizawa S", "firstName": "Shinichi", "initials": "S"}]}, "title": "Neural tube defects by NUAK1 and NUAK2 double mutation.", "citedByCount": 2, "source": "MED", "pmid": "22689267", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Mutant Strains", "majorTopic_YN": "N"}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Hybridization", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Neural Tube", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-22", "doi": "10.1002/dvdy.23816", "isOpenAccess": "N", "pageInfo": "1350-1364", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: NUAK1 and NUAK2, members of the AMP-activated protein kinase family of serine/threonine kinases, are prominently expressed in neuroectoderm, but their functions in neurulation have not been elucidated. RESULTS: NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida. Median hinge point was formed, but dorsolateral hinge point formation was not apparent in cranial neural plate; neither apical constriction nor apico-basal elongation took place efficiently in the double mutants during the 5-10-somite stages. Concomitantly, the apical concentration of phosphorylated myosin light chain 2, F-actin, and cortactin was insignificant, and development of acetylated \u03b1-tubulin-positive microtubules was poor. However, the distribution of F-actin, cortactin, Shroom3, Rho, myosin heavy chain IIB, phosphorylated myosin light chain 2, \u03b1-tubulin, \u03b3-tubulin, or acetylated \u03b1-tubulin was apparently normal in the double mutant neuroepithelia at the 5-somite stage. CONCLUSIONS: NUAK1 and NUAK2 complementarily function in the apical constriction and apico-basal elongation that associate with the dorsolateral hinge point formation in cephalic neural plate during the 5- to 10-somite stages. In the double mutant neural plate, phosphorylated myosin light chain 2, F-actin, and cortactin did not concentrate efficiently in apical surfaces, and acetylated \u03b1-tubulin-positive microtubules did not develop significantly.", "electronicPublicationDate": "2012-06-22", "language": "eng", "dateOfCompletion": "2012-11-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/dvdy.23816", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-08-01", "journal": {"medlineAbbreviation": "Dev Dyn", "isoabbreviation": "Dev. Dyn.", "title": "Developmental dynamics : an official publication of the American Association of Anatomists", "issn": "1058-8388", "nlmid": "9201927", "essn": "1097-0177"}, "monthOfPublication": 8, "volume": "241", "yearOfPublication": 2012, "journalIssueId": 1950003, "issue": "8", "dateOfPublication": "2012 Aug"}}, "23459936": {"pubYear": "2013", "dateOfCreation": "2013-05-14", "pubModel": "Print-Electronic", "authorString": "Divaris K, Monda KL, North KE, Olshan AF, Reynolds LM, Hsueh WC, Lange EM, Moss K, Barros SP, Weyant RJ, Liu Y, Newman AB, Beck JD, Offenbacher S.", "affiliation": "Department of Pediatric Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "1R01AG032098-01A1"}, {"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "UL1RR025005"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268200782096C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100005C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100006C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100007C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100008C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100009C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100010C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268201100011C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HSN268201100012C"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "N01AG6210"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "N01AG62101"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "N01AG62103"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "N01AG62106"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "P30 ES010126"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "P30ES010126"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01 ES014843"}, {"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "R01DE021418"}, {"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "R01DE11551"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01HL086694"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01HL087641"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01HL59367"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01HL74104"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01HG004402"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268200625226C"}]}, "hasPDF": "Y", "id": "23459936", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Kimon", "lastName": "Divaris", "affiliation": "Department of Pediatric Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.", "authorId": {"type": "ORCID", "value": "0000-0003-1290-7251"}, "fullName": "Divaris K", "initials": "K"}, {"lastName": "Monda", "fullName": "Monda KL", "firstName": "Keri L", "initials": "KL"}, {"lastName": "North", "fullName": "North KE", "firstName": "Kari E", "initials": "KE"}, {"lastName": "Olshan", "fullName": "Olshan AF", "firstName": "Andrew F", "initials": "AF"}, {"lastName": "Reynolds", "fullName": "Reynolds LM", "authorId": {"type": "ORCID", "value": "0000-0001-6157-0144"}, "firstName": "Lindsay M", "initials": "LM"}, {"lastName": "Hsueh", "fullName": "Hsueh WC", "firstName": "Wen-Chi", "initials": "WC"}, {"lastName": "Lange", "fullName": "Lange EM", "firstName": "Ethan M", "initials": "EM"}, {"lastName": "Moss", "fullName": "Moss K", "firstName": "Kevin", "initials": "K"}, {"lastName": "Barros", "fullName": "Barros SP", "firstName": "Silvana P", "initials": "SP"}, {"lastName": "Weyant", "fullName": "Weyant RJ", "firstName": "Robert J", "initials": "RJ"}, {"lastName": "Liu", "fullName": "Liu Y", "firstName": "Yongmei", "initials": "Y"}, {"lastName": "Newman", "fullName": "Newman AB", "authorId": {"type": "ORCID", "value": "0000-0002-0106-1150"}, "firstName": "Anne B", "initials": "AB"}, {"lastName": "Beck", "fullName": "Beck JD", "firstName": "James D", "initials": "JD"}, {"lastName": "Offenbacher", "fullName": "Offenbacher S", "firstName": "Steven", "initials": "S"}]}, "title": "Exploring the genetic basis of chronic periodontitis: a genome-wide association study.", "hasSuppl": "Y", "citedByCount": 36, "source": "MED", "pmid": "23459936", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1290-7251"}, {"type": "ORCID", "value": "0000-0001-6157-0144"}, {"type": "ORCID", "value": "0000-0002-0106-1150"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Age Factors", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Body Composition", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Meta-Analysis as Topic", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "Y"}, {"descriptorName": "Chronic Periodontitis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Loci", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-03-04", "language": "eng", "doi": "10.1093/hmg/ddt065", "isOpenAccess": "Y", "pageInfo": "2312-2324", "pmcid": "PMC3652417", "hasDbCrossReferences": "N", "abstractText": "Chronic periodontitis (CP) is a common oral disease that confers substantial systemic inflammatory and microbial burden and is a major cause of tooth loss. Here, we present the results of a genome-wide association study of CP that was carried out in a cohort of 4504 European Americans (EA) participating in the Atherosclerosis Risk in Communities (ARIC) Study (mean age-62 years, moderate CP-43% and severe CP-17%). We detected no genome-wide significant association signals for CP; however, we found suggestive evidence of association (P < 5 \u00d7 10(-6)) for six loci, including NIN, NPY, WNT5A for severe CP and NCR2, EMR1, 10p15 for moderate CP. Three of these loci had concordant effect size and direction in an independent sample of 656 adult EA participants of the Health, Aging, and Body Composition (Health ABC) Study. Meta-analysis pooled estimates were severe CP (n = 958 versus health: n = 1909)-NPY, rs2521634 [G]: odds ratio [OR = 1.49 (95% confidence interval (CI = 1.28-1.73, P = 3.5 \u00d7 10(-7)))]; moderate CP (n = 2293)-NCR2, rs7762544 [G]: OR = 1.40 (95% CI = 1.24-1.59, P = 7.5 \u00d7 10(-8)), EMR1, rs3826782 [A]: OR = 2.01 (95% CI = 1.52-2.65, P = 8.2 \u00d7 10(-7)). Canonical pathway analysis indicated significant enrichment of nervous system signaling, cellular immune response and cytokine signaling pathways. A significant interaction of NUAK1 (rs11112872, interaction P = 2.9 \u00d7 10(-9)) with smoking in ARIC was not replicated in Health ABC, although estimates of heritable variance in severe CP explained by all single nucleotide polymorphisms increased from 18 to 52% with the inclusion of a genome-wide interaction term with smoking. These genome-wide association results provide information on multiple candidate regions and pathways for interrogation in future genetic studies of CP.", "electronicPublicationDate": "2013-03-04", "license": "cc by-nc", "dateOfCompletion": "2013-12-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3652417?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3652417", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23459936&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23459936", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/hmg/ddt065", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-04-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-06-01", "journal": {"medlineAbbreviation": "Hum Mol Genet", "isoabbreviation": "Hum. Mol. Genet.", "title": "Human molecular genetics", "issn": "0964-6906", "nlmid": "9208958", "essn": "1460-2083"}, "monthOfPublication": 6, "volume": "22", "yearOfPublication": 2013, "journalIssueId": 2039085, "issue": "11", "dateOfPublication": "2013 Jun"}}, "12409306": {"pubYear": "2003", "dateOfCreation": "2002-12-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Multienzyme Complexes"}, {"registryNumber": "56-45-1", "name": "Serine"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "EC 2.7.1.-", "name": "NUAK1 protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "NUAK2 protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "AMP-Activated Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "PRKAA1 protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "PRKAA2 protein, human"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Proto-Oncogene Proteins c-akt"}, {"registryNumber": "EC 2.7.11.1", "name": "ataxia telangiectasia mutated protein"}, {"registryNumber": "EC 2.7.11.1", "name": "AKT1 protein, human"}]}, "authorString": "Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H.", "affiliation": "Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "12409306", "inEPMC": "N", "authorList": {"author": [{"lastName": "Suzuki", "fullName": "Suzuki A", "firstName": "Atsushi", "initials": "A"}, {"lastName": "Kusakai", "fullName": "Kusakai G", "firstName": "Gen-Ichi", "initials": "G"}, {"lastName": "Kishimoto", "fullName": "Kishimoto A", "firstName": "Atsuhiro", "initials": "A"}, {"lastName": "Lu", "fullName": "Lu J", "firstName": "Jie", "initials": "J"}, {"lastName": "Ogura", "fullName": "Ogura T", "firstName": "Tsutomu", "initials": "T"}, {"lastName": "Lavin", "fullName": "Lavin MF", "firstName": "Martin F", "initials": "MF"}, {"lastName": "Esumi", "fullName": "Esumi H", "firstName": "Hiroyasu", "initials": "H"}]}, "title": "Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein.", "citedByCount": 51, "source": "MED", "pmid": "12409306", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multienzyme Complexes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Serine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N"}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Alignment", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Enzyme Activation", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-akt", "majorTopic_YN": "N"}, {"descriptorName": "AMP-Activated Protein Kinases", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2002-10-29", "doi": "10.1074/jbc.m206025200", "isOpenAccess": "N", "pageInfo": "48-53", "hasDbCrossReferences": "Y", "abstractText": "We identified a novel human AMP-activated protein kinase (AMPK) family member, designated ARK5, encoding 661 amino acids with an estimated molecular mass of 74 kDa. The putative amino acid sequence reveals 47, 45.8, 42.4, and 55% homology to AMPK-alpha1, AMPK-alpha2, MELK, and SNARK, respectively, suggesting that it is a new member of the AMPK family. It has a putative Akt phosphorylation motif at amino acids 595-600, and Ser(600) was found to be phosphorylated by active Akt resulting in the activation of kinase activity toward the SAMS peptide, a consensus AMPK substrate. During nutrient starvation, ARK5 supported the survival of cells in an Akt-dependent manner. In addition, we also demonstrated that ARK5, when activated by Akt, phosphorylated the ATM protein that is mutated in the human genetic disorder ataxia-telangiectasia and also induced the phosphorylation of p53. On the basis of our current findings, we propose that a novel AMPK family member, ARK5, is the tumor cell survival factor activated by Akt and acts as an ATM kinase under the conditions of nutrient starvation.", "electronicPublicationDate": "2002-10-29", "language": "eng", "dateOfCompletion": "2003-02-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1074/jbc.M206025200", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-06-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2003-01-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 1, "volume": "278", "yearOfPublication": 2003, "journalIssueId": 1161449, "issue": "1", "dateOfPublication": "2003 Jan"}}}, "PRKG1": {"14568994": {"pubYear": "2003", "dateOfCreation": "2003-10-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.11.12", "name": "Cyclic GMP-Dependent Protein Kinases"}, {"registryNumber": "EC 2.7.11.12", "name": "Cyclic GMP-Dependent Protein Kinase Type I"}, {"registryNumber": "EC 2.7.11.12", "name": "Prkg1 protein, mouse"}]}, "authorString": "Feil R, Hartmann J, Luo C, Wolfsgruber W, Schilling K, Feil S, Barski JJ, Meyer M, Konnerth A, De Zeeuw CI, Hofmann F.", "affiliation": "Institut f\u00fcr Pharmakologie und Toxikologie, Technische Universit\u00e4t, Biedersteiner Str. 29, D-80802 M\u00fcnchen, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "14568994", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Feil", "fullName": "Feil R", "firstName": "Robert", "initials": "R"}, {"lastName": "Hartmann", "fullName": "Hartmann J", "firstName": "Jana", "initials": "J"}, {"lastName": "Luo", "fullName": "Luo C", "firstName": "Chongde", "initials": "C"}, {"lastName": "Wolfsgruber", "fullName": "Wolfsgruber W", "firstName": "Wiebke", "initials": "W"}, {"lastName": "Schilling", "fullName": "Schilling K", "firstName": "Karl", "initials": "K"}, {"lastName": "Feil", "fullName": "Feil S", "firstName": "Susanne", "initials": "S"}, {"lastName": "Barski", "fullName": "Barski JJ", "firstName": "Jaroslaw J", "initials": "JJ"}, {"lastName": "Meyer", "fullName": "Meyer M", "firstName": "Michael", "initials": "M"}, {"lastName": "Konnerth", "fullName": "Konnerth A", "firstName": "Arthur", "initials": "A"}, {"lastName": "De Zeeuw", "fullName": "De Zeeuw CI", "firstName": "Chris I", "initials": "CI"}, {"lastName": "Hofmann", "fullName": "Hofmann F", "firstName": "Franz", "initials": "F"}]}, "title": "Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I.", "hasSuppl": "N", "citedByCount": 57, "source": "MED", "pmid": "14568994", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Purkinje Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Cyclic GMP-Dependent Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Learning", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adaptation, Physiological", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Synaptic Transmission", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Long-Term Potentiation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reflex, Vestibulo-Ocular", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Cyclic GMP-Dependent Protein Kinase Type I", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2003-10-20", "doi": "10.1083/jcb.200306148", "isOpenAccess": "Y", "pageInfo": "295-302", "pmcid": "PMC2173527", "hasDbCrossReferences": "Y", "abstractText": "The molecular basis for cerebellar plasticity and motor learning remains controversial. Cerebellar Purkinje cells (PCs) contain a high concentration of cGMP-dependent protein kinase type I (cGKI). To investigate the function of cGKI in long-term depression (LTD) and cerebellar learning, we have generated conditional knockout mice lacking cGKI selectively in PCs. These cGKI mutants had a normal cerebellar morphology and intact synaptic calcium signaling, but strongly reduced LTD. Interestingly, no defects in general behavior and motor performance could be detected in the LTD-deficient mice, but the mutants exhibited an impaired adaptation of the vestibulo-ocular reflex (VOR). These results indicate that cGKI in PCs is dispensable for general motor coordination, but that it is required for cerebellar LTD and specific forms of motor learning, namely the adaptation of the VOR.", "electronicPublicationDate": "2003-10-20", "language": "eng", "dateOfCompletion": "2003-12-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2173527?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2173527", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1083/jcb.200306148", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "intl.jcb.org"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2003-10-01", "journal": {"medlineAbbreviation": "J Cell Biol", "isoabbreviation": "J. Cell Biol.", "title": "The Journal of cell biology", "issn": "0021-9525", "nlmid": "0375356", "essn": "1540-8140"}, "monthOfPublication": 10, "volume": "163", "yearOfPublication": 2003, "journalIssueId": 1167754, "issue": "2", "dateOfPublication": "2003 Oct"}}, "24925903": {"pubYear": "2014", "dateOfCreation": "2014-08-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "EC 2.7.11.12", "name": "Cyclic GMP-Dependent Protein Kinase Type I"}, {"registryNumber": "EC 2.7.11.12", "name": "Prkg1 protein, mouse"}, {"registryNumber": "H2D2X058MU", "name": "Cyclic GMP"}]}, "authorString": "Corradini E, Vallur R, Raaijmakers LM, Feil S, Feil R, Heck AJ, Scholten A.", "affiliation": "From \u2021Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands; \u00a7Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands;", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24925903", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "From \u2021Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands; \u00a7Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands;", "fullName": "Corradini E", "initials": "E", "firstName": "Eleonora", "lastName": "Corradini"}, {"affiliation": "\u00b6Interfakult\u00e4res Institut f\u00fcr Biochemie, Universit\u00e4t T\u00fcbingen, D-72074 T\u00fcbingen, Germany; \u2016Graduate School for Cellular and Molecular Neuroscience, Universit\u00e4t T\u00fcbingen, D-72074 T\u00fcbingen, Germany; **German Center for Neurodegenerative diseases (DZNE), D-72076 T\u00fcbingen, Germany.", "fullName": "Vallur R", "initials": "R", "firstName": "Raghavan", "lastName": "Vallur"}, {"affiliation": "From \u2021Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands; \u00a7Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands;", "fullName": "Raaijmakers LM", "initials": "LM", "firstName": "Linsey M", "lastName": "Raaijmakers"}, {"affiliation": "\u00b6Interfakult\u00e4res Institut f\u00fcr Biochemie, Universit\u00e4t T\u00fcbingen, D-72074 T\u00fcbingen, Germany;", "fullName": "Feil S", "initials": "S", "firstName": "Susanne", "lastName": "Feil"}, {"affiliation": "\u00b6Interfakult\u00e4res Institut f\u00fcr Biochemie, Universit\u00e4t T\u00fcbingen, D-72074 T\u00fcbingen, Germany;", "fullName": "Feil R", "initials": "R", "firstName": "Robert", "lastName": "Feil"}, {"affiliation": "From \u2021Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands; \u00a7Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands; a.j.r.heck@uu.nl a.scholten@uu.nl.", "fullName": "Heck AJ", "initials": "AJ", "firstName": "Albert J R", "lastName": "Heck"}, {"affiliation": "From \u2021Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands; \u00a7Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands; a.j.r.heck@uu.nl a.scholten@uu.nl.", "fullName": "Scholten A", "initials": "A", "firstName": "Arjen", "lastName": "Scholten"}]}, "title": "Alterations in the cerebellar (Phospho)proteome of a cyclic guanosine monophosphate (cGMP)-dependent protein kinase knockout mouse.", "hasSuppl": "Y", "citedByCount": 3, "source": "MED", "pmid": "24925903", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["pxd"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cyclic GMP", "majorTopic_YN": "N"}, {"descriptorName": "Proteomics", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Cyclic GMP-Dependent Protein Kinase Type I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "embargoDate": "2015-08-01", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-06-12", "doi": "10.1074/mcp.m113.035154", "isOpenAccess": "N", "pageInfo": "2004-2016", "pmcid": "PMC4125733", "hasDbCrossReferences": "N", "abstractText": "The cyclic nucleotide cyclic guanosine monophosphate (cGMP) plays an important role in learning and memory, but its signaling mechanisms in the mammalian brain are not fully understood. Using mass-spectrometry-based proteomics, we evaluated how the cerebellum adapts its (phospho)proteome in a knockout mouse model of cGMP-dependent protein kinase type I (cGKI). Our data reveal that a small subset of proteins in the cerebellum (\u223c3% of the quantified proteins) became substantially differentially expressed in the absence of cGKI. More changes were observed at the phosphoproteome level, with hundreds of sites being differentially phosphorylated between wild-type and knockout cerebellum. Most of these phosphorylated sites do not represent known cGKI substrates. An integrative computational network analysis of the data indicated that the differentially expressed proteins and proteins harboring differentially phosphorylated sites largely belong to a tight network in the Purkinje cells of the cerebellum involving important cGMP/cAMP signaling nodes (e.g. PDE5 and PKARII\u03b2) and Ca(2+) signaling (e.g. SERCA3). In this way, removal of cGKI could be linked to impaired cerebellar long-term depression at Purkinje cell synapses. In addition, we were able to identify a set of novel putative (phospho)proteins to be considered in this network. Overall, our data improve our understanding of cerebellar cGKI signaling and suggest novel players in cGKI-regulated synaptic plasticity.", "electronicPublicationDate": "2014-06-12", "language": "eng", "dateOfCompletion": "2015-04-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4125733", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1074/mcp.M113.035154", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-08-01", "journal": {"medlineAbbreviation": "Mol Cell Proteomics", "isoabbreviation": "Mol. Cell Proteomics", "title": "Molecular & cellular proteomics : MCP", "issn": "1535-9476", "nlmid": "101125647", "essn": "1535-9484"}, "monthOfPublication": 8, "volume": "13", "yearOfPublication": 2014, "journalIssueId": 2186701, "issue": "8", "dateOfPublication": "2014 Aug"}}, "12622406": {"pubYear": "2002", "dateOfCreation": "2003-03-07", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Genetic Markers"}, {"registryNumber": "EC 2.7.11.12", "name": "Cyclic GMP-Dependent Protein Kinases"}]}, "authorString": "De Luca V, Muglia P, Jain U, Basile VS, Sokolowski MB, Kennedy JL.", "affiliation": "Neurogenetics Section, Clarke Site, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "12622406", "inEPMC": "N", "authorList": {"author": [{"lastName": "De Luca", "fullName": "De Luca V", "firstName": "Vincenzo", "initials": "V"}, {"lastName": "Muglia", "fullName": "Muglia P", "firstName": "Pierandrea", "initials": "P"}, {"lastName": "Jain", "fullName": "Jain U", "firstName": "Umesh", "initials": "U"}, {"lastName": "Basile", "fullName": "Basile VS", "firstName": "Vincenzo S", "initials": "VS"}, {"lastName": "Sokolowski", "fullName": "Sokolowski MB", "firstName": "Marla B", "initials": "MB"}, {"lastName": "Kennedy", "fullName": "Kennedy JL", "firstName": "James L", "initials": "JL"}]}, "title": "A drosophila model for attention deficit hyperactivity disorder (ADHD): No evidence of association with PRKG1 gene.", "citedByCount": 3, "source": "MED", "pmid": "12622406", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Drosophila melanogaster", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Cyclic GMP-Dependent Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Attention Deficit Disorder with Hyperactivity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Testing", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2002-01-01", "doi": "10.1385/nmm:2:3:281", "isOpenAccess": "N", "pageInfo": "281-287", "hasDbCrossReferences": "N", "abstractText": "Attention deficit hyperactivity disorder (ADHD) is a prevalent psychiatric condition in children and follow up studies have indicated that 22-33% of patients continue to suffer from ADHD during late adolescence and adulthood. The action of psychostimulant drugs may be determined by additional mechanisms beyond the dopamine transporter and receptors. We are exploring new methodology for discovering these mechanisms. For example, in Drosophila, such an additional determinant of psychostimulant action could be protein kinase G (PKG) that affects food-search behavior. Here we initiated studies with the human homologue of PKG, the PRKG1 gene. The aim of this study was to investigate for the presence of linkage disequilibrium between the protein kinase G gene (PRKG1) and adult ADHD in a sample of nuclear families. Genotyping data for the C2276T polymorphism were analyzed using the Transmission Disequilibrium Test (TDT). Sixty three nuclear families were informative for the TDT on C2276T polymorphism, which showed no preferential transmission of either allele (chi-square = 0.778, df = 1, p = 0.316). These findings exclude a direct involvement of this genetic marker of the Protein kinase G gene in the pathogenesis of ADHD.", "language": "eng", "dateOfCompletion": "2003-05-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1385/NMM:2:3:281", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "HumanaPress"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2002-01-01", "journal": {"medlineAbbreviation": "Neuromolecular Med", "isoabbreviation": "Neuromolecular Med.", "title": "Neuromolecular medicine", "issn": "1535-1084", "nlmid": "101135365", "essn": "1559-1174"}, "monthOfPublication": 0, "volume": "2", "yearOfPublication": 2002, "journalIssueId": 1152812, "issue": "3", "dateOfPublication": "2002 "}}, "23922650": {"pubYear": "2013", "dateOfCreation": "2013-08-07", "pubModel": "Electronic-Print", "authorString": "Zhao Z, Webb BT, Jia P, Bigdeli TB, Maher BS, van den Oord E, Bergen SE, Amdur RL, O'Neill FA, Walsh D, Thiselton DL, Chen X, Pato CN, International Schizophrenia Consortium, Riley BP, Kendler KS, Fanous AH.", "affiliation": "Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH074027"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH083094"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH068881"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "N01 MH900001"}]}, "hasPDF": "Y", "id": "23922650", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.", "fullName": "Zhao Z", "initials": "Z", "firstName": "Zhongming", "lastName": "Zhao"}, {"lastName": "Webb", "fullName": "Webb BT", "authorId": {"type": "ORCID", "value": "0000-0002-0576-5366"}, "firstName": "Bradley T", "initials": "BT"}, {"lastName": "Jia", "fullName": "Jia P", "firstName": "Peilin", "initials": "P"}, {"lastName": "Bigdeli", "fullName": "Bigdeli TB", "firstName": "T Bernard", "initials": "TB"}, {"lastName": "Maher", "fullName": "Maher BS", "firstName": "Brion S", "initials": "BS"}, {"lastName": "van den Oord", "fullName": "van den Oord E", "firstName": "Edwin", "initials": "E"}, {"lastName": "Bergen", "fullName": "Bergen SE", "authorId": {"type": "ORCID", "value": "0000-0002-5888-0034"}, "firstName": "Sarah E", "initials": "SE"}, {"lastName": "Amdur", "fullName": "Amdur RL", "firstName": "Richard L", "initials": "RL"}, {"lastName": "O'Neill", "fullName": "O'Neill FA", "authorId": {"type": "ORCID", "value": "0000-0002-7531-7657"}, "firstName": "Francis A", "initials": "FA"}, {"lastName": "Walsh", "fullName": "Walsh D", "firstName": "Dermot", "initials": "D"}, {"lastName": "Thiselton", "fullName": "Thiselton DL", "firstName": "Dawn L", "initials": "DL"}, {"lastName": "Chen", "fullName": "Chen X", "firstName": "Xiangning", "initials": "X"}, {"lastName": "Pato", "fullName": "Pato CN", "firstName": "Carlos N", "initials": "CN"}, {"collectiveName": "International Schizophrenia Consortium"}, {"lastName": "Riley", "fullName": "Riley BP", "firstName": "Brien P", "initials": "BP"}, {"lastName": "Kendler", "fullName": "Kendler KS", "firstName": "Kenneth S", "initials": "KS"}, {"lastName": "Fanous", "fullName": "Fanous AH", "firstName": "Ayman H", "initials": "AH"}]}, "title": "Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis.", "hasSuppl": "Y", "citedByCount": 3, "source": "MED", "pmid": "23922650", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0576-5366"}, {"type": "ORCID", "value": "0000-0002-5888-0034"}, {"type": "ORCID", "value": "0000-0002-7531-7657"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Algorithms", "majorTopic_YN": "Y"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Databases, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Publishing", "majorTopic_YN": "N"}, {"descriptorName": "Meta-Analysis as Topic", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-07-29", "doi": "10.1371/journal.pone.0067776", "isOpenAccess": "Y", "pageInfo": "e67776", "pmcid": "PMC3726675", "hasDbCrossReferences": "N", "abstractText": "Integrating evidence from multiple domains is useful in prioritizing disease candidate genes for subsequent testing. We ranked all known human genes (n=3819) under linkage peaks in the Irish Study of High-Density Schizophrenia Families using three different evidence domains: 1) a meta-analysis of microarray gene expression results using the Stanley Brain collection, 2) a schizophrenia protein-protein interaction network, and 3) a systematic literature search. Each gene was assigned a domain-specific p-value and ranked after evaluating the evidence within each domain. For comparison to this ranking process, a large-scale candidate gene hypothesis was also tested by including genes with Gene Ontology terms related to neurodevelopment. Subsequently, genotypes of 3725 SNPs in 167 genes from a custom Illumina iSelect array were used to evaluate the top ranked vs. hypothesis selected genes. Seventy-three genes were both highly ranked and involved in neurodevelopment (category 1) while 42 and 52 genes were exclusive to neurodevelopment (category 2) or highly ranked (category 3), respectively. The most significant associations were observed in genes PRKG1, PRKCE, and CNTN4 but no individual SNPs were significant after correction for multiple testing. Comparison of the approaches showed an excess of significant tests using the hypothesis-driven neurodevelopment category. Random selection of similar sized genes from two independent genome-wide association studies (GWAS) of schizophrenia showed the excess was unlikely by chance. In a further meta-analysis of three GWAS datasets, four candidate SNPs reached nominal significance. Although gene ranking using integrated sources of prior information did not enrich for significant results in the current experiment, gene selection using an a priori hypothesis (neurodevelopment) was superior to random selection. As such, further development of gene ranking strategies using more carefully selected sources of information is warranted.", "electronicPublicationDate": "2013-07-29", "language": "eng", "dateOfCompletion": "2014-02-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3726675?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3726675", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23922650&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23922650", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0067776", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-04-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2056329, "issue": "7", "dateOfPublication": "2013 "}}}, "FTH1": {"27206843": {"pubYear": "2016", "dateOfCreation": "2016-07-26", "pubModel": "Print", "authorString": "Rogers JT, Venkataramani V, Washburn C, Liu Y, Tummala V, Jiang H, Smith A, Cahill CM.", "affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27206843", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "fullName": "Rogers JT", "initials": "JT", "firstName": "Jack T", "lastName": "Rogers"}, {"affiliation": "Department of Hematology and Medical Oncology, University Medical Center, Goettingen, Germany.", "fullName": "Venkataramani V", "initials": "V", "firstName": "Vivek", "lastName": "Venkataramani"}, {"affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "fullName": "Washburn C", "initials": "C", "firstName": "Cecilia", "lastName": "Washburn"}, {"affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "fullName": "Liu Y", "initials": "Y", "firstName": "Yanyan", "lastName": "Liu"}, {"affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "fullName": "Tummala V", "initials": "V", "firstName": "Vinusha", "lastName": "Tummala"}, {"affiliation": "State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao, China.", "fullName": "Jiang H", "initials": "H", "firstName": "Hong", "lastName": "Jiang"}, {"affiliation": "School of Biological Sciences, University of Missouri-K.C., Kansas City, Missouri, USA.", "fullName": "Smith A", "initials": "A", "firstName": "Ann", "lastName": "Smith"}, {"affiliation": "Neurochemistry Laboratory, Department of Psychiatry-Neuroscience, Massachusetts General Hospital (East), Harvard Medical School, Charlestown, Massachusetts, USA.", "fullName": "Cahill CM", "initials": "CM", "firstName": "Catherine M", "lastName": "Cahill"}]}, "title": "A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.", "citedByCount": 0, "source": "MED", "pmid": "27206843", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-05-21", "doi": "10.1111/jnc.13671", "isOpenAccess": "N", "pageInfo": "479-494", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Ferritin", "APP", "Neuronal cell", "Lead Toxicity", "Iron-responsive Element", "Iron Retention"]}, "abstractText": "Iron supplementation ameliorates the neurotoxicity of the environmental contaminant lead (Pb); however, the mechanism remains undefined. Iron is an essential nutrient but high levels are toxic due to the catalytic generation of destructive hydroxyl radicals. Using human neuroblastoma SH-SY5Y cells to model human neurons, we investigated the effect of Pb on proteins of iron homeostasis: the Alzheimer's amyloid precursor protein (APP), which stabilizes the iron exporter ferroportin 1; and, the heavy subunit of the iron-storage protein, ferritin (FTH). Lead (Pb(II) and Pb(IV) inhibited APP translation and raised cytosolic iron(II). Lead also increased iron regulatory protein-1 binding to the cognate 5'untranslated region-specific iron-responsive element (IRE) of APP and FTH mRNAs. Concurrent iron treatment rescued cells from Pb toxicity by specifically restoring APP synthesis, i.e. levels of the APP-related protein, APLP-2, were unchanged. Significantly, iron/IRE-independent over-expression of APP695\u00a0 protected SH-SY5Y cells from Pb toxicity, demonstrating that APP plays a key role in maintaining safe levels of intracellular iron. Overall, our data support a model of neurotoxicity where Pb enhances iron regulatory protein/IRE-mediated repression of APP and FTH translation. We propose novel treatment options for Pb poisoning to include chelators and the use of small molecules to maintain APP and FTH translation. We propose the following cascade for Lead (Pb) toxicity to neurons; by targeting the interaction between Iron regulatory protein-1 and Iron-responsive elements, Pb caused translational repression of proteins that control intracellular iron homeostasis, including the Alzheimer's amyloid precursor protein (APP) that stabilizes the iron exporter ferroportin, and the ferroxidase heavy subunit of the iron-storage protein, ferritin. When unregulated, IRE-independent over-expression of APP695 protected SH-SY5Y neurons from Pb toxicity. There is a novel and key role for APP in maintaining safe levels of intracellular iron pertinent to lead toxicity.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/jnc.13671", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-08-01", "journal": {"medlineAbbreviation": "J Neurochem", "isoabbreviation": "J. Neurochem.", "title": "Journal of neurochemistry", "issn": "0022-3042", "nlmid": "2985190R", "essn": "1471-4159"}, "monthOfPublication": 8, "volume": "138", "yearOfPublication": 2016, "journalIssueId": 2433393, "issue": "3", "dateOfPublication": "2016 Aug"}}, "18647502": {"pubYear": "2008", "dateOfCreation": "2008-07-23", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Proteins"}]}, "authorString": "Yang G, Wang L, Zhu M, Xu D.", "affiliation": "Department of Geriatric Neurology, Chinese PLA General Hospital, Beijing 100853, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "18647502", "inEPMC": "N", "authorList": {"author": [{"lastName": "Yang", "fullName": "Yang G", "firstName": "Guofeng", "initials": "G"}, {"lastName": "Wang", "fullName": "Wang L", "firstName": "Luning", "initials": "L"}, {"lastName": "Zhu", "fullName": "Zhu M", "firstName": "Mingwei", "initials": "M"}, {"lastName": "Xu", "fullName": "Xu D", "firstName": "Dan", "initials": "D"}]}, "title": "Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis.", "citedByCount": 7, "source": "MED", "pmid": "18647502", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Tauopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Postmortem Changes", "majorTopic_YN": "N"}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autopsy", "majorTopic_YN": "N"}, {"descriptorName": "Peptide Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Electrophoresis, Gel, Two-Dimensional", "majorTopic_YN": "N"}, {"descriptorName": "Isoelectric Focusing", "majorTopic_YN": "N"}, {"descriptorName": "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteomics", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Databases, Protein", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2008-07-01", "doi": "10.1179/174313208x284124", "isOpenAccess": "N", "pageInfo": "613-622", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVES: To identify differentially expressed proteins between tauopathies cases and controls and to explore molecular mechanisms of tauopathies. METHOD: Two-dimensional gel electrophoresis (2DE) was applied to separate the total proteins of temporal lobe obtained at autopsy from four tauopathies cases and four aged subjects without clinical or pathologic involvement of nervous system. The silver or Coomassie brilliant blue stained gels were analysed by 2-DE software Image Master 2D Elite. Selected differential protein spots were identified with MALDI-TOF/TOF tandem mass spectrometry. RESULTS: Glyceraldehyde 3-phosphate dehydrogenase, uracil DNA glycosylase, human superoxide dismutase, isocitrate dehydrogenase subunit, synaptotagmin I, thioredoxin peroxidase 1, glial fibrillary acidic protein, P25 alpha, enoyl coenzyme A hydratase short chain 1, pyridoxine-5'-phosphate oxidase, Mn-superoxide dismutase and alpha enolase were significantly upregulated in tauopathies brains, whereas antioxidant protein 2, ferritin heavy chain, glutamate dehydrogenase precursor, peptidyl-prolyl cis-trans isomerase A, serum albumin precursor and dihydropyrimidinase-related protein 2 were lowly expressed in tauopathies brains. CONCLUSIONS: We identified a number of tauopathy-related proteins that might be useful for discovering the molecular mechanisms of tauopathies, which could also be helpful for diagnosing and treating these disorders.", "language": "eng", "dateOfCompletion": "2008-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1179/174313208X284124", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://openurl.ingenta.com/content?genre=article&issn=0161-6412&volume=30&issue=6&spage=613", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "ingentaconnect"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-07-01", "journal": {"medlineAbbreviation": "Neurol Res", "isoabbreviation": "Neurol. Res.", "title": "Neurological research", "issn": "0161-6412", "nlmid": "7905298", "essn": "1743-1328"}, "monthOfPublication": 7, "volume": "30", "yearOfPublication": 2008, "journalIssueId": 1549779, "issue": "6", "dateOfPublication": "2008 Jul"}}, "24401274": {"pubYear": "2014", "dateOfCreation": "2014-02-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Receptors, CXCR4"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "9013-31-4", "name": "Apoferritins"}, {"registryNumber": "0", "name": "CXCL12 protein, human"}, {"registryNumber": "0", "name": "Chemokine CXCL12"}, {"registryNumber": "0", "name": "CXCR4 protein, human"}, {"registryNumber": "E1UOL152H7", "name": "Iron"}, {"registryNumber": "76I7G6D29C", "name": "Morphine"}]}, "authorString": "Pitcher J, Abt A, Myers J, Han R, Snyder M, Graziano A, Festa L, Kutzler M, Garcia F, Gao WJ, Fischer-Smith T, Rappaport J, Meucci O.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "DA023860"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "DA15014"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "DA32444"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH 085666"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30 CA056036"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA015014"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "U24 MH100931"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH085666"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R21 MH097623"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "T32 MH079785"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "T32-MH078795"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "U01 MH083506"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "U24 MH100928"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA032444"}]}, "hasPDF": "Y", "id": "24401274", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Pitcher", "fullName": "Pitcher J", "firstName": "Jonathan", "initials": "J"}, {"lastName": "Abt", "fullName": "Abt A", "firstName": "Anna", "initials": "A"}, {"lastName": "Myers", "fullName": "Myers J", "firstName": "Jaclyn", "initials": "J"}, {"lastName": "Han", "fullName": "Han R", "firstName": "Rachel", "initials": "R"}, {"lastName": "Snyder", "fullName": "Snyder M", "firstName": "Melissa", "initials": "M"}, {"lastName": "Graziano", "fullName": "Graziano A", "firstName": "Alessandro", "initials": "A"}, {"lastName": "Festa", "fullName": "Festa L", "firstName": "Lindsay", "initials": "L"}, {"lastName": "Kutzler", "fullName": "Kutzler M", "firstName": "Michele", "initials": "M"}, {"lastName": "Garcia", "fullName": "Garcia F", "firstName": "Fernando", "initials": "F"}, {"lastName": "Gao", "fullName": "Gao WJ", "firstName": "Wen-Jun", "initials": "WJ"}, {"lastName": "Fischer-Smith", "fullName": "Fischer-Smith T", "firstName": "Tracy", "initials": "T"}, {"lastName": "Rappaport", "fullName": "Rappaport J", "firstName": "Jay", "initials": "J"}, {"lastName": "Meucci", "fullName": "Meucci O", "firstName": "Olimpia", "initials": "O"}]}, "title": "Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.", "hasSuppl": "Y", "citedByCount": 6, "source": "MED", "pmid": "24401274", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dendritic Spines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Macaca", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "AIDS Dementia Complex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Substance-Related Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Iron", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Morphine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, CXCR4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Patch-Clamp Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Apoferritins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chemokine CXCL12", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-09", "doi": "10.1172/jci70090", "isOpenAccess": "N", "pageInfo": "656-669", "pmcid": "PMC3904611", "hasDbCrossReferences": "N", "abstractText": "Interaction of the chemokine CXCL12 with its receptor CXCR4 promotes neuronal function and survival during embryonic development and throughout adulthood. Previous studies indicated that \u03bc-opioid agonists specifically elevate neuronal levels of the protein ferritin heavy chain (FHC), which negatively regulates CXCR4 signaling and affects the neuroprotective function of the CXCL12/CXCR4 axis. Here, we determined that CXCL12/CXCR4 activity increased dendritic spine density, and also examined FHC expression and CXCR4 status in opiate abusers and patients with HIV-associated neurocognitive disorders (HAND), which is typically exacerbated by illicit drug use. Drug abusers and HIV patients with HAND had increased levels of FHC, which correlated with reduced CXCR4 activation, within cortical neurons. We confirmed these findings in a nonhuman primate model of SIV infection with morphine administration. Transfection of a CXCR4-expressing human cell line with an iron-deficient FHC mutant confirmed that increased FHC expression deregulated CXCR4 signaling and that this function of FHC was independent of iron binding. Furthermore, examination of morphine-treated rodents and isolated neurons expressing FHC shRNA revealed that FHC contributed to morphine-induced dendritic spine loss. Together, these data implicate FHC-dependent deregulation of CXCL12/CXCR4 as a contributing factor to cognitive dysfunction in neuroAIDS.", "electronicPublicationDate": "2014-01-09", "language": "eng", "dateOfCompletion": "2014-04-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3904611?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3904611", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24401274&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24401274", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1172/JCI70090", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-02-01", "journal": {"medlineAbbreviation": "J Clin Invest", "isoabbreviation": "J. Clin. Invest.", "title": "The Journal of clinical investigation", "issn": "0021-9738", "nlmid": "7802877", "essn": "1558-8238"}, "monthOfPublication": 2, "volume": "124", "yearOfPublication": 2014, "journalIssueId": 2121535, "issue": "2", "dateOfPublication": "2014 Feb"}}, "10716893": {"pubYear": "2000", "dateOfCreation": "2000-04-18", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "9007-73-2", "name": "Ferritins"}]}, "authorString": "Lakaye B, de Borman B, Minet A, Arckens L, Vergnes M, Marescaux C, Grisar T.", "affiliation": "Laboratory of Biochemistry, University of Li\u00e8ge, Li\u00e8ge, Belgium.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "10716893", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lakaye", "fullName": "Lakaye B", "initials": "B"}, {"lastName": "de Borman", "fullName": "de Borman B", "initials": "B"}, {"lastName": "Minet", "fullName": "Minet A", "initials": "A"}, {"lastName": "Arckens", "fullName": "Arckens L", "initials": "L"}, {"lastName": "Vergnes", "fullName": "Vergnes M", "initials": "M"}, {"lastName": "Marescaux", "fullName": "Marescaux C", "initials": "C"}, {"lastName": "Grisar", "fullName": "Grisar T", "initials": "T"}]}, "title": "Increased expression of mRNA encoding ferritin heavy chain in brain structures of a rat model of absence epilepsy.", "citedByCount": 10, "source": "MED", "pmid": "10716893", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hippocampus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Mutant Strains", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy, Absence", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Northern", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Hybridization", "majorTopic_YN": "N"}, {"descriptorName": "Age Factors", "majorTopic_YN": "N"}, {"descriptorName": "Transcription, Genetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Developmental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Chemistry", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Kindling, Neurologic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ferritins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2000-03-01", "doi": "10.1006/exnr.2000.7303", "isOpenAccess": "N", "pageInfo": "112-120", "hasDbCrossReferences": "N", "abstractText": "Differential mRNA display was carried out to find genes that are differentially regulated in the brain of a rat strain with absence epilepsy, the genetic absence epilepsy rats from Strasbourg (GAERS). Among the 32 differentially displayed cDNA fragments actually cloned and sequenced, one shows 100% identity with the rat heavy chain ferritin (H-ferritin) mRNA. Northern blot analysis confirmed the up-regulation of the H-ferritin mRNA. Using dot blotting, a 40% increase in expression was reported in the subcortical forebrain of the adult GAERS, while cortex, brain stem, and cerebellum appeared unmodified. This change was not observed in the brain of 25-day-old rats, an age at which the epileptic phenotype is not present. By in situ hybridization, the enhanced expression was localized in the hippocampus. The increase in mRNA encoding H-ferritin was not immunodetected at the protein level by Western blotting. These results are not apparently related to the neural substrate of SWD or to the distribution of local increase in glucose metabolism previously described in the GAERS. It is hypothesized that the up-regulation of the H-ferritin mRNA is part of a mechanism protecting the hippocampus, a seizure-prone area, against a possible overactivation during absence seizures.", "language": "eng", "dateOfCompletion": "2000-04-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1006/exnr.2000.7303", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2000-03-01", "journal": {"medlineAbbreviation": "Exp Neurol", "isoabbreviation": "Exp. Neurol.", "title": "Experimental neurology", "issn": "0014-4886", "nlmid": "0370712", "essn": "1090-2430"}, "monthOfPublication": 3, "volume": "162", "yearOfPublication": 2000, "journalIssueId": 1007697, "issue": "1", "dateOfPublication": "2000 Mar"}}, "20627326": {"pubYear": "2010", "dateOfCreation": "2010-07-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Receptors, CXCR4"}, {"registryNumber": "9013-31-4", "name": "Apoferritins"}, {"registryNumber": "0", "name": "CXCL12 protein, human"}, {"registryNumber": "0", "name": "Chemokine CXCL12"}, {"registryNumber": "0", "name": "CXCR4 protein, human"}]}, "authorString": "Pitcher J, Shimizu S, Burbassi S, Meucci O.", "affiliation": "Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, USA.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "5T32MH079785"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA015014"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA015014-08"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "T32 MH079785"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA019808-05"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01-DA15014"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01-DA19808"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA019808"}]}, "hasPDF": "Y", "id": "20627326", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, USA.", "fullName": "Pitcher J", "initials": "J", "firstName": "Jonathan", "lastName": "Pitcher"}, {"lastName": "Shimizu", "fullName": "Shimizu S", "firstName": "Saori", "initials": "S"}, {"lastName": "Burbassi", "fullName": "Burbassi S", "firstName": "Silvia", "initials": "S"}, {"lastName": "Meucci", "fullName": "Meucci O", "firstName": "Olimpia", "initials": "O"}]}, "title": "Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS.", "hasSuppl": "N", "citedByCount": 8, "source": "MED", "pmid": "20627326", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "AIDS Dementia Complex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Opioid-Related Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, CXCR4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Comorbidity", "majorTopic_YN": "N"}, {"descriptorName": "Apoferritins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chemokine CXCL12", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-06-08", "doi": "10.1016/j.jneuroim.2010.05.006", "isOpenAccess": "N", "pageInfo": "66-71", "pmcid": "PMC2910242", "hasDbCrossReferences": "N", "abstractText": "The chemokine CXCL12 and its receptor, CXCR4, regulate neuronal migration, differentiation, and survival. Alterations of CXCL12/CXCR4 signaling are implicated in different neuropathologies, including the neurological complications of HIV infection. Opiates are important co-factors for progression to neuroAIDS and can disrupt the CXCL12/CXCR4 axis in vitro and in vivo. This paper will review recently identified mechanisms of opiate-induced CXCR4 impairment in neurons and introduce results from pilot studies in human brain tissue, which highlight the role of the protein ferritin heavy chain in HIV neuropathology in patients with history of drug abuse.", "electronicPublicationDate": "2010-06-08", "language": "eng", "dateOfCompletion": "2010-10-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2910242?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2910242", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20627326", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20627326&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.jneuroim.2010.05.006", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-09-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-07-01", "journal": {"medlineAbbreviation": "J Neuroimmunol", "isoabbreviation": "J. Neuroimmunol.", "title": "Journal of neuroimmunology", "issn": "0165-5728", "nlmid": "8109498", "essn": "1872-8421"}, "monthOfPublication": 7, "volume": "224", "yearOfPublication": 2010, "journalIssueId": 1748861, "issue": "1-2", "dateOfPublication": "2010 Jul"}}, "24327207": {"pubYear": "2014", "dateOfCreation": "2014-08-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "frataxin"}, {"registryNumber": "0", "name": "Iron-Binding Proteins"}]}, "authorString": "Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, Li Y, Ng KM, Ho SL, Esteban MA, Binah O, Tse HF, Siu CW.", "affiliation": "Cardiology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24327207", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Cardiology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong, China.", "fullName": "Lee YK", "initials": "YK", "firstName": "Yee-Ki", "lastName": "Lee"}, {"lastName": "Ho", "fullName": "Ho PW", "firstName": "Philip Wing-Lok", "initials": "PW"}, {"lastName": "Schick", "fullName": "Schick R", "firstName": "Revital", "initials": "R"}, {"lastName": "Lau", "fullName": "Lau YM", "firstName": "Yee-Man", "initials": "YM"}, {"lastName": "Lai", "fullName": "Lai WH", "firstName": "Wing-Hon", "initials": "WH"}, {"lastName": "Zhou", "fullName": "Zhou T", "firstName": "Ting", "initials": "T"}, {"lastName": "Li", "fullName": "Li Y", "firstName": "Yanhua", "initials": "Y"}, {"lastName": "Ng", "fullName": "Ng KM", "firstName": "Kwong-Man", "initials": "KM"}, {"lastName": "Ho", "fullName": "Ho SL", "firstName": "Shu-Leung", "initials": "SL"}, {"lastName": "Esteban", "fullName": "Esteban MA", "firstName": "Miguel Angel", "initials": "MA"}, {"lastName": "Binah", "fullName": "Binah O", "authorId": {"type": "ORCID", "value": "0000-0002-0468-8530"}, "firstName": "Ofer", "initials": "O"}, {"lastName": "Tse", "fullName": "Tse HF", "firstName": "Hung-Fat", "initials": "HF"}, {"lastName": "Siu", "fullName": "Siu CW", "firstName": "Chung-Wah", "initials": "CW"}]}, "title": "Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.", "citedByCount": 5, "source": "MED", "pmid": "24327207", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0468-8530"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Myocytes, Cardiac", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pluripotent Stem Cells", "majorTopic_YN": "Y"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Friedreich Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cardiomyopathies", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Iron Overload", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}]}}, {"descriptorName": "Iron-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "In Vitro Techniques", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-11", "doi": "10.1007/s00424-013-1414-x", "isOpenAccess": "N", "pageInfo": "1831-1844", "hasDbCrossReferences": "N", "abstractText": "Friedreich ataxia (FRDA), a recessive neurodegenerative disorder commonly associated with hypertrophic cardiomyopathy, is due to GAA repeat expansions within the first intron of the frataxin (FXN) gene encoding the mitochondrial protein involved in iron-sulfur cluster biosynthesis. The triplet codon repeats lead to heterochromatin-mediated gene silencing and loss of frataxin. Nevertheless, inadequacy of existing FRDA-cardiac cellular models limited cardiomyopathy studies. We tested the hypothesis that iron homeostasis deregulation accelerates reduction in energy synthesis dynamics which contributes to impaired cardiac calcium homeostasis and contractile force. Silencing of FXN expressions occurred both in somatic FRDA-skin fibroblasts and two of the induced pluripotent stem cells (iPSC) clones; a sign of stress condition was shown in FRDA-iPSC cardiomyocytes with disorganized mitochondrial network and mitochondrial DNA (mtDNA) depletion; hypertrophic cardiac stress responses were observed by an increase in \u03b1-actinin-positive cell sizes revealed by FACS analysis as well as elevation in brain natriuretic peptide (BNP) gene expression; the intracellular iron accumulated in FRDA cardiomyocytes might be due to attenuated negative feedback response of transferring receptor (TSFR) expression and positive feedback response of ferritin (FTH1); energy synthesis dynamics, in terms of ATP production rate, was impaired in FRDA-iPSC cardiomyocytes, which were prone to iron overload condition. Energetic insufficiency determined slower Ca(2+) transients by retarding calcium reuptake to sarcoplasmic reticulum (SR) and impaired the positive inotropic and chronotropic responses to adrenergic stimulation. Our data showed for the first time that FRDA-iPSCs cardiac derivatives represent promising models to study cardiac stress response due to impaired iron homeostasis condition and mitochondrial damages. The cardiomyopathy phenotype was accelerated in an iron-overloaded condition early in calcium homeostasis aspect.", "electronicPublicationDate": "2013-12-11", "language": "eng", "dateOfCompletion": "2015-09-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00424-013-1414-x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-09-01", "journal": {"medlineAbbreviation": "Pflugers Arch", "isoabbreviation": "Pflugers Arch.", "title": "Pflugers Archiv : European journal of physiology", "issn": "0031-6768", "nlmid": "0154720", "essn": "1432-2013"}, "monthOfPublication": 9, "volume": "466", "yearOfPublication": 2014, "journalIssueId": 2190142, "issue": "9", "dateOfPublication": "2014 Sep"}}}, "CHEK1": {"24142626": {"pubYear": "2014", "dateOfCreation": "2013-11-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}]}, "authorString": "Parikh RA, Appleman LJ, Bauman JE, Sankunny M, Lewis DW, Vlad A, Gollin SM.", "affiliation": "Department of Internal Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30CA047904"}, {"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "R01DE014729"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P50CA097190"}]}, "hasPDF": "N", "id": "24142626", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Internal Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA.", "fullName": "Parikh RA", "initials": "RA", "firstName": "Rahul A", "lastName": "Parikh"}, {"lastName": "Appleman", "fullName": "Appleman LJ", "authorId": {"type": "ORCID", "value": "0000-0003-4951-7388"}, "firstName": "Leonard J", "initials": "LJ"}, {"lastName": "Bauman", "fullName": "Bauman JE", "firstName": "Julie E", "initials": "JE"}, {"lastName": "Sankunny", "fullName": "Sankunny M", "firstName": "Madhav", "initials": "M"}, {"lastName": "Lewis", "fullName": "Lewis DW", "firstName": "Dale W", "initials": "DW"}, {"lastName": "Vlad", "fullName": "Vlad A", "firstName": "Anda", "initials": "A"}, {"lastName": "Gollin", "fullName": "Gollin SM", "firstName": "Susanne M", "initials": "SM"}]}, "title": "Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.", "citedByCount": 2, "source": "MED", "pmid": "24142626", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4951-7388"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Chromosomes, Human, Pair 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 11", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carcinoma, Squamous Cell", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mouth Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Translocation, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Gene Dosage", "majorTopic_YN": "N"}, {"descriptorName": "Radiation Tolerance", "majorTopic_YN": "N"}, {"descriptorName": "Gene Knockdown Techniques", "majorTopic_YN": "N"}, {"descriptorName": "G2 Phase Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-10-21", "doi": "10.1002/gcc.22115", "isOpenAccess": "N", "pageInfo": "25-37", "hasDbCrossReferences": "N", "abstractText": "The ATR-CHEK1 pathway is upregulated and overactivated in Ataxia Telangiectasia (AT) cells, which lack functional ATM protein. Loss of ATM in AT confers radiosensitivity, although ATR-CHEK1 pathway overactivation compensates, leads to prolonged G(2) arrest after treatment with ionizing radiation (IR), and partially reverses the radiosensitivity. We observed similar upregulation of the ATR-CHEK1 pathway in a subset of oral squamous cell carcinoma (OSCC) cell lines with ATM loss. In the present study, we report copy number gain, amplification, or translocation of the ATR gene in 8 of 20 OSCC cell lines by FISH; whereas the CHEK1 gene showed copy number loss in 12 of 20 cell lines by FISH. Quantitative PCR showed overexpression of both ATR and CHEK1 in 7 of 11 representative OSCC cell lines. Inhibition of ATR or CHEK1 with their respective siRNAs resulted in increased sensitivity of OSCC cell lines to IR by the colony survival assay. siRNA-mediated ATR or CHEK1 knockdown led to loss of G(2) cell cycle accumulation and an increased sub-G(0) apoptotic cell population by flow cytometric analysis. In conclusion, the ATR-CHEK1 pathway is upregulated in a subset of OSCC with distal 11q loss and loss of the G(1) phase cell cycle checkpoint. The upregulated ATR-CHEK1 pathway appears to protect OSCC cells from mitotic catastrophe by enhancing the G(2) checkpoint. Knockdown of ATR and/or CHEK1 increases the sensitivity of OSCC cells to IR. These findings suggest that inhibition of the upregulated ATR-CHEK1 pathway may enhance the efficacy of ionizing radiation treatment of OSCC.", "electronicPublicationDate": "2013-10-21", "language": "eng", "dateOfCompletion": "2014-03-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/gcc.22115", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "Genes Chromosomes Cancer", "isoabbreviation": "Genes Chromosomes Cancer", "title": "Genes, chromosomes & cancer", "issn": "1045-2257", "nlmid": "9007329", "essn": "1098-2264"}, "monthOfPublication": 1, "volume": "53", "yearOfPublication": 2014, "journalIssueId": 2095557, "issue": "1", "dateOfPublication": "2014 Jan"}}, "23479505": {"pubYear": "2013", "dateOfCreation": "2013-03-12", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "ATR protein, human"}, {"registryNumber": "127-07-1", "name": "Hydroxyurea"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "HMGA2 Protein"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}]}, "authorString": "Natarajan S, Hombach-Klonisch S, Dr\u00f6ge P, Klonisch T.", "affiliation": "Department of Human Anatomy and Cell Science, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23479505", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Natarajan", "fullName": "Natarajan S", "firstName": "Suchitra", "initials": "S"}, {"lastName": "Hombach-Klonisch", "fullName": "Hombach-Klonisch S", "firstName": "Sabine", "initials": "S"}, {"lastName": "Dr\u00f6ge", "fullName": "Dr\u00f6ge P", "firstName": "Peter", "initials": "P"}, {"lastName": "Klonisch", "fullName": "Klonisch T", "firstName": "Thomas", "initials": "T"}]}, "title": "HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.", "hasSuppl": "Y", "citedByCount": 9, "source": "MED", "pmid": "23479505", "abstractText": "The non-histone chromatin binding protein high mobility group AT-hook 2 (HMGA2) is expressed in stem cells and many cancer cells, including tumor initiating cells, but not translated in normal human somatic cells. The presence of HMGA2 is correlated with advanced neoplastic disease and poor prognosis for patients. We had previously demonstrated a role of HMGA2 in DNA repair pathways. In the present study, we employed different human tumor cell models with endogenous and exogenous expression of HMGA2 and show that upon DNA damage, the presence of HMGA2 caused an increased and sustained phosphorylation of the ataxia telangiectasia and Rad3-related kinase (ATR) and its downstream target checkpoint kinase 1 (CHK1). The presence of activated pCHK1(Ser296) coincided with prolonged G2/M block and increased tumor cell survival, which was enhanced further in the presence of HMGA2. Our study, thus, identifies a novel relationship between the ATR-CHK1 DNA damage response pathway and HMGA2, which may support the DNA repair function of HMGA2 in cancer cells. Furthermore, our data provide a rationale for the use of inhibitors to ATR or CHK1 and HMGA2 in the treatment of HMGA2-positive human cancer cells.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hydroxyurea", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HMGA2 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "Y"}, {"descriptorName": "Apoptosis", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "RNA Interference", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-03-01", "isOpenAccess": "N", "pageInfo": "263-280", "pmcid": "PMC3593150", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "language": "eng", "dateOfCompletion": "2013-08-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3593150?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3593150", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23479505", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23479505&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-03-01", "journal": {"medlineAbbreviation": "Neoplasia", "isoabbreviation": "Neoplasia", "title": "Neoplasia (New York, N.Y.)", "issn": "1522-8002", "nlmid": "100886622", "essn": "1476-5586"}, "monthOfPublication": 3, "volume": "15", "yearOfPublication": 2013, "journalIssueId": 2018895, "issue": "3", "dateOfPublication": "2013 Mar"}}, "18344416": {"pubYear": "2008", "dateOfCreation": "2008-05-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "ATR protein, human"}, {"registryNumber": "0", "name": "H2AFX protein, human"}, {"registryNumber": "0", "name": "Histones"}, {"registryNumber": "56-45-1", "name": "Serine"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "0", "name": "ATRIP protein, human"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Casein Kinase II"}, {"registryNumber": "EC 2.7.11.1", "name": "ataxia telangiectasia mutated protein"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}]}, "authorString": "Kulkarni A, Das KC.", "affiliation": "Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL-55807"}]}, "hasPDF": "N", "id": "18344416", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kulkarni", "fullName": "Kulkarni A", "firstName": "Amit", "initials": "A"}, {"lastName": "Das", "fullName": "Das KC", "firstName": "Kumuda C", "initials": "KC"}]}, "title": "Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.", "citedByCount": 17, "source": "MED", "pmid": "18344416", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Adenocarcinoma", "majorTopic_YN": "N"}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N"}, {"descriptorName": "Hyperoxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Casein Kinase II", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Serine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Histones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Repair", "majorTopic_YN": "N"}, {"descriptorName": "RNA Interference", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2008-03-14", "doi": "10.1152/ajplung.00004.2008", "isOpenAccess": "N", "pageInfo": "L998-L1006", "hasDbCrossReferences": "Y", "abstractText": "Elevated level of oxygen (hyperoxia) is widely used in critical care units and in respiratory insufficiencies. In addition, hyperoxia has been implicated in many diseases such as bronchopulmonary dysplasia or acute respiratory distress syndrome. Although hyperoxia is known to cause DNA base modifications and strand breaks, the DNA damage response has not been adequately investigated. We have investigated the effect of hyperoxia on DNA damage signaling and show that hyperoxia is a unique stress that activates the ataxia telangiectasia mutant (ATM)- and Rad3-related protein kinase (ATR)-dependent p53 phosphorylations (Ser6, -15, -37, and -392), phosphorylation of histone H2AX (Ser139), and phosphorylation of checkpoint kinase 1 (Chk1). In addition, we show that phosphorylation of p53 (Ser6) and histone H2AX (Ser139) depend on both ATM and ATR. We demonstrate that ATR activation precedes ATM activation in hyperoxia. Finally, we show that ATR is required for ATM activation in hyperoxia. Taken together, we report that ATR is the major DNA damage signal transducer in hyperoxia that activates ATM.", "electronicPublicationDate": "2008-03-14", "language": "eng", "dateOfCompletion": "2008-06-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://intl-ajplung.physiology.org/cgi/content/abstract/294/5/L998", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "intl-ajplung.physiology.org"}, {"url": "http://intl-ajplung.physiology.org/cgi/content/full/294/5/L998", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "intl-ajplung.physiology.org"}, {"url": "http://dx.doi.org/10.1152/ajplung.00004.2008", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-05-01", "journal": {"medlineAbbreviation": "Am J Physiol Lung Cell Mol Physiol", "isoabbreviation": "Am. J. Physiol. Lung Cell Mol. Physiol.", "title": "American journal of physiology. Lung cellular and molecular physiology", "issn": "1040-0605", "nlmid": "100901229", "essn": "1522-1504"}, "monthOfPublication": 5, "volume": "294", "yearOfPublication": 2008, "journalIssueId": 1525624, "issue": "5", "dateOfPublication": "2008 May"}}, "25448276": {"pubYear": "2015", "dateOfCreation": "2015-01-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Chemical Warfare Agents"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}, {"registryNumber": "T8KEC9FH9P", "name": "Mustard Gas"}]}, "authorString": "Jowsey PA, Blain PG.", "affiliation": "Medical Toxicology Centre Wolfson Unit, Newcastle University, Newcastle upon Tyne NE2 4AA, UK. Electronic address: p.a.jowsey@ncl.ac.uk.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25448276", "inEPMC": "N", "authorList": {"author": [{"firstName": "Paul A", "lastName": "Jowsey", "affiliation": "Medical Toxicology Centre Wolfson Unit, Newcastle University, Newcastle upon Tyne NE2 4AA, UK. Electronic address: p.a.jowsey@ncl.ac.uk.", "authorId": {"type": "ORCID", "value": "0000-0003-2867-6857"}, "fullName": "Jowsey PA", "initials": "PA"}, {"affiliation": "Medical Toxicology Centre Wolfson Unit, Newcastle University, Newcastle upon Tyne NE2 4AA, UK.", "fullName": "Blain PG", "initials": "PG", "firstName": "Peter G", "lastName": "Blain"}]}, "title": "Checkpoint kinase 1 is activated and promotes cell survival after exposure to sulphur mustard.", "citedByCount": 1, "source": "MED", "pmid": "25448276", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2867-6857"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N"}, {"descriptorName": "Mustard Gas", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chemical Warfare Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Enzyme Activation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-11-18", "doi": "10.1016/j.toxlet.2014.11.013", "isOpenAccess": "N", "pageInfo": "413-421", "hasDbCrossReferences": "N", "abstractText": "Sulphur mustard (SM) is a vesicating agent that has been used several times as a weapon during military conflict and continues to pose a threat as an agent of warfare/terrorism. After exposure, SM exerts both acute and delayed long-term toxic effects principally to the skin, eyes and respiratory system. These effects are thought to be mediated, at least in part, by direct interaction of SM with DNA, forming a myriad of DNA lesions and initiating effects on cell cycle and cell death pathways. Previous studies have demonstrated that a complex network of cellular DNA damage response pathways are utilised in cells exposed to SM, consistent with SM causing multiple forms of DNA damage. The present study focused on the role of Checkpoint kinase 1 (CHK1), a protein with putative roles in homologous recombination repair, p53 activation and the initiation of cell cycle checkpoints after certain forms of DNA damage. The data showed that SM caused robust activation of CHK1, monitored by multi-site phosphorylation analysis and that this activation was dependent on the ataxia telangiectasia and Rad3-related (ATR) protein kinase. Furthermore, specific inhibition of CHK1 increased SM toxicity in multiple human cell lines, with concomitant increases in markers of apoptosis, DNA damage and mitosis. Finally, the effect of CHK1 inhibition on SM toxicity was much more marked in cells with non-functional p53.", "electronicPublicationDate": "2014-11-18", "language": "eng", "dateOfCompletion": "2015-04-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.toxlet.2014.11.013", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Toxicol Lett", "isoabbreviation": "Toxicol. Lett.", "title": "Toxicology letters", "issn": "0378-4274", "nlmid": "7709027", "essn": "1879-3169"}, "monthOfPublication": 1, "volume": "232", "yearOfPublication": 2015, "journalIssueId": 2241895, "issue": "2", "dateOfPublication": "2015 Jan"}}, "17879369": {"pubYear": "2007", "dateOfCreation": "2007-10-09", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "ATR protein, human"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}]}, "authorString": "Lewis KA, Bakkum-Gamez J, Loewen R, French AJ, Thibodeau SN, Cliby WA.", "affiliation": "Department of Gynecologic Oncology, Mayo Clinic, Rochester, MN 55905, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K22 CA87579"}]}, "hasPDF": "N", "id": "17879369", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lewis", "fullName": "Lewis KA", "firstName": "Kriste A", "initials": "KA"}, {"lastName": "Bakkum-Gamez", "fullName": "Bakkum-Gamez J", "firstName": "Jamie", "initials": "J"}, {"lastName": "Loewen", "fullName": "Loewen R", "firstName": "Ralitsa", "initials": "R"}, {"lastName": "French", "fullName": "French AJ", "firstName": "Amy J", "initials": "AJ"}, {"lastName": "Thibodeau", "fullName": "Thibodeau SN", "firstName": "Stephen N", "initials": "SN"}, {"lastName": "Cliby", "fullName": "Cliby WA", "firstName": "William A", "initials": "WA"}]}, "title": "Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers.", "citedByCount": 11, "source": "MED", "pmid": "17879369", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Colonic Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Microsatellite Repeats", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Microsatellite Instability", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-12-01", "doi": "10.1002/gcc.20486", "isOpenAccess": "N", "pageInfo": "1061-1068", "hasDbCrossReferences": "Y", "abstractText": "In response to certain types of DNA damage, ataxia telangiectasia and rad3-related (ATR) phosphorylates checkpoint kinase 1 (CHEK1) resulting in cell cycle arrest and subsequent DNA repair. ATR and CHEK1 contain mononucleotide microsatellite repeat regions, which are mutational targets in tumors with defective mismatch repair (MMR). This study examined the frequency of such mutations in colon cancers and their impact on biologic behavior. Screening for ATR mutations in 48 tumors was performed using denaturing high-performance liquid chromatography (DHPLC) and confirmed with sequencing analysis. The CHEK1 exon 7 A(9) region was sequenced in 20 of the 27 (74%) tumors with high frequency of microsatellite instability (MSI-H). Univariate and multivariate analyses were used to examine associations with clinical outcomes. Frequent mutations in MSI-H colon cancers were identified within the ATR (37%)/CHEK1(5%) damage response pathway. Stage and MSI status both independently predicted overall survival (OS) and disease-free survival (DFS). ATR status was not associated with stage, but was associated with a trend toward improved DFS: 0/9 cancers recurred in MSI-H cases harboring ATR mutations vs. 4/18 recurrences in MSI-H cases without ATR mutations. This suggests that ATR mutations may affect clinical behavior and response to therapy in MSI-H colon cancers.", "language": "eng", "dateOfCompletion": "2007-12-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/gcc.20486", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-12-01", "journal": {"medlineAbbreviation": "Genes Chromosomes Cancer", "isoabbreviation": "Genes Chromosomes Cancer", "title": "Genes, chromosomes & cancer", "issn": "1045-2257", "nlmid": "9007329", "essn": "1098-2264"}, "monthOfPublication": 12, "volume": "46", "yearOfPublication": 2007, "journalIssueId": 1473650, "issue": "12", "dateOfPublication": "2007 Dec"}}, "21383502": {"pubYear": "2011", "dateOfCreation": "2011-04-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 3.1.3.48", "name": "cdc25 Phosphatases"}, {"registryNumber": "EC 3.1.3.48", "name": "CDC25A protein, human"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}]}, "authorString": "Connell CM, Shibata A, Tookman LA, Archibald KM, Flak MB, Pirlo KJ, Lockley M, Wheatley SP, McNeish IA.", "affiliation": "Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601891"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G1002009"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "G0601891"}]}, "hasPDF": "Y", "id": "21383502", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.", "fullName": "Connell CM", "initials": "CM", "firstName": "Claire M", "lastName": "Connell"}, {"lastName": "Shibata", "fullName": "Shibata A", "firstName": "Atsushi", "initials": "A"}, {"lastName": "Tookman", "fullName": "Tookman LA", "firstName": "Laura A", "initials": "LA"}, {"lastName": "Archibald", "fullName": "Archibald KM", "firstName": "Kyra M", "initials": "KM"}, {"lastName": "Flak", "fullName": "Flak MB", "firstName": "Magdalena B", "initials": "MB"}, {"lastName": "Pirlo", "fullName": "Pirlo KJ", "firstName": "Katrina J", "initials": "KJ"}, {"lastName": "Lockley", "fullName": "Lockley M", "firstName": "Michelle", "initials": "M"}, {"lastName": "Wheatley", "fullName": "Wheatley SP", "firstName": "Sally P", "initials": "SP"}, {"lastName": "McNeish", "fullName": "McNeish IA", "authorId": {"type": "ORCID", "value": "0000-0002-9387-7586"}, "firstName": "Iain A", "initials": "IA"}]}, "title": "Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.", "hasSuppl": "Y", "citedByCount": 10, "source": "MED", "pmid": "21383502", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9387-7586"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Nude", "majorTopic_YN": "N"}, {"descriptorName": "Ovarian Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transplantation, Heterologous", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasm Transplantation", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "DNA Repair", "majorTopic_YN": "N"}, {"descriptorName": "DNA Replication", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Oncolytic Virotherapy", "majorTopic_YN": "Y"}, {"descriptorName": "Oncolytic Viruses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "cdc25 Phosphatases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-03-07", "doi": "10.1172/jci43976", "isOpenAccess": "N", "pageInfo": "1283-1297", "pmcid": "PMC3069766", "hasDbCrossReferences": "Y", "abstractText": "Oncolytic adenoviruses replicate selectively within and lyse malignant cells. As such, they are being developed as anticancer therapeutics. However, the sensitivity of ovarian cancers to adenovirus cytotoxicity varies greatly, even in cells of similar infectivity. Using both the adenovirus E1A-CR2 deletion mutant dl922-947 and WT adenovirus serotype 5 in a panel of human ovarian cancer cell lines that cover a 3-log range of sensitivity, we observed profound overreplication of genomic DNA only in highly sensitive cell lines. This was associated with the presence of extensive genomic DNA damage. Inhibition of ataxia telangiectasia and Rad3-related checkpoint kinase 1 (ATR-Chk1), but not ataxia telangiectasia mutated (ATM), promoted genomic DNA damage and overreplication in resistant and partially sensitive cells. This was accompanied by increased adenovirus cytotoxicity both in vitro and in vivo in tumor-bearing mice. We also demonstrated that Cdc25A was upregulated in highly sensitive ovarian cancer cell lines after adenovirus infection and was stabilized after loss of Chk1 activity. Knockdown of Cdc25A inhibited virus-induced DNA damage in highly sensitive cells and blocked the effects of Chk1 inhibition in resistant cells. Finally, inhibition of Chk1 decreased homologous recombination repair of virus-induced genomic DNA double-strand breaks. Thus, virus-induced host cell DNA damage signaling and repair are key determinants of oncolytic adenoviral activity, and promoting unscheduled DNA synthesis and/or impeding homologous recombination repair could potentiate the effects of oncolytic adenoviruses in the treatment of ovarian cancer.", "electronicPublicationDate": "2011-03-07", "language": "eng", "dateOfCompletion": "2011-06-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3069766?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3069766", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.jci.org/cgi/content/full/121/4/1283", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "www.jci.org"}, {"url": "http://www.jci.org/cgi/reprint/121/4/1283.pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "www.jci.org"}, {"url": "http://www.jci.org/cgi/content/abstract/121/4/1283", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "www.jci.org"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21383502&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21383502", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1172/JCI43976", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-02-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-04-01", "journal": {"medlineAbbreviation": "J Clin Invest", "isoabbreviation": "J. Clin. Invest.", "title": "The Journal of clinical investigation", "issn": "0021-9738", "nlmid": "7802877", "essn": "1558-8238"}, "monthOfPublication": 4, "volume": "121", "yearOfPublication": 2011, "journalIssueId": 1819483, "issue": "4", "dateOfPublication": "2011 Apr"}}, "16899408": {"pubYear": "2006", "dateOfCreation": "2006-08-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "9007-49-2", "name": "DNA"}, {"registryNumber": "0", "name": "Mutagens"}, {"registryNumber": "EC 3.4.22.-", "name": "Caspases"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "EC 3.4.22.-", "name": "Caspase 2"}, {"registryNumber": "EC 2.7.11.24", "name": "p38 Mitogen-Activated Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Proto-Oncogene Proteins c-akt"}]}, "authorString": "Roos WP, Kaina B.", "affiliation": "Department of Toxicology, University of Mainz, Obere Zahlbacher Strasse 67, D-55131 Mainz, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "16899408", "inEPMC": "N", "authorList": {"author": [{"lastName": "Roos", "fullName": "Roos WP", "authorId": {"type": "ORCID", "value": "0000-0002-0474-7414"}, "firstName": "Wynand P", "initials": "WP"}, {"lastName": "Kaina", "fullName": "Kaina B", "firstName": "Bernd", "initials": "B"}]}, "title": "DNA damage-induced cell death by apoptosis.", "citedByCount": 400, "source": "MED", "pmid": "16899408", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0474-7414"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Caspases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "p38 Mitogen-Activated Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutagens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Apoptosis", "majorTopic_YN": "Y"}, {"descriptorName": "DNA Repair", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins c-akt", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Caspase 2", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-08-08", "doi": "10.1016/j.molmed.2006.07.007", "isOpenAccess": "N", "pageInfo": "440-450", "hasDbCrossReferences": "N", "abstractText": "Following the induction of DNA damage, a prominent route of cell inactivation is apoptosis. During the last ten years, specific DNA lesions that trigger apoptosis have been identified. These include O6-methylguanine, base N-alkylations, bulky DNA adducts, DNA cross-links and DNA double-strand breaks (DSBs). Repair of these lesions are important in preventing apoptosis. An exception is O6-methylguanine-thymine lesions, which require mismatch repair for triggering apoptosis. Apoptosis induced by many chemical genotoxins is the consequence of blockage of DNA replication, which leads to collapse of replication forks and DSB formation. These DSBs are thought to be crucial downstream apoptosis-triggering lesions. DSBs are detected by ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related) proteins, which signal downstream to CHK1, CHK2 (checkpoint kinases) and p53. p53 induces transcriptional activation of pro-apoptotic factors such as FAS, PUMA and BAX. Many tumors harbor mutations in p53. There are p53 backup systems that involve CHK1 and/or CHK2-driven E2F1 activation and p73 upregulation, which in turn transcribes BAX, PUMA and NOXA. Another trigger of apoptosis upon DNA damage is the inhibition of RNA synthesis, which leads to a decline in the level of critical gene products such as MKP1 (mitogen-activated protein kinase phosphatase). This causes sustained activation of JNK (Jun kinase) and, finally, AP-1, which stimulates death-receptor activation. DNA damage-triggered signaling and execution of apoptosis is cell-type- and genotoxin-specific depending on the p53 (p63 and p73) status, death-receptor responsiveness, MAP-kinase activation and, most importantly, DNA repair capacity. Because most clinical anti-cancer drugs target DNA, increasing knowledge on DNA damage-triggered signaling leading to cell death is expected to provide new strategies for therapeutic interventions.", "electronicPublicationDate": "2006-08-08", "language": "eng", "dateOfCompletion": "2006-11-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.molmed.2006.07.007", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-09-01", "journal": {"medlineAbbreviation": "Trends Mol Med", "isoabbreviation": "Trends Mol Med", "title": "Trends in molecular medicine", "issn": "1471-4914", "nlmid": "100966035", "essn": "1471-499X"}, "monthOfPublication": 9, "volume": "12", "yearOfPublication": 2006, "journalIssueId": 1345079, "issue": "9", "dateOfPublication": "2006 Sep"}}, "19633697": {"pubYear": "2009", "dateOfCreation": "2009-09-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "ATR protein, human"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "0", "name": "Cdc5L protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}]}, "authorString": "Zhang N, Kaur R, Akhter S, Legerski RJ.", "affiliation": "Department of Genetics, The University of Texas MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA16672"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA097175"}]}, "hasPDF": "Y", "id": "19633697", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zhang", "fullName": "Zhang N", "firstName": "Nianxiang", "initials": "N"}, {"lastName": "Kaur", "fullName": "Kaur R", "firstName": "Ramandeep", "initials": "R"}, {"lastName": "Akhter", "fullName": "Akhter S", "firstName": "Shamima", "initials": "S"}, {"lastName": "Legerski", "fullName": "Legerski RJ", "firstName": "Randy J", "initials": "RJ"}]}, "title": "Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint.", "hasSuppl": "Y", "citedByCount": 31, "source": "MED", "pmid": "19633697", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N"}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "S Phase", "majorTopic_YN": "Y"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["INTACT", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-07-24", "doi": "10.1038/embor.2009.122", "isOpenAccess": "N", "pageInfo": "1029-1035", "pmcid": "PMC2750050", "hasDbCrossReferences": "Y", "abstractText": "Cell division cycle 5-like protein (Cdc5L) is a core component of the putative E3 ubiquitin ligase complex containing Prp19/Pso4, Plrg1 and Spf27. This complex has been shown to have a role in pre-messenger RNA splicing from yeast to humans; however, more recent studies have described a function for this complex in the cellular response to DNA damage. Here, we show that Cdc5L interacts physically with the cell-cycle checkpoint kinase ataxia-telangiectasia and Rad3-related (ATR). Depletion of Cdc5L by RNA-mediated interference methods results in a defective S-phase cell-cycle checkpoint and cellular sensitivity in response to replication-fork blocking agents. Furthermore, we show that Cdc5L is required for the activation of downstream effectors or mediators of ATR checkpoint function such as checkpoint kinase 1 (Chk1), cell cycle checkpoint protein Rad 17 (Rad17) and Fanconi anaemia complementation group D2 protein (FancD2). In addition, we have mapped the ATR-binding region in Cdc5L and show that a deletion mutant that is unable to interact with ATR is defective in the rescue of the checkpoint deficiency in Cdc5L-depleted cells. These findings show a new function for Cdc5L in the regulation of the ATR-mediated cell-cycle checkpoint in response to genotoxic agents.", "electronicPublicationDate": "2009-07-24", "language": "eng", "dateOfCompletion": "2009-11-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2750050?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2750050", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19633697&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19633697", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/embor.2009.122", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-09-01", "journal": {"medlineAbbreviation": "EMBO Rep", "isoabbreviation": "EMBO Rep.", "title": "EMBO reports", "issn": "1469-221X", "nlmid": "100963049", "essn": "1469-3178"}, "monthOfPublication": 9, "volume": "10", "yearOfPublication": 2009, "journalIssueId": 1646939, "issue": "9", "dateOfPublication": "2009 Sep"}}, "25962492": {"pubYear": "2015", "dateOfCreation": "2015-05-13", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.3.48", "name": "PTPN6 protein, human"}, {"registryNumber": "EC 3.1.3.48", "name": "Protein Tyrosine Phosphatase, Non-Receptor Type 6"}, {"registryNumber": "EC 2.7.1.11", "name": "checkpoint kinase 2"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "CHEK2 protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}]}, "authorString": "Pan X, Mou J, Liu S, Sun Z, Meng R, Zhou Z, Wu G, Peng G.", "affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25962492", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Pan X", "initials": "X", "firstName": "Xiaofen", "lastName": "Pan"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Mou J", "initials": "J", "firstName": "Jingjing", "lastName": "Mou"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Liu S", "initials": "S", "firstName": "Sha", "lastName": "Liu"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Sun Z", "initials": "Z", "firstName": "Ziyi", "lastName": "Sun"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Meng R", "initials": "R", "firstName": "Rui", "lastName": "Meng"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Zhou Z", "initials": "Z", "firstName": "Zhenwei", "lastName": "Zhou"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Wu G", "initials": "G", "firstName": "Gang", "lastName": "Wu"}, {"affiliation": "Cancer Center, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.", "fullName": "Peng G", "initials": "G", "firstName": "Gang", "lastName": "Peng"}]}, "title": "SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.", "citedByCount": 0, "source": "MED", "pmid": "25962492", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Nasopharyngeal Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "RT", "qualifierName": "radiotherapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Radiation, Ionizing", "majorTopic_YN": "N"}, {"descriptorName": "Radiation Tolerance", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Breaks, Double-Stranded", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Tyrosine Phosphatase, Non-Receptor Type 6", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Checkpoint Kinase 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-04-28", "doi": "10.3892/or.2015.3939", "isOpenAccess": "N", "pageInfo": "2999-3005", "hasDbCrossReferences": "Y", "abstractText": "The present study aimed to investigate the influence of SHP-1 on the radioresistance of the nasopharyngeal carcinoma (NPC) cell line CNE-2 and the relevant underlying mechanisms. The human NPC cell line CNE-2 was transfected with a lentivirus that contained the SHP-1 gene or a nonsense sequence (referred to as LP-H1802Lv201 and LP-NegLv201 cells, respectively). Cells were irradiated with different ionizing radiation (IR) doses. Cell survival, DNA double-strand breaks (DSBs), apoptosis, cell cycle distribution, and the expression of related proteins were assessed using colony formation assay, immunofluorescent assays (IFAs), flow cytometry (FCM) and western blot analyses, respectively. Compared with the control (CNE-2 cells) and LP-NegLv201 cells, LP-H1802Lv201 cells were more resistant to IR. IFAs showed that IR caused less histone H2AX phosphorylation (\u03b3H2AX) and RAD51 foci in the LP-H1802Lv201 cells. Compared with the control and LP-NegLv201 cells, LP-H1802Lv201 cells showed increased S phase arrest. After IR, the apoptotic rate of the LP-H1802Lv201 cells was lower in contrast to the control and LP-NegLv201 cells. Western blot analyses showed that IR increased the phosphorylation of ataxia telangiectasia mutated (ATM) kinase, checkpoint kinase 2 (CHK2), ataxia telangiectasia and Rad3-related (ATR) protein, checkpoint kinase 1 (CHK1) and p53. In LP-H1802Lv201 cells, the phosphorylation levels of ATM and CHK2 were significantly increased while the p53 phosphorylation level was decreased compared to these levels in the control and LP-NegLv201 cells. Phosphorylation of ATR and CHK1 did not show significant differences in the three cell groups. Overexpression of SHP-1 in the CNE-2 cells led to radioresistance and the radioresistance was related to enhanced DNA DSB repair, increased S phase arrest and decreased cell apoptosis.", "electronicPublicationDate": "2015-04-28", "language": "eng", "dateOfCompletion": "2016-02-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3892/or.2015.3939", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"medlineAbbreviation": "Oncol Rep", "isoabbreviation": "Oncol. Rep.", "title": "Oncology reports", "issn": "1021-335X", "nlmid": "9422756", "essn": "1791-2431"}, "monthOfPublication": 6, "volume": "33", "yearOfPublication": 2015, "journalIssueId": 2283341, "issue": "6", "dateOfPublication": "2015 Jun"}}, "22402442": {"pubYear": "2012", "dateOfCreation": "2012-05-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "cyclin B1"}, {"registryNumber": "0", "name": "Rad18 protein, mouse"}, {"registryNumber": "0", "name": "DNA, Single-Stranded"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "EC 2.7.11.22", "name": "CDC2 Protein Kinase"}, {"registryNumber": "0", "name": "Ccnb1 protein, mouse"}]}, "authorString": "Wigan M, Pinder A, Giles N, Pavey S, Burgess A, Wong S, Sturm RA, Gabrielli B.", "affiliation": "University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22402442", "inEPMC": "N", "authorList": {"author": [{"lastName": "Wigan", "fullName": "Wigan M", "firstName": "Matthew", "initials": "M"}, {"lastName": "Pinder", "fullName": "Pinder A", "firstName": "Alex", "initials": "A"}, {"lastName": "Giles", "fullName": "Giles N", "firstName": "Nichole", "initials": "N"}, {"lastName": "Pavey", "fullName": "Pavey S", "authorId": {"type": "ORCID", "value": "0000-0003-4519-5932"}, "firstName": "Sandra", "initials": "S"}, {"lastName": "Burgess", "fullName": "Burgess A", "authorId": {"type": "ORCID", "value": "0000-0003-4536-9226"}, "firstName": "Andrew", "initials": "A"}, {"lastName": "Wong", "fullName": "Wong S", "firstName": "Shushyan", "initials": "S"}, {"lastName": "Sturm", "fullName": "Sturm RA", "firstName": "Rick A", "initials": "RA"}, {"lastName": "Gabrielli", "fullName": "Gabrielli B", "firstName": "Brian", "initials": "B"}]}, "title": "A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma.", "citedByCount": 4, "source": "MED", "pmid": "22402442", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4519-5932"}, {"type": "ORCID", "value": "0000-0003-4536-9226"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Epidermis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Melanoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Skin Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "CDC2 Protein Kinase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA, Single-Stranded", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ultraviolet Rays", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "G1 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "G2 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "S Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Replication", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin B1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-08", "doi": "10.1038/jid.2012.41", "isOpenAccess": "N", "pageInfo": "1681-1688", "hasDbCrossReferences": "N", "abstractText": "UVR is a major environmental risk factor for the development of melanoma. Here we describe a coupled DNA-damage tolerance (DDT) mechanism and G2-phase cell cycle checkpoint induced in response to suberythemal doses of UVR that is commonly defective in melanomas. This coupled response is triggered by a small number of UVR-induced DNA lesions incurred during G1 phase that are not repaired by nucleotide excision repair (NER). These lesions are detected during S phase, but rather than stalling replication, they trigger the DDT-dependent formation of single-stranded DNA (ssDNA) gaps. The ssDNA attracts replication protein A (RPA), which initiates ATR-Chk1 (ataxia telangiectasia and Rad3-related/checkpoint kinase 1) G2-phase checkpoint signaling, and colocalizes with components of the RAD18 and RAD51 postreplication repair pathways. We demonstrate that depletion of RAD18 delays both the resolution of RPA foci and exit from the G2-phase arrest, indicating the involvement of RAD18-dependent postreplication repair in ssDNA gap repair during G2 phase. Moreover, the presence of RAD51 and BRCA1 suggests that an error-free mechanism may also contribute to repair. Loss of the UVR-induced G2-phase checkpoint results in increased UVR signature mutations after exposure to suberythemal UVR. We propose that defects in the UVR-induced G2-phase checkpoint and repair mechanism are likely to contribute to melanoma development.", "electronicPublicationDate": "2012-03-08", "language": "eng", "dateOfCompletion": "2012-07-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/jid.2012.41", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-06-01", "journal": {"medlineAbbreviation": "J Invest Dermatol", "isoabbreviation": "J. Invest. Dermatol.", "title": "The Journal of investigative dermatology", "issn": "0022-202X", "nlmid": "0426720", "essn": "1523-1747"}, "monthOfPublication": 6, "volume": "132", "yearOfPublication": 2012, "journalIssueId": 1932378, "issue": "6", "dateOfPublication": "2012 Jun"}}, "24730569": {"pubYear": "2014", "dateOfCreation": "2014-06-16", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.3.16", "name": "protein phosphatase 2C"}, {"registryNumber": "0", "name": "H2AFX protein, human"}, {"registryNumber": "0", "name": "Histones"}, {"registryNumber": "581-05-5", "name": "alpha-MSH"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Receptor, Melanocortin, Type 1"}, {"registryNumber": "156533-34-5", "name": "XPC protein, human"}, {"registryNumber": "EC 3.1.3.16", "name": "Phosphoprotein Phosphatases"}, {"registryNumber": "EC 2.7.11.1", "name": "ATM protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}]}, "authorString": "Swope V, Alexander C, Starner R, Schwemberger S, Babcock G, Abdel-Malek ZA.", "affiliation": "Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01ES009110"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "1R01ES017561"}]}, "hasPDF": "N", "id": "24730569", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA.", "fullName": "Swope V", "initials": "V", "firstName": "Viki", "lastName": "Swope"}, {"lastName": "Alexander", "fullName": "Alexander C", "firstName": "Christina", "initials": "C"}, {"lastName": "Starner", "fullName": "Starner R", "firstName": "Renny", "initials": "R"}, {"lastName": "Schwemberger", "fullName": "Schwemberger S", "firstName": "Sandy", "initials": "S"}, {"lastName": "Babcock", "fullName": "Babcock G", "firstName": "George", "initials": "G"}, {"lastName": "Abdel-Malek", "fullName": "Abdel-Malek ZA", "firstName": "Zalfa A", "initials": "ZA"}]}, "title": "Significance of the melanocortin 1 receptor in the DNA damage response of human melanocytes to ultraviolet radiation.", "citedByCount": 6, "source": "MED", "pmid": "24730569", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Melanocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Genomic Instability", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "alpha-MSH", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptor, Melanocortin, Type 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Histones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ultraviolet Rays", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Repair", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Phosphoprotein Phosphatases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-05-12", "doi": "10.1111/pcmr.12252", "isOpenAccess": "N", "pageInfo": "601-610", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Ultraviolet radiation", "Dna Damage Response", "Dna Photoproducts", "\u0391-melanocortin", "Melanocytes, Melanocortin 1 Receptor"]}, "abstractText": "Activation of the melanocortin 1 receptor (MC1R) by \u03b1-melanocortin (\u03b1-MSH) stimulates eumelanin synthesis and enhances repair of ultraviolet radiation (UV)-induced DNA damage. We report on the DNA damage response (DDR) of human melanocytes to UV and its enhancement by \u03b1-MSH. \u03b1-MSH up-regulated the levels of XPC, the enzyme that recognizes DNA damage sites, enhanced the UV-induced phosphorylation of the DNA damage sensors ataxia telangiectasia and Rad3-related (ATR) and ataxia telangiectasia mutated (ATM) and their respect-ive substrates checkpoint kinases 1 and 2, and increased phosphorylated H2AX (\u03b3H2AX) formation. These effects required functional MC1R and were absent in melanocytes expressing loss of function (LOF) MC1R. The levels of wild-type p53-induced phosphatase 1 (Wip1), which dephosphorylates \u03b3H2AX, correlated inversely with \u03b3H2AX. We propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and LOF of MC1R compromises the DDR and genomic stability of melanocytes.", "electronicPublicationDate": "2014-05-12", "language": "eng", "dateOfCompletion": "2015-02-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/pcmr.12252", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-07-01", "journal": {"medlineAbbreviation": "Pigment Cell Melanoma Res", "isoabbreviation": "Pigment Cell Melanoma Res", "title": "Pigment cell & melanoma research", "issn": "1755-1471", "nlmid": "101318927", "essn": "1755-148X"}, "monthOfPublication": 7, "volume": "27", "yearOfPublication": 2014, "journalIssueId": 2171226, "issue": "4", "dateOfPublication": "2014 Jul"}}, "25812484": {"pubYear": "2015", "dateOfCreation": "2015-03-31", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "cyclin-dependent kinase Inhibitor p21"}, {"registryNumber": "0", "name": "cyclin B1"}, {"registryNumber": "0", "name": "Quinazolines"}, {"registryNumber": "0", "name": "Stilbenes"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "0", "name": "CDKN1A protein, human"}, {"registryNumber": "0", "name": "TP53 protein, human"}, {"registryNumber": "EC 3.1.3.48", "name": "cdc25 Phosphatases"}, {"registryNumber": "EC 3.1.3.48", "name": "CDC25C protein, human"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.22", "name": "Cyclin-Dependent Kinases"}, {"registryNumber": "EC 2.7.1.11", "name": "checkpoint kinase 2"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "Q369O8926L", "name": "resveratrol"}, {"registryNumber": "EC 2.7.11.1", "name": "ATM protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "CHEK2 protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}, {"registryNumber": "0", "name": "CDK1 protein, human"}]}, "authorString": "Kim JY, Choi HE, Lee HH, Shin JS, Shin DH, Choi JH, Lee YS, Lee KT.", "affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25812484", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Kim JY", "initials": "JY", "firstName": "Jong-Yun", "lastName": "Kim"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Choi HE", "initials": "HE", "firstName": "Hye-Eun", "lastName": "Choi"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Lee HH", "initials": "HH", "firstName": "Hwi-Ho", "lastName": "Lee"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Shin JS", "initials": "JS", "firstName": "Ji-Sun", "lastName": "Shin"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Shin DH", "initials": "DH", "firstName": "Dong-Hyun", "lastName": "Shin"}, {"affiliation": "Department of Life and Nanopharmaceutical Science, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Choi JH", "initials": "JH", "firstName": "Jung-Hye", "lastName": "Choi"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Lee YS", "initials": "YS", "firstName": "Yong Sup", "lastName": "Lee"}, {"affiliation": "Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Hoegi-Dong, Seoul\u00a0130-701, Republic of Korea.", "fullName": "Lee KT", "initials": "KT", "firstName": "Kyung-Tae", "lastName": "Lee"}]}, "title": "Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G\u2082/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.", "citedByCount": 1, "source": "MED", "pmid": "25812484", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carcinoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Stilbenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Quinazolines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin-Dependent Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Division", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "G2 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Uterine Cervical Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin-Dependent Kinase Inhibitor p21", "majorTopic_YN": "N"}, {"descriptorName": "cdc25 Phosphatases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin B1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Checkpoint Kinase 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-03-20", "doi": "10.3892/or.2015.3871", "isOpenAccess": "N", "pageInfo": "2639-2647", "hasDbCrossReferences": "Y", "abstractText": "Styrylquinazolines are synthetic analogues of resveratrol and have been suggested to cause anti-inflammatory activity by modulating prostaglandin E\u2082 (PGE\u2082) production. In the present study, we evaluated cytotoxic effects of various styrylquinazoline derivatives and found that (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline (8-ADEQ) most potently inhibited the proliferation of the human cervical carcinoma HeLa cells. Exploring the growth-inhibitory mechanisms of 8-ADEQ, we found that it causes a cell cycle arrest at the G\u2082/M phase by DNA flow cytometric analysis, which was accompanied by upregulation of cyclin B1 expression and cyclin-dependent protein kinase 1 (Cdk1) phosphorylation. In addition, we observed that 8-ADEQ causes phosphorylation of the cell division cycle 25C (Cdc25C) protein through the activation of checkpoint kinases 1 (Chk1) and Chk2, which in turn were activated via ataxia telangiectasia mutated (ATM)/ataxia telangiectasia-Rad3-related (ATR) kinases in response to the DNA damage. Furthermore, ATM/ATR inhibitor caffeine, p53- or ATM/ATR-specific siRNA significantly attenuated 8-ADEQ-induced G\u2082/M arrest. These results suggest that the 8-ADEQ inhibits the proliferation of human cervical cancer HeLa cells by DNA damage-mediated G\u2082/M cell cycle arrest. 8-ADEQ\u2011induced G\u2082/M arrest is mediated by the activation of both Chk1/2-Cdc25 and p53-p21CIP1/WAF1 via ATM/ATR pathway, and indicates that 8-ADEQ appears to have potential in the treatment of cervical cancer.", "electronicPublicationDate": "2015-03-20", "language": "eng", "dateOfCompletion": "2015-12-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3892/or.2015.3871", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "Oncol Rep", "isoabbreviation": "Oncol. Rep.", "title": "Oncology reports", "issn": "1021-335X", "nlmid": "9422756", "essn": "1791-2431"}, "monthOfPublication": 5, "volume": "33", "yearOfPublication": 2015, "journalIssueId": 2268590, "issue": "5", "dateOfPublication": "2015 May"}}, "17687332": {"pubYear": "2007", "dateOfCreation": "2007-08-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "Atr protein, mouse"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "Telomeric Repeat Binding Protein 2"}, {"registryNumber": "0", "name": "POT1 protein, mouse"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "ataxia telangiectasia mutated protein"}]}, "authorString": "Denchi EL, de Lange T.", "affiliation": "Laboratory for Cell Biology and Genetics, The Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "hasPDF": "N", "id": "17687332", "inEPMC": "N", "authorList": {"author": [{"lastName": "Denchi", "fullName": "Denchi EL", "firstName": "Eros Lazzerini", "initials": "EL"}, {"lastName": "de Lange", "fullName": "de Lange T", "firstName": "Titia", "initials": "T"}]}, "title": "Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.", "citedByCount": 280, "pageInfo": "1068-1071", "source": "MED", "pmid": "17687332", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5378-4644"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Telomere", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fibroblasts", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Telomeric Repeat Binding Protein 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Repair", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Embryo, Mammalian", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-08-08", "doi": "10.1038/nature06065", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "17728746", "reference": "Nature. 2007 Aug 30;448(7157):1001-2"}]}, "hasDbCrossReferences": "Y", "abstractText": "When telomeres are rendered dysfunctional through replicative attrition of the telomeric DNA or by inhibition of shelterin, cells show the hallmarks of ataxia telangiectasia mutated (ATM) kinase signalling. In addition, dysfunctional telomeres might induce an ATM-independent pathway, such as ataxia telangiectasia and Rad3-related (ATR) kinase signalling, as indicated by the phosphorylation of the ATR target CHK1 in senescent cells and the response of ATM-deficient cells to telomere dysfunction. However, because telomere attrition is accompanied by secondary DNA damage, it has remained unclear whether there is an ATM-independent pathway for the detection of damaged telomeres. Here we show that damaged mammalian telomeres can activate both ATM and ATR and address the mechanism by which the shelterin complex represses these two important DNA damage signalling pathways. We analysed the telomere damage response on depletion of either or both of the shelterin proteins telomeric repeat binding factor 2 (TRF2) and protection of telomeres 1 (POT1) from cells lacking ATM and/or ATR kinase signalling. The data indicate that TRF2 and POT1 act independently to repress these two DNA damage response pathways. TRF2 represses ATM, whereas POT1 prevents activation of ATR. Unexpectedly, we found that either ATM or ATR signalling is required for efficient non-homologous end-joining of dysfunctional telomeres. The results reveal how mammalian telomeres use multiple mechanisms to avoid DNA damage surveillance and provide an explanation for the induction of replicative senescence and genome instability by shortened telomeres.", "electronicPublicationDate": "2007-08-08", "language": "eng", "dateOfCompletion": "2007-09-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/nature06065", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-08-01", "journal": {"medlineAbbreviation": "Nature", "isoabbreviation": "Nature", "title": "Nature", "issn": "0028-0836", "nlmid": "0410462", "essn": "1476-4687"}, "monthOfPublication": 8, "volume": "448", "yearOfPublication": 2007, "journalIssueId": 1459398, "issue": "7157", "dateOfPublication": "2007 Aug"}}, "22266465": {"pubYear": "2012", "dateOfCreation": "2012-04-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Plant Extracts"}, {"registryNumber": "0", "name": "Reactive Oxygen Species"}]}, "authorString": "Shrotriya S, Deep G, Gu M, Kaur M, Jain AK, Inturi S, Agarwal R, Agarwal C.", "affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA91883"}, {"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "R01 AT003623"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30 CA046934"}]}, "hasPDF": "Y", "id": "22266465", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA.", "fullName": "Shrotriya S", "initials": "S", "firstName": "Sangeeta", "lastName": "Shrotriya"}, {"lastName": "Deep", "fullName": "Deep G", "firstName": "Gagan", "initials": "G"}, {"lastName": "Gu", "fullName": "Gu M", "firstName": "Mallikarjuna", "initials": "M"}, {"lastName": "Kaur", "fullName": "Kaur M", "firstName": "Manjinder", "initials": "M"}, {"lastName": "Jain", "fullName": "Jain AK", "firstName": "Anil K", "initials": "AK"}, {"lastName": "Inturi", "fullName": "Inturi S", "firstName": "Swetha", "initials": "S"}, {"lastName": "Agarwal", "fullName": "Agarwal R", "firstName": "Rajesh", "initials": "R"}, {"lastName": "Agarwal", "fullName": "Agarwal C", "firstName": "Chapla", "initials": "C"}]}, "title": "Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells.", "hasSuppl": "N", "citedByCount": 14, "source": "MED", "pmid": "22266465", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Tumor Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Nude", "majorTopic_YN": "N"}, {"descriptorName": "Vitis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Seeds", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carcinoma, Squamous Cell", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Head and Neck Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Reactive Oxygen Species", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Plant Extracts", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fluorescent Antibody Technique", "majorTopic_YN": "N"}, {"descriptorName": "Cell Division", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "G2 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-01-19", "doi": "10.1093/carcin/bgs019", "isOpenAccess": "N", "pageInfo": "848-858", "pmcid": "PMC3324440", "hasDbCrossReferences": "N", "abstractText": "Head and neck squamous cell carcinoma (HNSCC) accounts for 6% of all malignancies in USA and unfortunately the recurrence of secondary primary tumors and resistance against conventional treatments decrease the overall 5 year survival rate in HNSCC patients. Thus, additional approaches are needed to control HNSCC. Here, for the first time, employing human HNSCC Detroit 562 and FaDu cells as well as normal human epidermal keratinocytes, we investigate grape seed extract (GSE) efficacy and associated mechanism in both cell culture and nude mice xenografts. GSE selectively inhibited the growth and caused cell cycle arrest and apoptotic death in both Detroit 562 and FaDu cells by activating DNA damage checkpoint cascade, including ataxia telangiectasia mutated/ataxia telangiectasia-Rad3-related-checkpoint kinase 1/2-cell division cycle 25C as well as caspases 8, 9 and 3. Consistent with these results, GSE treatment resulted in a strong DNA damage and a decrease in the levels of DNA repair molecules breast cancer gene 1 and Rad51 and DNA repair foci. GSE-caused accumulation of intracellular reactive oxygen species was identified as a major mechanism of its effect for growth inhibition, DNA damage and apoptosis, which was remarkably reversed by antioxidant N-acetylcysteine. GSE feeding to nude mice decreased Detroit 562 and FaDu xenograft tumor growth by 67 and 65% (P < 0.001), respectively. In immunohistochemical analysis, xenografts from GSE-fed groups showed decreased proliferation but increased DNA damage and apoptosis. Together, these findings show that GSE targets both DNA damage and repair and provide mechanistic insights for its efficacy selectively against HNSCC both in cell culture and mouse xenograft, supporting its translational potential against HNSCC.", "electronicPublicationDate": "2012-01-19", "language": "eng", "dateOfCompletion": "2012-05-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3324440?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3324440", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22266465&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22266465", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/carcin/bgs019", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-11-25", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-04-01", "journal": {"medlineAbbreviation": "Carcinogenesis", "isoabbreviation": "Carcinogenesis", "title": "Carcinogenesis", "issn": "0143-3334", "nlmid": "8008055", "essn": "1460-2180"}, "monthOfPublication": 4, "volume": "33", "yearOfPublication": 2012, "journalIssueId": 1922520, "issue": "4", "dateOfPublication": "2012 Apr"}}, "21289283": {"pubYear": "2011", "dateOfCreation": "2011-03-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "MYCN protein, human"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Protein Kinase Inhibitors"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Oncogene Proteins"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}]}, "authorString": "Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, Diskin SJ, Attiyeh EF, Sennett R, Norris G, Laudenslager M, Wood AC, Mayes PA, Jagannathan J, Winter C, Mosse YP, Maris JM.", "affiliation": "Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K08 CA136979"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "U10-CA98543"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01-CA87847"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K08 CA136979-01"}]}, "hasPDF": "Y", "id": "21289283", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Cole", "fullName": "Cole KA", "firstName": "Kristina A", "initials": "KA"}, {"lastName": "Huggins", "fullName": "Huggins J", "firstName": "Jonathan", "initials": "J"}, {"lastName": "Laquaglia", "fullName": "Laquaglia M", "firstName": "Michael", "initials": "M"}, {"lastName": "Hulderman", "fullName": "Hulderman CE", "firstName": "Chase E", "initials": "CE"}, {"lastName": "Russell", "fullName": "Russell MR", "firstName": "Mike R", "initials": "MR"}, {"lastName": "Bosse", "fullName": "Bosse K", "firstName": "Kristopher", "initials": "K"}, {"lastName": "Diskin", "fullName": "Diskin SJ", "firstName": "Sharon J", "initials": "SJ"}, {"lastName": "Attiyeh", "fullName": "Attiyeh EF", "firstName": "Edward F", "initials": "EF"}, {"lastName": "Sennett", "fullName": "Sennett R", "firstName": "Rachel", "initials": "R"}, {"lastName": "Norris", "fullName": "Norris G", "firstName": "Geoffrey", "initials": "G"}, {"lastName": "Laudenslager", "fullName": "Laudenslager M", "firstName": "Marci", "initials": "M"}, {"lastName": "Wood", "fullName": "Wood AC", "firstName": "Andrew C", "initials": "AC"}, {"lastName": "Mayes", "fullName": "Mayes PA", "firstName": "Patrick A", "initials": "PA"}, {"lastName": "Jagannathan", "fullName": "Jagannathan J", "firstName": "Jayanti", "initials": "J"}, {"lastName": "Winter", "fullName": "Winter C", "firstName": "Cynthia", "initials": "C"}, {"lastName": "Mosse", "fullName": "Mosse YP", "firstName": "Yael P", "initials": "YP"}, {"lastName": "Maris", "fullName": "Maris JM", "firstName": "John M", "initials": "JM"}]}, "title": "RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.", "hasSuppl": "Y", "citedByCount": 69, "source": "MED", "pmid": "21289283", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neuroblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N"}, {"descriptorName": "Protein Kinase Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Drug Delivery Systems", "majorTopic_YN": "N"}, {"descriptorName": "Drug Evaluation, Preclinical", "majorTopic_YN": "N"}, {"descriptorName": "S Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-02-02", "doi": "10.1073/pnas.1012351108", "isOpenAccess": "N", "pageInfo": "3336-3341", "pmcid": "PMC3044382", "hasDbCrossReferences": "N", "abstractText": "Neuroblastoma is a childhood cancer that is often fatal despite intense multimodality therapy. In an effort to identify therapeutic targets for this disease, we performed a comprehensive loss-of-function screen of the protein kinome. Thirty kinases showed significant cellular cytotoxicity when depleted, with loss of the cell cycle checkpoint kinase 1 (CHK1/CHEK1) being the most potent. CHK1 mRNA expression was higher in MYC-Neuroblastoma-related (MYCN)-amplified (P < 0.0001) and high-risk (P = 0.03) tumors. Western blotting revealed that CHK1 was constitutively phosphorylated at the ataxia telangiectasia response kinase target site Ser345 and the autophosphorylation site Ser296 in neuroblastoma cell lines. This pattern was also seen in six of eight high-risk primary tumors but not in control nonneuroblastoma cell lines or in seven of eight low-risk primary tumors. Neuroblastoma cells were sensitive to the two CHK1 inhibitors SB21807 and TCS2312, with median IC(50) values of 564 nM and 548 nM, respectively. In contrast, the control lines had high micromolar IC(50) values, indicating a strong correlation between CHK1 phosphorylation and CHK1 inhibitor sensitivity (P = 0.0004). Furthermore, cell cycle analysis revealed that CHK1 inhibition in neuroblastoma cells caused apoptosis during S-phase, consistent with its role in replication fork progression. CHK1 inhibitor sensitivity correlated with total MYC(N) protein levels, and inducing MYCN in retinal pigmented epithelial cells resulted in CHK1 phosphorylation, which caused growth inhibition when inhibited. These data show the power of a functional RNAi screen to identify tractable therapeutical targets in neuroblastoma and support CHK1 inhibition strategies in this disease.", "electronicPublicationDate": "2011-02-02", "language": "eng", "dateOfCompletion": "2011-05-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3044382?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3044382", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21289283&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21289283", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pnas.org/cgi/content/full/108/8/3336", "documentStyle": "html", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/reprint/108/8/3336.pdf", "documentStyle": "pdf", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/content/abstract/108/8/3336", "documentStyle": "abs", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://dx.doi.org/10.1073/pnas.1012351108", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-02-01", "journal": {"medlineAbbreviation": "Proc Natl Acad Sci U S A", "isoabbreviation": "Proc. Natl. Acad. Sci. U.S.A.", "title": "Proceedings of the National Academy of Sciences of the United States of America", "issn": "0027-8424", "nlmid": "7505876", "essn": "1091-6490"}, "monthOfPublication": 2, "volume": "108", "yearOfPublication": 2011, "journalIssueId": 1810409, "issue": "8", "dateOfPublication": "2011 Feb"}}, "20664703": {"pubYear": "2010", "dateOfCreation": "2010-07-28", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "E2F transcription factors"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}]}, "authorString": "Ganguly A, Shields CL.", "affiliation": "Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA. ganguly@mail.med.upenn.edu", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R21CA123196-01"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA118580-01"}]}, "hasPDF": "Y", "id": "20664703", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Ganguly", "fullName": "Ganguly A", "firstName": "Arupa", "initials": "A"}, {"lastName": "Shields", "fullName": "Shields CL", "firstName": "Carol L", "initials": "CL"}]}, "title": "Differential gene expression profile of retinoblastoma compared to normal retina.", "hasSuppl": "N", "citedByCount": 38, "source": "MED", "pmid": "20664703", "abstractText": " PURPOSE: The retinoblastoma gene (RB1) is a tumor suppressor gene that was first discovered in a rare ocular pediatric tumor called retinoblastoma (RB). The RB1 gene is essential for normal progression through the cell cycle and exerts part of its function through the family of transcription factors (E2F) and many other intermediaries. In the absence of normal RB1, genomic instability and chromosomal aberrations accumulate, leading to tumor initiation, progression, and ultimately metastasis. The purpose of this report was to identify the molecular pathways that are deregulated in retinoblastoma. METHODS: We compared gene expression signatures of matched normal retinal tissue and retinoblastoma (RB) tumor tissue from six individuals, using microarray analysis followed by statistical and bioinformatic analyses. RESULTS: We identified 1,116 genes with increased expression and 837 with decreased expression in RB tumor tissue compared to matched normal retinal tissue. Functional categories of the cognate genes with the greatest statistical support were cell cycle (309 genes), cell death (437 genes), DNA replication, recombination and repair (270 genes), cellular growth and proliferation (464 genes), and cellular assembly and organization (110 genes). The list included differentially expressed retinal cone-cell-specific markers. These data indicated the predominance of cone cells in RB and support the idea that the latter group of cells may be the cells of origin for RB. CONCLUSIONS: The genes differentially expressed in RB as compared to normal retina belong mainly to DNA damage-response pathways, including, but not limited to, breast cancer associated genes (BRCA1, BRCA2), ataxia telangiectasia mutated gene (ATM), ataxia telangiectasia and Rad3 related gene(ATR), E2F, checkpoint kinase 1 (CHK1) genes. In addition, novel pathways, such as aryl hydrocarbon receptor (AHR) signaling, polo-like kinase and mitosis, purine metabolism pathways were involved. The molecules AHR, CHK1, and polo-like kinases are of particular interest because there are several currently available drugs that target these molecules. Further studies are needed to determine if targeting these pathways in RB will have therapeutic value. It is also important to evaluate the relative importance of these pathways in different cells that make up the normal retina.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Retina", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Retinoblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "Y"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Consensus Sequence", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "E2F Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-07-13", "language": "eng", "isOpenAccess": "Y", "pageInfo": "1292-1303", "pmcid": "PMC2904042", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "electronicPublicationDate": "2010-07-13", "license": "cc by", "dateOfCompletion": "2010-11-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2904042?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2904042", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20664703&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20664703", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"title": "Molecular vision", "medlineAbbreviation": "Mol Vis", "isoabbreviation": "Mol. Vis.", "nlmid": "9605351", "essn": "1090-0535"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2010, "journalIssueId": 1687844, "dateOfPublication": "2010 "}}, "22446183": {"pubYear": "2012", "dateOfCreation": "2012-04-02", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antineoplastic Agents"}, {"registryNumber": "0", "name": "Thiophenes"}, {"registryNumber": "0", "name": "Neoplasm Proteins"}, {"registryNumber": "0", "name": "Protein Kinase Inhibitors"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "0", "name": "TP53 protein, human"}, {"registryNumber": "0", "name": "3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "7BU5H4V94A", "name": "7-hydroxystaurosporine"}, {"registryNumber": "8W8T17847W", "name": "Urea"}, {"registryNumber": "H88EPA0A3N", "name": "Staurosporine"}]}, "authorString": "Schoppy DW, Brown EJ.", "affiliation": "Abramson Family Cancer Research Institute and Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.", "pubTypeList": {"pubType": ["Comment", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "F30AG034027"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "2R01AG027376"}]}, "hasPDF": "Y", "id": "22446183", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Abramson Family Cancer Research Institute and Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.", "fullName": "Schoppy DW", "initials": "DW", "firstName": "David W", "lastName": "Schoppy"}, {"lastName": "Brown", "fullName": "Brown EJ", "firstName": "Eric J", "initials": "EJ"}]}, "title": "Chk'ing p53-deficient breast cancers.", "hasSuppl": "N", "citedByCount": 3, "pageInfo": "1202-1205", "source": "MED", "pmid": "22446183", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Breast Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Urea", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AA", "qualifierName": "analogs & derivatives", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Staurosporine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AA", "qualifierName": "analogs & derivatives", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thiophenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neoplasm Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antineoplastic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinase Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Molecular Targeted Therapy", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-26", "doi": "10.1172/jci63205", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 23, "type": "Comment on", "id": "22446188", "reference": "J Clin Invest. 2012 Apr;122(4):1541-52"}]}, "pmcid": "PMC3314482", "hasDbCrossReferences": "N", "abstractText": "Loss or functional impairment of p53 occurs in many human cancers, and its absence is often associated with a poor response to conventional chemotherapy. Hence, much effort is currently devoted to developing novel treatments for p53-deficient malignancies. One approach is to target pathways that are selectively required for the survival of p53-deficient cancer cells, thus exploiting a synthetic lethal interaction. Previous studies have demonstrated that inhibition of the ataxia telangiectasia and Rad3-related (ATR) and checkpoint kinase 1 (Chk1) pathway in p53-deficient cells can induce such a synthetic lethal outcome. In this issue of the JCI, Ma et al. take these findings a step closer to the clinic by demonstrating that highly specific inhibitors of Chk1 synergize with chemotherapy to stem progression of p53-deficient triple-negative breast cancers in a xenotransplant model of this disease. Together with other recent studies, this report highlights the promise of ATR and Chk1 inhibitors in targeted cancer treatment.", "electronicPublicationDate": "2012-03-26", "language": "eng", "dateOfCompletion": "2012-07-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3314482?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3314482", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22446183&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22446183", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1172/JCI63205", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-02-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-04-01", "journal": {"medlineAbbreviation": "J Clin Invest", "isoabbreviation": "J. Clin. Invest.", "title": "The Journal of clinical investigation", "issn": "0021-9738", "nlmid": "7802877", "essn": "1558-8238"}, "monthOfPublication": 4, "volume": "122", "yearOfPublication": 2012, "journalIssueId": 1919011, "issue": "4", "dateOfPublication": "2012 Apr"}}, "19259937": {"pubYear": "2009", "dateOfCreation": "2009-05-04", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Cyclin E"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.1.11", "name": "checkpoint kinase 2"}]}, "authorString": "Wang X, Lui VC, Poon RT, Lu P, Poon RY.", "affiliation": "Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong. xqwang@hkucc.hku.hk", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "19259937", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Wang", "fullName": "Wang X", "firstName": "XiaoQi", "initials": "X"}, {"lastName": "Lui", "fullName": "Lui VC", "firstName": "Vincent C H", "initials": "VC"}, {"lastName": "Poon", "fullName": "Poon RT", "firstName": "Ronnie T P", "initials": "RT"}, {"lastName": "Lu", "fullName": "Lu P", "firstName": "Ping", "initials": "P"}, {"lastName": "Poon", "fullName": "Poon RY", "firstName": "Randy Y C", "initials": "RY"}]}, "title": "DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "19259937", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5571-6231"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Immunoprecipitation", "majorTopic_YN": "N"}, {"descriptorName": "G2 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "S Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Embryonal Carcinoma Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-03-01", "doi": "10.1634/stemcells.2008-0690", "isOpenAccess": "Y", "pageInfo": "568-576", "pmcid": "PMC2798066", "hasDbCrossReferences": "N", "abstractText": "For mouse embryonic stem (ES) cells, the importance of the S and G(2) cell cycle checkpoints for genomic integrity is increased by the absence of the G(1) checkpoint. We have investigated ionizing radiation (IR)-mediated cell cycle checkpoints in undifferentiated and retinoic acid-differentiated human embryonal carcinoma (EC) cells. Like mouse ES cells, human EC cells did not undergo G(1) arrest after IR but displayed a prominent S-phase delay followed by a G(2)-phase delay. In contrast, although differentiated EC cells also failed to arrest at G(1)-phase after IR, they quickly exited S-phase and arrested in G(2)-phase. In differentiated EC cells, the G(2)-M-phase cyclin B1/CDC2 complex was upregulated after IR, but the G(1)-S-phase cyclin E and the cyclin E/CDK2 complex were expressed at constitutively low levels, which could be an important factor distinguishing DNA damage responses between undifferentiated and differentiated EC cells. S-phase arrest and expression of p21 could be inhibited by 7-hydroxystaurosporine, suggesting that the ataxia-telangiectasia and Rad-3-related-checkpoint kinase 1 (ATR-CHK1), and p21 pathways might play a role in the IR-mediated S-phase checkpoint in EC cells. IR-mediated phosphorylation of ataxia-telangiectasia mutated, (CHK1), and checkpoint kinase 2 were distinctly higher in undifferentiated EC cells compared with differentiated EC cells. Combined with the prominent S and G(2) checkpoints and a more efficient DNA damage repair system, these mechanisms operate together in the maintenance of genome stability for EC cells.", "language": "eng", "license": "cc by", "dateOfCompletion": "2009-08-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2798066?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2798066", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19259937", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://intl-stemcells.alphamedpress.org/cgi/content/abstract/27/3/568", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "intl-stemcells.alphamedpress.org"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19259937&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://intl-stemcells.alphamedpress.org/cgi/content/full/27/3/568", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "intl-stemcells.alphamedpress.org"}, {"url": "http://intl-stemcells.alphamedpress.org/cgi/reprint/27/3/568.pdf", "documentStyle": "pdf", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "intl-stemcells.alphamedpress.org"}, {"url": "http://dx.doi.org/10.1634/stemcells.2008-0690", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-03-01", "journal": {"medlineAbbreviation": "Stem Cells", "isoabbreviation": "Stem Cells", "title": "Stem cells (Dayton, Ohio)", "issn": "1066-5099", "nlmid": "9304532", "essn": "1549-4918"}, "monthOfPublication": 3, "volume": "27", "yearOfPublication": 2009, "journalIssueId": 1601919, "issue": "3", "dateOfPublication": "2009 Mar"}}, "23615744": {"pubYear": "2013", "dateOfCreation": "2013-06-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Recombinant Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "147336-22-9", "name": "Green Fluorescent Proteins"}]}, "authorString": "Lee KH, Onitsuka M, Honda K, Ohtake H, Omasa T.", "affiliation": "Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23615744", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.", "fullName": "Lee KH", "initials": "KH", "firstName": "Kyoung Ho", "lastName": "Lee"}, {"lastName": "Onitsuka", "fullName": "Onitsuka M", "firstName": "Masayoshi", "initials": "M"}, {"lastName": "Honda", "fullName": "Honda K", "firstName": "Kohsuke", "initials": "K"}, {"lastName": "Ohtake", "fullName": "Ohtake H", "firstName": "Hisao", "initials": "H"}, {"lastName": "Omasa", "fullName": "Omasa T", "firstName": "Takeshi", "initials": "T"}]}, "title": "Rapid construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering.", "citedByCount": 4, "source": "MED", "pmid": "23615744", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "CHO Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Cricetulus", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Green Fluorescent Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Recombinant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Engineering", "majorTopic_YN": "Y"}, {"descriptorName": "Sequence Analysis, DNA", "majorTopic_YN": "N"}, {"descriptorName": "Biotechnology", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "Gene Silencing", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Reporter", "majorTopic_YN": "N"}, {"descriptorName": "Transgenes", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle Checkpoints", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-25", "doi": "10.1007/s00253-013-4923-9", "isOpenAccess": "N", "pageInfo": "5731-5741", "hasDbCrossReferences": "Y", "abstractText": "The process of establishing high-producing cell lines for the manufacture of therapeutic proteins is usually both time-consuming and laborious due to the low probability of obtaining high-producing clones from a pool of transfected cells and slow cell growth under the strong selective pressure of screening to identify high-producing clones. We present a novel method to rapidly generate more high-producing cells by accelerating transgene amplification. A small interfering RNA (siRNA) expression vector against ataxia telangiectasia and Rad3 related (ATR), a cell cycle checkpoint kinase, was transfected into Chinese hamster ovary (CHO) cells. The influences of ATR downregulation on gene amplification and the productivity were investigated in CHO cells producing green fluorescent protein (GFP) and secreting monoclonal antibody (mAb). The ATR-downregulated cells showed up to a 6-fold higher ratio of GFP-positive cells than that of the control cell pool. Moreover, the downregulated mAb-producing cells had about a 4-fold higher specific production rate and a 3-fold higher volumetric productivity as compared with the mock cells. ATR-downregulated cells showed a much faster increase in transgene copy numbers during the gene amplification process via methotrexate (MTX) treatment in both GFP- and mAb-producing cells. Our results suggest that a pool of high-producing cells can be more rapidly generated by ATR downregulation as compared with conventional gene amplification by MTX treatment. This novel method may be a promising approach to reduce time and labor in the process of cell line development.", "electronicPublicationDate": "2013-04-25", "language": "eng", "dateOfCompletion": "2013-12-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00253-013-4923-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "Appl Microbiol Biotechnol", "isoabbreviation": "Appl. Microbiol. Biotechnol.", "title": "Applied microbiology and biotechnology", "issn": "0175-7598", "nlmid": "8406612", "essn": "1432-0614"}, "monthOfPublication": 7, "volume": "97", "yearOfPublication": 2013, "journalIssueId": 2049274, "issue": "13", "dateOfPublication": "2013 Jul"}}, "15175264": {"pubYear": "2004", "dateOfCreation": "2004-06-03", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "ATR protein, human"}, {"registryNumber": "0", "name": "H2AFX protein, human"}, {"registryNumber": "58-08-2", "name": "Caffeine"}, {"registryNumber": "9007-49-2", "name": "DNA"}, {"registryNumber": "0", "name": "Enzyme Inhibitors"}, {"registryNumber": "70-25-7", "name": "Methylnitronitrosoguanidine"}, {"registryNumber": "0", "name": "Histones"}, {"registryNumber": "0", "name": "Protein Kinase Inhibitors"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "62996-74-1", "name": "Staurosporine"}, {"registryNumber": "0", "name": "RPA1 protein, human"}, {"registryNumber": "0", "name": "Replication Protein A"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "ataxia telangiectasia mutated protein"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "7BU5H4V94A", "name": "7-hydroxystaurosporine"}]}, "authorString": "Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J.", "affiliation": "Institute of Molecular Cancer Research, University of Zurich, CH-8008 Zurich.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "15175264", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Stojic", "fullName": "Stojic L", "firstName": "Lovorka", "initials": "L"}, {"lastName": "Mojas", "fullName": "Mojas N", "firstName": "Nina", "initials": "N"}, {"lastName": "Cejka", "fullName": "Cejka P", "firstName": "Petr", "initials": "P"}, {"lastName": "Di Pietro", "fullName": "Di Pietro M", "firstName": "Massimiliano", "initials": "M"}, {"lastName": "Ferrari", "fullName": "Ferrari S", "authorId": {"type": "ORCID", "value": "0000-0002-6607-215X"}, "firstName": "Stefano", "initials": "S"}, {"lastName": "Marra", "fullName": "Marra G", "firstName": "Giancarlo", "initials": "G"}, {"lastName": "Jiricny", "fullName": "Jiricny J", "firstName": "Josef", "initials": "J"}]}, "title": "Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.", "hasSuppl": "N", "citedByCount": 115, "source": "MED", "pmid": "15175264", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6607-215X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Methylnitronitrosoguanidine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Staurosporine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AA", "qualifierName": "analogs & derivatives", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Caffeine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Histones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Enzyme Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Kinase Inhibitors", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "G2 Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Repair", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Methylation", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Dose-Response Relationship, Drug", "majorTopic_YN": "N"}, {"descriptorName": "Base Pair Mismatch", "majorTopic_YN": "N"}, {"descriptorName": "Replication Protein A", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2004-06-01", "doi": "10.1101/gad.294404", "isOpenAccess": "N", "pageInfo": "1331-1344", "pmcid": "PMC420358", "hasDbCrossReferences": "N", "abstractText": "S(N)1-type alkylating agents represent an important class of chemotherapeutics, but the molecular mechanisms underlying their cytotoxicity are unknown. Thus, although these substances modify predominantly purine nitrogen atoms, their toxicity appears to result from the processing of O(6)-methylguanine ((6Me)G)-containing mispairs by the mismatch repair (MMR) system, because cells with defective MMR are highly resistant to killing by these agents. In an attempt to understand the role of the MMR system in the molecular transactions underlying the toxicity of alkylating agents, we studied the response of human MMR-proficient and MMR-deficient cells to low concentrations of the prototypic methylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). We now show that MNNG treatment induced a cell cycle arrest that was absolutely dependent on functional MMR. Unusually, the cells arrested only in the second G(2) phase after treatment. Downstream targets of both ATM (Ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases were modified, but only the ablation of ATR, or the inhibition of CHK1, attenuated the arrest. The checkpoint activation was accompanied by the formation of nuclear foci containing the signaling and repair proteins ATR, the S(*)/T(*)Q substrate, gamma-H2AX, and replication protein A (RPA). The persistence of these foci implied that they may represent sites of irreparable damage.", "language": "eng", "dateOfCompletion": "2004-07-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC420358?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC420358", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1101/gad.294404", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-06-01", "journal": {"medlineAbbreviation": "Genes Dev", "isoabbreviation": "Genes Dev.", "title": "Genes & development", "issn": "0890-9369", "nlmid": "8711660", "essn": "1549-5477"}, "monthOfPublication": 6, "volume": "18", "yearOfPublication": 2004, "journalIssueId": 1154693, "issue": "11", "dateOfPublication": "2004 Jun"}}, "20212154": {"pubYear": "2010", "dateOfCreation": "2010-03-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 2.7.1.-", "name": "MAP-kinase-activated kinase 2"}, {"registryNumber": "0", "name": "MYC protein, human"}, {"registryNumber": "0", "name": "Myc protein, mouse"}, {"registryNumber": "0", "name": "3' Untranslated Regions"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins c-myc"}, {"registryNumber": "0", "name": "MicroRNAs"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "0", "name": "MIRN34 microRNA, human"}, {"registryNumber": "EC 2.7.11.24", "name": "p38 Mitogen-Activated Protein Kinases"}]}, "authorString": "Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, Heery DM, Gaestel M, Eilers M, Willis AE, Bushell M.", "affiliation": "Center for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council", "grantId": "BB/F02326X/2"}, {"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MC_UP_A600_1023"}]}, "hasPDF": "Y", "id": "20212154", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Center for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.", "fullName": "Cannell IG", "initials": "IG", "firstName": "Ian G", "lastName": "Cannell"}, {"lastName": "Kong", "fullName": "Kong YW", "firstName": "Yi W", "initials": "YW"}, {"lastName": "Johnston", "fullName": "Johnston SJ", "firstName": "Samantha J", "initials": "SJ"}, {"lastName": "Chen", "fullName": "Chen ML", "firstName": "Melissa L", "initials": "ML"}, {"lastName": "Collins", "fullName": "Collins HM", "authorId": {"type": "ORCID", "value": "0000-0001-6220-1236"}, "firstName": "Hilary M", "initials": "HM"}, {"lastName": "Dobbyn", "fullName": "Dobbyn HC", "firstName": "Helen C", "initials": "HC"}, {"lastName": "Elia", "fullName": "Elia A", "firstName": "Androulla", "initials": "A"}, {"lastName": "Kress", "fullName": "Kress TR", "firstName": "Theresia R", "initials": "TR"}, {"lastName": "Dickens", "fullName": "Dickens M", "firstName": "Martin", "initials": "M"}, {"lastName": "Clemens", "fullName": "Clemens MJ", "firstName": "Michael J", "initials": "MJ"}, {"lastName": "Heery", "fullName": "Heery DM", "authorId": {"type": "ORCID", "value": "0000-0002-5035-2392"}, "firstName": "David M", "initials": "DM"}, {"lastName": "Gaestel", "fullName": "Gaestel M", "authorId": {"type": "ORCID", "value": "0000-0002-4944-4652"}, "firstName": "Matthias", "initials": "M"}, {"lastName": "Eilers", "fullName": "Eilers M", "authorId": {"type": "ORCID", "value": "0000-0002-0376-6533"}, "firstName": "Martin", "initials": "M"}, {"lastName": "Willis", "fullName": "Willis AE", "firstName": "Anne E", "initials": "AE"}, {"lastName": "Bushell", "fullName": "Bushell M", "firstName": "Martin", "initials": "M"}]}, "title": "p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.", "hasSuppl": "Y", "citedByCount": 78, "source": "MED", "pmid": "20212154", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6220-1236"}, {"type": "ORCID", "value": "0000-0002-5035-2392"}, {"type": "ORCID", "value": "0000-0002-4944-4652"}, {"type": "ORCID", "value": "0000-0002-0376-6533"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "DNA Damage", "majorTopic_YN": "Y"}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "p38 Mitogen-Activated Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Proto-Oncogene Proteins c-myc", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "MicroRNAs", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "3' Untranslated Regions", "majorTopic_YN": "N"}, {"descriptorName": "S Phase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "MAP Kinase Signaling System", "majorTopic_YN": "N"}, {"descriptorName": "DNA Replication", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-03-08", "doi": "10.1073/pnas.0910015107", "isOpenAccess": "N", "pageInfo": "5375-5380", "pmcid": "PMC2851793", "hasDbCrossReferences": "Y", "abstractText": "The DNA damage response activates several pathways that stall the cell cycle and allow DNA repair. These consist of the well-characterized ATR (Ataxia telangiectasia and Rad-3 related)/CHK1 and ATM (Ataxia telangiectasia mutated)/CHK2 pathways in addition to a newly identified ATM/ATR/p38MAPK/MK2 checkpoint. Crucial to maintaining the integrity of the genome is the S-phase checkpoint that functions to prevent DNA replication until damaged DNA is repaired. Inappropriate expression of the proto-oncogene c-Myc is known to cause DNA damage. One mechanism by which c-Myc induces DNA damage is through binding directly to components of the prereplicative complex thereby promoting DNA synthesis, resulting in replication-associated DNA damage and checkpoint activation due to inappropriate origin firing. Here we show that following etoposide-induced DNA damage translation of c-Myc is repressed by miR-34c via a highly conserved target-site within the 3(') UTR. While miR-34c is induced by p53 following DNA damage, we show that in cells lacking p53 this is achieved by an alternative pathway which involves p38 MAPK signalling to MK2. The data presented here suggest that a major physiological target of miR-34c is c-Myc. Inhibition of miR-34c activity prevents S-phase arrest in response to DNA damage leading to increased DNA synthesis, DNA damage, and checkpoint activation in addition to that induced by etoposide alone, which are all reversed by subsequent c-Myc depletion. These data demonstrate that miR-34c is a critical regulator of the c-Myc expression following DNA damage acting downstream of p38 MAPK/MK2 and suggest that miR-34c serves to remove c-Myc to prevent inappropriate replication which may otherwise lead to genomic instability.", "electronicPublicationDate": "2010-03-08", "language": "eng", "dateOfCompletion": "2010-04-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2851793?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2851793", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20212154", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20212154&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pnas.org/cgi/reprint/107/12/5375.pdf", "documentStyle": "pdf", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/content/abstract/107/12/5375", "documentStyle": "abs", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/content/full/107/12/5375", "documentStyle": "html", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://dx.doi.org/10.1073/pnas.0910015107", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-03-01", "journal": {"medlineAbbreviation": "Proc Natl Acad Sci U S A", "isoabbreviation": "Proc. Natl. Acad. Sci. U.S.A.", "title": "Proceedings of the National Academy of Sciences of the United States of America", "issn": "0027-8424", "nlmid": "7505876", "essn": "1091-6490"}, "monthOfPublication": 3, "volume": "107", "yearOfPublication": 2010, "journalIssueId": 1717978, "issue": "12", "dateOfPublication": "2010 Mar"}}, "27350734": {"pubYear": "2016", "dateOfCreation": "2016-06-28", "pubModel": "Print", "authorString": "Nan YL, Hu YL, Liu ZK, Duan FF, Xu Y, Li S, Li T, Chen DF, Zeng XY.", "affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27350734", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Nan YL", "initials": "YL", "firstName": "Yue-Li", "lastName": "Nan"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Hu YL", "initials": "YL", "firstName": "Yan-Ling", "lastName": "Hu"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Liu ZK", "initials": "ZK", "firstName": "Zhi-Ke", "lastName": "Liu"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Duan FF", "initials": "FF", "firstName": "Fang-Fang", "lastName": "Duan"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Xu Y", "initials": "Y", "firstName": "Yang", "lastName": "Xu"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Li S", "initials": "S", "firstName": "Shu", "lastName": "Li"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Li T", "initials": "T", "firstName": "Ting", "lastName": "Li"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Chen DF", "initials": "DF", "firstName": "Da-Fang", "lastName": "Chen"}, {"affiliation": "Yue-Li Nan, Yang Xu, Shu Li, Ting Li, Xiao-Yun Zeng, Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.", "fullName": "Zeng XY", "initials": "XY", "firstName": "Xiao-Yun", "lastName": "Zeng"}]}, "title": "Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27350734", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2016-06-01", "doi": "10.3748/wjg.v22.i24.5558", "isOpenAccess": "N", "pageInfo": "5558-5567", "pmcid": "PMC4917616", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Hepatocellular carcinoma", "Genetic susceptibility", "Single nucleotide polymorphism", "Case-control study", "Cell Cycle Pathway Genes"]}, "abstractText": "To investigate the associiations between the polymorphisms of cell cycle pathway genes and the risk of hepatocellular carcinoma (HCC).We enrolled 1127 cases newly diagnosed with HCC from the Tumor Hospital of Guangxi Medical University and 1200 non-tumor patients from the First Affiliated Hospital of Guangxi Medical University. General demographic characteristics, behavioral information, and hematological indices were collected by unified questionnaires. Genomic DNA was isolated from peripheral venous blood using Phenol-Chloroform. The genotyping was performed using the Sequenom MassARRAY iPLEX genotyping method. The association between genetic polymorphisms and risk of HCC was shown by P-value and the odd ratio (OR) with 95% confidence interval (CI) using the unconditional logistic regression after adjusting for age, sex, nationality, smoking, drinking, family history of HCC, and hepatitis B virus (HBV) infection. Moreover, stratified analysis was conducted on the basis of the status of HBV infection, smoking, and alcohol drinking.The HCC risk was lower in patients with the MCM4 rs2305952 CC (OR = 0.22, 95%CI: 0.08-0.63, P = 0.01) and with the CHEK1 rs515255 TC, TT, TC/TT (OR = 0.73, 95%CI: 0.56-0.96, P = 0.02; OR = 0.67, 95%CI: 0.46-0.97, P = 0.04; OR = 0.72, 95%CI: 0.56-0.92, P = 0.01, respectively). Conversely, the HCC risk was higher in patients with the KAT2B rs17006625 GG (OR = 1.64, 95%CI: 1.01-2.64, P = 0.04). In addition, the risk was markedly lower for those who were carriers of MCM4 rs2305952 CC and were also HBsAg-positive and non-drinking and non-smoking (P < 0.05, respectively) and for those who were carriers of CHEK1 rs515255 TC, TT, TC/TT and were also HBsAg-negative and non-drinking (P < 0.05, respectively). Moreover, the risk was higher for those who were carriers of KAT2B rs17006625 GG and were also HBsAg-negative (P < 0.05).Of 12 cell cycle pathway genes, MCM4, CHEK1 and KAT2B polymorphisms may be associated with the risk of HCC.", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4917616?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4917616", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3748/wjg.v22.i24.5558", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-06-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"medlineAbbreviation": "World J Gastroenterol", "isoabbreviation": "World J. Gastroenterol.", "title": "World journal of gastroenterology", "issn": "1007-9327", "nlmid": "100883448", "essn": "2219-2840"}, "monthOfPublication": 6, "volume": "22", "yearOfPublication": 2016, "journalIssueId": 2423269, "issue": "24", "dateOfPublication": "2016 Jun"}}, "25174396": {"pubYear": "2015", "dateOfCreation": "2015-06-25", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antineoplastic Agents"}, {"registryNumber": "0", "name": "Thiophenes"}, {"registryNumber": "0", "name": "Sulfones"}, {"registryNumber": "0", "name": "Pyrazines"}, {"registryNumber": "0", "name": "3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide"}, {"registryNumber": "EC 2.7.-", "name": "Protein Kinases"}, {"registryNumber": "0", "name": "3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide"}, {"registryNumber": "EC 2.7.11.1", "name": "Checkpoint kinase 1"}, {"registryNumber": "EC 2.7.11.1", "name": "Ataxia Telangiectasia Mutated Proteins"}, {"registryNumber": "8W8T17847W", "name": "Urea"}, {"registryNumber": "EC 2.7.11.1", "name": "ATR protein, human"}]}, "authorString": "Krajewska M, Fehrmann RS, Schoonen PM, Labib S, de Vries EG, Franke L, van Vugt MA.", "affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25174396", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "fullName": "Krajewska M", "initials": "M", "firstName": "M", "lastName": "Krajewska"}, {"firstName": "R S N", "lastName": "Fehrmann", "affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0002-7516-315X"}, "fullName": "Fehrmann RS", "initials": "RS"}, {"affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "fullName": "Schoonen PM", "initials": "PM", "firstName": "P M", "lastName": "Schoonen"}, {"affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "fullName": "Labib S", "initials": "S", "firstName": "S", "lastName": "Labib"}, {"affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "fullName": "de Vries EG", "initials": "EG", "firstName": "E G E", "lastName": "de Vries"}, {"firstName": "L", "lastName": "Franke", "affiliation": "Department of Medical Genetics, University Medical Center Groningen, University of Groningen, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0002-5159-8802"}, "fullName": "Franke L", "initials": "L"}, {"affiliation": "Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.", "fullName": "van Vugt MA", "initials": "MA", "firstName": "M A T M", "lastName": "van Vugt"}]}, "title": "ATR inhibition preferentially targets homologous recombination-deficient tumor cells.", "citedByCount": 2, "source": "MED", "pmid": "25174396", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7516-315X"}, {"type": "ORCID", "value": "0000-0002-5159-8802"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sulfones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Urea", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AA", "qualifierName": "analogs & derivatives", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pyrazines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiophenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antineoplastic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Drug Resistance, Neoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Targeted Therapy", "majorTopic_YN": "N"}, {"descriptorName": "Homologous Recombination", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "MCF-7 Cells", "majorTopic_YN": "N"}, {"descriptorName": "Ataxia Telangiectasia Mutated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-09-01", "doi": "10.1038/onc.2014.276", "isOpenAccess": "N", "pageInfo": "3474-3481", "hasDbCrossReferences": "N", "abstractText": "Homologous recombination (HR) is required for faithful repair of double-strand DNA breaks. Defects in HR repair cause severe genomic instability and challenge cellular viability. Paradoxically, various cancers are HR defective and have apparently acquired characteristics to survive genomic instability. We aimed to identify these characteristics to uncover therapeutic targets for HR-deficient cancers. Cytogenetic analysis of 1143 ovarian cancers showed that the degree of genomic instability was correlated to amplification of replication checkpoint genes ataxia telangiectasia and Rad3-related kinase (ATR) and CHEK1. To test whether genomic instability leads to increased reliance on replication checkpoint signaling, we inactivated Rad51 to model HR-related genomic instability. Rad51 inactivation caused defective HR repair and induced aberrant replication dynamics. Notably, inhibition of Rad51 led to increased ATR/checkpoint kinase-1 (Chk1)-mediated replication stress signaling. Importantly, inhibition of ATR or Chk1 preferentially killed HR-deficient cancer cells. Combined, our data show that defective HR caused by Rad51 inhibition results in differential sensitivity for ATR and Chk1 inhibitors, implicating replication checkpoint kinases as potential drug targets for HR-defective cancers.", "electronicPublicationDate": "2014-09-01", "language": "eng", "dateOfCompletion": "2015-09-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/onc.2014.276", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"medlineAbbreviation": "Oncogene", "isoabbreviation": "Oncogene", "title": "Oncogene", "issn": "0950-9232", "nlmid": "8711562", "essn": "1476-5594"}, "monthOfPublication": 6, "volume": "34", "yearOfPublication": 2015, "journalIssueId": 2297673, "issue": "26", "dateOfPublication": "2015 Jun"}}}, "LAMA1": {"24204716": {"pubYear": "2013", "dateOfCreation": "2013-11-08", "pubModel": "Electronic-eCollection", "authorString": "Tsang KM, Croen LA, Torres AR, Kharrazi M, Delorenze GN, Windham GC, Yoshida CK, Zerbo O, Weiss LA.", "affiliation": "Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "PHS HHS", "grantId": "0034328"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "075491/Z/04"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "1U24MH081810"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0601030"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "G0601030"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH00219"}, {"orderIn": 0, "agency": "Medical Research Council"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH39437"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH52708"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH64547"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01 ES016669"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01-ES016669"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "MH00980"}]}, "hasPDF": "Y", "id": "24204716", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.", "fullName": "Tsang KM", "initials": "KM", "firstName": "Kathryn M", "lastName": "Tsang"}, {"lastName": "Croen", "fullName": "Croen LA", "firstName": "Lisa A", "initials": "LA"}, {"lastName": "Torres", "fullName": "Torres AR", "firstName": "Anthony R", "initials": "AR"}, {"lastName": "Kharrazi", "fullName": "Kharrazi M", "firstName": "Martin", "initials": "M"}, {"lastName": "Delorenze", "fullName": "Delorenze GN", "firstName": "Gerald N", "initials": "GN"}, {"lastName": "Windham", "fullName": "Windham GC", "firstName": "Gayle C", "initials": "GC"}, {"lastName": "Yoshida", "fullName": "Yoshida CK", "firstName": "Cathleen K", "initials": "CK"}, {"lastName": "Zerbo", "fullName": "Zerbo O", "firstName": "Ousseny", "initials": "O"}, {"lastName": "Weiss", "fullName": "Weiss LA", "firstName": "Lauren A", "initials": "LA"}]}, "title": "A genome-wide survey of transgenerational genetic effects in autism.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "24204716", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7849-9428"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Mother-Child Relations", "majorTopic_YN": "N"}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Databases, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-10-24", "doi": "10.1371/journal.pone.0076978", "isOpenAccess": "Y", "pageInfo": "e76978", "pmcid": "PMC3811986", "hasDbCrossReferences": "N", "abstractText": "Effects of parental genotype or parent-offspring genetic interaction are well established in model organisms for a variety of traits. However, these transgenerational genetic models are rarely studied in humans. We have utilized an autism case-control study with 735 mother-child pairs to perform genome-wide screening for maternal genetic effects and maternal-offspring genetic interaction. We used simple models of single locus parent-child interaction and identified suggestive results (P<10(-4)) that cannot be explained by main effects, but no genome-wide significant signals. Some of these maternal and maternal-child associations were in or adjacent to autism candidate genes including: PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, and SDK1. We attempted validation of potential autism association under maternal-specific models using maternal-paternal comparison in family-based GWAS datasets. Our results suggest that further study of parental genetic effects and parent-child interaction in autism is warranted.", "electronicPublicationDate": "2013-10-24", "language": "eng", "dateOfCompletion": "2014-08-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3811986?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3811986", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24204716&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24204716", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0076978", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-12-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2082438, "issue": "10", "dateOfPublication": "2013 "}}, "26599961": {"pubYear": "2016", "dateOfCreation": "2016-01-14", "pubModel": "Print", "authorString": "Abdel Razek AA, Castillo M.", "affiliation": "From the *Faculty of Medicine, Department of Diagnostic Radiology, Mansoura University, Mansoura, Egypt; and \u2020Department of Radiology, University of North Carolina, Chapel Hill, NC.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "26599961", "inEPMC": "N", "authorList": {"author": [{"firstName": "Ahmed Abdel Khalek", "lastName": "Abdel Razek", "affiliation": "From the *Faculty of Medicine, Department of Diagnostic Radiology, Mansoura University, Mansoura, Egypt; and \u2020Department of Radiology, University of North Carolina, Chapel Hill, NC.", "authorId": {"type": "ORCID", "value": "0000-0002-9613-5932"}, "fullName": "Abdel Razek AA", "initials": "AA"}, {"lastName": "Castillo", "fullName": "Castillo M", "firstName": "Mauricio", "initials": "M"}]}, "title": "Magnetic Resonance Imaging of Malformations of Midbrain-Hindbrain.", "citedByCount": 0, "source": "MED", "pmid": "26599961", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9613-5932"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Mesencephalon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Rhombencephalon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "Y"}, {"descriptorName": "Neuroimaging", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-11-23", "doi": "10.1097/rct.0000000000000340", "isOpenAccess": "N", "pageInfo": "14-25", "hasDbCrossReferences": "N", "abstractText": "We aim to review the magnetic resonance imaging appearance of malformations of midbrain and hindbrain. These can be classified as predominantly cerebellar malformations, combined cerebellar and brain stem malformations, and predominantly brain stem malformations. The diagnostic criteria for the majority of these morphological malformations are based on neuroimaging findings. The predominantly cerebellar malformations include predominantly vermian hypoplasia seen in Dandy-Walker malformation and rhombencephalosynapsis, global cerebellar hypoplasia reported in lissencephaly and microlissencephaly, and unilateral cerebellar hypoplasia seen in PHACES, vanishing cerebellum, and cerebellar cleft. Cerebellar dysplasias are seen in Chudley-McCullough syndrome, associated with LAMA1 mutations and GPR56 mutations; Lhermitte-Duclos disease; and focal cerebellar dysplasias. Cerebellar hyperplasias are seen in megalencephaly-related syndromes and hemimegalencephaly with ipsilateral cerebellomegaly. Cerebellar and brain stem malformations include tubulinopathies, Joubert syndrome, cobblestone malformations, pontocerebellar hypoplasias, and congenital disorders of glycosylation type Ia. Predominantly brain stem malformations include congenital innervation dysgenesis syndrome, pontine tegmental cap dysplasia, diencephalic-mesencephalic junction dysplasia, disconnection syndrome, and pontine clefts.", "language": "eng", "dateOfCompletion": "2016-05-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/RCT.0000000000000340", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "J Comput Assist Tomogr", "isoabbreviation": "J Comput Assist Tomogr", "title": "Journal of computer assisted tomography", "issn": "0363-8715", "nlmid": "7703942", "essn": "1532-3145"}, "monthOfPublication": 0, "volume": "40", "yearOfPublication": 2016, "journalIssueId": 2362933, "issue": "1", "dateOfPublication": "2016 Jan-Feb"}}, "23922496": {"pubYear": "2013", "dateOfCreation": "2013-08-07", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Delayed-Action Preparations"}, {"registryNumber": "0", "name": "Bronchodilator Agents"}, {"registryNumber": "0", "name": "Indans"}, {"registryNumber": "0", "name": "Quinolones"}, {"registryNumber": "0", "name": "indacaterol"}]}, "authorString": "Rossi A, Polese G.", "affiliation": "Pulmonary Unit, Cardiovascular and Thoracic Department, University and General Hospital, Verona, Italy. andrea.rossi2@ospedaleuniverona.it", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "Y", "id": "23922496", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Rossi", "fullName": "Rossi A", "firstName": "Andrea", "initials": "A"}, {"lastName": "Polese", "fullName": "Polese G", "firstName": "Guido", "initials": "G"}]}, "title": "Indacaterol: a comprehensive review.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "23922496", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pulmonary Disease, Chronic Obstructive", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Quinolones", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Indans", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Bronchodilator Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Delayed-Action Preparations", "majorTopic_YN": "N"}, {"descriptorName": "Forced Expiratory Volume", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Administration, Inhalation", "majorTopic_YN": "N"}, {"descriptorName": "Risk Reduction Behavior", "majorTopic_YN": "N"}, {"descriptorName": "Respiration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dose-Response Relationship, Drug", "majorTopic_YN": "N"}, {"descriptorName": "Physical Therapy Modalities", "majorTopic_YN": "N"}, {"descriptorName": "Clinical Trials as Topic", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-07-25", "doi": "10.2147/copd.s21625", "isOpenAccess": "Y", "pageInfo": "353-363", "pmcid": "PMC3728154", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Indacaterol", "chronic obstructive pulmonary disease"]}, "abstractText": "At present there is no cure for chronic obstructive pulmonary disease (COPD). However, some nonpharmacologic treatments, such as rehabilitation and lung volume reduction surgery, as well as pharmacologic intervention, can relieve some of the patient's symptoms and improve quality of life, while also reducing the rate of exacerbations and hospitalizations. There needs to be a paradigm shift away from the unjustified nihilistic approach to COPD towards considering it a preventable and treatable disease. After patients quit smoking and start to lead healthier lifestyles, long-acting bronchodilators, such as long-acting beta-adrenergic agents (LABA) and long-acting antimuscarinic agents (LAMA), are recommended as the cornerstone of treatment for COPD, either as monotherapy or in combination. COPD is characterized by a reduced maximum expiratory flow and slow forced emptying of the lungs, which progress over time and are not completely reversible. In this condition, gas gets trapped in the lungs and pulmonary hyperinflation occurs. LABA and LAMA improve airway patency and deflate the lungs. Indacaterol is the first once-daily LABA approved for treatment of COPD, and is administered by inhalation through the Breezhaler\u00ae device. The speed of bronchodilation is similar to that with salbutamol (ie, about five minutes) and longer (ie, 24 hours) than that with traditional LABA, with the same 12-hour effect as salmeterol and formoterol, both of which require twice-daily administration. This is why indacaterol has been called the \"ultra-LABA\". On the one hand, the fast onset of action provides immediate relief of symptoms, and on the other, its constant 24-hour bronchodilation provides \"pharmacologic stenting\" which facilitates lung emptying, thereby decreasing trapped gas and pulmonary hyperinflation. Once-daily administration of a fast and long-acting bronchodilator can improve patient adherence with therapy, which is known to be a major problem for many medical treatments. Dose-finding trials have shown that 75 \u03bcg is the minimum dose needed to achieve clinically important improvement. However, indacaterol 150 \u03bcg and 300 \u03bcg achieve an even greater improvement in lung function and patient-oriented outcomes. Further, these two doses of indacaterol significantly reduce pulmonary hyperinflation, thereby improving exercise tolerance and ability to perform day-to-day activities. It is more effective on lung volumes at the 300 \u03bcg dose than formoterol, and better than salmeterol and tiotropium at the 150 \u03bcg dose, at least in the acute setting. It is noteworthy that few studies document these results in patients with COPD and moderate airflow obstruction. These are exactly the kind of patients our research should be concentrating on, in view of the accelerated decay in forced expiratory volume in one second at this stage of the disease. Finally, all the relevant studies show that indacaterol is consistently well tolerated by patients with COPD at every stage, and that it has a high safety profile. ", "electronicPublicationDate": "2013-07-25", "language": "eng", "dateOfCompletion": "2013-11-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3728154?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3728154", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23922496", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23922496&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.2147/COPD.S21625", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Int J Chron Obstruct Pulmon Dis", "isoabbreviation": "Int J Chron Obstruct Pulmon Dis", "title": "International journal of chronic obstructive pulmonary disease", "issn": "1176-9106", "nlmid": "101273481", "essn": "1178-2005"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 1998016, "dateOfPublication": "2013 "}}}, "CD63": {"19192119": {"pubYear": "2009", "dateOfCreation": "2009-04-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antidepressive Agents"}, {"registryNumber": "0", "name": "Platelet Membrane Glycoproteins"}, {"registryNumber": "0", "name": "Antigens, CD"}, {"registryNumber": "0", "name": "P-Selectin"}, {"registryNumber": "0", "name": "Antigens, CD63"}, {"registryNumber": "0", "name": "CD63 protein, human"}]}, "authorString": "Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM.", "affiliation": "Northern Blood Research Centre, Department of Haematology and Transfusion Medicine, University of Sydney, Sydney, NSW, Australia. mmorelko@med.usyd.edu.au", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19192119", "inEPMC": "N", "authorList": {"author": [{"lastName": "Morel-Kopp", "fullName": "Morel-Kopp MC", "authorId": {"type": "ORCID", "value": "0000-0003-4795-1746"}, "firstName": "M-C", "initials": "MC"}, {"lastName": "McLean", "fullName": "McLean L", "firstName": "L", "initials": "L"}, {"lastName": "Chen", "fullName": "Chen Q", "firstName": "Q", "initials": "Q"}, {"lastName": "Tofler", "fullName": "Tofler GH", "firstName": "G H", "initials": "GH"}, {"lastName": "Tennant", "fullName": "Tennant C", "firstName": "C", "initials": "C"}, {"lastName": "Maddison", "fullName": "Maddison V", "firstName": "V", "initials": "V"}, {"lastName": "Ward", "fullName": "Ward CM", "firstName": "C M", "initials": "CM"}]}, "title": "The association of depression with platelet activation: evidence for a treatment effect.", "citedByCount": 17, "source": "MED", "pmid": "19192119", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4795-1746"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cardiovascular Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "P-Selectin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Platelet Membrane Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antidepressive Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Flow Cytometry", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Depression", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychotherapy", "majorTopic_YN": "N"}, {"descriptorName": "Platelet Activation", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, CD63", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-01-13", "doi": "10.1111/j.1538-7836.2009.03278.x", "isOpenAccess": "N", "pageInfo": "573-581", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Depression is associated with an increased risk of cardiovascular disease (CVD). Although the mechanism is uncertain, prothrombotic and inflammatory factors may play a role. OBJECTIVES: As platelets play a key role in CVD, we determined first, whether depressed individuals had more activated platelets than non-depressed individuals and second, whether treatment of depression reduced platelet activation levels. PATIENTS/METHODS: We recruited 108 depressed outpatients and 45 control subjects all without a history of CVD. After psychological assessment, the depressed patients were offered treatment with medication and/or psychotherapy. Flow cytometric markers of platelet activation and level of depression were assessed at baseline and at 4 weeks and 6 months after treatment. RESULTS: Depression was associated with increased platelet activation with a higher number of circulating CD62p (0.76x10(9) L(-1) vs. 0.46, P=0.019) and CD63 (P=0.05) positive platelets compared with controls. Patients with depression also had more circulating platelet-leukocyte aggregates than controls (P<0.001). There was a positive correlation between the severity of depression and the level of platelet activation. Platelets from depressed patients were also hyperreactive to adenosine 5 -diphosphate (ADP) stimulation with increased CD62p and CD63 exposure (P=0.003 and 0.019, respectively). Six months of treatment resulted in a reduced number of circulating CD62p and CD63 positive platelets (29.84% and 53.38% decrease) and a 20.9% reduction in CD63 exposure after ADP activation. CONCLUSIONS: Depression is associated with increased in vivo platelet activation and resolution of depression using psychotherapy and/or medication reduces platelet activation. These findings provide insights into the link between depression and cardiovascular risk.", "electronicPublicationDate": "2009-01-13", "language": "eng", "dateOfCompletion": "2009-08-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1538-7836.2009.03278.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-04-01", "journal": {"medlineAbbreviation": "J Thromb Haemost", "isoabbreviation": "J. Thromb. Haemost.", "title": "Journal of thrombosis and haemostasis : JTH", "issn": "1538-7933", "nlmid": "101170508", "essn": "1538-7836"}, "monthOfPublication": 4, "volume": "7", "yearOfPublication": 2009, "journalIssueId": 1612579, "issue": "4", "dateOfPublication": "2009 Apr"}}, "16618365": {"pubYear": "2006", "dateOfCreation": "2006-04-18", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "allergen Hev b 5"}, {"registryNumber": "0", "name": "Plant Proteins"}, {"registryNumber": "0", "name": "Allergens"}, {"registryNumber": "9006-04-6", "name": "Rubber"}, {"registryNumber": "37341-29-0", "name": "Immunoglobulin E"}, {"registryNumber": "0", "name": "Platelet Membrane Glycoproteins"}, {"registryNumber": "0", "name": "Antigens, CD"}, {"registryNumber": "0", "name": "Recombinant Proteins"}, {"registryNumber": "0", "name": "Antigens, Plant"}, {"registryNumber": "0", "name": "Antigens, CD63"}, {"registryNumber": "0", "name": "CD63 protein, human"}]}, "authorString": "Sanz ML, Garc\u00eda-Avil\u00e9s MC, Tabar AI, Anda M, Garc\u00eda BE, Barber D, Salcedo G, Rihs HP, Raulf-Heimsoth M.", "affiliation": "Department of Allergology and Clinical Immunology, Cl\u00ednica Universitaria, Universidad de Navarra, Pamplona, Spain. mlsanzar@unav.es", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "16618365", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sanz", "fullName": "Sanz ML", "firstName": "Mar\u00eda L", "initials": "ML"}, {"lastName": "Garc\u00eda-Avil\u00e9s", "fullName": "Garc\u00eda-Avil\u00e9s MC", "firstName": "M C", "initials": "MC"}, {"lastName": "Tabar", "fullName": "Tabar AI", "firstName": "Ana I", "initials": "AI"}, {"lastName": "Anda", "fullName": "Anda M", "firstName": "M", "initials": "M"}, {"lastName": "Garc\u00eda", "fullName": "Garc\u00eda BE", "firstName": "B E", "initials": "BE"}, {"lastName": "Barber", "fullName": "Barber D", "firstName": "Domingo", "initials": "D"}, {"lastName": "Salcedo", "fullName": "Salcedo G", "firstName": "Gabriel", "initials": "G"}, {"lastName": "Rihs", "fullName": "Rihs HP", "firstName": "Hans-Peter", "initials": "HP"}, {"lastName": "Raulf-Heimsoth", "fullName": "Raulf-Heimsoth M", "firstName": "Monika", "initials": "M"}]}, "title": "Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children.", "citedByCount": 7, "source": "MED", "pmid": "16618365", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5488-5700"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Latex Hypersensitivity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Rubber", "majorTopic_YN": "N"}, {"descriptorName": "Immunoglobulin E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Platelet Membrane Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Plant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Recombinant Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Allergens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Basophil Degranulation Test", "majorTopic_YN": "Y"}, {"descriptorName": "Flow Cytometry", "majorTopic_YN": "N"}, {"descriptorName": "Antibody Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, Plant", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, CD63", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-03-01", "doi": "10.1111/j.1399-3038.2005.00359.x", "isOpenAccess": "N", "pageInfo": "148-156", "hasDbCrossReferences": "N", "abstractText": "There are no documented studies that describe natural rubber latex (NRL) sensitization in children with a history of surgical intervention but without any congenital malformation (urogenital anomalies, spina bifida, etc.), although some authors have studied NRL allergy in children without a history of surgical intervention. The aim of this work was to evaluate the sensitization profile to single NRL allergens in children without spina bifida and without repeated surgical interventions, by using different recombinant and natural latex allergens in two analytical techniques: specific serum immunoglobulin E (IgE) quantification and flow cytometry determination of activated basophils expressing CD63, after stimulating cells from patients with NRL allergens. A total of 23 patients and 10 healthy children were selected. Conjunctival and in-use NRL provocation tests were carried out, as well as specific IgE determination in all patients' and controls' sera with the recombinant NRL allergens: rHev b 1, rHev b 2, rHev b 3, rHev b 5, rHev b 6.01, rHev b 6.02, rHev b 8, rHev b 9 and rHev b 11 and with NRL (k82) using appropriate ImmunoCAPs. The Basophil Activation Test (BAT) was performed with whole latex extract and with the recombinant allergens rHev b 5 and rHev b 6.01, as well as with the natural allergen Hev b 6.02. The sensitivity and the specificity of NRL-specific IgE (k82) were 100%. Positive IgE responses to rHev b 5 were found in sera of 10 children, to rHev b 6.01 in 16 and for rHev b 6.02 in 15 children's sera. Specific IgE to rHev b 8 was found in four sera of the children. We only found significant differences in sensitization to rHev b 5 in children with two or more surgical interventions compared with the non-intervened group or those with only one intervention. Specific IgE in sera of children with latex-fruit syndrome recognized rHev b 6.02, but not to rHev b 11. The patients sensitized to Hev b 8, Hev b 9 and/or Hev b 11 were atopic. The four patients presenting a positive response to the NRL profilin Hev b 8 were allergic to pollen. The BAT against whole NRL extract was positive in 22 of 23 children; against rHev b 5 in 14 of the patients studied; against rHev b 6.01 in seven cases and against nHev b 6.02 in 19 children. In all the control subjects, the results using this technique were negative. If combined rHev b 5, rHev b 6.01 and nHev b 6.02 together, BAT could detect 20 of the 23 children with latex allergy. The combined use of ImmunoCAP with all the recombinant NRL allergens and BAT with rHev b 5, rHev b 6.01 and nHev b 6.02, enabled the identification of NRL allergy in 22 of 23 patients. There is a positive and significant correlation between sensitization to Hev b 5 and the number of interventions. BAT and allergen-specific IgE determination could be used as first-line in vitro diagnostic tests in patients with NRL allergy.", "language": "eng", "dateOfCompletion": "2007-03-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/j.1399-3038.2005.00359.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-03-01", "journal": {"medlineAbbreviation": "Pediatr Allergy Immunol", "isoabbreviation": "Pediatr Allergy Immunol", "title": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology", "issn": "0905-6157", "nlmid": "9106718", "essn": "1399-3038"}, "monthOfPublication": 3, "volume": "17", "yearOfPublication": 2006, "journalIssueId": 1316014, "issue": "2", "dateOfPublication": "2006 Mar"}}, "20150644": {"pubYear": "2010", "dateOfCreation": "2010-02-12", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Tumor Markers, Biological"}, {"registryNumber": "0", "name": "Antigens, CD44"}, {"registryNumber": "0", "name": "CD44 protein, human"}]}, "authorString": "Wei KC, Huang CY, Chen PY, Feng LY, Wu TW, Chen SM, Tsai HC, Lu YJ, Tsang NM, Tseng CK, Pai PC, Shin JW.", "affiliation": "Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fu Shin Street, Kweishan, Taoyuan, Taiwan, R.O.C. kuochenwei@adm.cgmh.org.tw", "pubTypeList": {"pubType": ["Evaluation Studies", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20150644", "inEPMC": "N", "authorList": {"author": [{"lastName": "Wei", "fullName": "Wei KC", "firstName": "Kuo-Chen", "initials": "KC"}, {"lastName": "Huang", "fullName": "Huang CY", "firstName": "Chiung-Yin", "initials": "CY"}, {"lastName": "Chen", "fullName": "Chen PY", "firstName": "Pin-Yuan", "initials": "PY"}, {"lastName": "Feng", "fullName": "Feng LY", "firstName": "Li-Ying", "initials": "LY"}, {"lastName": "Wu", "fullName": "Wu TW", "firstName": "Tai-Wei Erich", "initials": "TW"}, {"lastName": "Chen", "fullName": "Chen SM", "firstName": "Shu-Mei", "initials": "SM"}, {"lastName": "Tsai", "fullName": "Tsai HC", "firstName": "Hong-Chieh", "initials": "HC"}, {"lastName": "Lu", "fullName": "Lu YJ", "firstName": "Yu-Jen", "initials": "YJ"}, {"lastName": "Tsang", "fullName": "Tsang NM", "firstName": "Ngan-Ming", "initials": "NM"}, {"lastName": "Tseng", "fullName": "Tseng CK", "firstName": "Chen-Kan", "initials": "CK"}, {"lastName": "Pai", "fullName": "Pai PC", "firstName": "Ping-Ching", "initials": "PC"}, {"lastName": "Shin", "fullName": "Shin JW", "firstName": "Jyh-Wei", "initials": "JW"}]}, "title": "Evaluation of the prognostic value of CD44 in glioblastoma multiforme.", "citedByCount": 13, "source": "MED", "pmid": "20150644", "abstractText": " BACKGROUND/AIM: Glioblastoma and astrocytoma are the most common brain tumors affecting adults 45-60 years of age. The poor prognosis for glioblastoma patients results from recurrence after treatment. There is therefore an urgent need to develop diagnostic and prognostic markers as well as new therapies. PATIENTS AND METHODS: Microarray analyses of clinical specimens from glioblastoma patients were used to identify potential tumor markers. Expression of candidate genes was analyzed by real-time reverse transcription-polymerase chain reaction and by immunoblotting and immunohistochemistry. RESULTS: Five potential markers (CD44 antigen (CD44), growth arrest and DNA-damage-inducible, alpha (GADD45A), fibronectin 1 (FN1), CD63 antigen (CD63) and secreted phosphoprotein 1 (SPP1)) showed expression patterns that correlated significantly with malignant glioma. In particular, expression of the CD44 antigen was elevated in more severe tumor types, and higher in tumor cores than in peripheral regions. However, lower levels of CD44 expression surprisingly correlated with lower survival. CONCLUSION: The CD44 antigen is a promising candidate for further development as a prognostic and therapeutic tool.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glioblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD44", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Markers, Biological", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-01-01", "isOpenAccess": "N", "pageInfo": "253-259", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2010-03-17", "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"medlineAbbreviation": "Anticancer Res", "isoabbreviation": "Anticancer Res.", "title": "Anticancer research", "issn": "0250-7005", "nlmid": "8102988", "essn": "1791-7530"}, "monthOfPublication": 1, "volume": "30", "yearOfPublication": 2010, "journalIssueId": 1698105, "issue": "1", "dateOfPublication": "2010 Jan"}}, "15740629": {"pubYear": "2005", "dateOfCreation": "2005-03-17", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Cytokines"}]}, "authorString": "van der Vaart H, Postma DS, Timens W, Hylkema MN, Willemse BW, Boezen HM, Vonk JM, de Reus DM, Kauffman HF, ten Hacken NH.", "affiliation": "Department of Pulmonology, University Medical Center Groningen, Groningen, the Netherlands. h.van.der.vaart@int.umcg.nl <h.van.der.vaart@int.umcg.nl>", "pubTypeList": {"pubType": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "15740629", "inEPMC": "Y", "authorList": {"author": [{"lastName": "van der Vaart", "fullName": "van der Vaart H", "firstName": "Hester", "initials": "H"}, {"lastName": "Postma", "fullName": "Postma DS", "firstName": "Dirkje S", "initials": "DS"}, {"lastName": "Timens", "fullName": "Timens W", "authorId": {"type": "ORCID", "value": "0000-0002-4146-6363"}, "firstName": "Wim", "initials": "W"}, {"lastName": "Hylkema", "fullName": "Hylkema MN", "authorId": {"type": "ORCID", "value": "0000-0002-6732-8903"}, "firstName": "Machteld N", "initials": "MN"}, {"lastName": "Willemse", "fullName": "Willemse BW", "firstName": "Brigitte W M", "initials": "BW"}, {"lastName": "Boezen", "fullName": "Boezen HM", "firstName": "H Marike", "initials": "HM"}, {"lastName": "Vonk", "fullName": "Vonk JM", "firstName": "Judith M", "initials": "JM"}, {"lastName": "de Reus", "fullName": "de Reus DM", "firstName": "Dorothea M", "initials": "DM"}, {"lastName": "Kauffman", "fullName": "Kauffman HF", "firstName": "Henk F", "initials": "HF"}, {"lastName": "ten Hacken", "fullName": "ten Hacken NH", "firstName": "Nick H T", "initials": "NH"}]}, "title": "Acute effects of cigarette smoking on inflammation in healthy intermittent smokers.", "hasSuppl": "Y", "citedByCount": 35, "source": "MED", "pmid": "15740629", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4146-6363"}, {"type": "ORCID", "value": "0000-0002-6732-8903"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pneumonia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acute Disease", "majorTopic_YN": "N"}, {"descriptorName": "Cytokines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Breath Tests", "majorTopic_YN": "N"}, {"descriptorName": "Respiratory Function Tests", "majorTopic_YN": "N"}, {"descriptorName": "Pilot Projects", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Over Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reference Values", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2005-03-01", "language": "eng", "doi": "10.1186/1465-9921-6-22", "isOpenAccess": "Y", "pageInfo": "22", "pmcid": "PMC554761", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Chronic smoking is the main risk factor for chronic obstructive pulmonary disease. Knowledge on the response to the initial smoke exposures might enhance the understanding of changes due to chronic smoking, since repetitive acute smoke effects may cumulate and lead to irreversible lung damage. METHODS: We investigated acute effects of smoking on inflammation in 16 healthy intermittent smokers in an open randomised cross-over study. We compared effects of smoking of two cigarettes on inflammatory markers in exhaled air, induced sputum, blood and urine at 0, 1, 3, 6, 12, 24, 48, 96 and 192 hours and outcomes without smoking. All sputum and blood parameters were log transformed and analysed using a linear mixed effect model. RESULTS: Significant findings were: Smoking increased exhaled carbon monoxide between 0 and 1 hour, and induced a greater decrease in blood eosinophils and sputum lymphocytes between 0 and 3 hours compared to non-smoking. Compared to non-smoking, smoking induced a greater interleukin-8 release from stimulated blood cells between 0 and 3 hours, and a greater increase in sputum lymphocytes and neutrophils between 3 and 12 hours. CONCLUSION: We conclude that besides an increase in inflammation, as known from chronic smoking, there is also a suppressive effect of smoking two cigarettes on particular inflammatory parameters.", "electronicPublicationDate": "2005-03-01", "license": "cc by", "dateOfCompletion": "2006-03-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC554761?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC554761", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1465-9921-6-22", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "BioMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-04-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-01-01", "journal": {"medlineAbbreviation": "Respir Res", "isoabbreviation": "Respir. Res.", "title": "Respiratory research", "issn": "1465-9921", "nlmid": "101090633", "essn": "1465-993X"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2005, "journalIssueId": 1279836, "dateOfPublication": "2005 "}}, "17303250": {"pubYear": "2007", "dateOfCreation": "2007-03-16", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Platelet Membrane Glycoproteins"}, {"registryNumber": "0", "name": "Antigens, CD"}, {"registryNumber": "0", "name": "P-Selectin"}, {"registryNumber": "0", "name": "Antigens, CD63"}, {"registryNumber": "0", "name": "CD63 protein, human"}]}, "authorString": "Vidovi\u0107 A, Vilibi\u0107 M, Markoti\u0107 A, Sabioncello A, Gotovac K, Folnegovi\u0107-Smalc V, Dekaris D.", "affiliation": "Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia. avidovic@imz.hr", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17303250", "inEPMC": "N", "authorList": {"author": [{"lastName": "Vidovi\u0107", "fullName": "Vidovi\u0107 A", "firstName": "Andelko", "initials": "A"}, {"lastName": "Vilibi\u0107", "fullName": "Vilibi\u0107 M", "firstName": "Maja", "initials": "M"}, {"lastName": "Markoti\u0107", "fullName": "Markoti\u0107 A", "firstName": "Alemka", "initials": "A"}, {"lastName": "Sabioncello", "fullName": "Sabioncello A", "firstName": "Ante", "initials": "A"}, {"lastName": "Gotovac", "fullName": "Gotovac K", "firstName": "Katja", "initials": "K"}, {"lastName": "Folnegovi\u0107-Smalc", "fullName": "Folnegovi\u0107-Smalc V", "firstName": "Vera", "initials": "V"}, {"lastName": "Dekaris", "fullName": "Dekaris D", "firstName": "Dragan", "initials": "D"}]}, "title": "Baseline level of platelet-leukocyte aggregates, platelet CD63 expression, and soluble P-selectin concentration in patients with posttraumatic stress disorder: a pilot study.", "citedByCount": 2, "source": "MED", "pmid": "17303250", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Blood Platelets", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Leukocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cardiovascular Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "P-Selectin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Platelet Membrane Glycoproteins", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, CD", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Body Mass Index", "majorTopic_YN": "N"}, {"descriptorName": "Flow Cytometry", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Pilot Projects", "majorTopic_YN": "N"}, {"descriptorName": "Combat Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Platelet Aggregation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Veterans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Croatia", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Antigens, CD63", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-02-14", "doi": "10.1016/j.psychres.2006.05.004", "isOpenAccess": "N", "pageInfo": "211-216", "hasDbCrossReferences": "N", "abstractText": "Platelets may have an important role in the development of cardiovascular disease (CVD) as a result of chronic stress. We conducted a pilot study to evaluate the effect of posttraumatic stress disorder (PTSD) on baseline platelet activation. Platelet-leukocyte aggregates (PLA) and CD63 expression were measured by flow cytometry, and soluble (s)P-selectin concentration was determined in sera of 20 Croatian male combat veterans with PTSD and 20 healthy civilians. Groups were matched in sex, age, body mass index (BMI) and traditional CVD risk factors. Our data showed no differences in measured parameters. Other platelet activation markers should be determined and a larger sample size used in future studies.", "electronicPublicationDate": "2007-02-14", "language": "eng", "dateOfCompletion": "2007-07-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.psychres.2006.05.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-03-01", "journal": {"medlineAbbreviation": "Psychiatry Res", "isoabbreviation": "Psychiatry Res", "title": "Psychiatry research", "issn": "0165-1781", "nlmid": "7911385", "essn": "1872-7123"}, "monthOfPublication": 3, "volume": "150", "yearOfPublication": 2007, "journalIssueId": 1383998, "issue": "2", "dateOfPublication": "2007 Mar"}}}, "SNX16": {"24345872": {"pubYear": "2014", "dateOfCreation": "2014-02-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Histones"}, {"registryNumber": "K3Z4F929H6", "name": "Lysine"}]}, "authorString": "Sui WG, He HY, Yan Q, Chen JJ, Zhang RH, Dai Y.", "affiliation": "181st Hospital, Nephrology Department, Guangxi Key Laboratory of Metabolic Diseases Research, GuilinGuangxi, China, Guangxi Key Laboratory of Metabolic Diseases Research, Nephrology Department, 181st Hospital, Guilin, Guangxi, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24345872", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "181st Hospital, Nephrology Department, Guangxi Key Laboratory of Metabolic Diseases Research, GuilinGuangxi, China, Guangxi Key Laboratory of Metabolic Diseases Research, Nephrology Department, 181st Hospital, Guilin, Guangxi, China.", "fullName": "Sui WG", "initials": "WG", "firstName": "W G", "lastName": "Sui"}, {"affiliation": "Guangxi Normal University, The Life Science College, GuilinGuangxi, China, The Life Science College, Guangxi Normal University, Guilin, Guangxi, China.", "fullName": "He HY", "initials": "HY", "firstName": "H Y", "lastName": "He"}, {"affiliation": "181st Hospital, Nephrology Department, Guangxi Key Laboratory of Metabolic Diseases Research, GuilinGuangxi, China, Guangxi Key Laboratory of Metabolic Diseases Research, Nephrology Department, 181st Hospital, Guilin, Guangxi, China.", "fullName": "Yan Q", "initials": "Q", "firstName": "Q", "lastName": "Yan"}, {"affiliation": "181st Hospital, Nephrology Department, Guangxi Key Laboratory of Metabolic Diseases Research, GuilinGuangxi, China, Guangxi Key Laboratory of Metabolic Diseases Research, Nephrology Department, 181st Hospital, Guilin, Guangxi, China.", "fullName": "Chen JJ", "initials": "JJ", "firstName": "J J", "lastName": "Chen"}, {"affiliation": "Guangxi Normal University, The Life Science College, GuilinGuangxi, China, The Life Science College, Guangxi Normal University, Guilin, Guangxi, China.", "fullName": "Zhang RH", "initials": "RH", "firstName": "R H", "lastName": "Zhang"}, {"affiliation": "Jinan University, Shenzhen People's Hospital, The Second Clinical Medical College, Clinical Medical Research Center, ShenzhenGuangdong, China, Clinical Medical Research Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.", "fullName": "Dai Y", "initials": "Y", "firstName": "Y", "lastName": "Dai"}]}, "title": "ChIP-seq analysis of histone H3K9 trimethylation in peripheral blood mononuclear cells of membranous nephropathy patients.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24345872", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Leukocytes, Mononuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glomerulonephritis, Membranous", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lysine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Histones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Chromatin Immunoprecipitation", "majorTopic_YN": "N"}, {"descriptorName": "Methylation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-12-12", "language": "eng", "doi": "10.1590/1414-431x20132809", "isOpenAccess": "Y", "pageInfo": "42-49", "pmcid": "PMC3932972", "hasDbCrossReferences": "N", "abstractText": "Membranous nephropathy (MN), characterized by the presence of diffuse thickening of the glomerular basement membrane and subepithelial in situ immune complex disposition, is the most common cause of idiopathic nephrotic syndrome in adults, with an incidence of 5-10 per million per year. A number of studies have confirmed the relevance of several experimental insights to the pathogenesis of human MN, but the specific biomarkers of MN have not been fully elucidated. As a result, our knowledge of the alterations in histone methylation in MN is unclear. We used chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) to analyze the variations in a methylated histone (H3K9me3) in peripheral blood mononuclear cells from 10 MN patients and 10 healthy subjects. There were 108 genes with significantly different expression in the MN patients compared with the normal controls. In MN patients, significantly increased activity was seen in 75 H3K9me3 genes, and decreased activity was seen in 33, compared with healthy subjects. Five positive genes, DiGeorge syndrome critical region gene 6 (DGCR6), sorting nexin 16 (SNX16), contactin 4 (CNTN4), baculoviral IAP repeat containing 3 (BIRC3), and baculoviral IAP repeat containing 2 (BIRC2), were selected and quantified. There were alterations of H3K9me3 in MN patients. These may be candidates to help explain pathogenesis in MN patients. Such novel findings show that H3K9me3 may be a potential biomarker or promising target for epigenetic-based MN therapies.", "electronicPublicationDate": "2013-12-12", "license": "cc by-nc", "dateOfCompletion": "2015-04-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3932972?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3932972", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24345872&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24345872", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1590/1414-431X20132809", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "Braz J Med Biol Res", "isoabbreviation": "Braz. J. Med. Biol. Res.", "title": "Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]", "issn": "0100-879X", "nlmid": "8112917", "essn": "1414-431X"}, "monthOfPublication": 1, "volume": "47", "yearOfPublication": 2014, "journalIssueId": 2126007, "issue": "1", "dateOfPublication": "2014 Jan"}}, "19754948": {"pubYear": "2009", "dateOfCreation": "2009-09-25", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Genetic Markers"}]}, "authorString": "Wolf C, Gramer E, M\u00fcller-Myhsok B, Pasutto F, Reinthal E, Wissinger B, Weisschuh N.", "affiliation": "Centre for Ophthalmology, Institute for Ophthalmic Research, Molecular Genetics Laboratory, Tuebingen, Germany. cwolf@mpipsykl.mpg.de", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "19754948", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Wolf", "fullName": "Wolf C", "firstName": "Christiane", "initials": "C"}, {"lastName": "Gramer", "fullName": "Gramer E", "firstName": "Eugen", "initials": "E"}, {"lastName": "M\u00fcller-Myhsok", "fullName": "M\u00fcller-Myhsok B", "firstName": "Bertram", "initials": "B"}, {"lastName": "Pasutto", "fullName": "Pasutto F", "firstName": "Francesca", "initials": "F"}, {"lastName": "Reinthal", "fullName": "Reinthal E", "firstName": "Eva", "initials": "E"}, {"lastName": "Wissinger", "fullName": "Wissinger B", "firstName": "Bernd", "initials": "B"}, {"lastName": "Weisschuh", "fullName": "Weisschuh N", "firstName": "Nicole", "initials": "N"}]}, "title": "Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study.", "hasSuppl": "Y", "citedByCount": 13, "source": "MED", "pmid": "19754948", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Open-Angle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2009-09-15", "language": "eng", "doi": "10.1186/1471-2350-10-91", "isOpenAccess": "Y", "pageInfo": "91", "pmcid": "PMC2751751", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Normal tension glaucoma is a major subtype of glaucoma, associated with intraocular pressures that are within the statistically normal range of the population. Monogenic forms following classical inheritance patterns are rare in this glaucoma subtype. Instead, multigenic inheritance is proposed for the majority of cases. The present study tested common sequence variants in candidate genes for association with normal tension glaucoma in the German population. METHODS: Ninety-eight SNPs were selected to tag the common genetic variation in nine genes, namely OPTN (optineurin), RDX (radixin), SNX16 (sorting nexin 16), OPA1 (optic atrophy 1), MFN1 (mitofusin 1), MFN2 (mitofusin 2), PARL (presenilin associated, rhomboid-like), SOD2 (superoxide dismutase 2, mitochondrial) and CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1). These SNPs were genotyped in 285 cases and 282 fully evaluated matched controls. Statistical analyses comprised single polymorphism association as well as haplogroup based association testing. RESULTS: Results suggested that genetic variation in five of the candidate genes (RDX, SNX16, OPA1, SOD2 and CYP1B1) is unlikely to confer major risk to develop normal tension glaucoma in the German population. In contrast, we observed a trend towards association of single SNPs in OPTN, MFN1, MFN2 and PARL. The SNPs of OPTN, MFN2 and PARL were further analysed by multimarker haplotype-based association testing. We identified a risk haplotype being more frequent in patients and a vice versa situation for the complementary protective haplotype in each of the three genes. CONCLUSION: Common variants of OPTN, PARL, MFN1 and MFN2 should be analysed in other cohorts to confirm their involvement in normal tension glaucoma.", "electronicPublicationDate": "2009-09-15", "license": "cc by", "dateOfCompletion": "2009-09-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2751751?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2751751", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.biomedcentral.com/1471-2350/10/91/abstract", "documentStyle": "abs", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/content/pdf/1471-2350-10-91.pdf", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/1471-2350/10/91", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19754948", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19754948&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1471-2350-10-91", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-31", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"title": "BMC medical genetics", "medlineAbbreviation": "BMC Med Genet", "isoabbreviation": "BMC Med. Genet.", "nlmid": "100968552", "essn": "1471-2350"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2009, "journalIssueId": 1594028, "dateOfPublication": "2009 "}}}, "NLGN4Y": {"16077734": {"pubYear": "2005", "dateOfCreation": "2005-11-24", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "neuroligin 1"}, {"registryNumber": "0", "name": "neuroligin 3"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Carrier Proteins"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Genetic Markers"}, {"registryNumber": "0", "name": "Cell Adhesion Molecules, Neuronal"}, {"registryNumber": "0", "name": "NLGN4X protein, human"}]}, "authorString": "Ylisaukko-oja T, Rehnstr\u00f6m K, Auranen M, Vanhala R, Alen R, Kempas E, Ellonen P, Turunen JA, Makkonen I, Riikonen R, Nieminen-von Wendt T, von Wendt L, Peltonen L, J\u00e4rvel\u00e4 I.", "affiliation": "Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland. tero.ylisaukko-oja@ktl.fi", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "16077734", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ylisaukko-oja", "fullName": "Ylisaukko-oja T", "firstName": "Tero", "initials": "T"}, {"lastName": "Rehnstr\u00f6m", "fullName": "Rehnstr\u00f6m K", "firstName": "Karola", "initials": "K"}, {"lastName": "Auranen", "fullName": "Auranen M", "firstName": "Mari", "initials": "M"}, {"lastName": "Vanhala", "fullName": "Vanhala R", "firstName": "Raija", "initials": "R"}, {"lastName": "Alen", "fullName": "Alen R", "firstName": "Reija", "initials": "R"}, {"lastName": "Kempas", "fullName": "Kempas E", "firstName": "Elli", "initials": "E"}, {"lastName": "Ellonen", "fullName": "Ellonen P", "firstName": "Pekka", "initials": "P"}, {"lastName": "Turunen", "fullName": "Turunen JA", "firstName": "Joni A", "initials": "JA"}, {"lastName": "Makkonen", "fullName": "Makkonen I", "firstName": "Ismo", "initials": "I"}, {"lastName": "Riikonen", "fullName": "Riikonen R", "firstName": "Raili", "initials": "R"}, {"lastName": "Nieminen-von Wendt", "fullName": "Nieminen-von Wendt T", "firstName": "Taina", "initials": "T"}, {"lastName": "von Wendt", "fullName": "von Wendt L", "firstName": "Lennart", "initials": "L"}, {"lastName": "Peltonen", "fullName": "Peltonen L", "firstName": "Leena", "initials": "L"}, {"lastName": "J\u00e4rvel\u00e4", "fullName": "J\u00e4rvel\u00e4 I", "firstName": "Irma", "initials": "I"}]}, "title": "Analysis of four neuroligin genes as candidates for autism.", "citedByCount": 62, "source": "MED", "pmid": "16077734", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Synapses", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carrier Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Adhesion Molecules, Neuronal", "majorTopic_YN": "N"}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microsatellite Repeats", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2005-12-01", "doi": "10.1038/sj.ejhg.5201474", "isOpenAccess": "N", "pageInfo": "1285-1292", "hasDbCrossReferences": "Y", "abstractText": "Neuroligins are cell-adhesion molecules located at the postsynaptic side of the synapse. Neuroligins interact with beta-neurexins and this interaction is involved in the formation of functional synapses. Mutations in two X-linked neuroligin genes, NLGN3 and NLGN4, have recently been implicated in pathogenesis of autism. The neuroligin gene family consists of five members (NLGN1 at 3q26, NLGN2 at 17p13, NLGN3 at Xq13, NLGN4 at Xp22, and NLGN4Y at Yq11), of which NLGN1 and NLGN3 are located within the best loci observed in our previous genome-wide scan for autism in the Finnish sample. Here, we report a detailed molecular genetic analysis of NLGN1, NLGN3, NLGN4, and NLNG4Y in the Finnish autism sample. Mutation analysis of 30 probands selected from families producing linkage evidence for Xq13 and/or 3q26 loci revealed several polymorphisms, but none of these seemed to be functional. Family-based association analysis in 100 families with autism spectrum disorders yielded only modest associations at NLGN1 (rs1488545, P=0.002), NLGN3 (DXS7132, P=0.014), and NLGN4 (DXS996, P=0.031). We conclude that neuroligin mutations most probably represent rare causes of autism and that it is unlikely that the allelic variants in these genes would be major risk factors for autism.", "language": "eng", "dateOfCompletion": "2008-07-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/sj.ejhg.5201474", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2010-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-12-01", "journal": {"medlineAbbreviation": "Eur J Hum Genet", "isoabbreviation": "Eur. J. Hum. Genet.", "title": "European journal of human genetics : EJHG", "issn": "1018-4813", "nlmid": "9302235", "essn": "1476-5438"}, "monthOfPublication": 12, "volume": "13", "yearOfPublication": 2005, "journalIssueId": 1271154, "issue": "12", "dateOfPublication": "2005 Dec"}}, "18628683": {"pubYear": "2008", "dateOfCreation": "2008-07-16", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Carrier Proteins"}, {"registryNumber": "0", "name": "NLGN4X protein, human"}]}, "authorString": "Yan J, Feng J, Schroer R, Li W, Skinner C, Schwartz CE, Cook EH, Sommer SS.", "affiliation": "Department of Molecular Genetics, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010-3000, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "18628683", "inEPMC": "N", "authorList": {"author": [{"lastName": "Yan", "fullName": "Yan J", "firstName": "Jin", "initials": "J"}, {"lastName": "Feng", "fullName": "Feng J", "firstName": "Jinong", "initials": "J"}, {"lastName": "Schroer", "fullName": "Schroer R", "firstName": "Richard", "initials": "R"}, {"lastName": "Li", "fullName": "Li W", "firstName": "Wenyan", "initials": "W"}, {"lastName": "Skinner", "fullName": "Skinner C", "firstName": "Cindy", "initials": "C"}, {"lastName": "Schwartz", "fullName": "Schwartz CE", "firstName": "Charles E", "initials": "CE"}, {"lastName": "Cook", "fullName": "Cook EH Jr", "authorId": {"type": "ORCID", "value": "0000-0002-5848-5114"}, "firstName": "Edwin H", "initials": "EH"}, {"lastName": "Sommer", "fullName": "Sommer SS", "firstName": "Steve S", "initials": "SS"}]}, "title": "Analysis of the neuroligin 4Y gene in patients with autism.", "citedByCount": 31, "source": "MED", "pmid": "18628683", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5848-5114"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carrier Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sequence Alignment", "majorTopic_YN": "N"}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-08-01", "doi": "10.1097/ypg.0b013e3282fb7fe6", "isOpenAccess": "N", "pageInfo": "204-207", "hasDbCrossReferences": "Y", "abstractText": "Frameshift and missense mutations in the X-linked neuroligin 4 (NLGN4, MIM# 300427) and neuroligin 3 (NLGN3, MIM# 300336) genes have been identified in patients with autism, Asperger syndrome and mental retardation. We hypothesize that sequence variants in NLGN4Y are associated with autism or mental retardation. The coding sequences and splice junctions of the NLGN4Y gene were analyzed in 335 male samples (290 with autism and 45 with mental retardation). A total of 1.1 Mb of genomic DNA was sequenced. One missense variant, p.I679V, was identified in a patient with autism, as well as his father with learning disabilities. The I679 residue is highly conserved in three members of the neuroligin family. The absence of p.I679V in 2986 control Y chromosomes and the high similarity of NLGN4 and NLGN4Y are consistent with the hypothesis that p.I679V contributes to the etiology of autism. The presence of only one structural variant in our population of 335 males with autism/mental retardation, the unavailability of significant family cosegregation and an absence of functional assays are, however, important limitations of this study.", "language": "eng", "dateOfCompletion": "2008-08-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/YPG.0b013e3282fb7fe6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://content.wkhealth.com/linkback/openurl?issn=0955-8829&volume=18&issue=4&spage=204", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "www.psychgenetics.com"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-08-01", "journal": {"medlineAbbreviation": "Psychiatr Genet", "isoabbreviation": "Psychiatr. Genet.", "title": "Psychiatric genetics", "issn": "0955-8829", "nlmid": "9106748", "essn": "1473-5873"}, "monthOfPublication": 8, "volume": "18", "yearOfPublication": 2008, "journalIssueId": 1542928, "issue": "4", "dateOfPublication": "2008 Aug"}}, "25558953": {"pubYear": "2015", "dateOfCreation": "2015-03-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Cell Adhesion Molecules, Neuronal"}, {"registryNumber": "0", "name": "NLGN4X protein, human"}]}, "authorString": "Ross JL, Tartaglia N, Merry DE, Dalva M, Zinn AR.", "affiliation": "Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA; Department of Pediatrics, Alfred I duPont Hospital for Children, Wilmington, DE.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "K23NS070337"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR001082"}, {"acronym": "DA", "orderIn": 0, "agency": "NIDA NIH HHS", "grantId": "R01 DA022727"}]}, "hasPDF": "Y", "id": "25558953", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA; Department of Pediatrics, Alfred I duPont Hospital for Children, Wilmington, DE.", "fullName": "Ross JL", "initials": "JL", "firstName": "J L", "lastName": "Ross"}, {"lastName": "Tartaglia", "fullName": "Tartaglia N", "firstName": "N", "initials": "N"}, {"lastName": "Merry", "fullName": "Merry DE", "firstName": "D E", "initials": "DE"}, {"lastName": "Dalva", "fullName": "Dalva M", "firstName": "M", "initials": "M"}, {"lastName": "Zinn", "fullName": "Zinn AR", "authorId": {"type": "ORCID", "value": "0000-0002-4935-3291"}, "firstName": "A R", "initials": "AR"}]}, "title": "Behavioral phenotypes in males with XYY and possible role of increased NLGN4Y expression in autism features.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25558953", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4935-3291"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Sex Chromosome Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "XYY Karyotype", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Adhesion Molecules, Neuronal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Child Behavior", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Attention Deficit Disorder with Hyperactivity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neuropsychological Tests", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-02-01", "doi": "10.1111/gbb.12200", "isOpenAccess": "N", "pageInfo": "137-144", "pmcid": "PMC4756915", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Neuroligin", "Social Function", "Xyy", "Nlgn4y"]}, "abstractText": "The male sex chromosome disorder, 47,XYY syndrome (XYY), is associated with increased risk for social-emotional difficulties, attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). We hypothesize that increased Y chromosome gene copy number in XYY leads to overexpression of Y-linked genes related to brain development and function, thereby increasing risk for these phenotypes. We measured expression in blood of two Y genes NLGN4Y and RPS4Y in 26 boys with XYY and 11 male controls and evaluated whether NLGN4Y expression correlates with anxiety, ADHD, depression and autistic behaviors (from questionnaires) in boys with XYY. The XYY cohort had increased risk of ASD behaviors on the social responsiveness scale (SRS) and increased attention deficits on the Conners' DSM-IV inattention and hyperactive scales. In contrast, there was no increase in reported symptoms of anxiety or depression by the XYY group. Peripheral expression of two Y genes in boys with XYY vs. typically developing controls was increased twofold in the XYY group. Results from the SRS total and autistic mannerisms scales, but not from the attention, anxiety or depression measures, correlated with peripheral expression of NLGN4Y in boys with XYY. Males with XYY have social phenotypes that include increased risk for autism-related behaviors and ADHD. Expression of NLGN4Y, a gene that may be involved in synaptic function, is increased in boys with XYY, and the level of expression correlates with overall social responsiveness and autism symptoms. Thus, further investigation of NLGN4Y as a plausible ASD risk gene in XYY is warranted.", "electronicPublicationDate": "2015-02-01", "language": "eng", "dateOfCompletion": "2015-12-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4756915?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4756915", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1111/gbb.12200", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-02-01", "journal": {"medlineAbbreviation": "Genes Brain Behav", "isoabbreviation": "Genes Brain Behav.", "title": "Genes, brain, and behavior", "issn": "1601-1848", "nlmid": "101129617", "essn": "1601-183X"}, "monthOfPublication": 2, "volume": "14", "yearOfPublication": 2015, "journalIssueId": 2267735, "issue": "2", "dateOfPublication": "2015 Feb"}}}, "BMI1": {"24460684": {"pubYear": "2014", "dateOfCreation": "2014-02-20", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Cell Adhesion Molecules"}, {"registryNumber": "0", "name": "Bone Morphogenetic Proteins"}, {"registryNumber": "0", "name": "cell aggregation factors"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Merve A, Dubuc AM, Zhang X, Remke M, Baxter PA, Li XN, Taylor MD, Marino S.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Department of Health", "grantId": "472"}, {"orderIn": 0, "agency": "Medical Research Council"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G0902001"}]}, "hasPDF": "Y", "id": "24460684", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Merve", "fullName": "Merve A", "firstName": "Ashirwad", "initials": "A"}, {"lastName": "Dubuc", "fullName": "Dubuc AM", "firstName": "Adrian M", "initials": "AM"}, {"lastName": "Zhang", "fullName": "Zhang X", "firstName": "Xinyu", "initials": "X"}, {"lastName": "Remke", "fullName": "Remke M", "authorId": {"type": "ORCID", "value": "0000-0002-9404-9993"}, "firstName": "Marc", "initials": "M"}, {"lastName": "Baxter", "fullName": "Baxter PA", "firstName": "Patricia A", "initials": "PA"}, {"lastName": "Li", "fullName": "Li XN", "firstName": "Xiao-Nan", "initials": "XN"}, {"lastName": "Taylor", "fullName": "Taylor MD", "firstName": "Michael D", "initials": "MD"}, {"affiliation": "Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK. s.marino@qmul.ac.uk.", "fullName": "Marino S", "initials": "S", "firstName": "Silvia", "lastName": "Marino"}]}, "title": "Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "24460684", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9404-9993"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Animals, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, SCID", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cerebellar Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Adhesion Molecules", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Bone Morphogenetic Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transplantation, Heterologous", "majorTopic_YN": "N"}, {"descriptorName": "Organ Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Cell Adhesion", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "In Vitro Techniques", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-24", "language": "eng", "doi": "10.1186/2051-5960-2-10", "isOpenAccess": "Y", "pageInfo": "10", "pmcid": "PMC3928978", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Medulloblastoma is the most common intracranial childhood malignancy and a genetically heterogeneous disease. Despite recent advances, current therapeutic approaches are still associated with high morbidity and mortality. Recent molecular profiling has suggested the stratification of medulloblastoma from one single disease into four distinct subgroups namely: WNT Group (best prognosis), SHH Group (intermediate prognosis), Group 3 (worst prognosis) and Group 4 (intermediate prognosis). BMI1 is a Polycomb group repressor complex gene overexpressed across medulloblastoma subgroups but most significantly in Group 4 tumours. Bone morphogenetic proteins are morphogens belonging to TGF-\u03b2 superfamily of growth factors, known to inhibit medulloblastoma cell proliferation and induce apoptosis. RESULTS: Here we demonstrate that human medulloblastoma of Group 4 characterised by the greatest overexpression of BMI1, also display deregulation of cell adhesion molecules. We show that BMI1 controls intraparenchymal invasion in a novel xenograft model of human MB of Group 4, while in vitro assays highlight that cell adhesion and motility are controlled by BMI1 in a BMP dependent manner. CONCLUSIONS: BMI1 controls MB cell migration and invasion through repression of the BMP pathway, raising the possibility that BMI1 could be used as a biomarker to identify groups of patients who may benefit from a treatment with BMP agonists.", "electronicPublicationDate": "2014-01-24", "license": "cc by", "dateOfCompletion": "2014-12-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3928978?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3928978", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24460684", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24460684&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/2051-5960-2-10", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "Acta neuropathologica communications", "medlineAbbreviation": "Acta Neuropathol Commun", "isoabbreviation": "Acta Neuropathol Commun", "nlmid": "101610673", "essn": "2051-5960"}, "monthOfPublication": 0, "volume": "2", "yearOfPublication": 2014, "journalIssueId": 2162833, "dateOfPublication": "2014 "}}, "25858624": {"pubYear": "2015", "dateOfCreation": "2015-04-10", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antineoplastic Agents"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "RNA, Neoplasm"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}, {"registryNumber": "Q20Q21Q62J", "name": "Cisplatin"}]}, "authorString": "Hong Y, Shang C, Xue YX, Liu YH.", "affiliation": "Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China (mainland).", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25858624", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China (mainland).", "fullName": "Hong Y", "initials": "Y", "firstName": "Yang", "lastName": "Hong"}, {"affiliation": "Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, China (mainland).", "fullName": "Shang C", "initials": "C", "firstName": "Chao", "lastName": "Shang"}, {"affiliation": "Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, China (mainland).", "fullName": "Xue YX", "initials": "YX", "firstName": "Yi-xue", "lastName": "Xue"}, {"affiliation": "Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China (mainland).", "fullName": "Liu YH", "initials": "YH", "firstName": "Yun-hui", "lastName": "Liu"}]}, "title": "Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25858624", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Astrocytoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glioblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cisplatin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Neoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antineoplastic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apoptosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA Interference", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Drug Resistance, Neoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-04-06", "doi": "10.12659/msm.893754", "isOpenAccess": "Y", "pageInfo": "1002-1007", "pmcid": "PMC4399481", "hasDbCrossReferences": "Y", "abstractText": "The aim of this study was to determine the influence of the BMI1 gene on chemotherapy sensitivity in human glioma cells.The expression of the BMI1 gene in 41 cases of human brain glioma was determined by quantitative real-time PCR. The silencing effect of RNA interference on the BMI1 gene was detected by Western blot. Methyl thiazolyl tetrazolium assay (MTT) and flow cytometry methods were used to determine the cell viability and apoptosis rate of the U251 cells with BMI1 silencing. After those U251 cells were treated with Cisplatin (DDP), the cell viability and apoptosis rate were further detected.The BMI1 mRNA in glioma was remarkably up-regulated, 176.3% as much as that in peri-cancerous tissues (P<0.05). The siRNA-BMI1 significantly and effectually inhibited the expression of BMI1 protein (P<0.05). The cell viability decreased in U251 cells with BMI1 silenced, and the apoptosis rate upgraded significantly (P<0.05 for both). After treating with DDP at various concentrations (1, 3, and 5 \u03bcg/ml), the cell viability in the BMI1-slienced U251 cells was much lower than that in corresponding control U251 cells at each DDP concentration (P<0.05 for all), and the apoptosis rate showed the opposite changing trends (P<0.05 for all).There is a notable relationship between the over-expression of BMI1 and the carcinogenesis of gliomas. The silence of BMI1 inhibited cell proliferation and enhanced the apoptosis of the U251 cells, and increased the chemotherapy sensitivity of U251 cells to DDP.", "electronicPublicationDate": "2015-04-06", "language": "eng", "dateOfCompletion": "2016-04-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4399481?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4399481", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.12659/MSM.893754", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Med Sci Monit", "isoabbreviation": "Med. Sci. Monit.", "title": "Medical science monitor : international medical journal of experimental and clinical research", "issn": "1234-1010", "nlmid": "9609063", "essn": "1643-3750"}, "monthOfPublication": 0, "volume": "21", "yearOfPublication": 2015, "journalIssueId": 2244047, "dateOfPublication": "2015"}}, "19048113": {"pubYear": "2008", "dateOfCreation": "2008-12-02", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Bmi1 protein, mouse"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "136601-57-5", "name": "Cyclin D1"}, {"registryNumber": "0", "name": "Cyclin-Dependent Kinase Inhibitor p16"}, {"registryNumber": "0", "name": "Cdkn2a protein, mouse"}, {"registryNumber": "0", "name": "Hedgehog Proteins"}, {"registryNumber": "0", "name": "glial fibrillary astrocytic protein, mouse"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Michael LE, Westerman BA, Ermilov AN, Wang A, Ferris J, Liu J, Blom M, Ellison DW, van Lohuizen M, Dlugosz AA.", "affiliation": "Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109-0932, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30CA46592"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA087837"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32GM007315"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA087837"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA087837-09"}]}, "hasPDF": "Y", "id": "19048113", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109-0932, USA.", "fullName": "Michael LE", "initials": "LE", "firstName": "Lowell Evan", "lastName": "Michael"}, {"lastName": "Westerman", "fullName": "Westerman BA", "firstName": "Bart A", "initials": "BA"}, {"lastName": "Ermilov", "fullName": "Ermilov AN", "firstName": "Alexandre N", "initials": "AN"}, {"lastName": "Wang", "fullName": "Wang A", "firstName": "Aiqin", "initials": "A"}, {"lastName": "Ferris", "fullName": "Ferris J", "firstName": "Jennifer", "initials": "J"}, {"lastName": "Liu", "fullName": "Liu J", "firstName": "Jianhong", "initials": "J"}, {"lastName": "Blom", "fullName": "Blom M", "firstName": "Marleen", "initials": "M"}, {"lastName": "Ellison", "fullName": "Ellison DW", "firstName": "David W", "initials": "DW"}, {"lastName": "van Lohuizen", "fullName": "van Lohuizen M", "firstName": "Maarten", "initials": "M"}, {"lastName": "Dlugosz", "fullName": "Dlugosz AA", "firstName": "Andrzej A", "initials": "AA"}]}, "title": "Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.", "hasSuppl": "Y", "citedByCount": 35, "source": "MED", "pmid": "19048113", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refseq"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin D1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "Y"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Cyclin-Dependent Kinase Inhibitor p16", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hedgehog Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2008-12-01", "doi": "10.1593/neo.81078", "isOpenAccess": "N", "pageInfo": "1343-9, 5p following 1349", "pmcid": "PMC2586685", "hasDbCrossReferences": "Y", "abstractText": "Inappropriate Hedgehog (Hh) signaling underlies development of a subset of medulloblastomas, and tumors with elevated HH signaling activity express the stem cell self-renewal gene BMI1. To test whether Bmi1 is required for Hh-driven medulloblastoma development, we varied Bmi1 gene dosage in transgenic mice expressing an oncogenic Hh effector, SmoA1, driven by a glial fibrillary acidic protein (GFAP) promoter. Whereas 100% of SmoA1; Bmi1(+/+) or SmoA1;Bmi1(+/-) mice examined between postnatal (P) days 14 and 26 had typical medulloblastomas (N = 29), tumors were not detected in any of the SmoA1;Bmi1(-/-) animals examined (N = 6). Instead, small ectopic collections of cells were present in the region of greatest tumor load in SmoA1 animals, suggesting that medulloblastomas were initiated but failed to undergo expansion into frank tumors. Cells within these Bmi1(-/-) lesions expressed SmoA1 but were largely nonproliferative, in contrast to cells in Bmi1(+/+) tumors (6.2% vs 81.9% PCNA-positive, respectively). Ectopic cells were negative for the progenitor marker nestin, strongly GFAP-positive, and highly apoptotic, relative to Bmi1(+/+) tumor cells (29.6% vs 6.3% TUNEL-positive). The alterations in proliferation and apoptosis in SmoA1;Bmi1(-/-) ectopic cells are associated with reduced levels of Cyclin D1 and elevated expression of cyclin-dependent kinase inhibitor p19(Arf), two inversely regulated downstream targets of Bmi1. These data provide the first demonstration that Bmi1 is required for spontaneous de novo development of a solid tumor arising in the brain, suggest a crucial role for Bmi1-dependent, nestin-expressing progenitor cells in medulloblastoma expansion, and implicate Bmi1 as a key factor required for Hh pathway-driven tumorigenesis.", "language": "eng", "dateOfCompletion": "2009-04-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2586685?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2586685", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19048113&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19048113", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1593/neo.81078", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://openurl.ingenta.com/content?genre=article&issn=1522-8002&volume=10&issue=12&spage=1343", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "ingentaconnect"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-09-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-12-01", "journal": {"medlineAbbreviation": "Neoplasia", "isoabbreviation": "Neoplasia", "title": "Neoplasia (New York, N.Y.)", "issn": "1522-8002", "nlmid": "100886622", "essn": "1476-5586"}, "monthOfPublication": 12, "volume": "10", "yearOfPublication": 2008, "journalIssueId": 1582164, "issue": "12", "dateOfPublication": "2008 Dec"}}, "25526772": {"pubYear": "2014", "dateOfCreation": "2015-02-25", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.2.1.48", "name": "long-chain-aldehyde dehydrogenase"}, {"registryNumber": "0", "name": "API5 protein, human"}, {"registryNumber": "0", "name": "AC133 antigen"}, {"registryNumber": "0", "name": "EIF4G2 protein, human"}, {"registryNumber": "0", "name": "Peptides"}, {"registryNumber": "0", "name": "Glycoproteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Antigens, CD"}, {"registryNumber": "0", "name": "Poly(A)-Binding Proteins"}, {"registryNumber": "EC 6.3.2.19", "name": "Ubiquitin-Protein Ligases"}, {"registryNumber": "EC 3.6.1.-", "name": "Kinesin"}, {"registryNumber": "0", "name": "Eukaryotic Initiation Factor-4G"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "0", "name": "Apoptosis Regulatory Proteins"}, {"registryNumber": "EC 1.2.-", "name": "Aldehyde Oxidoreductases"}, {"registryNumber": "EC 3.6.1.-", "name": "KIF5C protein, human"}, {"registryNumber": "EC 2.7.11.1", "name": "ribosomal protein S6 kinase, 90kDa, polypeptide 3"}, {"registryNumber": "EC 2.7.11.1", "name": "Ribosomal Protein S6 Kinases, 90-kDa"}, {"registryNumber": "EC 6.3.2.19", "name": "DTL protein, human"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Baxter PA, Lin Q, Mao H, Kogiso M, Zhao X, Liu Z, Huang Y, Voicu H, Gurusiddappa S, Su JM, Adesina AM, Perlaky L, Dauser RC, Leung HC, Muraszko KM, Heth JA, Fan X, Lau CC, Man TK, Chintagumpala M, Li XN.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K 12 CA090433"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K12 CA090433"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "T-32 CA115303"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA163737"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA148621"}]}, "hasPDF": "Y", "id": "25526772", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Baxter", "fullName": "Baxter PA", "firstName": "Patricia A", "initials": "PA"}, {"lastName": "Lin", "fullName": "Lin Q", "firstName": "Qi", "initials": "Q"}, {"lastName": "Mao", "fullName": "Mao H", "firstName": "Hua", "initials": "H"}, {"lastName": "Kogiso", "fullName": "Kogiso M", "firstName": "Mari", "initials": "M"}, {"lastName": "Zhao", "fullName": "Zhao X", "firstName": "Xiumei", "initials": "X"}, {"lastName": "Liu", "fullName": "Liu Z", "firstName": "Zhigang", "initials": "Z"}, {"lastName": "Huang", "fullName": "Huang Y", "firstName": "Yulun", "initials": "Y"}, {"lastName": "Voicu", "fullName": "Voicu H", "firstName": "Horatiu", "initials": "H"}, {"lastName": "Gurusiddappa", "fullName": "Gurusiddappa S", "firstName": "Sivashankarappa", "initials": "S"}, {"lastName": "Su", "fullName": "Su JM", "firstName": "Jack M", "initials": "JM"}, {"lastName": "Adesina", "fullName": "Adesina AM", "firstName": "Adekunle M", "initials": "AM"}, {"lastName": "Perlaky", "fullName": "Perlaky L", "firstName": "Laszlo", "initials": "L"}, {"lastName": "Dauser", "fullName": "Dauser RC", "firstName": "Robert C", "initials": "RC"}, {"lastName": "Leung", "fullName": "Leung HC", "firstName": "Hon-chiu Eastwood", "initials": "HC"}, {"lastName": "Muraszko", "fullName": "Muraszko KM", "firstName": "Karin M", "initials": "KM"}, {"lastName": "Heth", "fullName": "Heth JA", "firstName": "Jason A", "initials": "JA"}, {"lastName": "Fan", "fullName": "Fan X", "firstName": "Xing", "initials": "X"}, {"lastName": "Lau", "fullName": "Lau CC", "firstName": "Ching C", "initials": "CC"}, {"lastName": "Man", "fullName": "Man TK", "firstName": "Tsz-Kwong", "initials": "TK"}, {"lastName": "Chintagumpala", "fullName": "Chintagumpala M", "firstName": "Murali", "initials": "M"}, {"lastName": "Li", "fullName": "Li XN", "firstName": "Xiao-Nan", "initials": "XN"}]}, "title": "Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25526772", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Nude", "majorTopic_YN": "N"}, {"descriptorName": "Glioma", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Kinesin", "majorTopic_YN": "N"}, {"descriptorName": "Ubiquitin-Protein Ligases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aldehyde Oxidoreductases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Protein S6 Kinases, 90-kDa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Poly(A)-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Eukaryotic Initiation Factor-4G", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Xenograft Model Antitumor Assays", "majorTopic_YN": "N"}, {"descriptorName": "Down-Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Apoptosis Regulatory Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-12-20", "language": "eng", "doi": "10.1186/s40478-014-0160-4", "isOpenAccess": "Y", "pageInfo": "160", "pmcid": "PMC4289398", "hasDbCrossReferences": "N", "abstractText": "Clinical outcome of children with malignant glioma remains dismal. Here, we examined the role of over-expressed BMI1, a regulator of stem cell self-renewal, in sustaining tumor formation in pediatric glioma stem cells. Our investigation revealed BMI1 over-expression in 29 of 54 (53.7%) pediatric gliomas, 8 of 8 (100%) patient derived orthotopic xenograft (PDOX) mouse models, and in both CD133+ and CD133- glioma cells. We demonstrated that lentiviral-shRNA mediated silencing of suppressed cell proliferation in vitro in cells derived from 3 independent PDOX models and eliminated tumor-forming capacity of CD133+ and CD133- cells derived from 2 PDOX models in mouse brains. Gene expression profiling showed that most of the molecular targets of BMI1 ablation in CD133+ cells were different from that in CD133- cells. Importantly, we found that silencing BMI1 in CD133+ cells derived from 3 PDOX models did not affect most of the known genes previously associated with the activated BMI1, but modulated a novel set of core genes, including RPS6KA2, ALDH3A2, FMFB, DTL, API5, EIF4G2, KIF5c, LOC650152, C20ORF121, LOC203547, LOC653308, and LOC642489, to mediate the elimination of tumor formation. In summary, we identified the over-expressed BMI1 as a promising therapeutic target for glioma stem cells, and suggest that the signaling pathways associated with activated BMI1 in promoting tumor growth may be different from those induced by silencing BMI1 in blocking tumor formation. These findings highlighted the importance of careful re-analysis of the affected genes following the inhibition of abnormally activated oncogenic pathways to identify determinants that can potentially predict therapeutic efficacy.", "electronicPublicationDate": "2014-12-20", "license": "cc by", "dateOfCompletion": "2015-09-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4289398?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4289398", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s40478-014-0160-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-04-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "Acta neuropathologica communications", "medlineAbbreviation": "Acta Neuropathol Commun", "isoabbreviation": "Acta Neuropathol Commun", "nlmid": "101610673", "essn": "2051-5960"}, "monthOfPublication": 0, "volume": "2", "yearOfPublication": 2014, "journalIssueId": 2162833, "dateOfPublication": "2014 "}}, "23046527": {"pubYear": "2012", "dateOfCreation": "2012-12-12", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "51-21-8", "name": "Fluorouracil"}, {"registryNumber": "15663-27-1", "name": "Cisplatin"}, {"registryNumber": "0", "name": "Cyclin-Dependent Kinase Inhibitor p16"}, {"registryNumber": "0", "name": "Hedgehog Proteins"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Yoshikawa R, Tsujimura T, Tao L, Kamikonya N, Fujiwara Y.", "affiliation": "Department of Surgery, Kanzaki Hospital, 3-1-10, Hama, Amagasaki, Hyogo, 661-0967, Japan. reigetsu-yoshikawa@hotmail.co.jp", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23046527", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Yoshikawa", "fullName": "Yoshikawa R", "firstName": "Reigetsu", "initials": "R"}, {"lastName": "Tsujimura", "fullName": "Tsujimura T", "firstName": "Tohru", "initials": "T"}, {"lastName": "Tao", "fullName": "Tao L", "firstName": "Lihua", "initials": "L"}, {"lastName": "Kamikonya", "fullName": "Kamikonya N", "firstName": "Norihiko", "initials": "N"}, {"lastName": "Fujiwara", "fullName": "Fujiwara Y", "firstName": "Yoshinori", "initials": "Y"}]}, "title": "The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy.", "hasSuppl": "N", "citedByCount": 8, "source": "MED", "pmid": "23046527", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Carcinoma, Squamous Cell", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Esophageal Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Progression", "majorTopic_YN": "N"}, {"descriptorName": "Cisplatin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fluorouracil", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antineoplastic Combined Chemotherapy Protocols", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Disease-Free Survival", "majorTopic_YN": "N"}, {"descriptorName": "Preoperative Care", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Esophagectomy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cyclin-Dependent Kinase Inhibitor p16", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hedgehog Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neoplastic Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chemoradiotherapy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-10-09", "language": "eng", "doi": "10.1186/1471-2407-12-461", "isOpenAccess": "Y", "pageInfo": "461", "pmcid": "PMC3519675", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: The polycomb group (PcG) family BMI1, acting downstream of the hedgehog (Hh) pathway, plays an essential role in the self-renewal of haematopoietic, neural, and intestinal stem cells, and is dysregulated in many types of cancer. Our recent report has demonstrated that Hh signalling activation can predict very earlier relapse of oesophageal cancers. As data were not available on the clinical role of BMI1 expression in oesophageal cancers after chemoradiotherapy (CRT), we analysed whether it could be also used to predict disease progression and prognosis in oesophageal cancer patients undergoing trimodality therapy of preoperative CRT and oesophagectomy. METHODS: Expressions of BMI1 and p16INK4A, a downstream target of PcG, were analysed in 78 patients with histologically confirmed oesophageal squamous cell carcinoma (ESCC) after preoperative CRT by immunohistochemical staining. The association of BMI1 and p16INK4A expression with clinicopathologic characteristics was analysed by \u03c72-test. Survival analysis was carried out by the log-rank test using Kaplan-Meier method. RESULTS: Among 78 ESCC patients, 24 patients (30.8%) showed BMI1 positivity, mainly localised in the nuclei of tumour cells. Patients harbouring BMI1-positive tumour cells showed significantly poorer prognoses than those without such cells or residual tumours (mean disease-free survival (DFS) time 16.8 vs 71.2 months; 3-yr DFS 13.3% vs 49.9%, P=0.002; mean OS time 21.8 vs 76.6 months; 3-yr OS 16.2% vs 54.9%, P=0.0005). There was no significant correlation between p16INK4A expression and BMI1 expression. CONCLUSIONS: Our study shows that BMI1 expression is a predictor of early relapse and poor prognosis in ESCC after CRT. These findings suggest that BMI1 signal activation might be involved in promoting cancer regrowth and progression after CRT, and might be indicative of emergence of 'more aggressive' cancer progenitor cells.", "electronicPublicationDate": "2012-10-09", "license": "cc by", "dateOfCompletion": "2013-08-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3519675?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3519675", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23046527&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23046527", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1471-2407-12-461", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "BMC cancer", "medlineAbbreviation": "BMC Cancer", "isoabbreviation": "BMC Cancer", "nlmid": "100967800", "essn": "1471-2407"}, "monthOfPublication": 0, "volume": "12", "yearOfPublication": 2012, "journalIssueId": 1898849, "dateOfPublication": "2012 "}}, "25792222": {"pubYear": "2015", "dateOfCreation": "2015-11-21", "pubModel": "Print-Electronic", "authorString": "Spadaro PA, Flavell CR, Widagdo J, Ratnu VS, Troup M, Ragan C, Mattick JS, Bredy TW.", "affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R21 MH103812"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "1R21MH103812"}]}, "id": "25792222", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "fullName": "Spadaro PA", "initials": "PA", "firstName": "Paola A", "lastName": "Spadaro"}, {"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "fullName": "Flavell CR", "initials": "CR", "firstName": "Charlotte R", "lastName": "Flavell"}, {"firstName": "Jocelyn", "lastName": "Widagdo", "affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "authorId": {"type": "ORCID", "value": "0000-0001-9667-9203"}, "fullName": "Widagdo J", "initials": "J"}, {"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "fullName": "Ratnu VS", "initials": "VS", "firstName": "Vikram S", "lastName": "Ratnu"}, {"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "fullName": "Troup M", "initials": "M", "firstName": "Michael", "lastName": "Troup"}, {"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland.", "fullName": "Ragan C", "initials": "C", "firstName": "Chikako", "lastName": "Ragan"}, {"firstName": "John S", "lastName": "Mattick", "affiliation": "Garvan Institute of Medical Research, Darlinghurst, and St Vincent's Clinical School, University of New South Wales, Kensington, New South Wales, Australia.", "authorId": {"type": "ORCID", "value": "0000-0002-7680-7527"}, "fullName": "Mattick JS", "initials": "JS"}, {"affiliation": "Queensland Brain Institute, The University of Queensland Australia, Brisbane, Queensland. Electronic address: t.bredy@uq.edu.au.", "fullName": "Bredy TW", "initials": "TW", "firstName": "Timothy W", "lastName": "Bredy"}]}, "title": "Long Noncoding RNA-Directed Epigenetic Regulation of Gene Expression Is Associated With Anxiety-like Behavior in Mice.", "citedByCount": 3, "source": "MED", "pmid": "25792222", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9667-9203"}, {"type": "ORCID", "value": "0000-0002-7680-7527"}]}, "hasPDF": "N", "inPMC": "N", "embargoDate": "2016-12-15", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-02-11", "doi": "10.1016/j.biopsych.2015.02.004", "isOpenAccess": "N", "pageInfo": "848-859", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Behavior", "Anxiety", "Epigenetics", "Noncoding RNA", "Crybb1", "Gomafu"]}, "abstractText": "RNA-directed regulation of epigenetic processes has recently emerged as an important feature of mammalian differentiation and development. Perturbation of this regulatory system in the brain may contribute to the development of neuropsychiatric disorders.RNA sequencing was used to identify changes in the experience-dependent expression of long noncoding RNAs (lncRNAs) within the medial prefrontal cortex of adult mice. Transcripts were validated by real-time quantitative polymerase chain reaction and a candidate lncRNA, Gomafu, was selected for further investigation. The functional role of this schizophrenia-related lncRNA was explored in vivo by antisense oligonucleotide-mediated gene knockdown in the medial prefrontal cortex, followed by behavioral training and assessment of fear-related anxiety. Long noncoding RNA-directed epigenetic regulation of gene expression was investigated by chromatin and RNA immunoprecipitation assays.RNA sequencing analysis revealed changes in the expression of a significant number of genes related to neural plasticity and stress, as well as the dynamic regulation of lncRNAs. In particular, we detected a significant downregulation of Gomafu lncRNA. Our results revealed that Gomafu plays a role in mediating anxiety-like behavior and suggest that this may occur through an interaction with a key member of the polycomb repressive complex 1, BMI1, which regulates the expression of the schizophrenia-related gene beta crystallin (Crybb1). We also demonstrated a novel role for Crybb1 in mediating fear-induced anxiety-like behavior.Experience-dependent expression of lncRNAs plays an important role in the epigenetic regulation of adaptive behavior, and the perturbation of Gomafu may be related to anxiety and the development of neuropsychiatric disorders.", "electronicPublicationDate": "2015-02-11", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.biopsych.2015.02.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2015-11-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-12-01", "journal": {"medlineAbbreviation": "Biol Psychiatry", "isoabbreviation": "Biol. Psychiatry", "title": "Biological psychiatry", "issn": "0006-3223", "nlmid": "0213264", "essn": "1873-2402"}, "monthOfPublication": 12, "volume": "78", "yearOfPublication": 2015, "journalIssueId": 2344808, "issue": "12", "dateOfPublication": "2015 Dec"}}, "16528373": {"pubYear": "2006", "dateOfCreation": "2006-04-20", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RYBP protein, human"}, {"registryNumber": "0", "name": "PHC1 protein, human"}, {"registryNumber": "0", "name": "Carrier Proteins"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "EC 6.3.2.19", "name": "Ubiquitin-Protein Ligases"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "EC 6.3.2.19", "name": "RNF2 protein, human"}, {"registryNumber": "0", "name": "PCGF2 protein, human"}, {"registryNumber": "EC 6.3.2", "name": "RING1 protein, human"}, {"registryNumber": "0", "name": "Polycomb-Group Proteins"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "S\u00e1nchez-Beato M, S\u00e1nchez E, Gonz\u00e1lez-Carrer\u00f3 J, Morente M, D\u00edez A, S\u00e1nchez-Verde L, Mart\u00edn MC, Cigudosa JC, Vidal M, Piris MA.", "affiliation": "Lymphoma Group, Molecular Pathology Programme, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain. msbeato@cnio.es", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "N", "id": "16528373", "inEPMC": "N", "authorList": {"author": [{"lastName": "S\u00e1nchez-Beato", "fullName": "S\u00e1nchez-Beato M", "firstName": "Margarita", "initials": "M"}, {"lastName": "S\u00e1nchez", "fullName": "S\u00e1nchez E", "firstName": "Esther", "initials": "E"}, {"lastName": "Gonz\u00e1lez-Carrer\u00f3", "fullName": "Gonz\u00e1lez-Carrer\u00f3 J", "firstName": "Joaqu\u00edn", "initials": "J"}, {"lastName": "Morente", "fullName": "Morente M", "firstName": "Manuel", "initials": "M"}, {"lastName": "D\u00edez", "fullName": "D\u00edez A", "firstName": "Ana", "initials": "A"}, {"lastName": "S\u00e1nchez-Verde", "fullName": "S\u00e1nchez-Verde L", "firstName": "Lydia", "initials": "L"}, {"lastName": "Mart\u00edn", "fullName": "Mart\u00edn MC", "firstName": "Mar\u00eda Carmen", "initials": "MC"}, {"lastName": "Cigudosa", "fullName": "Cigudosa JC", "firstName": "Juan C", "initials": "JC"}, {"lastName": "Vidal", "fullName": "Vidal M", "authorId": {"type": "ORCID", "value": "0000-0003-4374-6761"}, "firstName": "Miguel", "initials": "M"}, {"lastName": "Piris", "fullName": "Piris MA", "authorId": {"type": "ORCID", "value": "0000-0001-5839-3634"}, "firstName": "Miguel A", "initials": "MA"}]}, "title": "Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.", "citedByCount": 39, "source": "MED", "pmid": "16528373", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4374-6761"}, {"type": "ORCID", "value": "0000-0001-5839-3634"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ubiquitin-Protein Ligases", "majorTopic_YN": "N"}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carrier Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tissue Array Analysis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Hybridization, Fluorescence", "majorTopic_YN": "N"}, {"descriptorName": "Pilot Projects", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb-Group Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-05-01", "doi": "10.1038/modpathol.3800577", "isOpenAccess": "N", "pageInfo": "684-694", "hasDbCrossReferences": "N", "abstractText": "In spite of the known function of polycomb group (PcG) genes in stem cell self-renewal, control of cellular proliferation and differentiation, its role in cancer pathogenesis is still poorly understood. We studied the expression by immunohistochemistry of several PcG-maintenance complex proteins (RING1, RNF2, BMI1, MEL18, HPH1 and RYBP) in nontumoral (154 samples) and tumoral (550 samples) human tissues using Tissue Microarrays. For selected genes (BMI1 and RING1) FISH analysis has been also carried out. PcG proteins had a tissue- and cell-type-specific expression pattern. Some of them were highly selectively expressed, such as HPH1, which was detected in germ cells in testis, pituitary and parathyroid glands and Langerhans islets, and RYBP, which was found in placenta, umbilical cord and thyroid gland. By contrast, RING1 was ubiquitously expressed in every normal tissue analyzed. Changes in expression associated with tumoral transformation have been found for BMI1 and RNF2, which exhibited increased expression in a large series of tumors, including gastrointestinal tumors, pituitary and parathyroid adenomas, and lymphomas, compared with their expression in normal-cell counterparts. The high level of expression of BMI1 protein observed in mantle-cell lymphomas and pituitary adenomas is associated in some cases with amplification of BMI1 locus. These findings imply that upregulation of BMI1 may constitute a malignancy marker in different types of cancer, mainly in lymphoid and endocrine tumors. RING1 was lost in a group of renal-cell carcinomas and testicular germ-cell tumors. Lastly, RYBP is anomalously expressed in Hodgkin's lymphomas and oligodendrogliomas, among others tumors. A significant finding of the study is the identification of unique PcG profiles for some tumors, such as testicular germ-cell tumors, which have high levels of HPH1 expression and loss of RING1 and/or BMI1; pituitary adenomas, which expressed every PcG protein analyzed; and clear-cell renal-cell carcinoma, which was the only tumor other than testicular germ-cell tumors that did not express RING1.", "language": "eng", "dateOfCompletion": "2006-07-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/modpathol.3800577", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-05-01", "journal": {"medlineAbbreviation": "Mod Pathol", "isoabbreviation": "Mod. Pathol.", "title": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc", "issn": "0893-3952", "nlmid": "8806605", "essn": "1530-0285"}, "monthOfPublication": 5, "volume": "19", "yearOfPublication": 2006, "journalIssueId": 1318013, "issue": "5", "dateOfPublication": "2006 May"}}, "23680149": {"pubYear": "2013", "dateOfCreation": "2013-05-17", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "activating transcription factor 3"}, {"registryNumber": "0", "name": "Bmi1 protein, mouse"}, {"registryNumber": "0", "name": "ATF3 protein, human"}, {"registryNumber": "0", "name": "Chromatin"}, {"registryNumber": "0", "name": "Bone Morphogenetic Proteins"}, {"registryNumber": "0", "name": "Transforming Growth Factor beta"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "CBX7 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Gargiulo G, Cesaroni M, Serresi M, de Vries N, Hulsman D, Bruggeman SW, Lancini C, van Lohuizen M.", "affiliation": "Division of Molecular Genetics and Centre for Biomedical Genetics, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23680149", "inEPMC": "N", "authorList": {"author": [{"lastName": "Gargiulo", "fullName": "Gargiulo G", "authorId": {"type": "ORCID", "value": "0000-0001-5414-4251"}, "firstName": "Gaetano", "initials": "G"}, {"lastName": "Cesaroni", "fullName": "Cesaroni M", "firstName": "Matteo", "initials": "M"}, {"lastName": "Serresi", "fullName": "Serresi M", "firstName": "Michela", "initials": "M"}, {"lastName": "de Vries", "fullName": "de Vries N", "firstName": "Nienke", "initials": "N"}, {"lastName": "Hulsman", "fullName": "Hulsman D", "firstName": "Danielle", "initials": "D"}, {"lastName": "Bruggeman", "fullName": "Bruggeman SW", "firstName": "Sophia W", "initials": "SW"}, {"lastName": "Lancini", "fullName": "Lancini C", "firstName": "Cesare", "initials": "C"}, {"lastName": "van Lohuizen", "fullName": "van Lohuizen M", "firstName": "Maarten", "initials": "M"}]}, "title": "In vivo RNAi screen for BMI1 targets identifies TGF-\u03b2/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.", "citedByCount": 33, "pageInfo": "660-676", "source": "MED", "pmid": "23680149", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5414-4251"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Nucleus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromatin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Glioblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transforming Growth Factor beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Bone Morphogenetic Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "RNA Interference", "majorTopic_YN": "N"}, {"descriptorName": "Homeostasis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Activating Transcription Factor 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neoplastic Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neural Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endoplasmic Reticulum Stress", "majorTopic_YN": "Y"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT", "ARXPR"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-05-01", "doi": "10.1016/j.ccr.2013.03.030", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "23746971", "reference": "Cell Stem Cell. 2013 Jun 6;12(6):639-41"}]}, "hasDbCrossReferences": "Y", "abstractText": "In mouse and human neural progenitor and glioblastoma \"stem-like\" cells, we identified key targets of the Polycomb-group protein BMI1 by combining ChIP-seq with in vivo RNAi screening. We discovered that Bmi1 is important in the cellular response to the transforming growth factor-\u03b2/bone morphogenetic protein (TGF-\u03b2/BMP) and endoplasmic reticulum (ER) stress pathways, in part converging on the Atf3 transcriptional repressor. We show that Atf3 is a tumor-suppressor gene inactivated in human glioblastoma multiforme together with Cbx7 and a few other candidates. Acting downstream of the ER stress and BMP pathways, ATF3 binds to cell-type-specific accessible chromatin preloaded with AP1 and participates in the inhibition of critical oncogenic networks. Our data support the feasibility of combining ChIP-seq and RNAi screens in solid tumors and highlight multiple p16(INK4a)/p19(ARF)-independent functions for Bmi1 in development and cancer.", "language": "eng", "dateOfCompletion": "2013-07-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.ccr.2013.03.030", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-07-29", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-05-01", "journal": {"medlineAbbreviation": "Cancer Cell", "isoabbreviation": "Cancer Cell", "title": "Cancer cell", "issn": "1535-6108", "nlmid": "101130617", "essn": "1878-3686"}, "monthOfPublication": 5, "volume": "23", "yearOfPublication": 2013, "journalIssueId": 2039897, "issue": "5", "dateOfPublication": "2013 May"}}, "15029199": {"pubYear": "2004", "dateOfCreation": "2004-03-18", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Gli protein"}, {"registryNumber": "0", "name": "Bmi1 protein, mouse"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Trans-Activators"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "Oncogene Proteins"}, {"registryNumber": "0", "name": "patched receptors"}, {"registryNumber": "0", "name": "Hedgehog Proteins"}, {"registryNumber": "0", "name": "SHH protein, human"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S.", "affiliation": "Institute of Clinical Pathology, Department of Pathology, University of Z\u00fcrich, Schmelzbergstrasse 12, 8091 Z\u00fcrich, Switzerland.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "15029199", "inEPMC": "N", "authorList": {"author": [{"lastName": "Leung", "fullName": "Leung C", "firstName": "Carly", "initials": "C"}, {"lastName": "Lingbeek", "fullName": "Lingbeek M", "firstName": "Merel", "initials": "M"}, {"lastName": "Shakhova", "fullName": "Shakhova O", "firstName": "Olga", "initials": "O"}, {"lastName": "Liu", "fullName": "Liu J", "firstName": "James", "initials": "J"}, {"lastName": "Tanger", "fullName": "Tanger E", "firstName": "Ellen", "initials": "E"}, {"lastName": "Saremaslani", "fullName": "Saremaslani P", "firstName": "Parvin", "initials": "P"}, {"lastName": "Van Lohuizen", "fullName": "Van Lohuizen M", "firstName": "Maarten", "initials": "M"}, {"lastName": "Marino", "fullName": "Marino S", "firstName": "Silvia", "initials": "S"}]}, "title": "Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.", "citedByCount": 275, "source": "MED", "pmid": "15029199", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Trans-Activators", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N"}, {"descriptorName": "Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Division", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Developmental", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Hedgehog Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2004-03-01", "doi": "10.1038/nature02385", "isOpenAccess": "N", "pageInfo": "337-341", "hasDbCrossReferences": "Y", "abstractText": "Overexpression of the polycomb group gene Bmi1 promotes cell proliferation and induces leukaemia through repression of Cdkn2a (also known as ink4a/Arf) tumour suppressors. Conversely, loss of Bmi1 leads to haematological defects and severe progressive neurological abnormalities in which de-repression of the ink4a/Arf locus is critically implicated. Here, we show that Bmi1 is strongly expressed in proliferating cerebellar precursor cells in mice and humans. Using Bmi1-null mice we demonstrate a crucial role for Bmi1 in clonal expansion of granule cell precursors both in vivo and in vitro. Deregulated proliferation of these progenitor cells, by activation of the sonic hedgehog (Shh) pathway, leads to medulloblastoma development. We also demonstrate linked overexpression of BMI1 and patched (PTCH), suggestive of SHH pathway activation, in a substantial fraction of primary human medulloblastomas. Together with the rapid induction of Bmi1 expression on addition of Shh or on overexpression of the Shh target Gli1 in cerebellar granule cell cultures, these findings implicate BMI1 overexpression as an alternative or additive mechanism in the pathogenesis of medulloblastomas, and highlight a role for Bmi1-containing polycomb complexes in proliferation of cerebellar precursor cells.", "language": "eng", "dateOfCompletion": "2004-04-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/nature02385", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "nature.com"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-03-01", "journal": {"medlineAbbreviation": "Nature", "isoabbreviation": "Nature", "title": "Nature", "issn": "0028-0836", "nlmid": "0410462", "essn": "1476-4687"}, "monthOfPublication": 3, "volume": "428", "yearOfPublication": 2004, "journalIssueId": 1131267, "issue": "6980", "dateOfPublication": "2004 Mar"}}, "22574128": {"pubYear": "2012", "dateOfCreation": "2012-05-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Bmi1 protein, mouse"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "EC 2.7.7.-", "name": "Integrases"}, {"registryNumber": "0", "name": "Glial Fibrillary Acidic Protein"}, {"registryNumber": "60617-12-1", "name": "beta-Endorphin"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "Retinoblastoma Protein"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "0", "name": "Cyclin-Dependent Kinase Inhibitor p16"}, {"registryNumber": "EC 2.7.7.-", "name": "Cre recombinase"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Westerman BA, Blom M, Tanger E, van der Valk M, Song JY, van Santen M, Gadiot J, Cornelissen-Steijger P, Zevenhoven J, Prosser HM, Uren A, Aronica E, van Lohuizen M.", "affiliation": "Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Medical Research Council", "grantId": "MC_UP_A652_1001"}]}, "hasPDF": "Y", "id": "22574128", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.", "fullName": "Westerman BA", "initials": "BA", "firstName": "Bart A", "lastName": "Westerman"}, {"lastName": "Blom", "fullName": "Blom M", "firstName": "Marleen", "initials": "M"}, {"lastName": "Tanger", "fullName": "Tanger E", "firstName": "Ellen", "initials": "E"}, {"lastName": "van der Valk", "fullName": "van der Valk M", "firstName": "Martin", "initials": "M"}, {"lastName": "Song", "fullName": "Song JY", "firstName": "Ji-Ying", "initials": "JY"}, {"lastName": "van Santen", "fullName": "van Santen M", "firstName": "Marije", "initials": "M"}, {"lastName": "Gadiot", "fullName": "Gadiot J", "firstName": "Jules", "initials": "J"}, {"lastName": "Cornelissen-Steijger", "fullName": "Cornelissen-Steijger P", "firstName": "Paulien", "initials": "P"}, {"lastName": "Zevenhoven", "fullName": "Zevenhoven J", "firstName": "John", "initials": "J"}, {"lastName": "Prosser", "fullName": "Prosser HM", "firstName": "Haydn M", "initials": "HM"}, {"lastName": "Uren", "fullName": "Uren A", "firstName": "Anthony", "initials": "A"}, {"lastName": "Aronica", "fullName": "Aronica E", "firstName": "Eleonora", "initials": "E"}, {"lastName": "van Lohuizen", "fullName": "van Lohuizen M", "firstName": "Maarten", "initials": "M"}]}, "title": "GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors.", "hasSuppl": "Y", "citedByCount": 7, "source": "MED", "pmid": "22574128", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pituitary Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glial Fibrillary Acidic Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Integrases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "beta-Endorphin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinoblastoma Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "Transgenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin-Dependent Kinase Inhibitor p16", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-05-04", "doi": "10.1371/journal.pone.0035943", "isOpenAccess": "Y", "pageInfo": "e35943", "pmcid": "PMC3344841", "hasDbCrossReferences": "Y", "abstractText": "Bmi1 is a member of the polycomb repressive complex 1 and plays different roles during embryonic development, depending on the developmental context. Bmi1 over expression is observed in many types of cancer, including tumors of astroglial and neural origin. Although genetic depletion of Bmi1 has been described to result in tumor inhibitory effects partly through INK4A/Arf mediated senescence and apoptosis and also through INK4A/Arf independent effects, it has not been proven that Bmi1 can be causally involved in the formation of these tumors. To see whether this is the case, we developed two conditional Bmi1 transgenic models that were crossed with GFAP-Cre mice to activate transgenic expression in neural and glial lineages. We show here that these mice generate intermediate and anterior lobe pituitary tumors that are positive for ACTH and beta-endorphin. Combined transgenic expression of Bmi1 together with conditional loss of Rb resulted in pituitary tumors but was insufficient to induce medulloblastoma therefore indicating that the oncogenic function of Bmi1 depends on regulation of p16(INK4A)/Rb rather than on regulation of p19(ARF)/p53. Human pituitary adenomas show Bmi1 overexpression in over 50% of the cases, which indicates that Bmi1 could be causally involved in formation of these tumors similarly as in our mouse model.", "electronicPublicationDate": "2012-05-04", "language": "eng", "dateOfCompletion": "2012-09-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3344841?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3344841", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22574128", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22574128&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0035943", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-07-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1929547, "issue": "5", "dateOfPublication": "2012 "}}, "24356439": {"pubYear": "2013", "dateOfCreation": "2013-12-20", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "forkhead transcription factors"}, {"registryNumber": "0", "name": "FOXG1 protein, human"}, {"registryNumber": "0", "name": "Tle6 protein, human"}]}, "authorString": "Verginelli F, Perin A, Dali R, Fung KH, Lo R, Longatti P, Guiot MC, Del Maestro RF, Rossi S, di Porzio U, Stechishin O, Weiss S, Stifani S.", "affiliation": "1] Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4 [2].", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "115711-1"}, {"orderIn": 0, "agency": "Alberta Innovates Health Solutions", "grantId": "201201230"}, {"orderIn": 0, "agency": "Canadian Institutes of Health Research", "grantId": "13957-3"}]}, "hasPDF": "Y", "id": "24356439", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "1] Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4 [2].", "fullName": "Verginelli F", "initials": "F", "firstName": "Federica", "lastName": "Verginelli"}, {"affiliation": "1] Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4 [2] [3].", "fullName": "Perin A", "initials": "A", "firstName": "Alessandro", "lastName": "Perin"}, {"affiliation": "Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "fullName": "Dali R", "initials": "R", "firstName": "Rola", "lastName": "Dali"}, {"affiliation": "Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "fullName": "Fung KH", "initials": "KH", "firstName": "Karen H", "lastName": "Fung"}, {"affiliation": "Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "fullName": "Lo R", "initials": "R", "firstName": "Rita", "lastName": "Lo"}, {"affiliation": "Department of Neurosurgery, Treviso Hospital, University of Padova, Padova 31100, Italy.", "fullName": "Longatti P", "initials": "P", "firstName": "Pierluigi", "lastName": "Longatti"}, {"affiliation": "Department of Neuropathology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "fullName": "Guiot MC", "initials": "MC", "firstName": "Marie-Christine", "lastName": "Guiot"}, {"affiliation": "Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "fullName": "Del Maestro RF", "initials": "RF", "firstName": "Rolando F", "lastName": "Del Maestro"}, {"affiliation": "Department of Pathology, Treviso Hospital, University of Padova, Padova 31100, Italy.", "fullName": "Rossi S", "initials": "S", "firstName": "Sabrina", "lastName": "Rossi"}, {"firstName": "Umberto", "lastName": "di Porzio", "affiliation": "Institute of Genetics and Biophysics, Adriano Buzzati Traverso, Napoli 80131, Italy.", "authorId": {"type": "ORCID", "value": "0000-0002-2139-8754"}, "fullName": "di Porzio U", "initials": "U"}, {"affiliation": "Department of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada T2N 4N1.", "fullName": "Stechishin O", "initials": "O", "firstName": "Owen", "lastName": "Stechishin"}, {"affiliation": "Department of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada T2N 4N1.", "fullName": "Weiss S", "initials": "S", "firstName": "Samuel", "lastName": "Weiss"}, {"firstName": "Stefano", "lastName": "Stifani", "affiliation": "Centre for Neuronal Survival, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada H3A 2B4.", "authorId": {"type": "ORCID", "value": "0000-0002-2376-7701"}, "fullName": "Stifani S", "initials": "S"}]}, "title": "Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "24356439", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2139-8754"}, {"type": "ORCID", "value": "0000-0002-2376-7701"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Astrocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Mice, SCID", "majorTopic_YN": "N"}, {"descriptorName": "Glioblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microscopy, Fluorescence", "majorTopic_YN": "N"}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasm Transplantation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Differentiation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Silencing", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Forkhead Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-01", "doi": "10.1038/ncomms3956", "isOpenAccess": "Y", "pageInfo": "2956", "pmcid": "PMC3984242", "hasDbCrossReferences": "Y", "abstractText": "Glioblastoma (GBM) is the most common and deadly malignant brain cancer, with a median survival of <2 years. GBM displays a cellular complexity that includes brain tumour-initiating cells (BTICs), which are considered as potential key targets for GBM therapies. Here we show that the transcription factors FOXG1 and Groucho/TLE are expressed in poorly differentiated astroglial cells in human GBM specimens and in primary cultures of GBM-derived BTICs, where they form a complex. FOXG1 knockdown in BTICs causes downregulation of neural stem/progenitor and proliferation markers, increased replicative senescence, upregulation of astroglial differentiation genes and decreased BTIC-initiated tumour growth after intracranial transplantation into host mice. These effects are phenocopied by Groucho/TLE knockdown or dominant inhibition of the FOXG1:Groucho/TLE complex. These results provide evidence that transcriptional programmes regulated by FOXG1 and Groucho/TLE are important for BTIC-initiated brain tumour growth, implicating FOXG1 and Groucho/TLE in GBM tumourigenesis.", "language": "eng", "dateOfCompletion": "2014-07-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3984242?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3984242", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24356439&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24356439", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/ncomms3956", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Nature communications", "medlineAbbreviation": "Nat Commun", "isoabbreviation": "Nat Commun", "nlmid": "101528555", "essn": "2041-1723"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2013, "journalIssueId": 2012237, "dateOfPublication": "2013 "}}, "23065639": {"pubYear": "2013", "dateOfCreation": "2012-12-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Bmi1 protein, mouse"}, {"registryNumber": "0", "name": "Receptors, Cell Surface"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "Basic Helix-Loop-Helix Transcription Factors"}, {"registryNumber": "0", "name": "Atoh1 protein, mouse"}, {"registryNumber": "0", "name": "patched receptors"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Behesti H, Bhagat H, Dubuc AM, Taylor MD, Marino S.", "affiliation": "Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Cancer Research UK", "grantId": "A7802"}, {"orderIn": 0, "agency": "Wellcome Trust"}, {"orderIn": 0, "agency": "Cancer Research UK", "grantId": "C23985"}]}, "hasPDF": "N", "id": "23065639", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Behesti", "fullName": "Behesti H", "firstName": "Hourinaz", "initials": "H"}, {"lastName": "Bhagat", "fullName": "Bhagat H", "firstName": "Heeta", "initials": "H"}, {"lastName": "Dubuc", "fullName": "Dubuc AM", "firstName": "Adrian M", "initials": "AM"}, {"lastName": "Taylor", "fullName": "Taylor MD", "firstName": "Michael D", "initials": "MD"}, {"lastName": "Marino", "fullName": "Marino S", "firstName": "Silvia", "initials": "S"}]}, "title": "Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation.", "hasSuppl": "Y", "citedByCount": 3, "source": "MED", "pmid": "23065639", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebellum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Cell Surface", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle", "majorTopic_YN": "N"}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N"}, {"descriptorName": "Epigenesis, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Lineage", "majorTopic_YN": "N"}, {"descriptorName": "Genes, p53", "majorTopic_YN": "N"}, {"descriptorName": "Models, Neurological", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Basic Helix-Loop-Helix Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neural Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcriptome", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-10-12", "language": "eng", "doi": "10.1242/dmm.009506", "isOpenAccess": "Y", "pageInfo": "49-63", "pmcid": "PMC3529338", "hasDbCrossReferences": "Y", "abstractText": "BMI1 is a potent inducer of neural stem cell self-renewal and neural progenitor cell proliferation during development and in adult tissue homeostasis. It is overexpressed in numerous human cancers - including medulloblastomas, in which its functional role is unclear. We generated transgenic mouse lines with targeted overexpression of Bmi1 in the cerebellar granule cell lineage, a cell type that has been shown to act as a cell of origin for medulloblastomas. Overexpression of Bmi1 in granule cell progenitors (GCPs) led to a decrease in cerebellar size due to decreased GCP proliferation and repression of the expression of cyclin genes, whereas Bmi1 overexpression in postmitotic granule cells improved cell survival in response to stress by altering the expression of genes in the mitochondrial cell death pathway and of Myc and Lef-1. Although no medulloblastomas developed in ageing cohorts of transgenic mice, crosses with Trp53(-/-) mice resulted in a low incidence of medulloblastoma formation. Furthermore, analysis of a large collection of primary human medulloblastomas revealed that tumours with a BMI1(high) TP53(low) molecular profile are significantly enriched in Group 4 human medulloblastomas. Our data suggest that different levels and timing of Bmi1 overexpression yield distinct cellular outcomes within the same cellular lineage. Importantly, Bmi1 overexpression at the GCP stage does not induce tumour formation, suggesting that BMI1 overexpression in GCP-derived human medulloblastomas probably occurs during later stages of oncogenesis and might serve to enhance tumour cell survival.", "electronicPublicationDate": "2012-10-12", "license": "cc by-nc-sa", "dateOfCompletion": "2013-06-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3529338", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23065639", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1242/dmm.009506", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Dis Model Mech", "isoabbreviation": "Dis Model Mech", "title": "Disease models & mechanisms", "issn": "1754-8403", "nlmid": "101483332", "essn": "1754-8411"}, "monthOfPublication": 1, "volume": "6", "yearOfPublication": 2013, "journalIssueId": 1995341, "issue": "1", "dateOfPublication": "2013 Jan"}}, "25636376": {"pubYear": "2015", "dateOfCreation": "2015-04-18", "pubModel": "Electronic", "authorString": "Sengupta S, Nguyen AM, van Landingham SW, Solomon SD, Do DV, Ferrucci L, Friedman DS, Ramulu PY.", "affiliation": "Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe St, Maumenee B-110, Baltimore, MD, 21287, USA. drsunny1980@gmail.com.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY018595"}, {"orderIn": 0, "agency": "Intramural NIH HHS"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY022976"}]}, "hasPDF": "Y", "id": "25636376", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe St, Maumenee B-110, Baltimore, MD, 21287, USA. drsunny1980@gmail.com.", "fullName": "Sengupta S", "initials": "S", "firstName": "Sabyasachi", "lastName": "Sengupta"}, {"affiliation": "Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe St, Maumenee B-110, Baltimore, MD, 21287, USA. anguye24@jhmi.edu.", "fullName": "Nguyen AM", "initials": "AM", "firstName": "Angeline M", "lastName": "Nguyen"}, {"affiliation": "Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe St, Maumenee B-110, Baltimore, MD, 21287, USA. swestbr3@jhmi.edu.", "fullName": "van Landingham SW", "initials": "SW", "firstName": "Suzanne W", "lastName": "van Landingham"}, {"affiliation": "Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe St, Maumenee B-110, Baltimore, MD, 21287, USA. ssolomon1@jhmi.edu.", "fullName": "Solomon SD", "initials": "SD", "firstName": "Sharon D", "lastName": "Solomon"}, {"affiliation": "Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA. diana.do@unmc.edu.", "fullName": "Do DV", "initials": "DV", "firstName": "Diana V", "lastName": "Do"}, {"affiliation": "The Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. ferruccilu@mail.nih.gov.", "fullName": "Ferrucci L", "initials": "L", "firstName": "Luigi", "lastName": "Ferrucci"}, {"affiliation": "Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, MD, USA. david.friedman@jhu.edu.", "fullName": "Friedman DS", "initials": "DS", "firstName": "David S", "lastName": "Friedman"}, {"affiliation": "Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, MD, USA. pramulu@jhmi.edu.", "fullName": "Ramulu PY", "initials": "PY", "firstName": "Pradeep Y", "lastName": "Ramulu"}]}, "title": "Evaluation of real-world mobility in age-related macular degeneration.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25636376", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Vision Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Motor Activity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Movement", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Visual Acuity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Visual Fields", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Travel", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Visually Impaired Persons", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Geographic Atrophy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Wet Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Accelerometry", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-30", "language": "eng", "doi": "10.1186/1471-2415-15-9", "isOpenAccess": "Y", "pageInfo": "9", "pmcid": "PMC4328075", "hasDbCrossReferences": "N", "abstractText": "Previous research has suggested an association between poor vision and decreased mobility, including restricted levels of physical activity and travel away from home. We sought to determine the impact of age-related macular degeneration (AMD) on these measures of mobility.Fifty-seven AMD patients with bilateral, or severe unilateral, visual impairment were compared to 59 controls with normal vision. All study subjects were between the ages of 60 and 80. Subjects wore accelerometers and cellular network-based tracking devices over 7 days of normal activity. Number of steps taken, time spent in moderate-to-vigorous physical activity (MVPA), number of excursions from home, and time spent away from home were the primary outcome measures.In multivariate negative binomial regression models adjusted for age, gender, race, comorbidities, and education, AMD participants took fewer steps than controls (18% fewer steps per day, p = 0.01) and spent significantly less time in MVPA (35% fewer minutes, p < 0.001). In multivariate logistic regression models adjusting for age, sex, race, cognition, comorbidities, and grip strength, AMD subjects showed an increased likelihood of not leaving their home on a given day (odds ratio = 1.36, p = 0.04), but did not show a significant difference in the magnitude of time spent away from home (9% fewer minutes, p = 0.11).AMD patients with poorer vision engage in significantly less physical activity and take fewer excursions away from the home. Further studies identifying the factors mediating the relationship between vision loss and mobility are needed to better understand how to improve mobility among AMD patients.", "electronicPublicationDate": "2015-01-30", "license": "cc by", "dateOfCompletion": "2015-12-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4328075?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4328075", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1471-2415-15-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "BMC ophthalmology", "medlineAbbreviation": "BMC Ophthalmol", "isoabbreviation": "BMC Ophthalmol", "nlmid": "100967802", "essn": "1471-2415"}, "monthOfPublication": 0, "volume": "15", "yearOfPublication": 2015, "journalIssueId": 2259061, "dateOfPublication": "2015 "}}, "20717685": {"pubYear": "2011", "dateOfCreation": "2011-01-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Tumor Markers, Biological"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "PCGF2 protein, human"}, {"registryNumber": "0", "name": "BMI1 protein, human"}, {"registryNumber": "EC 6.3.2.19", "name": "Polycomb Repressive Complex 1"}]}, "authorString": "Zakrzewska M, Zakrzewski K, Gre\u0161ner SM, Piaskowski S, Zalewska-Szewczyk B, Liberski PP.", "affiliation": "Department of Molecular Pathology and Neuropathology, Chair of Oncology, Medical University of \u0141\u00f3d\u017a, Czechos\u0142owacka 8/10, \u0141\u00f3d\u017a, Poland. magdalena.zakrzewska@umed.lodz.pl", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "20717685", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zakrzewska", "fullName": "Zakrzewska M", "firstName": "Magdalena", "initials": "M"}, {"lastName": "Zakrzewski", "fullName": "Zakrzewski K", "firstName": "Krzysztof", "initials": "K"}, {"lastName": "Gre\u0161ner", "fullName": "Gre\u0161ner SM", "firstName": "Sylwia M", "initials": "SM"}, {"lastName": "Piaskowski", "fullName": "Piaskowski S", "firstName": "Sylwester", "initials": "S"}, {"lastName": "Zalewska-Szewczyk", "fullName": "Zalewska-Szewczyk B", "firstName": "Beata", "initials": "B"}, {"lastName": "Liberski", "fullName": "Liberski PP", "firstName": "Pawe\u0142 P", "initials": "PP"}]}, "title": "Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "20717685", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Markers, Biological", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Kaplan-Meier Estimate", "majorTopic_YN": "N"}, {"descriptorName": "Polycomb Repressive Complex 1", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-08-18", "doi": "10.1007/s00381-010-1260-5", "isOpenAccess": "Y", "pageInfo": "79-86", "pmcid": "PMC3015167", "hasDbCrossReferences": "Y", "abstractText": " INTRODUCTION: Medulloblastoma is the most frequent type of embryonal tumor in the pediatric population, accounting for 20-25% of all brain tumors in children. Recently, the suspected contribution of the Polycomb group (PcG) genes in medulloblastoma development was described. PcG genes play an important role in developmental processes; they are also involved in the self-renewal of hematopoietic and neural stem cells as well as in malignant transformation. PURPOSE: In this study, we evaluated the expression of BMI1and PCGF2, members of family of PcG genes, and their potential target, MYC oncogene, and analyzed their association with demographic and clinical data. MATERIALS AND METHODS: Thirty-one children (18 males and 13 females, aged from 0.4 to 17\u00a0years) with medulloblastoma were included in this study. The gene's expression level was measured by quantitative real-time PCR, obtained using the two-color multiplexing technique. RESULTS: We found that the higher expression levels of BMI1 and PCGF2 genes were associated with significantly decreased patient survival (p\u2009=\u20090.02 and p\u2009=\u20090.012, respectively). Significant differences between gender were found, with a higher expression level of the PCGF2 gene observed among females (p\u2009=\u20090.02). CONCLUSION: Our analysis showed correlation between BMI1 and PCGF2 gene's expression and survival in children with medulloblastoma.", "electronicPublicationDate": "2010-08-18", "language": "eng", "dateOfCompletion": "2011-04-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3015167?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3015167", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20717685&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20717685", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s00381-010-1260-5", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-28", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Childs Nerv Syst", "isoabbreviation": "Childs Nerv Syst", "title": "Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery", "issn": "0256-7040", "nlmid": "8503227", "essn": "1433-0350"}, "monthOfPublication": 1, "volume": "27", "yearOfPublication": 2011, "journalIssueId": 1794530, "issue": "1", "dateOfPublication": "2011 Jan"}}}, "RANGAP1": {"20970342": {"pubYear": "2010", "dateOfCreation": "2010-11-08", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Schizosaccharomyces pombe Proteins"}, {"registryNumber": "0", "name": "Recombinant Fusion Proteins"}, {"registryNumber": "0", "name": "GTPase-Activating Proteins"}, {"registryNumber": "147336-22-9", "name": "Green Fluorescent Proteins"}, {"registryNumber": "0", "name": "rna1 protein, S pombe"}]}, "authorString": "Asakawa H, Kojidani T, Mori C, Osakada H, Sato M, Ding DQ, Hiraoka Y, Haraguchi T.", "affiliation": "Graduate School of Frontier Biosciences, Osaka University, Suita 565-0871, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20970342", "inEPMC": "N", "authorList": {"author": [{"lastName": "Asakawa", "fullName": "Asakawa H", "firstName": "Haruhiko", "initials": "H"}, {"lastName": "Kojidani", "fullName": "Kojidani T", "firstName": "Tomoko", "initials": "T"}, {"lastName": "Mori", "fullName": "Mori C", "firstName": "Chie", "initials": "C"}, {"lastName": "Osakada", "fullName": "Osakada H", "firstName": "Hiroko", "initials": "H"}, {"lastName": "Sato", "fullName": "Sato M", "firstName": "Mamiko", "initials": "M"}, {"lastName": "Ding", "fullName": "Ding DQ", "firstName": "Da-Qiao", "initials": "DQ"}, {"lastName": "Hiraoka", "fullName": "Hiraoka Y", "firstName": "Yasushi", "initials": "Y"}, {"lastName": "Haraguchi", "fullName": "Haraguchi T", "firstName": "Tokuko", "initials": "T"}]}, "title": "Virtual breakdown of the nuclear envelope in fission yeast meiosis.", "citedByCount": 22, "pageInfo": "1919-1925", "source": "MED", "pmid": "20970342", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Nuclear Envelope", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Pore", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytoplasm", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schizosaccharomyces", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "GTPase-Activating Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schizosaccharomyces pombe Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Green Fluorescent Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Recombinant Fusion Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anaphase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Active Transport, Cell Nucleus", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-10-21", "doi": "10.1016/j.cub.2010.09.070", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "21056831", "reference": "Curr Biol. 2010 Nov 9;20(21):R923-5"}]}, "hasDbCrossReferences": "Y", "abstractText": "Asymmetric localization of Ran regulators (RanGAP1 and RanGEF/RCC1) produces a gradient of RanGTP across the nuclear envelope. In higher eukaryotes, the nuclear envelope breaks down as the cell enters mitosis (designated \"open\" mitosis). This nuclear envelope breakdown (NEBD) leads to collapse of the RanGTP gradient and the diffusion of nuclear and cytoplasmic macromolecules in the cell, resulting in irreversible progression of the cell cycle. On the other hand, in many fungi, chromosome segregation takes place without NEBD (designated \"closed\" mitosis). Here we report that in the fission yeast Schizosaccharomyces pombe, despite the nuclear envelope and the nuclear pore complex remaining intact throughout both the meiotic and mitotic cell cycles, nuclear proteins diffuse into the cytoplasm transiently for a few minutes at the onset of anaphase of meiosis II. We also found that nuclear protein diffusion into the cytoplasm occurred coincidently with nuclear localization of Rna1, an S. pombe RanGAP1 homolog that is usually localized in the cytoplasm. These results suggest that nuclear localization of RanGAP1 and depression of RanGTP activity in the nucleus may be mechanistically tied to meiosis-specific diffusion of nuclear proteins into the cytoplasm. This nucleocytoplasmic shuffling of RanGAP1 and nuclear proteins represents virtual breakdown of the nuclear envelope.", "electronicPublicationDate": "2010-10-21", "language": "eng", "dateOfCompletion": "2011-03-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.cub.2010.09.070", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://www.current-biology.com/cgi/content/reprint/20/21/1919", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "www.current-biology.com"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-11-01", "journal": {"medlineAbbreviation": "Curr Biol", "isoabbreviation": "Curr. Biol.", "title": "Current biology : CB", "issn": "0960-9822", "nlmid": "9107782", "essn": "1879-0445"}, "monthOfPublication": 11, "volume": "20", "yearOfPublication": 2010, "journalIssueId": 1782022, "issue": "21", "dateOfPublication": "2010 Nov"}}, "27164557": {"pubYear": "2016", "dateOfCreation": "2016-05-11", "pubModel": "Electronic", "authorString": "Chen J, Bacanu SA, Yu H, Zhao Z, Jia P, Kendler KS, Kranzler HR, Gelernter J, Farrer L, Minica C, Pool R, Milaneschi Y, Boomsma DI, Penninx BW, Tyndale RF, Ware JJ, Vink JM, Kaprio J, Munaf\u00f2 M, Chen X, Cotinine meta-analysis group, FTND meta-analysis group.", "affiliation": "Nevada Institute of Personalized Medicine, University of Nevada at Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27164557", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Nevada Institute of Personalized Medicine, University of Nevada at Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.", "fullName": "Chen J", "initials": "J", "firstName": "Jingchun", "lastName": "Chen"}, {"affiliation": "Department of Psychiatry Virginia, Commonwealth University, 800 E. Leigh Street, Richmond, VA 23298, USA.", "fullName": "Bacanu SA", "initials": "SA", "firstName": "Silviu-Alin", "lastName": "Bacanu"}, {"affiliation": "Departments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.", "fullName": "Yu H", "initials": "H", "firstName": "Hui", "lastName": "Yu"}, {"affiliation": "Departments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.", "fullName": "Zhao Z", "initials": "Z", "firstName": "Zhongming", "lastName": "Zhao"}, {"affiliation": "Departments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.", "fullName": "Jia P", "initials": "P", "firstName": "Peilin", "lastName": "Jia"}, {"affiliation": "Department of Psychiatry Virginia, Commonwealth University, 800 E. Leigh Street, Richmond, VA 23298, USA.", "fullName": "Kendler KS", "initials": "KS", "firstName": "Kenneth S", "lastName": "Kendler"}, {"affiliation": "Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN4 MIRECC, Philadelphia VA Medical Center, Philadelphia, PA, USA.", "fullName": "Kranzler HR", "initials": "HR", "firstName": "Henry R", "lastName": "Kranzler"}, {"affiliation": "Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, and VA CT Healthcare Center, New Haven, CT 06516, USA.", "fullName": "Gelernter J", "initials": "J", "firstName": "Joel", "lastName": "Gelernter"}, {"affiliation": "Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.", "fullName": "Farrer L", "initials": "L", "firstName": "Lindsay", "lastName": "Farrer"}, {"affiliation": "Department of Biological Psychology, VU University, Amsterdam, Netherlands.", "fullName": "Minica C", "initials": "C", "firstName": "Camelia", "lastName": "Minica"}, {"affiliation": "Department of Biological Psychology, VU University, Amsterdam, Netherlands.", "fullName": "Pool R", "initials": "R", "firstName": "Rene", "lastName": "Pool"}, {"affiliation": "Department of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.", "fullName": "Milaneschi Y", "initials": "Y", "firstName": "Yuri", "lastName": "Milaneschi"}, {"affiliation": "Department of Biological Psychology, VU University, Amsterdam, Netherlands.", "fullName": "Boomsma DI", "initials": "DI", "firstName": "Dorret I", "lastName": "Boomsma"}, {"affiliation": "Department of Biological Psychology, VU University, Amsterdam, Netherlands.", "fullName": "Penninx BW", "initials": "BW", "firstName": "Brenda W J H", "lastName": "Penninx"}, {"affiliation": "Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.", "fullName": "Tyndale RF", "initials": "RF", "firstName": "Rachel F", "lastName": "Tyndale"}, {"affiliation": "MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.", "fullName": "Ware JJ", "initials": "JJ", "firstName": "Jennifer J", "lastName": "Ware"}, {"affiliation": "Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.", "fullName": "Vink JM", "initials": "JM", "firstName": "Jacqueline M", "lastName": "Vink"}, {"affiliation": "University of Helsinki, Institute for Molecular Medicine, P.O. Box 20 (Tukholmankatu 8), 00014 Helsinki, Finland.", "fullName": "Kaprio J", "initials": "J", "firstName": "Jaakko", "lastName": "Kaprio"}, {"affiliation": "UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK.", "fullName": "Munaf\u00f2 M", "initials": "M", "firstName": "Marcus", "lastName": "Munaf\u00f2"}, {"affiliation": "Department of Psychology, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.", "fullName": "Chen X", "initials": "X", "firstName": "Xiangning", "lastName": "Chen"}, {"collectiveName": "Cotinine meta-analysis group"}, {"collectiveName": "FTND meta-analysis group"}]}, "title": "Genetic Relationship between Schizophrenia and Nicotine Dependence.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27164557", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2167-7470"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2016-05-10", "language": "eng", "doi": "10.1038/srep25671", "isOpenAccess": "Y", "pageInfo": "25671", "pmcid": "PMC4862382", "hasDbCrossReferences": "N", "abstractText": "It is well known that most schizophrenia patients smoke cigarettes. There are different hypotheses postulating the underlying mechanisms of this comorbidity. We used summary statistics from large meta-analyses of plasma cotinine concentration (COT), Fagerstr\u00f6m test for nicotine dependence (FTND) and schizophrenia to examine the genetic relationship between these traits. We found that schizophrenia risk scores calculated at P-value thresholds of 5\u2009\u00d7\u200910(-3) and larger predicted FTND and cigarettes smoked per day (CPD), suggesting that genes most significantly associated with schizophrenia were not associated with FTND/CPD, consistent with the self-medication hypothesis. The COT risk scores predicted schizophrenia diagnosis at P-values of 5\u2009\u00d7\u200910(-3) and smaller, implying that genes most significantly associated with COT were associated with schizophrenia. These results implicated that schizophrenia and FTND/CPD/COT shared some genetic liability. Based on this shared liability, we identified multiple long non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), protein modification genes (MANBA, UBE2D3, and RANGAP1) and energy production genes (XYLB, MTRF1 and ENOX1) that were associated with both conditions. Further analyses revealed that these shared genes were enriched in calcium signaling, long-term potentiation and neuroactive ligand-receptor interaction pathways that played a critical role in cognitive functions and neuronal plasticity.", "electronicPublicationDate": "2016-05-10", "license": "cc by", "investigatorList": {"investigator": [{"lastName": "Ware", "fullName": "Ware JJ", "firstName": "Jennifer J", "initials": "JJ"}, {"lastName": "Chen", "fullName": "Chen X", "firstName": "Xiangning", "initials": "X"}, {"lastName": "Vink", "fullName": "Vink JM", "firstName": "Jacqueline M", "initials": "JM"}, {"lastName": "Loukola", "fullName": "Loukola A", "firstName": "Anu", "initials": "A"}, {"lastName": "Minica", "fullName": "Minica C", "firstName": "Camelia", "initials": "C"}, {"lastName": "Pool", "fullName": "Pool R", "firstName": "Rene", "initials": "R"}, {"lastName": "Milaneschi", "fullName": "Milaneschi Y", "firstName": "Yuri", "initials": "Y"}, {"lastName": "Mangino", "fullName": "Mangino M", "authorId": {"type": "ORCID", "value": "0000-0002-2167-7470"}, "firstName": "Massimo", "initials": "M"}, {"lastName": "Menni", "fullName": "Menni C", "firstName": "Cristina", "initials": "C"}, {"lastName": "Chen", "fullName": "Chen J", "firstName": "Jingchun", "initials": "J"}, {"lastName": "Peterson", "fullName": "Peterson R", "firstName": "Roseann", "initials": "R"}, {"lastName": "Auro", "fullName": "Auro K", "firstName": "Kirsi", "initials": "K"}, {"lastName": "Lyytik\u00e4inen", "fullName": "Lyytik\u00e4inen LP", "firstName": "Leo-Pekka", "initials": "LP"}, {"lastName": "Wedenoja", "fullName": "Wedenoja J", "firstName": "Juho", "initials": "J"}, {"lastName": "Stiby", "fullName": "Stiby AI", "firstName": "Alex I", "initials": "AI"}, {"lastName": "Hemani", "fullName": "Hemani G", "firstName": "Gibran", "initials": "G"}, {"lastName": "Willemsen", "fullName": "Willemsen G", "firstName": "Gonneke", "initials": "G"}, {"lastName": "Hottenga", "fullName": "Hottenga JJ", "firstName": "Jouke Jan", "initials": "JJ"}, {"lastName": "Korhonen", "fullName": "Korhonen T", "firstName": "Tellervo", "initials": "T"}, {"lastName": "Heli\u00f6vaara", "fullName": "Heli\u00f6vaara M", "firstName": "Markku", "initials": "M"}, {"lastName": "Perola", "fullName": "Perola M", "firstName": "Markus", "initials": "M"}, {"lastName": "Rose", "fullName": "Rose R", "firstName": "Richard", "initials": "R"}, {"lastName": "Paternoster", "fullName": "Paternoster L", "firstName": "Lavinia", "initials": "L"}, {"lastName": "Timpson", "fullName": "Timpson N", "firstName": "Nic", "initials": "N"}, {"lastName": "Wassenaar", "fullName": "Wassenaar CA", "firstName": "Catherine A", "initials": "CA"}, {"lastName": "Zhu", "fullName": "Zhu AZ", "firstName": "Andy Z X", "initials": "AZ"}, {"lastName": "Smith", "fullName": "Smith GD", "firstName": "George Davey", "initials": "GD"}, {"lastName": "Raitakari", "fullName": "Raitakari O", "firstName": "Olli", "initials": "O"}, {"lastName": "Lehtim\u00e4ki", "fullName": "Lehtim\u00e4ki T", "firstName": "Terho", "initials": "T"}, {"lastName": "K\u00e4h\u00f6nen", "fullName": "K\u00e4h\u00f6nen M", "firstName": "Mika", "initials": "M"}, {"lastName": "Koskinen", "fullName": "Koskinen S", "firstName": "Seppo", "initials": "S"}, {"lastName": "Spector", "fullName": "Spector T", "firstName": "Timothy", "initials": "T"}, {"lastName": "Penninx", "fullName": "Penninx BW", "firstName": "Brenda W J H", "initials": "BW"}, {"lastName": "Salomaa", "fullName": "Salomaa V", "firstName": "Veikko", "initials": "V"}, {"lastName": "Boomsma", "fullName": "Boomsma DI", "firstName": "Dorret I", "initials": "DI"}, {"lastName": "Tyndale", "fullName": "Tyndale RF", "firstName": "Rachel F", "initials": "RF"}, {"lastName": "Kaprio", "fullName": "Kaprio J", "firstName": "Jaakko", "initials": "J"}, {"lastName": "Munaf\u00f2", "fullName": "Munaf\u00f2 M", "firstName": "Marcus", "initials": "M"}, {"lastName": "Ware", "fullName": "Ware JJ", "firstName": "Jennifer J", "initials": "JJ"}, {"lastName": "Chen", "fullName": "Chen X", "firstName": "Xiangning", "initials": "X"}, {"lastName": "Vink", "fullName": "Vink JM", "firstName": "Jacqueline M", "initials": "JM"}, {"lastName": "Loukola", "fullName": "Loukola A", "firstName": "Anu", "initials": "A"}, {"lastName": "Minica", "fullName": "Minica C", "firstName": "Camelia", "initials": "C"}, {"lastName": "Chen", "fullName": "Chen J", "firstName": "Jingchun", "initials": "J"}, {"lastName": "Peterson", "fullName": "Peterson R", "firstName": "Roseann", "initials": "R"}, {"lastName": "Timpson", "fullName": "Timpson N", "firstName": "Nic", "initials": "N"}, {"lastName": "Taylor", "fullName": "Taylor M", "firstName": "Michelle", "initials": "M"}, {"lastName": "Boomsma", "fullName": "Boomsma DI", "firstName": "Dorret I", "initials": "DI"}, {"lastName": "Kaprio", "fullName": "Kaprio J", "firstName": "Jaakko", "initials": "J"}, {"lastName": "Munaf\u00f2", "fullName": "Munaf\u00f2 M", "firstName": "Marcus", "initials": "M"}, {"lastName": "Maes", "fullName": "Maes H", "firstName": "Hermine", "initials": "H"}, {"lastName": "Riley", "fullName": "Riley B", "firstName": "Brien", "initials": "B"}, {"lastName": "Kendler", "fullName": "Kendler KS", "firstName": "Kenneth S", "initials": "KS"}, {"lastName": "Gelernter", "fullName": "Gelernter J", "firstName": "Joel", "initials": "J"}, {"lastName": "Sherva", "fullName": "Sherva R", "firstName": "Richard", "initials": "R"}, {"lastName": "Farrer", "fullName": "Farrer L", "firstName": "Lindsay", "initials": "L"}, {"lastName": "Kranzler", "fullName": "Kranzler HR", "firstName": "Henry R", "initials": "HR"}, {"lastName": "Maher", "fullName": "Maher B", "firstName": "Brion", "initials": "B"}, {"lastName": "Vanyukov", "fullName": "Vanyukov M", "firstName": "Michael", "initials": "M"}]}, "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4862382?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4862382", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/srep25671", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"title": "Scientific reports", "medlineAbbreviation": "Sci Rep", "isoabbreviation": "Sci Rep", "nlmid": "101563288", "essn": "2045-2322"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2016, "journalIssueId": 2358449, "dateOfPublication": "2016"}}}, "PPARD": {"22498097": {"pubYear": "2012", "dateOfCreation": "2012-04-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Protease Inhibitors"}, {"registryNumber": "0", "name": "Growth Inhibitors"}, {"registryNumber": "1199-18-4", "name": "Oxidopamine"}, {"registryNumber": "0", "name": "Neuroprotective Agents"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "EC 3.4.24.17", "name": "Matrix Metalloproteinase 3"}, {"registryNumber": "0", "name": "Matrix Metalloproteinase Inhibitors"}]}, "authorString": "Sadeghian M, Marinova-Mutafchieva L, Broom L, Davis JB, Virley D, Medhurst AD, Dexter DT.", "affiliation": "Parkinson's Disease Research Group, Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Imperial College London, UK.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "N", "id": "22498097", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sadeghian", "fullName": "Sadeghian M", "firstName": "M", "initials": "M"}, {"lastName": "Marinova-Mutafchieva", "fullName": "Marinova-Mutafchieva L", "firstName": "L", "initials": "L"}, {"lastName": "Broom", "fullName": "Broom L", "firstName": "L", "initials": "L"}, {"lastName": "Davis", "fullName": "Davis JB", "firstName": "J B", "initials": "JB"}, {"lastName": "Virley", "fullName": "Virley D", "firstName": "D", "initials": "D"}, {"lastName": "Medhurst", "fullName": "Medhurst AD", "firstName": "A D", "initials": "AD"}, {"lastName": "Dexter", "fullName": "Dexter DT", "firstName": "D T", "initials": "DT"}]}, "title": "Full and partial peroxisome proliferation-activated receptor-\u03b3 agonists, but not \u03b4 agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.", "citedByCount": 12, "source": "MED", "pmid": "22498097", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Microglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Parkinsonian Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CI", "qualifierName": "chemically induced", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Oxidopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "N"}]}}, {"descriptorName": "Growth Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neuroprotective Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protease Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Matrix Metalloproteinase 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dopaminergic Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Matrix Metalloproteinase Inhibitors", "majorTopic_YN": "Y"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-04-11", "doi": "10.1016/j.jneuroim.2012.03.010", "isOpenAccess": "N", "pageInfo": "69-77", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) is a nuclear hormone receptor that has been shown to have anti-inflammatory and matrix metalloproteinase (MMP) inhibitor properties. PPAR\u03b3 agonists have been shown to have neuroprotective effects in various neurodegeneration models where inflammation is implicated, including models of Parkinson's disease. However, no studies have looked at the effects of partial PPAR\u03b3 agonists. EXPERIMENTAL APPROACH: The neuroprotective effects of the PPAR\u03b3 full agonist, pioglitazone (20 mg/kg), partial PPAR\u03b3 agonist GW855266X (15 mg/kg) and PPAR-\u03b4 full agonist GW610742X (10 mg/kg) were investigated in the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease when administered prior to or post 6-OHDA lesioning. The integrity of the nigrostriatal system was assessed by assessing the numbers dopaminergic neurons in the substantia nigra (SN) and by assessing striatal dopamine content. The degree of microglia activation in the SN was also immunohistochemistry assessed utilizing the marker OX-6 for activated microglia and CD-68 a marker for phagocytic microglia. Additionally we performed immunocytochemistry for MMP3 in the SN. Finally, we investigated whether a period of drug withdrawal for a further 7 days affected the neuroprotection produced by the PPAR\u03b3 agonists. KEY RESULTS: Both pioglitazone and GW855266X protected against 6-OHDA induced loss of dopaminergic neurons in the substantia nigra and depletion of striatal dopamine when administered orally twice daily for either 1) 7 day prior to and 7 days post lesioning or 2) for 7 days starting 2 days post lesioning when neurons will be severely traumatized. 6-OHDA lesioning was associated with an increase in microglia activation and in numbers of MMP-3 immunoreactive cells which was attenuated by pioglitazone and GW855266X. Neuroprotective effects were not replicated using the PPAR\u03b4 agonist GW610742X. Subsequent withdrawal of both pioglitazone and GW855266X, for a further 7 days negated any neuroprotective effect suggesting that long-term administration may be required to attenuate the inflammatory response. CONCLUSIONS AND IMPLICATIONS: For the first time a partial PPAR-\u03b3 agonist has been shown to be neuroprotectory when administered post lesioning in a parkinsonian model. Effects may be via the inhibition of microglial and MMP activation and support further research.", "electronicPublicationDate": "2012-04-11", "language": "eng", "dateOfCompletion": "2012-06-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jneuroim.2012.03.010", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-05-01", "journal": {"medlineAbbreviation": "J Neuroimmunol", "isoabbreviation": "J. Neuroimmunol.", "title": "Journal of neuroimmunology", "issn": "0165-5728", "nlmid": "8109498", "essn": "1872-8421"}, "monthOfPublication": 5, "volume": "246", "yearOfPublication": 2012, "journalIssueId": 1925719, "issue": "1-2", "dateOfPublication": "2012 May"}}, "18438697": "", "23811400": {"pubYear": "2013", "dateOfCreation": "2013-08-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Reactive Oxygen Species"}, {"registryNumber": "0", "name": "Peroxisome Proliferator-Activated Receptors"}, {"registryNumber": "SY7Q814VUP", "name": "Calcium"}, {"registryNumber": "31C4KY9ESH", "name": "Nitric Oxide"}]}, "authorString": "Aleshin S, Strokin M, Sergeeva M, Reiser G.", "affiliation": "Otto-von-Guericke-Universit\u00e4t Magdeburg, Medizinische Fakult\u00e4t, Institut f\u00fcr Neurobiochemie, Leipziger Stra\u00dfe 44, 39120 Magdeburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23811400", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Otto-von-Guericke-Universit\u00e4t Magdeburg, Medizinische Fakult\u00e4t, Institut f\u00fcr Neurobiochemie, Leipziger Stra\u00dfe 44, 39120 Magdeburg, Germany.", "fullName": "Aleshin S", "initials": "S", "firstName": "Stepan", "lastName": "Aleshin"}, {"lastName": "Strokin", "fullName": "Strokin M", "firstName": "Mikhail", "initials": "M"}, {"lastName": "Sergeeva", "fullName": "Sergeeva M", "firstName": "Marina", "initials": "M"}, {"lastName": "Reiser", "fullName": "Reiser G", "firstName": "Georg", "initials": "G"}]}, "title": "Peroxisome proliferator-activated receptor (PPAR)\u03b2/\u03b4, a possible nexus of PPAR\u03b1- and PPAR\u03b3-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.", "citedByCount": 16, "source": "MED", "pmid": "23811400", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neurodegenerative Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Calcium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nitric Oxide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Reactive Oxygen Species", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peroxisome Proliferator-Activated Receptors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Homeostasis", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-06-25", "doi": "10.1016/j.neuint.2013.06.012", "isOpenAccess": "N", "pageInfo": "322-330", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Reactive oxygen species", "Transcription factor", "LPS", "Ciliary neurotrophic factor", "Phospholipase C", "BDNF", "Lipopolysaccharide", "Brain-derived neurotrophic factor", "Inflammation", "CNTF", "ROS", "MS", "Ryanodine receptor", "Multiple sclerosis", "Cyclooxygenase-2", "AP-1", "inositol 1,4,5-trisphosphate", "PLC", "FGF-2", "MCAO", "peroxisome proliferator response element", "PPAR", "PPRE", "COX-2", "middle cerebral artery occlusion", "experimental autoimmune encephalomyelitis", "neuroprotection", "Oligodendrocytes", "Fibroblast Growth Factor-2", "Serca", "Peroxisome Proliferator-activated Receptors", "Reactive Nitrogen Species", "Rns", "EAE", "Nf\u03bab", "Nuclear Factor \u039ab", "Ryr", "Activator Protein 1", "Ip(3)", "Phospholipase A(2)", "Ol", "Pla(2)", "Ip(3)r", "Ip(3) Receptors", "Sarcoendoplasmic Reticulum Ca(2+)-atpase"]}, "abstractText": "Peroxisome proliferator-activated receptors (PPAR\u03b1, -\u03b2/\u03b4 and -\u03b3) are lipid-activated transcription factors. Synthetic PPAR\u03b1 and PPAR\u03b3 ligands have neuroprotective properties. Recently, PPAR\u03b2/\u03b4 activation emerged as the focus of a novel approach for the treatment of a wide range of neurodegenerative diseases. To fill the gap of knowledge about the role of PPAR\u03b2/\u03b4 in brain, new hypotheses about PPAR\u03b2/\u03b4 involvement in neuropathological processes are requested. In this paper, we describe a novel hypothesis, claiming the existence of tight interactions between the three PPAR isotypes, which we designate the \"PPAR triad\". We propose that PPAR\u03b2/\u03b4 has a central control of the PPAR triad. The majority of studies analyze the regulation only by one of the PPAR isotypes. A few reports describe the mutual regulation of expression levels of all three PPAR isotypes by PPAR agonists. Analysis of these studies where pairwise interactions of PPARs were described allows us to support the existence of the PPAR triad with central role for PPAR\u03b2/\u03b4. In the present review, we propose the hypothesis that in a wide range of brain disorders, PPAR\u03b2/\u03b4 plays a central role between PPAR\u03b1 and PPAR\u03b3. Finally, we prove the advantages of the PPAR triad concept by describing hypotheses of PPAR\u03b2/\u03b4 involvement in the regulation of myelination, glutamate-induced neurotoxicity, and signaling pathways of reactive oxygen species/NO/Ca(2+).", "electronicPublicationDate": "2013-06-25", "language": "eng", "dateOfCompletion": "2014-04-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neuint.2013.06.012", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-10-01", "journal": {"medlineAbbreviation": "Neurochem Int", "isoabbreviation": "Neurochem. Int.", "title": "Neurochemistry international", "issn": "0197-0186", "nlmid": "8006959", "essn": "1872-9754"}, "monthOfPublication": 10, "volume": "63", "yearOfPublication": 2013, "journalIssueId": 2070271, "issue": "4", "dateOfPublication": "2013 Oct"}}, "26836193": {"pubYear": "2016", "dateOfCreation": "2016-03-12", "pubModel": "Print", "authorString": "Tong M, Deochand C, Didsbury J, de la Monte SM.", "affiliation": "Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "AG-049510"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "AA-011431"}]}, "id": "26836193", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.", "fullName": "Tong M", "initials": "M", "firstName": "Ming", "lastName": "Tong"}, {"affiliation": "Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.", "fullName": "Deochand C", "initials": "C", "firstName": "Chetram", "lastName": "Deochand"}, {"affiliation": "T3D Therapeutics, Inc., Research Triangle Park, NC, USA.", "fullName": "Didsbury J", "initials": "J", "firstName": "John", "lastName": "Didsbury"}, {"affiliation": "Department of Neurosurgery, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.", "fullName": "de la Monte SM", "initials": "SM", "firstName": "Suzanne M", "lastName": "de la Monte"}]}, "title": "T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.", "citedByCount": 0, "source": "MED", "pmid": "26836193", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-01-22", "doi": "10.3233/jad-151013", "isOpenAccess": "N", "pageInfo": "123-138", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Amyloid", "Spatial learning and memory", "Alzheimer\u2019s disease", "Streptozotocin", "Slice Culture", "Type 3 Diabetes", "Ppar Agonist", "T3d-959"]}, "abstractText": "T3D-959, a dual PPAR-\u03b4/PPAR \u03b3 nuclear receptor agonist and former diabetes drug candidate, has been repositioned as an Alzheimer's disease (AD)-modifying therapy.This study examines the effectiveness and mechanisms of T3D-959's therapeutic effects using in vivo and ex vivo rat models of sporadic AD.A sporadic AD model was generated by intracerebral (i.c.) administration of streptozotocin (STZ). Control and i.c. STZ treated rats were gavaged with saline or T3D-959 (0.3 to 3.0\u200amg/kg/day) for 28 days. Spatial learning and memory were evaluated using the Morris water maze test. Frontal lobe slice cultures generated 24 hours after i.c. STZ or vehicle were used to study early effects of T3D-959 (0.5-1.0 \u03bcM) on viability and molecular markers of AD.T3D-959 significantly improved spatial learning and memory in i.c STZ-treated rats. Mechanistically, T3D-959 significantly improved culture viability and brain morphology, reduced levels of oxidative stress and A\u03b2, and normalized expression of phospho-tau, choline acetyltransferase, and myelin-associated glycoprotein. Protective effects occurred even at the lowest tested dose of T3D-959.Pre-clinical proof of concept has been demonstrated that T3D-959 can improve multiple pathologies of AD resulting in significant improvements in cognitive function and molecular and biochemical indices of neurodegeneration. These results support the theses that (1) effective disease modification in AD can be achieved by targeting relevant nuclear receptors, and (2) treating AD as a metabolic disease has the potential to be disease remedial. A Phase 2a trial of T3D-959 in mild-to-moderate AD patients has been initiated (ClinicalTrials.gov identifier NCT02560753).", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3233/JAD-151013", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "J Alzheimers Dis", "isoabbreviation": "J. Alzheimers Dis.", "title": "Journal of Alzheimer's disease : JAD", "issn": "1387-2877", "nlmid": "9814863", "essn": "1875-8908"}, "monthOfPublication": 0, "volume": "51", "yearOfPublication": 2016, "journalIssueId": 2424703, "issue": "1", "dateOfPublication": "2016 "}}, "26864581": {"pubYear": "2016", "dateOfCreation": "2016-05-12", "pubModel": "Print-Electronic", "authorString": "An YQ, Zhang CT, Du Y, Zhang M, Tang SS, Hu M, Long Y, Sun HB, Hong H.", "affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26864581", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "An YQ", "initials": "YQ", "firstName": "Yun-Qi", "lastName": "An"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Zhang CT", "initials": "CT", "firstName": "Chun Teng", "lastName": "Zhang"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Du Y", "initials": "Y", "firstName": "Yong", "lastName": "Du"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Zhang M", "initials": "M", "firstName": "Ming", "lastName": "Zhang"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Tang SS", "initials": "SS", "firstName": "Su Su", "lastName": "Tang"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Hu M", "initials": "M", "firstName": "Mei", "lastName": "Hu"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Long Y", "initials": "Y", "firstName": "Yan", "lastName": "Long"}, {"affiliation": "Department of Pharmacology, and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, 210009, China.", "fullName": "Sun HB", "initials": "HB", "firstName": "Hong Bing", "lastName": "Sun"}, {"affiliation": "Department of Pharmacology, China Pharmaceutical University, Nanjing, 210009, China. honghao@cpu.edu.cn.", "fullName": "Hong H", "initials": "H", "firstName": "Hao", "lastName": "Hong"}]}, "title": "PPAR\u03b4 agonist GW0742 ameliorates A\u03b21-42-induced hippocampal neurotoxicity in mice.", "citedByCount": 0, "source": "MED", "pmid": "26864581", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-02-11", "doi": "10.1007/s11011-016-9800-7", "isOpenAccess": "N", "pageInfo": "663-671", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Memory", "Neurotoxicity", "Peroxisome Proliferator-activated Receptor \u0394", "Amyloid-\u03b21\u201342"]}, "abstractText": "Amyloid-\u03b2 deposition is thought to be associated with memory deficits, neuroinflammation, apoptotic responses, and progressive neuronal death manifested in Alzheimer's disease. Peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) is a transcription factor with potent anti-inflammatory effect. In the current study, the effect of GW0742, a selective PPAR\u03b4 agonist, on A\u03b21-42-induced neurotoxicity was investigated in the hippocampus of mice. Intra-hippocampal infusion of aggregated A\u03b21-42 oligomer (410pmol/mouse) remarkably damaged learning and memory in the Morris water maze (MWM) and Y-maze tests, accompanied by decreased expression of PPAR\u03b4 in the hippocampus as confirmed by Western blot. Intra-hippocampal infusion of GW0742 (1.06\u00a0mM/mouse) significantly improved A\u03b21-42-induced memory deficits in mice, reversed A\u03b21-42-induced hippocampal PPAR\u03b4 down-regulation and repressed A\u03b21-42-triggered neuroinflammatory and apoptotic responses, indicated by decreased nuclear NF-\u03baB p65, TNF-\u03b1, IL-1\u03b2 as well as a decrease in cleaved caspase-3 and increased ratio of Bcl-2/Bax in the hippocampus. These results suggest that PPAR\u03b4 activation ameliorates A\u03b21-42-induced hippocampal neurotoxicity, and it might play a crucial role in Alzheimer's disease.", "electronicPublicationDate": "2016-02-11", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s11011-016-9800-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"medlineAbbreviation": "Metab Brain Dis", "isoabbreviation": "Metab Brain Dis", "title": "Metabolic brain disease", "issn": "0885-7490", "nlmid": "8610370", "essn": "1573-7365"}, "monthOfPublication": 6, "volume": "31", "yearOfPublication": 2016, "journalIssueId": 2408054, "issue": "3", "dateOfPublication": "2016 Jun"}}, "22040534": "", "20624891": "", "20406305": "", "22606049": {"pubYear": "2012", "dateOfCreation": "2012-05-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.1.-", "name": "LIPG protein, human"}, {"registryNumber": "0", "name": "ATP binding cassette transporter 1"}, {"registryNumber": "EC 3.4.21.-", "name": "PCSK9 protein, human"}, {"registryNumber": "EC 3.1.1.3", "name": "hepatic lipase, human"}, {"registryNumber": "EC 3.1.1.3", "name": "Lipase"}, {"registryNumber": "EC 2.3.1.9", "name": "Acetyl-CoA C-Acetyltransferase"}, {"registryNumber": "0", "name": "Receptors, LDL"}, {"registryNumber": "EC 1.5.1.20", "name": "Methylenetetrahydrofolate Reductase (NADPH2)"}, {"registryNumber": "EC 3.4.-", "name": "Proprotein Convertases"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}, {"registryNumber": "EC 2.3.1.9", "name": "ACAT1 protein, human"}, {"registryNumber": "EC 3.4.21.-", "name": "Serine Endopeptidases"}, {"registryNumber": "EC 1.5.1.20", "name": "MTHFR protein, human"}]}, "authorString": "Yin RX, Wu DF, Wu JZ, Cao XL, Aung LH, Miao L, Long XJ, Liu WY, Zhang L, Li M.", "affiliation": "Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, People's Republic of China. yinruixing@yahoo.com.cn", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22606049", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, People's Republic of China. yinruixing@yahoo.com.cn", "fullName": "Yin RX", "initials": "RX", "firstName": "Rui-Xing", "lastName": "Yin"}, {"lastName": "Wu", "fullName": "Wu DF", "firstName": "Dong-Feng", "initials": "DF"}, {"lastName": "Wu", "fullName": "Wu JZ", "firstName": "Jin-Zhen", "initials": "JZ"}, {"lastName": "Cao", "fullName": "Cao XL", "firstName": "Xiao-Li", "initials": "XL"}, {"lastName": "Aung", "fullName": "Aung LH", "firstName": "Lynn Htet Htet", "initials": "LH"}, {"lastName": "Miao", "fullName": "Miao L", "firstName": "Lin", "initials": "L"}, {"lastName": "Long", "fullName": "Long XJ", "firstName": "Xing-Jiang", "initials": "XJ"}, {"lastName": "Liu", "fullName": "Liu WY", "firstName": "Wan-Ying", "initials": "WY"}, {"lastName": "Zhang", "fullName": "Zhang L", "firstName": "Lin", "initials": "L"}, {"lastName": "Li", "fullName": "Li M", "firstName": "Meng", "initials": "M"}]}, "title": "Interactions of several lipid-related gene polymorphisms and cigarette smoking on blood pressure levels.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "22606049", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hypertension", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lipase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Serine Endopeptidases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proprotein Convertases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Methylenetetrahydrofolate Reductase (NADPH2)", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acetyl-CoA C-Acetyltransferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, LDL", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blood Pressure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ethnic Groups", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Lipid Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP Binding Cassette Transporter 1", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-05-10", "doi": "10.7150/ijbs.4401", "isOpenAccess": "Y", "pageInfo": "685-696", "pmcid": "PMC3354626", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Hypertension", "Blood pressure", "Genetic polymorphism", "Cigarette smoking", "Interaction."]}, "abstractText": "The interactions of single nucleotide polymorphisms (SNPs) and cigarette smoking on blood pressure levels are limited. The present study was undertaken to detect nine lipid-related SNPs and their interactions with cigarette smoking on blood pressure levels. Genotyping of ATP-binding cassette transporter A1 (ABCA-1) V825I, acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) rs1044925, low density lipoprotein receptor (LDL-R) Ava\u2161, hepatic lipase gene (LIPC) -250G>A, endothelial lipase gene (LIPG) 584C>T, methylenetetrahydrofolate reductase (MTHFR) 677C>T, proprotein convertase subtilisin-like kexin type 9 (PCSK9) E670G, peroxisome proliferator-activated receptor delta (PPARD) +294T>C, and Scavenger receptor class B type 1 (SCARB1) rs5888 was performed in 935 nonsmokers and 845 smokers. The interactions were detected by factorial regression analysis. The frequencies of genotypes (ACAT-1 and LIPG), alleles (ABCA-1), and both genotypes and alleles (LDL-R, LIPC, PPARD and SCARB1) were different between nonsmokers and smokers (P < 0.05-0.001). The levels of pulse pressure (PP, ABCA-1), and systolic, diastolic blood pressure (SBP, DBP) and PP (LIPC) in nonsmokers were different among the genotypes (P < 0.01-0.001). The levels of SBP (ABCA-1, ACAT-1, LIPG and PCSK9), DBP (ACAT-1, LDL-R, LIPC, PCSK9 and PPARD), and PP (LIPC, LIPG, MTHFR and PCSK9) in smokers were different among the genotypes (P < 0.01-0.001). The SNPs of ABCA-1, ACAT-1 and PCSK9; ACAT-1, LDL-R, MTHFR and PCSK9; and ABCA-1, LIPC, PCSK9 and PPARD were shown interactions with cigarette smoking to influence SBP, DBP and PP levels (P < 0.05-0.001); respectively. The differences in blood pressure levels between the nonsmokers and smokers might partly result from different interactions of several SNPs and cigarette smoking.", "electronicPublicationDate": "2012-05-10", "language": "eng", "dateOfCompletion": "2012-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3354626?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3354626", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22606049", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22606049&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.7150/ijbs.4401", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "International journal of biological sciences", "medlineAbbreviation": "Int J Biol Sci", "isoabbreviation": "Int. J. Biol. Sci.", "nlmid": "101235568", "essn": "1449-2288"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2012, "journalIssueId": 1928190, "issue": "5", "dateOfPublication": "2012 "}}, "19009042": "", "26822830": {"pubYear": "2016", "dateOfCreation": "2016-02-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "Receptors, Cytoplasmic and Nuclear"}]}, "authorString": "Crunkhorn S.", "pubTypeList": {"pubType": ["Comment", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neostriatum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Huntington Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Cytoplasmic and Nuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "id": "26822830", "inEPMC": "N", "authorList": {"author": [{"lastName": "Crunkhorn", "fullName": "Crunkhorn S", "firstName": "Sarah", "initials": "S"}]}, "title": "Huntington disease: Boosting PPAR\u03b4 blocks neurodegeneration.", "citedByCount": 0, "pageInfo": "83", "source": "MED", "pmid": "26822830", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-01-29", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment on", "id": "26642438", "reference": "Nat Med. 2016 Jan;22(1):37-45"}]}, "hasDbCrossReferences": "N", "doi": "10.1038/nrd.2016.1", "electronicPublicationDate": "2016-01-29", "language": "eng", "dateOfCompletion": "2016-06-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/nrd.2016.1", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-02-01", "journal": {"medlineAbbreviation": "Nat Rev Drug Discov", "isoabbreviation": "Nat Rev Drug Discov", "title": "Nature reviews. Drug discovery", "issn": "1474-1776", "nlmid": "101124171", "essn": "1474-1784"}, "monthOfPublication": 2, "volume": "15", "yearOfPublication": 2016, "journalIssueId": 2370155, "issue": "2", "dateOfPublication": "2016 Feb"}}, "22528839": {"pubYear": "2012", "dateOfCreation": "2012-07-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Lipopolysaccharides"}, {"registryNumber": "0", "name": "Interleukin-6"}, {"registryNumber": "0", "name": "Antigens, CD11b"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "EC 1.14.13.39", "name": "Nitric Oxide Synthase Type II"}, {"registryNumber": "0", "name": "ITGAM protein, human"}, {"registryNumber": "EC 1.14.13.39", "name": "NOS2 protein, human"}, {"registryNumber": "Q8X02027X3", "name": "Gemfibrozil"}]}, "authorString": "Jana M, Pahan K.", "affiliation": "Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison St., Suite 320, Chicago, IL 60612, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "AT6681"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS64564"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R21 NS071479"}, {"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "R01 AT006681"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R21 NS064564"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS71479"}]}, "hasPDF": "Y", "id": "22528839", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurological Sciences, Rush University Medical Center, 1735 West Harrison St., Suite 320, Chicago, IL 60612, USA.", "fullName": "Jana M", "initials": "M", "firstName": "Malabendu", "lastName": "Jana"}, {"lastName": "Pahan", "fullName": "Pahan K", "firstName": "Kalipada", "initials": "K"}]}, "title": "Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor \u03b2.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "22528839", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Microglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Gemfibrozil", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lipopolysaccharides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD11b", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interleukin-6", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nitric Oxide Synthase Type II", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-04-17", "doi": "10.1007/s11064-012-0781-6", "isOpenAccess": "N", "pageInfo": "1718-1729", "pmcid": "PMC3389313", "hasDbCrossReferences": "N", "abstractText": "Microglial activation participates in the pathogenesis of various neuroinflammatory and neurodegenerative diseases. However, mechanisms by which microglial activation could be controlled are poorly understood. Peroxisome proliferator-activated receptors (PPAR) are transcription factors belonging to the nuclear receptor super family with diverse effect. This study underlines the importance of PPAR\u03b2/\u03b4 in mediating the anti-inflammatory effect of gemfibrozil, an FDA-approved lipid-lowering drug, in primary human microglia. Bacterial lipopolysachharides (LPS) induced the expression of various proinflammatory molecules and upregulated the expression of microglial surface marker CD11b in human microglia. However, gemfibrozil markedly suppressed proinflammatory molecules and CD11b in LPS-stimulated microglia. Human microglia expressed PPAR-\u03b2 and -\u03b3, but not PPAR-\u03b1. Interestingly, either antisense knockdown of PPAR-\u03b2 or antagonism of PPAR-\u03b2 by a specific chemical antagonist abrogated gemfibrozil-mediated inhibition of microglial activation. On the other hand, blocking of PPAR-\u03b1 and -\u03b3 had no effect on gemfibrozil-mediated anti-inflammatory effect in microglia. These results highlight the fact that gemfibrozil regulates microglial activation by inhibiting inflammatory gene expression in a PPAR-\u03b2 dependent pathway and further reinforce its therapeutic application in several neuroinflammatory and neurodegenerative diseases.", "electronicPublicationDate": "2012-04-17", "language": "eng", "dateOfCompletion": "2012-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3389313?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3389313", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22528839&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22528839", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s11064-012-0781-6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-06-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-08-01", "journal": {"medlineAbbreviation": "Neurochem Res", "isoabbreviation": "Neurochem. Res.", "title": "Neurochemical research", "issn": "0364-3190", "nlmid": "7613461", "essn": "1573-6903"}, "monthOfPublication": 8, "volume": "37", "yearOfPublication": 2012, "journalIssueId": 1944851, "issue": "8", "dateOfPublication": "2012 Aug"}}, "19874267": "", "26028469": {"pubYear": "2015", "dateOfCreation": "2015-06-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "102-32-9", "name": "3,4-Dihydroxyphenylacetic Acid"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "VTD58H1Z2X", "name": "Dopamine"}]}, "authorString": "Mounsey RB, Martin HL, Nelson MC, Evans RM, Teismann P.", "affiliation": "School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "DK", "orderIn": 0, "agency": "NIDDK NIH HHS", "grantId": "DK057978"}, {"acronym": "DK", "orderIn": 0, "agency": "NIDDK NIH HHS", "grantId": "R37 DK057978"}, {"orderIn": 0, "agency": "Howard Hughes Medical Institute"}, {"orderIn": 0, "agency": "Biotechnology and Biological Sciences Research Council"}, {"orderIn": 0, "agency": "Wellcome Trust", "grantId": "WT080782MF"}]}, "hasPDF": "Y", "id": "26028469", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.", "fullName": "Mounsey RB", "initials": "RB", "firstName": "R B", "lastName": "Mounsey"}, {"affiliation": "School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom; Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.", "fullName": "Martin HL", "initials": "HL", "firstName": "H L", "lastName": "Martin"}, {"affiliation": "Gene Expression Laboratory, Salk Institute, La Jolla, CA, USA.", "fullName": "Nelson MC", "initials": "MC", "firstName": "M C", "lastName": "Nelson"}, {"affiliation": "Gene Expression Laboratory, Salk Institute, La Jolla, CA, USA.", "fullName": "Evans RM", "initials": "RM", "firstName": "R M", "lastName": "Evans"}, {"affiliation": "School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: p.teismann@abdn.ac.uk.", "fullName": "Teismann P", "initials": "P", "firstName": "P", "lastName": "Teismann"}]}, "title": "The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26028469", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuroglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "MPTP Poisoning", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "3,4-Dihydroxyphenylacetic Acid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fluorescent Antibody Technique", "majorTopic_YN": "N"}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Dopaminergic Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-29", "language": "eng", "doi": "10.1016/j.neuroscience.2015.05.048", "isOpenAccess": "Y", "pageInfo": "576-584", "pmcid": "PMC4512257", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["MPTP", "Neurodegeneration", "Peroxisome proliferator-activated receptor", "Parkinson\u2019s Disease"]}, "abstractText": "Activation of peroxisome proliferator-activated receptors (PPARs), namely PPAR\u03b3 and PPAR\u03b4, has been shown to provide neuroprotection in a number of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease (PD). The observed neuroprotective effects in experimental models of PD have been linked to anti-oxidant and anti-inflammatory actions. This study aimed to analyze the full influence of these receptors in neuroprotection by generating a nerve cell-specific conditional knock-out of these receptors and subjecting these genetically modified mice to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to model dopaminergic degeneration. Mice null for both receptors show the lowest levels of tyrosine hydroxylase (TH)-positive cell bodies following MPTP administration. Presence of one or both these receptors show a trend toward protection against this degeneration, as higher dopaminergic cell immunoreactivity and striatal monoamine levels are evident. These data supplement recent studies that have elected to use agonists of the receptors to regulate immune responses. The results place further importance on the activation of PPARs and the neuroprotective roles these have in inflammatory processes linked to neurodegenerative processes.", "electronicPublicationDate": "2015-05-29", "license": "cc by", "dateOfCompletion": "2016-03-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4512257?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4512257", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.neuroscience.2015.05.048", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-08-01", "journal": {"medlineAbbreviation": "Neuroscience", "isoabbreviation": "Neuroscience", "title": "Neuroscience", "issn": "0306-4522", "nlmid": "7605074", "essn": "1873-7544"}, "monthOfPublication": 8, "volume": "300", "yearOfPublication": 2015, "journalIssueId": 2298050, "dateOfPublication": "2015 Aug"}}, "23500098": {"pubYear": "2013", "dateOfCreation": "2013-04-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "GW0742"}, {"registryNumber": "0", "name": "Thiophenes"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "0", "name": "Sulfones"}, {"registryNumber": "102-32-9", "name": "3,4-Dihydroxyphenylacetic Acid"}, {"registryNumber": "0", "name": "Macrophage-1 Antigen"}, {"registryNumber": "0", "name": "Glial Fibrillary Acidic Protein"}, {"registryNumber": "0", "name": "Neuroprotective Agents"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "GSK0660"}, {"registryNumber": "VTD58H1Z2X", "name": "Dopamine"}]}, "authorString": "Martin HL, Mounsey RB, Sathe K, Mustafa S, Nelson MC, Evans RM, Teismann P.", "affiliation": "Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.", "pubTypeList": {"pubType": ["Journal Article"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01 HL105278"}, {"orderIn": 0, "agency": "Howard Hughes Medical Institute"}, {"acronym": "DK", "orderIn": 0, "agency": "NIDDK NIH HHS", "grantId": "R37 DK057978"}]}, "hasPDF": "Y", "id": "23500098", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.", "fullName": "Martin HL", "initials": "HL", "firstName": "H L", "lastName": "Martin"}, {"lastName": "Mounsey", "fullName": "Mounsey RB", "firstName": "R B", "initials": "RB"}, {"lastName": "Sathe", "fullName": "Sathe K", "firstName": "K", "initials": "K"}, {"lastName": "Mustafa", "fullName": "Mustafa S", "firstName": "S", "initials": "S"}, {"lastName": "Nelson", "fullName": "Nelson MC", "firstName": "M C", "initials": "MC"}, {"lastName": "Evans", "fullName": "Evans RM", "firstName": "R M", "initials": "RM"}, {"lastName": "Teismann", "fullName": "Teismann P", "firstName": "P", "initials": "P"}]}, "title": "A peroxisome proliferator-activated receptor-\u03b4 agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.", "hasSuppl": "N", "citedByCount": 9, "source": "MED", "pmid": "23500098", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Parkinsonian Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Dopamine", "majorTopic_YN": "N"}, {"descriptorName": "3,4-Dihydroxyphenylacetic Acid", "majorTopic_YN": "N"}, {"descriptorName": "Sulfones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiophenes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glial Fibrillary Acidic Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Macrophage-1 Antigen", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuroprotective Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Count", "majorTopic_YN": "N"}, {"descriptorName": "Dose-Response Relationship, Drug", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-03-07", "language": "eng", "doi": "10.1016/j.neuroscience.2013.02.058", "isOpenAccess": "Y", "pageInfo": "191-203", "pmcid": "PMC3661980", "hasDbCrossReferences": "Y", "abstractText": "Peroxisome proliferator-activated receptor (PPAR)-\u03b3 and PPAR\u03b1 have shown neuroprotective effects in models of Parkinson's disease (PD). The role of the third, more ubiquitous isoform PPAR\u03b4 has not been fully explored. This study investigated the role of PPAR\u03b4 in PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to model the dopaminergic neurodegeneration of PD. In vitro administration of the PPAR\u03b4 antagonist GSK0660 (1 \u03bcM) increased the detrimental effect of 1-methyl-4-phenylpyridinium iodide (MPP\u207a) on cell viability, which was reversed by co-treatment with agonist GW0742 (1 \u03bcM). GW0742 alone did not affect MPP\u207a toxicity. PPAR\u03b4 was expressed in the nucleus of dopaminergic neurons and in astrocytes. Striatal PPAR\u03b4 levels were increased (over two-fold) immediately after MPTP treatment (30 mg/kg for 5 consecutive days) compared to saline-treated mice. PPAR\u03b4 heterozygous mice were not protected against MPTP toxicity. Intra-striatal infusion of GW0742 (84 \u03bcg/day) reduced the MPTP-induced loss of dopaminergic neurons (5036\u00b1195) when compared to vehicle-infused mice (3953\u00b1460). These results indicate that agonism of PPAR\u03b4 provides protection against MPTP toxicity, in agreement with the effects of other PPAR agonists.", "electronicPublicationDate": "2013-03-07", "license": "cc by", "dateOfCompletion": "2013-11-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3661980", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23500098", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23500098&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.neuroscience.2013.02.058", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-11-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-06-01", "journal": {"medlineAbbreviation": "Neuroscience", "isoabbreviation": "Neuroscience", "title": "Neuroscience", "issn": "0306-4522", "nlmid": "7605074", "essn": "1873-7544"}, "monthOfPublication": 6, "volume": "240", "yearOfPublication": 2013, "journalIssueId": 2033348, "dateOfPublication": "2013 Jun"}}, "22779044": {"pubYear": "2012", "dateOfCreation": "2012-07-10", "pubModel": "Print-Electronic", "authorString": "Deng M, Zollanvari A, Alterovitz G.", "pubTypeList": {"pubType": ["Journal Article"]}, "grantsList": {"grant": [{"acronym": "LM", "orderIn": 0, "agency": "NLM NIH HHS", "grantId": "R00 LM009826"}]}, "id": "22779044", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Deng", "fullName": "Deng M", "firstName": "Michelle", "initials": "M"}, {"lastName": "Zollanvari", "fullName": "Zollanvari A", "firstName": "Amin", "initials": "A"}, {"lastName": "Alterovitz", "fullName": "Alterovitz G", "firstName": "Gil", "initials": "G"}]}, "title": "A bayesian translational framework for knowledge propagation, discovery, and integration under specific contexts.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "22779044", "abstractText": "The immense corpus of biomedical literature existing today poses challenges in information search and integration. Many links between pieces of knowledge occur or are significant only under certain contexts-rather than under the entire corpus. This study proposes using networks of ontology concepts, linked based on their co-occurrences in annotations of abstracts of biomedical literature and descriptions of experiments, to draw conclusions based on context-specific queries and to better integrate existing knowledge. In particular, a Bayesian network framework is constructed to allow for the linking of related terms from two biomedical ontologies under the queried context concept. Edges in such a Bayesian network allow associations between biomedical concepts to be quantified and inference to be made about the existence of some concepts given prior information about others. This approach could potentially be a powerful inferential tool for context-specific queries, applicable to ontologies in other fields as well.", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-19", "isOpenAccess": "Y", "pageInfo": "25-34", "pmcid": "PMC3392061", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "electronicPublicationDate": "2012-03-19", "language": "eng", "dateOfCompletion": "2012-08-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3392061?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3392061", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22779044&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22779044", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "dateOfRevision": "2016-08-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"issn": "2153-4063", "medlineAbbreviation": "AMIA Summits on Translational Science Proceedings", "title": "AMIA Summits on Translational Science Proceedings"}, "monthOfPublication": 0, "volume": "2012", "yearOfPublication": 2012, "journalIssueId": 1947103, "dateOfPublication": "2012 "}}, "20155818": "", "19422681": "", "26628385": {"pubYear": "2016", "dateOfCreation": "2015-12-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}]}, "authorString": "Teng Z, Jiang L, Hu Q, He Y, Guo Z, Wu Y, Huang Z, Cao F, Cheng C, Sun X, Guo Z.", "affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "26628385", "inEPMC": "N", "authorList": {"author": [{"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Teng Z", "initials": "Z", "firstName": "Zhipeng", "lastName": "Teng"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Jiang L", "initials": "L", "firstName": "Li", "lastName": "Jiang"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Hu Q", "initials": "Q", "firstName": "Qin", "lastName": "Hu"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "He Y", "initials": "Y", "firstName": "Yue", "lastName": "He"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Guo Z", "initials": "Z", "firstName": "Zhenni", "lastName": "Guo"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Wu Y", "initials": "Y", "firstName": "Yue", "lastName": "Wu"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Huang Z", "initials": "Z", "firstName": "Zhijian", "lastName": "Huang"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Cao F", "initials": "F", "firstName": "Fang", "lastName": "Cao"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo).", "fullName": "Cheng C", "initials": "C", "firstName": "Chongjie", "lastName": "Cheng"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo). sunxch1445@qq.com stonegzd@163.com.", "fullName": "Sun X", "initials": "X", "firstName": "Xiaochuan", "lastName": "Sun"}, {"affiliation": "From the Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Z.T., L.J., Y.W., Z.H., F.C., C.C., X.S., Zongduo Guo); Discipline of Neuroscience and Department of Anatomy, Histology and Embryology, Collaborative Innovation Center for Brain Science, and Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Q.H.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, China (Y.H.); and Department of Neurology, the First Hospital of Jilin University, Changchun, China (Zhenni Guo). sunxch1445@qq.com stonegzd@163.com.", "fullName": "Guo Z", "initials": "Z", "firstName": "Zongduo", "lastName": "Guo"}]}, "title": "Peroxisome Proliferator-Activated Receptor \u03b2/\u03b4 Alleviates Early Brain Injury After Subarachnoid Hemorrhage in Rats.", "citedByCount": 0, "source": "MED", "pmid": "26628385", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Brain Injuries", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Subarachnoid Hemorrhage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-12-01", "doi": "10.1161/strokeaha.115.011701", "isOpenAccess": "N", "pageInfo": "196-205", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Apoptosis", "MMP-9", "Subarachnoid hemorrhage", "Early Brain Injury", "Ppar\u03b2/\u03b4"]}, "abstractText": "Early brain injury is proposed to be the primary cause of the poor outcome after subarachnoid hemorrhage (SAH), which is closely related to the neural apoptosis. To date, the relationship between peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR\u03b2/\u03b4) and nuclear factor-\u03baB/matrix metalloproteinase-9 (NF-\u03baB/MMP-9) pathway, both of which are closely related to apoptotic effects, has been poorly studied in SAH. The present study was undertaken to evaluate the effects of PPAR\u03b2/\u03b4 on early brain injury and NF-\u03baB/MMP-9 pathway after SAH in rats.SAH model was established by injecting nonheparinized autologous arterial blood into the prechiasmatic cistern in male Sprague-Dawley rats. Adenoviruses or small interfering RNAs were injected into the right lateral cerebral ventricle to, respectively, up- or downregulate PPAR\u03b2/\u03b4 expression before SAH. All animals were assessed with a neurological score and then killed at 24 hours after SAH surgery. The indexes of brain water content, blood-brain barrier permeability, and apoptosis were used to detect brain injury. The expression of PPAR\u03b2/\u03b4, NF-\u03baB, and MMP-9 were measured by immunohistochemistry, gelatin zymography, and Western Blot methods, respectively. In addition, GW0742, a specific agonist of PPAR\u03b2/\u03b4, was used to treat SAH in rats, the effects of which were evaluated by neurological scoring and Evans blue extravasation.Overexpression of PPAR\u03b2/\u03b4 by adenoviruses treatment significantly ameliorated brain injury with improvement in neurological deficits, brain edema, blood-brain barrier impairment, and neural cell apoptosis at 24 hours after SAH in rats, whereas downregulation of PPAR\u03b2/\u03b4 by small interfering RNAs administration resulted in the reverse effects of the above. The expression levels of NF-\u03baB and MMP-9 were markedly downregulated when PPAR\u03b2/\u03b4 increased after PPAR\u03b2/\u03b4 adenovirus transfection and upregulated when PPAR\u03b2/\u03b4 decreased by PPAR\u03b2/\u03b4 small interfering RNAs treatment. Moreover, GW0742 improved neurological deficits and reduced Evans blue extravasation at 24 hours after SAH.PPAR\u03b2/\u03b4's overexpression may attenuate early brain injury after rats' SAH administration, which reduces neural apoptosis possibly through blocking NF-\u03baB/MMP-9 pathway.", "electronicPublicationDate": "2015-12-01", "language": "eng", "dateOfCompletion": "2016-05-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1161/STROKEAHA.115.011701", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Stroke", "isoabbreviation": "Stroke", "title": "Stroke; a journal of cerebral circulation", "issn": "0039-2499", "nlmid": "0235266", "essn": "1524-4628"}, "monthOfPublication": 1, "volume": "47", "yearOfPublication": 2016, "journalIssueId": 2357390, "issue": "1", "dateOfPublication": "2016 Jan"}}, "16979821": "", "18606951": "", "26160761": {"pubYear": "2016", "dateOfCreation": "2016-07-08", "pubModel": "Print-Electronic", "authorString": "Tong Q, Wu L, Gao Q, Ou Z, Zhu D, Zhang Y.", "affiliation": "Department of Geriatrics, Huai'an First People's Hospital, Nanjing Medical University, P.O. Box 223300, No. 6 Beijing Road West, Huai'an, People's Republic of China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26160761", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Geriatrics, Huai'an First People's Hospital, Nanjing Medical University, P.O. Box 223300, No. 6 Beijing Road West, Huai'an, People's Republic of China.", "fullName": "Tong Q", "initials": "Q", "firstName": "Qiang", "lastName": "Tong"}, {"affiliation": "Department of Neurology, Nanjing First Hospital, Nanjing Medical University, P.O. Box 210006, No. 68 Changle Road, Nanjing, People's Republic of China.", "fullName": "Wu L", "initials": "L", "firstName": "Liang", "lastName": "Wu"}, {"affiliation": "Department of Neurology, Nanjing First Hospital, Nanjing Medical University, P.O. Box 210006, No. 68 Changle Road, Nanjing, People's Republic of China.", "fullName": "Gao Q", "initials": "Q", "firstName": "Qing", "lastName": "Gao"}, {"affiliation": "Department of Neurology, Nanjing First Hospital, Nanjing Medical University, P.O. Box 210006, No. 68 Changle Road, Nanjing, People's Republic of China.", "fullName": "Ou Z", "initials": "Z", "firstName": "Zhou", "lastName": "Ou"}, {"affiliation": "Department of Pharmacology, School of Pharmacy, Nanjing Medical University, P.O. Box 211166, No. 818 Tianyuan East Road, Jiangning District, Nanjing, People's Republic of China.", "fullName": "Zhu D", "initials": "D", "firstName": "Dongya", "lastName": "Zhu"}, {"affiliation": "Department of Neurology, Nanjing First Hospital, Nanjing Medical University, P.O. Box 210006, No. 68 Changle Road, Nanjing, People's Republic of China. zhangyingdong@aliyun.com.", "fullName": "Zhang Y", "initials": "Y", "firstName": "Yingdong", "lastName": "Zhang"}]}, "title": "PPAR\u03b2/\u03b4 Agonist Provides Neuroprotection by Suppression of IRE1\u03b1-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.", "citedByCount": 0, "source": "MED", "pmid": "26160761", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-07-10", "doi": "10.1007/s12035-015-9309-9", "isOpenAccess": "N", "pageInfo": "3822-3831", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["ER stress", "neuroprotection", "Parkinson\u2019s Disease", "Ppar\u03b2/\u03b4"]}, "abstractText": "Two recent studies demonstrated that peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR\u03b2/\u03b4) agonists exerted neuroprotective effects in mouse model of Parkinson's disease (PD). However, the underlying mechanisms remain unknown. Endoplasmic reticulum (ER) stress plays a major role in rotenone-induced dopaminergic neuronal degeneration. In the present study, we explored whether GW501516, a selective and high-affinity PPAR\u03b2/\u03b4 agonist, could protect the dopaminergic neurons against degeneration and improve PD behavior via suppressing the ER stress in the rotenone rat model of PD. GW501516 was administered intracerebroventricular infusion. Catalepsy and open field tests were used to test catalepsy and locomotor activities. The levels of dopamine and its metabolites were determined using high-performance liquid chromatography. Western blot and immunohistochemistry analysis were performed to assess dopaminergic neuronal degeneration. Quantitative real-time RT-PCR and Western blot analysis were executed to detect ER stress. TUNEL and immunohistochemistry assays were used to detect ER stress-mediated apoptosis. Our results showed that GW501516 ameliorated the catalepsy symptom and increased locomotor activity. Meanwhile, GW501516 partially reversed the loss of dopaminergic neurons. Moreover, GW501516 suppressed the activation of ER stress markers including inositol-requiring enzyme 1\u03b1 (IRE1\u03b1) and caspase-12. Furthermore, GW501516 inhibited caspase-12-mediated neuronal apoptosis. These findings suggest that GW501516 conferred neuroprotection of not only biochemical and pathological attenuation but also behavioral improvement in the rotenone rat model of PD. More importantly, we demonstrated for the first time that suppressing IRE1\u03b1-caspase-12-mediated ER stress pathway may represent one potential mechanism underlying the neuroprotective effects of PPAR\u03b2/\u03b4 agonist in the rotenone rat model of PD.", "electronicPublicationDate": "2015-07-10", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s12035-015-9309-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-08-01", "journal": {"medlineAbbreviation": "Mol Neurobiol", "isoabbreviation": "Mol. Neurobiol.", "title": "Molecular neurobiology", "issn": "0893-7648", "nlmid": "8900963", "essn": "1559-1182"}, "monthOfPublication": 8, "volume": "53", "yearOfPublication": 2016, "journalIssueId": 2427962, "issue": "6", "dateOfPublication": "2016 Aug"}}, "25945080": {"pubYear": "2015", "dateOfCreation": "2015-05-06", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}]}, "authorString": "Giordano Attianese GM, Desvergne B.", "affiliation": "Center for Integrative Genomics, University of Lausanne, Switzerland.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25945080", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Center for Integrative Genomics, University of Lausanne, Switzerland.", "fullName": "Giordano Attianese GM", "initials": "GM", "firstName": "Greta M P", "lastName": "Giordano Attianese"}, {"affiliation": "Center for Integrative Genomics, University of Lausanne, Switzerland.", "fullName": "Desvergne B", "initials": "B", "firstName": "B\u00e9atrice", "lastName": "Desvergne"}]}, "title": "Integrative and systemic approaches for evaluating PPAR\u03b2/\u03b4 (PPARD) function.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "25945080", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["arrayexpress", " refsnp", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Systems Biology", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genomics", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Cell Physiological Processes", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-04-27", "language": "eng", "doi": "10.1621/nrs.13001", "isOpenAccess": "Y", "pageInfo": "e001", "pmcid": "PMC4419664", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Nuclear receptor", "Chip", "systems biology", "Ppar\u03b2/\u03b4"]}, "abstractText": "The peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptors that function as transcription factors regulating the expression of genes involved in cellular differentiation, development, metabolism and also tumorigenesis. Three PPAR isotypes (\u03b1, \u03b2/\u03b4 and \u03b3) have been identified, among which PPAR\u03b2/\u03b4 is the most difficult to functionally examine due to its tissue-specific diversity in cell fate determination, energy metabolism and housekeeping activities. PPAR\u03b2/\u03b4 acts both in a ligand-dependent and -independent manner. The specific type of regulation, activation or repression, is determined by many factors, among which the type of ligand, the presence/absence of PPAR\u03b2/\u03b4-interacting corepressor or coactivator complexes and PPAR\u03b2/\u03b4 protein post-translational modifications play major roles. Recently, new global approaches to the study of nuclear receptors have made it possible to evaluate their molecular activity in a more systemic fashion, rather than deeply digging into a single pathway/function. This systemic approach is ideally suited for studying PPAR\u03b2/\u03b4, due to its ubiquitous expression in various organs and its overlapping and tissue-specific transcriptomic signatures. The aim of the present review is to present in detail the diversity of PPAR\u03b2/\u03b4 function, focusing on the different information gained at the systemic level, and describing the global and unbiased approaches that combine a systems view with molecular understanding.", "electronicPublicationDate": "2015-04-27", "license": "cc by", "dateOfCompletion": "2016-01-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4419664?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4419664", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1621/nrs.13001", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Nuclear receptor signaling", "medlineAbbreviation": "Nucl Recept Signal", "isoabbreviation": "Nucl Recept Signal", "nlmid": "101237902", "essn": "1550-7629"}, "monthOfPublication": 0, "volume": "13", "yearOfPublication": 2015, "journalIssueId": 2281651, "dateOfPublication": "2015"}}, "24635117": {"pubYear": "2014", "dateOfCreation": "2014-05-09", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "GW0742"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Neuroprotective Agents"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}]}, "authorString": "Das NR, Gangwal RP, Damre MV, Sangamwar AT, Sharma SS.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24635117", "inEPMC": "N", "authorList": {"author": [{"lastName": "Das", "fullName": "Das NR", "firstName": "Nihar R", "initials": "NR"}, {"lastName": "Gangwal", "fullName": "Gangwal RP", "firstName": "Rahul P", "initials": "RP"}, {"lastName": "Damre", "fullName": "Damre MV", "authorId": {"type": "ORCID", "value": "0000-0002-4371-3815"}, "firstName": "Mangesh V", "initials": "MV"}, {"lastName": "Sangamwar", "fullName": "Sangamwar AT", "firstName": "Abhay T", "initials": "AT"}, {"affiliation": "Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, SAS Nagar, Punjab-160062, India. sssharma@niper.ac.in.", "fullName": "Sharma SS", "initials": "SS", "firstName": "Shyam S", "lastName": "Sharma"}]}, "title": "A PPAR-\u03b2/\u03b4 agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease.", "citedByCount": 3, "source": "MED", "pmid": "24635117", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4371-3815"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Parkinsonian Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neuroprotective Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "In Situ Nick-End Labeling", "majorTopic_YN": "N"}, {"descriptorName": "Cognition", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Maze Learning", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Fragmentation", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-05-01", "doi": "10.2174/1567202611666140318114037", "isOpenAccess": "N", "pageInfo": "114-124", "hasDbCrossReferences": "N", "abstractText": "Parkinson's disease (PD) is associated with higher risk of cognitive impairment that may lead to memory loss, confusion, and decreased attention span. In this study, we have investigated the effect of GW0742, a PPAR-\u03b2/\u03b4 agonist in rat model of cognitive impairment associated with PD. Bilateral intranigral administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) (100 \u00b5g/1 \u00b5l/side) produced significant cognitive dysfunctions. PPAR-\u03b2/\u03b4 agonist GW0742 at a dose of 30 and 100 \u00b5g/kg showed significant improvement in cognitive impairments caused by MPTP in rat model of PD as evident from passive avoidance and Morris water maze test. MPTP-induced massive oxidative damage and DNA fragmentation was ameliorated by GW0742 treatment as observed after MDA and GSH estimation and TUNEL assay. Tyrosine hydroxylase positive neurons were decreased by 25% of normal control in MPTP group and GW0742 treatment restored tyrosine hydroxylase levels showing neuroprotective nature. Further, we performed physiologically based pharmacokinetic (PBPK) modeling study using GastroPlus to characterize the kinetics of GW0742 in the brain. The predicted amounts of GW0742 in brain suggest that it has the ability to cross the blood brain barrier. This study implicates the involvement of PPAR-\u03b2/\u03b4 in PD induced cognitive impairment.", "language": "eng", "dateOfCompletion": "2014-12-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.2174/1567202611666140318114037", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-05-01", "journal": {"medlineAbbreviation": "Curr Neurovasc Res", "isoabbreviation": "Curr Neurovasc Res", "title": "Current neurovascular research", "issn": "1567-2026", "nlmid": "101208439", "essn": "1875-5739"}, "monthOfPublication": 5, "volume": "11", "yearOfPublication": 2014, "journalIssueId": 2158517, "issue": "2", "dateOfPublication": "2014 May"}}, "17167170": "", "22193206": {"pubYear": "2012", "dateOfCreation": "2012-02-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "74772-77-3", "name": "ciglitazone"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Acetates"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Eye Proteins"}, {"registryNumber": "0", "name": "Thiazolidinediones"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid"}]}, "authorString": "Sampath S, McLean LA, Buono C, Moulin P, Wolf A, Chibout SD, Pognan F, Busch S, Shangari N, Cruz E, Gurnani M, Patel P, Reising A.", "affiliation": "Investigative Toxicology, Novartis Institutes of Biomedical Research, East Hanover, New Jersey 07936, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "22193206", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sampath", "fullName": "Sampath S", "firstName": "Shruthi", "initials": "S"}, {"lastName": "McLean", "fullName": "McLean LA", "firstName": "Lee Anne", "initials": "LA"}, {"lastName": "Buono", "fullName": "Buono C", "firstName": "Chiara", "initials": "C"}, {"lastName": "Moulin", "fullName": "Moulin P", "firstName": "Pierre", "initials": "P"}, {"lastName": "Wolf", "fullName": "Wolf A", "firstName": "Armin", "initials": "A"}, {"lastName": "Chibout", "fullName": "Chibout SD", "firstName": "Salah-Dine", "initials": "SD"}, {"lastName": "Pognan", "fullName": "Pognan F", "firstName": "Francois", "initials": "F"}, {"lastName": "Busch", "fullName": "Busch S", "firstName": "Steve", "initials": "S"}, {"lastName": "Shangari", "fullName": "Shangari N", "firstName": "Nandita", "initials": "N"}, {"lastName": "Cruz", "fullName": "Cruz E", "firstName": "Elba", "initials": "E"}, {"lastName": "Gurnani", "fullName": "Gurnani M", "firstName": "Maya", "initials": "M"}, {"lastName": "Patel", "fullName": "Patel P", "firstName": "Parul", "initials": "P"}, {"lastName": "Reising", "fullName": "Reising A", "firstName": "Albert", "initials": "A"}]}, "title": "The use of rat lens explant cultures to study the mechanism of drug-induced cataractogenesis.", "citedByCount": 1, "source": "MED", "pmid": "22193206", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lens, Crystalline", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CI", "qualifierName": "chemically induced", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acetates", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiazolidinediones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Eye Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Tissue Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-12-21", "doi": "10.1093/toxsci/kfr344", "isOpenAccess": "N", "pageInfo": "128-139", "hasDbCrossReferences": "Y", "abstractText": "Lens explant cultures were used to assess the mechanism of drug-induced cataractogenic potential of NVS001, a peroxisome proliferator-activated receptor delta (PPAR\u03b4) agonist, which resulted in cataract in all treated animals during a 13-week rat study. Ciglitazone, a PPAR\u03b3 agonist and cataractogenic compound, was used as a positive control to validate this model. Rat lenses were extracted and cultured in medium supplemented with antibiotics for 24-h preincubation pretreatment. Lenses showing no signs of damage at the end of the preincubation pretreatment period were randomized into five experimental groups, (1) untreated control, (2) 0.1% dimethyl sulphoxide control, (3) 10\u03bcM NVS001, (4) 10\u03bcM ciglitazone, and (5) 10\u03bcM acetaminophen (negative control). Lenses were treated every 24 h after preincubation pretreatment for up to 48 h. Samples for viability, histology, and gene expression profiling were collected at 4, 24, and 48 h. There was a time-dependent increase in opacity, which correlated to a decrease in viability measured by adenosine triphosphate levels in NVS001 and ciglitazone-treated lenses compared with controls. NVS001 and ciglitazone had comparable cataractogenic effects after 48 h with histology showing rupture of the lens capsule, lens fiber degeneration, cortical lens vacuolation, and lens epithelial degeneration. Furthermore, no changes were seen when lenses were treated with acetaminophen. Gene expression analysis supported oxidative and osmotic stress, along with decreases in membrane and epithelial cell integrity as key factors in NVS001-induced cataracts. This study suggests that in vitro lens cultures can be used to assess cataractogenic potential of PPAR agonists and to study/understand the underlying molecular mechanism of cataractogenesis in rat.", "electronicPublicationDate": "2011-12-21", "language": "eng", "dateOfCompletion": "2012-07-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1093/toxsci/kfr344", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-03-01", "journal": {"medlineAbbreviation": "Toxicol Sci", "isoabbreviation": "Toxicol. Sci.", "title": "Toxicological sciences : an official journal of the Society of Toxicology", "issn": "1096-6080", "nlmid": "9805461", "essn": "1096-0929"}, "monthOfPublication": 3, "volume": "126", "yearOfPublication": 2012, "journalIssueId": 1909189, "issue": "1", "dateOfPublication": "2012 Mar"}}, "21192919": "", "25592770": {"pubYear": "2015", "dateOfCreation": "2015-04-22", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "GW0742"}, {"registryNumber": "0", "name": "Aif1 protein, mouse"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Anti-Inflammatory Agents"}, {"registryNumber": "EC 4.2.1.11", "name": "Phosphopyruvate Hydratase"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "Cell Adhesion Molecules"}, {"registryNumber": "0", "name": "Calcium-Binding Proteins"}, {"registryNumber": "0", "name": "Glial Fibrillary Acidic Protein"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "LEEP-CAM protein, human"}, {"registryNumber": "0", "name": "Complement C3"}, {"registryNumber": "80295-33-6", "name": "Complement C1q"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}]}, "authorString": "Malm T, Mariani M, Donovan LJ, Neilson L, Landreth GE.", "affiliation": "Department of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. tarja.malm@uef.fi.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG043522"}]}, "hasPDF": "Y", "id": "25592770", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. tarja.malm@uef.fi.", "fullName": "Malm T", "initials": "T", "firstName": "Tarja", "lastName": "Malm"}, {"affiliation": "Department of Neurosciences, Alzheimer Research Laboratory, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. mxh534@case.edu.", "fullName": "Mariani M", "initials": "M", "firstName": "Monica", "lastName": "Mariani"}, {"affiliation": "Department of Neurosciences, Alzheimer Research Laboratory, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. lxd156@case.edu.", "fullName": "Donovan LJ", "initials": "LJ", "firstName": "Lauren J", "lastName": "Donovan"}, {"affiliation": "Department of Neurosciences, Alzheimer Research Laboratory, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. len11@case.edu.", "fullName": "Neilson L", "initials": "L", "firstName": "Lee", "lastName": "Neilson"}, {"affiliation": "Department of Neurosciences, Alzheimer Research Laboratory, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. gel2@case.edu.", "fullName": "Landreth GE", "initials": "GE", "firstName": "Gary E", "lastName": "Landreth"}]}, "title": "Activation of the nuclear receptor PPAR\u03b4 is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "25592770", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Animals, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Inflammation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glial Fibrillary Acidic Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphopyruvate Hydratase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calcium-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Adhesion Molecules", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anti-Inflammatory Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Complement C3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Complement C1q", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Embryo, Mammalian", "majorTopic_YN": "N"}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-16", "language": "eng", "doi": "10.1186/s12974-014-0229-9", "isOpenAccess": "Y", "pageInfo": "7", "pmcid": "PMC4310027", "hasDbCrossReferences": "N", "abstractText": "Alzheimer's disease (AD) is a multifactorial disorder associated with the accumulation of soluble forms of beta-amyloid (A\u03b2) and its subsequent deposition into plaques. One of the major contributors to neuronal death is chronic and uncontrolled inflammatory activation of microglial cells around the plaques and their secretion of neurotoxic molecules. A shift in microglial activation towards a phagocytic phenotype has been proposed to confer benefit in models of AD. Peroxisome proliferator activator receptor \u03b4 (PPAR\u03b4) is a transcription factor with potent anti-inflammatory activation properties and PPAR\u03b4 agonism leads to reduction in brain A\u03b2 levels in 5XFAD mice. This study was carried out to elucidate the involvement of microglial activation in the PPAR\u03b4-mediated reduction of A\u03b2 burden and subsequent outcome to neuronal survival in a 5XFAD mouse model of AD.5XFAD mice were orally treated with the PPAR\u03b4 agonist GW0742 for 2 weeks. The brain A\u03b2 load, glial activation, and neuronal survival were assessed by immunohistochemistry and quantitative PCR. In addition, the ability of GW0742 to prevent direct neuronal death as well as inflammation-induced neuron death was analyzed in vitro.Our results show for the first time that a short treatment period of 5XFAD mice was effective in reducing the parenchymal A\u03b2 load without affecting the levels of intraneuronal A\u03b2. This was concomitant with a decrease in overall microglial activation and reduction in proinflammatory mediators. Instead, microglial immunoreactivity around A\u03b2 deposits was increased. Importantly, the reduction in the proinflammatory milieu elicited by GW0742 treatment resulted in attenuation of neuronal loss in vivo in the subiculum of 5XFAD mice. In addition, whereas GW0742 failed to protect primary neurons against glutamate-induced cell death, it prevented inflammation-induced neuronal death in microglia-neuron co-cultures in vitro.This study demonstrates that GW0742 treatment has a prominent anti-inflammatory effect in 5XFAD mice and suggests that PPAR\u03b4 agonists may have therapeutic utility in treating AD.", "electronicPublicationDate": "2015-01-16", "license": "cc by", "dateOfCompletion": "2016-08-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4310027?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4310027", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s12974-014-0229-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Journal of neuroinflammation", "medlineAbbreviation": "J Neuroinflammation", "isoabbreviation": "J Neuroinflammation", "nlmid": "101222974", "essn": "1742-2094"}, "monthOfPublication": 0, "volume": "12", "yearOfPublication": 2015, "journalIssueId": 2267245, "dateOfPublication": "2015 "}}, "20001953": "", "21234105": "", "23507144": {"pubYear": "2013", "dateOfCreation": "2013-06-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "advanced glycosylation end-product receptor"}, {"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Receptors, Immunologic"}, {"registryNumber": "0", "name": "tau Proteins"}, {"registryNumber": "0", "name": "Interleukin-6"}, {"registryNumber": "0", "name": "NF-kappa B"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "EC 3.4.-", "name": "Amyloid Precursor Protein Secretases"}, {"registryNumber": "EC 3.4.23.46", "name": "Bace1 protein, mouse"}, {"registryNumber": "0", "name": "glial fibrillary astrocytic protein, mouse"}, {"registryNumber": "EC 3.4.23.-", "name": "Aspartic Acid Endopeptidases"}, {"registryNumber": "EC 2.7.11.22", "name": "Cyclin-Dependent Kinase 5"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}, {"registryNumber": "EC 2.7.11.22", "name": "Cdk5 protein, mouse"}]}, "authorString": "Barroso E, del Valle J, Porquet D, Vieira Santos AM, Salvad\u00f3 L, Rodr\u00edguez-Rodr\u00edguez R, Guti\u00e9rrez P, Anglada-Huguet M, Alberch J, Camins A, Palomer X, Pall\u00e0s M, Michalik L, Wahli W, V\u00e1zquez-Carrera M.", "affiliation": "Unitat de Farmacologia, Department de Farmacologia i Qu\u00edmica Terap\u00e8utica, Facultat de Farm\u00e0cia, Universitat de Barcelona, Institut de Biomedicina de la UB, IBUB, Spain.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23507144", "inEPMC": "N", "authorList": {"author": [{"lastName": "Barroso", "fullName": "Barroso E", "firstName": "Emma", "initials": "E"}, {"lastName": "del Valle", "fullName": "del Valle J", "authorId": {"type": "ORCID", "value": "0000-0002-6703-8244"}, "firstName": "Jaume", "initials": "J"}, {"lastName": "Porquet", "fullName": "Porquet D", "firstName": "David", "initials": "D"}, {"lastName": "Vieira Santos", "fullName": "Vieira Santos AM", "firstName": "Ana M", "initials": "AM"}, {"lastName": "Salvad\u00f3", "fullName": "Salvad\u00f3 L", "firstName": "Laia", "initials": "L"}, {"lastName": "Rodr\u00edguez-Rodr\u00edguez", "fullName": "Rodr\u00edguez-Rodr\u00edguez R", "firstName": "Rosal\u00eda", "initials": "R"}, {"lastName": "Guti\u00e9rrez", "fullName": "Guti\u00e9rrez P", "firstName": "Patr\u00edcia", "initials": "P"}, {"lastName": "Anglada-Huguet", "fullName": "Anglada-Huguet M", "firstName": "Marta", "initials": "M"}, {"lastName": "Alberch", "fullName": "Alberch J", "firstName": "Jordi", "initials": "J"}, {"lastName": "Camins", "fullName": "Camins A", "firstName": "Antoni", "initials": "A"}, {"lastName": "Palomer", "fullName": "Palomer X", "firstName": "Xavier", "initials": "X"}, {"lastName": "Pall\u00e0s", "fullName": "Pall\u00e0s M", "authorId": {"type": "ORCID", "value": "0000-0003-3095-4254"}, "firstName": "Merc\u00e8", "initials": "M"}, {"lastName": "Michalik", "fullName": "Michalik L", "firstName": "Liliane", "initials": "L"}, {"lastName": "Wahli", "fullName": "Wahli W", "firstName": "Walter", "initials": "W"}, {"lastName": "V\u00e1zquez-Carrera", "fullName": "V\u00e1zquez-Carrera M", "firstName": "Manuel", "initials": "M"}]}, "title": "Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPAR\u03b2/\u03b4-null mice.", "citedByCount": 7, "source": "MED", "pmid": "23507144", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6703-8244"}, {"type": "ORCID", "value": "0000-0003-3095-4254"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebral Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Inflammation", "majorTopic_YN": "N"}, {"descriptorName": "tau Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "NF-kappa B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Immunologic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interleukin-6", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cognition", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "MAP Kinase Signaling System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cyclin-Dependent Kinase 5", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid Precursor Protein Secretases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aspartic Acid Endopeptidases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mild Cognitive Impairment", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-03-16", "doi": "10.1016/j.bbadis.2013.03.006", "isOpenAccess": "N", "pageInfo": "1241-1248", "hasDbCrossReferences": "Y", "abstractText": "The role of peroxisome proliferator activator receptor (PPAR)\u03b2/\u03b4 in the pathogenesis of Alzheimer's disease has only recently been explored through the use of PPAR\u03b2/\u03b4 agonists. Here we evaluated the effects of PPAR\u03b2/\u03b4 deficiency on the amyloidogenic pathway and tau hyperphosphorylation. PPAR\u03b2/\u03b4-null mice showed cognitive impairment in the object recognition task, accompanied by enhanced DNA-binding activity of NF-\u03baB in the cortex and increased expression of IL-6. In addition, two NF-\u03baB-target genes involved in \u03b2-amyloid (A\u03b2) synthesis and deposition, the \u03b2 site APP cleaving enzyme 1 (Bace1) and the receptor for advanced glycation endproducts (Rage), respectively, increased in PPAR\u03b2/\u03b4-null mice compared to wild type animals. The protein levels of glial fibrillary acidic protein (GFAP) increased in the cortex of PPAR\u03b2/\u03b4-null mice, which would suggest the presence of astrogliosis. Finally, tau hyperphosphorylation at Ser199 and enhanced levels of PHF-tau were associated with increased levels of the tau kinases CDK5 and phospho-ERK1/2 in the cortex of PPAR\u03b2/\u03b4(-/-) mice. Collectively, our findings indicate that PPAR\u03b2/\u03b4 deficiency results in cognitive impairment associated with enhanced inflammation, astrogliosis and tau hyperphosphorylation in the cortex.", "electronicPublicationDate": "2013-03-16", "language": "eng", "dateOfCompletion": "2013-09-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.bbadis.2013.03.006", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-08-01", "journal": {"title": "Biochimica et biophysica acta", "issn": "0006-3002", "isoabbreviation": "Biochim. Biophys. Acta", "medlineAbbreviation": "Biochim Biophys Acta", "nlmid": "0217513"}, "monthOfPublication": 8, "volume": "1832", "yearOfPublication": 2013, "journalIssueId": 2046799, "issue": "8", "dateOfPublication": "2013 Aug"}}, "24621497": {"pubYear": "2014", "dateOfCreation": "2014-04-16", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "29343-52-0", "name": "4-hydroxy-2-nonenal"}, {"registryNumber": "0", "name": "Aldehydes"}, {"registryNumber": "0", "name": "Membrane Glycoproteins"}, {"registryNumber": "0", "name": "Brain-Derived Neurotrophic Factor"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "EC 2.5.1.18", "name": "Glutathione S-Transferase pi"}, {"registryNumber": "EC 2.7.10.1", "name": "Protein-Tyrosine Kinases"}, {"registryNumber": "EC 2.7.10.1", "name": "Ntrk2 protein, mouse"}]}, "authorString": "Benedetti E, D'Angelo B, Cristiano L, Di Giacomo E, Fanelli F, Moreno S, Cecconi F, Fidoamore A, Antonosante A, Falcone R, Ippoliti R, Giordano A, Cimini A.", "affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24621497", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Benedetti E", "initials": "E", "firstName": "Elisabetta", "lastName": "Benedetti"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "D'Angelo B", "initials": "B", "firstName": "Barbara", "lastName": "D'Angelo"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Cristiano L", "initials": "L", "firstName": "Loredana", "lastName": "Cristiano"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Di Giacomo E", "initials": "E", "firstName": "Erica", "lastName": "Di Giacomo"}, {"affiliation": "Department of Science-LIME; Roma Tre University; Rome, Italy.", "fullName": "Fanelli F", "initials": "F", "firstName": "Francesca", "lastName": "Fanelli"}, {"affiliation": "Department of Science-LIME; Roma Tre University; Rome, Italy.", "fullName": "Moreno S", "initials": "S", "firstName": "Sandra", "lastName": "Moreno"}, {"firstName": "Francesco", "lastName": "Cecconi", "affiliation": "Department of Biology; University of Rome \"Tor Vergata\"; Rome, Italy.", "authorId": {"type": "ORCID", "value": "0000-0002-5614-4359"}, "fullName": "Cecconi F", "initials": "F"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Fidoamore A", "initials": "A", "firstName": "Alessia", "lastName": "Fidoamore"}, {"firstName": "Andrea", "lastName": "Antonosante", "affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "authorId": {"type": "ORCID", "value": "0000-0003-4151-7121"}, "fullName": "Antonosante A", "initials": "A"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Falcone R", "initials": "R", "firstName": "Roberta", "lastName": "Falcone"}, {"affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy.", "fullName": "Ippoliti R", "initials": "R", "firstName": "Rodolfo", "lastName": "Ippoliti"}, {"firstName": "Antonio", "lastName": "Giordano", "affiliation": "Department of Medical and Surgical Sciences and Neurosciences; University of Siena; Siena, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology; Temple University; Philadelphia, PA USA.", "authorId": {"type": "ORCID", "value": "0000-0002-5959-016X"}, "fullName": "Giordano A", "initials": "A"}, {"firstName": "Annamaria", "lastName": "Cimini", "affiliation": "Department of Life, Health, and Environmental Sciences; University of L'Aquila; Coppito L'Aquila, Italy; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology; Temple University; Philadelphia, PA USA.", "authorId": {"type": "ORCID", "value": "0000-0002-2737-7970"}, "fullName": "Cimini A", "initials": "A"}]}, "title": "Involvement of peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR \u03b2/\u03b4) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE).", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "24621497", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5614-4359"}, {"type": "ORCID", "value": "0000-0003-4151-7121"}, {"type": "ORCID", "value": "0000-0002-5959-016X"}, {"type": "ORCID", "value": "0000-0002-2737-7970"}, {"type": "ORCID", "value": "0000-0003-4151-7121"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aldehydes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Brain-Derived Neurotrophic Factor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Glycoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Aging", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Glutathione S-Transferase pi", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Tyrosine Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "embargoDate": "2015-04-15", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-03-04", "doi": "10.4161/cc.28295", "isOpenAccess": "N", "pageInfo": "1335-1344", "pmcid": "PMC4049970", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Aging", "Oxidative stress", "BDNF", "Transcription factors", "Neurodegenerative disease", "TrkB", "p75", "JNK"]}, "abstractText": "Aging and many neurological disorders, such as AD, are linked to oxidative stress, which is considered the common effector of the cascade of degenerative events. In this phenomenon, reactive oxygen species play a fundamental role in the oxidative decomposition of polyunsaturated fatty acids, resulting in the formation of a complex mixture of aldehydic end products, such as malondialdehyde, 4-hydroxynonenal, and other alkenals. Interestingly, 4-HNE has been indicated as an intracellular agonist of peroxisome proliferator-activated receptor \u03b2/\u03b4. In this study, we examined, at early and advanced AD stages (3, 9, and 18 months), the pattern of 4-HNE and its catabolic enzyme glutathione S-transferase P1 in relation to the expression of PPAR\u03b2/\u03b4, BDNF signaling, as mRNA and protein, as well as on their pathological forms (i.e., precursors or truncated forms). The data obtained indicate a novel detrimental age-dependent role of PPAR \u03b2/\u03b4 in AD by increasing pro-BDNF and decreasing BDNF/TrkB survival pathways, thus pointing toward the possibility that a specific PPAR\u03b2/\u03b4 antagonist may be used to counteract the disease progression.", "electronicPublicationDate": "2014-03-04", "language": "eng", "dateOfCompletion": "2015-08-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4049970?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4049970", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.4161/cc.28295", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "Cell Cycle", "isoabbreviation": "Cell Cycle", "title": "Cell cycle (Georgetown, Tex.)", "issn": "1538-4101", "nlmid": "101137841", "essn": "1551-4005"}, "monthOfPublication": 0, "volume": "13", "yearOfPublication": 2014, "journalIssueId": 2247101, "issue": "8", "dateOfPublication": "2014 "}}, "23559003": {"pubYear": "2013", "dateOfCreation": "2013-04-05", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "12-15-lipoxygenase"}, {"registryNumber": "0", "name": "Enzyme Inhibitors"}, {"registryNumber": "59985-28-3", "name": "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid"}, {"registryNumber": "0", "name": "Flavanones"}, {"registryNumber": "0", "name": "NF-kappa B"}, {"registryNumber": "EC 1.13.11.31", "name": "Arachidonate 12-Lipoxygenase"}, {"registryNumber": "EC 1.13.11.33", "name": "Arachidonate 15-Lipoxygenase"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "EC 2.7.11.24", "name": "Mitogen-Activated Protein Kinases"}, {"registryNumber": "49QAH60606", "name": "baicalein"}]}, "authorString": "Xu J, Zhang Y, Xiao Y, Ma S, Liu Q, Dang S, Jin M, Shi Y, Wan B, Zhang Y.", "affiliation": "Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23559003", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Xu", "fullName": "Xu J", "firstName": "J", "initials": "J"}, {"lastName": "Zhang", "fullName": "Zhang Y", "firstName": "Y", "initials": "Y"}, {"lastName": "Xiao", "fullName": "Xiao Y", "firstName": "Y", "initials": "Y"}, {"lastName": "Ma", "fullName": "Ma S", "firstName": "S", "initials": "S"}, {"lastName": "Liu", "fullName": "Liu Q", "firstName": "Q", "initials": "Q"}, {"lastName": "Dang", "fullName": "Dang S", "firstName": "S", "initials": "S"}, {"lastName": "Jin", "fullName": "Jin M", "firstName": "M", "initials": "M"}, {"lastName": "Shi", "fullName": "Shi Y", "firstName": "Y", "initials": "Y"}, {"lastName": "Wan", "fullName": "Wan B", "firstName": "B", "initials": "B"}, {"lastName": "Zhang", "fullName": "Zhang Y", "firstName": "Y", "initials": "Y"}]}, "title": "Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPAR\u03b2/\u03b4: a potential therapeutic role for CNS autoimmune disease.", "hasSuppl": "N", "citedByCount": 7, "source": "MED", "pmid": "23559003", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Microglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "T-Lymphocytes", "majorTopic_YN": "N"}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Encephalomyelitis, Autoimmune, Experimental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Flavanones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Arachidonate 12-Lipoxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Arachidonate 15-Lipoxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitogen-Activated Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "NF-kappa B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Enzyme Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-04", "language": "eng", "doi": "10.1038/cddis.2013.86", "isOpenAccess": "Y", "pageInfo": "e569", "pmcid": "PMC3668632", "hasDbCrossReferences": "N", "abstractText": "12/15-Lipoxygenase (12/15-LO) is an enzyme that converts polyunsaturated fatty acids into bioactive lipid derivatives. In this study, we showed that inhibition of 12/15-LO by baicalein (BA) significantly attenuated clinical severity of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Inhibited migration of autoimmune T cells into the central nervous system (CNS) by BA treatment could be attributed to reduced activation of microglia, which was indicated by suppressed phagocytosis, and decreased production of proinflammatory cytokines and chemokines in the CNS. We further observed that inhibition of 12/15-LO with BA led to increased expression of peroxisome proliferator-activated receptor (PPAR)\u03b2/\u03b4 in microglia of EAE mice. This was confirmed in vitro in primary microglia and a microglia cell line, BV2. In addition, we demonstrated that BA did not affect 12/15-LO or 5-lipoxygenase (5-LO) expression in microglia, but significantly decreased 12/15-LO products without influencing the levels of 5-LO metabolites. Moreover, among these compounds only 12/15-LO metabolite 12-hydroxyeicosatetraenoic acid was able to reverse BA-mediated upregulation of PPAR\u03b2/\u03b4 in BV2 cells. We also showed that inhibition of microglia activation by PPAR\u03b2/\u03b4 was associated with repressed NF-\u03baB and MAPK activities. Our findings indicate that inhibition of 12/15-LO induces PPAR\u03b2/\u03b4, demonstrating important regulatory properties of 12/15-LO in CNS inflammation. This reveals potential therapeutic applications for MS.", "electronicPublicationDate": "2013-04-04", "license": "cc by-nc-nd", "dateOfCompletion": "2013-08-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3668632?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3668632", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23559003", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23559003&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/cddis.2013.86", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "Cell death & disease", "medlineAbbreviation": "Cell Death Dis", "isoabbreviation": "Cell Death Dis", "nlmid": "101524092", "essn": "2041-4889"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2013, "journalIssueId": 1999726, "dateOfPublication": "2013 "}}, "22879602": {"pubYear": "2012", "dateOfCreation": "2012-10-08", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "0", "name": "Hypolipidemic Agents"}, {"registryNumber": "Q8X02027X3", "name": "Gemfibrozil"}]}, "authorString": "Jana M, Mondal S, Gonzalez FJ, Pahan K.", "affiliation": "Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "AT6681"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS64564"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R21 NS071479"}, {"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "R01 AT006681"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R21 NS064564"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS71479"}]}, "hasPDF": "N", "id": "22879602", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.", "fullName": "Jana M", "initials": "M", "firstName": "Malabendu", "lastName": "Jana"}, {"lastName": "Mondal", "fullName": "Mondal S", "firstName": "Susanta", "initials": "S"}, {"lastName": "Gonzalez", "fullName": "Gonzalez FJ", "firstName": "Frank J", "initials": "FJ"}, {"lastName": "Pahan", "fullName": "Pahan K", "firstName": "Kalipada", "initials": "K"}]}, "title": "Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-\u03b2.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "22879602", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Oligodendroglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Myelin Sheath", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Encephalomyelitis, Autoimmune, Experimental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Demyelinating Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gemfibrozil", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Response Elements", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hypolipidemic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-08-09", "doi": "10.1074/jbc.m112.398552", "isOpenAccess": "N", "pageInfo": "34134-34148", "pmcid": "PMC3464522", "hasDbCrossReferences": "Y", "abstractText": "An increase in CNS remyelination and a decrease in CNS inflammation are important steps to halt the progression of multiple sclerosis. Earlier studies have shown that gemfibrozil, a lipid-lowering drug, has anti-inflammatory properties. The current study identified another novel property of gemfibrozil in stimulating the expression of myelin-specific genes (myelin basic protein, myelin oligodendrocyte glycoprotein, 2',3'-cyclic-nucleotide 3'-phosphodiesterase, and proteolipid protein (PLP)) in primary human oligodendrocytes, mixed glial cells, and spinal cord organotypic cultures. Although gemfibrozil is a known activator of peroxisome proliferator-activated receptor-\u03b1 (PPAR-\u03b1), we were unable to detect PPAR-\u03b1 in either gemfibrozil-treated or untreated human oligodendrocytes, and gemfibrozil increased the expression of myelin genes in oligodendrocytes isolated from both wild type and PPAR-\u03b1(-/-) mice. On the other hand, gemfibrozil markedly increased the expression of PPAR-\u03b2 but not PPAR-\u03b3. Consistently, antisense knockdown of PPAR-\u03b2, but not PPAR-\u03b3, abrogated the stimulatory effect of gemfibrozil on myelin genes in human oligodendrocytes. Gemfibrozil also did not up-regulate myelin genes in oligodendroglia isolated from PPAR-\u03b2(-/-) mice. Chromatin immunoprecipitation analysis showed that gemfibrozil induced the recruitment of PPAR-\u03b2 to the promoter of PLP and myelin oligodendrocyte glycoprotein genes in human oligodendrocytes. Furthermore, gemfibrozil treatment also led to the recruitment of PPAR-\u03b2 to the PLP promoter in vivo in the spinal cord of experimental autoimmune encephalomyelitis mice and suppression of experimental autoimmune encephalomyelitis symptoms in PLP-T cell receptor transgenic mice. These results suggest that gemfibrozil stimulates the expression of myelin genes via PPAR-\u03b2 and that gemfibrozil, a prescribed drug for humans, may find further therapeutic use in demyelinating diseases.", "electronicPublicationDate": "2012-08-09", "language": "eng", "dateOfCompletion": "2012-12-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3464522", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22879602", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1074/jbc.M112.398552", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-06-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-10-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 10, "volume": "287", "yearOfPublication": 2012, "journalIssueId": 1972144, "issue": "41", "dateOfPublication": "2012 Oct"}}, "25530507": {"pubYear": "2015", "dateOfCreation": "2015-03-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Adrenergic Agents"}, {"registryNumber": "0", "name": "Brain-Derived Neurotrophic Factor"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR delta"}, {"registryNumber": "0", "name": "PPAR-beta"}, {"registryNumber": "8HW4YBZ748", "name": "Oxidopamine"}]}, "authorString": "Falcone R, Florio TM, Di Giacomo E, Benedetti E, Cristiano L, Antonosante A, Fidoamore A, Massimi M, Alecci M, Ippoliti R, Giordano A, Cimini A.", "affiliation": "Department of Life, Health and\ufeff Environmental Sciences, University of L'Aquila, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25530507", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Life, Health and\ufeff Environmental Sciences, University of L'Aquila, Italy.", "fullName": "Falcone R", "initials": "R", "firstName": "Roberta", "lastName": "Falcone"}, {"lastName": "Florio", "fullName": "Florio TM", "authorId": {"type": "ORCID", "value": "0000-0003-1770-2845"}, "firstName": "Tiziana Marilena", "initials": "TM"}, {"lastName": "Di Giacomo", "fullName": "Di Giacomo E", "firstName": "Erica", "initials": "E"}, {"lastName": "Benedetti", "fullName": "Benedetti E", "firstName": "Elisabetta", "initials": "E"}, {"lastName": "Cristiano", "fullName": "Cristiano L", "firstName": "Loredana", "initials": "L"}, {"lastName": "Antonosante", "fullName": "Antonosante A", "authorId": {"type": "ORCID", "value": "0000-0003-4151-7121"}, "firstName": "Andrea", "initials": "A"}, {"lastName": "Fidoamore", "fullName": "Fidoamore A", "firstName": "Alessia", "initials": "A"}, {"lastName": "Massimi", "fullName": "Massimi M", "firstName": "Mara", "initials": "M"}, {"lastName": "Alecci", "fullName": "Alecci M", "authorId": {"type": "ORCID", "value": "0000-0002-3958-992X"}, "firstName": "Marcello", "initials": "M"}, {"lastName": "Ippoliti", "fullName": "Ippoliti R", "firstName": "Rodolfo", "initials": "R"}, {"lastName": "Giordano", "fullName": "Giordano A", "authorId": {"type": "ORCID", "value": "0000-0002-5959-016X"}, "firstName": "Antonio", "initials": "A"}, {"lastName": "Cimini", "fullName": "Cimini A", "authorId": {"type": "ORCID", "value": "0000-0002-2737-7970"}, "firstName": "Annamaria", "initials": "A"}]}, "title": "PPAR\u03b2/\u03b4 and \u03b3 in a rat model of Parkinson's disease: possible involvement in PD symptoms.", "citedByCount": 0, "source": "MED", "pmid": "25530507", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1770-2845"}, {"type": "ORCID", "value": "0000-0003-4151-7121"}, {"type": "ORCID", "value": "0000-0002-3958-992X"}, {"type": "ORCID", "value": "0000-0002-5959-016X"}, {"type": "ORCID", "value": "0000-0002-2737-7970"}, {"type": "ORCID", "value": "0000-0003-4151-7121"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Oxidopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain-Derived Neurotrophic Factor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adrenergic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-01", "doi": "10.1002/jcb.25041", "isOpenAccess": "N", "pageInfo": "844-855", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Lipid Peroxidation", "Neurotrophins", "PPARs", "Mood Disorders"]}, "abstractText": "Parkinson's disease is one of the most common neurologic disorder, affecting about 1-4% of persons older than 60 years. Among the proposed mechanisms of PD generation, free radical damage is believed to play a pivotal role in the development and/or progression of the disease. Recently, PPARs, a class of transcription factors involved in several pathways both in physiological and pathological conditions, have been linked by us and others to neurodegeneration. Particularly, PPAR\u03b3 and its ligands have been indicated as potential therapeutic targets for the treatment of several pathological conditions associated with neuroinflammation within the CNS. The anti-inflammatory function of PPAR\u03b3 has attracted attention since agonists exert a broad spectrum of protective effects in several animal models of neurological diseases, including psychiatric diseases. On the other hand a detrimental role for PPAR\u03b2/\u03b4 has been proposed in Alzheimer, being closely related to the decrease of BDNF and Trkfl. On these bases, in this work we used a 6-OHDA hemi-lesioned rat model, inducing loss of dopaminergic neurons, to study the effects of the lesion at three time points from the lesion (1, 2, and 3 weeks), in relevant areas of PD motor symptoms, such as substantia nigra and globus pallidus and in the area of reward and mood control, the nucleus accumbens. In particular, it was studied: (i) the expression of BDNF and its downstream signals; (ii) the modulation of PPARs levels. The results obtained indicate the possible use of a dual PPAR\u03b2/\u03b4 antagonist/PPAR\u03b3 agonist to counteract primary and secondary signs of PD neurodegeneration.", "language": "eng", "dateOfCompletion": "2015-12-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/jcb.25041", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "J Cell Biochem", "isoabbreviation": "J. Cell. Biochem.", "title": "Journal of cellular biochemistry", "issn": "0730-2312", "nlmid": "8205768", "essn": "1097-4644"}, "monthOfPublication": 5, "volume": "116", "yearOfPublication": 2015, "journalIssueId": 2262415, "issue": "5", "dateOfPublication": "2015 May"}}, "26362775": {"pubYear": "2016", "dateOfCreation": "2016-01-28", "pubModel": "Electronic", "authorString": "Ji MJ, Yu XB, Mei ZL, An YQ, Tang SS, Hu M, Long Y, Miao MX, Hu QH, Sun HB, Kong LY, Hong H.", "affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26362775", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Ji MJ", "initials": "MJ", "firstName": "Miao-Jin", "lastName": "Ji"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Yu XB", "initials": "XB", "firstName": "Xu-Ben", "lastName": "Yu"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Mei ZL", "initials": "ZL", "firstName": "Zhen-Lin", "lastName": "Mei"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "An YQ", "initials": "YQ", "firstName": "Yun-Qi", "lastName": "An"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Tang SS", "initials": "SS", "firstName": "Su-Su", "lastName": "Tang"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Hu M", "initials": "M", "firstName": "Mei", "lastName": "Hu"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Long Y", "initials": "Y", "firstName": "Yan", "lastName": "Long"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Miao MX", "initials": "MX", "firstName": "Ming-Xing", "lastName": "Miao"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Hu QH", "initials": "QH", "firstName": "Qing-Hua", "lastName": "Hu"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Sun HB", "initials": "HB", "firstName": "Hong-Bin", "lastName": "Sun"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing.", "fullName": "Kong LY", "initials": "LY", "firstName": "Ling-Yi", "lastName": "Kong"}, {"affiliation": "Department of Pharmacology (Ms Ji, Mr Yu, Ms Mei, Ms An, Ms Tang, Ms Hu, Dr Long, Dr Miao, Dr Hu, and Dr Hong), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases (Ms Ji, Mr Yu, Ms Mei, Dr Hong, and Dr Sun), and State Key Laboratory of Natural Medicines (Ms Ji, Mr Yu, Ms Mei, Dr Kong, and Dr Hong), China Pharmaceutical University, Nanjing. honghao@cpu.edu.cn.", "fullName": "Hong H", "initials": "H", "firstName": "Hao", "lastName": "Hong"}]}, "title": "Hippocampal PPAR\u03b4 Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.", "hasSuppl": "Y", "citedByCount": 0, "source": "MED", "pmid": "26362775", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-09-10", "language": "eng", "doi": "10.1093/ijnp/pyv083", "isOpenAccess": "Y", "pmcid": "PMC4772271", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Depression", "Hippocampal Neurogenesis", "Peroxisome Proliferator-activated Receptors \u0394"]}, "abstractText": "Emerging data have demonstrated that peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) activation confers a potentially neuroprotective role in some neurodegenerative diseases. However, whether PPAR\u03b4 is involved in depression is unknown.In this study, PPAR\u03b4 was firstly investigated in the chronic mild stress (CMS) and learned helplessness (LH) models of depression. The changes in depressive behaviors and hippocampal neurogenesis were investigated after PPAR\u03b4 overexpression by microinfusion of the lentiviral vector, containing the coding sequence of mouse PPAR\u03b4 (LV-PPAR\u03b4), into the bilateral dentate gyri of the hippocampus or PPAR\u03b4 activation by repeated systemic administration of PPAR\u03b4 agonist GW0742 (5 or 10mg/kg.d, i.p., for 21 d).We found that both CMS and LH resulted in a significant decrease in the PPAR\u03b4 expression in the hippocampi of mice, and this change was reversed by treatment with the antidepressant fluoxetine. PPAR\u03b4 overexpression and PPAR\u03b4 activation each suppressed the CMS- and LH-induced depressive-like behavior and produced an antidepressive effect. In vivo or in vitro studies also showed that both overexpression and activation of PPAR\u03b4 enhanced proliferation or differentiation of neural stem cells in the hippocampi of mice.These results suggest that hippocampal PPAR\u03b4 upregulation represses stress-induced depressive behaviors, accompanied by enhancement of neurogenesis.", "electronicPublicationDate": "2015-09-10", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4772271?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4772271", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1093/ijnp/pyv083", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-02", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Int J Neuropsychopharmacol", "isoabbreviation": "Int. J. Neuropsychopharmacol.", "title": "The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)", "issn": "1461-1457", "nlmid": "9815893", "essn": "1469-5111"}, "monthOfPublication": 1, "volume": "19", "yearOfPublication": 2016, "journalIssueId": 2401060, "issue": "1", "dateOfPublication": "2016 Jan"}}, "21205987": "", "21382489": "", "21904539": "", "25516156": {"pubYear": "2015", "dateOfCreation": "2015-01-27", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "GW0742"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Phenylpropionates"}, {"registryNumber": "0", "name": "Alkanesulfonates"}, {"registryNumber": "0", "name": "Thiazolidinediones"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "PPAR alpha"}, {"registryNumber": "X4OV71U42S", "name": "pioglitazone"}, {"registryNumber": "U202363UOS", "name": "Fenofibrate"}, {"registryNumber": "Y9449Q51XH", "name": "Bezafibrate"}, {"registryNumber": "6734037O3L", "name": "tesaglitazar"}]}, "authorString": "Blednov YA, Benavidez JM, Black M, Ferguson LB, Schoenhard GL, Goate AM, Edenberg HJ, Wetherill L, Hesselbrock V, Foroud T, Harris RA.", "affiliation": "Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, Texas.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "AA006399"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10AA008401"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "AA013520"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "F31 AA024332"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "HHSN268200782096C"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268200782096C"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA006399"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA012404"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R37 AA006399"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "T32 AA007471"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U01 AA013520"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01 HG004438"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01HG004438"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10 AA008401"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "AA012404"}]}, "hasPDF": "Y", "id": "25516156", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, Texas.", "fullName": "Blednov YA", "initials": "YA", "firstName": "Yuri A", "lastName": "Blednov"}, {"lastName": "Benavidez", "fullName": "Benavidez JM", "firstName": "Jillian M", "initials": "JM"}, {"lastName": "Black", "fullName": "Black M", "firstName": "Mendy", "initials": "M"}, {"lastName": "Ferguson", "fullName": "Ferguson LB", "firstName": "Laura B", "initials": "LB"}, {"lastName": "Schoenhard", "fullName": "Schoenhard GL", "firstName": "Grant L", "initials": "GL"}, {"lastName": "Goate", "fullName": "Goate AM", "firstName": "Alison M", "initials": "AM"}, {"lastName": "Edenberg", "fullName": "Edenberg HJ", "firstName": "Howard J", "initials": "HJ"}, {"lastName": "Wetherill", "fullName": "Wetherill L", "firstName": "Leah", "initials": "L"}, {"lastName": "Hesselbrock", "fullName": "Hesselbrock V", "firstName": "Victor", "initials": "V"}, {"lastName": "Foroud", "fullName": "Foroud T", "firstName": "Tatiana", "initials": "T"}, {"lastName": "Harris", "fullName": "Harris RA", "firstName": "R Adron", "initials": "RA"}]}, "title": "Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are linked with alcohol consumption in mice and withdrawal and dependence in humans.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25516156", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Liver", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Alcoholism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Bezafibrate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenylpropionates", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alkanesulfonates", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thiazolidinediones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR alpha", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alcohol Drinking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}, {"descriptorName": "Fenofibrate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "embargoDate": "2016-01-01", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-12-16", "doi": "10.1111/acer.12610", "isOpenAccess": "N", "pageInfo": "136-145", "pmcid": "PMC4308472", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Fenofibrate", "C57BL/6J", "pioglitazone", "Genome-wide Association Study", "Fenofibric Acid", "Two-bottle Choice", "Tesag-litazar"]}, "abstractText": "Peroxisome proliferator-activated receptor (PPAR) agonists reduce voluntary ethanol (EtOH) consumption in rat models and are promising therapeutics in the treatment for drug addictions. We studied the effects of different classes of PPAR agonists on chronic EtOH intake and preference in mice with a genetic predisposition for high alcohol consumption and then examined human genomewide association data for polymorphisms in PPAR genes in alcohol-dependent subjects.Two different behavioral tests were used to measure intake of 15% EtOH in C57BL/6J male mice: 24-hour 2-bottle choice and limited access (3-hour) 2-bottle choice, drinking in the dark. We measured the effects of pioglitazone (10 and 30\u00a0mg/kg), fenofibrate (50 and 150\u00a0mg/kg), GW0742 (10\u00a0mg/kg), tesaglitazar (1.5\u00a0mg/kg), and bezafibrate (25 and 75\u00a0mg/kg) on EtOH intake and preference. Fenofibric acid, the active metabolite of fenofibrate, was quantified in mouse plasma, liver, and brain by liquid chromatography tandem mass spectrometry. Data from a human genome-wide association study (GWAS) completed in the Collaborative Study on the Genetics of Alcoholism (COGA) were then used to analyze the association of single nucleotide polymorphisms (SNPs) in different PPAR genes (PPARA, PPARD, PPARG, and PPARGC1A) with 2 phenotypes: DSM-IV alcohol dependence (AD) and the DSM-IV criterion of withdrawal.Activation of 2 isoforms of PPARs, \u03b1 and \u03b3, reduced EtOH intake and preference in the 2 different consumption tests in mice. However, a selective PPAR\u03b4 agonist or a pan agonist for all 3 PPAR isoforms did not decrease EtOH consumption. Fenofibric acid, the active metabolite of the PPAR\u03b1 agonist fenofibrate, was detected in liver, plasma, and brain after 1 or 8\u00a0days of oral treatment. The GWAS from COGA supported an association of SNPs in PPARA and PPARG with alcohol withdrawal and PPARGC1A with AD but found no association for PPARD with either phenotype.We provide convergent evidence using both mouse and human data for specific PPARs in alcohol action. Reduced EtOH intake in mice and the genetic association between AD or withdrawal in humans highlight the potential for repurposing FDA-approved PPAR\u03b1 or PPAR\u03b3 agonists for the treatment of AD.", "electronicPublicationDate": "2014-12-16", "language": "eng", "dateOfCompletion": "2016-05-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4308472?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4308472", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1111/acer.12610", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-08-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Alcohol Clin Exp Res", "isoabbreviation": "Alcohol. Clin. Exp. Res.", "title": "Alcoholism, clinical and experimental research", "issn": "0145-6008", "nlmid": "7707242", "essn": "1530-0277"}, "monthOfPublication": 1, "volume": "39", "yearOfPublication": 2015, "journalIssueId": 2246702, "issue": "1", "dateOfPublication": "2015 Jan"}}, "16098614": "", "18670616": "", "21685825": {"pubYear": "2012", "dateOfCreation": "2012-01-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "GW0742"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Protein Isoforms"}, {"registryNumber": "0", "name": "Neuroprotective Agents"}, {"registryNumber": "0", "name": "PPAR delta"}]}, "authorString": "Esposito E, Paterniti I, Meli R, Bramanti P, Cuzzocrea S.", "affiliation": "Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21685825", "inEPMC": "N", "authorList": {"author": [{"lastName": "Esposito", "fullName": "Esposito E", "firstName": "Emanuela", "initials": "E"}, {"lastName": "Paterniti", "fullName": "Paterniti I", "firstName": "Irene", "initials": "I"}, {"lastName": "Meli", "fullName": "Meli R", "authorId": {"type": "ORCID", "value": "0000-0002-6246-6813"}, "firstName": "Rosaria", "initials": "R"}, {"lastName": "Bramanti", "fullName": "Bramanti P", "firstName": "Placido", "initials": "P"}, {"lastName": "Cuzzocrea", "fullName": "Cuzzocrea S", "firstName": "Salvatore", "initials": "S"}]}, "title": "GW0742, a high-affinity PPAR-\u03b4 agonist, mediates protection in an organotypic model of spinal cord damage.", "citedByCount": 4, "source": "MED", "pmid": "21685825", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6246-6813"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Spinal Cord Injuries", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nerve Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Isoforms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neuroprotective Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Organ Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Models, Biological", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-01-01", "doi": "10.1097/brs.0b013e3182276d88", "isOpenAccess": "N", "pageInfo": "E73-8", "hasDbCrossReferences": "N", "abstractText": " STUDY DESIGN: Experimental study of spinal cord injury (SCI) using an organotypic slice culture. OBJECTIVE: To clarify the protective mechanism of PPAR-\u03b4 agonist GW0742 in the injured spinal cord using an in vitro model. SUMMARY OF BACKGROUND DATA: In vivo data suggest that ligands of the \u03b4 isoform have activity in a number of disease models that are partly driven by the inflammatory response. Moreover, reports from in vivo studies using models of ischemia reperfusion and Parkinson disease also have shown neuroprotection conferred by PPAR-\u03b4. The biological role and function of PPAR-\u03b4 remains relatively unclear. METHODS: Spinal cord from 6-week-old mice was cut into transverse slices of 400-\u03bcm thickness to generate the organotypic slice cultures. The slices were injured using a weight dropped onto the center of the slice. PPAR-\u03b4 agonist was applied at 10 \u03bcM at 1 hour before injury. RESULTS: Our study shows that GW0742 incubation (10 \u03bcM) at 1 hour before transverse lesion significantly reduced (1) p38 mitogen-activated protein kinase (MAPK), (2) c-Jun N-terminal kinase (JNK/SAP kinase), (3) NF-\u03baB activation, (4) loss of neurotrophic factors (BDNF, GDNF), (5) COX-2 expression, and (6) cell death. CONCLUSION: GW0742 reduces the cellular and molecular changes occurring in SCI by targeting different downstream pathways modulating PPAR-\u03b4 receptors.", "language": "eng", "dateOfCompletion": "2012-09-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/BRS.0b013e3182276d88", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Spine (Phila Pa 1976)", "isoabbreviation": "Spine", "title": "Spine", "issn": "0362-2436", "nlmid": "7610646", "essn": "1528-1159"}, "monthOfPublication": 1, "volume": "37", "yearOfPublication": 2012, "journalIssueId": 1893457, "issue": "2", "dateOfPublication": "2012 Jan"}}, "22203863": "", "22135673": "", "25776471": {"pubYear": "2015", "dateOfCreation": "2015-03-17", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Lipids"}, {"registryNumber": "0", "name": "PPAR delta"}]}, "authorString": "Huang Y, Nie S, Zhou S, Li K, Sun J, Zhao J, Fei B, Wang Z, Ye H, Hong Q, Gao X, Duan S.", "affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25776471", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Huang Y", "initials": "Y", "firstName": "Yi", "lastName": "Huang"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Nie S", "initials": "S", "firstName": "Sheng", "lastName": "Nie"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Zhou S", "initials": "S", "firstName": "Shengjun", "lastName": "Zhou"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Li K", "initials": "K", "firstName": "Keqin", "lastName": "Li"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Sun J", "initials": "J", "firstName": "Jie", "lastName": "Sun"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Zhao J", "initials": "J", "firstName": "Jikuang", "lastName": "Zhao"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Fei B", "initials": "B", "firstName": "Bing", "lastName": "Fei"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China.", "fullName": "Wang Z", "initials": "Z", "firstName": "Zhepei", "lastName": "Wang"}, {"affiliation": "Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China.", "fullName": "Ye H", "initials": "H", "firstName": "Huadan", "lastName": "Ye"}, {"affiliation": "Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China.", "fullName": "Hong Q", "initials": "Q", "firstName": "Qingxiao", "lastName": "Hong"}, {"affiliation": "Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315010, China; Zhou Liangfu Academician Workstation, Neurosurgery Ningbo Branch of Shanghai Huashan Hospital, Ningbo, Zhejiang 315010, China. Electronic address: qinyuecui@163.com.", "fullName": "Gao X", "initials": "X", "firstName": "Xiang", "lastName": "Gao"}, {"affiliation": "Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China. Electronic address: duanshiwei@nbu.edu.cn.", "fullName": "Duan S", "initials": "S", "firstName": "Shiwei", "lastName": "Duan"}]}, "title": "PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.", "citedByCount": 0, "source": "MED", "pmid": "25776471", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cerebral Hemorrhage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Lipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "PPAR delta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Sex Characteristics", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Lipid Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-12-23", "doi": "10.1016/j.biopha.2014.12.031", "isOpenAccess": "N", "pageInfo": "7-11", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Lipoprotein", "Intracerebral hemorrhage", "Brain tumor", "Ppard", "Rs2016520"]}, "abstractText": "The PPARD polymorphisms were shown to be associated with circulating lipoprotein metabolism in various diseases. We aimed to check the contribution of PPARD rs2016520 and lipid concentration to the risk of intracerebral hemorrhages (ICH) and brain tumors (BT) in Han Chinese. A total of 864 participants were included in the case-control study. The melting temperature shift (Tm-shift) method was used for rs2016520 genotyping. Under the recessive model, PPARD rs2016520 was shown to be associated with the risk of ICH (P=0.029, odds ratio (OR)=2.72), specifically in males (P=0.045, OR=3.98). Additionally, we also found that the levels of TC and LDL-C were significantly higher in participants with brain diseases than in the controls (TC: P<0.0001; LDL-C: P<0.0001). Significantly higher HDL-C and lower ApoA-I levels were observed in the male patients with brain diseases (HDL-C: P<0.0001; ApoA-I: P=0.008), in contrast of a higher TG level in female ICH (P=0.023). Subsequent interaction analysis between PPARD rs2016520 and lipoprotein metabolism showed that the LDL-C level was positively correlated with ICH in the rs2016520-AA carriers (P<0.0001), but not in the other genotype carriers (AG or GG, P=0.300). Our results showed that PPARD rs2016520 displayed a strong relationship with ICH risk in the male Han Chinese. The TC and LDL-C levels were positively higher in the patients with brain diseases than in the controls. The levels of TG, HDL-C and ApoA-I were shown to affect brain disease in a gender-dependent model. The genotype rs2016520-AA showed significant interaction with the circulating LDL-C levels in ICH.", "electronicPublicationDate": "2014-12-23", "language": "eng", "dateOfCompletion": "2016-02-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.biopha.2014.12.031", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "Biomed Pharmacother", "isoabbreviation": "Biomed. Pharmacother.", "title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "issn": "0753-3322", "nlmid": "8213295", "essn": "1950-6007"}, "monthOfPublication": 3, "volume": "70", "yearOfPublication": 2015, "journalIssueId": 2264482, "dateOfPublication": "2015 Mar"}}}, "GPC5": {"20692050": {"pubYear": "2010", "dateOfCreation": "2010-09-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Glypicans"}]}, "authorString": "Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF.", "affiliation": "Department of Neurology, Oslo University Hospital, Ullev\u00e5l, University of Oslo, Oslo, Norway. aslaug.r.lorentzen@gmail.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20692050", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lorentzen", "fullName": "Lorentzen AR", "firstName": "Aslaug R", "initials": "AR"}, {"lastName": "Melum", "fullName": "Melum E", "firstName": "Espen", "initials": "E"}, {"lastName": "Ellinghaus", "fullName": "Ellinghaus E", "authorId": {"type": "ORCID", "value": "0000-0003-2914-3382"}, "firstName": "Eva", "initials": "E"}, {"lastName": "Smestad", "fullName": "Smestad C", "firstName": "Cathrine", "initials": "C"}, {"lastName": "Mero", "fullName": "Mero IL", "firstName": "Inger-Lise", "initials": "IL"}, {"lastName": "Aarseth", "fullName": "Aarseth JH", "firstName": "Jan H", "initials": "JH"}, {"lastName": "Myhr", "fullName": "Myhr KM", "firstName": "Kjell-Morten", "initials": "KM"}, {"lastName": "Celius", "fullName": "Celius EG", "firstName": "Elisabeth G", "initials": "EG"}, {"lastName": "Lie", "fullName": "Lie BA", "firstName": "Benedicte A", "initials": "BA"}, {"lastName": "Karlsen", "fullName": "Karlsen TH", "firstName": "Tom H", "initials": "TH"}, {"lastName": "Franke", "fullName": "Franke A", "firstName": "Andre", "initials": "A"}, {"lastName": "Harbo", "fullName": "Harbo HF", "firstName": "Hanne F", "initials": "HF"}]}, "title": "Association to the Glypican-5 gene in multiple sclerosis.", "citedByCount": 6, "source": "MED", "pmid": "20692050", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2914-3382"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 13", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Norway", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Glypicans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-08-06", "doi": "10.1016/j.jneuroim.2010.07.003", "isOpenAccess": "N", "pageInfo": "194-197", "hasDbCrossReferences": "Y", "abstractText": "Multiple sclerosis (MS) is an inflammatory, demyelinating disease affecting the central nervous system. MS-associated variants have been reported at both HLA and non-HLA loci, the latter including chromosome 13q31-32 and the Glypican-5 and Glypican-6 genes. In order to further explore the 13q31-32 region in MS, we genotyped 33 SNPs in 1355 Norwegian MS patients and 1446 Norwegian controls. An intronic SNP in the Glypican-5 gene (rs9523787) showed association with MS (p(corr)=0.006). Thus, this study supports that MS susceptibility at 13q31-32 may localize to the Glypican-5 gene, which should lead to further fine-mapping, replication and functional studies of this gene.", "electronicPublicationDate": "2010-08-06", "language": "eng", "dateOfCompletion": "2010-10-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jneuroim.2010.07.003", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-09-01", "journal": {"medlineAbbreviation": "J Neuroimmunol", "isoabbreviation": "J. Neuroimmunol.", "title": "Journal of neuroimmunology", "issn": "0165-5728", "nlmid": "8109498", "essn": "1872-8421"}, "monthOfPublication": 9, "volume": "226", "yearOfPublication": 2010, "journalIssueId": 1761096, "issue": "1-2", "dateOfPublication": "2010 Sep"}}, "12392603": {"pubYear": "2002", "dateOfCreation": "2003-07-08", "pubModel": "Print-Electronic", "authorString": "Maheshwari M, Christian SL, Liu C, Badner JA, Detera-Wadleigh S, Gershon ES, Gibbs RA.", "affiliation": "Department of Molecular & Human Genetics, Human Genome Sequencing Center, One Baylor Plaza, N1519 Houston, TX 77030, USA. manjulam@bcm.tmc.edu", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "12392603", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Maheshwari", "fullName": "Maheshwari M", "firstName": "Manjula", "initials": "M"}, {"lastName": "Christian", "fullName": "Christian SL", "firstName": "S L", "initials": "SL"}, {"lastName": "Liu", "fullName": "Liu C", "firstName": "C", "initials": "C"}, {"lastName": "Badner", "fullName": "Badner JA", "firstName": "J A", "initials": "JA"}, {"lastName": "Detera-Wadleigh", "fullName": "Detera-Wadleigh S", "firstName": "S", "initials": "S"}, {"lastName": "Gershon", "fullName": "Gershon ES", "firstName": "E S", "initials": "ES"}, {"lastName": "Gibbs", "fullName": "Gibbs RA", "firstName": "Richard A", "initials": "RA"}]}, "title": "Mutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5).", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "12392603", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2002-10-22", "doi": "10.1186/1471-2164-3-30", "isOpenAccess": "Y", "pageInfo": "30", "pmcid": "PMC140024", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Multiple candidate regions as sites for Schizophrenia and Bipolar susceptibility genes have been reported, suggesting heterogeneity of susceptibility genes or oligogenic inheritance. Linkage analysis has suggested chromosome 13q32 as one of the regions with evidence of linkage to Schizophrenia and, separately, to Bipolar disorder (BP). SLC15A1 and GPC5 are two of the candidate genes within an approximately 10-cM region of linkage on chromosome 13q32. In order to identify a possible role for these candidates as susceptibility genes, we performed mutation screening on the coding regions of these two genes in 7 families (n-20) affected with Bipolar disorder showing linkage to 13q32. RESULTS: Genomic organization revealed 23 exons in SLC15A1 and 8 exons in GPC5 gene respectively. Sequencing of the exons did not reveal mutations in the GPC5 gene in the 7 families affected with BP. Two polymorphic variants were discovered in the SLC15A1 gene. One was T to C substitution in the third position of codon encoding alanine at 1403 position of mRNA in exon 17, and the other was A to G substitution in the untranslated region at position 2242 of mRNA in exon 23. CONCLUSIONS: Mutation analysis of 2 candidate genes for Bipolar disorder on chromosome 13q32 did not identify any potentially causative mutations within the coding regions or splice junctions of the SLC15A1 or GPC5 genes in 7 families showing linkage to 13q32. Further studies of the regulatory regions are needed to completely exclude these genes as causative for Bipolar disorder.", "electronicPublicationDate": "2002-10-22", "language": "eng", "dateOfCompletion": "2003-10-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC140024?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC140024", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1471-2164-3-30", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-04-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2002-10-01", "journal": {"title": "BMC genomics", "medlineAbbreviation": "BMC Genomics", "isoabbreviation": "BMC Genomics", "nlmid": "100965258", "essn": "1471-2164"}, "monthOfPublication": 10, "volume": "3", "yearOfPublication": 2002, "journalIssueId": 1156352, "issue": "1", "dateOfPublication": "2002 Oct"}}, "24943672": {"pubYear": "2014", "dateOfCreation": "2014-09-25", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "IRF5 protein, human"}, {"registryNumber": "77238-31-4", "name": "Interferon-beta"}, {"registryNumber": "0", "name": "GPC5 protein, human"}, {"registryNumber": "0", "name": "Interferon Regulatory Factors"}, {"registryNumber": "0", "name": "interferon regulatory factor-8"}, {"registryNumber": "0", "name": "Glypicans"}]}, "authorString": "Sellebjerg F, S\u00f8ndergaard HB, Koch-Henriksen N, S\u00f8rensen PS, Oturai AB.", "affiliation": "Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24943672", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.", "fullName": "Sellebjerg F", "initials": "F", "firstName": "F", "lastName": "Sellebjerg"}, {"lastName": "S\u00f8ndergaard", "fullName": "S\u00f8ndergaard HB", "firstName": "H B", "initials": "HB"}, {"lastName": "Koch-Henriksen", "fullName": "Koch-Henriksen N", "firstName": "N", "initials": "N"}, {"lastName": "S\u00f8rensen", "fullName": "S\u00f8rensen PS", "firstName": "P S", "initials": "PS"}, {"lastName": "Oturai", "fullName": "Oturai AB", "firstName": "A B", "initials": "AB"}]}, "title": "Prediction of response to interferon therapy in multiple sclerosis.", "citedByCount": 3, "source": "MED", "pmid": "24943672", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis, Relapsing-Remitting", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Progression", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Recurrence", "majorTopic_YN": "N"}, {"descriptorName": "Interferon-beta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Interferon Regulatory Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glypicans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-06-18", "doi": "10.1111/ane.12269", "isOpenAccess": "N", "pageInfo": "268-275", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Multiple sclerosis", "Interferon-beta", "Pharmacogenetics", "Treatment Response"]}, "abstractText": "OBJECTIVE: Single nucleotide polymorphisms (SNPs) in the genes encoding interferon response factor (IRF)-5, IRF-8 and glypican-5 (GPC5) have been associated with disease activity in multiple sclerosis (MS) patients treated with interferon (IFN)-\u03b2. We analysed whether SNPs in the IRF5, IRF8 and GPC5 genes are associated with clinical disease activity in MS patients beginning de novo treatment with IFN-\u03b2. METHODS: The SNPs rs2004640, rs3807306 and rs4728142 in IRF5, rs13333054 and rs17445836 in IRF8 and rs10492503 in GPC5 were genotyped in 575 patients with relapsing-remitting MS followed prospectively after the initiation of their first treatment with IFN-\u03b2. RESULTS: 62% of patients experienced relapses during the first 2 years of treatment, and 32% had disability progression during the first 5 years of treatment. Patients with a pretreatment annualized relapse rate >1 had an increased risk of relapse (hazard ratio 1.53, 95% confidence interval 1.24-1.90) and progression (hazard ratio 1.48, 95% confidence interval 1.10-1.99) on treatment and patients with breakthrough relapses in the form of relapses during the first 2 years of treatment had an increased risk of progression during the first 5 years of treatment (hazard ratio 2.04, 95% confidence interval 1.47-2.85).The gene variants in IRF5, IRF8 and GPC5 were not associated with risk of relapse or disease progression. CONCLUSIONS: Pretreatment relapse rate and clinical disease activity during the first 2 years of treatment may be associated with disease progression in MS patients treated with IFN-\u03b2. Genetic analysis of the studied gene variants do not provide additional information.", "electronicPublicationDate": "2014-06-18", "language": "eng", "dateOfCompletion": "2015-05-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/ane.12269", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "Acta Neurol Scand", "isoabbreviation": "Acta Neurol. Scand.", "title": "Acta neurologica Scandinavica", "issn": "0001-6314", "nlmid": "0370336", "essn": "1600-0404"}, "monthOfPublication": 10, "volume": "130", "yearOfPublication": 2014, "journalIssueId": 2204514, "issue": "4", "dateOfPublication": "2014 Oct"}}, "19022413": {"pubYear": "2009", "dateOfCreation": "2009-01-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "SPRY2 protein, human"}, {"registryNumber": "0", "name": "ZIC2 protein, human"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "GPC5 protein, human"}, {"registryNumber": "0", "name": "Glypicans"}]}, "authorString": "Qu\u00e9lin C, Bendavid C, Dubourg C, de la Rochebrochard C, Lucas J, Henry C, Jaillard S, Loget P, Loeuillet L, Lacombe D, Rival JM, David V, Odent S, Pasquier L.", "affiliation": "Service de G\u00e9n\u00e9tique M\u00e9dicale, CHU H\u00f4pital Sud, Rennes Cedex 2, France.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "19022413", "inEPMC": "N", "authorList": {"author": [{"lastName": "Qu\u00e9lin", "fullName": "Qu\u00e9lin C", "firstName": "Chlo\u00e9", "initials": "C"}, {"lastName": "Bendavid", "fullName": "Bendavid C", "firstName": "Claude", "initials": "C"}, {"lastName": "Dubourg", "fullName": "Dubourg C", "firstName": "Christ\u00e8le", "initials": "C"}, {"lastName": "de la Rochebrochard", "fullName": "de la Rochebrochard C", "firstName": "C\u00e9line", "initials": "C"}, {"lastName": "Lucas", "fullName": "Lucas J", "firstName": "Josette", "initials": "J"}, {"lastName": "Henry", "fullName": "Henry C", "firstName": "Catherine", "initials": "C"}, {"lastName": "Jaillard", "fullName": "Jaillard S", "firstName": "Sylvie", "initials": "S"}, {"lastName": "Loget", "fullName": "Loget P", "firstName": "Philippe", "initials": "P"}, {"lastName": "Loeuillet", "fullName": "Loeuillet L", "firstName": "Laurence", "initials": "L"}, {"lastName": "Lacombe", "fullName": "Lacombe D", "firstName": "Didier", "initials": "D"}, {"lastName": "Rival", "fullName": "Rival JM", "firstName": "Jean-Marie", "initials": "JM"}, {"lastName": "David", "fullName": "David V", "firstName": "V\u00e9ronique", "initials": "V"}, {"lastName": "Odent", "fullName": "Odent S", "firstName": "Sylvie", "initials": "S"}, {"lastName": "Pasquier", "fullName": "Pasquier L", "firstName": "Laurent", "initials": "L"}]}, "title": "Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress.", "citedByCount": 26, "source": "MED", "pmid": "19022413", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Skull", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 13", "majorTopic_YN": "Y"}, {"descriptorName": "Fetus", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Holoprosencephaly", "majorTopic_YN": "N"}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromosome Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Growth Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytogenetic Analysis", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Glypicans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intellectual Disability", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-10-31", "doi": "10.1016/j.ejmg.2008.10.002", "isOpenAccess": "N", "pageInfo": "41-46", "hasDbCrossReferences": "Y", "abstractText": "13q deletion is characterized by a wide phenotypic spectrum resulting from a partial deletion of the long arm of chromosome 13. The main clinical features are mental retardation, growth retardation, craniofacial dysmorphy and various congenital defects. Only one recent Italian study was aimed at determining genotype-phenotype correlations among 13q deletions from a group of mainly live born children, using array-CGH and FISH. In order to improve the molecular characterization of 13q monosomy, 12 new patients (9 foetuses and 3 children) were collected based on a cohort of holoprosencephaly (HPE) linked to ZIC2 gene deletion and/or patients with 13q deletion diagnosed by standard karyotype. First, quantitative gene screening using MLPA (Multiplex Ligation dependent Probe Amplification) was performed to look for ZIC2 gene deletion and then, CGH array analysis was carried out using the Agilent Human Genome CGH microarray 4x44K (Agilent Technologies, Santa Clara, USA). All the foetuses had severe cerebral midline malformations associated with a deletion including the ZIC2 gene. We report one patient with Steinfeld phenotype linked to this chromosomal anomaly, and suggest that some of the associations between cerebral midline malformation and limb defects might be related to 13q deletion. Further candidate genes are suspected to explain the malformations associated with cerebral anomalies in the hypothesis of a contiguous gene syndrome: SPRY2 in 13q31.1 is implicated in lens cell proliferation and differentiation for congenital cataract; GPC5 in 13q32 is mainly expressed in the mesenchyme of the developing limb bud for upper limb anomalies.", "electronicPublicationDate": "2008-10-31", "language": "eng", "dateOfCompletion": "2009-04-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.ejmg.2008.10.002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"medlineAbbreviation": "Eur J Med Genet", "isoabbreviation": "Eur J Med Genet", "title": "European journal of medical genetics", "issn": "1769-7212", "nlmid": "101247089", "essn": "1878-0849"}, "monthOfPublication": 0, "volume": "52", "yearOfPublication": 2009, "journalIssueId": 1589169, "issue": "1", "dateOfPublication": "2009 Jan-Feb"}}, "23223018": {"pubYear": "2013", "dateOfCreation": "2013-02-22", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Glypicans"}]}, "authorString": "Bassuk AG, Muthuswamy LB, Boland R, Smith TL, Hulstrand AM, Northrup H, Hakeman M, Dierdorff JM, Yung CK, Long A, Brouillette RB, Au KS, Gurnett C, Houston DW, Cornell RA, Manak JR.", "affiliation": "Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "1R01DE021071-01"}, {"acronym": "DE", "orderIn": 0, "agency": "NIDCR NIH HHS", "grantId": "R01 DE021071"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM083999"}]}, "hasPDF": "Y", "id": "23223018", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.", "fullName": "Bassuk AG", "initials": "AG", "firstName": "Alexander G", "lastName": "Bassuk"}, {"lastName": "Muthuswamy", "fullName": "Muthuswamy LB", "firstName": "Lakshmi B", "initials": "LB"}, {"lastName": "Boland", "fullName": "Boland R", "firstName": "Riley", "initials": "R"}, {"lastName": "Smith", "fullName": "Smith TL", "firstName": "Tiffany L", "initials": "TL"}, {"lastName": "Hulstrand", "fullName": "Hulstrand AM", "firstName": "Alissa M", "initials": "AM"}, {"lastName": "Northrup", "fullName": "Northrup H", "firstName": "Hope", "initials": "H"}, {"lastName": "Hakeman", "fullName": "Hakeman M", "firstName": "Matthew", "initials": "M"}, {"lastName": "Dierdorff", "fullName": "Dierdorff JM", "firstName": "Jason M", "initials": "JM"}, {"lastName": "Yung", "fullName": "Yung CK", "firstName": "Christina K", "initials": "CK"}, {"lastName": "Long", "fullName": "Long A", "firstName": "Abby", "initials": "A"}, {"lastName": "Brouillette", "fullName": "Brouillette RB", "firstName": "Rachel B", "initials": "RB"}, {"lastName": "Au", "fullName": "Au KS", "firstName": "Kit Sing", "initials": "KS"}, {"lastName": "Gurnett", "fullName": "Gurnett C", "firstName": "Christina", "initials": "C"}, {"lastName": "Houston", "fullName": "Houston DW", "firstName": "Douglas W", "initials": "DW"}, {"lastName": "Cornell", "fullName": "Cornell RA", "authorId": {"type": "ORCID", "value": "0000-0003-4207-9100"}, "firstName": "Robert A", "initials": "RA"}, {"lastName": "Manak", "fullName": "Manak JR", "firstName": "J Robert", "initials": "JR"}]}, "title": "Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate gene.", "hasSuppl": "Y", "citedByCount": 3, "source": "MED", "pmid": "23223018", "abstractText": "Neural tube defects (NTDs) are common birth defects of complex etiology. Family and population-based studies have confirmed a genetic component to NTDs. However, despite more than three decades of research, the genes involved in human NTDs remain largely unknown. We tested the hypothesis that rare copy number variants (CNVs), especially de novo germline CNVs, are a significant risk factor for NTDs. We used array-based comparative genomic hybridization (aCGH) to identify rare CNVs in 128 Caucasian and 61 Hispanic patients with non-syndromic lumbar-sacral myelomeningocele. We also performed aCGH analysis on the parents of affected individuals with rare CNVs where parental DNA was available (42 sets). Among the eight de novo CNVs that we identified, three generated copy number changes of entire genes. One large heterozygous deletion removed 27 genes, including PAX3, a known spina bifida-associated gene. A second CNV altered genes (PGPD8, ZC3H6) for which little is known regarding function or expression. A third heterozygous deletion removed GPC5 and part of GPC6, genes encoding glypicans. Glypicans are proteoglycans that modulate the activity of morphogens such as Sonic Hedgehog (SHH) and bone morphogenetic proteins (BMPs), both of which have been implicated in NTDs. Additionally, glypicans function in the planar cell polarity (PCP) pathway, and several PCP genes have been associated with NTDs. Here, we show that GPC5 orthologs are expressed in the neural tube, and that inhibiting their expression in frog and fish embryos results in NTDs. These results implicate GPC5 as a gene required for normal neural tube development.", "tmAccessionTypeList": {"accessionType": ["gen"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-4207-9100"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Zebrafish", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Spinal Dysraphism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Cell Polarity", "majorTopic_YN": "Y"}, {"descriptorName": "European Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hispanic Americans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Glypicans", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neural Tube", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EM", "qualifierName": "embryology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Copy Number Variations", "majorTopic_YN": "Y"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2012-12-07", "doi": "10.1093/hmg/dds515", "isOpenAccess": "N", "pageInfo": "1097-1111", "pmcid": "PMC3578410", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "electronicPublicationDate": "2012-12-07", "language": "eng", "dateOfCompletion": "2013-08-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3578410?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3578410", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23223018", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23223018&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1093/hmg/dds515", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-03-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-03-01", "journal": {"medlineAbbreviation": "Hum Mol Genet", "isoabbreviation": "Hum. Mol. Genet.", "title": "Human molecular genetics", "issn": "0964-6906", "nlmid": "9208958", "essn": "1460-2083"}, "monthOfPublication": 3, "volume": "22", "yearOfPublication": 2013, "journalIssueId": 2012812, "issue": "6", "dateOfPublication": "2013 Mar"}}}, "OCA2": {"22189180": {"pubYear": "2011", "dateOfCreation": "2012-01-20", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "86933-74-6", "name": "Neurokinin A"}, {"registryNumber": "0", "name": "ribosomal protein P0"}]}, "authorString": "Mostafa GA, Al-Ayadhi LY.", "affiliation": "Autism Research and Treatment Center, AL-Amodi Autism Research Chair, Department of Physiology, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia. hafezg@softhome.net", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22189180", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Mostafa", "fullName": "Mostafa GA", "firstName": "Gehan A", "initials": "GA"}, {"lastName": "Al-Ayadhi", "fullName": "Al-Ayadhi LY", "authorId": {"type": "ORCID", "value": "0000-0003-3269-0416"}, "firstName": "Laila Y", "initials": "LY"}]}, "title": "The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.", "hasSuppl": "N", "citedByCount": 8, "source": "MED", "pmid": "22189180", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3269-0416"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neurokinin A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Saudi Arabia", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-12-21", "language": "eng", "doi": "10.1186/1742-2094-8-180", "isOpenAccess": "Y", "pageInfo": "180", "pmcid": "PMC3261830", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND: Neurogenic inflammation is orchestrated by a large number of neuropeptides. Tachykinins (substance P, neurokinin A and neurokinin B) are pro-inflammatory neuropeptides that may play an important role in some autoimmune neuroinflammatory diseases. Autoimmunity may have a role in the pathogenesis of autism in some patients. We are the first to measure serum neurokinin A levels in autistic children. The relationship between serum levels of neurokinin A and anti-ribosomal P protein antibodies was also studied. METHODS: Serum neurokinin A and anti-ribosomal P protein antibodies were measured in 70 autistic children in comparison to 48 healthy-matched children. RESULTS: Autistic children had significantly higher serum neurokinin A levels than healthy controls (P < 0.001). Children with severe autism had significantly higher serum neurokinin A levels than patients with mild to moderate autism (P < 0.001). Increased serum levels of neurokinin A and anti-ribosomal P protein antibodies were found in 57.1% and 44.3%, respectively of autistic children. There was significant positive correlations between serum levels of neurokinin A and anti-ribosomal P protein antibodies (P = 0.004). CONCLUSIONS: Serum neurokinin A levels were elevated in some autistic children and they were significantly correlated to the severity of autism and to serum levels of anti-ribosomal P protein antibodies. However, this is an initial report that warrants further research to determine the pathogenic role of neurokinin A and its possible link to autoimmunity in autism. The therapeutic role of tachykinin receptor antagonists, a potential new class of anti-inflammatory medications, should also be studied in autism.", "electronicPublicationDate": "2011-12-21", "license": "cc by", "dateOfCompletion": "2012-04-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3261830?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3261830", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22189180", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22189180&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1742-2094-8-180", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"title": "Journal of neuroinflammation", "medlineAbbreviation": "J Neuroinflammation", "isoabbreviation": "J Neuroinflammation", "nlmid": "101222974", "essn": "1742-2094"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2011, "journalIssueId": 1810161, "dateOfPublication": "2011 "}}, "2241267": "", "15509569": {"pubYear": "2004", "dateOfCreation": "2004-12-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "0", "name": "Viral Proteins"}, {"registryNumber": "EC 2.7.7.6", "name": "DNA-Directed RNA Polymerases"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "DNA, Complementary"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}]}, "authorString": "Schneider U, Blechschmidt K, Schwemmle M, Staeheli P.", "affiliation": "Department of Virology, University of Freiburg, Hermann-Herder-Strasse 11, D-79104 Freiburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "15509569", "inEPMC": "N", "authorList": {"author": [{"lastName": "Schneider", "fullName": "Schneider U", "firstName": "Urs", "initials": "U"}, {"lastName": "Blechschmidt", "fullName": "Blechschmidt K", "firstName": "Kareen", "initials": "K"}, {"lastName": "Schwemmle", "fullName": "Schwemmle M", "firstName": "Martin", "initials": "M"}, {"lastName": "Staeheli", "fullName": "Staeheli P", "firstName": "Peter", "initials": "P"}]}, "title": "Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex.", "citedByCount": 15, "source": "MED", "pmid": "15509569", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Directed RNA Polymerases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N"}, {"descriptorName": "Viral Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Complementary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromatography, Gel", "majorTopic_YN": "N"}, {"descriptorName": "Two-Hybrid System Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Binding, Competitive", "majorTopic_YN": "N"}, {"descriptorName": "Protein Structure, Tertiary", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Dominant", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Point Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Plasmids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2004-10-27", "doi": "10.1074/jbc.m408913200", "isOpenAccess": "N", "pageInfo": "55290-55296", "hasDbCrossReferences": "N", "abstractText": "The active polymerase complex of Borna disease virus is composed of the viral proteins N, P, and L. The viral X (negative regulatory factor) protein acts as a regulator of polymerase activity. Interactions of P with N and X were previously studied, but interactions with L were poorly defined. Using a mammalian two-hybrid system, we observed that L specifically interacts with P but not with N, X, or itself. Mapping of the L-binding domain in the P molecule revealed that it overlaps with two adjacent domains required for multimerization and interaction with N. Competition experiments showed that the interaction between L and P was inefficient when N was present, indicating that L may preferentially interact with free P in infected cells. Interestingly, a multimerization-defective P mutant maintained the ability to interact with L, N, and X but failed to support reporter gene expression from an artificial Borna disease virus minigenome. Furthermore, dominant negative effects on minigenome activity were only observed when P mutants with an intact multimerization domain were used, suggesting that P multimers, rather than monomers, exhibit biological activity. P mutants lacking functional interaction domains for L or N still formed complexes with these viral proteins when wild-type P was available as a bridging molecule, indicating that P multimers have the potential to act as scaffolds on which the RNA polymerase complex is assembled.", "electronicPublicationDate": "2004-10-27", "language": "eng", "dateOfCompletion": "2005-02-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1074/jbc.M408913200", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-12-01", "journal": {"medlineAbbreviation": "J Biol Chem", "isoabbreviation": "J. Biol. Chem.", "title": "The Journal of biological chemistry", "issn": "0021-9258", "nlmid": "2985121R", "essn": "1083-351X"}, "monthOfPublication": 12, "volume": "279", "yearOfPublication": 2004, "journalIssueId": 1212981, "issue": "53", "dateOfPublication": "2004 Dec"}}, "15218174": {"pubYear": "2004", "dateOfCreation": "2004-06-25", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Viral Proteins"}, {"registryNumber": "0", "name": "RNA, Viral"}, {"registryNumber": "EC 2.7.7.6", "name": "DNA-Directed RNA Polymerases"}]}, "authorString": "Poenisch M, Unterstab G, Wolff T, Staeheli P, Schneider U.", "affiliation": "Abteilung Virologie, Institut f\u00fcr Medizinische Mikrobiologie & Hygiene, Universit\u00e4t Freiburg, D-79104 Freiburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "15218174", "inEPMC": "N", "authorList": {"author": [{"lastName": "Poenisch", "fullName": "Poenisch M", "firstName": "Marion", "initials": "M"}, {"lastName": "Unterstab", "fullName": "Unterstab G", "firstName": "Gunhild", "initials": "G"}, {"lastName": "Wolff", "fullName": "Wolff T", "firstName": "Thorsten", "initials": "T"}, {"lastName": "Staeheli", "fullName": "Staeheli P", "firstName": "Peter", "initials": "P"}, {"lastName": "Schneider", "fullName": "Schneider U", "firstName": "Urs", "initials": "U"}]}, "title": "The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein.", "citedByCount": 19, "source": "MED", "pmid": "15218174", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Directed RNA Polymerases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Viral Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Viral", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome, Viral", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2004-07-01", "doi": "10.1099/vir.0.80002-0", "isOpenAccess": "N", "pageInfo": "1895-1898", "hasDbCrossReferences": "N", "abstractText": "Borna disease virus polymerase activity is negatively regulated by the viral X protein. Using a virus minireplicon system it was found that all X mutants that no longer interacted with the viral P protein failed to exhibit significant inhibitory activity. The action of X could further be neutralized by expression of a P fragment that contained the X interaction domain but lacked all domains known to mediate interaction with other viral proteins. X thus appears to regulate the activity of the Borna disease virus polymerase by targeting the polymerase cofactor P.", "language": "eng", "dateOfCompletion": "2004-08-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1099/vir.0.80002-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "sgmjournals.org"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2004-07-01", "journal": {"medlineAbbreviation": "J Gen Virol", "isoabbreviation": "J. Gen. Virol.", "title": "The Journal of general virology", "issn": "0022-1317", "nlmid": "0077340", "essn": "1465-2099"}, "monthOfPublication": 7, "volume": "85", "yearOfPublication": 2004, "journalIssueId": 1161924, "issue": "Pt 7", "dateOfPublication": "2004 Jul"}}, "17543364": {"pubYear": "2007", "dateOfCreation": "2007-09-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "EC 1.13.12.-", "name": "Luciferases"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}, {"registryNumber": "EC 1.14.13.39", "name": "Nitric Oxide Synthase"}]}, "authorString": "Peng G, Zhang F, Zhang Q, Wu K, Zhu F, Wu J.", "affiliation": "The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, PR China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17543364", "inEPMC": "N", "authorList": {"author": [{"lastName": "Peng", "fullName": "Peng G", "firstName": "Guiqing", "initials": "G"}, {"lastName": "Zhang", "fullName": "Zhang F", "firstName": "Fengmin", "initials": "F"}, {"lastName": "Zhang", "fullName": "Zhang Q", "firstName": "Qi", "initials": "Q"}, {"lastName": "Wu", "fullName": "Wu K", "firstName": "Kailang", "initials": "K"}, {"lastName": "Zhu", "fullName": "Zhu F", "firstName": "Fan", "initials": "F"}, {"lastName": "Wu", "fullName": "Wu J", "firstName": "Jianguo", "initials": "J"}]}, "title": "Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes.", "citedByCount": 8, "source": "MED", "pmid": "17543364", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Astrocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "VI", "qualifierName": "virology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Luciferases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Binding Sites", "majorTopic_YN": "N"}, {"descriptorName": "Genes, Reporter", "majorTopic_YN": "N"}, {"descriptorName": "Nitric Oxide Synthase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Artificial Gene Fusion", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-06-01", "doi": "10.1016/j.virol.2007.04.031", "isOpenAccess": "N", "pageInfo": "446-452", "hasDbCrossReferences": "N", "abstractText": "Borna disease virus (BDV) is one of the potential infectious agents involved in the development of central nervous system (CNS) diseases. Neurons and astrocytes are the main targets of BDV infection, but little is known about the roles of BDV infection in the biological effects of astrocytes. Here we reported that BDV inhibits the activation of inducible nitric oxide synthase (iNOS) in murine astrocytes induced by bacterial LPS and PMA. To determine which protein of BDV is responsible for the regulation of iNOS expression, we co-transfected murine astrocytes with reporter plasmid iNOS-luciferase and plasmid expressing individual BDV proteins. Results from analyses of reporter activities revealed that only the phosphoprotein (P) of BDV had an inhibitory effect on the activation of iNOS. In addition, P protein inhibits nitric oxide production through regulating iNOS expression. We also reported that the nuclear factor kappa B (NF-kappaB) binding element, AP-1 recognition site, and interferon-stimulated response element (ISRE) on the iNOS promoter were involved in the repression of iNOS gene expression regulated by the P protein. Functional analysis indicated that sequences from amino acids 134 to 174 of the P protein are necessary for the regulation of iNOS. These data suggested that BDV may suppress signal transduction pathways, which resulted in the inhibition of iNOS activation in astrocytes.", "electronicPublicationDate": "2007-06-01", "language": "eng", "dateOfCompletion": "2007-10-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.virol.2007.04.031", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2008-11-21", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-09-01", "journal": {"medlineAbbreviation": "Virology", "isoabbreviation": "Virology", "title": "Virology", "issn": "0042-6822", "nlmid": "0110674", "essn": "1096-0341"}, "monthOfPublication": 9, "volume": "366", "yearOfPublication": 2007, "journalIssueId": 1468985, "issue": "2", "dateOfPublication": "2007 Sep"}}, "23428672": {"pubYear": "2013", "dateOfCreation": "2013-04-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "Interferon Type I"}, {"registryNumber": "0", "name": "MicroRNAs"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}, {"registryNumber": "0", "name": "MIRN155 microRNA, human"}]}, "authorString": "Zhai A, Qian J, Kao W, Li A, Li Y, He J, Zhang Q, Song W, Fu Y, Wu J, Chen X, Li H, Zhong Z, Ling H, Zhang F.", "affiliation": "The Heilongjiang Key Laboratory of Immunity and Infection, Key Laboratory of Pathogenic Biology Heilongjiang Higher Education Institutions, Department of Microbiology, Harbin Medical University, Harbin, Heilongjiang 150086, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23428672", "inEPMC": "N", "authorList": {"author": [{"lastName": "Zhai", "fullName": "Zhai A", "firstName": "Aixia", "initials": "A"}, {"lastName": "Qian", "fullName": "Qian J", "firstName": "Jun", "initials": "J"}, {"lastName": "Kao", "fullName": "Kao W", "firstName": "Wenping", "initials": "W"}, {"lastName": "Li", "fullName": "Li A", "firstName": "Aimei", "initials": "A"}, {"lastName": "Li", "fullName": "Li Y", "firstName": "Yujun", "initials": "Y"}, {"lastName": "He", "fullName": "He J", "firstName": "Junming", "initials": "J"}, {"lastName": "Zhang", "fullName": "Zhang Q", "firstName": "Qingmeng", "initials": "Q"}, {"lastName": "Song", "fullName": "Song W", "firstName": "Wuqi", "initials": "W"}, {"lastName": "Fu", "fullName": "Fu Y", "firstName": "Yingmei", "initials": "Y"}, {"lastName": "Wu", "fullName": "Wu J", "firstName": "Jing", "initials": "J"}, {"lastName": "Chen", "fullName": "Chen X", "firstName": "Xiaobei", "initials": "X"}, {"lastName": "Li", "fullName": "Li H", "firstName": "Hui", "initials": "H"}, {"lastName": "Zhong", "fullName": "Zhong Z", "firstName": "Zhaohua", "initials": "Z"}, {"lastName": "Ling", "fullName": "Ling H", "firstName": "Hong", "initials": "H"}, {"lastName": "Zhang", "fullName": "Zhang F", "firstName": "Fengmin", "initials": "F"}]}, "title": "Borna disease virus encoded phosphoprotein inhibits host innate immunity by regulating miR-155.", "citedByCount": 3, "source": "MED", "pmid": "23428672", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Borna Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "VI", "qualifierName": "virology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interferon Type I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "MicroRNAs", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Host-Pathogen Interactions", "majorTopic_YN": "N"}, {"descriptorName": "Immunity, Innate", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-02-18", "doi": "10.1016/j.antiviral.2013.02.009", "isOpenAccess": "N", "pageInfo": "66-75", "hasDbCrossReferences": "N", "abstractText": "It has been reported that the Borna disease virus (BDV) encoded phosphoprotein (P protein) can inhibit the activity of Traf family member-associated NF-kappaB activator (TANK)-binding kinase 1 (TBK-1), thus preventing the induction of type I interferon (IFN). However, the effects of microRNA on the regulation of BDV infection and the host's immune response have not been characterized. miR-155 was predicted to be complementary to the BDV P mRNA by RNAhybrid software. Here, we showed that miR-155 was down-regulated in BDV persistently infected human oligodendroglial (OL/BDV) cells and that the BDV P protein, but not the X protein, directly inhibited miR-155 expression in cells. When miR-155 was over-expressed, the inhibition of type I IFNs by BDV in cells was reversed, and the expression of type I IFNs was increased. When miR-155 expression was specifically blocked, cellular IFN expression and the induction of IFN by poly I:C treatment were suppressed. Furthermore, miR-155 promoted type I IFN production by targeting suppressor of cytokine signaling 1 (SOCS1) and SOCS3. Mutations in the nt1138-nt1158 region of SOCS3 abandoned the impact of miR-155 on the expression of SOCS3-enhanced green fluorescent protein (EGFP). The levels of BDV P mRNA and protein were significantly decreased in OL/BDV cells when miR-155 was over-expressed; however, miR-155-mutation did not affect the expression of BDV P-EGFP. Thus, BDV persistent infection inhibited the expression of type I IFNs through the suppression of miR-155, and miR-155 played an important immune regulatory role in BDV persistent infection.", "electronicPublicationDate": "2013-02-18", "language": "eng", "dateOfCompletion": "2013-09-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.antiviral.2013.02.009", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-04-01", "journal": {"medlineAbbreviation": "Antiviral Res", "isoabbreviation": "Antiviral Res.", "title": "Antiviral research", "issn": "0166-3542", "nlmid": "8109699", "essn": "1872-9096"}, "monthOfPublication": 4, "volume": "98", "yearOfPublication": 2013, "journalIssueId": 2030098, "issue": "1", "dateOfPublication": "2013 Apr"}}, "6852922": "", "8961909": "", "17289545": {"pubYear": "2007", "dateOfCreation": "2007-02-09", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}]}, "authorString": "Toubi E, Shoenfeld Y.", "affiliation": "Division of Clinical Immunology and Allergy, Bnai-Zion Medical Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17289545", "inEPMC": "N", "authorList": {"author": [{"lastName": "Toubi", "fullName": "Toubi E", "firstName": "Elias", "initials": "E"}, {"lastName": "Shoenfeld", "fullName": "Shoenfeld Y", "firstName": "Yehuda", "initials": "Y"}]}, "title": "Clinical and biological aspects of anti-P-ribosomal protein autoantibodies.", "citedByCount": 41, "source": "MED", "pmid": "17289545", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychotic Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-09-11", "doi": "10.1016/j.autrev.2006.07.004", "isOpenAccess": "N", "pageInfo": "119-125", "hasDbCrossReferences": "N", "abstractText": "Among the many clinical manifestations of systemic lupus erythematosus (SLE), central nervous system (CNS) involvement is of a prognostic importance. In this respect, anti-ribosomal P protein antibodies were shown by many to occur in association with SLE neuropsychiatric manifestations, mainly psychosis. The prevalence of anti-P antibodies was strongly related to disease activity wherein disease remission was associated with the disappearance of these antibodies. In addition to its association with CNS involvement, the occurrence of liver and kidney disease in SLE patients with anti-P antibodies was widely reported. Anti-P antibodies are able to bind T cells, monocytes, neurons and hepatocytes thereby enhancing the production of pro-inflammatory cytokines and both CNS and liver damage. Similar to the ability of anti-dsDNA antibodies, anti-P antibodies were shown to penetrate into living cells, leading to cell dysfunctions such as cell apoptosis. These biological aspects may play an important role in the pathogenesis of SLE.", "electronicPublicationDate": "2006-09-11", "language": "eng", "dateOfCompletion": "2007-04-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.autrev.2006.07.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-01-01", "journal": {"medlineAbbreviation": "Autoimmun Rev", "isoabbreviation": "Autoimmun Rev", "title": "Autoimmunity reviews", "issn": "1568-9972", "nlmid": "101128967", "essn": "1873-0183"}, "monthOfPublication": 1, "volume": "6", "yearOfPublication": 2007, "journalIssueId": 1377468, "issue": "3", "dateOfPublication": "2007 Jan"}}, "18815298": {"pubYear": "2008", "dateOfCreation": "2008-11-25", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antibodies"}, {"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "0", "name": "Microtubule-Associated Proteins"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}]}, "authorString": "Peng G, Yan Y, Zhu C, Wang S, Yan X, Lu L, Li W, Hu J, Wei W, Mu Y, Chen Y, Feng Y, Gong R, Wu K, Zhang F, Zhang X, Zhu Y, Wu J.", "affiliation": "State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, People's Republic of China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "18815298", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Peng", "fullName": "Peng G", "firstName": "Guiqing", "initials": "G"}, {"lastName": "Yan", "fullName": "Yan Y", "firstName": "Yan", "initials": "Y"}, {"lastName": "Zhu", "fullName": "Zhu C", "firstName": "Chengliang", "initials": "C"}, {"lastName": "Wang", "fullName": "Wang S", "firstName": "Shiqun", "initials": "S"}, {"lastName": "Yan", "fullName": "Yan X", "firstName": "Xiaohong", "initials": "X"}, {"lastName": "Lu", "fullName": "Lu L", "firstName": "Lili", "initials": "L"}, {"lastName": "Li", "fullName": "Li W", "firstName": "Wei", "initials": "W"}, {"lastName": "Hu", "fullName": "Hu J", "firstName": "Jing", "initials": "J"}, {"lastName": "Wei", "fullName": "Wei W", "firstName": "Wei", "initials": "W"}, {"lastName": "Mu", "fullName": "Mu Y", "authorId": {"type": "ORCID", "value": "0000-0002-5569-5255"}, "firstName": "Yongxin", "initials": "Y"}, {"lastName": "Chen", "fullName": "Chen Y", "firstName": "Yanni", "initials": "Y"}, {"lastName": "Feng", "fullName": "Feng Y", "firstName": "Yong", "initials": "Y"}, {"lastName": "Gong", "fullName": "Gong R", "firstName": "Rui", "initials": "R"}, {"lastName": "Wu", "fullName": "Wu K", "firstName": "Kailang", "initials": "K"}, {"lastName": "Zhang", "fullName": "Zhang F", "firstName": "Fengmin", "initials": "F"}, {"lastName": "Zhang", "fullName": "Zhang X", "firstName": "Xiaolian", "initials": "X"}, {"lastName": "Zhu", "fullName": "Zhu Y", "firstName": "Ying", "initials": "Y"}, {"lastName": "Wu", "fullName": "Wu J", "firstName": "Jianguo", "initials": "J"}]}, "title": "Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein.", "hasSuppl": "N", "citedByCount": 10, "source": "MED", "pmid": "18815298", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5569-5255"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Cell Membrane", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Nucleus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytosol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Cercopithecus aethiops", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microtubule-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Active Transport, Cell Nucleus", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-09-24", "doi": "10.1128/jvi.00877-08", "isOpenAccess": "N", "pageInfo": "12487-12497", "pmcid": "PMC2593307", "hasDbCrossReferences": "N", "abstractText": "Borna disease virus (BDV) is one of the infectious agents that causes diseases of the central nervous system in a wide range of vertebrate species and, perhaps, in humans. The phosphoprotein (P) of BDV, an essential cofactor of virus RNA-dependent RNA polymerase, is required for virus replication. In this study, we identified the gamma-aminobutyric acid receptor-associated protein (GABARAP) with functions in neurobiology as one of the viral P protein-interacting cellular factors by using an approach of phage display-based protein-protein interaction analysis. Direct binding between GABARAP and P protein was confirmed by coimmunoprecipitation, protein pull-down, and mammalian two-hybrid analyses. GABARAP originally was identified as a linker between the gamma-aminobutyric acid receptor (GABAR) and the microtubule to regulate receptor trafficking and plays important roles in the regulation of the inhibitory neural transmitter gamma-aminobutyric acid (GABA). We showed that GABARAP colocalizes with P protein in the cells infected with BDV or transfected with the P gene, which resulted in shifting the localization of GABARAP from the cytosol to the nucleus. We further demonstrated that P protein blocks the trafficking of GABAR, a principal GABA-gated ion channel that plays important roles in neural transmission, to the surface of cells infected with BDV or transfected with the P gene. We proposed that during BDV infection, P protein binds to GABARAP, shifts the distribution of GABARAP from the cytoplasm to the nucleus, and disrupts the trafficking of GABARs to the cell membranes, which may result in the inhibition of GABA-induced currents and in the enhancement of hyperactivity and anxiety.", "electronicPublicationDate": "2008-09-24", "language": "eng", "dateOfCompletion": "2009-01-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2593307?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2593307", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=18815298&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=18815298", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://jvi.asm.org/cgi/content/abstract/82/24/12487", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "jvi.asm.org"}, {"url": "http://dx.doi.org/10.1128/JVI.00877-08", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://jvi.asm.org/cgi/reprint/82/24/12487", "documentStyle": "pdf", "availability": "Free after 4 months", "availabilityCode": "F4", "site": "jvi.asm.org"}, {"url": "http://jvi.asm.org/cgi/content/full/82/24/12487", "documentStyle": "html", "availability": "Free after 4 months", "availabilityCode": "F4", "site": "jvi.asm.org"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2009-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-12-01", "journal": {"medlineAbbreviation": "J Virol", "isoabbreviation": "J. Virol.", "title": "Journal of virology", "issn": "0022-538X", "nlmid": "0113724", "essn": "1098-5514"}, "monthOfPublication": 12, "volume": "82", "yearOfPublication": 2008, "journalIssueId": 1580718, "issue": "24", "dateOfPublication": "2008 Dec"}}, "16385548": {"pubYear": "2006", "dateOfCreation": "2006-01-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}]}, "authorString": "Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IE, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JP.", "affiliation": "Dept. of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110 Ioannina, Greece.", "pubTypeList": {"pubType": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "16385548", "inEPMC": "N", "authorList": {"author": [{"lastName": "Karassa", "fullName": "Karassa FB", "firstName": "Fotini B", "initials": "FB"}, {"lastName": "Afeltra", "fullName": "Afeltra A", "authorId": {"type": "ORCID", "value": "0000-0003-2440-1995"}, "firstName": "Antonella", "initials": "A"}, {"lastName": "Ambrozic", "fullName": "Ambrozic A", "firstName": "Ales", "initials": "A"}, {"lastName": "Chang", "fullName": "Chang DM", "firstName": "Deh-Ming", "initials": "DM"}, {"lastName": "De Keyser", "fullName": "De Keyser F", "firstName": "Filip", "initials": "F"}, {"lastName": "Doria", "fullName": "Doria A", "authorId": {"type": "ORCID", "value": "0000-0003-0548-4983"}, "firstName": "Andrea", "initials": "A"}, {"lastName": "Galeazzi", "fullName": "Galeazzi M", "firstName": "Mauro", "initials": "M"}, {"lastName": "Hirohata", "fullName": "Hirohata S", "firstName": "Shunsei", "initials": "S"}, {"lastName": "Hoffman", "fullName": "Hoffman IE", "firstName": "Ilse E A", "initials": "IE"}, {"lastName": "Inanc", "fullName": "Inanc M", "firstName": "Murat", "initials": "M"}, {"lastName": "Massardo", "fullName": "Massardo L", "firstName": "Loreto", "initials": "L"}, {"lastName": "Mathieu", "fullName": "Mathieu A", "firstName": "Alessandro", "initials": "A"}, {"lastName": "Mok", "fullName": "Mok CC", "firstName": "Chi Chiu", "initials": "CC"}, {"lastName": "Morozzi", "fullName": "Morozzi G", "firstName": "Gabriella", "initials": "G"}, {"lastName": "Sanna", "fullName": "Sanna G", "firstName": "Giovanni", "initials": "G"}, {"lastName": "Spindler", "fullName": "Spindler AJ", "firstName": "Alberto J", "initials": "AJ"}, {"lastName": "Tzioufas", "fullName": "Tzioufas AG", "firstName": "Athanasios G", "initials": "AG"}, {"lastName": "Yoshio", "fullName": "Yoshio T", "firstName": "Taku", "initials": "T"}, {"lastName": "Ioannidis", "fullName": "Ioannidis JP", "firstName": "John P A", "initials": "JP"}]}, "title": "Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.", "citedByCount": 58, "source": "MED", "pmid": "16385548", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2440-1995"}, {"type": "ORCID", "value": "0000-0003-0548-4983"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Vasculitis, Central Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Sensitivity and Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-01-01", "doi": "10.1002/art.21539", "isOpenAccess": "N", "pageInfo": "312-324", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVE: To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P proteins (anti-P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for psychosis, mood disorder, or both, and for other diffuse manifestations. METHODS: This international meta-analysis combined standardized data from 1,537 lupus patients contributed by 14 research teams. Weighted estimation of sensitivity and specificity with fixed-effects and random-effects models, as well as summary receiver operating characteristic (SROC) curve analysis, was used to summarize test performance. The robustness of the overall estimates was examined in sensitivity analyses that included additional studies published up to November 1, 2004 in the Medline, EMBase, and Cochrane databases. RESULTS: Combining the data from the 14 teams, the weighted sensitivity and specificity estimates for the diagnosis of NPSLE were 26% (95% confidence interval [95% CI] 15-42%) and 80% (95% CI 74-85%), respectively. For psychosis, mood disorder, or both, the sensitivity and specificity were 27% (95% CI 14-47%) and 80% (95% CI 74-85%), respectively. For other diffuse manifestations, the sensitivity was 24% (95% CI 12-42%), and the specificity was 80% (95% CI 73-85%). The proportion of patients with anti-P antibodies did not vary markedly across different presentations of NPSLE. Between-study heterogeneity was substantial, but the SROC curves were consistent with the weighted estimates. In further analyses that included another 24 published studies, only the sensitivity for psychosis and/or mood disorder was slightly improved, but it was still suboptimal (42% [95% CI 30-53%]); the specificity remained essentially the same (81% [95% CI 76-85%]). CONCLUSION: Anti-P antibody testing has limited diagnostic value for NPSLE, and it is not helpful in differentiating among various disease phenotypes.", "language": "eng", "dateOfCompletion": "2006-03-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/art.21539", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-01-01", "journal": {"medlineAbbreviation": "Arthritis Rheum", "isoabbreviation": "Arthritis Rheum.", "title": "Arthritis and rheumatism", "issn": "0004-3591", "nlmid": "0370605", "essn": "1529-0131"}, "monthOfPublication": 1, "volume": "54", "yearOfPublication": 2006, "journalIssueId": 1282534, "issue": "1", "dateOfPublication": "2006 Jan"}}, "26688829": {"pubYear": "2015", "dateOfCreation": "2015-12-21", "pubModel": "Print-Electronic", "authorString": "Bougea A, Anagnostou E, Konstantinos G, George P, Triantafyllou N, Kararizou E.", "affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "id": "26688829", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "Bougea A", "initials": "A", "firstName": "Anastasia", "lastName": "Bougea"}, {"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "Anagnostou E", "initials": "E", "firstName": "Evangelos", "lastName": "Anagnostou"}, {"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "Konstantinos G", "initials": "G", "firstName": "Giatas", "lastName": "Konstantinos"}, {"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "George P", "initials": "P", "firstName": "Paraskevas", "lastName": "George"}, {"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "Triantafyllou N", "initials": "N", "firstName": "Nikolaos", "lastName": "Triantafyllou"}, {"affiliation": "1st Department of Neurology, University of Athens Medical School, Eginition Hospital, Athens, Greece.", "fullName": "Kararizou E", "initials": "E", "firstName": "Evangelia", "lastName": "Kararizou"}]}, "title": "A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjogren's Syndrome, and Associated Immunological Profiles.", "hasSuppl": "N", "citedByCount": 1, "pageInfo": "910352", "source": "MED", "pmid": "26688829", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-11-25", "doi": "10.1155/2015/910352", "isOpenAccess": "Y", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Erratum in", "id": "27144223", "reference": "Int J Chronic Dis. 2016;2016:9854813"}]}, "pmcid": "PMC4673346", "hasDbCrossReferences": "N", "abstractText": "Both central (CNS) and peripheral nervous system (PNS) complications are frequent and varied in connective tissue diseases. A systematic review was conducted between 1989 and 2014 in the databases Medline, Scopus, and Cochrane Library using the search terms, peripheral and central nervous complications and immunological profiles, to identify studies in specific connective tissue disorders such as rheumatoid arthritis, systemic lupus erythematosus, and primary Sj\u00f6gren's syndrome. A total of 675 references were identified, of which 118 were selected for detailed analysis and 22 were included in the final review with a total of 2338 participants. Our search focused only on studies upon connective tissue disorders such as rheumatoid arthritis, systemic lupus erythematosus, and primary Sj\u00f6gren's syndrome associated with seroimmunological data. The reported prevalence of CNS involvement ranges from 9 to 92% across the reported studies. However, the association between CNS and PNS manifestations and seroimmunological profiles remains controversial. \u03a4o date, no laboratory test has been shown as pathognomonic neither for CNS nor for PNS involvement.", "electronicPublicationDate": "2015-11-25", "language": "eng", "dateOfCompletion": "2015-12-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4673346?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4673346", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1155/2015/910352", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-05-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Int J Chronic Dis", "isoabbreviation": "Int J Chronic Dis", "title": "International journal of chronic diseases", "issn": "2356-6981", "nlmid": "101654921", "essn": "2314-5749"}, "monthOfPublication": 0, "volume": "2015", "yearOfPublication": 2015, "journalIssueId": 2346260, "dateOfPublication": "2015"}}, "11519163": {"pubYear": "2001", "dateOfCreation": "2001-08-24", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "L12E protein, Trypanosoma cruzi"}, {"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "0", "name": "Biological Markers"}, {"registryNumber": "0", "name": "Protozoan Proteins"}]}, "authorString": "Kawakatsu S, Wada T.", "affiliation": "Department of Neuropsychiatry, Yamagata University School of Medicine.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Case Reports", "English Abstract"]}, "hasPDF": "N", "id": "11519163", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kawakatsu", "fullName": "Kawakatsu S", "initials": "S"}, {"lastName": "Wada", "fullName": "Wada T", "initials": "T"}]}, "title": "[Rheumatic disease and depression].", "citedByCount": 2, "source": "MED", "pmid": "11519163", "abstractText": "We reviewed depressive symptoms in rheumatic disease. In systemic lupus erythematosus(SLE), depressive symptoms are frequently mentioned with the prevalence rate about 30% and usually respond to antidepressant. The duration of symptoms is within two months in most patients. Antibodies to ribosomal P protein appear to be a specific marker for SLE with depression. Single photon emission tomography but magnetic resonance imaging may also be useful for predicting the development of depressive symptoms. We also reported a patient of dermatomyositis with manic-depressive state who showed decreased cerebral blood flow in the left frontal and temporal regions during depressive state.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dermatomyositis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protozoan Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Diagnostic Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Prevalence", "majorTopic_YN": "N"}, {"descriptorName": "Depression", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2001-08-01", "isOpenAccess": "N", "pageInfo": "1578-1582", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "jpn", "dateOfCompletion": "2001-10-18", "hasTextMinedTerms": "N", "dateOfRevision": "2011-07-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2001-08-01", "journal": {"title": "Nihon rinsho. Japanese journal of clinical medicine", "issn": "0047-1852", "isoabbreviation": "Nippon Rinsho", "medlineAbbreviation": "Nihon Rinsho", "nlmid": "0420546"}, "monthOfPublication": 8, "volume": "59", "yearOfPublication": 2001, "journalIssueId": 1002577, "issue": "8", "dateOfPublication": "2001 Aug"}}, "25125603": {"pubYear": "2014", "dateOfCreation": "2014-09-16", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "80295-65-4", "name": "Complement Factor H"}, {"registryNumber": "0", "name": "ARMS2 protein, human"}]}, "authorString": "Klein BE, Howard KP, Iyengar SK, Sivakumaran TA, Meyers KJ, Cruickshanks KJ, Klein R.", "affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY06594"}]}, "hasPDF": "Y", "id": "25125603", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "fullName": "Klein BE", "initials": "BE", "firstName": "Barbara E K", "lastName": "Klein"}, {"affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "fullName": "Howard KP", "initials": "KP", "firstName": "Kerri P", "lastName": "Howard"}, {"affiliation": "Departments of Epidemiology & Biostatistics, Genetics & Genome Sciences and Ophthalmology & Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States.", "fullName": "Iyengar SK", "initials": "SK", "firstName": "Sudha K", "lastName": "Iyengar"}, {"affiliation": "Departments of Epidemiology & Biostatistics, Genetics & Genome Sciences and Ophthalmology & Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.", "fullName": "Sivakumaran TA", "initials": "TA", "firstName": "Theru A", "lastName": "Sivakumaran"}, {"affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "fullName": "Meyers KJ", "initials": "KJ", "firstName": "Kristin J", "lastName": "Meyers"}, {"affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "fullName": "Cruickshanks KJ", "initials": "KJ", "firstName": "Karen J", "lastName": "Cruickshanks"}, {"affiliation": "Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.", "fullName": "Klein R", "initials": "R", "firstName": "Ronald", "lastName": "Klein"}]}, "title": "Sunlight exposure, pigmentation, and incident age-related macular degeneration.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25125603", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Complement Factor H", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Incidence", "majorTopic_YN": "N"}, {"descriptorName": "Sunlight", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Environmental Exposure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Eye Color", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hair Color", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Wisconsin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Gene-Environment Interaction", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2015-03-01", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-08-14", "doi": "10.1167/iovs.14-14602", "isOpenAccess": "N", "pageInfo": "5855-5861", "pmcid": "PMC4165367", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Pigmentation", "Age-related macular degeneration", "Sunlight Exposure", "Hair Color", "Eye Color"]}, "abstractText": "PURPOSE: Examine potential effects of sunlight exposure, hair color, eye color, and selected gene single-nucleotide polymorphisms (SNPs) on incidence of AMD. METHODS: Subjects participated in up to five examinations over a 20-year period. Eye color, self-reported hair color as a teenager, and sunlight exposure were ascertained at the baseline examination. Presence and severity of AMD and its lesions were determined via fundus photographs. Genetic data were available on a subset of participants. The SNPs CFH Y402H rs1061170 and ARMS2 A69S rs10490924 were used to analyze genetic risk of AMD; OCA2 rs4778241 and HERC2 rs12913832 represented genetic determinants of eye color. RESULTS: Incidence of early AMD was higher in blond/red-haired persons compared with brown/black-haired persons (hazard ratio [HR] 1.25, P = 0.02) and in persons with high sun exposure in their thirties (HR 1.41, P = 0.02). However, neither was significant after adjustment for multiple comparisons. Eye (HR 1.36, P = 0.006) and hair color (HR 1.42, P = 0.003) were associated with incidence of any retinal pigmentary abnormalities (RPAs). Both remained significant after adjustment for multiple comparisons. Neither presence of alleles for light-colored eyes nor those associated with high risk of late AMD altered the association of eye or hair color with early AMD. None of the characteristics studied were significantly associated with late AMD. CONCLUSIONS: Modest associations of eye color, hair color, and HERC2 genotype with any RPAs were found. Genes for AMD did not affect these associations. Eye color phenotype was more strongly associated with outcomes than HERC2 or OCA2 genotype.", "electronicPublicationDate": "2014-08-14", "language": "eng", "dateOfCompletion": "2014-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4165367?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4165367", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1167/iovs.14-14602", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-03-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-09-01", "journal": {"medlineAbbreviation": "Invest Ophthalmol Vis Sci", "isoabbreviation": "Invest. Ophthalmol. Vis. Sci.", "title": "Investigative ophthalmology & visual science", "issn": "0146-0404", "nlmid": "7703701", "essn": "1552-5783"}, "monthOfPublication": 9, "volume": "55", "yearOfPublication": 2014, "journalIssueId": 2202873, "issue": "9", "dateOfPublication": "2014 Sep"}}, "3753538": "", "24670129": {"pubYear": "2014", "dateOfCreation": "2014-11-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}]}, "authorString": "Hirohata S, Kasama T, Kawahito Y, Takabayashi K.", "affiliation": "Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa , Japan.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24670129", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa , Japan.", "fullName": "Hirohata S", "initials": "S", "firstName": "Shunsei", "lastName": "Hirohata"}, {"lastName": "Kasama", "fullName": "Kasama T", "firstName": "Tsuyoshi", "initials": "T"}, {"lastName": "Kawahito", "fullName": "Kawahito Y", "firstName": "Yutaka", "initials": "Y"}, {"lastName": "Takabayashi", "fullName": "Takabayashi K", "firstName": "Katsuhiko", "initials": "K"}]}, "title": "Efficacy of anti-ribosomal P protein antibody testing for diagnosis of systemic lupus erythematosus.", "citedByCount": 1, "source": "MED", "pmid": "24670129", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rheumatic Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Diagnosis, Differential", "majorTopic_YN": "N"}, {"descriptorName": "Sensitivity and Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-03-26", "doi": "10.3109/14397595.2014.884529", "isOpenAccess": "N", "pageInfo": "939-944", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Diagnosis", "Anti-dna", "Anti-cardiolipin", "Anti-ribosomal P", "Anti-sm"]}, "abstractText": "OBJECTIVE: Anti-ribosomal P protein antibody (anti-P) is detected in a fraction of systemic lupus erythematosus (SLE) patients, especially with lupus psychosis, lupus nephritis, and lupus hepatitis. However, it has been unclear whether anti-P testing is specific for SLE. The current studies were designed to examine the efficacy of serum anti-P testing in diagnosis of SLE. METHOD: Multicenter retrospective study was performed with 102 SLE patients, 102 patients with non-SLE rheumatic diseases, and 100 normal healthy subjects, who gave informed consents. The diagnosis of SLE was confirmed according to the 1982 ACR revised criteria. Serum IgG anti-P was determined by ELISA using the C-terminal 22 amino-acids of ribosomal P protein conjugated to human serum albumin. The specificity and sensitivity of anti-P were compared with those of anti-DNA, anti-Sm, and anti-cardiolipin (CL) antibodies. RESULTS: Serum anti-P was positive in 38 of 102 SLE patients (37.3%), in 4 of 102 patients with non-SLE rheumatic diseases (3.9%), and in none of 100 normal subjects. Receiver operating characteristic (ROC) curve analysis revealed that anti-P provided higher AUC (area under the curve) than anti-Sm or anti-CL. Consistently, the sensitivity of anti-P (37.3%) was superior to that of anti-Sm (27.5%) and anti-CL (24.5%), but inferior to that of anti-DNA (51.0%), whereas the specificity of anti-P (96.1%) was superior to that of anti-CL (86.3%) and comparable to that of anti-DNA (96.1%) and anti-Sm (96.1%). CONCLUSION: These results indicate that serum anti-P testing might be an effective measure in diagnosing SLE, providing better diagnostic efficiency than anti-Sm and anti-CL.", "electronicPublicationDate": "2014-03-26", "language": "eng", "dateOfCompletion": "2015-06-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/14397595.2014.884529", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-11-01", "journal": {"medlineAbbreviation": "Mod Rheumatol", "isoabbreviation": "Mod Rheumatol", "title": "Modern rheumatology / the Japan Rheumatism Association", "issn": "1439-7595", "nlmid": "100959226", "essn": "1439-7609"}, "monthOfPublication": 11, "volume": "24", "yearOfPublication": 2014, "journalIssueId": 2216500, "issue": "6", "dateOfPublication": "2014 Nov"}}, "14714911": {"pubYear": "2003", "dateOfCreation": "2004-01-12", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "L12E protein, Trypanosoma cruzi"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "0", "name": "Biological Markers"}, {"registryNumber": "0", "name": "Protozoan Proteins"}]}, "authorString": "Reichlin M.", "affiliation": "Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA. morris-reichlin@omrf.ouhsc.edu", "pubTypeList": {"pubType": ["Journal Article", "Review", "Comparative Study"]}, "hasPDF": "N", "id": "14714911", "inEPMC": "N", "authorList": {"author": [{"lastName": "Reichlin", "fullName": "Reichlin M", "initials": "M"}]}, "title": "Ribosomal P antibodies and CNS lupus.", "citedByCount": 22, "source": "MED", "pmid": "14714911", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Vasculitis, Central Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CF", "qualifierName": "cerebrospinal fluid", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protozoan Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Severity of Illness Index", "majorTopic_YN": "N"}, {"descriptorName": "Risk Assessment", "majorTopic_YN": "N"}, {"descriptorName": "Sensitivity and Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2003-01-01", "doi": "10.1191/0961203303lu502oa", "isOpenAccess": "N", "pageInfo": "916-918", "hasDbCrossReferences": "N", "abstractText": "Within two years of the recognition of autoantibodies to ribosomal P proteins in patients with systemic lupus erythematosus (SLE) an association with anti-P autoantibodies with psychosis was noted. While there has been some controversy about this association, ample evidence suggests a meaningful relationship between anti-P antibodies and central nervous system (CNS) disease. This evidence consists of 1) seven independent studies showing a strong relationship between anti-P antibodies and CNS disease; 2) longitudinal studies showing fluctuations of anti-P antibodies with episodes of psychosis; 3) correlation of anti-P antibodies with general disease activity; and 4) acid eluates form lupus renal tissue were found to contain anti-P antibodies enriched 30-fold with respect to their specific activity in serum heralding a direct role of anti-P antibodies in disease expression. Finally, there is evidence that the P protein resides on normal cells in an immunologically accessible way and evidence exists that anti-P antibodies are able to bind and penerate cells in culture, and once inside cells can affect a profound inhibition of protein synthesis in living cells. Taken together, these observations provide evidence linking anti-P antibodies to various forms of CNS disease. While this is true, there are other autoantibodies in SLE patients such as anti-dsDNA and antiglial fibrillary protein which may also play a role in the CNS disease of SLE patients. Continued study will inform us of the relative contribution of these autoantibodies to CNS disease in SLE patients.", "language": "eng", "dateOfCompletion": "2004-02-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1191/0961203303lu502oa", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ingentaconnect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2003-01-01", "journal": {"medlineAbbreviation": "Lupus", "isoabbreviation": "Lupus", "title": "Lupus", "issn": "0961-2033", "nlmid": "9204265", "essn": "1477-0962"}, "monthOfPublication": 0, "volume": "12", "yearOfPublication": 2003, "journalIssueId": 1186538, "issue": "12", "dateOfPublication": "2003 "}}, "1986591": "", "17376920": {"pubYear": "2007", "dateOfCreation": "2007-05-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Coenzymes"}, {"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "EC 2.7.7.48", "name": "RNA Replicase"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}, {"registryNumber": "EC 2.7.11.1", "name": "Casein Kinase II"}, {"registryNumber": "EC 2.7.11.13", "name": "Protein Kinase C-epsilon"}]}, "authorString": "Schmid S, Mayer D, Schneider U, Schwemmle M.", "affiliation": "Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann Herder Strasse 11, D-79104 Freiburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "Y", "id": "17376920", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Schmid", "fullName": "Schmid S", "firstName": "Sonja", "initials": "S"}, {"lastName": "Mayer", "fullName": "Mayer D", "firstName": "Daniel", "initials": "D"}, {"lastName": "Schneider", "fullName": "Schneider U", "firstName": "Urs", "initials": "U"}, {"lastName": "Schwemmle", "fullName": "Schwemmle M", "firstName": "Martin", "initials": "M"}]}, "title": "Functional characterization of the major and minor phosphorylation sites of the P protein of Borna disease virus.", "hasSuppl": "N", "citedByCount": 16, "source": "MED", "pmid": "17376920", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "GD", "qualifierName": "growth & development", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Coenzymes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA Replicase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Casein Kinase II", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Substitution", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Down-Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Protein Kinase C-epsilon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-03-21", "doi": "10.1128/jvi.02233-06", "isOpenAccess": "N", "pageInfo": "5497-5507", "pmcid": "PMC1900310", "hasDbCrossReferences": "N", "abstractText": "The phosphoprotein P of Borna disease virus (BDV) is an essential cofactor of the viral RNA-dependent RNA polymerase. It is preferentially phosphorylated at serine residues 26 and 28 by protein kinase C epsilon (PKCepsilon) and, to a lesser extent, at serine residues 70 and 86 by casein kinase II (CKII). To determine whether P phosphorylation is required for viral polymerase activity, we generated P mutants lacking either the PKCepsilon or the CKII phosphate acceptor sites by replacing the corresponding serine residues with alanine (A). Alternatively, these sites were replaced by aspartic acid (D) to mimic phosphorylation. Functional characterization of the various mutants in the BDV minireplicon assay revealed that D substitutions at the CKII sites inhibited the polymerase-supporting activity of P, while A substitutions maintained wild-type activity. Likewise, D substitutions at the PKC sites did not impair the cofactor function of BDV-P, whereas A substitutions at these sites led to increased activity. Interestingly, recombinant viruses could be rescued only when P mutants with modified PKCepsilon sites were used but not when both CKII sites were altered. PKCepsilon mutant viruses showed a reduced capacity to spread in cell culture, while viral RNA and protein expression levels in persistently infected cells were almost normal. Further mutational analyses revealed that substitutions at individual CKII sites were, with the exception of a substitution of A for S86, detrimental for viral rescue. These data demonstrate that, in contrast to other viral P proteins, the cofactor activity of BDV-P is negatively regulated by phosphorylation.", "electronicPublicationDate": "2007-03-21", "language": "eng", "dateOfCompletion": "2007-07-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC1900310?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC1900310", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1128/JVI.02233-06", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "asm.org"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-06", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-06-01", "journal": {"medlineAbbreviation": "J Virol", "isoabbreviation": "J. Virol.", "title": "Journal of virology", "issn": "0022-538X", "nlmid": "0113724", "essn": "1098-5514"}, "monthOfPublication": 6, "volume": "81", "yearOfPublication": 2007, "journalIssueId": 1394928, "issue": "11", "dateOfPublication": "2007 Jun"}}, "15751081": {"pubYear": "2005", "dateOfCreation": "2005-03-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Epitopes"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "0", "name": "Receptors, IgG"}, {"registryNumber": "0", "name": "Tumor Necrosis Factor-alpha"}, {"registryNumber": "0", "name": "Interleukin-6"}, {"registryNumber": "0", "name": "FCGR1A protein, human"}]}, "authorString": "Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S.", "affiliation": "Teikyo University School of Medicine, Tokyo, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "15751081", "inEPMC": "N", "authorList": {"author": [{"lastName": "Nagai", "fullName": "Nagai T", "firstName": "Tatsuo", "initials": "T"}, {"lastName": "Arinuma", "fullName": "Arinuma Y", "firstName": "Yoshiyuki", "initials": "Y"}, {"lastName": "Yanagida", "fullName": "Yanagida T", "firstName": "Tamiko", "initials": "T"}, {"lastName": "Yamamoto", "fullName": "Yamamoto K", "firstName": "Kazuhiko", "initials": "K"}, {"lastName": "Hirohata", "fullName": "Hirohata S", "firstName": "Shunsei", "initials": "S"}]}, "title": "Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.", "citedByCount": 19, "source": "MED", "pmid": "15751081", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Monocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Necrosis Factor-alpha", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, IgG", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Interleukin-6", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epitopes", "majorTopic_YN": "N"}, {"descriptorName": "Cell Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Epitope Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2005-03-01", "doi": "10.1002/art.20869", "isOpenAccess": "N", "pageInfo": "847-855", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVE: Autoantibodies to ribosomal P proteins (anti-P antibodies) are detected in 12-16% of patients with systemic lupus erythematosus (SLE) and have been found to be associated with some manifestations of the disease, including lupus psychosis and hepatitis. Recent studies have disclosed that anti-P antibodies react with activated T cells but not with B cells, suggesting possible direct effects of anti-P antibodies on immune regulation. The present study was designed to explore the presence of the epitope recognized by anti-P antibodies on human peripheral blood monocytes. METHODS: Highly purified peripheral blood monocytes obtained from healthy donors were cultured with or without interferon-gamma (IFNgamma) in the presence of either anti-P antibodies purified by affinity chromatography from the sera of patients with SLE or control IgG. RESULTS: Flow cytometry analysis disclosed that fresh (day 0) monocytes did not express the ribosomal P epitope, whereas expression of the ribosomal P epitope was induced on annexin V-negative monocytes after activation through plastic adherence for 48 hours. More important, anti-P antibodies (compared with normal IgG or IgG from SLE patients devoid of anti-P antibodies) enhanced the production of tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6) by activated monocytes. Accordingly, anti-P antibodies also up-regulated the expression of TNFalpha and IL-6 messenger RNA in activated monocytes. Of note, F(ab')(2) fragments of anti-P antibodies, which do not result in Fcgamma receptor (FcgammaR) crosslinking, also effectively up-regulated the expression of TNFalpha and IL-6. CONCLUSION: These results indicate that human peripheral blood monocytes express the ribosomal P epitope upon activation, irrespective of induction of apoptosis. Moreover, the data suggest that anti-P antibodies might modify a variety of inflammatory responses through up-regulation of the expression of proinflammatory cytokines in monocytes, in a manner that does not involve FcgammaR crosslinking.", "language": "eng", "dateOfCompletion": "2005-05-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/art.20869", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2005-03-01", "journal": {"medlineAbbreviation": "Arthritis Rheum", "isoabbreviation": "Arthritis Rheum.", "title": "Arthritis and rheumatism", "issn": "0004-3591", "nlmid": "0370605", "essn": "1529-0131"}, "monthOfPublication": 3, "volume": "52", "yearOfPublication": 2005, "journalIssueId": 1222300, "issue": "3", "dateOfPublication": "2005 Mar"}}, "10363321": "", "10909150": {"pubYear": "2000", "dateOfCreation": "2000-09-06", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "0", "name": "Biological Markers"}]}, "authorString": "Johanet C, Andr\u00e9 C, Sibilia J, Baquey A, Oksman F, San Marco M, Humbel RL, Taillefer MF, Chr\u00e9tien P, Escande A, Cohen J, Chevailler A, Monier JC, Goetz J.", "affiliation": "Laboratoire d'immunologie, h\u00f4pital Saint-Antoine, Paris.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Multicenter Study", "English Abstract"]}, "hasPDF": "N", "id": "10909150", "inEPMC": "N", "authorList": {"author": [{"lastName": "Johanet", "fullName": "Johanet C", "initials": "C"}, {"lastName": "Andr\u00e9", "fullName": "Andr\u00e9 C", "initials": "C"}, {"lastName": "Sibilia", "fullName": "Sibilia J", "initials": "J"}, {"lastName": "Baquey", "fullName": "Baquey A", "initials": "A"}, {"lastName": "Oksman", "fullName": "Oksman F", "initials": "F"}, {"lastName": "San Marco", "fullName": "San Marco M", "initials": "M"}, {"lastName": "Humbel", "fullName": "Humbel RL", "initials": "RL"}, {"lastName": "Taillefer", "fullName": "Taillefer MF", "initials": "MF"}, {"lastName": "Chr\u00e9tien", "fullName": "Chr\u00e9tien P", "initials": "P"}, {"lastName": "Escande", "fullName": "Escande A", "initials": "A"}, {"lastName": "Cohen", "fullName": "Cohen J", "initials": "J"}, {"lastName": "Chevailler", "fullName": "Chevailler A", "initials": "A"}, {"lastName": "Monier", "fullName": "Monier JC", "initials": "JC"}, {"lastName": "Goetz", "fullName": "Goetz J", "initials": "J"}]}, "title": "[Clinical significance of antiribosomal antibodies. Study Group on Autoimmunity (GEAI)]", "citedByCount": 3, "source": "MED", "pmid": "10909150", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Biological Markers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blotting, Western", "majorTopic_YN": "N"}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Depressive Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Psychotic Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2000-06-01", "doi": "10.1016/s0248-8663(00)89226-7", "isOpenAccess": "N", "pageInfo": "510-516", "hasDbCrossReferences": "N", "abstractText": "PURPOSE: Autoantibodies directed against the ribosomal P proteins, P0, P1 and P2 (anti-P), have been related to lupus-related psychosis and/or depression. The diagnostic value of antibodies directed against other ribosomal proteins or 28S RNA (anti-no-P) remains unknown. A multicenter study including ten centers belonging to the study group for autoimmune diseases (GEAI) was conducted in order to determine the diagnostic value of anti-P and anti-no-P antibodies in a large population of patients. METHODS: The patients were selected on the basis of the presence of serum anti-ribosomal antibodies detected by indirect immunofluorescence (IF) on rat liver/kidney/stomach/pancreas sections and human HEp2 cells. The clinical course of all patients was studied using a predetermined survey. The specificity of anti-P antibodies were determined by Western blot. RESULTS: Anti-ribosomal antibodies were found in 82 patients. Fifty-five of them had systemic lupus erythematosus and 27 had another disease. Only 54% of the anti-ribosomal antibodies detected by IF were anti-P and were found in 69% of the patients with systemic lupus erythematosus. Anti-no-P antibodies (46%) were preferably detected in patients who suffered from another disease (78%). In patients with systemic lupus erythematosus, neurological and psychiatric disorders were more frequent in the no-P group (47% vs. 16%, P < 0.01) than arthritis, which was found more frequently in the P group (78% vs. 53%, P < 0.05). CONCLUSION: Anti P antibodies do not constitute a specific diagnostic marker of systemic lupus erythematosus, and lupus-related neuropsychiatric disorders would be preferably associated with the presence of anti no-P antibodies.", "language": "fre", "dateOfCompletion": "2000-09-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/S0248-8663(00)89226-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2000-06-01", "journal": {"medlineAbbreviation": "Rev Med Interne", "isoabbreviation": "Rev Med Interne", "title": "La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne", "issn": "0248-8663", "nlmid": "8101383", "essn": "1768-3122"}, "monthOfPublication": 6, "volume": "21", "yearOfPublication": 2000, "journalIssueId": 1046003, "issue": "6", "dateOfPublication": "2000 Jun"}}, "20333534": {"pubYear": "2010", "dateOfCreation": "2010-04-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "0", "name": "Viral Structural Proteins"}, {"registryNumber": "0", "name": "P protein, Borna disease virus"}, {"registryNumber": "EC 2.7.11.13", "name": "Protein Kinase C"}]}, "authorString": "Schmid S, Metz P, Prat CM, Gonzalez-Dunia D, Schwemmle M.", "affiliation": "Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, 79104, Freiburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20333534", "inEPMC": "N", "authorList": {"author": [{"lastName": "Schmid", "fullName": "Schmid S", "firstName": "Sonja", "initials": "S"}, {"lastName": "Metz", "fullName": "Metz P", "firstName": "Philippe", "initials": "P"}, {"lastName": "Prat", "fullName": "Prat CM", "firstName": "Christine M A", "initials": "CM"}, {"lastName": "Gonzalez-Dunia", "fullName": "Gonzalez-Dunia D", "authorId": {"type": "ORCID", "value": "0000-0002-2837-7120"}, "firstName": "Daniel", "initials": "D"}, {"lastName": "Schwemmle", "fullName": "Schwemmle M", "firstName": "Martin", "initials": "M"}]}, "title": "Protein kinase C-dependent phosphorylation of Borna disease virus P protein is required for efficient viral spread.", "citedByCount": 3, "source": "MED", "pmid": "20333534", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2837-7120"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Inbred Lew", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Borna disease virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Protein Kinase C", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Viral Structural Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-03-24", "doi": "10.1007/s00705-010-0645-9", "isOpenAccess": "N", "pageInfo": "789-793", "hasDbCrossReferences": "N", "abstractText": "Mutational analysis of the phosphate acceptor sites of the Borna disease virus (BDV) phosphoprotein (P) has suggested a role of phosphorylation for viral spread. However, the studied mutant viruses also had two amino acid exchanges in the X protein, because the reading frames of P and X overlap. To determine the relative contribution of P and X to viral attenuation, we studied a P variant with serine-to-leucine substitutions (P(S26L,S28L)) in which the wild-type X sequence was conserved. Viral spread of rBDV-P(S26L,S28L) was impaired in human oligodendroglioma cells and in adult rats. Thus, BDV-P phosphorylation contributes to efficient viral dissemination.", "electronicPublicationDate": "2010-03-24", "language": "eng", "dateOfCompletion": "2010-05-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00705-010-0645-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-05-01", "journal": {"medlineAbbreviation": "Arch Virol", "isoabbreviation": "Arch. Virol.", "title": "Archives of virology", "issn": "0304-8608", "nlmid": "7506870", "essn": "1432-8798"}, "monthOfPublication": 5, "volume": "155", "yearOfPublication": 2010, "journalIssueId": 1726445, "issue": "5", "dateOfPublication": "2010 May"}}, "20824297": {"pubYear": "2011", "dateOfCreation": "2011-02-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}, {"registryNumber": "187348-17-0", "name": "Interleukin-12"}, {"registryNumber": "0", "name": "ribosomal protein P0"}, {"registryNumber": "82115-62-6", "name": "Interferon-gamma"}, {"registryNumber": "0", "name": "Antibodies, Neutralizing"}]}, "authorString": "Nagai T, Yanagida T, Hirohata S.", "affiliation": "Department of Rheumatology and Infectious Disease, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, 228-8555, Japan. tnagai-tky@umin.net", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "20824297", "inEPMC": "N", "authorList": {"author": [{"lastName": "Nagai", "fullName": "Nagai T", "firstName": "Tatsuo", "initials": "T"}, {"lastName": "Yanagida", "fullName": "Yanagida T", "firstName": "Tamiko", "initials": "T"}, {"lastName": "Hirohata", "fullName": "Hirohata S", "firstName": "Shunsei", "initials": "S"}]}, "title": "Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes.", "citedByCount": 5, "source": "MED", "pmid": "20824297", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Leukocytes, Mononuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Th1 Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Interleukin-12", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Drug Therapy, Combination", "majorTopic_YN": "N"}, {"descriptorName": "Lymphocyte Activation", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interferon-gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antibodies, Neutralizing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-09-08", "doi": "10.3109/s10165-010-0354-y", "isOpenAccess": "N", "pageInfo": "57-62", "hasDbCrossReferences": "N", "abstractText": "Autoantibodies to ribosomal P proteins (anti-P) are detected in 12-16% of patients with systemic lupus erythematosus (SLE), and have been found to be associated with some manifestations, including lupus psychosis, nephritis and hepatitis. We have recently disclosed that anti-P react with activated human peripheral blood monocytes, and enhance their production of tumor necrosis factor-\u03b1 and interleukin (IL)-6. It is also possible that anti-P might regulate other monocyte functions, including the regulation of T helper (Th) responses. The current study was therefore undertaken to explore the effects of anti-P on the induction of Th1 responses. Peripheral blood mononuclear cells (PBMC) from healthy donors were cultured with affinity-purified anti-P or control IgG. Highly purified monocytes were cultured with interferon (IFN)-\u03b3 in the presence of anti-P or normal IgG. Anti-P significantly enhanced the production of IFN-\u03b3 by PBMC. Of note, anti-IL-12 monoclonal antibodies almost completely abrogated the anti-P-mediated upregulation of the IFN-\u03b3 production of PBMC. Accordingly, anti-P significantly enhanced the production of IL-12 by activated monocytes. These results indicate that anti-P induce Th1 responses by upregulating the production of IL-12 by activated monocytes. The data therefore suggest that anti-P play an important role in the pathogenesis of SLE through the promotion of Th1 responses.", "electronicPublicationDate": "2010-09-08", "language": "eng", "dateOfCompletion": "2011-06-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10165-010-0354-y", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://dx.doi.org/10.3109/s10165-010-0354-y", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-02-01", "journal": {"medlineAbbreviation": "Mod Rheumatol", "isoabbreviation": "Mod Rheumatol", "title": "Modern rheumatology / the Japan Rheumatism Association", "issn": "1439-7595", "nlmid": "100959226", "essn": "1439-7609"}, "monthOfPublication": 2, "volume": "21", "yearOfPublication": 2011, "journalIssueId": 1807022, "issue": "1", "dateOfPublication": "2011 Feb"}}, "23583561": {"pubYear": "2013", "dateOfCreation": "2013-09-02", "pubModel": "Print-Electronic", "authorString": "Reissmann M, Ludwig A.", "affiliation": "Humboldt University Berlin, Department for Crop and Animal Sciences, Berlin, Germany. monika.reissmann@rz.hu-berlin.de", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23583561", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Humboldt University Berlin, Department for Crop and Animal Sciences, Berlin, Germany. monika.reissmann@rz.hu-berlin.de", "fullName": "Reissmann M", "initials": "M", "firstName": "Monika", "lastName": "Reissmann"}, {"lastName": "Ludwig", "fullName": "Ludwig A", "firstName": "Arne", "initials": "A"}]}, "title": "Pleiotropic effects of coat colour-associated mutations in humans, mice and other mammals.", "citedByCount": 10, "source": "MED", "pmid": "23583561", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Hair Color", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Color", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Pleiotropy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-09", "doi": "10.1016/j.semcdb.2013.03.014", "isOpenAccess": "N", "pageInfo": "576-586", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Melanoma", "Reproduction", "Fitness", "Kit", "Albino", "Epistasis", "Retinal pigmented epithelium", "Gs", "As", "Chediak-Higashi syndrome", "Atrn", "Hps", "Lethal", "CHS", "Prader-willi Syndrome", "Angelman Syndrome", "Disorder", "Microphthalmia-associated Transcription Factor", "Endothelin Receptor Type B", "Mitf", "Csd", "Mc1r", "Tameness", "Pleiotropy", "Hirschsprung Disease", "Pmel", "Oca", "Snai2", "Hscr", "Rab27a", "Oa", "Edn3", "Ednrb", "Ocular Albinism", "Rpe", "Pws", "Syntaxin 17", "Pax3", "Slc24a5", "Rab38", "\u0391msh", "Ipe", "Lfs", "Mgrn1", "Myo5a", "Kitlg", "Tyr", "Congenital Stationary Night Blindness", "Ws", "Stx17", "Asip", "Melanocortin 1 Receptor", "Alpha-melanocyte-stimulating Hormone", "Endothelin 3", "Lyst", "Csnb", "Ostm1", "Slc2a9", "Agouti Signalling Protein", "Attractin (Mahogany)", "Bloc", "Biogenesis Of Lysosomal Organelles Complex", "Ccsd", "Canine Congenital Sensorineural Deafness", "Coat Colour Gene", "Congenital Sensorineural Deafness", "Griscelli Syndrome (Type 1 Or 2)", "Hermansky-pudlak Syndrome With Different Types", "Iris Pigment Epithelium", "Kit Ligand (Steel Factor)", "Lavender Foal Syndrome", "Leucism", "Lysosomal Trafficking Regulator", "Mcoa", "Mcoln3", "Mahogunin Ring Finger 1 (E3 Ubiquitin Protein Ligase)", "Mucolipin 3 (Trpml3)", "Multiple Congenital Ocular Anomalies", "Myosin Va (Heavy Chain 12, Myoxin)", "Oca2", "Olws", "Oculocutaneous Albinism Ii (Pink-eye Dilution Homolog)", "Oculocutaneous Albinism Type 1\u20134", "Osteopetrosis Associated Transmembrane Protein 1 (Grey Lethal Osteopetrosis)", "Overo Lethal White Syndrome", "Paired Box 3", "Premelanosome Protein (Pmel17, Silv)", "Rab27a Member Ras Oncogene Family", "Rab38 Member Ras Oncogene Family", "Slc45a2", "Snail Homolog 2 (Drosophila), (Slug), Sox10, Sry (Sex Determining Region Y)-box 10", "Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 9", "Solute Carrier Family 24, Member 5", "Solute Carrier Family 45, Member 2, Matp", "Trpm1", "Transient Receptor Potential Cation Channel, Subfamily M, Member 1 (Melastatin-1)", "Tyrosinase, Tyrp1, Tyrosinase-related Protein 1", "V-kit Hardy-zuckerman 4 Feline Sarcoma Viral Oncogene Homolog, Tyrosine Kinase Receptor (C-kit)", "Waardenburg Syndrome (Type 1, Type 2 Combined With Tietz Syndrome Type 3 Klein-waardenburg Syndrome, Type 4 Waardenburg-shah Syndrome)"]}, "abstractText": "The characterisation of the pleiotropic effects of coat colour-associated mutations in mammals illustrates that sensory organs and nerves are particularly affected by disorders because of the shared origin of melanocytes and neurocytes in the neural crest; e.g. the eye-colour is a valuable indicator of disorders in pigment production and eye dysfunctions. Disorders related to coat colour-associated alleles also occur in the skin (melanoma), reproductive tract and immune system. Additionally, the coat colour phenotype of an individual influences its general behaviour and fitness. Mutations in the same genes often produce similar coat colours and pleiotropic effects in different species (e.g., KIT [reproductive disorders, lethality], EDNRB [megacolon] and LYST [CHS]). Whereas similar disorders and similar-looking coat colour phenotypes sometimes have a different genetic background (e.g., deafness [EDN3/EDNRB, MITF, PAX and SNAI2] and visual diseases [OCA2, RAB38, SLC24A5, SLC45A2, TRPM1 and TYR]). The human predilection for fancy phenotypes that ignore disorders and genetic defects is a major driving force for the increase of pleiotropic effects in domestic species and laboratory subjects since domestication has commenced approximately 18,000 years ago.", "electronicPublicationDate": "2013-04-09", "language": "eng", "dateOfCompletion": "2014-10-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.semcdb.2013.03.014", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-06-01", "journal": {"medlineAbbreviation": "Semin Cell Dev Biol", "isoabbreviation": "Semin. Cell Dev. Biol.", "title": "Seminars in cell & developmental biology", "issn": "1084-9521", "nlmid": "9607332", "essn": "1096-3634"}, "monthOfPublication": 0, "volume": "24", "yearOfPublication": 2013, "journalIssueId": 2071149, "issue": "6-7", "dateOfPublication": "2013 Jun-Jul"}}, "16820990": {"pubYear": "2006", "dateOfCreation": "2006-07-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Autoantibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}]}, "authorString": "Reichlin M.", "affiliation": "Department of Medicine, Oklahoma University Health Sciences Center and Clinical Immunological Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. morris-reichlin@omrf.ouhsc.edu", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "16820990", "inEPMC": "N", "authorList": {"author": [{"lastName": "Reichlin", "fullName": "Reichlin M", "initials": "M"}]}, "title": "Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus.", "citedByCount": 10, "source": "MED", "pmid": "16820990", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Erythematosus, Systemic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoantibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2006-06-01", "doi": "10.1007/s10238-006-0094-7", "isOpenAccess": "N", "pageInfo": "49-52", "hasDbCrossReferences": "N", "abstractText": "This paper describes the clinical significance of antibodies to the ribosomal P proteins in systemic lupus erythematosus. It appears that liver disease due to the lupus process and not attributable to viral infection, alcohol or drugs is associated with anti-ribosomal P. In addition, there is a strong relationship to central nervous system disease and nephritis of antibodies to ribosomal P proteins. The prevalence of the anti-P antibodies is strongly related to disease activity wherein disease remission is associated with disappearance of anti-P antibodies. These phenomena taken together suggest an immunopathogenic role for anti-P antibodies. This idea is strongly supported by the observation that immunoglobulin G containing antiribosomal P activity binds and penetrates living cells with profoundly inhibitory effects on protein synthesis. Finally, a new era of research has been uncovered by the observation that in 54 of 55 instances normal sera passed over a ribosome-sepharose column unmasks anti-P antibodies, which can be eluted from the ribosome column with 3.0 M magnesium chloride. This suggests that anti-idiotypes regulate the expression of anti-P antibodies in normal persons and in lupus patients this regulation is ineffective, with the development of free anti-P antibodies in a proportion of patients with active disease.", "language": "eng", "dateOfCompletion": "2006-08-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10238-006-0094-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "SpringerLink"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-06-01", "journal": {"medlineAbbreviation": "Clin Exp Med", "isoabbreviation": "Clin. Exp. Med.", "title": "Clinical and experimental medicine", "issn": "1591-8890", "nlmid": "100973405", "essn": "1591-9528"}, "monthOfPublication": 6, "volume": "6", "yearOfPublication": 2006, "journalIssueId": 1333147, "issue": "2", "dateOfPublication": "2006 Jun"}}, "16505602": {"pubYear": "2006", "dateOfCreation": "2006-02-28", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "50-18-0", "name": "Cyclophosphamide"}, {"registryNumber": "81-81-2", "name": "Warfarin"}, {"registryNumber": "83-43-2", "name": "Methylprednisolone"}]}, "authorString": "Murayama J, Asanuma Y, Tsuda T, Nishida J, Moriguchi M.", "affiliation": "Clinical Department of Internal Medicine, Jichi Medical University Omiya Medical Center.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "English Abstract"]}, "hasPDF": "N", "id": "16505602", "inEPMC": "N", "authorList": {"author": [{"lastName": "Murayama", "fullName": "Murayama J", "firstName": "Junko", "initials": "J"}, {"lastName": "Asanuma", "fullName": "Asanuma Y", "firstName": "Yu", "initials": "Y"}, {"lastName": "Tsuda", "fullName": "Tsuda T", "firstName": "Tokutarou", "initials": "T"}, {"lastName": "Nishida", "fullName": "Nishida J", "firstName": "Junji", "initials": "J"}, {"lastName": "Moriguchi", "fullName": "Moriguchi M", "firstName": "Masato", "initials": "M"}]}, "title": "[Appearance of central nervous system lupus during corticosteroid therapy and warfarinization in a patient with pure red cell aplasia and antiphospholipid syndrome].", "citedByCount": 1, "source": "MED", "pmid": "16505602", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Vasculitis, Central Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Red-Cell Aplasia, Pure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antiphospholipid Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclophosphamide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}]}}, {"descriptorName": "Warfarin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Methylprednisolone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pulse Therapy, Drug", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-02-01", "doi": "10.2177/jsci.29.43", "isOpenAccess": "N", "pageInfo": "43-47", "hasDbCrossReferences": "N", "abstractText": "A 48-year-old woman presented to our hospital with epigastralgia and erythema on the left dorsalis pedis. Her medical history included deep venous thrombosis three months prior to admission to our hospital. Upon admission it was determined that she had severe anemia (hemoglobin level 4.6 g/dl). Bone marrow analysis indicated a markedly decreased number of erythroid progenitor cells. A skin biopsy specimen of the erythema revealed microthrombus. Anticardiolipin-beta2GPI antibody and lupus anticoagulant were positive. The patient was diagnosed with pure red cell aplasia (PRCA) and antiphospholipid syndrome (APS). After steroid pulse therapy and warfarinization, her anemia and purpura improved. Three months later she developed depression with positive anti-ribosomal P protein antibody that was indicative of central nervous system lupus. Although her psychometric condition did not respond to steroid pulse therapy, improvement was seen after she received three courses of cyclophosphamide pulse therapy. We report a rare case of CNS lupus that developed during corticosteroid therapy and warfarinization in a patient with PRCA and APS.", "language": "jpn", "dateOfCompletion": "2006-04-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.2177/jsci.29.43", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "J-STAGE"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-02-01", "journal": {"medlineAbbreviation": "Nihon Rinsho Meneki Gakkai Kaishi", "isoabbreviation": "Nihon Rinsho Meneki Gakkai Kaishi", "title": "Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology", "issn": "0911-4300", "nlmid": "9505992", "essn": "1349-7413"}, "monthOfPublication": 2, "volume": "29", "yearOfPublication": 2006, "journalIssueId": 1299724, "issue": "1", "dateOfPublication": "2006 Feb"}}, "10708460": "", "8814059": "", "8523585": "", "22420334": {"pubYear": "2012", "dateOfCreation": "2012-05-24", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antibodies"}, {"registryNumber": "0", "name": "Nerve Growth Factors"}, {"registryNumber": "0", "name": "S100 Proteins"}, {"registryNumber": "0", "name": "S-100 calcium-binding protein beta subunit"}]}, "authorString": "Al-Ayadhi LY, Mostafa GA.", "affiliation": "Autism Research and Treatment Center, Al-Amodi Autism Research Chair, Department of Physiology, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "22420334", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Al-Ayadhi", "fullName": "Al-Ayadhi LY", "authorId": {"type": "ORCID", "value": "0000-0003-3269-0416"}, "firstName": "Laila Yousef", "initials": "LY"}, {"lastName": "Mostafa", "fullName": "Mostafa GA", "firstName": "Gehan Ahmed", "initials": "GA"}]}, "title": "A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "22420334", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3269-0416"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Nerve Growth Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "S100 Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Enzyme-Linked Immunosorbent Assay", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Severity of Illness Index", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Autistic Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autoimmunity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Statistics as Topic", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-03-16", "language": "eng", "doi": "10.1186/1742-2094-9-54", "isOpenAccess": "Y", "pageInfo": "54", "pmcid": "PMC3359166", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: S100B is a calcium-binding protein that is produced primarily by astrocytes. Increased serum S100B protein levels reflect neurological damage. Autoimmunity may have a role in the pathogenesis of autism in some patients. Autoantibodies may cross the blood-brain barrier and combine with brain tissue antigens, forming immune complexes and resulting in neurological damage. We are the first to investigate the relationship between serum levels of S100B protein, a marker of neuronal damage, and antiribosomal P protein antibodies in autistic children. METHODS: Serum S100B protein and antiribosomal P antibodies were measured in 64 autistic children in comparison to 46 matched healthy children. RESULTS: Autistic children had significantly higher serum S100B protein levels than healthy controls (P < 0.001). Children with severe autism had significantly higher serum S100B protein than patients with mild to moderate autism (P = 0.01). Increased serum levels of antiribosomal P antibodies were found in 40.6% of autistic children. There were no significant correlations between serum levels of S100B protein and antiribosomal P antibodies (P = 0.29). CONCLUSIONS: S100B protein levels were elevated in autistic children and significantly correlated to autistic severity. This may indicate the presence of an underlying neuropathological condition in autistic patients. Antiribosomal P antibodies may not be a possible contributing factor to the elevated serum levels of S100B protein in some autistic children. However, further research is warranted to investigate the possible link between serum S100B protein levels and other autoantibodies, which are possible indicators of autoimmunity to central nervous system in autism.", "electronicPublicationDate": "2012-03-16", "license": "cc by", "dateOfCompletion": "2012-08-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3359166?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3359166", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22420334&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22420334", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1742-2094-9-54", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-06-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "Journal of neuroinflammation", "medlineAbbreviation": "J Neuroinflammation", "isoabbreviation": "J Neuroinflammation", "nlmid": "101222974", "essn": "1742-2094"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2012, "journalIssueId": 1902542, "dateOfPublication": "2012 "}}, "1417136": "", "25498354": {"pubYear": "2015", "dateOfCreation": "2015-02-14", "pubModel": "Print-Electronic", "authorString": "Simavli H, Que CJ, Akduman M, Rizzo JL, Tsikata E, de Boer JF, Chen TC.", "affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "UL1 RR025758"}]}, "hasPDF": "Y", "id": "25498354", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Huseyin", "lastName": "Simavli", "affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "authorId": {"type": "ORCID", "value": "0000-0003-1657-9099"}, "fullName": "Simavli H", "initials": "H"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "fullName": "Que CJ", "initials": "CJ", "firstName": "Christian John", "lastName": "Que"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "fullName": "Akduman M", "initials": "M", "firstName": "Mustafa", "lastName": "Akduman"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "fullName": "Rizzo JL", "initials": "JL", "firstName": "Jennifer L", "lastName": "Rizzo"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.", "fullName": "Tsikata E", "initials": "E", "firstName": "Edem", "lastName": "Tsikata"}, {"affiliation": "Department of Physics and Astronomy, Vrije Universiteit, Amsterdam, Netherlands.", "fullName": "de Boer JF", "initials": "JF", "firstName": "Johannes F", "lastName": "de Boer"}, {"affiliation": "Department of Ophthalmology, Harvard Medical School, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. Electronic address: teresa_chen@meei.harvard.edu.", "fullName": "Chen TC", "initials": "TC", "firstName": "Teresa C", "lastName": "Chen"}]}, "title": "Diagnostic capability of peripapillary retinal thickness in glaucoma using 3D volume scans.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25498354", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1657-9099"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Nerve Fibers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinal Ganglion Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Optic Disk", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Retina", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Open-Angle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "False Positive Reactions", "majorTopic_YN": "N"}, {"descriptorName": "Imaging, Three-Dimensional", "majorTopic_YN": "Y"}, {"descriptorName": "Tomography, Optical Coherence", "majorTopic_YN": "Y"}, {"descriptorName": "Area Under Curve", "majorTopic_YN": "N"}, {"descriptorName": "Sensitivity and Specificity", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Predictive Value of Tests", "majorTopic_YN": "N"}, {"descriptorName": "ROC Curve", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2016-03-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-12-09", "doi": "10.1016/j.ajo.2014.12.004", "isOpenAccess": "N", "pageInfo": "545-56.e2", "pmcid": "PMC4423415", "hasDbCrossReferences": "N", "abstractText": "To determine the diagnostic capability of spectral-domain optical coherence tomography (SD OCT) peripapillary retinal thickness (RT) measurements from 3-dimensional (3D) volume scans for primary open-angle glaucoma (POAG).Cross-sectional study.setting: Institutional. study population: 156 patients (89 POAG and 67 normal subjects). observation procedures: One eye of each subject was included. SD OCT peripapillary RT values from 3D volume scans were calculated for 4 quadrants of 3 different sized annuli. Peripapillary retinal nerve fiber layer (RNFL) thickness values were also determined. main outcome measures: Area under the receiver operating characteristic curve (AUROC) values, sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios.The top 5 RT AUROCs for all glaucoma patients and for a subset of early glaucoma patients were for the inferior quadrant of outer circumpapillary annulus of circular grid (OCA) 1 (0.959, 0.939), inferior quadrant of OCA2 (0.945, 0.921), superior quadrant of OCA1 (0.890, 0.811), inferior quadrant of OCA3 (0.887, 0.854), and superior quadrant of OCA2 (0.879, 0.807). Smaller RT annuli OCA1 and OCA2 consistently showed better diagnostic performance than the larger RT annulus OCA3. For both RNFL and RT measurements, best AUROC values were found for inferior RT OCA1 and OCA2, followed by inferior and overall RNFL thickness.Peripapillary RT measurements from 3D volume scans showed excellent diagnostic performance for detecting both glaucoma and early glaucoma patients. Peripapillary RT values have the same or better diagnostic capability compared to peripapillary RNFL thickness measurements, while also having fewer algorithm errors.", "electronicPublicationDate": "2014-12-09", "language": "eng", "dateOfCompletion": "2015-04-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4423415?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4423415", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.ajo.2014.12.004", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-01", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "Am J Ophthalmol", "isoabbreviation": "Am. J. Ophthalmol.", "title": "American journal of ophthalmology", "issn": "0002-9394", "nlmid": "0370500", "essn": "1879-1891"}, "monthOfPublication": 3, "volume": "159", "yearOfPublication": 2015, "journalIssueId": 2253917, "issue": "3", "dateOfPublication": "2015 Mar"}}, "23552370": {"pubYear": "2013", "dateOfCreation": "2013-04-04", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "2390-54-7", "name": "thioflavin T"}, {"registryNumber": "0", "name": "Blood Proteins"}, {"registryNumber": "0", "name": "Peptides"}, {"registryNumber": "0", "name": "Thiazoles"}, {"registryNumber": "0", "name": "Amyloid"}, {"registryNumber": "0", "name": "Molecular Chaperones"}, {"registryNumber": "0", "name": "Interleukin-6"}]}, "authorString": "Kurnellas MP, Adams CM, Sobel RA, Steinman L, Rothbard JB.", "affiliation": "Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5316, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "1R43AI0949"}, {"acronym": "DK", "orderIn": 0, "agency": "NIDDK NIH HHS", "grantId": "UO1DK078123"}, {"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "T32 AI007290"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01NS55997"}]}, "hasPDF": "Y", "id": "23552370", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Kurnellas", "fullName": "Kurnellas MP", "firstName": "Michael P", "initials": "MP"}, {"lastName": "Adams", "fullName": "Adams CM", "firstName": "Chris M", "initials": "CM"}, {"lastName": "Sobel", "fullName": "Sobel RA", "firstName": "Raymond A", "initials": "RA"}, {"lastName": "Steinman", "fullName": "Steinman L", "firstName": "Lawrence", "initials": "L"}, {"lastName": "Rothbard", "fullName": "Rothbard JB", "firstName": "Jonathan B", "initials": "JB"}]}, "title": "Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.", "hasSuppl": "Y", "citedByCount": 14, "pageInfo": "179ra42", "source": "MED", "pmid": "23552370", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Encephalomyelitis, Autoimmune, Experimental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Paralysis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}]}}, {"descriptorName": "Inflammation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Thiazoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blood Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Chaperones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Interleukin-6", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Biotinylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Hydrogen-Ion Concentration", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Protein Multimerization", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chemical Precipitation", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-04-01", "doi": "10.1126/scitranslmed.3005681", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 54, "type": "Comment in", "id": "23722340", "reference": "Nat Rev Drug Discov. 2013 Jun;12(6):421"}]}, "pmcid": "PMC3684024", "hasDbCrossReferences": "N", "abstractText": "The amyloid-forming proteins tau, \u03b1B crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS). Our previous work established that amyloidogenic peptides from the small heat shock protein \u03b1B crystallin (HspB5) and from amyloid \u03b2 fibrils, characteristic of Alzheimer's disease, were therapeutic in experimental autoimmune encephalomyelitis (EAE), reflecting aspects of the pathology of MS. To understand the molecular basis for the therapeutic effect, we showed a set of amyloidogenic peptides composed of six amino acids, including those from tau, amyloid \u03b2 A4, major prion protein (PrP), HspB5, amylin, serum amyloid P, and insulin B chain, to be anti-inflammatory and capable of reducing serological levels of interleukin-6 and attenuating paralysis in EAE. The chaperone function of the fibrils correlates with the therapeutic outcome. Fibrils composed of tau 623-628 precipitated 49 plasma proteins, including apolipoprotein B-100, clusterin, transthyretin, and complement C3, supporting the hypothesis that the fibrils are active biological agents. Amyloid fibrils thus may provide benefit in MS and other neuroinflammatory disorders.", "language": "eng", "dateOfCompletion": "2013-09-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3684024?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3684024", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23552370&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23552370", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1126/scitranslmed.3005681", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-04-01", "journal": {"medlineAbbreviation": "Sci Transl Med", "isoabbreviation": "Sci Transl Med", "title": "Science translational medicine", "issn": "1946-6234", "nlmid": "101505086", "essn": "1946-6242"}, "monthOfPublication": 4, "volume": "5", "yearOfPublication": 2013, "journalIssueId": 2026399, "issue": "179", "dateOfPublication": "2013 Apr"}}, "9268312": "", "3531224": "", "19171463": {"pubYear": "2009", "dateOfCreation": "2009-03-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antibodies"}, {"registryNumber": "0", "name": "Ribosomal Proteins"}]}, "authorString": "Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A.", "affiliation": "Department of Neurosciences, University of Padova, Padova, Italy. chiara.briani@unipd.it", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "19171463", "inEPMC": "N", "authorList": {"author": [{"lastName": "Briani", "fullName": "Briani C", "firstName": "C", "initials": "C"}, {"lastName": "Lucchetta", "fullName": "Lucchetta M", "firstName": "M", "initials": "M"}, {"lastName": "Ghirardello", "fullName": "Ghirardello A", "firstName": "A", "initials": "A"}, {"lastName": "Toffanin", "fullName": "Toffanin E", "firstName": "E", "initials": "E"}, {"lastName": "Zampieri", "fullName": "Zampieri S", "firstName": "S", "initials": "S"}, {"lastName": "Ruggero", "fullName": "Ruggero S", "firstName": "S", "initials": "S"}, {"lastName": "Scarlato", "fullName": "Scarlato M", "authorId": {"type": "ORCID", "value": "0000-0003-1060-8207"}, "firstName": "M", "initials": "M"}, {"lastName": "Quattrini", "fullName": "Quattrini A", "firstName": "A", "initials": "A"}, {"lastName": "Bassi", "fullName": "Bassi N", "firstName": "N", "initials": "N"}, {"lastName": "Ermani", "fullName": "Ermani M", "firstName": "M", "initials": "M"}, {"lastName": "Battistin", "fullName": "Battistin L", "firstName": "L", "initials": "L"}, {"lastName": "Doria", "fullName": "Doria A", "authorId": {"type": "ORCID", "value": "0000-0003-0548-4983"}, "firstName": "A", "initials": "A"}]}, "title": "Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study.", "citedByCount": 22, "source": "MED", "pmid": "19171463", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1060-8207"}, {"type": "ORCID", "value": "0000-0003-0548-4983"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lupus Vasculitis, Central Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CF", "qualifierName": "cerebrospinal fluid", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ribosomal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antibodies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CF", "qualifierName": "cerebrospinal fluid", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-01-25", "doi": "10.1016/j.jaut.2008.12.002", "isOpenAccess": "N", "pageInfo": "79-84", "hasDbCrossReferences": "N", "abstractText": " OBJECTIVE: Serum IgG antibodies (Abs) to phosphorylated ribosomal (P ribosomal) proteins have been inconsistently associated with neuropsychiatric manifestations in systemic lupus erythematosus (SLE). Our aim was to assess whether serum IgG Abs to ribosomal P proteins are associated with neuropsychiatric SLE. PATIENTS AND METHODS: We examined an inception cohort of 219 SLE patients. Neuropsychiatric SLE manifestations were characterized using the American College of Rheumatology (ACR) definition. Serum Abs to P ribosomal proteins were searched for by immunoblotting. In a subgroup of patients, Abs were investigated also in cerebrospinal fluid (CSF). RESULTS: Abs to P ribosomal proteins were detected in 45 (21%) patients, 23 of whom (51%) with neuropsychiatric involvement. Abs to P ribosomal protein were present both in serum and CSF. Abs to P ribosomal proteins significantly correlated with psychosis (p=0.017), mononeuropathy multiplex (p=0.040), malar rash (p=0.004), serum anti-Sm Abs (p=0.042), and lupus anticoagulant (p=0.036). SLE onset age was significantly younger in patients with Abs to P ribosomal proteins. Logistic regression analysis confirmed the relationship between Abs to P ribosomal proteins and psychosis, malar rash, SLE onset age and lupus anticoagulant. CONCLUSIONS: Abs to ribosomal P proteins are associated with psychosis and might be associated with peripheral nervous system complications.", "electronicPublicationDate": "2009-01-25", "language": "eng", "dateOfCompletion": "2009-06-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jaut.2008.12.002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-03-01", "journal": {"medlineAbbreviation": "J Autoimmun", "isoabbreviation": "J. Autoimmun.", "title": "Journal of autoimmunity", "issn": "0896-8411", "nlmid": "8812164", "essn": "1095-9157"}, "monthOfPublication": 3, "volume": "32", "yearOfPublication": 2009, "journalIssueId": 1606704, "issue": "2", "dateOfPublication": "2009 Mar"}}, "8630119": "", "3496538": ""}, "LAMC1": {"8733130": {"pubYear": "1996", "dateOfCreation": "1997-06-04", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "laminin gamma 1"}, {"registryNumber": "0", "name": "DGCR6 protein, human"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "0", "name": "Extracellular Matrix Proteins"}, {"registryNumber": "0", "name": "Laminin"}]}, "authorString": "Demczuk S, Thomas G, Aurias A.", "affiliation": "INSERM U434, Institut Curie, Paris, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "8733130", "inEPMC": "N", "authorList": {"author": [{"lastName": "Demczuk", "fullName": "Demczuk S", "initials": "S"}, {"lastName": "Thomas", "fullName": "Thomas G", "initials": "G"}, {"lastName": "Aurias", "fullName": "Aurias A", "initials": "A"}]}, "title": "Isolation of a novel gene from the DiGeorge syndrome critical region with homology to Drosophila gdl and to human LAMC1 genes.", "citedByCount": 18, "source": "MED", "pmid": "8733130", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Drosophila melanogaster", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DiGeorge Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Laminin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Extracellular Matrix Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Northern", "majorTopic_YN": "N"}, {"descriptorName": "Blotting, Southern", "majorTopic_YN": "N"}, {"descriptorName": "Chromosome Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Conserved Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology, Amino Acid", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology, Nucleic Acid", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Cosmids", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Databases, Factual", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["EMBL", "INTERPRO", "OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1996-05-01", "doi": "10.1093/hmg/5.5.633", "isOpenAccess": "N", "pageInfo": "633-638", "hasDbCrossReferences": "Y", "abstractText": "DiGeorge syndrome, and more widely the CATCH 22 syndrome, are associated with microdeletions in chromosomal region 22q11.2. A critical region of 500 kb has been delimited within which maps the breakpoint of a balanced translocation associated with mild CATCH 22 phenotypes. We report the isolation from this critical region of a novel gene, DGCR6, which maps 115 kb centromeric to the balanced translocation breakpoint. The DGCR6 gene product shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ-line cells development, and with the human laminin. gamma-1 chain, which upon polymerization with alpha- and beta- chains forms the laminin molecule. Laminin binds to cells through interaction with a receptor and has functions in cell attachment, migration and tissue organization during development. DGCR6 could be a candidate for involvement in the DiGeorge syndrome pathology by playing a role in neural crest cell migration into the third and fourth pharyngeal pouches, the structures from which derive the organs affected in DiGeorge syndrome.", "language": "eng", "dateOfCompletion": "1997-06-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1093/hmg/5.5.633", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "oxfordjournals.org"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "1996-05-01", "journal": {"medlineAbbreviation": "Hum Mol Genet", "isoabbreviation": "Hum. Mol. Genet.", "title": "Human molecular genetics", "issn": "0964-6906", "nlmid": "9208958", "essn": "1460-2083"}, "monthOfPublication": 5, "volume": "5", "yearOfPublication": 1996, "journalIssueId": 948824, "issue": "5", "dateOfPublication": "1996 May"}}}, "SASH1": {"25940791": {"pubYear": "2015", "dateOfCreation": "2015-08-18", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "KLHL6 protein, human"}, {"registryNumber": "0", "name": "SASH1 protein, human"}, {"registryNumber": "0", "name": "Carrier Proteins"}, {"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "kelch-like protein 24, human"}]}, "authorString": "Basson J, Sung YJ, de las Fuentes L, Schwander K, Cupples LA, Rao DC.", "affiliation": "Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "K25 HL121091"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "K25HL121091"}, {"acronym": "HC", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "N01-HC-25195"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "T32 HL091823"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01 HL107552"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "R01 HL118305"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "N02-HL-64278"}]}, "hasPDF": "N", "id": "25940791", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "fullName": "Basson J", "initials": "J", "firstName": "Jacob", "lastName": "Basson"}, {"affiliation": "Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "fullName": "Sung YJ", "initials": "YJ", "firstName": "Yun Ju", "lastName": "Sung"}, {"affiliation": "Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "fullName": "de las Fuentes L", "initials": "L", "firstName": "Lisa", "lastName": "de las Fuentes"}, {"affiliation": "Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "fullName": "Schwander K", "initials": "K", "firstName": "Karen", "lastName": "Schwander"}, {"affiliation": "Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.", "fullName": "Cupples LA", "initials": "LA", "firstName": "L Adrienne", "lastName": "Cupples"}, {"affiliation": "Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.", "fullName": "Rao DC", "initials": "DC", "firstName": "Dabeeru C", "lastName": "Rao"}]}, "title": "Influence of Smoking Status and Intensity on Discovery of Blood Pressure Loci Through Gene-Smoking Interactions.", "citedByCount": 0, "source": "MED", "pmid": "25940791", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Tobacco Use Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carrier Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blood Pressure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Loci", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2016-09-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-03", "doi": "10.1002/gepi.21904", "isOpenAccess": "N", "pageInfo": "480-488", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Blood pressure", "Smoking", "Gene Interactions", "Cardiovascular Genetics"]}, "abstractText": "Genetic variation accounts for approximately 30% of blood pressure (BP) variability but most of that variability has not been attributed to specific variants. Interactions between genes and BP-associated factors may explain some \"missing heritability.\" Cigarette smoking increases BP after short-term exposure and decreases BP with longer exposure. Gene-smoking interactions have discovered novel BP loci, but the contribution of smoking status and intensity to gene discovery is unknown.We analyzed gene-smoking intensity interactions for association with systolic BP (SBP) in three subgroups from the Framingham Heart Study: current smokers only (N = 1,057), current and former smokers (\"ever smokers,\" N = 3,374), and all subjects (N = 6,710). We used three smoking intensity variables defined at cutoffs of 10, 15, and 20 cigarettes per day (CPD). We evaluated the 1 degree-of-freedom (df) interaction and 2df joint test using generalized estimating equations.Analysis of current smokers using a CPD cutoff of 10 produced two loci associated with SBP. The rs9399633 minor allele was associated with increased SBP (5 mmHg) in heavy smokers (CPD > 10) but decreased SBP (7 mmHg) in light smokers (CPD \u2264 10). The rs11717948 minor allele was associated with decreased SBP (8 mmHg) in light smokers but decreased SBP (2 mmHg) in heavy smokers. Across all nine analyses, 19 additional loci reached P < 1 \u00d7 10(-6).Analysis of current smokers may have the highest power to detect gene-smoking interactions, despite the reduced sample size. Associations of loci near SASH1 and KLHL6/KLHL24 with SBP may be modulated by tobacco smoking.", "electronicPublicationDate": "2015-05-03", "language": "eng", "dateOfCompletion": "2016-03-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/gepi.21904", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2015-08-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-09-01", "journal": {"medlineAbbreviation": "Genet Epidemiol", "isoabbreviation": "Genet. Epidemiol.", "title": "Genetic epidemiology", "issn": "0741-0395", "nlmid": "8411723", "essn": "1098-2272"}, "monthOfPublication": 9, "volume": "39", "yearOfPublication": 2015, "journalIssueId": 2315163, "issue": "6", "dateOfPublication": "2015 Sep"}}, "26318107": {"pubYear": "2015", "dateOfCreation": "2015-09-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "SASH1 protein, human"}, {"registryNumber": "EC 1.14.14.1", "name": "Cytochrome P-450 CYP1A1"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "136601-57-5", "name": "Cyclin D1"}, {"registryNumber": "0", "name": "RNA, Small Interfering"}, {"registryNumber": "0", "name": "Tumor Suppressor Protein p53"}, {"registryNumber": "0", "name": "TP53 protein, human"}, {"registryNumber": "0", "name": "CCND1 protein, human"}, {"registryNumber": "0", "name": "Cyclin D3"}, {"registryNumber": "0", "name": "CCND3 protein, human"}, {"registryNumber": "EC 1.14.14.1", "name": "CYP1A1 protein, human"}]}, "authorString": "Weidmann H, Touat-Hamici Z, Durand H, Mueller C, Chardonnet S, Pionneau C, Charlotte F, Janssen KP, Verdugo R, Cambien F, Blankenberg S, Tiret L, Zeller T, Ninio E.", "affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France; University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; German Center for Cardiovascular Research (DZHK e.V.) Partner Site Hamburg, L\u00fcbeck, Kiel, Hamburg, Germany. Electronic address: h.weide@hotmail.fr.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "26318107", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France; University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; German Center for Cardiovascular Research (DZHK e.V.) Partner Site Hamburg, L\u00fcbeck, Kiel, Hamburg, Germany. Electronic address: h.weide@hotmail.fr.", "fullName": "Weidmann H", "initials": "H", "firstName": "Henri", "lastName": "Weidmann"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France.", "fullName": "Touat-Hamici Z", "initials": "Z", "firstName": "Zahia", "lastName": "Touat-Hamici"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France.", "fullName": "Durand H", "initials": "H", "firstName": "Herve", "lastName": "Durand"}, {"affiliation": "University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; German Center for Cardiovascular Research (DZHK e.V.) Partner Site Hamburg, L\u00fcbeck, Kiel, Hamburg, Germany.", "fullName": "Mueller C", "initials": "C", "firstName": "Christian", "lastName": "Mueller"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMS_2 Omique, Plateforme P3S, F-75005, Paris, France; INSERM, UMS 29 Omique, Plateforme P3S, F-75005, Paris, France.", "fullName": "Chardonnet S", "initials": "S", "firstName": "Solenne", "lastName": "Chardonnet"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMS_2 Omique, Plateforme P3S, F-75005, Paris, France; INSERM, UMS 29 Omique, Plateforme P3S, F-75005, Paris, France.", "fullName": "Pionneau C", "initials": "C", "firstName": "Cedric", "lastName": "Pionneau"}, {"affiliation": "Department of Pathology, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Paris, France.", "fullName": "Charlotte F", "initials": "F", "firstName": "Fr\u00e9d\u00e9ric", "lastName": "Charlotte"}, {"affiliation": "Department of Surgery, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, IsmaningerStrasse 22, Munich, Germany.", "fullName": "Janssen KP", "initials": "KP", "firstName": "Klaus-Peter", "lastName": "Janssen"}, {"affiliation": "Programa de Genetica Humana ICBM, Facultad de Medicina, Universidad de Chile, Chile.", "fullName": "Verdugo R", "initials": "R", "firstName": "Ricardo", "lastName": "Verdugo"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France.", "fullName": "Cambien F", "initials": "F", "firstName": "Francois", "lastName": "Cambien"}, {"affiliation": "University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; German Center for Cardiovascular Research (DZHK e.V.) Partner Site Hamburg, L\u00fcbeck, Kiel, Hamburg, Germany.", "fullName": "Blankenberg S", "initials": "S", "firstName": "Stefan", "lastName": "Blankenberg"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France.", "fullName": "Tiret L", "initials": "L", "firstName": "Laurence", "lastName": "Tiret"}, {"affiliation": "University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany; German Center for Cardiovascular Research (DZHK e.V.) Partner Site Hamburg, L\u00fcbeck, Kiel, Hamburg, Germany.", "fullName": "Zeller T", "initials": "T", "firstName": "Tanja", "lastName": "Zeller"}, {"affiliation": "Sorbonne Universit\u00e9s, UPMC, UMR_S 1166-ICAN, Genomics and Pathophysiology of Cardiovascular Diseases, Institute of Cardiometabolism and Nutrition, ICAN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France. Electronic address: ewa.ninio@upmc.fr.", "fullName": "Ninio E", "initials": "E", "firstName": "Ewa", "lastName": "Ninio"}]}, "title": "SASH1, a new potential link between smoking and atherosclerosis.", "citedByCount": 0, "source": "MED", "pmid": "26318107", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Aorta", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Endothelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neovascularization, Pathologic", "majorTopic_YN": "N"}, {"descriptorName": "Cytochrome P-450 CYP1A1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin D1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Small Interfering", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle", "majorTopic_YN": "N"}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N"}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Silencing", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Tumor Suppressor Protein p53", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Atherosclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin D3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcriptome", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-14", "doi": "10.1016/j.atherosclerosis.2015.08.013", "isOpenAccess": "N", "pageInfo": "571-579", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Atherosclerosis", "Smoking", "Ccnd1", "Tp53", "Ccnd3", "Sash1"]}, "abstractText": "We have previously reported that SASH1 expression is increased in circulating human monocytes from smokers and was positively correlated with the number of carotid atherosclerotic plaques. The aim of this study was to further validate the link between smoking, SASH1 and atherosclerosis within the vascular wall and to assess the impact of SASH1 expression on endothelial cell functions.Human carotids with atherosclerotic plaques were obtained from 58 patients (45 of them with known smoking status: smoker, non-smoker, ex-smokers), and were processed for gene expression analyses and immunostaining. To investigate its function, SASH1 was silenced in human aortic endothelial cells (HAECs) using two different siRNA and subcellular localization of SASH1 was determined by immunostaining and subcellular fractionation. Subsequently the transcriptomic analyses and functional experiments (wound healing, WST-1 proliferation or Matrigel assays) were performed to characterize SASH1 function.SASH1 was expressed in human vascular cells (HAECs, smooth muscle cells) and in monocytes/macrophages. Its tissue expression was significantly higher in the atherosclerotic carotids of smokers compared to non-smokers (p < 0.01). In HAECs, SASH1 was expressed mostly in the cytoplasm and SASH1 knockdown resulted in an increased cell migration, proliferation and angiogenesis. Transcriptomic and pathway analyses showed that SASH1 silencing results in a decreased CYP1A1 expression possibly through the inhibition of TP53 activity.We showed that SASH1 expression is increased in atherosclerotic carotids in smokers and its silencing affects endothelial angiogenic functions; therefore we provide a potential link between smoking and atherosclerosis through SASH1 expression.", "electronicPublicationDate": "2015-08-14", "language": "eng", "dateOfCompletion": "2016-08-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.atherosclerosis.2015.08.013", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-10-01", "journal": {"medlineAbbreviation": "Atherosclerosis", "isoabbreviation": "Atherosclerosis", "title": "Atherosclerosis", "issn": "0021-9150", "nlmid": "0242543", "essn": "1879-1484"}, "monthOfPublication": 10, "volume": "242", "yearOfPublication": 2015, "journalIssueId": 2325341, "issue": "2", "dateOfPublication": "2015 Oct"}}, "23372645": {"pubYear": "2013", "dateOfCreation": "2013-02-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "growth arrest-specific protein 6"}, {"registryNumber": "0", "name": "SASH1 protein, human"}, {"registryNumber": "0", "name": "Cation Transport Proteins"}, {"registryNumber": "0", "name": "Intercellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "PPAR gamma"}, {"registryNumber": "0", "name": "Zip8 protein, human"}]}, "authorString": "Verdugo RA, Zeller T, Rotival M, Wild PS, M\u00fcnzel T, Lackner KJ, Weidmann H, Ninio E, Tr\u00e9gou\u00ebt DA, Cambien F, Blankenberg S, Tiret L.", "affiliation": "INSERM UMR_S 937, Pierre and Marie Curie University, Paris, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23372645", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Verdugo", "fullName": "Verdugo RA", "firstName": "Ricardo A", "initials": "RA"}, {"lastName": "Zeller", "fullName": "Zeller T", "firstName": "Tanja", "initials": "T"}, {"lastName": "Rotival", "fullName": "Rotival M", "authorId": {"type": "ORCID", "value": "0000-0003-2519-8044"}, "firstName": "Maxime", "initials": "M"}, {"lastName": "Wild", "fullName": "Wild PS", "firstName": "Philipp S", "initials": "PS"}, {"lastName": "M\u00fcnzel", "fullName": "M\u00fcnzel T", "firstName": "Thomas", "initials": "T"}, {"lastName": "Lackner", "fullName": "Lackner KJ", "firstName": "Karl J", "initials": "KJ"}, {"lastName": "Weidmann", "fullName": "Weidmann H", "firstName": "Henri", "initials": "H"}, {"lastName": "Ninio", "fullName": "Ninio E", "firstName": "Ewa", "initials": "E"}, {"lastName": "Tr\u00e9gou\u00ebt", "fullName": "Tr\u00e9gou\u00ebt DA", "firstName": "David-Alexandre", "initials": "DA"}, {"lastName": "Cambien", "fullName": "Cambien F", "firstName": "Fran\u00e7ois", "initials": "F"}, {"lastName": "Blankenberg", "fullName": "Blankenberg S", "firstName": "Stefan", "initials": "S"}, {"lastName": "Tiret", "fullName": "Tiret L", "firstName": "Laurence", "initials": "L"}]}, "title": "Graphical modeling of gene expression in monocytes suggests molecular mechanisms explaining increased atherosclerosis in smokers.", "hasSuppl": "Y", "citedByCount": 3, "source": "MED", "pmid": "23372645", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2519-8044"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Carotid Arteries", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Monocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Intercellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cation Transport Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "PPAR gamma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Likelihood Functions", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "Y"}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Multigene Family", "majorTopic_YN": "N"}, {"descriptorName": "Algorithms", "majorTopic_YN": "N"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Atherosclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Plaque, Atherosclerotic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Transcriptome", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-23", "doi": "10.1371/journal.pone.0050888", "isOpenAccess": "Y", "pageInfo": "e50888", "pmcid": "PMC3553098", "hasDbCrossReferences": "N", "abstractText": "Smoking is a risk factor for atherosclerosis with reported widespread effects on gene expression in circulating blood cells. We hypothesized that a molecular signature mediating the relation between smoking and atherosclerosis may be found in the transcriptome of circulating monocytes. Genome-wide expression profiles and counts of atherosclerotic plaques in carotid arteries were collected in 248 smokers and 688 non-smokers from the general population. Patterns of co-expressed genes were identified by Independent Component Analysis (ICA) and network structure of the pattern-specific gene modules was inferred by the PC-algorithm. A likelihood-based causality test was implemented to select patterns that fit models containing a path \"smoking\u2192gene expression\u2192plaques\". Robustness of the causal inference was assessed by bootstrapping. At a FDR \u22640.10, 3,368 genes were associated to smoking or plaques, of which 93% were associated to smoking only. SASH1 showed the strongest association to smoking and PPARG the strongest association to plaques. Twenty-nine gene patterns were identified by ICA. Modules containing SASH1 and PPARG did not show evidence for the \"smoking\u2192gene expression\u2192plaques\" causality model. Conversely, three modules had good support for causal effects and exhibited a network topology consistent with gene expression mediating the relation between smoking and plaques. The network with the strongest support for causal effects was connected to plaques through SLC39A8, a gene with known association to HDL-cholesterol and cellular uptake of cadmium from tobacco, while smoking was directly connected to GAS6, a gene reported to have anti-inflammatory effects in atherosclerosis and to be up-regulated in the placenta of women smoking during pregnancy. Our analysis of the transcriptome of monocytes recovered genes relevant for association to smoking and atherosclerosis, and connected genes that before, were only studied in separate contexts. Inspection of correlation structure revealed candidates that would be missed by expression-phenotype association analysis alone.", "electronicPublicationDate": "2013-01-23", "language": "eng", "dateOfCompletion": "2013-07-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3553098?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3553098", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23372645&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23372645", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0050888", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 1999585, "issue": "1", "dateOfPublication": "2013 "}}, "20502693": {"pubYear": "2010", "dateOfCreation": "2010-05-26", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "DNA Probes"}]}, "authorString": "Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, Maouche S, Germain M, Lackner K, Rossmann H, Eleftheriadis M, Sinning CR, Schnabel RB, Lubos E, Mennerich D, Rust W, Perret C, Proust C, Nicaud V, Loscalzo J, H\u00fcbner N, Tregouet D, M\u00fcnzel T, Ziegler A, Tiret L, Blankenberg S, Cambien F.", "affiliation": "Medizinische Klinik und Poliklinik, Johannes-Gutenberg Universit\u00e4t Mainz, Mainz, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "20502693", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zeller", "fullName": "Zeller T", "firstName": "Tanja", "initials": "T"}, {"lastName": "Wild", "fullName": "Wild P", "firstName": "Philipp", "initials": "P"}, {"lastName": "Szymczak", "fullName": "Szymczak S", "firstName": "Silke", "initials": "S"}, {"lastName": "Rotival", "fullName": "Rotival M", "authorId": {"type": "ORCID", "value": "0000-0003-2519-8044"}, "firstName": "Maxime", "initials": "M"}, {"lastName": "Schillert", "fullName": "Schillert A", "firstName": "Arne", "initials": "A"}, {"lastName": "Castagne", "fullName": "Castagne R", "firstName": "Raphaele", "initials": "R"}, {"lastName": "Maouche", "fullName": "Maouche S", "authorId": {"type": "ORCID", "value": "0000-0001-8186-1635"}, "firstName": "Seraya", "initials": "S"}, {"lastName": "Germain", "fullName": "Germain M", "firstName": "Marine", "initials": "M"}, {"lastName": "Lackner", "fullName": "Lackner K", "firstName": "Karl", "initials": "K"}, {"lastName": "Rossmann", "fullName": "Rossmann H", "firstName": "Heidi", "initials": "H"}, {"lastName": "Eleftheriadis", "fullName": "Eleftheriadis M", "firstName": "Medea", "initials": "M"}, {"lastName": "Sinning", "fullName": "Sinning CR", "firstName": "Christoph R", "initials": "CR"}, {"lastName": "Schnabel", "fullName": "Schnabel RB", "firstName": "Renate B", "initials": "RB"}, {"lastName": "Lubos", "fullName": "Lubos E", "firstName": "Edith", "initials": "E"}, {"lastName": "Mennerich", "fullName": "Mennerich D", "firstName": "Detlev", "initials": "D"}, {"lastName": "Rust", "fullName": "Rust W", "firstName": "Werner", "initials": "W"}, {"lastName": "Perret", "fullName": "Perret C", "firstName": "Claire", "initials": "C"}, {"lastName": "Proust", "fullName": "Proust C", "firstName": "Carole", "initials": "C"}, {"lastName": "Nicaud", "fullName": "Nicaud V", "firstName": "Viviane", "initials": "V"}, {"lastName": "Loscalzo", "fullName": "Loscalzo J", "firstName": "Joseph", "initials": "J"}, {"lastName": "H\u00fcbner", "fullName": "H\u00fcbner N", "firstName": "Norbert", "initials": "N"}, {"lastName": "Tregouet", "fullName": "Tregouet D", "firstName": "David", "initials": "D"}, {"lastName": "M\u00fcnzel", "fullName": "M\u00fcnzel T", "firstName": "Thomas", "initials": "T"}, {"lastName": "Ziegler", "fullName": "Ziegler A", "authorId": {"type": "ORCID", "value": "0000-0002-8386-5397"}, "firstName": "Andreas", "initials": "A"}, {"lastName": "Tiret", "fullName": "Tiret L", "firstName": "Laurence", "initials": "L"}, {"lastName": "Blankenberg", "fullName": "Blankenberg S", "firstName": "Stefan", "initials": "S"}, {"lastName": "Cambien", "fullName": "Cambien F", "firstName": "Fran\u00e7ois", "initials": "F"}]}, "title": "Genetics and beyond--the transcriptome of human monocytes and disease susceptibility.", "hasSuppl": "Y", "citedByCount": 282, "source": "MED", "pmid": "20502693", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-2519-8044"}, {"type": "ORCID", "value": "0000-0001-8186-1635"}, {"type": "ORCID", "value": "0000-0002-8386-5397"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Monocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromosomes, Human, Pair 21", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "DNA Probes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "Y"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Immunity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Quantitative Trait, Heritable", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Quantitative Trait Loci", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome, Human", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Atherosclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2010-05-18", "doi": "10.1371/journal.pone.0010693", "isOpenAccess": "Y", "pageInfo": "e10693", "pmcid": "PMC2872668", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Variability of gene expression in human may link gene sequence variability and phenotypes; however, non-genetic variations, alone or in combination with genetics, may also influence expression traits and have a critical role in physiological and disease processes. METHODOLOGY/PRINCIPAL FINDINGS: To get better insight into the overall variability of gene expression, we assessed the transcriptome of circulating monocytes, a key cell involved in immunity-related diseases and atherosclerosis, in 1,490 unrelated individuals and investigated its association with >675,000 SNPs and 10 common cardiovascular risk factors. Out of 12,808 expressed genes, 2,745 expression quantitative trait loci were detected (P<5.78x10(-12)), most of them (90%) being cis-modulated. Extensive analyses showed that associations identified by genome-wide association studies of lipids, body mass index or blood pressure were rarely compatible with a mediation by monocyte expression level at the locus. At a study-wide level (P<3.9x10(-7)), 1,662 expression traits (13.0%) were significantly associated with at least one risk factor. Genome-wide interaction analyses suggested that genetic variability and risk factors mostly acted additively on gene expression. Because of the structure of correlation among expression traits, the variability of risk factors could be characterized by a limited set of independent gene expressions which may have biological and clinical relevance. For example expression traits associated with cigarette smoking were more strongly associated with carotid atherosclerosis than smoking itself. CONCLUSIONS/SIGNIFICANCE: This study demonstrates that the monocyte transcriptome is a potent integrator of genetic and non-genetic influences of relevance for disease pathophysiology and risk assessment.", "electronicPublicationDate": "2010-05-18", "language": "eng", "dateOfCompletion": "2010-09-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2872668?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2872668", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20502693&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20502693", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0010693", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-29", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "5", "yearOfPublication": 2010, "journalIssueId": 1729779, "issue": "5", "dateOfPublication": "2010 "}}}, "CCNB2": {"19223528": {"pubYear": "2009", "dateOfCreation": "2009-03-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "cyclin B2"}, {"registryNumber": "0", "name": "HMGA2 Protein"}, {"registryNumber": "0", "name": "Cyclin B"}, {"registryNumber": "124544-67-8", "name": "HMGA1a Protein"}, {"registryNumber": "0", "name": "CCNB2 protein, human"}, {"registryNumber": "0", "name": "Ccnb2 protein, mouse"}]}, "authorString": "De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, Trouillas J, Fedele M, Fusco A.", "affiliation": "Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facolt\u00e0 di Medicina e Chirurgia di Napoli, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19223528", "inEPMC": "N", "authorList": {"author": [{"lastName": "De Martino", "fullName": "De Martino I", "firstName": "Ivana", "initials": "I"}, {"lastName": "Visone", "fullName": "Visone R", "firstName": "Rosa", "initials": "R"}, {"lastName": "Wierinckx", "fullName": "Wierinckx A", "authorId": {"type": "ORCID", "value": "0000-0002-0186-6645"}, "firstName": "Anne", "initials": "A"}, {"lastName": "Palmieri", "fullName": "Palmieri D", "firstName": "Dario", "initials": "D"}, {"lastName": "Ferraro", "fullName": "Ferraro A", "authorId": {"type": "ORCID", "value": "0000-0002-2044-7569"}, "firstName": "Angelo", "initials": "A"}, {"lastName": "Cappabianca", "fullName": "Cappabianca P", "authorId": {"type": "ORCID", "value": "0000-0001-8277-498X"}, "firstName": "Paolo", "initials": "P"}, {"lastName": "Chiappetta", "fullName": "Chiappetta G", "firstName": "Gennaro", "initials": "G"}, {"lastName": "Forzati", "fullName": "Forzati F", "firstName": "Floriana", "initials": "F"}, {"lastName": "Lombardi", "fullName": "Lombardi G", "firstName": "Gaetano", "initials": "G"}, {"lastName": "Colao", "fullName": "Colao A", "firstName": "Annamaria", "initials": "A"}, {"lastName": "Trouillas", "fullName": "Trouillas J", "firstName": "Jacqueline", "initials": "J"}, {"lastName": "Fedele", "fullName": "Fedele M", "firstName": "Monica", "initials": "M"}, {"lastName": "Fusco", "fullName": "Fusco A", "authorId": {"type": "ORCID", "value": "0000-0003-3332-5197"}, "firstName": "Alfredo", "initials": "A"}]}, "title": "HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.", "citedByCount": 30, "source": "MED", "pmid": "19223528", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0186-6645"}, {"type": "ORCID", "value": "0000-0002-2044-7569"}, {"type": "ORCID", "value": "0000-0001-8277-498X"}, {"type": "ORCID", "value": "0000-0003-3332-5197"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "NIH 3T3 Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Adenoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pituitary Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cyclin B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HMGA1a Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "HMGA2 Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "Y"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Cyclin B2", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2009-02-17", "doi": "10.1158/0008-5472.can-08-4133", "isOpenAccess": "N", "pageInfo": "1844-1850", "hasDbCrossReferences": "Y", "abstractText": "The high mobility group As (HMGAs) belong to a family of nonhistone nuclear proteins that orchestrate the assembly of nucleoprotein complexes. Through a complex network of protein-DNA and protein-protein interaction, they play important roles in gene transcription, recombination, and chromatin structure. This protein family is involved, through different mechanisms, in both benign and malignant neoplasias. We have recently reported that transgenic mice carrying the Hmga1 or Hmga2 genes under transcriptional control of the cytomegalovirus promoter develop pituitary adenomas secreting prolactin and growth hormone. We have shown that the mechanism of the HMGA2-induced pituitary adenoma is based on the increased E2F1 activity. The expression profile of mouse normal pituitary glands and adenomas induced in HMGA transgenic mice revealed an increased expression of the ccnb2 gene, coding for the cyclin B2 protein, in the neoplastic tissues compared with the normal pituitary gland. Here, we show, by electrophoretic mobility shift assay and chromatin immunoprecipitation, a direct binding of HMGA proteins to the promoter of ccnb2 gene, whereas luciferase assays showed that HMGAs are able to up-regulate ccnb2 promoter activity. Finally, we report an increased CCNB2 expression in human pituitary adenomas of different histotypes that is directly correlated with HMGA1 and HMGA2 expression. Because cyclin B2 is involved in the regulation of the cell cycle, these results taken together indicate that HMGA-induced cyclin B2 overexpression gives an important contribution to experimental and human pituitary tumorigenesis.", "electronicPublicationDate": "2009-02-17", "language": "eng", "dateOfCompletion": "2009-03-20", "fullTextUrlList": {"fullTextUrl": [{"url": "http://cancerres.aacrjournals.org/cgi/content/abstract/69/5/1844", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "cancerres.aacrjournals.org"}, {"url": "http://cancerres.aacrjournals.org/cgi/content/full/69/5/1844", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "cancerres.aacrjournals.org"}, {"url": "http://dx.doi.org/10.1158/0008-5472.CAN-08-4133", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-03-01", "journal": {"medlineAbbreviation": "Cancer Res", "isoabbreviation": "Cancer Res.", "title": "Cancer research", "issn": "0008-5472", "nlmid": "2984705R", "essn": "1538-7445"}, "monthOfPublication": 3, "volume": "69", "yearOfPublication": 2009, "journalIssueId": 1601800, "issue": "5", "dateOfPublication": "2009 Mar"}}, "23335992": {"pubYear": "2013", "dateOfCreation": "2013-01-21", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "cyclin B1"}, {"registryNumber": "0", "name": "H2AFX protein, human"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Culture Media"}, {"registryNumber": "0", "name": "Actins"}, {"registryNumber": "0", "name": "Histones"}, {"registryNumber": "125361-02-6", "name": "Vinculin"}, {"registryNumber": "0", "name": "Reactive Oxygen Species"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "0", "name": "TP53BP1 protein, human"}, {"registryNumber": "EC 3.1.3.48", "name": "cdc25 Phosphatases"}, {"registryNumber": "EC 2.7.11.22", "name": "CDC2 Protein Kinase"}]}, "authorString": "Chang HY, Shih MH, Huang HC, Tsai SR, Juan HF, Lee SC.", "affiliation": "Department of Life Science, Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, Taiwan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "23335992", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Chang", "fullName": "Chang HY", "firstName": "Hsin-Yi", "initials": "HY"}, {"lastName": "Shih", "fullName": "Shih MH", "firstName": "Meng-Her", "initials": "MH"}, {"lastName": "Huang", "fullName": "Huang HC", "authorId": {"type": "ORCID", "value": "0000-0002-3386-0934"}, "firstName": "Hsuan-Cheng", "initials": "HC"}, {"lastName": "Tsai", "fullName": "Tsai SR", "firstName": "Shang-Ru", "initials": "SR"}, {"lastName": "Juan", "fullName": "Juan HF", "authorId": {"type": "ORCID", "value": "0000-0003-4876-3309"}, "firstName": "Hsueh-Fen", "initials": "HF"}, {"lastName": "Lee", "fullName": "Lee SC", "firstName": "Si-Chen", "initials": "SC"}]}, "title": "Middle infrared radiation induces G2/M cell cycle arrest in A549 lung cancer cells.", "hasSuppl": "Y", "citedByCount": 7, "source": "MED", "pmid": "23335992", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3386-0934"}, {"type": "ORCID", "value": "0000-0003-4876-3309"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Microtubules", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lung Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Reactive Oxygen Species", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Actins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "CDC2 Protein Kinase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Vinculin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Histones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Culture Media", "majorTopic_YN": "N"}, {"descriptorName": "Cell Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Temperature", "majorTopic_YN": "N"}, {"descriptorName": "Infrared Rays", "majorTopic_YN": "Y"}, {"descriptorName": "Cell Proliferation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Protein Transport", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "cdc25 Phosphatases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cyclin B1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "M Phase Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "G2 Phase Cell Cycle Checkpoints", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-15", "doi": "10.1371/journal.pone.0054117", "isOpenAccess": "Y", "pageInfo": "e54117", "pmcid": "PMC3546001", "hasDbCrossReferences": "Y", "abstractText": "There were studies investigating the effects of broadband infrared radiation (IR) on cancer cell, while the influences of middle-infrared radiation (MIR) are still unknown. In this study, a MIR emitter with emission wavelength band in the 3-5 \u00b5m region was developed to irradiate A549 lung adenocarcinoma cells. It was found that MIR exposure inhibited cell proliferation and induced morphological changes by altering the cellular distribution of cytoskeletal components. Using quantitative PCR, we found that MIR promoted the expression levels of ATM (ataxia telangiectasia mutated), ATR (ataxia-telangiectasia and Rad3-related and Rad3-related), TP53 (tumor protein p53), p21 (CDKN1A, cyclin-dependent kinase inhibitor 1A) and GADD45 (growth arrest and DNA-damage inducible), but decreased the expression levels of cyclin B coding genes, CCNB1 and CCNB2, as well as CDK1 (Cyclin-dependent kinase 1). The reduction of protein expression levels of CDC25C, cyclin B1 and the phosphorylation of CDK1 at Thr-161 altogether suggest G(2)/M arrest occurred in A549 cells by MIR. DNA repair foci formation of DNA double-strand breaks (DSB) marker \u03b3-H2AX and sensor 53BP1 was induced by MIR treatment, it implies the MIR induced G(2)/M cell cycle arrest resulted from DSB. This study illustrates a potential role for the use of MIR in lung cancer therapy by initiating DSB and blocking cell cycle progression.", "electronicPublicationDate": "2013-01-15", "language": "eng", "dateOfCompletion": "2013-06-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3546001?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3546001", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23335992&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23335992", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0054117", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 1999585, "issue": "1", "dateOfPublication": "2013 "}}}, "LLGL2": {"25813534": {"pubYear": "2015", "dateOfCreation": "2015-03-31", "pubModel": "Print-Electronic", "authorString": "Yamada Y, Matsui K, Takeuchi I, Oguri M, Fujimaki T.", "affiliation": "Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 514\u20118507, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25813534", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 514\u20118507, Japan.", "fullName": "Yamada Y", "initials": "Y", "firstName": "Yoshiji", "lastName": "Yamada"}, {"affiliation": "Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency, Tokyo 102\u20110076, Japan.", "fullName": "Matsui K", "initials": "K", "firstName": "Kota", "lastName": "Matsui"}, {"affiliation": "Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency, Tokyo 102\u20110076, Japan.", "fullName": "Takeuchi I", "initials": "I", "firstName": "Ichiro", "lastName": "Takeuchi"}, {"affiliation": "Department of Cardiology, Japanese Red Cross Nagoya First Hospital, Nagoya 453-8511, Japan.", "fullName": "Oguri M", "initials": "M", "firstName": "Mitsutoshi", "lastName": "Oguri"}, {"affiliation": "Department of Cardiovascular Medicine, Inabe General Hospital, Inabe, Mie 511-0428, Japan.", "fullName": "Fujimaki T", "initials": "T", "firstName": "Tetsuo", "lastName": "Fujimaki"}]}, "title": "Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25813534", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hypertension", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Population Surveillance", "majorTopic_YN": "Y"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Longitudinal Studies", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Blood Pressure", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-03-20", "language": "eng", "doi": "10.3892/ijmm.2015.2151", "isOpenAccess": "Y", "pageInfo": "1189-1198", "pmcid": "PMC4380208", "hasDbCrossReferences": "N", "abstractText": "We previously identified 9 genes and chromosomal region 3q28 as susceptibility loci for Japanese patients with myocardial infarction, ischemic stroke, or chronic kidney disease by genome-wide or candidate gene association studies. In the present study, we investigated the possible association of 13 single nucleotide polymorphisms (SNPs) at these 10 loci with the prevalence of hypertension or their association with blood pressure (BP) in community-dwelling individuals in Japan. The study subjects comprised 6,027 individuals (2,250 subjects with essential hypertension, 3,777 controls) who were recruited into the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study on atherosclerotic, cardiovascular and metabolic diseases. The subjects were recruited from individuals who visited the Health Care Center of Inabe General Hospital for an annual health checkup, and they are followed up each year (mean follow\u2011up period, 5 years). Longitudinal analysis with a generalized estimating equation and with adjustment for age, gender, body mass index and smoking status revealed that rs2116519 of family with sequence similarity 78, member B (FAM78B; P=0.0266), rs6929846 of butyrophilin, subfamily 2, member A1 (BTN2A1; P=0.0013), rs146021107 of pancreatic and duodenal homeobox 1 (PDX1; P=0.0031) and rs1671021 of lethal giant larvae homolog 2 (Drosophila) (LLGL2; P=0.0372) were significantly (P<0.05) associated with the prevalence of hypertension. Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for age, gender, body mass index and smoking status among individuals not taking anti-hypertensive medication revealed that rs6929846 of BTN2A1 was significantly associated with systolic (P=0.0017), diastolic (P=0.0008) and mean (P=0.0005) BP, and that rs2116519 of FAM78B, rs146021107 of PDX1 and rs1671021 of LLGL2 were significantly associated with diastolic (P=0.0495), systolic (P=0.0132), and both diastolic (P=0.0468) and mean (0.0471) BP, respectively. BTN2A1 may thus be a susceptibility gene for hypertension.", "electronicPublicationDate": "2015-03-20", "license": "cc by", "dateOfCompletion": "2015-12-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4380208?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4380208", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3892/ijmm.2015.2151", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"medlineAbbreviation": "Int J Mol Med", "isoabbreviation": "Int. J. Mol. Med.", "title": "International journal of molecular medicine", "issn": "1107-3756", "nlmid": "9810955", "essn": "1791-244X"}, "monthOfPublication": 5, "volume": "35", "yearOfPublication": 2015, "journalIssueId": 2268549, "issue": "5", "dateOfPublication": "2015 May"}}}, "TFAP4": {"20533062": {"pubYear": "2010", "dateOfCreation": "2010-07-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "enhancer-binding protein AP-4"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}]}, "authorString": "Lin CH, Chen CM, Hou YT, Wu YR, Hsieh-Li HM, Su MT, Lee-Chen GJ.", "affiliation": "Department of Life Science, National Taiwan Normal University, 88 Ting-Chou Road, Section 4, Taipei, 11677, Taiwan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20533062", "inEPMC": "N", "authorList": {"author": [{"lastName": "Lin", "fullName": "Lin CH", "firstName": "Chih-Hsin", "initials": "CH"}, {"lastName": "Chen", "fullName": "Chen CM", "firstName": "Chiung-Mei", "initials": "CM"}, {"lastName": "Hou", "fullName": "Hou YT", "firstName": "Yi-Ting", "initials": "YT"}, {"lastName": "Wu", "fullName": "Wu YR", "firstName": "Yih-Ru", "initials": "YR"}, {"lastName": "Hsieh-Li", "fullName": "Hsieh-Li HM", "firstName": "Hsiu-Mei", "initials": "HM"}, {"lastName": "Su", "fullName": "Su MT", "firstName": "Ming-Tsan", "initials": "MT"}, {"lastName": "Lee-Chen", "fullName": "Lee-Chen GJ", "firstName": "Guey-Jen", "initials": "GJ"}]}, "title": "The CAG repeat in SCA12 functions as a cis element to up-regulate PPP2R2B expression.", "citedByCount": 9, "source": "MED", "pmid": "20533062", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N"}, {"descriptorName": "Mutagenesis, Site-Directed", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Transcriptional Activation", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-06-09", "doi": "10.1007/s00439-010-0843-2", "isOpenAccess": "N", "pageInfo": "205-212", "hasDbCrossReferences": "Y", "abstractText": "PPP2R2B, a protein widely expressed in neurons, regulates the protein phosphatase 2A (PP2A) activity for dephosphorylation of tau and other substrates. CAG repeat expansion at the 5'-end of the PPP2R2B gene causes autosomal dominant spinocerebellar ataxia type 12. In the present study, we investigated the roles of CAG repeats and flanking cis elements and the associated proteins in controlling PPP2R2B expression. Deletion/site-directed mutagenesis, in silico searches and cDNA overexpression revealed that CREB1 and SP1 bind to the conserved sequence upstream the CAG repeats to up-regulate PPP2R2B expression, whereas TFAP4 binds to the conserved sequence downstream the CAG repeats to down-regulate PPP2R2B expression. The binding of CREB1, SP1, and TFAP4 to the PPP2R2B promoter was further confirmed by DNA pull-down and ChIP-PCR assays. CAG repeats itself also function as a cis element to up-regulate PPP2R2B expression as AT repeat length has no effect on PPP2R2B expression. Together, our data provide evidence that CREB1, SP1, and TFAP4 play roles in modulating PPP2R2B expression, thus offering a mechanism of regulating PP2A activity as the treatment of neurodegenerative diseases associated with abnormal PP2A activity.", "electronicPublicationDate": "2010-06-09", "language": "eng", "dateOfCompletion": "2010-08-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00439-010-0843-2", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-08-01", "journal": {"medlineAbbreviation": "Hum Genet", "isoabbreviation": "Hum. Genet.", "title": "Human genetics", "issn": "0340-6717", "nlmid": "7613873", "essn": "1432-1203"}, "monthOfPublication": 8, "volume": "128", "yearOfPublication": 2010, "journalIssueId": 1746535, "issue": "2", "dateOfPublication": "2010 Aug"}}}, "ETV6": {"7545545": {"pubYear": "1995", "dateOfCreation": "1995-10-13", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "11056-06-7", "name": "Bleomycin"}, {"registryNumber": "127-07-1", "name": "Hydroxyurea"}, {"registryNumber": "0", "name": "Fungal Proteins"}, {"registryNumber": "0", "name": "Saccharomyces cerevisiae Proteins"}, {"registryNumber": "3930-19-6", "name": "Streptonigrin"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "TEL1 protein, S cerevisiae"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}]}, "authorString": "Morrow DM, Tagle DA, Shiloh Y, Collins FS, Hieter P.", "affiliation": "Department of Molecular Biology and Genetics, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA16519"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS31763"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM162283"}]}, "hasPDF": "N", "id": "7545545", "inEPMC": "N", "authorList": {"author": [{"lastName": "Morrow", "fullName": "Morrow DM", "initials": "DM"}, {"lastName": "Tagle", "fullName": "Tagle DA", "initials": "DA"}, {"lastName": "Shiloh", "fullName": "Shiloh Y", "initials": "Y"}, {"lastName": "Collins", "fullName": "Collins FS", "initials": "FS"}, {"lastName": "Hieter", "fullName": "Hieter P", "initials": "P"}]}, "title": "TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1.", "citedByCount": 204, "source": "MED", "pmid": "7545545", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Saccharomyces cerevisiae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ataxia Telangiectasia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Damage", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hydroxyurea", "majorTopic_YN": "N"}, {"descriptorName": "Streptonigrin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N"}, {"descriptorName": "Bleomycin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Fungal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Saccharomyces cerevisiae Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Cloning, Molecular", "majorTopic_YN": "N"}, {"descriptorName": "Ultraviolet Rays", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology, Amino Acid", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genes, Fungal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gamma Rays", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "1995-09-01", "doi": "10.1016/0092-8674(95)90480-8", "isOpenAccess": "N", "pageInfo": "831-840", "hasDbCrossReferences": "Y", "abstractText": "Patients with the genetic disorder ataxia telangiectasia (AT) have mutations in the AT mutated (ATM) gene, which is homologous to TEL1 and the checkpoint gene MEC1. A tel1 deletion mutant, unlike a mec1 deletion, is viable and does not exhibit increased sensitivity to DNA-damaging agents. However, increased dosage of TEL1 rescues sensitivity of a mec1 mutant, mec1-1, to DNA-damaging agents and rescues viability of a mec1 disruption. mec1-1 tel1 delta 1 double mutants are synergistically sensitive to DNA-damaging agents, including radiomimetic drugs. These data indicate that TEL1 and MEC1 are functionally related and that functions of the ATM gene are apparently divided between at least two S. cerevisiae homologs.", "language": "eng", "dateOfCompletion": "1995-10-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/0092-8674(95)90480-8", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "1995-09-01", "journal": {"medlineAbbreviation": "Cell", "isoabbreviation": "Cell", "title": "Cell", "issn": "0092-8674", "nlmid": "0413066", "essn": "1097-4172"}, "monthOfPublication": 9, "volume": "82", "yearOfPublication": 1995, "journalIssueId": 1191162, "issue": "5", "dateOfPublication": "1995 Sep"}}, "10454554": {"pubYear": "1999", "dateOfCreation": "1999-09-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "telomerase RNA"}, {"registryNumber": "63231-63-0", "name": "RNA"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "0", "name": "Fungal Proteins"}, {"registryNumber": "0", "name": "Saccharomyces cerevisiae Proteins"}, {"registryNumber": "0", "name": "RNA, Fungal"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "0", "name": "RNA, Untranslated"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Tumor Suppressor Proteins"}, {"registryNumber": "0", "name": "Cell Cycle Proteins"}, {"registryNumber": "EC 2.7.7.49", "name": "Telomerase"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}, {"registryNumber": "EC 2.7.11.1", "name": "MEC1 protein, S cerevisiae"}, {"registryNumber": "EC 2.7.11.1", "name": "ataxia telangiectasia mutated protein"}, {"registryNumber": "0", "name": "RNA, Long Untranslated"}]}, "authorString": "Ritchie KB, Mallory JC, Petes TD.", "affiliation": "Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM24110"}]}, "hasPDF": "Y", "id": "10454554", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Ritchie", "fullName": "Ritchie KB", "firstName": "K B", "initials": "KB"}, {"lastName": "Mallory", "fullName": "Mallory JC", "firstName": "J C", "initials": "JC"}, {"lastName": "Petes", "fullName": "Petes TD", "firstName": "T D", "initials": "TD"}]}, "title": "Interactions of TLC1 (which encodes the RNA subunit of telomerase), TEL1, and MEC1 in regulating telomere length in the yeast Saccharomyces cerevisiae.", "hasSuppl": "N", "citedByCount": 154, "source": "MED", "pmid": "10454554", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Telomere", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Saccharomyces cerevisiae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Telomerase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "Y"}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Cycle Proteins", "majorTopic_YN": "N"}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Fungal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Saccharomyces cerevisiae Proteins", "majorTopic_YN": "Y"}, {"descriptorName": "Tumor Suppressor Proteins", "majorTopic_YN": "N"}, {"descriptorName": "RNA", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Fungal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Untranslated", "majorTopic_YN": "Y"}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Nucleic Acid Conformation", "majorTopic_YN": "N"}, {"descriptorName": "Protein Conformation", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genes, Fungal", "majorTopic_YN": "N"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "RNA, Long Untranslated", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "1999-09-01", "doi": "10.1128/mcb.19.9.6065", "isOpenAccess": "N", "pageInfo": "6065-6075", "pmcid": "PMC84515", "hasDbCrossReferences": "Y", "abstractText": "In the yeast Saccharomyces cerevisiae, chromosomes terminate with a repetitive sequence [poly(TG(1-3))] 350 to 500 bp in length. Strains with a mutation of TEL1, a homolog of the human gene (ATM) mutated in patients with ataxia telangiectasia, have short but stable telomeric repeats. Mutations of TLC1 (encoding the RNA subunit of telomerase) result in strains that have continually shortening telomeres and a gradual loss of cell viability; survivors of senescence arise as a consequence of a Rad52p-dependent recombination events that amplify telomeric and subtelomeric repeats. We show that a mutation in MEC1 (a gene related in sequence to TEL1 and ATM) reduces telomere length and that tel1 mec1 double mutant strains have a senescent phenotype similar to that found in tlc1 strains. As observed in tlc1 strains, survivors of senescence in the tel1 mec1 strains occur by a Rad52p-dependent amplification of telomeric and subtelomeric repeats. In addition, we find that strains with both tel1 and tlc1 mutations have a delayed loss of cell viability compared to strains with the single tlc1 mutation. This result argues that the role of Tel1p in telomere maintenance is not solely a direct activation of telomerase.", "language": "eng", "dateOfCompletion": "1999-09-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC84515?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC84515", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=10454554", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=10454554&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://mcb.asm.org/cgi/content/abstract/19/9/6065", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "mcb.asm.org"}, {"url": "http://dx.doi.org/10.1128/MCB.19.9.6065", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://mcb.asm.org/cgi/reprint/19/9/6065", "documentStyle": "pdf", "availability": "Free after 4 months", "availabilityCode": "F4", "site": "mcb.asm.org"}, {"url": "http://mcb.asm.org/cgi/content/full/19/9/6065", "documentStyle": "html", "availability": "Free after 4 months", "availabilityCode": "F4", "site": "mcb.asm.org"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-04-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "1999-09-01", "journal": {"medlineAbbreviation": "Mol Cell Biol", "isoabbreviation": "Mol. Cell. Biol.", "title": "Molecular and cellular biology", "issn": "0270-7306", "nlmid": "8109087", "essn": "1098-5549"}, "monthOfPublication": 9, "volume": "19", "yearOfPublication": 1999, "journalIssueId": 927487, "issue": "9", "dateOfPublication": "1999 Sep"}}, "7671310": {"pubYear": "1995", "dateOfCreation": "1995-10-13", "pubModel": "Print", "authorString": "Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD.", "affiliation": "Department of Biology, University of North Carolina, Chapel Hill 27599-3280, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM52319"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM24110"}]}, "hasPDF": "N", "id": "7671310", "inEPMC": "N", "authorList": {"author": [{"lastName": "Greenwell", "fullName": "Greenwell PW", "initials": "PW"}, {"lastName": "Kronmal", "fullName": "Kronmal SL", "initials": "SL"}, {"lastName": "Porter", "fullName": "Porter SE", "initials": "SE"}, {"lastName": "Gassenhuber", "fullName": "Gassenhuber J", "initials": "J"}, {"lastName": "Obermaier", "fullName": "Obermaier B", "initials": "B"}, {"lastName": "Petes", "fullName": "Petes TD", "initials": "TD"}]}, "title": "TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene.", "citedByCount": 215, "source": "MED", "pmid": "7671310", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Telomere", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Saccharomyces cerevisiae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cloning, Molecular", "majorTopic_YN": "N"}, {"descriptorName": "Mitosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sequence Homology, Amino Acid", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "RE", "qualifierName": "radiation effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genes, Fungal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["EMBL", "OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "1995-09-01", "doi": "10.1016/0092-8674(95)90479-4", "isOpenAccess": "N", "pageInfo": "823-829", "hasDbCrossReferences": "Y", "abstractText": "Yeast chromosomes terminate in tracts of simple repetitive DNA (poly[G1-3T]). Mutations in the gene TEL1 result in shortened telomeres. Sequence analysis of TEL1 indicates that it encodes a very large (322 kDa) protein with amino acid motifs found in phosphatidylinositol/protein kinases. The closest homolog to TEL1 is the human ataxia telangiectasia gene.", "language": "eng", "dateOfCompletion": "1995-10-13", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/0092-8674(95)90479-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "1995-09-01", "journal": {"medlineAbbreviation": "Cell", "isoabbreviation": "Cell", "title": "Cell", "issn": "0092-8674", "nlmid": "0413066", "essn": "1097-4172"}, "monthOfPublication": 9, "volume": "82", "yearOfPublication": 1995, "journalIssueId": 1191162, "issue": "5", "dateOfPublication": "1995 Sep"}}, "11820740": {"pubYear": "2001", "dateOfCreation": "2002-01-31", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Fungal Proteins"}, {"registryNumber": "0", "name": "Saccharomyces cerevisiae Proteins"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "EC 2.7.11.1", "name": "TEL1 protein, S cerevisiae"}, {"registryNumber": "EC 2.7.11.1", "name": "Protein-Serine-Threonine Kinases"}]}, "authorString": "Cao JP, Meyn MS, Eckardt-Schupp F, Fritz E.", "affiliation": "Soochow University, Suzhou, PR China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA60592"}]}, "hasPDF": "N", "id": "11820740", "inEPMC": "N", "authorList": {"author": [{"lastName": "Cao", "fullName": "Cao JP", "initials": "JP"}, {"lastName": "Meyn", "fullName": "Meyn MS", "initials": "MS"}, {"lastName": "Eckardt-Schupp", "fullName": "Eckardt-Schupp F", "initials": "F"}, {"lastName": "Fritz", "fullName": "Fritz E", "initials": "E"}]}, "title": "TEL1 from Saccharomyces cerevisiae suppresses chromosome aberrations induced by ionizing radiation in ataxia-telangiectasia cells without affecting cell cycle checkpoints.", "citedByCount": 0, "source": "MED", "pmid": "11820740", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Saccharomyces cerevisiae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ataxia Telangiectasia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosome Aberrations", "majorTopic_YN": "N"}, {"descriptorName": "Protein-Serine-Threonine Kinases", "majorTopic_YN": "N"}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Fungal Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Saccharomyces cerevisiae Proteins", "majorTopic_YN": "N"}, {"descriptorName": "Transfection", "majorTopic_YN": "N"}, {"descriptorName": "Dose-Response Relationship, Radiation", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Cycle", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Models, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2001-12-01", "doi": "10.1007/s00411-001-0125-4", "isOpenAccess": "N", "pageInfo": "309-315", "hasDbCrossReferences": "Y", "abstractText": "The TEL1 gene from Saccharomyces cerevisiae has been shown to be the closest sequence homologue to ATM, the gene mutated in ataxia-telangiectasia (A-T) patients. Functional homology shared between the ATM and Tell proteins has recently been demonstrated based on heterologous expression of the TEL1 gene in human cells derived from A-T patients. TEL1 expression complemented specific cellular A-T deficiencies, i.e. increased radiation-induced apoptosis, telomere shortening and spontaneous hyperrecombination. The mechanism of cellular A-T complementation by TEL1 appears to be independent of p53-dependent signaling cascades, since the deficiency of A-T cells to properly induce p53 upon ionizing radiation was not corrected by TEL1. We now find that the basic number of chromosome aberrations is increased and the number of radiation-induced chromosome aberrations is suppressed in A-T cells upon TEL1 expression. In cell cycle analyses, we find no changes in basic cell cycle distribution or in radiation-induced cell cycle checkpoints following TEL1 expression. We conclude that the radioprotective function of the Tel1 protein includes suppression of apoptosis and suppression of chromosome aberrations, and that both cellular end-points can be uncoupled from ionizing radiation-induced cell cycle checkpoints.", "language": "eng", "dateOfCompletion": "2002-07-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00411-001-0125-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "SpringerLink"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2001-12-01", "journal": {"medlineAbbreviation": "Radiat Environ Biophys", "isoabbreviation": "Radiat Environ Biophys", "title": "Radiation and environmental biophysics", "issn": "0301-634X", "nlmid": "0415677", "essn": "1432-2099"}, "monthOfPublication": 12, "volume": "40", "yearOfPublication": 2001, "journalIssueId": 1048493, "issue": "4", "dateOfPublication": "2001 Dec"}}, "23746548": {"pubYear": "2013", "dateOfCreation": "2013-07-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Repressor Proteins"}, {"registryNumber": "0", "name": "Microtubule-Associated Proteins"}, {"registryNumber": "0", "name": "proto-oncogene proteins c-ets"}, {"registryNumber": "0", "name": "ETS translocation variant 6 protein"}, {"registryNumber": "0", "name": "DCDC2 protein, human"}]}, "authorString": "Powers NR, Eicher JD, Butter F, Kong Y, Miller LL, Ring SM, Mann M, Gruen JR.", "affiliation": "Department of Genetics, Yale University, 464 Congress Avenue, Suite 243, New Haven, CT 06520, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust", "grantId": "092731"}, {"acronym": "DC", "orderIn": 0, "agency": "NIDCD NIH HHS", "grantId": "F31 DC012270"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "G9815508"}, {"orderIn": 0, "agency": "Medical Research Council"}, {"acronym": "HD", "orderIn": 0, "agency": "NICHD NIH HHS", "grantId": "P50 HD027802"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS043530"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32 GM007223"}, {"orderIn": 0, "agency": "Medical Research Council", "grantId": "MC_PC_15018"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dyslexia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Language Development Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microtubule-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Repressor Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Language Tests", "majorTopic_YN": "N"}, {"descriptorName": "Phylogeny", "majorTopic_YN": "N"}, {"descriptorName": "Binding Sites", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Microsatellite Repeats", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Linkage Disequilibrium", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Alleles", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-ets", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}]}, "id": "23746548", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Genetics, Yale University, 464 Congress Avenue, Suite 243, New Haven, CT 06520, USA.", "fullName": "Powers NR", "initials": "NR", "firstName": "Natalie R", "lastName": "Powers"}, {"lastName": "Eicher", "fullName": "Eicher JD", "firstName": "John D", "initials": "JD"}, {"lastName": "Butter", "fullName": "Butter F", "authorId": {"type": "ORCID", "value": "0000-0002-7197-7279"}, "firstName": "Falk", "initials": "F"}, {"lastName": "Kong", "fullName": "Kong Y", "authorId": {"type": "ORCID", "value": "0000-0002-2881-5274"}, "firstName": "Yong", "initials": "Y"}, {"lastName": "Miller", "fullName": "Miller LL", "firstName": "Laura L", "initials": "LL"}, {"lastName": "Ring", "fullName": "Ring SM", "firstName": "Susan M", "initials": "SM"}, {"lastName": "Mann", "fullName": "Mann M", "firstName": "Matthias", "initials": "M"}, {"lastName": "Gruen", "fullName": "Gruen JR", "firstName": "Jeffrey R", "initials": "JR"}]}, "title": "Alleles of a polymorphic ETV6 binding site in DCDC2 confer risk of reading and language impairment.", "hasSuppl": "Y", "citedByCount": 17, "pageInfo": "19-28", "source": "MED", "pmid": "23746548", "abstractText": "Reading disability (RD) and language impairment (LI) are common learning disabilities that make acquisition and utilization of reading and verbal language skills, respectively, difficult for affected individuals. Both disorders have a substantial genetic component with complex inheritance. Despite decades of study, reading and language, like many other complex traits, consistently evade identification of causative and functional variants. We previously identified a putative functional risk variant, named BV677278 for its GenBank accession number, for RD in DCDC2. This variant consists of an intronic microdeletion and a highly polymorphic short tandem repeat (STR) within its breakpoints. We have also shown this STR to bind to an unknown nuclear protein with high specificity. Here, we replicate BV677278's association with RD, expand its association to LI, identify the BV677278-binding protein as the transcription factor ETV6, and provide compelling genetic evidence that BV677278 is a regulatory element that influences reading and language skills. We also provide evidence that BV677278 interacts nonadditively with KIAA0319, an RD-associated gene, to adversely affect several reading and cognitive phenotypes. On the basis of these data, we propose a new name for BV677278: \"READ1\" or \"regulatory element associated with dyslexia 1.\"", "tmAccessionTypeList": {"accessionType": ["omim", " gen", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7197-7279"}, {"type": "ORCID", "value": "0000-0002-2881-5274"}]}, "hasPDF": "Y", "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-06-06", "doi": "10.1016/j.ajhg.2013.05.008", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 44, "type": "Erratum in", "reference": "Am J Hum Genet. 2014 May 1;94(5):798"}]}, "pmcid": "PMC3710765", "hasDbCrossReferences": "Y", "hasLabsLinks": "Y", "electronicPublicationDate": "2013-06-06", "language": "eng", "dateOfCompletion": "2013-09-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3710765?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3710765", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23746548&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23746548", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.ajhg.2013.05.008", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-03-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "Am J Hum Genet", "isoabbreviation": "Am. J. Hum. Genet.", "title": "American journal of human genetics", "issn": "0002-9297", "nlmid": "0370475", "essn": "1537-6605"}, "monthOfPublication": 7, "volume": "93", "yearOfPublication": 2013, "journalIssueId": 2057098, "issue": "1", "dateOfPublication": "2013 Jul"}}}, "OSBPL5": {"20201924": {"pubYear": "2010", "dateOfCreation": "2010-06-11", "pubModel": "Print-Electronic", "authorString": "Edenberg HJ, Koller DL, Xuei X, Wetherill L, McClintick JN, Almasy L, Bierut LJ, Bucholz KK, Goate A, Aliev F, Dick D, Hesselbrock V, Hinrichs A, Kramer J, Kuperman S, Nurnberger JI, Rice JP, Schuckit MA, Taylor R, Todd Webb B, Tischfield JA, Porjesz B, Foroud T.", "affiliation": "Department of Biochemistry, Indiana University School of Medicine, Indianapolis, 46202-5122, USA. edenberg@iupui.edu <edenberg@iupui.edu>", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural", "Comparative Study"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "PHS HHS", "grantId": "HHSN268200782096C"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "K02 AA018755"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA012725"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA012725-08"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R01 AA12725"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R24 AA012725"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10AA008401"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01 HG004438"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01 HG004438-03"}, {"acronym": "HG", "orderIn": 0, "agency": "NHGRI NIH HHS", "grantId": "U01HG004438"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10 AA008401"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10 AA008401-218163"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "R28 AA012725"}]}, "hasPDF": "Y", "id": "20201924", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Biochemistry, Indiana University School of Medicine, Indianapolis, 46202-5122, USA. edenberg@iupui.edu <edenberg@iupui.edu>", "fullName": "Edenberg HJ", "initials": "HJ", "firstName": "Howard J", "lastName": "Edenberg"}, {"lastName": "Koller", "fullName": "Koller DL", "firstName": "Daniel L", "initials": "DL"}, {"lastName": "Xuei", "fullName": "Xuei X", "firstName": "Xiaoling", "initials": "X"}, {"lastName": "Wetherill", "fullName": "Wetherill L", "firstName": "Leah", "initials": "L"}, {"lastName": "McClintick", "fullName": "McClintick JN", "firstName": "Jeanette N", "initials": "JN"}, {"lastName": "Almasy", "fullName": "Almasy L", "firstName": "Laura", "initials": "L"}, {"lastName": "Bierut", "fullName": "Bierut LJ", "firstName": "Laura J", "initials": "LJ"}, {"lastName": "Bucholz", "fullName": "Bucholz KK", "firstName": "Kathleen K", "initials": "KK"}, {"lastName": "Goate", "fullName": "Goate A", "firstName": "Alison", "initials": "A"}, {"lastName": "Aliev", "fullName": "Aliev F", "firstName": "Fazil", "initials": "F"}, {"lastName": "Dick", "fullName": "Dick D", "firstName": "Danielle", "initials": "D"}, {"lastName": "Hesselbrock", "fullName": "Hesselbrock V", "firstName": "Victor", "initials": "V"}, {"lastName": "Hinrichs", "fullName": "Hinrichs A", "firstName": "Anthony", "initials": "A"}, {"lastName": "Kramer", "fullName": "Kramer J", "firstName": "John", "initials": "J"}, {"lastName": "Kuperman", "fullName": "Kuperman S", "firstName": "Sam", "initials": "S"}, {"lastName": "Nurnberger", "fullName": "Nurnberger JI Jr", "authorId": {"type": "ORCID", "value": "0000-0002-7674-1767"}, "firstName": "John I", "initials": "JI"}, {"lastName": "Rice", "fullName": "Rice JP", "firstName": "John P", "initials": "JP"}, {"lastName": "Schuckit", "fullName": "Schuckit MA", "firstName": "Marc A", "initials": "MA"}, {"lastName": "Taylor", "fullName": "Taylor R", "firstName": "Robert", "initials": "R"}, {"lastName": "Todd Webb", "fullName": "Todd Webb B", "firstName": "B", "initials": "B"}, {"lastName": "Tischfield", "fullName": "Tischfield JA", "authorId": {"type": "ORCID", "value": "0000-0003-3217-8287"}, "firstName": "Jay A", "initials": "JA"}, {"lastName": "Porjesz", "fullName": "Porjesz B", "firstName": "Bernice", "initials": "B"}, {"lastName": "Foroud", "fullName": "Foroud T", "firstName": "Tatiana", "initials": "T"}]}, "title": "Genome-wide association study of alcohol dependence implicates a region on chromosome 11.", "hasSuppl": "Y", "citedByCount": 117, "source": "MED", "pmid": "20201924", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7674-1767"}, {"type": "ORCID", "value": "0000-0003-3217-8287"}, {"type": "ORCID", "value": "0000-0002-0576-5366"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 11", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alcoholism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Follow-Up Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Profiling", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}, {"abbreviation": "TD", "qualifierName": "trends", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2010-03-01", "doi": "10.1111/j.1530-0277.2010.01156.x", "isOpenAccess": "N", "pageInfo": "840-852", "pmcid": "PMC2884073", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: Alcohol dependence is a complex disease, and although linkage and candidate gene studies have identified several genes associated with the risk for alcoholism, these explain only a portion of the risk. METHODS: We carried out a genome-wide association study (GWAS) on a case-control sample drawn from the families in the Collaborative Study on the Genetics of Alcoholism. The cases all met diagnostic criteria for alcohol dependence according to the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; controls all consumed alcohol but were not dependent on alcohol or illicit drugs. To prioritize among the strongest candidates, we genotyped most of the top 199 single nucleotide polymorphisms (SNPs) (p < or = 2.1 x 10(-4)) in a sample of alcohol-dependent families and performed pedigree-based association analysis. We also examined whether the genes harboring the top SNPs were expressed in human brain or were differentially expressed in the presence of ethanol in lymphoblastoid cells. RESULTS: Although no single SNP met genome-wide criteria for significance, there were several clusters of SNPs that provided mutual support. Combining evidence from the case-control study, the follow-up in families, and gene expression provided strongest support for the association of a cluster of genes on chromosome 11 (SLC22A18, PHLDA2, NAP1L4, SNORA54, CARS, and OSBPL5) with alcohol dependence. Several SNPs nominated as candidates in earlier GWAS studies replicated in ours, including CPE, DNASE2B, SLC10A2, ARL6IP5, ID4, GATA4, SYNE1, and ADCY3. CONCLUSIONS: We have identified several promising associations that warrant further examination in independent samples.", "electronicPublicationDate": "2010-03-01", "language": "eng", "dateOfCompletion": "2011-02-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2884073?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2884073", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20201924", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20201924&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1111/j.1530-0277.2010.01156.x", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://content.wkhealth.com/linkback/openurl?issn=0145-6008&volume=34&issue=5&spage=840", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "www.alcoholism-cer.com"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-05-01", "journal": {"medlineAbbreviation": "Alcohol Clin Exp Res", "isoabbreviation": "Alcohol. Clin. Exp. Res.", "title": "Alcoholism, clinical and experimental research", "issn": "0145-6008", "nlmid": "7707242", "essn": "1530-0277"}, "monthOfPublication": 5, "volume": "34", "yearOfPublication": 2010, "journalIssueId": 1737902, "issue": "5", "dateOfPublication": "2010 May"}}}, "ACSL1": {"23060810": {"pubYear": "2012", "dateOfCreation": "2012-10-12", "pubModel": "Electronic-eCollection", "authorString": "Moull\u00e9 VS, Cansell C, Luquet S, Cruciani-Guglielmacci C.", "affiliation": "Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, BFA, EAC 4413 CNRS Paris, France.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "23060810", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Moull\u00e9", "fullName": "Moull\u00e9 VS", "firstName": "Valentine S F", "initials": "VS"}, {"lastName": "Cansell", "fullName": "Cansell C", "firstName": "C\u00e9line", "initials": "C"}, {"lastName": "Luquet", "fullName": "Luquet S", "firstName": "Serge", "initials": "S"}, {"lastName": "Cruciani-Guglielmacci", "fullName": "Cruciani-Guglielmacci C", "firstName": "C\u00e9line", "initials": "C"}]}, "title": "The multiple roles of fatty acid handling proteins in brain.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "23060810", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-09-28", "language": "eng", "doi": "10.3389/fphys.2012.00385", "isOpenAccess": "Y", "pageInfo": "385", "pmcid": "PMC3460233", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Fatty acids", "Brain", "Cognition", "Neuronal differentiation", "CD36", "Fabp", "Gpr40", "Fatp"]}, "abstractText": "Lipids are essential components of a living organism as energy source but also as constituent of the membrane lipid bilayer. In addition fatty acid (FA) derivatives interact with many signaling pathways. FAs have amphipathic properties and therefore require being associated to protein for both transport and intracellular trafficking. Here we will focus on several FA handling proteins, among which the fatty acid translocase/CD36 (FAT/CD36), members of fatty acid transport proteins (FATPs), and lipid chaperones fatty acid-binding proteins (FABPs). A decade of extensive studies has helped decipher the mechanism of action of these proteins in peripheral tissue with high lipid metabolism. However, considerably less information is available regarding their role in the brain, despite the high lipid content of this tissue. This review will primarily focus on the recent studies that have highlighted the crucial role of lipid handling proteins in brain FA transport, neuronal differentiation and development, cognitive processes and brain diseases. Finally a special focus will be made on the recent studies that have revealed the role of FAT/CD36 in brain lipid sensing and nervous control of energy balance.", "electronicPublicationDate": "2012-09-28", "license": "cc by", "dateOfCompletion": "2012-10-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3460233?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3460233", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23060810", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23060810&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.3389/fphys.2012.00385", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-08-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "Frontiers in physiology", "medlineAbbreviation": "Front Physiol", "isoabbreviation": "Front Physiol", "nlmid": "101549006", "essn": "1664-042X"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2012, "journalIssueId": 1899251, "dateOfPublication": "2012 "}}, "7642141": {"pubYear": "1995", "dateOfCreation": "1995-09-21", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Acetates"}, {"registryNumber": "0", "name": "Culture Media"}, {"registryNumber": "0", "name": "Isoenzymes"}, {"registryNumber": "64-17-5", "name": "Ethanol"}, {"registryNumber": "7440-44-0", "name": "Carbon"}, {"registryNumber": "EC 6.2.1.1", "name": "Acetate-CoA Ligase"}]}, "authorString": "Kratzer S, Sch\u00fcller HJ.", "affiliation": "Institut f\u00fcr Mikrobiologie, Biochemie und Genetik, Universit\u00e4t Erlangen/N\u00fcrnberg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "7642141", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kratzer", "fullName": "Kratzer S", "initials": "S"}, {"lastName": "Sch\u00fcller", "fullName": "Sch\u00fcller HJ", "initials": "HJ"}]}, "title": "Carbon source-dependent regulation of the acetyl-coenzyme A synthetase-encoding gene ACS1 from Saccharomyces cerevisiae.", "citedByCount": 22, "source": "MED", "pmid": "7642141", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Saccharomyces cerevisiae", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carbon", "majorTopic_YN": "N"}, {"descriptorName": "Ethanol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acetates", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Isoenzymes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acetate-CoA Ligase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Culture Media", "majorTopic_YN": "N"}, {"descriptorName": "Transcription, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation, Enzymologic", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Expression Regulation, Fungal", "majorTopic_YN": "Y"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Regulatory Sequences, Nucleic Acid", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Carbohydrate Metabolism", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["EMBL", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "1995-08-01", "doi": "10.1016/0378-1119(95)00289-i", "isOpenAccess": "N", "pageInfo": "75-79", "hasDbCrossReferences": "Y", "abstractText": "The yeast ACS1 gene, encoding acetyl-coenzyme A synthetase (ACS), was cloned using colony hybridization and a facA probe from Aspergillus nidulans. The complete sequence of 1.5 kb of the ACS1 upstream region was determined. Northern hybridization revealed a strong depression of ACS1 transcripts in a strain grown on the nonfermentable carbon sources, acetate or ethanol. In contrast to a previous report, delta acs1 null mutants did not exhibit a growth defect on acetate medium. Indeed, enzyme assays showed the presence of an additional constitutively expressed ACS activity in delta acs1 mutants. The carbon source-dependent expression was further investigated by the use of an ACS1::lacZ fusion gene, showing complete repression on easily fermentable sugars such as glucose, maltose, sucrose or galactose. Binding sites for the yeast general regulatory factors, Abf1p and Reb1p, together with a sequence reminiscent of the recently identified carbon source-responsive element (CSRE), could be detected in the ACS1 upstream region, presumably mediating the observed regulatory phenotype of this ACS isoenzyme.", "language": "eng", "dateOfCompletion": "1995-09-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/0378-1119(95)00289-I", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "1995-08-01", "journal": {"medlineAbbreviation": "Gene", "isoabbreviation": "Gene", "title": "Gene", "issn": "0378-1119", "nlmid": "7706761", "essn": "1879-0038"}, "monthOfPublication": 8, "volume": "161", "yearOfPublication": 1995, "journalIssueId": 888110, "issue": "1", "dateOfPublication": "1995 Aug"}}}, "CCDC86": {"23439384": {"pubYear": "2013", "dateOfCreation": "2013-04-08", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Antipsychotic Agents"}, {"registryNumber": "52-86-8", "name": "Haloperidol"}, {"registryNumber": "0", "name": "Nuclear Proteins"}, {"registryNumber": "0", "name": "cyclon protein, human"}]}, "authorString": "Chervenkov T, Shishkov R, Tonchev AB.", "affiliation": "Laboratory of Immunology, University Hospital St. Marina, Varna, Bulgaria.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "23439384", "inEPMC": "N", "authorList": {"author": [{"lastName": "Chervenkov", "fullName": "Chervenkov T", "firstName": "Trifon", "initials": "T"}, {"lastName": "Shishkov", "fullName": "Shishkov R", "firstName": "Rinaldo", "initials": "R"}, {"lastName": "Tonchev", "fullName": "Tonchev AB", "firstName": "Anton B", "initials": "AB"}]}, "title": "Expression and differential response to haloperidol treatment of Cyclon/CCDC86 mRNA in schizophrenia patients.", "citedByCount": 0, "source": "MED", "pmid": "23439384", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Leukocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Haloperidol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nuclear Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antipsychotic Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-02-21", "doi": "10.1016/j.neuint.2013.02.017", "isOpenAccess": "N", "pageInfo": "870-872", "hasDbCrossReferences": "Y", "abstractText": "A gene known as Cyclon (cytokine-induced protein with coiled-coil domain) or CCDC86 (coiled-coil domain-containing protein 86) is known for its expression in leukocytes in mice, where it regulates the immune response. We investigated whether Cyclon/CCDC68 is expressed in leukocytes of schizophrenia patients and whether it might be used as a biological marker for the disease endophenotype segregation. We examined the level of mRNA of Cyclon/CCDC68 in white blood cells obtained from schizophrenia patients in relapse and remission as well as in healthy controls. The mRNA of Cyclon/CCDC68 was expressed by white blood cells of both schizophrenia patients and healthy controls. There was a dichotomous change in the levels of Cyclon/CCDC68 of relapsed patients before and after treatment. High Cyclon/CCDC68 levels were associated with a recent disease and presence of psychotic symptoms, while low levels were associated with a long duration of the disease and an absence of psychotic symptoms. These data indicate that Cyclon/CCDC68 levels correlate with the clinical presentation of relapsed schizophrenia. Cyclon/CCDC68 might be involved in the immune system disturbances observed in schizophrenia.", "electronicPublicationDate": "2013-02-21", "language": "eng", "dateOfCompletion": "2013-10-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neuint.2013.02.017", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-05-01", "journal": {"medlineAbbreviation": "Neurochem Int", "isoabbreviation": "Neurochem. Int.", "title": "Neurochemistry international", "issn": "0197-0186", "nlmid": "8006959", "essn": "1872-9754"}, "monthOfPublication": 5, "volume": "62", "yearOfPublication": 2013, "journalIssueId": 2027937, "issue": "6", "dateOfPublication": "2013 May"}}}, "ANKFN1": {"22194214": {"pubYear": "2012", "dateOfCreation": "2012-06-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "IL12B protein, human"}, {"registryNumber": "0", "name": "interleukin-12 subunit p40"}, {"registryNumber": "EC 6.3.2.19", "name": "CBLB protein, human"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "EC 6.3.2.-", "name": "Proto-Oncogene Proteins c-cbl"}, {"registryNumber": "0", "name": "TMEM39A protein, human"}]}, "authorString": "Varad\u00e9 J, Comabella M, Ortiz MA, Arroyo R, Fern\u00e1ndez O, Pinto-Medel MJ, Fedetz M, Izquierdo G, Lucas M, G\u00f3mez CL, Rabasa AC, Alcina A, Matesanz F, Alloza I, Antig\u00fcedad A, Garc\u00eda-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalb\u00e1n X, Vandenbroeck K, Urcelay E.", "affiliation": "Immunology Department, Hospital Cl\u00ednico San Carlos, Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC), Spain.", "pubTypeList": {"pubType": ["Journal Article", "Validation Studies", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22194214", "inEPMC": "N", "authorList": {"author": [{"lastName": "Varad\u00e9", "fullName": "Varad\u00e9 J", "authorId": {"type": "ORCID", "value": "0000-0002-3964-110X"}, "firstName": "Jezabel", "initials": "J"}, {"lastName": "Comabella", "fullName": "Comabella M", "firstName": "Manuel", "initials": "M"}, {"lastName": "Ortiz", "fullName": "Ortiz MA", "firstName": "Miguel A", "initials": "MA"}, {"lastName": "Arroyo", "fullName": "Arroyo R", "firstName": "Rafael", "initials": "R"}, {"lastName": "Fern\u00e1ndez", "fullName": "Fern\u00e1ndez O", "firstName": "Oscar", "initials": "O"}, {"lastName": "Pinto-Medel", "fullName": "Pinto-Medel MJ", "firstName": "M Jes\u00fas", "initials": "MJ"}, {"lastName": "Fedetz", "fullName": "Fedetz M", "firstName": "Mar\u00eda", "initials": "M"}, {"lastName": "Izquierdo", "fullName": "Izquierdo G", "firstName": "Guillermo", "initials": "G"}, {"lastName": "Lucas", "fullName": "Lucas M", "firstName": "Miguel", "initials": "M"}, {"lastName": "G\u00f3mez", "fullName": "G\u00f3mez CL", "firstName": "Carlos L\u00f3pez", "initials": "CL"}, {"lastName": "Rabasa", "fullName": "Rabasa AC", "firstName": "Antonio Catal\u00e1", "initials": "AC"}, {"lastName": "Alcina", "fullName": "Alcina A", "firstName": "Antonio", "initials": "A"}, {"lastName": "Matesanz", "fullName": "Matesanz F", "authorId": {"type": "ORCID", "value": "0000-0002-9429-1819"}, "firstName": "Fuencisla", "initials": "F"}, {"lastName": "Alloza", "fullName": "Alloza I", "firstName": "Iraide", "initials": "I"}, {"lastName": "Antig\u00fcedad", "fullName": "Antig\u00fcedad A", "firstName": "Alfredo", "initials": "A"}, {"lastName": "Garc\u00eda-Barcina", "fullName": "Garc\u00eda-Barcina M", "firstName": "Mar\u00eda", "initials": "M"}, {"lastName": "Otaegui", "fullName": "Otaegui D", "firstName": "David", "initials": "D"}, {"lastName": "Olascoaga", "fullName": "Olascoaga J", "firstName": "Javier", "initials": "J"}, {"lastName": "Saiz", "fullName": "Saiz A", "authorId": {"type": "ORCID", "value": "0000-0002-5793-8791"}, "firstName": "Albert", "initials": "A"}, {"lastName": "Blanco", "fullName": "Blanco Y", "firstName": "Yolanda", "initials": "Y"}, {"lastName": "Montalb\u00e1n", "fullName": "Montalb\u00e1n X", "firstName": "Xavier", "initials": "X"}, {"lastName": "Vandenbroeck", "fullName": "Vandenbroeck K", "firstName": "Koen", "initials": "K"}, {"lastName": "Urcelay", "fullName": "Urcelay E", "authorId": {"type": "ORCID", "value": "0000-0001-8470-8396"}, "firstName": "Elena", "initials": "E"}]}, "title": "Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes.", "citedByCount": 5, "source": "MED", "pmid": "22194214", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3964-110X"}, {"type": "ORCID", "value": "0000-0002-9429-1819"}, {"type": "ORCID", "value": "0000-0002-5793-8791"}, {"type": "ORCID", "value": "0000-0001-8470-8396"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-cbl", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Interleukin-12 Subunit p40", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2011-12-22", "doi": "10.1177/1352458511432741", "isOpenAccess": "N", "pageInfo": "959-965", "hasDbCrossReferences": "Y", "abstractText": " BACKGROUND AND OBJECTIVES: Ten genes previously showing different evidence of association with multiple sclerosis have been selected to validate. METHODS: Eleven polymorphisms were genotyped with the iPLEX\u2122 Sequenom in a well-powered collection of Spanish origin including 2863 multiple sclerosis cases and 2930 controls. RESULTS: Replication extended to the following polymorphisms: PKN2 (rs305217), GTF2B (rs7538427), EPHA4 (rs1517440), YTHDF3 (rs12115114), ANKFN1 (rs17758761) and PTPRM (rs4798571), which did not reach the threshold of significance in a follow-up of the first genome-wide association study (GWAS) conducted in multiple sclerosis; TMEM39A (rs1132200), which appeared as a newly identified susceptibility gene in the same study; a gene previously reaching GWAS significance in Italy, CBLB (rs9657904); IL12B (rs6887695, rs10045431), a susceptibility gene shared by diverse autoimmune diseases and, finally, another gene showing inconclusive association with multiple sclerosis, CNR1 (rs1049353). CONCLUSIONS: Pooled analysis corroborated the effect on MS predisposition of three genes: TMEM39A [rs1132200: p(M-H)=0.001; OR(M-H) (95% CI)= 0.84 (0.75-0.93)], IL12B [rs6887695: p(M-H)=0.03; OR(M-H) (95% CI)= 1.09 (1.01-1.17)] and CBLB [rs9657904: p(M-H)=0.01; OR(M-H) (95% CI)= 0.89 (0.81-0.97)].", "electronicPublicationDate": "2011-12-22", "language": "eng", "dateOfCompletion": "2012-11-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1177/1352458511432741", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-07-01", "journal": {"medlineAbbreviation": "Mult Scler", "isoabbreviation": "Mult. Scler.", "title": "Multiple sclerosis (Houndmills, Basingstoke, England)", "issn": "1352-4585", "nlmid": "9509185", "essn": "1477-0970"}, "monthOfPublication": 7, "volume": "18", "yearOfPublication": 2012, "journalIssueId": 1944110, "issue": "7", "dateOfPublication": "2012 Jul"}}}, "SOD2": {"19461950": "", "25818327": {"pubYear": "2015", "dateOfCreation": "2015-09-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.-", "name": "superoxide dismutase 1"}, {"registryNumber": "EC 1.11.1.6", "name": "Catalase"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Saygi S, Erol \u0130, Alehan F, Yal\u00e7\u0131n YY, Kubat G, Ata\u00e7 FB.", "affiliation": "Department of Pediatrics, Division of Child Neurology, Baskent University Faculty of Medicine, Adana, Turkey semra_saygi@yahoo.com.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25818327", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pediatrics, Division of Child Neurology, Baskent University Faculty of Medicine, Adana, Turkey semra_saygi@yahoo.com.", "fullName": "Saygi S", "initials": "S", "firstName": "Semra", "lastName": "Saygi"}, {"affiliation": "Department of Pediatrics, Division of Child Neurology, Baskent University Faculty of Medicine, Adana, Turkey.", "fullName": "Erol \u0130", "initials": "\u0130", "firstName": "\u0130lknur", "lastName": "Erol"}, {"affiliation": "Department of Pediatrics, Division of Child Neurology, Baskent University Faculty of Medicine, Adana, Turkey.", "fullName": "Alehan F", "initials": "F", "firstName": "F\u00fcsun", "lastName": "Alehan"}, {"affiliation": "Department of Medical Biology, Baskent University School of Medicine, Ankara, Turkey.", "fullName": "Yal\u00e7\u0131n YY", "initials": "YY", "firstName": "Yaprak Y\u0131lmaz", "lastName": "Yal\u00e7\u0131n"}, {"affiliation": "Kazan Vocational School Business Administration Program, Baskent University, Ankara, Turkey.", "fullName": "Kubat G", "initials": "G", "firstName": "G\u00f6zde", "lastName": "Kubat"}, {"affiliation": "Department of Medical Biology, Baskent University School of Medicine, Ankara, Turkey.", "fullName": "Ata\u00e7 FB", "initials": "FB", "firstName": "Fatma Belgin", "lastName": "Ata\u00e7"}]}, "title": "Superoxide Dismutase and Catalase Genotypes in Pediatric Migraine Patients.", "citedByCount": 0, "source": "MED", "pmid": "25818327", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Catalase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Migraine with Aura", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Migraine without Aura", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotyping Techniques", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-03-27", "doi": "10.1177/0883073815575366", "isOpenAccess": "N", "pageInfo": "1586-1590", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Catalase", "Children", "Superoxide dismutases", "Oxidative stress", "Gene polymorphism", "Migraine"]}, "abstractText": "This study compared superoxide dismutase (SOD) and catalase (CAT) alleles in 97 consecutive children and adolescents with migraine to 96 healthy children and adolescents. Isolated genomic DNA was used as a template for SOD1 (35 A/C), SOD2 16 C/T, and CAT2 [(-262 C/T) and (-21 A/T)] allele genotyping. The SOD2 16 C/T genotype and C allele frequency differed significantly between controls and migraine (P = .047; P = .038). CAT -21 AA genotype and A allele frequency were significantly higher in both migraine with aura patients (P = .013; P = .004) and migraine without aura patients (P = .003; P = .001) compared to controls. To our knowledge, this is the first demonstration of differences in SOD and CAT genotypes between pediatric migraine patients and age-matched controls. Further studies on the functional implications of these genetic variants on neural antioxidant capacity and the use of antioxidant modulators for migraine treatment are warranted.", "electronicPublicationDate": "2015-03-27", "language": "eng", "dateOfCompletion": "2016-06-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1177/0883073815575366", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-10-01", "journal": {"medlineAbbreviation": "J Child Neurol", "isoabbreviation": "J. Child Neurol.", "title": "Journal of child neurology", "issn": "0883-0738", "nlmid": "8606714", "essn": "1708-8283"}, "monthOfPublication": 10, "volume": "30", "yearOfPublication": 2015, "journalIssueId": 2324902, "issue": "12", "dateOfPublication": "2015 Oct"}}, "22937105": "", "22244747": "", "17376152": "", "26696693": {"pubYear": "2015", "dateOfCreation": "2015-12-23", "pubModel": "Print-Electronic", "authorString": "Gamarra D, Elcoroaristizabal X, Fern\u00e1ndez-Mart\u00ednez M, de Pancorbo MM.", "affiliation": "BIOMICS Research Group, Department of Zoology and Cellular Biology A, Lascaray Research Center (CIEA), University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, 01006 Alava, Spain.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26696693", "inEPMC": "Y", "authorList": {"author": [{"firstName": "David", "lastName": "Gamarra", "affiliation": "BIOMICS Research Group, Department of Zoology and Cellular Biology A, Lascaray Research Center (CIEA), University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, 01006 Alava, Spain.", "authorId": {"type": "ORCID", "value": "0000-0002-9010-5783"}, "fullName": "Gamarra D", "initials": "D"}, {"affiliation": "BIOMICS Research Group, Department of Zoology and Cellular Biology A, Lascaray Research Center (CIEA), University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, 01006 Alava, Spain.", "fullName": "Elcoroaristizabal X", "initials": "X", "firstName": "Xabier", "lastName": "Elcoroaristizabal"}, {"affiliation": "Department of Neurology, Hospital Universitario Cruces, BioCruces Health Research Institute, Barakaldo, 48093 Bizkaia, Spain.", "fullName": "Fern\u00e1ndez-Mart\u00ednez M", "initials": "M", "firstName": "Manuel", "lastName": "Fern\u00e1ndez-Mart\u00ednez"}, {"affiliation": "BIOMICS Research Group, Department of Zoology and Cellular Biology A, Lascaray Research Center (CIEA), University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, 01006 Alava, Spain.", "fullName": "de Pancorbo MM", "initials": "MM", "firstName": "Marian M", "lastName": "de Pancorbo"}]}, "title": "Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOE\u03b54 Allele.", "hasSuppl": "Y", "citedByCount": 0, "source": "MED", "pmid": "26696693", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9010-5783"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-12-01", "doi": "10.1155/2015/746329", "isOpenAccess": "Y", "pageInfo": "746329", "pmcid": "PMC4678069", "hasDbCrossReferences": "N", "abstractText": "Oxidative stress plays an important part in amnestic mild cognitive impairment (aMCI), the prodromal phase of Alzheimer's disease (AD). Recent evidence shows that polymorphisms in the SOD2 gene affect the elimination of the reactive oxygen species (ROS) generated in mitochondria. The aim of this study was to determine whether the functional rs4880 SNP in the SOD2 gene is a risk factor associated with aMCI and sporadic AD. 216 subjects with aMCI, 355 with AD, and 245 controls have been studied. The SNP rs4880 of the SOD2 gene was genotyped by RT-PCR and the APOE genotype was determined by PCR and RFLPs. Different multinomial logistic regression models were used to determine the risk levels for aMCI and AD. Although the T allele of the SOD2 rs4880 SNP gene (rs4880-T) is not an independent risk for aMCI or AD, this allele increases the risk to aMCI patients carrying at least one APOE\u03b54 allele. Moreover, rs4880-T allele and APOE\u03b54 allele combination has been found to produce an increased risk for AD compared to aMCI reference patients. These results suggest that APOE\u03b54 and rs4880-T genotype may be a risk for aMCI and a predictor of progression from aMCI to AD.", "electronicPublicationDate": "2015-12-01", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4678069?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4678069", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1155/2015/746329", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-12-25", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Dis Markers", "isoabbreviation": "Dis. Markers", "title": "Disease markers", "issn": "0278-0240", "nlmid": "8604127", "essn": "1875-8630"}, "monthOfPublication": 0, "volume": "2015", "yearOfPublication": 2015, "journalIssueId": 2254888, "dateOfPublication": "2015"}}, "27158370": {"pubYear": "2016", "dateOfCreation": "2016-05-09", "pubModel": "Electronic-eCollection", "authorString": "Jiang W, Tang L, Zeng J, Chen B.", "affiliation": "Department of Ophthalmology, Second Xiangya Hospital, Central South University Changsha 410011, Hunan, China.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27158370", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Ophthalmology, Second Xiangya Hospital, Central South University Changsha 410011, Hunan, China.", "fullName": "Jiang W", "initials": "W", "firstName": "Wenmin", "lastName": "Jiang"}, {"affiliation": "Department of Ophthalmology, Second Xiangya Hospital, Central South University Changsha 410011, Hunan, China.", "fullName": "Tang L", "initials": "L", "firstName": "Luosheng", "lastName": "Tang"}, {"affiliation": "Department of Ophthalmology, Second Xiangya Hospital, Central South University Changsha 410011, Hunan, China.", "fullName": "Zeng J", "initials": "J", "firstName": "Jun", "lastName": "Zeng"}, {"affiliation": "Department of Ophthalmology, Second Xiangya Hospital, Central South University Changsha 410011, Hunan, China.", "fullName": "Chen B", "initials": "B", "firstName": "Baihua", "lastName": "Chen"}]}, "title": "Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27158370", "abstractText": "This study aimed to determine whether chronic intraocular pressure (IOP) elevation induces retinal oxidative stress and alters mitochondrial morphology and function of retinal ganglion cells (RGC) and to explore the effects of AAV-SOD2 gene therapy on the RGC survival and mitochondrial dysfunction.Chronic experimental glaucoma was induced unilaterally in adult male Sprague-Dawley rats by laser burns at trabecular meshwork and episcleral veins 2 times with an interval of one week. One eye of each rat was intravitreally pretreated with recombinant adeno-associated virus expressing SOD2 (AAV-SOD2) or recombinant AAV expressing GFP (AAV-GFP) 21 days before glaucoma induction. RGCs counting, morphometric analysis of retina and optic nerve, and detection of activities of retinal SOD2 and catalase, MDA, mitochondrial morphology, mitochondrial dynamin protein OPA1 and DRP-1 expressions were conducted at 4, 8, 12 and 24 weeks.Severe RGC loss, degeneration of optic nerve, reduced thickness of RGC layer and nerve fiber layer, significant decrease in total SOD and catalase activities, mitochondrial dysfunction and increased MDA were observed at 4, 8, 12 and 24 weeks after glaucoma. Pretreatment with AAV-SOD2 significantly reduced MDA and attenuated the damage to RGCs through a mitochondria-related pathway.AAV mediated pre-treatment with SOD2 is able to attenuate oxidative stress and improve mitochondrial dysfunction of RGC and optic nerve secondary to glaucoma. Thus, SOD2 may be used to prevent the retinal RGCs from glaucoma, which provides a promising strategy for glaucoma therapy.", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2016-02-15", "isOpenAccess": "N", "pageInfo": "799-810", "pmcid": "PMC4846927", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["SOD", "Retinal ganglion cells", "Chronic Intraocular Pressure"]}, "hasLabsLinks": "Y", "electronicPublicationDate": "2016-02-15", "language": "eng", "dateOfCompletion": "2016-05-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4846927?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4846927", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}]}, "dateOfRevision": "2016-05-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"title": "American journal of translational research", "medlineAbbreviation": "Am J Transl Res", "isoabbreviation": "Am J Transl Res", "nlmid": "101493030", "essn": "1943-8141"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2016, "journalIssueId": 2406589, "issue": "2", "dateOfPublication": "2016 "}}, "24919441": {"pubYear": "2014", "dateOfCreation": "2014-09-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "NF-E2-related factor 2"}, {"registryNumber": "EC 2.5.1.-", "name": "glutathione S-transferase T1"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 2.5.1.18", "name": "Glutathione Transferase"}, {"registryNumber": "EC 2.5.1.18", "name": "GSTP1 protein, human"}, {"registryNumber": "EC 2.5.1.18", "name": "Glutathione S-Transferase pi"}, {"registryNumber": "0", "name": "NFE2L2 protein, human"}, {"registryNumber": "EC 2.5.1.18", "name": "glutathione S-transferase M1"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}, {"registryNumber": "OF5P57N2ZX", "name": "Alanine"}, {"registryNumber": "HG18B9YRS7", "name": "Valine"}, {"registryNumber": "04Y7590D77", "name": "Isoleucine"}]}, "authorString": "Reszka E, Jablonowski Z, Wieczorek E, Jablonska E, Krol MB, Gromadzinska J, Grzegorczyk A, Sosnowski M, Wasowicz W.", "affiliation": "Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Teresy St. 8, 91-348, Lodz, Poland, edyta@imp.lodz.pl.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24919441", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Teresy St. 8, 91-348, Lodz, Poland, edyta@imp.lodz.pl.", "fullName": "Reszka E", "initials": "E", "firstName": "Edyta", "lastName": "Reszka"}, {"lastName": "Jablonowski", "fullName": "Jablonowski Z", "firstName": "Zbigniew", "initials": "Z"}, {"lastName": "Wieczorek", "fullName": "Wieczorek E", "authorId": {"type": "ORCID", "value": "0000-0002-4390-2042"}, "firstName": "Edyta", "initials": "E"}, {"lastName": "Jablonska", "fullName": "Jablonska E", "firstName": "Ewa", "initials": "E"}, {"lastName": "Krol", "fullName": "Krol MB", "firstName": "Magdalena Beata", "initials": "MB"}, {"lastName": "Gromadzinska", "fullName": "Gromadzinska J", "firstName": "Jolanta", "initials": "J"}, {"lastName": "Grzegorczyk", "fullName": "Grzegorczyk A", "firstName": "Adam", "initials": "A"}, {"lastName": "Sosnowski", "fullName": "Sosnowski M", "firstName": "Marek", "initials": "M"}, {"lastName": "Wasowicz", "fullName": "Wasowicz W", "firstName": "Wojciech", "initials": "W"}]}, "title": "Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24919441", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4390-2042"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glutathione Transferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Alanine", "majorTopic_YN": "N"}, {"descriptorName": "Isoleucine", "majorTopic_YN": "N"}, {"descriptorName": "Valine", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Age Factors", "majorTopic_YN": "N"}, {"descriptorName": "Sex Factors", "majorTopic_YN": "N"}, {"descriptorName": "Epistasis, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "NF-E2-Related Factor 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Glutathione S-Transferase pi", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Urinary Bladder Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Real-Time Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasm Grading", "majorTopic_YN": "N"}, {"descriptorName": "Gene-Environment Interaction", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-06-12", "doi": "10.1007/s00432-014-1733-0", "isOpenAccess": "Y", "pageInfo": "1723-1731", "pmcid": "PMC4160566", "hasDbCrossReferences": "Y", "abstractText": "PURPOSE: NRF2 transcription factor is involved in modulation of various antioxidant and metabolic genes and, therefore, may modulate anti-carcinogenic potential. Association between polymorphisms of NRF2 and five NRF2-regulated genes and urinary bladder cancer (BC) risk was analyzed. METHODS: The study group included 244 BC patients, while the control group comprised 365 individuals with no evidence of malignancy. Genotyping of GSTM1 (deletion), GSTT1 (deletion), GSTA1 -69C/T (rs3957357), GSTP1 Ile105Val (rs1695), SOD2 Ala16Val (rs4880) and NRF2 -617C/A (rs6721961) in blood genomic DNA was performed by means of real-time PCR assays. The associations between gene polymorphism and BC risk were computed by logistic regression. RESULTS: The frequency of GSTA1, GSTP1, SOD2 and NRF2 genotypes did not differ in both groups. A significantly higher BC risk was associated with GSTM1 null genotype after adjusting to age, sex and smoking habit (OR 1.85, 95 % CI 1.30-2.62; P = 0.001). GSTT1 null (OR 0.50, 95 % CI 0.31-0.81; P = 0.005) and GSTP1 Val105Val (OR 0.52, 95 % CI 0.27-0.98; P = 0.04) genotypes were associated with reduced BC risk separately or in combination (OR 0.24, 95 % CI 0.11-0.51; P < 0.0001) (P heterogeneity = 0.01). Combined GSTT1 null and SOD2 with at least one 16Val allele among never smokers encompass reduced BC risk (OR 0.14, 95 % CI 0.03-0.63; P = 0.01) (P heterogeneity = 0.04). CONCLUSIONS: This study supports hypothesis that GSTM1 null genotype may be a moderate BC risk factor. The gene-gene and gene-environment interactions associated with combined GSTP1/GSTT1 and combined GSTT1/SOD2 genetic polymorphisms along with cigarette smoking habit may play a significant role in BC risk modulation.", "electronicPublicationDate": "2014-06-12", "language": "eng", "dateOfCompletion": "2014-11-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4160566?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4160566", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s00432-014-1733-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "J Cancer Res Clin Oncol", "isoabbreviation": "J. Cancer Res. Clin. Oncol.", "title": "Journal of cancer research and clinical oncology", "issn": "0171-5216", "nlmid": "7902060", "essn": "1432-1335"}, "monthOfPublication": 10, "volume": "140", "yearOfPublication": 2014, "journalIssueId": 2200642, "issue": "10", "dateOfPublication": "2014 Oct"}}, "16123448": "", "24035474": {"pubYear": "2014", "dateOfCreation": "2013-12-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}, {"registryNumber": "EC 1.6.5.2", "name": "NAD(P)H Dehydrogenase (Quinone)"}, {"registryNumber": "EC 1.6.5.2", "name": "NQO1 protein, human"}]}, "authorString": "Goerlitz D, Amr S, Dash C, Saleh DA, El Daly M, Abdel-Hamid M, El Kafrawy S, Hifnawy T, Ezzat S, Abdel-Aziz MA, Khaled H, Zheng YL, Mikhail N, Loffredo CA.", "affiliation": "Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA115618"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01CA115618"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA132996"}]}, "hasPDF": "Y", "id": "24035474", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.", "fullName": "Goerlitz D", "initials": "D", "firstName": "David", "lastName": "Goerlitz"}, {"affiliation": "Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.", "fullName": "Amr S", "initials": "S", "firstName": "Sania", "lastName": "Amr"}, {"affiliation": "Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.", "fullName": "Dash C", "initials": "C", "firstName": "Chiranjeev", "lastName": "Dash"}, {"affiliation": "Department of Public Health, Cairo University, Cairo, Egypt.", "fullName": "Saleh DA", "initials": "DA", "firstName": "Doa'a A", "lastName": "Saleh"}, {"affiliation": "Department of Microbiology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; National Liver Institute, Menoufiya University, Shibin El Kom, Egypt.", "fullName": "El Daly M", "initials": "M", "firstName": "Mai", "lastName": "El Daly"}, {"affiliation": "Department of Microbiology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; Department of Microbiology, Minia University, Minia, Egypt.", "fullName": "Abdel-Hamid M", "initials": "M", "firstName": "Mohamed", "lastName": "Abdel-Hamid"}, {"affiliation": "Department of Microbiology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; National Liver Institute, Menoufiya University, Shibin El Kom, Egypt; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.", "fullName": "El Kafrawy S", "initials": "S", "firstName": "Sherif", "lastName": "El Kafrawy"}, {"affiliation": "Public Health Department, Beni Suif University, Beni Suif, Egypt.", "fullName": "Hifnawy T", "initials": "T", "firstName": "Tamer", "lastName": "Hifnawy"}, {"affiliation": "National Liver Institute, Menoufiya University, Shibin El Kom, Egypt.", "fullName": "Ezzat S", "initials": "S", "firstName": "Sameera", "lastName": "Ezzat"}, {"affiliation": "Department of Urology, Assiut University, Assiut, Egypt.", "fullName": "Abdel-Aziz MA", "initials": "MA", "firstName": "Mohamed A", "lastName": "Abdel-Aziz"}, {"affiliation": "Department of Medical Oncology, National Cancer Institute, Cairo, Egypt.", "fullName": "Khaled H", "initials": "H", "firstName": "Hussein", "lastName": "Khaled"}, {"affiliation": "Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.", "fullName": "Zheng YL", "initials": "YL", "firstName": "Yun-Ling", "lastName": "Zheng"}, {"affiliation": "Department of Microbiology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; Department of Urology, Assiut University, Assiut, Egypt.", "fullName": "Mikhail N", "initials": "N", "firstName": "Nabiel", "lastName": "Mikhail"}, {"affiliation": "Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. Electronic address: cal9@georgetown.edu.", "fullName": "Loffredo CA", "initials": "CA", "firstName": "Christopher A", "lastName": "Loffredo"}]}, "title": "Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "24035474", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Schistosoma haematobium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Schistosomiasis haematobia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PS", "qualifierName": "parasitology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "NAD(P)H Dehydrogenase (Quinone)", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Logistic Models", "majorTopic_YN": "N"}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Egypt", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Urinary Bladder Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PS", "qualifierName": "parasitology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Host-Parasite Interactions", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-09-10", "doi": "10.1016/j.urolonc.2013.06.016", "isOpenAccess": "N", "pageInfo": "47.e15-20", "pmcid": "PMC3885358", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Bladder cancer", "Smoking", "epidemiology", "schistosomiasis", "Sod2", "Nqo1"]}, "abstractText": "BACKGROUND: Bladder cancer is the most prevalent form of cancer in men among Egyptians, for whom tobacco smoke exposure and Schistosoma haematobium (SH) infection are the major risk factors. We hypothesized that functional polymorphisms in NAD(P)H: quinone oxidoreductase 1 (NQO1) and superoxide dismutase 2 (SOD2), modulators of the effects of reactive oxidative species, can influence an individual's susceptibility to these carcinogenic exposures and hence the risk of bladder cancer. METHODS: We assessed the effects of potential interactions between functional polymorphisms in the NQO1 and SOD2 genes and exposure to smoking and SH infection on bladder cancer risk among 902 cases and 804 population-based controls in Egypt. We used unconditional logistic regression to estimate the odds ratios (OR) and confidence intervals (CI) 95%. RESULTS: Water pipe and cigarette smoking were more strongly associated with cancer risk among individuals with the TT genotype for SOD2 (OR [CI 95%] = 4.41 [1.86-10.42]) as compared with those with the CC genotype (OR [CI 95%] = 2.26 [0.97-6.74]). Conversely, the risk associated with SH infection was higher among the latter (OR [CI 95%] = 3.59 [2.21-5.84]) than among the former (OR [CI 95%] = 1.86 [1.33-2.60]). Polymorphisms in NQO1 genotype showed a similar pattern, but to a much lesser extent. The highest odds for having bladder cancer following SH infection were observed among individuals with the CC genotypes for both NQO1 and SOD2 (OR [CI 95%] = 4.41 [2.32-8.38]). CONCLUSION: Our findings suggest that genetic polymorphisms in NQO1 and SOD2 play important roles in the etiology of bladder cancer by modulating the effects of known contributing factors such as smoking and SH infection.", "electronicPublicationDate": "2013-09-10", "language": "eng", "dateOfCompletion": "2014-09-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3885358?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3885358", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.urolonc.2013.06.016", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "Urol Oncol", "isoabbreviation": "Urol. Oncol.", "title": "Urologic oncology", "issn": "1078-1439", "nlmid": "9805460", "essn": "1873-2496"}, "monthOfPublication": 1, "volume": "32", "yearOfPublication": 2014, "journalIssueId": 2108580, "issue": "1", "dateOfPublication": "2014 Jan"}}, "18824496": "", "24204153": {"pubYear": "2013", "dateOfCreation": "2013-11-08", "pubModel": "Print-Electronic", "authorString": "Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K.", "affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24204153", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Saruwatari", "fullName": "Saruwatari J", "firstName": "Junji", "initials": "J"}, {"lastName": "Yasui-Furukori", "fullName": "Yasui-Furukori N", "firstName": "Norio", "initials": "N"}, {"lastName": "Kamihashi", "fullName": "Kamihashi R", "firstName": "Ryoko", "initials": "R"}, {"lastName": "Yoshimori", "fullName": "Yoshimori Y", "firstName": "Yuki", "initials": "Y"}, {"lastName": "Oniki", "fullName": "Oniki K", "firstName": "Kentaro", "initials": "K"}, {"lastName": "Tsuchimine", "fullName": "Tsuchimine S", "firstName": "Shoko", "initials": "S"}, {"lastName": "Noai", "fullName": "Noai M", "firstName": "Madoka", "initials": "M"}, {"lastName": "Sato", "fullName": "Sato Y", "firstName": "Yasushi", "initials": "Y"}, {"lastName": "Nakagami", "fullName": "Nakagami T", "firstName": "Taku", "initials": "T"}, {"lastName": "Sugawara", "fullName": "Sugawara N", "firstName": "Norio", "initials": "N"}, {"lastName": "Saito", "fullName": "Saito M", "firstName": "Manabu", "initials": "M"}, {"lastName": "Fujii", "fullName": "Fujii A", "firstName": "Akira", "initials": "A"}, {"lastName": "Kajiwara", "fullName": "Kajiwara A", "firstName": "Ayami", "initials": "A"}, {"lastName": "Mihara", "fullName": "Mihara S", "firstName": "Shuichi", "initials": "S"}, {"lastName": "Ogata", "fullName": "Ogata Y", "firstName": "Yasuhiro", "initials": "Y"}, {"lastName": "Kaneko", "fullName": "Kaneko S", "firstName": "Sunao", "initials": "S"}, {"lastName": "Nakagawa", "fullName": "Nakagawa K", "firstName": "Kazuko", "initials": "K"}]}, "title": "Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "24204153", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-11-01", "language": "eng", "doi": "10.2147/ndt.s52585", "isOpenAccess": "Y", "pageInfo": "1683-1698", "pmcid": "PMC3818100", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Polymorphism", "Schizophrenia", "Oxidative stress", "metabolic syndrome", "glutathione S-transferase", "Superoxide Dismutase 2"]}, "abstractText": " BACKGROUND: This study investigated the possible association between common and potentially functional polymorphisms of antioxidant enzymes and metabolic abnormalities in patients with schizophrenia. METHODS: The possible associations of the glutathione S-transferase (GST) M1 null and GSTT1 null genotypes, and the superoxide dismutase 2 (SOD2) Val16Ala polymorphism with the risks of being overweight and having metabolic syndrome were examined using a logistic regression analysis in 154 schizophrenic Japanese patients and 203 controls. RESULTS: Among smokers with schizophrenia, the risks of being overweight and having decreased high-density lipoprotein cholesterol were significantly higher in those with the GSTM1 null genotype than in those with the present genotype (odds ratio 3.20 and 3.15, P=0.03 and P=0.04, respectively), while among nonsmokers with schizophrenia, the risk of an abnormal waist circumference was lower in those with the GSTM1 null genotype (odds ratio 0.34, P=0.04). The risk of a decreased high-density lipoprotein cholesterol level was significantly higher in patients with the combined GSTM1 null and GSTT1 present genotypes than in those with the present genotypes of both genes (odds ratio 3.60, P<0.01). The SOD2 Val16Ala polymorphism was not associated with risk of metabolic abnormalities in either group. CONCLUSION: The present study suggests that the GSTM1 null genotype, in combination with smoking status or GSTT1 genotype, might be associated with the metabolic abnormalities in patients with schizophrenia.", "electronicPublicationDate": "2013-11-01", "license": "cc by-nc", "dateOfCompletion": "2013-11-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3818100?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3818100", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24204153", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24204153&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.2147/NDT.S52585", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-11-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"medlineAbbreviation": "Neuropsychiatr Dis Treat", "isoabbreviation": "Neuropsychiatr Dis Treat", "title": "Neuropsychiatric disease and treatment", "issn": "1176-6328", "nlmid": "101240304", "essn": "1178-2021"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2013, "journalIssueId": 1998081, "dateOfPublication": "2013 "}}, "23785434": "", "25279756": {"pubYear": "2014", "dateOfCreation": "2014-10-04", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}, {"registryNumber": "0", "name": "Biomarkers"}]}, "authorString": "Santiago JA, Scherzer CR, Potashkin JA.", "affiliation": "The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "P01 NS058793"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "P50 AG005134"}, {"acronym": "AG", "orderIn": 0, "agency": "NIA NIH HHS", "grantId": "R01 AG044113"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS082157"}, {"acronym": "AT", "orderIn": 0, "agency": "NCCIH NIH HHS", "grantId": "U01 AT000613"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS082080"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS064155"}]}, "hasPDF": "Y", "id": "25279756", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.", "fullName": "Santiago JA", "initials": "JA", "firstName": "Jose A", "lastName": "Santiago"}, {"affiliation": "The Neurogenomics Laboratory, Harvard Medical School and Brigham and Women's Hospital, Cambridge, Massachusetts, United States of America.", "fullName": "Scherzer CR", "initials": "CR", "firstName": "Clemens R", "lastName": "Scherzer"}, {"affiliation": "The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.", "fullName": "Potashkin JA", "initials": "JA", "firstName": "Judith A", "lastName": "Potashkin"}]}, "title": "Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.", "hasSuppl": "N", "citedByCount": 8, "source": "MED", "pmid": "25279756", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Diabetes Mellitus, Type 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "Y"}, {"descriptorName": "Up-Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Algorithms", "majorTopic_YN": "N"}, {"descriptorName": "Databases, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Gene Regulatory Networks", "majorTopic_YN": "N"}, {"descriptorName": "Biomarkers", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-10-03", "language": "eng", "doi": "10.1371/journal.pone.0109042", "isOpenAccess": "Y", "pageInfo": "e109042", "pmcid": "PMC4184821", "hasDbCrossReferences": "N", "abstractText": "Increasing evidence indicates that Parkinson's disease (PD) and type 2 diabetes (T2DM) share dysregulated molecular networks. We identified 84 genes shared between PD and T2DM from curated disease-gene databases. Nitric oxide biosynthesis, lipid and carbohydrate metabolism, insulin secretion and inflammation were identified as common dysregulated pathways. A network prioritization approach was implemented to rank genes according to their distance to seed genes and their involvement in common biological pathways. Quantitative polymerase chain reaction assays revealed that a highly ranked gene, superoxide dismutase 2 (SOD2), is upregulated in PD patients compared to healthy controls in 192 whole blood samples from two independent clinical trials, the Harvard Biomarker Study (HBS) and the Diagnostic and Prognostic Biomarkers in Parkinson's disease (PROBE). The results from this study reinforce the idea that shared molecular networks between PD and T2DM provides an additional source of biologically meaningful biomarkers. Evaluation of this biomarker in de novo PD patients and in a larger prospective longitudinal study is warranted.", "electronicPublicationDate": "2014-10-03", "license": "cc by", "dateOfCompletion": "2015-12-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4184821?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4184821", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0109042", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-06-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2014, "journalIssueId": 2206285, "issue": "10", "dateOfPublication": "2014 "}}, "17251466": "", "16129095": "", "20800516": "", "26400460": {"pubYear": "2015", "dateOfCreation": "2015-12-02", "pubModel": "Print-Electronic", "authorString": "Brown AL, Lupo PJ, Okcu MF, Lau CC, Rednam S, Scheurer ME.", "affiliation": "Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "K07CA131505"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30CA125123"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R25CA160078"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P50CA127001"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P50 CA127001"}]}, "id": "26400460", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Austin L", "lastName": "Brown", "affiliation": "Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.", "authorId": {"type": "ORCID", "value": "0000-0001-5802-5073"}, "fullName": "Brown AL", "initials": "AL"}, {"firstName": "Philip J", "lastName": "Lupo", "affiliation": "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.", "authorId": {"type": "ORCID", "value": "0000-0003-0978-5863"}, "fullName": "Lupo PJ", "initials": "PJ"}, {"affiliation": "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.", "fullName": "Okcu MF", "initials": "MF", "firstName": "Mehmet Fatih", "lastName": "Okcu"}, {"affiliation": "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.", "fullName": "Lau CC", "initials": "CC", "firstName": "Ching C", "lastName": "Lau"}, {"affiliation": "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.", "fullName": "Rednam S", "initials": "S", "firstName": "Surya", "lastName": "Rednam"}, {"affiliation": "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.", "fullName": "Scheurer ME", "initials": "ME", "firstName": "Michael E", "lastName": "Scheurer"}]}, "title": "SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "26400460", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5802-5073"}, {"type": "ORCID", "value": "0000-0003-0978-5863"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-09-24", "language": "eng", "doi": "10.1002/cam4.516", "isOpenAccess": "Y", "pageInfo": "1679-1686", "pmcid": "PMC4673994", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Superoxide dismutase", "Genetics", "Cisplatin", "Hearing loss", "Ototoxicity", "Platinum Chemotherapy"]}, "abstractText": "Manganese superoxide dismutase (MnSOD), encoded by the SOD2 gene, is involved in the detoxification of superoxide anion. Superoxide is likely a source of oxidative stress in the cochlea following treatment with platinum agents and radiation. Therefore, we examined SOD2 variants in association with ototoxicity among cisplatin-treated childhood medulloblastoma patients. Blood samples were obtained from 71 eligible patients treated for pediatric medulloblastoma at Texas Children's Cancer Center (1987-2010). Ototoxicity was defined as requiring the use of a hearing aid sometime after the initiation of therapy. DNA was genotyped on the Illumina HumanOmni-1 Quad BeadChip. A linkage disequilibrium (LD)-based single-nucleotide polymorphism (SNP) selection strategy was used to identify a minimal set of informative variants. Associations between SNPs and ototoxicity were assessed using logistic regression. Of the 71 eligible patients, 26 (37%) suffered from cisplatin-related ototoxicity. Study participants were primarily male (73%) and non-Hispanic white (42%). Five SOD2 variants (rs7855, rs5746151, rs5746136, rs2758331, and rs4880) identified by the LD-based selection strategy were genotyped. After correcting for multiple comparisons, the C-allele of the rs4880 variant was significantly associated with ototoxicity (odds ratio = 3.06, 95% confidence interval: 1.30-7.20) in adjusted models. The rs4880 T > C substitution results in a Val > Ala amino acid change at position 16 of the MnSOD mitochondrial targeting sequence. The Ala variant, which has been associated with increased MnSOD activity, was associated with hearing damage in this study. Platinum-based therapies increase the expression of MnSOD, which may result in an abundance of hydrogen peroxide, a reactive oxygen species. Therefore, oxidative stress may be an important mechanism in therapy-related cochlear damage.", "electronicPublicationDate": "2015-09-24", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4673994?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4673994", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1002/cam4.516", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-11-01", "journal": {"title": "Cancer medicine", "medlineAbbreviation": "Cancer Med", "isoabbreviation": "Cancer Med", "nlmid": "101595310", "essn": "2045-7634"}, "monthOfPublication": 11, "volume": "4", "yearOfPublication": 2015, "journalIssueId": 2347818, "issue": "11", "dateOfPublication": "2015 Nov"}}, "23500038": "", "22158479": "", "26247724": {"pubYear": "2015", "dateOfCreation": "2015-08-07", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Tfam protein, mouse"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "EC 3.6.1.-", "name": "GTP Phosphohydrolases"}, {"registryNumber": "0", "name": "High Mobility Group Proteins"}, {"registryNumber": "0", "name": "Protective Agents"}, {"registryNumber": "0", "name": "bcl-Associated Death Protein"}, {"registryNumber": "EC 3.6.5.5", "name": "Dynamins"}, {"registryNumber": "0", "name": "Bad protein, mouse"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}, {"registryNumber": "0", "name": "Quinazolinones"}, {"registryNumber": "0", "name": "3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone"}, {"registryNumber": "EC 3.6.5.5", "name": "Dnm1l protein, mouse"}, {"registryNumber": "0", "name": "P110 peptide"}]}, "authorString": "Kim KY, Perkins GA, Shim MS, Bushong E, Alcasid N, Ju S, Ellisman MH, Weinreb RN, Ju WK.", "affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY018658"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "P30EY022589"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY018658"}, {"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "P41 RR004050"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "P41GM103412-24"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "P41 GM103412"}]}, "hasPDF": "Y", "id": "26247724", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Kim KY", "initials": "KY", "firstName": "K-Y", "lastName": "Kim"}, {"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Perkins GA", "initials": "GA", "firstName": "G A", "lastName": "Perkins"}, {"affiliation": "Laboratory for Optic Nerve Biology, Department of Ophthalmology, Hamilton Glaucoma Center, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Shim MS", "initials": "MS", "firstName": "M S", "lastName": "Shim"}, {"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Bushong E", "initials": "E", "firstName": "E", "lastName": "Bushong"}, {"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Alcasid N", "initials": "N", "firstName": "N", "lastName": "Alcasid"}, {"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Ju S", "initials": "S", "firstName": "S", "lastName": "Ju"}, {"affiliation": "Department of Neuroscience, Center for Research in Biological Systems, National Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Ellisman MH", "initials": "MH", "firstName": "M H", "lastName": "Ellisman"}, {"affiliation": "Laboratory for Optic Nerve Biology, Department of Ophthalmology, Hamilton Glaucoma Center, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Weinreb RN", "initials": "RN", "firstName": "R N", "lastName": "Weinreb"}, {"affiliation": "Laboratory for Optic Nerve Biology, Department of Ophthalmology, Hamilton Glaucoma Center, University of California, San Diego, La Jolla, CA, USA.", "fullName": "Ju WK", "initials": "WK", "firstName": "W-K", "lastName": "Ju"}]}, "title": "DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26247724", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Axons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinal Ganglion Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Optic Disk", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred DBA", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "GTP Phosphohydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dynamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "High Mobility Group Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Protective Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tissue Culture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Intraocular Pressure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "bcl-Associated Death Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Quinazolinones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Dynamics", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-06", "language": "eng", "doi": "10.1038/cddis.2015.180", "isOpenAccess": "Y", "pageInfo": "e1839", "pmcid": "PMC4558491", "hasDbCrossReferences": "Y", "abstractText": "Glaucoma is the leading cause of irreversible blindness and is characterized by slow and progressive degeneration of the optic nerve head axons and retinal ganglion cell (RGC), leading to loss of visual function. Although oxidative stress and/or alteration of mitochondrial (mt) dynamics induced by elevated intraocular pressure (IOP) are associated with this neurodegenerative disease, the mechanisms that regulate mt dysfunction-mediated glaucomatous neurodegeneration are poorly understood. Using a mouse model of glaucoma, DBA/2J (D2), which spontaneously develops elevated IOP, as well as an in vitro RGC culture system, we show here that oxidative stress, as evidenced by increasing superoxide dismutase 2 (SOD2) and mt transcription factor A (Tfam) protein expression, triggers mt fission and loss by increasing dynamin-related protein 1 (DRP1) in the retina of glaucomatous D2 mice as well as in cultured RGCs exposed to elevated hydrostatic pressure in vitro. DRP1 inhibition by overexpressing DRP1 K38A mutant blocks mt fission and triggers a subsequent reduction of oxidative stress, as evidenced by decreasing SOD2 and Tfam protein expression. DRP1 inhibition promotes RGC survival by increasing phosphorylation of Bad at serine 112 in the retina and preserves RGC axons by maintaining mt integrity in the glial lamina of glaucomatous D2 mice. These findings demonstrate an important vicious cycle involved in glaucomatous neurodegeneration that starts with elevated IOP producing oxidative stress; the oxidative stress then leads to mt fission and a specific form of mt dysfunction that generates further oxidative stress, thus perpetuating the cycle. Our findings suggest that DRP1 is a potential therapeutic target for ameliorating oxidative stress-mediated mt fission and dysfunction in RGC and its axons during glaucomatous neurodegeneration. Thus, DRP1 inhibition may provide a new therapeutic strategy for protecting both RGCs and their axons in glaucoma and other optic neuropathies.", "electronicPublicationDate": "2015-08-06", "license": "cc by", "dateOfCompletion": "2016-04-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4558491?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4558491", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1038/cddis.2015.180", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-07-08", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Cell death & disease", "medlineAbbreviation": "Cell Death Dis", "isoabbreviation": "Cell Death Dis", "nlmid": "101524092", "essn": "2041-4889"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2015, "journalIssueId": 2243486, "dateOfPublication": "2015"}}, "19546321": "", "23761047": {"pubYear": "2014", "dateOfCreation": "2014-02-10", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.-", "name": "superoxide dismutase 1"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "9007-43-6", "name": "Cytochromes c"}, {"registryNumber": "0", "name": "Mitochondrial Proteins"}]}, "authorString": "I\u00f1arrea P, Alarcia R, Alava MA, Capablo JL, Casanova A, I\u00f1iguez C, Iturralde M, Larrod\u00e9 P, Mart\u00edn J, Mostacero E, Ara JR.", "affiliation": "Department of Biochemistry, Molecular and Cellular Biology, Science Faculty, University of Zaragoza, 50009, Zaragoza, Spain, inarrea@unizar.es.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "23761047", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Biochemistry, Molecular and Cellular Biology, Science Faculty, University of Zaragoza, 50009, Zaragoza, Spain, inarrea@unizar.es.", "fullName": "I\u00f1arrea P", "initials": "P", "firstName": "Pedro", "lastName": "I\u00f1arrea"}, {"lastName": "Alarcia", "fullName": "Alarcia R", "firstName": "Raquel", "initials": "R"}, {"lastName": "Alava", "fullName": "Alava MA", "firstName": "Mar\u00eda A", "initials": "MA"}, {"lastName": "Capablo", "fullName": "Capablo JL", "firstName": "Jos\u00e9 L", "initials": "JL"}, {"lastName": "Casanova", "fullName": "Casanova A", "firstName": "Alvaro", "initials": "A"}, {"lastName": "I\u00f1iguez", "fullName": "I\u00f1iguez C", "firstName": "Cristina", "initials": "C"}, {"lastName": "Iturralde", "fullName": "Iturralde M", "firstName": "Mar\u00eda", "initials": "M"}, {"lastName": "Larrod\u00e9", "fullName": "Larrod\u00e9 P", "firstName": "Pilar", "initials": "P"}, {"lastName": "Mart\u00edn", "fullName": "Mart\u00edn J", "firstName": "Jes\u00fas", "initials": "J"}, {"lastName": "Mostacero", "fullName": "Mostacero E", "firstName": "Enrique", "initials": "E"}, {"lastName": "Ara", "fullName": "Ara JR", "firstName": "Jos\u00e9 R", "initials": "JR"}]}, "title": "Mitochondrial complex enzyme activities and cytochrome C expression changes in multiple sclerosis.", "citedByCount": 2, "source": "MED", "pmid": "23761047", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Blood Platelets", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Multiple Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytochromes c", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondrial Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Enzymologic", "majorTopic_YN": "Y"}, {"descriptorName": "Enzyme Activation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-06-13", "doi": "10.1007/s12035-013-8481-z", "isOpenAccess": "N", "pageInfo": "1-9", "hasDbCrossReferences": "Y", "abstractText": "Blood platelets have been widely proposed as biomarkers in studies of mitochondrial function and aging-related and neurodegenerative diseases. Defects in mitochondrial function were found not only in the substantia nigra of Parkinson's disease patients but also in their blood platelets. Similarly, it has also been described in the blood platelet mitochondria of Alzheimer's disease patients. To study mitochondrial aerobic metabolism function and protein expression in platelets of multiple sclerosis (MS) patients and control subjects, mitochondrial aconitase, mitochondrial superoxide dismutases 1 and 2 (SOD1 and SOD2), and respiratory complex enzyme activities in platelets of MS patients and control subjects were determined. Likewise, mitochondrial lipid peroxidation and mitochondrial SOD1 and cytochrome c expressions were investigated. Mitochondrial aconitase activity was higher in MS patients than in controls (P\u2009<\u20090.05). A significant increase on all respiratory complex activities in MS patients was observed (P\u2009<\u20090.05). Mitochondrial lipid peroxidation was significantly higher in MS patients than in controls (P\u2009<\u20090.05). Significant changes of cytochrome c and mitochondrial SOD1 expressions were detected (P\u2009<\u20090.05), with a decrease of 44\u2009\u00b1\u20095 % and an increase of 46\u2009\u00b1\u20096 %, respectively. Our study reveals that significant changes in mitochondrial aerobic metabolism function and mitochondrial SOD1 and cytochrome c expressions are produced in platelets of MS patients.", "electronicPublicationDate": "2013-06-13", "language": "eng", "dateOfCompletion": "2014-10-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s12035-013-8481-z", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-02-01", "journal": {"medlineAbbreviation": "Mol Neurobiol", "isoabbreviation": "Mol. Neurobiol.", "title": "Molecular neurobiology", "issn": "0893-7648", "nlmid": "8900963", "essn": "1559-1182"}, "monthOfPublication": 2, "volume": "49", "yearOfPublication": 2014, "journalIssueId": 2125115, "issue": "1", "dateOfPublication": "2014 Feb"}}, "23212700": "", "10561523": "", "26306184": {"pubYear": "2015", "dateOfCreation": "2015-08-26", "pubModel": "Electronic-eCollection", "authorString": "Weaver J, Liu KJ.", "affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, BRaIN Imaging Center, MSC10 5620, 1 University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA ; Center of Biomedical Research Excellence, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26306184", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, BRaIN Imaging Center, MSC10 5620, 1 University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA ; Center of Biomedical Research Excellence, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA.", "fullName": "Weaver J", "initials": "J", "firstName": "John", "lastName": "Weaver"}, {"affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, BRaIN Imaging Center, MSC10 5620, 1 University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA ; Center of Biomedical Research Excellence, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA ; Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 USA.", "fullName": "Liu KJ", "initials": "KJ", "firstName": "Ke Jian", "lastName": "Liu"}]}, "title": "Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "26306184", "hasLabsLinks": "N", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-25", "language": "eng", "doi": "10.1186/s13618-015-0032-4", "isOpenAccess": "Y", "pageInfo": "11", "pmcid": "PMC4547432", "hasDbCrossReferences": "N", "abstractText": "Stroke, one of the most debilitating cerebrovascular and nuerological diseases, is a serious life-threatening condition and a leading cause of long-term adult disability and brain damage, either directly or by secondary complications. Most effective treatments for stroke are time dependent such as the only FDA-approved therapy, reperfusion with tissue-type plasminogen activator; thus, improving tissue oxygenation with normobaric hyperoxia (NBO) has been considered a logical and potential important therapy. NBO is considered a good approach because of its potential clinical advantages, and many studies suggest that NBO is neuroprotective, reducing ischemic brain injury and infarct volume in addition to improving pathologic and neurobehavorial outcomes. However, increased reactive oxygen species (ROS) generation may occur when tissue oxygen level is too high or too low. Therefore, a major concern with NBO therapy in acute ischemic stroke is the potential increase of ROS, which could exacerbate brain injury. The purpose of this review is to critically review the current literature reports on the effect of NBO treatment on ROS and oxidative stress with respect to acute ischemic stroke. Considering the available data from relevant animal models, NBO does not increase ROS or oxidative stress if applied for a short duration; therefore, the potential that NBO is a viable neuroprotective strategy for acute ischemic stroke is compelling. The benefits of NBO may significantly outweigh the risks of potential increase in ROS generation for the treatment of acute ischemic stroke.", "electronicPublicationDate": "2015-08-25", "license": "cc by", "dateOfCompletion": "2015-08-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4547432?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4547432", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s13618-015-0032-4", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-08-27", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Medical gas research", "medlineAbbreviation": "Med Gas Res", "isoabbreviation": "Med Gas Res", "nlmid": "101564536", "essn": "2045-9912"}, "monthOfPublication": 0, "volume": "5", "yearOfPublication": 2015, "journalIssueId": 2257822, "dateOfPublication": "2015 "}}, "25295643": {"pubYear": "2015", "dateOfCreation": "2015-01-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Palmirotta R, Barbanti P, De Marchis ML, Egeo G, Aurilia C, Fofi L, Ialongo C, Valente MG, Ferroni P, Della-Morte D, Guadagni F.", "affiliation": "1 Interinstitutional Multidisciplinary Biobank (BioBIM), Biomarker Discovery and Advanced Technologies (BioDAT), IRCCS San Raffaele Pisana , Rome, Italy .", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25295643", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Raffaele", "lastName": "Palmirotta", "affiliation": "1 Interinstitutional Multidisciplinary Biobank (BioBIM), Biomarker Discovery and Advanced Technologies (BioDAT), IRCCS San Raffaele Pisana , Rome, Italy .", "authorId": {"type": "ORCID", "value": "0000-0002-9401-7377"}, "fullName": "Palmirotta R", "initials": "R"}, {"lastName": "Barbanti", "fullName": "Barbanti P", "firstName": "Piero", "initials": "P"}, {"lastName": "De Marchis", "fullName": "De Marchis ML", "authorId": {"type": "ORCID", "value": "0000-0002-3720-6550"}, "firstName": "Maria Laura", "initials": "ML"}, {"lastName": "Egeo", "fullName": "Egeo G", "firstName": "Gabriella", "initials": "G"}, {"lastName": "Aurilia", "fullName": "Aurilia C", "firstName": "Cinzia", "initials": "C"}, {"lastName": "Fofi", "fullName": "Fofi L", "firstName": "Luisa", "initials": "L"}, {"lastName": "Ialongo", "fullName": "Ialongo C", "firstName": "Cristiano", "initials": "C"}, {"lastName": "Valente", "fullName": "Valente MG", "firstName": "Maria Giovanna", "initials": "MG"}, {"lastName": "Ferroni", "fullName": "Ferroni P", "authorId": {"type": "ORCID", "value": "0000-0002-9877-8712"}, "firstName": "Patrizia", "initials": "P"}, {"lastName": "Della-Morte", "fullName": "Della-Morte D", "firstName": "David", "initials": "D"}, {"lastName": "Guadagni", "fullName": "Guadagni F", "firstName": "Fiorella", "initials": "F"}]}, "title": "Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "25295643", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["omim", " ensembl", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9401-7377"}, {"type": "ORCID", "value": "0000-0002-3720-6550"}, {"type": "ORCID", "value": "0000-0002-9877-8712"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Migraine with Aura", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2016-01-20", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-11-11", "doi": "10.1089/ars.2014.6069", "isOpenAccess": "N", "pageInfo": "275-279", "pmcid": "PMC4283069", "hasDbCrossReferences": "Y", "abstractText": "Several studies suggest a role of oxidative stress in the physiopathology of migraine, particularly in the form with aura. In a case-control study, we investigated the association between migraine and superoxide dismutase 1 (SOD1) and superoxide dismutase 2 (SOD2) genes in a cohort of 490 consecutive unrelated Caucasian migraineurs (migraine with aura [MwA], n=107; migraine without aura [MwoA], n=246; chronic migraine [CM], n=137) and 246 healthy controls recruited at our Headache and Pain Unit and stored in the Interinstitutional Multidisciplinary BioBank (BioBIM). Migraine phenotype was carefully detailed using face-to-face interviews. We examined polymorphisms of SOD1 gene (A/C substitution-rs2234694) and SOD2 gene (C/T transition-rs4880-Ala16Val). The rs4880 TT (Val/Val) genotype was associated (p=0.042) with the presence of unilateral cranial autonomic symptoms (UAs) in MwA patients. We also found a mild correlation between SOD2 rs4880 genotype and the type of acute migraine treatment (p=0.048) in MwA patients. Our findings suggest that SOD2 is a disease-modifier gene influencing oxidative mechanisms in MwA. These observations lead to the hypothesis that SOD2 polymorphism may cause a defective control of the oxidative phenomena linked to cortical spreading depression, the neurophysiological hallmark of migraine aura, causing an overstimulation of trigeminal neurons and UAs triggering.", "electronicPublicationDate": "2014-11-11", "language": "eng", "dateOfCompletion": "2015-09-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4283069?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4283069", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1089/ars.2014.6069", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-01-20", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Antioxid Redox Signal", "isoabbreviation": "Antioxid. Redox Signal.", "title": "Antioxidants & redox signaling", "issn": "1523-0864", "nlmid": "100888899", "essn": "1557-7716"}, "monthOfPublication": 1, "volume": "22", "yearOfPublication": 2015, "journalIssueId": 2242673, "issue": "3", "dateOfPublication": "2015 Jan"}}, "11879807": "", "23939143": {"pubYear": "2013", "dateOfCreation": "2013-09-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anti-Inflammatory Agents, Non-Steroidal"}, {"registryNumber": "0", "name": "Lipopolysaccharides"}, {"registryNumber": "24939-03-5", "name": "Poly I-C"}, {"registryNumber": "0", "name": "Acute-Phase Proteins"}, {"registryNumber": "5072-26-4", "name": "Buthionine Sulfoximine"}, {"registryNumber": "0", "name": "Proto-Oncogene Proteins"}, {"registryNumber": "0", "name": "NF-kappa B"}, {"registryNumber": "0", "name": "neutrophil gelatinase-associated lipocalin protein, rat"}, {"registryNumber": "0", "name": "Lipocalins"}, {"registryNumber": "144O8QL0L1", "name": "Diclofenac"}]}, "authorString": "Ramm S, Mally A.", "affiliation": "Department of Toxicology, University of W\u00fcrzburg, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23939143", "inEPMC": "N", "authorList": {"author": [{"firstName": "Susanne", "lastName": "Ramm", "affiliation": "Department of Toxicology, University of W\u00fcrzburg, Germany.", "authorId": {"type": "ORCID", "value": "0000-0003-1108-5620"}, "fullName": "Ramm S", "initials": "S"}, {"lastName": "Mally", "fullName": "Mally A", "firstName": "Angela", "initials": "A"}]}, "title": "Role of drug-independent stress factors in liver injury associated with diclofenac intake.", "citedByCount": 2, "pageInfo": "83-96", "source": "MED", "pmid": "23939143", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1108-5620"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Diclofenac", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lipopolysaccharides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Buthionine Sulfoximine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Acute-Phase Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "NF-kappa B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proto-Oncogene Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Poly I-C", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anti-Inflammatory Agents, Non-Steroidal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TO", "qualifierName": "toxicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Lipocalins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Stress, Physiological", "majorTopic_YN": "N"}, {"descriptorName": "Drug-Induced Liver Injury", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-08-09", "doi": "10.1016/j.tox.2013.08.002", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Erratum in", "reference": "Toxicology. 2014 Feb 28;316:71-4"}]}, "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Interleukin 1", "LPS", "Lipopolysaccharide", "Mitogen activated protein kinase", "MAPK", "Inflammation", "IL-1", "Hepatotoxicity", "NGAL", "BSO", "NSAID", "TNF-\u03b1", "Drug safety", "AP1", "Nuclear factor-\u03baB", "NRF2", "Nonsteroidal Anti-inflammatory Drug", "Hmgb1", "Diclofenac", "Nuclear Factor-e2-related Factor 2", "Nf\u03bab", "Idr", "Pic", "Poly I:c", "High Mobility Group Box 1", "Tumor Necrosis Factor \u0391", "Cinc-1", "Activator Protein 1", "Dcl", "Dcl Acyl Glucuronide", "Dcl Mercapturic Acid", "Dcl-ag", "Dcl-ma", "Cytokine-induced Neutrophil Chemoattractant 1", "Dl-buthionine Sulfoximine", "Idiosyncratic Drug Reaction", "Neutrophil Gelatinase-activated Lipocalin"]}, "abstractText": "Although a basic understanding of the chemical and biological events leading to idiosyncratic drug toxicity is still lacking, it appears that drug-independent risk factors that increase reactive metabolite formation or alter cellular stress and immune response may be critical determinants in the response to an otherwise non-toxic drug. Thus, we were interested to determine the impact of various drug-independent stress factors - lipopolysaccharide (LPS), poly I:C (PIC) or glutathione depletion via buthionine sulfoximine (BSO) - on the toxicity of diclofenac (Dcl), a model drug associated with rare but significant cases of serious hepatotoxicity, and to understand if enhanced toxicity occurs through alterations of drug metabolism and/or modulation of stress response pathways. Co-treatment of rats repeatedly given therapeutic doses of Dcl for 7 days with a single dose of LPS 2h before the last Dcl dose resulted in severe liver toxicity. Neither LPS nor diclofenac alone or in combination with PIC or BSO had such an effect. While it is thought that bioactivation to reactive Dcl acyl glucuronides (AG) and subsequent protein adduct formation contribute to Dcl induced liver injury, LC-MS/MS analyses did not reveal increased formation of 4'- and 5-hydroxy-Dcl, Dcl-AG or Dcl-AG dependent protein adducts in animals treated with LPS/Dcl. Hepatic gene expression analysis suggested enhanced activation of NF\u03baB and MAPK pathways and up-regulation of co-stimulatory molecules (IL-1\u03b2, TNF-\u03b1, CINC-1) by LPS/Dcl and PIC/Dcl, while protective factors (HSPs, SOD2) were down-regulated. LPS/Dcl led to extensive release of pro-inflammatory cytokines (IL-1\u03b2, IL-6, IFN-\u03b3, TNF-\u03b1) and factors thought to constitute danger signals (HMGB1, CINC-1) into plasma. Taken together, our results show that Dcl enhanced the inflammatory response induced by LPS - and to a lesser extent by PIC - through up-regulation of pro-inflammatory molecules and down-regulation of protective factors. This suggests sensitization of cells to cellular stress mediated by non-drug-related risk factors by therapeutic doses of Dcl, rather than potentiation of Dcl toxicity by the stress factors.", "electronicPublicationDate": "2013-08-09", "language": "eng", "dateOfCompletion": "2013-11-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.tox.2013.08.002", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2014-03-31", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-10-01", "journal": {"medlineAbbreviation": "Toxicology", "isoabbreviation": "Toxicology", "title": "Toxicology", "issn": "0300-483X", "nlmid": "0361055", "essn": "1879-3185"}, "monthOfPublication": 10, "volume": "312", "yearOfPublication": 2013, "journalIssueId": 2083304, "dateOfPublication": "2013 Oct"}}, "22639527": "", "23727323": "", "18930810": "", "26301039": {"pubYear": "2015", "dateOfCreation": "2015-08-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Izuo N, Nojiri H, Uchiyama S, Noda Y, Kawakami S, Kojima S, Sasaki T, Shirasawa T, Shimizu T.", "affiliation": "Department of Advanced Aging Medicine, Chiba University Graduate School of Medicine, Inohana, Chuo-ku, Chiba 260-8670, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26301039", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Advanced Aging Medicine, Chiba University Graduate School of Medicine, Inohana, Chuo-ku, Chiba 260-8670, Japan.", "fullName": "Izuo N", "initials": "N", "firstName": "Naotaka", "lastName": "Izuo"}, {"affiliation": "Department of Orthopedics, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-0033, Japan.", "fullName": "Nojiri H", "initials": "H", "firstName": "Hidetoshi", "lastName": "Nojiri"}, {"affiliation": "Molecular Gerontology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.", "fullName": "Uchiyama S", "initials": "S", "firstName": "Satoshi", "lastName": "Uchiyama"}, {"firstName": "Yoshihiro", "lastName": "Noda", "affiliation": "Molecular Gerontology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.", "authorId": {"type": "ORCID", "value": "0000-0002-2657-2555"}, "fullName": "Noda Y", "initials": "Y"}, {"affiliation": "Molecular Gerontology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.", "fullName": "Kawakami S", "initials": "S", "firstName": "Satoru", "lastName": "Kawakami"}, {"affiliation": "Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.", "fullName": "Kojima S", "initials": "S", "firstName": "Shuji", "lastName": "Kojima"}, {"affiliation": "Department of Medical Engineering and Technology, Kitasato University School of Allied of Health Science, Kitasato, Sagamihara, Kanagawa 252-0373, Japan ; Redox Biology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.", "fullName": "Sasaki T", "initials": "T", "firstName": "Toru", "lastName": "Sasaki"}, {"affiliation": "Molecular Gerontology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan ; Department of Ageing Control Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-0033, Japan.", "fullName": "Shirasawa T", "initials": "T", "firstName": "Takuji", "lastName": "Shirasawa"}, {"firstName": "Takahiko", "lastName": "Shimizu", "affiliation": "Department of Advanced Aging Medicine, Chiba University Graduate School of Medicine, Inohana, Chuo-ku, Chiba 260-8670, Japan ; Molecular Gerontology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.", "authorId": {"type": "ORCID", "value": "0000-0002-3351-3342"}, "fullName": "Shimizu T", "initials": "T"}]}, "title": "Brain-Specific Superoxide Dismutase 2 Deficiency Causes Perinatal Death with Spongiform Encephalopathy in Mice.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26301039", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2657-2555"}, {"type": "ORCID", "value": "0000-0002-3351-3342"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Brain Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Creutzfeldt-Jakob Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "N"}, {"descriptorName": "Perinatal Death", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-08-02", "doi": "10.1155/2015/238914", "isOpenAccess": "Y", "pageInfo": "238914", "pmcid": "PMC4537744", "hasDbCrossReferences": "N", "abstractText": "Oxidative stress is believed to greatly contribute to the pathogenesis of various diseases, including neurodegeneration. Impairment of mitochondrial energy production and increased mitochondrial oxidative damage are considered early pathological events that lead to neurodegeneration. Manganese superoxide dismutase (Mn-SOD, SOD2) is a mitochondrial antioxidant enzyme that converts toxic superoxide to hydrogen peroxide. To investigate the pathological role of mitochondrial oxidative stress in the central nervous system, we generated brain-specific SOD2-deficient mice (B-Sod2(-/-)) using nestin-Cre-loxp system. B-Sod2(-/-) showed perinatal death, along with severe growth retardation. Interestingly, these mice exhibited spongiform neurodegeneration in motor cortex, hippocampus, and brainstem, accompanied by gliosis. In addition, the mutant mice had markedly decreased mitochondrial complex II activity, but not complex I or IV, in the brain based on enzyme histochemistry. Furthermore, brain lipid peroxidation was significantly increased in the B-Sod2(-/-), without any compensatory alterations of the activities of other antioxidative enzymes, such as catalase or glutathione peroxidase. These results suggest that SOD2 protects the neural system from oxidative stress in the perinatal stage and is essential for infant survival and central neural function in mice.", "electronicPublicationDate": "2015-08-02", "language": "eng", "dateOfCompletion": "2016-05-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4537744?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4537744", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1155/2015/238914", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Oxid Med Cell Longev", "isoabbreviation": "Oxid Med Cell Longev", "title": "Oxidative medicine and cellular longevity", "issn": "1942-0900", "nlmid": "101479826", "essn": "1942-0994"}, "monthOfPublication": 0, "volume": "2015", "yearOfPublication": 2015, "journalIssueId": 2250719, "dateOfPublication": "2015"}}, "8940623": "", "16094314": "", "22200564": "", "11496103": "", "19754948": "", "17359361": "", "23580200": "", "19493484": "", "25372290": {"pubYear": "2014", "dateOfCreation": "2014-11-06", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anticonvulsants"}, {"registryNumber": "EC 2.3.2.2", "name": "gamma-Glutamyltransferase"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}, {"registryNumber": "614OI1Z5WI", "name": "Valproic Acid"}]}, "authorString": "Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagaswa K.", "affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25372290", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Ogusu N", "initials": "N", "firstName": "Naoki", "lastName": "Ogusu"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Saruwatari J", "initials": "J", "firstName": "Junji", "lastName": "Saruwatari"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Nakashima H", "initials": "H", "firstName": "Hiroo", "lastName": "Nakashima"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Noai M", "initials": "M", "firstName": "Madoka", "lastName": "Noai"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Nishimura M", "initials": "M", "firstName": "Miki", "lastName": "Nishimura"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Deguchi M", "initials": "M", "firstName": "Mariko", "lastName": "Deguchi"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Oniki K", "initials": "K", "firstName": "Kentaro", "lastName": "Oniki"}, {"affiliation": "Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan.", "fullName": "Yasui-Furukori N", "initials": "N", "firstName": "Norio", "lastName": "Yasui-Furukori"}, {"affiliation": "Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan.", "fullName": "Kaneko S", "initials": "S", "firstName": "Sunao", "lastName": "Kaneko"}, {"affiliation": "Kumamoto Saishunso National Hospital, Kumamoto, Japan; Kumamoto Ezuko Ryoiku Iryo Center, Kumamoto, Japan.", "fullName": "Ishitsu T", "initials": "T", "firstName": "Takateru", "lastName": "Ishitsu"}, {"affiliation": "Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.", "fullName": "Nakagaswa K", "initials": "K", "firstName": "Kazuko", "lastName": "Nakagaswa"}]}, "title": "Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of \u03b3-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25372290", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Valproic Acid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "gamma-Glutamyltransferase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anticonvulsants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Substitution", "majorTopic_YN": "Y"}, {"descriptorName": "Pharmacogenetics", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Algorithms", "majorTopic_YN": "N"}, {"descriptorName": "Models, Biological", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-11-05", "language": "eng", "doi": "10.1371/journal.pone.0111066", "isOpenAccess": "Y", "pageInfo": "e111066", "pmcid": "PMC4220988", "hasDbCrossReferences": "Y", "abstractText": "BACKGROUND: There has been accumulating evidence that there are associations among \u03b3-glutamyltransferase (\u03b3-GT) elevation and all-cause mortality, cardiovascular diseases and metabolic diseases, including nonalcoholic fatty liver disease. The primary objective of this study was to evaluate the impact of the most common and potentially functional polymorphisms of antioxidant enzyme genes, i.e. superoxide dismutase 2 (SOD2), glutathione S-transferase M1 and glutathione S-transferase T1, on the \u03b3-GT elevation during valproic acid (VPA) therapy. METHODS AND FINDINGS: This retrospective study included 237 and 169 VPA-treated Japanese patients with epilepsy for population pharmacokinetic and pharmacokinetic-pharmacodynamic analyses, respectively. A nonlinear mixed-effect model represented the pharmacokinetics of VPA and the relationships between VPA exposure and \u03b3-GT elevation. A one-compartment model of the pharmacokinetic parameters of VPA adequately described the data; while the model for the probability of the \u03b3-GT elevation was fitted using a logistic regression model, in which the logit function of the probability was a linear function of VPA exposure. The SOD2 Val16Ala polymorphism and complication with intellectual disability were found to be significant covariates influencing the intercept of the logit function for the probability of an elevated \u03b3-GT level. The predicted mean percentages of the subjects with \u03b3-GT elevation were about 2- to 3-fold, 3- to 4-fold and 4- to 8-fold greater in patients with the SOD2 Val/Val genotype but without any intellectual disability, those with the SOD2 Val/Ala or Ala/Ala genotype and intellectual disability and those with the SOD2 Val/Val genotype and intellectual disability, respectively, compared to those with the SOD2 Val/Ala or Ala/Ala genotype without intellectual disability. CONCLUSION: Our results showed that the SOD2 Val16Ala polymorphism has an impact on the relationship between VPA exposure and \u03b3-GT elevation in patients with epilepsy. These results suggest that determining the SOD2 genotype could be helpful for preventing the VPA-induced \u03b3-GT elevation.", "electronicPublicationDate": "2014-11-05", "license": "cc by", "dateOfCompletion": "2015-06-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4220988?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4220988", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0111066", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2014, "journalIssueId": 2216242, "issue": "11", "dateOfPublication": "2014 "}}, "26020962": {"pubYear": "2015", "dateOfCreation": "2015-05-29", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "1C6V77QF41", "name": "Cholecalciferol"}]}, "authorString": "Moghimi E, Solomon JA, Gianforcaro A, Hamadeh MJ.", "affiliation": "School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada; Muscle Health Research Centre, York University, Toronto, Ontario, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "26020962", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada; Muscle Health Research Centre, York University, Toronto, Ontario, Canada.", "fullName": "Moghimi E", "initials": "E", "firstName": "Elnaz", "lastName": "Moghimi"}, {"affiliation": "School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada; Muscle Health Research Centre, York University, Toronto, Ontario, Canada.", "fullName": "Solomon JA", "initials": "JA", "firstName": "Jesse A", "lastName": "Solomon"}, {"affiliation": "School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada; Muscle Health Research Centre, York University, Toronto, Ontario, Canada.", "fullName": "Gianforcaro A", "initials": "A", "firstName": "Alexandro", "lastName": "Gianforcaro"}, {"affiliation": "School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada; Muscle Health Research Centre, York University, Toronto, Ontario, Canada.", "fullName": "Hamadeh MJ", "initials": "MJ", "firstName": "Mazen J", "lastName": "Hamadeh"}]}, "title": "Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26020962", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cholecalciferol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-28", "language": "eng", "doi": "10.1371/journal.pone.0126355", "isOpenAccess": "Y", "pageInfo": "e0126355", "pmcid": "PMC4447353", "hasDbCrossReferences": "N", "abstractText": "Dietary vitamin D3 (D3) restriction reduces paw grip endurance and motor performance in G93A mice, and increases inflammation and apoptosis in the quadr\u00edceps of females. ALS, a neuromuscular disease, causes progressive degeneration of motor neurons in the brain and spinal cord.We analyzed the spinal cords of G93A mice following dietary D3 restriction at 2.5% the adequate intake (AI) for oxidative damage (4-HNE, 3-NY), antioxidant enzymes (SOD2, catalase, GPx1), inflammation (TNF-\u03b1, IL-6, IL-10), apoptosis (bax/bcl-2 ratio, cleaved/pro-caspase 3 ratio), neurotrophic factor (GDNF) and neuron count (ChAT, SMI-36/SMI-32 ratio).Beginning at age 25 d, 42 G93A mice were provided food ad libitum with either adequate (AI;1 IU D3/g feed; 12 M, 11 F) or deficient (DEF; 0.025 IU D3/g feed; 10 M, 9 F) D3. At age 113 d, the spinal cords were analyzed for protein content. Differences were considered significant at P \u2264 0.10, since this was a pilot study.DEF mice had 16% higher 4-HNE (P = 0.056), 12% higher GPx1 (P = 0.057) and 23% higher Bax/Bcl2 ratio (P = 0.076) vs. AI. DEF females had 29% higher GPx1 (P = 0.001) and 22% higher IL-6 (P = 0.077) vs. AI females. DEF males had 23% higher 4-HNE (P = 0.066) and 18% lower SOD2 (P = 0.034) vs. AI males. DEF males had 27% lower SOD2 (P = 0.004), 17% lower GPx1 (P = 0.070), 29% lower IL-6 (P = 0.023) and 22% lower ChAT (P = 0.082) vs. DEF females.D3 deficiency exacerbates disease pathophysiology in the spinal cord of G93A mice, the exact mechanisms are sex-specific. This is in accord with our previous results in the quadriceps, as well as functional and disease outcomes.", "electronicPublicationDate": "2015-05-28", "license": "cc by", "dateOfCompletion": "2016-04-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4447353?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4447353", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0126355", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-06-10", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2015, "journalIssueId": 2278532, "issue": "5", "dateOfPublication": "2015"}}, "17927981": "", "23718983": {"pubYear": "2013", "dateOfCreation": "2013-07-08", "pubModel": "Electronic-Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "NF-E2-related factor 2"}, {"registryNumber": "0", "name": "Antioxidants"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "0", "name": "NFE2L2 protein, human"}]}, "authorString": "Yu B, Chen J, Liu D, Zhou H, Xiao W, Xia X, Huang Z.", "affiliation": "Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. yubolan@gmail.com", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23718983", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Key Laboratory for Reproductive Medicine of Guangdong Province, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. yubolan@gmail.com", "fullName": "Yu B", "initials": "B", "firstName": "Bolan", "lastName": "Yu"}, {"lastName": "Chen", "fullName": "Chen J", "firstName": "Jingyi", "initials": "J"}, {"lastName": "Liu", "fullName": "Liu D", "firstName": "Dan", "initials": "D"}, {"lastName": "Zhou", "fullName": "Zhou H", "firstName": "Hua", "initials": "H"}, {"lastName": "Xiao", "fullName": "Xiao W", "firstName": "Weiwei", "initials": "W"}, {"lastName": "Xia", "fullName": "Xia X", "firstName": "Xuefeng", "initials": "X"}, {"lastName": "Huang", "fullName": "Huang Z", "firstName": "Zhaofeng", "initials": "Z"}]}, "title": "Cigarette smoking is associated with human semen quality in synergy with functional NRF2 polymorphisms.", "citedByCount": 4, "source": "MED", "pmid": "23718983", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spermatozoa", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Semen", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antioxidants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Spermatogenesis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "NF-E2-Related Factor 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Promoter Regions, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Semen Analysis", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2013-07-05", "doi": "10.1095/biolreprod.113.109389", "isOpenAccess": "N", "pageInfo": "5", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Spermatogenesis", "Semen quality", "Smoking", "synergetic effect", "NRF2"]}, "abstractText": "Although cigarette smoking is considered a major risk factor for several human diseases, the effects of smoking on male fertility are controversial. Studies on the consequences of smoking, which also take into account genetic background, may facilitate understanding of the interactions between genes and smoking and their effects on male fertility. In this study, genetic variants of two functional polymorphisms of erythroid 2-related factor 2 (NRF2), mRNA expression levels of the antioxidant gene NRF2, catalase (CAT), superoxide dismutase isoenzyme-2 (SOD2), glutathione S-transferase-M1 (GSTM1), and seminal SOD activities were compared in 314 heavy smokers and 314 matched nonsmokers. The NRF2 rs6721961 TT genotype was found to be associated with low semen quality in heavy smokers (OR [95% CI] = 2.370 [1.106-5.081]). This variant genotype was found more frequently in heavy smokers with low semen quality than in those with high semen quality (P = 0.011). Heavy smokers with this genotype had significantly lower sperm concentrations and sperm counts (P < 0.05) when compared with those without this genotype. Smoking was also significantly associated with decreased seminal SOD activity (P < 0.05) and reduced NRF2 and SOD2 mRNA expression in heavy smokers with this variant genotype. These results were specific to heavy smokers with the NRF2 rs6721961 TT genotypes, but did not apply to nonsmokers or heavy smokers that did not carry this genotype. This study suggests an association between cigarette smoking in heavy smokers with NRF2 rs6721961 TT genotype and a decrease in semen quality.", "electronicPublicationDate": "2013-07-05", "language": "eng", "dateOfCompletion": "2014-03-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1095/biolreprod.113.109389", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "Biol Reprod", "isoabbreviation": "Biol. Reprod.", "title": "Biology of reproduction", "issn": "0006-3363", "nlmid": "0207224", "essn": "1529-7268"}, "monthOfPublication": 7, "volume": "89", "yearOfPublication": 2013, "journalIssueId": 2077415, "issue": "1", "dateOfPublication": "2013 Jul"}}, "24070129": {"pubYear": "2015", "dateOfCreation": "2015-06-20", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Abu-Amero KK, Azad TA, Mousa A, Osman EA, Sultan T, Al-Obeidan SA.", "affiliation": "Department of Ophthalmology, College of Medicine, King Saud University , Riyadh , Saudi Arabia and.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "24070129", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Ophthalmology, College of Medicine, King Saud University , Riyadh , Saudi Arabia and.", "fullName": "Abu-Amero KK", "initials": "KK", "firstName": "Khaled K", "lastName": "Abu-Amero"}, {"lastName": "Azad", "fullName": "Azad TA", "firstName": "Taif Anwar", "initials": "TA"}, {"lastName": "Mousa", "fullName": "Mousa A", "firstName": "Ahmed", "initials": "A"}, {"lastName": "Osman", "fullName": "Osman EA", "firstName": "Essam A", "initials": "EA"}, {"lastName": "Sultan", "fullName": "Sultan T", "firstName": "Tahira", "initials": "T"}, {"lastName": "Al-Obeidan", "fullName": "Al-Obeidan SA", "firstName": "Saleh A", "initials": "SA"}]}, "title": "Association of SOD2 Mutation (c.47T > C) with Various Primary Angle Closure Glaucoma Clinical Indices.", "citedByCount": 0, "source": "MED", "pmid": "24070129", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Angle-Closure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Gonioscopy", "majorTopic_YN": "N"}, {"descriptorName": "Tonometry, Ocular", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Intraocular Pressure", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2013-09-27", "doi": "10.3109/13816810.2013.838276", "isOpenAccess": "N", "pageInfo": "180-183", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["glaucoma", "Saudi Arabia", "Primary Angle Closure Glaucoma", "Superoxidae Dismutatse"]}, "abstractText": "We investigated whether the c.47T>C polymorphism (SNP rs4880) in the manganese superoxide dismutase (SOD2) gene is a risk factor for primary angle closure glaucoma (PACG) in the Saudi population. Among cases (n=139), the prevalence of various genotypes were 25.9%, 46.8% and 27.3% for T/T, C/T and C/C genotypes respectively. This trend was similar in the controls (n=403); 22.6%, 50.1% and 27.3% for T/T, C/T and C/C respectively. The differences in genotype distribution were not statistically significant (p=0.391 and 0.682 respectively). The minor allele frequency was 50.7% in cases and 52.4% in controls; this difference was not statistically significant (p=0.676). Investigating the potential association between this SOD2 polymorphism and different clinical indices, there was a statistically significant difference among different genotype groups in terms of three important clinical indices for PACG; Mean age at onset, duration of onset to and the mean LogMAR visual acuity (p=0.041, 0.018 and 0.033 respectively). The three markers are highly associated prognostic factors to diseases severity. If our results are proven in larger cohort and in various populations, then this SNP may have potentiality to be used as an indicator for PACG severity.", "electronicPublicationDate": "2013-09-27", "language": "eng", "dateOfCompletion": "2016-02-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/13816810.2013.838276", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"medlineAbbreviation": "Ophthalmic Genet", "isoabbreviation": "Ophthalmic Genet.", "title": "Ophthalmic genetics", "issn": "1381-6810", "nlmid": "9436057", "essn": "1744-5094"}, "monthOfPublication": 6, "volume": "36", "yearOfPublication": 2015, "journalIssueId": 2296493, "issue": "2", "dateOfPublication": "2015 Jun"}}, "23289810": "", "20712757": "", "27207918": {"pubYear": "2016", "dateOfCreation": "2016-05-21", "pubModel": "Print-Electronic", "authorString": "Gitik M, Srivastava V, Hodgkinson CA, Shen PH, Goldman D, Meyerhoff DJ.", "affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27207918", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "fullName": "Gitik M", "initials": "M", "firstName": "Miri", "lastName": "Gitik"}, {"affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "fullName": "Srivastava V", "initials": "V", "firstName": "Vibhuti", "lastName": "Srivastava"}, {"affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "fullName": "Hodgkinson CA", "initials": "CA", "firstName": "Colin A", "lastName": "Hodgkinson"}, {"affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "fullName": "Shen PH", "initials": "PH", "firstName": "Pei-Hong", "lastName": "Shen"}, {"firstName": "David", "lastName": "Goldman", "affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.", "authorId": {"type": "ORCID", "value": "0000-0002-1724-5405"}, "fullName": "Goldman D", "initials": "D"}, {"affiliation": "Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, Maryland (Drs Gitik, Srivastava, and Hodgkinson, Ms Shen, and Dr Goldman); Department of Radiology and Biomedical Imaging, University of California, San Francisco, California (Dr Meyerhoff); Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California (Dr Meyerhoff).Current address (V.S.): Molecular Genetic Technology Program, School of Health Professions, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. dieter.meyerhoff@ucsf.edu.", "fullName": "Meyerhoff DJ", "initials": "DJ", "firstName": "Dieter J", "lastName": "Meyerhoff"}]}, "title": "Association of Superoxide Dismutase 2 (SOD2) Genotype with Gray Matter Volume Shrinkage in Chronic Alcohol Users: Replication and Further Evaluation of an Addiction Gene Panel.", "citedByCount": 0, "source": "MED", "pmid": "27207918", "hasLabsLinks": "Y", "hasTextMinedTerms": "N", "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-1724-5405"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-05-09", "doi": "10.1093/ijnp/pyw033", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Genetics", "Neuroimaging", "Alcohol Use Disorder", "Gray Matter Volume", "Superoxide Dismutase 2 (Sod2)"]}, "abstractText": "Reduction in brain volume, especially gray matter volume, has been shown to be one of the many deleterious effects of prolonged alcohol consumption. High variance in the degree of gray matter tissue shrinkage among alcohol-dependent individuals and a previous neuroimaging genetics report suggest the involvement of environmental and/or genetic factors, such as superoxide dismutase 2 (SOD2). Identification of such underlying factors will help in the clinical management of alcohol dependence.We analyzed quantitative magnetic resonance imaging and genotype data from 103 alcohol users, including both light drinkers and treatment-seeking alcohol-dependent individuals. Genotyping was performed using a custom gene array that included genes selected from 8 pathways relevant to chronic alcohol-related brain volume loss.We replicated a significant association of a functional SOD2 single nucleotide polymorphism with normalized gray matter volume, which had been reported previously in an independent smaller sample of alcohol-dependent individuals. The SOD2-related genetic protection was observed only at the cohort's lower drinking range. Additional associations between normalized gray matter volume and other candidate genes such as alcohol dehydrogenase gene cluster (ADH), GCLC, NOS3, and SYT1 were observed across the entire sample but did not survive corrections for multiple comparisons.Converging independent evidence for a SOD2 gene association with gray matter volume shrinkage in chronic alcohol users suggests that SOD2 genetic variants predict differential brain volume loss mediated by free radicals. This study also provides the first catalog of genetic variations relevant to gray matter loss in chronic alcohol users. The identified gene-brain structure relationships are functionally pertinent and merit replication.", "electronicPublicationDate": "2016-05-09", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1093/ijnp/pyw033", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-05-21", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-05-01", "journal": {"medlineAbbreviation": "Int J Neuropsychopharmacol", "isoabbreviation": "Int. J. Neuropsychopharmacol.", "title": "The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)", "issn": "1461-1457", "nlmid": "9815893", "essn": "1469-5111"}, "monthOfPublication": 5, "yearOfPublication": 2016, "journalIssueId": 2410919, "dateOfPublication": "2016 May"}}, "19753309": "", "18411704": "", "25933618": {"pubYear": "2015", "dateOfCreation": "2015-06-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "0", "name": "Hemoglobin A, Glycosylated"}, {"registryNumber": "0", "name": "Antigens, CD31"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Ziegler D, Strom A, Br\u00fcggemann J, Ziegler I, Ringel B, P\u00fcttgen S, Roden M, GDS Group.", "affiliation": "Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf'm Hennekamp 65, 40225, D\u00fcsseldorf, Germany, dan.ziegler@ddz.uni-duesseldorf.de.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25933618", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf'm Hennekamp 65, 40225, D\u00fcsseldorf, Germany, dan.ziegler@ddz.uni-duesseldorf.de.", "fullName": "Ziegler D", "initials": "D", "firstName": "Dan", "lastName": "Ziegler"}, {"lastName": "Strom", "fullName": "Strom A", "firstName": "Alexander", "initials": "A"}, {"lastName": "Br\u00fcggemann", "fullName": "Br\u00fcggemann J", "firstName": "Jutta", "initials": "J"}, {"lastName": "Ziegler", "fullName": "Ziegler I", "firstName": "Iris", "initials": "I"}, {"lastName": "Ringel", "fullName": "Ringel B", "firstName": "Bernd", "initials": "B"}, {"lastName": "P\u00fcttgen", "fullName": "P\u00fcttgen S", "firstName": "Sonja", "initials": "S"}, {"lastName": "Roden", "fullName": "Roden M", "firstName": "Michael", "initials": "M"}, {"collectiveName": "GDS Group"}]}, "title": "Overexpression of cutaneous mitochondrial superoxide dismutase in recent-onset type 2 diabetes.", "citedByCount": 0, "source": "MED", "pmid": "25933618", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Vagus Nerve", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sympathetic Nervous System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peripheral Nerves", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endothelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Skin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Diabetes Mellitus, Type 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hemoglobin A, Glycosylated", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, CD31", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Heart Rate", "majorTopic_YN": "N"}, {"descriptorName": "Neural Conduction", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-02", "doi": "10.1007/s00125-015-3609-5", "isOpenAccess": "N", "pageInfo": "1621-1625", "hasDbCrossReferences": "Y", "abstractText": "Oxidative stress and microvascular damage have been implicated in the pathogenesis of diabetic neuropathy, with manganese superoxide dismutase 2 (SOD2) responsible for superoxide detoxification in mitochondria. We hypothesised that patients with recently diagnosed type 2 diabetes would show an altered cutaneous expression of SOD2 and endothelial cell area.In this cross-sectional study, we assessed skin biopsies using immunohistochemistry, peripheral nerve function and heart rate variability in 69 participants of the German Diabetes Study with recently diagnosed type 2 diabetes and 51 control individuals.Subepidermal SOD2 area in the distal leg was increased by ~60% in the diabetic group vs the controls (0.24 \u00b1 0.02% vs 0.15 \u00b1 0.02%; p = 0.0005) and was correlated with an increasing duration of diabetes (r = 0.271; p = 0.024) and with the low frequency/high frequency ratio (\u03b2 = 0.381; p = 0.002) as an indicator of sympathovagal balance. The area of the subepidermal endothelial cells (measured by CD31 staining) did not differ between the groups.Cutaneous antioxidative defence is enhanced in relation to the duration of diabetes and is linked to a cardiac sympathovagal imbalance towards a sympathetic predominance in individuals with recently diagnosed type 2 diabetes without evidence of endothelial cell damage. Whether cutaneous SOD2 levels can predict the development of diabetic neuropathy remains to be determined in prospective studies.", "electronicPublicationDate": "2015-05-02", "language": "eng", "dateOfCompletion": "2016-03-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00125-015-3609-5", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-07-01", "journal": {"medlineAbbreviation": "Diabetologia", "isoabbreviation": "Diabetologia", "title": "Diabetologia", "issn": "0012-186X", "nlmid": "0006777", "essn": "1432-0428"}, "monthOfPublication": 7, "volume": "58", "yearOfPublication": 2015, "journalIssueId": 2296283, "issue": "7", "dateOfPublication": "2015 Jul"}}, "19219857": "", "22119635": "", "18006575": "", "18759352": "", "23805041": "", "22218650": "", "25417767": {"pubYear": "2015", "dateOfCreation": "2015-02-06", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Zhou Y, Shuai P, Li X, Liu X, Wang J, Yang Y, Hao F, Lin H, Zhang D, Gong B.", "affiliation": "Sichuan Key Laboratory for Disease Gene Study .", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25417767", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Sichuan Key Laboratory for Disease Gene Study .", "fullName": "Zhou Y", "initials": "Y", "firstName": "Yu", "lastName": "Zhou"}, {"lastName": "Shuai", "fullName": "Shuai P", "firstName": "Ping", "initials": "P"}, {"lastName": "Li", "fullName": "Li X", "firstName": "Xiulan", "initials": "X"}, {"lastName": "Liu", "fullName": "Liu X", "firstName": "Xiaoqi", "initials": "X"}, {"lastName": "Wang", "fullName": "Wang J", "firstName": "Jin", "initials": "J"}, {"lastName": "Yang", "fullName": "Yang Y", "firstName": "Yin", "initials": "Y"}, {"lastName": "Hao", "fullName": "Hao F", "firstName": "Fang", "initials": "F"}, {"lastName": "Lin", "fullName": "Lin H", "firstName": "He", "initials": "H"}, {"lastName": "Zhang", "fullName": "Zhang D", "firstName": "Dingding", "initials": "D"}, {"lastName": "Gong", "fullName": "Gong B", "firstName": "Bo", "initials": "B"}]}, "title": "Association of SOD2 polymorphisms with primary open angle glaucoma in a Chinese population.", "citedByCount": 0, "source": "MED", "pmid": "25417767", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Open-Angle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "China", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genotyping Techniques", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-11-24", "doi": "10.3109/13816810.2014.985844", "isOpenAccess": "N", "pageInfo": "43-49", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["SNPs", "Sod2", "Poag"]}, "abstractText": "BACKGROUND: Genetic factors have been studied extensively for their role in the pathogenesis of primary open angle glaucoma (POAG). This study was conducted to investigate whether manganese superoxide dismutase (SOD2) variants play a significant role in POAG in a Chinese population. METHODS: This study included of 416 unrelated POAG patients and 997 unrelated control subjects. Four SOD2 tag single nucleotide polymorphisms (SNPs), including rs6917589 rs2842980, rs5746136 and rs4880, were genotyped by dye terminator-based SNaPshot method. The genotype and allele frequencies were evaluated using the \u03c7(2) tests. RESULTS: Allelic association analysis showed that there were suggestive differences in the allelic distributions between POAG cases and controls for SNPs rs6917589 and rs5746136 (p\u2009=\u20090.0.046 and p\u2009=\u20090.032, respectively), but no statistically significant association was detected between the two SNPs and POAG after Bonferroni correction (p\u2009>\u20090.0125). The allele and genotype frequency in SNPs rs2842980 and rs4880 showed no statistically significant difference between POAG cases and controls (p\u2009=\u20090.128 and p\u2009=\u20090.867, respectively). SNP rs5746136 had a significant association with POAG in the recessive model (p\u2009=\u20090.003155). Haplotype ATGT generated from the four SNPs showed a trend of association with POAG (p\u2009=\u20090.0098). CONCLUSION: Our results showed a trend of association with POAG, suggesting that SOD2 may play a significant role in the development of POAG in the Chinese population. Further work with a larger sample size and functional study is needed to confirm the importance of the SOD2 gene in the pathogenesis of glaucoma.", "electronicPublicationDate": "2014-11-24", "language": "eng", "dateOfCompletion": "2015-08-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3109/13816810.2014.985844", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "Ophthalmic Genet", "isoabbreviation": "Ophthalmic Genet.", "title": "Ophthalmic genetics", "issn": "1381-6810", "nlmid": "9436057", "essn": "1744-5094"}, "monthOfPublication": 3, "volume": "36", "yearOfPublication": 2015, "journalIssueId": 2251540, "issue": "1", "dateOfPublication": "2015 Mar"}}, "25052559": {"pubYear": "2014", "dateOfCreation": "2014-09-04", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Carcinogens"}, {"registryNumber": "9035-51-2", "name": "Cytochrome P-450 Enzyme System"}, {"registryNumber": "0", "name": "Genetic Markers"}]}, "authorString": "Cotterchio M, Mirea L, Ozcelik H, Kreiger N.", "affiliation": "Prevention and Cancer Control, Cancer Care Ontario, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25052559", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Prevention and Cancer Control, Cancer Care Ontario, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.", "fullName": "Cotterchio M", "initials": "M", "firstName": "Michelle", "lastName": "Cotterchio"}, {"lastName": "Mirea", "fullName": "Mirea L", "firstName": "Lucia", "initials": "L"}, {"lastName": "Ozcelik", "fullName": "Ozcelik H", "firstName": "Hilmi", "initials": "H"}, {"lastName": "Kreiger", "fullName": "Kreiger N", "firstName": "Nancy", "initials": "N"}]}, "title": "Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.", "citedByCount": 2, "source": "MED", "pmid": "25052559", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Breast Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cytochrome P-450 Enzyme System", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Markers", "majorTopic_YN": "N"}, {"descriptorName": "Carcinogens", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Questionnaires", "majorTopic_YN": "N"}, {"descriptorName": "Registries", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Menopause", "majorTopic_YN": "Y"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Ontario", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-07-23", "doi": "10.1111/tbj.12304", "isOpenAccess": "N", "pageInfo": "468-480", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Breast neoplasms", "Single Nucleotide Polymorphisms", "Tobacco Smoke"]}, "abstractText": "Cigarette smoking is strongly associated with various diseases including many cancers; however, evidence regarding breast cancer risk remains inconclusive with some studies reporting no association, and others an increased risk with long duration and early initiation of smoking. Genetic variation in carcinogen-metabolizing enzymes may modify these associations. Breast cancer cases were identified from the Ontario Cancer Registry (OCR) during 2003-2004 and population controls through random digit dialing methods. All subjects completed self-administered questionnaires. Subsequently, saliva samples were obtained from cases (N = 1,776) and controls (N = 1,839) for deoxyribonucleic acid (DNA) extraction. Multivariate logistic regression was used to estimate odds ratio (OR) and 95% confidence intervals (CI) for active smoking variables, and interactions were assessed between smoking and 36 carcinogen-metabolizing candidate gene variants. No statistically significant association was found between active smoking and breast cancer risk among all women nor when stratified by menopausal status; however, nonsignificant increased premenopausal breast cancer risk was observed among current smokers and women smoking before first pregnancy. Several statistically significant interactions were observed between smoking and genetic variants (CYP1A2 1548C>T, CYP1A1 3801T>C, CYP1B1 4326G>C, NAT1 c.-85-1014T>A, UGT1A7 W208R 622T>C, SOD2 c.47T>C, GSTT1 deletion). However, in analyses stratified by these genotypes, smoking ORs had wide confidence intervals (and with few exceptions included 1.0) making interpretations difficult. Active smoking was not associated with breast cancer risk, although several significant interactions were observed between smoking, carcinogen-metabolizing genetic variants, and breast cancer risk.", "electronicPublicationDate": "2014-07-23", "language": "eng", "dateOfCompletion": "2015-05-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1111/tbj.12304", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-09-01", "journal": {"medlineAbbreviation": "Breast J", "isoabbreviation": "Breast J", "title": "The breast journal", "issn": "1075-122X", "nlmid": "9505539", "essn": "1524-4741"}, "monthOfPublication": 0, "volume": "20", "yearOfPublication": 2014, "journalIssueId": 2212824, "issue": "5", "dateOfPublication": "2014 Sep-Oct"}}, "27161188": {"pubYear": "2016", "dateOfCreation": "2016-05-10", "pubModel": "Print-Electronic", "authorString": "Wang J, Li J, Peng K, Fu ZY, Tang J, Yang MJ, Chen QC.", "affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China; School of Basic Medical Sciences, Dali University, Dali, China. Electronic address: wangjing1807@foxmail.com.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27161188", "inEPMC": "N", "authorList": {"author": [{"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China; School of Basic Medical Sciences, Dali University, Dali, China. Electronic address: wangjing1807@foxmail.com.", "fullName": "Wang J", "initials": "J", "firstName": "Jing", "lastName": "Wang"}, {"affiliation": "School of Basic Medical Sciences, Dali University, Dali, China; School of Clinical Medicine, Dali University, Dali, China.", "fullName": "Li J", "initials": "J", "firstName": "Jun", "lastName": "Li"}, {"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China.", "fullName": "Peng K", "initials": "K", "firstName": "Kang", "lastName": "Peng"}, {"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China.", "fullName": "Fu ZY", "initials": "ZY", "firstName": "Zi-Ying", "lastName": "Fu"}, {"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China.", "fullName": "Tang J", "initials": "J", "firstName": "Jia", "lastName": "Tang"}, {"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China.", "fullName": "Yang MJ", "initials": "MJ", "firstName": "Ming-Jian", "lastName": "Yang"}, {"affiliation": "School of Life Sciences and Hubei Key Lab of Genetic Regulation and Integrative Biology, Central China Normal University, Wuhan, China. Electronic address: chenqc@mail.ccnu.edu.cn.", "fullName": "Chen QC", "initials": "QC", "firstName": "Qi-Cai", "lastName": "Chen"}]}, "title": "Association of the C47T polymorphism in superoxide dismutase gene 2 with noise-induced hearing loss: a meta-analysis.", "citedByCount": 0, "source": "MED", "pmid": "27161188", "hasLabsLinks": "N", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-04-19", "doi": "10.1016/j.bjorl.2016.01.008", "isOpenAccess": "N", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Polymorphism", "Meta-analysis", "Noise-induced Hearing Loss", "Metan\u00e1lise", "Polimorfismo", "Gene Da Super\u00f3xido Dismutase 2", "Perda Auditiva Induzida Por Ru\u00eddo", "Superoxide Dismutase Gene 2"]}, "abstractText": "Currently, there is limited information about the relationship between manganese superoxide dismutase (sod2) c47t polymorphism and susceptibility to noise-induced hearing loss (NIHL).The aim of this meta-analysis was to clarify the association between SOD2 C47T polymorphism and NIHL.A search in PubMed and Web of Science was performed to collect data. All full-text, English-written studies containing sufficient and complete case-and-control data about the relationship between SOD2 C47T polymorphism and NIHL were included. Three eligible studies, comprising 1094 subjects, were identified. pooled odds ratios (ORs) and 95% confidence intervals (CI) were calculated to evaluate the strength of the association between SOD2 C47T polymorphism and NIHL.No significant association between C47T polymorphism and risk of NIHL was found with the following combinations: T vs. C (OR=0.83; 95% CI=0.63-1.09); TT vs. CC (OR=0.49; 95% CI=0.22-1.09); CT vs. CC (OR=0.54; 95% CI=0.25-1.17); TT vs. CC+CT (OR=0.82; 95% CI=0.50-1.32); CC vs. TT+TC (OR=0.49; 95% CI=0.23-1.04). However, in subgroup analysis, a significant association was found for TT vs. CC+CT (OR=0.77; 95% CI=0.42-1.41) in the Chinese population.The present meta-analysis suggests that SOD2 C47T polymorphism is significantly associated with increased risk of NIHL in the Chinese population. Further large and well-designed studies are needed to confirm this association.", "electronicPublicationDate": "2016-04-19", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.bjorl.2016.01.008", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-05-11", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-04-01", "journal": {"medlineAbbreviation": "Braz J Otorhinolaryngol", "isoabbreviation": "Braz J Otorhinolaryngol", "title": "Brazilian journal of otorhinolaryngology", "issn": "1808-8694", "nlmid": "101207337", "essn": "1808-8686"}, "monthOfPublication": 4, "yearOfPublication": 2016, "journalIssueId": 2401883, "dateOfPublication": "2016 Apr"}}, "20534900": "", "19778569": "", "20864405": "", "11161607": "", "22001364": "", "25299611": {"pubYear": "2014", "dateOfCreation": "2014-10-10", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ALS2 protein, human"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "0", "name": "Apolipoproteins E"}, {"registryNumber": "0", "name": "Guanine Nucleotide Exchange Factors"}, {"registryNumber": "0", "name": "Heterogeneous-Nuclear Ribonucleoproteins"}, {"registryNumber": "0", "name": "RNA-Binding Protein FUS"}, {"registryNumber": "EC 3.6.1.-", "name": "SETX protein, human"}, {"registryNumber": "0", "name": "C9orf72 protein, human"}, {"registryNumber": "EC 3.6.4.13", "name": "RNA Helicases"}, {"registryNumber": "0", "name": "FUS protein, human"}]}, "authorString": "Couthouis J, Raphael AR, Daneshjou R, Gitler AD.", "affiliation": "Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS065317"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS073660"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "R01 NS065317"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS07360"}]}, "hasPDF": "Y", "id": "25299611", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Julien", "lastName": "Couthouis", "affiliation": "Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.", "authorId": {"type": "ORCID", "value": "0000-0002-2378-4595"}, "fullName": "Couthouis J", "initials": "J"}, {"affiliation": "Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.", "fullName": "Raphael AR", "initials": "AR", "firstName": "Alya R", "lastName": "Raphael"}, {"affiliation": "Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.", "fullName": "Daneshjou R", "initials": "R", "firstName": "Roxana", "lastName": "Daneshjou"}, {"affiliation": "Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.", "fullName": "Gitler AD", "initials": "AD", "firstName": "Aaron D", "lastName": "Gitler"}]}, "title": "Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25299611", "abstractText": "Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive degeneration of motor neurons, ultimately leading to paralysis and death. Approximately 10% of ALS cases are familial, with the remaining 90% of cases being sporadic. Genetic studies in familial cases of ALS have been extremely informative in determining the causative mutations behind ALS, especially as the same mutations identified in familial ALS can also cause sporadic disease. However, the cause of ALS in approximately 30% of familial cases and in the majority of sporadic cases remains unknown. Sporadic ALS cases represent an underutilized resource for genetic information about ALS; therefore, we undertook a targeted sequencing approach of 169 known and candidate ALS disease genes in 242 sporadic ALS cases and 129 matched controls to try to identify novel variants linked to ALS. We found a significant enrichment in novel and rare variants in cases versus controls, indicating that we are likely identifying disease associated mutations. This study highlights the utility of next generation sequencing techniques combined with functional studies and rare variant analysis tools to provide insight into the genetic etiology of a heterogeneous sporadic disease.", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2378-4595"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA Helicases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Guanine Nucleotide Exchange Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apolipoproteins E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Heterogeneous-Nuclear Ribonucleoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA-Binding Protein FUS", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-10-09", "language": "eng", "doi": "10.1371/journal.pgen.1004704", "isOpenAccess": "Y", "pageInfo": "e1004704", "pmcid": "PMC4191946", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "electronicPublicationDate": "2014-10-09", "license": "cc by", "dateOfCompletion": "2016-04-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4191946?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4191946", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pgen.1004704", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-23", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-10-01", "journal": {"medlineAbbreviation": "PLoS Genet", "isoabbreviation": "PLoS Genet.", "title": "PLoS genetics", "issn": "1553-7390", "nlmid": "101239074", "essn": "1553-7404"}, "monthOfPublication": 10, "volume": "10", "yearOfPublication": 2014, "journalIssueId": 2207099, "issue": "10", "dateOfPublication": "2014 Oct"}}, "22516022": "", "17394531": "", "22877234": "", "21215776": "", "16807759": "", "22723845": "", "24119114": {"pubYear": "2013", "dateOfCreation": "2013-11-15", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}, {"registryNumber": "EC 1.15.1.1", "name": "superoxide dismutase 2"}]}, "authorString": "Ascencio-Montiel Ide J, Parra EJ, Valladares-Salgado A, G\u00f3mez-Zamudio JH, Kumate-Rodriguez J, Escobedo-de-la-Pe\u00f1a J, Cruz M.", "affiliation": "Biochemistry Research Unit, Hospital de Especialidades, Centro M\u00e9dico Nacional \"Siglo XXI\", Instituto Mexicano del Seguro Social, Mexico DF, Mexico. mcruzl@yahoo.com.", "pubTypeList": {"pubType": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "Y", "id": "24119114", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Biochemistry Research Unit, Hospital de Especialidades, Centro M\u00e9dico Nacional \"Siglo XXI\", Instituto Mexicano del Seguro Social, Mexico DF, Mexico. mcruzl@yahoo.com.", "fullName": "Ascencio-Montiel Ide J", "initials": "Ide J", "firstName": "Iv\u00e1n de Jes\u00fas", "lastName": "Ascencio-Montiel"}, {"lastName": "Parra", "fullName": "Parra EJ", "firstName": "Esteban J", "initials": "EJ"}, {"lastName": "Valladares-Salgado", "fullName": "Valladares-Salgado A", "firstName": "Ad\u00e1n", "initials": "A"}, {"lastName": "G\u00f3mez-Zamudio", "fullName": "G\u00f3mez-Zamudio JH", "firstName": "Jaime H", "initials": "JH"}, {"lastName": "Kumate-Rodriguez", "fullName": "Kumate-Rodriguez J", "firstName": "Jes\u00fas", "initials": "J"}, {"lastName": "Escobedo-de-la-Pe\u00f1a", "fullName": "Escobedo-de-la-Pe\u00f1a J", "authorId": {"type": "ORCID", "value": "0000-0003-1942-7402"}, "firstName": "Jorge", "initials": "J"}, {"lastName": "Cruz", "fullName": "Cruz M", "firstName": "Miguel", "initials": "M"}]}, "title": "SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican type 2 diabetes patients: a comparative study and meta-analysis.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24119114", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1942-7402"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Albuminuria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Diabetes Mellitus, Type 2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Logistic Models", "majorTopic_YN": "N"}, {"descriptorName": "Odds Ratio", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Alleles", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Mexico", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EH", "qualifierName": "ethnology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-10-11", "language": "eng", "doi": "10.1186/1471-2350-14-110", "isOpenAccess": "Y", "pageInfo": "110", "pmcid": "PMC3853578", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Several studies in type 2 diabetes patients have shown significant associations between the SOD2 gene Val16Ala polymorphism and albuminuria, but this association has not been explored in the Mexican population. METHODS: We evaluated the association between the SOD2 gene Val16Ala polymorphism (rs4880) and macroalbuminuria in a sample of 994 unrelated Mexican type 2 diabetes patients. The study included 119 subjects with urinary albumin >300 mg/dL and 875 subjects with urinary albumin \u2264 30 mg/dL. Genotyping of the SOD2 gene Val16Ala SNP was carried out with Real-Time Polymerase Chain Reaction (RT-PCR). RESULTS: The frequency of the TT genotype was 6.7% higher in participants with macroalbuminuria than in the normoalbuminuria group (16.8% vs. 10.1%). Using a logistic regression analysis, we observed that individuals with the CC genotype had significantly lower risks of macroalbuminuria than those with the TT genotype (OR=0.42, p=0.034). We carried out a meta-analysis combining our data with data from four previous studies and estimated an odds ratio (95% CI) for the C allele (with respect to the reference T allele) of 0.65 (0.52-0.80, p<0.001). CONCLUSIONS: A significant association was found between the SOD2 Val16Ala polymorphism and macroalbuminuria in a sample of Mexican type 2 diabetes patients.", "electronicPublicationDate": "2013-10-11", "license": "cc by", "dateOfCompletion": "2014-01-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3853578?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3853578", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24119114&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24119114", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/1471-2350-14-110", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "BMC medical genetics", "medlineAbbreviation": "BMC Med Genet", "isoabbreviation": "BMC Med. Genet.", "nlmid": "100968552", "essn": "1471-2350"}, "monthOfPublication": 0, "volume": "14", "yearOfPublication": 2013, "journalIssueId": 2002739, "dateOfPublication": "2013 "}}, "9006653": "", "15345661": ""}, "PUM1": {"18776931": {"pubYear": "2008", "dateOfCreation": "2008-09-08", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "PUM1 protein, human"}, {"registryNumber": "0", "name": "PUM2 protein, human"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "DNA Primers"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "MicroRNAs"}]}, "authorString": "Galgano A, Forrer M, Jaskiewicz L, Kanitz A, Zavolan M, Gerber AP.", "affiliation": "Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Comparative Study"]}, "hasPDF": "Y", "id": "18776931", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Galgano", "fullName": "Galgano A", "firstName": "Alessia", "initials": "A"}, {"lastName": "Forrer", "fullName": "Forrer M", "firstName": "Michael", "initials": "M"}, {"lastName": "Jaskiewicz", "fullName": "Jaskiewicz L", "firstName": "Lukasz", "initials": "L"}, {"lastName": "Kanitz", "fullName": "Kanitz A", "firstName": "Alexander", "initials": "A"}, {"lastName": "Zavolan", "fullName": "Zavolan M", "firstName": "Mihaela", "initials": "M"}, {"lastName": "Gerber", "fullName": "Gerber AP", "firstName": "Andr\u00e9 P", "initials": "AP"}]}, "title": "Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.", "hasSuppl": "Y", "citedByCount": 110, "source": "MED", "pmid": "18776931", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Drosophila melanogaster", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "MicroRNAs", "majorTopic_YN": "Y"}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "Y"}, {"descriptorName": "Binding Sites", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Motifs", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Multigene Family", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT", "ARXPR"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2008-09-08", "doi": "10.1371/journal.pone.0003164", "isOpenAccess": "Y", "pageInfo": "e3164", "pmcid": "PMC2522278", "hasDbCrossReferences": "Y", "abstractText": "Genome-wide identification of mRNAs regulated by RNA-binding proteins is crucial to uncover post-transcriptional gene regulatory systems. The conserved PUF family RNA-binding proteins repress gene expression post-transcriptionally by binding to sequence elements in 3'-UTRs of mRNAs. Despite their well-studied implications for development and neurogenesis in metazoa, the mammalian PUF family members are only poorly characterized and mRNA targets are largely unknown. We have systematically identified the mRNAs associated with the two human PUF proteins, PUM1 and PUM2, by the recovery of endogenously formed ribonucleoprotein complexes and the analysis of associated RNAs with DNA microarrays. A largely overlapping set comprised of hundreds of mRNAs were reproducibly associated with the paralogous PUM proteins, many of them encoding functionally related proteins. A characteristic PUF-binding motif was highly enriched among PUM bound messages and validated with RNA pull-down experiments. Moreover, PUF motifs as well as surrounding sequences exhibit higher conservation in PUM bound messages as opposed to transcripts that were not found to be associated, suggesting that PUM function may be modulated by other factors that bind conserved elements. Strikingly, we found that PUF motifs are enriched around predicted miRNA binding sites and that high-confidence miRNA binding sites are significantly enriched in the 3'-UTRs of experimentally determined PUM1 and PUM2 targets, strongly suggesting an interaction of human PUM proteins with the miRNA regulatory system. Our work suggests extensive connections between the RBP and miRNA post-transcriptional regulatory systems and provides a framework for deciphering the molecular mechanism by which PUF proteins regulate their target mRNAs.", "electronicPublicationDate": "2008-09-08", "language": "eng", "dateOfCompletion": "2008-11-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2522278?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2522278", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=18776931&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=18776931", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0003164", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2009-11-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2008-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2008, "journalIssueId": 1553793, "issue": "9", "dateOfPublication": "2008 "}}}, "NTM": {"26155783": {"pubYear": "2015", "dateOfCreation": "2015-08-22", "pubModel": "Print-Electronic", "authorString": "Kotilainen H, Valtonen V, Tukiainen P, Poussa T, Eskola J, J\u00e4rvinen A.", "affiliation": "University of Helsinki and Division of Infectious Diseases, Inflammation Center, Department of Medicine, Helsinki University Hospital, Helsinki, Finland, hannele.kotilainen@welho.com.", "pubTypeList": {"pubType": ["Journal Article", "Comparative Study"]}, "hasPDF": "Y", "id": "26155783", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "University of Helsinki and Division of Infectious Diseases, Inflammation Center, Department of Medicine, Helsinki University Hospital, Helsinki, Finland, hannele.kotilainen@welho.com.", "fullName": "Kotilainen H", "initials": "H", "firstName": "H", "lastName": "Kotilainen"}, {"lastName": "Valtonen", "fullName": "Valtonen V", "firstName": "V", "initials": "V"}, {"lastName": "Tukiainen", "fullName": "Tukiainen P", "firstName": "P", "initials": "P"}, {"lastName": "Poussa", "fullName": "Poussa T", "firstName": "T", "initials": "T"}, {"lastName": "Eskola", "fullName": "Eskola J", "firstName": "J", "initials": "J"}, {"lastName": "J\u00e4rvinen", "fullName": "J\u00e4rvinen A", "firstName": "A", "initials": "A"}]}, "title": "Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26155783", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Lung", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mycobacterium avium Complex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PY", "qualifierName": "pathogenicity", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mycobacterium avium-intracellulare Infection", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lung Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Prognosis", "majorTopic_YN": "N"}, {"descriptorName": "Survival Rate", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-07-09", "language": "eng", "doi": "10.1007/s10096-015-2432-8", "isOpenAccess": "Y", "pageInfo": "1909-1918", "pmcid": "PMC4545189", "hasDbCrossReferences": "N", "abstractText": "We compared the clinical findings and survival in patients with Mycobacterium avium complex (MAC) and other non-tuberculous mycobacteria (NTM). A total of 167 adult non-human immunodeficiency virus (HIV) patients with at least one positive culture for NTM were included. Medical records were reviewed. The patients were categorised according to the 2007 American Thoracic Society (ATS) criteria. MAC comprised 59 % of all NTM findings. MAC patients were more often female (70 % vs. 34 %, p\u2009<\u20090.001) and had less fatal underlying diseases (23 % vs. 47 %, p\u2009=\u20090.001) as compared to other NTM patients. Symptoms compatible with NTM infection had lasted for less than a year in 34 % of MAC patients but in 54 % of other NTM patients (p\u2009=\u20090.037). Pulmonary MAC patients had a significantly lower risk of death compared to pulmonary other NTM (hazard ratio [HR] 0.50, 95 % confidence interval [CI] 0.33-0.77, p\u2009=\u20090.002) or subgroup of other slowly growing NTM (HR 0.55, 95 % CI 0.31-0.99, p\u2009=\u20090.048) or as rapidly growing NTM (HR 0.47, 95 % CI 0.25-0.87, p\u2009=\u20090.02). The median survival time was 13.0 years (95 % CI 5.9-20.1) for pulmonary MAC but 4.6 years (95 % CI 3.4-5.9) for pulmonary other NTM. Serious underlying diseases (HR\u20093.21, 95 % CI 2.05-5.01, p\u2009<\u20090.001) and age (HR 1.07, 95 % CI 1.04-1.09, p\u2009<\u20090.001) were the significant predictors of mortality and female sex was a predictor of survival (HR 0.38, 95 % CI 0.24-0.59, p\u2009<\u20090.001) in the multivariate analysis. Pulmonary MAC patients had better prognosis than pulmonary other NTM patients. The symptom onset suggests a fairly rapid disease course.", "electronicPublicationDate": "2015-07-09", "license": "cc", "dateOfCompletion": "2016-06-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4545189?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4545189", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s10096-015-2432-8", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-26", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-09-01", "journal": {"medlineAbbreviation": "Eur J Clin Microbiol Infect Dis", "isoabbreviation": "Eur. J. Clin. Microbiol. Infect. Dis.", "title": "European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology", "issn": "0934-9723", "nlmid": "8804297", "essn": "1435-4373"}, "monthOfPublication": 9, "volume": "34", "yearOfPublication": 2015, "journalIssueId": 2316195, "issue": "9", "dateOfPublication": "2015 Sep"}}, "26666259": {"pubYear": "2016", "dateOfCreation": "2015-12-15", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anti-Bacterial Agents"}]}, "authorString": "Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, Hempstead SE, Koetz K, Sabadosa KA, Sermet-Gaudelus I, Smyth AR, van Ingen J, Wallace RJ, Winthrop KL, Marshall BC, Haworth CS, US Cystic Fibrosis Foundation and European Cystic Fibrosis Society.", "affiliation": "Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.", "pubTypeList": {"pubType": ["Consensus Development Conference", "Journal Article", "Practice Guideline", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Intramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Wellcome Trust"}, {"orderIn": 0, "agency": "Intramural NIH HHS"}]}, "hasPDF": "Y", "id": "26666259", "inEPMC": "Y", "authorList": {"author": [{"firstName": "R Andres", "lastName": "Floto", "affiliation": "Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.", "authorId": {"type": "ORCID", "value": "0000-0002-2188-5659"}, "fullName": "Floto RA", "initials": "RA"}, {"affiliation": "Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.", "fullName": "Olivier KN", "initials": "KN", "firstName": "Kenneth N", "lastName": "Olivier"}, {"affiliation": "Department of Pediatrics, Columbia University Medical Center, Pediatric Infectious Diseases, New York, New York, USA.", "fullName": "Saiman L", "initials": "L", "firstName": "Lisa", "lastName": "Saiman"}, {"affiliation": "Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, Colorado, USA.", "fullName": "Daley CL", "initials": "CL", "firstName": "Charles L", "lastName": "Daley"}, {"affiliation": "INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France AP-HP, Service de Microbiologie, H\u00f4pital Raymond Poincar\u00e9, Garches, France.", "fullName": "Herrmann JL", "initials": "JL", "firstName": "Jean-Louis", "lastName": "Herrmann"}, {"affiliation": "Department of Medicine, National Jewish Health, Denver, Colorado, USA.", "fullName": "Nick JA", "initials": "JA", "firstName": "Jerry A", "lastName": "Nick"}, {"affiliation": "The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.", "fullName": "Noone PG", "initials": "PG", "firstName": "Peadar G", "lastName": "Noone"}, {"affiliation": "Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.", "fullName": "Bilton D", "initials": "D", "firstName": "Diana", "lastName": "Bilton"}, {"affiliation": "Department of Respiratory Medicine, Freeman Hospital, High Heaton, Newcastle, UK.", "fullName": "Corris P", "initials": "P", "firstName": "Paul", "lastName": "Corris"}, {"affiliation": "Department of Pediatrics University of Washington School of Medicine, Seattle, Washington, USA.", "fullName": "Gibson RL", "initials": "RL", "firstName": "Ronald L", "lastName": "Gibson"}, {"affiliation": "The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.", "fullName": "Hempstead SE", "initials": "SE", "firstName": "Sarah E", "lastName": "Hempstead"}, {"affiliation": "Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.", "fullName": "Koetz K", "initials": "K", "firstName": "Karsten", "lastName": "Koetz"}, {"affiliation": "The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.", "fullName": "Sabadosa KA", "initials": "KA", "firstName": "Kathryn A", "lastName": "Sabadosa"}, {"affiliation": "Service de Pneumo-P\u00e9diatrie, Universit\u00e9 Ren\u00e9 Descartes, H\u00f4pital Necker-Enfants Malades, Paris, France.", "fullName": "Sermet-Gaudelus I", "initials": "I", "firstName": "Isabelle", "lastName": "Sermet-Gaudelus"}, {"affiliation": "Division of Child Health, Obstetrics & Gynaecology, University of Nottingham, Nottingham, UK.", "fullName": "Smyth AR", "initials": "AR", "firstName": "Alan R", "lastName": "Smyth"}, {"firstName": "Jakko", "lastName": "van Ingen", "affiliation": "Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.", "authorId": {"type": "ORCID", "value": "0000-0002-0581-2003"}, "fullName": "van Ingen J", "initials": "J"}, {"affiliation": "Department of Microbiology, University of Texas Health Science Center, Tyler, Texas, USA.", "fullName": "Wallace RJ", "initials": "RJ", "firstName": "Richard J", "lastName": "Wallace"}, {"affiliation": "Oregon Health and Sciences University, Portland, Oregon, USA.", "fullName": "Winthrop KL", "initials": "KL", "firstName": "Kevin L", "lastName": "Winthrop"}, {"affiliation": "Cystic Fibrosis Foundation, Bethesda, Maryland, USA.", "fullName": "Marshall BC", "initials": "BC", "firstName": "Bruce C", "lastName": "Marshall"}, {"affiliation": "Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.", "fullName": "Haworth CS", "initials": "CS", "firstName": "Charles S", "lastName": "Haworth"}, {"collectiveName": "US Cystic Fibrosis Foundation and European Cystic Fibrosis Society"}]}, "title": "US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.", "hasSuppl": "Y", "citedByCount": 0, "source": "MED", "pmid": "26666259", "abstractText": "Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease such as cystic fibrosis (CF). Pulmonary disease caused by NTM has emerged as a major threat to the health of individuals with CF but remains difficult to diagnose and problematic to treat. In response to this challenge, the US Cystic Fibrosis Foundation (CFF) and the European Cystic Fibrosis Society (ECFS) convened an expert panel of specialists to develop consensus recommendations for the screening, investigation, diagnosis and management of NTM pulmonary disease in individuals with CF. Nineteen experts were invited to participate in the recommendation development process. Population, Intervention, Comparison, Outcome (PICO) methodology and systematic literature reviews were employed to inform draft recommendations. An anonymous voting process was used by the committee to reach consensus. All committee members were asked to rate each statement on a scale of: 0, completely disagree, to 9, completely agree; with 80% or more of scores between 7 and 9 being considered 'good' agreement. Additionally, the committee solicited feedback from the CF communities in the USA and Europe and considered the feedback in the development of the final recommendation statements. Three rounds of voting were conducted to achieve 80% consensus for each recommendation statement. Through this process, we have generated a series of pragmatic, evidence-based recommendations for the screening, investigation, diagnosis and treatment of NTM infection in individuals with CF as an initial step in optimising management for this challenging condition.", "tmAccessionTypeList": {"accessionType": ["nct"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2188-5659"}, {"type": "ORCID", "value": "0000-0002-0581-2003"}, {"type": "ORCID", "value": "0000-0002-2188-5659"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Pneumonia, Bacterial", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cystic Fibrosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anti-Bacterial Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mass Screening", "majorTopic_YN": "N"}, {"descriptorName": "Injections, Intravenous", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Societies, Medical", "majorTopic_YN": "N"}, {"descriptorName": "United States", "majorTopic_YN": "N"}, {"descriptorName": "Europe", "majorTopic_YN": "N"}, {"descriptorName": "Mycobacterium Infections, Nontuberculous", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nontuberculous Mycobacteria", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2016-01-01", "doi": "10.1136/thoraxjnl-2015-207360", "isOpenAccess": "Y", "pageInfo": "i1-22", "pmcid": "PMC4717371", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Cystic Fibrosis", "Bacterial Infection"]}, "hasLabsLinks": "Y", "language": "eng", "license": "cc by", "dateOfCompletion": "2016-04-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4717371?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4717371", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1136/thoraxjnl-2015-207360", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-01-29", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Thorax", "isoabbreviation": "Thorax", "title": "Thorax", "issn": "0040-6376", "nlmid": "0417353", "essn": "1468-3296"}, "monthOfPublication": 1, "volume": "71 Suppl 1", "yearOfPublication": 2016, "journalIssueId": 2354682, "dateOfPublication": "2016 Jan"}}, "21036197": {"pubYear": "2011", "dateOfCreation": "2011-01-11", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "neurotrimin"}, {"registryNumber": "0", "name": "Receptors, Glucocorticoid"}, {"registryNumber": "0", "name": "Neural Cell Adhesion Molecules"}, {"registryNumber": "0", "name": "GPI-Linked Proteins"}]}, "authorString": "Pan Y, Wang KS, Aragam N.", "affiliation": "Department of Mathematics and Statistics, College of Arts and Sciences, East Tennessee State University, Johnson City, TN 37614, USA.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01 GM31575"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01MH081803"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10AA08403"}, {"acronym": "AA", "orderIn": 0, "agency": "NIAAA NIH HHS", "grantId": "U10AA08401"}, {"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01MH62873"}]}, "hasPDF": "N", "id": "21036197", "inEPMC": "N", "authorList": {"author": [{"lastName": "Pan", "fullName": "Pan Y", "firstName": "Yue", "initials": "Y"}, {"lastName": "Wang", "fullName": "Wang KS", "firstName": "Ke-Sheng", "initials": "KS"}, {"lastName": "Aragam", "fullName": "Aragam N", "firstName": "Nagesh", "initials": "N"}]}, "title": "NTM and NR3C2 polymorphisms influencing intelligence: family-based association studies.", "citedByCount": 9, "source": "MED", "pmid": "21036197", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 11", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alcoholism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neural Cell Adhesion Molecules", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Glucocorticoid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intelligence", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Attention Deficit Disorder with Hyperactivity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intelligence Tests", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "Y"}, {"descriptorName": "International Cooperation", "majorTopic_YN": "Y"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Family Health", "majorTopic_YN": "Y"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "GPI-Linked Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-10-29", "doi": "10.1016/j.pnpbp.2010.10.016", "isOpenAccess": "N", "pageInfo": "154-160", "hasDbCrossReferences": "Y", "abstractText": "Family, twin, and adoption studies have indicated that human intelligence quotient (IQ) has significant genetic components. We performed a low-density genome-wide association analysis with a family-based association test to identify genetic variants influencing IQ, as measured by Wechsler Adult Intelligence Scale full-score IQ (FSIQ). We examined 11,120 single-nucleotide polymorphisms (SNPs) from the Affymetrix GeneChips 10K mapping array genotyped in 292 nuclear families from Genetic Analysis Workshop 14, a subset from the Collaborative Study on the Genetics of Alcoholism (COGA). A replication analysis was performed using part of International Multi-Center ADHD Genetics Project (IMAGE) dataset. Twenty-two SNPs were identified as having suggestive associations with IQ (p<10(-3)) in the COGA sample and eleven of the SNPs were located within known genes. In particular, NTM at 11q25 (rs411280, p = 0.000764) and NR3C2 at 4q31.1 (rs3846329, p = 0.000675) were two novel genes which have not been associated with IQ in other studies. It has been reported that NTM might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and major depression. The associations of these two genes were well-replicated by single-marker and haplotype analyses in the IMAGE sample. In conclusion, our findings provide evidence that chromosome regions of 11q25 and 4q31.1 contain genes affecting IQ. This study will serve as a resource for replication in other populations.", "electronicPublicationDate": "2010-10-29", "language": "eng", "dateOfCompletion": "2011-05-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pnpbp.2010.10.016", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Prog Neuropsychopharmacol Biol Psychiatry", "isoabbreviation": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "title": "Progress in neuro-psychopharmacology & biological psychiatry", "issn": "0278-5846", "nlmid": "8211617", "essn": "1878-4216"}, "monthOfPublication": 1, "volume": "35", "yearOfPublication": 2011, "journalIssueId": 1798786, "issue": "1", "dateOfPublication": "2011 Jan"}}, "14519498": {"pubYear": "2003", "dateOfCreation": "2003-10-01", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "47165-04-8", "name": "DAPI"}, {"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Indoles"}, {"registryNumber": "0", "name": "Tubulin"}, {"registryNumber": "0", "name": "DNA-Binding Proteins"}, {"registryNumber": "0", "name": "Transcription Factors"}, {"registryNumber": "0", "name": "NR4A2 protein, human"}, {"registryNumber": "0", "name": "Nuclear Receptor Subfamily 4, Group A, Member 2"}]}, "authorString": "Misiuta IE, Anderson L, McGrogan MP, Sanberg PR, Willing AE, Zigova T.", "affiliation": "Center of Excellence for Aging and Brain Repair, University of South Florida College of Medicine, Tampa, FL, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S.", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS40583-01"}]}, "hasPDF": "N", "id": "14519498", "inEPMC": "N", "authorList": {"author": [{"lastName": "Misiuta", "fullName": "Misiuta IE", "firstName": "Iwona E", "initials": "IE"}, {"lastName": "Anderson", "fullName": "Anderson L", "firstName": "Lynn", "initials": "L"}, {"lastName": "McGrogan", "fullName": "McGrogan MP", "firstName": "Michael P", "initials": "MP"}, {"lastName": "Sanberg", "fullName": "Sanberg PR", "firstName": "Paul R", "initials": "PR"}, {"lastName": "Willing", "fullName": "Willing AE", "firstName": "Alison E", "initials": "AE"}, {"lastName": "Zigova", "fullName": "Zigova T", "firstName": "Tanja", "initials": "T"}]}, "title": "The transcription factor Nurr1 in human NT2 cells and hNT neurons.", "citedByCount": 10, "source": "MED", "pmid": "14519498", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tumor Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Neoplasms, Germ Cell and Embryonal", "majorTopic_YN": "N"}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Indoles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tubulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "DNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Transcription Factors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Blotting, Northern", "majorTopic_YN": "N"}, {"descriptorName": "Cell Count", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Survival", "majorTopic_YN": "N"}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "Nuclear Receptor Subfamily 4, Group A, Member 2", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2003-10-01", "doi": "10.1016/s0165-3806(03)00221-9", "isOpenAccess": "N", "pageInfo": "107-115", "hasDbCrossReferences": "N", "abstractText": "Human, neuronally committed hNT or NT2-N cells, originally derived from the Ntera2/D1 (NT2) clone after exposure to retinoic acid (RA), represent a potentially important source of cells to treat neurodegenerative diseases. Our previous in vitro experiments showed that hNT cells possess immunocytochemically detectable markers typical of dopaminergic (DA) ventral mesencephalic (VM) neurons, including tyrosine hydroxylase (TH), dopamine transporter (DAT), dopamine receptor (D2), and aldehyde dehydrogenase (AHD-2). In the current study, we sought to examine whether Nurr1, an orphan receptor of the nuclear receptor superfamily shown to be essential for the development, differentiation and survival of midbrain DA neurons, would be expressed in 3, 4, or 5 week RA-induced hNT neurons and their NT2 precursors. Our immunocytochemical analyses indicate that NT2 cells as well as hNT neurons independent of the length of RA-driven differentiation were Nurr1-immunoreactive. RT-PCR analysis confirmed the expression of Nurr1-specific mRNA in both NT2 precursors and the hNT neurons. Furthermore, immunocytochemical co-expression of Nurr1 and TH was detected in hNT neurons. The findings of this study suggest that Nurr1 may be important during the development of hNT neurons and involved in their differentiation into the dopaminergic phenotype.", "language": "eng", "dateOfCompletion": "2003-12-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/S0165-3806(03)00221-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2003-10-01", "journal": {"title": "Brain research. Developmental brain research", "issn": "0165-3806", "isoabbreviation": "Brain Res. Dev. Brain Res.", "medlineAbbreviation": "Brain Res Dev Brain Res", "nlmid": "8908639"}, "monthOfPublication": 10, "volume": "145", "yearOfPublication": 2003, "journalIssueId": 1160256, "issue": "1", "dateOfPublication": "2003 Oct"}}, "6833798": {"pubYear": "1983", "dateOfCreation": "1983-05-05", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antigens, Viral"}, {"registryNumber": "0", "name": "Antibodies, Monoclonal"}]}, "authorString": "Rammohan KW, McFarland HF, Bellini WJ, Gheuens J, McFarlin DE.", "pubTypeList": {"pubType": ["Journal Article"]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Hybridomas", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred BALB C", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Measles virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Encephalitis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Measles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antibodies, Monoclonal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antigens, Viral", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Radioimmunoassay", "majorTopic_YN": "N"}, {"descriptorName": "Hemagglutination Tests", "majorTopic_YN": "N"}, {"descriptorName": "Neutralization Tests", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Cricetinae", "majorTopic_YN": "N"}]}, "id": "6833798", "inEPMC": "N", "authorList": {"author": [{"lastName": "Rammohan", "fullName": "Rammohan KW", "initials": "KW"}, {"lastName": "McFarland", "fullName": "McFarland HF", "initials": "HF"}, {"lastName": "Bellini", "fullName": "Bellini WJ", "initials": "WJ"}, {"lastName": "Gheuens", "fullName": "Gheuens J", "initials": "J"}, {"lastName": "McFarlin", "fullName": "McFarlin DE", "initials": "DE"}]}, "title": "Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus.", "citedByCount": 6, "source": "MED", "pmid": "6833798", "abstractText": "The acute encephalopathy induced by hamster neurotropic (HNT) measles virus in BALB/c mice was abolished, and a subacute encephalitis was induced instead, when antibody to Edmonston (Ed) measles virus was administered three days after inoculation of HNT virus. Ascites fluid from 79XIC1, a monocolonal antibody to the hemaglutinin of strain Ed, had similar effects in vivo. However, other monoclonal antibodies to the hemagglutinin of Ed strain--79XVV17 and 80IIIB2--were ineffective in vivo at all doses tested. By viral neutralization, immunofluorescence, and radioimmunoprecipitation assays, it was shown that the hemagglutinin of HNT virus reacted with 79XIC1 antibody but lacked the epitopes recognized by 79XVV17 or 80IIIB2 antibody, a finding that explains their different reactivity in vivo. These observations also identified previously unrecognized antigenic differences between the hemagglutinin of Ed and HNT measles viruses.", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1983-03-01", "isOpenAccess": "N", "pageInfo": "546-550", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "1983-05-05", "hasTextMinedTerms": "N", "dateOfRevision": "2005-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "1983-03-01", "journal": {"medlineAbbreviation": "J Infect Dis", "isoabbreviation": "J. Infect. Dis.", "title": "The Journal of infectious diseases", "issn": "0022-1899", "nlmid": "0413675", "essn": "1537-6613"}, "monthOfPublication": 3, "volume": "147", "yearOfPublication": 1983, "journalIssueId": 534866, "issue": "3", "dateOfPublication": "1983 Mar"}}, "2410442": {"pubYear": "1985", "dateOfCreation": "1985-09-12", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Antigens, Viral"}, {"registryNumber": "0", "name": "Viral Proteins"}, {"registryNumber": "0", "name": "RNA, Viral"}, {"registryNumber": "0", "name": "DNA, Recombinant"}]}, "authorString": "Gendelman HE, Moench TR, Narayan O, Griffin DE, Clements JE.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, U.S. Gov't, P.H.S.", "Comparative Study"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "1-P0 1-NS-15721"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS16145"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS12127"}]}, "hasPDF": "N", "id": "2410442", "inEPMC": "N", "authorList": {"author": [{"lastName": "Gendelman", "fullName": "Gendelman HE", "initials": "HE"}, {"lastName": "Moench", "fullName": "Moench TR", "initials": "TR"}, {"lastName": "Narayan", "fullName": "Narayan O", "initials": "O"}, {"lastName": "Griffin", "fullName": "Griffin DE", "initials": "DE"}, {"lastName": "Clements", "fullName": "Clements JE", "initials": "JE"}]}, "title": "A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues.", "citedByCount": 33, "source": "MED", "pmid": "2410442", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Macrophages", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Sheep", "majorTopic_YN": "N"}, {"descriptorName": "Rabbits", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Measles virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Visna-maedi virus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}, {"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Viral Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA, Recombinant", "majorTopic_YN": "N"}, {"descriptorName": "RNA, Viral", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antigens, Viral", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Immunoenzyme Techniques", "majorTopic_YN": "Y"}, {"descriptorName": "Staining and Labeling", "majorTopic_YN": "N"}, {"descriptorName": "Nucleic Acid Hybridization", "majorTopic_YN": "Y"}, {"descriptorName": "Genes, Viral", "majorTopic_YN": "N"}, {"descriptorName": "Cricetinae", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1985-06-01", "doi": "10.1016/0166-0934(85)90033-3", "isOpenAccess": "N", "pageInfo": "93-103", "hasDbCrossReferences": "N", "abstractText": "This report describes a combined immunocytochemical and in situ hybridization procedure which allows visualization of cellular or viral antigens and viral RNA in the same cell. Cultures infected with visna or measles virus were fixed in periodate-lysine-paraformaldehyde-glutaraldehyde, stained by the avidin-biotin-peroxidase technique using antibodies to viral or cellular proteins and then incubated with radiolabeled specific DNA probes (in situ hybridization). The immunoperoxidase stain was preserved through the hybridization procedure. Nonspecific 'sticking' of probes over peroxidase stained cells was prevented by incorporation of 0.1% Triton X-100 into the hybridization solution and the post-hybridization washes. The in situ hybridization signal (silver grains/cell) on peroxidase-stained cells was reduced relative to hybridization with unstained cells. The double labeling technique was also applied to sections of paraffin-embedded tissues from a sheep infected with visna virus and mice infected with the HNT strain of measles virus. Visna virus RNA was detected in immunocytochemically identified macrophages in the synovium. A greater number of these cells had viral RNA than had viral protein. In measles virus-infected brains viral RNA was detected only in cells with viral protein. This technique provides a new approach to the study of viral pathogenesis by: identifying the types of cells which are infected in the host and identifying points of blockade in the virus life cycle during persistent infections.", "language": "eng", "dateOfCompletion": "1985-09-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/0166-0934(85)90033-3", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2007-11-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "1985-06-01", "journal": {"medlineAbbreviation": "J Virol Methods", "isoabbreviation": "J. Virol. Methods", "title": "Journal of virological methods", "issn": "0166-0934", "nlmid": "8005839", "essn": "1879-0984"}, "monthOfPublication": 6, "volume": "11", "yearOfPublication": 1985, "journalIssueId": 702284, "issue": "2", "dateOfPublication": "1985 Jun"}}, "16650481": {"pubYear": "2006", "dateOfCreation": "2006-06-07", "pubModel": "Print-Electronic", "authorString": "Stanghellini G, Bertelli M, Raballo A.", "affiliation": "University of Chieti, Viale Don Minzoni 45, 50100 Florence, Italy. giostan@libero.it", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "16650481", "inEPMC": "N", "authorList": {"author": [{"lastName": "Stanghellini", "fullName": "Stanghellini G", "authorId": {"type": "ORCID", "value": "0000-0001-5164-7013"}, "firstName": "Giovanni", "initials": "G"}, {"lastName": "Bertelli", "fullName": "Bertelli M", "firstName": "Marco", "initials": "M"}, {"lastName": "Raballo", "fullName": "Raballo A", "authorId": {"type": "ORCID", "value": "0000-0003-3709-4111"}, "firstName": "Andrea", "initials": "A"}]}, "title": "Typus melancholicus: personality structure and the characteristics of major unipolar depressive episode.", "citedByCount": 6, "source": "MED", "pmid": "16650481", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-5164-7013"}, {"type": "ORCID", "value": "0000-0003-3709-4111"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Depressive Disorder", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Depressive Disorder, Major", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Personality Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "PX", "qualifierName": "psychology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Psychopathology", "majorTopic_YN": "N"}, {"descriptorName": "Personality Inventory", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SN", "qualifierName": "statistics & numerical data", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Psychometrics", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SN", "qualifierName": "statistics & numerical data", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Statistics as Topic", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2006-05-02", "doi": "10.1016/j.jad.2006.03.005", "isOpenAccess": "N", "pageInfo": "159-167", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: The melancholic type of personality (TM) has long been considered in continental and Japanese psychopathology as a relevant vulnerability trait constellation for the development of depression. METHOD: The symptom presentation in an outpatient population of 116 subjects suffering from a DSM-IV major depressive episode was rated according to the standardized documentation system of the Association for Methodology and Documentation in Psychiatry (AMDP). Personality features were explored by means of the Criteria for Typus Melancholicus (CTM). RESULTS: Statistically significant differences in depression-related psychopathological scores (i.e. higher level of guilt feelings, feeling of the loss of feelings, loss of vital drive and lower degrees of irritability and dysphoria) were found between TM and non-TM subjects, supporting the phenomenic specificity of TM depression at both symptom and subsyndromal level. LIMITATION AND CONCLUSIONS: Although our results were obtained in a selected sample of outpatients at an University Mental Health Center, they are indicative of psychopathological differences between TM and NTM in the core symptoms of depression. These differences highlight the importance of including TM criteria for phenotypic characterization of depressive disorder, suggesting that it may improve diagnostic and therapeutic practice and might be a reasonable psychopathologic endophenotype in investigating affective-spectrum vulnerability in at-risk populations.", "electronicPublicationDate": "2006-05-02", "language": "eng", "dateOfCompletion": "2006-11-09", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.jad.2006.03.005", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2009-09-28", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-07-01", "journal": {"medlineAbbreviation": "J Affect Disord", "isoabbreviation": "J Affect Disord", "title": "Journal of affective disorders", "issn": "0165-0327", "nlmid": "7906073", "essn": "1573-2517"}, "monthOfPublication": 7, "volume": "93", "yearOfPublication": 2006, "journalIssueId": 1327944, "issue": "1-3", "dateOfPublication": "2006 Jul"}}, "20090922": {"pubYear": "2010", "dateOfCreation": "2010-01-21", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "zonula occludens-1 protein"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "50-02-2", "name": "Dexamethasone"}, {"registryNumber": "0", "name": "Actins"}, {"registryNumber": "0", "name": "Cross-Linking Reagents"}, {"registryNumber": "0", "name": "Connexin 43"}, {"registryNumber": "0", "name": "TJP1 protein, human"}]}, "authorString": "Zhuo YH, He Y, Leung KW, Hou F, Li YQ, Chai F, Ge J.", "affiliation": "State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "20090922", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zhuo", "fullName": "Zhuo YH", "firstName": "Ye Hong", "initials": "YH"}, {"lastName": "He", "fullName": "He Y", "firstName": "Yuan", "initials": "Y"}, {"lastName": "Leung", "fullName": "Leung KW", "firstName": "Kar Wah", "initials": "KW"}, {"lastName": "Hou", "fullName": "Hou F", "firstName": "Fei", "initials": "F"}, {"lastName": "Li", "fullName": "Li YQ", "firstName": "Yi Qing", "initials": "YQ"}, {"lastName": "Chai", "fullName": "Chai F", "firstName": "Fang", "initials": "F"}, {"lastName": "Ge", "fullName": "Ge J", "firstName": "Jian", "initials": "J"}]}, "title": "Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "20090922", "abstractText": " PURPOSE: Patients reproduce symptoms of primary open-angle glaucoma (POAG) when treated with glucocorticoids (GCs) topically on the eyes. Here we investigated the effects of GCs on junctional protein expression and cytoskeleton organization in primary human trabecular meshwork (TM) cultures to understand the molecular pathologies of POAG. METHODS: Human TM cells from POAG (GTM) and age-matched nondiseased (NTM) individuals were obtained by standard surgical trabeculectomy. Some of the cultures were treated with dexamethasone (DEX), a synthetic GC, at 1-5 x 10(-7) mol/l for 1-7 days. The expression levels of zonula occluden-1 (ZO-1) and connexin43 (Cx43) in TM cells with or without DEX treatment were measured using reverse transcription (RT)-PCR, immunocytochemistry, and western blot analysis. RESULTS: mRNA and proteins of ZO-1 and Cx43 were found in both NTM and GTM cells. ZO-1 and Cx43 were located on the plasma membrane, especially along the border of adjacent cells. ZO-1 had no marked changes in localization in NTM and GTM cells after treatment with 10(-7) mol/l DEX for 48 h, whereas Cx43 appeared to increase in the cytoplasm. mRNA of two ZO-1 isoforms, alpha+ and alpha-, were present in TM cells, and the former was expressed less than the latter. Only ZO-1 alpha- isoform protein was expressed in NTM cells, whereas proteins of both isoforms were found in GTM cells. DEX increased the protein levels of ZO-1 and Cx43 in both NTM and GTM cells. DEX also altered the F-actin architecture and promoted cross-linked actin network formation, the effects of which were more pronounced in GTM cells. CONCLUSIONS: Our findings not only provide molecular insights to the pathogenesis of GC-induced glaucoma but also suggest that junctional proteins ZO-1 and Cx43 as well as F-actin are targets for developing new modalities in glaucoma therapy.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Trabecular Meshwork", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Intercellular Junctions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cytoskeleton", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Open-Angle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dexamethasone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Actins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Connexin 43", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cross-Linking Reagents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Count", "majorTopic_YN": "N"}, {"descriptorName": "Cell Shape", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Zonula Occludens-1 Protein", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-01-16", "language": "eng", "isOpenAccess": "Y", "pageInfo": "61-71", "pmcid": "PMC2807616", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "electronicPublicationDate": "2010-01-16", "license": "cc by", "dateOfCompletion": "2010-03-10", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2807616?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2807616", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20090922&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20090922", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-31", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"title": "Molecular vision", "medlineAbbreviation": "Mol Vis", "isoabbreviation": "Mol. Vis.", "nlmid": "9605351", "essn": "1090-0535"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2010, "journalIssueId": 1687844, "dateOfPublication": "2010 "}}, "26727713": {"pubYear": "2016", "dateOfCreation": "2016-01-04", "pubModel": "Print-Electronic", "authorString": "Evangelopoulos ME, Koutoulidis V, Andreadou E, Evangelopoulos DS, Kilidireas C.", "affiliation": "a 1 Demyelinating Diseases Unit, Department of Neurology, Eginition Hospital , University of Athens , Athens , Greece.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "26727713", "inEPMC": "N", "authorList": {"author": [{"affiliation": "a 1 Demyelinating Diseases Unit, Department of Neurology, Eginition Hospital , University of Athens , Athens , Greece.", "fullName": "Evangelopoulos ME", "initials": "ME", "firstName": "M E", "lastName": "Evangelopoulos"}, {"affiliation": "b 2 Department of Radiology, Aretaieion Hospital , University of Athens , Athens , Greece.", "fullName": "Koutoulidis V", "initials": "V", "firstName": "V", "lastName": "Koutoulidis"}, {"affiliation": "a 1 Demyelinating Diseases Unit, Department of Neurology, Eginition Hospital , University of Athens , Athens , Greece.", "fullName": "Andreadou E", "initials": "E", "firstName": "E", "lastName": "Andreadou"}, {"affiliation": "c 3 3rd Department of Orthopaedic Surgery, KAT Hospital , University of Athens , Athens , Greece.", "fullName": "Evangelopoulos DS", "initials": "DS", "firstName": "D S", "lastName": "Evangelopoulos"}, {"affiliation": "a 1 Demyelinating Diseases Unit, Department of Neurology, Eginition Hospital , University of Athens , Athens , Greece.", "fullName": "Kilidireas C", "initials": "C", "firstName": "C", "lastName": "Kilidireas"}]}, "title": "Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod.", "citedByCount": 0, "source": "MED", "pmid": "26727713", "abstractText": "Interruption of natalizumab (NTM) treatment in multiple sclerosis (MS) patients may be followed by disease reactivation. On the other hand, patients with positive John Cunningham virus (JCV) antibodies treated with NTM over 24\u00a0months demonstrate a higher risk for developing progressive multifocal encephalopathy (PML). No established therapeutic approach is available for treating these patients to prevent disease reactivation.Of the MS patients treated with NTM at the authors' institution, 30 were found positive for JCV abs. NTM was interrupted followed by a washout period of 6\u00a0months. During this period, 20/30 patients received monthly intravenous (i.v.) methylprednisolone (MPD) 1000 mg infusion and regular clinical assessment. On months 3 and 6, brain MRI was performed and 1000 mg MPD was administered for 5 days.All patients were clinically and radiologically stable at the time of NTM break. No clinical relapse was observed during the six-month washout period for the MS patients under monthly MPD treatment, while one patient had a relapse and active lesions in the MRI on month 6. Of the other patients not receiving i.v. MPD regularly after NTM withdrawal, one showed several active lesions in brain MRI and the other had a severe relapse.Despite the limited size of this patients' cohort, the results of this study support that monthly MPD treatment for 6\u00a0months may result in a clinically stable disease status, thus ensuring safe transition to another second-line therapy such as fingolimod, following NTM withdrawal.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-01-04", "isOpenAccess": "N", "pageInfo": "1-6", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Multiple sclerosis", "Fingolimod", "Natalizumab", "Pulsed Corticosteroid Treatment"]}, "hasLabsLinks": "Y", "electronicPublicationDate": "2016-01-04", "language": "eng", "dateOfRevision": "2016-01-05", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"medlineAbbreviation": "Int J Neurosci", "isoabbreviation": "Int. J. Neurosci.", "title": "The International journal of neuroscience", "issn": "0020-7454", "nlmid": "0270707", "essn": "1563-5279"}, "monthOfPublication": 1, "yearOfPublication": 2016, "journalIssueId": 2358503, "dateOfPublication": "2016 Jan"}}, "25389776": {"pubYear": "2014", "dateOfCreation": "2014-11-13", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.3.1", "name": "Alkaline Phosphatase"}, {"registryNumber": "EC 3.1.3.2", "name": "Acid Phosphatase"}, {"registryNumber": "EC 3.4.24.35", "name": "Matrix Metalloproteinase 9"}, {"registryNumber": "EC 2.7.11.24", "name": "Mitogen-Activated Protein Kinase 1"}, {"registryNumber": "EC 2.7.11.24", "name": "Mitogen-Activated Protein Kinase 3"}, {"registryNumber": "EC 2.7.11.24", "name": "p38 Mitogen-Activated Protein Kinases"}]}, "authorString": "Lerner N, Beit-Yannai E.", "affiliation": "Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "25389776", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.", "fullName": "Lerner N", "initials": "N", "firstName": "Natalie", "lastName": "Lerner"}, {"affiliation": "Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.", "fullName": "Beit-Yannai E", "initials": "E", "firstName": "Elie", "lastName": "Beit-Yannai"}]}, "title": "Cross-talk between ciliary epithelium and trabecular meshwork cells in-vitro: a new insight into glaucoma.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "25389776", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Trabecular Meshwork", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ciliary Body", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Epithelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Acid Phosphatase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alkaline Phosphatase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitogen-Activated Protein Kinase 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitogen-Activated Protein Kinase 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "p38 Mitogen-Activated Protein Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Coculture Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Cell Communication", "majorTopic_YN": "Y"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Matrix Metalloproteinase 9", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-11-12", "language": "eng", "doi": "10.1371/journal.pone.0112259", "isOpenAccess": "Y", "pageInfo": "e112259", "pmcid": "PMC4229184", "hasDbCrossReferences": "N", "abstractText": "PURPOSE: It is assumed that the non-pigmented ciliary epithelium plays a role in regulating intraocular pressure via its neuroendocrine activities. To test this hypothesis, we investigated the effect on a human trabecular meshwork (TM) cell line (NTM) of co-culture with a human non-pigmented ciliary epithelium cell line (ODM-2). METHODS: The cellular cross-talk between ODM-2 and NTM cells was studied in a co-culture system in which the two cell types were co-cultured for 5 to 60 min or 2, 4 and 8h and then removed from the co-culture and analyzed. Analyses of the ERK and p38 mitogen-activated protein kinase (MAPK) pathways and of the activity of TM phosphatases and matrix metalloproteins (MMPs) were performed. Acid and alkaline phosphatase activity was determined by the DiFMUP (6, 8-difluoro-4-methylumbelliferyl phosphate) assay. MMP levels were determined by gelatin zymography. RESULTS: Exposure of NTM cells to ODM-2 cells led to the activation of the MAPK signal transduction pathways in NTM cells within 5 min of co-culture. Phosphorylation of ERK1/ERK2 and p38 peaked at 10 and 15 min and then decreased over time. Interaction between ODM-2 and NTM cells promoted the expression of MMP-9 in the NTM cells after 4h of co-culture. CONCLUSIONS: Our findings provide support for the hypothesis that crosstalk does indeed take place between ODM-2 and NTM cells. Future studies should be designed to determine the relationship between the MMP system, MAPK kinases and phosphatases. Manipulation of these signaling molecules and the related NTM signal transduction pathways may provide targets for developing improved treatments for glaucoma.", "electronicPublicationDate": "2014-11-12", "license": "cc by", "dateOfCompletion": "2015-07-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4229184?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4229184", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0112259", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "9", "yearOfPublication": 2014, "journalIssueId": 2216242, "issue": "11", "dateOfPublication": "2014 "}}, "10739641": {"pubYear": "2000", "dateOfCreation": "2000-05-23", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "51-61-6", "name": "Dopamine"}, {"registryNumber": "300-62-9", "name": "Amphetamine"}, {"registryNumber": "EC 1.14.16.2", "name": "Tyrosine 3-Monooxygenase"}, {"registryNumber": "7447-41-8", "name": "Lithium Chloride"}, {"registryNumber": "1199-18-4", "name": "Oxidopamine"}]}, "authorString": "Baker KA, Hong M, Sadi D, Mendez I.", "affiliation": "Department of Anatomy and Neurobiology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "10739641", "inEPMC": "N", "authorList": {"author": [{"lastName": "Baker", "fullName": "Baker KA", "initials": "KA"}, {"lastName": "Hong", "fullName": "Hong M", "initials": "M"}, {"lastName": "Sadi", "fullName": "Sadi D", "initials": "D"}, {"lastName": "Mendez", "fullName": "Mendez I", "initials": "I"}]}, "title": "Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.", "citedByCount": 33, "source": "MED", "pmid": "10739641", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Substantia Nigra", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Corpus Striatum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "TR", "qualifierName": "transplantation", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Wistar", "majorTopic_YN": "N"}, {"descriptorName": "Teratocarcinoma", "majorTopic_YN": "N"}, {"descriptorName": "Parkinson Disease, Secondary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CI", "qualifierName": "chemically induced", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Lithium Chloride", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dopamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oxidopamine", "majorTopic_YN": "N"}, {"descriptorName": "Amphetamine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tyrosine 3-Monooxygenase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Stem Cell Transplantation", "majorTopic_YN": "Y"}, {"descriptorName": "Transplantation, Heterologous", "majorTopic_YN": "N"}, {"descriptorName": "Cell Count", "majorTopic_YN": "N"}, {"descriptorName": "Motor Activity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Graft Survival", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2000-04-01", "doi": "10.1006/exnr.1999.7337", "isOpenAccess": "N", "pageInfo": "350-360", "hasDbCrossReferences": "N", "abstractText": "The clinical findings on neural transplantation for Parkinson's disease (PD) reported thus far are promising but many issues must be addressed before neural transplantation can be considered a routine therapeutic option for PD. The future of neural transplantation for the treatment of neurological disorders may rest in the discovery of a suitable alternative cell type for fetal tissue. One such alternative may be neurons derived from a human teratocarcinoma (hNT). hNT neurons have been shown to survive and integrate within the host brain following transplantation and provide functional recovery in animal models of stroke and Huntington's disease. In this study, we describe the transplantation of hNT neurons in the substantia nigra (SN) and striatum of the rat model for PD. Twenty-seven rats were grafted with one of three hNT neuronal products; hNT neurons, hNT-DA neurons, or lithium chloride (LiCl) pretreated hNT-DA neurons. Robust hNT grafts could be seen with anti-neural cell adhesion molecule and anti-neuron-specific enolase immunostaining. Immunostaining for tyrosine hydroxylase (TH) expression revealed no TH-immunoreactive (THir) neurons in any animals with hNT neuronal grafts. THir cells were observed in 43% of animals with hNT-DA neuronal grafts and all animals with LiCl pretreated hNT-DA neuronal grafts (100%). The number of THir neurons in these animals was low and not sufficient to produce significant functional recovery. In summary, this study has demonstrated that hNT neurons survive transplantation and express TH in the striatum and SN. Although hNT neurons are promising as an alternative to fetal tissue and may have potential clinical applications in the future, further improvements in enhancing TH expression are needed.", "language": "eng", "dateOfCompletion": "2000-05-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1006/exnr.1999.7337", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "2000-04-01", "journal": {"medlineAbbreviation": "Exp Neurol", "isoabbreviation": "Exp. Neurol.", "title": "Experimental neurology", "issn": "0014-4886", "nlmid": "0370712", "essn": "1090-2430"}, "monthOfPublication": 4, "volume": "162", "yearOfPublication": 2000, "journalIssueId": 1012549, "issue": "2", "dateOfPublication": "2000 Apr"}}, "6335868": {"pubYear": "1984", "dateOfCreation": "1985-06-18", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Peptides"}, {"registryNumber": "9015-71-8", "name": "Corticotropin-Releasing Hormone"}, {"registryNumber": "66796-54-1", "name": "Pro-Opiomelanocortin"}, {"registryNumber": "113-79-1", "name": "Arginine Vasopressin"}]}, "authorString": "Chan JS, Gaspar L, Iguchi H, Seidah NG, Ling N, Chr\u00e9tien M.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "In Vitro"]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Sheep", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Adenoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pituitary Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nelson Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Corticotropin-Releasing Hormone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pro-Opiomelanocortin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Drug Synergism", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Arginine Vasopressin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}]}, "id": "6335868", "inEPMC": "N", "authorList": {"author": [{"lastName": "Chan", "fullName": "Chan JS", "initials": "JS"}, {"lastName": "Gaspar", "fullName": "Gaspar L", "initials": "L"}, {"lastName": "Iguchi", "fullName": "Iguchi H", "initials": "H"}, {"lastName": "Seidah", "fullName": "Seidah NG", "initials": "NG"}, {"lastName": "Ling", "fullName": "Ling N", "initials": "N"}, {"lastName": "Chr\u00e9tien", "fullName": "Chr\u00e9tien M", "initials": "M"}]}, "title": "Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.", "citedByCount": 3, "source": "MED", "pmid": "6335868", "abstractText": "The effects of synthetic ovine corticotropin-releasing factor (oCRF), arginine vasopressin (AVP), alpha-melanocortin (alpha MSH), and dexamethasone on the release of pro-opiomelanocortin (POMC)-related peptides were studied on a pituitary adenoma of a patient with Nelson's syndrome. CRF, at doses up to 100 ng/ml, has no effect on IR-ACTH, IR-hNT or IR-beta LPH secretion by the pituitary adenoma cells within the first week of monolayer culture. During the second week of in vitro conditions, however, the cells responded to oCRF (1-100 ng/ml) with a significant increase in all three POMC-related peptides. AVP (10 and 100 ng/ml) was effective in stimulating secretion of the three POMC-related peptides on day 6 in vitro; in addition, during the second week in culture, AVP (1 ng/ml) acted synergistically with 1-100 ng/ml of oCRF to release IR-ACTH, IR-hNT and IR-beta LPH at least 3-4 fold higher than CRF alone. alpha MSH (10 micrograms/ml) and dexamethasone (10(-6)M) did not alter the release of any of the three peptides. These results demonstrate that CRF and AVP can act synergistically on human pituitary tissue in vitro to promote the release of POMC-related peptides and also in vivo as shown by others.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "1984-01-01", "isOpenAccess": "N", "pageInfo": "205-208", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "1985-06-18", "hasTextMinedTerms": "N", "dateOfRevision": "2006-11-15", "hasBook": "N", "journalInfo": {"printPublicationDate": "1984-01-01", "journal": {"medlineAbbreviation": "Clin Invest Med", "isoabbreviation": "Clin Invest Med", "title": "Clinical and investigative medicine. Medecine clinique et experimentale", "issn": "0147-958X", "nlmid": "7804071", "essn": "1488-2353"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 1984, "journalIssueId": 684289, "issue": "4", "dateOfPublication": "1984 "}}, "27124111": {"pubYear": "2016", "dateOfCreation": "2016-04-29", "pubModel": "Electronic-eCollection", "authorString": "McDonnell F, Irnaten M, Clark AF, O'Brien CJ, Wallace DM.", "affiliation": "School of Medicine and Medical Science, University College Dublin, Dublin 4, Ireland.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27124111", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Fiona", "lastName": "McDonnell", "affiliation": "School of Medicine and Medical Science, University College Dublin, Dublin 4, Ireland.", "authorId": {"type": "ORCID", "value": "0000-0001-7563-7258"}, "fullName": "McDonnell F", "initials": "F"}, {"affiliation": "Dept. Ophthalmology, Mater Misericordiae University Hospital, Dublin 7, Ireland.", "fullName": "Irnaten M", "initials": "M", "firstName": "Mustapha", "lastName": "Irnaten"}, {"affiliation": "Dept. Cell Biology & Immunology and the North Texas Eye Research Institute, U. North Texas Health Science Center, Ft. Worth, Texas, United States of America.", "fullName": "Clark AF", "initials": "AF", "firstName": "Abbot F", "lastName": "Clark"}, {"affiliation": "Dept. Ophthalmology, Mater Misericordiae University Hospital, Dublin 7, Ireland.", "fullName": "O'Brien CJ", "initials": "CJ", "firstName": "Colm J", "lastName": "O'Brien"}, {"affiliation": "Dept. Ophthalmology, Mater Misericordiae University Hospital, Dublin 7, Ireland.", "fullName": "Wallace DM", "initials": "DM", "firstName": "Deborah M", "lastName": "Wallace"}]}, "title": "Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGF\u03b21 Expression in Human Trabecular Meshwork Cells.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27124111", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-7563-7258"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2016-04-28", "language": "eng", "doi": "10.1371/journal.pone.0153354", "isOpenAccess": "Y", "pageInfo": "e0153354", "pmcid": "PMC4849706", "hasDbCrossReferences": "N", "abstractText": "Fibrosis and a hypoxic environment are associated with the trabecular meshwork (TM) region in the blinding disease glaucoma. Hypoxia has been shown to alter DNA methylation, an epigenetic mechanism involved in regulating gene expression such as the pro-fibrotic transforming growth factor (TGF) \u03b21 and the anti-fibrotic Ras protein activator like 1 (RASAL1). The purpose of this study was to compare DNA methylation levels, and the expression of TGF\u03b21 and RASAL1 in primary human normal (NTM) with glaucomatous (GTM) cells and in NTM cells under hypoxic conditions.Global DNA methylation was assessed by ELISA in cultured age-matched NTM and GTM cells. qPCR was conducted for TGF\u03b21, collagen 1\u03b11 (COL1A1), and RASAL1 expression. Western immunoblotting was used to determine protein expression. For hypoxia experiments, NTM cells were cultured in a 1%O2, 5%CO2 and 37\u00b0C environment. NTM and GTM cells were treated with TGF\u03b21 (10ng/ml) and the methylation inhibitor 5-azacytidine (5-aza) (0.5\u03bcM) respectively to determine their effects on DNA Methyltransferase 1 (DNMT1) and RASAL1 expression.We found increased DNA methylation, increased TGF\u03b21 expression and decreased RASAL1 expression in GTM cells compared to NTM cells. Similar results were obtained in NTM cells under hypoxic conditions. TGF\u03b21 treatment increased DNMT1 and COL1A1, and decreased RASAL1 expression in NTM cells. 5-aza treatment decreased DNMT1, TGF\u03b21 and COL1A1 expression, and increased RASAL1 expression in GTM cells.TGF\u03b21 and RASAL1 expression, global DNA methylation, and expression of associated methylation enzymes were altered between NTM and GTM cells. We found that hypoxia in NTM cells induced similar results to the GTM cells. Furthermore, DNA methylation, TGF\u03b21 and RASAL1 appear to have an interacting relationship that may play a role in driving pro-fibrotic disease progression in the glaucomatous TM.", "electronicPublicationDate": "2016-04-28", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4849706?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4849706", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0153354", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-05-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "11", "yearOfPublication": 2016, "journalIssueId": 2392598, "issue": "4", "dateOfPublication": "2016"}}, "20464337": {"pubYear": "2009", "dateOfCreation": "2010-05-13", "pubModel": "Print", "authorString": "Sardar P, Bandyopadhyay D, Roy D, Guha P, Guha G, Banerjee AK.", "affiliation": "Department of Medicine, Medical College Kolkata, Kolkata, West Bengal, India. medicopartha@gmail.com", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "20464337", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sardar", "fullName": "Sardar P", "firstName": "Partha", "initials": "P"}, {"lastName": "Bandyopadhyay", "fullName": "Bandyopadhyay D", "firstName": "Dipanjan", "initials": "D"}, {"lastName": "Roy", "fullName": "Roy D", "firstName": "Deeptarka", "initials": "D"}, {"lastName": "Guha", "fullName": "Guha P", "firstName": "Pradipta", "initials": "P"}, {"lastName": "Guha", "fullName": "Guha G", "firstName": "Goutam", "initials": "G"}, {"lastName": "Banerjee", "fullName": "Banerjee AK", "firstName": "Amit Kumar", "initials": "AK"}]}, "title": "Non Tuberculous Mycobacteria and toxoplasma co-infection of the central nervous system in a patient with AIDS.", "citedByCount": 0, "source": "MED", "pmid": "20464337", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mycobacterium Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Toxoplasmosis, Cerebral", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}]}}, {"descriptorName": "AIDS-Related Opportunistic Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Tomography, X-Ray Computed", "majorTopic_YN": "N"}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2009-12-01", "doi": "10.1590/s1413-86702009000600011", "isOpenAccess": "N", "pageInfo": "449-451", "hasDbCrossReferences": "N", "abstractText": "New-onset seizures are frequent manifestations in patients infected with Human Immunodeficiency Virus (HIV). We describe the clinical and radiological findings in an 25yr old AIDS patient presenting with new onset seizures as the primary manifestation of cerebral toxoplasmosis and Non Tuberculous Mycobacterial [NTM] co-infection. Cranial computed tomography showed a subtle ventricular dilatation whereas magnetic resonance imaging disclosed prominent temporal horn. Toxoplasma tachyzoites and rapidly growing mycobacteria were recovered from CSF. Seizures were complex partial in nature and refractory to antiepileptic therapy.", "language": "eng", "dateOfCompletion": "2010-06-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1590/S1413-86702009000600011", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "SciELO"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-12-01", "journal": {"medlineAbbreviation": "Braz J Infect Dis", "isoabbreviation": "Braz J Infect Dis", "title": "The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases", "issn": "1413-8670", "nlmid": "9812937", "essn": "1678-4391"}, "monthOfPublication": 12, "volume": "13", "yearOfPublication": 2009, "journalIssueId": 1730873, "issue": "6", "dateOfPublication": "2009 Dec"}}, "11922659": {"pubYear": "2002", "dateOfCreation": "2002-03-29", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.-", "name": "SOD1 G93A protein"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}]}, "authorString": "Garbuzova-Davis S, Willing AE, Milliken M, Saporta S, Zigova T, Cahill DW, Sanberg PR.", "affiliation": "Departments of Neurosurgery, Center for Aging and Brain Repair, Tampa, Florida 33612, USA. sgarbuzo@hsc.ust.edu", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "11922659", "inEPMC": "N", "authorList": {"author": [{"lastName": "Garbuzova-Davis", "fullName": "Garbuzova-Davis S", "firstName": "Svitlana", "initials": "S"}, {"lastName": "Willing", "fullName": "Willing AE", "firstName": "Alison E", "initials": "AE"}, {"lastName": "Milliken", "fullName": "Milliken M", "firstName": "Melissa", "initials": "M"}, {"lastName": "Saporta", "fullName": "Saporta S", "firstName": "Samuel", "initials": "S"}, {"lastName": "Zigova", "fullName": "Zigova T", "firstName": "Tanya", "initials": "T"}, {"lastName": "Cahill", "fullName": "Cahill DW", "firstName": "David W", "initials": "DW"}, {"lastName": "Sanberg", "fullName": "Sanberg PR", "firstName": "Paul R", "initials": "PR"}]}, "title": "Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.", "citedByCount": 45, "pageInfo": "169-180", "source": "MED", "pmid": "11922659", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anterior Horn Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TR", "qualifierName": "transplantation", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Disease Progression", "majorTopic_YN": "N"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Transplantation, Heterologous", "majorTopic_YN": "N"}, {"descriptorName": "Immunohistochemistry", "majorTopic_YN": "N"}, {"descriptorName": "Survival Rate", "majorTopic_YN": "N"}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Motor Activity", "majorTopic_YN": "N"}, {"descriptorName": "Graft Survival", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Neoplastic Stem Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TR", "qualifierName": "transplantation", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Embryonal Carcinoma Stem Cells", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2002-04-01", "doi": "10.1006/exnr.2002.7860", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Erratum in", "reference": "Exp Neurol 2002 Jun;175(2):451"}]}, "hasDbCrossReferences": "N", "abstractText": "Transplantation of hNT Neurons derived from the human teratocarcinoma cell-line (NTera2/D1) has been shown to ameliorate motor dysfunction in a number of injury or disease models in which the deficits are fairly localized. However, these cells have not been used before in a model with more extensive neurodegeneration. The aim of this study is to determine the effects of hNT Neuron transplants on motor neuron function in a mouse model of familial amyotrophic lateral sclerosis (FALS) in which there is a substitution of Alanine for Glycine at position 93 of the human SOD1 gene (G93A). Amyotrophic lateral sclerosis is a fatal degenerative motor neuron disease affecting the spinal cord, brainstem, and cortex. This disease clinically manifests as progressive muscular weakness and atrophy, leading to paralysis and death within 3-5 years of diagnosis. The FALS represents 10-13% of all cases. A range of behavioral tests was used to examine spontaneous locomotor activity, coordination, and muscle strength of mice. Long-term (10-11 weeks) transplantation of hNT Neurons into the L(4)-L(5) segments of the ventral horn spinal cord of FALS(G93A) mice at 7 weeks of age (before onset of overt behavioral symptoms of disease) delayed the onset of motor dysfunction for at least 3 weeks. The average lifespan of the transplanted mice was 128 days compared to 106 days for media-injected group. The last mouse in the hNT Neuron transplanted group was euthanized at 135 days of age when it display partial paralysis of the hindlimbs. Immunohistochemical analysis of the implanted spinal cords demonstrated the survival of grafted hNT Neurons and showed many healthy-appearing motor neurons near the implant site. These results suggest that hNT Neuron transplantation may be a promising therapeutic strategy for ALS.", "language": "eng", "dateOfCompletion": "2002-05-02", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1006/exnr.2002.7860", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2008-11-21", "hasBook": "N", "journalInfo": {"printPublicationDate": "2002-04-01", "journal": {"medlineAbbreviation": "Exp Neurol", "isoabbreviation": "Exp. Neurol.", "title": "Experimental neurology", "issn": "0014-4886", "nlmid": "0370712", "essn": "1090-2430"}, "monthOfPublication": 4, "volume": "174", "yearOfPublication": 2002, "journalIssueId": 1066400, "issue": "2", "dateOfPublication": "2002 Apr"}}, "17127560": {"pubYear": "2006", "dateOfCreation": "2006-11-27", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "EC 1.15.1.-", "name": "superoxide dismutase 1"}, {"registryNumber": "EC 1.15.1.1", "name": "Superoxide Dismutase"}]}, "authorString": "Garbuzova-Davis S, Willing AE, Saporta S, Justen EB, Misiuta IE, Dellis J, Sanberg PR.", "affiliation": "Center of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida, College of Medicine, Health Sciences Center, Tampa, FL 33612, USA. sgarbuzo@hsc.usf.edu", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17127560", "inEPMC": "N", "authorList": {"author": [{"lastName": "Garbuzova-Davis", "fullName": "Garbuzova-Davis S", "firstName": "Svitlana", "initials": "S"}, {"lastName": "Willing", "fullName": "Willing AE", "firstName": "Alison E", "initials": "AE"}, {"lastName": "Saporta", "fullName": "Saporta S", "firstName": "Samuel", "initials": "S"}, {"lastName": "Justen", "fullName": "Justen EB", "firstName": "Eleanor B", "initials": "EB"}, {"lastName": "Misiuta", "fullName": "Misiuta IE", "firstName": "Iwona E", "initials": "IE"}, {"lastName": "Dellis", "fullName": "Dellis J", "firstName": "James", "initials": "J"}, {"lastName": "Sanberg", "fullName": "Sanberg PR", "firstName": "Paul R", "initials": "PR"}]}, "title": "Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis.", "citedByCount": 6, "source": "MED", "pmid": "17127560", "abstractText": "hNT cells, derived from a human teratocarcinoma cell line, are versatile neuron-like cells that have been studied as possible treatment vehicles for neurodegenerative diseases. Previously, we showed the postponement of motor deficit symptoms in a G93A mouse model of amyotrophic lateral sclerosis (ALS) by transplanting hNT cells into the lumbar spinal cord. In this study, we examined the engraftment of hNT cells at multiple sites within the lumbar spinal cord by morphological analysis of neuritic process development. Results demonstrated that cells implanted at multiple sites established neuritic processes of different lengths independent of the number of cell implants. The hNT fiber outgrowth was a maximum of 0.15-0.3 mm from the transplants and mostly spread within the gray matter; interconnections between implants were not found. Therefore, we suggest that the observed postponement of motor deficit symptoms in G93A mice was not a result of neuritic outgrowth from the implanted hNT cells.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Spinal Cord", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}, {"abbreviation": "SU", "qualifierName": "surgery", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "TR", "qualifierName": "transplantation", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Amyotrophic Lateral Sclerosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CN", "qualifierName": "congenital", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}, {"abbreviation": "SU", "qualifierName": "surgery", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "Y"}, {"descriptorName": "Superoxide Dismutase", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Treatment Outcome", "majorTopic_YN": "N"}, {"descriptorName": "Reoperation", "majorTopic_YN": "N"}, {"descriptorName": "Survival Rate", "majorTopic_YN": "N"}, {"descriptorName": "Nerve Regeneration", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2006-12-01", "isOpenAccess": "N", "pageInfo": "221-226", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "language": "eng", "dateOfCompletion": "2007-01-11", "hasTextMinedTerms": "N", "dateOfRevision": "2009-11-17", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-12-01", "journal": {"medlineAbbreviation": "Amyotroph Lateral Scler", "isoabbreviation": "Amyotroph Lateral Scler", "title": "Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases", "issn": "1748-2968", "nlmid": "101283386", "essn": "1471-180X"}, "monthOfPublication": 12, "volume": "7", "yearOfPublication": 2006, "journalIssueId": 1361061, "issue": "4", "dateOfPublication": "2006 Dec"}}, "24274658": {"pubYear": "2013", "dateOfCreation": "2013-12-02", "pubModel": "Electronic", "authorString": "Lee AR, Lee J, Choi SM, Seong MW, Kim SA, Kim M, Chae KO, Lee JS, Yim JJ.", "affiliation": "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Republic of Korea. yimjj@snu.ac.kr.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24274658", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Republic of Korea. yimjj@snu.ac.kr.", "fullName": "Lee AR", "initials": "AR", "firstName": "Ae-Ra", "lastName": "Lee"}, {"lastName": "Lee", "fullName": "Lee J", "firstName": "Jinwoo", "initials": "J"}, {"lastName": "Choi", "fullName": "Choi SM", "firstName": "Sun-Mi", "initials": "SM"}, {"lastName": "Seong", "fullName": "Seong MW", "firstName": "Moon-Woo", "initials": "MW"}, {"lastName": "Kim", "fullName": "Kim SA", "firstName": "Sung A", "initials": "SA"}, {"lastName": "Kim", "fullName": "Kim M", "firstName": "Myoungsil", "initials": "M"}, {"lastName": "Chae", "fullName": "Chae KO", "firstName": "Kyung Ok", "initials": "KO"}, {"lastName": "Lee", "fullName": "Lee JS", "firstName": "Ji Sun", "initials": "JS"}, {"lastName": "Yim", "fullName": "Yim JJ", "firstName": "Jae-Joon", "initials": "JJ"}]}, "title": "Phenotypic, immunologic, and clinical characteristics of patients with nontuberculous mycobacterial lung disease in Korea.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "24274658", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["nct"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lung Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "Y"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Prospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Republic of Korea", "majorTopic_YN": "N"}, {"descriptorName": "Mycobacterium Infections, Nontuberculous", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "IM", "qualifierName": "immunology", "majorTopic_YN": "N"}, {"abbreviation": "MI", "qualifierName": "microbiology", "majorTopic_YN": "Y"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nontuberculous Mycobacteria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "IP", "qualifierName": "isolation & purification", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-11-25", "language": "eng", "doi": "10.1186/1471-2334-13-558", "isOpenAccess": "Y", "pageInfo": "558", "pmcid": "PMC4222821", "hasDbCrossReferences": "N", "abstractText": "This study aimed to elucidate the phenotypic, immunologic, and clinical characteristics of Korean patients with nontuberculous mycobacterial (NTM) lung disease and compare them with non-NTM bronchiectasis (BE) patients.We prospectively recruited patients between 20 and 80\u00a0years of age who had nodular BE type NTM lung disease. Phenotypic, immunologic, and clinical characteristics were evaluated through physical examination, laboratory tests, pulmonary function tests, and radiographic examinations. Questionnaires were also answered. The results of the evaluations were compared with the results of non-NTM BE patients.A total of 84 patients with NTM lung disease and 47 non-NTM BE patients participated in the study. Mycobacterium avium complex lung disease and M. abscessus lung disease were most common. Patients with NTM lung disease had lower body mass index than non-NTM BE patients. Scoliosis was observed more frequently in patients with NTM lung disease than in non-NTM BE patients.Significant similarities were seen between Korean patients with NTM lung disease and patients from other countries. Differences in phenotypic and clinical characteristics between NTM lung disease and non-NTM BE patients suggest differences in the immunopathogenesis of NTM lung disease and non-NTM BE.ClinicalTrials.gov Registration number; NCT01616745.", "electronicPublicationDate": "2013-11-25", "license": "cc by", "dateOfCompletion": "2014-09-25", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4222821?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4222821", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1471-2334-13-558", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-06-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "BMC infectious diseases", "medlineAbbreviation": "BMC Infect Dis", "isoabbreviation": "BMC Infect. Dis.", "nlmid": "100968551", "essn": "1471-2334"}, "monthOfPublication": 0, "volume": "13", "yearOfPublication": 2013, "journalIssueId": 2000648, "dateOfPublication": "2013 "}}}, "ABCC4": {"25339146": {"pubYear": "2015", "dateOfCreation": "2015-01-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "prostaglandin F2alpha receptor"}, {"registryNumber": "0", "name": "ABCC4 protein, human"}, {"registryNumber": "0", "name": "Antihypertensive Agents"}, {"registryNumber": "0", "name": "Prostaglandins F, Synthetic"}, {"registryNumber": "0", "name": "Receptors, Prostaglandin"}, {"registryNumber": "0", "name": "Multidrug Resistance-Associated Proteins"}, {"registryNumber": "EC 1.14.99.1", "name": "Cyclooxygenase 1"}, {"registryNumber": "EC 1.14.99.1", "name": "PTGS1 protein, human"}, {"registryNumber": "6Z5B6HVF6O", "name": "latanoprost"}]}, "authorString": "Gao LC, Wang D, Liu FQ, Huang ZY, Huang HG, Wang GH, Chen X, Shi QZ, Hong L, Wu LP, Tang J.", "affiliation": "Department of Pharmacy, Department of Oncology, Cancer Institute, Changsha Central Hospital, Changsha, Hunan, China, gonedog1224@hotmail.com.", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25339146", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Pharmacy, Department of Oncology, Cancer Institute, Changsha Central Hospital, Changsha, Hunan, China, gonedog1224@hotmail.com.", "fullName": "Gao LC", "initials": "LC", "firstName": "Li-chen", "lastName": "Gao"}, {"lastName": "Wang", "fullName": "Wang D", "firstName": "Di", "initials": "D"}, {"lastName": "Liu", "fullName": "Liu FQ", "firstName": "Fang-qun", "initials": "FQ"}, {"lastName": "Huang", "fullName": "Huang ZY", "firstName": "Zheng-yu", "initials": "ZY"}, {"lastName": "Huang", "fullName": "Huang HG", "firstName": "Hong-guang", "initials": "HG"}, {"lastName": "Wang", "fullName": "Wang GH", "firstName": "Gui-hua", "initials": "GH"}, {"lastName": "Chen", "fullName": "Chen X", "firstName": "Xi", "initials": "X"}, {"lastName": "Shi", "fullName": "Shi QZ", "firstName": "Qun-zhi", "initials": "QZ"}, {"lastName": "Hong", "fullName": "Hong L", "firstName": "Li", "initials": "L"}, {"lastName": "Wu", "fullName": "Wu LP", "firstName": "Li-ping", "initials": "LP"}, {"lastName": "Tang", "fullName": "Tang J", "firstName": "Jie", "initials": "J"}]}, "title": "Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.", "citedByCount": 1, "source": "MED", "pmid": "25339146", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Glaucoma, Open-Angle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Prostaglandins F, Synthetic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Multidrug Resistance-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Prostaglandin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Antihypertensive Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intraocular Pressure", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Asian Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Cyclooxygenase 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-10-23", "doi": "10.1007/s00228-014-1769-8", "isOpenAccess": "N", "pageInfo": "43-50", "hasDbCrossReferences": "Y", "abstractText": "PURPOSE: The purpose of this study is to evaluate the association between variants in prostaglandin-endoperoxide synthase 1 (PTGS1), prostaglandin F (2\u03b1) receptor (PTGFR), and multidrug resistance protein 4 (MRP4) genes and intraocular pressure (IOP) response to latanoprost in Chinese patients with primary open-angle glaucoma (POAG). METHODS: The IOP response to latanoprost was evaluated by percent IOP reduction (%\u0394IOP) in the treated eye with the formula %\u0394IOP\u2009=\u2009(Baseline IOP values\u2009-\u2009IOP values posttreatment)\u2009/\u2009Baseline IOP values\u2009\u00d7\u2009100 %. Polymorphisms in PTGS1 (rs3842787 and rs10306114), PTGFR (rs3753380 and rs3766355), and MRP4 (rs11568658 and rs11568668) genes were detected by direct DNA sequencing. The differences among %\u0394IOP of genotypes or haplotypes were obtained by use of the Mann-Whitney U test. Association analyses were performed by multiple linear regression analysis. RESULTS: Latanoprost were prescribed to 63 subjects, 60 of which met the inclusion/exclusion criteria for the current study. Notably, the %\u0394IOP in the rs11568658 GT heterozygous genotype was 10.4 %\u0394IOP lower than that of GG homozygous wild-type on day 7 (15.7 \u00b1 2.52 vs. 26.1 \u00b1 2.88, P=0.003), and the corresponding results in the rs10306114 AG heterozygous genotype and AT haplotype constructed by rs3753380 and rs3766355 on day 7 were 7.2 and 10.3 %\u0394IOP (P<0.05). Interestingly, similar results were also observed on day 30 (P=0.008, P=0.006, and P=0.002, respectively). Multiple regression analysis showed that heterozygous genotypes of rs10306114, rs11568658, and carrier of AT haplotype were significantly correlated with the lower %\u0394IOP. On day 30, the above variations explained 9.9, 10.7, and 17.7 % of the total variability of %\u0394IOP in the Chinese POAG patients, respectively. CONCLUSION: rs10306114, rs3753380, rs3766355, and rs11568658 single-nucleotide polymorphisms (SNPs) correlate with a response to latanoprost treatment in patients with POAG. These SNPs may be important determinants of variability in response to latanoprost.", "electronicPublicationDate": "2014-10-23", "language": "eng", "dateOfCompletion": "2015-08-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s00228-014-1769-8", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "Eur J Clin Pharmacol", "isoabbreviation": "Eur. J. Clin. Pharmacol.", "title": "European journal of clinical pharmacology", "issn": "0031-6970", "nlmid": "1256165", "essn": "1432-1041"}, "monthOfPublication": 1, "volume": "71", "yearOfPublication": 2015, "journalIssueId": 2237866, "issue": "1", "dateOfPublication": "2015 Jan"}}, "24343710": {"pubYear": "2014", "dateOfCreation": "2015-05-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Membrane Transport Proteins"}, {"registryNumber": "0", "name": "Anti-HIV Agents"}]}, "authorString": "Nicol MR, Fedoriw Y, Mathews M, Prince HM, Patterson KB, Geller E, Mollan K, Mathews S, Kroetz DL, Kashuba AD.", "affiliation": "Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "P30 AI050410"}, {"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "P30 AI50410"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "U01 GM061390"}, {"orderIn": 0, "agency": "PHS HHS", "grantId": "U01 A1095031"}, {"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "U01 AI095031"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32 GM086330"}]}, "hasPDF": "Y", "id": "24343710", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Nicol MR", "initials": "MR", "firstName": "Melanie R", "lastName": "Nicol"}, {"affiliation": "UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Fedoriw Y", "initials": "Y", "firstName": "Yuri", "lastName": "Fedoriw"}, {"affiliation": "UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Mathews M", "initials": "M", "firstName": "Michelle", "lastName": "Mathews"}, {"affiliation": "Center for AIDS Research, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Prince HM", "initials": "HM", "firstName": "Heather M A", "lastName": "Prince"}, {"affiliation": "UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Patterson KB", "initials": "KB", "firstName": "Kristine B", "lastName": "Patterson"}, {"affiliation": "UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Geller E", "initials": "E", "firstName": "Elizabeth", "lastName": "Geller"}, {"affiliation": "Center for AIDS Research, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Mollan K", "initials": "K", "firstName": "Katie", "lastName": "Mollan"}, {"affiliation": "UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Mathews S", "initials": "S", "firstName": "Stephanie", "lastName": "Mathews"}, {"affiliation": "UCSF School of Pharmacy, University of California, San Francisco, NC, USA.", "fullName": "Kroetz DL", "initials": "DL", "firstName": "Deanna L", "lastName": "Kroetz"}, {"affiliation": "Center for AIDS Research, University of North Carolina, Chapel Hill, NC, USA.", "fullName": "Kashuba AD", "initials": "AD", "firstName": "Angela D M", "lastName": "Kashuba"}]}, "title": "Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention.", "hasSuppl": "N", "citedByCount": 5, "source": "MED", "pmid": "24343710", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Colon", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Rectum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cervix Uteri", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Vagina", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "HIV Infections", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Transport Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anti-HIV Agents", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression", "majorTopic_YN": "N"}, {"descriptorName": "Menopause", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2015-06-17", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-02", "doi": "10.1002/jcph.248", "isOpenAccess": "N", "pageInfo": "574-583", "pmcid": "PMC4061289", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Pharmacokinetics", "HIV", "Prevention", "Mucosal", "Antiretrovirals", "transporters"]}, "abstractText": "Effective antiretroviral (ARV)-based HIV prevention strategies require optimizing drug exposure in mucosal tissues; yet factors influencing mucosal tissue disposition remain unknown. We hypothesized drug transporter expression in vaginal, cervical, and colorectal tissues is a contributing factor and selected 3 efflux (ABCB1/MDR1, ABCC2/MRP2, ABCC4/MRP4) and 3 uptake (SLC22A6/OAT1, SLC22A8/OAT3, SLCO1B1/OATP1B1) transporters to further investigate based on their affinity for 2 ARVs central to prevention (tenofovir, maraviroc). Tissue was collected from 98 donors. mRNA and protein expression were quantified using qPCR and immunohistochemistry (IHC). Hundred percent of tissues expressed efflux transporter mRNA. IHC localized them to the epithelium and/or submucosa. Multivariable analysis adjusted for age, smoking, and co-medications revealed significant (P\u2009<\u20090.05) differences in efflux transporter mRNA between tissue types (vaginal ABCB1 3.9-fold\u2009>\u2009colorectal; vaginal ABCC2 2.9-fold\u2009>\u2009colorectal; colorectal ABCC4 2.0-fold\u2009>\u2009cervical). In contrast, uptake transporter mRNA was expressed in <25% of tissues. OAT1 protein was detected in 0% of female genital tissues and in 100% of colorectal tissues, but only in rare epithelial cells. These data support clinical findings of higher maraviroc and tenofovir concentrations in rectal tissue compared to vaginal or cervical tissue after oral dosing. Quantifying mucosal transporter expression and localization can facilitate ARV selection to target these tissues.", "electronicPublicationDate": "2014-01-02", "language": "eng", "dateOfCompletion": "2015-11-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4061289?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4061289", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1002/jcph.248", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-02-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-05-01", "journal": {"medlineAbbreviation": "J Clin Pharmacol", "isoabbreviation": "J Clin Pharmacol", "title": "Journal of clinical pharmacology", "issn": "0091-2700", "nlmid": "0366372", "essn": "1552-4604"}, "monthOfPublication": 5, "volume": "54", "yearOfPublication": 2014, "journalIssueId": 2284965, "issue": "5", "dateOfPublication": "2014 May"}}, "19841609": {"pubYear": "2009", "dateOfCreation": "2012-07-04", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Anticonvulsants"}, {"registryNumber": "50-06-6", "name": "Phenobarbital"}]}, "authorString": "Kennerly EM, Idaghdour Y, Olby NJ, Munana KR, Gibson G.", "affiliation": "Department of Genetics, Gardner Hall, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "GM-08443-13"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "2-R01-GM 61600"}]}, "hasPDF": "N", "id": "19841609", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kennerly", "fullName": "Kennerly EM", "firstName": "Erin M", "initials": "EM"}, {"lastName": "Idaghdour", "fullName": "Idaghdour Y", "firstName": "Youssef", "initials": "Y"}, {"lastName": "Olby", "fullName": "Olby NJ", "firstName": "Natasha J", "initials": "NJ"}, {"lastName": "Munana", "fullName": "Munana KR", "firstName": "Karen R", "initials": "KR"}, {"lastName": "Gibson", "fullName": "Gibson G", "firstName": "Greg", "initials": "G"}]}, "title": "Pharmacogenetic association study of 30 genes with phenobarbital drug response in epileptic dogs.", "citedByCount": 5, "source": "MED", "pmid": "19841609", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Dogs", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "VE", "qualifierName": "veterinary", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dog Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phenobarbital", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Anticonvulsants", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Pharmacogenetics", "majorTopic_YN": "N"}, {"descriptorName": "Drug Resistance", "majorTopic_YN": "Y"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2009-12-01", "doi": "10.1097/fpc.0b013e3283307cba", "isOpenAccess": "N", "pageInfo": "911-922", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: Epilepsy, with a prevalence as high as 6%, is the most common neurological disorder in dogs. Although several antiepileptic drugs are in common use, in one-third of all epileptic dogs, adequate seizure control is not achieved with a single medication, and hence a combinatorial drug treatment must be adopted. Exploration of the genetic mechanisms involved in drug response may provide better treatment options for epileptic patients. METHODS AND RESULTS: A custom Illumina BeadChip was designed for high throughput genotyping of 384 single nucleotide polymorphisms in 30 genes involved in drug metabolism, drug targeting, and drug transport. A case-control association study of 125 epileptic dogs identified five genes with suggestive association to phenobarbital drug response: KCNQ3, P=0.0003; SNC2A2, P=0.0008; EPOX HYD, P=0.0005; ABCC4, P=0.0091; and GABRA2, P=0.0130. These associations are not significant after adjustment for multiple comparisons, but on functional grounds may tag strong candidate genes. The study was powered to detect alleles with at least 3.5-fold additive increases in responsiveness. A combined area under the curve value of 0.74 from receiver operating curve analysis also provides suggestive support for their consideration as canine pharmacogenetic markers. CONCLUSION: Further replication and assessment of breed specificity is required before these markers can be considered as predictive of responsiveness to phenobarbital in dogs.", "language": "eng", "dateOfCompletion": "2012-09-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/FPC.0b013e3283307cba", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-12-01", "journal": {"medlineAbbreviation": "Pharmacogenet Genomics", "isoabbreviation": "Pharmacogenet. Genomics", "title": "Pharmacogenetics and genomics", "issn": "1744-6872", "nlmid": "101231005", "essn": "1744-6880"}, "monthOfPublication": 12, "volume": "19", "yearOfPublication": 2009, "journalIssueId": 1790022, "issue": "12", "dateOfPublication": "2009 Dec"}}, "24464805": {"pubYear": "2014", "dateOfCreation": "2014-03-03", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Abcc4 protein, mouse"}, {"registryNumber": "0", "name": "Antimetabolites, Antineoplastic"}, {"registryNumber": "0", "name": "Multidrug Resistance-Associated Proteins"}, {"registryNumber": "0", "name": "Abcg2 protein, mouse"}, {"registryNumber": "YL5FZ2Y5U1", "name": "Methotrexate"}]}, "authorString": "Sane R, Wu SP, Zhang R, Gallo JM.", "affiliation": "Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "CA073728"}]}, "hasPDF": "Y", "id": "24464805", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York.", "fullName": "Sane R", "initials": "R", "firstName": "Ramola", "lastName": "Sane"}, {"lastName": "Wu", "fullName": "Wu SP", "firstName": "Shu-Pei", "initials": "SP"}, {"lastName": "Zhang", "fullName": "Zhang R", "firstName": "Rong", "initials": "R"}, {"lastName": "Gallo", "fullName": "Gallo JM", "firstName": "James M", "initials": "JM"}]}, "title": "The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24464805", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Blood-Brain Barrier", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Inbred C57BL", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Knockout", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Brain Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Methotrexate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Multidrug Resistance-Associated Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antimetabolites, Antineoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "PK", "qualifierName": "pharmacokinetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N"}, {"descriptorName": "Microdialysis", "majorTopic_YN": "N"}, {"descriptorName": "Area Under Curve", "majorTopic_YN": "N"}, {"descriptorName": "Biological Transport", "majorTopic_YN": "N"}, {"descriptorName": "Gene Knockout Techniques", "majorTopic_YN": "N"}]}, "inPMC": "N", "embargoDate": "2015-04-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-01-24", "doi": "10.1124/dmd.113.055228", "isOpenAccess": "N", "pageInfo": "537-540", "pmcid": "PMC3965903", "hasDbCrossReferences": "N", "abstractText": "Methotrexate (MTX) is the cornerstone of chemotherapy for primary central nervous system lymphoma, yet how the blood-brain barrier (BBB) efflux transporters ABCG2 and ABCC4 influence the required high-dose therapy is unknown. To evaluate their role, we used four mouse strains, C57BL/6 (wild-type; WT), Abcg2(-/-), Abcc4(-/-), and Abcg2(-/-);Abcc4(-/-) (double knockout; DKO) to conduct brain microdialysis studies after single intravenous MTX doses of 50 mg/kg. When the area under the concentration-time curve for plasma (AUC(plasma)) was used to assess systemic exposure to MTX, the rank order was Abcc4(-/-) < WT < Abcg2(-/-) < Abcg2(-/-)Abcc4(-/-). Only the DKO exposure was significantly higher than that of the WT group (P < 0.01), a reflection of the role of Abcg2 in biliary excretion and Abcc4 in renal excretion. MTX brain interstitial fluid concentrations obtained by microdialysis were used to calculate the area under the concentration-time curve for the brain (AUC(brain)), which found the rank order of exposure to be WT < Abcc4(-/-) < Abcg2(-/-) < Abcg2(-/-)Abcc4(-/-) with the largest difference being 4-fold: 286.13 \u00b1 130 \u03bcg*min/ml (DKO) versus 66.85 \u00b1 26 (WT). Because the transporters affected the systemic disposition of MTX, particularly in the DKO group, the ratio of the AUC(brain)/AUC(plasma) or the brain/plasma partition coefficient Kp was calculated, revealing that the DKO strain had a significantly higher value (0.23 \u00b1 0.09) than the WT strain (0.11 \u00b1 0.05). Both Abcg2 and Abcc4 limited BBB penetration of MTX; however, only when both drug efflux pumps were negated did the brain accumulation of MTX significantly increase. These findings indicate a contributory role of both ABCG2 and ABCC4 to limiting MTX distribution in patients.", "electronicPublicationDate": "2014-01-24", "language": "eng", "dateOfCompletion": "2014-10-28", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3965903?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3965903", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1124/dmd.113.055228", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-04-22", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-04-01", "journal": {"medlineAbbreviation": "Drug Metab Dispos", "isoabbreviation": "Drug Metab. Dispos.", "title": "Drug metabolism and disposition: the biological fate of chemicals", "issn": "0090-9556", "nlmid": "9421550", "essn": "1521-009X"}, "monthOfPublication": 4, "volume": "42", "yearOfPublication": 2014, "journalIssueId": 2133720, "issue": "4", "dateOfPublication": "2014 Apr"}}}, "SERAC1": {"23401890": {"pubYear": "2012", "dateOfCreation": "2013-02-11", "pubModel": "Print", "authorString": "Alexoudi A, Schneider SA.", "pubTypeList": {"pubType": ["Comment", "Journal Article"]}, "id": "23401890", "inEPMC": "N", "authorList": {"author": [{"lastName": "Alexoudi", "fullName": "Alexoudi A", "firstName": "Athanasia", "initials": "A"}, {"lastName": "Schneider", "fullName": "Schneider SA", "firstName": "Susanne A", "initials": "SA"}]}, "title": "Mutations in the phospholipid remodeling gene SERAC1 cause MEGDEL syndrome.", "citedByCount": 1, "pageInfo": "1738", "source": "MED", "pmid": "23401890", "hasLabsLinks": "N", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-12-01", "doi": "10.1002/mds.25228", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment on", "id": "22683713", "reference": "Nat Genet. 2012 Jul;44(7):797-802"}]}, "hasDbCrossReferences": "N", "abstractText": " ", "language": "eng", "dateOfCompletion": "2013-08-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/mds.25228", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-12-01", "journal": {"medlineAbbreviation": "Mov Disord", "isoabbreviation": "Mov. Disord.", "title": "Movement disorders : official journal of the Movement Disorder Society", "issn": "0885-3185", "nlmid": "8610688", "essn": "1531-8257"}, "monthOfPublication": 12, "volume": "27", "yearOfPublication": 2012, "journalIssueId": 1996619, "issue": "14", "dateOfPublication": "2012 Dec"}}, "23918762": {"pubYear": "2013", "dateOfCreation": "2013-08-15", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Electron Transport Chain Complex Proteins"}, {"registryNumber": "EC 3.1.1.-", "name": "Carboxylic Ester Hydrolases"}, {"registryNumber": "EC 3.1.1.-", "name": "SERAC1 protein, human"}]}, "authorString": "Sarig O, Goldsher D, Nousbeck J, Fuchs-Telem D, Cohen-Katsenelson K, Iancu TC, Manov I, Saada A, Sprecher E, Mandel H.", "affiliation": "Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "23918762", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.", "fullName": "Sarig O", "initials": "O", "firstName": "Ofer", "lastName": "Sarig"}, {"lastName": "Goldsher", "fullName": "Goldsher D", "firstName": "Dorit", "initials": "D"}, {"lastName": "Nousbeck", "fullName": "Nousbeck J", "firstName": "Janna", "initials": "J"}, {"lastName": "Fuchs-Telem", "fullName": "Fuchs-Telem D", "firstName": "Dana", "initials": "D"}, {"lastName": "Cohen-Katsenelson", "fullName": "Cohen-Katsenelson K", "firstName": "Ksenya", "initials": "K"}, {"lastName": "Iancu", "fullName": "Iancu TC", "firstName": "Theodore C", "initials": "TC"}, {"lastName": "Manov", "fullName": "Manov I", "firstName": "Irena", "initials": "I"}, {"lastName": "Saada", "fullName": "Saada A", "firstName": "Ann", "initials": "A"}, {"lastName": "Sprecher", "fullName": "Sprecher E", "firstName": "Eli", "initials": "E"}, {"lastName": "Mandel", "fullName": "Mandel H", "firstName": "Hanna", "initials": "H"}]}, "title": "Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1.", "citedByCount": 6, "source": "MED", "pmid": "23918762", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Liver", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "UL", "qualifierName": "ultrastructure", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Liver Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hearing Loss, Sensorineural", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Leigh Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Carboxylic Ester Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Electron Transport Chain Complex Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Chromosome Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Consanguinity", "majorTopic_YN": "N"}, {"descriptorName": "Microsatellite Repeats", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Homozygote", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-08-05", "doi": "10.1002/ajmg.a.36059", "isOpenAccess": "N", "pageInfo": "2204-2215", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Megdel Syndrome", "Serac1", "Infantile Hepatopathy"]}, "abstractText": "3-Methylglutaconic aciduria (3-MGCA) type IV is defined as a heterogeneous group of inborn errors featuring in common 3-MGCA and associated with primary mitochondrial dysfunction leading to a spectrum of multisystem conditions. We studied four patients who presented at birth with a clinical picture simulating a primary mitochondrial hepatic disorder consistent with the MEGDEL syndrome including 3-MGCA, sensorineural deafness, encephalopathy and a brain magnetic resonance imaging with signs of Leigh disease. All affected children displayed biochemical features consistent with mitochondrial OXPHOS dysfunction including hepatic mitochondrial DNA depletion in one patient. Homozygosity mapping identified a candidate locus on 6q25.2-6q26. Using whole exome sequencing, we identified two novel homozygous mutations in SERAC1 recently reported to harbor mutations in MEGDEL syndrome. Both mutations were found to lead to decreased or absent expression of SERAC1. The present findings indicate that infantile hepatopathy is a cardinal feature of MEGDEL syndrome. We thus propose to rename the disease MEGDHEL syndrome.", "electronicPublicationDate": "2013-08-05", "language": "eng", "dateOfCompletion": "2014-03-26", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.a.36059", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2014-09-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-09-01", "journal": {"medlineAbbreviation": "Am J Med Genet A", "isoabbreviation": "Am. J. Med. Genet. A", "title": "American journal of medical genetics. Part A", "issn": "1552-4825", "nlmid": "101235741", "essn": "1552-4833"}, "monthOfPublication": 9, "volume": "161A", "yearOfPublication": 2013, "journalIssueId": 2195749, "issue": "9", "dateOfPublication": "2013 Sep"}}, "25051967": {"pubYear": "2015", "dateOfCreation": "2015-06-20", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.1.-", "name": "Carboxylic Ester Hydrolases"}, {"registryNumber": "EC 3.1.1.-", "name": "SERAC1 protein, human"}]}, "authorString": "Dweikat IM, Abdelrazeq S, Ayesh S, Jundi T.", "affiliation": "An-Najah National University, Metabolic. Faculty of Medicine and Health Sciences, Nablus i.dweikat@najah.edu.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "25051967", "inEPMC": "N", "authorList": {"author": [{"affiliation": "An-Najah National University, Metabolic. Faculty of Medicine and Health Sciences, Nablus i.dweikat@najah.edu.", "fullName": "Dweikat IM", "initials": "IM", "firstName": "Imad M", "lastName": "Dweikat"}, {"affiliation": "Makassed Hospital, Jerusalem.", "fullName": "Abdelrazeq S", "initials": "S", "firstName": "Samer", "lastName": "Abdelrazeq"}, {"affiliation": "Makassed Hospital, Jerusalem.", "fullName": "Ayesh S", "initials": "S", "firstName": "Suhail", "lastName": "Ayesh"}, {"affiliation": "Makassed Hospital, Jerusalem.", "fullName": "Jundi T", "initials": "T", "firstName": "Tawfeeq", "lastName": "Jundi"}]}, "title": "MEGDEL Syndrome in a Child From Palestine: Report of a Novel Mutation in SERAC1 Gene.", "citedByCount": 1, "source": "MED", "pmid": "25051967", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Hearing Loss, Sensorineural", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Leigh Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Muscle Hypotonia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carboxylic Ester Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Motor Skills Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Consanguinity", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Arabs", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2014-07-22", "doi": "10.1177/0883073814541474", "isOpenAccess": "N", "pageInfo": "1053-1056", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Sensorineural Deafness", "Megdel", "Leigh-like Syndrome"]}, "abstractText": "We report the first Palestinian child manifesting with 3-methylglutaconic aciduria psychomotor delay, muscle hypotonia, sensori-neural deafness, and Leigh-like lesions on brain magnetic resonance imaging (MRI), a clinical phenotype that is characteristic of MEGDEL syndrome. MEGDEL syndrome was recently found to be caused by mutations in SERAC1, encoding a protein essential for mitochondrial function, phospholipid remodeling, and intracellular cholesterol trafficking. We identified a novel homozygous mutation in SERAC1 gene (c.1018delT) that generates frame shift and premature termination of protein translation. Plasma and cerebrospinal fluid lactate, plasma alanine, and respiratory chain complexes in fresh muscle were normal. This report further expands the genetic spectrum of MEGDEL syndrome and adds to the evidence that it is associated with variable patterns of respiratory chain abnormalities.", "electronicPublicationDate": "2014-07-22", "language": "eng", "dateOfCompletion": "2016-03-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1177/0883073814541474", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-07-01", "journal": {"medlineAbbreviation": "J Child Neurol", "isoabbreviation": "J. Child Neurol.", "title": "Journal of child neurology", "issn": "0883-0738", "nlmid": "8606714", "essn": "1708-8283"}, "monthOfPublication": 7, "volume": "30", "yearOfPublication": 2015, "journalIssueId": 2296474, "issue": "8", "dateOfPublication": "2015 Jul"}}, "24997715": {"pubYear": "2014", "dateOfCreation": "2014-11-06", "pubModel": "Print-Electronic", "authorString": "Lumish HS, Yang Y, Xia F, Wilson A, Chung WK.", "affiliation": "College of Physicians and Surgeons, Columbia University, New York, NY, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24997715", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "College of Physicians and Surgeons, Columbia University, New York, NY, USA.", "fullName": "Lumish HS", "initials": "HS", "firstName": "Heidi S", "lastName": "Lumish"}, {"lastName": "Yang", "fullName": "Yang Y", "firstName": "Yaping", "initials": "Y"}, {"lastName": "Xia", "fullName": "Xia F", "firstName": "Fan", "initials": "F"}, {"lastName": "Wilson", "fullName": "Wilson A", "firstName": "Ashley", "initials": "A"}, {"lastName": "Chung", "fullName": "Chung WK", "firstName": "Wendy K", "initials": "WK"}]}, "title": "The Expanding MEGDEL Phenotype: Optic Nerve Atrophy, Microcephaly, and Myoclonic Epilepsy in a Child with SERAC1 Mutations.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "24997715", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["omim", " pfam", " "]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-07-06", "doi": "10.1007/8904_2014_322", "isOpenAccess": "N", "pageInfo": "75-79", "pmcid": "PMC4221303", "hasDbCrossReferences": "N", "abstractText": "The inborn errors of metabolism associated with 3-methylglutaconic aciduria are a diverse group of disorders characterized by the excretion of 3-methylglutaconic and 3-methylglutaric acids in the urine. Mutations in several genes have been identified in association with 3-methylglutaconic aciduria. We describe a patient of Saudi Arabian descent with 3-methylglutaconic aciduria, sensorineural hearing loss, encephalopathy, and Leigh-like pattern on MRI (MEGDEL syndrome), as well as developmental delay and developmental regression, bilateral optic nerve atrophy, microcephaly, and myoclonic epilepsy. The patient had an earlier age of onset of optic atrophy than previously described in other MEGDEL syndrome patients. Whole exome sequencing revealed two loss-of-function mutations in SERAC1 in trans: c.438delC (p.T147Rfs*22) and c.442C>T (p.R148X), confirmed by Sanger sequencing. One of these mutations is novel (c.438delC). This case contributes to refining the MEGDEL phenotype.", "electronicPublicationDate": "2014-07-06", "language": "eng", "dateOfCompletion": "2014-11-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4221303?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4221303", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/8904_2014_322", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2014-12-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "JIMD Rep", "isoabbreviation": "JIMD Rep", "title": "JIMD reports", "issn": "2192-8304", "nlmid": "101568557", "essn": "2192-8312"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2014, "journalIssueId": 2218443, "dateOfPublication": "2014 "}}, "22683713": {"pubYear": "2012", "dateOfCreation": "2012-06-28", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phospholipids"}, {"registryNumber": "57-88-5", "name": "Cholesterol"}, {"registryNumber": "0", "name": "Cardiolipins"}, {"registryNumber": "0", "name": "Phosphatidylglycerols"}, {"registryNumber": "EC 3.1.1.-", "name": "Carboxylic Ester Hydrolases"}, {"registryNumber": "EC 3.1.1.-", "name": "SERAC1 protein, human"}]}, "authorString": "Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, Kulik W, Lammens M, Christin C, Kluijtmans LA, Rodenburg RJ, Nijtmans LG, Gr\u00fcnewald A, Klein C, Gerhold JM, Kozicz T, van Hasselt PM, Harakalova M, Kloosterman W, Bari\u0107 I, Pronicka E, Ucar SK, Naess K, Singhal KK, Krumina Z, Gilissen C, van Bokhoven H, Veltman JA, Smeitink JA, Lefeber DJ, Spelbrink JN, Wevers RA, Morava E, de Brouwer AP.", "affiliation": "Department of Pediatrics, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands. s.wortmann@cukz.umcn.nl", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"acronym": "GENCODYS", "orderIn": 0, "agency": "European Commission FP7", "grantId": "FP7_241995"}]}, "hasPDF": "N", "id": "22683713", "inEPMC": "N", "authorList": {"author": [{"lastName": "Wortmann", "fullName": "Wortmann SB", "firstName": "Saskia B", "initials": "SB"}, {"lastName": "Vaz", "fullName": "Vaz FM", "firstName": "Fr\u00e9d\u00e9ric M", "initials": "FM"}, {"lastName": "Gardeitchik", "fullName": "Gardeitchik T", "firstName": "Thatjana", "initials": "T"}, {"lastName": "Vissers", "fullName": "Vissers LE", "firstName": "Lisenka E L M", "initials": "LE"}, {"lastName": "Renkema", "fullName": "Renkema GH", "firstName": "G Herma", "initials": "GH"}, {"lastName": "Schuurs-Hoeijmakers", "fullName": "Schuurs-Hoeijmakers JH", "firstName": "Janneke H M", "initials": "JH"}, {"lastName": "Kulik", "fullName": "Kulik W", "firstName": "Wim", "initials": "W"}, {"lastName": "Lammens", "fullName": "Lammens M", "firstName": "Martin", "initials": "M"}, {"lastName": "Christin", "fullName": "Christin C", "firstName": "Christin", "initials": "C"}, {"lastName": "Kluijtmans", "fullName": "Kluijtmans LA", "firstName": "Leo A J", "initials": "LA"}, {"lastName": "Rodenburg", "fullName": "Rodenburg RJ", "firstName": "Richard J", "initials": "RJ"}, {"lastName": "Nijtmans", "fullName": "Nijtmans LG", "firstName": "Leo G J", "initials": "LG"}, {"lastName": "Gr\u00fcnewald", "fullName": "Gr\u00fcnewald A", "firstName": "Anne", "initials": "A"}, {"lastName": "Klein", "fullName": "Klein C", "firstName": "Christine", "initials": "C"}, {"lastName": "Gerhold", "fullName": "Gerhold JM", "authorId": {"type": "ORCID", "value": "0000-0002-4972-1947"}, "firstName": "Joachim M", "initials": "JM"}, {"lastName": "Kozicz", "fullName": "Kozicz T", "authorId": {"type": "ORCID", "value": "0000-0001-6915-4364"}, "firstName": "Tamas", "initials": "T"}, {"lastName": "van Hasselt", "fullName": "van Hasselt PM", "firstName": "Peter M", "initials": "PM"}, {"lastName": "Harakalova", "fullName": "Harakalova M", "firstName": "Magdalena", "initials": "M"}, {"lastName": "Kloosterman", "fullName": "Kloosterman W", "firstName": "Wigard", "initials": "W"}, {"lastName": "Bari\u0107", "fullName": "Bari\u0107 I", "firstName": "Ivo", "initials": "I"}, {"lastName": "Pronicka", "fullName": "Pronicka E", "firstName": "Ewa", "initials": "E"}, {"lastName": "Ucar", "fullName": "Ucar SK", "firstName": "Sema Kalkan", "initials": "SK"}, {"lastName": "Naess", "fullName": "Naess K", "firstName": "Karin", "initials": "K"}, {"lastName": "Singhal", "fullName": "Singhal KK", "firstName": "Kapil K", "initials": "KK"}, {"lastName": "Krumina", "fullName": "Krumina Z", "firstName": "Zita", "initials": "Z"}, {"lastName": "Gilissen", "fullName": "Gilissen C", "authorId": {"type": "ORCID", "value": "0000-0003-1693-9699"}, "firstName": "Christian", "initials": "C"}, {"lastName": "van Bokhoven", "fullName": "van Bokhoven H", "firstName": "Hans", "initials": "H"}, {"lastName": "Veltman", "fullName": "Veltman JA", "firstName": "Joris A", "initials": "JA"}, {"lastName": "Smeitink", "fullName": "Smeitink JA", "firstName": "Jan A M", "initials": "JA"}, {"lastName": "Lefeber", "fullName": "Lefeber DJ", "firstName": "Dirk J", "initials": "DJ"}, {"lastName": "Spelbrink", "fullName": "Spelbrink JN", "firstName": "Johannes N", "initials": "JN"}, {"lastName": "Wevers", "fullName": "Wevers RA", "firstName": "Ron A", "initials": "RA"}, {"lastName": "Morava", "fullName": "Morava E", "firstName": "Eva", "initials": "E"}, {"lastName": "de Brouwer", "fullName": "de Brouwer AP", "firstName": "Arjan P M", "initials": "AP"}]}, "title": "Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness.", "citedByCount": 47, "pageInfo": "797-802", "source": "MED", "pmid": "22683713", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-4972-1947"}, {"type": "ORCID", "value": "0000-0001-6915-4364"}, {"type": "ORCID", "value": "0000-0003-1693-9699"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Transformed", "majorTopic_YN": "N"}, {"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Hela Cells", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fibroblasts", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Deafness", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Dystonia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cholesterol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Carboxylic Ester Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phospholipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Phosphatidylglycerols", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cardiolipins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sequence Alignment", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Oxidative Phosphorylation", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "HEK293 Cells", "majorTopic_YN": "N"}, {"descriptorName": "Exome", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-10", "doi": "10.1038/ng.2325", "isOpenAccess": "N", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 1, "type": "Comment in", "id": "23401890", "reference": "Mov Disord. 2012 Dec;27(14):1738"}]}, "hasDbCrossReferences": "Y", "abstractText": "Using exome sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired oxidative phosphorylation and 3-methylglutaconic aciduria. We localized SERAC1 at the interface between the mitochondria and the endoplasmic reticulum in the mitochondria-associated membrane fraction that is essential for phospholipid exchange. A phospholipid analysis in patient fibroblasts showed elevated concentrations of phosphatidylglycerol-34:1 (where the species nomenclature denotes the number of carbon atoms in the two acyl chains:number of double bonds in the two acyl groups) and decreased concentrations of phosphatidylglycerol-36:1 species, resulting in an altered cardiolipin subspecies composition. We also detected low concentrations of bis(monoacyl-glycerol)-phosphate, leading to the accumulation of free cholesterol, as shown by abnormal filipin staining. Complementation of patient fibroblasts with wild-type human SERAC1 by lentiviral infection led to a decrease and partial normalization of the mean ratio of phosphatidylglycerol-34:1 to phosphatidylglycerol-36:1. Our data identify SERAC1 as a key player in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular cholesterol trafficking.", "electronicPublicationDate": "2012-06-10", "language": "eng", "dateOfCompletion": "2012-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1038/ng.2325", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2013-02-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-07-01", "journal": {"medlineAbbreviation": "Nat Genet", "isoabbreviation": "Nat. Genet.", "title": "Nature genetics", "issn": "1061-4036", "nlmid": "9216904", "essn": "1546-1718"}, "monthOfPublication": 7, "volume": "44", "yearOfPublication": 2012, "journalIssueId": 1959983, "issue": "7", "dateOfPublication": "2012 Jul"}}, "25595726": {"pubYear": "2015", "dateOfCreation": "2015-02-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.4.21.92", "name": "Endopeptidase Clp"}, {"registryNumber": "EC 3.4.21.92", "name": "CLPB protein, human"}]}, "authorString": "Kanabus M, Shahni R, Saldanha JW, Murphy E, Plagnol V, Hoff WV, Heales S, Rahman S.", "affiliation": "Genetics and Genomic Medicine, UCL Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Great Ormond Street Hospital Childrens Charity", "grantId": "V1260"}]}, "hasPDF": "N", "id": "25595726", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Genetics and Genomic Medicine, UCL Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.", "fullName": "Kanabus M", "initials": "M", "firstName": "Marta", "lastName": "Kanabus"}, {"lastName": "Shahni", "fullName": "Shahni R", "firstName": "Rojeen", "initials": "R"}, {"lastName": "Saldanha", "fullName": "Saldanha JW", "firstName": "Jos\u00e9 W", "initials": "JW"}, {"lastName": "Murphy", "fullName": "Murphy E", "firstName": "Elaine", "initials": "E"}, {"lastName": "Plagnol", "fullName": "Plagnol V", "authorId": {"type": "ORCID", "value": "0000-0002-5597-9215"}, "firstName": "Vincent", "initials": "V"}, {"lastName": "Hoff", "fullName": "Hoff WV", "firstName": "William Van't", "initials": "WV"}, {"lastName": "Heales", "fullName": "Heales S", "firstName": "Simon", "initials": "S"}, {"lastName": "Rahman", "fullName": "Rahman S", "firstName": "Shamima", "initials": "S"}]}, "title": "Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mitochondrial protein disaggregation.", "citedByCount": 1, "source": "MED", "pmid": "25595726", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5597-9215"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nephrocalcinosis", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Endopeptidase Clp", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Risk Factors", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Siblings", "majorTopic_YN": "N"}, {"descriptorName": "Heredity", "majorTopic_YN": "N"}, {"descriptorName": "Protein Conformation", "majorTopic_YN": "N"}, {"descriptorName": "Structure-Activity Relationship", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Models, Molecular", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Membranes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Kidney Diseases, Cystic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "EN", "qualifierName": "enzymology", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Exome", "majorTopic_YN": "N"}, {"descriptorName": "Protein Aggregation, Pathological", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-01-18", "doi": "10.1007/s10545-015-9813-0", "isOpenAccess": "N", "pageInfo": "211-219", "hasDbCrossReferences": "Y", "abstractText": "Whole exome sequencing was used to investigate the genetic cause of mitochondrial disease in two siblings with a syndrome of congenital lamellar cataracts associated with nephrocalcinosis, medullary cysts and 3-methylglutaconic aciduria. Autosomal recessive inheritance in a gene encoding a mitochondrially targeted protein was assumed; the only variants which satisfied these criteria were c.1882C>T (p.Arg628Cys) and c.1915G>A (p.Glu639Lys) in the CLPB gene, encoding a heat shock protein/chaperonin responsible for disaggregating mitochondrial and cytosolic proteins. Functional studies, including quantitative PCR (qPCR) and Western blot, support pathogenicity of these mutations. Furthermore, molecular modelling suggests that the mutations disrupt interactions between subunits so that the CLPB hexamer cannot form or is unstable, thus impairing its role as a protein disaggregase. We conclude that accumulation of protein aggregates underlies the development of cataracts and nephrocalcinosis in CLPB deficiency, which is a novel genetic cause of 3-methylglutaconic aciduria. A common mitochondrial cause for 3-methylglutaconic aciduria appears to be disruption of the architecture of the mitochondrial membranes, as in Barth syndrome (tafazzin deficiency), Sengers syndrome (acylglycerol kinase deficiency) and MEGDEL syndrome (impaired remodelling of the mitochondrial membrane lipids because of SERAC1 mutations). We now propose that perturbation of the mitochondrial membranes by abnormal protein aggregates leads to 3-methylglutaconic aciduria in CLPB deficiency.", "electronicPublicationDate": "2015-01-18", "language": "eng", "dateOfCompletion": "2016-03-03", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10545-015-9813-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-03-01", "journal": {"medlineAbbreviation": "J Inherit Metab Dis", "isoabbreviation": "J. Inherit. Metab. Dis.", "title": "Journal of inherited metabolic disease", "issn": "0141-8955", "nlmid": "7910918", "essn": "1573-2665"}, "monthOfPublication": 3, "volume": "38", "yearOfPublication": 2015, "journalIssueId": 2257522, "issue": "2", "dateOfPublication": "2015 Mar"}}, "25691889": {"pubYear": "2015", "dateOfCreation": "2015-02-18", "pubModel": "Electronic-eCollection", "authorString": "Lu YW, Claypool SM.", "affiliation": "Department of Physiology, School of Medicine, Johns Hopkins University Baltimore, MD, USA.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "grantsList": {"grant": [{"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "R01 GM111548"}]}, "id": "25691889", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Physiology, School of Medicine, Johns Hopkins University Baltimore, MD, USA.", "fullName": "Lu YW", "initials": "YW", "firstName": "Ya-Wen", "lastName": "Lu"}, {"affiliation": "Department of Physiology, School of Medicine, Johns Hopkins University Baltimore, MD, USA.", "fullName": "Claypool SM", "initials": "SM", "firstName": "Steven M", "lastName": "Claypool"}]}, "title": "Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "25691889", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["omim"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-02-03", "language": "eng", "doi": "10.3389/fgene.2015.00003", "isOpenAccess": "Y", "pageInfo": "3", "pmcid": "PMC4315098", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Cardiolipin", "Phospholipid Metabolism", "Barth Syndrome", "Mitochondrial Disease", "Hereditary Spastic Paraplegia", "Megdel", "Dcma", "Sengers Syndrome"]}, "abstractText": "The human nuclear and mitochondrial genomes co-exist within each cell. While the mitochondrial genome encodes for a limited number of proteins, transfer RNAs, and ribosomal RNAs, the vast majority of mitochondrial proteins are encoded in the nuclear genome. Of the multitude of mitochondrial disorders known to date, only a fifth are maternally inherited. The recent characterization of the mitochondrial proteome therefore serves as an important step toward delineating the nosology of a large spectrum of phenotypically heterogeneous diseases. Following the identification of the first nuclear gene defect to underlie a mitochondrial disorder, a plenitude of genetic variants that provoke mitochondrial pathophysiology have been molecularly elucidated and classified into six categories that impact: (1) oxidative phosphorylation (subunits and assembly factors); (2) mitochondrial DNA maintenance and expression; (3) mitochondrial protein import and assembly; (4) mitochondrial quality control (chaperones and proteases); (5) iron-sulfur cluster homeostasis; and (6) mitochondrial dynamics (fission and fusion). Here, we propose that an additional class of genetic variant be included in the classification schema to acknowledge the role of genetic defects in phospholipid biosynthesis, remodeling, and metabolism in mitochondrial pathophysiology. This seventh class includes a small but notable group of nuclear-encoded proteins whose dysfunction impacts normal mitochondrial phospholipid metabolism. The resulting human disorders present with a diverse array of pathologic consequences that reflect the variety of functions that phospholipids have in mitochondria and highlight the important role of proper membrane homeostasis in mitochondrial biology.", "electronicPublicationDate": "2015-02-03", "license": "cc by", "dateOfCompletion": "2015-02-18", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4315098?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4315098", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.3389/fgene.2015.00003", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2015-03-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Frontiers in genetics", "medlineAbbreviation": "Front Genet", "isoabbreviation": "Front Genet", "nlmid": "101560621", "essn": "1664-8021"}, "monthOfPublication": 0, "volume": "6", "yearOfPublication": 2015, "journalIssueId": 2253353, "dateOfPublication": "2015 "}}, "25778941": {"pubYear": "2015", "dateOfCreation": "2015-07-07", "pubModel": "Print-Electronic", "authorString": "Mayr JA, Haack TB, Freisinger P, Karall D, Makowski C, Koch J, Feichtinger RG, Zimmermann FA, Rolinski B, Ahting U, Meitinger T, Prokisch H, Sperl W.", "affiliation": "Department of Paediatrics, Paracelsus Medical University, SALK Salzburg, Salzburg, 5020, Austria, H.Mayr@salk.at.", "pubTypeList": {"pubType": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "25778941", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Johannes A", "lastName": "Mayr", "affiliation": "Department of Paediatrics, Paracelsus Medical University, SALK Salzburg, Salzburg, 5020, Austria, H.Mayr@salk.at.", "authorId": {"type": "ORCID", "value": "0000-0001-6970-336X"}, "fullName": "Mayr JA", "initials": "JA"}, {"lastName": "Haack", "fullName": "Haack TB", "firstName": "Tobias B", "initials": "TB"}, {"lastName": "Freisinger", "fullName": "Freisinger P", "firstName": "Peter", "initials": "P"}, {"lastName": "Karall", "fullName": "Karall D", "firstName": "Daniela", "initials": "D"}, {"lastName": "Makowski", "fullName": "Makowski C", "firstName": "Christine", "initials": "C"}, {"lastName": "Koch", "fullName": "Koch J", "firstName": "Johannes", "initials": "J"}, {"lastName": "Feichtinger", "fullName": "Feichtinger RG", "firstName": "Ren\u00e9 G", "initials": "RG"}, {"lastName": "Zimmermann", "fullName": "Zimmermann FA", "firstName": "Franz A", "initials": "FA"}, {"lastName": "Rolinski", "fullName": "Rolinski B", "firstName": "Boris", "initials": "B"}, {"lastName": "Ahting", "fullName": "Ahting U", "firstName": "Uwe", "initials": "U"}, {"lastName": "Meitinger", "fullName": "Meitinger T", "firstName": "Thomas", "initials": "T"}, {"lastName": "Prokisch", "fullName": "Prokisch H", "firstName": "Holger", "initials": "H"}, {"lastName": "Sperl", "fullName": "Sperl W", "firstName": "Wolfgang", "initials": "W"}]}, "title": "Spectrum of combined respiratory chain defects.", "hasSuppl": "N", "citedByCount": 3, "source": "MED", "pmid": "25778941", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["omim"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-6970-336X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mitochondrial Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Energy Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oxidative Phosphorylation", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-03-17", "doi": "10.1007/s10545-015-9831-y", "isOpenAccess": "Y", "pageInfo": "629-640", "pmcid": "PMC4493854", "hasDbCrossReferences": "N", "abstractText": "Inherited disorders of mitochondrial energy metabolism form a large and heterogeneous group of metabolic diseases. More than 250 gene defects have been reported to date and this number continues to grow. Mitochondrial diseases can be grouped into (1) disorders of oxidative phosphorylation (OXPHOS) subunits and their assembly factors, (2) defects of mitochondrial DNA, RNA and protein synthesis, (3) defects in the substrate-generating upstream reactions of OXPHOS, (4) defects in relevant cofactors and (5) defects in mitochondrial homeostasis. Deficiency of more than one respiratory chain enzyme is a common finding. Combined defects are found in 49 % of the known disease-causing genes of mitochondrial energy metabolism and in 57 % of patients with OXPHOS defects identified in our diagnostic centre. Combined defects of complexes I, III, IV and V are typically due to deficiency of mitochondrial DNA replication, RNA metabolism or translation. Defects in cofactors can result in combined defects of various combinations, and defects of mitochondrial homeostasis can result in a generalised decrease of all OXPHOS enzymes. Noteworthy, identification of combined defects can be complicated by different degrees of severity of each affected enzyme. Furthermore, even defects of single respiratory chain enzymes can result in combined defects due to aberrant formation of respiratory chain supercomplexes. Combined OXPHOS defects have a great variety of clinical manifestations in terms of onset, course severity and tissue involvement. They can present as classical encephalomyopathy but also with hepatopathy, nephropathy, haematologic findings and Perrault syndrome in a subset of disorders.", "electronicPublicationDate": "2015-03-17", "language": "eng", "dateOfCompletion": "2016-04-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4493854?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4493854", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/s10545-015-9831-y", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-07-01", "journal": {"medlineAbbreviation": "J Inherit Metab Dis", "isoabbreviation": "J. Inherit. Metab. Dis.", "title": "Journal of inherited metabolic disease", "issn": "0141-8955", "nlmid": "7910918", "essn": "1573-2665"}, "monthOfPublication": 7, "volume": "38", "yearOfPublication": 2015, "journalIssueId": 2301043, "issue": "4", "dateOfPublication": "2015 Jul"}}, "27331002": {"pubYear": "2016", "dateOfCreation": "2016-06-22", "pubModel": "Electronic-eCollection", "authorString": "Harbulot C, Paquay S, Dorboz I, Pichard S, Bourillon A, Benoist JF, Jardel C, Ogier de Baulny H, Boespflug-Tanguy O, Schiff M.", "affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27331002", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France.", "fullName": "Harbulot C", "initials": "C", "firstName": "Carole", "lastName": "Harbulot"}, {"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France; Reference Center for Inborn Errors of Metabolism, Robert Debr\u00e9 University Hospital, APHP, Paris, France.", "fullName": "Paquay S", "initials": "S", "firstName": "St\u00e9phanie", "lastName": "Paquay"}, {"affiliation": "Inserm U1141 and Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9, site Robert Debr\u00e9, Paris, France.", "fullName": "Dorboz I", "initials": "I", "firstName": "Imen", "lastName": "Dorboz"}, {"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France; Reference Center for Inborn Errors of Metabolism, Robert Debr\u00e9 University Hospital, APHP, Paris, France.", "fullName": "Pichard S", "initials": "S", "firstName": "Samia", "lastName": "Pichard"}, {"affiliation": "Biochemistry, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France.", "fullName": "Bourillon A", "initials": "A", "firstName": "Agn\u00e8s", "lastName": "Bourillon"}, {"affiliation": "Biochemistry, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France.", "fullName": "Benoist JF", "initials": "JF", "firstName": "Jean-Fran\u00e7ois", "lastName": "Benoist"}, {"affiliation": "Biochemistry, H\u00f4pital de la Salp\u00eatri\u00e8re, APHP, Paris, France.", "fullName": "Jardel C", "initials": "C", "firstName": "Claude", "lastName": "Jardel"}, {"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France; Reference Center for Inborn Errors of Metabolism, Robert Debr\u00e9 University Hospital, APHP, Paris, France.", "fullName": "Ogier de Baulny H", "initials": "H", "firstName": "H\u00e9l\u00e8ne", "lastName": "Ogier de Baulny"}, {"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France; Inserm U1141 and Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9, site Robert Debr\u00e9, Paris, France.", "fullName": "Boespflug-Tanguy O", "initials": "O", "firstName": "Odile", "lastName": "Boespflug-Tanguy"}, {"affiliation": "Child Neurology, H\u00f4pital Robert Debr\u00e9, APHP, Paris, France; Reference Center for Inborn Errors of Metabolism, Robert Debr\u00e9 University Hospital, APHP, Paris, France; Inserm U1141 and Universit\u00e9 Paris-Diderot, Sorbonne Paris Cit\u00e9, site Robert Debr\u00e9, Paris, France.", "fullName": "Schiff M", "initials": "M", "firstName": "Manuel", "lastName": "Schiff"}]}, "title": "Transient neonatal renal failure and massive polyuria in MEGDEL syndrome.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "27331002", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["omim"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2016-03-10", "language": "eng", "doi": "10.1016/j.ymgmr.2016.03.001", "isOpenAccess": "Y", "pageInfo": "8-10", "pmcid": "PMC4908062", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Kidney", "Mitochondrial Disease", "Serac1", "Megdel"]}, "abstractText": "MEGDEL (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome) syndrome is a mitochondrial disorder associated with recessive mutations in SERAC1.To report transient neonatal renal findings in MEGDEL syndrome.This 7\u00a0year-old girl was the first child of consanguineous Turkish parents. She exhibited an acute neonatal deterioration with severe lactic acidosis and liver failure. Initial evaluation revealed massive polyuria and renal failure with 3-methylglutaconic aciduria. Symptoms and biological findings progressively improved with symptomatic treatment but lactic acidosis and high lactate to pyruvate ratio along with 3-methylglutaconic aciduria persisted. At 8\u00a0months of age, a subacute neurological degradation occurred with severe hypotonia, dystonia with extrapyramidal movements and failure to thrive. Brain MRI revealed basal ganglia lesions suggestive of Leigh syndrome. At 3\u00a0years of age, sensorineural deafness was documented. MEGDEL syndrome was further confirmed by the identification of an already reported homozygous mutation in SERAC1.Transient neonatal polyuria and renal failure have not been reported to date in SERAC1 defective patients. Such neonatal kidney findings expand the clinical spectrum of MEGDEL syndrome.", "electronicPublicationDate": "2016-03-10", "license": "cc by-nc-nd", "dateOfCompletion": "2016-06-22", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4908062?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4908062", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1016/j.ymgmr.2016.03.001", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2016-06-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-06-01", "journal": {"title": "Molecular genetics and metabolism reports", "medlineAbbreviation": "Mol Genet Metab Rep", "isoabbreviation": "Mol Genet Metab Rep", "nlmid": "101624422", "essn": "2214-4269"}, "monthOfPublication": 6, "volume": "7", "yearOfPublication": 2016, "journalIssueId": 2401511, "dateOfPublication": "2016 Jun"}}, "23707711": {"pubYear": "2013", "dateOfCreation": "2013-08-26", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "EC 3.1.1.-", "name": "Carboxylic Ester Hydrolases"}, {"registryNumber": "EC 3.1.1.-", "name": "SERAC1 protein, human"}]}, "authorString": "Tort F, Garc\u00eda-Silva MT, Ferrer-Cort\u00e8s X, Navarro-Sastre A, Garcia-Villoria J, Coll MJ, Vidal E, Jim\u00e9nez-Almaz\u00e1n J, Dopazo J, Briones P, Elpeleg O, Ribes A.", "affiliation": "Secci\u00f3 d'Errors Cong\u00e8nits del Metabolisme, Servei de Bioqu\u00edmica i Gen\u00e8tica Molecular, Hospital Clinic, IDIBAPS, 08028, Barcelona, Spain.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23707711", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Secci\u00f3 d'Errors Cong\u00e8nits del Metabolisme, Servei de Bioqu\u00edmica i Gen\u00e8tica Molecular, Hospital Clinic, IDIBAPS, 08028, Barcelona, Spain.", "fullName": "Tort F", "initials": "F", "firstName": "Frederic", "lastName": "Tort"}, {"lastName": "Garc\u00eda-Silva", "fullName": "Garc\u00eda-Silva MT", "firstName": "Mar\u00eda Teresa", "initials": "MT"}, {"lastName": "Ferrer-Cort\u00e8s", "fullName": "Ferrer-Cort\u00e8s X", "authorId": {"type": "ORCID", "value": "0000-0001-9091-900X"}, "firstName": "X\u00e8nia", "initials": "X"}, {"lastName": "Navarro-Sastre", "fullName": "Navarro-Sastre A", "firstName": "Aleix", "initials": "A"}, {"lastName": "Garcia-Villoria", "fullName": "Garcia-Villoria J", "firstName": "Judith", "initials": "J"}, {"lastName": "Coll", "fullName": "Coll MJ", "firstName": "Maria Josep", "initials": "MJ"}, {"lastName": "Vidal", "fullName": "Vidal E", "authorId": {"type": "ORCID", "value": "0000-0002-4217-1807"}, "firstName": "Enrique", "initials": "E"}, {"lastName": "Jim\u00e9nez-Almaz\u00e1n", "fullName": "Jim\u00e9nez-Almaz\u00e1n J", "firstName": "Jorge", "initials": "J"}, {"lastName": "Dopazo", "fullName": "Dopazo J", "authorId": {"type": "ORCID", "value": "0000-0003-3318-120X"}, "firstName": "Joaqu\u00edn", "initials": "J"}, {"lastName": "Briones", "fullName": "Briones P", "firstName": "Paz", "initials": "P"}, {"lastName": "Elpeleg", "fullName": "Elpeleg O", "firstName": "Orly", "initials": "O"}, {"lastName": "Ribes", "fullName": "Ribes A", "firstName": "Antonia", "initials": "A"}]}, "title": "Exome sequencing identifies a new mutation in SERAC1 in a patient with 3-methylglutaconic aciduria.", "citedByCount": 5, "source": "MED", "pmid": "23707711", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9091-900X"}, {"type": "ORCID", "value": "0000-0002-4217-1807"}, {"type": "ORCID", "value": "0000-0003-3318-120X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Carboxylic Ester Hydrolases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "High-Throughput Nucleotide Sequencing", "majorTopic_YN": "Y"}, {"descriptorName": "Exome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-05-03", "doi": "10.1016/j.ymgme.2013.04.021", "isOpenAccess": "N", "pageInfo": "73-77", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Exome", "Serac1", "3-Methylglutaconic", "Megdel"]}, "abstractText": "3-Methylglutaconic aciduria (3-MGA-uria) is a heterogeneous group of syndromes characterized by an increased excretion of 3-methylglutaconic and 3-methylglutaric acids. Five types of 3-MGA-uria (I to V) with different clinical presentations have been described. Causative mutations in TAZ, OPA3, DNAJC19, ATP12, ATP5E, and TMEM70 have been identified. After excluding the known genetic causes of 3-MGA-uria we used exome sequencing to investigate a patient with Leigh syndrome and 3-MGA-uria. We identified a homozygous variant in SERAC1 (c.202C>T; p.Arg68*), that generates a premature stop codon at position 68 of SERAC1 protein. Western blot analysis in patient's fibroblasts showed a complete absence of SERAC1 that was consistent with the prediction of a truncated protein and supports the pathogenic role of the mutation. During the course of this project a parallel study identified mutations in SERAC1 as the genetic cause of the disease in 15 patients with MEGDEL syndrome, which was compatible with the clinical and biochemical phenotypes of the patient described here. In addition, our patient developed microcephaly and optic atrophy, two features not previously reported in MEGDEL syndrome. We highlight the usefulness of exome sequencing to reveal the genetic bases of human rare diseases even if only one affected individual is available.", "electronicPublicationDate": "2013-05-03", "language": "eng", "dateOfCompletion": "2014-03-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.ymgme.2013.04.021", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-09-01", "journal": {"medlineAbbreviation": "Mol Genet Metab", "isoabbreviation": "Mol. Genet. Metab.", "title": "Molecular genetics and metabolism", "issn": "1096-7192", "nlmid": "9805456", "essn": "1096-7206"}, "monthOfPublication": 0, "volume": "110", "yearOfPublication": 2013, "journalIssueId": 2069079, "issue": "1-2", "dateOfPublication": "2013 Sep-Oct"}}, "25178427": {"pubYear": "2015", "dateOfCreation": "2015-01-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Phospholipids"}, {"registryNumber": "33515-09-2", "name": "Gonadotropin-Releasing Hormone"}]}, "authorString": "Wortmann SB, Espeel M, Almeida L, Reimer A, Bosboom D, Roels F, de Brouwer AP, Wevers RA.", "affiliation": "Nijmegen Centre for Mitochondrial Disorders (NCMD) at the Amalia Children's Hospital, Radboudumc, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "25178427", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Nijmegen Centre for Mitochondrial Disorders (NCMD) at the Amalia Children's Hospital, Radboudumc, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "fullName": "Wortmann SB", "initials": "SB", "firstName": "Saskia B", "lastName": "Wortmann"}, {"lastName": "Espeel", "fullName": "Espeel M", "firstName": "Marc", "initials": "M"}, {"lastName": "Almeida", "fullName": "Almeida L", "authorId": {"type": "ORCID", "value": "0000-0003-1370-961X"}, "firstName": "Ligia", "initials": "L"}, {"lastName": "Reimer", "fullName": "Reimer A", "firstName": "Annette", "initials": "A"}, {"lastName": "Bosboom", "fullName": "Bosboom D", "firstName": "Dennis", "initials": "D"}, {"lastName": "Roels", "fullName": "Roels F", "firstName": "Frank", "initials": "F"}, {"lastName": "de Brouwer", "fullName": "de Brouwer AP", "firstName": "Arjan P M", "initials": "AP"}, {"lastName": "Wevers", "fullName": "Wevers RA", "firstName": "Ron A", "initials": "RA"}]}, "title": "Inborn errors of metabolism in the biosynthesis and remodelling of phospholipids.", "citedByCount": 0, "source": "MED", "pmid": "25178427", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-1370-961X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Osteochondrodysplasias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Muscular Dystrophies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Spastic Paraplegia, Hereditary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anophthalmos", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microphthalmos", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Hemolytic-Uremic Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cardiomyopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hypogonadism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phospholipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Family Health", "majorTopic_YN": "N"}, {"descriptorName": "Gonadotropin-Releasing Hormone", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DF", "qualifierName": "deficiency", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Barth Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2014-09-02", "doi": "10.1007/s10545-014-9759-7", "isOpenAccess": "N", "pageInfo": "99-110", "hasDbCrossReferences": "N", "abstractText": "Since the proposal to define a separate subgroup of inborn errors of metabolism involved in the biosynthesis and remodelling of phospholipids, sphingolipids and long chain fatty acids in 2013, this group is rapidly expanding. This review focuses on the disorders involved in the biosynthesis of phospholipids. Phospholipids are involved in uncountable cellular processes, e.g. as structural components of membranes, by taking part in vesicle and mitochondrial fusion and fission or signal transduction. Here we provide an overview on both pathophysiology and the extremely heterogeneous clinical presentations of the disorders reported so far (Sengers syndrome (due to mutations in AGK), MEGDEL syndrome (or SERAC defect, SERAC1), Barth syndrome (or TAZ defect, TAZ), congenital muscular dystrophy due to CHKB deficiency (CHKB). Boucher-Neuh\u00e4user/Gordon Holmes syndrome (PNPLA6), PHARC syndrome (ABHD12), hereditary spastic paraplegia type 28, 54 and 56 (HSP28, DDHD1; HSP54, DDHD2; HSP56, CYP2U1), Lenz Majewski syndrome (PTDSS1), spondylometaphyseal dysplasia with cone-rod dystrophy (PCYT1A), atypical haemolytic-uremic syndrome due to DGKE deficiency (DGKE).", "electronicPublicationDate": "2014-09-02", "language": "eng", "dateOfCompletion": "2015-10-08", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10545-014-9759-7", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"medlineAbbreviation": "J Inherit Metab Dis", "isoabbreviation": "J. Inherit. Metab. Dis.", "title": "Journal of inherited metabolic disease", "issn": "0141-8955", "nlmid": "7910918", "essn": "1573-2665"}, "monthOfPublication": 1, "volume": "38", "yearOfPublication": 2015, "journalIssueId": 2237978, "issue": "1", "dateOfPublication": "2015 Jan"}}, "23296368": {"pubYear": "2013", "dateOfCreation": "2013-10-31", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "5746-90-7", "name": "3-methylglutaconic acid"}, {"registryNumber": "0", "name": "Glutarates"}]}, "authorString": "Wortmann SB, Duran M, Anikster Y, Barth PG, Sperl W, Zschocke J, Morava E, Wevers RA.", "affiliation": "Nijmegen Centre for Mitochondrial Disorders at the Department of Pediatrics, Institute of Genetic and Metabolic Disease, Nijmegen, The Netherlands, s.wortmann@cukz.umcn.nl.", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "23296368", "inEPMC": "N", "authorList": {"author": [{"affiliation": "Nijmegen Centre for Mitochondrial Disorders at the Department of Pediatrics, Institute of Genetic and Metabolic Disease, Nijmegen, The Netherlands, s.wortmann@cukz.umcn.nl.", "fullName": "Wortmann SB", "initials": "SB", "firstName": "Saskia B", "lastName": "Wortmann"}, {"lastName": "Duran", "fullName": "Duran M", "firstName": "Marinus", "initials": "M"}, {"lastName": "Anikster", "fullName": "Anikster Y", "firstName": "Yair", "initials": "Y"}, {"lastName": "Barth", "fullName": "Barth PG", "firstName": "Peter G", "initials": "PG"}, {"lastName": "Sperl", "fullName": "Sperl W", "firstName": "Wolfgang", "initials": "W"}, {"lastName": "Zschocke", "fullName": "Zschocke J", "firstName": "Johannes", "initials": "J"}, {"lastName": "Morava", "fullName": "Morava E", "firstName": "Eva", "initials": "E"}, {"lastName": "Wevers", "fullName": "Wevers RA", "firstName": "Ron A", "initials": "RA"}]}, "title": "Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature.", "citedByCount": 8, "source": "MED", "pmid": "23296368", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Optic Atrophy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Spastic Paraplegia, Hereditary", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebellar Ataxia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chorea", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cardiomyopathy, Dilated", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Metabolism, Inborn Errors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glutarates", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Diagnosis, Differential", "majorTopic_YN": "N"}, {"descriptorName": "Terminology as Topic", "majorTopic_YN": "Y"}, {"descriptorName": "Barth Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-01-08", "doi": "10.1007/s10545-012-9580-0", "isOpenAccess": "N", "pageInfo": "923-928", "hasDbCrossReferences": "N", "abstractText": "Increased urinary 3-methylglutaconic acid excretion is a relatively common finding in metabolic disorders, especially in mitochondrial disorders. In most cases 3-methylglutaconic acid is only slightly elevated and accompanied by other (disease specific) metabolites. There is, however, a group of disorders with significantly and consistently increased 3-methylglutaconic acid excretion, where the 3-methylglutaconic aciduria is a hallmark of the phenotype and the key to diagnosis. Until now these disorders were labelled by roman numbers (I-V) in the order of discovery regardless of pathomechanism. Especially, the so called \"unspecified\" 3-methylglutaconic aciduria type IV has been ever growing, leading to biochemical and clinical diagnostic confusion. Therefore, we propose the following pathomechanism based classification and a simplified diagnostic flow chart for these \"inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature\". One should distinguish between \"primary 3-methylglutaconic aciduria\" formerly known as type I (3-methylglutaconyl-CoA hydratase deficiency, AUH defect) due to defective leucine catabolism and the--currently known--three groups of \"secondary 3-methylglutaconic aciduria\". The latter should be further classified and named by their defective protein or the historical name as follows: i) defective phospholipid remodelling (TAZ defect or Barth syndrome, SERAC1 defect or MEGDEL syndrome) and ii) mitochondrial membrane associated disorders (OPA3 defect or Costeff syndrome, DNAJC19 defect or DCMA syndrome, TMEM70 defect). The remaining patients with significant and consistent 3-methylglutaconic aciduria in whom the above mentioned syndromes have been excluded, should be referred to as \"not otherwise specified (NOS) 3-MGA-uria\" until elucidation of the underlying pathomechanism enables proper (possibly extended) classification.", "electronicPublicationDate": "2013-01-08", "language": "eng", "dateOfCompletion": "2014-07-15", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1007/s10545-012-9580-0", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-11-01", "journal": {"medlineAbbreviation": "J Inherit Metab Dis", "isoabbreviation": "J. Inherit. Metab. Dis.", "title": "Journal of inherited metabolic disease", "issn": "0141-8955", "nlmid": "7910918", "essn": "1573-2665"}, "monthOfPublication": 11, "volume": "36", "yearOfPublication": 2013, "journalIssueId": 2088030, "issue": "6", "dateOfPublication": "2013 Nov"}}, "24757000": {"pubYear": "2014", "dateOfCreation": "2014-11-06", "pubModel": "Print-Electronic", "authorString": "Wortmann SB, Kluijtmans LA, Sequeira S, Wevers RA, Morava E.", "affiliation": "Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders (NCMD), Amalia Children's Hospital, Radboud University Medical Centre, 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "24757000", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders (NCMD), Amalia Children's Hospital, Radboud University Medical Centre, 9101, 6500 HB, Nijmegen, The Netherlands, Saskia.Wortmann-Hagemann@radboudumc.nl.", "fullName": "Wortmann SB", "initials": "SB", "firstName": "Saskia B", "lastName": "Wortmann"}, {"lastName": "Kluijtmans", "fullName": "Kluijtmans LA", "firstName": "Leo A J", "initials": "LA"}, {"lastName": "Sequeira", "fullName": "Sequeira S", "firstName": "Silvia", "initials": "S"}, {"lastName": "Wevers", "fullName": "Wevers RA", "firstName": "Ron A", "initials": "RA"}, {"lastName": "Morava", "fullName": "Morava E", "firstName": "Eva", "initials": "E"}]}, "title": "Leucine Loading Test is Only Discriminative for 3-Methylglutaconic Aciduria Due to AUH Defect.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "24757000", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["omim"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-04-23", "doi": "10.1007/8904_2014_309", "isOpenAccess": "N", "pageInfo": "1-6", "pmcid": "PMC4221300", "hasDbCrossReferences": "N", "abstractText": "Currently, six inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature are known. The \"Primary 3-methylglutaconic aciduria,\" 3-methylglutaconyl-CoA hydratase deficiency or AUH defect, is a disorder of leucine catabolism. For all other subtypes, also denoted \"Secondary 3-methylglutaconic acidurias\" (TAZ defect or Barth syndrome, SERAC1 defect or MEGDEL syndrome, OPA3 defect or Costeff syndrome, DNAJC19 defect or DCMA syndrome, TMEM70 defect, \"not otherwise specified (NOS) 3-MGA-uria\"), the origin of 3-methylglutaconic aciduria remains enigmatic but is hypothesized to be independent from leucine catabolism. Here we show the results of leucine loading test in 21 patients with different inborn errors of metabolism who present with 3-methylglutaconic aciduria. After leucine loading urinary 3-methylglutaconic acid levels increased only in the patients with an AUH defect. This strongly supports the hypothesis that 3-methylglutaconic aciduria is independent from leucine breakdown in other inborn errors of metabolism with 3-methylglutaconic aciduria and also provides a simple test to discriminate between primary and secondary 3-methylglutaconic aciduria in regular patient care.", "electronicPublicationDate": "2014-04-23", "language": "eng", "dateOfCompletion": "2014-11-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4221300?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4221300", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1007/8904_2014_309", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2014-12-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"medlineAbbreviation": "JIMD Rep", "isoabbreviation": "JIMD Rep", "title": "JIMD reports", "issn": "2192-8304", "nlmid": "101568557", "essn": "2192-8312"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2014, "journalIssueId": 2218443, "dateOfPublication": "2014 "}}}, "FLNA": {"21050879": {"pubYear": "2011", "dateOfCreation": "2010-12-27", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Calcium Channel Blockers"}, {"registryNumber": "0", "name": "Sodium Channels"}, {"registryNumber": "52468-60-7", "name": "Flunarizine"}, {"registryNumber": "0", "name": "Potassium Channels, Voltage-Gated"}]}, "authorString": "Ye Q, Yan LY, Xue LJ, Wang Q, Zhou ZK, Xiao H, Wan Q.", "affiliation": "Department of Neurology, the First Affiliated Hospital of Nanjing Medical University, Guangzhou Street 300, Nanjing, Jiangsu Province 210029, PR China.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "N", "id": "21050879", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ye", "fullName": "Ye Q", "firstName": "Qing", "initials": "Q"}, {"lastName": "Yan", "fullName": "Yan LY", "firstName": "Lan-Yun", "initials": "LY"}, {"lastName": "Xue", "fullName": "Xue LJ", "firstName": "Liu-Jun", "initials": "LJ"}, {"lastName": "Wang", "fullName": "Wang Q", "firstName": "Qiang", "initials": "Q"}, {"lastName": "Zhou", "fullName": "Zhou ZK", "firstName": "Zhi-Kui", "initials": "ZK"}, {"lastName": "Xiao", "fullName": "Xiao H", "firstName": "Hiang", "initials": "H"}, {"lastName": "Wan", "fullName": "Wan Q", "firstName": "Qi", "initials": "Q"}]}, "title": "Flunarizine blocks voltage-gated Na(+) and Ca(2+) currents in cultured rat cortical neurons: A possible locus of action in the prevention of migraine.", "citedByCount": 10, "source": "MED", "pmid": "21050879", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebral Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurons", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Flunarizine", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Potassium Channels, Voltage-Gated", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Sodium Channels", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calcium Channel Blockers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Patch-Clamp Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Ion Channel Gating", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Potentials", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Migraine Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}, {"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-11-02", "doi": "10.1016/j.neulet.2010.10.064", "isOpenAccess": "N", "pageInfo": "394-399", "hasDbCrossReferences": "N", "abstractText": "Although flunarizine (FLN) has been widely used for migraine prophylaxis with clear success, the mechanisms of its actions in migraine prophylaxis are not completely understood. It has been hypothesized that migraine is a channelopathy, and abnormal activities of voltage-gated Na(+) and Ca(2+) channels might represent a potential mechanism of cortical hyperexcitability predisposing to migraine. The aim of the present study was to investigate the effects of FLN on Na(+) and Ca(2+) channels of cultured rat cortical neurons. Sodium currents (I(Na)) and calcium currents (I(Ca)) in cultured rat cortical neurons were monitored using whole-cell patch-clamp recordings. Both I(Na) and I(Ca) were blocked by FLN in a concentration-dependent manner with IC(50) values of 0.94\u03bcM and 1.77\u03bcM, respectively. The blockade of I(Na) was more powerful at more depolarizing holding potentials. The steady-state inactivation curve of I(Na) was shifted towards more hyperpolarizing potentials by FLN. FLN significantly delayed the recovery from fast inactivation of I(Na). Furthermore, the action of FLN in blocking I(Na) was enhanced at higher rates of channel activation. Blockades of these currents might help explain the mechanism underlying the preventive effect of FLN on migraine attacks.", "electronicPublicationDate": "2010-11-02", "language": "eng", "dateOfCompletion": "2011-04-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.neulet.2010.10.064", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Neurosci Lett", "isoabbreviation": "Neurosci. Lett.", "title": "Neuroscience letters", "issn": "0304-3940", "nlmid": "7600130", "essn": "1872-7972"}, "monthOfPublication": 1, "volume": "487", "yearOfPublication": 2011, "journalIssueId": 1794065, "issue": "3", "dateOfPublication": "2011 Jan"}}, "16684786": "", "15459826": "", "25522158": {"pubYear": "2014", "dateOfCreation": "2014-12-19", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}]}, "authorString": "Huang KC, Yang KC, Lin H, Tsao TT, Lee SA.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "25522158", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Huang", "fullName": "Huang KC", "firstName": "Kuo-Chuan", "initials": "KC"}, {"lastName": "Yang", "fullName": "Yang KC", "firstName": "Ko-Chun", "initials": "KC"}, {"lastName": "Lin", "fullName": "Lin H", "firstName": "Han", "initials": "H"}, {"lastName": "Tsao", "fullName": "Tsao TT", "firstName": "Theresa Tsun-Hui", "initials": "TT"}, {"lastName": "Lee", "fullName": "Lee SA", "firstName": "Sheng-An", "initials": "SA"}]}, "title": "Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25522158", "hasLabsLinks": "Y", "tmAccessionTypeList": {"accessionType": ["bioproject"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mitochondria", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cluster Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Alignment", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Analysis, RNA", "majorTopic_YN": "Y"}, {"descriptorName": "Protein Interaction Mapping", "majorTopic_YN": "N"}, {"descriptorName": "Schizophrenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Blood Coagulation", "majorTopic_YN": "Y"}, {"descriptorName": "Gene Regulatory Networks", "majorTopic_YN": "N"}, {"descriptorName": "Transcriptome", "majorTopic_YN": "Y"}]}, "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2014-12-08", "language": "eng", "doi": "10.1186/1471-2164-15-s9-s6", "isOpenAccess": "Y", "pageInfo": "S6", "pmcid": "PMC4290619", "hasDbCrossReferences": "N", "abstractText": "BACKGROUND: Transcriptome sequencing of brain samples provides detailed enrichment analysis of differential expression and genetic interactions for evaluation of mitochondrial and coagulation function of schizophrenia. It is implicated that schizophrenia genetic and protein interactions may give rise to biological dysfunction of energy metabolism and hemostasis. These findings may explain the biological mechanisms responsible for negative and withdraw symptoms of schizophrenia and antipsychotic-induced venous thromboembolism. RESULTS: Published BA22 RNA-Seq brain data of 9 schizophrenic patients and 9 controls samples were analyzed. The differentially expressed genes in the BA22 brain samples of schizophrenia are proposed as schizophrenia candidate marker genes (SCZCGs). The genetic interactions between mitochondrial genes and many under-expressed SCZCGs indicate the genetic predisposition of mitochondria dysfunction in schizophrenia. The biological functions of SCZCGs, as listed in the Pathway Interaction Database (PID), indicate that these genes have roles in DNA binding transcription factor, signal and cancer-related pathways, coagulation and cell cycle regulation and differentiation pathways. CONCLUSIONS: It is implicated that the energy metabolism and hemostatic process have important roles in the pathogenesis for schizophrenia. The cross-talk of genetic interaction by these co-expressed genes and reached candidate genes may address the key network in disease pathology. The accuracy of candidate genes evaluated from different quantification tools could be improved by crosstalk analysis of overlapping genes in genetic networks.", "electronicPublicationDate": "2014-12-08", "license": "cc by", "dateOfCompletion": "2015-08-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4290619?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4290619", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/1471-2164-15-S9-S6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-01-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2014-01-01", "journal": {"title": "BMC genomics", "medlineAbbreviation": "BMC Genomics", "isoabbreviation": "BMC Genomics", "nlmid": "100965258", "essn": "1471-2164"}, "monthOfPublication": 0, "volume": "15 Suppl 9", "yearOfPublication": 2014, "journalIssueId": 2257463, "dateOfPublication": "2014 "}}, "15378534": "", "21960593": {"pubYear": "2011", "dateOfCreation": "2011-11-29", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Nurden P, Debili N, Coupry I, Bryckaert M, Youlyouz-Marfak I, Sol\u00e9 G, Pons AC, Berrou E, Adam F, Kauskot A, Lamazi\u00e8re JM, Rameau P, Fergelot P, Rooryck C, Cailley D, Arveiler B, Lacombe D, Vainchenker W, Nurden A, Goizet C.", "affiliation": "Centre de R\u00e9f\u00e9rence des Pathologies Plaquettaires, Plateforme Technologique d'Innovation Biom\u00e9dicale, H\u00f4pital Xavier Arnozan, Pessac, France. paquita.nurden@cnrshl.u-bordeaux2.fr", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21960593", "inEPMC": "N", "authorList": {"author": [{"lastName": "Nurden", "fullName": "Nurden P", "firstName": "Paquita", "initials": "P"}, {"lastName": "Debili", "fullName": "Debili N", "firstName": "Najet", "initials": "N"}, {"lastName": "Coupry", "fullName": "Coupry I", "firstName": "Isabelle", "initials": "I"}, {"lastName": "Bryckaert", "fullName": "Bryckaert M", "firstName": "Marijke", "initials": "M"}, {"lastName": "Youlyouz-Marfak", "fullName": "Youlyouz-Marfak I", "firstName": "Ibtissam", "initials": "I"}, {"lastName": "Sol\u00e9", "fullName": "Sol\u00e9 G", "firstName": "Guilhem", "initials": "G"}, {"lastName": "Pons", "fullName": "Pons AC", "firstName": "Anne-C\u00e9cile", "initials": "AC"}, {"lastName": "Berrou", "fullName": "Berrou E", "firstName": "Eliane", "initials": "E"}, {"lastName": "Adam", "fullName": "Adam F", "firstName": "Fr\u00e9d\u00e9ric", "initials": "F"}, {"lastName": "Kauskot", "fullName": "Kauskot A", "firstName": "Alexandre", "initials": "A"}, {"lastName": "Lamazi\u00e8re", "fullName": "Lamazi\u00e8re JM", "firstName": "Jean-Marie Daniel", "initials": "JM"}, {"lastName": "Rameau", "fullName": "Rameau P", "firstName": "Philippe", "initials": "P"}, {"lastName": "Fergelot", "fullName": "Fergelot P", "firstName": "Patricia", "initials": "P"}, {"lastName": "Rooryck", "fullName": "Rooryck C", "firstName": "Caroline", "initials": "C"}, {"lastName": "Cailley", "fullName": "Cailley D", "firstName": "Doroth\u00e9e", "initials": "D"}, {"lastName": "Arveiler", "fullName": "Arveiler B", "firstName": "Beno\u00eet", "initials": "B"}, {"lastName": "Lacombe", "fullName": "Lacombe D", "firstName": "Didier", "initials": "D"}, {"lastName": "Vainchenker", "fullName": "Vainchenker W", "firstName": "William", "initials": "W"}, {"lastName": "Nurden", "fullName": "Nurden A", "firstName": "Alan", "initials": "A"}, {"lastName": "Goizet", "fullName": "Goizet C", "firstName": "Cyril", "initials": "C"}]}, "title": "Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome.", "citedByCount": 36, "source": "MED", "pmid": "21960593", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Thrombocytopenia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}, {"abbreviation": "CL", "qualifierName": "classification", "majorTopic_YN": "Y"}, {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Platelet Count", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-09-29", "doi": "10.1182/blood-2011-07-365601", "isOpenAccess": "N", "pageInfo": "5928-5937", "hasDbCrossReferences": "Y", "abstractText": "Filaminopathies A caused by mutations in the X-linked FLNA gene are responsible for a wide spectrum of rare diseases including 2 main phenotypes, the X-linked dominant form of periventricular nodular heterotopia (FLNA-PVNH) and the otopalatodigital syndrome spectrum of disorders. In platelets, filamin A (FLNa) tethers the principal receptors ensuring the platelet-vessel wall interaction, glycoprotein Ib\u03b1 and integrin \u03b1IIb\u03b23, to the underlying cytoskeleton. Hemorrhage, coagulopathy, and thrombocytopenia are mentioned in several reports on patients with FLNA-PVNH. Abnormal platelet morphology in 2 patients with FLNA-PVNH prompted us to examine a third patient with similar platelet morphology previously diagnosed with immunologic thrombocytopenic purpura. Her enlarged platelets showed signs of FLNa degradation in Western blotting, and a heterozygous missense mutation in FLNA was detected. An irregular distribution of FLNa within the total platelet population was shown by confocal microscopy for all 3 patients. In vitro megakaryocyte cultures showed an abnormal differentiation, including an irregular distribution of FLNa with a frayed aspect, the presence of enlarged \u03b1-granules, and an abnormal fragmentation of the cytoplasm. Mutations in FLNA may represent an unrecognized cause of macrothrombocytopenia with an altered platelet production and a modified platelet-vessel wall interaction.", "electronicPublicationDate": "2011-09-29", "language": "eng", "dateOfCompletion": "2012-01-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1182/blood-2011-07-365601", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2012-02-24", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-11-01", "journal": {"medlineAbbreviation": "Blood", "isoabbreviation": "Blood", "title": "Blood", "issn": "0006-4971", "nlmid": "7603509", "essn": "1528-0020"}, "monthOfPublication": 11, "volume": "118", "yearOfPublication": 2011, "journalIssueId": 1884611, "issue": "22", "dateOfPublication": "2011 Nov"}}, "21267586": {"pubYear": "2011", "dateOfCreation": "2011-02-14", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "GAB1 protein, human"}, {"registryNumber": "0", "name": "Phosphoproteins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Tumor Markers, Biological"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "Adaptor Proteins, Signal Transducing"}, {"registryNumber": "0", "name": "Wnt proteins"}, {"registryNumber": "0", "name": "beta Catenin"}, {"registryNumber": "0", "name": "Hedgehog Proteins"}, {"registryNumber": "0", "name": "SHH protein, human"}, {"registryNumber": "0", "name": "YAP1 (Yes-associated) protein, human"}]}, "authorString": "Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ.", "affiliation": "Department of Pathology MS# 250, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. David.Ellison@stjude.org", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "The Brain Tumour Charity", "grantId": "16/97"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P01 CA096832"}, {"acronym": "GM", "orderIn": 0, "agency": "NIGMS NIH HHS", "grantId": "T32 GM008490"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA129541"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "R01 CA129541-04"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P01 CA096832-08"}]}, "hasPDF": "Y", "id": "21267586", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pathology MS# 250, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. David.Ellison@stjude.org", "fullName": "Ellison DW", "initials": "DW", "firstName": "David W", "lastName": "Ellison"}, {"lastName": "Dalton", "fullName": "Dalton J", "firstName": "James", "initials": "J"}, {"lastName": "Kocak", "fullName": "Kocak M", "authorId": {"type": "ORCID", "value": "0000-0002-3386-1734"}, "firstName": "Mehmet", "initials": "M"}, {"lastName": "Nicholson", "fullName": "Nicholson SL", "firstName": "Sarah Leigh", "initials": "SL"}, {"lastName": "Fraga", "fullName": "Fraga C", "firstName": "Charles", "initials": "C"}, {"lastName": "Neale", "fullName": "Neale G", "firstName": "Geoff", "initials": "G"}, {"lastName": "Kenney", "fullName": "Kenney AM", "firstName": "Anna M", "initials": "AM"}, {"lastName": "Brat", "fullName": "Brat DJ", "firstName": "Dan J", "initials": "DJ"}, {"lastName": "Perry", "fullName": "Perry A", "authorId": {"type": "ORCID", "value": "0000-0002-8300-7261"}, "firstName": "Arie", "initials": "A"}, {"lastName": "Yong", "fullName": "Yong WH", "firstName": "William H", "initials": "WH"}, {"lastName": "Taylor", "fullName": "Taylor RE", "firstName": "Roger E", "initials": "RE"}, {"lastName": "Bailey", "fullName": "Bailey S", "firstName": "Simon", "initials": "S"}, {"lastName": "Clifford", "fullName": "Clifford SC", "firstName": "Steven C", "initials": "SC"}, {"lastName": "Gilbertson", "fullName": "Gilbertson RJ", "firstName": "Richard J", "initials": "RJ"}]}, "title": "Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.", "hasSuppl": "Y", "citedByCount": 110, "source": "MED", "pmid": "21267586", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3386-1734"}, {"type": "ORCID", "value": "0000-0002-8300-7261"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Medulloblastoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cerebellar Neoplasms", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adaptor Proteins, Signal Transducing", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tumor Markers, Biological", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation, Neoplastic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Wnt Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "beta Catenin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hedgehog Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Kaplan-Meier Estimate", "majorTopic_YN": "N"}, {"descriptorName": "Filamins", "majorTopic_YN": "N"}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-01-26", "doi": "10.1007/s00401-011-0800-8", "isOpenAccess": "N", "pageInfo": "381-396", "pmcid": "PMC3519926", "hasDbCrossReferences": "N", "abstractText": "Medulloblastoma is heterogeneous, being characterized by molecular subgroups that demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling pathway characterizes two of these molecular subgroups, the former associated with low-risk disease and the latter potentially targeted by novel SHH pathway inhibitors. This manuscript reports the validation of a novel diagnostic immunohistochemical method to distinguish SHH, WNT, and non-SHH/WNT tumors and details their associations with clinical, pathological and cytogenetic variables. A cohort (n\u00a0=\u00a0235) of medulloblastomas from patients aged 0.4-52\u00a0years was studied for expression of four immunohistochemical markers: GAB1, \u03b2-catenin, filamin A, and YAP1. Immunoreactivity (IR) for GAB1 characterizes only SHH tumors and nuclear IR for \u03b2-catenin only WNT tumors. IRs for filamin A and YAP1 identify SHH and WNT tumors. SHH, WNT, and non-SHH/WNT tumors contributed 31, 14, and 55% to the series. All desmoplastic/nodular (D/N) medulloblastomas were SHH tumors, while most WNT tumors (94%) had a classic phenotype. Monosomy 6 was strongly associated with WNT tumors, while PTCH1 loss occurred almost exclusively among SHH tumors. MYC or MYCN amplification and chromosome 17 imbalance occurred predominantly among non-SHH/WNT tumors. Among patients aged 3-16\u00a0years and entered onto the SIOP PNET3 trial, outcome was significantly better for children with WNT tumors, when compared to SHH or non-SHH/WNT tumors, which showed similar survival curves. However, high-risk factors (M+ disease, LC/A pathology, MYC amplification) significantly influenced survival in both SHH and non-SHH/WNT groups. We describe a robust method for detecting SHH, WNT, and non-SHH/WNT molecular subgroups in formalin-fixed medulloblastoma samples. In corroborating other studies that indicate the value of combining clinical, pathological, and molecular variables in therapeutic stratification schemes for medulloblastoma, we also provide the first outcome data based on a clinical trial cohort and novel data on how molecular subgroups are distributed across the range of disease.", "electronicPublicationDate": "2011-01-26", "language": "eng", "dateOfCompletion": "2011-06-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3519926?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3519926", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21267586&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21267586", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1007/s00401-011-0800-8", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-11-30", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-03-01", "journal": {"medlineAbbreviation": "Acta Neuropathol", "isoabbreviation": "Acta Neuropathol.", "title": "Acta neuropathologica", "issn": "0001-6322", "nlmid": "0412041", "essn": "1432-0533"}, "monthOfPublication": 3, "volume": "121", "yearOfPublication": 2011, "journalIssueId": 1807830, "issue": "3", "dateOfPublication": "2011 Mar"}}, "11914408": "", "16372260": "", "20460118": {"pubYear": "2010", "dateOfCreation": "2010-07-06", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "MAPT protein, human"}, {"registryNumber": "0", "name": "myosin VI"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "tau Proteins"}, {"registryNumber": "0", "name": "Myosin Heavy Chains"}]}, "authorString": "Feuillette S, Deramecourt V, Laquerriere A, Duyckaerts C, Delisle MB, Maurage CA, Blum D, Bu\u00e9e L, Fr\u00e9bourg T, Campion D, Lecourtois M.", "affiliation": "Inserm U614, Institute for Biomedical Research, Faculty of Medicine, University of Rouen, Rouen, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20460118", "inEPMC": "N", "authorList": {"author": [{"lastName": "Feuillette", "fullName": "Feuillette S", "firstName": "S\u00e9bastien", "initials": "S"}, {"lastName": "Deramecourt", "fullName": "Deramecourt V", "firstName": "Vincent", "initials": "V"}, {"lastName": "Laquerriere", "fullName": "Laquerriere A", "firstName": "Annie", "initials": "A"}, {"lastName": "Duyckaerts", "fullName": "Duyckaerts C", "firstName": "Charles", "initials": "C"}, {"lastName": "Delisle", "fullName": "Delisle MB", "firstName": "Marie-Bernadette", "initials": "MB"}, {"lastName": "Maurage", "fullName": "Maurage CA", "firstName": "Claude-Alain", "initials": "CA"}, {"lastName": "Blum", "fullName": "Blum D", "firstName": "David", "initials": "D"}, {"lastName": "Bu\u00e9e", "fullName": "Bu\u00e9e L", "authorId": {"type": "ORCID", "value": "0000-0002-6261-4230"}, "firstName": "Luc", "initials": "L"}, {"lastName": "Fr\u00e9bourg", "fullName": "Fr\u00e9bourg T", "firstName": "Thierry", "initials": "T"}, {"lastName": "Campion", "fullName": "Campion D", "firstName": "Dominique", "initials": "D"}, {"lastName": "Lecourtois", "fullName": "Lecourtois M", "firstName": "Magalie", "initials": "M"}]}, "title": "Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.", "citedByCount": 7, "source": "MED", "pmid": "20460118", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-6261-4230"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Neurofibrillary Tangles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 17", "majorTopic_YN": "N"}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice, Transgenic", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Supranuclear Palsy, Progressive", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pick Disease of the Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tauopathies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Myosin Heavy Chains", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "tau Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Frontotemporal Dementia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-05-10", "doi": "10.1016/j.brainres.2010.05.007", "isOpenAccess": "N", "pageInfo": "182-189", "hasDbCrossReferences": "Y", "abstractText": "Tauopathies, including Alzheimer's disease (AD), fronto-temporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), Pick's disease and progressive supranuclear palsy, are neurodegenerative disorders neuropathologically characterized by the presence of intraneuronal fibrillary inclusions composed of abnormally phosphorylated-Tau. Tau protein is a neuronal microtubule-associated protein (MAP) involved in microtubules polymerization and stabilization. So far, the molecular mechanisms underlying Tau-mediated cellular toxicity remain elusive. To address the determinants of Tau neurotoxicity, we previously performed a misexpression screening in a Drosophila tauopathy model to identify genetic modifiers of the human Tau-induced neurodegeneration. We identified several components of the actin network as modifiers of Tau V337M-induced neurodegeneration, i.e. Filamin-A, Myosin VI, Paxillin and Transgelin-3. The aim of this study was to assess whether these genetic interactions were associated with a colocalization of the proteins (i) in the brains of patients with Tau pathologies, and (ii) in the brain of transgenic mice overexpressing human mutant Tau. We found that Filamin-A and Myosin VI indeed colocalize with fibrillary Tau protein in AD and FTDP-17 and in Thy-Tau22 transgenic mice.", "electronicPublicationDate": "2010-05-10", "language": "eng", "dateOfCompletion": "2010-10-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.brainres.2010.05.007", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-07-01", "journal": {"medlineAbbreviation": "Brain Res", "isoabbreviation": "Brain Res.", "title": "Brain research", "issn": "0006-8993", "nlmid": "0045503", "essn": "1872-6240"}, "monthOfPublication": 7, "volume": "1345", "yearOfPublication": 2010, "journalIssueId": 1743974, "dateOfPublication": "2010 Jul"}}, "20888935": {"pubYear": "2011", "dateOfCreation": "2011-02-28", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Masurel-Paulet A, Haan E, Thompson EM, Goizet C, Thauvin-Robinet C, Tai A, Kennedy D, Smith G, Khong TY, Sol\u00e9 G, Guerineau E, Coupry I, Huet F, Robertson S, Faivre L.", "affiliation": "Centre de G\u00e9n\u00e9tique, H\u00f4pital d'Enfants, 10 bd Mar\u00e9chal de Lattre de Tassigny, 21034 Dijon Cedex, France.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20888935", "inEPMC": "N", "authorList": {"author": [{"lastName": "Masurel-Paulet", "fullName": "Masurel-Paulet A", "firstName": "Alice", "initials": "A"}, {"lastName": "Haan", "fullName": "Haan E", "firstName": "Eric", "initials": "E"}, {"lastName": "Thompson", "fullName": "Thompson EM", "firstName": "Elizabeth M", "initials": "EM"}, {"lastName": "Goizet", "fullName": "Goizet C", "firstName": "Cyril", "initials": "C"}, {"lastName": "Thauvin-Robinet", "fullName": "Thauvin-Robinet C", "firstName": "Christel", "initials": "C"}, {"lastName": "Tai", "fullName": "Tai A", "firstName": "Andrew", "initials": "A"}, {"lastName": "Kennedy", "fullName": "Kennedy D", "firstName": "Declan", "initials": "D"}, {"lastName": "Smith", "fullName": "Smith G", "firstName": "Greg", "initials": "G"}, {"lastName": "Khong", "fullName": "Khong TY", "firstName": "Teck Yee", "initials": "TY"}, {"lastName": "Sol\u00e9", "fullName": "Sol\u00e9 G", "firstName": "Guilhem", "initials": "G"}, {"lastName": "Guerineau", "fullName": "Guerineau E", "firstName": "Elodie", "initials": "E"}, {"lastName": "Coupry", "fullName": "Coupry I", "firstName": "Isabelle", "initials": "I"}, {"lastName": "Huet", "fullName": "Huet F", "firstName": "Fr\u00e9d\u00e9ric", "initials": "F"}, {"lastName": "Robertson", "fullName": "Robertson S", "firstName": "Stephen", "initials": "S"}, {"lastName": "Faivre", "fullName": "Faivre L", "firstName": "Laurence", "initials": "L"}]}, "title": "Lung disease associated with periventricular nodular heterotopia and an FLNA mutation.", "citedByCount": 10, "source": "MED", "pmid": "20888935", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lung Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CN", "qualifierName": "congenital", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Periventricular Nodular Heterotopia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-10-01", "doi": "10.1016/j.ejmg.2010.09.010", "isOpenAccess": "N", "pageInfo": "25-28", "hasDbCrossReferences": "N", "abstractText": "X-linked periventricular nodular heterotopia (PH) is a neuronal migration disorder caused by mutations in the gene encoding filamin A (FLNA). High phenotypic diversity, ranging from PH to otopalatodigital syndrome and frontometaphyseal dysplasia has been described in association with FLNA mutations. Extra-neurological features including cardiovascular abnormalities, coagulopathy, skeletal dysplasia and joint hypermobility have sometimes been described in patients with PH. Respiratory manifestations have not been associated with FLNA disorders with the exception of tracheal stenosis and pulmonary hypoplasia associated with frontometaphyseal dysplasia and Melnick-Needles syndrome. Here, we report on a male patient aged 6 years presenting with a mosaic nonsense mutation c.994delG within the FLNA gene, PH and\u00a0severe congenital lung disease comprising bilateral atelectasis, lung cysts, tracheobronchomalacia, pulmonary arterial hypertension and long-term oxygen dependence; histology of resected lung showed panpulmonary emphysema with marked reduction of bronchial cartilage. Rare male patients with PH and FLNA mutations have already been reported, usually with early lethality. These observations suggest the possibility of a link between FLNA mutations and congenital lung disease. A prospective study of patients with PH and FLNA mutations would be helpful in order to test this hypothesis.", "electronicPublicationDate": "2010-10-01", "language": "eng", "dateOfCompletion": "2011-06-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.ejmg.2010.09.010", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-01-01", "journal": {"medlineAbbreviation": "Eur J Med Genet", "isoabbreviation": "Eur J Med Genet", "title": "European journal of medical genetics", "issn": "1769-7212", "nlmid": "101247089", "essn": "1878-0849"}, "monthOfPublication": 0, "volume": "54", "yearOfPublication": 2011, "journalIssueId": 1810996, "issue": "1", "dateOfPublication": "2011 Jan-Feb"}}, "12622665": "", "25944616": {"pubYear": "2015", "dateOfCreation": "2015-06-10", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "EC 2.7.11.1", "name": "Proto-Oncogene Proteins c-akt"}, {"registryNumber": "N712M78A8G", "name": "Arsenic"}]}, "authorString": "Li L, Lu Y, Stemmer PM, Chen F.", "affiliation": "Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "P30 ES020957"}, {"acronym": "CA", "orderIn": 0, "agency": "NCI NIH HHS", "grantId": "P30CA22453"}, {"acronym": "OD", "orderIn": 0, "agency": "NIH HHS", "grantId": "S10 OD 010700"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01 ES020137"}, {"acronym": "ES", "orderIn": 0, "agency": "NIEHS NIH HHS", "grantId": "R01 ES017217"}]}, "hasPDF": "Y", "id": "25944616", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.", "fullName": "Li L", "initials": "L", "firstName": "Lingzhi", "lastName": "Li"}, {"affiliation": "Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.", "fullName": "Lu Y", "initials": "Y", "firstName": "Yongju", "lastName": "Lu"}, {"affiliation": "The Proteomics Core and Institute of Environmental Health Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.", "fullName": "Stemmer PM", "initials": "PM", "firstName": "Paul M", "lastName": "Stemmer"}, {"affiliation": "Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.", "fullName": "Chen F", "initials": "F", "firstName": "Fei", "lastName": "Chen"}]}, "title": "Filamin A phosphorylation by Akt promotes cell migration in response to arsenic.", "hasSuppl": "N", "citedByCount": 2, "source": "MED", "pmid": "25944616", "abstractText": "We had previously reported that trivalent arsenic (As(3+)), a well-known environmental carcinogen, induces phosphorylation of several putative Akt substrates. In the present report, we characterized one of these substrates by immunoprecipitation and proteomics analysis. The results indicate that a cytoskeleton remodeling protein, filamin A, with a molecular weight around 280 kDa, is phosphorylated by Akt in HEK-293 cells treated with As(3+), which was also confirmed in human bronchial epithelial cell line, BEAS-2B cells. Additional biochemical and biological studies revealed that serine 2152 (S2152) of filamin A is phosphorylated by activated Akt in the cells treated with As(3+). To further confirm the importance of Akt-dependent filamin A S2152 phosphorylation in As(3+)-induced cell migration, we over-expressed either wild type filamin A or the mutated filamin A in which the S2152 was substituted with alanine (S2152A). The capability of cell migration was reduced significantly in the cells expressing the mutated filamin A (S2152A). Clinically, we found that increased expression of filamin A predicts poorer overall survival of the lung cancer patients with adenocarcinoma. Thus, these data suggest that Akt dependent filamin A phosphorylation is one of the key events in mediating As(3+)-induced carcinogenesis. Antagonizing Akt signaling can ameliorate As(3+)-induced filamin A phosphorylation and cell migration, which may serve as a molecular targeting strategy for malignancies associated with environmental As(3+) exposure.", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line, Tumor", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Arsenic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Survival Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-akt", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Filamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-05-01", "isOpenAccess": "Y", "pageInfo": "12009-12019", "pmcid": "PMC4494919", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Arsenic", "Migration", "Filamin A", "AKT", "Patient Survival"]}, "hasLabsLinks": "Y", "language": "eng", "license": "cc by", "dateOfCompletion": "2016-04-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4494919?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4494919", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-07-19", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-05-01", "journal": {"title": "Oncotarget", "medlineAbbreviation": "Oncotarget", "isoabbreviation": "Oncotarget", "nlmid": "101532965", "essn": "1949-2553"}, "monthOfPublication": 5, "volume": "6", "yearOfPublication": 2015, "journalIssueId": 2288269, "issue": "14", "dateOfPublication": "2015 May"}}, "22190899": {"pubYear": "2011", "dateOfCreation": "2011-12-22", "pubModel": "Print-Electronic", "authorString": "Berland S, Alme K, Brendehaug A, Houge G, Hovland R.", "affiliation": "Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "22190899", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen.", "fullName": "Berland S", "initials": "S", "firstName": "S", "lastName": "Berland"}, {"lastName": "Alme", "fullName": "Alme K", "firstName": "K", "initials": "K"}, {"lastName": "Brendehaug", "fullName": "Brendehaug A", "firstName": "A", "initials": "A"}, {"lastName": "Houge", "fullName": "Houge G", "firstName": "G", "initials": "G"}, {"lastName": "Hovland", "fullName": "Hovland R", "firstName": "R", "initials": "R"}]}, "title": "PHF6 Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females.", "hasSuppl": "N", "citedByCount": 10, "source": "MED", "pmid": "22190899", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["omim"]}, "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2011-07-19", "doi": "10.1159/000330111", "isOpenAccess": "N", "pageInfo": "294-300", "pmcid": "PMC3214959", "hasDbCrossReferences": "N", "abstractText": "In a 16-year-old girl with intellectual disability, irregular teeth, slight body asymmetry, and striated skin pigmentation, highly skewed X-inactivation increased the likelihood of an X-linked cause of her condition. Among these, prominent supraorbital ridges and hearing loss suggested a filaminopathy, but no filamin A mutation was found. The correct diagnosis, Borjeson-Forssman-Lehmann syndrome (BFLS, MIM#301900), was first made when a copy number array identified a de novo 15-kb deletion of the terminal 3 exons of the PHF6 gene. In retrospect, her phenotype resembled that of males with BFLS. Such deletions of PHF6 have not been reported previously. This might be because PHF6 mutations are rarely looked for in females since classical BFLS so far has been thought to be a male-specific syndrome, and large PHF6 deletions might be incompatible with male fetal survival. If this is the case, sporadic BFLS could be more frequent in females than in males.", "electronicPublicationDate": "2011-07-19", "language": "eng", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3214959?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3214959", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1159/000330111", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-09-01", "journal": {"medlineAbbreviation": "Mol Syndromol", "isoabbreviation": "Mol Syndromol", "title": "Molecular syndromology", "issn": "1661-8769", "nlmid": "101525192", "essn": "1661-8777"}, "monthOfPublication": 9, "volume": "1", "yearOfPublication": 2011, "journalIssueId": 1891693, "issue": "6", "dateOfPublication": "2011 Sep"}}, "22815492": {"pubYear": "2012", "dateOfCreation": "2012-07-20", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "amyloid beta-protein (1-42)"}, {"registryNumber": "0", "name": "Peptide Fragments"}, {"registryNumber": "0", "name": "Receptors, Nicotinic"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "Cytokines"}, {"registryNumber": "0", "name": "tau Proteins"}, {"registryNumber": "0", "name": "Receptors, N-Methyl-D-Aspartate"}, {"registryNumber": "0", "name": "Toll-Like Receptor 4"}, {"registryNumber": "0", "name": "alpha7 nicotinic acetylcholine receptor"}, {"registryNumber": "0", "name": "Amyloid beta-Peptides"}]}, "authorString": "Wang HY, Bakshi K, Frankfurt M, Stucky A, Goberdhan M, Shah SM, Burns LH.", "affiliation": "Department of Physiology, Pharmacology and Neuroscience, City University of New York Medical School, New York, New York 10031, USA. hywang@sci.ccny.cuny.edu", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "22815492", "inEPMC": "N", "authorList": {"author": [{"lastName": "Wang", "fullName": "Wang HY", "firstName": "Hoau-Yan", "initials": "HY"}, {"lastName": "Bakshi", "fullName": "Bakshi K", "firstName": "Kalindi", "initials": "K"}, {"lastName": "Frankfurt", "fullName": "Frankfurt M", "authorId": {"type": "ORCID", "value": "0000-0003-3737-0497"}, "firstName": "Maya", "initials": "M"}, {"lastName": "Stucky", "fullName": "Stucky A", "firstName": "Andres", "initials": "A"}, {"lastName": "Goberdhan", "fullName": "Goberdhan M", "firstName": "Marissa", "initials": "M"}, {"lastName": "Shah", "fullName": "Shah SM", "firstName": "Sanket M", "initials": "SM"}, {"lastName": "Burns", "fullName": "Burns LH", "firstName": "Lindsay H", "initials": "LH"}]}, "title": "Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A.", "citedByCount": 7, "source": "MED", "pmid": "22815492", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0003-3737-0497"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Neurofibrillary Tangles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Peptide Fragments", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "tau Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, N-Methyl-D-Aspartate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, Nicotinic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cytokines", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphorylation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Toll-Like Receptor 4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amyloid beta-Peptides", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2012-07-01", "doi": "10.1523/jneurosci.0354-12.2012", "isOpenAccess": "N", "pageInfo": "9773-9784", "hasDbCrossReferences": "N", "abstractText": "PTI-125 is a novel compound demonstrating a promising new approach to treating Alzheimer's disease (AD), characterized by neurodegeneration and amyloid plaque and neurofibrillary pathologies. We show that the toxic signaling of amyloid-\u03b2(42) (A\u03b2(42)) by the \u03b17-nicotinic acetylcholine receptor (\u03b17nAChR), which results in tau phosphorylation and formation of neurofibrillary tangles, requires the recruitment of the scaffolding protein filamin A (FLNA). By binding FLNA with high affinity, PTI-125 prevents A\u03b2(42)'s toxic cascade, decreasing phospho-tau and A\u03b2 aggregates and reducing the dysfunction of \u03b17nAChRs, NMDARs, and insulin receptors. PTI-125 prevents A\u03b2(42) signaling by drastically reducing its affinity for \u03b17nAChRs and can even dissociate existing A\u03b2(42)-\u03b17nAChR complexes. Additionally, PTI-125 prevents A\u03b2-induced inflammatory cytokine release by blocking FLNA recruitment to toll-like receptor 4, illustrating an anti-inflammatory effect. PTI-125's broad spectrum of beneficial effects is demonstrated here in an intracerebroventricular A\u03b2(42) infusion mouse model of AD and in human postmortem AD brain tissue.", "language": "eng", "dateOfCompletion": "2012-10-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1523/JNEUROSCI.0354-12.2012", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-07-01", "journal": {"medlineAbbreviation": "J Neurosci", "isoabbreviation": "J. Neurosci.", "title": "The Journal of neuroscience : the official journal of the Society for Neuroscience", "issn": "0270-6474", "nlmid": "8102140", "essn": "1529-2401"}, "monthOfPublication": 7, "volume": "32", "yearOfPublication": 2012, "journalIssueId": 1950559, "issue": "29", "dateOfPublication": "2012 Jul"}}, "20190856": {"pubYear": "2010", "dateOfCreation": "2010-03-01", "pubModel": "Electronic-eCollection", "authorString": "Bolduc FV, Bell K, Rosenfelt C, Cox H, Tully T.", "affiliation": "Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor New York, NY, USA.", "pubTypeList": {"pubType": ["Journal Article"]}, "grantsList": {"grant": [{"acronym": "MH", "orderIn": 0, "agency": "NIMH NIH HHS", "grantId": "R01 MH066910-04"}]}, "id": "20190856", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Bolduc", "fullName": "Bolduc FV", "firstName": "Fran\u00e7ois V", "initials": "FV"}, {"lastName": "Bell", "fullName": "Bell K", "firstName": "Kimberly", "initials": "K"}, {"lastName": "Rosenfelt", "fullName": "Rosenfelt C", "firstName": "Cory", "initials": "C"}, {"lastName": "Cox", "fullName": "Cox H", "firstName": "Hilary", "initials": "H"}, {"lastName": "Tully", "fullName": "Tully T", "firstName": "Tim", "initials": "T"}]}, "title": "Fragile x mental retardation 1 and filamin a interact genetically in Drosophila long-term memory.", "hasSuppl": "N", "citedByCount": 13, "source": "MED", "pmid": "20190856", "hasLabsLinks": "Y", "hasTextMinedTerms": "Y", "hasPDF": "Y", "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-01-08", "doi": "10.3389/neuro.04.022.2009", "isOpenAccess": "Y", "pageInfo": "22", "pmcid": "PMC2813723", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Memory", "Mental retardation", "Filamin A", "dendritic spine", "Fragile X"]}, "abstractText": "The last decade has witnessed the identification of single-gene defects associated with an impressive number of mental retardation syndromes. Fragile X syndrome, the most common cause of mental retardation for instance, results from disruption of the FMR1 gene. Similarly, Periventricular Nodular Heterotopia, which includes cerebral malformation, epilepsy and cognitive disabilities, derives from disruption of the Filamin A gene. While it remains unclear whether defects in common molecular pathways may underlie the cognitive dysfunction of these various syndromes, defects in cytoskeletal structure nonetheless appear to be common to several mental retardation syndromes. FMR1 is known to interact with Rac, profilin, PAK and Ras, which are associated with dendritic spine defects. In Drosophila, disruptions of the dFmr1 gene impair long-term memory (LTM), and the Filamin A homolog (cheerio) was identified in a behavioral screen for LTM mutants. Thus, we investigated the possible interaction between cheerio and dFmr1 during LTM formation in Drosophila. We show that LTM specifically is defective in dFmr1/cheerio double heterozygotes, while it is normal in single heterozygotes for either dFmr1 or cheerio. In dFmr1 mutants, Filamin (Cheerio) levels are lower than normal after spaced training. These observations support the notion that decreased actin cross-linking may underlie the persistence of long and thin dendritic spines in Fragile X patients and animal models. More generally, our results represent the first demonstration of a genetic interaction between mental retardation genes in an in vivo model system of memory formation.", "electronicPublicationDate": "2010-01-08", "language": "eng", "dateOfCompletion": "2011-07-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2813723?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2813723", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=20190856&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=20190856", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.3389/neuro.04.022.2009", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "dateOfRevision": "2013-08-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-01-01", "journal": {"title": "Frontiers in neural circuits", "medlineAbbreviation": "Front Neural Circuits", "isoabbreviation": "Front Neural Circuits", "nlmid": "101477940", "essn": "1662-5110"}, "monthOfPublication": 0, "volume": "3", "yearOfPublication": 2010, "journalIssueId": 1694787, "dateOfPublication": "2010 "}}, "17560504": {"pubYear": "2007", "dateOfCreation": "2007-06-11", "pubModel": "Print", "authorString": "Ruggieri M, Spalice A, Polizzi A, Roggini M, Iannetti P.", "affiliation": "Institute of Neurological Science, National Research Council, Catania, Italy. m.ruggieri@isn.cnr.it", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "17560504", "inEPMC": "N", "authorList": {"author": [{"lastName": "Ruggieri", "fullName": "Ruggieri M", "authorId": {"type": "ORCID", "value": "0000-0002-2658-4249"}, "firstName": "Martino", "initials": "M"}, {"lastName": "Spalice", "fullName": "Spalice A", "firstName": "Alberto", "initials": "A"}, {"lastName": "Polizzi", "fullName": "Polizzi A", "firstName": "Agata", "initials": "A"}, {"lastName": "Roggini", "fullName": "Roggini M", "firstName": "Mario", "initials": "M"}, {"lastName": "Iannetti", "fullName": "Iannetti P", "firstName": "Paola", "initials": "P"}]}, "title": "Bilateral periventricular nodular heterotopia with amniotic band syndrome.", "citedByCount": 7, "source": "MED", "pmid": "17560504", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-2658-4249"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cerebral Ventricles", "majorTopic_YN": "Y"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Foot Deformities, Congenital", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amniotic Band Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Choristoma", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-06-01", "doi": "10.1016/j.pediatrneurol.2007.02.006", "isOpenAccess": "N", "pageInfo": "407-410", "hasDbCrossReferences": "N", "abstractText": "The amniotic (constriction) band syndrome is characterized by distal ring constrictions, intrauterine amputations, and acrosyndactyly. External constriction by amniotic bands is the generally accepted mechanism: early amniotic rupture leads to formation of mesodermal fibrous strands that constrict, entangle, and amputate distal portions of limbs. Etiology is heterogeneous. Anecdotal cases involving central nervous system abnormalities (e.g., acrania, anencephaly, polymicrogyria, congenital bilateral perisylvian syndrome, neuronal heterotopia, septo-optic dysplasia, and spinal cord tethering) have been reported. We describe a 9-year-old girl with typical features of constriction band syndrome localized to the lower limbs who had also profound mental retardation and drug-resistant epilepsy associated with bilateral periventricular nodular heterotopia (a brain malformation of neuronal migration and proliferation caused by mutations in the X-linked filamin 1 gene [FLN1] on chromosome Xq28). The karyotype was normal, as was mutational screening for FLN1. The occurrence of bilateral periventricular nodular heterotopia in the context of amniotic band syndrome is novel (chance occurrence of both: 0.000004%).", "language": "eng", "dateOfCompletion": "2007-08-27", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.pediatrneurol.2007.02.006", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "ScienceDirect"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-06-01", "journal": {"medlineAbbreviation": "Pediatr Neurol", "isoabbreviation": "Pediatr. Neurol.", "title": "Pediatric neurology", "issn": "0887-8994", "nlmid": "8508183", "essn": "1873-5150"}, "monthOfPublication": 6, "volume": "36", "yearOfPublication": 2007, "journalIssueId": 1400783, "issue": "6", "dateOfPublication": "2007 Jun"}}, "23934111": {"pubYear": "2013", "dateOfCreation": "2013-09-12", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Receptors, GABA-A"}, {"registryNumber": "EC 2.4.1.-", "name": "N-Acetylglucosaminyltransferases"}, {"registryNumber": "139135-51-6", "name": "fragile X mental retardation protein"}, {"registryNumber": "0", "name": "FMR1 protein, human"}, {"registryNumber": "0", "name": "GABRB3 protein, human"}, {"registryNumber": "EC 2.4.1.-", "name": "ALG13 protein, human"}]}, "authorString": "Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural", "Research Support, American Recovery and Reinvestment Act"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "1RC2NS070342"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS053998"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS077274"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS077276"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS077303"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "NS077364"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR000005"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS053998"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS077274"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS077276"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS077303"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS077364"}, {"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "U01AI067854"}, {"acronym": "AI", "orderIn": 0, "agency": "NIAID NIH HHS", "grantId": "R56AI098588"}]}, "hasPDF": "Y", "id": "23934111", "inEPMC": "Y", "authorList": {"author": [{"collectiveName": "Epi4K Consortium"}, {"collectiveName": "Epilepsy Phenome/Genome Project"}, {"lastName": "Allen", "fullName": "Allen AS", "firstName": "Andrew S", "initials": "AS"}, {"lastName": "Berkovic", "fullName": "Berkovic SF", "firstName": "Samuel F", "initials": "SF"}, {"lastName": "Cossette", "fullName": "Cossette P", "firstName": "Patrick", "initials": "P"}, {"lastName": "Delanty", "fullName": "Delanty N", "firstName": "Norman", "initials": "N"}, {"lastName": "Dlugos", "fullName": "Dlugos D", "firstName": "Dennis", "initials": "D"}, {"lastName": "Eichler", "fullName": "Eichler EE", "firstName": "Evan E", "initials": "EE"}, {"lastName": "Epstein", "fullName": "Epstein MP", "firstName": "Michael P", "initials": "MP"}, {"lastName": "Glauser", "fullName": "Glauser T", "firstName": "Tracy", "initials": "T"}, {"lastName": "Goldstein", "fullName": "Goldstein DB", "firstName": "David B", "initials": "DB"}, {"lastName": "Han", "fullName": "Han Y", "firstName": "Yujun", "initials": "Y"}, {"lastName": "Heinzen", "fullName": "Heinzen EL", "firstName": "Erin L", "initials": "EL"}, {"lastName": "Hitomi", "fullName": "Hitomi Y", "firstName": "Yuki", "initials": "Y"}, {"lastName": "Howell", "fullName": "Howell KB", "firstName": "Katherine B", "initials": "KB"}, {"lastName": "Johnson", "fullName": "Johnson MR", "firstName": "Michael R", "initials": "MR"}, {"lastName": "Kuzniecky", "fullName": "Kuzniecky R", "firstName": "Ruben", "initials": "R"}, {"lastName": "Lowenstein", "fullName": "Lowenstein DH", "firstName": "Daniel H", "initials": "DH"}, {"lastName": "Lu", "fullName": "Lu YF", "firstName": "Yi-Fan", "initials": "YF"}, {"lastName": "Madou", "fullName": "Madou MR", "firstName": "Maura R Z", "initials": "MR"}, {"lastName": "Marson", "fullName": "Marson AG", "firstName": "Anthony G", "initials": "AG"}, {"lastName": "Mefford", "fullName": "Mefford HC", "firstName": "Heather C", "initials": "HC"}, {"lastName": "Esmaeeli Nieh", "fullName": "Esmaeeli Nieh S", "firstName": "Sahar", "initials": "S"}, {"lastName": "O'Brien", "fullName": "O'Brien TJ", "authorId": {"type": "ORCID", "value": "0000-0002-7198-8621"}, "firstName": "Terence J", "initials": "TJ"}, {"lastName": "Ottman", "fullName": "Ottman R", "firstName": "Ruth", "initials": "R"}, {"lastName": "Petrovski", "fullName": "Petrovski S", "authorId": {"type": "ORCID", "value": "0000-0002-1527-961X"}, "firstName": "Slav\u00e9", "initials": "S"}, {"lastName": "Poduri", "fullName": "Poduri A", "firstName": "Annapurna", "initials": "A"}, {"lastName": "Ruzzo", "fullName": "Ruzzo EK", "firstName": "Elizabeth K", "initials": "EK"}, {"lastName": "Scheffer", "fullName": "Scheffer IE", "firstName": "Ingrid E", "initials": "IE"}, {"lastName": "Sherr", "fullName": "Sherr EH", "firstName": "Elliott H", "initials": "EH"}, {"lastName": "Yuskaitis", "fullName": "Yuskaitis CJ", "firstName": "Christopher J", "initials": "CJ"}, {"lastName": "Abou-Khalil", "fullName": "Abou-Khalil B", "firstName": "Bassel", "initials": "B"}, {"lastName": "Alldredge", "fullName": "Alldredge BK", "firstName": "Brian K", "initials": "BK"}, {"lastName": "Bautista", "fullName": "Bautista JF", "firstName": "Jocelyn F", "initials": "JF"}, {"lastName": "Berkovic", "fullName": "Berkovic SF", "firstName": "Samuel F", "initials": "SF"}, {"lastName": "Boro", "fullName": "Boro A", "firstName": "Alex", "initials": "A"}, {"lastName": "Cascino", "fullName": "Cascino GD", "firstName": "Gregory D", "initials": "GD"}, {"lastName": "Consalvo", "fullName": "Consalvo D", "firstName": "Damian", "initials": "D"}, {"lastName": "Crumrine", "fullName": "Crumrine P", "firstName": "Patricia", "initials": "P"}, {"lastName": "Devinsky", "fullName": "Devinsky O", "firstName": "Orrin", "initials": "O"}, {"lastName": "Dlugos", "fullName": "Dlugos D", "firstName": "Dennis", "initials": "D"}, {"lastName": "Epstein", "fullName": "Epstein MP", "firstName": "Michael P", "initials": "MP"}, {"lastName": "Fiol", "fullName": "Fiol M", "firstName": "Miguel", "initials": "M"}, {"lastName": "Fountain", "fullName": "Fountain NB", "firstName": "Nathan B", "initials": "NB"}, {"lastName": "French", "fullName": "French J", "authorId": {"type": "ORCID", "value": "0000-0003-2242-8027"}, "firstName": "Jacqueline", "initials": "J"}, {"lastName": "Friedman", "fullName": "Friedman D", "firstName": "Daniel", "initials": "D"}, {"lastName": "Geller", "fullName": "Geller EB", "firstName": "Eric B", "initials": "EB"}, {"lastName": "Glauser", "fullName": "Glauser T", "firstName": "Tracy", "initials": "T"}, {"lastName": "Glynn", "fullName": "Glynn S", "firstName": "Simon", "initials": "S"}, {"lastName": "Haut", "fullName": "Haut SR", "firstName": "Sheryl R", "initials": "SR"}, {"lastName": "Hayward", "fullName": "Hayward J", "firstName": "Jean", "initials": "J"}, {"lastName": "Helmers", "fullName": "Helmers SL", "firstName": "Sandra L", "initials": "SL"}, {"lastName": "Joshi", "fullName": "Joshi S", "firstName": "Sucheta", "initials": "S"}, {"lastName": "Kanner", "fullName": "Kanner A", "firstName": "Andres", "initials": "A"}, {"lastName": "Kirsch", "fullName": "Kirsch HE", "firstName": "Heidi E", "initials": "HE"}, {"lastName": "Knowlton", "fullName": "Knowlton RC", "firstName": "Robert C", "initials": "RC"}, {"lastName": "Kossoff", "fullName": "Kossoff EH", "firstName": "Eric H", "initials": "EH"}, {"lastName": "Kuperman", "fullName": "Kuperman R", "firstName": "Rachel", "initials": "R"}, {"lastName": "Kuzniecky", "fullName": "Kuzniecky R", "firstName": "Ruben", "initials": "R"}, {"lastName": "Lowenstein", "fullName": "Lowenstein DH", "firstName": "Daniel H", "initials": "DH"}, {"lastName": "McGuire", "fullName": "McGuire SM", "firstName": "Shannon M", "initials": "SM"}, {"lastName": "Motika", "fullName": "Motika PV", "firstName": "Paul V", "initials": "PV"}, {"lastName": "Novotny", "fullName": "Novotny EJ", "firstName": "Edward J", "initials": "EJ"}, {"lastName": "Ottman", "fullName": "Ottman R", "firstName": "Ruth", "initials": "R"}, {"lastName": "Paolicchi", "fullName": "Paolicchi JM", "firstName": "Juliann M", "initials": "JM"}, {"lastName": "Parent", "fullName": "Parent JM", "firstName": "Jack M", "initials": "JM"}, {"lastName": "Park", "fullName": "Park K", "firstName": "Kristen", "initials": "K"}, {"lastName": "Poduri", "fullName": "Poduri A", "firstName": "Annapurna", "initials": "A"}, {"lastName": "Scheffer", "fullName": "Scheffer IE", "firstName": "Ingrid E", "initials": "IE"}, {"lastName": "Shellhaas", "fullName": "Shellhaas RA", "firstName": "Ren\u00e9e A", "initials": "RA"}, {"lastName": "Sherr", "fullName": "Sherr EH", "firstName": "Elliott H", "initials": "EH"}, {"lastName": "Shih", "fullName": "Shih JJ", "firstName": "Jerry J", "initials": "JJ"}, {"lastName": "Singh", "fullName": "Singh R", "firstName": "Rani", "initials": "R"}, {"lastName": "Sirven", "fullName": "Sirven J", "firstName": "Joseph", "initials": "J"}, {"lastName": "Smith", "fullName": "Smith MC", "firstName": "Michael C", "initials": "MC"}, {"lastName": "Sullivan", "fullName": "Sullivan J", "firstName": "Joseph", "initials": "J"}, {"lastName": "Lin Thio", "fullName": "Lin Thio L", "firstName": "Liu", "initials": "L"}, {"lastName": "Venkat", "fullName": "Venkat A", "firstName": "Anu", "initials": "A"}, {"lastName": "Vining", "fullName": "Vining EP", "firstName": "Eileen P G", "initials": "EP"}, {"lastName": "Von Allmen", "fullName": "Von Allmen GK", "firstName": "Gretchen K", "initials": "GK"}, {"lastName": "Weisenberg", "fullName": "Weisenberg JL", "firstName": "Judith L", "initials": "JL"}, {"lastName": "Widdess-Walsh", "fullName": "Widdess-Walsh P", "firstName": "Peter", "initials": "P"}, {"lastName": "Winawer", "fullName": "Winawer MR", "firstName": "Melodie R", "initials": "MR"}]}, "title": "De novo mutations in epileptic encephalopathies.", "hasSuppl": "Y", "citedByCount": 222, "pageInfo": "217-221", "source": "MED", "pmid": "23934111", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-7198-8621"}, {"type": "ORCID", "value": "0000-0002-1527-961X"}, {"type": "ORCID", "value": "0000-0003-2242-8027"}, {"type": "ORCID", "value": "0000-0002-2311-2174"}, {"type": "ORCID", "value": "0000-0002-3953-9842"}, {"type": "ORCID", "value": "0000-0003-4580-841X"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Spasms, Infantile", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "N-Acetylglucosaminyltransferases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Receptors, GABA-A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Probability", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Child Development Disorders, Pervasive", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Fragile X Mental Retardation Protein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intellectual Disability", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PP", "qualifierName": "physiopathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mutation Rate", "majorTopic_YN": "N"}, {"descriptorName": "Exome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lennox Gastaut Syndrome", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["OMIM"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-08-11", "doi": "10.1038/nature12439", "isOpenAccess": "Y", "commentCorrectionList": {"commentCorrection": [{"source": "MED", "orderIn": 32, "type": "Comment in", "id": "24094099", "reference": "Neuron. 2013 Oct 2;80(1):9-11"}]}, "pmcid": "PMC3773011", "hasDbCrossReferences": "Y", "abstractText": "Epileptic encephalopathies are a devastating group of severe childhood epilepsy disorders for which the cause is often unknown. Here we report a screen for de novo mutations in patients with two classical epileptic encephalopathies: infantile spasms (n = 149) and Lennox-Gastaut syndrome (n = 115). We sequenced the exomes of 264 probands, and their parents, and confirmed 329 de novo mutations. A likelihood analysis showed a significant excess of de novo mutations in the \u223c4,000 genes that are the most intolerant to functional genetic variation in the human population (P = 2.9\u2009\u00d7\u200910(-3)). Among these are GABRB3, with de novo mutations in four patients, and ALG13, with the same de novo mutation in two patients; both genes show clear statistical evidence of association with epileptic encephalopathy. Given the relevant site-specific mutation rates, the probabilities of these outcomes occurring by chance are P = 4.1\u2009\u00d7\u200910(-10) and P = 7.8\u2009\u00d7\u200910(-12), respectively. Other genes with de novo mutations in this cohort include CACNA1A, CHD2, FLNA, GABRA1, GRIN1, GRIN2B, HNRNPU, IQSEC2, MTOR and NEDD4L. Finally, we show that the de novo mutations observed are enriched in specific gene sets including genes regulated by the fragile X protein (P\u2009<\u200910(-8)), as has been reported previously for autism spectrum disorders.", "electronicPublicationDate": "2013-08-11", "language": "eng", "dateOfCompletion": "2013-12-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3773011?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3773011", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23934111&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23934111", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1038/nature12439", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-03-09", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-09-01", "journal": {"medlineAbbreviation": "Nature", "isoabbreviation": "Nature", "title": "Nature", "issn": "0028-0836", "nlmid": "0410462", "essn": "1476-4687"}, "monthOfPublication": 9, "volume": "501", "yearOfPublication": 2013, "journalIssueId": 2074971, "issue": "7466", "dateOfPublication": "2013 Sep"}}, "25755106": {"pubYear": "2015", "dateOfCreation": "2015-05-24", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "FLNA protein, human"}]}, "authorString": "Parrini E, Mei D, Pisanti MA, Catarzi S, Pucatti D, Bianchini C, Mascalchi M, Bertini E, Morrone A, Cavaliere ML, Guerrini R.", "affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "25755106", "inEPMC": "N", "authorList": {"author": [{"firstName": "Elena", "lastName": "Parrini", "affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "authorId": {"type": "ORCID", "value": "0000-0001-8933-7694"}, "fullName": "Parrini E", "initials": "E"}, {"firstName": "Davide", "lastName": "Mei", "affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "authorId": {"type": "ORCID", "value": "0000-0001-6790-6251"}, "fullName": "Mei D", "initials": "D"}, {"affiliation": "Medical Genetic Unit, AORN Cardarelli, Naples, Italy.", "fullName": "Pisanti MA", "initials": "MA", "firstName": "Maria Antonietta", "lastName": "Pisanti"}, {"affiliation": "Molecular and Cell Biology Laboratory, Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital, Florence, Italy.", "fullName": "Catarzi S", "initials": "S", "firstName": "Serena", "lastName": "Catarzi"}, {"affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "fullName": "Pucatti D", "initials": "D", "firstName": "Daniela", "lastName": "Pucatti"}, {"affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "fullName": "Bianchini C", "initials": "C", "firstName": "Claudia", "lastName": "Bianchini"}, {"affiliation": "Quantitative and Functional Neuroradiology Research Program, Meyer Children Hospital and Careggi General Hospital, Florence, Italy.", "fullName": "Mascalchi M", "initials": "M", "firstName": "Mario", "lastName": "Mascalchi"}, {"affiliation": "Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Ges\u00f9 Children's Research Hospital, Rome, Italy.", "fullName": "Bertini E", "initials": "E", "firstName": "Enrico", "lastName": "Bertini"}, {"firstName": "Amelia", "lastName": "Morrone", "affiliation": "Molecular and Cell Biology Laboratory, Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital, Florence, Italy Department of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Florence, Italy.", "authorId": {"type": "ORCID", "value": "0000-0003-2890-8179"}, "fullName": "Morrone A", "initials": "A"}, {"affiliation": "Medical Genetic Unit, AORN Cardarelli, Naples, Italy.", "fullName": "Cavaliere ML", "initials": "ML", "firstName": "Maria Luigia", "lastName": "Cavaliere"}, {"affiliation": "Pediatric Neurology and Neurogenetics Unit and Laboratories, Neuroscience Department, A. Meyer Children's Hospital-University of Florence, Florence, Italy.", "fullName": "Guerrini R", "initials": "R", "firstName": "Renzo", "lastName": "Guerrini"}]}, "title": "Familial periventricular nodular heterotopia, epilepsy and Melnick-Needles Syndrome caused by a single FLNA mutation with combined gain-of-function and loss-of-function effects.", "citedByCount": 0, "source": "MED", "pmid": "25755106", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-8933-7694"}, {"type": "ORCID", "value": "0000-0001-6790-6251"}, {"type": "ORCID", "value": "0000-0003-2890-8179"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Bone and Bones", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lymphocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Osteochondrodysplasias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Alignment", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Computational Biology", "majorTopic_YN": "N"}, {"descriptorName": "RNA Splicing", "majorTopic_YN": "N"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "N"}, {"descriptorName": "Exons", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "X Chromosome Inactivation", "majorTopic_YN": "N"}, {"descriptorName": "Genes, X-Linked", "majorTopic_YN": "N"}, {"descriptorName": "Periventricular Nodular Heterotopia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "Y"}, {"descriptorName": "High-Throughput Nucleotide Sequencing", "majorTopic_YN": "N"}, {"descriptorName": "Nonsense Mediated mRNA Decay", "majorTopic_YN": "N"}, {"descriptorName": "Filamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2015-03-09", "doi": "10.1136/jmedgenet-2014-102959", "isOpenAccess": "N", "pageInfo": "405-412", "hasDbCrossReferences": "Y", "keywordList": {"keyword": ["Mutation", "Epilepsy", "Periventricular Nodular Heterotopia", "Melnick-needles Syndrome", "Flna"]}, "abstractText": "Loss-of-function mutations of the FLNA gene cause a neuronal migration disorder defined as X-linked periventricular nodular heterotopia (PNH); gain-of-function mutations are associated with a group of X-linked skeletal dysplasias designed as otopalatodigital (OPD) spectrum. We describe a family in which a woman and her three daughters exhibited a complex phenotype combining PNH, epilepsy and Melnick-Needles syndrome (MNS), a skeletal disorder assigned to the OPD spectrum. All four individuals harboured a novel non-conservative missense mutation in FLNA exon 3.In all affected family members, we performed mutation analysis of the FLNA gene, RT-PCR, ultradeep sequencing analysis in FLNA cDNAs and western blot in lymphocyte cells to further characterise the mutation. We also assessed the effects on RT-PCR products of treatment of patients' lymphocytes with cycloheximide, a nonsense mediated mRNA decay (NMD) inhibitor.We identified a novel c.622G>C change in FLNA exon 3, leading to the substitution of a highly conserved aminoacid (p.Gly208Arg). Gel electrophoresis and ultradeep sequencing revealed the missense mutation as well as retention of intron 3. Cycloheximide treatment demonstrated that the aberrant mRNA transcript-retaining intron 3 is subjected to NMD. Western blot analysis confirmed reduced FLNA levels in lymphocyte cells.The novel c.622G>C substitution leads to two aberrant FLNA transcripts, one of which carries the missense mutation, plus a longer transcript resulting from intron 3 retention. We propose that the exceptional co-occurrence of PNH and MNS, two otherwise mutually exclusive allelic phenotypes, is the consequence of a single mutational event resulting in co-occurring gain-of-function and loss-of-function effects.", "electronicPublicationDate": "2015-03-09", "language": "eng", "dateOfCompletion": "2016-02-24", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1136/jmedgenet-2014-102959", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-06-01", "journal": {"medlineAbbreviation": "J Med Genet", "isoabbreviation": "J. Med. Genet.", "title": "Journal of medical genetics", "issn": "0022-2593", "nlmid": "2985087R", "essn": "1468-6244"}, "monthOfPublication": 6, "volume": "52", "yearOfPublication": 2015, "journalIssueId": 2287225, "issue": "6", "dateOfPublication": "2015 Jun"}}, "17009344": {"pubYear": "2006", "dateOfCreation": "2006-11-27", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Colombani M, Laurent N, Le Merrer M, Delezoide AL, Thauvin-Robinet C, Huet F, Sagot P, Couvreur S, Rousseau T, Robertson SP, Faivre L.", "affiliation": "D\u00e9partement de G\u00e9n\u00e9tique, H\u00f4pital d'Enfants, Dijon, France.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "17009344", "inEPMC": "N", "authorList": {"author": [{"lastName": "Colombani", "fullName": "Colombani M", "firstName": "Marina", "initials": "M"}, {"lastName": "Laurent", "fullName": "Laurent N", "firstName": "Nicole", "initials": "N"}, {"lastName": "Le Merrer", "fullName": "Le Merrer M", "firstName": "Martine", "initials": "M"}, {"lastName": "Delezoide", "fullName": "Delezoide AL", "firstName": "Anne-Lise", "initials": "AL"}, {"lastName": "Thauvin-Robinet", "fullName": "Thauvin-Robinet C", "firstName": "Christel", "initials": "C"}, {"lastName": "Huet", "fullName": "Huet F", "firstName": "Fr\u00e9d\u00e9ric", "initials": "F"}, {"lastName": "Sagot", "fullName": "Sagot P", "firstName": "Paul", "initials": "P"}, {"lastName": "Couvreur", "fullName": "Couvreur S", "firstName": "St\u00e9phanie", "initials": "S"}, {"lastName": "Rousseau", "fullName": "Rousseau T", "firstName": "Thierry", "initials": "T"}, {"lastName": "Robertson", "fullName": "Robertson SP", "firstName": "Stephen P", "initials": "SP"}, {"lastName": "Faivre", "fullName": "Faivre L", "firstName": "Laurence", "initials": "L"}]}, "title": "A new osteochondrodysplasia with severe osteopenia, preaxial polydactyly, clefting and dysmorphic features resembling filamin-related disorders.", "citedByCount": 2, "source": "MED", "pmid": "17009344", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Face", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Osteochondrodysplasias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "US", "qualifierName": "ultrasonography", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Bone Diseases, Metabolic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cleft Palate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "US", "qualifierName": "ultrasonography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Polydactyly", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "US", "qualifierName": "ultrasonography", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fetal Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "US", "qualifierName": "ultrasonography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "US", "qualifierName": "ultrasonography", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Abortion, Induced", "majorTopic_YN": "N"}, {"descriptorName": "Autopsy", "majorTopic_YN": "N"}, {"descriptorName": "Cytogenetic Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-12-01", "doi": "10.1002/pd.1576", "isOpenAccess": "N", "pageInfo": "1151-1155", "hasDbCrossReferences": "N", "abstractText": " BACKGROUND: We report a 19-week gestation female foetus with a new syndrome characterised by increased nuchal translucency and severe micromelia with campomelia evident from the early second trimester. METHODS AND RESULTS: Cytogenetic studies performed on amniocytes revealed a normal female karyotype. Autopsy after termination of pregnancy showed facial dysmorphism, cleft palate, bowed, shortened limbs, hypoplasia of the preaxial elements in all four limbs with accompanying accessory ossification centres in the feet, and severe calvarial underossification. A diagnosis of otopalatodigital syndrome type 2, associated with mutations in FLNA, a gene encoding the cytoskeletal protein filamin A, was considered but discarded due to the severity of micromelia, early lethality, and the presence of generalised osteopenia instead of hyperostosis. The degree of undermodelling and campomelia was reminiscent of another group of conditions that include atelosteogenesis types 1 and 3, caused by mutations in FLNB. Sequencing analysis did not reveal any pathogenic mutation in the three paralogous filamin genes: FLNA, FLNB and FLNC. CONCLUSION: Clinical, radiological and cytogenetic findings suggest that this phenotype is a new entity whose aetiopathogenesis may be functionally related to the filaminopathies.", "language": "eng", "dateOfCompletion": "2007-02-21", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/pd.1576", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-12-01", "journal": {"medlineAbbreviation": "Prenat Diagn", "isoabbreviation": "Prenat. Diagn.", "title": "Prenatal diagnosis", "issn": "0197-3851", "nlmid": "8106540", "essn": "1097-0223"}, "monthOfPublication": 12, "volume": "26", "yearOfPublication": 2006, "journalIssueId": 1363406, "issue": "12", "dateOfPublication": "2006 Dec"}}, "19728866": {"pubYear": "2009", "dateOfCreation": "2009-10-29", "pubModel": "Print-Electronic", "authorString": "Linghu B, Snitkin ES, Hu Z, Xia Y, Delisi C.", "affiliation": "Bioinformatics Program, Boston University, 24 Cummington Street, Boston, MA 02215, USA. blinghu@bu.edu", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "RR", "orderIn": 0, "agency": "NCRR NIH HHS", "grantId": "R01 RR022971"}]}, "hasPDF": "Y", "id": "19728866", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Bioinformatics Program, Boston University, 24 Cummington Street, Boston, MA 02215, USA. blinghu@bu.edu", "fullName": "Linghu B", "initials": "B", "firstName": "Bolan", "lastName": "Linghu"}, {"lastName": "Snitkin", "fullName": "Snitkin ES", "firstName": "Evan S", "initials": "ES"}, {"lastName": "Hu", "fullName": "Hu Z", "firstName": "Zhenjun", "initials": "Z"}, {"lastName": "Xia", "fullName": "Xia Y", "firstName": "Yu", "initials": "Y"}, {"lastName": "Delisi", "fullName": "Delisi C", "firstName": "Charles", "initials": "C"}]}, "title": "Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network.", "hasSuppl": "Y", "citedByCount": 96, "source": "MED", "pmid": "19728866", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Reproducibility of Results", "majorTopic_YN": "N"}, {"descriptorName": "Protein Interaction Mapping", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genomics", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genome, Human", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Algorithms", "majorTopic_YN": "N"}, {"descriptorName": "Software", "majorTopic_YN": "N"}, {"descriptorName": "Gene Regulatory Networks", "majorTopic_YN": "N"}, {"descriptorName": "Genome-Wide Association Study", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2009-09-03", "language": "eng", "doi": "10.1186/gb-2009-10-9-r91", "isOpenAccess": "Y", "pageInfo": "R91", "pmcid": "PMC2768980", "hasDbCrossReferences": "N", "abstractText": "We integrate 16 genomic features to construct an evidence-weighted functional-linkage network comprising 21,657 human genes. The functional-linkage network is used to prioritize candidate genes for 110 diseases, and to reliably disclose hidden associations between disease pairs having dissimilar phenotypes, such as hypercholesterolemia and Alzheimer's disease. Many of these disease-disease associations are supported by epidemiology, but with no previous genetic basis. Such associations can drive novel hypotheses on molecular mechanisms of diseases and therapies.", "electronicPublicationDate": "2009-09-03", "license": "cc by", "dateOfCompletion": "2010-02-17", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2768980?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2768980", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.biomedcentral.com/content/pdf/1465-6906-10-R91.pdf", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/1465-6906/10/R91", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://www.biomedcentral.com/1465-6906/10/R91/abstract", "documentStyle": "abs", "availability": "Open access", "availabilityCode": "OA", "site": "BioMedCentral"}, {"url": "http://genomebiology.com/2009/10/9/R91", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "genomebiology.com"}, {"url": "http://genomebiology.com/2009/10/9/R91/abstract", "documentStyle": "abs", "availability": "Open access", "availabilityCode": "OA", "site": "genomebiology.com"}, {"url": "http://genomebiology.com/content/pdf/gb-2009-10-9-R91.pdf", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "genomebiology.com"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19728866", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19728866&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1186/gb-2009-10-9-r91", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-04", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"medlineAbbreviation": "Genome Biol", "isoabbreviation": "Genome Biol.", "title": "Genome biology", "issn": "1474-7596", "nlmid": "100960660", "essn": "1474-760X"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2009, "journalIssueId": 1660560, "issue": "9", "dateOfPublication": "2009 "}}, "12612583": "", "22740120": {"pubYear": "2012", "dateOfCreation": "2012-07-23", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Reinstein E, Chang BS, Robertson SP, Rimoin DL, Katzir T.", "affiliation": "Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "22740120", "inEPMC": "N", "authorList": {"author": [{"lastName": "Reinstein", "fullName": "Reinstein E", "firstName": "Eyal", "initials": "E"}, {"lastName": "Chang", "fullName": "Chang BS", "firstName": "Bernard S", "initials": "BS"}, {"lastName": "Robertson", "fullName": "Robertson SP", "firstName": "Stephen P", "initials": "SP"}, {"lastName": "Rimoin", "fullName": "Rimoin DL", "firstName": "David L", "initials": "DL"}, {"lastName": "Katzir", "fullName": "Katzir T", "firstName": "Tami", "initials": "T"}]}, "title": "Filamin A mutation associated with normal reading skills and dyslexia in a family with periventricular heterotopia.", "citedByCount": 2, "source": "MED", "pmid": "22740120", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Dyslexia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Neuropsychological Tests", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Reading", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Periventricular Nodular Heterotopia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-06-27", "doi": "10.1002/ajmg.a.35455", "isOpenAccess": "N", "pageInfo": "1897-1901", "hasDbCrossReferences": "Y", "abstractText": "Periventricular heterotopia (PH) is a disorder of neuronal migration during fetal development that is characterized by morphologically normal neurons being located in an anatomically abnormal position in the mature brain. PH is usually diagnosed in patients presenting with a seizure disorder, when neuroimaging demonstrates the ectopically placed nodules of neurons. PH is a genetically and phenotypically heterogeneous disorder. The most commonly identified genetic cause is the X-linked dominant inheritance of mutations in the Filamin A (FLNA) gene. Multiple lines of evidence support the contribution of genetic factors in dyslexia. As dyslexia does not show a single-gene pattern of inheritance, it is classified as a complex genetic disorder. We have recently identified a specific reading fluency deficit in a variable group of patients with PH, in the context of normal intelligence. Here, we present a study of a mother-daughter pair who share bilateral widespread gray matter heterotopia caused by a novel mutation in FLNA and the same pattern of X-chromosome inactivation but who exhibit divergent reading and cognitive profiles. This novel observation highlights the uncertainty of using heterotopia anatomy in clinical practice to predict behavioral outcome.", "electronicPublicationDate": "2012-06-27", "language": "eng", "dateOfCompletion": "2012-11-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.a.35455", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-08-01", "journal": {"medlineAbbreviation": "Am J Med Genet A", "isoabbreviation": "Am. J. Med. Genet. A", "title": "American journal of medical genetics. Part A", "issn": "1552-4825", "nlmid": "101235741", "essn": "1552-4833"}, "monthOfPublication": 8, "volume": "158A", "yearOfPublication": 2012, "journalIssueId": 1950879, "issue": "8", "dateOfPublication": "2012 Aug"}}, "19773341": {"pubYear": "2009", "dateOfCreation": "2009-11-20", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Clark AR, Sawyer GM, Robertson SP, Sutherland-Smith AJ.", "affiliation": "Institute of Molecular BioSciences, Massey University, Palmerston North, New Zealand.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "19773341", "inEPMC": "N", "authorList": {"author": [{"lastName": "Clark", "fullName": "Clark AR", "authorId": {"type": "ORCID", "value": "0000-0002-1701-9010"}, "firstName": "Alice R", "initials": "AR"}, {"lastName": "Sawyer", "fullName": "Sawyer GM", "firstName": "Gregory M", "initials": "GM"}, {"lastName": "Robertson", "fullName": "Robertson SP", "firstName": "Stephen P", "initials": "SP"}, {"lastName": "Sutherland-Smith", "fullName": "Sutherland-Smith AJ", "firstName": "Andrew J", "initials": "AJ"}]}, "title": "Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders.", "citedByCount": 18, "source": "MED", "pmid": "19773341", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-1701-9010"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Toes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fingers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ear Ossicles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fibroblasts", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Palate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Bone Diseases, Developmental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nervous System Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Crystallography, X-Ray", "majorTopic_YN": "N"}, {"descriptorName": "Cell Adhesion", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cell Movement", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Protein Structure, Tertiary", "majorTopic_YN": "N"}, {"descriptorName": "Mutation, Missense", "majorTopic_YN": "N"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "PDB", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-09-22", "doi": "10.1093/hmg/ddp442", "isOpenAccess": "N", "pageInfo": "4791-4800", "hasDbCrossReferences": "Y", "abstractText": "Filamin A (FLNA) crosslinks F-actin and binds proteins consistent with roles integrating cell signalling and the cytoskeleton. FLNA missense mutations are associated with the otopalatodigital syndrome (OPD) spectrum of skeletal disorders, clustering in discrete domains. One cluster is found in the second calponin homology domain of the FLNA actin-binding domain (ABD), implicating this region as essential for mediating correct function. Here we show that OPD (FLNA E254K) fibroblast lysates have equivalent concentrations of FLNA compared with controls and that recombinant FLNA E254K ABD has increased in vitro F-actin binding (K(d) 13 microm) compared with wild type (WT; K(d) 48 microm). These observations are consistent with a gain-of-function mechanism for OPD. We have determined the crystal structures of the WT and E254K FLNA ABDs at 2.3 A resolution, revealing that they adopt similar closed conformations. The E254K mutation removes a conserved salt bridge but does not disrupt the ABD structure. The solution structures are also equivalent as determined by circular dichroism spectroscopy, but differential scanning fluorimetry denaturation showed reduced stability (decreased T(m) of 5.6 degrees C) for E254K relative to WT. Ex vivo characterization of E254K OPD patient fibroblasts revealed they have similar motility and adhesion as control cells, implying that many core functions mediated by FLNA are unaffected, consistent with OPD only affecting specific tissues despite FLNA being widely expressed. These data provide the first biochemical evidence for a gain-of-function mechanism for the OPD disorders, and mechanistically distinguishes them from the loss-of-function phenotypes that manifest as disorders of neuronal migration.", "electronicPublicationDate": "2009-09-22", "language": "eng", "dateOfCompletion": "2010-02-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://hmg.oxfordjournals.org/cgi/content/abstract/18/24/4791", "documentStyle": "abs", "availability": "Free", "availabilityCode": "F", "site": "hmg.oxfordjournals.org"}, {"url": "http://hmg.oxfordjournals.org/cgi/content/full/18/24/4791", "documentStyle": "html", "availability": "Free after 12 months", "availabilityCode": "F12", "site": "hmg.oxfordjournals.org"}, {"url": "http://dx.doi.org/10.1093/hmg/ddp442", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-12-01", "journal": {"medlineAbbreviation": "Hum Mol Genet", "isoabbreviation": "Hum. Mol. Genet.", "title": "Human molecular genetics", "issn": "0964-6906", "nlmid": "9208958", "essn": "1460-2083"}, "monthOfPublication": 12, "volume": "18", "yearOfPublication": 2009, "journalIssueId": 1666243, "issue": "24", "dateOfPublication": "2009 Dec"}}, "20871226": {"pubYear": "2010", "dateOfCreation": "2010-09-27", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Kapur RP, Robertson SP, Hannibal MC, Finn LS, Morgan T, van Kogelenberg M, Loren DJ.", "affiliation": "Departments of Pathology, Seattle Children's Hospital, University of Washington, WA, USA. raj.kapur@seattlechildrens.org", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "20871226", "inEPMC": "N", "authorList": {"author": [{"lastName": "Kapur", "fullName": "Kapur RP", "firstName": "Raj P", "initials": "RP"}, {"lastName": "Robertson", "fullName": "Robertson SP", "firstName": "Stephen P", "initials": "SP"}, {"lastName": "Hannibal", "fullName": "Hannibal MC", "firstName": "Mark C", "initials": "MC"}, {"lastName": "Finn", "fullName": "Finn LS", "firstName": "Laura S", "initials": "LS"}, {"lastName": "Morgan", "fullName": "Morgan T", "firstName": "Timothy", "initials": "T"}, {"lastName": "van Kogelenberg", "fullName": "van Kogelenberg M", "firstName": "Margriet", "initials": "M"}, {"lastName": "Loren", "fullName": "Loren DJ", "firstName": "David J", "initials": "DJ"}]}, "title": "Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and x-linked intestinal pseudo-obstruction.", "citedByCount": 8, "source": "MED", "pmid": "20871226", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Muscle, Smooth", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intestine, Large", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intestine, Small", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Mucous Membrane", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Myocytes, Smooth Muscle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Intestinal Pseudo-Obstruction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Diseases, X-Linked", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-10-01", "doi": "10.1097/pas.0b013e3181f0ae47", "isOpenAccess": "N", "pageInfo": "1528-1543", "hasDbCrossReferences": "N", "abstractText": "X-linked intestinal pseudo-obstruction, a rare disorder caused by mutations in FLNA, the gene encoding the cytoskeletal protein filamin A, has been regarded as a hereditary enteric neuropathy largely on the basis of sparse and incomplete pathologic studies. Diffuse abnormal layering of small intestinal smooth muscle (DAL) is a rare malformation, which has only been described in 4 patients (all male, 3 in the same family) with intestinal pseudo-obstruction. We report DAL in 5 male patients (2 families) with intestinal pseudo-obstruction and mutations in FLNA. Light microscopic, ultrastructural, and immunohistochemical studies showed abnormal lamination of the small intestinal muscularis propria with associated absent or severely reduced FLNA immunoreactivity. Intestinal samples from the oldest patient in the series, a teenager, showed multinucleate myocytes in small and large intestine, along the submucosal surface of the muscularis propria. As neither DAL nor the pattern of myocyte multinucleation observed in our patients have been described outside the context of X-linked intestinal pseudo-obstruction, these histopathologic features may be specific for this hereditary disorder and suggest an underlying myopathic basis for dysmotility in affected patients.", "language": "eng", "dateOfCompletion": "2010-10-14", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1097/PAS.0b013e3181f0ae47", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}, {"url": "http://content.wkhealth.com/linkback/openurl?issn=0147-5185&volume=34&issue=10&spage=1528", "documentStyle": "abs", "availability": "Subscription required", "availabilityCode": "S", "site": "www.ajsp.com"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-10-01", "journal": {"medlineAbbreviation": "Am J Surg Pathol", "isoabbreviation": "Am. J. Surg. Pathol.", "title": "The American journal of surgical pathology", "issn": "0147-5185", "nlmid": "7707904", "essn": "1532-0979"}, "monthOfPublication": 10, "volume": "34", "yearOfPublication": 2010, "journalIssueId": 1764279, "issue": "10", "dateOfPublication": "2010 Oct"}}, "24039908": {"pubYear": "2013", "dateOfCreation": "2013-09-16", "pubModel": "Electronic-eCollection", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Nerve Tissue Proteins"}, {"registryNumber": "0", "name": "RNA-Binding Proteins"}, {"registryNumber": "0", "name": "Antigens, Nuclear"}, {"registryNumber": "0", "name": "neuronal nuclear antigen NeuN, human"}, {"registryNumber": "0", "name": "RBFOX1 protein, human"}]}, "authorString": "Lal D, Reinthaler EM, Altm\u00fcller J, Toliat MR, Thiele H, N\u00fcrnberg P, Lerche H, Hahn A, M\u00f8ller RS, Muhle H, Sander T, Zimprich F, Neubauer BA.", "affiliation": "Cologne Center for Genomics, University of Cologne, Cologne, Germany ; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany ; Department of Neuropediatrics, University Medical Clinic Giessen, Giessen, Germany.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "24039908", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Cologne Center for Genomics, University of Cologne, Cologne, Germany ; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany ; Department of Neuropediatrics, University Medical Clinic Giessen, Giessen, Germany.", "fullName": "Lal D", "initials": "D", "firstName": "Dennis", "lastName": "Lal"}, {"lastName": "Reinthaler", "fullName": "Reinthaler EM", "firstName": "Eva M", "initials": "EM"}, {"lastName": "Altm\u00fcller", "fullName": "Altm\u00fcller J", "firstName": "Janine", "initials": "J"}, {"lastName": "Toliat", "fullName": "Toliat MR", "firstName": "Mohammad R", "initials": "MR"}, {"lastName": "Thiele", "fullName": "Thiele H", "firstName": "Holger", "initials": "H"}, {"lastName": "N\u00fcrnberg", "fullName": "N\u00fcrnberg P", "firstName": "Peter", "initials": "P"}, {"lastName": "Lerche", "fullName": "Lerche H", "firstName": "Holger", "initials": "H"}, {"lastName": "Hahn", "fullName": "Hahn A", "firstName": "Andreas", "initials": "A"}, {"lastName": "M\u00f8ller", "fullName": "M\u00f8ller RS", "firstName": "Rikke S", "initials": "RS"}, {"lastName": "Muhle", "fullName": "Muhle H", "firstName": "Hiltrud", "initials": "H"}, {"lastName": "Sander", "fullName": "Sander T", "firstName": "Thomas", "initials": "T"}, {"lastName": "Zimprich", "fullName": "Zimprich F", "firstName": "Fritz", "initials": "F"}, {"lastName": "Neubauer", "fullName": "Neubauer BA", "firstName": "Bernd A", "initials": "BA"}]}, "title": "RBFOX1 and RBFOX3 mutations in rolandic epilepsy.", "hasSuppl": "N", "citedByCount": 21, "source": "MED", "pmid": "24039908", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy, Rolandic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "RNA-Binding Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Nerve Tissue Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Antigens, Nuclear", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pedigree", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Exons", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-09-06", "doi": "10.1371/journal.pone.0073323", "isOpenAccess": "Y", "pageInfo": "e73323", "pmcid": "PMC3765197", "hasDbCrossReferences": "Y", "abstractText": "Partial deletions of the gene encoding the neuronal splicing regulator RBFOX1 have been reported in a range of neurodevelopmental diseases, including idiopathic generalized epilepsy. The RBFOX1 protein and its homologues (RBFOX2 and RBFOX3) regulate alternative splicing of many neuronal transcripts involved in the homeostatic control of neuronal excitability. In this study, we explored if structural microdeletions and exonic sequence variations in RBFOX1, RBFOX2, RBFOX3 confer susceptibility to rolandic epilepsy (RE), a common idiopathic focal childhood epilepsy. By high-density SNP array screening of 289 unrelated RE patients, we identified two hemizygous deletions, a 365\u2009kb deletion affecting two untranslated 5'-terminal exons of RBFOX1 and a 43 kb deletion spanning exon 3 of RBFOX3. Exome sequencing of 242 RE patients revealed two novel probably deleterious variants in RBFOX1, a frameshift mutation (p.A233Vfs*74) and a hexanucleotide deletion (p.A299_A300del), and a novel nonsense mutation in RBFOX3 (p.Y287*). Although the three variants were inherited from unaffected parents, they were present in all family members exhibiting the RE trait clinically or electroencephalographically with only one exception. In contrast, no deleterious mutations of RBFOX1 and RBFOX3 were found in the exomes of 6503 non-RE subjects deposited in the Exome Variant Server database. The observed RBFOX3 exon 3 deletion and nonsense mutation suggest that RBFOX3 represents a novel risk factor for RE, indicating that exon deletions and truncating mutations of RBFOX1 and RBFOX3 contribute to the genetic variance of partial and generalized idiopathic epilepsy syndromes.", "electronicPublicationDate": "2013-09-06", "language": "eng", "dateOfCompletion": "2014-06-07", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3765197?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3765197", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=24039908&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=24039908", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0073323", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "8", "yearOfPublication": 2013, "journalIssueId": 2074012, "issue": "9", "dateOfPublication": "2013 "}}, "21484998": {"pubYear": "2011", "dateOfCreation": "2011-04-20", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "DNA Primers"}]}, "authorString": "Parrini E, Rivas IL, Toral JF, Pucatti D, Giglio S, Mei D, Guerrini R.", "affiliation": "Pediatric Neurology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "21484998", "inEPMC": "N", "authorList": {"author": [{"lastName": "Parrini", "fullName": "Parrini E", "authorId": {"type": "ORCID", "value": "0000-0001-8933-7694"}, "firstName": "Elena", "initials": "E"}, {"lastName": "Rivas", "fullName": "Rivas IL", "firstName": "Isabel Llano", "initials": "IL"}, {"lastName": "Toral", "fullName": "Toral JF", "firstName": "Joaquin Fernandez", "initials": "JF"}, {"lastName": "Pucatti", "fullName": "Pucatti D", "firstName": "Daniela", "initials": "D"}, {"lastName": "Giglio", "fullName": "Giglio S", "authorId": {"type": "ORCID", "value": "0000-0002-3954-326X"}, "firstName": "Sabrina", "initials": "S"}, {"lastName": "Mei", "fullName": "Mei D", "authorId": {"type": "ORCID", "value": "0000-0001-6790-6251"}, "firstName": "Davide", "initials": "D"}, {"lastName": "Guerrini", "fullName": "Guerrini R", "firstName": "Renzo", "initials": "R"}]}, "title": "In-frame deletion in FLNA causing familial periventricular heterotopia with skeletal dysplasia in males.", "citedByCount": 2, "source": "MED", "pmid": "21484998", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-8933-7694"}, {"type": "ORCID", "value": "0000-0002-3954-326X"}, {"type": "ORCID", "value": "0000-0001-6790-6251"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Bone Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "DNA Primers", "majorTopic_YN": "N"}, {"descriptorName": "Reverse Transcriptase Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Gene Deletion", "majorTopic_YN": "Y"}, {"descriptorName": "Base Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "X Chromosome Inactivation", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-04-11", "doi": "10.1002/ajmg.a.33880", "isOpenAccess": "N", "pageInfo": "1140-1146", "hasDbCrossReferences": "N", "abstractText": "Periventricular heterotopia (PH) is an etiologically heterogeneous disorder characterized by nodules of neurons ectopically placed along the lateral ventricles. Truncating and missense mutations of the FLNA gene have been identified in almost 100% of families and 26% of sporadic patients with PH. The otopalatodigital syndrome spectrum is caused by distinct FLNA missense mutations or in-frame deletions disrupting the development of craniofacial and long bones. We report on a clinical, neuroimaging, X-ray, and molecular study of a family in which classical bilateral PH appeared as an isolated anatomic feature in the mother and was associated with skeletal abnormalities and facial dysmorphisms in her two sons. Both boys exhibited PH associated with flat face and spatulate finger tips, short broad phalanx and metacarpus, and bowed radius with dislocated wrist joints. All three patients harbored the c.7865_7870del in-frame deletion (p.2622_2623delDK) in the carboxyl-terminal domain (repeat 24) of FLNA. The X-inactivation observed in the mother was skewed towards the mutant allele, resulting in the preferential expression of the wild-type allele. The in-frame deletion in the carboxyl-terminal domain of FLNA caused a phenotype in which PH was associated with skeletal features suggestive of the otopalatodigital syndrome spectrum in boys. There appears to be a continuum among allelic disorders due to FLNA mutations.", "electronicPublicationDate": "2011-04-11", "language": "eng", "dateOfCompletion": "2011-08-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.a.33880", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-05-01", "journal": {"medlineAbbreviation": "Am J Med Genet A", "isoabbreviation": "Am. J. Med. Genet. A", "title": "American journal of medical genetics. Part A", "issn": "1552-4825", "nlmid": "101235741", "essn": "1552-4833"}, "monthOfPublication": 5, "volume": "155A", "yearOfPublication": 2011, "journalIssueId": 1838913, "issue": "5", "dateOfPublication": "2011 May"}}, "21412975": {"pubYear": "2011", "dateOfCreation": "2011-05-13", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Murphy-Ryan M, Babovic-Vuksanovic D, Lindor N.", "affiliation": "Mayo Medical School, Rochester, Minnesota, USA.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "21412975", "inEPMC": "N", "authorList": {"author": [{"lastName": "Murphy-Ryan", "fullName": "Murphy-Ryan M", "firstName": "Maureen", "initials": "M"}, {"lastName": "Babovic-Vuksanovic", "fullName": "Babovic-Vuksanovic D", "firstName": "Dusica", "initials": "D"}, {"lastName": "Lindor", "fullName": "Lindor N", "firstName": "Noralane", "initials": "N"}]}, "title": "Bifid tongue, corneal clouding, and Dandy-Walker malformation in a male infant with otopalatodigital syndrome type 2.", "citedByCount": 1, "source": "MED", "pmid": "21412975", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Osteochondrodysplasias", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Hand Deformities, Congenital", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Craniofacial Abnormalities", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "RA", "qualifierName": "radiography", "majorTopic_YN": "N"}]}}, {"descriptorName": "Tongue, Fissured", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Dandy-Walker Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Corneal Opacity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Amino Acid Substitution", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Infant, Newborn", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-03-15", "doi": "10.1002/ajmg.a.33901", "isOpenAccess": "N", "pageInfo": "855-859", "hasDbCrossReferences": "Y", "abstractText": "We report on a male infant with otopalatodigital syndrome type 2 (OPD2) associated with a novel c.514C>G FLNA mutation and unusual clinical features including bifid tongue and congenital corneal clouding. Bifid tongue and congenital corneal clouding have each only been described once previously in a patient with OPD2, and this is the first description of Dandy-Walker malformation (DWM) in OPD2. The presence of these clinical findings in a mutation-confirmed case of OPD2 supports the notion that corneal clouding, bifid tongue, and DWM are part of the constellation of abnormalities caused by mutations in FLNA.", "electronicPublicationDate": "2011-03-15", "language": "eng", "dateOfCompletion": "2011-08-30", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.a.33901", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2011-04-01", "journal": {"medlineAbbreviation": "Am J Med Genet A", "isoabbreviation": "Am. J. Med. Genet. A", "title": "American journal of medical genetics. Part A", "issn": "1552-4825", "nlmid": "101235741", "essn": "1552-4833"}, "monthOfPublication": 4, "volume": "155A", "yearOfPublication": 2011, "journalIssueId": 1843356, "issue": "4", "dateOfPublication": "2011 Apr"}}, "17431908": {"pubYear": "2007", "dateOfCreation": "2007-04-30", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}]}, "authorString": "Mari\u00f1o-Enr\u00edquez A, Lapunzina P, Robertson SP, Rodr\u00edguez JI.", "affiliation": "Department of Pathology, La Paz University Hospital, Madrid, Spain.", "pubTypeList": {"pubType": ["Journal Article", "Case Reports"]}, "hasPDF": "N", "id": "17431908", "inEPMC": "N", "authorList": {"author": [{"lastName": "Mari\u00f1o-Enr\u00edquez", "fullName": "Mari\u00f1o-Enr\u00edquez A", "firstName": "Adri\u00e1n", "initials": "A"}, {"lastName": "Lapunzina", "fullName": "Lapunzina P", "firstName": "Pablo", "initials": "P"}, {"lastName": "Robertson", "fullName": "Robertson SP", "firstName": "Stephen P", "initials": "SP"}, {"lastName": "Rodr\u00edguez", "fullName": "Rodr\u00edguez JI", "firstName": "Jos\u00e9 I", "initials": "JI"}]}, "title": "Otopalatodigital syndrome type 2 in two siblings with a novel filamin A 629G>T mutation: clinical, pathological, and molecular findings.", "citedByCount": 1, "source": "MED", "pmid": "17431908", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Fingers", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Ear Ossicles", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Palate", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AB", "qualifierName": "abnormalities", "majorTopic_YN": "N"}]}}, {"descriptorName": "Aborted Fetus", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Bone Diseases, Developmental", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CN", "qualifierName": "congenital", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Abnormalities, Multiple", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Diseases, X-Linked", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Syndrome", "majorTopic_YN": "N"}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Autopsy", "majorTopic_YN": "N"}, {"descriptorName": "DNA Mutational Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Siblings", "majorTopic_YN": "N"}, {"descriptorName": "Amino Acid Sequence", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Homology, Amino Acid", "majorTopic_YN": "N"}, {"descriptorName": "Point Mutation", "majorTopic_YN": "Y"}, {"descriptorName": "Molecular Sequence Data", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["OMIM", "UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2007-05-01", "doi": "10.1002/ajmg.a.31696", "isOpenAccess": "N", "pageInfo": "1120-1125", "hasDbCrossReferences": "Y", "abstractText": "Otopalatodigital syndrome type 2 (OPD2) is an uncommon X-linked condition characterized by dysmorphic facies, a skeletal dysplasia affecting the axial and appendicular skeleton and extraskeletal anomalies including malformations of the brain, heart, genitourinary system, and intestines. Missense mutations of the FLNA gene, which encodes for the protein filamin A, have recently been shown to cause OPD2 and the allelic syndromes otopalatodigital type 1, Melnick-Needles, and frontometaphyseal dysplasia. Collectively these conditions constitute the otopalatodigital spectrum disorders. We report on two sibs affected by OPD2. The diagnosis was achieved at autopsy of a macerated male stillborn with typical external and skeletal findings of OPD2. A subsequent pregnancy was terminated due to ultrasonographic findings resembling those observed in the previous sibling. Histopathological studies revealed osseus sclerosis and do not support the previously reported membranous ossification defect observed in this condition. Mutation analysis demonstrated a novel mutation, 629G>T, in FLNA that had arisen de novo in the mother. This missense mutation predicts the substitution C210F within the second calponin homology domain of the actin-binding domain of filamin A. The identical substitution has been recently identified in an analogous amino-acid position within the actin binding domain of beta-spectrin leading to hereditary spherocytosis. The observation that phenylalanine is normally present in the same position in other proteins (utrophin, dystrophin) but leads to disease when present in filamin A implies that the function and/or structure of these actin binding domains are not entirely equivalent.", "language": "eng", "dateOfCompletion": "2007-06-29", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1002/ajmg.a.31696", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "WileyInterScience"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2008-05-21", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-05-01", "journal": {"medlineAbbreviation": "Am J Med Genet A", "isoabbreviation": "Am. J. Med. Genet. A", "title": "American journal of medical genetics. Part A", "issn": "1552-4825", "nlmid": "101235741", "essn": "1552-4833"}, "monthOfPublication": 5, "volume": "143A", "yearOfPublication": 2007, "journalIssueId": 1529916, "issue": "10", "dateOfPublication": "2007 May"}}, "26471271": {"pubYear": "2015", "dateOfCreation": "2015-10-16", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}]}, "authorString": "Lange M, Kasper B, Bohring A, Rutsch F, Kluger G, Hoffjan S, Spranger S, Behnecke A, Ferbert A, Hahn A, Oehl-Jaschkowitz B, Graul-Neumann L, Diepold K, Schreyer I, Bernhard MK, Mueller F, Siebers-Renelt U, Beleza-Meireles A, Uyanik G, Janssens S, Boltshauser E, Winkler J, Schuierer G, Hehr U.", "affiliation": "Department of Neurosurgery, University of Regensburg, Medical Center, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. max.lange@ukr.de.", "pubTypeList": {"pubType": ["Journal Article"]}, "hasPDF": "Y", "id": "26471271", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Neurosurgery, University of Regensburg, Medical Center, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. max.lange@ukr.de.", "fullName": "Lange M", "initials": "M", "firstName": "Max", "lastName": "Lange"}, {"affiliation": "Department of Neurology, Epilepsy Center, University of Erlangen, Medical Center, Erlangen, Germany. Burkhard.Kasper@uk-erlangen.de.", "fullName": "Kasper B", "initials": "B", "firstName": "Burkhard", "lastName": "Kasper"}, {"affiliation": "Institute of Human Genetics, University of Muenster, Muenster, Germany. abohring@uni-muenster.de.", "fullName": "Bohring A", "initials": "A", "firstName": "Axel", "lastName": "Bohring"}, {"affiliation": "Department of General Pediatrics, Muenster University Children's Hospital, Muenster, Germany. frank.rutsch@ukmuenster.de.", "fullName": "Rutsch F", "initials": "F", "firstName": "Frank", "lastName": "Rutsch"}, {"affiliation": "Neurop\u00e4diatrie, Sch\u00f6n Klinik Vogtareuth, Vogtareuth, Germany und Paracelsus Medical University, Salzburg/Austria, Salzburg, Austria. GKluger@Schoen-Kliniken.de.", "fullName": "Kluger G", "initials": "G", "firstName": "Gerhard", "lastName": "Kluger"}, {"affiliation": "Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany. Sabine.Hoffjan@rub.de.", "fullName": "Hoffjan S", "initials": "S", "firstName": "Sabine", "lastName": "Hoffjan"}, {"affiliation": "Praxis fuer Humangenetik, Klinikum Bremen-Mitte, Bremen, Germany. sspranger@aol.com.", "fullName": "Spranger S", "initials": "S", "firstName": "Stephanie", "lastName": "Spranger"}, {"affiliation": "Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. anne.behnecke@med.uni-heidelberg.de.", "fullName": "Behnecke A", "initials": "A", "firstName": "Anne", "lastName": "Behnecke"}, {"affiliation": "Klinik f\u00fcr Neurologie, Klinikum Kassel and Medical School, Kassel, Germany. ferbert@klinikum-kassel.de.", "fullName": "Ferbert A", "initials": "A", "firstName": "Andreas", "lastName": "Ferbert"}, {"affiliation": "Department of Neuropediatrics, University of Giessen, Giessen, Germany. Andreas.Hahn@paediat.med.uni-giessen.de.", "fullName": "Hahn A", "initials": "A", "firstName": "Andreas", "lastName": "Hahn"}, {"affiliation": "Praxis fuer Humangenetik, Homburg, Saar, Germany. oehl-jaschkowitz@genetik-saar.de.", "fullName": "Oehl-Jaschkowitz B", "initials": "B", "firstName": "Barbara", "lastName": "Oehl-Jaschkowitz"}, {"affiliation": "Ambulantes Gesundheitszentrum der Charit\u00e9 (Humangenetik), Universit\u00e4tsmedizin Berlin, Berlin, Germany. luitgard.graul-neumann@charite.de.", "fullName": "Graul-Neumann L", "initials": "L", "firstName": "Luitgard", "lastName": "Graul-Neumann"}, {"affiliation": "Department of Neuropediatrics, Klinikum Kassel, Kassel, Germany. katharina.diepold@klinikum-kassel.de.", "fullName": "Diepold K", "initials": "K", "firstName": "Katharina", "lastName": "Diepold"}, {"affiliation": "Institut f\u00fcr Humangenetik, Uni Jena, Jena, Germany. Isolde.schreyer@mti.uni-jena.de.", "fullName": "Schreyer I", "initials": "I", "firstName": "Isolde", "lastName": "Schreyer"}, {"affiliation": "Department of Pediatrics, University of Leipzig Medical Center, Leipzig, Germany. matthias.bernhard@medizin.uni-leipzig.de.", "fullName": "Bernhard MK", "initials": "MK", "firstName": "Matthias K", "lastName": "Bernhard"}, {"affiliation": "Center for Human Genetics, Regensburg, Germany. info@humangenetik-regensburg.de.", "fullName": "Mueller F", "initials": "F", "firstName": "Franziska", "lastName": "Mueller"}, {"affiliation": "Institute of Human Genetics, University of Muenster, Muenster, Germany. Ulrike.Siebers-Renelt@ukmuenster.de.", "fullName": "Siebers-Renelt U", "initials": "U", "firstName": "Ulrike", "lastName": "Siebers-Renelt"}, {"affiliation": "Genetics Clinic, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. ana.beleza@gstt.nhs.uk.", "fullName": "Beleza-Meireles A", "initials": "A", "firstName": "Ana", "lastName": "Beleza-Meireles"}, {"affiliation": "Zentrum f\u00fcr Medizinische Genetik, Hanusch-Krankenhaus der Wiener Gebietskrankenkasse, Wien, Austria. goekhan.uyanik@wgkk.at.", "fullName": "Uyanik G", "initials": "G", "firstName": "Goekhan", "lastName": "Uyanik"}, {"affiliation": "Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium. sandra.janssens@ugent.be.", "fullName": "Janssens S", "initials": "S", "firstName": "Sandra", "lastName": "Janssens"}, {"affiliation": "Division of Neuropediatrics, University Children's Hospital Z\u00fcrich, Z\u00fcrich, Switzerland. eugen.boltshauser@bluewin.ch.", "fullName": "Boltshauser E", "initials": "E", "firstName": "Eugen", "lastName": "Boltshauser"}, {"affiliation": "Division of Molecular Neurology, University Hospital, Friedrich-Alexander-University Erlangen-Nuernberg, Erlangen, Germany. Juergen.winkler@uk-erlangen.de.", "fullName": "Winkler J", "initials": "J", "firstName": "Juergen", "lastName": "Winkler"}, {"affiliation": "Department of Neuroradiology, University of Regensburg, Medical Center, Regensburg, Germany. Gerhard.Schuierer@medbo.de.", "fullName": "Schuierer G", "initials": "G", "firstName": "Gerhard", "lastName": "Schuierer"}, {"affiliation": "Department of Human Genetics, University of Regensburg, Medical Center, Regensburg, Germany. ute.hehr@ukr.de.", "fullName": "Hehr U", "initials": "U", "firstName": "Ute", "lastName": "Hehr"}]}, "title": "47 patients with FLNA associated periventricular nodular heterotopia.", "hasSuppl": "N", "citedByCount": 1, "source": "MED", "pmid": "26471271", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Retrospective Studies", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Mutation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Periventricular Nodular Heterotopia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Filamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-10-15", "language": "eng", "doi": "10.1186/s13023-015-0331-9", "isOpenAccess": "Y", "pageInfo": "134", "pmcid": "PMC4608144", "hasDbCrossReferences": "N", "abstractText": "Heterozygous loss of function mutations within the Filamin A gene in Xq28 are the most frequent cause of bilateral neuronal periventricular nodular heterotopia (PVNH). Most affected females are reported to initially present with difficult to treat seizures at variable age of onset. Psychomotor development and cognition may be normal or mildly to moderately impaired. Distinct associated extracerebral findings have been observed and may help to establish the diagnosis including patent ductus arteriosus Botalli, progressive dystrophic cardiac valve disease and aortic dissection, chronic obstructive lung disease or chronic constipation. Genotype-phenotype correlations could not yet be established.Sanger sequencing and MLPA was performed for a large cohort of 47 patients with Filamin A associated PVNH (age range 1 to 65\u00a0years). For 34 patients more detailed clinical information was available from a structured questionnaire and medical charts on family history, development, epileptologic findings, neurological examination, cognition and associated clinical findings. Available detailed cerebral MR imaging was assessed for 20 patients.Thirty-nine different FLNA mutations were observed, they are mainly truncating (37/39) and distributed throughout the entire coding region. No obvious correlation between the number and extend of PVNH and the severity of the individual clinical manifestation was observed. 10 of the mutation carriers so far are without seizures at a median age of 19.7\u00a0years. 22 of 24 patients with available educational data were able to attend regular school and obtain professional education according to age.We report the clinical and mutation spectrum as well as MR imaging for a large cohort of 47 patients with Filamin A associated PVNH including two adult males. Our data are reassuring in regard to psychomotor and cognitive development, which is within normal range for the majority of patients. However, a concerning median diagnostic latency of 17 to 20\u00a0years was noted between seizure onset and the genetic diagnosis, intensely delaying appropriate medical surveillance for potentially life threatening cardiovascular complications as well as genetic risk assessment and counseling prior to family planning for this X-linked dominant inherited disorder with high perinatal lethality in hemizygous males.", "electronicPublicationDate": "2015-10-15", "license": "cc by", "dateOfCompletion": "2016-07-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4608144?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4608144", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s13023-015-0331-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-10-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "Orphanet journal of rare diseases", "medlineAbbreviation": "Orphanet J Rare Dis", "isoabbreviation": "Orphanet J Rare Dis", "nlmid": "101266602", "essn": "1750-1172"}, "monthOfPublication": 0, "volume": "10", "yearOfPublication": 2015, "journalIssueId": 2260859, "dateOfPublication": "2015 "}}, "16538226": "", "20726836": {"pubYear": "2010", "dateOfCreation": "2010-09-30", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "Anti-Inflammatory Agents, Non-Steroidal"}, {"registryNumber": "0", "name": "Narcotic Antagonists"}, {"registryNumber": "0", "name": "Analgesics, Opioid"}, {"registryNumber": "0", "name": "Contractile Proteins"}, {"registryNumber": "0", "name": "Microfilament Proteins"}, {"registryNumber": "0", "name": "Receptors, Opioid, mu"}]}, "authorString": "Burns LH, Wang HY.", "affiliation": "Pain Therapeutics Inc., San Mateo, CA 94404, USA. lburns@paintrials.com", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "N", "id": "20726836", "inEPMC": "N", "authorList": {"author": [{"lastName": "Burns", "fullName": "Burns LH", "firstName": "Lindsay H", "initials": "LH"}, {"lastName": "Wang", "fullName": "Wang HY", "firstName": "Hoau-Yan", "initials": "HY"}]}, "title": "PTI-609: a novel analgesic that binds filamin A to control opioid signaling.", "citedByCount": 5, "source": "MED", "pmid": "20726836", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Opioid-Related Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PC", "qualifierName": "prevention & control", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microfilament Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Contractile Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Receptors, Opioid, mu", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "AG", "qualifierName": "agonists", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Analgesics, Opioid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Narcotic Antagonists", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Anti-Inflammatory Agents, Non-Steroidal", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Technology, Pharmaceutical", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Drug Design", "majorTopic_YN": "Y"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Patents as Topic", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-11-01", "doi": "10.2174/157488910793362386", "isOpenAccess": "N", "pageInfo": "210-220", "hasDbCrossReferences": "N", "abstractText": "Binding a critical pentapeptide region on the scaffolding protein filamin A regulates signaling of mu opioid receptors (MORs) so that their activation should not result in the opioid tolerance, dependence and addiction associated with current opioid painkillers. Additionally, we show that compounds that bind this site on filamin A reduce release of inflammatory cytokines. PTI-609 is a new chemical entity that binds filamin A with picomolar affinity and also activates opioid receptors via a novel binding domain. PTI-609 and analogs have similar analgesic efficacy to morphine by oral administration in mice, provide some anti-inflammatory activity in the rat collagen-induced arthritis model, and show no conditioned place preference at analgesic doses, suggesting no potential for abuse and addiction. PTI-609 was designed after discovering filamin A as the high-affinity target of naltrexone or naloxone. Combined with opiates, ultra-low-dose naloxone or naltrexone can enhance and prolong the analgesia of the opiate alone and prevent or attenuate opioid tolerance, dependence and addictive properties. We will review here the mechanism of action of ultra-low-dose naltrexone and naloxone, the discovery of filamin A as their high-affinity target, and the rationale as to why the current, dualfunction new chemical entity should not only be easier to develop but also more consistently efficacious than opioids combined with ultra-low-dose naltrexone. This new class of compounds, as well as the concept, screening assay and pharmacophore model, are covered in a family of recent patent applications.", "language": "eng", "dateOfCompletion": "2011-01-31", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.2174/157488910793362386", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2011-11-10", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-11-01", "journal": {"medlineAbbreviation": "Recent Pat CNS Drug Discov", "isoabbreviation": "Recent Pat CNS Drug Discov", "title": "Recent patents on CNS drug discovery", "issn": "1574-8898", "nlmid": "101265656", "essn": "2212-3954"}, "monthOfPublication": 11, "volume": "5", "yearOfPublication": 2010, "journalIssueId": 1765255, "issue": "3", "dateOfPublication": "2010 Nov"}}, "26340046": {"pubYear": "2015", "dateOfCreation": "2015-10-05", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "filamins"}, {"registryNumber": "0", "name": "FLNA protein, human"}]}, "authorString": "Fallil Z, Pardoe H, Bachman R, Cunningham B, Parulkar I, Shain C, Poduri A, Knowlton R, Kuzniecky R, EPGP Investigators.", "affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA.", "pubTypeList": {"pubType": ["Journal Article", "Multicenter Study", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "K23 NS069784"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS053998"}, {"acronym": "NS", "orderIn": 0, "agency": "NINDS NIH HHS", "grantId": "U01 NS 053998"}]}, "hasPDF": "N", "id": "26340046", "inEPMC": "N", "authorList": {"author": [{"affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA.", "fullName": "Fallil Z", "initials": "Z", "firstName": "Zianka", "lastName": "Fallil"}, {"firstName": "Heath", "lastName": "Pardoe", "affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA.", "authorId": {"type": "ORCID", "value": "0000-0002-0123-2167"}, "fullName": "Pardoe H", "initials": "H"}, {"affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA.", "fullName": "Bachman R", "initials": "R", "firstName": "Robert", "lastName": "Bachman"}, {"affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA.", "fullName": "Cunningham B", "initials": "B", "firstName": "Benjamin", "lastName": "Cunningham"}, {"affiliation": "Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, USA.", "fullName": "Parulkar I", "initials": "I", "firstName": "Isha", "lastName": "Parulkar"}, {"affiliation": "Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, USA.", "fullName": "Shain C", "initials": "C", "firstName": "Catherine", "lastName": "Shain"}, {"affiliation": "Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, USA.", "fullName": "Poduri A", "initials": "A", "firstName": "Annapurna", "lastName": "Poduri"}, {"affiliation": "UCSF Epilepsy Center, UCSF, San Francisco, CA, USA.", "fullName": "Knowlton R", "initials": "R", "firstName": "Robert", "lastName": "Knowlton"}, {"affiliation": "NYU Epilepsy Center, Langone Medical Center, New York University, New York, NY, USA. Electronic address: ruben.kuzniecky@nyumc.org.", "fullName": "Kuzniecky R", "initials": "R", "firstName": "Ruben", "lastName": "Kuzniecky"}, {"collectiveName": "EPGP Investigators"}]}, "title": "Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.", "citedByCount": 0, "source": "MED", "pmid": "26340046", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0123-2167"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Epilepsy", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Seizures", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fever", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Magnetic Resonance Imaging", "majorTopic_YN": "N"}, {"descriptorName": "Cohort Studies", "majorTopic_YN": "N"}, {"descriptorName": "Developmental Disabilities", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Age of Onset", "majorTopic_YN": "N"}, {"descriptorName": "Sex Characteristics", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Child, Preschool", "majorTopic_YN": "N"}, {"descriptorName": "Infant", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Periventricular Nodular Heterotopia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CO", "qualifierName": "complications", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Neuroimaging", "majorTopic_YN": "N"}, {"descriptorName": "Filamins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "embargoDate": "2016-10-01", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2015-09-01", "doi": "10.1016/j.yebeh.2015.07.041", "isOpenAccess": "N", "pageInfo": "321-327", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Epilepsy", "Periventricular Nodular Heterotopia", "Epilepsy Phenome/genome Project"]}, "abstractText": "Periventricular nodular heterotopia (PVNH) is a malformation of cortical development due to impaired neuronal migration resulting in the formation of nodular masses of neurons and glial cells in close proximity to the ventricular walls. We report the clinical characteristics of the largest case series of FLNA-negative patients with seizures and bilateral periventricular heterotopia.Participants were recruited through the Epilepsy Phenome/Genome Project (EPGP), a multicenter collaborative effort to collect detailed phenotypic data and DNA on a large number of individuals with epilepsy, including a cohort with symptomatic epilepsy related to PVNH. Included subjects had epilepsy, and MRI confirmed bilateral PVNH. Magnetic resonance imaging studies were visually and quantitatively reviewed to investigate the topographic extent of PVNH, symmetry, and laterality.We analyzed data on 71 patients with bilateral PVNH. The incidence of febrile seizures was 16.6%. There was at least one other family member with epilepsy in 36.9% of this population. Developmental delay was present in 21.8%. Focal onset seizures were the most common type of seizure presentation (79.3%). High heterotopia burden was strongly associated with female gender and trigonal nodular localization. There was no evidence for differences in brain volume between PVNH subjects and controls. No relationship was observed between heterotopic volume and gender, developmental delay, location of PVNH, ventricular or cerebellar abnormalities, laterality of seizure onset, age at seizure onset, and duration of epilepsy.A direct correlation was observed between high heterotopia burden, female gender, and trigonal location in this large cohort of FLNA-negative bilateral PVNH patients with epilepsy. Quantitative MRI measurements indicated that this correlation is based on the diffuse nature of the heterotopic nodules rather than on the total volume of abnormal heterotopic tissue.", "electronicPublicationDate": "2015-09-02", "language": "eng", "dateOfCompletion": "2016-05-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.yebeh.2015.07.041", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "dateOfRevision": "2015-10-07", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-10-01", "journal": {"medlineAbbreviation": "Epilepsy Behav", "isoabbreviation": "Epilepsy Behav", "title": "Epilepsy & behavior : E&B", "issn": "1525-5050", "nlmid": "100892858", "essn": "1525-5069"}, "monthOfPublication": 10, "volume": "51", "yearOfPublication": 2015, "journalIssueId": 2330069, "dateOfPublication": "2015 Oct"}}}, "SCARB1": {"27428740": {"pubYear": "2016", "dateOfCreation": "2016-07-18", "pubModel": "Print-Electronic", "authorString": "Stanislovaitiene D, Zaliuniene D, Krisciukaitis A, Petrolis R, Smalinskiene A, Lesauskaite V, Tamosiunas A, Lesauskaite V.", "affiliation": "a Department of Ophthalmology , Medicine Academy, Lithuanian University of Health Sciences , Kaunas , Lithuania.", "pubTypeList": {"pubType": ["Journal Article"]}, "id": "27428740", "inEPMC": "N", "authorList": {"author": [{"affiliation": "a Department of Ophthalmology , Medicine Academy, Lithuanian University of Health Sciences , Kaunas , Lithuania.", "fullName": "Stanislovaitiene D", "initials": "D", "firstName": "Daiva", "lastName": "Stanislovaitiene"}, {"affiliation": "a Department of Ophthalmology , Medicine Academy, Lithuanian University of Health Sciences , Kaunas , Lithuania.", "fullName": "Zaliuniene D", "initials": "D", "firstName": "Dalia", "lastName": "Zaliuniene"}, {"affiliation": "b Neuroscience Institute, Medicine Academy , Lithuanian University of Health Sciences , Kaunas , Lithuania.", "fullName": "Krisciukaitis A", "initials": "A", "firstName": "Algimantas", "lastName": "Krisciukaitis"}, {"affiliation": "b Neuroscience Institute, Medicine Academy , Lithuanian University of Health Sciences , Kaunas , Lithuania.", "fullName": "Petrolis R", "initials": "R", "firstName": "Robertas", "lastName": "Petrolis"}, {"affiliation": "c Institute of Cardiology, Medicine Academy, Lithuanian University of Health Sciences , Kaunas, Lithuania.", "fullName": "Smalinskiene A", "initials": "A", "firstName": "Alina", "lastName": "Smalinskiene"}, {"affiliation": "d Department of Geriatrics , Medicine Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.", "fullName": "Lesauskaite V", "initials": "V", "firstName": "Vita", "lastName": "Lesauskaite"}, {"affiliation": "c Institute of Cardiology, Medicine Academy, Lithuanian University of Health Sciences , Kaunas, Lithuania.", "fullName": "Tamosiunas A", "initials": "A", "firstName": "Abdonas", "lastName": "Tamosiunas"}, {"affiliation": "c Institute of Cardiology, Medicine Academy, Lithuanian University of Health Sciences , Kaunas, Lithuania.", "fullName": "Lesauskaite V", "initials": "V", "firstName": "Vaiva", "lastName": "Lesauskaite"}]}, "title": "SCARB1 rs5888 is associated with the risk of age-related macular degeneration susceptibility and an impaired macular area.", "citedByCount": 0, "source": "MED", "pmid": "27428740", "abstractText": "Age-related macular degeneration (ARMD), a progressive retinal disease, is responsible for an impaired central vision in about 180 million people worldwide. Current options for ARMD prevention and treatment are limited due to an incomplete understanding of disease etiopathogenesis. We aimed to test the hypothesis that the single nucleotide polymorphism rs5888 of SCARB1 gene reflecting lipid and antioxidant micronutrient metabolism pathways is associated with ARMD susceptibility and to evaluate if there is any relation between SCARB1 rs5888 and the macular lesion area.The prospective case-control study included patients with ARMD (n = 215) and the reference group (n = 238) drawn from a random sample of the Lithuanian population (n = 1436). The genotyping test of SCARB1 rs5888 was carried out using the real-time polymerase chain reaction method.Regression analysis adjusted by gender and age demonstrated that SCARB1 rs5888 TT genotype significantly decreased the odds for ARMD development (OR: 0.61, 95%; CI: 0.380-0.981, p = 0.04). A smoking habit and leading an outdoor life are associated with larger macular lesion areas in ARMD patients (0.54 (0.00-39.06) vs. 3.09 (0.02-19.30) and 0.27 (0.00-34.57) vs. 0.75 (0.00-39.06), respectively). In late stage ARMD subjects with CT genotype, the macular lesion area was larger than in TT carriers (7.64 (0.49-39.06) mm(2) vs. 5.02 (0.03-37.06) mm(2), p = 0.006).SCARB1 rs5888 and environmental oxidative stress have a prominent role in ARMD susceptibility, early ARMD progression to advanced stage disease and even in the outcome of the disease-an area of macular lesion.", "hasTextMinedTerms": "N", "hasPDF": "N", "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2016-07-18", "isOpenAccess": "N", "pageInfo": "1-5", "hasDbCrossReferences": "N", "keywordList": {"keyword": ["Oxidative stress", "Single Nucleotide Polymorphism (SNP)", "Scavenger Receptor Class B Type 1 Gene (Scarb1)", "Age-related Macular Degeneration (Armd)", "Area Of Macular Lesion"]}, "hasLabsLinks": "N", "electronicPublicationDate": "2016-07-18", "language": "eng", "dateOfRevision": "2016-07-18", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-07-01", "journal": {"medlineAbbreviation": "Ophthalmic Genet", "isoabbreviation": "Ophthalmic Genet.", "title": "Ophthalmic genetics", "issn": "1381-6810", "nlmid": "9436057", "essn": "1744-5094"}, "monthOfPublication": 7, "yearOfPublication": 2016, "journalIssueId": 2431138, "dateOfPublication": "2016 Jul"}}, "26563154": {"pubYear": "2015", "dateOfCreation": "2015-11-13", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Lipids"}, {"registryNumber": "0", "name": "Apolipoprotein A-I"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}, {"registryNumber": "0", "name": "Cholesterol, HDL"}]}, "authorString": "Niemsiri V, Wang X, Pirim D, Radwan ZH, Bunker CH, Barmada MM, Kamboh MI, Demirci FY.", "affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. vin4@pitt.edu.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL084613"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "HL044413"}]}, "hasPDF": "Y", "id": "26563154", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. vin4@pitt.edu.", "fullName": "Niemsiri V", "initials": "V", "firstName": "Vipavee", "lastName": "Niemsiri"}, {"affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. xbw1@pitt.edu.", "fullName": "Wang X", "initials": "X", "firstName": "Xingbin", "lastName": "Wang"}, {"affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. dip16@pitt.edu.", "fullName": "Pirim D", "initials": "D", "firstName": "Dilek", "lastName": "Pirim"}, {"affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. zhr2@pitt.edu.", "fullName": "Radwan ZH", "initials": "ZH", "firstName": "Zaheda H", "lastName": "Radwan"}, {"affiliation": "Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. bunkerc@pitt.edu.", "fullName": "Bunker CH", "initials": "CH", "firstName": "Clareann H", "lastName": "Bunker"}, {"firstName": "M Michael", "lastName": "Barmada", "affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. barmada@pitt.edu.", "authorId": {"type": "ORCID", "value": "0000-0002-3604-6460"}, "fullName": "Barmada MM", "initials": "MM"}, {"firstName": "M Ilyas", "lastName": "Kamboh", "affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. kamboh@pitt.edu.", "authorId": {"type": "ORCID", "value": "0000-0002-3453-1438"}, "fullName": "Kamboh MI", "initials": "MI"}, {"firstName": "F Yesim", "lastName": "Demirci", "affiliation": "Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA, 15261, USA. fyd1@pitt.edu.", "authorId": {"type": "ORCID", "value": "0000-0001-6907-9843"}, "fullName": "Demirci FY", "initials": "FY"}]}, "title": "Genetic contribution of SCARB1 variants to lipid traits in African Blacks: a candidate gene association study.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26563154", "abstractText": "High-density lipoprotein cholesterol (HDL-C) exerts many anti-atherogenic properties including its role in reverse cholesterol transport (RCT). Scavenger receptor class B member 1 (SCARB1) plays a key role in RCT by selective uptake of HDL cholesteryl esters. We aimed to explore the genetic contribution of SCARB1 to affecting lipid levels in African Blacks from Nigeria.We resequenced 13 exons and exon-intron boundaries of SCARB1 in 95 individuals with extreme HDL-C levels using Sanger method. Then, we genotyped 147 selected variants (78 sequence variants, 69 HapMap tagSNPs, and 2 previously reported relevant variants) in the entire sample of 788 African Blacks using either the iPLEX Gold or TaqMan methods. A total of 137 successfully genotyped variants were further evaluated for association with major lipid traits.The initial gene-based analysis demonstrated evidence of association with HDL-C and apolipoprotein A-I (ApoA-I). The follow-up single-site analysis revealed nominal evidence of novel associations of nine common variants with HDL-C and/or ApoA-I (P < 0.05). The strongest association was between rs11057851 and HDL-C (P = 0.0043), which remained significant after controlling for multiple testing using false discovery rate. Rare variant association testing revealed a group of 23 rare variants (frequencies \u2264 1%) associated with HDL-C (P = 0.0478). Haplotype analysis identified four SCARB1 regions associated with HDL-C (global P < 0.05).To our knowledge, this is the first report of a comprehensive association study of SCARB1 variations with lipid traits in an African Black population. Our results showed the consistent association of SCARB1 variants with HDL-C across various association analyses, supporting the role of SCARB1 in lipoprotein-lipid regulatory mechanism.", "tmAccessionTypeList": {"accessionType": ["omim", " refsnp", " refseq", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3604-6460"}, {"type": "ORCID", "value": "0000-0002-3453-1438"}, {"type": "ORCID", "value": "0000-0001-6907-9843"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Lipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Apolipoprotein A-I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Linear Models", "majorTopic_YN": "N"}, {"descriptorName": "Sequence Analysis, DNA", "majorTopic_YN": "N"}, {"descriptorName": "Gene Frequency", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Haplotypes", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "African Continental Ancestry Group", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nigeria", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cholesterol, HDL", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "Y"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Genetic Association Studies", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2015-11-12", "language": "eng", "doi": "10.1186/s12881-015-0250-6", "isOpenAccess": "Y", "pageInfo": "106", "pmcid": "PMC4643515", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "electronicPublicationDate": "2015-11-12", "license": "cc by", "dateOfCompletion": "2016-04-01", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4643515?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4643515", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s12881-015-0250-6", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-11-16", "hasBook": "N", "journalInfo": {"printPublicationDate": "2015-01-01", "journal": {"title": "BMC medical genetics", "medlineAbbreviation": "BMC Med Genet", "isoabbreviation": "BMC Med. Genet.", "nlmid": "100968552", "essn": "1471-2350"}, "monthOfPublication": 0, "volume": "16", "yearOfPublication": 2015, "journalIssueId": 2295060, "dateOfPublication": "2015 "}}, "17183097": {"pubYear": "2007", "dateOfCreation": "2006-12-21", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "50-99-7", "name": "Glucose"}, {"registryNumber": "0", "name": "Fatty Acids, Nonesterified"}, {"registryNumber": "0", "name": "Fats"}, {"registryNumber": "EC 1.14.99.-", "name": "Fatty Acid Desaturases"}, {"registryNumber": "0", "name": "Linoleic Acids, Conjugated"}]}, "authorString": "Odens LJ, Burgos R, Innocenti M, VanBaale MJ, Baumgard LH.", "affiliation": "The Department of Animal Sciences, University of Arizona, Tucson 85721, USA.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "17183097", "inEPMC": "N", "authorList": {"author": [{"lastName": "Odens", "fullName": "Odens LJ", "initials": "LJ"}, {"lastName": "Burgos", "fullName": "Burgos R", "initials": "R"}, {"lastName": "Innocenti", "fullName": "Innocenti M", "initials": "M"}, {"lastName": "VanBaale", "fullName": "VanBaale MJ", "initials": "MJ"}, {"lastName": "Baumgard", "fullName": "Baumgard LH", "initials": "LH"}]}, "title": "Effects of varying doses of supplemental conjugated linoleic acid on production and energetic variables during the transition period.", "citedByCount": 13, "source": "MED", "pmid": "17183097", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Milk", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "SE", "qualifierName": "secretion", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Cattle", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Fatty Acid Desaturases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Glucose", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fats", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Fatty Acids, Nonesterified", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Linoleic Acids, Conjugated", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Random Allocation", "majorTopic_YN": "N"}, {"descriptorName": "Energy Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Lactation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Pregnancy", "majorTopic_YN": "N"}, {"descriptorName": "Time Factors", "majorTopic_YN": "N"}, {"descriptorName": "Dietary Supplements", "majorTopic_YN": "Y"}, {"descriptorName": "Female", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2007-01-01", "doi": "10.3168/jds.s0022-0302(07)72630-9", "isOpenAccess": "N", "pageInfo": "293-305", "hasDbCrossReferences": "N", "abstractText": "Supplementing a high dose of dietary conjugated linoleic acid (CLA) inhibits milk fat synthesis in dairy cows immediately postpartum. During negative net energy balance (EBAL), it appears that moderate CLA-induced milk fat depression causes a positive response in milk yield; however, as milk fat depression becomes more severe, the milk yield response diminishes. Multiparous Holstein cows (n = 31) were randomly assigned to 1 of 3 treatments beginning 9 +/- 6 d before expected calving and ceased at 40 d in milk (DIM): 1) 578 g/d of a rumen-inert (RI) palm fatty acid distillate (control), 2) 600 g/d of RI-CLA for the entire trial period (CLA-1), and 3) 600 g/d of RI-CLA until 10 DIM followed by 200 g/d for the remainder of the trial (CLA-2). Each dose provided equal amounts of fatty acids by replacing and balancing each treatment with a RI palm fatty acid distillate. Doses provided a total of 522 g of fatty acids/ d and 0, 174, or 58 (depending upon DIM) g of CLA (mixed isomers)/d. To improve palatability, doses were mixed with 600 g/d of dried molasses; one-half of the supplement was fed at 0800 h, and the remainder at 1900 h. Individual milk yield, dry matter intake, and body weight were recorded daily and milk composition determined every other day. There was no overall CLA effect on either the content or yield of milk protein or lactose. Both CLA treatments decreased overall milk fat content (26.0 and 18.3%) and yield (22.5 and 17.3%) with CLA-induced milk fat depression becoming significant by d 8. The CLA-induced milk fat depression increased in magnitude with progressing DIM until reaching a plateau on d 18 for CLA-1 (43%) and on d 14 for CLA-2 (33%), although neither milk fat trans-10, cis-12 CLA content (1.8 mg/g) nor its transfer efficiency (6.3%) changed over time. Treatments had no effect on overall dry matter intake or milk yield, but there was a treatment x time interaction for milk production, as cows fed either CLA treatment had increased milk yield after the second week of lactation. Cows fed either CLA treatment had a significant improvement in overall EBAL (-5.1 vs. -1.8 Mcal/d), a decrease in nonesterified fatty acid levels (12%), and an increase in glucose levels (11%). A dietary supplement containing trans-10, cis-12 CLA markedly improves EBAL and bioenergetic variables and increases milk yield in the total mixed ration-fed transitioning dairy cow.", "language": "eng", "dateOfCompletion": "2008-09-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.3168/jds.S0022-0302(07)72630-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2007-01-01", "journal": {"medlineAbbreviation": "J Dairy Sci", "isoabbreviation": "J. Dairy Sci.", "title": "Journal of dairy science", "issn": "0022-0302", "nlmid": "2985126R", "essn": "1525-3198"}, "monthOfPublication": 1, "volume": "90", "yearOfPublication": 2007, "journalIssueId": 1367930, "issue": "1", "dateOfPublication": "2007 Jan"}}, "23562302": {"pubYear": "2013", "dateOfCreation": "2013-08-06", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Lipoproteins"}, {"registryNumber": "0", "name": "Xanthophylls"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}, {"registryNumber": "X72A60C9MT", "name": "Lutein"}, {"registryNumber": "0", "name": "Zeaxanthins"}]}, "authorString": "McKay GJ, Loane E, Nolan JM, Patterson CC, Meyers KJ, Mares JA, Yonova-Doing E, Hammond CJ, Beatty S, Silvestri G.", "affiliation": "Centre for Public Health, Royal Victoria Hospital, Queen's University Belfast, Belfast, Northern Ireland. g.j.mckay@qub.ac.uk", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "1R01EY018246"}, {"orderIn": 0, "agency": "Economic and Social Research Council", "grantId": "ES/G007438/1"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY013018"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "U10 EY013018"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY016886"}, {"orderIn": 0, "agency": "Department of Health", "grantId": "SRF/01/010"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY016886"}]}, "hasPDF": "Y", "id": "23562302", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Centre for Public Health, Royal Victoria Hospital, Queen's University Belfast, Belfast, Northern Ireland. g.j.mckay@qub.ac.uk", "fullName": "McKay GJ", "initials": "GJ", "firstName": "Gareth J", "lastName": "McKay"}, {"lastName": "Loane", "fullName": "Loane E", "firstName": "Edward", "initials": "E"}, {"lastName": "Nolan", "fullName": "Nolan JM", "authorId": {"type": "ORCID", "value": "0000-0002-5503-7084"}, "firstName": "John M", "initials": "JM"}, {"lastName": "Patterson", "fullName": "Patterson CC", "firstName": "Christopher C", "initials": "CC"}, {"lastName": "Meyers", "fullName": "Meyers KJ", "firstName": "Kristin J", "initials": "KJ"}, {"lastName": "Mares", "fullName": "Mares JA", "firstName": "Julie A", "initials": "JA"}, {"lastName": "Yonova-Doing", "fullName": "Yonova-Doing E", "firstName": "Ekaterina", "initials": "E"}, {"lastName": "Hammond", "fullName": "Hammond CJ", "authorId": {"type": "ORCID", "value": "0000-0002-3227-2620"}, "firstName": "Christopher J", "initials": "CJ"}, {"lastName": "Beatty", "fullName": "Beatty S", "firstName": "Stephen", "initials": "S"}, {"lastName": "Silvestri", "fullName": "Silvestri G", "firstName": "Giuliana", "initials": "G"}]}, "title": "Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids.", "hasSuppl": "N", "citedByCount": 4, "source": "MED", "pmid": "23562302", "abstractText": "OBJECTIVE: To investigate association of scavenger receptor class B, member 1 (SCARB1) genetic variants with serum carotenoid levels of lutein (L) and zeaxanthin (Z) and macular pigment optical density (MPOD). DESIGN: A cross-sectional study of healthy adults aged 20 to 70. PARTICIPANTS: We recruited 302 participants after local advertisement. METHODS: We measured MPOD by customized heterochromatic flicker photometry. Fasting blood samples were taken for serum L and Z measurement by high-performance liquid chromatography and lipoprotein analysis by spectrophotometric assay. Forty-seven single nucleotide polymorphisms (SNPs) across SCARB1 were genotyped using Sequenom technology. Association analyses were performed using PLINK to compare allele and haplotype means, with adjustment for potential confounding and correction for multiple comparisons by permutation testing. Replication analysis was performed in the TwinsUK and Carotenoids in Age-Related Eye Disease Study (CAREDS) cohorts. MAIN OUTCOME MEASURES: Odds ratios for MPOD area, serum L and Z concentrations associated with genetic variations in SCARB1 and interactions between SCARB1 and gender. RESULTS: After multiple regression analysis with adjustment for age, body mass index, gender, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, smoking, and dietary L and Z levels, 5 SNPs were significantly associated with serum L concentration and 1 SNP with MPOD (P<0.01). Only the association between rs11057841 and serum L withstood correction for multiple comparisons by permutation testing (P<0.01) and replicated in the TwinsUK cohort (P = 0.014). Independent replication was also observed in the CAREDS cohort with rs10846744 (P = 2\u00d710(-4)), an SNP in high linkage disequilibrium with rs11057841 (r(2) = 0.93). No interactions by gender were found. Haplotype analysis revealed no stronger association than obtained with single SNP analyses. CONCLUSIONS: Our study has identified association between rs11057841 and serum L concentration (24% increase per T allele) in healthy subjects, independent of potential confounding factors. Our data supports further evaluation of the role for SCARB1 in the transport of macular pigment and the possible modulation of age-related macular degeneration risk through combating the effects of oxidative stress within the retina. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosures may be found after the references.", "tmAccessionTypeList": {"accessionType": ["refsnp", " omim", " "]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-5503-7084"}, {"type": "ORCID", "value": "0000-0002-3227-2620"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Retina", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Xanthophylls", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lutein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lipoproteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromatography, High Pressure Liquid", "majorTopic_YN": "N"}, {"descriptorName": "Photometry", "majorTopic_YN": "N"}, {"descriptorName": "Cross-Sectional Studies", "majorTopic_YN": "N"}, {"descriptorName": "Visual Acuity", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Single Nucleotide", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Variation", "majorTopic_YN": "Y"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}, {"descriptorName": "Genotyping Techniques", "majorTopic_YN": "N"}, {"descriptorName": "Zeaxanthins", "majorTopic_YN": "N"}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2013-04-05", "doi": "10.1016/j.ophtha.2013.01.030", "isOpenAccess": "N", "pageInfo": "1632-1640", "pmcid": "PMC3946979", "hasDbCrossReferences": "Y", "hasLabsLinks": "N", "electronicPublicationDate": "2013-04-05", "language": "eng", "dateOfCompletion": "2013-11-06", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3946979?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3946979", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23562302", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23562302&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1016/j.ophtha.2013.01.030", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2014-12-06", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-08-01", "journal": {"medlineAbbreviation": "Ophthalmology", "isoabbreviation": "Ophthalmology", "title": "Ophthalmology", "issn": "0161-6420", "nlmid": "7802443", "essn": "1549-4713"}, "monthOfPublication": 8, "volume": "120", "yearOfPublication": 2013, "journalIssueId": 2063487, "issue": "8", "dateOfPublication": "2013 Aug"}}, "17205118": {"pubYear": "2006", "dateOfCreation": "2007-01-05", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "RNA, Messenger"}, {"registryNumber": "0", "name": "Calmodulin"}, {"registryNumber": "97C5T2UQ7J", "name": "Cholesterol"}]}, "authorString": "Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, Lowe R, Huestis MA, Hyde TM, Kleinman JE, Freed WJ.", "affiliation": "Cellular Neurobiology Research Branch and Chemistry and Drug Metabolism Section, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America. elehrman@intra.nida.nih.gov", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Intramural"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Intramural NIH HHS"}]}, "hasPDF": "Y", "id": "17205118", "inEPMC": "Y", "authorList": {"author": [{"firstName": "Elin", "lastName": "Lehrmann", "affiliation": "Cellular Neurobiology Research Branch and Chemistry and Drug Metabolism Section, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America. elehrman@intra.nida.nih.gov", "authorId": {"type": "ORCID", "value": "0000-0002-9869-9475"}, "fullName": "Lehrmann E", "initials": "E"}, {"lastName": "Colantuoni", "fullName": "Colantuoni C", "firstName": "Carlo", "initials": "C"}, {"lastName": "Deep-Soboslay", "fullName": "Deep-Soboslay A", "firstName": "Amy", "initials": "A"}, {"lastName": "Becker", "fullName": "Becker KG", "authorId": {"type": "ORCID", "value": "0000-0002-6794-6656"}, "firstName": "Kevin G", "initials": "KG"}, {"lastName": "Lowe", "fullName": "Lowe R", "firstName": "Ross", "initials": "R"}, {"lastName": "Huestis", "fullName": "Huestis MA", "firstName": "Marilyn A", "initials": "MA"}, {"lastName": "Hyde", "fullName": "Hyde TM", "firstName": "Thomas M", "initials": "TM"}, {"lastName": "Kleinman", "fullName": "Kleinman JE", "firstName": "Joel E", "initials": "JE"}, {"lastName": "Freed", "fullName": "Freed WJ", "firstName": "William J", "initials": "WJ"}]}, "title": "Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.", "hasSuppl": "Y", "citedByCount": 18, "source": "MED", "pmid": "17205118", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-9869-9475"}, {"type": "ORCID", "value": "0000-0002-6794-6656"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Prefrontal Cortex", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endoplasmic Reticulum", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Golgi Apparatus", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Cocaine-Related Disorders", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Marijuana Abuse", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phencyclidine Abuse", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cholesterol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calmodulin", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "RNA, Messenger", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Autopsy", "majorTopic_YN": "N"}, {"descriptorName": "Oligonucleotide Array Sequence Analysis", "majorTopic_YN": "N"}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Polymerase Chain Reaction", "majorTopic_YN": "N"}, {"descriptorName": "Transcription, Genetic", "majorTopic_YN": "Y"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Lipid Metabolism", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2006-12-27", "doi": "10.1371/journal.pone.0000114", "isOpenAccess": "Y", "pageInfo": "e114", "pmcid": "PMC1762434", "hasDbCrossReferences": "N", "abstractText": "A major goal of drug abuse research is to identify and understand drug-induced changes in brain function that are common to many or all drugs of abuse. As these may underlie drug dependence and addiction, the purpose of the present study was to examine if different drugs of abuse effect changes in gene expression that converge in common molecular pathways. Microarray analysis was employed to assay brain gene expression in postmortem anterior prefrontal cortex (aPFC) from 42 human cocaine, cannabis and/or phencyclidine abuse cases and 30 control cases, which were characterized by toxicology and drug abuse history. Common transcriptional changes were demonstrated for a majority of drug abuse cases (N = 34), representing a number of consistently changed functional classes: Calmodulin-related transcripts (CALM1, CALM2, CAMK2B) were decreased, while transcripts related to cholesterol biosynthesis and trafficking (FDFT1, APOL2, SCARB1), and Golgi/endoplasmic reticulum (ER) functions (SEMA3B, GCC1) were all increased. Quantitative PCR validated decreases in calmodulin 2 (CALM2) mRNA and increases in apolipoprotein L, 2 (APOL2) and semaphorin 3B (SEMA3B) mRNA for individual cases. A comparison between control cases with and without cardiovascular disease and elevated body mass index indicated that these changes were not due to general cellular and metabolic stress, but appeared specific to the use of drugs. Therefore, humans who abused cocaine, cannabis and/or phencyclidine share a decrease in transcription of calmodulin-related genes and increased transcription related to lipid/cholesterol and Golgi/ER function. These changes represent common molecular features of drug abuse, which may underlie changes in synaptic function and plasticity that could have important ramifications for decision-making capabilities in drug abusers.", "electronicPublicationDate": "2006-12-27", "language": "eng", "dateOfCompletion": "2010-03-16", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC1762434?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC1762434", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0000114", "documentStyle": "doi", "availability": "Open access", "availabilityCode": "OA", "site": "PLOS"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2015-08-13", "hasBook": "N", "journalInfo": {"printPublicationDate": "2006-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "1", "yearOfPublication": 2006, "journalIssueId": 1369502, "dateOfPublication": "2006 "}}, "22792172": {"pubYear": "2012", "dateOfCreation": "2012-07-13", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "7440-70-2", "name": "Calcium"}, {"registryNumber": "10102-43-9", "name": "Nitric Oxide"}, {"registryNumber": "67763-96-6", "name": "Insulin-Like Growth Factor I"}, {"registryNumber": "0", "name": "Vascular Endothelial Growth Factor A"}, {"registryNumber": "0", "name": "Cadherins"}, {"registryNumber": "96314-98-6", "name": "Fura-2"}, {"registryNumber": "0", "name": "Insulin-Like Growth Factor Binding Protein 3"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "EC 1.14.13.39", "name": "Nitric Oxide Synthase Type III"}, {"registryNumber": "EC 2.7.11.1", "name": "Proto-Oncogene Proteins c-akt"}, {"registryNumber": "EC 2.7.1.-", "name": "Phosphatidylinositol 3-Kinases"}, {"registryNumber": "0", "name": "Claudin-5"}]}, "authorString": "Jarajapu YP, Cai J, Yan Y, Li Calzi S, Kielczewski JL, Hu P, Shaw LC, Firth SM, Chan-Ling T, Boulton ME, Baxter RC, Grant MB.", "affiliation": "Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida, United States of America.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY007739"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "EY012601"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY007739"}, {"acronym": "TR", "orderIn": 0, "agency": "NCATS NIH HHS", "grantId": "UL1 TR000064"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY018358"}, {"acronym": "HL", "orderIn": 0, "agency": "NHLBI NIH HHS", "grantId": "U01 HL087366"}, {"acronym": "EY", "orderIn": 0, "agency": "NEI NIH HHS", "grantId": "R01 EY012601"}]}, "hasPDF": "Y", "id": "22792172", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Jarajapu", "fullName": "Jarajapu YP", "firstName": "Yagna P R", "initials": "YP"}, {"lastName": "Cai", "fullName": "Cai J", "firstName": "Jun", "initials": "J"}, {"lastName": "Yan", "fullName": "Yan Y", "firstName": "Yuanqing", "initials": "Y"}, {"lastName": "Li Calzi", "fullName": "Li Calzi S", "firstName": "Sergio", "initials": "S"}, {"lastName": "Kielczewski", "fullName": "Kielczewski JL", "firstName": "Jennifer L", "initials": "JL"}, {"lastName": "Hu", "fullName": "Hu P", "firstName": "Ping", "initials": "P"}, {"lastName": "Shaw", "fullName": "Shaw LC", "firstName": "Lynn C", "initials": "LC"}, {"lastName": "Firth", "fullName": "Firth SM", "firstName": "Sue M", "initials": "SM"}, {"lastName": "Chan-Ling", "fullName": "Chan-Ling T", "authorId": {"type": "ORCID", "value": "0000-0002-8225-3671"}, "firstName": "Tailoi", "initials": "T"}, {"lastName": "Boulton", "fullName": "Boulton ME", "firstName": "Michael E", "initials": "ME"}, {"lastName": "Baxter", "fullName": "Baxter RC", "authorId": {"type": "ORCID", "value": "0000-0001-5061-2142"}, "firstName": "Robert C", "initials": "RC"}, {"lastName": "Grant", "fullName": "Grant MB", "firstName": "Maria B", "initials": "MB"}]}, "title": "Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.", "hasSuppl": "N", "citedByCount": 12, "source": "MED", "pmid": "22792172", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-8225-3671"}, {"type": "ORCID", "value": "0000-0001-5061-2142"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Blood-Retinal Barrier", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Cerebral Arteries", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Retinal Vessels", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intercellular Junctions", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Endothelial Cells", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Rats", "majorTopic_YN": "N"}, {"descriptorName": "Rats, Sprague-Dawley", "majorTopic_YN": "N"}, {"descriptorName": "Retinal Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Neovascularization, Pathologic", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Calcium", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nitric Oxide", "majorTopic_YN": "N"}, {"descriptorName": "Fura-2", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DU", "qualifierName": "diagnostic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Vascular Endothelial Growth Factor A", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Insulin-Like Growth Factor I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Insulin-Like Growth Factor Binding Protein 3", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cadherins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Signal Transduction", "majorTopic_YN": "N"}, {"descriptorName": "Protein Binding", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Proto-Oncogene Proteins c-akt", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Nitric Oxide Synthase Type III", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AI", "qualifierName": "antagonists & inhibitors", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Phosphatidylinositol 3-Kinases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Claudin-5", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2012-07-06", "doi": "10.1371/journal.pone.0039398", "isOpenAccess": "Y", "pageInfo": "e39398", "pmcid": "PMC3391198", "hasDbCrossReferences": "Y", "abstractText": "Previously, we showed that insulin growth factor (IGF)-1 binding protein-3 (IGFBP-3), independent of IGF-1, reduces pathological angiogenesis in a mouse model of the oxygen-induced retinopathy (OIR). The current study evaluates novel endothelium-dependent functions of IGFBP-3 including blood retinal barrier (BRB) integrity and vasorelaxation. To evaluate vascular barrier function, either plasmid expressing IGFBP-3 under the regulation of an endothelial-specific promoter or a control plasmid was injected into the vitreous humor of mouse pups (P1) and compared to the non-injected eyes of the same pups undergoing standard OIR protocol. Prior to sacrifice, the mice were given an injection of horseradish peroxidase (HRP). IGFBP-3 plasmid-injected eyes displayed near-normal vessel morphology and enhanced vascular barrier function. Further, in vitro IGFBP-3 protects retinal endothelial cells from VEGF-induced loss of junctional integrity by antagonizing the dissociation of the junctional complexes. To assess the vasodilatory effects of IGFBP-3, rat posterior cerebral arteries were examined in vitro. Intraluminal IGFBP-3 decreased both pressure- and serotonin-induced constrictions by stimulating nitric oxide (NO) release that were blocked by L-NAME or scavenger receptor-B1 neutralizing antibody (SRB1-Ab). Both wild-type and IGF-1-nonbinding mutant IGFBP-3 (IGFBP-3NB) stimulated eNOS activity/NO release to a similar extent in human microvascular endothelial cells (HMVECs). NO release was neither associated with an increase in intracellular calcium nor decreased by Ca(2+)/calmodulin-dependent protein kinase II (CamKII) blockade; however, dephosphorylation of eNOS-Thr(495) was observed. Phosphatidylinositol 3-kinase (PI3K) activity and Akt-Ser(473) phosphorylation were both increased by IGFBP-3 and selectively blocked by the SRB1-Ab or PI3K blocker LY294002. In conclusion, IGFBP-3 mediates protective effects on BRB integrity and mediates robust NO release to stimulate vasorelaxation via activation of SRB1. This response is IGF-1- and calcium-independent, but requires PI3K/Akt activation, suggesting that IGFBP-3 has novel protective effects on retinal and systemic vasculature and may be a therapeutic candidate for ocular complications such as diabetic retinopathy.", "electronicPublicationDate": "2012-07-06", "language": "eng", "dateOfCompletion": "2013-03-19", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3391198?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3391198", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=22792172&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=22792172", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0039398", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-12", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "7", "yearOfPublication": 2012, "journalIssueId": 1947059, "issue": "7", "dateOfPublication": "2012 "}}, "20510150": {"pubYear": "2010", "dateOfCreation": "2010-05-31", "pubModel": "Print", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "PLEKHA1 protein, human"}, {"registryNumber": "0", "name": "Membrane Proteins"}, {"registryNumber": "0", "name": "Proteins"}, {"registryNumber": "80295-65-4", "name": "Complement Factor H"}, {"registryNumber": "0", "name": "Intracellular Signaling Peptides and Proteins"}, {"registryNumber": "0", "name": "Angiogenesis Inhibitors"}, {"registryNumber": "0", "name": "complement factor H, human"}, {"registryNumber": "0", "name": "ABCA4 protein, human"}, {"registryNumber": "EC 3.4.21.-", "name": "Serine Endopeptidases"}, {"registryNumber": "0", "name": "Apolipoprotein E4"}, {"registryNumber": "0", "name": "ARMS2 protein, human"}, {"registryNumber": "EC 3.4.21.-", "name": "HtrA1 protein, human"}]}, "authorString": "Leveziel N, Puche N, Zerbib J, Benlian P, Coscas G, Soubrane G, Souied E.", "affiliation": "h\u00f4pital intercommunal de Cr\u00e9teil, avenue de Verdun, Cr\u00e9teil, France. nicolas.leveziel@yahoo.fr", "pubTypeList": {"pubType": ["Journal Article", "Review", "English Abstract"]}, "hasPDF": "N", "id": "20510150", "inEPMC": "N", "authorList": {"author": [{"lastName": "Leveziel", "fullName": "Leveziel N", "firstName": "Nicolas", "initials": "N"}, {"lastName": "Puche", "fullName": "Puche N", "firstName": "Nathalie", "initials": "N"}, {"lastName": "Zerbib", "fullName": "Zerbib J", "firstName": "Jennyfer", "initials": "J"}, {"lastName": "Benlian", "fullName": "Benlian P", "authorId": {"type": "ORCID", "value": "0000-0002-3423-8979"}, "firstName": "Pascale", "initials": "P"}, {"lastName": "Coscas", "fullName": "Coscas G", "firstName": "Gabriel", "initials": "G"}, {"lastName": "Soubrane", "fullName": "Soubrane G", "firstName": "Gis\u00e8le", "initials": "G"}, {"lastName": "Souied", "fullName": "Souied E", "firstName": "Eric", "initials": "E"}]}, "title": "[Genetic factors associated with age-related macular degeneration].", "citedByCount": 3, "source": "MED", "pmid": "20510150", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3423-8979"}, {"type": "ORCID", "value": "0000-0001-8533-9457"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Chromosomes, Human, Pair 1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Chromosomes, Human, Pair 10", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "N"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Obesity", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "EP", "qualifierName": "epidemiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "N"}, {"descriptorName": "Serine Endopeptidases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Angiogenesis Inhibitors", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Intracellular Signaling Peptides and Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Complement Factor H", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Membrane Proteins", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Smoking", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}]}}, {"descriptorName": "Age Factors", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Phenotype", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Apolipoprotein E4", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Clinical Trials as Topic", "majorTopic_YN": "N"}, {"descriptorName": "Meta-Analysis as Topic", "majorTopic_YN": "N"}, {"descriptorName": "Multicenter Studies as Topic", "majorTopic_YN": "N"}]}, "inPMC": "N", "hasTMAccessionNumbers": "N", "hasReferences": "N", "firstPublicationDate": "2010-05-01", "doi": "10.1051/medsci/2010265509", "isOpenAccess": "N", "pageInfo": "509-515", "hasDbCrossReferences": "N", "abstractText": "Age related macular degeneration (AMD) is the leading cause of vision loss in the elderly in developed countries. Genetic factors play a major role in this multifactorial and polygenic disease. Genomewide analysis identified two loci on 1q25-31 and 10q26 chromosomes associated with AMD, and association studies highlighted the implication of SNPs located in the complement H factor gene (CFH) on 1q25-31 and in PLEKHA1-HTRA1-LOC387715 on 10q26 in the disease. Homozygous carriers for the at-risk alleles of the CFH, HTRA1, and LOC387715 genes have an increased risk to develop exudative AMD with odds ratio of 6.2, 6.9, et 7.3 respectively. Moreover, other genes involved in the complement cascade, namely the genes of the C2, C3 component, and factor B, are associated to the disease. The SCARB1 gene has also recently been associated to AMD. Genotype-phenotype correlations have been performed in AMD patients and found that occult CNV are more often associated to CFH at-risk allele and classic CNV to HTRA1 at-risk allele. This last allele seems also linked to more severe forms of the disease. These new major genetic factors could lead to a new clinical approach of AMD and to the discovery of new therapeutic targets.", "language": "fre", "dateOfCompletion": "2010-08-11", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1051/medsci/2010265509", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-05-01", "journal": {"medlineAbbreviation": "Med Sci (Paris)", "isoabbreviation": "Med Sci (Paris)", "title": "Medecine sciences : M/S", "issn": "0767-0974", "nlmid": "8710980", "essn": "1958-5381"}, "monthOfPublication": 5, "volume": "26", "yearOfPublication": 2010, "journalIssueId": 1734640, "issue": "5", "dateOfPublication": "2010 May"}}, "21076037": {"pubYear": "2010", "dateOfCreation": "2010-12-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Scarb1 protein, mouse"}, {"registryNumber": "0", "name": "Amyloid"}, {"registryNumber": "0", "name": "Apolipoprotein A-I"}, {"registryNumber": "0", "name": "Apolipoproteins E"}, {"registryNumber": "0", "name": "Amyloid beta-Protein Precursor"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}]}, "authorString": "Thanopoulou K, Fragkouli A, Stylianopoulou F, Georgopoulos S.", "affiliation": "Department of Cell Biology, Biomedical Research Foundation, Academy of Athens, 115 27 Athens, Greece.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "21076037", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Thanopoulou", "fullName": "Thanopoulou K", "firstName": "Kalliopi", "initials": "K"}, {"lastName": "Fragkouli", "fullName": "Fragkouli A", "firstName": "Apostolia", "initials": "A"}, {"lastName": "Stylianopoulou", "fullName": "Stylianopoulou F", "firstName": "Fotini", "initials": "F"}, {"lastName": "Georgopoulos", "fullName": "Georgopoulos S", "firstName": "Spiros", "initials": "S"}]}, "title": "Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.", "hasSuppl": "Y", "citedByCount": 25, "source": "MED", "pmid": "21076037", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Blood Vessels", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Brain", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BS", "qualifierName": "blood supply", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"descriptorName": "Astrocytes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Microglia", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Macrophages", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Mice", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Disease Models, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Amyloid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Amyloid beta-Protein Precursor", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apolipoprotein A-I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apolipoproteins E", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Behavior, Animal", "majorTopic_YN": "N"}, {"descriptorName": "Phagocytosis", "majorTopic_YN": "N"}, {"descriptorName": "Protein Processing, Post-Translational", "majorTopic_YN": "N"}, {"descriptorName": "Protein Transport", "majorTopic_YN": "N"}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Plaque, Amyloid", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2010-11-12", "doi": "10.1073/pnas.1005888107", "isOpenAccess": "N", "pageInfo": "20816-20821", "pmcid": "PMC2996412", "hasDbCrossReferences": "Y", "abstractText": "Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein receptor that regulates cholesterol efflux from the peripheral tissues to the liver. SR-BI has been identified on astrocytes and vascular smooth muscle cells in Alzheimer's disease brain and has been shown to mediate adhesion of microglia to fibrillar amyloid-\u03b2 (A\u03b2). Here we report that SR-BI mediates perivascular macrophage response and regulates A\u03b2-related pathology and cerebral amyloid angiopathy in an Alzheimer's mouse model. Reduction or deletion of SR-BI gene in heterozygous or homozygous deficient mice (SR-BI(+/-), (-/-)) resulted in a significant increase in perivascular macrophages in the brain. SR-BI deletion had no effect on apolipoprotein E or apolipoprotein AI levels in the mouse brain. Our analysis revealed increased levels of SR-BI expression in the brains of human amyloid precursor protein (Swedish, Indiana) transgenic mice (J20 line). To evaluate the role of SR-BI in Alzheimer's disease pathogenesis, we inactivated one SR-BI allele in J20 transgenic mice. SR-BI reduction in J20/SR-BI(+/-) mice enhanced fibrillar amyloid deposition and cerebral amyloid angiopathy and also exacerbated learning and memory deficits compared with J20 littermates. Immunohistochemical analysis revealed localization of SR-BI on perivascular macrophages in tight association with A\u03b2 deposits. Our data suggest that SR-BI reduction impairs the response of perivascular macrophages to A\u03b2 and enhances the A\u03b2-related phenotype and cerebral amyloid angiopathy in J20 mice. These results reveal that SR-BI, a scavenger receptor primarily involved in high-density lipoprotein cholesterol transport, plays an essential role in Alzheimer's disease and cerebral amyloid angiopathy.", "electronicPublicationDate": "2010-11-12", "language": "eng", "dateOfCompletion": "2011-01-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2996412?pdf=render", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2996412", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=21076037", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=21076037&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pnas.org/cgi/reprint/107/48/20816.pdf", "documentStyle": "pdf", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/content/abstract/107/48/20816", "documentStyle": "abs", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://www.pnas.org/cgi/content/full/107/48/20816", "documentStyle": "html", "availability": "Free after 6 months", "availabilityCode": "F6", "site": "www.pnas.org"}, {"url": "http://dx.doi.org/10.1073/pnas.1005888107", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-07-03", "hasBook": "N", "journalInfo": {"printPublicationDate": "2010-11-01", "journal": {"medlineAbbreviation": "Proc Natl Acad Sci U S A", "isoabbreviation": "Proc. Natl. Acad. Sci. U.S.A.", "title": "Proceedings of the National Academy of Sciences of the United States of America", "issn": "0027-8424", "nlmid": "7505876", "essn": "1091-6490"}, "monthOfPublication": 11, "volume": "107", "yearOfPublication": 2010, "journalIssueId": 1786995, "issue": "48", "dateOfPublication": "2010 Nov"}}, "19806217": {"pubYear": "2009", "dateOfCreation": "2009-10-06", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "Lipids"}, {"registryNumber": "127-40-2", "name": "Lutein"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}]}, "authorString": "Zerbib J, Seddon JM, Richard F, Reynolds R, Leveziel N, Benlian P, Borel P, Feingold J, Munnich A, Soubrane G, Kaplan J, Rozet JM, Souied EH.", "affiliation": "Creteil University Eye Clinic, Faculte de Medecine Henri Mondor, Creteil, France.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "Y", "id": "19806217", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Zerbib", "fullName": "Zerbib J", "firstName": "Jennyfer", "initials": "J"}, {"lastName": "Seddon", "fullName": "Seddon JM", "firstName": "Johanna M", "initials": "JM"}, {"lastName": "Richard", "fullName": "Richard F", "firstName": "Florence", "initials": "F"}, {"lastName": "Reynolds", "fullName": "Reynolds R", "firstName": "Robyn", "initials": "R"}, {"lastName": "Leveziel", "fullName": "Leveziel N", "firstName": "Nicolas", "initials": "N"}, {"lastName": "Benlian", "fullName": "Benlian P", "authorId": {"type": "ORCID", "value": "0000-0002-3423-8979"}, "firstName": "Pascale", "initials": "P"}, {"lastName": "Borel", "fullName": "Borel P", "firstName": "Patrick", "initials": "P"}, {"lastName": "Feingold", "fullName": "Feingold J", "firstName": "Josu\u00e9", "initials": "J"}, {"lastName": "Munnich", "fullName": "Munnich A", "firstName": "Arnold", "initials": "A"}, {"lastName": "Soubrane", "fullName": "Soubrane G", "firstName": "Gis\u00e8le", "initials": "G"}, {"lastName": "Kaplan", "fullName": "Kaplan J", "firstName": "Josseline", "initials": "J"}, {"lastName": "Rozet", "fullName": "Rozet JM", "firstName": "Jean-Michel", "initials": "JM"}, {"lastName": "Souied", "fullName": "Souied EH", "firstName": "Eric H", "initials": "EH"}]}, "title": "rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration.", "hasSuppl": "Y", "citedByCount": 21, "source": "MED", "pmid": "19806217", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3423-8979"}, {"type": "ORCID", "value": "0000-0001-8533-9457"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Genetic Predisposition to Disease", "majorTopic_YN": "Y"}, {"descriptorName": "Lutein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Genotype", "majorTopic_YN": "N"}, {"descriptorName": "Heterozygote", "majorTopic_YN": "N"}, {"descriptorName": "Polymorphism, Genetic", "majorTopic_YN": "N"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Middle Aged", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Lipid Metabolism", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "Y"}, {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2009-10-05", "doi": "10.1371/journal.pone.0007341", "isOpenAccess": "Y", "pageInfo": "e7341", "pmcid": "PMC2752725", "hasDbCrossReferences": "Y", "abstractText": "Major genetic factors for age-related macular degeneration (AMD) have recently been identified as susceptibility risk factors, including variants in the CFH gene and the ARMS2 LOC387715/HTRA1locus. Our purpose was to perform a case-control study in two populations among individuals who did not carry risk variants for CFHY402H and LOC387715 A69S (ARMS2), called \"study\" individuals, in order to identify new genetic risk factors. Based on a candidate gene approach, we analyzed SNP rs5888 of the SCARB1 gene, coding for SRBI, which is involved in the lipid and lutein pathways. This study was conducted in a French series of 1241 AMD patients and 297 controls, and in a North American series of 1257 patients with advanced AMD and 1732 controls. Among these individuals, we identified 61 French patients, 77 French controls, 85 North American patients and 338 North American controls who did not carry the CFH nor ARMS2 polymorphisms. An association between AMD and the SCARB1 gene was seen among the study subjects. The genotypic distribution of the rs5888 polymorphism was significantly different between cases and controls in the French population (p<0.006). Heterozygosity at the rs5888 SNP increased risk of AMD compared to the CC genotypes in the French study population (odds ratio (OR) = 3.5, CI95%: 1.4-8.9, p<0.01) and after pooling the 2 populations (OR = 2.9, 95% CI: 1.6-5.3, p<0.002). Subgroup analysis in exudative forms of AMD revealed a pooled OR of 3.6 for individuals heterozygous for rs5888 (95% CI: 1.7-7.6, p<0.0015). These results suggest the possible contribution of SCARB1, a new genetic factor in AMD, and implicate a role for cholesterol and antioxidant micronutrient (lutein and vitamin E) metabolism in AMD.", "electronicPublicationDate": "2009-10-05", "language": "eng", "dateOfCompletion": "2010-03-12", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC2752725?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC2752725", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=19806217", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=19806217&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.1371/journal.pone.0007341", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2013-05-31", "hasBook": "N", "journalInfo": {"printPublicationDate": "2009-01-01", "journal": {"title": "PloS one", "medlineAbbreviation": "PLoS One", "isoabbreviation": "PLoS ONE", "nlmid": "101285081", "essn": "1932-6203"}, "monthOfPublication": 0, "volume": "4", "yearOfPublication": 2009, "journalIssueId": 1653929, "issue": "10", "dateOfPublication": "2009 "}}, "23711372": {"pubYear": "2013", "dateOfCreation": "2013-07-01", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "29343-52-0", "name": "4-hydroxy-2-nonenal"}, {"registryNumber": "0", "name": "Lipids"}, {"registryNumber": "0", "name": "Aldehydes"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}]}, "authorString": "Sticozzi C, Belmonte G, Pecorelli A, Cervellati F, Leoncini S, Signorini C, Ciccoli L, De Felice C, Hayek J, Valacchi G.", "affiliation": "Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "hasPDF": "N", "id": "23711372", "inEPMC": "N", "authorList": {"author": [{"lastName": "Sticozzi", "fullName": "Sticozzi C", "firstName": "Claudia", "initials": "C"}, {"lastName": "Belmonte", "fullName": "Belmonte G", "firstName": "Giuseppe", "initials": "G"}, {"lastName": "Pecorelli", "fullName": "Pecorelli A", "firstName": "Alessandra", "initials": "A"}, {"lastName": "Cervellati", "fullName": "Cervellati F", "authorId": {"type": "ORCID", "value": "0000-0002-0051-2597"}, "firstName": "Franco", "initials": "F"}, {"lastName": "Leoncini", "fullName": "Leoncini S", "authorId": {"type": "ORCID", "value": "0000-0002-7027-1207"}, "firstName": "Silvia", "initials": "S"}, {"lastName": "Signorini", "fullName": "Signorini C", "firstName": "Cinzia", "initials": "C"}, {"lastName": "Ciccoli", "fullName": "Ciccoli L", "firstName": "Lucia", "initials": "L"}, {"lastName": "De Felice", "fullName": "De Felice C", "authorId": {"type": "ORCID", "value": "0000-0002-9881-3119"}, "firstName": "Claudio", "initials": "C"}, {"lastName": "Hayek", "fullName": "Hayek J", "authorId": {"type": "ORCID", "value": "0000-0002-0440-2491"}, "firstName": "Joussef", "initials": "J"}, {"lastName": "Valacchi", "fullName": "Valacchi G", "firstName": "Giuseppe", "initials": "G"}]}, "title": "Scavenger receptor B1 post-translational modifications in Rett syndrome.", "citedByCount": 11, "source": "MED", "pmid": "23711372", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-0051-2597"}, {"type": "ORCID", "value": "0000-0002-7027-1207"}, {"type": "ORCID", "value": "0000-0002-9881-3119"}, {"type": "ORCID", "value": "0000-0002-0440-2491"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cells, Cultured", "majorTopic_YN": "N"}, {"descriptorName": "Fibroblasts", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Rett Syndrome", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Aldehydes", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lipids", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Case-Control Studies", "majorTopic_YN": "N"}, {"descriptorName": "Lipid Peroxidation", "majorTopic_YN": "N"}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "N"}, {"descriptorName": "Adolescent", "majorTopic_YN": "N"}, {"descriptorName": "Adult", "majorTopic_YN": "N"}, {"descriptorName": "Child", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Ubiquitination", "majorTopic_YN": "Y"}, {"descriptorName": "Young Adult", "majorTopic_YN": "N"}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-05-24", "doi": "10.1016/j.febslet.2013.05.042", "isOpenAccess": "N", "pageInfo": "2199-2204", "hasDbCrossReferences": "Y", "abstractText": "The modulation of the HDL receptor scavenger receptor B1 (SRB1) was evaluated in skin fibroblasts isolated from patients with Rett syndrome (RTT), a genetic form of infantile autism. Patients showed an altered plasma lipid profile, while their skin fibroblasts showed a dramatic reduction in SRB1 (immunogold, Western blot and immunohistochemistry). The decreased SRB1 levels were demonstrated to be the consequence of its binding with 4-hydroxy-2-nonenal (4HNE), a product of lipid peroxidation, and its increased ubiquitination. Our findings show for the first time a loss of SRB1 in RTT cells and its relationship with a chronic oxidative stress status.", "electronicPublicationDate": "2013-05-24", "language": "eng", "dateOfCompletion": "2013-09-05", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.febslet.2013.05.042", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-07-01", "journal": {"medlineAbbreviation": "FEBS Lett", "isoabbreviation": "FEBS Lett.", "title": "FEBS letters", "issn": "0014-5793", "nlmid": "0155157", "essn": "1873-3468"}, "monthOfPublication": 7, "volume": "587", "yearOfPublication": 2013, "journalIssueId": 2052274, "issue": "14", "dateOfPublication": "2013 Jul"}}, "26754576": {"pubYear": "2016", "dateOfCreation": "2016-01-12", "pubModel": "Electronic", "authorString": "Goodarzynejad H, Boroumand M, Behmanesh M, Ziaee S, Jalali A.", "affiliation": "Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.", "pubTypeList": {"pubType": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "id": "26754576", "inEPMC": "Y", "authorList": {"author": [{"affiliation": "Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.", "fullName": "Goodarzynejad H", "initials": "H", "firstName": "Hamidreza", "lastName": "Goodarzynejad"}, {"affiliation": "Department of Molecular Pathology, Tehran Heart Center, Tehran University of Medical Sciences, North Karegar Ave.and Jalal-Al-Ahmad cross, Tehran, Iran. maboroumand@yahoo.com.", "fullName": "Boroumand M", "initials": "M", "firstName": "Mohammadali", "lastName": "Boroumand"}, {"affiliation": "Department of Genetics, School of Biological Sciences, Tarbiat Modares University, P.O. Box: 14115-154, Tehran, Iran. behmanesh@modares.ac.ir.", "fullName": "Behmanesh M", "initials": "M", "firstName": "Mehrdad", "lastName": "Behmanesh"}, {"affiliation": "Department of Laboratory Medicine and Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.", "fullName": "Ziaee S", "initials": "S", "firstName": "Shayan", "lastName": "Ziaee"}, {"affiliation": "Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.", "fullName": "Jalali A", "initials": "A", "firstName": "Arash", "lastName": "Jalali"}]}, "title": "The rs5888 single nucleotide polymorphism in scavenger receptor class B type 1 (SCARB1) gene and the risk of premature coronary artery disease: a case-control study.", "hasSuppl": "N", "citedByCount": 0, "source": "MED", "pmid": "26754576", "hasLabsLinks": "N", "tmAccessionTypeList": {"accessionType": ["refsnp"]}, "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "hasPDF": "Y", "inPMC": "N", "hasTMAccessionNumbers": "Y", "hasReferences": "Y", "firstPublicationDate": "2016-01-12", "language": "eng", "doi": "10.1186/s12944-016-0176-9", "isOpenAccess": "Y", "pageInfo": "7", "pmcid": "PMC4709878", "hasDbCrossReferences": "N", "abstractText": "Several single nucleotide polymorphisms (SNPs) in lipid transport genes have been shown to be associated with premature coronary artery disease (PCAD). The scavenger receptor BI (SCARB1) is a key component of the reverse cholesterol transport and lipid metabolism. We aimed to examine the relationship between the rs5888 SNP within SCARB1and the risk of angiographically determined PCAD.We used an age cut-off of 55 years for women and 45 years for men to define PCAD. Five-hundred and five patients with newly diagnosed angiographically documented PCAD (\u2265 50 % luminal stenosis of any coronary vessel) as case group compared with 546 controls (subjects with no luminal stenosis at coronary arteries). The severity of CAD was determined by vessel score as well as Gensini score. A real-time polymerase chain reaction (PCR) and High Resolution Melting (HRM) analysis was used to distinguish between genotypes.T allele as compared to C allele was associated with increased odds of PCAD in total population (adjusted OR = 1.3, 95 % CI = 1.0 to 1.5; p = 0.020), and in women (adjusted OR = 1.3, 95 % CI = 1.0 to 1.8; p = 0.037), but not in men (adjusted OR = 1.2, 95 % CI = 0.9 to 1.5; p = 0.311). There was also no significant association between the examined polymorphism and the severity of CAD in whole or in men or women subgroups.Our findings suggest that the SNP (rs5888) within SCARB1 is independently associated with PCAD in a sex-dependent manner.", "electronicPublicationDate": "2016-01-12", "license": "cc by", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC4709878?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC4709878", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://dx.doi.org/10.1186/s12944-016-0176-9", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "dateOfRevision": "2016-01-14", "hasBook": "N", "journalInfo": {"printPublicationDate": "2016-01-01", "journal": {"title": "Lipids in health and disease", "medlineAbbreviation": "Lipids Health Dis", "isoabbreviation": "Lipids Health Dis", "nlmid": "101147696", "essn": "1476-511X"}, "monthOfPublication": 0, "volume": "15", "yearOfPublication": 2016, "journalIssueId": 2401708, "dateOfPublication": "2016 "}}, "22178419": {"pubYear": "2012", "dateOfCreation": "2012-01-30", "pubModel": "Print-Electronic", "chemicalList": {"chemical": [{"registryNumber": "0", "name": "ATP binding cassette transporter 1"}, {"registryNumber": "59-02-9", "name": "alpha-Tocopherol"}, {"registryNumber": "542-78-9", "name": "Malondialdehyde"}, {"registryNumber": "0", "name": "Apolipoprotein A-I"}, {"registryNumber": "126547-89-5", "name": "Intercellular Adhesion Molecule-1"}, {"registryNumber": "0", "name": "Scavenger Receptors, Class B"}, {"registryNumber": "0", "name": "SCARB1 protein, human"}, {"registryNumber": "0", "name": "Cholesterol, HDL"}]}, "authorString": "Khalil A, Berrougui H, Pawelec G, Fulop T.", "affiliation": "Research Centre on Aging, University of Sherbrooke, Sherbrooke, Quebec, Canada. a.khalil@USherbrooke.ca", "pubTypeList": {"pubType": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "grantsList": {"grant": [{"orderIn": 0, "agency": "Canadian Institutes of Health Research"}]}, "hasPDF": "N", "id": "22178419", "inEPMC": "N", "authorList": {"author": [{"lastName": "Khalil", "fullName": "Khalil A", "firstName": "Abdelouahed", "initials": "A"}, {"lastName": "Berrougui", "fullName": "Berrougui H", "firstName": "Hicham", "initials": "H"}, {"lastName": "Pawelec", "fullName": "Pawelec G", "authorId": {"type": "ORCID", "value": "0000-0002-3600-0163"}, "firstName": "Graham", "initials": "G"}, {"lastName": "Fulop", "fullName": "Fulop T", "firstName": "Tamas", "initials": "T"}]}, "title": "Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease.", "citedByCount": 7, "source": "MED", "pmid": "22178419", "hasLabsLinks": "N", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0002-3600-0163"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Cell Line", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Alzheimer Disease", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Inflammation", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Malondialdehyde", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "alpha-Tocopherol", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "Apolipoprotein A-I", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "N"}]}}, {"descriptorName": "ATP-Binding Cassette Transporters", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Intercellular Adhesion Molecule-1", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}]}}, {"descriptorName": "Gene Expression Regulation", "majorTopic_YN": "N"}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "Y"}, {"descriptorName": "Aged", "majorTopic_YN": "N"}, {"descriptorName": "Aged, 80 and over", "majorTopic_YN": "N"}, {"descriptorName": "Female", "majorTopic_YN": "N"}, {"descriptorName": "Male", "majorTopic_YN": "N"}, {"descriptorName": "Scavenger Receptors, Class B", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cholesterol, HDL", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BL", "qualifierName": "blood", "majorTopic_YN": "Y"}]}}]}, "inPMC": "N", "dbCrossReferenceList": {"dbName": ["UNIPROT"]}, "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2011-12-09", "doi": "10.1016/j.mad.2011.11.008", "isOpenAccess": "N", "pageInfo": "20-29", "hasDbCrossReferences": "Y", "abstractText": "The aim of our study was to investigate the effect of Alzheimer's disease (AD) on the cholesterol efflux capacity and anti-inflammatory activity of HDL. HDL and apoA-I were isolated from 20 healthy subjects and from 39 AD patients. Our results showed that serum- and HDL-mediated cholesterol efflux is significantly impaired in AD patients. This impairment of serum and HDL cholesterol efflux capacity was significantly inversely correlated to the AD severity as evaluated by MMSE scores. Results obtained from SR-BI-enriched Fu5AH and ABCA1-enriched J774 cells revealed that AD impaired the interaction of HDL and apoA-I with both the ABCA1 transporter and SR-BI receptor. Purified apoA-I from AD patients also failed to remove free excess cholesterol from ABCA1-enriched J774 macrophages. Interestingly, the decrease in plasma \u03b1-tocopherol content and the increase in MDA formation and HDL relative electrophoretic mobility indicated that AD patients had higher levels of oxidative stress. The anti-inflammatory activity of HDL was also significantly lower in AD patients as measured by the level of ICAM-1 expression. In conclusion, our study provides evidence for the first time that the functionality of HDL is impaired in AD and that this alteration might be caused by AD-associated oxidative stress and inflammation.", "electronicPublicationDate": "2011-12-09", "language": "eng", "dateOfCompletion": "2012-05-23", "fullTextUrlList": {"fullTextUrl": [{"url": "http://dx.doi.org/10.1016/j.mad.2011.11.008", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "N", "hasBook": "N", "journalInfo": {"printPublicationDate": "2012-01-01", "journal": {"medlineAbbreviation": "Mech Ageing Dev", "isoabbreviation": "Mech. Ageing Dev.", "title": "Mechanisms of ageing and development", "issn": "0047-6374", "nlmid": "0347227", "essn": "1872-6216"}, "monthOfPublication": 1, "volume": "133", "yearOfPublication": 2012, "journalIssueId": 1900068, "issue": "1", "dateOfPublication": "2012 Jan"}}, "23698168": {"pubYear": "2013", "dateOfCreation": "2013-05-23", "pubModel": "Electronic", "chemicalList": {"chemical": [{"registryNumber": "144-68-3", "name": "zeaxanthin"}, {"registryNumber": "127-40-2", "name": "Lutein"}, {"registryNumber": "0", "name": "Reactive Oxygen Species"}, {"registryNumber": "0", "name": "Xanthophylls"}]}, "authorString": "Koushan K, Rusovici R, Li W, Ferguson LR, Chalam KV.", "affiliation": "Department of Ophthalmology, University of Florida, 580 West 8th Street, Tower II, 3rd Fl., Jacksonville, FL 32209, USA. Keyvan.Koushan@jax.ufl.edu", "pubTypeList": {"pubType": ["Journal Article", "Review"]}, "hasPDF": "Y", "id": "23698168", "inEPMC": "Y", "authorList": {"author": [{"lastName": "Koushan", "fullName": "Koushan K", "firstName": "Keyvan", "initials": "K"}, {"lastName": "Rusovici", "fullName": "Rusovici R", "firstName": "Raluca", "initials": "R"}, {"lastName": "Li", "fullName": "Li W", "firstName": "Wenhua", "initials": "W"}, {"lastName": "Ferguson", "fullName": "Ferguson LR", "firstName": "Lee R", "initials": "LR"}, {"lastName": "Chalam", "fullName": "Chalam KV", "authorId": {"type": "ORCID", "value": "0000-0001-9325-8665"}, "firstName": "Kakarla V", "initials": "KV"}]}, "title": "The role of lutein in eye-related disease.", "hasSuppl": "N", "citedByCount": 9, "source": "MED", "pmid": "23698168", "hasLabsLinks": "Y", "subsetList": {"subset": [{"code": "IM", "name": "Index Medicus"}]}, "authorIdList": {"authorId": [{"type": "ORCID", "value": "0000-0001-9325-8665"}]}, "meshHeadingList": {"meshHeading": [{"descriptorName": "Animals", "majorTopic_YN": "N"}, {"descriptorName": "Humans", "majorTopic_YN": "N"}, {"descriptorName": "Eye Diseases", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DH", "qualifierName": "diet therapy", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Cataract", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DH", "qualifierName": "diet therapy", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Macular Degeneration", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DH", "qualifierName": "diet therapy", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"descriptorName": "Reactive Oxygen Species", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"descriptorName": "Xanthophylls", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Lutein", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"descriptorName": "Oxidative Stress", "majorTopic_YN": "Y"}, {"descriptorName": "Aging", "majorTopic_YN": "N"}, {"descriptorName": "Light", "majorTopic_YN": "N", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}]}}]}, "inPMC": "Y", "hasTMAccessionNumbers": "N", "hasReferences": "Y", "firstPublicationDate": "2013-05-22", "language": "eng", "doi": "10.3390/nu5051823", "isOpenAccess": "Y", "pageInfo": "1823-1839", "pmcid": "PMC3708350", "hasDbCrossReferences": "N", "abstractText": "The lens and retina of the human eye are exposed constantly to light and oxygen. In situ phototransduction and oxidative phosphorylation within photoreceptors produces a high level of phototoxic and oxidative related stress. Within the eye, the carotenoids lutein and zeaxanthin are present in high concentrations in contrast to other human tissues. We discuss the role of lutein and zeaxanthin in ameliorating light and oxygen damage, and preventing age-related cellular and tissue deterioration in the eye. Epidemiologic research shows an inverse association between levels of lutein and zeaxanthin in eye tissues and age related degenerative diseases such as macular degeneration (AMD) and cataracts. We examine the role of these carotenoids as blockers of blue-light damage and quenchers of oxygen free radicals. This article provides a review of possible mechanisms of lutein action at a cellular and molecular level. Our review offers insight into current clinical trials and experimental animal studies involving lutein, and possible role of nutritional intervention in common ocular diseases that cause blindness.", "electronicPublicationDate": "2013-05-22", "license": "cc by", "dateOfCompletion": "2013-11-04", "fullTextUrlList": {"fullTextUrl": [{"url": "http://europepmc.org/articles/PMC3708350?pdf=render", "documentStyle": "pdf", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://europepmc.org/articles/PMC3708350", "documentStyle": "html", "availability": "Open access", "availabilityCode": "OA", "site": "Europe_PMC"}, {"url": "http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=23698168", "documentStyle": "html", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=23698168&action=stream&blobtype=pdf", "documentStyle": "pdf", "availability": "Free", "availabilityCode": "F", "site": "PubMedCentral"}, {"url": "http://dx.doi.org/10.3390/nu5051823", "documentStyle": "doi", "availability": "Subscription required", "availabilityCode": "S", "site": "DOI"}]}, "hasTextMinedTerms": "Y", "hasBook": "N", "journalInfo": {"printPublicationDate": "2013-05-01", "journal": {"title": "Nutrients", "medlineAbbreviation": "Nutrients", "isoabbreviation": "Nutrients", "nlmid": "101521595", "essn": "2072-6643"}, "monthOfPublication": 5, "volume": "5", "yearOfPublication": 2013, "journalIssueId": 2048113, "issue": "5", "dateOfPublication": "2013 May"}}}}